Androgen antagonistic effect of estramustine phosphate ( EMP ) metabolites on wild - type and mutated androgen receptor .
【GOLD_E】
Androgen	chem
estramustinephosphate	chem
EMP	chem
androgen	chem▼
androgenreceptor	geneY
【PRE_E】#嵌套实体
Androgen	chem
estramustinephosphate	chem
EMP	chem
androgenreceptor	geneY
【GOLD_R】
Androgen	androgenreceptor	C6▼
estramustinephosphate	androgenreceptor	C6▼
EMP	androgenreceptor	C6▼
【PRE_R】#少预测*3

Estramustine phosphate is used frequently , alone or in combination with other antitumor agents , for the treatment of hormone - refractory prostate cancer .
【GOLD_E】
Estramustinephosphate	chem
【PRE_E】
Estramustinephosphate	chem
【GOLD_R】
【PRE_R】

Estramustine phosphate is metabolically activated in vivo , and its metabolites , estramustine , estromustine , estrone , and beta - estradiol inhibit the assembly of microtubules [ for review see : Kreis W , In : Concepts , Mechanisms , and New Targets for Chemotherapy ( Ed .
【GOLD_E】
Estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
beta-estradiol	chem
【PRE_E】#预测错误*1
Estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
beta-estradiol	chem
microtubules	geneN▼
【GOLD_R】
【PRE_R】

Muggia FM ) , pp .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

163 - 184 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Kluwer Academic Publishers , Boston , 1995 ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We investigated , by displacement of [ 3H ] methyltrienolone in the presence of 2.5 mM of triamcinolone acetonide , the binding of estramustine phosphate and its metabolites , estramustine , estromustine , estrone , and beta - estradiol , as well as other antiandrogen agents including alpha - estradiol , bicalutamide , and hydroxyflutamide , to the mutated androgen receptor ( m - AR ) in LNCaP cells and to the wild - type androgen receptor in wild - type AR cDNA expression plasmid ( w - pAR0 ) cDNA - transfected HeLa cells .
【GOLD_E】
[3H]methyltrienolone	chem
triamcinoloneacetonide	chem
estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
beta-estradiol	chem
alpha-estradiol	chem
bicalutamide	chem
hydroxyflutamide	chem
androgen	chem▼
androgen	chem▼
androgenreceptor	geneY
AR	geneY
androgenreceptor	geneY
AR	geneY
【PRE_E】#重叠实体*2 边界错误*1
[3H]methyltrienolone	chem
triamcinoloneacetonide	chem
estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
beta-estradiol	chem
alpha-estradiol	chem
bicalutamide	chem
hydroxyflutamide	chem
androgenreceptor	geneY
m-AR	geneY▼
androgenreceptor	geneY
AR	geneY
【GOLD_R】
【PRE_R】
bicalutamide	m-AR	C4
hydroxyflutamide	m-AR	C4
hydroxyflutamide	AR	C4

Analogous to the antiandrogens , bicalutamide and hydroxyflutamide , binding of estramustine phosphate metabolites to the androgen receptor was observed .
【GOLD_E】
bicalutamide	chem
hydroxyflutamide	chem
androgenreceptor	geneY
estramustinephosphate	chem
androgen	chem▼
【PRE_E】#重叠实体*1 标注错误*1
antiandrogens	chem▼
bicalutamide	chem
hydroxyflutamide	chem
estramustinephosphate	chem
androgenreceptor	geneY
【GOLD_R】
【PRE_R】

The EC50 values ( in microM ) were : estramustine phosphate , > 10 ; estramustine , 3.129 + / - 0.312 ; estromustine ; 2.612 + / - 0.584 ; estrone , 0.800 + / - 0.090 ; alpha - estradiol , 1.051 + / - 0.096 ; beta - estradiol , 0.523 + / - 0.028 ; bicalutamide , 4.920 + / - 0.361 ; and hydroxyflutamide , 0.254 + / - 0.012 .
【GOLD_E】
alpha-estradiol	chem
beta-estradiol	chem
bicalutamide	chem
hydroxyflutamide	chem
estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
【PRE_E】#预测错误*1
estramustinephosphate	chem
estramustine	chem
estromustine	chem
estrone	chem
alpha-estradiol	chem
1.051+/-0.096	chem▼
beta-estradiol	chem
bicalutamide	chem
hydroxyflutamide	chem
【GOLD_R】
【PRE_R】

The transactivation assay demonstrated that , analogous to bicalutamide , estramustine could not induce luciferase activity in either w - pAR0 or m - pARL transfected HeLa cells .
【GOLD_E】
bicalutamide	chem
estramustine	chem
【PRE_E】#预测错误*1
bicalutamide	chem
estramustine	chem
m-pARL	geneY▼
【GOLD_R】
【PRE_R】

In contrast , a strong induction of the reporter activity by dihydrotestosterone was observed .
【GOLD_E】
dihydrotestosterone	chem
【PRE_E】
dihydrotestosterone	chem
【GOLD_R】
【PRE_R】

Down - regulation of prostate - specific antigen ( PSA ) expression , an AR - target gene , by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor .
【GOLD_E】
estramustine	chem
bicalutamide	chem
androgen	chem▼
prostate-specificantigen	geneY
PSA	geneY
AR	geneY
androgenreceptor	geneY
【PRE_E】#重叠实体*1
prostate-specificantigen	geneY
PSA	geneY
AR	geneY
estramustine	chem
bicalutamide	chem
androgenreceptor	geneY
【GOLD_R】
estramustine	prostate-specificantigen	C4
estramustine	PSA	C4
estramustine	AR	C4
bicalutamide	prostate-specificantigen	C4▼
bicalutamide	PSA	C4▼
bicalutamide	AR	C4
estramustine	androgenreceptor	C4▼
bicalutamide	androgenreceptor	C4▼
【PRE_R】#由于抽取方式损失了2个关系，由于距离过长androgenreceptor未被预测出关系
prostate-specificantigen	estramustine	C4
PSA	estramustine	C4
AR	estramustine	C4
AR	bicalutamide	C4

Exposure of LNCaP cells to estramustine for 24 hr caused transcriptional inhibition of PSA in a concentration - dependent manner .
【GOLD_E】
estramustine	chem
PSA	geneY
【PRE_E】
estramustine	chem
PSA	geneY
【GOLD_R】
estramustine	PSA	C4
【PRE_R】
estramustine	PSA	C4

The levels of PSA mRNA decreased 56 and 90 % when LNCaP cells were treated with 5 and 10 microM of estramustine , respectively ( IC50 = 10.97 + / - 1.68 microM ) .
【GOLD_E】
estramustine	chem
PSA	geneY
【PRE_E】
PSA	geneY
estramustine	chem
【GOLD_R】
estramustine	PSA	C4
【PRE_R】
PSA	estramustine	C4

Binding of hydroxyflutamide to m - AR in LNCaP cells resulted in a concentration - dependent stimulation of PSA expression , suggesting that hydroxyflutamide acted as an agonist of the m - AR .
【GOLD_E】
hydroxyflutamide	chem
hydroxyflutamide	chem
AR	geneY
PSA	geneY
AR	geneY
【PRE_E】#边界错误*2
hydroxyflutamide	chem
m-AR	geneY▼
PSA	geneY
hydroxyflutamide	chem
m-AR	geneY▼
【GOLD_R】
hydroxyflutamide	PSA	C3
hydroxyflutamide	AR	C5
【PRE_R】#关系类别错误*1，边界错误*1，预测错误*1
hydroxyflutamide	m-AR	C4
hydroxyflutamide	PSA	C4
hydroxyflutamide	m-AR	C5

Our data indicate that estramustine phosphate metabolites perform as androgen antagonists of AR , an additional mechanism involved in the therapeutic effect of estramustine phosphate in patients with prostate cancer .
【GOLD_E】
estramustinephosphate	chem
androgen	chem
estramustinephosphate	chem
AR	geneY
【PRE_E】
estramustinephosphate	chem
androgen	chem
AR	geneY
estramustinephosphate	chem
【GOLD_R】
estramustinephosphate	AR	C6
androgen	AR	C6
【PRE_R】#少预测*2

Static Laue diffraction studies on acetylcholinesterase .
【GOLD_E】
acetylcholinesterase	geneY
【PRE_E】
acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Acetylcholinesterase ( AChE ) is one of nature 's fastest enzymes , despite the fact that its three - dimensional structure reveals its active site to be deeply sequestered within the molecule .
【GOLD_E】
Acetylcholinesterase	geneY
AChE	geneY
【PRE_E】
Acetylcholinesterase	geneY
AChE	geneY
【GOLD_R】
【PRE_R】

This raises questions with respect to traffic of substrate to , and products from , the active site , which may be investigated by time - resolved crystallography .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In order to address one aspect of the feasibility of performing time - resolved studies on AChE , a data set has been collected using the Laue technique on a trigonal crystal of Torpedo californica AChE soaked with the reversible inhibitor edrophonium , using a total X - ray exposure time of 24 ms .
【GOLD_E】
edrophonium	chem
AChE	geneY
TorpedocalifornicaAChE	geneY
【PRE_E】
AChE	geneY
TorpedocalifornicaAChE	geneY
edrophonium	chem
【GOLD_R】
edrophonium	TorpedocalifornicaAChE	C4
【PRE_R】#少预测*1

Electron - density maps obtained from the Laue data , which are of surprisingly good quality compared with similar maps from monochromatic data , show essentially the same features .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

They clearly reveal the bound ligand , as well as a structural change in the conformation of the active - site Ser200 induced upon binding .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synthesis of thrombin - inhibiting heparin mimetics without side effects .
【GOLD_E】
thrombin	geneY
【PRE_E】
thrombin	geneY
【GOLD_R】
【PRE_R】

Unwanted side effects of pharmacologically active compounds can usually be eliminated by structural modifications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

But the complex heterogeneous structure of the polysaccharide heparin has limited this approach to fragmentation , leading to slightly better - tolerated heparin preparations of low molecular mass .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Despite this improvement , heparin - induced thrombocytopaenia ( HIT ) , related to an interaction with platelet factor 4 ( PF4 ) and , to a lesser extent , haemorrhages , remain significant side effects of heparinotherapy .
【GOLD_E】
plateletfactor4	geneY
PF4	geneY
【PRE_E】#预测错误*1
plateletfactor4	geneY
PF4	geneY
heparinotherapy	chem▼
【GOLD_R】
【PRE_R】

Breakthroughs in oligosaccharide chemistry made possible the total synthesis of the pentasaccharide antithrombin - binding site of heparin .
【GOLD_E】
antithrombin	geneY
【PRE_E】#边界错误*1
pentasaccharideantithrombin-bindingsite	geneN▼
【GOLD_R】
【PRE_R】

This pentasaccharide represents a new family of potential antithrombotic drugs , devoid of thrombin inhibitory properties , and free of undesired interactions with blood and vessel components .
【GOLD_E】
thrombin	geneY
【PRE_E】#标注错误*1
pentasaccharide	chem▼
thrombin	geneY
【GOLD_R】
【PRE_R】

To obtain more potent and well - tolerated antithrombotic drugs , we wished to synthesize heparin mimetics able to inhibit thrombin , that is , longer oligosaccharides .
【GOLD_E】
thrombin	geneY
【PRE_E】
thrombin	geneY
【GOLD_R】
【PRE_R】

Like thrombin inhibition , undesired interactions are directly correlated to the charge and the size of the molecules , so we had to design structures that were able to discriminate between thrombin and other proteins , particularly PF4 .
【GOLD_E】
thrombin	geneY
thrombin	geneY
PF4	geneY
【PRE_E】
thrombin	geneY
thrombin	geneY
PF4	geneN
【GOLD_R】
【PRE_R】

Here we describe the use of multistep converging synthesis to obtain sulphated oligosaccharides that meet these requirements .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites .
【GOLD_E】
prostaglandin	chem
cyclooxygenase2	geneY
【PRE_E】
cyclooxygenase2	geneY
prostaglandin	chem
【GOLD_R】
prostaglandin	cyclooxygenase2	C9▼
【PRE_R】#预测少*1

BACKGROUND & AIMS : The critical role of cyclooxygenase ( COX ) products in maintenance of renal function in cirrhosis with ascites discourages the use of nonsteroidal anti - inflammatory drugs in this disease .
【GOLD_E】
cyclooxygenase	geneN
COX	geneN
【PRE_E】
cyclooxygenase	geneN
COX	geneN
【GOLD_R】
【PRE_R】

The recent development of selective COX - 2 inhibitors opens new avenues for the use of these compounds in decompensated cirrhosis .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

The current study evaluates the effects of a selective COX - 2 inhibitor ( SC - 236 ) on renal function in cirrhotic rats with ascites .
【GOLD_E】
COX-2	geneY
SC-236	chem
【PRE_E】
COX-2	geneY
SC-236	chem
【GOLD_R】
SC-236	COX-2	C4
【PRE_R】
COX-2	SC-236	C4

METHODS : In protocol 1 , urine volume , urinary excretion of sodium and prostaglandins , glomerular filtration rate , and renal plasma flow were measured before and after administration of SC - 236 ( n = 12 ) or ketorolac ( n = 10 ) to rats with cirrhosis .
【GOLD_E】
sodium	chem
prostaglandins	chem
SC-236	chem
ketorolac	chem
【PRE_E】
sodium	chem
prostaglandins	chem
SC-236	chem
ketorolac	chem
【GOLD_R】
【PRE_R】

Protocol 2 was aimed at assessing the effects of COX inhibitors on renal water metabolism in 28 cirrhotic rats .
【GOLD_E】
COX	geneN
【PRE_E】
COX	geneN
【GOLD_R】
【PRE_R】

RESULTS : Administration of SC - 236 to cirrhotic animals did not produce significant renal effects , whereas administration of the nonselective COX - 1 / COX - 2 inhibitor , ketorolac , resulted in a marked reduction in urine volume , urinary excretion of prostaglandins , and glomerular filtration rate and in a significant impairment in renal water metabolism .
【GOLD_E】
COX-1	geneY
COX-2	geneY
prostaglandins	chem
SC-236	chem
ketorolac	chem
【PRE_E】
SC-236	chem
COX-1	geneY
COX-2	geneY
ketorolac	chem
prostaglandins	chem
【GOLD_R】
ketorolac	COX-1	C4▼
ketorolac	COX-2	C4
prostaglandins	COX-1	C9▼
prostaglandins	COX-2	C9▼
【PRE_R】#少预测*3 预测错误*1
SC-236	COX-1	C4▼
COX-2	ketorolac	C4

CONCLUSIONS : These findings indicate that SC - 236 does not significantly impair renal function in rats with cirrhosis .
【GOLD_E】
SC-236	chem
【PRE_E】
SC-236	chem
【GOLD_R】
【PRE_R】

Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils .
【GOLD_E】
leukotrieneC4	chem
fluticasonepropionate	chem
cPLA2	geneY
【PRE_E】
cPLA2	geneY
leukotrieneC4	chem
fluticasonepropionate	chem
【GOLD_R】
fluticasonepropionate	cPLA2	C4▼
【PRE_R】#少预测*1

We examined the effect of the highly lipophilic corticosteroid , fluticasone propionate ( FP ) , in causing ( 1 ) inhibition of nuclear translocation of cytosolic phospholipase A2 ( cPLA2 ) , and ( 2 ) blockade of leukotriene C4 ( LTC4 ) synthesis in isolated human eosinophils in vitro .
【GOLD_E】
LTC4	chem
fluticasonepropionate	chem
FP	chem
cytosolicphospholipaseA2	geneY
cPLA2	geneY
leukotrieneC4	chem
【PRE_E】
corticosteroid	chem
fluticasonepropionate	chem
FP	chem
cytosolicphospholipaseA2	geneY
cPLA2	geneY
leukotrieneC4	chem
LTC4	chem
【GOLD_R】
【PRE_R】
corticosteroid	cytosolicphospholipaseA2	C4
fluticasonepropionate	cytosolicphospholipaseA2	C4
FP	cytosolicphospholipaseA2	C4
FP	cPLA2	C4

Eosinophils were isolated from peripheral blood , treated with either buffer or 10 ( - ) 10 M to 10 ( - ) 6 M FP in the presence of 10 pg / ml human recombinant interleukin - 5 ( rhIL - 5 ) and activated with formyl - met - leu - phe ( FMLP ) + cytochalasin B ( CB ) .
【GOLD_E】
FP	chem
formyl-met-leu-phe	chem
FMLP	chem
cytochalasinB	chem
CB	chem
humanrecombinantinterleukin-5	geneY
rhIL-5	geneY
【PRE_E】
humanrecombinantinterleukin-5	geneY
rhIL-5	geneY
formyl-met-leu-phe	chem
FMLP	chem
cytochalasinB	chem
【GOLD_R】
【PRE_R】

At 24 h , stimulated LTC4 secretion from eosinophils was unchanged ; however , when corrected for cell viability , LTC4 secretion decreased from 1,429 + / - 327 pg / 10 ( 6 ) cells to 762 + / - 113 pg / 10 ( 6 ) cells for eosinophils treated for 48 h with > / = 10 ( - ) 8 M FP ( p < 0.003 ) .
【GOLD_E】
LTC4	chem
LTC4	chem
FP	chem
【PRE_E】
LTC4	geneY
【GOLD_R】
【PRE_R】

FMLP / CB - stimulated translocation of cPLA2 to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by FP .
【GOLD_E】
FMLP	chem
CB	chem
FP	chem
cPLA2	geneY
【PRE_E】
FMLP	chem
cPLA2	geneY
FP	chem
【GOLD_R】
FP	cPLA2	C4
【PRE_R】
cPLA2	FP	C3

By contrast , membrane expression of annexin - 1 , which was not minimal at 30 min , was substantial at 48 h for eosinophils treated with > 10 ( - ) 10 M FP , and inhibition of LTC4 synthesis was reversed by exogenous arachidonic acid ( AA ) .
【GOLD_E】
FP	chem
LTC4	chem
annexin-1	geneY
arachidonicacid	chem
AA	chem
【PRE_E】
annexin-1	geneY
LTC4	geneY
arachidonicacid	chem
【GOLD_R】
【PRE_R】

We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 ( PLA2 ) .
【GOLD_E】
phospholipaseA2	geneY
PLA2	geneY
FP	chem
LTC4	chem
【PRE_E】
FP	geneY
LTC4	chem
phospholipaseA2	geneY
PLA2	geneY
【GOLD_R】
FP	phospholipaseA2	C4
LTC4	phospholipaseA2	C9
LTC4	PLA2	C9
【PRE_R】
FP	LTC4	C3
LTC4	PLA2	C3

Inhibition of LTC4 synthesis precedes the global cytotoxic effects of FP as indicated by the simultaneous upregulation of annexin - 1 expression .
【GOLD_E】
annexin-1	geneY
LTC4	chem
FP	chem
【PRE_E】
LTC4	chem
FP	chem
annexin-1	geneY
【GOLD_R】
FP	annexin-1	C3
【PRE_R】
FP	annexin-1	C3

Inhibited stimulated secretion corresponds to inhibited translocation of cPLA2 to the nuclear envelope during cellular activation .
【GOLD_E】
cPLA2	geneY
【PRE_E】
cPLA2	geneY
【GOLD_R】
【PRE_R】

Desipramine treatment decreases 3H - nisoxetine binding and norepinephrine transporter mRNA in SK - N - SHSY5Y cells .
【GOLD_E】
norepinephrinetransporter	geneY
Desipramine	chem
3H-nisoxetine	chem
norepinephrine	chem
【PRE_E】
Desipramine	chem
3H-nisoxetine	chem
norepinephrinetransporter	geneY
【GOLD_R】
Desipramine	norepinephrinetransporter	C4
【PRE_R】

The antidepressant desipramine has been shown to decrease synaptic membrane concentrations of the norepinephrine re - uptake transporter ( NET ) in vivo and in vitro , on both an acute and a chronic basis .
【GOLD_E】
NET	geneY
norepinephrinere-uptaketransporter	geneY
desipramine	chem
norepinephrine	chem
【PRE_E】
desipramine	chem
norepinephrinere-uptaketransporter	geneY
NET	geneY
【GOLD_R】
desipramine	NET	C4
desipramine	norepinephrinere-uptaketransporter	C4
【PRE_R】
desipramine	NET	C4

The possible contribution of decreased NET synthesis to the chronic downregulation of the NETs has not been definitively established .
【GOLD_E】
NET	geneY
NETs	geneY
【PRE_E】
NET	geneY
【GOLD_R】
【PRE_R】

In this study , we treated SK - N - SHSY5Y cells with 100 nM desipramine for 24 or 72 h , and measured 3H - nisoxetine binding ( as an estimate of NETs ) and NET mRNA by quantitative reverse transcription polymerase chain reaction .
【GOLD_E】
NETs	geneY
NET	geneY
desipramine	chem
3H-nisoxetine	chem
【PRE_E】
desipramine	chem
3H-nisoxetine	chem
NET	geneY
【GOLD_R】
【PRE_R】

Similar to what has been reported previously , membrane 3H - nisoxetine binding was significantly decreased at both 24 and 72 h ( approximately 50 % at both time points ) .
【GOLD_E】
3H-nisoxetine	chem
【PRE_E】
3H-nisoxetine	chem
【GOLD_R】
【PRE_R】

However , a significant decrease ( 64 + / - 8 % of paired control ) of NET mRNA was observed only at the 72 - h time point .
【GOLD_E】
NET	geneY
【PRE_E】
NET	geneY
【GOLD_R】
【PRE_R】

We conclude that decreased NET synthesis may contribute to the chronic , but not acute , effect of desipramine to downregulate the NET .
【GOLD_E】
NET	geneY
NET	geneY
desipramine	chem
【PRE_E】
NET	geneY
desipramine	chem
NET	geneY
【GOLD_R】
desipramine	NET	C4
【PRE_R】
NET	desipramine	C4
desipramine	NET	C4

Inhibition of the human ether - a - go - go - related gene ( HERG ) potassium channel by cisapride : affinity for open and inactivated states .
【GOLD_E】
ether	chem
potassium	chem
cisapride	chem
humanether-a-go-go-relatedgene(HERG)potassiumchannel	geneY
【PRE_E】
humanether-a-go-go-relatedgene(HERG	geneY
potassiumchannel	geneN
cisapride	chem
【GOLD_R】
cisapride	humanether-a-go-go-relatedgene(HERG)potassiumchannel	C4
【PRE_R】

1 Cisapride is a prokinetic agent which has been associated with QT prolongation , torsades de pointes and cardiac arrest .
【GOLD_E】
Cisapride	chem
【PRE_E】
Cisapride	chem
【GOLD_R】
【PRE_R】

The cellular mechanism for these observations is high affinity blockade of IKr ( encoded by HERG ) .
【GOLD_E】
IKr	geneN
HERG	geneY
【PRE_E】
IKr	geneY
HERG	geneY
【GOLD_R】
【PRE_R】

2 In a chronic transfection model using CHO - K1 cells , cisapride inhibited HERG tail currents after a step to + 25 mV with similar potency at room and physiological temperatures ( IC50 16 .
【GOLD_E】
HERG	geneY
cisapride	chem
【PRE_E】
cisapride	chem
HERG	geneY
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
cisapride	HERG	C4

4 nM at 20 - 22 degrees C and 23.6 nM at 37 degrees C ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

3 Channel inhibition exhibited time - , voltage - and frequency - dependence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In an envelope of tails test , channel blockade increased from 27 + / - 8 % after a 120 ms depolarizing step to 50 + / - 4 % after a 1.0 s step .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These findings suggested affinity for open and / or inactivated channel states .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

4 Inactivation was significantly accelerated by cisapride in a concentration - dependent manner and there was a small ( - 7 mV ) shift in the voltage dependence of steady state inactivation .
【GOLD_E】
cisapride	chem
【PRE_E】
cisapride	chem
【GOLD_R】
【PRE_R】

5 Channel blockade by cisapride was modulated by [ K + ] o , with a 26 % reduction in the potency of channel blockade when [ K + ] o was increased from 1 to 10 mM .
【GOLD_E】
K+	chem
cisapride	chem
K+	chem
【PRE_E】
5Channel	geneN
cisapride	chem
[K+]o	chem
[K+]o	chem
【GOLD_R】
【PRE_R】

6 In conclusion , HERG channel inhibition by cisapride exhibits features consistent with open and inactivated state binding and is sensitive to external potassium concentration .
【GOLD_E】
HERG	geneY
cisapride	chem
potassium	chem
【PRE_E】
HERG	geneY
cisapride	chem
potassium	chem
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
HERG	cisapride	C4

These features may have significant clinical implications with regard to the mechanism and treatment of cisapride - induced proarrhythmia .
【GOLD_E】
cisapride	chem
【PRE_E】
cisapride	chem
【GOLD_R】
【PRE_R】

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine : inhibition of dorsal raphe cell firing and the role of 5 - HT1A receptor activation .
【GOLD_E】
ziprasidone	chem
clozapine	chem
olanzapine	chem
5-HT1Areceptor	geneY
【PRE_E】
ziprasidone	chem
clozapine	chem
olanzapine	chem
5-HT1A	geneY
【GOLD_R】
【PRE_R】

Ziprasidone is a novel antipsychotic agent which binds with high affinity to 5 - HT1A receptors ( Ki = 3.4 nM ) , in addition to 5 - HT1D , 5 - HT2 , and D2 sites .
【GOLD_E】
Ziprasidone	chem
5-HT1D	geneY
5-HT2	geneY
D2	geneY
5-HT1Areceptors	geneY
【PRE_E】
Ziprasidone	chem
5-HT1A	geneY
5-HT1D	geneY
5-HT2	geneY
D2	geneY
【GOLD_R】
【PRE_R】

While it is an antagonist at these latter receptors , ziprasidone behaves as a 5 - HT1A agonist in vitro in adenylate cyclase measurements .
【GOLD_E】
ziprasidone	chem
adenylate	chem
5-HT1A	geneY
adenylatecyclase	geneN
【PRE_E】
ziprasidone	chem
5-HT1A	geneY
adenylatecyclase	geneN
【GOLD_R】
ziprasidone	5-HT1A	C5
【PRE_R】

The goal of the present study was to examine the 5 - HT1A properties of ziprasidone in vivo using as a marker of central 5 - HT1A activity the inhibition of firing of serotonin - containing neurons in the dorsal raphe nucleus .
【GOLD_E】
ziprasidone	chem
serotonin	chem
5-HT1A	geneY
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
ziprasidone	chem
5-HT1A	geneY
serotonin	chem
【GOLD_R】
【PRE_R】

In anesthetized rats , ziprasidone dose - dependently slowed raphe unit activity ( ED50 = 300 micrograms / kg i.v . ) as did the atypical antipsychotics clozapine ( ED50 = 250 micrograms / kg i.v . ) and olanzapine ( ED50 = 1000 micrograms / kg i.v . ) .
【GOLD_E】
ziprasidone	chem
clozapine	chem
olanzapine	chem
【PRE_E】
ziprasidone	chem
clozapine	chem
olanzapine	chem
【GOLD_R】
【PRE_R】

Pretreatment with the 5 - HT1A antagonist WAY - 100,635 ( 10 micrograms / kg i.v . ) prevented the ziprasidone - induced inhibition ; the same dose of WAY - 100,635 had little effect on the inhibition produced by clozapine and olanzapine .
【GOLD_E】
WAY-100,635	chem
ziprasidone	chem
WAY-100,635	chem
clozapine	chem
olanzapine	chem
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
WAY-100,635	chem
ziprasidone	chem
WAY-100,635	chem
clozapine	chem
olanzapine	chem
【GOLD_R】
WAY-100,635	5-HT1A	C6
WAY-100,635	5-HT1A	C6
【PRE_R】

Because all three agents also bind to alpha 1 receptors , antagonists of which inhibit serotonin neuronal firing , this aspect of their pharmacology was assessed with desipramine ( DMI ) , a NE re - uptake blocker previously shown to reverse the effects of alpha 1 antagonists on raphe unit activity .
【GOLD_E】
alpha1receptors	geneN
serotonin	chem
desipramine	chem
DMI	chem
NE	chem
【PRE_E】
alpha1receptors	geneN
serotonin	chem
desipramine	chem
DMI	chem
NE	chem
alpha1	geneY
【GOLD_R】
【PRE_R】

DMI ( 5 mg / kg i.v . ) failed to reverse the inhibitory effect of ziprasidone but produced nearly complete reversal of that of clozapine and olanzapine .
【GOLD_E】
DMI	chem
ziprasidone	chem
clozapine	chem
olanzapine	chem
【PRE_E】
DMI	chem
ziprasidone	chem
clozapine	chem
olanzapine	chem
【GOLD_R】
【PRE_R】

These profiles suggest a mechanism of action for each agent , 5 - HT1A agonism for ziprasidone and alpha 1 antagonism for clozapine and olanzapine .
【GOLD_E】
ziprasidone	chem
clozapine	chem
olanzapine	chem
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
ziprasidone	chem
clozapine	chem
olanzapine	chem
【GOLD_R】
ziprasidone	5-HT1A	C5
【PRE_R】
5-HT1A	clozapine	C5
5-HT1A	olanzapine	C5

The 5 - HT1A agonist activity reported here clearly distinguishes ziprasidone from currently available antipsychotic agents and suggests that this property may play a significant role in its pharmacologic actions .
【GOLD_E】
ziprasidone	chem
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
ziprasidone	chem
【GOLD_R】
ziprasidone	5-HT1A	C5
【PRE_R】
5-HT1A	ziprasidone	C5

Reduction of oral ethanol self - administration in rats by monoamine oxidase inhibitors .
【GOLD_E】
ethanol	chem
monoamine	chem
monoamineoxidase	geneN
【PRE_E】
ethanol	chem
monoamineoxidase	geneN
【GOLD_R】
【PRE_R】

Evidence for a role of dopamine and serotonin in the control of ethanol intake in animals suggests that monoamine oxidase ( MAO ) inhibitors , which increase the synaptic availability of serotonin and dopamine by blocking their metabolism , might have efficacy in the treatment of alcohol dependence .
【GOLD_E】
serotonin	chem
dopamine	chem
dopamine	chem
alcohol	chem
serotonin	chem
ethanol	chem
monoamineoxidase	geneN
MAO	geneN
monoamine	chem
【PRE_E】
dopamine	chem
serotonin	chem
ethanol	chem
monoamineoxidase	geneN
MAO	geneN
serotonin	chem
dopamine	chem
alcohol	chem
【GOLD_R】
【PRE_R】

The aim of the present study was , therefore , to evaluate several MAO inhibitors for their capacity to affect ethanol self - administration in rats trained to self - administer ethanol ( 10 % v / v ) orally in a free - choice two - lever operant task .
【GOLD_E】
ethanol	chem
ethanol	chem
MAO	geneN
【PRE_E】
MAO	geneN
ethanol	chem
ethanol	chem
【GOLD_R】
【PRE_R】

The nonselective and irreversible MAO inhibitors , phenelzine ( 3 - 10 mg / kg ) , tranylcypromine ( 1 - 3 mg / kg ) , and nialamide ( 30 mg / kg ) , decreased rates of responding maintained by ethanol reinforcement .
【GOLD_E】
phenelzine	chem
tranylcypromine	chem
nialamide	chem
ethanol	chem
MAO	geneN
【PRE_E】
MAO	geneN
phenelzine	chem
tranylcypromine	chem
nialamide	chem
ethanol	chem
【GOLD_R】
phenelzine	MAO	C4
tranylcypromine	MAO	C4
nialamide	MAO	C4
【PRE_R】
MAO	phenelzine	C4
MAO	tranylcypromine	C4
MAO	nialamide	C4
MAO	ethanol	C4

The reversible MAO - A inhibitor , befloxatone ( 0.3 - 3 mg / kg ) , and the irreversible MAO - A inhibitor , clorgyline ( 10 - 30 mg / kg ) , also reduced ethanol self - administration .
【GOLD_E】
befloxatone	chem
clorgyline	chem
ethanol	chem
MAO-A	geneY
MAO-A	geneY
【PRE_E】
MAO-A	geneY
befloxatone	chem
MAO-A	geneY
clorgyline	chem
ethanol	chem
【GOLD_R】
befloxatone	MAO-A	C4
clorgyline	MAO-A	C4
【PRE_R】
MAO-A	befloxatone	C4
befloxatone	MAO-A	C4
MAO-A	clorgyline	C4
MAO-A	ethanol	C4

However , befloxatone - induced effects leveled off at a 50 % decrease .
【GOLD_E】
befloxatone	chem
【PRE_E】
befloxatone	chem
【GOLD_R】
【PRE_R】

The irreversible MAO - B inhibitors , pargyline ( 30 mg / kg ) and l - deprenyl ( 3 - 10 mg / kg ) also decreased responding maintained by ethanol reinforcement ; these results are consistent with previous findings that both drugs decreased ethanol intake in mice .
【GOLD_E】
pargyline	chem
l-deprenyl	chem
MAO-B	geneY
ethanol	chem
ethanol	chem
【PRE_E】
MAO-B	geneY
pargyline	chem
l-deprenyl	chem
ethanol	chem
ethanol	chem
【GOLD_R】
pargyline	MAO-B	C4
l-deprenyl	MAO-B	C4
【PRE_R】
MAO-B	pargyline	C4
MAO-B	l-deprenyl	C4
MAO-B	ethanol	C4
MAO-B	ethanol	C4

In conclusion , the present results showing that several MAO inhibitors decreased ethanol self - administration in rats are consistent with previous findings that synaptic levels of serotonin and dopamine play a critical role in the control of ethanol self - administration .
【GOLD_E】
MAO	geneN
ethanol	chem
serotonin	chem
dopamine	chem
ethanol	chem
【PRE_E】
MAO	geneN
ethanol	chem
serotonin	chem
dopamine	chem
ethanol	chem
【GOLD_R】
【PRE_R】
MAO	ethanol	C4

Decreased intracellular proteolysis correlates with the maintenance of a specific isoenzyme of cytochrome P - 450 .
【GOLD_E】
cytochromeP-450	geneN
【PRE_E】
cytochromeP-450	geneY
【GOLD_R】
【PRE_R】

The rates of intracellular protein degradation , of identically labelled populations of proteins , were compared in hepatocytes cultured at 37 degrees ( on an adsorbed collagen layer ) and in cells preserved on gelatin gels at 10 degrees C .
【GOLD_E】
【PRE_E】
collagen	geneN
【GOLD_R】
【PRE_R】

The half - lives of the long - lived proteins were 35.4 + / - 8.6 h ( N = 4 ) and 692.9 + / - 216.9 h ( N = 4 ) respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Proteolysis was substantially decreased at 10 degrees C but the rate of decrease remained constant .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hepatocytes rapidly removed resorufin from the culture medium .
【GOLD_E】
resorufin	chem
【PRE_E】
resorufin	chem
【GOLD_R】
【PRE_R】

The resorufin was not being conjugated or accumulated within the cells .
【GOLD_E】
resorufin	chem
【PRE_E】
resorufin	chem
【GOLD_R】
【PRE_R】

Dicumarol , a potent inhibitor of quinone oxidoreductase , at high concentration ( 500 microm ) caused only a 72 % decrease in the utilization of resorufin .
【GOLD_E】
Dicumarol	chem
quinone	chem
resorufin	chem
quinoneoxidoreductase	geneN
【PRE_E】
Dicumarol	chem
quinoneoxidoreductase	geneY
resorufin	chem
【GOLD_R】
Dicumarol	quinoneoxidoreductase	C4
【PRE_R】

The microsomal detoxifying enzyme , cytochrome P - 450 1A1 remained at a constant level in the preserved hepatocyte monolayers .
【GOLD_E】
cytochromeP-4501A1	geneY
【PRE_E】
cytochromeP-4501A1	geneY
【GOLD_R】
【PRE_R】

The results of this study strongly favour storing hepatocytes at 10 degrees C rather than at 4 degrees or 37 degrees C .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A novel mutation of the erythroid - specific gamma - Aminolevulinate synthase gene in a patient with non - inherited pyridoxine - responsive sideroblastic anemia .
【GOLD_E】
erythroid-specificgamma-Aminolevulinatesynthase	geneN
pyridoxine	chem
gamma-Aminolevulinate	chem
【PRE_E】
erythroid-specificgamma-Aminolevulinatesynthase	geneY
pyridoxine	chem
【GOLD_R】
【PRE_R】

A novel missense mutation , G663A , in exon 5 of the erythroid - specific delta - aminolevulinate synthase gene ( ALAS2 ) was identified in a Japanese male with pyridoxine - responsive sideroblastic anemia .
【GOLD_E】
G663A	geneN
erythroid-specificdelta-aminolevulinatesynthase	geneY
pyridoxine	chem
delta-aminolevulinate	chem
ALAS2	geneY
【PRE_E】
G663A	geneN
erythroid-specificdelta-aminolevulinatesynthasegene	geneY
ALAS2	geneY
pyridoxine	chem
【GOLD_R】
【PRE_R】

Activity of the mutant delta - aminolevulinate synthase protein expressed in vitro was 15.1 % compared with the normal control , but was increased up to 34.5 % by the addition of pyridoxal 5 ' - phosphate , consistent with the clinical response of the patient to pyridoxine treatment .
【GOLD_E】
delta-aminolevulinate	chem
pyridoxal5'-phosphate	chem
pyridoxine	chem
delta-aminolevulinatesynthase	geneY
【PRE_E】
delta-aminolevulinatesynthase	geneY
pyridoxal5'-phosphate	chem
pyridoxine	chem
【GOLD_R】
pyridoxal5'-phosphate	delta-aminolevulinatesynthase	C3
【PRE_R】

The same mutation was also detected in genomic DNa from the oral mucosal membrane of the patiet ; however , it was not detected in other family member .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These findings suggest that this G663A mutation is responsible for sideroblastic anemia in the proband , and may be an index mutation in this pedigree .
【GOLD_E】
G663A	geneN
【PRE_E】
G663A	geneN
【GOLD_R】
【PRE_R】

Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans .
【GOLD_E】
rivastigmine	chem
acetylcholinesterase	geneY
【PRE_E】
acetylcholinesterase	geneY
rivastigmine	chem
【GOLD_R】
rivastigmine	acetylcholinesterase	C4
【PRE_R】
acetylcholinesterase	rivastigmine	C4

This study sought to examine the feasibility of prolonged assessment of acetylcholinesterase ( AChE ) activity in the cerebrospinal fluid ( CSF ) of volunteers and to test the hypothesis that rivastigmine ( ENA - 713 ; Exelon , Novartis Pharma AG , Basel , Switzerland ) selectively inhibits AChE in CSF in humans at a dose producing minimal inhibition of the peripheral enzyme .
【GOLD_E】
AChE	geneY
acetylcholinesterase	geneY
AChE	geneY
rivastigmine	chem
ENA-713	chem
Exelon	chem
【PRE_E】
acetylcholinesterase	geneY
AChE	geneY
rivastigmine	chem
ENA-713	chem
Exelon	chem
Novartis	chem
AG	chem
Basel	chem
AChE	geneY
CSF	geneY
【GOLD_R】
【PRE_R】
acetylcholinesterase	rivastigmine	C4
AChE	rivastigmine	C4
AChE	ENA-713	C4
AChE	Exelon	C4
Novartis	AChE	C4
AG	AChE	C4
Basel	AChE	C4
Basel	CSF	C4

Lumbar CSF samples were collected continuously ( 0.1 mL x min ( - 1 ) ) for 49 hours from eight healthy volunteers who took either placebo or a single oral dose of rivastigmine ( 3 mg ) .
【GOLD_E】
rivastigmine	chem
【PRE_E】
rivastigmine	chem
【GOLD_R】
【PRE_R】

CSF specimens and samples of blood cells and blood plasma were analyzed at intervals for rivastigmine and its metabolite NAP 226 - 90 ( [ - ] [ 3 - ( [ 1 - dimethylaminolethyl ) - phenol ] ) , erythrocyte AChE activity , CSF AChE activity , and plasma and CSF butyrylcholinesterase ( BuChE ) activity .
【GOLD_E】
rivastigmine	chem
NAP226-90	chem
[-][3-([1-dimethylaminolethyl)-phenol]	chem
AChE	geneY
AChE	geneY
butyrylcholinesterase	geneY
BuChE	geneY
【PRE_E】
rivastigmine	chem
NAP226	chem
[-][3-([1-dimethylaminolethyl)-phenol	chem
AChE	geneY
CSFAChE	geneY
CSFbutyrylcholinesterase	geneY
BuChE	geneY
【GOLD_R】
【PRE_R】
rivastigmine	AChE	C4
NAP226	AChE	C4
[-][3-([1-dimethylaminolethyl)-phenol	AChE	C4
[-][3-([1-dimethylaminolethyl)-phenol	CSFAChE	C4
[-][3-([1-dimethylaminolethyl)-phenol	BuChE	C4

Safety evaluations were performed 23 hours after drug dosing and at the end of the study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Evaluable data were obtained from six subjects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mean time to maximal rivastigmine plasma concentration ( tmax ) was 0.83 + / - 0.26 hours , the mean maximal plasma concentration ( Cmax ) was 4.88 + / - 3.82 ng x mL ( - 1 ) , the mean plasma area under the concentration versus time curve ( AUC0 - infinity ) was 7.43 + / - 4.74 ng x hr x mL ( - 1 ) , and the mean plasma t1 / 2 was 0.85 + / - 0.115 hours .
【GOLD_E】
rivastigmine	chem
【PRE_E】
rivastigmine	chem
【GOLD_R】
【PRE_R】

The concentration of rivastigmine in CSF was lower than the quantification limit for assay ( 0.65 ng x mL ( - 1 ) ) , but NAP 226 - 90 reached a mean Cmax of 3.14 + / - 0.57 ng x mL ( - 1 ) .
【GOLD_E】
rivastigmine	chem
NAP226-90	chem
【PRE_E】
rivastigmine	chem
【GOLD_R】
【PRE_R】

Only minimal inhibition of erythrocyte AChE activity ( approximately 3 % ) was observed .
【GOLD_E】
AChE	geneY
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

Inhibition of AChE in the CSF after rivastigmine administration was significantly greater than after placebo for up to 8.4 hours after the dose and was maximal ( 40 % ) at 2.4 hours .
【GOLD_E】
AChE	geneY
rivastigmine	chem
【PRE_E】
AChE	geneY
rivastigmine	chem
【GOLD_R】
rivastigmine	AChE	C4
【PRE_R】
AChE	rivastigmine	C4

Plasma BuChE activity was significantly lower after rivastigmine than after placebo , but this was not clinically relevant .
【GOLD_E】
BuChE	geneY
rivastigmine	chem
【PRE_E】
BuChE	geneY
rivastigmine	chem
【GOLD_R】
rivastigmine	BuChE	C4
【PRE_R】
BuChE	rivastigmine	C4

BuChE activity in CSF was significantly lower after rivastigmine than after placebo for up to 3.6 hours after dosing , but this difference was not sustained .
【GOLD_E】
BuChE	geneY
rivastigmine	chem
【PRE_E】
BuChE	geneY
rivastigmine	chem
【GOLD_R】
rivastigmine	BuChE	C4
【PRE_R】
BuChE	rivastigmine	C4

This study confirms the feasibility of using continuous measurement of AChE activity in CSF over prolonged periods , that rivastigmine markedly inhibits CSF AChE after a single oral dose of 3 mg , and that the inhibition of central AChE is substantially greater than that of peripheral AChE or BuChE .
【GOLD_E】
AChE	geneY
AChE	geneY
AChE	geneY
AChE	geneY
BuChE	geneY
rivastigmine	chem
【PRE_E】
AChE	geneY
rivastigmine	chem
CSFAChE	geneY
AChE	geneY
AChE	geneY
BuChE	geneY
【GOLD_R】
rivastigmine	AChE	C4
rivastigmine	AChE	C4
rivastigmine	AChE	C4
rivastigmine	BuChE	C4
【PRE_R】
AChE	rivastigmine	C4
rivastigmine	CSFAChE	C4
rivastigmine	AChE	C4
rivastigmine	AChE	C4
rivastigmine	BuChE	C4

Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX .
【GOLD_E】
factorXIapple3domain	geneN
factorIX	geneY
aminoacids	chem
【PRE_E】
aminoacids	chem
factorXIapple3domain	geneN
factorIX	geneY
【GOLD_R】
【PRE_R】

Activated coagulation factor XI ( factor XIa ) proteolytically cleaves its substrate , factor IX , in an interaction requiring the factor XI A3 domain ( Sun , Y. , and Gailani , D .
【GOLD_E】
factorXIA3domain	geneN
factorXIa	geneY
factorIX	geneY
ActivatedcoagulationfactorXI	geneY
【PRE_E】
coagulationfactorXI	geneY
factorXIa	geneY
factorIX	geneY
factorXIA3domain	geneN
【GOLD_R】
【PRE_R】

( 1996 ) J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Biol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

271 , 29023 - 29028 ) .
【GOLD_E】
【PRE_E】
29023-29028	chem
【GOLD_R】
【PRE_R】

To identify key amino acids involved in factor IX activation , recombinant factor XIa proteins containing alanine substitutions for wild - type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay .
【GOLD_E】
factorIX	geneY
factorXIa	geneY
aminoacids	chem
alanine	chem
【PRE_E】
aminoacids	chem
factorIX	geneY
factorXIa	geneY
alanine	chem
【GOLD_R】
【PRE_R】

Substitutions for Ile ( 183 ) - Val ( 191 ) and Ser ( 195 ) - Ile ( 197 ) at the N terminus and for Ser ( 258 ) - Ser ( 264 ) at the C terminus of the A3 domain markedly decreased factor XI coagulant activity .
【GOLD_E】
A3domain	geneN
factorXI	geneY
N	chem
C	chem
【PRE_E】
Ile(183)-Val	chem
Ser	chem
N	chem
Ser	chem
Ser	chem
C	chem
A3domain	geneN
factorXI	geneY
【GOLD_R】
【PRE_R】

The plasma protease prekallikrein is structurally homologous to factor XI , but activated factor IX poorly .
【GOLD_E】
plasmaprotease	geneN
prekallikrein	geneY
factorXI	geneY
factorIX	geneY
【PRE_E】
protease	geneN
prekallikrein	geneN
factorXI	geneY
factorIX	geneY
【GOLD_R】
【PRE_R】

A chimeric factor XIa molecule with the A3 domain replaced with A3 from prekallikrein ( FXI / PKA3 ) activated factor IX with a K ( m ) 35 - fold greater than that of wild - type factor XI .
【GOLD_E】
factorXIa	geneY
A3domain	geneN
prekallikrein	geneY
FXI	geneY
PKA3	geneN
activatedfactorIX	geneY
factorXI	geneY
【PRE_E】
factorXIa	geneY
A3domainreplacedwithA3fromprekallikrein	geneN
FXI	geneN
PKA3	geneN
factorIX	geneY
K(m)35	geneY
typefactorXI	geneY
【GOLD_R】
【PRE_R】

FXI / PKA3 was used as a template for a series of proteins in which prekallikrein A3 sequence was replaced with factor XI sequence to restore factor IX activation .
【GOLD_E】
factorIX	geneY
FXI	geneY
PKA3	geneN
prekallikrein	geneY
factorXI	geneY
【PRE_E】
FXI/PKA3	geneN
prekallikreinA3	geneN
factorXI	geneY
factorIX	geneY
【GOLD_R】
【PRE_R】

Clotting and kinetics studies using these chimeras confirmed the results obtained with alanine mutants .
【GOLD_E】
alanine	chem
【PRE_E】
alanine	chem
【GOLD_R】
【PRE_R】

Amino acids between Ile ( 183 ) and Val ( 191 ) are necessary for proper factor IX activation , but additional sequence between Ser ( 195 ) and Ile ( 197 ) or between Phe ( 260 ) and Ser ( 265 ) is required for complete restoration of activation .
【GOLD_E】
factorIX	geneY
Aminoacids	chem
【PRE_E】
Aminoacids	chem
Val	chem
factorIX	geneY
Ser	chem
Ile	chem
Phe	chem
Ser	chem
【GOLD_R】
【PRE_R】

Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha ( 2 ) - adrenergic receptors ( AR ) s , serotonin ( 5 - HT ) ( 1A ) , 5 - HT ( 1B ) , 5 - HT ( 1D ) and dopamine D ( 2 ) and D ( 3 ) receptors . Significance for the modulation of frontocortical monoaminergic transmission and depressive states .
【GOLD_E】
serotonin	chem
5-HT	chem
5-HT	chem
5-HT	chem
dopamine	chem
yohimbine	chem
fluparoxan	chem
(AR)s	geneN
(5-HT)(1A)	geneY
5-HT(1B)	geneY
5-HT(1D)	geneY
dopamineD(2)andD(3)receptors	geneN
alpha(2)-adrenergicreceptors	geneN
【PRE_E】
yohimbine	chem
fluparoxanatalpha(2)-adrenergicreceptors(AR)s,serotonin(5-HT)(1A)	geneN
5-HT(1B)	geneY
5-HT(1D)	geneY
dopamineD(2)	geneY
D(3)	geneY
【GOLD_R】
yohimbine	(AR)s	C5
yohimbine	(5-HT)(1A)	C5
yohimbine	5-HT(1B)	C5
yohimbine	5-HT(1D)	C5
yohimbine	alpha(2)-adrenergicreceptors	C5
fluparoxan	(AR)s	C5
fluparoxan	alpha(2)-adrenergicreceptors	C5
yohimbine	(AR)s	C6
yohimbine	(5-HT)(1A)	C6
yohimbine	5-HT(1B)	C6
yohimbine	5-HT(1D)	C6
yohimbine	alpha(2)-adrenergicreceptors	C6
fluparoxan	(AR)s	C6
fluparoxan	alpha(2)-adrenergicreceptors	C6
【PRE_R】
yohimbine	5-HT(1B)	C6
yohimbine	5-HT(1D)	C6

Herein , we evaluate the interaction of the alpha ( 2 ) - AR antagonist , yohimbine , as compared to fluparoxan , at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic , dopaminergic and serotonergic transmission in freely - moving rats .
【GOLD_E】
yohimbine	chem
fluparoxan	chem
monoaminergicreceptors	geneN
alpha(2)-ARantagonist	geneN
【PRE_E】
alpha(2)-AR	geneY
yohimbine	chem
fluparoxan	chem
【GOLD_R】
yohimbine	alpha(2)-ARantagonist	C6
fluparoxan	alpha(2)-ARantagonist	C6
【PRE_R】

Yohimbine displays marked affinity at human ( h ) alpha ( 2A ) - , halpha ( 2B ) - and halpha ( 2C ) - ARs , significant affinity for h5 - HT ( 1A ) , h5 - HT ( 1B ) , h5 - HT ( 1D ) , and hD ( 2 ) receptors and weak affinity for hD ( 3 ) receptors .
【GOLD_E】
Yohimbine	chem
human(h)alpha(2A)-,halpha(2B)-andhalpha(2C)-ARs	geneN
h5-HT(1A)	geneY
h5-HT(1B)	geneY
h5-HT(1D)	geneY
hD(2)receptors	geneY
hD(3)receptors	geneY
【PRE_E】
Yohimbine	chem
human(h)alpha(2A)-,halpha(2B)-andhalpha(2C)-ARs	geneN
h5-HT(1A)	geneY
h5-HT(1B)	geneY
h5-HT(1D)	geneY
hD(2)	geneY
hD(3)receptors	geneN
【GOLD_R】
【PRE_R】

In [ ( 35 ) S ] GTPgammaS binding protocols , yohimbine exerts antagonist actions at halpha ( 2A ) - AR , h5 - HT ( 1B ) , h5 - HT ( 1D ) , and hD ( 2 ) sites , yet partial agonist actions at h5 - HT ( 1A ) sites .
【GOLD_E】
(35)S	chem
yohimbine	chem
halpha(2A)-AR	geneY
h5-HT(1B)	geneY
h5-HT(1D)	geneY
hD(2)	geneY
h5-HT(1A)	geneY
【PRE_E】
[(35)S]GTPgammaS	chem
yohimbine	chem
halpha(2A)-AR	geneY
h5-HT(1B)	geneY
h5-HT(1D)	geneY
hD(2)	geneY
h5-HT(1A)	geneY
【GOLD_R】
yohimbine	h5-HT(1A)	C5
yohimbine	halpha(2A)-AR	C6
yohimbine	h5-HT(1B)	C6
yohimbine	h5-HT(1D)	C6
yohimbine	hD(2)	C6
【PRE_R】
[(35)S]GTPgammaS	halpha(2A)-AR	C6
yohimbine	halpha(2A)-AR	C6
yohimbine	h5-HT(1B)	C6
yohimbine	h5-HT(1D)	C6
yohimbine	hD(2)	C6
yohimbine	h5-HT(1A)	C6

In vivo , agonist actions of yohimbine at 5 - HT ( 1A ) sites are revealed by WAY100,635 - reversible induction of hypothermia in the rat .
【GOLD_E】
yohimbine	chem
5-HT	chem
WAY100,635	chem
5-HT(1A)	geneY
【PRE_E】
yohimbine	chem
5-HT(1A)	geneY
WAY100,635	chem
【GOLD_R】
yohimbine	5-HT(1A)	C5
WAY100,635	5-HT(1A)	C6
【PRE_R】
yohimbine	5-HT(1A)	C6

In guinea pigs , antagonist actions of yohimbine at 5 - HT ( 1B ) receptors are revealed by blockade of hypothermia evoked by the 5 - HT ( 1B ) agonist , GR46,611 .
【GOLD_E】
yohimbine	chem
5-HT	chem
5-HT	chem
GR46,611	chem
5-HT(1B)	geneY
5-HT(1B)	geneY
【PRE_E】
yohimbine	chem
5-HT(1B)	geneY
5-HT(1B)	geneY
GR46,611	chem
【GOLD_R】
GR46,611	5-HT(1B)	C5
yohimbine	5-HT(1B)	C6
【PRE_R】
yohimbine	5-HT(1B)	C6
5-HT(1B)	GR46,611	C6

In distinction to yohimbine , fluparoxan shows only modest partial agonist actions at h5 - HT ( 1A ) sites versus marked antagonist actions at halpha ( 2 ) - ARs .
【GOLD_E】
yohimbine	chem
fluparoxan	chem
h5-HT(1A)	geneY
halpha(2)-ARs	geneN
【PRE_E】
yohimbine	chem
fluparoxan	chem
h5-HT(1A)	geneY
halpha(2)-ARs	geneY
【GOLD_R】
yohimbine	h5-HT(1A)	C5
fluparoxan	h5-HT(1A)	C5
yohimbine	halpha(2)-ARs	C6
fluparoxan	halpha(2)-ARs	C6
【PRE_R】
yohimbine	h5-HT(1A)	C6
yohimbine	halpha(2)-ARs	C6

While fluparoxan selectively enhances hippocampal noradrenaline ( NAD ) turnover , yohimbine also enhances striatal dopamine ( DA ) turnover and suppresses striatal turnover of 5 - HT .
【GOLD_E】
fluparoxan	chem
noradrenaline	chem
NAD	chem
yohimbine	chem
dopamine	chem
DA	chem
5-HT	chem
【PRE_E】
fluparoxan	chem
noradrenaline	chem
NAD	chem
yohimbine	chem
dopamine	chem
DA	chem
5-HT	chem
【GOLD_R】
【PRE_R】

Further , yohimbine decreases firing of serotonergic neurones in raphe nuclei , an action reversed by WAY100,635 .
【GOLD_E】
yohimbine	chem
WAY100,635	chem
【PRE_E】
yohimbine	chem
WAY100,635	chem
【GOLD_R】
【PRE_R】

Fluparoxan increases extracellular levels of DA and NAD , but not 5 - HT , in frontal cortex .
【GOLD_E】
Fluparoxan	chem
DA	chem
NAD	chem
5-HT	chem
【PRE_E】
Fluparoxan	chem
DA	chem
NAD	chem
5-HT	chem
【GOLD_R】
【PRE_R】

In analogy , yohimbine enhances FCX levels of DA and NAD , yet suppresses those of 5 - HT , the latter effect being antagonized by WAY100,635 .
【GOLD_E】
yohimbine	chem
DA	chem
NAD	chem
5-HT	chem
WAY100,635	chem
【PRE_E】
yohimbine	chem
FCX	geneY
DA	chem
NAD	geneN
5-HT	chem
WAY100,635	chem
【GOLD_R】
【PRE_R】
FCX	DA	C9
DA	NAD	C9

The induction by fluoxetine of FCX levels of 5 - HT , DA , and NAD is potentiated by fluparoxan .
【GOLD_E】
5-HT	chem
DA	chem
NAD	chem
fluparoxan	chem
【PRE_E】
fluoxetine	chem
FCX	chem
5-HT	chem
DA	chem
NAD	geneN
fluparoxan	chem
【GOLD_R】
【PRE_R】

Yohimbine likewise facilitates the influence of fluoxetine upon DA and NAD levels , but not those of 5 - HT .
【GOLD_E】
Yohimbine	chem
fluoxetine	chem
DA	chem
NAD	chem
5-HT	chem
【PRE_E】
Yohimbine	chem
fluoxetine	chem
DA	chem
NAD	chem
5-HT	chem
【GOLD_R】
【PRE_R】

In conclusion , the alpha ( 2 ) - AR antagonist properties of yohimbine increase DA and NAD levels both alone and in association with fluoxetine .
【GOLD_E】
yohimbine	chem
DA	chem
NAD	chem
alpha(2)-AR	geneN
【PRE_E】
alpha(2)-AR	geneY
yohimbine	chem
DA	chem
NAD	chem
fluoxetine	chem
【GOLD_R】
yohimbine	alpha(2)-AR	C6
【PRE_R】
alpha(2)-AR	DA	C5

However , in contrast to the selective alpha ( 2 ) - AR antagonist , fluparoxan , the 5 - HT ( 1A ) agonist actions of yohimbine suppress 5 - HT levels alone and underlie its inability to augment the influence of fluoxetine upon 5 - HT levels .
【GOLD_E】
fluparoxan	chem
5-HT	chem
yohimbine	chem
5-HT	chem
fluoxetine	chem
5-HT	chem
alpha(2)-AR	geneN
5-HT(1A)	geneY
【PRE_E】
alpha(2)-AR	geneN
fluparoxan	chem
5-HT(1A)	geneY
yohimbine	chem
5-HT	chem
fluoxetine	chem
5-HT	chem
【GOLD_R】
yohimbine	5-HT(1A)	C5
fluparoxan	alpha(2)-AR	C6
【PRE_R】
alpha(2)-AR	fluparoxan	C6
fluparoxan	5-HT(1A)	C6
5-HT(1A)	yohimbine	C6
5-HT(1A)	5-HT	C6

The antitussive activity of delta - opioid receptor stimulation in guinea pigs .
【GOLD_E】
delta-opioidreceptor	geneY
【PRE_E】
delta-opioidreceptor	geneY
【GOLD_R】
【PRE_R】

In this study , the activity of the delta - opioid receptor subtype - selective agonist , SB 227122 , was investigated in a guinea pig model of citric acid - induced cough .
【GOLD_E】
SB227122	chem
delta-opioidreceptor	geneY
citricacid	chem
【PRE_E】
delta-opioidreceptor	geneN
SB227122	chem
citricacid	chem
【GOLD_R】
SB227122	delta-opioidreceptor	C5
【PRE_R】

Parenteral administration of selective agonists of the delta - opioid receptor ( SB 227122 ) , mu - opioid receptor ( codeine and hydrocodone ) , and kappa - opioid receptor ( BRL 52974 ) produced dose - related inhibition of citric acid - induced cough with ED ( 50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg / kg , respectively .
【GOLD_E】
BRL52974	chem
citricacid	chem
delta-opioidreceptor	geneY
mu-opioidreceptor	geneY
kappa-opioidreceptor	geneY
SB227122	chem
codeine	chem
hydrocodone	chem
【PRE_E】
delta-opioidreceptor	geneY
SB227122	chem
mu-opioidreceptor	geneY
codeine	chem
hydrocodone	chem
kappa-opioidreceptor	geneY
BRL52974	chem
citricacid	chem
【GOLD_R】
BRL52974	kappa-opioidreceptor	C5
SB227122	delta-opioidreceptor	C5
codeine	mu-opioidreceptor	C5
hydrocodone	mu-opioidreceptor	C5
【PRE_R】
delta-opioidreceptor	SB227122	C5
mu-opioidreceptor	codeine	C6
hydrocodone	kappa-opioidreceptor	C6

The nonselective opioid receptor antagonist , naloxone ( 3 mg / kg , i.m . ) , attenuated the antitussive effects of codeine or SB 227122 , indicating that the antitussive activity of both compounds is opioid receptor - mediated .
【GOLD_E】
naloxone	chem
codeine	chem
SB227122	chem
opioidreceptor	geneN
opioidreceptor	geneN
【PRE_E】
opioidreceptor	geneN
naloxone	chem
codeine	chem
SB227122	chem
opioidreceptor	geneN
【GOLD_R】
codeine	opioidreceptor	C5
codeine	opioidreceptor	C5
SB227122	opioidreceptor	C5
SB227122	opioidreceptor	C5
naloxone	opioidreceptor	C6
【PRE_R】

The delta - receptor antagonist , SB 244525 ( 10 mg / kg , i.p . ) , inhibited the antitussive effect of SB 227122 ( 20 mg / kg , i.p . ) .
【GOLD_E】
SB244525	chem
SB227122	chem
delta-receptor	geneY
【PRE_E】
delta-receptor	geneN
SB244525	chem
SB227122	chem
【GOLD_R】
SB227122	delta-receptor	C5
SB244525	delta-receptor	C6
【PRE_R】
delta-receptor	SB244525	C6
delta-receptor	SB227122	C6

In contrast , combined pretreatment with beta - funaltrexamine ( mu - receptor antagonist ; 20 mg / kg , s.c. ) and norbinaltorphimine ( kappa - receptor antagonist ; 20 mg / kg , s.c. ) , at doses that inhibited the antitussive activity of mu - and kappa - receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg / kg , i.p . ) .
【GOLD_E】
beta-funaltrexamine	chem
norbinaltorphimine	chem
SB227122	chem
mu-andkappa-receptor	geneN
mu-receptor	geneY
kappa-receptor	geneY
【PRE_E】
beta-funaltrexamine	geneY
mu-receptor	geneN
norbinaltorphimine(kappa-receptor	geneN
mu-andkappa-receptor	geneN
SB227122	chem
【GOLD_R】
beta-funaltrexamine	mu-receptor	C6
norbinaltorphimine	kappa-receptor	C6
【PRE_R】

The sigma - receptor antagonist rimcazole ( 3 mg / kg , i.p . ) inhibited the antitussive effect of dextromethorphan ( 30 mg / kg , i.p . ) , a sigma - receptor agonist , but not that of SB 227122 .
【GOLD_E】
sigma-receptor	geneN
rimcazole	chem
dextromethorphan	chem
SB227122	chem
【PRE_E】
sigma-receptor	geneN
rimcazole	chem
dextromethorphan	chem
sigma-receptor	geneY
SB227122	chem
【GOLD_R】
dextromethorphan	sigma-receptor	C5
rimcazole	sigma-receptor	C6
【PRE_R】
sigma-receptor	rimcazole	C6
rimcazole	sigma-receptor	C6

These studies provide compelling evidence that the antitussive effects of SB 227122 in this guinea pig cough model are mediated by agonist activity at the delta - opioid receptor .
【GOLD_E】
delta-opioidreceptor	geneY
SB227122	chem
【PRE_E】
SB227122	chem
delta-opioidreceptor	geneY
【GOLD_R】
SB227122	delta-opioidreceptor	C5
【PRE_R】

COX - 2 - specific inhibition : implications for clinical practice .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Although conventional nonsteroidal anti - inflammatory drugs ( NSAIDs ) have long been a major therapeutic choice for the management of arthritic conditions , the potential adverse effects of these agents sometimes compromise their clinical utility .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

New modes of therapy have recently been introduced , and data on the cyclooxygenase - 2 ( COX - 2 ) - specific inhibitors celecoxib and rofecoxib suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs .
【GOLD_E】
celecoxib	chem
rofecoxib	chem
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
cyclooxygenase-2	geneY
COX-2	geneY
celecoxib	chem
rofecoxib	chem
【GOLD_R】
celecoxib	cyclooxygenase-2	C4
celecoxib	COX-2	C4
rofecoxib	cyclooxygenase-2	C4
rofecoxib	COX-2	C4
【PRE_R】
cyclooxygenase-2	celecoxib	C4
COX-2	celecoxib	C4
COX-2	rofecoxib	C4

Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone , lawsone derivatives , brequinar sodium and polyporic acid .
【GOLD_E】
brequinarsodium	chem
polyporicacid	chem
dihydroorotate	chem
atovaquone	chem
lawsone	chem
humanandratdihydroorotatedehydrogenase	geneN
【PRE_E】
humanandratdihydroorotatedehydrogenase	geneY
atovaquone	chem
lawsone	chem
brequinarsodium	chem
polyporicacid	chem
【GOLD_R】
brequinarsodium	humanandratdihydroorotatedehydrogenase	C4
polyporicacid	humanandratdihydroorotatedehydrogenase	C4
atovaquone	humanandratdihydroorotatedehydrogenase	C4
lawsone	humanandratdihydroorotatedehydrogenase	C4
【PRE_R】
humanandratdihydroorotatedehydrogenase	atovaquone	C4
humanandratdihydroorotatedehydrogenase	lawsone	C4
humanandratdihydroorotatedehydrogenase	brequinarsodium	C4
humanandratdihydroorotatedehydrogenase	polyporicacid	C4

Mitochondrially - bound dihydroorotate dehydrogenase ( EC 1.3.99.11 ) catalyzes the fourth sequential step in the de novo synthesis of uridine monophosphate .
【GOLD_E】
dihydroorotate	chem
dihydroorotatedehydrogenase	geneY
EC1.3.99.11	geneY
uridinemonophosphate	chem
【PRE_E】
Mitochondrially-bounddihydroorotatedehydrogenase	geneY
EC1.3.99.11	geneY
uridinemonophosphate	chem
【GOLD_R】
uridinemonophosphate	dihydroorotatedehydrogenase	C9
uridinemonophosphate	EC1.3.99.11	C9
【PRE_R】
EC1.3.99.11	uridinemonophosphate	C9

The enzyme has been identified as or surmised to be the pharmacological target for isoxazol , triazine , cinchoninic acid and ( naphtho ) quinone derivatives , which exerted antiproliferative , immunosuppressive , and antiparasitic effects .
【GOLD_E】
isoxazol	chem
triazine	chem
cinchoninicacid	chem
(naphtho)quinone	chem
【PRE_E】
isoxazol	chem
triazine	chem
cinchoninicacid	chem
(naphtho)quinone	chem
【GOLD_R】
【PRE_R】

Despite this broad spectrum of biological and clinical relevance , there have been no comparative studies on drug - dihydroorotate dehydrogenase interactions .
【GOLD_E】
dihydroorotate	chem
dihydroorotatedehydrogenase	geneY
【PRE_E】
dihydroorotatedehydrogenase	geneN
【GOLD_R】
【PRE_R】

Here , we describe a study of the inhibition of the purified recombinant human and rat dihydroorotate dehydrogenase by ten compounds .
【GOLD_E】
dihydroorotate	chem
humanandratdihydroorotatedehydrogenase	geneN
【PRE_E】
humanandratdihydroorotatedehydrogenase	geneN
【GOLD_R】
【PRE_R】

1,4 - Naphthoquinone , 5,8 - hydroxy - naphthoquinone and the natural compounds juglon , plumbagin and polyporic acid ( quinone derivative ) were found to function as alternative electron acceptors with 10 - 30 % of control enzyme activity .
【GOLD_E】
1,4-Naphthoquinone	chem
5,8-hydroxy-naphthoquinone	chem
juglon	chem
plumbagin	chem
polyporicacid	chem
quinone	chem
【PRE_E】
1,4-Naphthoquinone	chem
5,8-hydroxy-naphthoquinone	chem
juglon	chem
plumbagin	chem
polyporicacid	chem
quinone	chem
【GOLD_R】
【PRE_R】

The human and rat enzyme activity was decreased by 50 % by the natural compound lawsone ( > 500 and 49 microM , respectively ) and by the derivatives dichloroally - lawsone ( 67 and 10 nM ) , lapachol ( 618 and 61 nM ) and atovaquone ( 15 microM and 698 nM ) .
【GOLD_E】
dichloroally-lawsone	chem
lapachol	chem
lawsone	chem
atovaquone	chem
【PRE_E】
lawsone	chem
dichloroally-lawsone	chem
lapachol	chem
atovaquone	chem
【GOLD_R】
【PRE_R】

With respect to the quinone co - substrate of the dihydroorotate dehydrogenase , atovaquone ( Kic = 2.7 microM ) and dichloroally - lawsone ( Kic = 9.8 nM ) were shown to be competitive inhibitors of human dihydroorotate dehydrogenase .
【GOLD_E】
dihydroorotatedehydrogenase	geneY
humandihydroorotatedehydrogenase	geneY
quinone	chem
dihydroorotate	chem
atovaquone	chem
dichloroally-lawsone	chem
dihydroorotate	chem
【PRE_E】
quinone	chem
dihydroorotatedehydrogenase	geneN
atovaquone	chem
Kic	chem
dichloroally-lawsone	chem
Kic	chem
humandihydroorotatedehydrogenase	geneY
【GOLD_R】
atovaquone	humandihydroorotatedehydrogenase	C4
dichloroally-lawsone	humandihydroorotatedehydrogenase	C4
quinone	dihydroorotatedehydrogenase	C9
【PRE_R】
atovaquone	humandihydroorotatedehydrogenase	C4
Kic	humandihydroorotatedehydrogenase	C4
dichloroally-lawsone	humandihydroorotatedehydrogenase	C4
Kic	humandihydroorotatedehydrogenase	C4

Atovaquone ( Kic = 60 nM ) was also acompetitive inhibitor of the rat enzyme .
【GOLD_E】
Atovaquone	chem
【PRE_E】
Atovaquone	chem
Kic	chem
【GOLD_R】
【PRE_R】

Dichloroally ] - lawsone was found to be a time - dependent inhibitor of the rat enzyme , with the lowest inhibition constant ( Ki * = 0.77 nM ) determined so far for mammalian dihydroorotate dehydrogenases .
【GOLD_E】
Dichloroally]-lawsone	chem
dihydroorotate	chem
mammaliandihydroorotatedehydrogenases	geneN
【PRE_E】
Dichloroally]-lawsone	chem
mammaliandihydroorotatedehydrogenases	geneY
【GOLD_R】
Dichloroally]-lawsone	mammaliandihydroorotatedehydrogenases	C4
【PRE_R】

Another inhibitor , brequinar was previously reported to be a slow - binding inhibitor of the human dihydroorotate dehydrogenase [ W .
【GOLD_E】
brequinar	chem
dihydroorotate	chem
humandihydroorotatedehydrogenase	geneY
【PRE_E】
brequinar	chem
humandihydroorotatedehydrogenase	geneY
W	geneY
【GOLD_R】
brequinar	humandihydroorotatedehydrogenase	C4
【PRE_R】
brequinar	humandihydroorotatedehydrogenase	C4
brequinar	W	C4

Knecht , M .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Loffler , Species - related inhibition of human and rat dihyroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives , Biochem .
【GOLD_E】
dihyroorotate	chem
isoxazol	chem
cinchoninicacid	chem
humanandratdihyroorotatedehydrogenase	geneN
【PRE_E】
humanandratdihyroorotatedehydrogenase	geneY
isoxazol	chem
cinchoninicacid	chem
【GOLD_R】
isoxazol	humanandratdihyroorotatedehydrogenase	C4
cinchoninicacid	humanandratdihyroorotatedehydrogenase	C4
【PRE_R】
humanandratdihyroorotatedehydrogenase	isoxazol	C4
humanandratdihyroorotatedehydrogenase	cinchoninicacid	C4

Pharmacol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

56 ( 1998 ) 1259 - 1264 ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The slow binding features of this potent inhibitor ( Ki * = 1.8 nM ) with the human enzyme , were verified and seen to be one of the reasons for the narrow therapeutic window ( efficacy versus toxicity ) reported from clinical trials on its antiproliferative and immunosuppressive action .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

With respect to the substrate dihydroorotate , atovaquone was an uncompetitive inhibitor of human dihydroorotate dehydrogenase ( Kiu = 11.6 microM ) and a non - competitive inhibitor of the rat enzyme ( Kiu = 905 / Kic = 1,012 nM ) .
【GOLD_E】
dihydroorotate	chem
atovaquone	chem
dihydroorotate	chem
humandihydroorotatedehydrogenase	geneY
【PRE_E】
dihydroorotate	chem
atovaquone	chem
humandihydroorotatedehydrogenase	geneY
【GOLD_R】
dihydroorotate	humandihydroorotatedehydrogenase	C4
atovaquone	humandihydroorotatedehydrogenase	C4
【PRE_R】
dihydroorotate	humandihydroorotatedehydrogenase	C4
atovaquone	humandihydroorotatedehydrogenase	C4

1.5 mM polyporic acid , a natural quinone from fungi , influenced the activity of the human enzyme only slightly ; the activity of the rat enzyme was decreased by 30 % .
【GOLD_E】
polyporicacid	chem
quinone	chem
【PRE_E】
polyporicacid	chem
quinone	chem
【GOLD_R】
【PRE_R】

Sodium channel blockers identify risk for sudden death in patients with ST - segment elevation and right bundle branch block but structurally normal hearts .
【GOLD_E】
Sodium	chem
Sodiumchannel	geneN
【PRE_E】
Sodiumchannel	geneN
【GOLD_R】
【PRE_R】

BACKGROUND : A mutation in the cardiac sodium channel gene ( SCN5A ) has been described in patients with the syndrome of right bundle branch block , ST - segment elevation in leads V1 to V3 , and sudden death ( Brugada syndrome ) .
【GOLD_E】
cardiacsodiumchannel	geneN
SCN5A	geneY
sodium	chem
【PRE_E】
sodiumchannelgene	geneY
SCN5A	geneY
【GOLD_R】
【PRE_R】

These electrocardiographic manifestations are transient in many patients with the syndrome .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The present study examined arrhythmic risk in patients with overt and concealed forms of the disease and the effectiveness of sodium channel blockers to unmask the syndrome and , thus , identify patients at risk .
【GOLD_E】
sodiumchannel	geneN
sodium	chem
【PRE_E】
sodiumchannel	geneN
【GOLD_R】
【PRE_R】

METHODS AND RESULTS : The effect of intravenous ajmaline ( 1 mg / kg ) , procainamide ( 10 mg / kg ) , or flecainide ( 2 mg / kg ) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG ( group A ) , 11 members of 3 families in whom a SCN5A mutation was associated with the syndrome and 8 members in whom it was not ( group B ) , and 53 control subjects ( group C ) .
【GOLD_E】
SCN5A	geneY
ajmaline	chem
procainamide	chem
flecainide	chem
【PRE_E】
ajmaline	chem
procainamide	chem
flecainide	chem
ECG	chem
ECG	chem
SCN5A	geneY
【GOLD_R】
【PRE_R】

Ajmaline , procainamide , or flecainide administration resulted in ST - segment elevation and right bundle branch block in all patients in group A and in all 11 patients with the mutation in group B .
【GOLD_E】
Ajmaline	chem
procainamide	chem
flecainide	chem
【PRE_E】
Ajmaline	chem
procainamide	chem
flecainide	chem
【GOLD_R】
【PRE_R】

A similar pattern could not be elicited in the 8 patients in group B who lacked the mutation or in any person in group C .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The follow - up period ( 37 + / - 33 months ) revealed no differences in the incidence of arrhythmia between the 34 patients in whom the phenotypic manifestation of the syndrome was transient and the 24 patients in whom it was persistent ( log - rank , 0.639 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : The data demonstrated a similar incidence of potentially lethal arrhythmias in patients displaying transient versus persistent ST - segment elevation and right bundle branch block , as well as the effectiveness of sodium channel blockers to unmask the syndrome and , thus , identify patients at risk .
【GOLD_E】
sodiumchannel	geneN
sodium	chem
【PRE_E】
sodiumchannel	geneN
【GOLD_R】
【PRE_R】

Determinants of voltage - dependent inactivation affect Mibefradil block of calcium channels .
【GOLD_E】
Mibefradil	chem
calcium	chem
calciumchannels	geneN
【PRE_E】
Mibefradil	chem
calciumchannels	geneN
【GOLD_R】
Mibefradil	calciumchannels	C4
【PRE_R】

The voltage gated calcium channel family is a major target for a range of therapeutic drugs .
【GOLD_E】
voltagegatedcalciumchannel	geneN
calcium	chem
【PRE_E】
voltagegatedcalciumchannel	geneN
【GOLD_R】
【PRE_R】

Mibefradil ( Ro 40 - 5967 ) belongs to a new chemical class of these molecules which differs from other Ca2 + antagonists by its ability to potently block T - type Ca2 + channels .
【GOLD_E】
Mibefradil	chem
Ro40-5967	chem
T-typeCa2+channels	geneN
Ca2+	chem
Ca2+	chem
【PRE_E】
Mibefradil	chem
40-5967	chem
Ca2+	chem
T-typeCa2+channels	geneN
【GOLD_R】
Mibefradil	T-typeCa2+channels	C4
Ro40-5967	T-typeCa2+channels	C4
【PRE_R】

However , this molecule has also been shown to inhibit other Ca2 + channel subtypes .
【GOLD_E】
Ca2+channel	geneN
Ca2+	chem
【PRE_E】
Ca2+channel	geneN
【GOLD_R】
【PRE_R】

To further analyze the mechanism governing the Ca2 + channel - Mibefradil interaction , we examined the effect of Mibefradil on various recombinant Ca2 + channels expressed in mammalian cells from their cloned cDNAs , using Ca2 + as the permeant ion at physiological concentration .
【GOLD_E】
Mibefradil	chem
Mibefradil	chem
Ca2+	chem
Ca2+	chem
Ca2+channel	geneN
Ca2+channels	geneN
Ca2+	chem
【PRE_E】
Ca2+channel	geneN
Mibefradil	chem
Mibefradil	chem
Ca2+channels	geneN
Ca2+	chem
【GOLD_R】
【PRE_R】

Expression of alpha1A , alpha1C , and alpha1E in tsA 201 cells resulted in Ca2 + currents with functional characteristics closely related to those of their native counterparts .
【GOLD_E】
Ca2+	chem
【PRE_E】
alpha1A	geneY
alpha1C	geneY
alpha1E	geneY
tsA	chem
Ca2+	chem
【GOLD_R】
【PRE_R】
alpha1A	tsA	C3
alpha1C	tsA	C3

Mibefradil blocked alpha1A and alpha1E with a Kd comparable to that reported for T - type channels , but had a lower affinity ( approximately 30 - fold ) for alpha1C .
【GOLD_E】
Mibefradil	chem
T-typechannels	geneN
【PRE_E】
Mibefradil	chem
alpha1A	geneY
alpha1E	geneY
T-typechannels	geneN
alpha1C	geneY
【GOLD_R】
Mibefradil	T-typechannels	C4
【PRE_R】
Mibefradil	alpha1A	C4
Mibefradil	alpha1E	C4
Mibefradil	T-typechannels	C4
Mibefradil	alpha1C	C4

For each channel , inhibition by Mibefradil was consistent with high - affinity binding to the inactivated state .
【GOLD_E】
Mibefradil	chem
【PRE_E】
Mibefradil	chem
【GOLD_R】
【PRE_R】

Modulation of the voltage - dependent inactivation properties by the nature of the coexpressed beta subunit or the alpha1 splice variant altered block at the Mibefradil receptor site .
【GOLD_E】
Mibefradil	chem
【PRE_E】
coexpressedbeta	geneN
Mibefradilreceptor	geneN
【GOLD_R】
【PRE_R】

Therefore , we conclude that the tissue and sub - cellular localization of calcium channel subunits as well as their specific associations are essential parameters to understand the in vivo effects of Mibefradil .
【GOLD_E】
calciumchannel	geneN
calcium	chem
Mibefradil	chem
【PRE_E】
calciumchannel	geneN
Mibefradil	chem
【GOLD_R】
【PRE_R】

Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

We have investigated the effect of treatment with tranexamic acid , an inhibitor of fibrinolysis , on blood loss , blood transfusion requirements and blood coagulation in a randomized , double - blind , placebo - controlled study of 42 patients after total knee arthroplasty .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

Tranexamic acid 15 mg kg - 1 ( n = 21 ) or an equivalent volume of normal saline ( n = 21 ) was given 30 min before surgery and subsequently every 8 h for 3 days .
【GOLD_E】
Tranexamicacid	chem
【PRE_E】
Tranexamicacid	chem
【GOLD_R】
【PRE_R】

Coagulation and fibrinolysis values , blood loss and blood units administered were measured before administration of tranexamic acid , 8 h after the end of surgery and at 24 and 72 h after operation .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

Coagulation profile was examined ( bleeding time , platelet count , prothrombin time ( PT ) , activated partial thromboplastin time ( aPTT ) , plasminogen , beta - thromboglobulin and fibrinogen ) .
【GOLD_E】
prothrombin	geneY
thromboplastin	geneY
plasminogen	geneY
beta-thromboglobulin	geneY
fibrinogen	geneN
【PRE_E】
prothrombin	geneY
thromboplastin	geneY
plasminogen	geneN
beta-thromboglobulin	geneY
fibrinogen	geneN
【GOLD_R】
【PRE_R】

Fibrinolysis was evaluated by measurement of concentrations of D - dimer and fibrinogen degradation products ( FDP ) .
【GOLD_E】
fibrinogendegradationproducts	geneN
FDP	geneN
【PRE_E】
D	chem
fibrinogen	geneN
【GOLD_R】
【PRE_R】

Total blood loss in the tranexamic acid group was 678 ( SD 352 ) ml compared with 1419 ( 607 ) ml in the control group ( P < 0.001 ) , and occurred primarily during the first 24 h after surgery .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

Thirteen patients received 1 - 5 u. of packed red blood cells in the control group compared with two patients in the tranexamic acid group , who received 3 u .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

( P < 0.001 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Postoperative packed cell volume values were higher in the tranexamic acid group despite fewer blood transfusions .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

Postoperative concentrations of plasminogen were decreased significantly in the tranexamic acid group ( P < 0.001 ) .
【GOLD_E】
plasminogen	geneY
tranexamicacid	chem
【PRE_E】
plasminogen	geneN
tranexamicacid	chem
【GOLD_R】
tranexamicacid	plasminogen	C4
【PRE_R】
plasminogen	tranexamicacid	C4

Platelet count , PT , aPTT , bleeding time , beta - thromboglobulin , fibrinogen and FDP concentrations did not differ between groups , but D - dimer concentrations were increased in the control group .
【GOLD_E】
beta-thromboglobulin	geneY
fibrinogen	geneN
FDP	geneN
【PRE_E】
beta-thromboglobulin	geneY
fibrinogen	geneN
FDP	geneN
【GOLD_R】
【PRE_R】

Thromboembolic complications occurred in two patients in the control group compared with none in the tranexamic acid group .
【GOLD_E】
tranexamicacid	chem
【PRE_E】
tranexamicacid	chem
【GOLD_R】
【PRE_R】

Correlations between serotonin level and single - cell firing in the rat 's nucleus raphe magnus .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

The relation between serotonin release and electrical activity was examined in the nucleus raphe magnus of rats anesthetized with pentobarbital .
【GOLD_E】
serotonin	chem
pentobarbital	chem
【PRE_E】
serotonin	chem
pentobarbital	chem
【GOLD_R】
【PRE_R】

Serotonin levels were monitored through a carbon - fiber microelectrode by fast cyclic voltammetry ( usually at 1 Hz ) .
【GOLD_E】
carbon	chem
Serotonin	chem
【PRE_E】
Serotonin	chem
carbon	chem
cyclicvoltammetry	chem
【GOLD_R】
【PRE_R】

Single - cell firing was recorded through the same microelectrode , except during the voltammetry waveform and associated electrical artifact ( totaling about 30 ms ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Multi - barrel micropipettes incorporating the voltammetry electrode were used for iontophoresis of drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cells were inhibited , excited or unaffected by noxious mechanical skin stimulation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These were respectively designated as off ( M ) cells , on ( M ) cells and neutral ( M ) cells , M denoting mechanical .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

During 3 min of pinching , serotonin slowly rose near seven of 14 on ( M ) cells and 26 of 46 off ( M ) cells ; it fell near two off ( M ) cells ; it was unchanged near all other cells , including six neutral ( M ) cells .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

On a finer spatiotemporal scale , near four of seven on ( M ) cells , 10 of 14 off ( M ) cells and 0 of four neutral ( M ) cells , average serotonin levels fell significantly within + / - 100 ms of spontaneous spikes .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

Lower serotonin may have caused the higher spike probability ; the converse is theoretically unlikely , since delays between release and detection are estimated to exceed 100 ms .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

Increased serotonin and decreased firing were always seen following iontophoresis or intravenous injection ( 1 mg / kg ) of the serotonin re - uptake inhibitor clomipramine ( n = 7 ) .
【GOLD_E】
serotonin	chem
serotonin	chem
clomipramine	chem
【PRE_E】
serotonin	chem
serotonin	chem
clomipramine	chem
【GOLD_R】
【PRE_R】

Iontophoresis of + / - propranolol , whose serotonergic actions include antagonism and partial agonism at 5 - HT1 receptors , also increased serotonin and decreased firing ( n = 4 ) .
【GOLD_E】
5-HT1	geneN
+/-propranolol	chem
serotonin	chem
【PRE_E】
+/-propranolol	chem
5-HT1	geneY
serotonin	chem
【GOLD_R】
+/-propranolol	5-HT1	C5
+/-propranolol	5-HT1	C6
【PRE_R】

Methiothepin ( intravenous , 1 mg / kg ) , whose serotonergic actions include 5 - HT1 and 5 - HT2 antagonism , typically raised serotonin levels ( four of five cells ) and always blocked inhibition by clomipramine ( n = 3 ) .
【GOLD_E】
Methiothepin	chem
serotonin	chem
clomipramine	chem
5-HT1	geneN
5-HT2	geneN
【PRE_E】
Methiothepin	chem
5-HT1	geneY
5-HT2	geneN
serotonin	chem
clomipramine	chem
【GOLD_R】
Methiothepin	5-HT1	C6
Methiothepin	5-HT2	C6
【PRE_R】
Methiothepin	5-HT2	C6

Iontophoresis of glutamate always lowered serotonin and increased firing ( n = 4 ) .
【GOLD_E】
glutamate	chem
serotonin	chem
【PRE_E】
glutamate	chem
serotonin	chem
【GOLD_R】
【PRE_R】

Since serotonin levels and firing were usually inversely correlated , except near on ( M ) cells during pinch , we propose that serotonin is released from terminals of incoming nociceptive afferents .
【GOLD_E】
serotonin	chem
serotonin	chem
【PRE_E】
serotonin	chem
serotonin	chem
【GOLD_R】
【PRE_R】

Prior neuroanatomical knowledge favors a midbrain origin for these afferents , while some of the drug findings suggest that their terminals possess inhibitory serotonergic autoreceptors , possibly of 5 - HT1b subtype .
【GOLD_E】
5-HT1b	geneY
【PRE_E】
5-HT1b	geneY
【GOLD_R】
【PRE_R】

The released serotonin could contribute to the inhibition of off ( M ) cells and excitation of on ( M ) cells by noxious stimulation , since inhibitory 5 - HT1a receptors and excitatory 5 - HT2 receptors , respectively , have previously been shown to dominate their serotonergic responses .
【GOLD_E】
serotonin	chem
5-HT1a	geneY
5-HT2	geneN
【PRE_E】
serotonin	chem
5-HT1a	geneY
5-HT2receptors	geneN
【GOLD_R】
【PRE_R】

The Hsp90 - specific inhibitor geldanamycin selectively disrupts kinase - mediated signaling events of T - lymphocyte activation .
【GOLD_E】
Hsp90	geneN
kinase	geneN
geldanamycin	chem
【PRE_E】
Hsp90	geneN
geldanamycin	chem
kinase	geneN
T-lymphocyte	geneN
【GOLD_R】
geldanamycin	Hsp90	C4
geldanamycin	kinase	C4
【PRE_R】
geldanamycin	kinase	C4
geldanamycin	T-lymphocyte	C4

The 90 - kDa heat shock protein ( Hsp90 ) is the most abundant molecular chaperone of eukaryotic cells .
【GOLD_E】
Hsp90	geneN
90-kDaheatshockprotein	geneN
molecularchaperone	geneN
【PRE_E】
90-kDaheatshockprotein	geneN
Hsp90	geneN
chaperone	geneN
【GOLD_R】
【PRE_R】

Its chaperone function in folding nascent proteins seems to be restricted to a subset of proteins including major components of signal transduction pathways ( eg , nuclear hormone receptors , transcription factors , and protein kinases ) .
【GOLD_E】
nuclearhormonereceptors	geneN
proteinkinases	geneN
【PRE_E】
chaperone	geneN
nuclearhormonereceptors	geneN
proteinkinases	geneN
【GOLD_R】
【PRE_R】

Improper function of these proteins can be induced by selective disruption of their complexes with Hsp90 using the benzoquinonoid ansamycin geldanamycin .
【GOLD_E】
Hsp90	geneN
benzoquinonoidansamycin	chem
geldanamycin	chem
【PRE_E】
Hsp90	geneN
benzoquinonoidansamycingeldanamycin	chem
【GOLD_R】
benzoquinonoidansamycin	Hsp90	C4
geldanamycin	Hsp90	C4
【PRE_R】
Hsp90	benzoquinonoidansamycingeldanamycin	C4

In this study , we demonstrate that geldanamycin treatment blocks interleukin ( IL ) - 2 secretion , IL - 2 receptor expression , and proliferation of stimulated T - lymphocytes .
【GOLD_E】
interleukin(IL)-2	geneY
IL-2receptor	geneN
geldanamycin	chem
【PRE_E】
geldanamycin	chem
interleukin(IL)-2	geneY
IL-2	geneY
【GOLD_R】
geldanamycin	interleukin(IL)-2	C4
geldanamycin	IL-2receptor	C4
【PRE_R】
geldanamycin	interleukin(IL)-2	C4
geldanamycin	IL-2	C4

Moreover , geldanamycin decreases the amount and phosphorylation of Lck and Raf - 1 kinases and prevents activation of the extracellular signal regulated kinase ( ERK ) - 2 kinase .
【GOLD_E】
Lck	geneY
Raf-1	geneY
kinases	geneN
extracellularsignalregulatedkinase(ERK)-2	geneY
kinase	geneN
geldanamycin	chem
【PRE_E】
geldanamycin	chem
Lck	geneN
Raf-1kinases	geneY
extracellularsignalregulatedkinase(ERK)-2kinase	geneN
【GOLD_R】
geldanamycin	Lck	C4
geldanamycin	Raf-1	C4
geldanamycin	kinases	C4
geldanamycin	Lck	C4
geldanamycin	Raf-1	C4
geldanamycin	kinases	C4
geldanamycin	extracellularsignalregulatedkinase(ERK)-2	C4
geldanamycin	kinase	C4
【PRE_R】
geldanamycin	Lck	C4
geldanamycin	Raf-1kinases	C4
geldanamycin	extracellularsignalregulatedkinase(ERK)-2kinase	C4

Geldanamycin also disrupts the T - cell receptor - mediated activation of nuclear factor of activated T - cells ( NF - AT ) .
【GOLD_E】
T-cellreceptor	geneN
nuclearfactorofactivatedT-cells	geneN
NF-AT	geneN
Geldanamycin	chem
【PRE_E】
Geldanamycin	chem
T-cellreceptor	geneN
nuclearfactor	geneN
NF-AT	geneN
【GOLD_R】
Geldanamycin	T-cellreceptor	C4
Geldanamycin	nuclearfactorofactivatedT-cells	C4
Geldanamycin	NF-AT	C4
【PRE_R】
Geldanamycin	NF-AT	C3

Treatment with geldanamycin , however , does not affect the activation of lysophosphatide acyltransferase , which is a plasma membrane enzyme coupled to the T - cell receptor after T - cell stimulation .
【GOLD_E】
T-cellreceptor	geneN
geldanamycin	chem
lysophosphatideacyltransferase	geneN
【PRE_E】
geldanamycin	chem
lysophosphatideacyltransferase	geneN
T-cellreceptor	geneN
【GOLD_R】
【PRE_R】

Through demonstrating the selective inhibition of kinase - related T - lymphocyte responses by geldanamycin , our results emphasize the substantial role of Hsp90 - kinase complexes in T - cell activation .
【GOLD_E】
kinase	geneN
Hsp90	geneN
kinase	geneN
geldanamycin	chem
【PRE_E】
kinase	geneN
T-lymphocyte	geneN
geldanamycin	chem
Hsp90-kinase	geneN
【GOLD_R】
geldanamycin	kinase	C4
【PRE_R】
T-lymphocyte	geldanamycin	C4

Carnitine biosynthesis . Purification of gamma - butyrobetaine hydroxylase from rat liver .
【GOLD_E】
Carnitine	chem
gamma-butyrobetaine	chem
gamma-butyrobetainehydroxylase	geneY
【PRE_E】
Carnitine	chem
gamma-butyrobetainehydroxylase	geneY
【GOLD_R】
【PRE_R】

gamma - Butyrobetaine hydroxylase catalyse the last step in carnitine biosynthesis , the formation of L - carnitine from gamma - butyrobetaine , a reaction dependent on Fe2 + , alpha - ketoglutarate , ascorbate and oxygen .
【GOLD_E】
carnitine	chem
L-carnitine	chem
gamma-Butyrobetainehydroxylase	geneY
gamma-Butyrobetaine	chem
gamma-butyrobetaine	chem
Fe2+	chem
alpha-ketoglutarate	chem
ascorbate	chem
oxygen	chem
【PRE_E】
gamma-Butyrobetainehydroxylase	geneY
carnitine	chem
L-carnitine	chem
gamma-butyrobetaine	chem
Fe2+	chem
alpha-ketoglutarate	chem
ascorbate	chem
oxygen	chem
【GOLD_R】
carnitine	gamma-Butyrobetainehydroxylase	C9
L-carnitine	gamma-Butyrobetainehydroxylase	C9
gamma-butyrobetaine	gamma-Butyrobetainehydroxylase	C9
【PRE_R】

Initial attempts to purify the protein from rat liver showed that gamma - butyrobetaine hydroxylase is unstable .
【GOLD_E】
gamma-butyrobetainehydroxylase	geneY
gamma-butyrobetaine	chem
【PRE_E】
gamma-butyrobetainehydroxylase	geneY
【GOLD_R】
【PRE_R】

We , therefore , determined the influence of various compounds on the stability of gamma - butyrobetaine hydroxylase at different storage temperatures .
【GOLD_E】
gamma-butyrobetainehydroxylase	geneY
gamma-butyrobetaine	chem
【PRE_E】
gamma-butyrobetainehydroxylase	geneY
【GOLD_R】
【PRE_R】

The enzyme activity was best conserved by storing the protein at 4 degrees C in the presence of 200 g / l glycerol and 10 mM DTT .
【GOLD_E】
DTT	chem
glycerol	chem
【PRE_E】
glycerol	chem
DTT	chem
【GOLD_R】
【PRE_R】

We subsequently purified the enzyme from rat liver to apparent homogeneity by liquid chromatography .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism .
【GOLD_E】
Aspirin	chem
sodiumsalicylate	chem
ETAreceptors	geneY
【PRE_E】
Aspirin	chem
sodiumsalicylate	chem
endothelinETAreceptors	geneY
【GOLD_R】
【PRE_R】
Aspirin	endothelinETAreceptors	C4
sodiumsalicylate	endothelinETAreceptors	C4

Aspirin is a commonly used drug with a wide pharmacological spectrum including antiplatelet , anti - inflammatory , and neuroprotective actions .
【GOLD_E】
Aspirin	chem
【PRE_E】
Aspirin	chem
【GOLD_R】
【PRE_R】

This study shows that aspirin and sodium salicylate , its major blood metabolite , reverse contractile actions of endothelin - 1 ( ET - 1 ) in isolated rat aorta and human mammary arteries .
【GOLD_E】
endothelin-1	geneN
ET-1	geneN
aspirin	chem
sodiumsalicylate	chem
【PRE_E】
aspirin	chem
sodiumsalicylate	chem
endothelin-1	geneY
ET-1	geneY
【GOLD_R】
【PRE_R】

They also prevent the intracellular Ca ( 2 + ) mobilizing action of ET - 1 in cultured endothelial cells but not those of neuromedin B or UTP .
【GOLD_E】
ET-1	geneY
neuromedinB	geneY
Ca(2+)	chem
【PRE_E】
Ca(2+)	chem
ET-1	geneY
neuromedinBorUTP	geneN
【GOLD_R】
【PRE_R】

Inhibition of the actions of ET - 1 by salicylates is apparently competitive .
【GOLD_E】
ET-1	geneY
salicylates	chem
【PRE_E】
ET-1	geneY
【GOLD_R】
salicylates	ET-1	C4
【PRE_R】

Salicylates inhibit ( 125 ) I - ET - 1 binding to recombinant rat ETA receptors .
【GOLD_E】
ET-1	geneY
ratETAreceptors	geneY
Salicylates	chem
(125)I	chem
【PRE_E】
Salicylates	chem
(125)I-ET-1	chem
ratETAreceptors	geneY
【GOLD_R】
【PRE_R】

Salicylic acid promotes dissociation of ( 125 ) I - ET - 1 ETA receptor complexes both in the absence and the presence of unlabeled ET - 1 .
【GOLD_E】
Salicylicacid	chem
(125)I	chem
ET-1	geneY
ETAreceptor	geneY
ET-1	geneY
【PRE_E】
Salicylicacid	chem
(125)I-ET-1ETAreceptor	geneN
ET-1	geneY
【GOLD_R】
【PRE_R】

It has no influence on the rate of association of ( 125 ) I - ET - 1 to ETA receptors .
【GOLD_E】
(125)I	chem
ET-1	geneY
ETAreceptors	geneY
【PRE_E】
(125)I-ET-1	geneY
ETAreceptors	geneY
【GOLD_R】
【PRE_R】

Salicylates do not promote dissociation of ( 125 ) I - ET - 1 ETB receptor complexes .
【GOLD_E】
Salicylates	chem
(125)I	chem
ET-1	geneY
ETBreceptor	geneY
【PRE_E】
Salicylates	chem
(125)I-ET-1ETBreceptor	geneN
【GOLD_R】
【PRE_R】

Salicylates potentiate relaxing actions of receptor antagonists such as bosentan .
【GOLD_E】
Salicylates	chem
bosentan	chem
【PRE_E】
bosentan	chem
【GOLD_R】
【PRE_R】

It is concluded that salicylates are allosteric inhibitors of ETA receptors .
【GOLD_E】
ETAreceptors	geneY
salicylates	chem
【PRE_E】
salicylates	chem
ETAreceptors	geneY
【GOLD_R】
【PRE_R】

The results also suggest that : 1 ) irreversible ET - 1 binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of salicylates and ETA receptor antagonists should be used to evaluate the physiopathological role of ET - 1 and may be of therapeutic interest in the treatment of ischemic heart disease .
【GOLD_E】
ET-1	geneY
ETAreceptor	geneY
ET-1	geneY
salicylates	chem
【PRE_E】
ET-1	geneY
ETAreceptor	geneN
ET-1	geneY
【GOLD_R】
【PRE_R】

A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C .
【GOLD_E】
mitomycinC	chem
NQO1	geneN
【PRE_E】
NQO1	geneY
mitomycinC	chem
【GOLD_R】
mitomycinC	NQO1	C9
【PRE_R】

Mitomycin C ( MMC ) is a prototype bioreductive drug employed to treat a variety of cancers including head and neck cancer .
【GOLD_E】
MitomycinC	chem
MMC	chem
【PRE_E】
MitomycinC	chem
MMC	chem
【GOLD_R】
【PRE_R】

Among the various enzymes , dicoumarol inhibitable cytosolic NAD ( P ) H : quinone oxidoreductase1 ( NQO1 ) was shown to catalyse bioreductive activation of MMC leading to cross - linking of the DNA and cytotoxicity .
【GOLD_E】
MMC	chem
NAD(P)H:quinoneoxidoreductase1	geneN
NQO1	geneN
dicoumarol	chem
NAD(P)H	chem
quinone	chem
【PRE_E】
dicoumarolinhibitablecytosolicNAD(P)H:quinoneoxidoreductase1	geneY
NQO1	geneY
MMC	chem
【GOLD_R】
dicoumarol	NAD(P)H:quinoneoxidoreductase1	C4
dicoumarol	NQO1	C4
MMC	NAD(P)H:quinoneoxidoreductase1	C9
MMC	NQO1	C9
【PRE_R】
NQO1	MMC	C9

However , the role of NQO1 in metabolic activation of MMC has been disputed .
【GOLD_E】
MMC	chem
NQO1	geneN
【PRE_E】
NQO1	geneY
MMC	chem
【GOLD_R】
MMC	NQO1	C9
【PRE_R】
NQO1	MMC	C9

In this report , we present cellular and animal models to demonstrate that NQO1 may play only a minor role in metabolic activation of MMC .
【GOLD_E】
MMC	chem
NQO1	geneN
【PRE_E】
NQO1	geneY
MMC	chem
【GOLD_R】
MMC	NQO1	C9
【PRE_R】

We further demonstrate that bioreductive activation of MMC is catalysed by a unique cytosolic activity which is related but distinct from NQO1 .
【GOLD_E】
MMC	chem
NQO1	geneN
【PRE_E】
MMC	chem
NQO1	geneY
【GOLD_R】
【PRE_R】

Chinese hamster ovary ( CHO ) cells were developed that permanently express higher levels of cDNA - derived NQO1 .
【GOLD_E】
NQO1	geneN
【PRE_E】
NQO1	geneY
【GOLD_R】
【PRE_R】

These cells showed significantly increased protection against menadione toxicity .
【GOLD_E】
menadione	chem
【PRE_E】
menadione	chem
【GOLD_R】
【PRE_R】

However , they failed to demonstrate higher cytotoxicity due to exposure to MMC under oxygen ( normal air ) or hypoxia , as compared to the wild - type control CHO cells .
【GOLD_E】
MMC	chem
oxygen	chem
【PRE_E】
MMC	chem
oxygen	chem
【GOLD_R】
【PRE_R】

Disruption of the NQO1 gene by homologous recombination generated NQO1 - / - mice that do not express the NQO1 gene resulting in the loss of NQO1 protein and activity .
【GOLD_E】
NQO1	geneN
NQO1	geneN
NQO1	geneN
NQO1	geneN
【PRE_E】
NQO1	geneY
NQO1	geneY
NQO1	geneY
NQO1	geneY
【GOLD_R】
【PRE_R】

The cytosolic fractions from liver and colon tissues of NQO1 - / - mice showed similar amounts of DNA cross - linking upon exposure to MMC , as observed in NQO1 + / + mice .
【GOLD_E】
NQO1	geneN
NQO1	geneN
MMC	chem
【PRE_E】
NQO1	geneY
MMC	chem
NQO1	geneY
【GOLD_R】
【PRE_R】

The unique cytosolic activity that activated MMC in cytosolic fractions of liver and colon tissues of NQO1 - / - mice was designated as cytosolic MMC reductase .
【GOLD_E】
NQO1	geneN
MMCreductase	geneN
MMC	chem
MMC	chem
【PRE_E】
MMC	chem
NQO1	geneY
cytosolicMMCreductase	geneY
【GOLD_R】
【PRE_R】

This activity , like NQO1 , was inhibited by dicoumarol and immunologically related to NQO1 .
【GOLD_E】
NQO1	geneN
NQO1	geneN
dicoumarol	chem
【PRE_E】
NQO1	geneY
dicoumarol	chem
NQO1	geneY
【GOLD_R】
dicoumarol	NQO1	C4
【PRE_R】
NQO1	dicoumarol	C4
dicoumarol	NQO1	C4

Troglitazone reduces plasminogen activator inhibitor - 1 expression and secretion in cultured human adipocytes .
【GOLD_E】
plasminogenactivatorinhibitor-1	geneY
Troglitazone	chem
【PRE_E】
Troglitazone	chem
plasminogenactivatorinhibitor-1	geneY
【GOLD_R】
Troglitazone	plasminogenactivatorinhibitor-1	C4
【PRE_R】
Troglitazone	plasminogenactivatorinhibitor-1	C4

AIMS / HYPOTHESIS : Increased plasma plasminogen activator inhibitor - 1 ( PAI - 1 ) concentrations are characteristic for subjects with insulin resistance and could contribute to the increased cardiovascular risk in this state .
【GOLD_E】
plasmaplasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
insulin	geneY
【PRE_E】
plasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

In this study , we investigated the effect of troglitazone , a ligand of the nuclear receptor peroxisome proliferator activated receptor - gamma , on PAI - 1 expression and secretion in human adipocytes .
【GOLD_E】
nuclearreceptor	geneN
peroxisomeproliferatoractivatedreceptor-gamma	geneY
PAI-1	geneY
troglitazone	chem
【PRE_E】
troglitazone	chem
nuclearreceptorperoxisomeproliferatoractivatedreceptor-gamma	geneN
PAI-1	geneY
【GOLD_R】
【PRE_R】

METHODS : We used two models : in vitro differentiated subcutaneous and omental adipocytes cultured under serum - free conditions and isolated subcutaneous and omental fat cells kept in suspension culture .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Plasminogen activator inhibitor - 1 protein was measured by ELISA , PAI - 1 mRNA by a semiquantitative RT - PCR technique .
【GOLD_E】
Plasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
【PRE_E】
Plasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
【GOLD_R】
【PRE_R】

RESULTS : Exposure of in vitro differentiated subcutaneous adipocytes from young normal - weight females to 1 microgram / ml troglitazone for 72 h caused a reduction of both PAI - 1 secretion ( by 29 + / - 5 % ; p < 0.01 ) and PAI - 1 mRNA expression ( by 26 + / - 3 % ; p < 0.05 ) .
【GOLD_E】
PAI-1	geneY
PAI-1	geneY
troglitazone	chem
【PRE_E】
troglitazone	chem
PAI-1	geneY
PAI-1	geneY
【GOLD_R】
troglitazone	PAI-1	C4
troglitazone	PAI-1	C4
【PRE_R】
troglitazone	PAI-1	C4
troglitazone	PAI-1	C4

In cultures from severely obese subjects , troglitazone induced a decrease of PAI - 1 antigen secretion from newly differentiated omental adipocytes by 49 + / - 8 % ( p < 0.01 ) and from subcutaneous adipocytes by 30 + / - 7 % ( p < 0.05 ) .
【GOLD_E】
troglitazone	chem
PAI-1	geneY
【PRE_E】
troglitazone	chem
PAI-1	geneY
【GOLD_R】
troglitazone	PAI-1	C4
【PRE_R】
troglitazone	PAI-1	C4

Exposure of freshly isolated subcutaneous and omental adipocytes in suspension culture to troglitazone induced a similar reduction of PAI - 1 concentration in the culture medium ( by 35 + / - 11 % , p < 0.05 , and 33 + / - 8 % , p < 0.05 compared with control , respectively ) .
【GOLD_E】
PAI-1	geneY
troglitazone	chem
【PRE_E】
troglitazone	chem
PAI-1	geneY
【GOLD_R】
troglitazone	PAI-1	C4
【PRE_R】
troglitazone	PAI-1	C4

CONCLUSION / INTERPRETATION : This study provides evidence that troglitazone reduces PAI - 1 production in human adipocytes , probably at the transcriptional level .
【GOLD_E】
PAI-1	geneY
troglitazone	chem
【PRE_E】
troglitazone	chem
PAI-1	geneY
【GOLD_R】
troglitazone	PAI-1	C4
【PRE_R】
troglitazone	PAI-1	C3

This observation could point to a new beneficial effect of troglitazone , particularly in obese subjects , which could be associated with a reduced cardiovascular risk .
【GOLD_E】
troglitazone	chem
【PRE_E】
troglitazone	chem
【GOLD_R】
【PRE_R】

Effect of JTH - 601 , a novel alpha ( 1 ) - adrenoceptor antagonist , on prostate function in dogs .
【GOLD_E】
alpha(1)-adrenoceptor	geneN
【PRE_E】
JTH-601	chem
alpha(1)-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

We examined the effect of JTH - 601 ( 3 - inverted question markN - [ 2 - ( 4 - hydroxy - 2 - isopropyl - 5 - methylphenoxy ) ethyl ] - N - methylaminom ethyl inverted question mark - 4 - methoxy - 2,5,6 - trimethylphenol hemifumarate ) , a new alpha ( 1L ) - adrenoceptor antagonist , on prostatic function in isolated canine prostate and in anesthetized dogs .
【GOLD_E】
N-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom	chem
alpha(1L)-adrenoceptor	geneN
ethyl	chem
4-methoxy-2,5,6-trimethylphenolhemifumarate	chem
JTH-601	chem
【PRE_E】
JTH-601	chem
markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminomethyl	chem
mark-4-methoxy-2,5,6-trimethylphenolhemifumarate	chem
alpha(1L)-adrenoceptor	geneN
【GOLD_R】
N-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom	alpha(1L)-adrenoceptor	C6
ethyl	alpha(1L)-adrenoceptor	C6
4-methoxy-2,5,6-trimethylphenolhemifumarate	alpha(1L)-adrenoceptor	C6
JTH-601	alpha(1L)-adrenoceptor	C6
【PRE_R】
markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminomethyl	alpha(1L)-adrenoceptor	C6

In the contraction study , phenylephrine and noradrenaline produced concentration - dependent contractions in canine prostate and carotid artery , respectively .
【GOLD_E】
phenylephrine	chem
noradrenaline	chem
【PRE_E】
phenylephrine	chem
noradrenaline	chem
【GOLD_R】
【PRE_R】

In these tissues , JTH - 601 , prazosin ( a non - selective alpha ( 1 ) - adrenoceptor antagonist ) , and tamsulosin ( an alpha ( 1A ) - adrenoceptor antagonist ) competitively antagonized contraction in a concentration - dependent manner .
【GOLD_E】
JTH-601	chem
prazosin	chem
tamsulosin	chem
alpha(1)-adrenoceptor	geneN
alpha(1A)-adrenoceptor	geneY
【PRE_E】
JTH-601	chem
prazosin	chem
alpha(1)-adrenoceptor	geneN
tamsulosin	chem
alpha(1A)-adrenoceptor	geneY
【GOLD_R】
JTH-601	alpha(1)-adrenoceptor	C6
prazosin	alpha(1)-adrenoceptor	C6
tamsulosin	alpha(1A)-adrenoceptor	C6
【PRE_R】
JTH-601	alpha(1)-adrenoceptor	C6
alpha(1)-adrenoceptor	tamsulosin	C6
tamsulosin	alpha(1A)-adrenoceptor	C6

The pA ( 2 ) ( pK ( B ) ) values with prostate were 8.49 + / - 0.07 for JTH - 601 , 7.94 + / - 0.04 for prazosin and 9.42 + / - 0.22 for tamsulosin .
【GOLD_E】
prazosin	chem
tamsulosin	chem
【PRE_E】
pA(2)	geneY
JTH-601	chem
prazosin	chem
tamsulosin	chem
【GOLD_R】
【PRE_R】

The ratio of pA ( 2 ) ( carotid artery / prostate ) , i.e . prostatic selectivity , was 10.471 for JTH - 601 , 0.008 for prazosin and 0.371 for tamsulosin , respectively .
【GOLD_E】
JTH-601	chem
prazosin	chem
tamsulosin	chem
【PRE_E】
pA(2)	geneY
JTH-601	chem
prazosin	chem
tamsulosin	chem
【GOLD_R】
【PRE_R】

In anesthetized dogs , JTH - 601 ( 1 mg / kg , i.d . ) significantly decreased urethral pressure by 15 % without affecting blood pressure or heart rate .
【GOLD_E】
JTH-601	chem
【PRE_E】
JTH-601	chem
【GOLD_R】
【PRE_R】

Tamsulosin ( 0.1 mg / kg , i.d . ) decreased urethral pressure to the same extent as did JTH - 601 , but with a significant effect on blood pressure and heart rate .
【GOLD_E】
Tamsulosin	chem
JTH-601	chem
【PRE_E】
Tamsulosin	chem
JTH-601	chem
【GOLD_R】
【PRE_R】

JTH - 601 showed higher selectivity for canine prostate both in vitro and in vivo .
【GOLD_E】
JTH-601	chem
【PRE_E】
JTH-601	chem
【GOLD_R】
【PRE_R】

In prostate , an important role of the alpha ( 1L ) - adrenoceptor is suggested in the smooth muscle contraction mediated by alpha ( 1 ) - adrenoceptors .
【GOLD_E】
alpha(1L)-adrenoceptor	geneN
alpha(1)-adrenoceptors	geneN
【PRE_E】
alpha(1L)-adrenoceptor	geneN
alpha(1)-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

JTH - 601 is expected to be an effective alpha ( 1 ) - adrenoceptor antagonist for the treatment of urinary outlet obstruction by benign prostatic hypertrophy with a minimum effect on the cardiovascular system .
【GOLD_E】
alpha(1)-adrenoceptor	geneN
JTH-601	chem
【PRE_E】
JTH-601	chem
alpha(1)-adrenoceptor	geneY
【GOLD_R】
JTH-601	alpha(1)-adrenoceptor	C6
【PRE_R】
JTH-601	alpha(1)-adrenoceptor	C6

Severe impairment of salivation in Na + / K + / 2Cl - cotransporter ( NKCC1 ) - deficient mice .
【GOLD_E】
Na+	chem
K+	chem
2Cl-	chem
Na+/K+/2Cl-cotransporter	geneN
NKCC1	geneY
【PRE_E】
Na+/K+/2Cl-cotransporter	geneN
NKCC1	geneY
【GOLD_R】
【PRE_R】

The salivary fluid secretory mechanism is thought to require Na ( + ) / K ( + ) / 2Cl ( - ) cotransporter - mediated Cl ( - ) uptake .
【GOLD_E】
Na(+)	chem
K(+)	chem
2Cl(-)	chem
Cl(-)	chem
Na(+)/K(+)/2Cl(-)cotransporter	geneN
【PRE_E】
Na(+)/K(+)/2Cl(-)cotransporter	geneN
Cl(-)	chem
【GOLD_R】
Cl(-)	Na(+)/K(+)/2Cl(-)cotransporter	C9
【PRE_R】

To directly test this possibility we studied the in vivo and in vitro functioning of acinar cells from the parotid glands of mice with targeted disruption of Na ( + ) / K ( + ) / 2Cl ( - ) cotransporter isoform 1 ( Nkcc1 ) , the gene encoding the salivary Na ( + ) / K ( + ) / 2Cl ( - ) cotransporter .
【GOLD_E】
Na(+)	chem
K(+)	chem
2Cl(-)	chem
Na(+)	chem
K(+)	chem
2Cl(-)	chem
Na(+)/K(+)/2Cl(-)cotransporterisoform1	geneY
Nkcc1	geneY
Na(+)/K(+)/2Cl(-)cotransporter	geneN
【PRE_E】
Na(+)/K(+)/2Cl(-)cotransporterisoform1	geneN
Nkcc1	geneY
Na(+)/K(+)/2Cl(-)cotransporter	geneN
【GOLD_R】
【PRE_R】

In wild - type mice NKCC1 was localized to the basolateral membranes of parotid acinar cells , whereas expression was not detected in duct cells .
【GOLD_E】
NKCC1	geneY
【PRE_E】
NKCC1	geneY
【GOLD_R】
【PRE_R】

The lack of functional NKCC1 resulted in a dramatic reduction ( > 60 % ) in the volume of saliva secreted in response to a muscarinic agonist , the primary in situ salivation signal .
【GOLD_E】
NKCC1	geneY
【PRE_E】
NKCC1	geneY
【GOLD_R】
【PRE_R】

Consistent with defective Cl ( - ) uptake , a loss of bumetanide - sensitive Cl ( - ) influx was observed in parotid acinar cells from mice lacking NKCC1 .
【GOLD_E】
Cl(-)	chem
bumetanide	chem
Cl(-)	chem
NKCC1	geneY
【PRE_E】
Cl(-)	chem
bumetanide	chem
Cl(-)	chem
NKCC1	geneY
【GOLD_R】
【PRE_R】
Cl(-)	NKCC1	C9

Cl ( - ) / HCO ( 3 ) ( - ) exchanger activity was increased in parotid acinar cells isolated from knockout mice suggesting that the residual saliva secreted by mice lacking NKCC1 is associated with anion exchanger - dependent Cl ( - ) uptake .
【GOLD_E】
Cl(-)	chem
HCO(3)(-)	chem
NKCC1	geneY
Cl(-)	chem
Cl(-)/HCO(3)(-)exchanger	geneN
【PRE_E】
Cl(-)/HCO(3)(-)exchanger	geneY
NKCC1	geneY
anionexchanger	geneN
Cl(-)	chem
【GOLD_R】
【PRE_R】
NKCC1	Cl(-)	C9

Indeed , expression of the Cl ( - ) / HCO ( 3 ) ( - ) exchanger AE2 was enhanced suggesting that this transporter compensates for the loss of functional Na ( + ) / K ( + ) / 2Cl ( - ) cotransporter .
【GOLD_E】
Cl(-)/HCO(3)(-)exchanger	geneN
AE2	geneN
Na(+)/K(+)/2Cl(-)cotransporter	geneN
Cl(-)	chem
HCO(3)(-)	chem
Na(+)	chem
K(+)	chem
2Cl(-)	chem
【PRE_E】
Cl(-)/HCO(3)(-)exchangerAE2	geneN
Na(+)/K(+)/2Cl(-)cotransporter	geneN
【GOLD_R】
【PRE_R】

Furthermore , the ability of the parotid gland to conserve NaCl was abolished in NKCC1 - deficient mice .
【GOLD_E】
NKCC1	geneY
NaCl	chem
【PRE_E】
NaCl	chem
NKCC1	geneY
【GOLD_R】
【PRE_R】

This deficit was not associated with changes in the morphology of the ducts , but transcript levels for the alpha - , beta - , and gamma - subunits of the epithelial Na ( + ) channel were reduced .
【GOLD_E】
Na(+)	chem
【PRE_E】
Na(+)channel	geneN
【GOLD_R】
【PRE_R】

These data directly demonstrate that NKCC1 is the major Cl ( - ) uptake mechanism across the basolateral membrane of acinar cells and is critical for driving saliva secretion in vivo .
【GOLD_E】
Cl(-)	chem
NKCC1	geneY
【PRE_E】
NKCC1	geneY
Cl(-)	chem
【GOLD_R】
Cl(-)	NKCC1	C9
【PRE_R】

Evaluation of in vivo binding properties of 3H - NMPB and 3H - QNB in mouse brain .
【GOLD_E】
3H-NMPB	chem
3H-QNB	chem
【PRE_E】
3H-NMPB	chem
3H-QNB	chem
【GOLD_R】
【PRE_R】

UNLABELLED : Apparent muscarinic acetylcholine ( mAch ) receptor occupancy in mouse cerebral cortex , hippocampus , and striatum by scopolamine , an antagonist , and biperiden , a relatively selective M1 antagonist , was estimated with competitive binding studies using two different radioligands : 3H - N - methyl piperidyl benzilate ( 3H - NMPB ) and 3H - quinuclidinyl benzilate ( 3H - QNB ) .
【GOLD_E】
3H-NMPB	chem
acetylcholine	chem
3H-quinuclidinylbenzilate	chem
3H-QNB	chem
M1	geneY
muscarinicacetylcholine(mAch)receptor	geneN
scopolamine	chem
biperiden	chem
3H-N-methylpiperidylbenzilate	chem
【PRE_E】
acetylcholine(mAch)receptor	geneN
scopolamine	chem
biperiden	chem
3H-N-methylpiperidylbenzilate	chem
3H-NMPB	chem
3H-quinuclidinylbenzilate	chem
3H-QNB	chem
【GOLD_R】
scopolamine	muscarinicacetylcholine(mAch)receptor	C6
biperiden	M1	C6
【PRE_R】

Both radioligands labeled mAch receptors in these brain regions , and the relative regional distributions of the specific binding of 3H - NMPB in vivo paralleled the distribution of mAch receptors .
【GOLD_E】
3H-NMPB	chem
mAchreceptors	geneN
mAchreceptors	geneN
【PRE_E】
mAchreceptors	geneY
3H-NMPB	chem
mAchreceptors	geneN
【GOLD_R】
【PRE_R】

3H - NMPB binding in vivo was much more sensitive to direct competitive inhibition by scopolamine than was 3H - QNB .
【GOLD_E】
3H-NMPB	chem
scopolamine	chem
3H-QNB	chem
【PRE_E】
3H-NMPB	chem
scopolamine	chem
3H-QNB	chem
【GOLD_R】
【PRE_R】

A similar discrepancy in sensitivity to competitors between 3H - NMPB and 3H - QNB was also observed when biperiden was used as a competitor , indicating that binding to different subtypes of the mAch receptor could not account for the observed differences in sensitivity to competition .
【GOLD_E】
3H-NMPB	chem
3H-QNB	chem
biperiden	chem
mAchreceptor	geneN
【PRE_E】
3H-NMPB	chem
3H-QNB	chem
biperiden	chem
mAchreceptor	geneY
【GOLD_R】
【PRE_R】

An in vivo saturation study suggested that the apparent association rate constant ( k on ) of 3H - QNB binding might be changed by ligand concentration .
【GOLD_E】
3H-QNB	chem
【PRE_E】
3H-QNB	chem
【GOLD_R】
【PRE_R】

The heterogeneity of the free ligand concentration in intact brain was assessed in relation to the ligand concentration dependency of the apparent association rate constant ( k on ) of 3H - QNB binding .
【GOLD_E】
3H-QNB	chem
【PRE_E】
3H-QNB	chem
【GOLD_R】
【PRE_R】

This finding , together with the more favorable accumulation of 3H - NMPB in cerebral cortex , hippocampus , and striatum , leads us to conclude that 3H - NMPB , or its positron emitting counterpart , should be the more favorable radiotracer for the estimation of mAch receptor occupancy by cholinergic drugs in the brain .
【GOLD_E】
mAchreceptor	geneN
3H-NMPB	chem
3H-NMPB	chem
【PRE_E】
3H-NMPB	chem
3H-NMPB	chem
mAchreceptor	geneY
【GOLD_R】
【PRE_R】

KEYWORDS : mAch receptor , QNB , NMPB , in vivo , mouse .
【GOLD_E】
mAchreceptor	geneN
QNB	chem
NMPB	chem
【PRE_E】
mAchreceptor	geneY
QNB	chem
NMPB	chem
【GOLD_R】
【PRE_R】

Impaired expression of the uncoupling protein - 3 gene in skeletal muscle during lactation : fibrates and troglitazone reverse lactation - induced downregulation of the uncoupling protein - 3 gene .
【GOLD_E】
troglitazone	chem
uncouplingprotein-3	geneY
uncouplingprotein-3	geneY
【PRE_E】
uncouplingprotein-3	geneY
fibrates	chem
troglitazone	chem
uncouplingprotein-3	geneY
【GOLD_R】
troglitazone	uncouplingprotein-3	C3
【PRE_R】
uncouplingprotein-3	troglitazone	C3
fibrates	uncouplingprotein-3	C4

The expression of uncoupling protein ( UCP ) - 3 mRNA in skeletal muscle is dramatically reduced during lactation in mice .
【GOLD_E】
uncouplingprotein(UCP)-3	geneY
【PRE_E】
uncouplingprotein(UCP)-3	geneY
【GOLD_R】
【PRE_R】

The reduction in UCP - 3 mRNA levels lowers the amount of the UCP - 3 protein in skeletal muscle mitochondria during lactation .
【GOLD_E】
UCP-3	geneY
UCP-3	geneY
【PRE_E】
UCP-3	geneY
UCP-3	geneY
【GOLD_R】
【PRE_R】

Spontaneous or abrupt weaning reverses the downregulation of the UCP - 3 mRNA but not the reduction in UCP - 3 protein levels .
【GOLD_E】
UCP-3	geneY
UCP-3	geneY
【PRE_E】
UCP-3	geneY
UCP-3	geneY
【GOLD_R】
【PRE_R】

In lactating and virgin mice , however , fasting increases UCP - 3 mRNA levels .
【GOLD_E】
UCP-3	geneY
【PRE_E】
UCP-3	geneY
【GOLD_R】
【PRE_R】

Changes in UCP - 3 mRNA occur in parallel with modifications in the levels of free fatty acids , which are reduced in lactation and are upregulated due to weaning or fasting .
【GOLD_E】
fattyacids	chem
UCP-3	geneY
【PRE_E】
UCP-3	geneY
fattyacids	chem
【GOLD_R】
【PRE_R】

Modifications in the energy nutritional stress of lactating dams achieved by manipulating litter sizes do not influence UCP - 3 mRNA levels in skeletal muscle .
【GOLD_E】
UCP-3	geneY
【PRE_E】
UCP-3	geneY
【GOLD_R】
【PRE_R】

Conversely , when mice are fed a high - fat diet after parturition , the downregulation of UCP - 3 mRNA and UCP - 3 protein levels due to lactation is partially reversed , as is the reduction in serum free fatty acid levels .
【GOLD_E】
fattyacid	chem
UCP-3	geneY
UCP-3	geneY
【PRE_E】
UCP-3	geneY
UCP-3	geneY
fattyacid	chem
【GOLD_R】
【PRE_R】
UCP-3	fattyacid	C3
UCP-3	fattyacid	C3

Treatment of lactating mice with a single injection of bezafibrate , an activator of the peroxisome proliferator - activated receptor ( PPAR ) , raises UCP - 3 mRNA in skeletal muscle to levels similar to those in virgin mice .
【GOLD_E】
peroxisomeproliferator-activatedreceptor	geneN
PPAR	geneN
UCP-3	geneY
bezafibrate	chem
【PRE_E】
bezafibrate	chem
peroxisomeproliferator-activatedreceptor	geneY
PPAR	geneY
UCP-3	geneY
【GOLD_R】
bezafibrate	peroxisomeproliferator-activatedreceptor	C3
bezafibrate	PPAR	C3
bezafibrate	UCP-3	C3
【PRE_R】
bezafibrate	peroxisomeproliferator-activatedreceptor	C3
bezafibrate	PPAR	C3
bezafibrate	UCP-3	C3

4 - chloro - 6 - [ ( 2,3 - xylidine ) - pirimidinylthio ] acetic acid ( WY - 14,643 ) , a specific ligand of the PPAR - alpha subtype , causes the most dramatic increase in UCP - 3 mRNA , whereas troglitazone , a specific activator of PPAR - gamma , also significantly increases UCP - 3 mRNA abundance in skeletal muscle of lactating mice .
【GOLD_E】
PPAR-alpha	geneY
UCP-3	geneY
PPAR-gamma	geneY
UCP-3	geneY
4-chloro-6-[(2,3-xylidine)-pirimidinylthio]aceticacid	chem
WY-14,643	chem
troglitazone	chem
【PRE_E】
4-chloro-6-[(2,3-xylidine)-pirimidinylthio]aceticacid	chem
WY-14,643	chem
PPAR-alpha	geneY
UCP-3	geneY
troglitazone	chem
PPAR-gamma	geneY
UCP-3	geneY
【GOLD_R】
troglitazone	PPAR-gamma	C3
4-chloro-6-[(2,3-xylidine)-pirimidinylthio]aceticacid	UCP-3	C3
WY-14,643	UCP-3	C3
troglitazone	UCP-3	C3
【PRE_R】
UCP-3	troglitazone	C3
troglitazone	PPAR-gamma	C3
troglitazone	UCP-3	C3

However , in virgin mice , bezafibrate and WY - 14,643 do not significantly affect UCP - 3 mRNA expression , whereas troglitazone is at least as effective as it is in lactating dams .
【GOLD_E】
UCP-3	geneY
bezafibrate	chem
WY-14,643	chem
troglitazone	chem
【PRE_E】
bezafibrate	chem
WY-14,643	chem
UCP-3	geneY
troglitazone	chem
【GOLD_R】
【PRE_R】

It is proposed that the UCP - 3 gene is regulated in skeletal muscle during lactation in response to changes in circulating free fatty acids by mechanisms involving activation of PPARs .
【GOLD_E】
UCP-3	geneY
PPARs	geneN
fattyacids	chem
【PRE_E】
UCP-3	geneY
fattyacids	chem
PPARs	geneN
【GOLD_R】
fattyacids	PPARs	C3
【PRE_R】

The impaired expression of the UCP - 3 gene is consistent with the involvement of UCP - 3 gene regulation in the reduction of the use of fatty acids as fuel by the skeletal muscle and in impaired adaptative thermogenesis , both of which are major metabolic adaptations that occur during lactation .
【GOLD_E】
UCP-3	geneY
UCP-3	geneY
fattyacids	chem
【PRE_E】
UCP-3	geneY
UCP-3	geneY
fattyacids	chem
【GOLD_R】
【PRE_R】

The apoptosome : heart and soul of the cell death machine .
【GOLD_E】
【PRE_E】
apoptosome	geneN
【GOLD_R】
【PRE_R】

Apoptosis is a fundamental biologic process by which metazoan cells orchestrate their own self - demise .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Genetic analyses of the nematode C elegans identified three core components of the suicide apparatus which include CED - 3 , CED - 4 , and CED - 9 .
【GOLD_E】
CED-3	geneY
CED-4	geneY
CED-9	geneY
【PRE_E】
CED-3	geneY
CED-4	geneY
CED-9	geneY
【GOLD_R】
【PRE_R】

An analogous set of core constituents exists in mammalian cells and includes caspase - 9 , Apaf - 1 , and bcl - 2 / xL , respectively .
【GOLD_E】
bcl-2/xL	geneN
caspase-9	geneY
Apaf-1	geneY
【PRE_E】
caspase-9	geneY
Apaf-1	geneY
bcl-2	geneY
xL	geneY
【GOLD_R】
【PRE_R】

CED - 3 and CED - 4 , along with their mammalian counterparts , function to kill cells , whereas CED - 9 and its mammalian equivalents protect cells from death .
【GOLD_E】
CED-3	geneY
CED-4	geneY
CED-9	geneY
【PRE_E】
CED-3	geneY
CED-4	geneY
CED-9	geneY
【GOLD_R】
【PRE_R】

These central components biochemically intermingle in a ternary complex recently dubbed the `` apoptosome. `` The C elegans protein EGL - 1 and its mammalian counterparts , pro - apoptotic members of the bcl - 2 family , induce cell death by disrupting apoptosome interactions .
【GOLD_E】
inEGL	geneY
hebcl	geneN
【PRE_E】
EGL-1	geneY
bcl-2	geneY
【GOLD_R】
【PRE_R】

Thus , EGL - 1 may represent a primordial signal integrator for the apoptosome .
【GOLD_E】
EGL-1	geneY
【PRE_E】
EGL-1	geneY
primordialsignalintegrator	geneN
apoptosome	geneN
【GOLD_R】
【PRE_R】

Various biochemical processes including oligomerization , adenosine triphosphate ATP / dATP binding , and cytochrome c interaction play a role in regulating the ternary death complex .
【GOLD_E】
cytochromec	geneY
adenosinetriphosphate	chem
ATP	chem
【PRE_E】
adenosinetriphosphateATP	chem
dATP	chem
cytochromec	geneY
【GOLD_R】
【PRE_R】

Recent studies suggest that cell death receptors , such as CD95 , may amplify their suicide signal by activating the apoptosome .
【GOLD_E】
deathreceptors	geneN
CD95	geneY
【PRE_E】
CD95	geneY
apoptosome	geneN
【GOLD_R】
【PRE_R】

These mutual associations by core components of the suicide apparatus provide a molecular framework in which diverse death signals likely interface .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Understanding the apoptosome and its cellular connections will facilitate the design of novel therapeutic strategies for cancer and other disease states in which apoptosis plays a pivotal role .
【GOLD_E】
【PRE_E】
apoptosome	geneN
【GOLD_R】
【PRE_R】

Retigabine , a novel anti - convulsant , enhances activation of KCNQ2 / Q3 potassium channels .
【GOLD_E】
Retigabine	chem
potassium	chem
KCNQ2/Q3	geneN
potassiumchannels	geneN
【PRE_E】
Retigabine	chem
convulsant	chem
KCNQ2/Q3potassiumchannels	geneN
【GOLD_R】
Retigabine	potassiumchannels	C3
【PRE_R】

Retigabine [ N - ( 2 - amino - 4 - [ fluorobenzylamino ] - phenyl ) carbamic acid ; D - 23129 ] is a novel anticonvulsant , unrelated to currently available antiepileptic agents , with activity in a broad range of seizure models .
【GOLD_E】
D-23129	chem
Retigabine	chem
N-(2-amino-4-[fluorobenzylamino]-phenyl)carbamicacid	chem
【PRE_E】
Retigabine	chem
N-(2-amino-4-[fluorobenzylamino]-phenyl)carbamicacid	chem
D-23129	chem
【GOLD_R】
【PRE_R】

In the present study , we sought to determine whether retigabine could enhance current through M - like currents in PC12 cells and KCNQ2 / Q3 K ( + ) channels expressed in Chinese hamster ovary cells ( CHO - KCNQ2 / Q3 ) .
【GOLD_E】
KCNQ2/Q3	geneN
K(+)channels	geneN
KCNQ2/Q3	geneN
K(+)	chem
【PRE_E】
retigabine	chem
KCNQ2/Q3K(+)channels	geneN
KCNQ2/Q3	geneN
【GOLD_R】
【PRE_R】

In differentiated PC12 cells , retigabine enhanced a linopirdine - sensitive current .
【GOLD_E】
linopirdine	chem
【PRE_E】
retigabine	chem
linopirdine	chem
【GOLD_R】
【PRE_R】

The effect of retigabine was associated with a slowing of M - like tail current deactivation in these cells .
【GOLD_E】
retigabine	chem
【PRE_E】
retigabine	chem
【GOLD_R】
【PRE_R】

Retigabine ( 0.1 to 10 microM ) induced a potassium current and hyperpolarized CHO cells expressing KCNQ2 / Q3 cells but not in wild - type cells .
【GOLD_E】
Retigabine	chem
potassium	chem
KCNQ2/Q3	geneN
【PRE_E】
Retigabine	chem
potassium	chem
KCNQ2/Q3	geneN
【GOLD_R】
【PRE_R】

Retigabine - induced currents in CHO - KCNQ2 / Q3 cells were inhibited by 60.6 + / - 11 % ( n = 4 ) by the KCNQ2 / Q3 blocker , linopirdine ( 10 microM ) , and 82.7 + / - 5.4 % ( n = 4 ) by BaCl ( 2 ) ( 10 mM ) .
【GOLD_E】
Retigabine	chem
linopirdine	chem
BaCl(2)	chem
KCNQ2/Q3	geneN
KCNQ2/Q3	geneN
【PRE_E】
Retigabine	chem
KCNQ2/Q3	geneN
KCNQ2/Q3	geneN
linopirdine	chem
BaCl(2)	chem
【GOLD_R】
【PRE_R】
KCNQ2/Q3	linopirdine	C4

The mechanism by which retigabine enhanced KCNQ2 / Q3 currents involved large , drug - induced , leftward shifts in the voltage dependence of channel activation ( - 33.1 + / - 2.6 mV , n = 4 , by 10 microM retigabine ) .
【GOLD_E】
retigabine	chem
KCNQ2/Q3	geneN
retigabine	chem
【PRE_E】
retigabine	chem
KCNQ2/Q3	geneN
retigabine	chem
【GOLD_R】
【PRE_R】

Retigabine shifted the voltage dependence of channel activation with an EC ( 50 ) value of 1.6 + / - 0.3 microM ( slope factor was 1.2 + / - 0.1 , n = 4 to 5 cells per concentration ) .
【GOLD_E】
Retigabine	chem
【PRE_E】
Retigabine	chem
【GOLD_R】
【PRE_R】

Retigabine ( 0.1 to 10 microM ) also slowed the rate of channel deactivation , predominantly by increasing the contribution of a slowly deactivating tail current component .
【GOLD_E】
Retigabine	chem
【PRE_E】
Retigabine	chem
【GOLD_R】
【PRE_R】

Our findings identify KCNQ2 / Q3 channels as a molecular target for retigabine and suggest that activation of KCNQ2 / Q3 channels may be responsible for at least some of the anticonvulsant activity of this agent .
【GOLD_E】
KCNQ2/Q3	geneN
KCNQ2/Q3	geneN
retigabine	chem
【PRE_E】
KCNQ2/Q3	geneN
retigabine	chem
KCNQ2/Q3	geneN
【GOLD_R】
【PRE_R】

Serotonin transporter gene regulatory region polymorphism ( 5 - HTTLPR ) , [ 3H ] paroxetine binding in healthy control subjects and alcohol - dependent patients and their relationships to impulsivity .
【GOLD_E】
Serotonin	chem
[3H]paroxetine	chem
Serotonintransporter	geneY
5-HTTLPR	geneY
【PRE_E】
Serotonintransporter	geneY
5-HTTLPR	chem
[3H]paroxetine	chem
alcohol	chem
【GOLD_R】
【PRE_R】

The aim of this study was to investigate [ 3H ] paroxetine binding and impulsivity in alcohol - dependent and age - matched control subjects in relation to a 5 ' - promoter region serotonin transporter ( 5 - HTT ) polymorphism ( 5 - HTTLPR ) .
【GOLD_E】
[3H]paroxetine	chem
alcohol	chem
serotonintransporter	geneY
5-HTT	geneY
5-HTTLPR	geneY
serotonin	chem
【PRE_E】
[3H]paroxetine	chem
alcohol	chem
5'-promoterregionserotonintransporter	geneY
5-HTT	geneY
5-HTTLPR	geneY
【GOLD_R】
【PRE_R】

Alcohol - dependent subjects were hypothesized to show a decreased number of bindings sites and a lower dissociation constant .
【GOLD_E】
【PRE_E】
Alcohol	chem
【GOLD_R】
【PRE_R】

5 - HTTLPR S - genotype carriers in both alcohol - dependent and control subjects were expected to show significantly fewer binding sites and a lower dissociation constant .
【GOLD_E】
alcohol	chem
5-HTTLPR	geneY
【PRE_E】
5-HTTLPR	geneY
alcohol	chem
【GOLD_R】
【PRE_R】

Influences of impulsive traits , chronic daily alcohol intake , duration of alcohol dependence , age of onset and age on [ 3H ] paroxetine binding were also investigated .
【GOLD_E】
alcohol	chem
alcohol	chem
[3H]paroxetine	chem
【PRE_E】
alcohol	chem
alcohol	chem
[3H]paroxetine	chem
【GOLD_R】
【PRE_R】

Inpatients meeting DSM IV alcohol dependence criteria and of German descent were recruited to avoid ethnic stratification effects .
【GOLD_E】
alcohol	chem
【PRE_E】
alcohol	chem
【GOLD_R】
【PRE_R】

One hundred and seventeen control subjects of similar social status were recruited from a town community .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Blood samples were taken from both alcohol - dependent and control subjects to determine 5 - HTTLPR genotypes using PCR of lymphocyte DNA , and to perform platelet [ 3H ] paroxetine binding ( binding capacity : B ( max ) ; and dissociation constant : K ( D ) ) .
【GOLD_E】
[3H]paroxetine	chem
alcohol	chem
5-HTTLPR	geneY
【PRE_E】
alcohol	chem
5-HTTLPR	geneY
[3H]paroxetine	chem
【GOLD_R】
【PRE_R】

Impulsivity was assessed using the Barratt impulsiveness scale version 5 ( BIS - 5 ) in alcohol - dependent subjects only .
【GOLD_E】
alcohol	chem
【PRE_E】
alcohol	chem
【GOLD_R】
【PRE_R】

Alcohol - dependent subjects were subdivided into low or high impulsivity groups using a median - split of the BIS - 5 scale .
【GOLD_E】
Alcohol	chem
【PRE_E】
Alcohol	chem
【GOLD_R】
【PRE_R】

The control group was slightly older than the alcohol - dependent group ( not statistically significant ) .
【GOLD_E】
【PRE_E】
alcohol	chem
【GOLD_R】
【PRE_R】

[ 3H ] paroxetine binding was investigated in 72 control subjects and 72 patients , of which five patients met type 2 alcohol dependence criteria .
【GOLD_E】
[3H]paroxetine	chem
alcohol	chem
【PRE_E】
[3H]paroxetine	chem
alcohol	chem
【GOLD_R】
【PRE_R】

Genotyping was carried out in all patients and control subjects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A significant influence of duration of alcohol dependence was found on the [ 3H ] paroxetine binding K ( D ) but not B ( max . ) Neither alcohol - dependent nor control subjects showed any differences in B ( max ) or K ( D ) .
【GOLD_E】
alcohol	chem
[3H]paroxetine	chem
alcohol	chem
【PRE_E】
alcohol	chem
[3H]paroxetine	chem
K(D)	chem
alcohol	chem
【GOLD_R】
【PRE_R】

S - allele carriers did not show a decreased binding or lower dissociation constant .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Furthermore , no significant interaction between B ( max ) and K ( D ) with either 5 - HTTLPR genotype or impulsivity was revealed .
【GOLD_E】
5-HTTLPR	geneY
【PRE_E】
5-HTTLPR	geneY
【GOLD_R】
【PRE_R】

This was the first study to investigate platelet [ 3H ] paroxetine binding in alcohol - dependent and age - matched control subjects in relation to the 5 - HTTLPR genotype .
【GOLD_E】
[3H]paroxetine	chem
alcohol	chem
5-HTTLPR	geneY
【PRE_E】
[3H]paroxetine	chem
alcohol	chem
5-HTTLPR	geneY
【GOLD_R】
【PRE_R】

No differences concerning 5 - HTTLPR - alleles were found in these groups Furthermore , no significant interaction between these parameters and impulsivity was shown in alcohol - dependent subjects .
【GOLD_E】
alcohol	chem
5-HTTLPR	geneY
【PRE_E】
5-HTTLPR	geneY
alcohol	chem
【GOLD_R】
【PRE_R】

These results do not support previous results of altered [ 3H ] paroxetine binding sites in alcohol - dependent subjects or 5 - HTTLPR S - allele carriers .
【GOLD_E】
[3H]paroxetine	chem
5-HTTLPR	geneY
【PRE_E】
[3H]paroxetine	chem
alcohol	chem
5-HTTLPR	geneY
【GOLD_R】
【PRE_R】

K ( D ) might be influenced by duration of alcohol dependence , but not sufficiently to yield differences between alcohol - dependent and control subjects .
【GOLD_E】
alcohol	chem
alcohol	chem
【PRE_E】
K(D)	chem
alcohol	chem
alcohol	chem
【GOLD_R】
【PRE_R】

Arachidonic acid and nonsteroidal anti - inflammatory drugs induce conformational changes in the human prostaglandin endoperoxide H2 synthase - 2 ( cyclooxygenase - 2 ) .
【GOLD_E】
prostaglandinendoperoxideH2	chem
cyclooxygenase-2	geneY
humanprostaglandinendoperoxideH2synthase-2	geneY
Arachidonicacid	chem
【PRE_E】
Arachidonicacid	chem
humanprostaglandinendoperoxideH2synthase-2	geneY
cyclooxygenase-2	geneY
【GOLD_R】
【PRE_R】

By using the technique of site - directed spin labeling combined with EPR spectroscopy , we have observed that binding of arachidonic acid and nonsteroidal anti - inflammatory drugs induces conformational changes in the human prostaglandin endoperoxide H ( 2 ) synthase enzyme ( PGHS - 2 ) .
【GOLD_E】
humanprostaglandinendoperoxideH(2)synthaseenzyme	geneN
PGHS-2	geneY
arachidonicacid	chem
prostaglandinendoperoxideH(2)	chem
【PRE_E】
EPR	geneY
arachidonicacid	chem
humanprostaglandinendoperoxideH(2)synthase	geneY
PGHS-2	geneY
【GOLD_R】
【PRE_R】

Line shape broadening resulting from spin - spin coupling of nitroxide pairs introduced into the membrane - binding helices of PGHS - 2 was used to calculate the inter - helical distances and changes in these distances that occur in response to binding various ligands .
【GOLD_E】
PGHS-2	geneY
nitroxide	chem
【PRE_E】
nitroxide	chem
PGHS-2	geneY
【GOLD_R】
【PRE_R】

The inter - residue distances determined for the PGHS - 2 holoenzyme using EPR were 1 - 7.9 A shorter than those of the crystal structure of the PGHS - 2 holoenzyme .
【GOLD_E】
PGHS-2	geneY
PGHS-2	geneY
【PRE_E】
PGHS-2	geneY
EPRwere1-7.9A	geneN
PGHS-2	geneY
【GOLD_R】
【PRE_R】

However , inter - helical distances calculated and determined by EPR for PGHS - 2 complexed with arachidonic acid , flurbiprofen , and SC - 58125 were in close agreement with those obtained from the cognate crystal structures .
【GOLD_E】
PGHS-2	geneY
arachidonicacid	chem
flurbiprofen	chem
SC-58125	chem
【PRE_E】
EPR	geneY
PGHS-2	geneY
arachidonicacid	chem
flurbiprofen	chem
SC-58125	chem
【GOLD_R】
【PRE_R】
EPR	flurbiprofen	C9
PGHS-2	flurbiprofen	C9
PGHS-2	SC-58125	C9

These results indicate that the structure of the solubilized PGHS - 2 holoenzyme measured in solution differs from the crystal structure of PGHS - 2 holoenzyme obtained by x - ray analysis .
【GOLD_E】
PGHS-2	geneY
PGHS-2	geneY
【PRE_E】
PGHS-2	geneY
PGHS-2	geneY
【GOLD_R】
【PRE_R】

Furthermore , binding of ligands induces a conformational change in the holo - PGHS - 2 , converting it to a structure similar to those obtained by x - ray analysis .
【GOLD_E】
PGHS-2	geneY
【PRE_E】
PGHS-2	geneY
【GOLD_R】
【PRE_R】

Proteolysis protection assays had previously provided circumstantial evidence that binding of heme and non - steroidal anti - inflammatory drugs alters the conformation of PGHS , but the present experiments are the first to directly measure such changes .
【GOLD_E】
PGHS	geneN
steroidal	chem
【PRE_E】
steroidal	chem
PGHS	geneN
【GOLD_R】
【PRE_R】

The finding that arachidonate can also induce a conformational change in PGHS - 2 was unexpected , and the magnitude of changes suggests this structural flexibility may be integral to the cyclooxygenase catalytic mechanism .
【GOLD_E】
PGHS-2	geneY
cyclooxygenase	geneN
arachidonate	chem
【PRE_E】
arachidonate	chem
PGHS-2	geneY
cyclooxygenase	geneN
【GOLD_R】
【PRE_R】
arachidonate	PGHS-2	C3

Suppression of NF - kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta .
【GOLD_E】
sulfasalazine	chem
NF-kappaB	geneN
IkappaBkinasesalphaandbeta	geneN
【PRE_E】
NF-kappaB	geneN
sulfasalazine	chem
IkappaBkinasesalphaandbeta	geneN
【GOLD_R】
sulfasalazine	NF-kappaB	C4
【PRE_R】
NF-kappaB	sulfasalazine	C4
sulfasalazine	IkappaBkinasesalphaandbeta	C4

BACKGROUND & AIMS : Activation of NF - kappaB / Rel has been implicated in the pathogenesis of inflammatory bowel disease ( IBD ) .
【GOLD_E】
NF-kappaB	geneN
Rel	geneY
【PRE_E】
NF-kappaB	geneN
Rel	geneY
【GOLD_R】
【PRE_R】

Various drugs used in the treatment of IBD , such as glucocorticoids , 5 - aminosalicylic acid , and sulfasalazine , interfere with NF - kappaB / Rel signaling .
【GOLD_E】
5-aminosalicylicacid	chem
sulfasalazine	chem
NF-kappaB	geneN
Rel	geneY
【PRE_E】
5-aminosalicylicacid	chem
sulfasalazine	chem
NF-kappaB	geneN
Rel	geneY
【GOLD_R】
【PRE_R】
5-aminosalicylicacid	NF-kappaB	C4
sulfasalazine	NF-kappaB	C4
sulfasalazine	Rel	C4

The aim of this study was to define the molecular mechanism by which sulfasalazine inhibits NF - kappaB activation .
【GOLD_E】
sulfasalazine	chem
NF-kappaB	geneN
【PRE_E】
sulfasalazine	chem
NF-kappaB	geneN
【GOLD_R】
sulfasalazine	NF-kappaB	C4
【PRE_R】
sulfasalazine	NF-kappaB	C4

METHODS : The effects of sulfasalazine and its moieties on NF - kappaB signaling were evaluated using electromobility shift , transfection , and immune complex kinase assays .
【GOLD_E】
sulfasalazine	chem
NF-kappaB	geneN
【PRE_E】
sulfasalazine	chem
NF-kappaB	geneN
complexkinase	geneN
【GOLD_R】
【PRE_R】
sulfasalazine	NF-kappaB	C4
sulfasalazine	complexkinase	C4

The direct effect of sulfasalazine on IkappaB kinase ( IKK ) activity was investigated using purified recombinant IKK - alpha and - beta proteins .
【GOLD_E】
sulfasalazine	chem
IkappaBkinase	geneN
IKK	geneN
IKK-alphaand-beta	geneN
【PRE_E】
sulfasalazine	chem
IkappaBkinase	geneN
IKK	geneN
IKK-alphaand-beta	geneN
【GOLD_R】
【PRE_R】
sulfasalazine	IKK	C4

RESULTS : NF - kappaB / Rel activity induced by tumor necrosis factor alpha , 12 - O - tetradecanoylphorbol - 13 - acetate , or overexpression of NF - kappaB - inducing kinase , IKK - alpha , IKK - beta , or constitutively active IKK - alpha and IKK - beta mutants was inhibited dose dependently by sulfasalazine .
【GOLD_E】
12-O-tetradecanoylphorbol-13-acetate	chem
sulfasalazine	chem
NF-kappaB	geneN
Rel	geneY
tumornecrosisfactoralpha	geneY
NF-kappaB-inducingkinase	geneY
IKK-alpha	geneY
IKK-beta	geneY
IKK-alpha	geneY
IKK-beta	geneY
【PRE_E】
NF-kappaB	geneN
Rel	geneY
tumornecrosisfactoralpha	geneY
12-O-tetradecanoylphorbol-13-acetate	chem
NF-kappaB-inducingkinase	geneN
IKK-alpha	geneY
IKK-beta	geneY
IKK-alpha	geneY
IKK-beta	geneY
sulfasalazine	chem
【GOLD_R】
12-O-tetradecanoylphorbol-13-acetate	NF-kappaB	C3
12-O-tetradecanoylphorbol-13-acetate	Rel	C3
sulfasalazine	NF-kappaB	C4
sulfasalazine	Rel	C4
sulfasalazine	NF-kappaB-inducingkinase	C4
sulfasalazine	IKK-alpha	C4
sulfasalazine	IKK-beta	C4
sulfasalazine	IKK-alpha	C4
sulfasalazine	IKK-beta	C4
【PRE_R】
NF-kappaB	sulfasalazine	C4
Rel	12-O-tetradecanoylphorbol-13-acetate	C3
12-O-tetradecanoylphorbol-13-acetate	IKK-alpha	C3
12-O-tetradecanoylphorbol-13-acetate	IKK-beta	C3
IKK-alpha	sulfasalazine	C4
IKK-beta	sulfasalazine	C4

Sulfasalazine inhibited tumor necrosis factor alpha - induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells , as well as the catalytic activity of purified IKK - alpha and IKK - beta in vitro .
【GOLD_E】
Sulfasalazine	chem
tumornecrosisfactoralpha	geneY
IKK	geneN
IKK-alpha	geneY
IKK-beta	geneY
【PRE_E】
Sulfasalazine	chem
tumornecrosisfactoralpha	geneY
IKK	geneN
IKK-alpha	geneY
IKK-beta	geneY
【GOLD_R】
Sulfasalazine	tumornecrosisfactoralpha	C4
Sulfasalazine	IKK	C4
Sulfasalazine	IKK-alpha	C4
Sulfasalazine	IKK-beta	C4
【PRE_R】
Sulfasalazine	tumornecrosisfactoralpha	C4
Sulfasalazine	IKK	C4
Sulfasalazine	IKK-beta	C4

In contrast , the moieties of sulfasalazine , 5 - aminosalicylic acid , and sulfapyridine or 4 - aminosalicylic acid had no effect .
【GOLD_E】
sulfasalazine	chem
5-aminosalicylicacid	chem
sulfapyridine	chem
4-aminosalicylicacid	chem
【PRE_E】
sulfasalazine	chem
5-aminosalicylicacid	chem
sulfapyridine	chem
4-aminosalicylicacid	chem
【GOLD_R】
【PRE_R】

Activation of extracellular signal - related kinase ( ERK ) 1 and 2 , c - Jun - N - terminal kinase ( JNK ) 1 , and p38 was unaffected by sulfasalazine .
【GOLD_E】
extracellularsignal-relatedkinase(ERK)1and2	geneN
c-Jun-N-terminalkinase(JNK)1	geneY
p38	geneN
N	chem
sulfasalazine	chem
【PRE_E】
extracellularsignal-relatedkinase(ERK)1and2	geneN
c-Jun-N-terminalkinase(JNK)1	geneY
p38	geneN
sulfasalazine	chem
【GOLD_R】
【PRE_R】

The decrease in substrate phosphorylation by IKK - alpha and - beta is associated with a decrease in autophosphorylation of IKKs and can be antagonized by excess adenosine triphosphate .
【GOLD_E】
IKK-alphaand-beta	geneN
IKKs	geneN
adenosinetriphosphate	chem
【PRE_E】
IKK-alphaand-beta	geneN
IKKs	geneN
adenosinetriphosphate	chem
【GOLD_R】
adenosinetriphosphate	IKKs	C4
【PRE_R】
IKKs	adenosinetriphosphate	C4

CONCLUSIONS : These data identify sulfasalazine as a direct inhibitor of IKK - alpha and - beta by antagonizing adenosine triphosphate binding .
【GOLD_E】
IKK-alphaand-beta	geneN
sulfasalazine	chem
adenosinetriphosphate	chem
【PRE_E】
sulfasalazine	chem
IKK-alphaand-beta	geneY
adenosinetriphosphate	chem
【GOLD_R】
【PRE_R】
sulfasalazine	IKK-alphaand-beta	C4

The suppression of NF - kappaB activation by inhibition of the IKKs contributes to the well - known anti - inflammatory and immunosuppressive effects of sulfasalazine .
【GOLD_E】
sulfasalazine	chem
NF-kappaB	geneN
IKKs	geneN
【PRE_E】
NF-kappaB	geneN
IKKs	geneN
sulfasalazine	chem
【GOLD_R】
sulfasalazine	NF-kappaB	C4
sulfasalazine	IKKs	C4
【PRE_R】
NF-kappaB	sulfasalazine	C4
IKKs	sulfasalazine	C4

Biochemistry of cyclooxygenase ( COX ) - 2 inhibitors and molecular pathology of COX - 2 in neoplasia .
【GOLD_E】
cyclooxygenase(COX)-2	geneY
COX-2	geneY
【PRE_E】
cyclooxygenase(COX)-2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

Several types of human tumors overexpress cyclooxygenase ( COX ) - 2 but not COX - 1 , and gene knockout transfection experiments demonstrate a central role of COX - 2 in experimental tumorigenesis .
【GOLD_E】
COX-2	geneY
cyclooxygenase(COX)-2	geneY
COX-1	geneY
【PRE_E】
humantumorsoverexpresscyclooxygenase(COX)-2	geneY
COX-1	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

COX - 2 produces prostaglandins that inhibit apoptosis and stimulate angiogenesis and invasiveness .
【GOLD_E】
COX-2	geneY
prostaglandins	chem
【PRE_E】
COX-2	geneY
prostaglandins	chem
【GOLD_R】
prostaglandins	COX-2	C9
【PRE_R】

Selective COX - 2 inhibitors reduce prostaglandin synthesis , restore apoptosis , and inhibit cancer cell proliferation .
【GOLD_E】
COX-2	geneY
prostaglandin	chem
【PRE_E】
COX-2	geneY
prostaglandin	chem
【GOLD_R】
【PRE_R】

In animal studies they limit carcinogen - induced tumorigenesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast , aspirin - like nonselective NSAIDs such as sulindac and indomethacin inhibit not only the enzymatic action of the highly inducible , proinflammatory COX - 2 but the constitutively expressed , cytoprotective COX - 1 as well .
【GOLD_E】
indomethacin	chem
COX-2	geneY
COX-1	geneY
aspirin	chem
sulindac	chem
【PRE_E】
aspirin	chem
sulindac	chem
indomethacin	chem
COX-2	geneY
COX-1	geneY
【GOLD_R】
indomethacin	COX-2	C4
indomethacin	COX-1	C4
aspirin	COX-2	C4
aspirin	COX-1	C4
sulindac	COX-2	C4
sulindac	COX-1	C4
【PRE_R】
aspirin	COX-2	C4
sulindac	COX-2	C4
indomethacin	COX-2	C4
indomethacin	COX-1	C4

Consequently , nonselective NSAIDs can cause platelet dysfunction , gastrointestinal ulceration , and kidney damage .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For that reason , selective inhibition of COX - 2 to treat neoplastic proliferation is preferable to nonselective inhibition .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Selective COX - 2 inhibitors , such as meloxicam , celecoxib ( SC - 58635 ) , and rofecoxib ( MK - 0966 ) , are NSAIDs that have been modified chemically to preferentially inhibit COX - 2 but not COX - 1 .
【GOLD_E】
meloxicam	chem
celecoxib	chem
SC-58635	chem
COX-2	geneY
COX-1	geneY
rofecoxib	chem
MK-0966	chem
COX-2	geneY
【PRE_E】
COX-2	geneY
meloxicam	chem
celecoxib	chem
SC-58635	chem
rofecoxib	chem
MK-0966	chem
COX-2	geneY
COX-1	geneY
【GOLD_R】
meloxicam	COX-2	C4
meloxicam	COX-2	C4
celecoxib	COX-2	C4
celecoxib	COX-2	C4
SC-58635	COX-2	C4
SC-58635	COX-2	C4
rofecoxib	COX-2	C4
rofecoxib	COX-2	C4
MK-0966	COX-2	C4
MK-0966	COX-2	C4
【PRE_R】
COX-2	meloxicam	C4
COX-2	celecoxib	C4
COX-2	SC-58635	C4
rofecoxib	COX-2	C4
MK-0966	COX-2	C4
MK-0966	COX-1	C4

For instance , meloxicam inhibits the growth of cultured colon cancer cells ( HCA - 7 and Moser - S ) that express COX - 2 but has no effect on HCT - 116 tumor cells that do not express COX - 2 .
【GOLD_E】
COX-2	geneY
COX-2	geneY
meloxicam	chem
【PRE_E】
meloxicam	chem
HCA-7	geneY
COX-2	geneY
COX-2	geneY
【GOLD_R】
meloxicam	COX-2	C4
【PRE_R】
meloxicam	HCA-7	C4
meloxicam	COX-2	C4

NS - 398 induces apoptosis in COX - 2 expressing LNCaP prostate cancer cells and , surprisingly , in colon cancer S / KS cells that does not express COX - 2 .
【GOLD_E】
COX-2	geneY
COX-2	geneY
NS-398	chem
【PRE_E】
NS-398	chem
COX-2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】
NS-398	COX-2	C4

This effect may due to induction of apoptosis through uncoupling of oxidative phosphorylation and down - regulation of Bcl - 2 , as has been demonstrated for some nonselective NSAIDs , for instance , flurbiprofen .
【GOLD_E】
Bcl-2	geneY
flurbiprofen	chem
【PRE_E】
Bcl-2	geneY
flurbiprofen	chem
【GOLD_R】
flurbiprofen	Bcl-2	C4
【PRE_R】

COX - 2 mRNA and COX - 2 protein is constitutively expressed in the kidney , brain , spinal cord , and ductus deferens , and in the uterus during implantation .
【GOLD_E】
COX-2	geneY
COX-2	geneY
【PRE_E】
COX-2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

In addition , COX - 2 is constitutively and dominantly expressed in the pancreatic islet cells .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

These findings might somewhat limit the use of presently available selective COX - 2 inhibitors in cancer prevention but will probably not deter their successful application for the treatment of human cancers .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

The aromatic - L - amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells .
【GOLD_E】
aromatic-L-aminoacid	chem
aromatic-L-aminoaciddecarboxylase	geneY
【PRE_E】
aromatic-L-aminoaciddecarboxylase	geneN
carbidopa	chem
【GOLD_R】
【PRE_R】

The carcinoid tumor is an uncommon neuroendocrine neoplasm the hallmark of which is excessive serotonin production .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

In studying kinetics of tryptophan hydroxylase and aromatic - L - amino acid decarboxylase ( AAAD ) in human carcinoid hepatic metastases and adjacent normal liver ( J .
【GOLD_E】
tryptophanhydroxylase	geneN
aromatic-L-aminoaciddecarboxylase	geneY
AAAD	geneY
tryptophan	chem
aromatic-L-aminoacid	chem
【PRE_E】
tryptophanhydroxylase	geneY
aromatic-L-aminoaciddecarboxylase	geneY
AAAD	geneY
【GOLD_R】
【PRE_R】

A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Gilbert et al , Biochem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Pharmacol . , 50 : 845 - 850 , 1995 ) , we identified one significant difference : the Vmax of carcinoid AAAD was 50 - fold higher than that in normal liver .
【GOLD_E】
AAAD	geneY
【PRE_E】
carcinoidAAAD	geneY
【GOLD_R】
【PRE_R】

Here , we report Western and Northern analyses detecting large quantities of AAAD polypeptide and mRNA in human carcinoid primary as well as metastatic tumors compared with normal surrounding tissues .
【GOLD_E】
AAAD	geneY
【PRE_E】
AAADpolypeptide	geneY
【GOLD_R】
【PRE_R】

To assess the feasibility of targeting these high AAAD levels for chemotherapy , AAAD inhibitors carbidopa ( alpha - methyl - dopahydrazine ) , alpha - monofluoromethyldopa ( MFMD ) , and 3 - hydroxybenzylhydrazine ( NSD - 1015 ) were incubated ( 72 h ) with NCI - H727 human lung carcinoid cells .
【GOLD_E】
carbidopa	chem
alpha-methyl-dopahydrazine	chem
alpha-monofluoromethyldopa	chem
MFMD	chem
3-hydroxybenzylhydrazine	chem
NSD-1015	chem
AAAD	geneY
AAAD	geneY
【PRE_E】
AAAD	chem
AAAD	geneY
carbidopa	chem
alpha-methyl-dopahydrazine	chem
alpha-monofluoromethyldopa	chem
MFMD	chem
3-hydroxybenzylhydrazine	chem
NSD-1015	chem
【GOLD_R】
carbidopa	AAAD	C4
alpha-methyl-dopahydrazine	AAAD	C4
alpha-monofluoromethyldopa	AAAD	C4
MFMD	AAAD	C4
3-hydroxybenzylhydrazine	AAAD	C4
NSD-1015	AAAD	C4
【PRE_R】
AAAD	carbidopa	C4
AAAD	alpha-methyl-dopahydrazine	C4
AAAD	alpha-monofluoromethyldopa	C4
AAAD	MFMD	C4
AAAD	3-hydroxybenzylhydrazine	C4
AAAD	NSD-1015	C4

Carbidopa and MFMD were lethal ( IC50 = 29 + / - 2 microM and 56 + / - 6 microM , respectively ) ; NSD - 1015 had no effect on proliferation .
【GOLD_E】
Carbidopa	chem
MFMD	chem
NSD-1015	chem
【PRE_E】
Carbidopa	chem
MFMD	chem
NSD-1015	chem
【GOLD_R】
【PRE_R】

On exposure to other human tumor lines , carbidopa was lethal only to NCI - H146 and NCI - H209 small cell lung carcinoma ( SCLC ) lines ( IC50 = 12 + / - 1 microM and 22 + / - 5 microM , respectively ) .
【GOLD_E】
carbidopa	chem
【PRE_E】
carbidopa	chem
【GOLD_R】
【PRE_R】

Carbidopa ( 100 microM ) decreased growth of ( but did not kill ) SK - N - SH neuroblastoma and A204 rhabdomyosarcoma cells and did not affect proliferation of DU 145 prostate , MCF7 breast , or NCI - H460 large cell lung carcinoma lines .
【GOLD_E】
Carbidopa	chem
【PRE_E】
Carbidopa	chem
【GOLD_R】
【PRE_R】

The rank order of lines by AAAD activity was NCI - H146 > NCI - H209 > SK - N - SH > NCI - H727 , whereas A204 , DU 145 , MCF7 , and NCI - H460 had no measurable activity .
【GOLD_E】
AAAD	geneY
【PRE_E】
AAAD	geneY
DU145	geneY
【GOLD_R】
【PRE_R】

For lung tumor lines ( carcinoid , two SCLC , and one large cell lung carcinoma ) , AAAD activity was correlated with the potency of carbidopa - induced cytotoxicity .
【GOLD_E】
AAAD	geneY
carbidopa	chem
【PRE_E】
AAAD	geneY
carbidopa	chem
【GOLD_R】
【PRE_R】

However , carcinoid cell death was not solely attributable to complete inhibition of either AAAD activity or the serotonin synthetic pathway .
【GOLD_E】
AAAD	geneY
serotonin	chem
【PRE_E】
AAAD	geneN
serotonin	chem
【GOLD_R】
【PRE_R】

In further evaluating potential applications of these findings with carbidopa , we determined that sublethal doses of carbidopa produced additive cytotoxic effects in carcinoid cells in combination with etoposide and cytotoxic synergy in SCLC cells when coincubated with topotecan .
【GOLD_E】
topotecan	chem
carbidopa	chem
carbidopa	chem
【PRE_E】
carbidopa	chem
carbidopa	chem
etoposide	chem
topotecan	chem
【GOLD_R】
【PRE_R】

Hexahydrochromeno [ 4,3 - b ] pyrrole derivatives as acetylcholinesterase inhibitors .
【GOLD_E】
Hexahydrochromeno[4,3-b]pyrrole	chem
acetylcholinesterase	geneY
【PRE_E】
Hexahydrochromeno[4,3-b]pyrrole	chem
acetylcholinesterase	geneY
【GOLD_R】
Hexahydrochromeno[4,3-b]pyrrole	acetylcholinesterase	C4
【PRE_R】
Hexahydrochromeno[4,3-b]pyrrole	acetylcholinesterase	C4

In a search for less flexible analogues of caproctamine ( 1 ) , a diamine diamide endowed with an interesting AChE affinity profile , we discovered compound 2 , in which the terminal 2 - methoxybenzyl groups of 1 have been incorporated into a tricyclic system .
【GOLD_E】
diamide	chem
AChE	geneY
2-methoxybenzyl	chem
tricyclic	chem
caproctamine	chem
diamine	chem
【PRE_E】
caproctamine(1)	chem
diaminediamide	chem
AChE	geneY
2-methoxybenzyl	chem
tricyclic	chem
【GOLD_R】
【PRE_R】

Since this compound retains good AChE inhibitory activity and its hexahydrochromeno [ 4,3 - b ] pyrrole moiety is reminiscent of the hexahydropyrrolo [ 2,3 - b ] indole of physostigmine ( 3 ) , we have designed and synthesized carbamates 4 - 6 , and their biological evaluation has been assessed in vitro against human AChE and BChE .
【GOLD_E】
AChE	geneY
humanAChE	geneY
BChE	geneY
hexahydrochromeno[4,3-b]pyrrole	chem
hexahydropyrrolo[2,3-b]indoleofphysostigmine	chem
carbamates	chem
【PRE_E】
AChE	geneY
hexahydrochromeno[4,3-b]pyrrole	chem
hexahydropyrrolo[2,3-b]indole	chem
physostigmine	chem
carbamates4-6	chem
humanAChE	geneY
BChE	geneY
【GOLD_R】
hexahydrochromeno[4,3-b]pyrrole	AChE	C4
hexahydropyrrolo[2,3-b]indoleofphysostigmine	AChE	C4
【PRE_R】
AChE	hexahydrochromeno[4,3-b]pyrrole	C4
AChE	hexahydropyrrolo[2,3-b]indole	C4
AChE	physostigmine	C4
physostigmine	BChE	C4

The 6 - carbamate 4 was almost as potent as physostigmine and was 60 - and 550 - fold more potent than the 7 - carbamate 5 and the 8 - carbamate 6 , respectively .
【GOLD_E】
6-carbamate	chem
physostigmine	chem
【PRE_E】
6-carbamate4	chem
physostigmine	chem
7-carbamate5	chem
8-carbamate6	chem
【GOLD_R】
【PRE_R】

The two enantiomers of 4 , ( - ) - 4 and ( + ) - 4 , did not show a marked enantioselectivity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Finally , a similar time - dependent pattern of inhibition of AChE was observed for 3 and 4 .
【GOLD_E】
AChE	geneY
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

Brugada syndrome without mutation of the cardiac sodium channel gene in a Taiwanese patient .
【GOLD_E】
cardiacsodiumchannel	geneY
sodium	chem
【PRE_E】
sodiumchannel	geneN
【GOLD_R】
【PRE_R】

We describe a 45 - year - old Taiwanese man with specific features of Brugada syndrome but no clinical features of structural heart disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

He was successfully treated with an implantable cardioverter - defibrillator .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

His electrocardiogram ( ECG ) patterns changed intermittently .
【GOLD_E】
【PRE_E】
His	chem
【GOLD_R】
【PRE_R】

Alpha - adrenoceptor stimulation and beta - adrenoceptor blockade augmented the characteristic ST - segment elevation , whereas alpha - adrenoceptor blockade and beta - adrenoceptor stimulation mitigated the ST - segment elevation .
【GOLD_E】
Alpha-adrenoceptor	geneN
beta-adrenoceptor	geneN
alpha-adrenoceptor	geneN
beta-adrenoceptor	geneN
【PRE_E】
Alpha-adrenoceptor	geneY
beta-adrenoceptor	geneY
alpha-adrenoceptor	geneY
beta-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Intravenous procainamide administration did not aggravate ST - segment elevation when ECG had shown coved ST elevation in the right precordial leads .
【GOLD_E】
procainamide	chem
【PRE_E】
procainamide	chem
ECG	chem
【GOLD_R】
【PRE_R】

Molecular study did not reveal the same mutations in the cardiac sodium channel gene ( SCN5A ) as previously reported in Brugada syndrome .
【GOLD_E】
sodium	chem
cardiacsodiumchannel	geneY
SCN5A	geneY
【PRE_E】
sodiumchannelgene	geneY
SCN5A	geneY
【GOLD_R】
【PRE_R】

This case demonstrates the genetic heterogeneity of SCN5A in Brugada syndrome .
【GOLD_E】
SCN5A	geneY
【PRE_E】
SCN5A	geneY
【GOLD_R】
【PRE_R】

Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4 + T cells in a murine model implanted with B16 melanoma .
【GOLD_E】
CYP11A1	geneY
【PRE_E】
Th	geneY
steroidogenicCYP11A1	geneY
【GOLD_R】
【PRE_R】

The association between the balance of Th1 / Th2 cell responses and CYP11A1 expression in CD4 + T cells was investigated in a murine model implanted with highly metastatic B16F10 melanoma cells ( B16F10 mice ) .
【GOLD_E】
CYP11A1	geneY
【PRE_E】
CYP11A1	geneY
【GOLD_R】
【PRE_R】

When 2 x 10 ( 5 ) cells / mouse of B16F10 cells were inoculated into C57BL / 6 mice , Th2 cell responses and pulmonary metastasis were increased .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , corticosterone levels in splenic tissue or serum and CYP11A1 mRNA expression ( mRNA encoding cholesterol side - chain cleavage p450 enzyme ) in CD4 + T cells were increased in these mice .
【GOLD_E】
cholesterolside-chaincleavagep450enzyme	geneY
corticosterone	chem
cholesterol	chem
CYP11A1	geneY
【PRE_E】
corticosterone	chem
CYP11A1	geneY
cholesterol	chem
p450	geneN
【GOLD_R】
【PRE_R】
corticosterone	CYP11A1	C3
corticosterone	p450	C3

When the anti - corticosterone drug aminoglutethimide ( CYP11A1 inhibitor ) was administered to B16F10 mice , corticosterone levels in splenic tissue or serum and CYP11A1 mRNA expression were decreased at 14 days after tumor inoculation .
【GOLD_E】
CYP11A1	geneY
CYP11A1	geneY
aminoglutethimide	chem
corticosterone	chem
【PRE_E】
corticosterone	chem
aminoglutethimide	chem
CYP11A1	geneY
corticosterone	chem
CYP11A1	geneY
【GOLD_R】
aminoglutethimide	CYP11A1	C4
aminoglutethimide	CYP11A1	C4
【PRE_R】
corticosterone	CYP11A1	C4
aminoglutethimide	CYP11A1	C4
aminoglutethimide	CYP11A1	C4

In addition , Th1 cell responses were restored and pulmonary metastasis was reduced by aminoglutethimide .
【GOLD_E】
aminoglutethimide	chem
【PRE_E】
aminoglutethimide	chem
【GOLD_R】
【PRE_R】

These results indicated that the breakdown of Th cell responses and increase of pulmonary metastasis were due to an increase in steroidogenic CYP11A1 mRNA expression in CD4 + T cells .
【GOLD_E】
CYP11A1	geneY
【PRE_E】
Th	geneY
steroidogenicCYP11A1	geneY
【GOLD_R】
【PRE_R】

Moreover , it was suggested that promotion of CYP11A1 mRNA expression in Th2 cells was partially involved due to an increase in level of corticosterone in splenic tissue and the breakdown of Th cell responses locally in the splenic tissue , which then affected the maintenance of Th2 cell functions in the microenvironment of tumor - bearing mice .
【GOLD_E】
corticosterone	chem
CYP11A1	geneY
【PRE_E】
CYP11A1	geneY
corticosterone	chem
Th	geneY
【GOLD_R】
【PRE_R】
CYP11A1	corticosterone	C3
corticosterone	Th	C3

A nonsense mutation in the NDUFS4 gene encoding the 18 kDa ( AQDQ ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh - like syndrome .
【GOLD_E】
NDUFS4	geneY
18kDa(AQDQ)subunitofcomplexI	geneY
【PRE_E】
NDUFS4	geneY
AQDQ	geneN
complexI	geneN
【GOLD_R】
【PRE_R】

Sequence analysis of mitochondrial and nuclear candidate genes of complex I in children with deficiency of this complex and exhibiting Leigh - like syndrome has revealed , in one of them , a novel mutation in the NDUFS4 gene encoding the 18 kDa subunit .
【GOLD_E】
complexI	geneN
NDUFS4	geneY
【PRE_E】
complexI	geneN
NDUFS4	geneY
【GOLD_R】
【PRE_R】

Phosphorylation of this subunit by cAMP - dependent protein kinase has previously been found to activate the complex .
【GOLD_E】
cAMP	chem
cAMP-dependentproteinkinase	geneN
【PRE_E】
cAMP-dependentproteinkinase	geneN
【GOLD_R】
【PRE_R】

The present mutation consists of a homozygous G - - > A transition at nucleotide position + 44 of the coding sequence of the gene , resulting in the change of a tryptophan codon to a stop codon .
【GOLD_E】
tryptophan	chem
【PRE_E】
G-->A	geneN
nucleotide	chem
tryptophan	chem
【GOLD_R】
【PRE_R】

Such mutation causes premature termination of the protein after only 14 amino acids of the putative mitochondrial targeting peptide .
【GOLD_E】
aminoacids	chem
【PRE_E】
aminoacids	chem
【GOLD_R】
【PRE_R】

Fibroblast cultures from the patient exhibited severe reduction of the rotenone - sensitive NADH - - > UQ oxidoreductase activity of complex I , which was insensitive to cAMP stimulation .
【GOLD_E】
NADH-->UQoxidoreductase	geneN
complexI	geneN
NADH	chem
cAMP	chem
【PRE_E】
rotenone-sensitiveNADH-->UQoxidoreductase	geneN
complexI	geneN
cAMP	chem
【GOLD_R】
【PRE_R】

Two - dimensional electrophoresis showed the absence of detectable normally assembled complex I in the inner mitochondrial membrane .
【GOLD_E】
complexI	geneN
【PRE_E】
complexI	geneN
【GOLD_R】
【PRE_R】

These findings show that the expression of the NDUFS4 gene is essential for the assembly of a functional complex I .
【GOLD_E】
NDUFS4	geneY
complexI	geneN
【PRE_E】
NDUFS4	geneY
complexI	geneN
【GOLD_R】
【PRE_R】

Glucagon - like peptide ( GLP ) - 2 reduces chemotherapy - associated mortality and enhances cell survival in cells expressing a transfected GLP - 2 receptor .
【GOLD_E】
Glucagon-likepeptide(GLP)-2	geneY
GLP-2receptor	geneY
【PRE_E】
Glucagon-likepeptide(GLP)-2	geneY
GLP-2receptor	geneY
【GOLD_R】
【PRE_R】

Chemotherapeutic agents produce cytotoxicity via induction of apoptosis and cell cycle arrest .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rapidly proliferating cells in the bone marrow and intestinal crypts are highly susceptible to chemotherapy , and damage to these cellular compartments may preclude maximally effective chemotherapy administration .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Glucagon - like peptide ( GLP ) - 2 is an enteroendocrine - derived regulatory peptide that inhibits crypt cell apoptosis after administration of agents that damage the intestinal epithelium .
【GOLD_E】
Glucagon-likepeptide(GLP)-2	geneY
【PRE_E】
Glucagon-likepeptide(GLP)-2	geneY
enteroendocrine-derivedregulatorypeptide	geneY
【GOLD_R】
【PRE_R】

We report here that a human degradation - resistant GLP - 2 analogue , h [ Gly2 ] - GLP - 2 significantly improves survival , reduces bacteremia , attenuates epithelial injury , and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of topoisomerase I inhibitor irinotecan hydrochloride or the antimetabolite 5 - fluorouracil . h [ Gly2 ] - GLP - 2 significantly improved survival and reduced weight loss but did not impair chemotherapy effectiveness in tumor - bearing mice treated with cyclical irinotecan .
【GOLD_E】
GLP-2	geneY
GLP-2	geneY
topoisomeraseI	geneY
GLP-2	geneY
Gly2	chem
irinotecanhydrochloride	chem
5-fluorouracil	chem
Gly2	chem
【PRE_E】
GLP-2	geneY
h[Gly2]-GLP-2	geneY
topoisomeraseI	geneY
irinotecanhydrochloride	chem
5-fluorouracil	chem
h[Gly2]-GLP-2	chem
irinotecan	chem
【GOLD_R】
irinotecanhydrochloride	topoisomeraseI	C4
【PRE_R】
topoisomeraseI	irinotecanhydrochloride	C4
topoisomeraseI	5-fluorouracil	C4
topoisomeraseI	h[Gly2]-GLP-2	C4
topoisomeraseI	irinotecan	C4

Furthermore , h [ Gly2 ] - GLP - 2 reduced chemotherapy - induced apoptosis , decreased activation of caspase - 8 and - 3 , and inhibited poly ( ADP - ribose ) polymerase cleavage in heterologous cells transfected with the GLP - 2 receptor .
【GOLD_E】
GLP-2receptor	geneY
Gly2	chem
ADP-ribose	chem
GLP-2	geneY
caspase-8and-3	geneN
poly(ADP-ribose)polymerase	geneN
【PRE_E】
h[Gly2]-GLP-2	chem
caspase-8and-3	geneY
poly(ADP-ribose)polymerase	geneN
GLP-2	geneY
【GOLD_R】
Gly2	poly(ADP-ribose)polymerase	C4
【PRE_R】
h[Gly2]-GLP-2	caspase-8and-3	C4

These observations demonstrate that the antiapoptotic effects of GLP - 2 on intestinal crypt cells may be useful for the attenuation of chemotherapy - induced intestinal mucositis .
【GOLD_E】
GLP-2	geneY
【PRE_E】
GLP-2	geneY
【GOLD_R】
【PRE_R】

On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys : practical and theoretical concerns .
【GOLD_E】
dopamine	chem
dopaminetransporter	geneN
【PRE_E】
dopaminetransporter	geneY
【GOLD_R】
【PRE_R】

RATIONALE : Drugs that are self - administered appear to vary in their potency and effectiveness as positive reinforcers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Understanding mechanisms that determine relative effectiveness of drugs as reinforcers will enhance our understanding of drug abuse .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVES : The hypothesis of the present study was that differences among dopamine transporter ( DAT ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as DA uptake inhibitors .
【GOLD_E】
dopamine	chem
DA	chem
dopaminetransporter	geneN
DAT	geneN
【PRE_E】
dopaminetransporter	geneY
DAT	geneY
DA	chem
【GOLD_R】
DA	dopaminetransporter	C9
DA	DAT	C9
【PRE_R】

Accordingly , self - administration of a group of local anesthetics that are DAT ligands was compared to their effects as DA uptake blockers in vitro in brain tissue .
【GOLD_E】
DA	chem
DAT	geneN
【PRE_E】
DAT	geneY
DA	chem
【GOLD_R】
DA	DAT	C9
【PRE_R】

METHODS : Rhesus monkeys were allowed to self - administer cocaine and other local anesthetics i.v . under a progressive - ratio schedule .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

The same compounds were compared in standard in vitro DA uptake assays using monkey caudate tissue .
【GOLD_E】
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

RESULTS : The rank order of both potency and effectiveness as reinforcers was cocaine > dimethocaine > procaine > chloroprocaine .
【GOLD_E】
cocaine	chem
dimethocaine	chem
procaine	chem
chloroprocaine	chem
【PRE_E】
cocaine	chem
dimethocaine	chem
procaine	chem
chloroprocaine	chem
【GOLD_R】
【PRE_R】

Tetracaine did not maintain self - administration .
【GOLD_E】
Tetracaine	chem
【PRE_E】
Tetracaine	chem
【GOLD_R】
【PRE_R】

For inhibiting DA uptake , the potency order was cocaine > dimethocaine > tetracaine > procaine > chloro - procaine .
【GOLD_E】
DA	chem
cocaine	chem
dimethocaine	chem
tetracaine	chem
procaine	chem
chloro-procaine	chem
【PRE_E】
DA	chem
cocaine	chem
dimethocaine	chem
tetracaine	chem
procaine	chem
chloro	chem
procaine	chem
【GOLD_R】
【PRE_R】

At maximum , these compounds were equally effective in blocking DA uptake .
【GOLD_E】
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

Lidocaine did not inhibit DA uptake .
【GOLD_E】
DA	chem
Lidocaine	chem
【PRE_E】
Lidocaine	chem
DA	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : The potency of local anesthetics as positive reinforcers is likely related to their potency as DA uptake inhibitors .
【GOLD_E】
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

Variation in their effectiveness as positive reinforcers was not a function of differences in effectiveness as DA uptake blockers , but may be related to relative potency over the concentrations that are achieved in vivo .
【GOLD_E】
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

Effects at sodium channels may limit the reinforcing effects of local anesthetics .
【GOLD_E】
sodium	chem
sodiumchannels	geneN
【PRE_E】
sodiumchannels	geneN
【GOLD_R】
【PRE_R】

Contribution of the Na + - K + - 2Cl - cotransporter NKCC1 to Cl - secretion in rat OMCD .
【GOLD_E】
Na+	chem
K+	chem
2Cl-	chem
Cl-	chem
Na+-K+-2Cl-cotransporter	geneN
NKCC1	geneY
【PRE_E】
Na+-K+-2Cl-cotransporterNKCC1	geneN
Cl	chem
ratOMCD	geneY
【GOLD_R】
Cl-	Na+-K+-2Cl-cotransporter	C9
Cl-	NKCC1	C9
【PRE_R】

In rat kidney the `` secretory `` isoform of the Na + - K + - 2Cl - cotransporter ( NKCC1 ) localizes to the basolateral membrane of the alpha - intercalated cell .
【GOLD_E】
heN	chem
+-	chem
+-2C	chem
heNa+-K+-2Cl-cotransport	geneN
r(NKC	geneY
【PRE_E】
Na+-K+-2Cl-cotransporter	geneN
NKCC1	geneY
【GOLD_R】
【PRE_R】

The purpose of this study was to determine whether rat outer medullary collecting duct ( OMCD ) secretes Cl - and whether transepithelial Cl - transport occurs , in part , through Cl - uptake across the basolateral membrane mediated by NKCC1 in series with Cl - efflux across the apical membrane .
【GOLD_E】
NKCC1	geneY
Cl-	chem
Cl-	chem
Cl-	chem
Cl-	chem
【PRE_E】
transepithelialCl	chem
Cl	chem
NKCC1	geneY
Cl	chem
【GOLD_R】
Cl-	NKCC1	C9
Cl-	NKCC1	C9
【PRE_R】
transepithelialCl	NKCC1	C9

OMCD tubules from rats treated with deoxycorticosterone pivalate were perfused in vitro in symmetrical HCO / CO2 - buffered solutions .
【GOLD_E】
deoxycorticosteronepivalate	chem
HCO	chem
CO2	chem
【PRE_E】
OMCD	geneY
deoxycorticosteronepivalate	chem
HCO	chem
CO2	chem
【GOLD_R】
【PRE_R】

Cl - secretion was observed in this segment , accompanied by a lumen positive transepithelial potential .
【GOLD_E】
Cl-	chem
【PRE_E】
Cl	chem
【GOLD_R】
【PRE_R】

Bumetanide ( 100 microM ) , when added to the bath , reduced Cl - secretion by 78 % , although the lumen positive transepithelial potential and fluid flux were unchanged .
【GOLD_E】
Bumetanide	chem
Cl-	chem
【PRE_E】
Bumetanide	chem
Cl	chem
【GOLD_R】
【PRE_R】

Bumetanide - sensitive Cl - secretion was dependent on extracellular Na + and either K + or NH , consistent with the ion dependency of NKCC1 - mediated Cl - transport .
【GOLD_E】
Bumetanide	chem
Cl-	chem
Na+	chem
K+	chem
NH	chem
Cl-	chem
NKCC1	geneY
【PRE_E】
Bumetanide	chem
Cl	chem
Na+	chem
K+	chem
NH	chem
NKCC1	geneY
Cl	chem
【GOLD_R】
Cl-	NKCC1	C9
【PRE_R】
NH	NKCC1	C9
NKCC1	Cl	C9

In conclusion , OMCD tubules from deoxycorticosterone pivalate - treated rats secrete Cl - into the luminal fluid through NKCC1 - mediated Cl - uptake across the basolateral membrane in series with Cl - efflux across the apical membrane .
【GOLD_E】
deoxycorticosteronepivalate	chem
NKCC1	geneY
Cl-	chem
Cl-	chem
Cl-	chem
【PRE_E】
OMCD	geneY
deoxycorticosteronepivalate	chem
NKCC1	geneY
Cl	chem
Cl	chem
【GOLD_R】
Cl-	NKCC1	C9
Cl-	NKCC1	C9
Cl-	NKCC1	C9
【PRE_R】
OMCD	deoxycorticosteronepivalate	C9
deoxycorticosteronepivalate	NKCC1	C9
NKCC1	Cl	C9

The physiological role of NKCC1 - mediated Cl - uptake remains to be determined .
【GOLD_E】
NKCC1	geneY
Cl-	chem
【PRE_E】
NKCC1	geneY
Cl	chem
【GOLD_R】
Cl-	NKCC1	C9
【PRE_R】

However , the role of NKCC1 in the process of fluid secretion could not be demonstrated .
【GOLD_E】
NKCC1	geneY
【PRE_E】
NKCC1	geneY
【GOLD_R】
【PRE_R】

Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1 : identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds .
【GOLD_E】
humanmineralocorticoidreceptor	geneY
【PRE_E】
humanmineralocorticoidreceptor	geneY
【GOLD_R】
【PRE_R】

Pseudohypoaldosteronism type 1 ( PHA1 ) is characterized by neonatal salt wasting resistant to mineralocorticoids .
【GOLD_E】
【PRE_E】
mineralocorticoids	geneY
【GOLD_R】
【PRE_R】

There are 2 forms of PHA1 : the autosomal recessive form with symptoms persisting into adulthood , caused by mutations in the amiloride - sensitive luminal sodium channel , and the autosomal dominant or sporadic form , which shows milder symptoms that remit with age .
【GOLD_E】
amiloride	chem
sodium	chem
amiloride-sensitiveluminalsodiumchannel	geneN
【PRE_E】
amiloride-sensitiveluminalsodiumchannel	geneN
【GOLD_R】
【PRE_R】

Mutations in the gene encoding the human mineralocorticoid receptor ( hMR ) are , at least in some patients , responsible for the latter form of PHA1 .
【GOLD_E】
humanmineralocorticoidreceptor	geneY
hMR	geneY
【PRE_E】
humanmineralocorticoidreceptor	geneY
hMR	geneY
【GOLD_R】
【PRE_R】

We here report the results of a genetic study in a sporadic case and in 5 affected patients from 2 families with autosomal dominant PHA1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the sporadic case we identified a new frameshift mutation , Ins2871C , in exon 9 of the hMR gene .
【GOLD_E】
Ins2871C	geneN
hMR	geneY
【PRE_E】
Ins2871C	geneN
hMR	geneY
【GOLD_R】
【PRE_R】

Family members were asymptomatic and had no mutation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This mutation is the first described in exon 9 and impairs the last 27 amino acids of the hormone - binding domain .
【GOLD_E】
aminoacids	chem
hormone-bindingdomain	geneN
【PRE_E】
aminoacids	chem
hormone-bindingdomain	geneN
【GOLD_R】
【PRE_R】

In 2 kindreds with autosomal dominant PHA1 we found no mutation of the hMR gene .
【GOLD_E】
hMR	geneY
【PRE_E】
hMR	geneY
【GOLD_R】
【PRE_R】

Our results confirm the hypothesis that autosomal dominant or sporadic PHA1 is a genetically heterogeneous disease involving other , as yet unidentified , genes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The broad - spectrum anti - emetic activity of AS - 8112 , a novel dopamine D2 , D3 and 5 - HT3 receptors antagonist .
【GOLD_E】
AS-8112	chem
dopamine	chem
dopamineD2,D3	geneN
5-HT3receptors	geneY
【PRE_E】
AS-8112	chem
dopamineD2,D3and5-HT3	geneN
【GOLD_R】
AS-8112	5-HT3receptors	C6
【PRE_R】

The anti - emetic and pharmacological profile of AS - 8112 ( ( R ) - 5 - bromo - N - ( 1 - ethyl - 4 - methylhexahydro - 1H - 1,4 - diazepin - 6 - yl ) - 2 - methoxy - 6 - methy lamino - 3 - pyridinecarboxamide.2 fumarate ) , a novel and potent dopamine D2 , D3 and 5 - hydroxytryptamine - 3 ( 5 - HT3 ) receptors ligand , was investigated in the present study .
【GOLD_E】
dopamine	chem
5-hydroxytryptamine	chem
AS-8112	chem
(R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide.2fumarate	chem
dopamineD2,D3	geneN
5-hydroxytryptamine-3(5-HT3)receptors	geneY
【PRE_E】
AS-8112	chem
(R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide.2fumarate	chem
dopamineD2,D3and5-hydroxytryptamine-3(5-HT3)receptors	geneN
【GOLD_R】
【PRE_R】

In guinea - pig isolated colon , AS - 8112 produced a rightward shift of the concentration - response curves of 2 - methyl - 5HT , a 5 - HT3 receptor agonist ( pA2 value of 7.04 ) .
【GOLD_E】
AS-8112	chem
2-methyl-5HT	chem
5-HT3receptor	geneY
【PRE_E】
AS-8112	chem
2-methyl-5HT	chem
5-HT3	geneY
【GOLD_R】
2-methyl-5HT	5-HT3receptor	C5
AS-8112	5-HT3receptor	C6
【PRE_R】
2-methyl-5HT	5-HT3	C5

Other 5 - HT3 receptor antagonists also produced such a shift in the following antagonistic - potency order : granisetron > ondansetron = AS - 8112 > > metoclopramide .
【GOLD_E】
granisetron	chem
ondansetron	chem
AS-8112	chem
metoclopramide	chem
5-HT3receptor	geneY
【PRE_E】
5-HT3	geneY
granisetron	chem
ondansetron	chem
AS-8112	chem
metoclopramide	chem
【GOLD_R】
granisetron	5-HT3receptor	C6
ondansetron	5-HT3receptor	C6
AS-8112	5-HT3receptor	C6
metoclopramide	5-HT3receptor	C6
【PRE_R】

In mice , AS - 8112 ( 1.0 - 3.0 mg kg ( - 1 ) s.c. ) potently inhibited hypothermia induced by the dopamine D3 receptor agonist ; R ( + ) - 7 - OH - DPAT ( R ( + ) - 7 - hydroxy - 2 - ( N , N - di - n - propylamino ) tetraline ) ( 0.3 mg kg ( - 1 ) s.c. ) .
【GOLD_E】
AS-8112	chem
dopamine	chem
R(+)-7-OH-DPAT	chem
R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline	chem
dopamineD3receptor	geneY
【PRE_E】
AS-8112	chem
dopamineD3receptor	geneY
R(+)-7-OH-DPAT	chem
R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline	chem
【GOLD_R】
AS-8112	dopamineD3receptor	C4
R(+)-7-OH-DPAT	dopamineD3receptor	C5
R(+)-7-hydroxy-2-(N,N-di-n-propylamino)tetraline	dopamineD3receptor	C5
【PRE_R】

Domperidone and haloperidol , which have affinity for dopamine D3 receptor , also inhibited R ( + ) - 7 - OH - DPAT - induced hypothermia .
【GOLD_E】
Domperidone	chem
haloperidol	chem
dopamine	chem
R(+)-7-OH-DPAT	chem
dopamineD3receptor	geneY
【PRE_E】
Domperidone	chem
haloperidol	chem
dopamineD3receptor	geneY
R(+)-7-OH-DPAT	chem
【GOLD_R】
【PRE_R】

In ferrets or dogs , AS - 8112 dose - dependently inhibited emesis induced by R ( + ) - 7 - OH - DPAT , apomorphine , morphine or cisplatin with ID50 values of 2.22 microg kg ( - 1 ) s.c. , 10.5 microg kg ( - 1 ) s.c. , 14.2 microg kg ( - 1 ) i.v . and 17.6 microg kg ( - 1 ) i.v . , respectively .
【GOLD_E】
R(+)-7-OH-DPAT	chem
AS-8112	chem
apomorphine	chem
morphine	chem
cisplatin	chem
【PRE_E】
AS-8112	chem
R(+)-7-OH-DPAT	chem
apomorphine	chem
morphine	chem
cisplatin	chem
【GOLD_R】
【PRE_R】

Moreover , oral administration of AS - 8112 significantly inhibited emesis induced by these emetogens .
【GOLD_E】
AS-8112	chem
【PRE_E】
AS-8112	chem
【GOLD_R】
【PRE_R】

AS - 8112 ( 0.3 mg kg ( - 1 ) i.v . ) significantly inhibited emesis induced by cyclophosphamide and doxorubicin .
【GOLD_E】
AS-8112	chem
cyclophosphamide	chem
doxorubicin	chem
【PRE_E】
AS-8112	chem
cyclophosphamide	chem
doxorubicin	chem
【GOLD_R】
【PRE_R】

In conclusion , AS - 8112 is a potent dopamine D2 , D3 and 5 - HT3 receptors antagonist , and a novel anti - emetic agent with a broad - spectrum of anti - emetic activity .
【GOLD_E】
dopamine	chem
dopamineD2,D3	geneN
5-HT3receptors	geneY
AS-8112	chem
【PRE_E】
AS-8112	chem
dopamineD2,D3	geneY
5-HT3	geneY
【GOLD_R】
AS-8112	5-HT3receptors	C6
【PRE_R】
AS-8112	5-HT3	C5

These results suggest that this compound is worthy of clinical investigation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Heparin - binding exosite of factor Xa .
【GOLD_E】
factorXa	geneY
【PRE_E】
Heparin-bindingexosite	geneN
factorXa	geneY
【GOLD_R】
【PRE_R】

Recent studies have indicated that the basic residues Arg ( 93 ) , Lys ( 96 ) , Arg ( 125 ) , Arg ( 165 ) , Lys ( 169 ) , Lys ( 236 ) , and Arg ( 240 ) ( chymotrypsin numbering ) constitute an exosite in the catalytic domain of factor Xa that can effectively bind heparin only if the acidic N - terminal Gla domain of the proteinase was neutralized by physiological levels of calcium .
【GOLD_E】
Arg	chem
Arg	chem
Lys	chem
chymotrypsin	geneN
factorXa	geneY
N-terminalGladomain	geneN
proteinase	geneN
Lys	chem
Arg	chem
N	chem
calcium	chem
Arg	chem
Lys	chem
【PRE_E】
Arg	chem
Lys	chem
Arg	chem
Arg	chem
Lys	chem
Lys	chem
Arg	chem
chymotrypsin	chem
factorXa	geneY
N	chem
Gladomain	geneN
proteinase	geneN
calcium	chem
【GOLD_R】
【PRE_R】

Binding of a full - length heparin chain to this site of factor Xa in the presence of calcium makes a significant contribution to acceleration of the proteinase inhibition by antithrombin through a ternary complex bridging or template mechanism .
【GOLD_E】
factorXa	geneY
proteinase	geneN
antithrombin	geneY
calcium	chem
【PRE_E】
factorXa	geneY
calcium	chem
proteinase	geneN
antithrombin	geneY
【GOLD_R】
【PRE_R】
calcium	proteinase	C4
calcium	antithrombin	C4

Moreover , certain basic residues of this site , particularly Arg ( 165 ) and Lys ( 169 ) , play a key role in factor Va and / or prothrombin recognition by factor Xa in the prothrombinase complex .
【GOLD_E】
factorVa	geneY
prothrombin	geneY
factorXa	geneY
Arg	chem
Lys	chem
【PRE_E】
Arg	chem
Lys	chem
factorVa	geneY
prothrombin	geneY
factorXa	geneY
prothrombinase	geneN
【GOLD_R】
【PRE_R】

This article reviews recent structural , mutagenesis and kinetic data that lead to identification of this exosite and discusses how the binding of protein or polysaccharide cofactors to this site of factor Xa can modulate the specificity and physiological function of this key coagulant enzyme in plasma .
【GOLD_E】
factorXa	geneY
【PRE_E】
factorXa	geneY
【GOLD_R】
【PRE_R】

Rofecoxib : a review of its use in the management of osteoarthritis , acute pain and rheumatoid arthritis .
【GOLD_E】
Rofecoxib	chem
【PRE_E】
Rofecoxib	chem
【GOLD_R】
【PRE_R】

Rofecoxib is a selective cyclo - oxygenase ( COX ) - 2 inhibitor which has little or no effect on the COX - 1 isoenzyme at doses up to 1000 mg / day .
【GOLD_E】
Rofecoxib	chem
cyclo-oxygenase(COX)-2	geneY
COX-1	geneY
【PRE_E】
Rofecoxib	chem
cyclo-oxygenase(COX)-2	geneY
COX-1	geneY
【GOLD_R】
Rofecoxib	cyclo-oxygenase(COX)-2	C4
【PRE_R】
Rofecoxib	cyclo-oxygenase(COX)-2	C4

Rofecoxib has greater selectivity for COX - 2 than celecoxib , meloxicam , diclofenac and indomethacin .
【GOLD_E】
celecoxib	chem
meloxicam	chem
diclofenac	chem
indomethacin	chem
COX-2	geneY
Rofecoxib	chem
【PRE_E】
Rofecoxib	chem
COX-2	geneY
celecoxib	chem
meloxicam	chem
diclofenac	chem
indomethacin	chem
【GOLD_R】
Rofecoxib	COX-2	C4
【PRE_R】
Rofecoxib	COX-2	C4

In well - controlled clinical trials , rofecoxib 12.5 to 500 mg / day has been evaluated for its efficacy in the treatment of osteoarthritis , acute pain and rheumatoid arthritis [ lower dosages ( 5 to 125 mg / day ) were generally used in the chronic pain indications ] .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

In the treatment of patients with osteoarthritis , rofecoxib was more effective in providing symptomatic relief than placebo , paracetamol ( acetaminophen ) and celecoxib and was similar in efficacy to ibuprofen , diclofenac , naproxen and nabumetone .
【GOLD_E】
rofecoxib	chem
paracetamol	chem
acetaminophen	chem
celecoxib	chem
ibuprofen	chem
diclofenac	chem
naproxen	chem
nabumetone	chem
【PRE_E】
rofecoxib	chem
paracetamol	chem
acetaminophen	chem
celecoxib	chem
ibuprofen	chem
diclofenac	chem
naproxen	chem
nabumetone	chem
【GOLD_R】
【PRE_R】

Overall , both the physician 's assessment of disease status and the patient 's assessment of response to therapy tended to favour rofecoxib .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

In patients with postsurgical dental pain , pain after spinal fusion or orthopaedic surgery , or primary dysmenorrhoea , rofecoxib provided more rapid and more sustained pain relief and reduced requirements for supplemental morphine use after surgery than placebo .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
morphine	chem
【GOLD_R】
【PRE_R】

Rofecoxib was more efficacious than celecoxib in patients with acute dental pain and pain after spinal fusion surgery , although celecoxib may have been used at a subtherapeutic dose .
【GOLD_E】
Rofecoxib	chem
celecoxib	chem
celecoxib	chem
【PRE_E】
Rofecoxib	chem
celecoxib	chem
celecoxib	chem
【GOLD_R】
【PRE_R】

In comparison with traditional nonsteroidal anti - inflammatory drugs ( NSAIDs ) ibuprofen , diclofenac and naproxen sodium , rofecoxib was similar in efficacy in the treatment of acute pain .
【GOLD_E】
rofecoxib	chem
ibuprofen	chem
diclofenac	chem
naproxensodium	chem
【PRE_E】
ibuprofen	chem
diclofenac	chem
naproxensodium	chem
rofecoxib	chem
【GOLD_R】
【PRE_R】

Although naproxen sodium provided more rapid pain relief than rofecoxib in patients with primary dysmenorrhoea , the reverse was true after orthopaedic surgery : rofecoxib provided more rapid pain relief and less supplemental morphine was needed .
【GOLD_E】
naproxensodium	chem
rofecoxib	chem
rofecoxib	chem
morphine	chem
【PRE_E】
naproxensodium	chem
rofecoxib	chem
rofecoxib	chem
morphine	chem
【GOLD_R】
【PRE_R】

Rofecoxib was as effective as naproxen in providing symptomatic relief for over 8700 patients with rheumatoid arthritis .
【GOLD_E】
Rofecoxib	chem
naproxen	chem
【PRE_E】
Rofecoxib	chem
naproxen	chem
【GOLD_R】
【PRE_R】

Compared with traditional NSAID therapy , rofecoxib had a significantly lower incidence of endoscopically confirmed gastroduodenal ulceration and , in approximately 13,000 patients with osteoarthritis and rheumatoid arthritis , a lower incidence of gastrointestinal ( GI ) adverse events .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

Rofecoxib was generally well tolerated in all indications with an overall tolerability profile similar to traditional NSAIDs .
【GOLD_E】
Rofecoxib	chem
【PRE_E】
Rofecoxib	chem
【GOLD_R】
【PRE_R】

The most common adverse events in rofecoxib recipients were nausea , dizziness and headache .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

In conclusion , rofecoxib is at least as effective as traditional NSAID therapy in providing pain relief for both chronic and acute pain conditions .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

Rofecoxib provides an alternative treatment option to traditional NSAID therapy in the management of symptomatic pain relief in patients with osteoarthritis .
【GOLD_E】
Rofecoxib	chem
【PRE_E】
Rofecoxib	chem
【GOLD_R】
【PRE_R】

Initial data from patients with primary dysmenorrhoea and postoperative pain are promising and further trials may confirm its place in the treatment of these indications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rofecoxib has also shown promising results in patients with rheumatoid arthritis and is likely to become a valuable addition to current drug therapy for this patient population .
【GOLD_E】
Rofecoxib	chem
【PRE_E】
Rofecoxib	chem
【GOLD_R】
【PRE_R】

Importantly , rofecoxib is associated with a lower incidence of GI adverse events than traditional NSAIDs making it a primary treatment option in patients at risk of developing GI complications or patients with chronic conditions requiring long term treatment .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

Clinical , biochemical and molecular genetic data in five children with Gitelman 's syndrome .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Gitelman 's variant of Bartter 's syndrome , inherited hypokalemic alkalosis , is caused by mutation in the thiazide - sensitive NaCl co - transporter ( NCCT ) .
【GOLD_E】
thiazide	chem
NaCl	chem
thiazide-sensitiveNaClco-transporter	geneY
NCCT	geneY
【PRE_E】
thiazide-sensitiveNaClco-transporter	geneY
NCCT	geneY
【GOLD_R】
【PRE_R】

The main clinical symptoms are : muscular weakness , carpopedal spasm , constipation and short stature .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The diagnosis was suspected in five children according to clinical criteria .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All patients exhibited carpopedal spasm during febrile illness , three patients had short stature .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Biochemical features were : metabolic alkalosis , hypokalemia , hypomagnesemia , low IGF - I levels , hyperkaliuria , hypernatriuria , hypocalciuria and normoprostaglandinuria .
【GOLD_E】
IGF-I	geneY
【PRE_E】
IGF-I	geneY
【GOLD_R】
【PRE_R】

Three patients had elevated plasma renin activity and hyperaldosteronism .
【GOLD_E】
renin	geneY
【PRE_E】
renin	geneY
【GOLD_R】
【PRE_R】

Mutational analysis of the NCCT gene confirmed the diagnosis in all five patients .
【GOLD_E】
NCCT	geneY
【PRE_E】
NCCT	geneY
【GOLD_R】
【PRE_R】

Different forms of therapy , potassium and magnesium substitution , spironolactone and indomethacin failed to fully correct hypokalemia and hypomagnesemia , but markedly improved growth velocity and normalized IGF - I levels in the three patients with short stature .
【GOLD_E】
IGF-I	geneY
potassium	chem
magnesium	chem
spironolactone	chem
indomethacin	chem
【PRE_E】
potassium	chem
magnesium	chem
spironolactone	chem
indomethacin	chem
hypokalemia	chem
hypomagnesemia	chem
IGF-I	geneY
【GOLD_R】
【PRE_R】
spironolactone	IGF-I	C4
indomethacin	IGF-I	C4
hypokalemia	IGF-I	C4
hypomagnesemia	IGF-I	C4

During therapy , clinical symptoms disappeared .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We conclude that Gitelman 's syndrome is a disorder with a variable symptom profile , but can be suspected on clinical signs already in early childhood .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The early diagnosis is essential in preventing complications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Peroxisome proliferator - activated receptor subtype - specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat .
【GOLD_E】
Peroxisomeproliferator-activatedreceptor	geneN
【PRE_E】
Peroxisomeproliferator-activatedreceptor	geneN
【GOLD_R】
【PRE_R】

Fibrates and thiazolidinediones are used clinically to treat hypertriglyceridemia and hyperglycemia , respectively .
【GOLD_E】
Fibrates	chem
thiazolidinediones	chem
【PRE_E】
Fibrates	chem
thiazolidinediones	chem
【GOLD_R】
【PRE_R】

Fibrates bind to the peroxisome proliferator - activated receptor ( PPAR ) - alpha , and thiazolidinediones are ligands of PPAR - gamma .
【GOLD_E】
peroxisomeproliferator-activatedreceptor(PPAR)-alpha	geneY
PPAR-gamma	geneY
Fibrates	chem
thiazolidinediones	chem
【PRE_E】
Fibrates	chem
peroxisomeproliferator-activatedreceptor(PPAR)-alpha	geneY
thiazolidinediones	chem
PPAR-gamma	geneY
【GOLD_R】
【PRE_R】

These intracellular receptors form heterodimers with retinoid X receptor to modulate gene transcription .
【GOLD_E】
retinoidXreceptor	geneN
retinoid	chem
【PRE_E】
retinoidXreceptor	geneY
【GOLD_R】
【PRE_R】

To elucidate the target genes regulated by these compounds , we treated Zucker diabetic fatty rats ( ZDF ) for 15 days with a PPAR - alpha - specific compound , fenofibrate , a PPAR - gamma - specific ligand , rosiglitazone , and a PPAR - alpha / - gamma coagonist , GW2331 , and measured the levels of several messenger RNAs ( mRNAs ) in liver by real - time polymerase chain reaction .
【GOLD_E】
fenofibrate	chem
rosiglitazone	chem
GW2331	chem
PPAR-alpha	geneY
PPAR-gamma	geneY
PPAR-alpha/-gamma	geneN
【PRE_E】
PPAR-alpha	geneY
fenofibrate	chem
PPAR-gamma	geneY
rosiglitazone	chem
PPAR-alpha/-gammacoagonist	geneN
GW2331	geneY
【GOLD_R】
【PRE_R】

All 3 compounds decreased serum glucose and triglyceride levels .
【GOLD_E】
glucose	chem
triglyceride	chem
【PRE_E】
glucose	chem
triglyceride	chem
【GOLD_R】
【PRE_R】

Fenofibrate and GW2331 induced expression of acyl - coenzyme A ( CoA ) oxidase and enoyl - CoA hydratase and reduced apolipoprotein C - III and phosphoenolpyruvate carboxykinase mRNAs .
【GOLD_E】
Fenofibrate	chem
GW2331	chem
acyl-coenzymeA	chem
CoA	chem
enoyl-CoA	chem
phosphoenolpyruvate	chem
acyl-coenzymeA(CoA)oxidase	geneN
enoyl-CoAhydratase	geneY
apolipoproteinC-III	geneY
phosphoenolpyruvatecarboxykinase	geneN
【PRE_E】
Fenofibrate	chem
GW2331	chem
acyl-coenzymeA(CoA)oxidase	geneY
enoyl-CoAhydratase	geneY
apolipoproteinC-III	geneY
phosphoenolpyruvatecarboxykinase	geneY
【GOLD_R】
Fenofibrate	acyl-coenzymeA(CoA)oxidase	C3
Fenofibrate	enoyl-CoAhydratase	C3
GW2331	acyl-coenzymeA(CoA)oxidase	C3
GW2331	enoyl-CoAhydratase	C3
Fenofibrate	apolipoproteinC-III	C4
Fenofibrate	phosphoenolpyruvatecarboxykinase	C4
GW2331	apolipoproteinC-III	C4
GW2331	phosphoenolpyruvatecarboxykinase	C4
【PRE_R】
Fenofibrate	apolipoproteinC-III	C3
GW2331	apolipoproteinC-III	C3
GW2331	phosphoenolpyruvatecarboxykinase	C3

Rosiglitazone modestly increased apolipoprotein C - III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue .
【GOLD_E】
Rosiglitazone	chem
glucosetransporter4	geneY
phosphoenolpyruvatecarboxykinase	geneN
glucose	chem
phosphoenolpyruvate	chem
apolipoproteinC-III	geneY
【PRE_E】
Rosiglitazone	chem
apolipoproteinC-III	geneY
glucosetransporter4	geneY
phosphoenolpyruvatecarboxykinase	geneY
【GOLD_R】
Rosiglitazone	glucosetransporter4	C3
Rosiglitazone	phosphoenolpyruvatecarboxykinase	C3
Rosiglitazone	apolipoproteinC-III	C3
【PRE_R】
Rosiglitazone	apolipoproteinC-III	C3
Rosiglitazone	phosphoenolpyruvatecarboxykinase	C3

We identified a novel target in liver , mitogen - activated phosphokinase phosphatase 1 , whose down - regulation by PPAR - alpha agonists may improve insulin sensitivity in that tissue by prolonging insulin responses .
【GOLD_E】
mitogen-activatedphosphokinasephosphatase1	geneY
PPAR-alpha	geneY
insulin	geneN
insulin	geneN
【PRE_E】
mitogen-activatedphosphokinasephosphatase1	geneY
PPAR-alpha	geneY
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

The results of these studies suggest that activation of PPAR - alpha as well as PPAR - gamma in therapy for type 2 diabetes will enhance glucose and triglyceride control by combining actions in hepatic and peripheral tissues .
【GOLD_E】
PPAR-alpha	geneY
PPAR-gamma	geneY
glucose	chem
triglyceride	chem
【PRE_E】
PPAR-alpha	geneY
PPAR-gamma	geneY
glucose	chem
triglyceride	chem
【GOLD_R】
【PRE_R】

Serotonergic effects and extracellular brain levels of eletriptan , zolmitriptan and sumatriptan in rat brain .
【GOLD_E】
eletriptan	chem
zolmitriptan	chem
sumatriptan	chem
【PRE_E】
eletriptan	chem
zolmitriptan	chem
sumatriptan	chem
【GOLD_R】
【PRE_R】

In vivo microdialysis was used to assess the central serotonergic effects and extracellular brain levels of the 5 - HT ( 1B / 1D ) receptor agonists eletriptan , zolmitriptan and sumatriptan in rats after intravenous and intracerebral administration , while their binding affinities and functional potencies were determined at 5 - HT ( 1B ) , 5 - HT ( 1D ) and 5 - HT ( 1A ) receptors .
【GOLD_E】
sumatriptan	chem
5-HT(1B/1D)	geneN
5-HT(1B)	geneY
5-HT(1D)	geneY
5-HT(1A)	geneY
eletriptan	chem
zolmitriptan	chem
【PRE_E】
5-HT(1B/1D)receptor	geneN
eletriptan	chem
zolmitriptan	chem
sumatriptan	chem
5-HT(1B)	geneY
5-HT(1D)	geneY
5-HT(1A)	geneY
【GOLD_R】
【PRE_R】

In vitro studies showed that all three triptans are high affinity , full agonists at 5 - HT ( 1B / 1D ) receptors , but that sumatriptan is functionally less potent as a 5 - HT ( 1B / 1D ) agonist than zolmitriptan and eletriptan .
【GOLD_E】
triptans	chem
sumatriptan	chem
zolmitriptan	chem
eletriptan	chem
5-HT(1B/1D)	geneN
5-HT(1B/1D)	geneN
【PRE_E】
5-HT(1B/1D)receptors	geneN
sumatriptan	chem
5-HT(1B/1D	geneN
zolmitriptan	chem
eletriptan	chem
【GOLD_R】
【PRE_R】
5-HT(1B/1D	zolmitriptan	C6
5-HT(1B/1D	eletriptan	C6

Local intracortical perfusion with the compounds via the dialysis probe decreased cortical 5 - HT ( 5 - hydroxytryptamine , serotonin ) release with ED ( 50 ) values of approximately 0.1 microM for eletriptan and zolmitriptan and 0.5 microM for sumatriptan .
【GOLD_E】
5-HT	chem
5-hydroxytryptamine	chem
serotonin	chem
eletriptan	chem
zolmitriptan	chem
sumatriptan	chem
【PRE_E】
5-HT	chem
5-hydroxytryptamine	chem
serotonin	chem
eletriptan	chem
zolmitriptan	chem
sumatriptan	chem
【GOLD_R】
【PRE_R】

At 3.2 mg / kg i.v . , both eletriptan and zolmitriptan decreased 5 - HT levels by about 35 % , while sumatriptan had no effect , despite the fact that maximal sumatriptan concentrations in cortical dialysates were higher ( 8.8 nM at 20 min ) than those of zolmitriptan ( 5.9 nM at 20 min ) and eletriptan ( 2.6 nM at 40 min ) .
【GOLD_E】
zolmitriptan	chem
eletriptan	chem
zolmitriptan	chem
5-HT	chem
sumatriptan	chem
sumatriptan	chem
eletriptan	chem
【PRE_E】
eletriptan	chem
zolmitriptan	chem
5-HT	chem
sumatriptan	chem
sumatriptan	chem
zolmitriptan	chem
eletriptan	chem
【GOLD_R】
【PRE_R】

The observation that eletriptan and zolmitriptan produce almost identical central serotonergic effects , after intracerebral as well as after systemic administration , is in agreement with their comparable functional 5 - HT ( 1B / 1D ) receptor agonist potencies and their free levels in cortical dialysates after 3.2 mg / kg i.v .
【GOLD_E】
5-HT(1B/1D)	geneN
eletriptan	chem
zolmitriptan	chem
【PRE_E】
eletriptan	chem
zolmitriptan	chem
5-HT(1B/1D)receptor	geneY
【GOLD_R】
【PRE_R】

On the other hand , the lack of central serotonergic effects of 3.2 mg / kg i.v . sumatriptan is likely due to its weaker functional 5 - HT ( 1B / 1D ) receptor agonist potency than eletriptan and zolmitriptan , rather than lower brain levels , consistent with sumatriptan 's fivefold lower potency after intracerebral administration .
【GOLD_E】
5-HT(1B/1D)	geneN
sumatriptan	chem
eletriptan	chem
zolmitriptan	chem
【PRE_E】
sumatriptan	chem
5-HT(1B/1D)receptor	geneY
eletriptan	chem
zolmitriptan	chem
【GOLD_R】
【PRE_R】
5-HT(1B/1D)receptor	eletriptan	C6

Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active .
【GOLD_E】
Urokinaseplasminogenactivator	geneY
plasmin	geneY
hemofiltrateCCchemokine1	geneY
【PRE_E】
Urokinaseplasminogenactivator	geneY
plasmin	geneY
hemofiltrateCCchemokine1	geneY
【GOLD_R】
【PRE_R】

We have previously isolated from human hemofiltrate an N - terminally truncated form of the hemofiltrate CC chemokine 1 ( HCC - 1 ) , and characterized HCC - 1 [ 9 - 74 ] as a strong agonist of CCR1 , CCR5 , and to a lower extent CCR3 .
【GOLD_E】
CCR3	geneY
N	chem
hemofiltrateCCchemokine1	geneY
HCC-1	geneY
HCC-1[9-74]	geneY
CCR1	geneY
CCR5	geneY
【PRE_E】
humanhemofiltrate	geneY
N	chem
hemofiltrateCCchemokine1	geneY
CCR1	geneY
CCR5	geneY
CCR3	geneY
【GOLD_R】
【PRE_R】

In this study , we show that conditioned media from human tumor cell lines PC - 3 and 143B contain proteolytic activities that convert HCC - 1 into the [ 9 - 74 ] form .
【GOLD_E】
HCC-1	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

This activity was fully inhibited by inhibitors of urokinase - type plasminogen activator ( uPA ) , including PA inhibitor - 1 , an anti - uPA mAb , and amiloride .
【GOLD_E】
urokinase-typeplasminogenactivator	geneY
uPA	geneY
PAinhibitor-1	geneY
uPA	geneY
【PRE_E】
urokinase-typeplasminogenactivator	geneY
uPA	geneY
PAinhibitor-1	geneY
uPAmAb	geneY
amiloride	chem
【GOLD_R】
【PRE_R】
urokinase-typeplasminogenactivator	amiloride	C4
uPA	amiloride	C4
PAinhibitor-1	amiloride	C4
uPAmAb	amiloride	C4

Pure preparations of uPA processed HCC - 1 with high efficiency , without further degrading HCC - 1 [ 9 - 74 ] .
【GOLD_E】
uPA	geneY
HCC-1	geneY
HCC-1[9-74]	geneY
【PRE_E】
uPA	geneY
【GOLD_R】
【PRE_R】

Plasmin could also generate HCC - 1 [ 9 - 74 ] , but degraded the active product as well .
【GOLD_E】
Plasmin	geneY
HCC-1[9-74]	geneY
【PRE_E】
Plasmin	geneY
【GOLD_R】
【PRE_R】

The kinetics of HCC - 1 cleavage by uPA and plasmin ( Michaelis constant , K ( m ) , of 0.76 + / - 0.4 microM for uPA , and 0.096 + / - 0.05 microM for plasmin ; catalytic rate constant , k ( cat ) : 3.36 + / - 0.96 s ( - 1 ) for uPA and 6 + / - 3.6 s ( - 1 ) for plasmin ) are fully compatible with a role in vivo .
【GOLD_E】
HCC-1	geneY
uPA	geneY
plasmin	geneY
uPA	geneY
plasmin	geneY
uPA	geneY
plasmin	geneY
【PRE_E】
uPA	geneY
plasmin	geneY
uPA	geneN
plasmin	geneY
uPA	geneN
plasmin	geneY
【GOLD_R】
【PRE_R】

The activation of an abundant inactive precursor into a broad - spectrum chemokine by uPA and plasmin directly links the production of uPA by numerous tumors and their ability to recruit mononuclear leukocytes , without the need for the transcriptional activation of chemokine genes .
【GOLD_E】
uPA	geneY
plasmin	geneY
uPA	geneY
chemokine	geneN
【PRE_E】
chemokine	geneN
uPA	geneY
plasmin	geneY
uPA	geneY
chemokine	geneN
【GOLD_R】
【PRE_R】

Cembranoid and long - chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction .
【GOLD_E】
Cembranoid	chem
long-chainalkanol	chem
acetylcholine	chem
nicotinicacetylcholinereceptor	geneN
【PRE_E】
Cembranoid	chem
long-chainalkanol	chem
nicotinicacetylcholinereceptor	geneN
【GOLD_R】
【PRE_R】

Long - chain alkanols are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral nicotinic acetylcholine receptor ( AChR ) by binding to one or more specific sites on the AChR .
【GOLD_E】
Long-chainalkanols	chem
nicotinicacetylcholinereceptor	geneN
AChR	geneN
AChR	geneN
acetylcholine	chem
【PRE_E】
Long-chainalkanols	chem
peripheralnicotinicacetylcholinereceptor	geneN
AChR	geneN
AChR	geneN
【GOLD_R】
Long-chainalkanols	nicotinicacetylcholinereceptor	C4
【PRE_R】
Long-chainalkanols	AChR	C4

Cembranoids are naturally occurring , uncharged noncompetitive inhibitors of peripheral and neuronal AChRs , which have no demonstrable general anesthetic activity in vivo .
【GOLD_E】
AChRs	geneN
Cembranoids	chem
【PRE_E】
Cembranoids	chem
AChRs	geneY
【GOLD_R】
Cembranoids	AChRs	C4
【PRE_R】
Cembranoids	AChRs	C4

In this study , [ 3H ] tenocyclidine ( [ 3H ] TCP ) , an analogue of the cationic noncompetitive inhibitor phencyclidine ( PCP ) , was used to characterize the cembranoid and long - chain alkanol sites on the desensitized Torpedo californica AChR and to investigate if these sites interact .
【GOLD_E】
[3H]tenocyclidine	chem
[3H]TCP	chem
phencyclidine	chem
PCP	chem
cembranoid	chem
long-chainalkanol	chem
AChR	geneN
【PRE_E】
[3H]tenocyclidine	chem
[3H]TCP	chem
phencyclidine	chem
PCP	chem
cembranoid	chem
long-chainalkanol	chem
TorpedocalifornicaAChR	geneY
【GOLD_R】
【PRE_R】

These studies confirm that there is a single cembranoid site which sterically overlaps the [ 3H ] TCP channel site .
【GOLD_E】
[3H]TCP	chem
【PRE_E】
cembranoid	chem
[3H]TCP	chem
【GOLD_R】
【PRE_R】

This cembranoid site probably also overlaps the sites for the cationic noncompetitive inhibitors , procaine and quinacrine .
【GOLD_E】
cembranoid	chem
procaine	chem
quinacrine	chem
【PRE_E】
procaine	chem
quinacrine	chem
【GOLD_R】
【PRE_R】

Evidence is also presented for one or more allosteric cembranoid sites which negatively modulate cembranoid affinity for the inhibitory site .
【GOLD_E】
cembranoid	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast , long - chain alkanols inhibit [ 3H ] TCP binding through an allosteric mechanism involving two or more alkanol sites which display positive cooperativity toward each other .
【GOLD_E】
long-chainalkanols	chem
[3H]TCP	chem
alkanol	chem
【PRE_E】
alkanols	chem
[3H]TCP	chem
alkanol	chem
【GOLD_R】
【PRE_R】

Double inhibitor studies show that the cembranoid inhibitory site and the alkanol sites are not independent of each other but interfere allosterically with each other 's inhibition of [ 3H ] TCP binding .
【GOLD_E】
cembranoid	chem
alkanol	chem
[3H]TCP	chem
【PRE_E】
cembranoid	chem
alkanol	chem
[3H]TCP	chem
【GOLD_R】
【PRE_R】

The simplest models consistent with the observed data are presented and discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sulfasalazine , a potent suppressor of lymphoma growth by inhibition of the x ( c ) - cystine transporter : a new action for an old drug .
【GOLD_E】
Sulfasalazine	chem
cystine	chem
x(c)-cystinetransporter	geneY
【PRE_E】
Sulfasalazine	chem
x(c)-cystinetransporter	geneY
【GOLD_R】
Sulfasalazine	x(c)-cystinetransporter	C4
【PRE_R】
Sulfasalazine	x(c)-cystinetransporter	C4

Although cyst ( e ) ine is nutritionally a non - essential amino acid , lymphoid cells can not synthesize it , rendering their growth dependent on uptake of cyst ( e ) ine from their microenvironment .
【GOLD_E】
cyst(e)ine	chem
cyst(e)ine	chem
non-essentialaminoacid	chem
【PRE_E】
cyst(e)ine	chem
aminoacid	chem
cyst(e)ine	chem
【GOLD_R】
【PRE_R】

Accordingly , we previously suggested that the x ( c ) - plasma membrane cystine transporter provided a target for lymphoid cancer therapy .
【GOLD_E】
x(c)-plasmamembranecystinetransporter	geneY
cystine	chem
【PRE_E】
x(c)-plasmamembranecystinetransporter	geneN
【GOLD_R】
【PRE_R】

Its inhibition could lead to cyst ( e ) ine deficiency in lymphoma cells via reduction of both their cystine uptake and cysteine supply by somatic cells .
【GOLD_E】
cystine	chem
cysteine	chem
cyst(e)ine	chem
【PRE_E】
cyst(e)ine	chem
cystine	chem
cysteine	chem
【GOLD_R】
【PRE_R】

In this study , using rat Nb2 lymphoma cultures , drugs were screened for growth arrest based on x ( c ) - inhibition .
【GOLD_E】
x(c)	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

Sulfasalazine was fortuitously found to be a novel , potent inhibitor of the x ( c ) - transporter .
【GOLD_E】
Sulfasalazine	chem
x(c)-transporter	geneY
【PRE_E】
Sulfasalazine	chem
x(c)-transporter	geneY
【GOLD_R】
Sulfasalazine	x(c)-transporter	C4
【PRE_R】
Sulfasalazine	x(c)-transporter	C4

It showed high rat lymphoma growth - inhibitory and lytic activity in vitro ( IC50 = 0.16 mM ) , based specifically on inhibition of x ( c ) - - mediated cystine uptake , in contrast to its colonic metabolites , sulfapyridine and 5 - aminosalicylic acid .
【GOLD_E】
cystine	chem
sulfapyridine	chem
5-aminosalicylicacid	chem
x(c)	geneY
【PRE_E】
ratlymphomagrowth-inhibitory	geneY
x(c)--mediatedcystine	chem
sulfapyridine	chem
5-aminosalicylicacid	chem
【GOLD_R】
sulfapyridine	x(c)	C4
5-aminosalicylicacid	x(c)	C4
cystine	x(c)	C9
【PRE_R】
ratlymphomagrowth-inhibitory	sulfapyridine	C4
ratlymphomagrowth-inhibitory	5-aminosalicylicacid	C4

Sulfasalazine was even more effective against human non - Hodgkin 's lymphoma ( DoHH2 ) cultures .
【GOLD_E】
Sulfasalazine	chem
【PRE_E】
Sulfasalazine	chem
【GOLD_R】
【PRE_R】

In rats ( n = 13 ) , sulfasalazine ( i.p . ) markedly inhibited growth of well - developed , rapidly growing rat Nb2 lymphoma transplants without apparent side - effects .
【GOLD_E】
sulfasalazine	chem
【PRE_E】
sulfasalazine	chem
ratNb2lymphoma	geneY
【GOLD_R】
【PRE_R】

Reduced , macrophage - mediated supply of cysteine was probably involved .
【GOLD_E】
cysteine	chem
【PRE_E】
cysteine	chem
【GOLD_R】
【PRE_R】

In five rats , 90 - 100 % tumor growth suppression , relative to controls , was obtained .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The x ( c ) - cystine transporter represents a novel target for sulfasalazine - like drugs with high potential for application in therapy of lymphoblastic and other malignancies dependent on extracellular cyst ( e ) ine .
【GOLD_E】
x(c)-cystinetransporter	geneY
cystine	chem
sulfasalazine	chem
cyst(e)ine	chem
【PRE_E】
x(c)-cystinetransporter	geneN
sulfasalazine	chem
lymphoblastic	chem
cyst(e)ine	chem
【GOLD_R】
cyst(e)ine	x(c)-cystinetransporter	C9
【PRE_R】

Advances in antihypertensive combination therapy : benefits of low - dose thiazide diuretics in conjunction with omapatrilat , a vasopeptidase inhibitor .
【GOLD_E】
omapatrilat	chem
thiazide	chem
vasopeptidase	geneN
【PRE_E】
thiazide	chem
omapatrilat	chem
vasopeptidase	geneN
【GOLD_R】
omapatrilat	vasopeptidase	C4
【PRE_R】
thiazide	vasopeptidase	C4
omapatrilat	vasopeptidase	C4

The preferred initial agents for the treatment of high blood pressure are low - dose thiazide diuretics , beta blockers , calcium antagonists , and angiotensin - converting enzyme ( ACE ) inhibitors .
【GOLD_E】
thiazide	chem
angiotensin-convertingenzyme	geneY
ACE	geneY
calcium	chem
angiotensin	chem
【PRE_E】
thiazide	chem
calcium	chem
angiotensin-convertingenzyme	geneY
ACE	geneY
【GOLD_R】
【PRE_R】
thiazide	ACE	C4

In high - risk patients , including those with diabetes , renal insufficiency , left ventricular dysfunction , and atherosclerosis , ACE inhibitors may have specific benefit in reducing cardiovascular morbidity and mortality .
【GOLD_E】
ACE	geneY
【PRE_E】
ACE	geneY
【GOLD_R】
【PRE_R】

Omapatrilat , the prototypical vasopeptidase inhibitor , inhibits not only ACE but also neutral endopeptidase .
【GOLD_E】
vasopeptidase	geneN
ACE	geneY
neutralendopeptidase	geneY
Omapatrilat	chem
【PRE_E】
Omapatrilat	chem
vasopeptidase	geneN
ACE	geneY
neutralendopeptidase	geneN
【GOLD_R】
Omapatrilat	vasopeptidase	C4
Omapatrilat	ACE	C4
Omapatrilat	neutralendopeptidase	C4
【PRE_R】
Omapatrilat	vasopeptidase	C4
Omapatrilat	ACE	C4

Like conventional ACE inhibitors , omapatrilat causes extracellular volume reduction and vasodilatation ; moreover , it increases levels of atrial and brain natriuretic peptides and bradykinin .
【GOLD_E】
omapatrilat	chem
bradykinin	chem
ACE	geneY
atrialandbrainnatriureticpeptides	geneN
bradykinin	geneY
【PRE_E】
ACE	geneY
omapatrilat	chem
atrialandbrainnatriureticpeptides	geneN
bradykinin	geneY
【GOLD_R】
omapatrilat	atrialandbrainnatriureticpeptides	C3
omapatrilat	bradykinin	C3
omapatrilat	ACE	C4
【PRE_R】
ACE	omapatrilat	C4

Effective blood pressure control , especially in the high - risk patient , usually necessitates combination therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A recent study randomized 274 subjects with mild to severe hypertension ( stages 1 - 3 diastolic blood pressure elevation ) and confirmed the benefits of omapatrilat combined with hydrochlorothiazide in patients not controlled on hydrochlorothiazide alone .
【GOLD_E】
omapatrilat	chem
hydrochlorothiazide	chem
hydrochlorothiazide	chem
【PRE_E】
omapatrilat	chem
hydrochlorothiazide	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

The frequencies of adverse events , serious adverse events , and discontinuation attributed to adverse events were similar for omapatrilat and placebo .
【GOLD_E】
omapatrilat	chem
【PRE_E】
omapatrilat	chem
【GOLD_R】
【PRE_R】

Furthermore , there were no clinically significant changes in serum creatinine , potassium , or other laboratory parameters .
【GOLD_E】
creatinine	chem
potassium	chem
【PRE_E】
creatinine	chem
potassium	chem
【GOLD_R】
【PRE_R】

Adding omapatrilat to the background of hydrochlorothiazide treatment produced statistically significant additional reductions in trough diastolic and systolic blood pressures at weeks 4 and 8 .
【GOLD_E】
omapatrilat	chem
hydrochlorothiazide	chem
【PRE_E】
omapatrilat	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Neonatal red blood cells : amiloride - insensitive Na + - H + transport isoform would express Na + - Li + exchange .
【GOLD_E】
amiloride	chem
Na+	chem
H+	chem
Na+	chem
Li+	chem
【PRE_E】
amiloride	chem
Na+-H+	chem
Na+-Li+	chem
【GOLD_R】
【PRE_R】

Neonatal red cells ( umbilical cord blood ) were in vitro incubated in isotonic media ( thiocyanate as predominant anion ) .
【GOLD_E】
thiocyanate	chem
【PRE_E】
thiocyanate	chem
【GOLD_R】
【PRE_R】

This experimental condition was selected as it was known that this chaotropic anion induced activation of Na + - H + exchange .
【GOLD_E】
Na+	chem
H+	chem
【PRE_E】
Na+-H+	chem
【GOLD_R】
【PRE_R】

The transport amiloride - sensitive mechanism , that decreased the acidic intracellular pH change occurring in this medium , would correspond to Na + - H + exchange ( NHE1 isoform ) .
【GOLD_E】
NHE1	geneY
amiloride	chem
Na+	chem
H+	chem
【PRE_E】
amiloride	chem
Na+-H+exchange	geneN
NHE1	geneY
【GOLD_R】
Na+	NHE1	C9
H+	NHE1	C9
【PRE_R】

However , the Na + - Li + exchange , also determined in the cells in the above - mentioned medium was not affected by amiloride .
【GOLD_E】
Na+	chem
Li+	chem
amiloride	chem
【PRE_E】
Na+-Li+	chem
amiloride	chem
【GOLD_R】
【PRE_R】

The present data suggest that an amiloride insensitive Na + - H + exchange isoform would express Na + - Li + countertransport in these cells .
【GOLD_E】
Na+	chem
H+	chem
Na+	chem
Li+	chem
amiloride	chem
【PRE_E】
amiloride	chem
Na+-H+	chem
Na+-Li+countertransport	chem
【GOLD_R】
【PRE_R】

Aspirin and salicylate bind to immunoglobulin heavy chain binding protein ( BiP ) and inhibit its ATPase activity in human fibroblasts .
【GOLD_E】
Aspirin	chem
salicylate	chem
immunoglobulinheavychainbindingprotein	geneY
BiP	geneY
ATPase	geneN
【PRE_E】
Aspirin	chem
salicylate	chem
immunoglobulinheavychainbindingprotein	geneY
BiP	geneY
ATPase	geneN
【GOLD_R】
Aspirin	ATPase	C4
salicylate	ATPase	C4
【PRE_R】

Salicylic acid ( SA ) , an endogenous signaling molecule of plants , possesses anti - inflammatory and anti - neoplastic actions in human .
【GOLD_E】
Salicylicacid	chem
SA	chem
【PRE_E】
Salicylicacid	chem
SA	chem
【GOLD_R】
【PRE_R】

Its derivative , aspirin , is the most commonly used anti - inflammatory and analgesic drug .
【GOLD_E】
【PRE_E】
aspirin	chem
【GOLD_R】
【PRE_R】

Aspirin and sodium salicylate ( salicylates ) have been reported to have multiple pharmacological actions .
【GOLD_E】
Aspirin	chem
sodiumsalicylate	chem
salicylates	chem
【PRE_E】
Aspirin	chem
sodiumsalicylate	chem
salicylates	chem
【GOLD_R】
【PRE_R】

However , it is unclear whether they bind to a cellular protein .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we report for the first time the purification from human fibroblasts of a approximately 78 kDa salicylate binding protein with sequence identity to immunoglobulin heavy chain binding protein ( BiP ) .
【GOLD_E】
salicylatebindingprotein	geneN
immunoglobulinheavychainbindingprotein	geneY
BiP	geneY
【PRE_E】
salicylate	chem
immunoglobulinheavychainbindingprotein	geneY
BiP	geneY
【GOLD_R】
【PRE_R】

The Kd values of SA binding to crude extract and to recombinant BiP were 45.2 and 54.6 microM , respectively .
【GOLD_E】
BiP	geneY
SA	chem
【PRE_E】
BiP	geneY
【GOLD_R】
【PRE_R】

BiP is a chaperone protein containing a polypeptide binding site recognizing specific heptapeptide sequence and an ATP binding site .
【GOLD_E】
BiP	geneY
chaperoneprotein	geneN
heptapeptidesequence	geneN
ATPbindingsite	geneN
ATP	chem
【PRE_E】
BiP	geneY
chaperone	geneN
heptapeptidesequence	geneN
ATPbindingsite	geneN
【GOLD_R】
【PRE_R】

A heptapeptide with the specific sequence displaced SA binding in a concentration - dependent manner whereas a control heptapeptide did not .
【GOLD_E】
SA	chem
【PRE_E】
SA	geneN
【GOLD_R】
【PRE_R】

Salicylates inhibited ATPase activity stimulated by this specific heptapeptide but did not block ATP binding or induce BiP expression .
【GOLD_E】
Salicylates	chem
BiP	geneY
ATPase	geneN
ATP	chem
【PRE_E】
ATPase	geneN
ATP	chem
BiP	geneY
【GOLD_R】
Salicylates	ATPase	C4
【PRE_R】

These results indicate that salicylates bind specifically to the polypeptide binding site of BiP in human cells that may interfere with folding and transport of proteins important in inflammation .
【GOLD_E】
BiP	geneY
salicylates	chem
【PRE_E】
salicylates	chem
BiP	geneY
【GOLD_R】
【PRE_R】

Compensatory changes in enzymes of arginine metabolism during renal hypertrophy in mice .
【GOLD_E】
arginine	chem
【PRE_E】
arginine	chem
【GOLD_R】
【PRE_R】

The present study investigates enzyme activities of the urea cycle , transamidinase and ornithine - proline inter - conversion in the hypertrophied kidney after unilateral nephrectomy in mice .
【GOLD_E】
transamidinase	geneY
ornithine	chem
proline	chem
【PRE_E】
urea	chem
transamidinase	chem
ornithine-proline	chem
【GOLD_R】
【PRE_R】

Surgical removal of the left kidney in mice led to compensatory enlargement of the right kidney after 1 and 14 days .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This renal growth was associated with an increase in glomerular volume ( but not number ) and enlargement of the proximal convoluted tubules .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The total renal protein content increased in proportion to the increase in kidney weight , but the protein per gram weight of kidney did not change .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The specific activity of only ornithine aminotransferase ( OAT ) , the rate - limiting enzyme in the conversion of ornithine to proline , increased in 2 weeks of hypertrophy .
【GOLD_E】
ornithine	chem
ornithine	chem
proline	chem
ornithineaminotransferase	geneY
OAT	geneY
【PRE_E】
ornithineaminotransferase	geneY
OAT	geneY
ornithine	chem
proline	chem
【GOLD_R】
proline	ornithineaminotransferase	C9
proline	OAT	C9
ornithine	ornithineaminotransferase	C9
ornithine	OAT	C9
【PRE_R】
OAT	ornithine	C9
OAT	proline	C9

The specific activity of all other enzymes was unchanged .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , the total enzyme activity per kidney of all the enzymes , without exception , was elevated in the hypertrophied kidney .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

While the increase in total OAT activity was much more than the increase in kidney weight , all other enzymes increased more or less in proportion to the increase in renal mass .
【GOLD_E】
OAT	geneY
【PRE_E】
OAT	geneY
【GOLD_R】
【PRE_R】

The results suggest that compensation in OAT activity to chronic reduction in renal mass was complete , but only partial in the case of other enzymes .
【GOLD_E】
OAT	geneY
【PRE_E】
OAT	geneY
【GOLD_R】
【PRE_R】

Analgesia and COX - 2 inhibition .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

While non - steroidal anti - inflammatory drugs ( NSAIDs ) are the mainstay of therapy for the management of acute pain and rheumatoid arthritis , toxicity associated with chronic administration limits their benefit - to - risk relationship in many patients .
【GOLD_E】
steroidal	chem
【PRE_E】
steroidal	chem
【GOLD_R】
【PRE_R】

A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia , and the in vivo selectivity of a selective cyclooxygenase ( COX ) - 2 inhibitor ( celecoxib ) in comparison to a dual COX - 1 / COX - 2 inhibitor ( ketorolac ) .
【GOLD_E】
celecoxib	chem
ketorolac	chem
cytokines	geneN
cyclooxygenase(COX)-2	geneY
COX-1	geneY
COX-2	geneY
【PRE_E】
cytokines	geneN
cyclooxygenase(COX)-2	geneY
celecoxib	chem
COX-1	geneY
COX-2	geneY
ketorolac	chem
【GOLD_R】
celecoxib	cyclooxygenase(COX)-2	C4
ketorolac	COX-1	C4
ketorolac	COX-2	C4
【PRE_R】
cytokines	celecoxib	C4
cyclooxygenase(COX)-2	celecoxib	C4
celecoxib	COX-1	C4
COX-2	ketorolac	C4

Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 ( PGE2 ; a product of both COX - 1 and COX - 2 ) and thromboxane B2 ( as a biomarker for COX - 1 activity ) with parallel assessments of pain .
【GOLD_E】
prostaglandinE2	chem
PGE2	chem
thromboxaneB2	chem
COX-1	geneY
COX-2	geneY
COX-1	geneY
【PRE_E】
prostaglandinE2	chem
PGE2	chem
COX-1	geneY
COX-2	geneY
thromboxaneB2	chem
COX-1	geneY
【GOLD_R】
prostaglandinE2	COX-1	C9
prostaglandinE2	COX-2	C9
PGE2	COX-1	C9
PGE2	COX-2	C9
【PRE_R】

The time course of PGE2 production was consistent with early release due to COX - 1 activity followed by increased production 2 - 3 hours after surgery , consistent with COX - 2 expression .
【GOLD_E】
PGE2	chem
COX-1	geneY
COX-2	geneY
【PRE_E】
PGE2	chem
COX-1	geneY
COX-2	geneY
【GOLD_R】
PGE2	COX-1	C9
PGE2	COX-2	C9
【PRE_R】

Ketorolac 30 mg at pain onset suppressed both pain and peripheral PGE2 levels .
【GOLD_E】
Ketorolac	chem
PGE2	chem
【PRE_E】
Ketorolac	chem
PGE2	chem
【GOLD_R】
【PRE_R】

Ketorolac 1 mg either at the site of injury or intramuscularly also produced analgesia but without any effect on peripheral PGE2 levels .
【GOLD_E】
Ketorolac	chem
PGE2	chem
【PRE_E】
Ketorolac	chem
PGE2	chem
【GOLD_R】
【PRE_R】

Celecoxib selectively suppressed PGE2 but not TxB2 at time points consistent with COX - 2 activity , while producing analgesia .
【GOLD_E】
COX-2	geneY
Celecoxib	chem
PGE2	chem
TxB2	chem
【PRE_E】
Celecoxib	chem
PGE2	chem
TxB2	chem
COX-2	geneY
【GOLD_R】
Celecoxib	COX-2	C4
PGE2	COX-2	C9
【PRE_R】
Celecoxib	COX-2	C4

These studies demonstrate the ability to assess the time course and selective effects of COX - 2 inhibitors in vivo and suggest that suppression of COX - 2 mediated PGE2 is temporally related to NSAID analgesia .
【GOLD_E】
COX-2	geneY
COX-2	geneY
PGE2	chem
【PRE_E】
COX-2	geneY
COX-2	geneY
PGE2	chem
【GOLD_R】
PGE2	COX-2	C9
【PRE_R】

[ 3H ] dofetilide binding to HERG transfected membranes : a potential high throughput preclinical screen .
【GOLD_E】
[3H]dofetilide	chem
HERG	geneY
【PRE_E】
[3H]dofetilide	chem
HERG	geneY
【GOLD_R】
【PRE_R】

The pharmacological characteristics of [ 3H ] dofetilide binding were examined in membranes prepared from human embryonic kidney ( HEK293 ) cells stably expressing human ether - a - go - go related gene ( HERG ) K + channels .
【GOLD_E】
humanether-a-go-gorelatedgene(HERG)K+channels	geneY
ether	chem
K+	chem
[3H]dofetilide	chem
【PRE_E】
[3H]dofetilide	chem
humanether-a-go-gorelatedgene(HERG)K+channels	geneY
【GOLD_R】
【PRE_R】

The classIII antiarrhythmic compounds dofetilide , clofilium , 4 ' - [ [ 1 - [ 2 - ( 6 - methyl - 2 - pyridyl ) ethyl ] - 4 - piperidyl ] carbonyl ] methanesulfonanilide ( E - 4031 ) , N - methyl - N - [ 2 - [ methyl - ( 1 - methyl - 1H - benzimidazol - 2 - yl ) amino ] ethyl ] - 4 - [ ( methylsulfo nyl ) amino ] benzene - sulfonamide ( WAY - 123,398 ) and d - sotalol all inhibited [ 3H ] dofetilide binding .
【GOLD_E】
d-sotalol	chem
[3H]dofetilide	chem
dofetilide	chem
clofilium	chem
4'-[[1-[2-(6-methyl-2-pyridyl)ethyl]-4-piperidyl]carbonyl]methanesulfonanilide	chem
E-4031	chem
N-methyl-N-[2-[methyl-(1-methyl-1H-benzimidazol-2-yl)amino]ethyl]-4-[(methylsulfonyl)amino]benzene-sulfonamide	chem
WAY-123,398	chem
【PRE_E】
dofetilide	chem
clofilium	chem
4'-[[1-[2-(6-methyl-2-pyridyl)ethyl]-4-piperidyl]carbonyl]methanesulfonanilide	chem
E-4031	chem
N-methyl-N-[2-[methyl-(1-methyl-1H-benzimidazol-2-yl)amino]ethyl]-4-[(methylsulfonyl)amino]benzene-sulfonamide	chem
WAY-123,398	chem
d-sotalol	chem
[3H]dofetilide	chem
【GOLD_R】
【PRE_R】

In addition , the structurally unrelated compounds pimozide , terfenadine and haloperidol , all of which prolong the QT interval in man , also inhibited binding .
【GOLD_E】
pimozide	chem
terfenadine	chem
haloperidol	chem
【PRE_E】
pimozide	chem
terfenadine	chem
haloperidol	chem
【GOLD_R】
【PRE_R】

These data indicate that a [ 3H ] dofetilide binding assay using HERG membranes may help identify compounds that prolong the QT interval .
【GOLD_E】
[3H]dofetilide	chem
HERG	geneY
【PRE_E】
[3H]dofetilide	chem
HERG	geneY
【GOLD_R】
【PRE_R】

Effects of the antidepressant / antipanic drug phenelzine on alanine and alanine transaminase in rat brain .
【GOLD_E】
phenelzine	chem
alanine	chem
alanine	chem
alaninetransaminase	geneN
【PRE_E】
phenelzine	chem
alanine	chem
alaninetransaminase	geneN
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Phenelzine ( PLZ ) is an antidepressant with anxiolytic properties .
【GOLD_E】
Phenelzine	chem
PLZ	chem
【PRE_E】
Phenelzine	chem
PLZ	chem
【GOLD_R】
【PRE_R】

Acute and chronic PLZ administration increase brain GABA levels , an effect due , at least in part , to an inhibition of the activity of the GABA metabolizing enzyme , GABA transaminase ( GABA - T ) .
【GOLD_E】
GABA	chem
PLZ	chem
GABAtransaminase	geneY
GABA-T	geneY
GABA	chem
GABA	chem
【PRE_E】
PLZ	chem
GABA	chem
GABA	chem
GABAtransaminase	geneY
GABA-T	geneY
【GOLD_R】
PLZ	GABAtransaminase	C4
PLZ	GABA-T	C4
GABA	GABAtransaminase	C9
GABA	GABA-T	C9
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Previous preliminary reports have indicated that acute PLZ treatment also elevates brain alanine levels .
【GOLD_E】
PLZ	chem
alanine	chem
【PRE_E】
PLZ	chem
alanine	chem
【GOLD_R】
【PRE_R】

As with GABA , the metabolism of alanine involves a pyridoxal phosphate - dependent transaminase .
【GOLD_E】
GABA	chem
alanine	chem
pyridoxalphosphate	chem
pyridoxalphosphate-dependenttransaminase	geneN
【PRE_E】
GABA	chem
alanine	chem
pyridoxalphosphate-dependenttransaminase	geneN
【GOLD_R】
alanine	pyridoxalphosphate-dependenttransaminase	C9
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the study reported here , the effects of acute PLZ treatment on the levels of various amino acids , some of which are also metabolized by pyridoxal phosphate - dependent transaminases were compared in rat whole brain .
【GOLD_E】
PLZ	chem
aminoacids	chem
pyridoxalphosphate	chem
pyridoxalphosphate-dependenttransaminases	geneN
【PRE_E】
PLZ	chem
aminoacids	chem
pyridoxalphosphate	chem
transaminases	geneN
【GOLD_R】
aminoacids	pyridoxalphosphate-dependenttransaminases	C9
【PRE_R】

Of the 6 amino acids investigated , only GABA and alanine levels were elevated ( in a time - and dose - dependent manner ) .
【GOLD_E】
aminoacids	chem
GABA	chem
alanine	chem
【PRE_E】
aminoacids	chem
GABA	chem
alanine	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The elevation in brain alanine levels could be explained , at least in part , by a time - and dose - dependent inhibitory effect of PLZ on alanine transaminase ( ALA - T ) , although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced .
【GOLD_E】
alanine	chem
PLZ	chem
alanine	chem
ALA	chem
GABA	chem
alaninetransaminase	geneN
ALA-T	geneN
【PRE_E】
alanine	chem
PLZ	chem
alaninetransaminase	geneN
ALA-T	geneN
GABA	chem
【GOLD_R】
PLZ	alaninetransaminase	C4
PLZ	ALA-T	C4
alanine	alaninetransaminase	C9
alanine	ALA-T	C9
【PRE_R】

In addition , we also showed that the elevation in alanine levels and the inhibition of alanine transaminase in the brain are retained after 14 days of PLZ treatment , and that PLZ produces a marked increase in extracellular levels of alanine .
【GOLD_E】
alanine	chem
alanine	chem
alaninetransaminase	geneN
PLZ	chem
PLZ	chem
alanine	chem
【PRE_E】
alanine	chem
alaninetransaminase	geneN
PLZ	chem
PLZ	chem
alanine	chem
【GOLD_R】
PLZ	alaninetransaminase	C4
alanine	alaninetransaminase	C9
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These results are discussed in terms of their relevance to synaptic function and to the pharmacological profile of PLZ .
【GOLD_E】
PLZ	chem
【PRE_E】
PLZ	chem
【GOLD_R】
【PRE_R】

Nicotine - induced contraction in the rat coronary artery : possible involvement of the endothelium , reactive oxygen species and COX - 1 metabolites .
【GOLD_E】
Nicotine	chem
oxygen	chem
COX-1	geneY
【PRE_E】
Nicotine	chem
oxygen	chem
COX-1	geneY
【GOLD_R】
【PRE_R】

Nicotine caused a contraction of the rat coronary artery in the presence of Nomega - nitro - L - arginine methyl ester ( L - NAME ) and arachidonic acid , and did not in the absence of these agents .
【GOLD_E】
Nicotine	chem
Nomega-nitro-L-argininemethylester	chem
L-NAME	chem
arachidonicacid	chem
【PRE_E】
Nicotine	chem
Nomega-nitro-L-argininemethylester	chem
L-NAME	chem
arachidonicacid	chem
【GOLD_R】
【PRE_R】

The present experiments were undertaken to pharmacologically characterize the nicotine - induced contraction in ring preparations of the rat coronary artery .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

The contraction was abolished by chemical removal of endothelium saponin .
【GOLD_E】
saponin	chem
【PRE_E】
saponin	chem
【GOLD_R】
【PRE_R】

Oxygen radical scavengers , superoxide dismutase and catalase , significantly attenuated the contraction .
【GOLD_E】
Oxygen	chem
superoxidedismutase	geneN
catalase	geneY
【PRE_E】
Oxygen	chem
superoxidedismutase	geneN
catalase	geneY
【GOLD_R】
【PRE_R】

Cyclooxygenase - 1 ( COX - 1 ) inhibitors ( flurbiprofen , ketoprofen and ketrolack ) attenuated the nicotine - induced contraction in a concentration - dependent manner , and cyclooxygenase - 2 ( COX - 2 ) inhibitors at high concentrations ( nimesulide and NS - 389 ) slightly attenuated the contraction .
【GOLD_E】
flurbiprofen	chem
ketoprofen	chem
ketrolack	chem
nicotine	chem
nimesulide	chem
NS-389	chem
Cyclooxygenase-1	geneY
COX-1	geneY
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
Cyclooxygenase-1	geneY
COX-1	geneY
flurbiprofen	chem
ketoprofen	chem
ketrolack	chem
nicotine	chem
cyclooxygenase-2	geneY
COX-2	geneY
nimesulide	chem
NS-389	chem
【GOLD_R】
flurbiprofen	Cyclooxygenase-1	C4
flurbiprofen	COX-1	C4
ketoprofen	Cyclooxygenase-1	C4
ketoprofen	COX-1	C4
ketrolack	Cyclooxygenase-1	C4
ketrolack	COX-1	C4
nimesulide	cyclooxygenase-2	C4
nimesulide	COX-2	C4
NS-389	cyclooxygenase-2	C4
NS-389	COX-2	C4
【PRE_R】
Cyclooxygenase-1	flurbiprofen	C4
COX-1	flurbiprofen	C4
COX-1	ketoprofen	C4
ketrolack	cyclooxygenase-2	C4
nicotine	cyclooxygenase-2	C4
COX-2	nimesulide	C4
COX-2	NS-389	C4

A TXA2 synthetase inhibitor ( OKY - 046 ) attenuated the contraction to a small extent only at high concentrations .
【GOLD_E】
TXA2	chem
OKY-046	chem
TXA2synthetase	geneY
【PRE_E】
TXA2synthetase	geneY
OKY-046	chem
【GOLD_R】
OKY-046	TXA2synthetase	C4
【PRE_R】

A TXA2 receptor antagonist ( S - 1452 ) attenuated the contraction in a concentration - dependent manner .
【GOLD_E】
TXA2	chem
S-1452	chem
TXA2receptor	geneY
【PRE_E】
TXA2receptor	geneY
S-1452	chem
【GOLD_R】
S-1452	TXA2receptor	C6
【PRE_R】

A nicotinic receptor antagonist ( hexamethonium ) attenuated the contraction in part and an alpha - adrenoceptor antagonist ( prazosin ) nearly abolished the contraction .
【GOLD_E】
nicotinicreceptor	geneN
alpha-adrenoceptor	geneN
hexamethonium	chem
prazosin	chem
【PRE_E】
hexamethonium	chem
alpha-adrenoceptor	geneN
prazosin	chem
【GOLD_R】
hexamethonium	nicotinicreceptor	C6
prazosin	alpha-adrenoceptor	C6
【PRE_R】
hexamethonium	alpha-adrenoceptor	C6

From these results , it was suggested that the contraction induced by nicotine in the rat coronary artery in the presence of L - NAME and arachidonic acid is endothelium dependent , and involves reactive oxygen species and endothelial COX - 1 metabolites of arachidonic acid .
【GOLD_E】
arachidonicacid	chem
COX-1	geneY
nicotine	chem
L-NAME	chem
arachidonicacid	chem
oxygen	chem
【PRE_E】
nicotine	chem
L-NAME	chem
arachidonicacid	chem
oxygen	chem
COX-1	geneY
arachidonicacid	chem
【GOLD_R】
【PRE_R】

Part of the contraction is probably due to release of norepinephrine .
【GOLD_E】
norepinephrine	chem
【PRE_E】
norepinephrine	chem
【GOLD_R】
【PRE_R】

Efficacy and safety of the factor VIII / von Willebrand factor concentrate , haemate - P / humate - P : ristocetin cofactor unit dosing in patients with von Willebrand disease .
【GOLD_E】
vonWillebrandfactor	geneY
ristocetin	chem
factorVIII	geneY
【PRE_E】
factorVIII	geneY
vonWillebrandfactor	geneY
haemate-P/humate-P:ristocetin	geneN
vonWillebrand	geneY
【GOLD_R】
【PRE_R】

The present study was initiated to evaluate the safety and efficacy of Haemate - P ( Humate - P in North America ) ( anti - hemophilic FVIII / VWF complex [ human ] dried , pasteurized ) dosed in ristocetin cofactor units ( VWF : RCo ) in the treatment of von Willebrand disease ( VWD ) patients in Canada .
【GOLD_E】
ristocetin	chem
FVIII	geneY
VWF	geneY
【PRE_E】
Haemate-P	geneY
FVIII	geneN
VWF	geneN
ristocetincofactorunits	geneN
VWF	geneN
RCo	geneN
vonWillebrand	geneY
【GOLD_R】
【PRE_R】

This retrospective data collection reviewed the medical records of VWD patients treated under the Canadian Emergency Drug Release Program from November 22 , 1991 , to April 30 , 1996 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Data collection was accomplished by on - site retrieval from source data for 97 patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Dosing was based on the German package insert , which lists only Factor VIII : C ( FVIII : C ) units , which were converted in the study analysis to VWF : RCo units based on the analysis of the individual manufactured lots of product used in these patients ( average ratio of 2.6 IU VWF : RCo per IU FVIII : C ) .
【GOLD_E】
FactorVIII:C	geneY
FVIII:C	geneY
FVIII:C	geneY
【PRE_E】
FactorVIII	geneY
FVIII:C	geneN
VWF	geneN
RCo	geneN
VWF	geneY
RCo	geneN
FVIII	geneN
【GOLD_R】
【PRE_R】

Twenty five different lots of Haemate - P / Humate - P were used to treat 437 different events in the 97 study patients ( 344 hemorrhagic events , 73 surgical interventions and 20 prophylactic infusion cycles ) .
【GOLD_E】
【PRE_E】
Humate	chem
【GOLD_R】
【PRE_R】

Overall , the median dose of concentrate per infusion used to treat surgical events was 69.1 IU VWF : RCo / kg ( range 11.9 - 222.8 ) ; bleeding events 55.3 IU VWF : RCo / kg ( range 17.1 - 227.5 ) and prophylaxis 41.6 IU VWF : RCo / kg ( range 34.6 - 81.0 ) .
【GOLD_E】
【PRE_E】
VWF	geneY
VWF	geneY
VWF	geneY
【GOLD_R】
【PRE_R】

Treatment periods varied , with the majority of events treated for < or = 10 days ( 91 % ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Fifty percent of events that were treated longer than 10 days were given for prophylactic reasons .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Efficacy was determined in a standardized manner by the physician , based on dosing in VWF : RCo activity .
【GOLD_E】
【PRE_E】
VWF	geneN
RCo	geneN
【GOLD_R】
【PRE_R】

An overall clinical result of `` excellent `` or `` good `` was reported in 97 % ( 424 / 437 ) of treatment events .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A pediatric sub - population analysis of the patient population reported `` excellent / good `` efficacy in 100 % ( 17 / 17 ) of treatment events in infants , 95 % ( 155 / 164 ) in children , and 94 % ( 76 / 81 ) in adolescent patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Related adverse events ( AEs ) were observed in only 4 ( 4 % ) patients and were not deemed to be serious .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The findings in this study confirm the safety and efficacy of Haemate - P / Humate - P using VWF : RCo dosing in pediatric and adult patients with various types of VWD .
【GOLD_E】
VWF	geneY
【PRE_E】
Humate	chem
VWF	geneN
RCo	geneN
VWD	geneN
【GOLD_R】
【PRE_R】

Differential binding mode of diverse cyclooxygenase inhibitors .
【GOLD_E】
cyclooxygenase	geneN
【PRE_E】
cyclooxygenase	geneN
【GOLD_R】
【PRE_R】

Non - steroidal anti - inflammatory drugs ( NSAIDs ) are competitive inhibitors of cyclooxygenase ( COX ) , the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid .
【GOLD_E】
cyclooxygenase	geneN
COX	geneN
prostaglandins	chem
thromboxanes	chem
arachidonicacid	chem
steroidal	chem
【PRE_E】
steroidal	chem
cyclooxygenase	geneN
COX	geneN
prostaglandins	chem
thromboxanes	chem
arachidonicacid	chem
【GOLD_R】
steroidal	cyclooxygenase	C4
steroidal	COX	C4
prostaglandins	cyclooxygenase	C9
prostaglandins	COX	C9
thromboxanes	cyclooxygenase	C9
thromboxanes	COX	C9
arachidonicacid	cyclooxygenase	C9
arachidonicacid	COX	C9
【PRE_R】
steroidal	cyclooxygenase	C4
steroidal	COX	C4

There are at least two different isoforms of the enzyme known as COX - 1 and - 2 .
【GOLD_E】
COX-1and-2	geneN
【PRE_E】
COX-1and-2	geneN
【GOLD_R】
【PRE_R】

Site directed mutagenesis studies suggest that non - selective COX inhibitors of diverse chemical families exhibit differential binding modes to the two isozymes .
【GOLD_E】
COX	geneN
【PRE_E】
COX	geneN
【GOLD_R】
【PRE_R】

These results can not clearly be explained from the sole analysis of the crystal structures of COX available from X - ray diffraction studies .
【GOLD_E】
COX	geneN
【PRE_E】
COX	geneN
【GOLD_R】
【PRE_R】

With the aim to elucidate the structural features governing the differential inhibitory binding behavior of these inhibitors , molecular modeling studies were undertaken to generate atomic models compatible with the experimental data available .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Accordingly , docking of different COX inhibitors , including selective and non - selective ligands : rofecoxib , ketoprofen , suprofen , carprofen , zomepirac , indomethacin , diclofenac and meclofenamic acid were undertaken using the AMBER program .
【GOLD_E】
zomepirac	chem
indomethacin	chem
diclofenac	chem
COX	geneN
meclofenamicacid	chem
rofecoxib	chem
ketoprofen	chem
suprofen	chem
carprofen	chem
【PRE_E】
COX	geneN
rofecoxib	chem
ketoprofen	chem
suprofen	chem
carprofen	chem
zomepirac	chem
indomethacin	chem
diclofenac	chem
meclofenamicacid	chem
AMBER	geneN
【GOLD_R】
zomepirac	COX	C4
indomethacin	COX	C4
diclofenac	COX	C4
meclofenamicacid	COX	C4
rofecoxib	COX	C4
ketoprofen	COX	C4
suprofen	COX	C4
carprofen	COX	C4
【PRE_R】
COX	rofecoxib	C4
COX	ketoprofen	C4
COX	suprofen	C4
COX	carprofen	C4
zomepirac	AMBER	C4
indomethacin	AMBER	C4
diclofenac	AMBER	C4
meclofenamicacid	AMBER	C4

The results of the present study provide new insights into a better understanding of the differential binding mode of diverse families of COX inhibitors , and are expected to contribute to the design of new selective compounds .
【GOLD_E】
COX	geneN
【PRE_E】
COX	geneN
【GOLD_R】
【PRE_R】

Pure antiestrogens and breast cancer .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Tamoxifen , which is the most commonly used drug for treatment of breast cancer , has both estrogen agonist and antagonist actions .
【GOLD_E】
Tamoxifen	chem
estrogen	chem
【PRE_E】
Tamoxifen	chem
estrogen	chem
【GOLD_R】
【PRE_R】

Pure antiestrogens are devoid of any estrogen agonist effects .
【GOLD_E】
estrogen	chem
【PRE_E】
estrogen	chem
【GOLD_R】
【PRE_R】

ICI 182,780 ( fulvestrant ) ( Faslodex ) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor ( ER ) .
【GOLD_E】
ICI164,384	chem
estrogen	chem
estrogen	chem
estrogenreceptor	geneY
ER	geneY
ICI182,780	chem
fulvestrant	chem
Faslodex	chem
【PRE_E】
ICI182,780	chem
fulvestrant)	chem
Faslodex	chem
ICI164,384	chem
estrogen	chem
estrogenreceptor	geneY
ER	geneY
【GOLD_R】
【PRE_R】
ICI182,780	ER	C4
fulvestrant)	ER	C4
ICI164,384	ER	C4

Preclinical and clinical studies show that fulvestrant and ICI 164,384 are more potent than tamoxifen in inhibiting the growth of breast cancer cells .
【GOLD_E】
fulvestrant	chem
ICI164,384	chem
tamoxifen	chem
【PRE_E】
fulvestrant	chem
ICI164,384	chem
tamoxifen	chem
【GOLD_R】
【PRE_R】

They are devoid of any estrogen - agonist action on the uterus and vagina but lack the beneficial effects of tamoxifen on the bone and serum lipid profile .
【GOLD_E】
estrogen	chem
tamoxifen	chem
【PRE_E】
estrogen	chem
tamoxifen	chem
【GOLD_R】
【PRE_R】

Fulvestrant is the first pure antiestrogen to complete phase III clinical trials .
【GOLD_E】
Fulvestrant	chem
antiestrogen	chem
【PRE_E】
Fulvestrant	chem
【GOLD_R】
【PRE_R】

Such studies have shown that fulvestrant is at least as good as anastrozole in the treatment of post - menopausal women with advanced breast cancer who had relapsed or progressed on prior endocrine therapy .
【GOLD_E】
fulvestrant	chem
anastrozole	chem
【PRE_E】
fulvestrant	chem
anastrozole	chem
【GOLD_R】
【PRE_R】

The drug was well tolerated and only minor side - effects were reported .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Its potential role in the adjuvant setting will be determined by its adverse effects on bone mass and serum lipids .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

EM - 800 and EM - 652 are the most potent pure antiestrogens and EM - 652 has the highest affinity of all antiestrogens to ER .
【GOLD_E】
ER	geneY
EM-800	chem
EM-652	chem
EM-652	chem
【PRE_E】
EM-652	chem
EM-652	chem
【GOLD_R】
【PRE_R】

They have no stimulatory effects on the uterus or vagina .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It seems reasonable to expect that pure antiestrogens will be good alternatives to tamoxifen and aromatase inhibitors in the treatment of breast cancer .
【GOLD_E】
tamoxifen	chem
【PRE_E】
tamoxifen	chem
aromatase	geneY
【GOLD_R】
【PRE_R】
tamoxifen	aromatase	C4

Hepatotoxicity of commonly used drugs : nonsteroidal anti - inflammatory drugs , antihypertensives , antidiabetic agents , anticonvulsants , lipid - lowering agents , psychotropic drugs .
【GOLD_E】
【PRE_E】
antihypertensives	chem
anticonvulsants	chem
【GOLD_R】
【PRE_R】

Hepatotoxic adverse drug reactions have contributed to the decline of many promising therapies , even among mainstream medication classes ( bromfenac and troglitazone are recent examples ) .
【GOLD_E】
bromfenac	chem
troglitazone	chem
【PRE_E】
bromfenac	chem
troglitazone	chem
【GOLD_R】
【PRE_R】

The spectrum of nonsteroidal anti - inflammatory drug - related liver toxicity continues to expand , with reports in children , interactive toxicity in persons with hepatitis C , and recognition of the toxicity of both the preferential and selective cyclooxygenase - 2 inhibitors .
【GOLD_E】
cyclooxygenase-2	geneY
【PRE_E】
hepatitisC	chem
cyclooxygenase-2	geneY
【GOLD_R】
【PRE_R】
hepatitisC	cyclooxygenase-2	C4

Of the antihypertensive agents , methyldopa is now rarely prescribed and adverse effects are reported infrequently , whereas cases of liver injury associated with the angiotensin receptor and converting enzyme inhibitors are increasingly reported .
【GOLD_E】
angiotensin	chem
angiotensinreceptor	geneN
convertingenzyme	geneY
【PRE_E】
methyldopa	chem
angiotensinreceptor	geneY
【GOLD_R】
【PRE_R】

Of the antidiabetic agents , acarbose , gliclazide , metformin , and human insulin have been implicated in causing liver injury .
【GOLD_E】
acarbose	chem
gliclazide	chem
metformin	chem
humaninsulin	geneY
【PRE_E】
acarbose	chem
gliclazide	chem
metformin	chem
humaninsulin	geneY
【GOLD_R】
【PRE_R】

To date , the newer thiazolidinediones do not appear to share the hepatotoxic potential of troglitazone , although a few reports of acute hepatitis have accrued .
【GOLD_E】
thiazolidinediones	chem
troglitazone	chem
【PRE_E】
thiazolidinediones	chem
troglitazone	chem
【GOLD_R】
【PRE_R】

Although liver injury has been associated with the `` statins , `` the frequency of such toxicity is lower than that of the background population and the value of biochemical monitoring remains unproved .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Newer concepts in anticonvulsant hepatotoxicity have been the recognition of the reactive metabolite syndrome , delineation of the risk factors for valproic acid toxicity , the potential role of carnitine in preventing valproic acid hepatotoxicity , and the toxicity of second - line antiepileptic drugs .
【GOLD_E】
valproicacid	chem
carnitine	chem
valproicacid	chem
【PRE_E】
valproicacid	chem
carnitine	chem
valproicacid	chem
【GOLD_R】
【PRE_R】

Liver injury associated with newer psychotropic agents , particularly the selective serotonin reuptake inhibitors , is also discussed .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

The focus of the review is the hepatotoxicity of commonly used drugs with particular reference to recent and novel reports of toxicity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Well - known causes of liver injury such as chlorpromazine , phenytoin , and methyldopa are not discussed .
【GOLD_E】
chlorpromazine	chem
phenytoin	chem
methyldopa	chem
【PRE_E】
chlorpromazine	chem
phenytoin	chem
methyldopa	chem
【GOLD_R】
【PRE_R】

Pharmacological , pharmacokinetic and clinical properties of olopatadine hydrochloride , a new antiallergic drug .
【GOLD_E】
olopatadinehydrochloride	chem
【PRE_E】
olopatadinehydrochloride	chem
【GOLD_R】
【PRE_R】

Olopatadine hydrochloride ( olopatadine , 11 - [ ( Z ) - 3 - ( dimethylamino ) propylidene ] - 6,11 - dihydrodibenz [ b , e ] oxepin - 2 - acetic acid monohydrochloride ) is a novel antiallergic / histamine H1 - receptor antagonistic drug that was synthesized and evaluated in our laboratories .
【GOLD_E】
olopatadine	chem
11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-aceticacidmonohydrochloride	chem
Olopatadinehydrochloride	chem
histamineH1-receptor	geneY
histamine	chem
【PRE_E】
Olopatadinehydrochloride	chem
olopatadine	chem
11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-aceticacidmonohydrochloride	chem
histamineH1-receptor	geneY
【GOLD_R】
olopatadine	histamineH1-receptor	C6
11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-aceticacidmonohydrochloride	histamineH1-receptor	C6
Olopatadinehydrochloride	histamineH1-receptor	C6
【PRE_R】

Oral administration of olopatadine at doses of 0.03 mg / kg or higher inhibited the symptoms of experimental allergic skin responses , rhinoconjunctivitis and bronchial asthma in sensitized guinea pigs and rats .
【GOLD_E】
olopatadine	chem
【PRE_E】
olopatadine	chem
【GOLD_R】
【PRE_R】

Olopatadine is a selective histamine H1 - receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as leukotriene and thromboxane from human polymorphonuclear leukocytes and eosinophils .
【GOLD_E】
Olopatadine	chem
histamine	chem
leukotriene	chem
thromboxane	chem
histamineH1-receptor	geneY
【PRE_E】
Olopatadine	chem
histamineH1-receptor	geneY
leukotriene	chem
thromboxane	chem
【GOLD_R】
Olopatadine	histamineH1-receptor	C6
【PRE_R】

Olopatadine also inhibited the tachykininergic contraction in the guinea pig bronchi by prejunctional inhibition of peripheral sensory nerves .
【GOLD_E】
Olopatadine	chem
【PRE_E】
Olopatadine	chem
【GOLD_R】
【PRE_R】

Olopatadine exerted no significant effects on action potential duration in isolated guinea pig ventricular myocytes , myocardium and human ether - a - go - go - related gene channel .
【GOLD_E】
Olopatadine	chem
humanether-a-go-go-relatedgenechannel	geneY
【PRE_E】
Olopatadine	chem
humanether-a-go-go-relatedgenechannel	geneY
【GOLD_R】
【PRE_R】
Olopatadine	humanether-a-go-go-relatedgenechannel	C4

Olopatadine was highly and rapidly absorbed in healthy human volunteers .
【GOLD_E】
Olopatadine	chem
【PRE_E】
Olopatadine	chem
【GOLD_R】
【PRE_R】

The urinary excretion of olopatadine accounted for not less than 58 % and the contribution of metabolism was considerably low in the clearance of olopatadine in humans .
【GOLD_E】
olopatadine	chem
olopatadine	chem
【PRE_E】
olopatadine	chem
olopatadine	chem
【GOLD_R】
【PRE_R】

Olopatadine is one of the few renal clearance drugs in antiallergic drugs .
【GOLD_E】
Olopatadine	chem
【PRE_E】
Olopatadine	chem
【GOLD_R】
【PRE_R】

Olopatadine was shown to be useful for the treatment of allergic rhinitis and chronic urticaria in double - blind clinical trials .
【GOLD_E】
Olopatadine	chem
【PRE_E】
Olopatadine	chem
【GOLD_R】
【PRE_R】

Olopatadine was approved in Japan for the treatment of allergic rhinitis , chronic urticaria , eczema dermatitis , prurigo , pruritus cutaneous , psoriasis vulgaris and erythema exsudativum multiforme in December , 2000 .
【GOLD_E】
Olopatadine	chem
【PRE_E】
Olopatadine	chem
【GOLD_R】
【PRE_R】

Ophthalmic solution of olopatadine was also approved in the United States for the treatment of seasonal allergic conjunctivitis in December , 1996 ( Appendix : also in the European Union , it was approved in February 2002 ) .
【GOLD_E】
olopatadine	chem
【PRE_E】
olopatadine	chem
【GOLD_R】
【PRE_R】

Serotonin transporter polymorphisms and measures of impulsivity , aggression , and sensation seeking among African - American cocaine - dependent individuals .
【GOLD_E】
cocaine	chem
Serotonintransporter	geneY
Serotonin	chem
【PRE_E】
Serotonintransporter	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

Considerable evidence indicates that serotonergic mechanisms , particularly the serotonin transporter ( 5HTT ) , may mediate central effects of cocaine and may also be involved in impulsive and aggressive behavior .
【GOLD_E】
5HTT	geneY
serotonintransporter	geneY
cocaine	chem
serotonin	chem
【PRE_E】
serotonintransporter	geneY
5HTT	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

We investigated whether polymorphisms in the 5HTT gene were related to traits of impulsivity , sensation seeking , and aggression among cocaine abusers .
【GOLD_E】
5HTT	geneY
cocaine	chem
【PRE_E】
5HTT	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

Standardized measures of these personality traits were obtained in a sample of 105 severely affected cocaine - dependent African - American subjects and 44 African - American controls .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

Two polymorphisms of the 5HTT gene were examined involving the 5 ' promoter ( 5HTTLPR ) region and a 17 base pair variable - number - tandem - repeat ( VNTR ) marker among cocaine patients .
【GOLD_E】
5HTT	geneY
5HTTLPR	geneN
variable-number-tandem-repeat	geneN
VNTR	geneN
cocaine	chem
【PRE_E】
5HTT	geneY
5'promoter	geneN
5HTTLPR	geneY
VNTR	geneN
cocaine	chem
【GOLD_R】
【PRE_R】

No significant relationships were observed between polymorphic variants of the 5HTTLPR and VNTR regions and scores on any of the trait measures .
【GOLD_E】
5HTTLPR	geneN
VNTR	geneN
【PRE_E】
5HTTLPR	geneY
VNTR	geneY
【GOLD_R】
【PRE_R】

Similarly , demographic variables and measures of severity of substance use and depression were unrelated to allele frequencies or genotype distributions of the variants among cocaine patients .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

As expected , cocaine patients scored significantly higher on total scores of impulsivity , aggression , and sensation seeking compared to controls .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

The findings do not seem to support an association between these polymorphisms in the 5HTT gene and impulsive - aggressive traits among cocaine - dependent African - American individuals .
【GOLD_E】
5HTT	geneY
cocaine	chem
【PRE_E】
5HTT	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

A molecular mechanism of action of theophylline : Induction of histone deacetylase activity to decrease inflammatory gene expression .
【GOLD_E】
theophylline	chem
histonedeacetylase	geneN
【PRE_E】
theophylline	chem
histonedeacetylase	geneN
【GOLD_R】
theophylline	histonedeacetylase	C3
【PRE_R】

The molecular mechanism for the anti - inflammatory action of theophylline is currently unknown , but low - dose theophylline is an effective add - on therapy to corticosteroids in controlling asthma .
【GOLD_E】
theophylline	chem
theophylline	chem
【PRE_E】
theophylline	chem
theophylline	chem
【GOLD_R】
【PRE_R】

Corticosteroids act , at least in part , by recruitment of histone deacetylases ( HDACs ) to the site of active inflammatory gene transcription .
【GOLD_E】
histonedeacetylases	geneN
HDACs	geneN
Corticosteroids	chem
【PRE_E】
histonedeacetylases	geneN
HDACs	geneN
【GOLD_R】
【PRE_R】

They thereby inhibit the acetylation of core histones that is necessary for inflammatory gene transcription .
【GOLD_E】
【PRE_E】
histones	geneN
【GOLD_R】
【PRE_R】

We show both in vitro and in vivo that low - dose theophylline enhances HDAC activity in epithelial cells and macrophages .
【GOLD_E】
HDAC	geneN
theophylline	chem
【PRE_E】
theophylline	chem
HDAC	geneN
【GOLD_R】
theophylline	HDAC	C3
【PRE_R】
theophylline	HDAC	C3

This increased HDAC activity is then available for corticosteroid recruitment and predicts a cooperative interaction between corticosteroids and theophylline .
【GOLD_E】
HDAC	geneN
corticosteroid	chem
corticosteroids	chem
theophylline	chem
【PRE_E】
HDAC	geneN
corticosteroid	chem
theophylline	chem
【GOLD_R】
【PRE_R】

This mechanism occurs at therapeutic concentrations of theophylline and is dissociated from phosphodiesterase inhibition ( the mechanism of bronchodilation ) or the blockade of adenosine receptors , which are partially responsible for its side effects .
【GOLD_E】
theophylline	chem
adenosine	chem
phosphodiesterase	geneN
adenosinereceptors	geneN
【PRE_E】
theophylline	chem
phosphodiesterase	geneN
adenosinereceptors	geneN
【GOLD_R】
【PRE_R】

Thus we have shown that low - dose theophylline exerts an anti - asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes .
【GOLD_E】
HDAC	geneN
theophylline	chem
corticosteroids	chem
【PRE_E】
theophylline	chem
HDAC	geneN
【GOLD_R】
theophylline	HDAC	C3
【PRE_R】

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver .
【GOLD_E】
rifamycinSV	chem
rifampicin	chem
【PRE_E】
rifamycin	chem
rifampicin	chem
【GOLD_R】
【PRE_R】

The antibiotics rifamycin SV and rifampicin substantially reduce sulfobromophthalein ( BSP ) elimination in humans .
【GOLD_E】
rifampicin	chem
sulfobromophthalein	chem
BSP	chem
rifamycinSV	chem
【PRE_E】
rifamycin	chem
rifampicin	chem
sulfobromophthalein	chem
【GOLD_R】
【PRE_R】

In rats , rifamycin SV and rifampicin were shown to interfere with hepatic organic anion uptake by inhibition of the organic anion transporting polypeptides Oatp1 and Oatp2 .
【GOLD_E】
rifamycinSV	chem
organicaniontransportingpolypeptides	geneN
Oatp1	geneY
Oatp2	geneY
rifampicin	chem
【PRE_E】
rifamycinSV	chem
rifampicin	chem
organicaniontransportingpolypeptidesOatp1	geneN
Oatp2	geneY
【GOLD_R】
rifamycinSV	organicaniontransportingpolypeptides	C4
rifamycinSV	Oatp1	C4
rifamycinSV	Oatp2	C4
rifampicin	organicaniontransportingpolypeptides	C4
rifampicin	Oatp1	C4
rifampicin	Oatp2	C4
【PRE_R】
rifamycinSV	organicaniontransportingpolypeptidesOatp1	C4
rifampicin	organicaniontransportingpolypeptidesOatp1	C4
rifampicin	Oatp2	C4

Therefore , we investigated the effects of rifamycin SV and rifampicin on the OATPs of human liver and determined whether rifampicin is a substrate of 1 or several of these carriers .
【GOLD_E】
rifamycinSV	chem
rifampicin	chem
rifampicin	chem
OATPs	geneN
【PRE_E】
rifamycin	chem
rifampicin	chem
OATPs	geneN
rifampicin	chem
【GOLD_R】
【PRE_R】

In complementary RNA ( cRNA ) - injected Xenopus laevis oocytes , rifamycin SV ( 10 micromol / L ) cis - inhibited human organic anion transporting polypeptide C ( SLC21A6 ) ( OATP - C ) , human organic anion transporting polypeptide 8 ( SLC21A8 ) ( OATP8 ) , human organic anion transporting polypeptide B ( SLC21A9 ) ( OATP - B ) , and human organic anion transporting polypeptide A ( SLC21A3 ) ( OATP - A ) mediated BSP uptake by 69 % , 79 % , 89 % , and 57 % , respectively , as compared with uptake into control oocytes .
【GOLD_E】
rifamycinSV	chem
humanorganicaniontransportingpolypeptideC	geneY
SLC21A6	geneY
OATP-C	geneY
humanorganicaniontransportingpolypeptide8	geneY
SLC21A8	geneY
OATP8	geneY
humanorganicaniontransportingpolypeptideB	geneY
SLC21A9	geneY
OATP-B	geneY
humanorganicaniontransportingpolypeptideA	geneY
SLC21A3	geneY
OATP-A	geneY
【PRE_E】
rifamycinSV	chem
humanorganicaniontransportingpolypeptideC	geneY
SLC21A6	geneY
OATP-C	geneY
humanorganicaniontransportingpolypeptide8	geneY
SLC21A8	geneY
OATP8	geneY
humanorganicaniontransportingpolypeptideB	geneY
SLC21A9	geneY
OATP-B	geneY
humanorganicaniontransportingpolypeptideA	geneY
SLC21A3	geneY
OATP-A	geneY
【GOLD_R】
rifamycinSV	humanorganicaniontransportingpolypeptideC	C4
rifamycinSV	SLC21A6	C4
rifamycinSV	OATP-C	C4
rifamycinSV	humanorganicaniontransportingpolypeptide8	C4
rifamycinSV	SLC21A8	C4
rifamycinSV	OATP8	C4
rifamycinSV	humanorganicaniontransportingpolypeptideB	C4
rifamycinSV	SLC21A9	C4
rifamycinSV	OATP-B	C4
rifamycinSV	humanorganicaniontransportingpolypeptideA	C4
rifamycinSV	SLC21A3	C4
rifamycinSV	OATP-A	C4
【PRE_R】

In the presence of 100 micromol / L rifamycin SV , BSP uptake was almost completely abolished .
【GOLD_E】
rifamycinSV	chem
BSP	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Approximate K ( i ) values were 2 micromol / L for OATP - C , 3 micromol / L for OATP8 , 3 micromol / L for OATP - B and 11 micromol / L for OATP - A .
【GOLD_E】
OATP-C	geneY
OATP8	geneY
OATP-B	geneY
OATP-A	geneY
【PRE_E】
OATP-C	geneY
OATP8,3micromol	geneN
OATP-B	geneY
OATP-A	geneY
【GOLD_R】
【PRE_R】

Rifampicin ( 10 micromol / L ) inhibited OATP8 - mediated BSP uptake by 50 % , whereas inhibition of OATP - C - , OATP - B - , and OATP - A - mediated BSP transport was below 15 % .
【GOLD_E】
Rifampicin	chem
OATP8	geneY
BSP	chem
OATP-C	geneY
OATP-B	geneY
OATP-A	geneY
BSP	chem
【PRE_E】
Rifampicin	chem
OATP8	geneY
OATP-C	geneY
OATP-B	geneY
OATP-A	geneY
BSP	geneY
【GOLD_R】
Rifampicin	OATP8	C4
Rifampicin	OATP-C	C4
Rifampicin	OATP-B	C4
Rifampicin	OATP-A	C4
BSP	OATP8	C9
BSP	OATP-C	C9
BSP	OATP-B	C9
BSP	OATP-A	C9
【PRE_R】
Rifampicin	OATP8	C4
Rifampicin	OATP-C	C4
Rifampicin	OATP-B	C4
Rifampicin	OATP-A	C4
Rifampicin	BSP	C4

100 micromol / L rifampicin inhibited OATP - C - and OATP8 - , OATP - B - and OATP - A - mediated BSP uptake by 66 % , 96 % , 25 % , and 49 % , respectively .
【GOLD_E】
OATP-C	geneY
OATP8	geneY
OATP-B	geneY
OATP-A	geneY
rifampicin	chem
BSP	chem
【PRE_E】
rifampicin	chem
OATP-C	geneY
OATP8	geneY
OATP-B	geneY
OATP-A	geneY
【GOLD_R】
rifampicin	OATP-C	C4
rifampicin	OATP8	C4
rifampicin	OATP-B	C4
rifampicin	OATP-A	C4
BSP	OATP-C	C9
BSP	OATP8	C9
BSP	OATP-B	C9
BSP	OATP-A	C9
【PRE_R】
rifampicin	OATP-C	C4
rifampicin	OATP8	C4

The corresponding K ( i ) values were 17 micromol / L for OATP - C , 5 micromol / L for OATP8 , and 51 micromol / L for OATP - A .
【GOLD_E】
OATP-C	geneY
OATP8	geneY
OATP-A	geneY
【PRE_E】
OATP-C	geneY
OATP8	geneY
OATP-A	geneY
【GOLD_R】
【PRE_R】

Direct transport of rifampicin could be shown for OATP - C ( apparent K ( m ) value 13 micromol / L ) and OATP8 ( 2.3 micromol / L ) .
【GOLD_E】
OATP-C	geneY
OATP8	geneY
rifampicin	chem
【PRE_E】
rifampicin	chem
OATP-C	geneY
OATP8	geneY
【GOLD_R】
rifampicin	OATP-C	C9
rifampicin	OATP8	C9
【PRE_R】

In conclusion , these results show that rifamycin SV and rifampicin interact with OATP - mediated substrate transport to different extents .
【GOLD_E】
rifamycinSV	chem
rifampicin	chem
OATP	geneN
【PRE_E】
rifamycinSV	chem
rifampicin	chem
OATP	geneN
【GOLD_R】
【PRE_R】
rifampicin	OATP	C9

Inhibition of human liver OATPs can explain the previously observed effects of rifamycin SV and rifampicin on hepatic organic anion elimination .
【GOLD_E】
rifamycinSV	chem
rifampicin	chem
humanliverOATPs	geneN
【PRE_E】
humanliverOATPs	geneN
rifamycinSV	chem
rifampicin	chem
【GOLD_R】
rifamycinSV	humanliverOATPs	C4
rifampicin	humanliverOATPs	C4
【PRE_R】
humanliverOATPs	rifamycinSV	C4
humanliverOATPs	rifampicin	C4

Metformin increases AMP - activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes .
【GOLD_E】
Metformin	chem
AMP	chem
AMP-activatedproteinkinase	geneN
【PRE_E】
Metformin	chem
AMP-activatedproteinkinase	geneN
【GOLD_R】
Metformin	AMP-activatedproteinkinase	C3
【PRE_R】

Metformin is an effective hypoglycemic drug that lowers blood glucose concentrations by decreasing hepatic glucose production and increasing glucose disposal in skeletal muscle ; however , the molecular site of metformin action is not well understood .
【GOLD_E】
glucose	chem
Metformin	chem
glucose	chem
glucose	chem
metformin	chem
【PRE_E】
Metformin	chem
glucose	chem
glucose	chem
glucose	chem
metformin	chem
【GOLD_R】
【PRE_R】

AMP - activated protein kinase ( AMPK ) activity increases in response to depletion of cellular energy stores , and this enzyme has been implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis .
【GOLD_E】
AMP	chem
glucose	chem
AMP-activatedproteinkinase	geneN
AMPK	geneN
【PRE_E】
AMP-activatedproteinkinase	geneN
AMPK	geneN
glucose	chem
【GOLD_R】
glucose	AMP-activatedproteinkinase	C9
glucose	AMPK	C9
【PRE_R】

We recently reported that AMPK is activated by metformin in cultured rat hepatocytes , mediating the inhibitory effects of the drug on hepatic glucose production .
【GOLD_E】
metformin	chem
glucose	chem
AMPK	geneN
【PRE_E】
AMPK	geneN
metformin	chem
glucose	chem
【GOLD_R】
metformin	AMPK	C3
【PRE_R】
AMPK	metformin	C3

In the present study , we evaluated whether therapeutic doses of metformin increase AMPK activity in vivo in subjects with type 2 diabetes .
【GOLD_E】
metformin	chem
AMPK	geneN
【PRE_E】
metformin	chem
AMPK	geneN
【GOLD_R】
metformin	AMPK	C3
【PRE_R】
metformin	AMPK	C3

Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle , and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl - CoA carboxylase - 2 activity .
【GOLD_E】
Metformin	chem
acetyl-CoA	chem
AMPKalpha2	geneY
AMPK	geneN
acetyl-CoAcarboxylase-2	geneY
【PRE_E】
Metformin	chem
AMPKalpha2	geneN
AMPK	geneN
Thr172	geneY
acetyl-CoAcarboxylase-2	geneY
【GOLD_R】
Metformin	AMPKalpha2	C3
Metformin	AMPK	C3
Metformin	acetyl-CoAcarboxylase-2	C4
【PRE_R】
Metformin	AMPKalpha2	C4

The increase in AMPK alpha2 activity was likely due to a change in muscle energy status because ATP and phosphocreatine concentrations were lower after metformin treatment .
【GOLD_E】
AMPKalpha2	geneY
ATP	chem
phosphocreatine	chem
metformin	chem
【PRE_E】
AMPKalpha2	geneY
ATP	chem
phosphocreatine	chem
metformin	chem
【GOLD_R】
metformin	AMPKalpha2	C3
【PRE_R】

Metformin - induced increases in AMPK activity were associated with higher rates of glucose disposal and muscle glycogen concentrations .
【GOLD_E】
AMPK	geneN
Metformin	chem
glucose	chem
【PRE_E】
Metformin	chem
AMPK	geneN
glucose	chem
【GOLD_R】
Metformin	AMPK	C3
【PRE_R】
Metformin	AMPK	C3
AMPK	glucose	C3

These findings suggest that the metabolic effects of metformin in subjects with type 2 diabetes may be mediated by the activation of AMPK alpha2 .
【GOLD_E】
AMPKalpha2	geneY
【PRE_E】
metformin	chem
AMPKalpha2	geneN
【GOLD_R】
【PRE_R】
metformin	AMPKalpha2	C4

Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF - alpha production .
【GOLD_E】
Thalidomide	chem
alcoholic	chem
TNF-alpha	geneY
【PRE_E】
Thalidomide	chem
TNF-alpha	geneY
【GOLD_R】
Thalidomide	TNF-alpha	C4
【PRE_R】

BACKGROUND & AIMS : Sensitization of Kupffer cells ( KCs ) to lipopolysaccharide ( LPS ) and overproduction of tumor necrosis factor ( TNF ) alpha are critical for progression of alcoholic liver injury .
【GOLD_E】
alcoholic	chem
tumornecrosisfactor(TNF)alpha	geneY
【PRE_E】
tumornecrosisfactor(TNF)alpha	geneY
【GOLD_R】
【PRE_R】

Thalidomide has been shown to suppress TNF - alpha production from macrophages .
【GOLD_E】
Thalidomide	chem
TNF-alpha	geneY
【PRE_E】
Thalidomide	chem
TNF-alpha	geneY
【GOLD_R】
Thalidomide	TNF-alpha	C4
【PRE_R】

Accordingly , the purpose of this study was to determine whether thalidomide could prevent alcohol - induced liver injury .
【GOLD_E】
thalidomide	chem
alcohol	chem
【PRE_E】
thalidomide	chem
alcohol	chem
【GOLD_R】
【PRE_R】

METHODS : Rats were given ethanol ( 5 g / kg body wt ) and thalidomide ( 5 mg / kg ) once every 24 hours intragastrically .
【GOLD_E】
ethanol	chem
thalidomide	chem
【PRE_E】
ethanol	chem
thalidomide	chem
【GOLD_R】
【PRE_R】

To assess the sensitization of Kupffer cells , LPS ( 5 mg / kg intravenously ) was administered and liver histology was evaluated 24 hours later .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

KCs were isolated after 4 weeks of ethanol treatment and intracellular Ca2 + ( [ Ca2 + ] i ) was measured using fura - 2 , whereas TNF - alpha was evaluated by reverse - transcription polymerase chain reaction and enzyme - linked immunosorbent assay .
【GOLD_E】
ethanol	chem
Ca2+	chem
Ca2+	chem
TNF-alpha	geneY
【PRE_E】
ethanol	chem
Ca2+	chem
Ca2+]i	chem
TNF-alpha	geneY
【GOLD_R】
【PRE_R】

CD14 was determined by Western and fluorescence staining .
【GOLD_E】
CD14	geneY
【PRE_E】
CD14	geneY
【GOLD_R】
【PRE_R】

RESULTS : Treatment with ethanol for 8 weeks caused marked steatosis , necrosis , and inflammation in the liver .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
【GOLD_R】
【PRE_R】

These pathologic parameters were diminished markedly by treatment with thalidomide .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

In the 4 - week ethanol group , the LPS - induced liver damage was aggravated and KCs were sensitized to LPS .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
【GOLD_R】
【PRE_R】

Coadministration of thalidomide with ethanol prevented the KC sensitization completely .
【GOLD_E】
thalidomide	chem
ethanol	chem
【PRE_E】
thalidomide	chem
ethanol	chem
【GOLD_R】
【PRE_R】

Furthermore , thalidomide abolished the LPS - induced increase in CD14 expression and [ Ca2 + ] i elevation in KCs .
【GOLD_E】
CD14	geneY
thalidomide	chem
Ca2+	chem
【PRE_E】
thalidomide	chem
CD14	geneY
Ca2+]i	chem
KCs	geneY
【GOLD_R】
thalidomide	CD14	C4
【PRE_R】
thalidomide	CD14	C3

Gut permeability was increased about 10 - fold after 4 weeks of ethanol exposure , which was not affected by thalidomide .
【GOLD_E】
ethanol	chem
thalidomide	chem
【PRE_E】
ethanol	chem
thalidomide	chem
【GOLD_R】
【PRE_R】

Moreover , thalidomide reduced the LPS - induced TNF - alpha production by KCs by decreasing TNF - alpha messenger RNA .
【GOLD_E】
TNF-alpha	geneY
TNF-alpha	geneY
thalidomide	chem
【PRE_E】
thalidomide	chem
TNF-alpha	geneY
TNF-alpha	geneY
【GOLD_R】
thalidomide	TNF-alpha	C4
thalidomide	TNF-alpha	C4
【PRE_R】
thalidomide	TNF-alpha	C4
thalidomide	TNF-alpha	C4

CONCLUSIONS : These results collectively indicate that thalidomide prevents alcoholic liver injury through suppression of TNF - alpha production and abolishment of KC sensitization .
【GOLD_E】
thalidomide	chem
TNF-alpha	geneY
【PRE_E】
thalidomide	chem
TNF-alpha	geneY
KC	geneY
【GOLD_R】
thalidomide	TNF-alpha	C4
【PRE_R】
thalidomide	TNF-alpha	C4
thalidomide	KC	C4

Identification and characterization of a novel flavin - containing spermine oxidase of mammalian cell origin .
【GOLD_E】
flavin	chem
spermine	chem
spermineoxidase	geneN
【PRE_E】
flavin-containingspermineoxidase	geneN
【GOLD_R】
【PRE_R】

During polyamine catabolism , spermine and spermidine are first acetylated by spermidine / spermine N ( 1 ) - acetyltransferase ( SSAT ) and subsequently oxidized by polyamine oxidase ( PAO ) to produce spermidine and putrescine , respectively .
【GOLD_E】
spermidine	chem
putrescine	chem
spermine	chem
spermidine	chem
polyamine	chem
spermidine	chem
spermine	chem
N	chem
SSAT	geneY
polyamineoxidase	geneY
PAO	geneY
spermidine/spermineN(1)-acetyltransferase	geneY
polyamine	chem
【PRE_E】
polyamine	chem
spermine	chem
spermidine	chem
spermidine/spermineN(1)-acetyltransferase	geneY
SSAT	geneY
polyamineoxidase	geneN
PAO	geneN
spermidine	chem
putrescine	chem
【GOLD_R】
spermidine	polyamineoxidase	C9
spermidine	PAO	C9
putrescine	polyamineoxidase	C9
putrescine	PAO	C9
spermine	SSAT	C9
spermine	spermidine/spermineN(1)-acetyltransferase	C9
spermidine	SSAT	C9
spermidine	spermidine/spermineN(1)-acetyltransferase	C9
polyamine	SSAT	C9
polyamine	spermidine/spermineN(1)-acetyltransferase	C9
【PRE_R】
spermine	SSAT	C9
spermidine	SSAT	C9
PAO	spermidine	C9
PAO	putrescine	C9

In attempting to clone the PAO involved in this back - conversion pathway , we encountered an oxidase that preferentially cleaves spermine in the absence of prior acetylation by SSAT .
【GOLD_E】
spermine	chem
PAO	geneY
oxidase	geneN
SSAT	geneY
【PRE_E】
PAO	geneN
oxidase	geneN
spermine	chem
SSAT	geneY
【GOLD_R】
spermine	SSAT	C9
【PRE_R】
PAO	spermine	C9

A BLAST search using maize PAO sequences identified homologous mammalian cDNAs derived from human hepatoma and mouse mammary carcinoma : the encoded proteins differed by 20 amino acids .
【GOLD_E】
aminoacids	chem
maizePAO	geneY
【PRE_E】
maizePAO	geneY
mammaliancDNAs	geneN
aminoacids	chem
【GOLD_R】
【PRE_R】

When either cDNA was transiently transfected into HEK - 293 cells , intracellular spermine pools decreased by 75 % while spermidine and N ( 1 ) - acetylspermidine pools increased , suggesting that spermine was selectively and directly oxidized by the enzyme .
【GOLD_E】
spermine	chem
spermidine	chem
N(1)-acetylspermidine	chem
spermine	chem
【PRE_E】
spermine	chem
spermidine	chem
N(1)-acetylspermidine	chem
spermine	chem
【GOLD_R】
【PRE_R】

Substrate specificity using lysates of oxidase - transfected HEK - 293 cells revealed that the newly identified oxidase strongly favoured spermine over N ( 1 ) - acetylspermine and that it failed to act on N ( 1 ) - acetylspermidine , spermidine or the preferred PAO substrate , N ( 1 ) , N ( 12 ) - diacetylspermine .
【GOLD_E】
N(1)-acetylspermidine	chem
spermine	chem
N(1)-acetylspermine	chem
spermidine	chem
PAO	geneY
N(1),N(12)-diacetylspermine	chem
oxidase	geneN
oxidase	geneN
【PRE_E】
oxidase	geneN
oxidase	geneN
spermine	chem
N(1)-acetylspermine	chem
N(1)-acetylspermidine	chem
spermidine	chem
PAO	geneN
N(1)	chem
N(12)-diacetylspermine	chem
【GOLD_R】
spermine	oxidase	C9
N(1)-acetylspermine	oxidase	C9
N(1),N(12)-diacetylspermine	PAO	C9
【PRE_R】
oxidase	spermine	C9
oxidase	N(1)-acetylspermine	C9
N(1)-acetylspermine	PAO	C9

The PAO inhibitor , MDL - 72,527 , only partially blocked oxidation of spermine while a previously reported PAO substrate , N ( 1 ) - ( n - octanesulphonyl ) spermine , potently inhibited the reaction .
【GOLD_E】
PAO	geneY
PAO	geneY
MDL-72,527	chem
spermine	chem
N(1)-(n-octanesulphonyl)spermine	chem
【PRE_E】
PAO	geneN
MDL-72,527	chem
spermine	chem
PAO	geneN
N(1)-(n-octanesulphonyl)spermine	chem
【GOLD_R】
MDL-72,527	PAO	C4
N(1)-(n-octanesulphonyl)spermine	PAO	C9
【PRE_R】
PAO	MDL-72,527	C4
spermine	PAO	C9
PAO	N(1)-(n-octanesulphonyl)spermine	C9

Overall , the data indicate that the enzyme represents a novel mammalian oxidase which , on the basis of substrate specificity , we have designated spermine oxidase in order to distinguish it from the PAO involved in polyamine back - conversion .
【GOLD_E】
mammalianoxidase	geneN
spermineoxidase	geneN
PAO	geneN
spermine	chem
polyamine	chem
【PRE_E】
mammalianoxidase	geneN
spermineoxidase	geneN
PAO	geneN
polyamine	chem
【GOLD_R】
【PRE_R】

The identification of an enzyme capable of directly oxidizing spermine to spermidine has important implications for understanding polyamine homoeostasis and for interpreting metabolic and cellular responses to clinically relevant polyamine analogues and inhibitors .
【GOLD_E】
spermine	chem
spermidine	chem
polyamine	chem
【PRE_E】
oxidizingspermine	chem
spermidine	chem
polyamine	chem
polyamine	chem
【GOLD_R】
【PRE_R】

Low incidence of paradoxical platelet activation by glycoprotein IIb / IIIa inhibitors .
【GOLD_E】
glycoproteinIIb/IIIa	geneN
【PRE_E】
glycoproteinIIb/IIIa	geneN
【GOLD_R】
【PRE_R】

The human platelet antigen - 1 ( HPA - 1 , Pl ( A ) ) polymorphism has been proposed to influence the inhibitory actions of abciximab .
【GOLD_E】
HPA-1	geneN
Pl(A)	geneN
humanplateletantigen-1	geneN
【PRE_E】
humanplateletantigen-1	geneY
Pl(A)	geneY
abciximab	chem
【GOLD_R】
【PRE_R】
humanplateletantigen-1	abciximab	C4

Thus , we hypothesized that this polymorphism might also be the cause for paradoxical activation of platelets by GPIIb / IIIa inhibitors .
【GOLD_E】
GPIIb/IIIa	geneN
【PRE_E】
GPIIb/IIIa	geneN
【GOLD_R】
【PRE_R】

The effects of abciximab ( 1 - 10 microg / ml ) , tirofiban ( 3 - 30 nM ) , or eptifibatide ( 0.3 - 3 microg / ml ) on basal and ADP ( 3 microM ) - induced CD62P externalization were measured in n = 62 healthy blood donors and n = 177 patients with stable coronary artery disease .
【GOLD_E】
CD62P	geneY
tirofiban	chem
eptifibatide	chem
ADP	chem
【PRE_E】
abciximab	chem
tirofiban	chem
eptifibatide	chem
ADP	chem
CD62P	geneY
【GOLD_R】
【PRE_R】
tirofiban	CD62P	C4
eptifibatide	CD62P	C4

All subjects were genotyped for the human platelet antigen - 1 ( HPA - 1 , Pl ( A ) ) polymorphism by GALIOS ( R ) and fluorescence correlation spectroscopy .
【GOLD_E】
humanplateletantigen-1	geneN
HPA-1	geneN
Pl(A)	geneN
【PRE_E】
humanplateletantigen-1	geneY
Pl(A)	geneY
GALIOS(R)	geneY
【GOLD_R】
【PRE_R】

Although a significant platelet hyperreactivity was observed in the patients , the HPA - 1 genotype did not influence basal or ADP - induced CD62P expression .
【GOLD_E】
HPA-1	geneN
CD62P	geneY
ADP	chem
【PRE_E】
ADP	chem
CD62P	geneY
【GOLD_R】
ADP	CD62P	C3
【PRE_R】

A moderate ( twofold ) stimulation of CD62P expression by abciximab but not by tirofiban or eptifibatide was observed in one patient .
【GOLD_E】
CD62P	geneY
tirofiban	chem
eptifibatide	chem
【PRE_E】
CD62P	geneY
abciximab	chem
tirofiban	chem
eptifibatide	chem
【GOLD_R】
【PRE_R】

Interestingly , this patient carried the HPA - 1 b / b genotype .
【GOLD_E】
HPA-1	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

In no other subject any activation of platelets by GP IIb / IIIa inhibitors was observed and there were no statistically significant differences between HPA - 1 genotypes with respect to the effects of GP IIb / IIIa inhibitors on basal or ADP - stimulated CD62P expression .
【GOLD_E】
GPIIb/IIIa	geneN
CD62P	geneY
ADP	chem
GPIIb/IIIa	geneN
HPA-1	geneN
【PRE_E】
GPIIb/IIIa	geneN
GPIIb	geneN
IIIa	geneN
ADP	chem
CD62P	geneY
【GOLD_R】
ADP	CD62P	C3
【PRE_R】

It is concluded that paradoxical platelet activation by abciximab is a rare ( < 2 % ) phenomenon .
【GOLD_E】
【PRE_E】
abciximab	chem
【GOLD_R】
【PRE_R】

HPA - 1 b / b genotype might be a contributing factor but clearly does not predict platelet activation by GP IIb / IIIa inhibitors .
【GOLD_E】
HPA-1	geneN
GPIIb/IIIa	geneN
【PRE_E】
GPIIb/IIIa	geneN
【GOLD_R】
【PRE_R】

Toxic , halogenated cysteine S - conjugates and targeting of mitochondrial enzymes of energy metabolism .
【GOLD_E】
cysteineS-conjugates	chem
【PRE_E】
cysteineS	chem
【GOLD_R】
【PRE_R】

Several haloalkenes are metabolized in part to nephrotoxic cysteine S - conjugates ; for example , trichloroethylene and tetrafluoroethylene are converted to S - ( 1,2 - dichlorovinyl ) - L - cysteine ( DCVC ) and S - ( 1,1,2,2 - tetrafluoroethyl ) - L - cysteine ( TFEC ) , respectively .
【GOLD_E】
S-(1,2-dichlorovinyl)-L-cysteine	chem
DCVC	chem
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine	chem
TFEC	chem
cysteineS-conjugates	chem
haloalkenes	chem
trichloroethylene	chem
tetrafluoroethylene	chem
【PRE_E】
haloalkenes	chem
cysteineS	chem
trichloroethylene	chem
tetrafluoroethylene	chem
S-(1,2-dichlorovinyl)-L-cysteine	chem
DCVC	chem
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine	chem
TFEC	chem
【GOLD_R】
【PRE_R】

Although DCVC - induced toxicity has been investigated since the 1950s , the toxicity of TFEC and other haloalkene - derived cysteine S - conjugates has been studied more recently .
【GOLD_E】
DCVC	chem
TFEC	chem
haloalkene-derivedcysteineS-conjugates	chem
【PRE_E】
DCVC	chem
TFEC	geneY
haloalkene	chem
cysteineS	chem
【GOLD_R】
【PRE_R】

Some segments of the US population are exposed to haloalkenes either through drinking water or in the workplace .
【GOLD_E】
haloalkenes	chem
【PRE_E】
haloalkenes	chem
【GOLD_R】
【PRE_R】

Therefore , it is important to define the toxicological consequences of such exposures .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Most halogenated cysteine S - conjugates are metabolized by cysteine S - conjugate beta - lyases to pyruvate , ammonia , and an alpha - chloroenethiolate ( with DCVC ) or an alpha - difluoroalkylthiolate ( with TFEC ) that may eliminate halide to give a thioacyl halide , which reacts with epsilon - amino groups of lysine residues in proteins .
【GOLD_E】
cysteineS-conjugates	chem
cysteineS-conjugate	chem
pyruvate	chem
ammonia	chem
alpha-chloroenethiolate	chem
DCVC	chem
alpha-difluoroalkylthiolate	chem
TFEC	chem
halide	chem
thioacylhalide	chem
epsilon-amino	chem
lysine	chem
beta-lyases	geneN
【PRE_E】
cysteineS	chem
cysteineS	chem
pyruvate	chem
ammonia	chem
alpha-chloroenethiolate	chem
DCVC	chem
alpha-difluoroalkylthiolate	chem
TFEC	geneY
halide	chem
thioacylhalide	chem
epsilon-amino	chem
lysine	chem
【GOLD_R】
pyruvate	beta-lyases	C9
ammonia	beta-lyases	C9
alpha-chloroenethiolate	beta-lyases	C9
DCVC	beta-lyases	C9
alpha-difluoroalkylthiolate	beta-lyases	C9
TFEC	beta-lyases	C9
cysteineS-conjugates	beta-lyases	C9
【PRE_R】
alpha-chloroenethiolate	TFEC	C9
DCVC	TFEC	C9
alpha-difluoroalkylthiolate	TFEC	C9
TFEC	halide	C9
TFEC	thioacylhalide	C9
TFEC	epsilon-amino	C9

Nine mammalian pyridoxal 5 ' - phosphate ( PLP ) - containing enzymes catalyze cysteine S - conjugate beta - lyase reactions , including mitochondrial aspartate aminotransferase ( mitAspAT ) , and mitochondrial branched - chain amino acid aminotransferase ( BCAT ( m ) ) .
【GOLD_E】
cysteineS-conjugate	chem
aspartate	chem
pyridoxal5'-phosphate	chem
PLP	chem
beta-lyase	geneN
mitochondrialaspartateaminotransferase	geneY
mitAspAT	geneY
branched-chainaminoacid	chem
mitochondrialbranched-chainaminoacidaminotransferase	geneY
BCAT(m)	geneY
【PRE_E】
pyridoxal5'-phosphate	chem
PLP	chem
cysteineS	chem
beta-lyase	chem
mitochondrialaspartateaminotransferase	geneY
mitAspAT	geneY
mitochondrialbranched-chainaminoacidaminotransferase	geneY
BCAT(m)	geneY
【GOLD_R】
【PRE_R】
pyridoxal5'-phosphate	mitAspAT	C9
PLP	mitAspAT	C9
cysteineS	mitAspAT	C9
beta-lyase	mitAspAT	C9
beta-lyase	BCAT(m)	C9

Most of the cysteine S - conjugate beta - lyases are syncatalytically inactivated .
【GOLD_E】
beta-lyases	geneN
cysteineS-conjugate	chem
【PRE_E】
cysteineS-conjugatebeta-lyases	geneN
【GOLD_R】
【PRE_R】

TFEC - induced toxicity is associated with covalent modification of several mitochondrial enzymes of energy metabolism .
【GOLD_E】
TFEC	chem
【PRE_E】
TFEC	geneY
【GOLD_R】
【PRE_R】

Interestingly , the alpha - ketoglutarate - and branched - chain alpha - keto acid dehydrogenase complexes ( KGDHC and BCDHC ) , but not the pyruvate dehydrogenase complex ( PDHC ) , are susceptible to inactivation . mitAspAT and BCAT ( m ) may form metabolons with KGDHC and BCDHC , respectively , but no PLP enzyme is known to associate with PDHC .
【GOLD_E】
PLP	chem
alpha-ketoglutarate-andbranched-chainalpha-ketoaciddehydrogenasecomplexes	geneN
KGDHC	geneN
BCDHC	geneN
pyruvatedehydrogenasecomplex	geneN
PDHC	geneN
mitAspAT	geneY
BCAT(m)	geneY
KGDHC	geneN
BCDHC	geneN
PLPenzyme	geneN
PDHC	geneN
alpha-ketoglutarate	chem
branched-chainalpha-ketoacid	chem
pyruvate	chem
【PRE_E】
alpha-ketoglutarate-andbranched-chainalpha-ketoaciddehydrogenase	geneN
KGDHC	geneN
BCDHC	geneN
pyruvatedehydrogenasecomplex	geneY
PDHC	geneY
mitAspAT	geneN
BCAT(m)	geneY
KGDHC	geneN
BCDHC	chem
PLP	chem
PDHC	geneY
【GOLD_R】
【PRE_R】
KGDHC	BCDHC	C9
BCDHC	BCDHC	C9
PDHC	BCDHC	C9
mitAspAT	BCDHC	C9
BCAT(m)	BCDHC	C9
KGDHC	BCDHC	C9
PLP	PDHC	C9

Consequently , we hypothesize that not only do these metabolons facilitate substrate channeling , but they also facilitate toxicant channeling , thereby promoting the inactivation of proximate mitochondrial enzymes and the induction of mitochondrial dysfunction .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A heterozygote phenotype is present in the jvs + / - mutant mouse livers .
【GOLD_E】
【PRE_E】
jvs	geneY
【GOLD_R】
【PRE_R】

The juvenile visceral steatosis ( jvs ) mouse , having a mutation in the carnitine transporter gene Octn2 , is a model of primary systemic carnitine deficiency in humans ( SCD , OMIM 212140 ) .
【GOLD_E】
carnitine	chem
Octn2	geneY
carnitine	chem
【PRE_E】
carnitinetransporter	geneY
Octn2	geneY
carnitine	chem
OMIM212140	geneY
【GOLD_R】
carnitine	Octn2	C9
【PRE_R】

Like humans with SCD , homozygous jvs - / - mice have hepatic and cardiac steatoses , reduced plasma and tissue carnitines , and increased urinary carnitine clearance .
【GOLD_E】
carnitines	chem
carnitine	chem
【PRE_E】
SCD	geneY
carnitines	chem
carnitine	chem
【GOLD_R】
【PRE_R】
SCD	carnitines	C9
SCD	carnitine	C9

Because symptomatic heterozygotes have been reported for some fatty acid oxidation disorders , including SCD , we compared the jvs heterozygotes to normal control mice .
【GOLD_E】
fattyacid	chem
【PRE_E】
fattyacid	chem
SCD	geneN
jvs	geneY
【GOLD_R】
【PRE_R】

We measured the free and esterified carnitine , total cholesterol , and triglycerides in adult liver samples , myocardium , and skeletal muscle .
【GOLD_E】
carnitine	chem
cholesterol	chem
triglycerides	chem
【PRE_E】
carnitine	chem
cholesterol	chem
triglycerides	chem
【GOLD_R】
【PRE_R】

Our results indicate significant differences between the livers of nonfasting adult normal ( n = 8 ) vs jvs heterozygotes ( n = 8 ) ( means + / - SEM , p < 0.01 ) for the following parameters : free carnitine , 2.28 + / - 0.36 nmol / mg protein vs 0.41 + / - 0.13 ; total carnitine , 3.48 + / - 0.36 vs 1.27 + / - 0.25 ; triglycerides , 0.14 + / - 0.04 vs 0.39 + / - 0.02 ; and total cholesterol , 0.21 + / - 0.02 vs 0.39 + / - 0.04 , but not for esterified carnitine , 1.18 + / - 0.17 vs 0.90 + / - 0.17 ( p > 0.05 ) .
【GOLD_E】
carnitine	chem
carnitine	chem
triglycerides	chem
cholesterol	chem
carnitine	chem
【PRE_E】
carnitine	chem
carnitine	chem
triglycerides	chem
cholesterol	chem
carnitine	chem
【GOLD_R】
【PRE_R】

There is also a negative correlation between hepatic free carnitine and triglycerides from jvs heterozygotes ( p < 0.05 ) .
【GOLD_E】
carnitine	chem
triglycerides	chem
【PRE_E】
carnitine	chem
triglycerides	chem
【GOLD_R】
【PRE_R】

Similar results were obtained with myocardium and skeletal muscle .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We conclude that free and total carnitine levels are significantly lower in the heterozygote mouse liver and heart while triglyceride and total cholesterol levels are significantly higher .
【GOLD_E】
carnitine	chem
triglyceride	chem
cholesterol	chem
【PRE_E】
carnitine	chem
triglyceride	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

We speculate that in situations of lipolytic stress , some SCD heterozygotes might develop clinical symptoms of carnitine deficiency .
【GOLD_E】
carnitine	chem
【PRE_E】
SCD	geneN
carnitine	chem
【GOLD_R】
【PRE_R】

Organic cation transporter mRNA and function in the rat superior cervical ganglion .
【GOLD_E】
Organiccationtransporter	geneN
【PRE_E】
Organiccationtransporter	geneY
【GOLD_R】
【PRE_R】

Reuptake of extracellular noradrenaline ( NA ) into superior cervical ganglion ( SCG ) neurones is mediated by means of the noradrenaline transporter ( NAT , uptake 1 ) .
【GOLD_E】
noradrenaline	chem
NA	chem
noradrenalinetransporter	geneY
NAT	geneY
noradrenaline	chem
【PRE_E】
noradrenaline	chem
NA	chem
noradrenalinetransporter	geneY
NAT	geneY
【GOLD_R】
noradrenaline	noradrenalinetransporter	C9
noradrenaline	NAT	C9
NA	noradrenalinetransporter	C9
NA	NAT	C9
【PRE_R】

We now demonstrate by single - cell RT - PCR that mRNA of the organic cation transporter 3 ( OCT3 , uptake 2 ) occurs in rat SCG neurones as well .
【GOLD_E】
organiccationtransporter3	geneY
OCT3	geneY
【PRE_E】
organiccationtransporter3	geneY
OCT3	geneY
uptake2	geneY
【GOLD_R】
【PRE_R】

Furthermore , our RT - PCR analyses reveal the presence of mRNA for novel organic cation transporters 1 and 2 ( OCTN1 and OCTN2 ) , but not for OCT1 or OCT2 in the ganglion .
【GOLD_E】
novelorganiccationtransporters1and2	geneN
OCTN1	geneY
OCTN2	geneY
OCT1	geneY
OCT2	geneY
【PRE_E】
organiccationtransporters1and2	geneN
OCTN1	geneY
OCTN2	geneY
OCT1	geneY
OCT2	geneY
【GOLD_R】
【PRE_R】

Making use of the NAT as a powerful , neurone - specific transporter system , we loaded [ 3H ] - N - methyl - 4 - phenylpyridinium ( [ 3H ] - MPP + ) into cultured rat SCG neurones .
【GOLD_E】
[3H]-N-methyl-4-phenylpyridinium	chem
[3H]-MPP+	chem
NAT	geneY
【PRE_E】
NAT	geneY
neurone-specifictransporter	geneN
[3H]-N-methyl-4-phenylpyridinium	chem
[3H]-MPP+	chem
【GOLD_R】
【PRE_R】

The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine , but reduced ( in the presence of desipramine ) by the OCT3 inhibitors cyanine 863 , oestradiol and corticosterone .
【GOLD_E】
desipramine	chem
reserpine	chem
desipramine	chem
oestradiol	chem
corticosterone	chem
OCT3	geneY
【PRE_E】
desipramine	chem
reserpine	chem
desipramine	chem
OCT3	geneY
cyanine863	chem
oestradiol	chem
corticosterone	chem
【GOLD_R】
oestradiol	OCT3	C4
corticosterone	OCT3	C4
【PRE_R】
desipramine	OCT3	C4
reserpine	OCT3	C4
OCT3	cyanine863	C4

In contrast , cyanine 863 enhanced the radioactive outflow from cultures preloaded with [ 3H ] - NA .
【GOLD_E】
[3H]-NA	chem
【PRE_E】
cyanine863	chem
[3H]-NA	chem
【GOLD_R】
【PRE_R】

Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon : first , the primary radioactive product isolated from supernatants of cultures loaded with [ 3H ] - NA was the metabolite [ 3H ] - DHPG ; and second , inhibition of MAO significantly reduced the radioactive outflow in response to cyanine 863 .
【GOLD_E】
[3H]-NA	chem
MAO	geneN
[3H]-DHPG	chem
【PRE_E】
cyanine863	chem
[3H]-NA	chem
[3H]-DHPG	chem
MAO	geneN
cyanine863	chem
【GOLD_R】
【PRE_R】
[3H]-DHPG	MAO	C4
MAO	cyanine863	C4

The outflow of [ 3H ] - MPP + was significantly enhanced by MPP + , guanidine , choline and amantadine as potential substrates for OCT - related transmembrane transporters .
【GOLD_E】
OCT	geneN
transmembranetransporters	geneN
[3H]-MPP+	chem
MPP+	chem
guanidine	chem
choline	chem
amantadine	chem
【PRE_E】
[3H]-MPP+	chem
MPP+	chem
guanidine	chem
choline	chem
amantadine	chem
OCT-relatedtransmembranetransporters	geneN
【GOLD_R】
[3H]-MPP+	OCT	C9
[3H]-MPP+	transmembranetransporters	C9
MPP+	OCT	C9
MPP+	transmembranetransporters	C9
guanidine	OCT	C9
guanidine	transmembranetransporters	C9
choline	OCT	C9
choline	transmembranetransporters	C9
amantadine	OCT	C9
amantadine	transmembranetransporters	C9
【PRE_R】

However , desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP + , indicating the NAT and not an OCT as their primary site of action .
【GOLD_E】
MPP+	chem
NAT	geneY
OCT	geneN
desipramine	chem
【PRE_E】
desipramine	chem
MPP+	chem
NAT	geneN
OCT	geneY
【GOLD_R】
MPP+	NAT	C9
【PRE_R】

The MPP + - induced release of [ 3H ] - MPP + was fully prevented by a combined application of desipramine and cyanine 863 .
【GOLD_E】
MPP+	chem
[3H]-MPP+	chem
desipramine	chem
【PRE_E】
MPP+	chem
[3H]-MPP+	chem
desipramine	chem
cyanine863	chem
【GOLD_R】
【PRE_R】

No trans - stimulation of [ 3H ] - MPP + outflow was observed by the OCTN1 and OCTN2 substrate carnitine at 100 microM .
【GOLD_E】
[3H]-MPP+	chem
OCTN1	geneY
OCTN2	geneY
【PRE_E】
Notrans	chem
[3H]-MPP+	chem
OCTN1	geneY
OCTN2	geneY
carnitine	chem
【GOLD_R】
【PRE_R】

Our observations indicate an OCT - mediated transmembrane transport of [ 3H ] - MPP + .
【GOLD_E】
[3H]-MPP+	chem
OCT	geneN
【PRE_E】
OCT	geneY
[3H]-MPP+	chem
【GOLD_R】
[3H]-MPP+	OCT	C9
【PRE_R】

Amongst the three OCTs expressed in the SCG , OCT3 best fits the profile of substrates and antagonists that cause trans - stimulation and trans - inhibition , respectively , of [ 3H ] - MPP + release .
【GOLD_E】
[3H]-MPP+	chem
OCTs	geneN
OCT3	geneY
【PRE_E】
OCTs	geneN
SCG	geneY
OCT3	geneY
[3H]-MPP+	chem
【GOLD_R】
[3H]-MPP+	OCTs	C9
[3H]-MPP+	OCT3	C9
【PRE_R】

Neuroprotection by propargylamines in Parkinson 's disease : suppression of apoptosis and induction of prosurvival genes .
【GOLD_E】
propargylamines	chem
【PRE_E】
propargylamines	chem
【GOLD_R】
【PRE_R】

In Parkinson 's disease ( PD ) , therapies to delay or suppress the progression of cell death in nigrostriatal dopamine neurons have been proposed by use of various agents .
【GOLD_E】
dopamine	chem
【PRE_E】
dopamine	chem
【GOLD_R】
【PRE_R】

An inhibitor of type B monoamine oxidase ( MAO - B ) , ( - ) deprenyl ( selegiline ) , was reported to have neuroprotective activity , but clinical trials failed to confirm it .
【GOLD_E】
(-)deprenyl	chem
selegiline	chem
typeBmonoamineoxidase	geneY
MAO-B	geneY
monoamine	chem
【PRE_E】
typeBmonoamineoxidase	geneN
MAO-B	geneY
(-)deprenyl	chem
selegiline	chem
【GOLD_R】
(-)deprenyl	typeBmonoamineoxidase	C4
(-)deprenyl	MAO-B	C4
selegiline	typeBmonoamineoxidase	C4
selegiline	MAO-B	C4
【PRE_R】

However , the animal and cellular models of PD proved that selegiline protects neurons from cell death .
【GOLD_E】
selegiline	chem
【PRE_E】
selegiline	chem
【GOLD_R】
【PRE_R】

Among selegiline - related propargylamines , ( R ) ( + ) - N - propargyl - 1 - aminoindan ( rasagiline ) was the most effective to suppress the cell death in in vivo and in vitro experiments .
【GOLD_E】
selegiline	chem
propargylamines	chem
(R)(+)-N-propargyl-1-aminoindan	chem
rasagiline	chem
【PRE_E】
selegiline	chem
propargylamines	chem
(R)(+)-N-propargyl-1-aminoindan	chem
rasagiline	chem
【GOLD_R】
【PRE_R】

In this paper , the mechanism of the neuroprotection by rasagiline was examined using human dopaminergic SH - SY5Y cells against cell death induced by an endogenous dopaminergic neurotoxin N - methyl ( R ) salsolinol ( NM ( R ) Sal ) .
【GOLD_E】
rasagiline	chem
N-methyl(R)salsolinol	chem
NM(R)Sal	chem
【PRE_E】
rasagiline	chem
N-methyl(R)salsolinol	chem
Sal	chem
【GOLD_R】
【PRE_R】

NM ( R ) Sal induced apoptosis ( but not necrosis ) in SH - SY5Y cells , and the apoptotic cascade was initiated by mitochondrial permeability transition ( PT ) and activated by stepwise reactions .
【GOLD_E】
NM(R)Sal	chem
【PRE_E】
(R)Sal	chem
【GOLD_R】
【PRE_R】

Rasagiline prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic Bcl - 2 and a neurotrophic factor , glial cell line - derived neurotrophic factor ( GDNF ) .
【GOLD_E】
Rasagiline	chem
Bcl-2	geneY
neurotrophicfactor	geneN
glialcellline-derivedneurotrophicfactor	geneY
GDNF	geneY
【PRE_E】
Rasagiline	chem
PT	chem
Bcl-2	geneY
neurotrophicfactor	geneY
glialcellline-derivedneurotrophicfactor	geneY
GDNF	geneY
【GOLD_R】
Rasagiline	Bcl-2	C3
Rasagiline	neurotrophicfactor	C3
Rasagiline	glialcellline-derivedneurotrophicfactor	C3
Rasagiline	GDNF	C3
【PRE_R】
Rasagiline	GDNF	C4

Long - term administration of propargylamines to rats increased the activities of antioxidative enzymes superoxide dismutase ( SOD ) and catalase in the brain regions containing dopamine neurons .
【GOLD_E】
superoxidedismutase	geneN
SOD	geneN
catalase	geneY
propargylamines	chem
superoxide	chem
dopamine	chem
【PRE_E】
propargylamines	chem
superoxidedismutase	geneN
SOD	geneN
catalase	geneY
dopamine	chem
【GOLD_R】
propargylamines	superoxidedismutase	C3
propargylamines	SOD	C3
propargylamines	catalase	C3
【PRE_R】
propargylamines	SOD	C3
propargylamines	catalase	C3

Rasagiline and related propargylamines may rescue degenerating dopamine neurons through inhibiting death signal transduction initiated by mitochondria PT .
【GOLD_E】
Rasagiline	chem
propargylamines	chem
dopamine	chem
【PRE_E】
Rasagiline	chem
propargylamines	chem
dopamine	chem
PT	chem
【GOLD_R】
【PRE_R】

Pharmacodynamics and pharmacokinetics of phenylbutazone in calves .
【GOLD_E】
phenylbutazone	chem
【PRE_E】
phenylbutazone	chem
【GOLD_R】
【PRE_R】

Phenylbutazone ( PBZ ) was administered to six calves intravenously ( i.v . ) and orally at a dose rate of 4.4 mg / kg in a three - period cross - over study incorporating a placebo treatment to establish its pharmacokinetic and pharmacodynamic properties .
【GOLD_E】
Phenylbutazone	chem
PBZ	chem
【PRE_E】
Phenylbutazone	chem
PBZ	chem
【GOLD_R】
【PRE_R】

Extravascular distribution was determined by measuring penetration into tissue chamber fluid in the absence of stimulation ( transudate ) and after stimulation of chamber tissue with the mild irritant carrageenan ( exudate ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PBZ pharmacokinetics after i.v . dosage was characterized by slow clearance ( 1.29 mL / kg / h ) , long - terminal half - life ( 53.4 h ) , low distribution volume ( 0.09 L / kg ) and low concentrations in plasma of the metabolite oxyphenbutazone ( OPBZ ) , confirming previously published data for adult cattle .
【GOLD_E】
PBZ	chem
oxyphenbutazone	chem
OPBZ	chem
【PRE_E】
PBZ	chem
oxyphenbutazone	chem
OPBZ	chem
【GOLD_R】
【PRE_R】

After oral dosage bioavailability ( F ) was 66 % .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Passage into exudate was slow and limited , and penetration into transudate was even slower and more limited ; area under curve values for plasma , exudate and transudate after i.v . dosage were 3604 , 1117 and 766 microg h / mL and corresponding values after oral dosage were 2435 , 647 and 486 microg h / mL .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These concentrations were approximately 15 - 20 ( plasma ) and nine ( exudate ) times greater than those previously reported in horses ( receiving the same dose rate of PBZ ) .
【GOLD_E】
PBZ	chem
【PRE_E】
PBZ	chem
【GOLD_R】
【PRE_R】

In the horse , the lower concentrations had produced marked inhibition of eicosanoid synthesis and suppressed the inflammatory response .
【GOLD_E】
【PRE_E】
eicosanoid	chem
【GOLD_R】
【PRE_R】

The higher concentrations in calves were insufficient to inhibit significantly exudate prostaglandin E2 ( PGE2 ) , leukotriene B4 ( LTB4 ) and beta - glucuronidase concentrations and exudate leucocyte numbers , serum thromboxane B2 ( TxB2 ) , and bradykinin - induced skin swelling .
【GOLD_E】
beta-glucuronidase	geneY
bradykinin	geneY
prostaglandinE2	chem
PGE2	chem
leukotrieneB4	chem
LTB4	chem
thromboxaneB2	chem
TxB2	chem
【PRE_E】
prostaglandinE2	chem
PGE2	chem
leukotrieneB4	chem
LTB4	chem
beta-glucuronidase	geneY
thromboxaneB2	chem
TxB2	chem
bradykinin	geneY
【GOLD_R】
【PRE_R】

These differences from the horse might be the result of : ( a ) the presence in equine biological fluids of higher concentrations than in calves of the active PBZ metabolite , OPBZ ; ( b ) a greater degree of binding of PBZ to plasma protein in calves ; ( c ) species differences in the sensitivity to PBZ of the cyclo - oxygenase ( COX ) isoenzymes , COX - 1 and COX - 2 or ; ( d ) a combination of these factors .
【GOLD_E】
PBZ	chem
OPBZ	chem
PBZ	chem
PBZ	chem
cyclo-oxygenase	geneN
COX	geneN
COX-1	geneY
COX-2	geneY
【PRE_E】
PBZ	chem
OPBZ	chem
PBZ	chem
PBZ	chem
cyclo-oxygenase	geneN
COX	geneN
COX-1	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】
PBZ	cyclo-oxygenase	C3

To achieve clinical efficacy with single doses of PBZ in calves , higher dosages than 4.4 mg / kg will be probably required .
【GOLD_E】
PBZ	chem
【PRE_E】
PBZ	chem
【GOLD_R】
【PRE_R】

Practical asymmetric synthesis of aprepitant , a potent human NK - 1 receptor antagonist , via a stereoselective Lewis acid - catalyzed trans acetalization reaction .
【GOLD_E】
NK-1receptor	geneY
aprepitant	chem
【PRE_E】
aprepitant	chem
humanNK-1	geneY
Lewisacid-catalyzedtransacetalization	chem
【GOLD_R】
aprepitant	NK-1receptor	C6
【PRE_R】
aprepitant	humanNK-1	C6

A streamlined and high - yielding synthesis of aprepitant ( 1 ) , a potent substance P ( SP ) receptor antagonist , is described .
【GOLD_E】
substanceP(SP)receptor	geneY
aprepitant	chem
substanceP	chem
SP	chem
【PRE_E】
aprepitant	chem
P(SP)receptor	geneY
【GOLD_R】
aprepitant	substanceP(SP)receptor	C6
【PRE_R】
aprepitant	P(SP)receptor	C6

The enantiopure oxazinone 16 starting material was synthesized via a novel crystallization - induced dynamic resolution process .
【GOLD_E】
oxazinone	chem
【PRE_E】
enantiopureoxazinone16	chem
【GOLD_R】
【PRE_R】

Conversion of 16 to the penultimate intermediate cis - sec - amine 9 features a highly stereoselective Lewis acid - catalyzed trans acetalization of chiral alcohol 3 with trichloroacetimidate 18 followed by inversion of the adjacent chiral center on the morpholine ring .
【GOLD_E】
cis-sec-amine	chem
chiralalcohol	chem
trichloroacetimidate	chem
morpholine	chem
【PRE_E】
cis-sec-amine9	chem
alcohol3	chem
trichloroacetimidate18	chem
morpholine	chem
【GOLD_R】
【PRE_R】

The six - step process for the synthesis of 9 was accomplished in extremely high overall yield ( 81 % ) and with only two isolations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Signaling through Gi family members in platelets . Redundancy and specificity in the regulation of adenylyl cyclase and other effectors .
【GOLD_E】
adenylyl	chem
Gi	geneN
adenylylcyclase	geneN
【PRE_E】
Gi	geneN
adenylylcyclase	geneN
【GOLD_R】
【PRE_R】

Platelet responses at sites of vascular injury are regulated by intracellular cAMP levels , which rise rapidly when prostacyclin ( PGI ( 2 ) ) is released from endothelial cells .
【GOLD_E】
prostacyclin	chem
cAMP	chem
PGI(2)	chem
【PRE_E】
cAMP	chem
prostacyclin	chem
PGI(2)	chem
【GOLD_R】
【PRE_R】

Platelet agonists such as ADP and epinephrine suppress PGI ( 2 ) - stimulated cAMP formation by activating receptors coupled to G ( i ) family members , four of which are present in platelets .
【GOLD_E】
ADP	chem
PGI(2)	chem
cAMP	chem
G(i)	geneN
【PRE_E】
ADP	chem
epinephrine	chem
PGI(2)	geneY
cAMP	chem
G(i)	geneN
【GOLD_R】
【PRE_R】

To address questions about the specificity of receptor : G protein coupling , the regulation of cAMP formation in vivo and the contribution of G ( i ) - mediated pathways that do not involve adenylyl cyclase , we studied platelets from mice that lacked the alpha subunits of one or more of the three most abundantly expressed G ( i ) family members and compared the results with platelets from mice that lacked the PGI ( 2 ) receptor , IP .
【GOLD_E】
cAMP	chem
adenylyl	chem
PGI(2)	chem
Gprotein	geneN
G(i)	geneN
adenylylcyclase	geneN
G(i)	geneN
PGI(2)receptor	geneY
IP	geneY
【PRE_E】
Gprotein	geneN
cAMP	chem
G(i)	geneN
adenylylcyclase	geneN
G(i)	geneN
PGI(2)receptor	geneY
【GOLD_R】
【PRE_R】

As reported previously , loss of G ( i2 ) alpha or G ( z ) alpha inhibited aggregation in response to ADP and epinephrine , respectively , producing defects that could not be reversed by adding an adenylyl cyclase inhibitor .
【GOLD_E】
ADP	chem
epinephrine	chem
adenylyl	chem
G(i2)alpha	geneY
G(z)alpha	geneY
adenylylcyclase	geneN
【PRE_E】
G(i2)alpha	geneY
G(z)alpha	geneY
ADP	chem
epinephrine	chem
adenylylcyclase	geneN
【GOLD_R】
【PRE_R】

Platelets that lacked both G ( i2 ) alpha and G ( z ) alpha showed impaired responses to both agonists , but the impairment was no greater than in the individual knockouts .
【GOLD_E】
G(i2)alpha	geneY
G(z)alpha	geneY
【PRE_E】
G(i2)alpha	geneY
G(z)alpha	geneY
【GOLD_R】
【PRE_R】

Loss of G ( i3 ) alpha had no effect either alone or in combination with G ( z ) alpha .
【GOLD_E】
G(i3)alpha	geneY
G(z)alpha	geneY
【PRE_E】
G(i3)alpha	geneY
G(z)alpha	geneY
【GOLD_R】
【PRE_R】

Loss of either G ( z ) alpha or G ( i2 ) alpha impaired the ability of ADP and epinephrine to inhibit PGI ( 2 ) - stimulated adenylyl cyclase activity and caused a 40 % - 50 % rise in basal cAMP levels , whereas loss of G ( i3 ) alpha did not .
【GOLD_E】
G(z)alpha	geneY
G(i2)alpha	geneY
adenylylcyclase	geneN
G(i3)alpha	geneY
ADP	chem
epinephrine	chem
PGI(2)	chem
adenylyl	chem
cAMP	chem
【PRE_E】
G(z)alpha	geneY
G(i2)alpha	geneY
ADP	chem
epinephrine	chem
PGI(2)	geneY
adenylylcyclase	geneN
cAMP	chem
G(i3)alpha	geneY
【GOLD_R】
【PRE_R】
ADP	PGI(2)	C4
epinephrine	PGI(2)	C4

Conversely , deletion of IP abolished responses to PGI ( 2 ) and caused cAMP levels to fall by 30 % , effects that did not translate into enhanced responsiveness to agonists ex vivo .
【GOLD_E】
IP	geneY
PGI(2)	chem
cAMP	chem
【PRE_E】
PGI(2)	chem
cAMP	chem
【GOLD_R】
【PRE_R】

From these results we conclude that 1 ) cAMP levels in circulating platelets reflect ongoing signaling through G ( i2 ) , G ( z ) , and IP , but not G ( i3 ) ; 2 ) platelet epinephrine ( alpha ( 2A ) - adrenergic ) and ADP ( P2Y12 ) receptors display strong preferences among G ( i ) family members with little evidence of redundancy ; and 3 ) these receptor preferences do not extend to G ( i3 ) .
【GOLD_E】
cAMP	chem
epinephrine	chem
ADP	chem
G(i2)	geneN
G(z)	geneN
IP	geneY
G(i3)	geneN
(alpha(2A)-adrenergic	geneY
P2Y12	geneY
G(i)	geneN
G(i3)	geneN
【PRE_E】
cAMP	chem
G(i2)	geneY
G(z)	geneY
G(i3);2)	geneN
epinephrine	chem
alpha(2A)-adrenergic)	geneY
ADP(P2Y12)receptors	geneN
G(i)	geneN
G(i3)	geneN
【GOLD_R】
【PRE_R】

Finally , the failure of ADP and epinephrine to inhibit basal , as opposed to PGI ( 2 ) - stimulated , cAMP formation highlights the need during platelet activation for G ( i ) signaling pathways that involve effectors other than adenylyl cyclase .
【GOLD_E】
ADP	chem
epinephrine	chem
PGI(2)	chem
cAMP	chem
adenylyl	chem
G(i)	geneN
adenylylcyclase	geneN
【PRE_E】
ADP	chem
epinephrine	chem
PGI(2)	chem
cAMP	chem
G(i)	geneN
adenylylcyclase	geneN
【GOLD_R】
【PRE_R】

Effects of pentosan polysulfate sodium on the estrogen - induced pituitary prolactinoma in Fischer 344 rats .
【GOLD_E】
sodium	chem
estrogen	chem
【PRE_E】
sodium	chem
estrogen	chem
【GOLD_R】
【PRE_R】

The development of estrogen - induced pituitary prolactinoma in Fischer 344 ( F344 ) rats is associated with enhanced neovascularization .
【GOLD_E】
estrogen	chem
【PRE_E】
estrogen	chem
【GOLD_R】
【PRE_R】

This type of tumor is a rich source of basic fibroblast growth factor ( bFGF ) , which possesses strong mitogenic and angiogenic properties .
【GOLD_E】
basicfibroblastgrowthfactor	geneY
bFGF	geneY
【PRE_E】
basicfibroblastgrowthfactor	geneY
bFGF	geneY
【GOLD_R】
【PRE_R】

Pentosan polysulfate sodium ( PPS ) has been shown to exert antitumor activity by antagonizing the binding of bFGF to cell surface receptors .
【GOLD_E】
sodium	chem
bFGF	geneY
【PRE_E】
Pentosanpolysulfatesodium	chem
PPS	chem
bFGF	geneY
cellsurfacereceptors	geneN
【GOLD_R】
sodium	bFGF	C6
【PRE_R】
Pentosanpolysulfatesodium	bFGF	C4
PPS	bFGF	C4
PPS	cellsurfacereceptors	C4

We have examined the effects of pentosan on tumor growth , hyperprolactinemia and angiogenesis in diethylstilbestrol - induced anterior pituitary adenoma in F344 rats .
【GOLD_E】
diethylstilbestrol	chem
【PRE_E】
pentosan	chem
hyperprolactinemia	chem
diethylstilbestrol	chem
【GOLD_R】
【PRE_R】

Chronic treatment with PPS did not cause any changes in the pituitary weight and serum prolactin concentration in comparison with untreated animals .
【GOLD_E】
【PRE_E】
prolactin	geneY
【GOLD_R】
【PRE_R】

The density of microvessels identified by CD - 31 was also not affected by the tested drug .
【GOLD_E】
【PRE_E】
CD	chem
【GOLD_R】
【PRE_R】

On the other hand , pentosan has been found to decrease cell proliferation evaluated by a number of PCNA - positive stained cell nuclei .
【GOLD_E】
【PRE_E】
pentosan	chem
PCNA	geneY
【GOLD_R】
【PRE_R】

Moreover , the TUNEL method has revealed an increased number of apoptotic bodies within the anterior pituitary after treatment with PPS .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Despite the antiproliferative and proapoptotic activity of pentosan , the drug failed to inhibit tumor growth .
【GOLD_E】
【PRE_E】
pentosan	chem
【GOLD_R】
【PRE_R】

This fact might be due to the lack of antiangiogenic activity of PPS in this experimental design .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Localization of the ammonium transporter proteins RhBG and RhCG in mouse kidney .
【GOLD_E】
ammoniumtransporterproteins	geneN
RhBG	geneY
RhCG	geneY
ammonium	chem
【PRE_E】
ammoniumtransporter	geneN
RhBG	geneY
RhCG	geneY
【GOLD_R】
【PRE_R】

Ammonia is both produced and transported by renal epithelial cells , and it regulates renal ion transport .
【GOLD_E】
Ammonia	chem
【PRE_E】
Ammonia	chem
【GOLD_R】
【PRE_R】

Recent studies have identified a family of putative ammonium transporters ; mRNA for two members of this family , Rh B - glycoprotein ( RhBG ) and Rh C - glycoprotein ( RhCG ) , is expressed in the kidney .
【GOLD_E】
ammoniumtransporters	geneN
RhB-glycoprotein	geneY
RhBG	geneY
RhC-glycoprotein	geneY
RhCG	geneY
ammonium	chem
【PRE_E】
ammoniumtransporters	geneN
RhB-glycoprotein	geneN
RhBG	geneN
RhC-glycoprotein	geneN
RhCG	geneN
【GOLD_R】
【PRE_R】

The purpose of this study was to determine the cellular location of RhBG and RhCG protein in the mouse kidney .
【GOLD_E】
RhBG	geneY
RhCG	geneY
【PRE_E】
RhBG	geneY
RhCG	geneY
【GOLD_R】
【PRE_R】

We generated RhBG - and RhCG - specific anti - peptide antibodies .
【GOLD_E】
RhBG	geneY
RhCG	geneY
【PRE_E】
RhBG	geneY
RhCG	geneY
【GOLD_R】
【PRE_R】

Immunoblot analysis confirmed that both proteins were expressed in the mouse kidney .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RhBG localization with immunohistochemistry revealed discrete basolateral labeling in the connecting segment ( CNT ) and in the majority of initial collecting tubule ( ICT ) and cortical collecting duct ( CCD ) cells .
【GOLD_E】
RhBG	geneY
【PRE_E】
RhBG	geneY
【GOLD_R】
【PRE_R】

In the outer medullary collecting duct ( OMCD ) and inner medullary collecting duct ( IMCD ) only a subpopulation of cells exhibited basolateral immunoreactivity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Colocalization of RhBG with carbonic anhydrase II , the thiazide - sensitive transporter , and the anion exchangers AE1 and pendrin demonstrated RhBG immunoreactivity in all CNT cells and all CCD and ICT principal cells .
【GOLD_E】
RhBG	geneY
RhBG	geneY
carbonicanhydraseII	geneY
thiazide	chem
anionexchangers	geneN
AE1	geneY
pendrin	geneY
【PRE_E】
RhBG	geneY
carbonicanhydraseII	geneY
thiazide-sensitivetransporter	geneN
anionexchangersAE1	geneY
pendrin	geneY
RhBG	geneY
【GOLD_R】
【PRE_R】

In the ICT and CCD , basolateral RhBG immunoreactivity is also present in A - type intercalated cells but not in pendrin - positive CCD intercalated cells .
【GOLD_E】
RhBG	geneY
pendrin	geneY
【PRE_E】
RhBG	geneY
pendrin	geneY
【GOLD_R】
【PRE_R】

In the OMCD and IMCD , only intercalated cells exhibit RhBG immunoreactivity .
【GOLD_E】
RhBG	geneY
【PRE_E】
OMCD	geneY
IMCD	geneY
RhBG	geneY
【GOLD_R】
【PRE_R】

Immunoreactivity for a second putative ammonium transporter , RhCG , was present in the apical region of cells with almost the same distribution as RhBG .
【GOLD_E】
ammoniumtransporter	geneN
RhCG	geneY
RhBG	geneY
ammonium	chem
【PRE_E】
ammoniumtransporter	geneN
RhCG	geneY
RhBG	geneY
【GOLD_R】
【PRE_R】

However , RhCG immunoreactivity was present in all CCD cells , and it was present in outer stripe OMCD principal cells , in addition to OMCD and IMCD intercalated cells .
【GOLD_E】
RhCG	geneY
【PRE_E】
RhCG	geneY
OMCD	geneY
OMCD	geneY
IMCD	geneY
【GOLD_R】
【PRE_R】

Thus the majority of RhBG and RhCG protein expression is present in the same epithelial cell types in the CNT and collecting duct but with opposite polarity .
【GOLD_E】
RhBG	geneY
RhCG	geneY
【PRE_E】
RhBG	geneY
RhCG	geneY
CNT	chem
【GOLD_R】
【PRE_R】

These findings suggest that RhBG and RhCG may play important and cell - specific roles in ammonium transport and signaling in these regions of the kidney .
【GOLD_E】
RhBG	geneY
RhCG	geneY
ammonium	chem
【PRE_E】
RhBG	geneY
RhCG	geneY
ammonium	chem
【GOLD_R】
ammonium	RhBG	C9
ammonium	RhCG	C9
【PRE_R】

Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction .
【GOLD_E】
Phosphodiesterasetype5	geneY
【PRE_E】
Phosphodiesterasetype5	geneY
【GOLD_R】
【PRE_R】

The scientific rationale of pharmacologically inhibiting phosphodiesterase type 5 ( PDE5 ) in the treatment of erectile dysfunction ( ED ) is reviewed .
【GOLD_E】
phosphodiesterasetype5	geneY
PDE5	geneY
【PRE_E】
phosphodiesterasetype5	geneY
PDE5	geneY
【GOLD_R】
【PRE_R】

Published literature on the nitric oxide - cyclic guanosine monophosphate ( cGMP ) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed .
【GOLD_E】
PDE5	geneY
PDE5	geneY
nitricoxide	chem
cyclicguanosinemonophosphate	chem
cGMP	chem
【PRE_E】
nitricoxide-cyclicguanosinemonophosphate	chem
cGMP	chem
PDE5	geneY
sildenafil	chem
PDE5	geneY
【GOLD_R】
【PRE_R】
PDE5	sildenafil	C4
sildenafil	PDE5	C4

The key second messenger in the mediation of penile erection is cGMP .
【GOLD_E】
【PRE_E】
cGMP	chem
【GOLD_R】
【PRE_R】

PDE5 is the predominant PDE in the corpus cavernosum , and cGMP is its primary substrate .
【GOLD_E】
PDE5	geneY
PDE	geneN
cGMP	chem
【PRE_E】
PDE5	geneY
PDE	geneN
cGMP	chem
【GOLD_R】
cGMP	PDE5	C9
cGMP	PDE	C9
【PRE_R】

Therefore , in men with ED , elevation of cGMP in corpus cavernosal tissue via selective inhibition of cGMP - specific PDE5 is a means of improving erectile function at minimal risk of adverse events .
【GOLD_E】
PDE5	geneY
cGMP	chem
cGMP	chem
【PRE_E】
cGMP	chem
cGMP	chem
PDE5	geneY
【GOLD_R】
cGMP	PDE5	C4
【PRE_R】

This approach is validated by the clinical efficacy and safety of sildenafil , the pioneering drug for selective PDE5 inhibitor therapy for ED .
【GOLD_E】
sildenafil	chem
PDE5	geneY
【PRE_E】
sildenafil	chem
PDE5	geneY
【GOLD_R】
sildenafil	PDE5	C4
【PRE_R】
sildenafil	PDE5	C4

Sildenafil exhibits inhibitory potency against PDE5 and a 10 - fold lower dose - related inhibitory potency against rod outer segment PDE6 , the predominant PDE in the phototransduction cascade in rods .
【GOLD_E】
Sildenafil	chem
PDE	geneN
PDE5	geneY
PDE6	geneN
【PRE_E】
Sildenafil	chem
PDE5	geneY
PDE6	geneN
PDE	geneN
phototransduction	geneN
【GOLD_R】
Sildenafil	PDE	C4
Sildenafil	PDE5	C4
Sildenafil	PDE6	C4
【PRE_R】
Sildenafil	PDE5	C4
Sildenafil	PDE6	C4
Sildenafil	PDE	C4
Sildenafil	phototransduction	C4

Thus , its pharmacologic profile is predictable , with close correlation between pharmacodynamic and pharmacokinetic properties .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Clinically , sildenafil improves erectile function in a large percentage of men with ED .
【GOLD_E】
sildenafil	chem
【PRE_E】
sildenafil	chem
【GOLD_R】
【PRE_R】

The most common adverse events are due to PDE5 inhibition in vascular and visceral smooth muscle ; similar adverse events are expected during therapeutic use of all PDE5 inhibitors .
【GOLD_E】
PDE5	geneY
PDE5	geneY
【PRE_E】
PDE5	geneY
PDE5	geneY
【GOLD_R】
【PRE_R】

As free sildenafil plasma concentrations approach concentrations sufficient to inhibit retinal PDE6 , usually at higher therapeutic doses , transient , reversible visual adverse events can occur , albeit infrequently .
【GOLD_E】
PDE6	geneN
sildenafil	chem
【PRE_E】
sildenafil	chem
retinalPDE6	geneN
【GOLD_R】
sildenafil	PDE6	C4
【PRE_R】
sildenafil	retinalPDE6	C4

Selective inhibition of PDE5 is a rational therapeutic approach in ED , as proved by the clinical success of sildenafil .
【GOLD_E】
PDE5	geneY
sildenafil	chem
【PRE_E】
PDE5	geneY
sildenafil	chem
【GOLD_R】
sildenafil	PDE5	C4
【PRE_R】
PDE5	sildenafil	C4

Study of the nematode putative GABA type - A receptor subunits : evidence for modulation by ivermectin .
【GOLD_E】
GABA	chem
ivermectin	chem
GABAtype-Areceptor	geneN
【PRE_E】
GABAtype-Areceptor	geneY
ivermectin	chem
【GOLD_R】
【PRE_R】

Two alleles of the HG1 gene , which encodes a putative GABA receptor alpha / gamma subunit , were isolated from Haemonchus contortus .
【GOLD_E】
GABA	chem
HG1	geneY
GABAreceptoralpha/gamma	geneN
【PRE_E】
HG1	geneY
GABAreceptoralpha/gamma	geneN
【GOLD_R】
【PRE_R】

These two alleles were shown previously to be associated with ivermectin susceptibility ( HG1A ) and resistance ( HG1E ) , respectively .
【GOLD_E】
HG1A	geneY
HG1E	geneY
ivermectin	chem
【PRE_E】
ivermectin	chem
HG1A	geneN
【GOLD_R】
【PRE_R】

Sequence analysis indicates that they differ in four amino acids .
【GOLD_E】
aminoacids	chem
【PRE_E】
aminoacids	chem
【GOLD_R】
【PRE_R】

To explore the functional properties of the two alleles , a full - length cDNA encoding the beta subunit , a key functional component of the GABA receptor , was isolated from Caenorhabditis elegans ( gab - 1 , corresponding to the GenBank locus ZC482.1 ) and coexpressed in Xenopus oocytes with the HG1 alleles .
【GOLD_E】
GABA	chem
GABAreceptor	geneN
gab-1	geneY
GenBanklocusZC482.1	geneY
HG1	geneY
【PRE_E】
GABAreceptor	geneY
gab-1	geneY
ZC482.1	geneN
【GOLD_R】
【PRE_R】

When gab - 1 was coexpressed with either the HG1A allele or the HG1E allele in Xenopus oocytes , gamma - aminobutyric acid ( GABA ) - responsive channels with different sensitivity to the agonist were formed .
【GOLD_E】
gamma-aminobutyricacid	chem
GABA	chem
gab-1	geneY
HG1A	geneY
HG1E	geneY
gamma-aminobutyricacid(GABA)-responsivechannels	geneN
【PRE_E】
gab-1	geneY
HG1A	geneN
HG1E	geneY
gamma-aminobutyricacid(GABA)-responsivechannels	geneN
【GOLD_R】
【PRE_R】

The effects of ivermectin on the hetero - oligomeric receptors were determined .
【GOLD_E】
ivermectin	chem
【PRE_E】
ivermectin	chem
hetero-oligomericreceptors	geneN
【GOLD_R】
【PRE_R】

Application of ivermectin alone had no effect on the receptors .
【GOLD_E】
ivermectin	chem
【PRE_E】
ivermectin	chem
【GOLD_R】
【PRE_R】

However , when coapplied with 10 micro m GABA , ivermectin potentiated the GABA - evoked current of the GAB - 1 / HG1A receptor , but attenuated the GABA response of the GAB - 1 / HG1E receptor .
【GOLD_E】
GAB-1	geneY
HG1A	geneY
GABA	chem
GAB-1	geneY
HG1E	geneY
ivermectin	chem
GABA	chem
GABA	chem
【PRE_E】
GABA	chem
ivermectin	chem
GABA	chem
GAB-1	geneY
HG1A	geneY
GABA	chem
GAB-1	geneY
HG1Ereceptor	geneY
【GOLD_R】
ivermectin	GAB-1	C3
ivermectin	HG1A	C3
ivermectin	GAB-1	C4
ivermectin	HG1E	C4
【PRE_R】

We demonstrated that the coexpressed HG1 and GAB - 1 receptors are GABA - responsive , and provide evidence for the possible involvement of GABA receptors in the mechanism of ivermectin resistance .
【GOLD_E】
HG1	geneY
GAB-1	geneY
GABAreceptors	geneN
GABA	chem
GABA	chem
ivermectin	chem
【PRE_E】
HG1andGAB-1receptors	geneN
GABA	chem
GABAreceptors	geneN
ivermectin	chem
【GOLD_R】
【PRE_R】

Yohimbine dimers exhibiting selectivity for the human alpha 2C - adrenoceptor subtype .
【GOLD_E】
humanalpha2C-adrenoceptor	geneY
Yohimbine	chem
【PRE_E】
Yohimbine	chem
humanalpha2C-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Yohimbine is a potent and selective alpha2 - versus alpha1 - adrenoceptor antagonist .
【GOLD_E】
alpha2-versusalpha1-adrenoceptor	geneN
Yohimbine	chem
【PRE_E】
Yohimbine	chem
alpha2-versusalpha1-adrenoceptor	geneN
【GOLD_R】
Yohimbine	alpha2-versusalpha1-adrenoceptor	C6
【PRE_R】

To date , drugs with high specificity for the alpha2 - adrenoceptor show marginal selectivity among the three alpha2 - adrenoceptor subtypes .
【GOLD_E】
alpha2-adrenoceptor	geneN
alpha2-adrenoceptor	geneN
【PRE_E】
alpha2-adrenoceptor	geneN
alpha2-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

Initial studies showed that yohimbine was about 4 - and 15 - fold more selective for the human alpha2C - adrenoceptor in comparison with the alpha2A - and alpha2B - adrenoceptors , respectively .
【GOLD_E】
humanalpha2C-adrenoceptor	geneY
alpha2A-andalpha2B-adrenoceptors	geneN
yohimbine	chem
【PRE_E】
yohimbine	chem
humanalpha2C-adrenoceptor	geneY
alpha2A-andalpha2B-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

To improve on this alpha2 - adrenoceptor subtype selectivity , a series of yohimbine dimers ( varying from n = 2 to 24 spacer atoms ) were prepared and evaluated for receptor binding on human alpha2 - adrenoceptor subtypes expressed in Chinese hamster ovary cells .
【GOLD_E】
alpha2-adrenoceptor	geneN
humanalpha2-adrenoceptor	geneN
yohimbine	chem
【PRE_E】
alpha2-adrenoceptor	geneN
yohimbine	chem
humanalpha2-adrenoceptor	geneN
【GOLD_R】
【PRE_R】
alpha2-adrenoceptor	yohimbine	C6
yohimbine	humanalpha2-adrenoceptor	C6

Each dimeric analog showed higher affinities for alpha2A - and alpha2C - adrenoceptor versus the alpha2B - adrenoceptor ; and yohimbine dimers with spacers of n = 2 , 3 , 4 , 18 , and 24 exhibited selectivity for the alpha2C - adrenoceptor .
【GOLD_E】
alpha2A-andalpha2C-adrenoceptor	geneN
alpha2B-adrenoceptor	geneY
alpha2C-adrenoceptor	geneY
yohimbine	chem
【PRE_E】
alpha2A-andalpha2C-adrenoceptor	geneN
alpha2B-adrenoceptor	geneY
yohimbine	chem
alpha2C-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

The yohimbine dimers n = 3 and n = 24 showed the highest potency and selectivity ( 32 - and 82 - fold . respectively ) for the alpha2C - adrenoceptor in receptor binding and in functional studies ( 42 - and 29 - fold , respectively ) measuring cAMP changes using a cell - based luciferase reporter gene assay .
【GOLD_E】
cAMP	chem
yohimbine	chem
alpha2C-adrenoceptor	geneY
【PRE_E】
yohimbine	chem
alpha2C-adrenoceptor	geneY
cAMP	chem
【GOLD_R】
【PRE_R】

The dimers ( n = 3 and n = 24 ) had high selectivity ( > 1000 - fold ) for the alpha2C - adrenoceptor compared with the three alpha1 - adrenoceptor subtypes .
【GOLD_E】
alpha2C-adrenoceptor	geneY
alpha1-adrenoceptor	geneN
【PRE_E】
alpha2C-adrenoceptor	geneY
alpha1-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

These findings demonstrate that the addition of spacer linkages to bivalent yohimbine molecules provides a successful approach to the development of ligands that are potent and highly selective for the alpha2C - adrenoceptor .
【GOLD_E】
alpha2C-adrenoceptor	geneY
yohimbine	chem
【PRE_E】
yohimbine	chem
alpha2C-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists , imiquimod and resiquimod .
【GOLD_E】
resiquimod	chem
imiquimod	chem
cytokines	geneN
TLR7	geneY
【PRE_E】
cytokines	geneN
TLR7	geneN
imiquimod	chem
resiquimod	chem
【GOLD_R】
resiquimod	TLR7	C5
imiquimod	TLR7	C5
【PRE_R】

The immune response modifiers , imiquimod and resiquimod , are TLR7 agonists that induce type I interferon in numerous species , including humans .
【GOLD_E】
imiquimod	chem
TLR7	geneY
typeIinterferon	geneN
resiquimod	chem
【PRE_E】
resiquimod	chem
TLR7	geneY
typeIinterferon	geneY
【GOLD_R】
imiquimod	typeIinterferon	C3
resiquimod	typeIinterferon	C3
imiquimod	TLR7	C5
resiquimod	TLR7	C5
【PRE_R】
resiquimod	TLR7	C6

Recently , it was shown that plasmacytoid dendritic cells ( pDC ) are the primary interferon - producing cells in the blood in response to viral infections .
【GOLD_E】
interferon	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we characterize the activation of human pDC with the TLR7 agonists imiquimod and resiquimod .
【GOLD_E】
TLR7	geneY
imiquimod	chem
resiquimod	chem
【PRE_E】
humanpDC	geneN
TLR7	geneY
imiquimod	chem
resiquimod	chem
【GOLD_R】
imiquimod	TLR7	C5
resiquimod	TLR7	C5
【PRE_R】
TLR7	imiquimod	C6
TLR7	resiquimod	C6

Results indicate that imiquimod and resiquimod induce IFN - alpha and IFN - omega from purified pDC , and pDC are the principle IFN - producing cells in the blood .
【GOLD_E】
IFN-alpha	geneN
IFN-omega	geneN
IFN	geneN
imiquimod	chem
resiquimod	chem
【PRE_E】
imiquimod	chem
resiquimod	chem
IFN-alpha	geneY
IFN-omega	geneY
pDC	geneY
pDC	geneY
IFN	geneN
【GOLD_R】
imiquimod	IFN-alpha	C3
imiquimod	IFN-omega	C3
【PRE_R】
imiquimod	IFN-alpha	C4
resiquimod	IFN-alpha	C4
resiquimod	IFN-omega	C4

Resiquimod - stimulated pDC also produce a number of other cytokines including TNF - alpha and IP - 10 .
【GOLD_E】
cytokines	geneN
TNF-alpha	geneY
IP-10	geneY
Resiquimod	chem
【PRE_E】
Resiquimod	chem
pDC	geneY
cytokines	geneN
TNF-alpha	geneY
【GOLD_R】
Resiquimod	cytokines	C3
Resiquimod	TNF-alpha	C3
Resiquimod	IP-10	C3
【PRE_R】
Resiquimod	pDC	C3

Resiquimod enhances co - stimulatory marker expression , CCR7 expression , and pDC viability .
【GOLD_E】
CCR7	geneY
Resiquimod	chem
【PRE_E】
Resiquimod	chem
CCR7	geneY
【GOLD_R】
Resiquimod	CCR7	C3
【PRE_R】

Resiquimod was compared throughout the study to the pDC survival factors , IL - 3 and IFN - alpha ; resiquimod more effectively matures pDC than either IL - 3 or IFN - alpha alone .
【GOLD_E】
resiquimod	chem
IL-3	geneY
IFN-alpha	geneN
IL-3	geneY
IFN-alpha	geneN
Resiquimod	chem
【PRE_E】
Resiquimod	chem
IL-3	geneY
IFN-alpha	geneY
IL-3	geneY
IFN-alpha	geneY
【GOLD_R】
【PRE_R】

These results demonstrate that imidazoquinoline molecules directly induce pDC maturation as determined by cytokine induction , CCR7 and co - stimulatory marker expression and prolonging viability .
【GOLD_E】
imidazoquinoline	chem
cytokine	geneN
CCR7	geneY
【PRE_E】
imidazoquinoline	chem
pDC	geneN
cytokine	geneN
CCR7	geneY
【GOLD_R】
imidazoquinoline	cytokine	C3
【PRE_R】

Induction of heat shock proteins ( HSPs ) by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide - induced cell death .
【GOLD_E】
sodiumarsenite	chem
hydrogenperoxide	chem
heatshockproteins	geneN
HSPs	geneN
【PRE_E】
heatshockproteins	geneN
HSPs	geneN
sodiumarsenite	chem
hydrogenperoxide	chem
【GOLD_R】
sodiumarsenite	heatshockproteins	C3
sodiumarsenite	HSPs	C3
【PRE_R】

Induction of heat shock proteins ( HSPs ) protects cells from oxidative injury .
【GOLD_E】
heatshockproteins	geneN
HSPs	geneN
【PRE_E】
heatshockproteins	geneN
HSPs	geneN
【GOLD_R】
【PRE_R】

Here Hsp72 , Hsp27 and heme oxygenase - 1 ( HO - 1 ) were induced in cultured rat astrocytes , and protection against oxidative stress was investigated .
【GOLD_E】
hemeoxygenase-1	geneY
HO-1	geneY
Hsp72	geneY
Hsp27	geneY
【PRE_E】
Hsp72	geneY
Hsp27	geneY
hemeoxygenase-1	geneY
HO-1	geneY
【GOLD_R】
【PRE_R】

Astrocytes were treated with sodium arsenite ( 20 - 50 micro m ) for 1 h , which was non - toxic to cells , 24 h later they were exposed to 400 micro m H2O2 for 1 h , and cell death was evaluated at different time points .
【GOLD_E】
sodiumarsenite	chem
H2O2	chem
【PRE_E】
sodiumarsenite	chem
H2O2	chem
【GOLD_R】
【PRE_R】

Arsenite triggered strong induction of HSPs , which was prevented by 1 micro g / mL cycloheximide ( CXH ) .
【GOLD_E】
cycloheximide	chem
CXH	chem
HSPs	geneN
Arsenite	chem
【PRE_E】
Arsenite	chem
HSPs	geneN
cycloheximide	chem
CXH	chem
【GOLD_R】
Arsenite	HSPs	C3
cycloheximide	HSPs	C4
CXH	HSPs	C4
【PRE_R】

H2O2 caused cell loss and increased cell death with features of apoptosis , i.e .
【GOLD_E】
H2O2	chem
【PRE_E】
H2O2	chem
【GOLD_R】
【PRE_R】

TdT - mediated dUTP nick - end labelling ( TUNEL ) reaction and caspase - 3 activation .
【GOLD_E】
caspase-3	geneY
【PRE_E】
dUTP	chem
caspase-3	geneY
【GOLD_R】
【PRE_R】

These features were abrogated by pre - treatment with arsenite , which prevented cell loss and significantly reduced the number of dead cells .
【GOLD_E】
arsenite	chem
【PRE_E】
arsenite	chem
【GOLD_R】
【PRE_R】

The protective effect of arsenite was not detected in the presence of CHX .
【GOLD_E】
arsenite	chem
CHX	chem
【PRE_E】
arsenite	chem
CHX	chem
【GOLD_R】
【PRE_R】

Pre - treatment with arsenite increased protein kinase B ( Akt ) and extracellular signal regulated kinase 1 / 2 ( ERK1 / 2 ) phosphorylation after H2O2 .
【GOLD_E】
ERK1/2	geneN
H2O2	chem
proteinkinaseB	geneN
Akt	geneN
extracellularsignalregulatedkinase1/2	geneN
【PRE_E】
arsenite	chem
proteinkinaseB	geneN
Akt	geneN
extracellularsignalregulatedkinase1/2	geneN
ERK1/2	geneN
H2O2	chem
【GOLD_R】
H2O2	proteinkinaseB	C3
H2O2	Akt	C3
【PRE_R】
arsenite	proteinkinaseB	C3
arsenite	Akt	C3
ERK1/2	H2O2	C3

However , while Akt phosphorylation was prevented by CHX , Erk1 / 2 phosphorylation was further enhanced by CHX .
【GOLD_E】
Akt	geneN
Erk1/2	geneN
CHX	chem
【PRE_E】
Akt	geneN
CHX	chem
Erk1/2	geneN
CHX	chem
【GOLD_R】
CHX	Akt	C4
【PRE_R】
Akt	CHX	C3
Akt	CHX	C3

The results show that transient arsenite pre - treatment induces Hsp72 , HO - 1 and , to a lesser extent , Hsp27 ; it reduces H2O2 - induced astrocyte death ; and it causes selective activation of Akt following H2O2 .
【GOLD_E】
Hsp72	geneY
HO-1	geneY
Hsp27	geneY
Akt	geneN
arsenite	chem
H2O2	chem
H2O2	chem
【PRE_E】
arsenite	chem
Hsp72	geneY
HO-1	geneY
Hsp27	geneY
H2O2	chem
Akt	geneN
H2O2	chem
【GOLD_R】
arsenite	Akt	C3
H2O2	Akt	C3
arsenite	Hsp72	C3
arsenite	HO-1	C3
arsenite	Hsp27	C3
【PRE_R】
arsenite	Hsp72	C3
arsenite	HO-1	C3
arsenite	Hsp27	C3
arsenite	Akt	C3

It is suggested that HSP expression at the time of H2O2 exposure protects astrocytes from oxidative injury and apoptotic cell death by means of pro - survival Akt .
【GOLD_E】
HSP	geneN
Akt	geneN
H2O2	chem
【PRE_E】
HSP	geneN
H2O2	chem
Akt	geneN
【GOLD_R】
【PRE_R】
H2O2	Akt	C3

Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE / NEP inhibitors GW660511X and omapatrilat .
【GOLD_E】
GW660511X	chem
omapatrilat	chem
bradykinin	chem
bradykinin	geneN
ACE	geneN
NEP	geneN
【PRE_E】
bradykinin	geneY
ACE	geneY
NEP	geneY
GW660511X	chem
omapatrilat	chem
【GOLD_R】
GW660511X	ACE	C4
GW660511X	NEP	C4
omapatrilat	ACE	C4
omapatrilat	NEP	C4
【PRE_R】
ACE	GW660511X	C4
NEP	GW660511X	C4
NEP	omapatrilat	C4

Several studies have suggested that the accumulation of bradykinin , or that of one its metabolites BK1 - 8 , is involved in the occurrence of side effects such as AE associated with the use of various ACEi .
【GOLD_E】
bradykinin	chem
ACE	geneY
bradykinin	geneY
【PRE_E】
bradykinin	geneY
BK1-8	geneY
【GOLD_R】
【PRE_R】

In this work a novel approach combining HPLC - UV on - line with oaTOF - MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK ( 79 / 81 Br - Phe5 ) BrBK in the presence of two new dual ACE / NEP inhibitors ( GW660511X and omapatrilat ) currently under clinical trial .
【GOLD_E】
BK	chem
Br-Phe5	chem
BrBK	chem
GW660511X	chem
omapatrilat	chem
BK	geneN
79/81Br-Phe5	geneN
BrBK	geneN
ACE	geneN
NEP	geneN
【PRE_E】
BK(79/81Br-Phe5)BrBK	geneN
ACE	geneY
NEP	geneY
GW660511X	chem
omapatrilat	chem
【GOLD_R】
GW660511X	ACE	C4
GW660511X	NEP	C4
omapatrilat	ACE	C4
omapatrilat	NEP	C4
【PRE_R】
ACE	GW660511X	C4
NEP	GW660511X	C4
NEP	omapatrilat	C4

In human plasma the BrBK half - life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + / - 2.4 , 51.2 + / - 4.7 and 114.7 + / - 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and Br - Phe .
【GOLD_E】
BrBK	chem
GW660511X	chem
omapatrilat	chem
BrBK	chem
BrBK1-8	chem
BrBK1-7	chem
BrBK1-5	chem
Br-Phe	chem
BrBK	geneY
BrBK	geneY
BrBK1-8	geneY
BrBK1-7	geneY
BrBK1-5	geneY
Br-Phe	geneY
【PRE_E】
BrBK	geneY
GW660511X	chem
omapatrilat	chem
BrBK1-5	chem
Br-Phe	chem
【GOLD_R】
【PRE_R】

In the presence of inhibitors , however , the levels of these resultant metabolites were different .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Unlike GW660511X , omapatrilat abolished the production of BrBK1 - 5 and BrBK1 - 7 , suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found .
【GOLD_E】
GW660511X	chem
omapatrilat	chem
BrBK1-5	chem
BrBK1-7	chem
GW660511X	chem
BrBK1-5	geneY
BrBK1-7	geneY
ACE	geneY
NEP	geneY
【PRE_E】
GW660511X	chem
omapatrilat	chem
BrBK1-5	geneY
BrBK1-7	geneY
ACE	geneY
GW660511X	chem
NEP	geneY
【GOLD_R】
omapatrilat	BrBK1-5	C4
omapatrilat	BrBK1-7	C4
omapatrilat	ACE	C4
GW660511X	ACE	C4
【PRE_R】
GW660511X	BrBK1-5	C4
omapatrilat	BrBK1-5	C4
omapatrilat	BrBK1-7	C4
ACE	GW660511X	C4
GW660511X	NEP	C4

In addition the production of BrBK1 - 8 was enhanced in the presence of these inhibitors with a greater accumulation being observed with omapatrilat .
【GOLD_E】
BrBK1-8	chem
omapatrilat	chem
BrBK1-8	geneY
【PRE_E】
BrBK1-8	geneY
omapatrilat	chem
【GOLD_R】
omapatrilat	BrBK1-8	C3
【PRE_R】

The production of Br - Phe5 was reduced with GW660511X while no significant change was observed with omapatrilat after 4 h of incubation .
【GOLD_E】
Br-Phe5	chem
GW660511X	chem
Br-Phe5	geneY
omapatrilat	chem
【PRE_E】
Br-Phe5	chem
GW660511X	chem
omapatrilat	chem
【GOLD_R】
GW660511X	Br-Phe5	C4
【PRE_R】

In rat plasma the BrBK half - life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + / - 1.7 , 22.06 + / - 3.1 and 25.3 + / - 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and Br - Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .
【GOLD_E】
BrBK1-8	chem
BrBK1-7	chem
BrBK1-5	chem
Br-Phe5	chem
BrBK2-9	chem
BrBK4-8	chem
BrBK2-8	chem
BrBK	geneY
BrBK	geneY
BrBK1-8	geneY
BrBK1-7	geneY
BrBK1-5	geneY
Br-Phe5	geneY
BrBK2-9	geneY
BrBK4-8	geneY
BrBK2-8	geneN
BrBK	chem
GW660511X	chem
omapatrilat	chem
BrBK	chem
【PRE_E】
BrBK	geneY
GW660511X	chem
omapatrilat	chem
Br-Phe5	chem
【GOLD_R】
【PRE_R】

GW660511X and omapatrilat reduced the production of BrBK1 - 5 and BrBK1 - 7 with more effect being observed with omapatrilat .
【GOLD_E】
GW660511X	chem
omapatrilat	chem
BrBK1-5	chem
BrBK1-7	chem
omapatrilat	chem
BrBK1-5	geneY
BrBK1-7	geneY
【PRE_E】
GW660511X	chem
omapatrilat	chem
BrBK1-5	geneY
BrBK1-7	geneY
omapatrilat	chem
【GOLD_R】
GW660511X	BrBK1-5	C4
GW660511X	BrBK1-7	C4
omapatrilat	BrBK1-5	C4
omapatrilat	BrBK1-7	C4
omapatrilat	BrBK1-5	C4
omapatrilat	BrBK1-7	C4
【PRE_R】
GW660511X	BrBK1-5	C4
omapatrilat	BrBK1-5	C4
BrBK1-7	omapatrilat	C4

GW660511X and omapatrilat increased the production of both BrBK1 - 8 and Br - Phe5 but not that of BrBK4 - 8 and BrBK2 - 8 .
【GOLD_E】
GW660511X	chem
omapatrilat	chem
BrBK1-8	chem
Br-Phe5	chem
BrBK4-8	chem
BrBK2-8	chem
BrBK1-8	geneN
Br-Phe5	geneN
BrBK4-8	geneN
BrBK2-8	geneN
【PRE_E】
GW660511X	chem
omapatrilat	chem
BrBK1-8	geneN
Br-Phe5	chem
BrBK4-8	geneY
BrBK2-8	geneY
【GOLD_R】
GW660511X	BrBK1-8	C3
GW660511X	Br-Phe5	C3
omapatrilat	BrBK1-8	C3
omapatrilat	Br-Phe5	C3
【PRE_R】

This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100 - fold lower in human , but less than 10 - fold lower in rat plasma , suggesting that rat may not be a suitable in vivo model for the evaluation of ACE / NEP inhibition in relation to effects in humans .
【GOLD_E】
GW660511X	chem
omapatrilat	chem
ACE	geneY
NEP	geneY
【PRE_E】
GW660511X	chem
omapatrilat	chem
ACE	geneY
NEP	geneY
【GOLD_R】
GW660511X	ACE	C4
GW660511X	NEP	C4
omapatrilat	NEP	C4
【PRE_R】
GW660511X	ACE	C4
omapatrilat	ACE	C4
omapatrilat	NEP	C4

Activity of opioid ligands in cells expressing cloned mu opioid receptors .
【GOLD_E】
muopioidreceptors	geneY
【PRE_E】
muopioidreceptors	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : The aim of the present study was to describe the activity of a set of opioid drugs , including partial agonists , in a cell system expressing only mu opioid receptors .
【GOLD_E】
muopioidreceptors	geneY
【PRE_E】
muopioidreceptors	geneY
【GOLD_R】
【PRE_R】

Receptor activation was assessed by measuring the inhibition of forskolin - stimulated cyclic adenosine mono phosphate ( cAMP ) production .
【GOLD_E】
forskolin	chem
cyclicadenosinemonophosphate	chem
cAMP	chem
【PRE_E】
forskolin	chem
cyclicadenosinemonophosphate	chem
cAMP	chem
【GOLD_R】
【PRE_R】

Efficacies and potencies of these ligands were determined relative to the endogenous ligand beta - endorphin and the common mu agonist , morphine .
【GOLD_E】
morphine	chem
beta-endorphin	geneY
【PRE_E】
beta-endorphin	geneY
morphine	chem
【GOLD_R】
【PRE_R】

RESULTS : Among the ligands studied naltrexone , WIN 44,441 and SKF 10047 , were classified as antagonists , while the remaining ligands were agonists .
【GOLD_E】
naltrexone	chem
WIN44,441	chem
SKF10047	chem
【PRE_E】
naltrexone	chem
WIN44,441	chem
SKF10047	chem
【GOLD_R】
【PRE_R】

Agonist efficacy was assessed by determining the extent of inhibition of forskolin - stimulated cAMP production .
【GOLD_E】
forskolin	chem
cAMP	chem
【PRE_E】
forskolin	chem
cAMP	chem
【GOLD_R】
【PRE_R】

The rank order of efficacy of the agonists was fentanyl = hydromorphone = beta - endorphin > etorphine = lofentanil = butorphanol = morphine = nalbuphine = nalorphine > cyclazocine = dezocine = metazocine > or = xorphanol .
【GOLD_E】
fentanyl	chem
hydromorphone	chem
etorphine	chem
lofentanil	chem
butorphanol	chem
morphine	chem
nalbuphine	chem
nalorphine	chem
cyclazocine	chem
dezocine	chem
metazocine	chem
xorphanol	chem
【PRE_E】
fentanyl	chem
hydromorphone	chem
beta-endorphin	geneY
etorphine	chem
lofentanil	chem
butorphanol	chem
morphine	chem
nalbuphine	chem
nalorphine	chem
cyclazocine	chem
dezocine	chem
metazocine	chem
xorphanol	chem
【GOLD_R】
【PRE_R】

The rank order of potency of these ligands was different from that of their efficacies ; etorphine > hydromorphone > dezocine > xorphanol = nalorphine = butorphanol = lofentanil > metazocine > nalbuphine > cyclazocine > fentanyl > morphine > > > > beta - endorphin .
【GOLD_E】
cyclazocine	chem
fentanyl	chem
morphine	chem
etorphine	chem
hydromorphone	chem
dezocine	chem
xorphanol	chem
nalorphine	chem
butorphanol	chem
lofentanil	chem
metazocine	chem
nalbuphine	chem
【PRE_E】
etorphine	chem
hydromorphone	chem
dezocine	chem
xorphanol	chem
nalorphine	chem
butorphanol	chem
lofentanil	chem
metazocine	chem
nalbuphine	chem
cyclazocine	chem
fentanyl	chem
morphine	chem
beta-endorphin	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : These results elucidate the relative activities of a set of opioid ligands at mu opioid receptor and can serve as the initial step in a systematic study leading to understanding of the mode of action of opioid ligands at this receptor .
【GOLD_E】
muopioidreceptor	geneY
【PRE_E】
muopioidreceptor	geneY
【GOLD_R】
【PRE_R】

Furthermore , these results can assist in understanding the physiological effect of many opioid ligands acting through mu opioid receptors .
【GOLD_E】
muopioidreceptors	geneY
【PRE_E】
muopioidreceptors	geneY
【GOLD_R】
【PRE_R】

Ventricular tachyarrhythmias in a canine model of LQT3 : arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine .
【GOLD_E】
mexiletine	chem
【PRE_E】
mexiletine	chem
【GOLD_R】
【PRE_R】

The ventricular tachyarrhythmias associated with the LQT3 syndrome are typically bradycardia - dependent .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , some episodes can be associated with exercise or emotional stress , suggesting a different arrhythmogenic mechanism when sympathetic activity predominates .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study examined the potential arrhythmogenic mechanisms during periods of autonomically mediated transient heart rate acceleration in a canine anthopleurin - A model of LQT3 syndrome .
【GOLD_E】
anthopleurin-A	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

Using plunge needle electrodes , transmural unipolar electrograms of the left ventricle were recorded from endocardial ( Endo ) , mid - myocardial ( Mid ) and epicardial ( Epi ) sites .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The activation - recovery interval ( ARI ) was measured to estimate local refractoriness .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The cardiac cycle length was gradually shortened by cessation of vagal stimulation ( vagal stimulation protocol ( VSP ) ) , and intramural electrograms and onset mode of ventricular tachyarrhythmias were analyzed in 7 experiments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The VSP was performed 8 times before and 5 times after administration of mexiletine in each experiment .
【GOLD_E】
mexiletine	chem
【PRE_E】
VSP	geneN
mexiletine	chem
【GOLD_R】
【PRE_R】

Before mexiletine , vagal stimulation slowed the heart rate and created large transmural ARI dispersion because of a greater ARI prolongation at Mid rather than Epi / Endo sites .
【GOLD_E】
mexiletine	chem
【PRE_E】
mexiletine	chem
Epi	chem
【GOLD_R】
【PRE_R】

After cessation of vagal stimulation , unipolar electrograms started to show ARI alternans and ventricular premature beats developed sporadically .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sustained ventricular tachyarrhythmias were induced in 12 of the 56 trials of the VSP .
【GOLD_E】
【PRE_E】
VSP	geneN
【GOLD_R】
【PRE_R】

Initiation of ventricular tachyarrhythmias was associated with delayed conduction at Mid / Endo sites .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mexiletine attenuated transmural ARI dispersion , and neither ARI alternans nor ventricular tachyarrhythmias was observed during all 35 trials of the VSP after mexiletine administration .
【GOLD_E】
Mexiletine	chem
mexiletine	chem
【PRE_E】
Mexiletine	chem
mexiletine	chem
【GOLD_R】
【PRE_R】

Heart rate acceleration induced by an abrupt shift to a state of predominant sympathetic activity enhances arrhythmias in this LQT3 model .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mexiletine homogenizes ventricular repolarization , suppresses premature complexes and was antiarrhythmic during ventricular tachyarrhythmias induced by the VSP .
【GOLD_E】
Mexiletine	chem
【PRE_E】
Mexiletine	chem
【GOLD_R】
【PRE_R】

Butyrylcholinesterase : an important new target in Alzheimer 's disease therapy .
【GOLD_E】
Butyrylcholinesterase	geneY
【PRE_E】
Butyrylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Acetylcholinesterase ( AChE ) predominates in the healthy brain , with butyrylcholinesterase ( BuChE ) considered to play a minor role in regulating brain acetylcholine ( ACh ) levels .
【GOLD_E】
AChE	geneY
butyrylcholinesterase	geneY
BuChE	geneY
acetylcholine	chem
ACh	chem
Acetylcholinesterase	geneY
【PRE_E】
Acetylcholinesterase	geneY
AChE	geneY
butyrylcholinesterase	geneY
BuChE	geneY
acetylcholine	chem
ACh	chem
【GOLD_R】
acetylcholine	AChE	C9
acetylcholine	butyrylcholinesterase	C9
acetylcholine	BuChE	C9
acetylcholine	Acetylcholinesterase	C9
ACh	AChE	C9
ACh	butyrylcholinesterase	C9
ACh	BuChE	C9
ACh	Acetylcholinesterase	C9
【PRE_R】

However , BuChE activity progressively increases in patients with Alzheimer 's disease ( AD ) , while AChE activity remains unchanged or declines .
【GOLD_E】
AChE	geneY
BuChE	geneY
【PRE_E】
BuChE	geneY
AChE	geneY
【GOLD_R】
【PRE_R】

Both enzymes therefore represent legitimate therapeutic targets for ameliorating the cholinergic deficit considered to be responsible for the declines in cognitive , behavioral and global functioning characteristic of AD .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The two enzymes differ in substrate specificity , kinetics and activity in different brain regions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Experimental evidence from the use of agents with enhanced selectivity for BuChE ( cymserine analogues , MF - 8622 ) and the dual inhibitor of both AChE and BuChE , rivastigmine , indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias .
【GOLD_E】
BuChE	geneY
AChE	geneY
BuChE	geneY
AChE	geneY
BuChE	geneY
cymserine	chem
MF-8622	chem
rivastigmine	chem
【PRE_E】
BuChE	geneY
cymserine	chem
MF-8622	chem
AChE	geneY
BuChE	geneY
rivastigmine	chem
AChE	geneY
BuChE	geneY
【GOLD_R】
rivastigmine	AChE	C4
rivastigmine	BuChE	C4
rivastigmine	AChE	C4
rivastigmine	BuChE	C4
【PRE_R】
BuChE	cymserine	C4
MF-8622	AChE	C4
BuChE	rivastigmine	C4
rivastigmine	AChE	C4
rivastigmine	BuChE	C4

Recent evidence suggests that both AChE and BuChE may have roles in the aetiology and progression of AD beyond regulation of synaptic ACh levels .
【GOLD_E】
AChE	geneY
BuChE	geneY
【PRE_E】
AChE	geneY
BuChE	geneY
ACh	chem
【GOLD_R】
【PRE_R】

The development of specific BuChE inhibitors and further experience with the dual enzyme inhibitor rivastigmine will improve understanding of the aetiology of AD and should lead to a wider variety of potent treatment options .
【GOLD_E】
rivastigmine	chem
BuChE	geneY
【PRE_E】
BuChE	geneY
rivastigmine	chem
【GOLD_R】
rivastigmine	BuChE	C4
【PRE_R】
BuChE	rivastigmine	C4

A low toxicity maintenance regime , using eicosapentaenoic acid and readily available drugs , for mantle cell lymphoma and other malignancies with excess cyclin D1 levels .
【GOLD_E】
eicosapentaenoicacid	chem
cyclinD1	geneY
【PRE_E】
eicosapentaenoicacid	chem
cyclinD1	geneY
【GOLD_R】
【PRE_R】

Mantle cell lymphoma is a difficult to treat non - Hodgkin 's lymphoma ( NHL ) whose biochemistry is unusually well characterised .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Almost all and perhaps all patients overexpress the cyclin D1 protein which is crucial in driving cells from the G1 to the S phase .
【GOLD_E】
cyclinD1	geneY
【PRE_E】
cyclinD1	geneY
【GOLD_R】
【PRE_R】

This overexpression may be responsible for the refractoriness .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Despite this understanding , treatments for mantle cell lymphoma are based on standard NHL regimes of cyclophosphamide , doxorubicin , vincristine and prednisone , perhaps supplemented with the monoclonal antibody rituximab .
【GOLD_E】
prednisone	chem
cyclophosphamide	chem
doxorubicin	chem
vincristine	chem
【PRE_E】
cyclophosphamide	chem
doxorubicin	chem
vincristine	chem
prednisone	chem
【GOLD_R】
【PRE_R】

There has never been any attempt to direct treatment to the cyclin D1 mechanism or to angiogenesis which is now known to be important in all lymphomas .
【GOLD_E】
cyclinD1	geneY
【PRE_E】
cyclinD1	geneY
【GOLD_R】
【PRE_R】

Both these targets lend themselves to long - term maintenance regimes of relatively low toxicity which can be used as adjuvants to standard therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Agents which have recently been shown to block cyclin D1 translation by regulating calcium levels are the unsaturated essential fatty acid , eicosapentaenoic acid ( EPA ) , the antidiabetic thiazolidinediones , and the antifungal agent , clotrimazole .
【GOLD_E】
unsaturatedessentialfattyacid	chem
eicosapentaenoicacid	chem
cyclinD1	geneY
EPA	chem
thiazolidinediones	chem
clotrimazole	chem
【PRE_E】
cyclinD1	geneY
calcium	chem
fattyacid	chem
eicosapentaenoicacid	chem
EPA	chem
thiazolidinediones	chem
clotrimazole	chem
【GOLD_R】
unsaturatedessentialfattyacid	cyclinD1	C4
eicosapentaenoicacid	cyclinD1	C4
EPA	cyclinD1	C4
thiazolidinediones	cyclinD1	C4
clotrimazole	cyclinD1	C4
【PRE_R】
cyclinD1	clotrimazole	C4

Two types of agent which have been shown to inhibit angiogenesis are the teratogen , thalidomide , and the selective inhibitors of cyclo - oxygenase 2 ( COX - 2 ) .
【GOLD_E】
cyclo-oxygenase2	geneY
COX-2	geneY
thalidomide	chem
【PRE_E】
thalidomide	chem
cyclo-oxygenase2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】
thalidomide	cyclo-oxygenase2	C4
thalidomide	COX-2	C4

Retinoids exert synergistic effects with EPA and have been shown to inhibit both tumour growth and angiogenesis .
【GOLD_E】
Retinoids	chem
EPA	chem
【PRE_E】
Retinoids	chem
EPA	chem
【GOLD_R】
【PRE_R】

The mechanisms of action of these various agents are discussed , and specific suggestions are made for low toxicity maintenance therapy of mantle cell lymphoma and of other tumours which overexpress cyclin D1 .
【GOLD_E】
cyclinD1	geneY
【PRE_E】
cyclinD1	geneY
【GOLD_R】
【PRE_R】

Angiotensin AT1 receptor antagonist losartan and the defence reaction in the anaesthetised rat . Effect on the carotid chemoreflex .
【GOLD_E】
AngiotensinAT1receptor	geneY
Angiotensin	chem
losartan	chem
【PRE_E】
AngiotensinAT1receptor	geneY
losartan	chem
【GOLD_R】
losartan	AngiotensinAT1receptor	C6
【PRE_R】

Modulation at the level of the nucleus tractus solitarii ( NTS ) appears to be an effective way of controlling cardiovascular reflexes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Angiotensin II acting on angiotensin AT1 receptors at the central nervous system appears to have an important role in these modulatory processes .
【GOLD_E】
AngiotensinII	chem
angiotensin	chem
AngiotensinII	geneY
angiotensinAT1receptors	geneY
【PRE_E】
AngiotensinII	geneY
angiotensinAT1receptors	geneY
【GOLD_R】
【PRE_R】

The hypothalamic defence area ( HDA ) is a potential source of descending fibres containing angiotensin II that innervate the NTS .
【GOLD_E】
angiotensinII	chem
angiotensinII	geneY
【PRE_E】
angiotensinII	geneY
【GOLD_R】
【PRE_R】

We investigated the effect of AT1 receptor blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent pancuronium bromide .
【GOLD_E】
AT1receptor	geneY
pancuroniumbromide	chem
【PRE_E】
AT1	geneY
NTS	chem
HDA	chem
pancuroniumbromide	chem
【GOLD_R】
pancuroniumbromide	AT1receptor	C4
【PRE_R】

The characteristic increase in heart rate , blood pressure and phrenic nerve activity evoked by electrical stimulation of HDA is decreased by the microinjection of the AT1 receptor antagonist losartan into the NTS and the cardiovascular response to carotid body chemical stimulation is also reduced .
【GOLD_E】
AT1receptor	geneY
【PRE_E】
HDA	chem
AT1	geneY
losartan	chem
NTS	chem
【GOLD_R】
【PRE_R】
AT1	NTS	C6

These results support the hypothesis that AT1 receptors in the NTS play a role in the modulation of cardiovascular reflexes , and modify the influence exerted on the processing of these reflexes by other areas of the central nervous system .
【GOLD_E】
AT1receptors	geneY
【PRE_E】
AT1receptors	geneN
NTS	geneN
【GOLD_R】
【PRE_R】

Defective processing of the transforming growth factor - beta1 in azoxymethane - induced mouse colon tumors .
【GOLD_E】
transforminggrowthfactor-beta1	geneY
azoxymethane	chem
【PRE_E】
transforminggrowthfactor-beta1	geneY
azoxymethane	chem
【GOLD_R】
【PRE_R】

High levels of the cell growth inhibitor transforming growth factor - beta1 ( TGF - beta1 ) are often found in a variety of human cancers .
【GOLD_E】
transforminggrowthfactor-beta1	geneY
TGF-beta1	geneY
【PRE_E】
transforminggrowthfactor-beta1	geneY
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

However , the physiological significance of this overexpression depends on the availability of the biologically active form of TGF - beta1 within the extracellular matrix of the tumor microenvironment .
【GOLD_E】
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

To determine the expression and activation status of TGF - beta1 in chemically induced tumors , 6 - wk - old A / J mice were injected intraperitoneally with either azoxymethane ( AOM ) ( 10 mg / kg body weight , once a week for 6 wk ) or normal saline solution , and colon tumors were isolated 24 wk following the last injection .
【GOLD_E】
TGF-beta1	geneY
azoxymethane	chem
AOM	chem
【PRE_E】
TGF-beta1	geneY
azoxymethane	chem
AOM	chem
【GOLD_R】
【PRE_R】

An enzyme - linked immunosorbent assay for TGF - beta1 revealed a significant increase ( 1.7 - fold , P < 0.05 ) in total TGF - beta1 protein in tumors .
【GOLD_E】
TGF-beta1	geneY
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

Interestingly , while 80 % of the total TGF - beta1 in the control colon tissues was in the active form , only 50 % was found to be active in tumors .
【GOLD_E】
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

Together with our earlier observations that TGF - beta1 mRNA levels are unchanged in A / J tumors , these data further support a mechanism whereby elevated TGF - beta1 levels result from a defective activation and turnover of this protein .
【GOLD_E】
TGF-beta1	geneY
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

Because plasmin is known to be a major activator of TGF - beta1 in vivo , we hypothesized that reduced plasmin activity may be responsible for the observed dysregulation of TGF - beta1 processing in these behaviorally benign tumors .
【GOLD_E】
TGF-beta1	geneY
plasmin	geneY
TGF-beta1	geneY
plasmin	geneY
【PRE_E】
plasmin	geneY
TGF-beta1	geneY
plasmin	geneY
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

With a fluorogenic peptide substrate for serine proteases , a deficiency in plasmin activity was found in the tumors .
【GOLD_E】
serineproteases	geneN
plasmin	geneY
serine	chem
【PRE_E】
serineproteases	geneN
plasmin	geneY
【GOLD_R】
【PRE_R】

Furthermore , semiquantitative reverse transcription ( RT ) - polymerase chain reaction ( PCR ) analysis of a panel of genes involved in the plasminogen activation system , including plasminogen activator inhibitor - 1 ( PAI - 1 ) , urokinase - plasminogen activator ( u - PA ) , and urokinase - receptor ( u - PAR - 1 ) , demonstrated a significant upregulation ( approximately fourfold to sixfold , P < 0.05 ) in the expression of each of these genes in the tumor tissue .
【GOLD_E】
plasminogen	geneY
plasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
urokinase-plasminogenactivator	geneY
u-PA	geneY
urokinase-receptor	geneY
u-PAR-1	geneY
【PRE_E】
semiquantitativereversetranscription(RT)-polymerase	geneN
plasminogen	geneN
plasminogenactivatorinhibitor-1	geneY
PAI-1	geneY
urokinase-plasminogenactivator	geneY
u-PA	geneY
urokinase-receptor	geneY
u-PAR-1	geneY
【GOLD_R】
【PRE_R】

In addition , no significant changes were observed in the expression levels of thrombospondin - 1 ( TSP - 1 ) and insulin - like growth factor type II receptor ( IGF - IIR ) , which also mediate the activation of latent TGF - beta1 .
【GOLD_E】
thrombospondin-1	geneY
TSP-1	geneY
insulin-likegrowthfactortypeIIreceptor	geneY
IGF-IIR	geneY
TGF-beta1	geneY
【PRE_E】
thrombospondin-1	geneY
TSP-1	geneY
insulin-likegrowthfactortypeIIreceptor	geneY
IGF-IIR	geneY
latentTGF-beta1	geneY
【GOLD_R】
【PRE_R】

To gain further insight into the functionality of the TGF - beta1 pathway , cDNA microarrays were performed and the expression levels of a panel of 21 TGF - beta1 - specific target genes were determined in AOM - induced tumors that overexpress the ligand .
【GOLD_E】
TGF-beta1	geneY
TGF-beta1	geneY
AOM	chem
【PRE_E】
TGF-beta1	geneY
TGF-beta1	geneY
AOM	chem
【GOLD_R】
【PRE_R】

A significant dysregulation in the expression of each of these targets was observed , providing evidence of aberrant TGF - beta1 signaling in tumors .
【GOLD_E】
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

Overall , the present study demonstrates a very low plasmin activity in A / J colon tumors , possibly as a result of the potent inhibitory effect of PAI - 1 on the plasminogen activation cascade .
【GOLD_E】
plasmin	geneY
PAI-1	geneY
plasminogen	geneY
【PRE_E】
plasmin	geneY
PAI-1	geneY
plasminogen	geneN
【GOLD_R】
【PRE_R】

The observed deficiency in plasmin activity may not be sufficiently compensated for by other mechanisms of latent TGF - beta1 activation , including TSP - 1 and IGF - IIR , thereby resulting in a decreased fraction of the biologically active form of TGF - beta1 and subsequent aberration in TGF - beta1 - specific gene regulation in A / J tumors .
【GOLD_E】
plasmin	geneY
TGF-beta1	geneY
TSP-1	geneY
IGF-IIR	geneY
TGF-beta1	geneY
TGF-beta1	geneY
【PRE_E】
plasmin	geneY
TGF-beta1	geneY
TSP-1	geneY
IGF-IIR	geneN
TGF-beta1	geneY
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

Inhibition by pentosan polysulfate ( PPS ) of heparin - binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals .
【GOLD_E】
heparin-bindinggrowthfactors	geneN
【PRE_E】
pentosanpolysulfate	chem
PPS	chem
【GOLD_R】
【PRE_R】

BACKGROUND : In a proliferating tumor , locally secreted polypeptide growth factors , which have autocrine and paracrine functions , induce vascularization essential for tumor growth and metastasis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These growth factors may serve as targets for tumor therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We have shown that the heparinoid pentosan polysulfate ( PPS ) can block growth of subcutaneous human tumor xenografts in nude mice and angiogenesis induced by the heparin - binding , Kaposi 's sarcoma - derived fibroblast growth factor ( K - FGF ) .
【GOLD_E】
Kaposi'ssarcoma-derivedfibroblastgrowthfactor	geneN
K-FGF	geneN
【PRE_E】
heparinoidpentosanpolysulfate	chem
PPS	chem
Kaposi'ssarcoma-derivedfibroblastgrowthfactor	geneY
K-FGF	geneY
【GOLD_R】
【PRE_R】
heparinoidpentosanpolysulfate	Kaposi'ssarcoma-derivedfibroblastgrowthfactor	C4
PPS	Kaposi'ssarcoma-derivedfibroblastgrowthfactor	C4
PPS	K-FGF	C4

PURPOSE : The purpose of this study was to determine whether PPS might also interfere with stimulation of endothelial cells by other growth factors released from tumor cells and whether the promising antitumor effects of PPS extend to other human tumor cell lines .
【GOLD_E】
【PRE_E】
PPS	chem
PPS	chem
【GOLD_R】
【PRE_R】

We studied the effects of PPS on stimulation by heparin - binding growth factors released from seven human tumor cell lines in vitro and on tumors growing from these cell lines in athymic nude mice .
【GOLD_E】
heparin-bindinggrowthfactors	geneN
【PRE_E】
PPS	chem
【GOLD_R】
【PRE_R】

METHODS : Seven human cell lines established from breast , prostate , epidermoid , and lung carcinomas and rhabdomyosarcoma were used in in vivo as well as in vitro studies of the effects of PPS .
【GOLD_E】
【PRE_E】
PPS	chem
【GOLD_R】
【PRE_R】

We also studied in vitro the effects of PPS on growth factor - induced colony formation of normal rat kidney fibroblasts and human adrenal carcinoma cells .
【GOLD_E】
【PRE_E】
PPS	chem
growthfactor	geneY
【GOLD_R】
【PRE_R】

RESULTS : The tumor cell lines released growth factors into their media that stimulated growth of endothelial and epithelial cells as well as fibroblasts .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Heparin - affinity chromatography showed that heparin - binding growth factors contributed substantially to this paracrine activity and that PPS inhibited this stimulus .
【GOLD_E】
heparin-bindinggrowthfactors	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Six of the seven tumor cell lines were resistant to PPS in soft - agar cloning assays and hence did not appear to depend on autocrine stimulation by the heparin - binding growth factors .
【GOLD_E】
heparin-bindinggrowthfactors	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast to this in vitro resistance , subcutaneous growth of tumors from all cell lines in athymic nude mice was inhibited in a dose - dependent fashion by daily intraperitoneal injections of PPS .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : We conclude that heparin - binding growth factors contribute substantially to tumor growth in vivo and that PPS acts by blocking the paracrine effects of heparin - binding growth factors released from the tumor cells .
【GOLD_E】
heparin-bindinggrowthfactors	geneN
heparin-bindinggrowthfactors	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

IMPLICATION : PPS could become a novel treatment tool targeting tumor growth factors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors .
【GOLD_E】
ORL1	geneY
opioidreceptors	geneN
preproorphaninprecursorpeptide	geneN
GTPgammaS	chem
【PRE_E】
GTPgammaS	chem
ORL1	geneY
opioidreceptors	geneN
【GOLD_R】
【PRE_R】

Utilizing agonist - stimulated GTPgammaS autoradiography , we analyzed the ability of preproorphanin FQ ( ppOFQ ) peptides to stimulate [ 35S ] - GTPgammaS binding in adult rat brain .
【GOLD_E】
[35S]-GTPgammaS	chem
preproorphaninFQ(ppOFQ)peptides	geneN
GTPgammaS	chem
【PRE_E】
GTPgammaS	chem
preproorphaninFQ	geneY
ppOFQ	geneY
[35S]-GTPgammaS	chem
【GOLD_R】
【PRE_R】

Orphanin FQ ( OFQ ) stimulated [ 35S ] - GTPgammaS binding in a pattern similar to that described for [ 125I ] - OFQ at the endogenous opioid receptor - like ( ORL1 ) receptor .
【GOLD_E】
OrphaninFQ	geneY
OFQ	geneY
OFQ	geneY
opioidreceptor-like(ORL1)receptor	geneY
[35S]-GTPgammaS	chem
125I	chem
【PRE_E】
OrphaninFQ	geneY
OFQ	geneY
[35S]-GTPgammaS	chem
[125I]-OFQ	chem
opioidreceptor-like(ORL1)receptor	geneY
【GOLD_R】
【PRE_R】

The ppOFQ peptides nocistatin and orphanin FQ2 ( OFQ II ( 1 - 17 ) ) had no effect , suggesting that they do not mediate their reported analgesic effects via a G ( i / o ) - coupled receptor ( i.e . opioid or ORL1 ) .
【GOLD_E】
ppOFQ	geneN
orphaninFQ2	geneY
OFQII(1-17)	geneY
G(i/o)-coupledreceptor	geneN
ORL1	geneY
【PRE_E】
ppOFQ	geneY
nocistatin	chem
orphaninFQ2	geneY
OFQII	geneY
G(i/o)-coupledreceptor	geneN
ORL1	geneY
【GOLD_R】
【PRE_R】

Unlike OFQ II ( 1 - 17 ) , high concentrations of its C - terminal extension , OFQ II ( 1 - 28 ) , stimulated [ 35S ] - GTPgammaS binding in a mu ( mu ) opioid receptor - like distribution and the effect was blocked by naloxone .
【GOLD_E】
OFQII(1-17)	geneY
OFQII(1-28)	geneY
mu(mu)opioidreceptor	geneY
C	chem
[35S]-GTPgammaS	chem
naloxone	chem
【PRE_E】
OFQII	geneY
C	chem
OFQII	geneY
[35S]-GTPgammaS	chem
mu(mu)opioidreceptor	geneY
naloxone	chem
【GOLD_R】
【PRE_R】

To explore these observations , we evaluated the receptor binding profile of OFQ II ( 1 - 28 ) at the cloned ORL1 and mu opioid receptors .
【GOLD_E】
OFQII(1-28)	geneY
ORL1	geneY
muopioidreceptors	geneY
【PRE_E】
OFQII	geneY
ORL1	geneY
muopioidreceptors	geneY
【GOLD_R】
【PRE_R】

OFQ II ( 1 - 28 ) had no specific binding at either ORL1 or mu opioid receptors at concentrations up to 50 microM .
【GOLD_E】
OFQII(1-28)	geneY
ORL1	geneY
muopioidreceptors	geneY
【PRE_E】
OFQII	geneY
ORL1	geneY
muopioidreceptors	geneY
【GOLD_R】
【PRE_R】

This lack of affinity was not consistent with a mu - mediated effect , as suggested by preliminary observation using functional autoradiography in rat brain sections .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Although behavioral studies suggest that OFQ II ( 1 - 28 ) possesses analgesic activity , this effect does not appear to be mediated via direct binding at the mu opioid receptor .
【GOLD_E】
OFQII(1-28)	geneY
muopioidreceptor	geneY
【PRE_E】
OFQII	geneY
muopioidreceptor	geneY
【GOLD_R】
【PRE_R】

Taken together , these findings support the view that ( 1 ) OFQ is the only ppOFQ peptide that binds to and activates the ORL1 receptor and ( 2 ) OFQ II ( 1 - 28 ) does not bind or stimulate [ 35S ] - GTPgammaS binding in cells expressing the mu opioid receptor .
【GOLD_E】
OFQ	geneY
ppOFQ	geneN
ORL1	geneN
OFQII(1-28)	geneY
muopioidreceptor	geneY
[35S]-GTPgammaS	chem
【PRE_E】
(1)OFQ	chem
ppOFQ	geneY
ORL1receptor	geneY
OFQII	geneY
[35S]-GTPgammaS	chem
muopioidreceptor	geneY
【GOLD_R】
【PRE_R】

Tethered dimers as NAD synthetase inhibitors with antibacterial activity .
【GOLD_E】
NADsynthetase	geneN
NAD	chem
【PRE_E】
NADsynthetase	geneY
【GOLD_R】
【PRE_R】

The solution - phase parallel synthesis of tethered dimers was employed to identify lead inhibitors of bacterial NAD synthetase .
【GOLD_E】
NAD	chem
bacterialNADsynthetase	geneN
【PRE_E】
bacterialNADsynthetase	geneY
【GOLD_R】
【PRE_R】

Active dimers contained two aromatic end groups joined by a polymethylene linker , with one end group containing a permanent positive charge .
【GOLD_E】
【PRE_E】
polymethylene	chem
【GOLD_R】
【PRE_R】

Effective inhibitors of NAD synthetase also inhibited the growth of Gram - positive ( but not Gram - negative ) bacteria , including antibiotic - resistant strains .
【GOLD_E】
NAD	chem
NADsynthetase	geneN
【PRE_E】
NADsynthetase	geneY
【GOLD_R】
【PRE_R】

The desmethyl precursors of active inhibitors lacked a permanent positive charge and were inactive as either enzyme inhibitors or antibacterial agents .
【GOLD_E】
【PRE_E】
desmethyl	chem
【GOLD_R】
【PRE_R】

Similarly , a close structural analogue of the most active inhibitors contained two additional ether oxygens in the tether and was inactive in both assays .
【GOLD_E】
oxygens	chem
【PRE_E】
etheroxygens	chem
【GOLD_R】
【PRE_R】

These results are consistent with the premise that NAD synthetase inhibition is responsible for the antibacterial actions and support further studies on NAD synthetase as a new target for antibacterial agents .
【GOLD_E】
NADsynthetase	geneN
NAD	chem
NAD	chem
NADsynthetase	geneN
【PRE_E】
NADsynthetase	geneY
NADsynthetase	geneY
【GOLD_R】
【PRE_R】

Blockade of LTC4 synthesis caused by additive inhibition of gIV - PLA2 phosphorylation : Effect of salmeterol and PDE4 inhibition in human eosinophils .
【GOLD_E】
PDE4	chem
LTC4	chem
salmeterol	chem
PDE4	geneN
gIV-PLA2	geneN
【PRE_E】
LTC4	chem
gIV-PLA2	geneY
salmeterol	chem
PDE4	geneN
【GOLD_R】
LTC4	gIV-PLA2	C9
【PRE_R】
LTC4	gIV-PLA2	C4
gIV-PLA2	salmeterol	C4
salmeterol	PDE4	C4

BACKGROUND : Prior investigations have demonstrated that beta ( 2 ) - adrenoceptor stimulation is ineffective in inhibiting synthesis of eicosanoids in human eosinophils .
【GOLD_E】
beta(2)-adrenoceptor	geneY
【PRE_E】
beta(2)-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

This effect has been postulated to relate to density or structural differences in the beta ( 2 ) - adrenoceptor or its coupled G - protein .
【GOLD_E】
beta(2)-adrenoceptor	geneY
G-protein	geneN
【PRE_E】
beta(2)-adrenoceptor	geneN
G-protein	geneN
【GOLD_R】
【PRE_R】

However , recent reports indicate that cAMP - specific PDE4 activity in eosinophils is 10 - fold that of other inflammatory cells .
【GOLD_E】
cAMP	chem
PDE4	chem
cAMP-specificPDE4	geneN
【PRE_E】
cAMP	chem
PDE4	geneN
【GOLD_R】
【PRE_R】

We postulated that selective blockade of PDE4 in eosinophils would unmask the inhibitory effect of beta ( 2 ) - adrenoceptor stimulation and that this inhibition would result from decreased phosphor - ylation of cytosolic group IV - PLA ( 2 ) ( gIV - PLA ( 2 ) ) .
【GOLD_E】
PDE4	chem
PDE4	geneN
beta(2)-adrenoceptor	geneY
cytosolicgroupIV-PLA(2)	geneN
gIV-PLA(2)	geneN
【PRE_E】
PDE4	geneN
beta(2)-adrenoceptor	geneN
IV-PLA(2)	geneY
gIV-PLA(2)	geneY
【GOLD_R】
【PRE_R】

OBJECTIVE : To determine ( a ) whether PDE4 inhibition alone with rolipram blocked secretions of arachidonic acid ( AA ) and leukotriene C ( 4 ) ( LTC ( 4 ) ) caused by activation of eosinophils with formyl - met - leu - phe plus cytochalasin B ( FMLP / B ) , ( b ) to determine if PDE4 inhibition plus beta ( 2 ) - adrenoceptor agonist act additively to augment endogenous cAMP concentration , and ( c ) to determine the mechanism by which additive inhibition of AA and LTC ( 4 ) synthesis is regulated by cAMP .
【GOLD_E】
cAMP	chem
PDE4	chem
rolipram	chem
arachidonicacid	chem
AA	chem
leukotrieneC(4)	chem
LTC(4)	chem
AA	chem
formyl-met-leu-phe	chem
cytochalasinB	chem
PDE4	chem
LTC(4)	chem
PDE4	geneN
cAMP	chem
PDE4	geneN
beta(2)-adrenoceptor	geneY
【PRE_E】
PDE4	geneN
rolipram	chem
arachidonicacid	chem
leukotrieneC(4)	chem
LTC(4)	chem
formyl-met-leu-phe	chem
cytochalasinB	chem
FMLP/B	geneN
PDE4	geneN
beta(2)-adrenoceptor	geneY
cAMP	chem
LTC(4)	chem
cAMP	chem
【GOLD_R】
rolipram	PDE4	C4
【PRE_R】
PDE4	rolipram	C4
PDE4	arachidonicacid	C4
formyl-met-leu-phe	PDE4	C4
cytochalasinB	PDE4	C4
cytochalasinB	beta(2)-adrenoceptor	C4

METHODS : Human eosinophils were pretreated with buffer , salmeterol or rolipram ( singly or combination ) before FMLP / B activation .
【GOLD_E】
salmeterol	chem
rolipram	chem
【PRE_E】
salmeterol	chem
rolipram	chem
FMLP/B	geneN
【GOLD_R】
【PRE_R】

Release of AA and LTC ( 4 ) , intracellular cAMP concentration , and phosphorylation and activation of gIV - PLA ( 2 ) were determined .
【GOLD_E】
gIV-PLA(2)	geneN
AA	chem
LTC(4)	chem
cAMP	chem
【PRE_E】
LTC(4)	chem
cAMP	chem
gIV-PLA(2)	geneY
【GOLD_R】
【PRE_R】

RESULTS : Rolipram unmasked the inhibitory effect of beta ( 2 ) - adrenoceptor stimulation with salmeterol and significantly attenuated the stimulated release of AA and subsequent LTC ( 4 ) .
【GOLD_E】
Rolipram	chem
salmeterol	chem
AA	chem
LTC(4)	chem
beta(2)-adrenoceptor	geneN
【PRE_E】
Rolipram	chem
beta(2)-adrenoceptor	geneY
salmeterol	chem
LTC(4)	geneY
【GOLD_R】
salmeterol	beta(2)-adrenoceptor	C3
【PRE_R】
Rolipram	beta(2)-adrenoceptor	C4
beta(2)-adrenoceptor	salmeterol	C4

Inhibition corresponded to increased cAMP production caused by rolipram alone or rolipram plus salmeterol and blocked proportionately the phosphorylation and activation of gIV - PLA ( 2 ) in FMLP / B - activated eosinophils .
【GOLD_E】
cAMP	chem
rolipram	chem
rolipram	chem
salmeterol	chem
gIV-PLA(2)	geneN
【PRE_E】
cAMP	chem
rolipram	chem
rolipram	chem
salmeterol	chem
gIV-PLA(2)	geneY
FMLP/B	geneN
【GOLD_R】
rolipram	gIV-PLA(2)	C4
salmeterol	gIV-PLA(2)	C4
【PRE_R】
salmeterol	gIV-PLA(2)	C3
salmeterol	FMLP/B	C3

CONCLUSIONS : Inhibition of PDE4 by rolipram unmasks beta ( 2 ) - adrenergic blockade of LTC ( 4 ) synthesis caused by FMLP / B .
【GOLD_E】
PDE4	chem
rolipram	chem
LTC(4)	chem
PDE4	geneN
beta(2)-adrenergic	geneY
【PRE_E】
PDE4	geneN
rolipram	chem
LTC(4)	chem
FMLP/B	geneN
【GOLD_R】
rolipram	PDE4	C4
【PRE_R】

A phase 1 study of tazarotene in adults with advanced cancer .
【GOLD_E】
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma .
【GOLD_E】
tazarotenicacid	chem
retinoidreceptors	geneN
RARbeta	geneY
RARgamma	geneY
Tazarotene	chem
retinoid	chem
acetylenicretinoid	chem
【PRE_E】
Tazarotene	chem
acetylenicretinoid	chem
tazarotenicacid	chem
retinoidreceptorsRARbeta	geneY
RARgamma	geneY
【GOLD_R】
【PRE_R】
Tazarotene	RARgamma	C4
acetylenicretinoid	RARgamma	C4

The safety , toxicity and pharmacokinetics of oral tazarotene were determined over 12 weeks of treatment in 34 patients with advanced cancer .
【GOLD_E】
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Commonly seen toxicities were mucocutaneous symptoms , musculoskeletal pain and headache .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Dose - limiting toxicities were hypercalcaemia , hypertriglyceridaemia and musculoskeletal pain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The maximum tolerated dose of tazarotene in this schedule is 25.2 mg day ( - 1 ) .
【GOLD_E】
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Plasma concentrations of tazarotenic acid were found to peak rapidly within 1 - 3 h of dosing and thereafter declined quickly .
【GOLD_E】
tazarotenicacid	chem
【PRE_E】
tazarotenicacid	chem
【GOLD_R】
【PRE_R】

The C ( max ) and AUC values on day 0 , and weeks 2 and 4 were similar indicating no drug accumulation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The dose - normalised C ( max ) and AUC values at different dose levels and different study days appeared to be similar indicating linear pharmacokinetics .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

No objective responses were seen , although stable disease was seen in six out of eight evaluable patients receiving the three highest dose levels of tazarotene ( 16.8 , 25.2 or 33.4 mg day ( - 1 ) ) .
【GOLD_E】
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

We conclude that oral tazarotene is well tolerated when administered daily for 12 weeks , has a favourable toxicity profile compared with other retinoids and merits further investigation as an anticancer therapy .
【GOLD_E】
tazarotene	chem
retinoids	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2 - adrenoceptor activation .
【GOLD_E】
clenbuterol	chem
beta2-adrenoceptor	geneY
【PRE_E】
clenbuterol	chem
beta2-adrenoceptor	geneY
【GOLD_R】
clenbuterol	beta2-adrenoceptor	C3
【PRE_R】
clenbuterol	beta2-adrenoceptor	C3

The potent anabolic effects of the beta 2 - adrenoceptor agonist clenbuterol on skeletal muscle have been reported to be independent of actions on beta - adrenoceptors .
【GOLD_E】
beta-adrenoceptors	geneN
beta2-adrenoceptor	geneY
clenbuterol	chem
【PRE_E】
beta2-adrenoceptor	geneY
clenbuterol	chem
beta-adrenoceptors	geneN
【GOLD_R】
clenbuterol	beta2-adrenoceptor	C5
【PRE_R】
beta2-adrenoceptor	clenbuterol	C5

In the present study clenbuterol , presented to rats in the diet ( 4 mg / kg ) , caused significant increases in gastrocnemius muscle mass , protein , and RNA content and a decrease in epididymal fat pad mass .
【GOLD_E】
clenbuterol	chem
【PRE_E】
clenbuterol	chem
【GOLD_R】
【PRE_R】

These effects were not mimicked by oral administration of the beta 2 - adrenoceptor agonist salbutamol even at high dose ( 52 mg / kg diet ) , and the effects of clenbuterol were not inhibited by addition of DL - propranolol ( 200 mg / kg diet ) .
【GOLD_E】
beta2-adrenoceptor	geneY
salbutamol	chem
clenbuterol	chem
DL-propranolol	chem
【PRE_E】
beta2-adrenoceptor	geneY
salbutamol	chem
clenbuterol	chem
DL-propranolol	chem
【GOLD_R】
salbutamol	beta2-adrenoceptor	C5
clenbuterol	beta2-adrenoceptor	C5
【PRE_R】
beta2-adrenoceptor	salbutamol	C5

However , the selective beta 2 - antagonist ICI - 118,551 ( 200 mg / kg diet ) reversed the anabolic effects of clenbuterol , and a high dose of DL - propranolol ( 1,000 mg / kg diet ) also inhibited these actions of clenbuterol .
【GOLD_E】
clenbuterol	chem
ICI-118,551	chem
clenbuterol	chem
DL-propranolol	chem
【PRE_E】
ICI-118,551	chem
clenbuterol	chem
DL-propranolol	chem
clenbuterol	chem
【GOLD_R】
【PRE_R】

Furthermore , continuous infusion of salbutamol ( 1.15 mg.kg body wt - 1.day - 1 ) via miniosmotic pumps did cause significant increases in muscle mass , protein , and RNA content .
【GOLD_E】
salbutamol	chem
【PRE_E】
salbutamol	chem
【GOLD_R】
【PRE_R】

These results indicate that the anabolic effects of clenbuterol are dependent on interaction with the beta 2 - adrenoceptor .
【GOLD_E】
beta2-adrenoceptor	geneY
clenbuterol	chem
【PRE_E】
clenbuterol	chem
beta2-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

However , a long duration of action appears to be required to induce the anabolic effects of beta 2 - agonists .
【GOLD_E】
【PRE_E】
beta2	geneY
【GOLD_R】
【PRE_R】

Evidence that an alpha 2A - adrenoceptor subtype mediates antinociception in mice .
【GOLD_E】
alpha2A-adrenoceptor	geneY
【PRE_E】
alpha2A-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

In the hot - plate test in mice , the antinociceptive action of the alpha 2 - adrenoceptor agonist , UK 14,304 , was abolished by the alpha 2 - adrenoceptor antagonist , idazoxan , the potent alpha 2A - adrenoceptor antagonist , RX 821002 and the preferential alpha 2A - adrenoceptor antagonist , BRL 44408 .
【GOLD_E】
UK14,304	chem
alpha2-adrenoceptor	geneN
alpha2A-adrenoceptor	geneY
alpha2A-adrenoceptor	geneY
alpha2-adrenoceptor	geneN
idazoxan	chem
RX821002	chem
BRL44408	chem
【PRE_E】
alpha2-adrenoceptor	geneN
14,304	chem
alpha2-adrenoceptor	geneN
idazoxan	chem
alpha2A-adrenoceptor	geneY
RX821002	chem
alpha2A-adrenoceptor	geneY
BRL44408	chem
【GOLD_R】
UK14,304	alpha2-adrenoceptor	C5
idazoxan	alpha2-adrenoceptor	C6
RX821002	alpha2A-adrenoceptor	C6
BRL44408	alpha2A-adrenoceptor	C6
【PRE_R】
alpha2-adrenoceptor	14,304	C6
14,304	alpha2-adrenoceptor	C6
alpha2-adrenoceptor	idazoxan	C6
idazoxan	alpha2A-adrenoceptor	C6
alpha2A-adrenoceptor	RX821002	C6
RX821002	alpha2A-adrenoceptor	C6
alpha2A-adrenoceptor	BRL44408	C6

In contrast , the preferential alpha 2B - ( and alpha 2C ) - adrenoceptor ligands ( ' antagonists ' ) , ARC - 239 , BRL 41992 and prazosin were inactive .
【GOLD_E】
alpha2B-(andalpha2C)-adrenoceptor	geneN
ARC-239	chem
BRL41992	chem
prazosin	chem
【PRE_E】
alpha2B-(andalpha2C)-adrenoceptor	geneN
ARC-239	chem
BRL41992	chem
prazosin	chem
【GOLD_R】
【PRE_R】

The preferential alpha 2A - adrenoceptor partial agonist , guanfacine , partially inhibited UK 14,304 - induced antinociception .
【GOLD_E】
alpha2A-adrenoceptor	geneY
guanfacine	chem
UK14,304	chem
【PRE_E】
alpha2A-adrenoceptor	geneY
guanfacine	chem
UK14,304	chem
【GOLD_R】
guanfacine	alpha2A-adrenoceptor	C5
UK14,304	alpha2A-adrenoceptor	C5
【PRE_R】

Further , guanfacine BRL 44408 reversibly elicited submaximal antinociception .
【GOLD_E】
BRL44408	chem
guanfacine	chem
【PRE_E】
BRL44408	chem
【GOLD_R】
【PRE_R】

It is concluded that alpha 2A - adrenoceptors mediate antinociception in mice .
【GOLD_E】
alpha2A-adrenoceptors	geneY
【PRE_E】
alpha2A-adrenoceptors	geneY
【GOLD_R】
【PRE_R】

Crystal structure of serine dehydratase from rat liver .
【GOLD_E】
serine	chem
serinedehydratase	geneY
【PRE_E】
serinedehydratase	geneY
【GOLD_R】
【PRE_R】

SDH ( L - serine dehydratase , EC 4.3.1.17 ) catalyzes the pyridoxal 5 ' - phosphate ( PLP ) - dependent dehydration of L - serine to yield pyruvate and ammonia .
【GOLD_E】
L-serine	chem
L-serine	chem
pyridoxal5'-phosphate	chem
pyruvate	chem
PLP	chem
SDH	geneY
EC4.3.1.17	geneY
(L-serinedehydratase	geneY
ammonia	chem
【PRE_E】
SDH	geneY
L-serinedehydratase	geneY
EC4.3.1.17	geneY
pyridoxal5'-phosphate	chem
PLP	chem
L-serine	chem
pyruvate	chem
ammonia	chem
【GOLD_R】
pyruvate	SDH	C9
pyruvate	EC4.3.1.17	C9
pyruvate	(L-serinedehydratase	C9
ammonia	SDH	C9
ammonia	EC4.3.1.17	C9
ammonia	(L-serinedehydratase	C9
L-serine	SDH	C9
L-serine	EC4.3.1.17	C9
L-serine	(L-serinedehydratase	C9
【PRE_R】
SDH	pyridoxal5'-phosphate	C9
EC4.3.1.17	pyridoxal5'-phosphate	C9
EC4.3.1.17	PLP	C9
EC4.3.1.17	L-serine	C9
EC4.3.1.17	pyruvate	C9
EC4.3.1.17	ammonia	C9

Liver SDH plays an important role in gluconeogenesis .
【GOLD_E】
SDH	geneY
【PRE_E】
SDH	geneY
gluconeogenesis	chem
【GOLD_R】
【PRE_R】

Formation of pyruvate by SDH is a two - step reaction in which the hydroxyl group of serine is cleaved to produce aminoacrylate , and then the aminoacrylate is deaminated by nonenzymatic hydrolysis to produce pyruvate .
【GOLD_E】
pyruvate	chem
hydroxyl	chem
serine	chem
aminoacrylate	chem
aminoacrylate	chem
pyruvate	chem
SDH	geneY
【PRE_E】
pyruvate	chem
SDH	geneY
hydroxyl	chem
serine	chem
aminoacrylate	chem
aminoacrylate	chem
pyruvate	chem
【GOLD_R】
pyruvate	SDH	C9
pyruvate	SDH	C9
aminoacrylate	SDH	C9
【PRE_R】
pyruvate	SDH	C9

The crystal structure of rat liver apo - SDH was determined by single isomorphous replacement at 2.8 A resolution .
【GOLD_E】
ratliverapo-SDH	geneY
【PRE_E】
ratliverapo-SDH	geneY
【GOLD_R】
【PRE_R】

The holo - SDH crystallized with O - methylserine ( OMS ) was also determined at 2.6 A resolution by molecular replacement .
【GOLD_E】
O-methylserine	chem
OMS	chem
holo-SDH	geneY
【PRE_E】
SDH	geneY
O-methylserine	chem
OMS	chem
【GOLD_R】
【PRE_R】

SDH is composed of two domains , and each domain has a typical alphabeta - open structure .
【GOLD_E】
SDH	geneY
【PRE_E】
SDH	geneY
【GOLD_R】
【PRE_R】

The active site is located in the cleft between the two domains .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The holo - SDH contained PLP - OMS aldimine in the active site , indicating that OMS can form the Schiff base linkage with PLP , but the subsequent dehydration did not occur .
【GOLD_E】
aldimine	chem
OMS	chem
Schiffbase	chem
PLP	chem
holo-SDH	geneY
【PRE_E】
SDH	geneY
PLP	chem
PLP	chem
【GOLD_R】
【PRE_R】

Apo - SDH forms a dimer by inserting the small domain into the catalytic cleft of the partner subunit so that the active site is closed .
【GOLD_E】
Apo-SDH	geneY
【PRE_E】
Apo	geneN
SDH	geneY
【GOLD_R】
【PRE_R】

Holo - SDH also forms a dimer by making contacts at the back of the clefts so that the dimerization does not close the catalytic cleft .
【GOLD_E】
Holo-SDH	geneY
【PRE_E】
SDH	geneY
【GOLD_R】
【PRE_R】

The phosphate group of PLP is surrounded by a characteristic G - rich sequence ( ( 168 ) GGGGL ( 172 ) ) and forms hydrogen bonds with the amide groups of those amino acid residues , suggesting that the phosphate group can be protonated .
【GOLD_E】
G-richsequence	geneN
PLP	chem
GGGGL	geneN
GGGGL	chem
hydrogen	chem
amide	chem
aminoacid	chem
phosphate	chem
【PRE_E】
phosphate	chem
PLP	chem
G	geneN
GGGGL	chem
hydrogen	chem
amide	chem
aminoacid	chem
phosphate	chem
【GOLD_R】
【PRE_R】

N ( 1 ) of PLP participates in a hydrogen bond with Cys303 , and similar hydrogen bonds with N ( 1 ) participating are seen in other beta - elimination enzymes .
【GOLD_E】
PLP	chem
hydrogen	chem
hydrogen	chem
【PRE_E】
N(1)	chem
PLP	chem
hydrogen	chem
Cys303	chem
hydrogen	chem
N(1)	chem
【GOLD_R】
【PRE_R】

These hydrogen bonding schemes indicate that N ( 1 ) is not protonated , and thus , the pyridine ring can not take a quinone - like structure .
【GOLD_E】
hydrogen	chem
pyridine	chem
quinone	chem
【PRE_E】
hydrogen	chem
N(1)	chem
protonated	chem
pyridine	chem
quinone	chem
【GOLD_R】
【PRE_R】

These characteristics of the bound PLP suggest that SDH catalysis is not facilitated by forming the resonance - stabilized structure of the PLP - Ser aldimine as seen in aminotransferases .
【GOLD_E】
PLP	chem
PLP-Seraldimine	chem
SDH	geneY
aminotransferases	geneN
【PRE_E】
PLP	chem
SDH	geneY
PLP	chem
Seraldimine	chem
aminotransferases	geneN
【GOLD_R】
【PRE_R】

A possible catalytic mechanism involves the phosphate group , surrounded by the characteristic sequence , acting as a general acid to donate a proton to the leaving hydroxyl group of serine .
【GOLD_E】
phosphate	chem
hydroxyl	chem
serine	chem
【PRE_E】
phosphate	chem
hydroxyl	chem
serine	chem
【GOLD_R】
【PRE_R】

Epidermal growth factor receptor autocrine signaling in RIE - 1 cells transformed by the Ras oncogene enhances radiation resistance .
【GOLD_E】
Epidermalgrowthfactorreceptor	geneY
Ras	geneN
【PRE_E】
Epidermalgrowthfactorreceptor	geneY
Ras	geneN
【GOLD_R】
【PRE_R】

Oncogenic forms of the small GTPase Ras increase the resistance of cells to killing by ionizing radiation ( IR ) .
【GOLD_E】
GTPase	geneN
Ras	geneN
【PRE_E】
GTPase	geneN
Ras	geneN
【GOLD_R】
【PRE_R】

Although not all of the signaling pathways for radioresistance are well defined , it is now clear that Ras - dependent signaling pathways involved in radioresistance include those mediated by phosphatidylinositol 3 ' - kinase ( PI3 - K ) and Raf .
【GOLD_E】
Ras	geneN
phosphatidylinositol3'-kinase	geneN
PI3-K	geneN
Raf	geneN
phosphatidylinositol	chem
【PRE_E】
Ras	geneN
phosphatidylinositol3'-kinase	geneN
PI3-K	geneY
Raf	geneN
【GOLD_R】
【PRE_R】

Nevertheless , PI3 - K and Raf together are not sufficient to reconstitute all of the resistance conferred by Ras , indicating that other effectors must also contribute .
【GOLD_E】
PI3-K	geneN
Raf	geneN
Ras	geneN
【PRE_E】
PI3-K	geneY
Raf	geneN
Ras	geneN
【GOLD_R】
【PRE_R】

We show here that Ras - driven autocrine signaling through the epidermal growth factor receptor ( EGFR ) also contributes to radioresistance in Ras - transformed cells .
【GOLD_E】
Ras	geneN
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
Ras	geneN
【PRE_E】
Ras	geneN
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
Ras	geneN
【GOLD_R】
【PRE_R】

Conditioned media ( CM ) collected from RIE - 1 rat intestinal epithelial cells expressing oncogenic Ras increased the survival of irradiated cells .
【GOLD_E】
Ras	geneN
【PRE_E】
Ras	geneN
【GOLD_R】
【PRE_R】

Ras - CM contains elevated levels of the EGFR ligand transforming growth factor alpha ( TGF - alpha ) .
【GOLD_E】
Ras	geneN
EGFR	geneY
transforminggrowthfactoralpha	geneY
TGF-alpha	geneY
【PRE_E】
Ras	geneN
EGFR	geneY
transforminggrowthfactoralpha	geneY
TGF-alpha	geneY
【GOLD_R】
【PRE_R】

Both Ras - CM and TGF - alpha stimulated EGFR phosphorylation , and exogenous TGF - alpha mimicked the effects of Ras - CM to increase radioresistance .
【GOLD_E】
Ras	geneN
TGF-alpha	geneY
EGFR	geneY
TGF-alpha	geneY
Ras	geneN
【PRE_E】
Ras	geneN
TGF-alpha	geneY
EGFR	geneY
TGF-alpha	geneY
Ras	geneN
【GOLD_R】
【PRE_R】

Blocking EGFR signaling with the EGFR / HER - 2 kinase inhibitor ( KI ) GW572016 decreased the postradiation survival of irradiated Ras - transformed cells and normal cells but had no effect on the survival of unirradiated cells .
【GOLD_E】
Ras	geneN
GW572016	chem
EGFR	geneY
EGFR	geneY
HER-2	geneY
【PRE_E】
EGFR	geneY
EGFR	geneY
HER-2kinase	geneN
GW572016	chem
Ras	geneN
【GOLD_R】
GW572016	Ras	C4
GW572016	EGFR	C4
GW572016	EGFR	C4
GW572016	HER-2	C4
【PRE_R】
EGFR	GW572016	C4
EGFR	GW572016	C4
HER-2kinase	GW572016	C4
GW572016	Ras	C4

Ras - CM and TGF - alpha also increase PI3 - K activity downstream of the EGFR and increase postradiation survival , both of which are abrogated by GW572016 .
【GOLD_E】
Ras	geneN
TGF-alpha	geneY
PI3-K	geneN
EGFR	geneY
GW572016	chem
【PRE_E】
Ras-CM	geneY
TGF-alpha	geneY
PI3-K	geneY
EGFR	geneY
GW572016	chem
【GOLD_R】
GW572016	PI3-K	C4
GW572016	EGFR	C4
【PRE_R】
Ras-CM	GW572016	C4
TGF-alpha	GW572016	C4
PI3-K	GW572016	C4
EGFR	GW572016	C4

Thus , Ras utilizes autocrine signaling through EGFR to increase radioresistance , and the EGFR KI GW572016 acts as a radiosensitizer .
【GOLD_E】
Ras	geneN
EGFR	geneY
EGFR	geneY
GW572016	chem
【PRE_E】
Ras	geneN
EGFR	geneY
EGFR	geneY
GW572016	chem
【GOLD_R】
GW572016	Ras	C4
GW572016	EGFR	C4
【PRE_R】
Ras	GW572016	C4
EGFR	GW572016	C4

The observation that Ras - transformed cells can be sensitized to killing by ionizing radiation with GW572016 demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras - driven autocrine signaling through EGFR .
【GOLD_E】
Ras	geneN
EGFR	geneY
Ras	geneN
EGFR	geneY
GW572016	chem
【PRE_E】
Ras	geneN
GW572016	chem
EGFR	geneY
KIs	geneN
Ras	geneN
EGFR	geneY
【GOLD_R】
GW572016	Ras	C4
GW572016	EGFR	C4
【PRE_R】

Characterization of beta 3 - adrenoceptor - mediated relaxation in rat abdominal aorta smooth muscle .
【GOLD_E】
beta3-adrenoceptor	geneY
【PRE_E】
beta3-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

The present study was carried out to characterize beta - adrenoceptor subtypes mediating relaxation of rat abdominal aorta smooth muscle .
【GOLD_E】
beta-adrenoceptor	geneN
【PRE_E】
beta-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

( - ) - Isoprenaline and a nonconventional beta ( 3 ) - adrenoceptor agonist , ( + / - ) - [ 4 - [ 3 - [ ( 1,1 - dimethylethyl ) amino ] - 2 - hydroxypropoxy ] - 1,3 - dihydro - 2H - benzimida zol - 2 - one ] hydrochloride ( ( + / - ) - CGP12177A ) , induced concentration - dependent relaxation of ( - ) - phenylephrine ( 0.3 microM ) preconstricted spiral preparations .
【GOLD_E】
beta(3)-adrenoceptor	geneY
(-)-Isoprenaline	chem
(+/-)-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one]hydrochloride	chem
(+/-)-CGP12177A	chem
(-)-phenylephrine	chem
【PRE_E】
(-)-Isoprenaline	chem
beta(3)-adrenoceptor	geneY
(+/-)-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one]hydrochloride	chem
(+/-)-CGP12177A	chem
(-)-phenylephrine	chem
【GOLD_R】
(+/-)-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one]hydrochloride	beta(3)-adrenoceptor	C5
(+/-)-CGP12177A	beta(3)-adrenoceptor	C5
【PRE_R】

Pretreatment with a combination of ( + / - ) - 2 - hydroxy - 5 - [ 2 - [ [ 2 - hydroxy - 3 - [ 4 - [ 1 - methyl - 4 - ( trifluoromethyl ) - 1H - imidazol - 2 - yl ] phenoxy ] propyl ] amino ] ethoxy ] - benzamide methanesulfonate ( CGP20712A , a selective beta ( 1 ) - adrenoceptor antagonist ) and ( + / - ) - 1 - [ 2,3 - ( dihydro - 7 - methyl - 1H - inden - 4 - yl ) oxy ] - 3 - [ ( 1 - methylethyl ) amino ] - 2 - buta nol hydrochloride ( ICI - 118,5511 , a selective beta ( 2 ) - adrenoceptor antagonist ) ( 0.1 microM for each ) produced a 14 - fold rightward shift of the concentration - response curve for ( - ) - isoprenaline ; however , the relaxation in response to ( + / - ) - CGP12177A was unaffected by the blockade of beta ( 1 ) - and beta ( 2 ) - adrenoceptors .
【GOLD_E】
(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamidemethanesulfonate	chem
CGP20712A	chem
(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanolhydrochloride	chem
ICI-118,5511	chem
(-)-isoprenaline	chem
(+/-)-CGP12177A	chem
beta(1)-andbeta(2)-adrenoceptors	geneN
beta(1)-adrenoceptor	geneY
beta(2)-adrenoceptor	geneY
【PRE_E】
(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamidemethanesulfonate	chem
CGP20712A	chem
beta(1)-adrenoceptor	geneY
(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanolhydrochloride	chem
【GOLD_R】
(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamidemethanesulfonate	beta(1)-adrenoceptor	C6
CGP20712A	beta(1)-adrenoceptor	C6
(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanolhydrochloride	beta(2)-adrenoceptor	C6
ICI-118,5511	beta(2)-adrenoceptor	C6
【PRE_R】
CGP20712A	beta(1)-adrenoceptor	C6
beta(1)-adrenoceptor	(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanolhydrochloride	C6

In the presence of CGP20712A and ICI - 118,551 ( 0.1 microM for each ) , the concentration - response curves for ( - ) - isoprenaline and ( + / - ) - CGP12177A were shifted to the right by a nonselective beta ( 1 ) - , beta ( 2 ) - and beta ( 3 ) - adrenoceptor antagonist , ( + / - ) - bupranolol ( 3 and 10 microM ) .
【GOLD_E】
beta(1)-,beta(2)-andbeta(3)-adrenoceptor	geneN
CGP20712A	chem
ICI-118,551	chem
(-)-isoprenaline	chem
(+/-)-CGP12177A	chem
(+/-)-bupranolol	chem
【PRE_E】
CGP20712A	chem
ICI-118,551	chem
(-)-isoprenaline	chem
(+/-)-CGP12177A	chem
beta(1)-,beta(2)-andbeta(3)-adrenoceptor	geneN
(+/-)-bupranolol	chem
【GOLD_R】
【PRE_R】
CGP20712A	beta(1)-,beta(2)-andbeta(3)-adrenoceptor	C6
ICI-118,551	beta(1)-,beta(2)-andbeta(3)-adrenoceptor	C6
(-)-isoprenaline	beta(1)-,beta(2)-andbeta(3)-adrenoceptor	C6
(+/-)-CGP12177A	beta(1)-,beta(2)-andbeta(3)-adrenoceptor	C6
beta(1)-,beta(2)-andbeta(3)-adrenoceptor	(+/-)-bupranolol	C6

These results clearly suggest that beta ( 3 ) - adrenoceptors are involved in beta - adrenoceptor - mediated relaxation of rat abdominal aorta smooth muscle .
【GOLD_E】
beta(3)-adrenoceptors	geneY
beta-adrenoceptor	geneN
【PRE_E】
beta(3)-adrenoceptors	geneN
beta-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

Use of the norepinephrine transporter as a reporter gene for non - invasive imaging of genetically modified cells .
【GOLD_E】
norepinephrine	chem
norepinephrinetransporter	geneY
【PRE_E】
norepinephrinetransporter	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : The norepinephrine transporter ( NET ) is a high - affinity transporter for catecholamines .
【GOLD_E】
norepinephrinetransporter	geneY
NET	geneY
norepinephrine	chem
catecholamines	chem
【PRE_E】
norepinephrinetransporter	geneY
NET	geneY
catecholamines	chem
【GOLD_R】
【PRE_R】

Its expression is almost exclusively restricted to the sympathetic nervous system .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study we evaluated whether the NET can be used as a reporter gene for non - invasive imaging of genetically modified cells with radiolabeled probes .
【GOLD_E】
NET	geneY
【PRE_E】
NET	geneY
【GOLD_R】
【PRE_R】

METHODS : Human A431 , HT1080 and murine CMS - 5 cells were retrovirally transduced with bovine NET cDNA .
【GOLD_E】
bovineNET	geneY
【PRE_E】
bovineNET	geneY
【GOLD_R】
【PRE_R】

Transduced and parental cells were incubated in vitro with [ ( 131 ) I ] meta - iodobenzylguanidine ( [ ( 131 ) I ] MIBG ) .
【GOLD_E】
[(131)I]meta-iodobenzylguanidine	chem
[(131)I]MIBG	chem
【PRE_E】
[(131)I]meta-iodobenzylguanidine	chem
[(131)I]MIBG	chem
【GOLD_R】
【PRE_R】

The specificity of tracer uptake was determined by adding the NET inhibitor imipramine .
【GOLD_E】
NET	geneY
imipramine	chem
【PRE_E】
NET	geneY
imipramine	chem
【GOLD_R】
imipramine	NET	C4
【PRE_R】
NET	imipramine	C4

Rat PC12 cells served as positive controls .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Parental and A431NET cells were xenotransplanted into nude mice and tumor uptake of [ ( 123 ) I ] MIBG in vivo was determined after tracer administration .
【GOLD_E】
NET	geneY
[(123)I]MIBG	chem
【PRE_E】
[(123)I]MIBG	chem
【GOLD_R】
【PRE_R】

RESULTS : In vitro stably transduced cells showed a 66 - to 120 - fold higher [ ( 131 ) I ] MIBG uptake than parental cells .
【GOLD_E】
[(131)I]MIBG	chem
【PRE_E】
[(131)I]MIBG	chem
【GOLD_R】
【PRE_R】

Incubation with imipramine reduced [ ( 131 ) I ] MIBG uptake of transduced cells to the level found in parental cells .
【GOLD_E】
imipramine	chem
[(131)I]MIBG	chem
【PRE_E】
imipramine	chem
[(131)I]MIBG	chem
【GOLD_R】
【PRE_R】

More than 70 % of the initial radioactivity was retained in all transduced cell lines after 2 h incubation with tracer - free medium .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

[ ( 131 ) I ] MIBG uptake in PC12 cells , which express the NET endogenously , was 20 - to 28 - fold lower than in transduced cells .
【GOLD_E】
NET	geneY
[(131)I]MIBG	chem
【PRE_E】
[(131)I]MIBG	chem
NET	geneY
【GOLD_R】
[(131)I]MIBG	NET	C9
【PRE_R】

In vivo , A431NET tumors demonstrated a 33 - fold higher [ ( 123 ) I ] MIBG uptake than parental tumors .
【GOLD_E】
NET	geneY
[(123)I]MIBG	chem
【PRE_E】
[(123)I]MIBG	chem
【GOLD_R】
[(123)I]MIBG	NET	C9
【PRE_R】

Gamma camera images 24 h after tracer injection showed no tracer uptake in parental A431 tumors , but clear images of A431NET tumors .
【GOLD_E】
NET	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : Transduction of tumor cells with NET cDNA causes highly specific uptake and significant retention of catecholamine analogs in vitro and in vivo .
【GOLD_E】
NET	geneY
catecholamine	chem
【PRE_E】
NET	geneY
catecholamine	chem
【GOLD_R】
【PRE_R】

These characteristics make the NET suitable as a reporter gene for non - invasive monitoring of gene transfer .
【GOLD_E】
NET	geneY
【PRE_E】
NET	geneY
【GOLD_R】
【PRE_R】

Comparative pharmacology of human beta - adrenergic receptor subtypes - - characterization of stably transfected receptors in CHO cells .
【GOLD_E】
humanbeta-adrenergicreceptor	geneN
【PRE_E】
humanbeta-adrenergicreceptor	geneY
【GOLD_R】
【PRE_R】

Although many beta1 - receptor antagonists and beta2 - receptor agonists have been used in pharmacotherapy for many years their pharmacological properties at all three known subtypes of beta - adrenergic receptors are not always well characterized .
【GOLD_E】
beta1-receptor	geneY
beta-adrenergicreceptors	geneN
beta2-receptor	geneY
【PRE_E】
beta1-receptor	geneN
beta2-receptor	geneY
beta-adrenergicreceptors	geneN
【GOLD_R】
【PRE_R】

The aim of this study was , therefore , to provide comparative binding characteristics of agonists ( epinephrine , norepinephrine , isoproterenol , fenoterol , salbutamol , salmeterol , terbutalin , formoterol , broxaterol ) and antagonists ( propranolol , alprenolol , atenolol , metoprolol , bisoprolol , carvedilol , pindolol , BRL 37344 , CGP 20712 , SR 59230A , CGP 12177 , ICI 118551 ) at all three subtypes of human beta - adrenergic receptors in an identical cellular background .
【GOLD_E】
formoterol	chem
broxaterol	chem
propranolol	chem
alprenolol	chem
atenolol	chem
metoprolol	chem
bisoprolol	chem
carvedilol	chem
pindolol	chem
BRL37344	chem
CGP20712	chem
SR59230A	chem
CGP12177	chem
ICI118551	chem
humanbeta-adrenergicreceptors	geneN
epinephrine	chem
norepinephrine	chem
isoproterenol	chem
fenoterol	chem
salbutamol	chem
salmeterol	chem
terbutalin	chem
【PRE_E】
epinephrine	chem
norepinephrine	chem
isoproterenol	chem
fenoterol	chem
salbutamol	chem
salmeterol	chem
terbutalin	chem
formoterol	chem
broxaterol	chem
propranolol	chem
alprenolol	chem
atenolol	chem
metoprolol	chem
bisoprolol	chem
carvedilol	chem
pindolol	chem
BRL37344	chem
CGP20712	chem
SR59230A	chem
CGP12177	chem
ICI118551	chem
humanbeta-adrenergicreceptors	geneY
【GOLD_R】
formoterol	humanbeta-adrenergicreceptors	C5
broxaterol	humanbeta-adrenergicreceptors	C5
epinephrine	humanbeta-adrenergicreceptors	C5
norepinephrine	humanbeta-adrenergicreceptors	C5
isoproterenol	humanbeta-adrenergicreceptors	C5
fenoterol	humanbeta-adrenergicreceptors	C5
salbutamol	humanbeta-adrenergicreceptors	C5
salmeterol	humanbeta-adrenergicreceptors	C5
terbutalin	humanbeta-adrenergicreceptors	C5
propranolol	humanbeta-adrenergicreceptors	C6
alprenolol	humanbeta-adrenergicreceptors	C6
atenolol	humanbeta-adrenergicreceptors	C6
metoprolol	humanbeta-adrenergicreceptors	C6
bisoprolol	humanbeta-adrenergicreceptors	C6
carvedilol	humanbeta-adrenergicreceptors	C6
pindolol	humanbeta-adrenergicreceptors	C6
BRL37344	humanbeta-adrenergicreceptors	C6
CGP20712	humanbeta-adrenergicreceptors	C6
SR59230A	humanbeta-adrenergicreceptors	C6
CGP12177	humanbeta-adrenergicreceptors	C6
ICI118551	humanbeta-adrenergicreceptors	C6
【PRE_R】

We generated Chinese hamster ovary ( CHO ) cells stably expressing the three beta - adrenergic receptor subtypes at comparable levels .
【GOLD_E】
beta-adrenergicreceptor	geneN
【PRE_E】
beta-adrenergicreceptor	geneN
【GOLD_R】
【PRE_R】

We characterized these receptor subtypes and analyzed the affinity of routinely used drugs as well as experimental compounds in competition binding studies , using the non - selective antagonist 125I - cyanopindolol as a radioligand .
【GOLD_E】
125I-cyanopindolol	chem
【PRE_E】
125I-cyanopindolol	chem
【GOLD_R】
【PRE_R】

Furthermore , we analyzed the beta - receptor - mediated adenylyl cyclase activity in isolated membranes from these cell lines .
【GOLD_E】
beta-receptor	geneN
adenylylcyclase	geneN
adenylyl	chem
【PRE_E】
beta-receptor	geneY
adenylylcyclase	geneN
【GOLD_R】
【PRE_R】

The results from our experiments show that all compounds exhibit distinct patterns of selectivity and activity at the three beta - receptor subtypes .
【GOLD_E】
beta-receptor	geneN
【PRE_E】
beta-receptor	geneN
【GOLD_R】
【PRE_R】

In particular , a number of beta2 - or beta3 - receptor agonists that are inverse agonists at the other subtypes were identified .
【GOLD_E】
beta2-orbeta3-receptor	geneN
【PRE_E】
beta2-orbeta3-receptor	geneN
【GOLD_R】
【PRE_R】

In addition , beta1 - receptor antagonists with agonistic activity at beta2 - and beta3 - receptors were found .
【GOLD_E】
beta1-receptor	geneY
beta2-andbeta3-receptors	geneN
【PRE_E】
beta1-receptor	geneY
beta2-andbeta3-receptors	geneN
【GOLD_R】
【PRE_R】

These specific mixtures of agonism , antagonism , and inverse agonism at different subtypes may have important implications for the therapeutic use of the respective compounds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ocular hypotensive FP prostaglandin ( PG ) analogs : PG receptor subtype binding affinities and selectivities , and agonist potencies at FP and other PG receptors in cultured cells .
【GOLD_E】
PG	chem
prostaglandin	chem
PG	chem
PG	chem
FP	geneY
PGreceptors	geneN
PGreceptor	geneN
【PRE_E】
FPprostaglandin	chem
FPandotherPGreceptors	geneN
【GOLD_R】
【PRE_R】

Natural prostaglandins ( PGs ) such as PGD2 , PGE2 , PGF2 ( 2alpha ) , and PGI2 exhibited the highest affinity for their respective cognate receptors , but were the least selective agents when tested in receptor binding assays .
【GOLD_E】
PGs	chem
PGD2	chem
PGE2	chem
PGF2(2alpha)	chem
PGI2	chem
prostaglandins	chem
【PRE_E】
prostaglandins	chem
PGs	chem
PGD2	chem
PGE2	chem
PGF2	chem
2alpha	chem
PGI2	chem
【GOLD_R】
【PRE_R】

Travoprost acid ( [ + ] - fluprostenol ) was the most FP - receptor - selective compound , exhibiting a high affinity ( Ki = 35 + / - 5 nM ) for the FP receptor , and minimal affinity for DP ( Ki = 52,000 nM ) , EP1 ( Ki = 9540 nM ) , EP3 ( Ki = 3501 nM ) , EP4 ( Ki = 41,000 nM ) , IP ( Ki > 90,000 nM ) , and TP ( Ki = 121,000 nM ) receptors .
【GOLD_E】
FP-receptor	geneY
FPreceptor	geneY
DP	geneN
EP1	geneY
EP3	geneY
EP4	geneY
IP	geneY
TP	geneY
Travoprostacid	chem
[+]-fluprostenol	chem
【PRE_E】
Travoprostacid	chem
[+]-fluprostenol	chem
FP-receptor	geneY
FPreceptor	geneY
DP	geneY
EP1	geneY
EP3	geneY
EP4	geneY
TP	geneY
【GOLD_R】
【PRE_R】

Travoprost acid was the most potent PG analog tested in FP receptor functional phosphoinositide turnover assays in the following cell types : human ciliary muscle ( EC50 = 1.4 nM ) , human trabecular meshwork ( EC50 = 3.6 nM ) , and mouse fibroblasts and rat aortic smooth muscle cells ( EC50 = 2.6 nM ) .
【GOLD_E】
Travoprostacid	chem
PG	chem
phosphoinositide	chem
FPreceptor	geneY
【PRE_E】
Travoprostacid	chem
FPreceptor	geneY
phosphoinositide	chem
【GOLD_R】
【PRE_R】

Although latanoprost acid exhibited a relatively high affinity for the FP receptor ( Ki = 98 nM ) , it had significant functional activity at FP ( EC50 = 32 - 124 nM ) and EP1 ( EC50 = 119 nM ) receptors .
【GOLD_E】
latanoprostacid	chem
FPreceptor	geneY
FP	geneY
EP1	geneY
【PRE_E】
latanoprostacid	chem
FPreceptor	geneY
EP1(EC50=119nM)receptors	geneN
【GOLD_R】
【PRE_R】

Bimatoprost acid was less selective , exhibiting a relatively high affinity for the FP ( Ki = 83 nM ) , EP1 ( Ki = 95 nM ) , and EP3 ( Ki = 387 nM ) receptors .
【GOLD_E】
Bimatoprostacid	chem
FP	geneY
EP1	geneY
EP3	geneY
【PRE_E】
Bimatoprostacid	chem
EP1	geneY
EP3(Ki=387nM)receptors	geneN
【GOLD_R】
【PRE_R】

Bimatoprost acid exhibited functional activity at the EP1 ( EC50 = 2.7 nM ) and FP ( EC50 = 2.8 - 3.8 nM in most cells ) receptors .
【GOLD_E】
EP1	geneN
FP	geneY
Bimatoprostacid	chem
【PRE_E】
Bimatoprostacid	chem
EP1	geneY
【GOLD_R】
【PRE_R】

Bimatoprost ( nonhydrolyzed amide ) also behaved as an FP agonist at the cloned human FP receptor ( EC50 = 681 nM ) , in h - TM ( EC50 = 3245 nM ) and other cell types .
【GOLD_E】
FP	geneY
humanFPreceptor	geneY
Bimatoprost	chem
【PRE_E】
Bimatoprost	chem
nonhydrolyzedamide	chem
FP	geneY
humanFPreceptor	geneY
【GOLD_R】
【PRE_R】
Bimatoprost	FP	C6

Unoprostone and S - 1033 bound with low affinity ( Ki = 5.9 microM to > 22 microM ) to the FP receptor , were not selective , but activated the FP receptor .
【GOLD_E】
FPreceptor	geneY
FPreceptor	geneY
Unoprostone	chem
S-1033	chem
【PRE_E】
Unoprostone	chem
S-1033	chem
FPreceptor	geneY
FPreceptor	geneY
【GOLD_R】
【PRE_R】

In conclusion , travoprost acid has the highest affinity , the highest FP - receptor - selectivity , and the highest potency at the FP receptor as compared to the other ocular hypotensive PG analogs known so far , including free acids of latanoprost , bimatoprost , and unoprostone isopropyl ester .
【GOLD_E】
FP-receptor	geneY
FPreceptor	geneY
travoprostacid	chem
freeacidsoflatanoprost,bimatoprost,andunoprostoneisopropylester	chem
【PRE_E】
travoprostacid	chem
FP-receptor	geneY
FPreceptor	geneY
acids	chem
latanoprost	chem
bimatoprost	chem
unoprostoneisopropylester	chem
【GOLD_R】
【PRE_R】
travoprostacid	FPreceptor	C4
FPreceptor	unoprostoneisopropylester	C4

Loss of beta - adrenoceptor response in myocytes overexpressing the Na + / Ca ( 2 + ) - exchanger .
【GOLD_E】
Na+/Ca(2+)-exchanger	geneN
beta-adrenoceptor	geneN
Na+	chem
Ca(2+)	chem
【PRE_E】
beta-adrenoceptor	geneN
Na+/Ca(2+)-exchanger	geneN
【GOLD_R】
【PRE_R】

Increased Na + / Ca ( 2 + ) - exchanger ( NCX ) and altered beta - adrenoceptor ( betaAR ) responses are observed in failing human heart .
【GOLD_E】
NCX	geneN
beta-adrenoceptor	geneN
Na+	chem
betaAR	geneN
Ca(2+)	chem
Na+/Ca(2+)-exchanger	geneN
【PRE_E】
Na+/Ca(2+)-exchanger	geneN
NCX	geneN
beta-adrenoceptor	geneY
betaAR	geneN
【GOLD_R】
【PRE_R】

To determine the possible interaction between these changes , we investigated the effect of NCX overexpression on responses to isoproterenol in adult rat ventricular myocytes .
【GOLD_E】
NCX	geneN
【PRE_E】
NCX	geneN
isoproterenol	chem
【GOLD_R】
【PRE_R】

Responses to isoproterenol were largely mediated through the beta1AR in control myocytes .
【GOLD_E】
beta1AR	geneY
isoproterenol	chem
【PRE_E】
isoproterenol	chem
beta1AR	geneY
【GOLD_R】
【PRE_R】

Adenovirally - mediated overexpression of NCX , at levels , which did not alter basal contraction of myocytes , markedly depressed the isoproterenol concentration - response curve .
【GOLD_E】
NCX	geneN
isoproterenol	chem
【PRE_E】
Adenovirally	geneY
NCX	geneN
isoproterenol	chem
【GOLD_R】
【PRE_R】

Responses to isoproterenol could be restored to normal by beta2AR blockade , suggesting a beta2AR - mediated inhibition of beta1AR signalling .
【GOLD_E】
beta2AR	geneY
beta2AR	geneY
beta1AR	geneY
isoproterenol	chem
【PRE_E】
isoproterenol	chem
beta2AR	geneY
beta2AR	geneY
beta1AR	geneY
【GOLD_R】
【PRE_R】

Pertussis toxin normalised isoproterenol responses in NCX cells , indicating that beta2AR effects were mediated by Gi .
【GOLD_E】
Pertussistoxin	geneN
NCX	geneN
beta2AR	geneY
Gi	geneN
isoproterenol	chem
【PRE_E】
Pertussistoxin	geneN
isoproterenol	chem
NCX	geneN
beta2AR	geneY
Gi	geneN
【GOLD_R】
【PRE_R】

Negative - inotropic effects of high concentrations of ICI 118,551 , previously shown to be due to beta2AR - Gi coupling , were increased in NCX cells .
【GOLD_E】
beta2AR	geneY
Gi	geneN
NCX	geneN
【PRE_E】
ICI118,551	chem
beta2AR	geneY
Gi	geneN
NCX	geneN
【GOLD_R】
【PRE_R】

We conclude that NCX upregulation can markedly alter the consequences of betaAR stimulation and that this may contribute to the alterations in betaAR response seen in failing human heart .
【GOLD_E】
betaAR	geneN
betaAR	geneN
NCX	geneN
【PRE_E】
NCX	geneN
betaAR	geneN
betaAR	geneN
【GOLD_R】
【PRE_R】

Manipulation of kinetic profiles in 2 - aryl propionic acid cyclooxygenase inhibitors .
【GOLD_E】
cyclooxygenase	geneN
2-arylpropionicacid	chem
【PRE_E】
2-arylpropionicacidcyclooxygenase	geneN
【GOLD_R】
2-arylpropionicacid	cyclooxygenase	C4
【PRE_R】

The nonsteroidal anti - inflammatory drugs flurbiprofen and ibuprofen were modified in an attempt to alter the kinetics of inhibitor binding by COX - 1 .
【GOLD_E】
flurbiprofen	chem
ibuprofen	chem
COX-1	geneY
【PRE_E】
flurbiprofen	chem
ibuprofen	chem
COX-1	geneY
【GOLD_R】
【PRE_R】
flurbiprofen	COX-1	C4
ibuprofen	COX-1	C4

Contrary to prior predictions , a halogen substituent is not sufficient to confer slow tight - binding behavior .
【GOLD_E】
halogen	chem
【PRE_E】
halogen	chem
【GOLD_R】
【PRE_R】

Conversion of the carboxylate moiety of flurbiprofen to an ester or amide abolishes slow tight - binding behavior , regardless of halogenation state .
【GOLD_E】
carboxylate	chem
flurbiprofen	chem
ester	chem
amide	chem
【PRE_E】
carboxylate	chem
flurbiprofen	chem
ester	chem
amide	chem
halogenation	chem
【GOLD_R】
【PRE_R】

Effects of the EGFR / HER2 kinase inhibitor GW572016 on EGFR - and HER2 - overexpressing breast cancer cell line proliferation , radiosensitization , and resistance .
【GOLD_E】
GW572016	chem
EGFR	geneY
HER2	geneY
kinase	geneN
EGFR	geneY
HER2	geneY
【PRE_E】
EGFR	geneY
HER2	geneY
kinase	geneN
GW572016	chem
EGFR	geneY
HER2	geneY
【GOLD_R】
GW572016	EGFR	C4
GW572016	HER2	C4
GW572016	kinase	C4
【PRE_R】
EGFR	GW572016	C4
HER2	GW572016	C4
kinase	GW572016	C4

PURPOSE : Two members of the epidermal growth factor receptor family , EGFR and HER2 , have been implicated in radioresistance in breast cancer and other malignancies .
【GOLD_E】
EGFR	geneY
HER2	geneY
【PRE_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
HER2	geneY
【GOLD_R】
【PRE_R】

To gauge the potential clinical utility of targeting both EGFR and HER2 to control growth and radiosensitize human breast cancers , we examined the effect of a dual EGFR / HER2 inhibitor , GW572016 , on the proliferation and radiation response of either EGFR - or HER2 - overexpressing human breast cancer cell lines .
【GOLD_E】
EGFR	geneY
HER2	geneY
EGFR	geneY
HER2	geneY
EGFR	geneY
HER2	geneY
GW572016	chem
【PRE_E】
EGFR	geneY
HER2	geneY
EGFR	geneY
HER2	geneY
GW572016	chem
EGFR	geneY
HER2	geneY
【GOLD_R】
GW572016	EGFR	C4
GW572016	HER2	C4
【PRE_R】
HER2	GW572016	C4

METHODS AND MATERIALS : Primary human breast cancer cell lines that endogenously overexpress EGFR or HER2 and luminal mammary epithelial H16N2 cells stably transfected with HER2 were evaluated for the effect of GW572016 on inhibition of ligand - induced or constitutive receptor phosphorylation , proliferation , radiosensitization , and inhibition of downstream signaling .
【GOLD_E】
EGFR	geneY
HER2	geneY
HER2	geneY
constitutivereceptor	geneN
GW572016	chem
【PRE_E】
EGFR	geneY
HER2	geneY
HER2	geneY
GW572016	chem
constitutivereceptor	geneN
【GOLD_R】
【PRE_R】
GW572016	constitutivereceptor	C4

RESULTS : GW572016 inhibited constitutive and / or ligand - induced EGFR or HER2 tyrosine phosphorylation of all five cell lines , which correlated with the antiproliferative response in all but one cell line .
【GOLD_E】
tyrosine	chem
EGFR	geneY
HER2	geneY
GW572016	chem
【PRE_E】
GW572016	chem
EGFR	geneY
HER2	geneY
tyrosine	chem
【GOLD_R】
GW572016	EGFR	C4
GW572016	HER2	C4
【PRE_R】
GW572016	EGFR	C4

GW572016 radiosensitized EGFR - overexpressing cell lines , but HER2 - overexpressing cells were unable to form colonies after brief exposure to GW572016 even in the absence of radiation , and thus could not be evaluated for radiosensitization .
【GOLD_E】
EGFR	geneY
HER2	geneY
GW572016	chem
GW572016	chem
【PRE_E】
GW572016	chem
EGFR	geneY
HER2	geneY
GW572016	chem
【GOLD_R】
【PRE_R】
GW572016	EGFR	C4

One cell line was resistant to the antiproliferative and radiosensitizing effects of GW572016 , despite receptor inhibition .
【GOLD_E】
GW572016	chem
【PRE_E】
radiosensitizing	chem
GW572016	chem
despitereceptor	geneN
【GOLD_R】
【PRE_R】
radiosensitizing	despitereceptor	C4
GW572016	despitereceptor	C4

Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of GW572016 to inhibit downstream ERK and Akt activation , despite inhibition of HER2 phosphorylation .
【GOLD_E】
ERK	geneN
Akt	geneN
HER2	geneY
GW572016	chem
【PRE_E】
GW572016	chem
ERK	geneN
Akt	geneN
HER2	geneY
【GOLD_R】
GW572016	HER2	C4
【PRE_R】
GW572016	ERK	C4
GW572016	Akt	C4
GW572016	HER2	C4

In contrast , sensitive HER2 - overexpressing cell lines demonstrated inhibition of both ERK and Akt phosphorylation .
【GOLD_E】
HER2	geneY
ERK	geneN
Akt	geneN
【PRE_E】
HER2	geneY
ERK	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

CONCLUSION : GW572016 potently inhibits receptor phosphorylation in either EGFR - or HER2 - overexpressing cell lines and has both antiproliferative and radiosensitizing effects .
【GOLD_E】
EGFR	geneY
HER2	geneY
GW572016	chem
【PRE_E】
GW572016	chem
receptor	geneN
EGFR	geneY
HER2	geneY
radiosensitizing	chem
【GOLD_R】
GW572016	EGFR	C4
GW572016	HER2	C4
【PRE_R】
GW572016	receptor	C4
GW572016	EGFR	C4
HER2	radiosensitizing	C4

Resistance to GW572016 was not due to a lack of receptor inhibition , but rather with a lack of inhibition of ERK and Akt , suggesting that measurement of inhibition of crucial signaling pathways may better predict response than inhibition of receptor phosphorylation .
【GOLD_E】
ERK	geneN
Akt	geneN
GW572016	chem
【PRE_E】
GW572016	chem
ERK	geneN
Akt	geneN
【GOLD_R】
【PRE_R】
GW572016	ERK	C4
GW572016	Akt	C4

The SUM185 cell line provides a valuable model for studying mechanisms of resistance of EGFR / HER2 inhibitor therapy .
【GOLD_E】
EGFR	geneY
HER2	geneN
【PRE_E】
EGFR	geneY
HER2	geneY
【GOLD_R】
【PRE_R】

Aquaporin - 1 deletion reduces osmotic water permeability and cerebrospinal fluid production .
【GOLD_E】
Aquaporin-1	geneY
【PRE_E】
Aquaporin-1	geneY
【GOLD_R】
【PRE_R】

Aquaporin - 1 ( AQP1 ) is a water channel that is strongly expressed at the ventricular - facing surface of choroid plexus epithelium .
【GOLD_E】
Aquaporin-1	geneY
AQP1	geneY
waterchannel	geneN
【PRE_E】
Aquaporin-1	geneY
AQP1	geneY
【GOLD_R】
【PRE_R】

Using wildtype and AQP1 null mice , we developed novel methods to compare the water permeability in isolated choroid plexus , and cerebrospinal fluid ( CSF ) production in living mice .
【GOLD_E】
AQP1	geneY
【PRE_E】
AQP1	geneY
【GOLD_R】
【PRE_R】

Osmotically - induced water transport was rapid in freshly isolated choroid plexus from wildtype mice as measured by a spatial - filtering optical method , and reduced by 5 - fold by AQP1 deletion .
【GOLD_E】
AQP1	geneY
【PRE_E】
Osmotically	chem
AQP1	geneY
【GOLD_R】
【PRE_R】

CSF production , an isosmolar fluid secretion process , was measured by a dye dilution method involving fluid collections using a second microneedle introduced into the cisterna magna .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CSF production in wildtype mice was ( in microl / min ) 0.37 + / - 0.04 microl / min ( control ) , 0.16 + / - 0.03 microl / min ( acetazolamide - treated ) and 1.14 + / - 0.15 microl / min ( forskolin - treated ) , and reduced by up to 25 % in AQP1 null mice .
【GOLD_E】
acetazolamide	chem
forskolin	chem
AQP1	geneY
【PRE_E】
acetazolamide	chem
forskolin	chem
AQP1	geneY
【GOLD_R】
【PRE_R】

The impaired CSF production in AQP1 null mice provides direct functional evidence for the involvement of AQP1 in CSF formation .
【GOLD_E】
AQP1	geneY
AQP1	geneY
【PRE_E】
AQP1	geneY
AQP1	geneY
【GOLD_R】
【PRE_R】

Metformin , but not leptin , regulates AMP - activated protein kinase in pancreatic islets : impact on glucose - stimulated insulin secretion .
【GOLD_E】
Metformin	chem
AMP	chem
glucose	chem
insulin	geneN
AMP-activatedproteinkinase	geneN
【PRE_E】
Metformin	chem
leptin	geneY
AMP-activatedproteinkinase	geneN
glucose	chem
insulin	geneY
【GOLD_R】
glucose	insulin	C3
【PRE_R】
glucose	insulin	C3

Metformin , a drug widely used in the treatment of type 2 diabetes , has recently been shown to act on skeletal muscle and liver in part through the activation of AMP - activated protein kinase ( AMPK ) .
【GOLD_E】
AMP-activatedproteinkinase	geneN
AMPK	geneN
Metformin	chem
AMP	chem
【PRE_E】
Metformin	chem
AMP-activatedproteinkinase	geneN
AMPK	geneN
【GOLD_R】
Metformin	AMP-activatedproteinkinase	C3
Metformin	AMPK	C3
【PRE_R】

Whether metformin or the satiety factor leptin , which also stimulates AMPK in muscle , regulates this enzyme in pancreatic islets is unknown .
【GOLD_E】
AMPK	geneN
metformin	chem
【PRE_E】
metformin	chem
leptin	geneY
AMPK	geneN
【GOLD_R】
metformin	AMPK	C3
【PRE_R】
metformin	leptin	C3
metformin	AMPK	C3

We have recently shown that forced increases in AMPK activity inhibit insulin secretion from MIN6 cells ( da Silva Xavier G , Leclerc I , Varadi A , Tsuboi T , Moule SK , and Rutter GA .
【GOLD_E】
AMPK	geneN
insulin	geneN
【PRE_E】
AMPK	geneN
insulin	geneY
【GOLD_R】
【PRE_R】

Biochem J 371 : 761 - 774 , 2003 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we explore whether 1 ) glucose , metformin , or leptin regulates AMPK activity in isolated islets from rodent and human and 2 ) whether changes in AMPK activity modulate insulin secretion from human islets .
【GOLD_E】
AMPK	geneN
AMPK	geneN
insulin	geneY
glucose	chem
metformin	chem
【PRE_E】
glucose	chem
metformin	chem
leptin	geneY
AMPK	geneN
AMPK	geneN
insulin	geneY
【GOLD_R】
【PRE_R】
glucose	leptin	C3
metformin	leptin	C3
metformin	AMPK	C3
metformin	AMPK	C3
metformin	insulin	C3

Increases in glucose concentration from 0 to 3 and from 3 to 17 mM inhibited AMPK activity in primary islets from mouse , rat , and human , confirming previous findings in insulinoma cells .
【GOLD_E】
AMPK	geneN
glucose	chem
【PRE_E】
glucose	chem
AMPK	geneN
【GOLD_R】
glucose	AMPK	C4
【PRE_R】

Incubation with metformin ( 0.2 - 1 mM ) activated AMPK in both human islets and MIN6 beta - cells in parallel with an inhibition of insulin secretion , whereas leptin ( 10 - 100 nM ) was without effect in MIN6 cells .
【GOLD_E】
metformin	chem
insulin	geneN
AMPK	geneN
【PRE_E】
metformin	chem
AMPK	geneN
insulin	geneY
leptin	geneY
【GOLD_R】
metformin	AMPK	C3
metformin	insulin	C4
【PRE_R】
metformin	AMPK	C4
metformin	insulin	C4

These studies demonstrate that AMPK activity is subject to regulation by both glucose and metformin in pancreatic islets and clonal beta - cells .
【GOLD_E】
AMPK	geneN
glucose	chem
metformin	chem
【PRE_E】
AMPK	geneN
glucose	chem
metformin	chem
【GOLD_R】
【PRE_R】
AMPK	glucose	C3
AMPK	metformin	C3

The inhibitory effects of metformin on insulin secretion may therefore need to be considered with respect to the use of this drug for the treatment of type 2 diabetes .
【GOLD_E】
insulin	geneN
metformin	chem
【PRE_E】
metformin	chem
insulin	geneY
【GOLD_R】
metformin	insulin	C4
【PRE_R】

A novel retinoic acid - responsive element regulates retinoic acid - induced BLR1 expression .
【GOLD_E】
retinoicacid	chem
retinoicacid	chem
BLR1	geneN
retinoicacid-responsiveelement	geneN
【PRE_E】
retinoicacid	chem
retinoicacid	chem
BLR1	geneY
【GOLD_R】
retinoicacid	BLR1	C3
【PRE_R】

The mechanism of action of retinoic acid ( RA ) is of broad relevance to cell and developmental biology , nutrition , and cancer chemotherapy .
【GOLD_E】
retinoicacid	chem
RA	chem
【PRE_E】
retinoicacid	chem
【GOLD_R】
【PRE_R】

RA is known to induce expression of the Burkitt 's lymphoma receptor 1 ( BLR1 ) gene which propels RA - induced cell cycle arrest and differentiation of HL - 60 human myeloblastic leukemia cells , motivating the present analysis of transcriptional regulation of blr1 expression by RA .
【GOLD_E】
RA	chem
RA	chem
Burkitt'slymphomareceptor1	geneY
BLR1	geneY
blr1	geneY
RA	chem
【PRE_E】
Burkitt'slymphomareceptor1	geneY
BLR1	geneY
blr1	geneY
【GOLD_R】
RA	blr1	C3
RA	Burkitt'slymphomareceptor1	C3
RA	BLR1	C3
【PRE_R】

The RA - treated HL - 60 cells used here expressed all RA receptor ( RAR ) and retinoid X receptor ( RXR ) subtypes ( as detected by Northern analysis ) except RXRgamma .
【GOLD_E】
RA	chem
RA	chem
retinoid	chem
RAreceptor	geneN
RAR	geneN
retinoidXreceptor	geneN
RXR	geneN
RXRgamma	geneY
【PRE_E】
RAR	geneY
retinoidXreceptor	geneY
RXR	geneN
RXRgamma	geneY
【GOLD_R】
【PRE_R】

Treatment with RAR - and RXR - selective ligands showed that RARalpha synergized with RXRalpha to transcriptionally activate blr1 expression .
【GOLD_E】
RAR	geneN
RXR	geneN
RARalpha	geneY
RXRalpha	geneY
blr1	geneY
【PRE_E】
RAR	geneY
RXR	geneN
RARalpha	geneY
RXRalpha	geneY
blr1	geneY
【GOLD_R】
【PRE_R】

A 5 ' - flanking region capable of supporting RA - induced blr1 activation in HL - 60 cells was found to contain a 205 - bp sequence in the distal portion that was necessary for transcriptional activation by RA .
【GOLD_E】
RA	chem
RA	chem
blr1	geneY
【PRE_E】
blr1	geneY
【GOLD_R】
RA	blr1	C3
【PRE_R】

Within this sequence DNase I footprinting revealed that RA induced binding of a nuclear protein complex to an element containing two GT boxes .
【GOLD_E】
RA	chem
GTboxes	geneN
DNaseI	geneY
nuclearproteincomplex	geneN
【PRE_E】
DNaseI	geneY
nuclearprotein	geneN
【GOLD_R】
【PRE_R】

Electromobility shift assays ( EMSAs ) and supershift assays showed that this element bound recombinant RARalpha and RXRalpha .
【GOLD_E】
RARalpha	geneY
RXRalpha	geneY
【PRE_E】
EMSAs	geneY
RARalpha	geneY
RXRalpha	geneY
【GOLD_R】
【PRE_R】

Without RA there was neither complex binding nor transcriptional activation .
【GOLD_E】
RA	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Both GT boxes were needed for binding the complex , and mutation of either GT box caused the loss of transcriptional activation by RA .
【GOLD_E】
GTboxes	geneN
GTbox	geneN
RA	chem
【PRE_E】
GTbox	geneN
【GOLD_R】
【PRE_R】

The ability of this cis - acting RAR - RXR binding element to activate transcription in response to RA also depended on downstream sequences where an octamer transcription factor 1 ( Oct1 ) site and a nuclear factor of activated T cells ( NFATc ) site between this element and the transcriptional start , as well as a cyclic AMP response element binding factor ( CREB ) site between the transcriptional start and first exon of the blr1 gene , were necessary .
【GOLD_E】
RAR-RXRbindingelement	geneN
octamertranscriptionfactor1	geneY
Oct1	geneY
nuclearfactorofactivatedTcells	geneY
NFATc	geneY
cyclicAMPresponseelementbindingfactor	geneN
CREB	geneN
blr1	geneY
RA	chem
cyclicAMP	chem
【PRE_E】
RAR	geneY
RXRbindingelement	geneN
octamertranscriptionfactor1	geneY
Oct1	geneY
nuclearfactorofactivatedTcells	geneN
NFATc	geneN
cyclicAMPresponseelementbindingfactor	geneN
CREB	geneN
blr1	geneY
【GOLD_R】
RA	nuclearfactorofactivatedTcells	C4
【PRE_R】

Each of these sites bound its corresponding transcription factor .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A transcription factor - transcription factor binding array analysis of nuclear lysate from RA - treated cells indicated several prominent RARalpha binding partners ; among these , Oct1 , NFATc3 , and CREB2 were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex .
【GOLD_E】
RARalpha	geneY
Oct1	geneY
NFATc3	geneY
CREB2	geneY
RA	chem
【PRE_E】
RARalpha	geneY
Oct1	geneY
NFATc3	geneY
CREB2	geneY
EMSA	geneN
【GOLD_R】
【PRE_R】

RA upregulated expression of these three factors .
【GOLD_E】
RA	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In sum the results of the present study indicate that RA - induced expression of blr1 expression depends on a novel RA response element .
【GOLD_E】
RA	chem
blr1	geneY
RAresponseelement	geneN
RA	chem
【PRE_E】
blr1	geneY
RAresponseelement	geneN
【GOLD_R】
RA	blr1	C3
【PRE_R】

This cis - acting element approximately 1 kb upstream of the transcriptional start consists of two GT boxes that bind RAR and RXR in a nuclear protein complex that also contains Oct1 , NFATc3 , and CREB2 bound to their cognate downstream consensus binding sites .
【GOLD_E】
GTboxes	geneN
RAR	geneN
RXR	geneN
nuclearproteincomplex	geneN
Oct1	geneY
NFATc3	geneY
CREB2	geneY
【PRE_E】
RAR	geneY
RXR	geneN
Oct1	geneY
NFATc3	geneY
CREB2	geneY
【GOLD_R】
【PRE_R】

The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function .
【GOLD_E】
desipramine	chem
norepinephrine	chem
norepinephrinetransporter	geneY
【PRE_E】
desipramine	chem
norepinephrinetransporter	geneY
【GOLD_R】
desipramine	norepinephrinetransporter	C4
【PRE_R】

The present study examined the potential membrane retention of desipramine ( DMI ) following exposures of 293 - hNET cells to DMI , and its effect on [ 3H ] NE uptake .
【GOLD_E】
DMI	chem
DMI	chem
hNET	geneY
[3H]NE	chem
desipramine	chem
【PRE_E】
desipramine	chem
DMI	chem
hNET	geneY
DMI	chem
[3H]NE	chem
【GOLD_R】
【PRE_R】

Incubation of cells with 500 nM DMI for 1 h or 1 day persistently inhibited the uptake of [ 3H ] NE up to 7 days , despite daily repeated washing of cells with drug - free medium .
【GOLD_E】
DMI	chem
[3H]NE	chem
【PRE_E】
DMI	chem
[3H]NE	chem
【GOLD_R】
【PRE_R】

Uptake inhibition was paralleled by persistent retention of DMI associated with cells , as determined by HPLC and by radiotracer experiments using [ 3H ] DMI .
【GOLD_E】
DMI	chem
[3H]DMI	chem
【PRE_E】
DMI	chem
[3H]DMI	chem
【GOLD_R】
【PRE_R】

[ 3H ] DMI trapped in membranes was displaceable by the structurally unrelated NET inhibitor , nisoxetine , in a concentration - dependent manner , implying interaction of retained [ 3H ] DMI with the NET .
【GOLD_E】
[3H]DMI	chem
NET	geneY
NET	geneY
[3H]DMI	chem
nisoxetine	chem
【PRE_E】
[3H]DMI	chem
NET	geneY
nisoxetine	chem
[3H]DMI	chem
NET	geneY
【GOLD_R】
nisoxetine	NET	C4
【PRE_R】
NET	nisoxetine	C4

A similar cellular retention was observed following incubation of cells with nisoxetine .
【GOLD_E】
nisoxetine	chem
【PRE_E】
nisoxetine	chem
【GOLD_R】
【PRE_R】

The results demonstrate that DMI and nisoxetine are persistently retained in cell membranes , at least partly in association with the NET .
【GOLD_E】
DMI	chem
nisoxetine	chem
NET	geneY
【PRE_E】
DMI	chem
nisoxetine	chem
NET	geneY
【GOLD_R】
【PRE_R】

The retention and slow diffusion of DMI and nisoxetine from membranes may contribute to their pharmacological and modulatory action on NET .
【GOLD_E】
DMI	chem
nisoxetine	chem
NET	geneY
【PRE_E】
DMI	chem
nisoxetine	chem
NET	geneY
【GOLD_R】
【PRE_R】

AT1 - receptor antagonism in hypertension : what has been learned with irbesartan ?
【GOLD_E】
irbesartan	chem
AT1	geneY
【PRE_E】
AT1-receptor	geneY
irbesartan	chem
【GOLD_R】
【PRE_R】

Irbesartan is a long - acting angiotensin II antagonist acting specifically at the level of the Type 1 - receptor subtype ( AT1 - receptor ) .
【GOLD_E】
AT1	geneY
angiotensinII	geneY
Irbesartan	chem
angiotensinII	chem
【PRE_E】
Irbesartan	chem
angiotensinII	geneY
Type1-receptor	geneY
AT1-receptor	geneY
【GOLD_R】
Irbesartan	angiotensinII	C6
【PRE_R】
Irbesartan	AT1-receptor	C5

This compound lowers blood pressure dose - dependently in hypertensive patients and has a placebo - like tolerability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The antihypertensive efficacy of irbesartan is greatly enhanced by the coadministration of a diuretic , and fixed - dose combinations of irbesartan and hydrochlorothiazide are now available .
【GOLD_E】
irbesartan	chem
irbesartan	chem
hydrochlorothiazide	chem
【PRE_E】
irbesartan	chem
irbesartan	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Irbesartan - based treatment appears especially effective for high - risk patients , such as those with diabetes , renal disease and cardiac hypertrophy .
【GOLD_E】
Irbesartan	chem
【PRE_E】
Irbesartan	chem
【GOLD_R】
【PRE_R】

In patients with Type 2 diabetes , irbesartan delays the development of nephropathy as well as the progression of renal failure .
【GOLD_E】
irbesartan	chem
【PRE_E】
irbesartan	chem
【GOLD_R】
【PRE_R】

Irbesartan may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se : this AT1 - blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the pro - inflammatory effects of angiotensin II .
【GOLD_E】
AT1	geneY
angiotensinII	geneY
Irbesartan	chem
angiotensinII	chem
【PRE_E】
Irbesartan	chem
AT1	geneY
angiotensinII	geneY
【GOLD_R】
Irbesartan	angiotensinII	C4
Irbesartan	AT1	C4
【PRE_R】
Irbesartan	AT1	C4

Irbesartan given alone or in combination with a diuretic therefore represents a rational approach to treat hypertensive patients .
【GOLD_E】
【PRE_E】
Irbesartan	chem
【GOLD_R】
【PRE_R】

Binding of ( - ) - [ 3H ] - CGP12177 at two sites in recombinant human beta 1 - adrenoceptors and interaction with beta - blockers .
【GOLD_E】
(-)-[3H]-CGP12177	chem
humanbeta1-adrenoceptors	geneY
【PRE_E】
(-)-[3H]-CGP12177	chem
humanbeta1-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

To verify the hypothesis that the non - conventional partial agonist ( - ) - CGP12177 binds at two beta ( 1 ) - adrenoceptor sites , human beta ( 1 ) - adrenoceptors , expressed in CHO cells , were labelled with ( - ) - [ ( 3 ) H ] - CGP12177 .
【GOLD_E】
(-)-[(3)H]-CGP12177	chem
(-)-CGP12177	chem
humanbeta(1)-adrenoceptors	geneY
beta(1)-adrenoceptor	geneY
【PRE_E】
(-)-CGP12177	chem
beta(1)-adrenoceptor	geneN
humanbeta(1)-adrenoceptors	geneN
(-)-[(3)H]-CGP12177	chem
【GOLD_R】
(-)-CGP12177	humanbeta(1)-adrenoceptors	C5
(-)-CGP12177	beta(1)-adrenoceptor	C5
【PRE_R】

We compared the binding affinity and antagonist potency of 12 clinically used beta - blockers against the cyclic AMP - enhancing effects of ( - ) - isoprenaline and ( - ) - CGP12177 . ( - ) - [ ( 3 ) H ] - CGP12177 bound to a high affinity site ( H ; K ( H ) = 0.47 nM ) and low affinity site ( L ) ; K ( L ) = 235 nM ) .
【GOLD_E】
cyclicAMP	chem
(-)-isoprenaline	chem
(-)-CGP12177	chem
(-)-[(3)H]-CGP12177	chem
【PRE_E】
cyclicAMP	chem
(-)-isoprenaline	chem
(-)-CGP12177	chem
(-)-[(3)H]-CGP12177	chem
【GOLD_R】
【PRE_R】

( - ) - [ ( 3 ) H ] - CGP12177 dissociated from the beta ( 1 ) - adrenoceptors with a fast component ( k ( off ) = 0.45 min ( - 1 ) ) , consistent with the L - site , and a slow component ( k ( off ) = 0.017 - 0.033 min ( - 1 ) ) , consistent with the H - site .
【GOLD_E】
(-)-[(3)H]-CGP12177	chem
beta(1)-adrenoceptors	geneY
【PRE_E】
(-)-[(3)H]-CGP12177	chem
beta(1)-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

( - ) - Isoprenaline and ( - ) - CGP12177 caused 96 - fold and 12 - fold maximal increases in cyclic AMP levels with - logEC ( 50 ) M of 8.2 and 7.6 .
【GOLD_E】
(-)-Isoprenaline	chem
(-)-CGP12177	chem
cyclicAMP	chem
【PRE_E】
(-)-Isoprenaline	chem
(-)-CGP12177	chem
cyclicAMP	chem
【GOLD_R】
【PRE_R】

( - ) - CGP12177 antagonised the effects of ( - ) - isoprenaline with a pK ( B ) of 9.9 .
【GOLD_E】
(-)-CGP12177	chem
(-)-isoprenaline	chem
【PRE_E】
(-)-CGP12177	chem
(-)-isoprenaline	chem
【GOLD_R】
【PRE_R】

The beta - blockers antagonised the effects of ( - ) - isoprenaline more than the effects of ( - ) - CGP12177 with potency ratios : ( - ) - atenolol 1,000 , ( + / - ) - metropolol 676 , ( - ) - pindolol 631 , ( - ) - timolol 589 , ( + / - ) - carvedilol 204 , ( + / - ) - oxprenolol 138 , ( + / - ) - sotalol 132 , ( - ) - propranolol 120 , ( + / - ) - bisoprolol 95 , ( + / - ) - alprenolol 81 , ( + / - ) - nadolol 68 and ( - ) - bupranolol 56 .
【GOLD_E】
(+/-)-bisoprolol	chem
(+/-)-alprenolol	chem
(+/-)-nadolol	chem
(-)-bupranolol	chem
(-)-CGP12177	chem
(-)-atenolol	chem
(-)-isoprenaline	chem
(+/-)-metropolol	chem
(-)-pindolol	chem
(-)-timolol	chem
(+/-)-carvedilol	chem
(+/-)-oxprenolol	chem
(+/-)-sotalol	chem
(-)-propranolol	chem
【PRE_E】
(-)-isoprenaline	chem
(-)-CGP12177	chem
(-)-atenolol	chem
(+/-)-metropolol676	chem
(-)-pindolol631	chem
(-)-timolol589	chem
(+/-)-carvedilol204	chem
(+/-)-oxprenolol138	chem
(+/-)-sotalol132	chem
(-)-propranolol	chem
(+/-)-bisoprolol	chem
(+/-)-alprenolol	chem
(+/-)-nadolol	chem
【GOLD_R】
【PRE_R】

In intact cells the binding constants of beta - blockers , estimated from competition with 3 - 5 nM ( - ) - [ ( 3 ) H ] - CGP12177 ( binding to the H - site ) , correlated with the corresponding affinities estimated from antagonism of the ( - ) - isoprenaline effects .
【GOLD_E】
(-)-[(3)H]-CGP12177	chem
(-)-isoprenaline	chem
【PRE_E】
(-)-[(3)H]-CGP12177	chem
H	chem
(-)-isoprenaline	chem
【GOLD_R】
【PRE_R】

We conclude that ( - ) - [ ( 3 ) H ] - CGP12177 binds at two sites in the recombinant beta ( 1 ) - adrenoceptor .
【GOLD_E】
(-)-[(3)H]-CGP12177	chem
beta(1)-adrenoceptor	geneY
【PRE_E】
(-)-[(3)H]-CGP12177	chem
beta(1)-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

( - ) - CGP12177 is an antagonist of catecholamine effects through the H - site and a non - conventional partial agonist through the L - site . beta - blockers are more potent antagonists through the H - site than the L - site .
【GOLD_E】
(-)-CGP12177	chem
catecholamine	chem
【PRE_E】
(-)-CGP12177	chem
catecholamine	chem
H	chem
H	chem
【GOLD_R】
【PRE_R】

Imiquimod , a Toll - like receptor - 7 agonist , induces perforin in cytotoxic T lymphocytes in vitro .
【GOLD_E】
Toll-likereceptor-7	geneY
perforin	geneY
Imiquimod	chem
【PRE_E】
Toll-likereceptor-7	geneY
perforin	geneN
【GOLD_R】
Imiquimod	perforin	C3
Imiquimod	Toll-likereceptor-7	C5
【PRE_R】

Imiquimod ( IMQ ) , an activator of Toll - like receptor - 7 ( TLR - 7 ) , induces by several routes a profound anti - viral and anti - tumor effect in vivo .
【GOLD_E】
Toll-likereceptor-7	geneY
TLR-7	geneY
Imiquimod	chem
IMQ	chem
【PRE_E】
Imiquimod	chem
IMQ	chem
Toll-likereceptor-7	geneY
TLR-7	geneY
【GOLD_R】
Imiquimod	Toll-likereceptor-7	C3
Imiquimod	TLR-7	C3
IMQ	Toll-likereceptor-7	C3
IMQ	TLR-7	C3
【PRE_R】
Imiquimod	TLR-7	C4
IMQ	TLR-7	C4

Physiologically , the immune system is using perforin - containing granules of cytotoxic T lymphocytes ( CTL ) towards the same biological purpose .
【GOLD_E】
perforin	geneY
【PRE_E】
perforin	geneN
【GOLD_R】
【PRE_R】

This functional synergism prompted our current experiments addressing the question whether IMQ may influence perforin - release and / or induce perforin in CTLs in vitro .
【GOLD_E】
perforin	geneY
perforin	geneY
IMQ	chem
【PRE_E】
IMQ	geneY
perforin	geneN
perforin	geneN
CTLs	geneN
【GOLD_R】
【PRE_R】

In peripheral lymphocytes of healthy and diseased subjects , IMQ induced a significant increase of perforin ( + ) CTLs within 12h in all experiments performed .
【GOLD_E】
perforin	geneY
IMQ	chem
【PRE_E】
IMQ	chem
perforin(+)	chem
【GOLD_R】
IMQ	perforin	C3
【PRE_R】

This effect was most pronounced in CTLs of patients suffering from atopic dermatitis , a model disorder for subnormal perforin expression : as compared to perforin ( + ) CTLs detected at time point zero ( 100 % ) , up to 270 % of perforin ( + ) CTLs were induced by 2.5 microg / ml [ corrected ] IMQ .
【GOLD_E】
perforin	geneY
perforin	geneY
perforin	geneY
IMQ	chem
【PRE_E】
perforin	geneY
perforin	geneY
CTLs	geneY
perforin(+)CTLs	geneY
【GOLD_R】
IMQ	perforin	C3
【PRE_R】

Perforin release from peripheral blood CTLs after PMA / ionomycin - stimulation was not influenced significantly by IMQ .
【GOLD_E】
Perforin	geneY
IMQ	chem
【PRE_E】
Perforin	geneY
PMA	chem
ionomycin	chem
IMQ	chem
【GOLD_R】
【PRE_R】

Thus , the biological activity of IMQ appears to exceed its previously known functions , inasmuch as it boosts up significantly the perforin - granule system .
【GOLD_E】
IMQ	chem
perforin	geneY
【PRE_E】
IMQ	geneY
perforin	geneN
【GOLD_R】
IMQ	perforin	C3
【PRE_R】

Caffeine as a psychomotor stimulant : mechanism of action .
【GOLD_E】
Caffeine	chem
【PRE_E】
Caffeine	chem
【GOLD_R】
【PRE_R】

The popularity of caffeine as a psychoactive drug is due to its stimulant properties , which depend on its ability to reduce adenosine transmission in the brain .
【GOLD_E】
adenosine	chem
caffeine	chem
【PRE_E】
caffeine	chem
adenosine	chem
【GOLD_R】
【PRE_R】

Adenosine A ( 1 ) and A ( 2A ) receptors are expressed in the basal ganglia , a group of structures involved in various aspects of motor control .
【GOLD_E】
AdenosineA(1)andA(2A)receptors	geneN
Adenosine	chem
【PRE_E】
AdenosineA(1)	geneY
A(2A)	geneY
【GOLD_R】
【PRE_R】

Caffeine acts as an antagonist to both types of receptors .
【GOLD_E】
Caffeine	chem
【PRE_E】
Caffeine	chem
【GOLD_R】
【PRE_R】

Increasing evidence indicates that the psychomotor stimulant effect of caffeine is generated by affecting a particular group of projection neurons located in the striatum , the main receiving area of the basal ganglia .
【GOLD_E】
caffeine	chem
【PRE_E】
caffeine	chem
【GOLD_R】
【PRE_R】

These cells express high levels of adenosine A ( 2A ) receptors , which are involved in various intracellular processes , including the expression of immediate early genes and regulation of the dopamine - and cyclic AMP - regulated 32 - kDa phosphoprotein DARPP - 32 .
【GOLD_E】
adenosineA(2A)receptors	geneY
dopamine-andcyclicAMP-regulated32-kDaphosphoprotein	geneY
DARPP-32	geneY
adenosine	chem
dopamine	chem
cyclicAMP	chem
【PRE_E】
adenosineA(2A)receptors	geneY
dopamine-andcyclicAMP-regulated32	geneN
DARPP-32	geneY
【GOLD_R】
【PRE_R】

The present review focuses on the effects of caffeine on striatal signal transduction and on their involvement in caffeine - mediated motor stimulation .
【GOLD_E】
caffeine	chem
caffeine	chem
【PRE_E】
caffeine	chem
caffeine	chem
【GOLD_R】
【PRE_R】

Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive rats .
【GOLD_E】
imidapril	chem
irbesartan	chem
【PRE_E】
imidapril	chem
irbesartan	chem
【GOLD_R】
【PRE_R】

AIM : To investigate the remodeling of mesenteric artery and the expression of TGF - beta1 , c - Jun in mesenteric artery and effects of imidapril and irbesartan on the remodeling in spontaneously hypertensive rats ( SHR ) .
【GOLD_E】
TGF-beta1	geneY
c-Jun	geneY
imidapril	chem
irbesartan	chem
【PRE_E】
TGF-beta1	geneY
c-Jun	geneY
imidapril	chem
irbesartan	chem
【GOLD_R】
【PRE_R】

METHODS : Thirty SHR ( male / female , 21 / 9 ) , aged 13 wk , were randomly divided into 3 groups ( 7 male rats and 3 female rats each group ) : SHR group , imidapril group ( imidapril 3 mg / kg.d was given in drinking water for 14 wk ) , and irbesartan group ( irbesartan 50 mg / kg.d was given in drinking water foe 14 wk ) .
【GOLD_E】
imidapril	chem
imidapril	chem
irbesartan	chem
irbesartan	chem
【PRE_E】
imidapril	chem
imidapril	chem
irbesartan	chem
irbesartan	chem
【GOLD_R】
【PRE_R】

Ten homogeneous Wistar Kyoto rats , 5 males and 5 females , weighing 206 + / - 49 g , were selected as normal control group ( WKY group ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Systolic pressure was measured on d 1 , 2 , 4 , 6 , 8 , 10 , 12 and 14 during the experiment and the rats were killed at the end of the experiment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Angiotensin II ( Ang II ) level in plasma and mesenteric arteries was measured by radioimmunoassay .
【GOLD_E】
AngiotensinII	chem
AngII	chem
AngiotensinII	geneY
AngII	geneY
【PRE_E】
AngiotensinII	geneY
AngII	geneY
【GOLD_R】
【PRE_R】

The morphology of the secondary branches of mesenteric artery were examined by light microscopy and electron microscopy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Reverse transcription polymerase chain reaction ( RT - PCR ) was used to detect the expression of transforming growth factor TGF - beta1 and c - Jun mRNA .
【GOLD_E】
transforminggrowthfactor	geneY
TGF-beta1	geneY
c-Jun	geneY
【PRE_E】
transforminggrowthfactorTGF-beta1	geneY
c-Jun	geneY
【GOLD_R】
【PRE_R】

RESULTS : Compared with imidapril group and irbesartan group , the blood pressure was remarkably increased in SHR group .
【GOLD_E】
imidapril	chem
irbesartan	chem
【PRE_E】
imidapril	chem
irbesartan	chem
【GOLD_R】
【PRE_R】

Ang II level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group , and was higher in irbesartan group and lower in imidapril group .
【GOLD_E】
AngII	geneY
AngII	chem
irbesartan	chem
imidapril	chem
【PRE_E】
AngII	geneY
irbesartan	chem
imidapril	chem
【GOLD_R】
irbesartan	AngII	C3
imidapril	AngII	C4
【PRE_R】

The remodeling of mesenteric arteries in SHR group was mostly obvious among the 4 groups .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The ratio of TGF - beta1 absorbed light value to GAPDH absorbed light value in the SHR group was 0.887 + / - 0.019 , which was significantly higher than that in WKY group , imidapril group , and irbesartan group with the ratios of 0.780 + / - 0.018 , 0.803 + / - 0.005 , and 0.847 + / - 0.017 , respectively ( P < 0.01 ) .
【GOLD_E】
TGF-beta1	geneY
GAPDH	geneY
imidapril	chem
irbesartan	chem
【PRE_E】
TGF-beta1	geneY
GAPDH	geneN
imidapril	chem
irbesartan	chem
【GOLD_R】
imidapril	TGF-beta1	C3
imidapril	GAPDH	C3
irbesartan	TGF-beta1	C3
irbesartan	GAPDH	C3
【PRE_R】

Ang II level in plasma and mesenteric arteries in imidapril group was significantly lower than that in irbesartan group ( P < 0.05 ) .
【GOLD_E】
AngII	chem
imidapril	chem
irbesartan	chem
AngII	geneY
【PRE_E】
AngII	geneY
imidapril	chem
irbesartan	chem
【GOLD_R】
irbesartan	AngII	C3
imidapril	AngII	C4
【PRE_R】

The c - Jun absorbed light value / GAPDH absorbed light value of mesenteric arteries in the SHR group was 0.850 + / - 0.015 , which was significantly higher than that in the WKY , imidapril , and irbesartan groups ( 0.582 + / - 0.013 , 0.743 + / - 0.012 , and 0.789 + / - 0.013 , respectively , P < 0.01 ) , and was significantly lower in imidapril group than in irbesartan group ( P < 0.05 ) .
【GOLD_E】
imidapril	chem
irbesartan	chem
imidapril	chem
irbesartan	chem
c-Jun	geneY
GAPDH	geneY
【PRE_E】
c-Jun	geneY
GAPDH	geneN
imidapril	chem
irbesartan	chem
imidapril	chem
irbesartan	chem
【GOLD_R】
imidapril	c-Jun	C3
imidapril	GAPDH	C3
irbesartan	c-Jun	C3
irbesartan	GAPDH	C3
【PRE_R】

CONCLUSION : Imidapril and irbesartan can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of TGF - beta1 , c - Jun in SHR .
【GOLD_E】
Imidapril	chem
irbesartan	chem
TGF-beta1	geneY
c-Jun	geneY
【PRE_E】
Imidapril	chem
irbesartan	chem
TGF-beta1	geneY
c-Jun	geneY
【GOLD_R】
Imidapril	TGF-beta1	C4
Imidapril	c-Jun	C4
irbesartan	TGF-beta1	C4
irbesartan	c-Jun	C4
【PRE_R】
Imidapril	TGF-beta1	C4
irbesartan	TGF-beta1	C4
irbesartan	c-Jun	C4

Imidapril is more effective than irbesartan .
【GOLD_E】
Imidapril	chem
irbesartan	chem
【PRE_E】
Imidapril	chem
irbesartan	chem
【GOLD_R】
【PRE_R】

Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles .
【GOLD_E】
norepinephrine	chem
norepinephrinetransporter	geneY
【PRE_E】
norepinephrinetransporter	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : To assess the sensitivity of biochemical , physiological , and pharmacological markers of peripheral norepinephrine ( NE ) transporter ( NET ) function , we chronically antagonized NET by a range of doses of duloxetine [ ( + ) - N - methyl - 3 - ( 1 - naphthalenyloxy ) - 2 thiophenepropanamine ] , which blocks the NE reuptake process .
【GOLD_E】
NE	chem
duloxetine	chem
(+)-N-methyl-3-(1-naphthalenyloxy)-2thiophenepropanamine	chem
NE	chem
norepinephrine(NE)transporter	geneY
NET	geneY
NET	geneY
norepinephrine	chem
【PRE_E】
norepinephrine(NE)transporter	geneY
NET	geneY
NET	geneY
duloxetine	chem
(+)-N-methyl-3-(1-naphthalenyloxy)-2thiophenepropanamine	chem
NE	chem
【GOLD_R】
duloxetine	NET	C6
(+)-N-methyl-3-(1-naphthalenyloxy)-2thiophenepropanamine	NET	C6
NE	NET	C9
【PRE_R】
NET	(+)-N-methyl-3-(1-naphthalenyloxy)-2thiophenepropanamine	C4
NET	(+)-N-methyl-3-(1-naphthalenyloxy)-2thiophenepropanamine	C4

METHODS AND RESULTS : Duloxetine was administered in a randomized , placebo - controlled study in 15 healthy volunteers .
【GOLD_E】
Duloxetine	chem
【PRE_E】
Duloxetine	chem
【GOLD_R】
【PRE_R】

Plasma from duloxetine - treated subjects ( ex vivo effect ) dose - dependently decreased radioligand binding to human NET ( maximum inhibition was 60 % ) ( P = 0.02 ) .
【GOLD_E】
duloxetine	chem
humanNET	geneY
【PRE_E】
duloxetine	chem
humanNET	geneY
【GOLD_R】
【PRE_R】

The dose of intravenous tyramine required to raise systolic blood pressure by 30 mm Hg ( PD30 ) increased dose - dependently with duloxetine and was significant at the end of the 120 - mg / d dosage ( P < 0.001 ) .
【GOLD_E】
【PRE_E】
tyramine	chem
duloxetine	chem
【GOLD_R】
【PRE_R】

The plasma dihydoxyphenylglycol to NE ( DHPG / NE ) ratio was reduced significantly at 2 weeks of treatment with 80 mg / d duloxetine ( 11.3 at baseline , 3.4 at 240 mg / d , P < 0.001 ) .
【GOLD_E】
dihydoxyphenylglycol	chem
NE	chem
DHPG	chem
NE	chem
duloxetine	chem
【PRE_E】
dihydoxyphenylglycol	chem
NE	chem
DHPG	chem
NE	chem
duloxetine	chem
【GOLD_R】
【PRE_R】

Plasma NE was significantly increased starting at 120 mg / d duloxetine .
【GOLD_E】
duloxetine	chem
NE	chem
【PRE_E】
NE	chem
duloxetine	chem
【GOLD_R】
【PRE_R】

Urine results ( corrected for 24 - hour creatinine excretion ) showed a dose - dependent change from the baseline urinary excretion for NE , DHPG , and the DHPG / NE ratio .
【GOLD_E】
creatinine	chem
NE	chem
DHPG	chem
DHPG	chem
NE	chem
【PRE_E】
creatinine	chem
NE	chem
DHPG	chem
DHPG	chem
NE	chem
【GOLD_R】
【PRE_R】

The most sensitive measure , the DHPG / NE ratio , was significant at the 80 - mg dose .
【GOLD_E】
DHPG	chem
NE	chem
【PRE_E】
DHPG	chem
NE	chem
【GOLD_R】
【PRE_R】

Urinary NE excretion was significantly raised after 2 weeks of treatment with 80 mg / d duloxetine ( P < 0.001 ) , the lowest dose used in the study .
【GOLD_E】
NE	chem
duloxetine	chem
【PRE_E】
NE	chem
duloxetine	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : These findings suggest that the degree of NET blockade can be assessed with the plasma or urine DHPG / NE ratio and the pressor effect of tyramine .
【GOLD_E】
DHPG	chem
NE	chem
NET	geneY
【PRE_E】
NET	geneY
DHPG	chem
NE	chem
tyramine	chem
【GOLD_R】
【PRE_R】

Also , the DHPG / NE ratio is more sensitive at the lower end of NET inhibition , whereas tyramine exhibits a linear relation , with NET inhibition commencing at a higher dose .
【GOLD_E】
DHPG	chem
NE	chem
NET	geneY
NET	geneY
【PRE_E】
DHPG	chem
NE	chem
NET	geneY
tyramine	chem
NET	geneY
【GOLD_R】
【PRE_R】
DHPG	NET	C4
NET	tyramine	C4
tyramine	NET	C4

Auranofin increases apoptosis and ischaemia - reperfusion injury in the rat isolated heart .
【GOLD_E】
Auranofin	chem
【PRE_E】
Auranofin	chem
【GOLD_R】
【PRE_R】

Auranofin , an antirheumatic gold compound , is an inhibitor of selenocysteine enzymes , such as thioredoxin reductase and glutathione peroxidase .
【GOLD_E】
glutathioneperoxidase	geneN
selenocysteineenzymes	geneN
thioredoxinreductase	geneY
Auranofin	chem
glutathione	chem
selenocysteine	chem
【PRE_E】
Auranofin	chem
selenocysteine	geneN
thioredoxinreductase	geneY
glutathioneperoxidase	geneN
【GOLD_R】
Auranofin	glutathioneperoxidase	C4
Auranofin	selenocysteineenzymes	C4
Auranofin	thioredoxinreductase	C4
【PRE_R】
Auranofin	selenocysteine	C4
Auranofin	thioredoxinreductase	C4

These enzymes play an important role in protecting cardiac tissue from oxidative stress generated during ischaemia - reperfusion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Auranofin ( 100 mg / kg ) was administered to rats and their hearts were subjected to an in vitro model of ischaemia - reperfusion .
【GOLD_E】
Auranofin	chem
【PRE_E】
Auranofin	chem
【GOLD_R】
【PRE_R】

The activity of thioredoxin reductase and glutathione peroxidase was determined in liver and heart tissues in an attempt to correlate enzymatic activity with heart recovery after ischaemia - reperfusion .
【GOLD_E】
thioredoxinreductase	geneY
glutathioneperoxidase	geneN
glutathione	chem
【PRE_E】
thioredoxinreductase	geneY
glutathioneperoxidase	geneN
【GOLD_R】
【PRE_R】

There was significantly less thioredoxin reductase activity in rat liver extracts , whereas the level of glutathione activity remained unchanged , demonstrating that the dose of auranofin used was able to selectively inhibit one of these enzyme systems .
【GOLD_E】
thioredoxinreductase	geneY
glutathione	chem
auranofin	chem
【PRE_E】
thioredoxinreductase	geneY
glutathione	chem
auranofin	chem
【GOLD_R】
auranofin	thioredoxinreductase	C4
【PRE_R】

Rats administered auranofin displayed significantly impaired recovery from ischaemic insult .
【GOLD_E】
auranofin	chem
【PRE_E】
auranofin	chem
【GOLD_R】
【PRE_R】

The end diastolic pressure was increased , whereas the rate pressure product was significantly decreased .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The level of postischaemic apoptosis was also assessed by examining caspase - 3 activity in tissue homogenates .
【GOLD_E】
caspase-3	geneY
【PRE_E】
caspase-3	geneY
【GOLD_R】
【PRE_R】

Auranofin significantly increased the degree of postischaemic apoptosis , leading to poor postischaemic recovery .
【GOLD_E】
Auranofin	chem
【PRE_E】
Auranofin	chem
【GOLD_R】
【PRE_R】

Gallium and other main group metal compounds as antitumor agents .
【GOLD_E】
Gallium	chem
【PRE_E】
Gallium	chem
【GOLD_R】
【PRE_R】

Gallium has been the second metal to show activity against malignant tumors in humans soon after the establishment of platinum drugs in routine clinical practice .
【GOLD_E】
Gallium	chem
platinum	chem
【PRE_E】
Gallium	chem
platinum	chem
【GOLD_R】
【PRE_R】

It has the unique property of inhibiting tumor growth as a simple cation , mainly because of its close resemblance to ferric iron .
【GOLD_E】
ferriciron	chem
【PRE_E】
ferriciron	chem
【GOLD_R】
【PRE_R】

Even though its inability to shift between the trivalent and a divalent oxidation state precludes that gallium behaves as an iron analogue in every respect , it strongly interferes with cellular acquisition of iron from blood by competitive interaction with transferrin and transferrin receptor - mediated endocytosis .
【GOLD_E】
gallium	chem
iron	chem
transferrin	geneY
transferrinreceptor	geneN
【PRE_E】
trivalent	chem
gallium	chem
iron	chem
iron	chem
transferrin	geneN
transferrinreceptor	geneN
【GOLD_R】
【PRE_R】

Furthermore , gallium also seems to affect intracellular availability of iron already taken up via this pathway , probably due to its inhibitory activity on vacuolar - type H ( + ) - ATPases .
【GOLD_E】
gallium	chem
iron	chem
H(+)	chem
vacuolar-typeH(+)-ATPases	geneN
【PRE_E】
gallium	chem
iron	chem
vacuolar-typeH(+)-ATPases	geneN
【GOLD_R】
gallium	vacuolar-typeH(+)-ATPases	C4
【PRE_R】

Apart from the consequences of iron deprivation , gallium exerts cytotoxic effects by direct interaction with the iron - dependent enzyme ribonucleotide reductase , resulting in reduced dNTP pools and inhibition of DNA synthesis .
【GOLD_E】
iron	chem
gallium	chem
iron	chem
ribonucleotide	chem
ribonucleotidereductase	geneN
【PRE_E】
iron	chem
gallium	chem
iron-dependentenzymeribonucleotidereductase	geneN
dNTP	geneN
【GOLD_R】
【PRE_R】

Both the abundance of transferrin receptors and upregulation of ribonucleotide reductase render tumors susceptible to gallium - induced cytotoxicity .
【GOLD_E】
ribonucleotide	chem
transferrinreceptors	geneN
ribonucleotidereductase	geneN
gallium	chem
【PRE_E】
transferrinreceptors	geneN
ribonucleotidereductase	geneY
gallium	chem
【GOLD_R】
【PRE_R】

However , some experimental findings raise the question whether these effects resulting from the iron - mimicking properties of gallium are solely responsible for its antineoplastic activity or whether additional mechanisms are involved , such as antimitotic effects which result from its capability of inhibiting tubulin polymerization .
【GOLD_E】
tubulin	geneN
iron	chem
gallium	chem
【PRE_E】
iron	chem
gallium	chem
tubulin	geneN
【GOLD_R】
iron	tubulin	C4
gallium	tubulin	C4
【PRE_R】

The limitations experienced with gallium nitrate and gallium chloride , which call for a prolonged exposure to low steady - state gallium levels in blood in order to adequately exploit the affinity of gallium to tumor tissues and to avoid severe toxic effects , may be overcome by oral gallium complexes such as tris ( 3 - hydroxy - 2 - methyl - 4H - pyran - 4 - onato ) gallium ( III ) ( gallium maltolate ) or tris ( 8 - quinolinolato ) gallium ( III ) ( KP46 ) , which are currently being evaluated in clinical trials and show promise to initiate a revival of gallium in the clinical setting .
【GOLD_E】
gallium	chem
gallium	chem
tris(3-hydroxy-2-methyl-4H-pyran-4-onato)gallium(III)	chem
galliummaltolate	chem
tris(8-quinolinolato)gallium(III)	chem
KP46	chem
gallium	chem
galliumnitrate	chem
galliumchloride	chem
gallium	chem
【PRE_E】
galliumnitrate	chem
galliumchloride	chem
gallium	chem
gallium	chem
gallium	chem
tris(3-hydroxy-2-methyl-4H-pyran-4-onato)gallium(III)	chem
galliummaltolate	chem
tris(8-quinolinolato)gallium(III)	chem
KP46	chem
gallium	chem
【GOLD_R】
【PRE_R】

These two investigational drugs , albeit differing in their complex stability , have both been developed with the intention of providing gallium in a form which allows sufficient intestinal absorption , but without altering its pharmacodynamic effects .
【GOLD_E】
gallium	chem
【PRE_E】
gallium	chem
【GOLD_R】
【PRE_R】

Gallium complexes based on other rationales are scarce and , with regard to the well - known antineoplastic potential of this metal , noticeably under - explored .
【GOLD_E】
Gallium	chem
【PRE_E】
Gallium	chem
【GOLD_R】
【PRE_R】

With the recent approval of arsenic trioxide for the second - line treatment of acute promyelocytic leukemia , the clinical revival of arsenic compounds , which have been the mainstay of antileukemic therapy before the age of modern cancer chemotherapy , has already begun .
【GOLD_E】
trioxide	chem
arsenic	chem
【PRE_E】
arsenictrioxide	chem
arsenic	chem
antileukemic	chem
【GOLD_R】
【PRE_R】

Currently , strong efforts are being made to explore the activity spectrum in other ( less rare ) malignancies and to gain a deeper insight into the mode of action .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Although this development is currently focusing on arsenic trioxide , it should be suited to stimulate investigations into the therapeutic potential of other arsenic compounds as well .
【GOLD_E】
arsenictrioxide	chem
arsenic	chem
【PRE_E】
arsenictrioxide	chem
arsenic	chem
【GOLD_R】
【PRE_R】

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam .
【GOLD_E】
levetiracetam	chem
synapticvesicleproteinSV2A	geneY
【PRE_E】
SV2A	geneY
levetiracetam	chem
【GOLD_R】
【PRE_R】

Here , we show that the synaptic vesicle protein SV2A is the brain binding site of levetiracetam ( LEV ) , a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy .
【GOLD_E】
levetiracetam	chem
LEV	chem
synapticvesicleproteinSV2A	geneY
【PRE_E】
vesicleproteinSV2A	geneY
levetiracetam	chem
LEV	chem
【GOLD_R】
【PRE_R】

The LEV - binding site is enriched in synaptic vesicles , and photoaffinity labeling of purified synaptic vesicles confirms that it has an apparent molecular mass of approximately 90 kDa .
【GOLD_E】
LEV	chem
【PRE_E】
LEV-bindingsite	geneN
【GOLD_R】
【PRE_R】

Brain membranes and purified synaptic vesicles from mice lacking SV2A do not bind a tritiated LEV derivative , indicating that SV2A is necessary for LEV binding .
【GOLD_E】
SV2A	geneY
SV2A	geneY
LEV	chem
LEV	chem
【PRE_E】
SV2A	geneY
LEV	chem
SV2A	geneY
LEV	chem
【GOLD_R】
【PRE_R】

LEV and related compounds bind to SV2A expressed in fibroblasts , indicating that SV2A is sufficient for LEV binding .
【GOLD_E】
SV2A	geneY
SV2A	geneY
LEV	chem
LEV	chem
【PRE_E】
SV2A	geneY
SV2A	geneY
LEV	chem
【GOLD_R】
【PRE_R】

No binding was observed to the related isoforms SV2B and SV2C .
【GOLD_E】
SV2B	geneY
SV2C	geneY
【PRE_E】
No	chem
SV2B	geneY
SV2C	geneY
【GOLD_R】
【PRE_R】

Furthermore , there is a high degree of correlation between binding affinities of a series of LEV derivatives to SV2A in fibroblasts and to the LEV - binding site in brain .
【GOLD_E】
LEV	chem
SV2A	geneY
LEV	chem
【PRE_E】
LEV	chem
SV2A	geneY
LEV-bindingsite	geneN
【GOLD_R】
【PRE_R】

Finally , there is a strong correlation between the affinity of a compound for SV2A and its ability to protect against seizures in an audiogenic mouse animal model of epilepsy .
【GOLD_E】
SV2A	geneY
【PRE_E】
SV2A	geneY
【GOLD_R】
【PRE_R】

These experimental results suggest that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A , supporting previous indications that LEV possesses a mechanism of action distinct from that of other antiepileptic drugs .
【GOLD_E】
SV2A	geneY
SV2A	geneY
LEV	chem
LEV	chem
LEV	chem
【PRE_E】
SV2A	geneY
LEV	chem
LEV	chem
SV2A	geneY
LEV	chem
【GOLD_R】
【PRE_R】

Further , these results indicate that proteins involved in vesicle exocytosis , and SV2 in particular , are promising targets for the development of new CNS drug therapies .
【GOLD_E】
SV2	geneN
【PRE_E】
SV2	geneN
【GOLD_R】
【PRE_R】

Electrophysiological properties of mouse horizontal cell GABAA receptors .
【GOLD_E】
GABAAreceptors	geneN
【PRE_E】
mousehorizontalcellGABAAreceptors	geneY
【GOLD_R】
【PRE_R】

GABA - induced currents have been characterized in isolated horizontal cells from lower vertebrates but not in mammalian horizontal cells .
【GOLD_E】
GABA	chem
【PRE_E】
GABA	chem
【GOLD_R】
【PRE_R】

Therefore horizontal cells were isolated after enzymatical and mechanical dissociation of the adult mouse retina and visually identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We recorded from horizontal cell bodies using the whole cell and outside - out configuration of the patch - clamp technique .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Extracellular application of GABA induced inward currents carried by chloride ions .
【GOLD_E】
chloride	chem
GABA	chem
【PRE_E】
GABA	chem
chloride	chem
【GOLD_R】
【PRE_R】

GABA - evoked currents were completely and reversibly blocked by the competitive GABAA receptor antagonist bicuculline ( IC50 = 1.7 microM ) , indicating expression of GABAA but not GABAC receptors .
【GOLD_E】
GABA	chem
bicuculline	chem
GABAAreceptor	geneN
GABAA	geneN
GABACreceptors	geneN
【PRE_E】
GABA	chem
GABAA	geneY
bicuculline	chem
GABAA	geneY
GABACreceptors	geneN
【GOLD_R】
bicuculline	GABAAreceptor	C6
【PRE_R】
GABAA	bicuculline	C6
bicuculline	GABAA	C6

Their affinity for GABA was moderate ( EC50 = 30 microM ) , and the Hill coefficient was 1.3 , corresponding to two GABA binding sites .
【GOLD_E】
GABA	chem
GABA	chem
GABAbindingsites	geneN
【PRE_E】
GABA	chem
GABA	chem
【GOLD_R】
【PRE_R】

GABA responses were partially reduced by picrotoxin with differential effects on peak and steady - state current values .
【GOLD_E】
GABA	chem
picrotoxin	chem
【PRE_E】
GABA	chem
picrotoxin	chem
【GOLD_R】
【PRE_R】

Zinc blocked the GABA response with an IC50 value of 7.3 microM in a noncompetitive manner .
【GOLD_E】
Zinc	chem
GABA	chem
【PRE_E】
Zinc	chem
GABA	chem
【GOLD_R】
【PRE_R】

Furthermore , GABA receptors of horizontal cells were modulated by extracellular application of diazepam , zolpidem , methyl 6,7 - dimethoxy - 4 - ethyl - beta - carboxylate , pentobarbital , and alphaxalone , thus showing typical pharmacological properties of CNS GABAA receptors .
【GOLD_E】
GABAreceptors	geneN
GABAAreceptors	geneN
GABA	chem
diazepam	chem
zolpidem	chem
methyl6,7-dimethoxy-4-ethyl-beta-carboxylate	chem
pentobarbital	chem
alphaxalone	chem
【PRE_E】
GABAreceptors	geneN
diazepam	chem
zolpidem	chem
methyl6,7-dimethoxy-4-ethyl-beta-carboxylate	chem
pentobarbital	chem
alphaxalone	chem
GABAAreceptors	geneN
【GOLD_R】
【PRE_R】

GABA - evoked single - channel currents were characterized by a main conductance state of 29.8 pS and two subconductance states ( 20.2 and 10.8 pS , respectively ) .
【GOLD_E】
GABA	chem
【PRE_E】
GABA	chem
【GOLD_R】
【PRE_R】

Kinetic analysis of single - channel events within bursts revealed similar mean open and closed times for the main conductance and the 20.2 - pS subconductance state , resulting in open probabilities of 44.6 and 42.7 % , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The ratio of open to closed times , however , was significantly different for the 10.8 - pS subconductance state with an open probability of 57.2 % .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Decreased histamine H1 receptor binding in the brain of depressed patients .
【GOLD_E】
histamineH1receptor	geneY
histamine	chem
【PRE_E】
histamineH1receptor	geneY
【GOLD_R】
【PRE_R】

The central histaminergic neuron system modulates the wakefulness , sleep - awake cycle , appetite control , learning and memory , and emotion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Previous studies have reported changes in neuronal histamine release and its metabolism under stress conditions in the mammalian brain .
【GOLD_E】
histamine	chem
【PRE_E】
histamine	chem
【GOLD_R】
【PRE_R】

In this study , we examined , using positron emission tomography ( PET ) and [ ( 11 ) C ] - doxepin , whether the histaminergic neuron system is involved in human depression .
【GOLD_E】
[(11)C]-doxepin	chem
【PRE_E】
[(11)C]-doxepin	chem
【GOLD_R】
【PRE_R】

Cerebral histamine H1 receptor ( H ( 1 ) R ) binding was measured in 10 patients with major depression and in 10 normal age - matched subjects using PET and [ ( 11 ) C ] - doxepin .
【GOLD_E】
histamineH1receptor	geneY
H(1)R	geneY
histamine	chem
[(11)C]-doxepin	chem
【PRE_E】
histamineH1receptor	geneY
H(1)R	geneY
[(11)C]-doxepin	chem
【GOLD_R】
【PRE_R】

Data were calculated by a graphical analysis on voxel - by - voxel and ROI ( region of interests ) basis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Binding potential ( BP ) values for [ ( 11 ) C ] - doxepin binding in the frontal and prefrontal cortices , and cingulate gyrus were significantly lower in the depressed patients than those in the normal control subjects .
【GOLD_E】
[(11)C]-doxepin	chem
【PRE_E】
[(11)C]-doxepin	chem
【GOLD_R】
【PRE_R】

There was no area of the brain where [ ( 11 ) C ] - doxepin binding was significantly higher in the depressed patients than in the controls .
【GOLD_E】
[(11)C]-doxepin	chem
【PRE_E】
[(11)C]-doxepin	chem
【GOLD_R】
【PRE_R】

ROI - based analysis also revealed that BP values for [ ( 11 ) C ] - doxepin binding in the frontal cortex and cingulate gyrus decreased in proportion to self - rating depressive scales scores .
【GOLD_E】
[(11)C]-doxepin	chem
【PRE_E】
[(11)C]-doxepin	chem
【GOLD_R】
【PRE_R】

The results of this study demonstrate that depressed patients have decreased brain H ( 1 ) R binding and that this decrease correlates with the severity of depression symptoms .
【GOLD_E】
H(1)R	geneY
【PRE_E】
H(1)R	geneY
【GOLD_R】
【PRE_R】

It is therefore suggested that the histaminergic neuron system plays an important role in the pathophysiology of depression and that its modulation may prove to be useful in the treatment of depression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Central effects of fexofenadine and cetirizine : measurement of psychomotor performance , subjective sleepiness , and brain histamine H1 - receptor occupancy using 11C - doxepin positron emission tomography .
【GOLD_E】
histamine	chem
11C-doxepin	chem
fexofenadine	chem
cetirizine	chem
histamineH1-receptor	geneY
【PRE_E】
fexofenadine	chem
cetirizine	chem
histamineH1-receptor	geneY
11C-doxepin	chem
【GOLD_R】
【PRE_R】

Histamine H1 - receptor ( H1R ) antagonists , or antihistamines , often induce sedative side effects when used for the treatment of allergic disorders .
【GOLD_E】
antihistamines	chem
Histamine	chem
HistamineH1-receptor	geneY
H1R	geneY
【PRE_E】
HistamineH1-receptor	geneY
H1R	geneY
【GOLD_R】
antihistamines	HistamineH1-receptor	C6
antihistamines	H1R	C6
【PRE_R】

This study compared the sedative profiles of the second - generation antihistamines , fexofenadine and cetirizine , using 3 different criteria : subjective sleepiness evaluated by the Stanford Sleepiness Scale , objective psychomotor tests ( simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations ) , and measurement of histamine H1 - receptor occupancy ( H1RO ) in the brain .
【GOLD_E】
antihistamines	chem
fexofenadine	chem
cetirizine	chem
histamine	chem
histamineH1-receptor	geneY
【PRE_E】
fexofenadine	chem
cetirizine	chem
histamineH1-receptor	geneY
【GOLD_R】
【PRE_R】

Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double - blind , placebo - controlled crossover study .
【GOLD_E】
fexofenadine	chem
cetirizine	chem
【PRE_E】
fexofenadine	chem
cetirizine	chem
【GOLD_R】
【PRE_R】

Hydroxyzine 30 mg was included as a positive control .
【GOLD_E】
Hydroxyzine	chem
【PRE_E】
Hydroxyzine	chem
【GOLD_R】
【PRE_R】

H1RO was measured using positron emission tomography ( PET ) with ( 11 ) C - doxepin in 12 of the 20 subjects , and a further 11 volunteers were recruited to act as controls .
【GOLD_E】
(11)C-doxepin	chem
【PRE_E】
H1RO	chem
(11)C-doxepin	chem
【GOLD_R】
【PRE_R】

In psychomotor tests , fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks , as well as significantly less impairing than hydroxyzine on all tasks .
【GOLD_E】
fexofenadine	chem
cetirizine	chem
hydroxyzine	chem
【PRE_E】
fexofenadine	chem
cetirizine	chem
hydroxyzine	chem
【GOLD_R】
【PRE_R】

For subjective sleepiness , fexofenadine was not significantly different from placebo , whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo .
【GOLD_E】
fexofenadine	chem
cetirizine	chem
fexofenadine	chem
【PRE_E】
fexofenadine	chem
cetirizine	chem
fexofenadine	chem
【GOLD_R】
【PRE_R】

H1RO was negligible with fexofenadine ( - 0.1 % ) but moderately high with cetirizine ( 26.0 % ) .
【GOLD_E】
fexofenadine	chem
cetirizine	chem
【PRE_E】
H1RO	chem
fexofenadine	chem
cetirizine	chem
【GOLD_R】
【PRE_R】

In conclusion , fexofenadine 120 mg is distinguishable from cetirizine 20 mg , as assessed by H1RO and psychomotor testing .
【GOLD_E】
fexofenadine	chem
cetirizine	chem
【PRE_E】
fexofenadine	chem
cetirizine	chem
H1RO	chem
【GOLD_R】
【PRE_R】

A novel membrane sensor for histamine H1 - receptor antagonist `` fexofenadine `` .
【GOLD_E】
histamine	chem
`fexofenadin	chem
histamineH1-receptor	geneY
【PRE_E】
histamineH1-receptor	geneY
fexofenadine	chem
【GOLD_R】
`fexofenadin	histamineH1-receptor	C6
【PRE_R】

The construction and general performance of thirteen new polymeric membrane sensors for the determination of fexofenadine hydrochloride based on its ion exchange with reineckate , tetraphenylborate and tetraiodomercurate have been studied .
【GOLD_E】
fexofenadinehydrochloride	chem
tetraphenylborate	chem
tetraiodomercurate	chem
【PRE_E】
fexofenadinehydrochloride	chem
reineckate	chem
tetraphenylborate	chem
tetraiodomercurate	chem
【GOLD_R】
【PRE_R】

The effects of membrane composition , type of plasticizer , pH value of sample solution and concentration of the analyte in the sensor internal solution have been thoroughly investigated .
【GOLD_E】
【PRE_E】
plasticizer	chem
【GOLD_R】
【PRE_R】

The novel sensor based on reineckate exchanger shows a stable , potentiometric response for fexofenadine in the concentration range of 1 x 10 ( - 2 ) - 2.5 x 10 ( - 6 ) M at 25 degrees C that is independent of pH in the range of 2.0 - 4.5 .
【GOLD_E】
fexofenadine	chem
【PRE_E】
reineckateexchanger	geneN
fexofenadine	chem
【GOLD_R】
【PRE_R】

The sensor possesses a Nernstian cationic slope of 62.3 + / - 0.7 mV / concentration decade and a lower detection limit of 1.3 x 10 ( - 6 ) M with a fast response time of 20 - 40 s .
【GOLD_E】
【PRE_E】
Nernstian	chem
【GOLD_R】
【PRE_R】

Selectivity coefficients for a number of interfering ions and excipients relative to fexofenadine were investigated .
【GOLD_E】
fexofenadine	chem
【PRE_E】
fexofenadine	chem
【GOLD_R】
【PRE_R】

There is negligible interference from almost all studied cations , anions , and pharmaceutical excipients , however , citrizine that has a structure homologous to that of fexofenadine was found to interfere .
【GOLD_E】
citrizine	chem
fexofenadine	chem
【PRE_E】
citrizine	chem
fexofenadine	chem
【GOLD_R】
【PRE_R】

The determination of fexofenadine in aqueous solution shows an average recovery of 99.83 % with a mean relative standard deviation ( RSD ) of 0.5 % .
【GOLD_E】
fexofenadine	chem
【PRE_E】
fexofenadine	chem
【GOLD_R】
【PRE_R】

Direct potentiometric determination of fexofenadine in tablets gave results that compare favorably with those obtained by standard spectrophotometric methods .
【GOLD_E】
fexofenadine	chem
【PRE_E】
fexofenadine	chem
【GOLD_R】
【PRE_R】

Potentiometric titration of fexofenadine with phosphomolybdic acid as a titrant has been monitored with the proposed sensor as an end point indicator electrode .
【GOLD_E】
fexofenadine	chem
phosphomolybdicacid	chem
【PRE_E】
fexofenadine	chem
phosphomolybdicacid	chem
【GOLD_R】
【PRE_R】

Thymidylate synthase : a critical target in cancer therapy ?
【GOLD_E】
Thymidylate	chem
Thymidylatesynthase	geneY
【PRE_E】
Thymidylatesynthase	geneY
【GOLD_R】
【PRE_R】

For the last four decades , synthesis and testing of potentially active drugs ( e.g . , antimetabolites ) have focused on structural modification of existing metabolites as precursors of DNA and RNA synthesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In recent years , the focus has shifted to synthesis of target - specific agents .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , the current emphasis of drug development is directed at inhibiting specific target ( s ) expressed preferentially , if not exclusively , in tumor tissues , with the ultimate goal of improving the therapeutic efficacy and selectivity of these new agents .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Preclinically , proof - of - principle studies were carried out in tumors with specific expression of the intended target .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

With the hope of translating preclinical findings to the design of implementation of clinical trials .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thymidylate synthase ( TS ) continues to be a critical target for 5 - fluorouracil ( 5 - FU ) and its prodrugs , UFT / LV ( Orzel ) , capecitabine ( Xeloda ) , and S - 1 , primarily because this enzyme is essential for the synthesis of 2 - deoxythymidine - 5 - monophosphate , a precursor for DNA synthesis .
【GOLD_E】
Thymidylate	chem
5-fluorouracil	chem
5-FU	chem
UFT	chem
LV	chem
Orzel	chem
capecitabine	chem
Xeloda	chem
S-1	chem
2-deoxythymidine-5-monophosphate	chem
Thymidylatesynthase	geneY
TS	geneY
【PRE_E】
Thymidylatesynthase	geneY
TS	geneY
5-fluorouracil	chem
5-FU	chem
UFT	chem
LV	chem
Orzel	chem
capecitabine	chem
Xeloda	chem
2-deoxythymidine-5-monophosphate	chem
【GOLD_R】
2-deoxythymidine-5-monophosphate	Thymidylatesynthase	C9
2-deoxythymidine-5-monophosphate	TS	C9
【PRE_R】

While fluoropyrimidine antimetabolites have other sites of action , antifolates ZD1694 ( raltitrexed , Tomudex ) and AG337 ( Thymitag ) are more specific and potent TS inhibitors .
【GOLD_E】
fluoropyrimidine	chem
TS	geneY
ZD1694	chem
raltitrexed	chem
Tomudex	chem
AG337	chem
Thymitag	chem
【PRE_E】
fluoropyrimidine	chem
antifolatesZD1694	chem
raltitrexed	chem
Tomudex	chem
AG337	chem
Thymitag	chem
TS	geneY
【GOLD_R】
ZD1694	TS	C4
raltitrexed	TS	C4
Tomudex	TS	C4
AG337	TS	C4
Thymitag	TS	C4
【PRE_R】
fluoropyrimidine	TS	C4
antifolatesZD1694	TS	C4
raltitrexed	TS	C4
Tomudex	TS	C4
AG337	TS	C4
Thymitag	TS	C4

Thus , it is hoped that pronounced and sustained inhibition of this enzyme could result in downstream regulation of molecular markers associated with sensitivity and resistance to these agents .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It is also critical to recognize that the degree and duration of inhibition of the target enzyme may depend on the expression level of the target enzyme , thymidylate synthase .
【GOLD_E】
thymidylatesynthase	geneY
【PRE_E】
thymidylatesynthase	geneY
【GOLD_R】
【PRE_R】

Correlative studies in preclinical and clinical systems demonstrated a close relationship between the enzyme level ( mRNA and protein ) and response to therapy of colorectal cancer patients treated with fluoropyrimidine or Tomudex .
【GOLD_E】
fluoropyrimidine	chem
Tomudex	chem
【PRE_E】
fluoropyrimidine	chem
Tomudex	chem
【GOLD_R】
【PRE_R】

However , significant overlap was demonstrated between responders and non - responders .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These data are consistent with the hypothesis that prediction of response to anticancer drugs is multifactorial , and TS is one target .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

Clinically , although overall response of colorectal cancer patients to a variety of TS inhibitors is similar , toxicity profiles are different .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

The availability of the 5 - FU prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that thymidine phosphorylase , the activating enzyme for 5 - FU , is expressed at a higher level in tumor tissue compared with normal tissue counterparts .
【GOLD_E】
thymidine	chem
5-FU	chem
thymidinephosphorylase	geneY
5-FU	chem
【PRE_E】
5-FU	chem
thymidinephosphorylase	geneY
5-FU	chem
【GOLD_R】
5-FU	thymidinephosphorylase	C9
【PRE_R】

It is likely that successful application of TS inhibitors will not only be based on measurement of the TS level in tumors vs. normal tissues , but on the delineation of the consequences of this inhibition on molecular markers associated with cellular proliferation , apoptosis and cell cycle regulation .
【GOLD_E】
TS	geneY
TS	geneY
【PRE_E】
TS	geneY
TS	geneY
【GOLD_R】
【PRE_R】

[ Pharmacological treatment of obesity ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The pharmacological treatment of obesity should be considered when can not be achieved a 10 % weight loss with diet therapy and physical activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The drugs effective in obesity treatment may act by different mechanisms such as reduction in food intake , inhibition of fat absorption , increase of thermogenesis and stimulation of adipocyte apoptosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

At present , we only have two marketed drugs for obesity treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sibutramine is an inhibitor of norepinephrine , dopamine and serotonina reuptake which inhibits food intake and increases thermogenesis .
【GOLD_E】
Sibutramine	chem
norepinephrine	chem
dopamine	chem
【PRE_E】
Sibutramine	chem
norepinephrine	chem
dopamine	chem
serotonina	chem
【GOLD_R】
【PRE_R】

Sibutramine administration for a year can induce a weight loss of 4 - 7 % .
【GOLD_E】
Sibutramine	chem
【PRE_E】
Sibutramine	chem
【GOLD_R】
【PRE_R】

Its main side effects are hypertension , headache , insomnia and constipation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Orlistat is an inhibitor of pancreatic lipase which is able to block the absorption of 30 % of ingested fat .
【GOLD_E】
pancreaticlipase	geneN
Orlistat	chem
【PRE_E】
Orlistat	chem
pancreaticlipase	geneY
【GOLD_R】
Orlistat	pancreaticlipase	C4
【PRE_R】
Orlistat	pancreaticlipase	C4

Its administration induces weight loss and reduction of ulterior weight regain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Also , this drug improves hypertension dyslipdaemia and helps to prevent diabetes in 52 % of cases when administered over four years .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The increase in frequency of stools and interference with vitamin absorption are its main side effects .
【GOLD_E】
【PRE_E】
vitamin	chem
【GOLD_R】
【PRE_R】

Glucagon - like peptide 1 , which increases insulin sensitivity and satiety , adiponectin and PPAR - gamma agonists which reduce insulin resistance and modulates adipocyte generation are the basis for future therapeutic approaches of obesity .
【GOLD_E】
insulin	geneY
Glucagon-likepeptide1	geneY
insulin	geneY
adiponectin	geneY
PPAR-gamma	geneY
【PRE_E】
Glucagon-likepeptide1	geneY
insulin	geneY
adiponectin	geneY
PPAR-gamma	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Phosphatase inhibitors induce PPAR - gamma phosphorylation and UCP - 1 expression leading to an increase in thermogenesis and reduction in appetite .
【GOLD_E】
Phosphatase	geneN
PPAR-gamma	geneY
UCP-1	geneY
【PRE_E】
Phosphatase	geneN
PPAR-gamma	geneY
UCP-1	geneY
【GOLD_R】
【PRE_R】

Viability assessment in sandwich - cultured rat hepatocytes after xenobiotic exposure .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Troglitazone , bosentan and glibenclamide inhibit the bile salt export pump ( Bsep ) which transports taurocholate into bile .
【GOLD_E】
taurocholate	chem
Troglitazone	chem
bilesaltexportpump	geneY
Bsep	geneY
bosentan	chem
glibenclamide	chem
【PRE_E】
Troglitazone	chem
bosentan	chem
glibenclamide	chem
Bsep	geneY
taurocholate	chem
【GOLD_R】
Troglitazone	bilesaltexportpump	C4
Troglitazone	Bsep	C4
bosentan	bilesaltexportpump	C4
bosentan	Bsep	C4
glibenclamide	bilesaltexportpump	C4
glibenclamide	Bsep	C4
taurocholate	bilesaltexportpump	C9
taurocholate	Bsep	C9
【PRE_R】
Troglitazone	Bsep	C4
bosentan	Bsep	C4
glibenclamide	Bsep	C4

Sandwich - cultured rat hepatocytes maintain functional sodium taurocholate co - transporting polypeptide and Bsep transport proteins , and may be useful to study inhibition of transport by xenobiotics at concentrations below the lowest observable adverse effect level ( LOAEL ) .
【GOLD_E】
sodiumtaurocholateco-transportingpolypeptide	geneY
Bsep	geneY
sodiumtaurocholate	chem
【PRE_E】
sodiumtaurocholateco-transportingpolypeptide	geneN
Bsep	geneY
LOAEL	chem
【GOLD_R】
【PRE_R】

The purpose of this study was to compare viability assessments determined with the neutral red , lactate dehydrogenase ( LDH ) , alamar blue , 3 - [ 4,5 - dimethylthiazol - 2 - yl ] - 2,5 - diphenyltetrazolium bromide ( MTT ) and propidium iodide assays in sandwich - cultured rat hepatocytes following exposure to xenobiotics known to inhibit Bsep , and to define the LOAEL for these xenobiotics in this system .
【GOLD_E】
lactate	chem
alamarblue	chem
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide	chem
MTT	chem
propidiumiodide	chem
lactatedehydrogenase	geneN
LDH	geneN
Bsep	geneY
【PRE_E】
lactatedehydrogenase	geneN
LDH	geneN
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide	chem
MTT	chem
propidiumiodide	chem
Bsep	geneY
LOAEL	chem
【GOLD_R】
【PRE_R】
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide	Bsep	C4
MTT	Bsep	C4

The neutral red assay was not amenable to use in this model due to crystal formation on the collagen .
【GOLD_E】
collagen	geneN
【PRE_E】
collagen	geneN
【GOLD_R】
【PRE_R】

Troglitazone decreased viability in every assay examined , with a LOAEL approximately 100 microM .
【GOLD_E】
Troglitazone	chem
【PRE_E】
Troglitazone	chem
LOAEL	chem
【GOLD_R】
【PRE_R】

Bosentan also decreased viability as measured by the LDH , MTT and propidium iodide assays , with a LOAEL approximately 200 microM ; however , a significant decrease in viability was not observed with the alamar blue assay .
【GOLD_E】
Bosentan	chem
LDH	geneN
MTT	chem
propidiumiodide	chem
alamarblue	chem
【PRE_E】
Bosentan	chem
LDH	geneN
MTT	chem
propidiumiodide	chem
LOAEL	chem
【GOLD_R】
【PRE_R】

Glibenclamide did not decrease viability with any assay at the xenobiotic concentrations examined in this study .
【GOLD_E】
Glibenclamide	chem
【PRE_E】
Glibenclamide	chem
【GOLD_R】
【PRE_R】

Based on the results of this study , the LDH or propidium iodide assays would be the methods of choice to assess viability in sandwich - cultured rat hepatocytes after xenobiotic exposure .
【GOLD_E】
LDH	geneN
propidiumiodide	chem
【PRE_E】
LDH	geneN
propidiumiodide	chem
【GOLD_R】
【PRE_R】

Valdecoxib : assessment of cyclooxygenase - 2 potency and selectivity .
【GOLD_E】
Valdecoxib	chem
cyclooxygenase-2	geneY
【PRE_E】
Valdecoxib	chem
cyclooxygenase-2	geneY
【GOLD_R】
【PRE_R】
Valdecoxib	cyclooxygenase-2	C4

The discovery of a second isoform of cyclooxygenase ( COX ) led to the search for compounds that could selectively inhibit COX - 2 in humans while sparing prostaglandin formation from COX - 1 .
【GOLD_E】
prostaglandin	chem
COX-2	geneY
COX-1	geneY
secondisoformofcyclooxygenase	geneY
COX	geneN
【PRE_E】
cyclooxygenase	geneN
COX	geneN
COX-2	geneY
prostaglandin	chem
COX-1	geneY
【GOLD_R】
prostaglandin	COX-1	C9
【PRE_R】

Celecoxib and rofecoxib were among the molecules developed from these efforts .
【GOLD_E】
Celecoxib	chem
rofecoxib	chem
【PRE_E】
Celecoxib	chem
rofecoxib	chem
【GOLD_R】
【PRE_R】

We report here the pharmacological properties of a third selective COX - 2 inhibitor , valdecoxib , which is the most potent and in vitro selective of the marketed COX - 2 inhibitors that we have studied .
【GOLD_E】
valdecoxib	chem
COX-2	geneY
COX-2	geneY
【PRE_E】
COX-2	geneY
valdecoxib	chem
COX-2	geneY
【GOLD_R】
valdecoxib	COX-2	C4
valdecoxib	COX-2	C4
【PRE_R】
COX-2	valdecoxib	C4
valdecoxib	COX-2	C4

Recombinant human COX - 1 and COX - 2 were used to screen for new highly potent and in vitro selective COX - 2 inhibitors and compare kinetic mechanisms of binding and enzyme inhibition with other COX inhibitors .
【GOLD_E】
humanCOX-1	geneY
COX-2	geneY
COX-2	geneY
COX	geneN
【PRE_E】
humanCOX-1	geneY
COX-2	geneY
COX-2	geneY
COX	geneN
【GOLD_R】
【PRE_R】

Valdecoxib potently inhibits recombinant COX - 2 , with an IC ( 50 ) of 0.005 microM ; this compares with IC values of 0.05 microM for celecoxib , 0.5 microM for rofecoxib , and 5 microM for etoricoxib .
【GOLD_E】
Valdecoxib	chem
celecoxib	chem
rofecoxib	chem
etoricoxib	chem
COX-2	geneY
【PRE_E】
Valdecoxib	chem
COX-2	geneY
celecoxib	chem
rofecoxib	chem
etoricoxib	chem
【GOLD_R】
Valdecoxib	COX-2	C4
celecoxib	COX-2	C4
rofecoxib	COX-2	C4
etoricoxib	COX-2	C4
【PRE_R】
Valdecoxib	COX-2	C4
COX-2	celecoxib	C4
COX-2	rofecoxib	C4
COX-2	etoricoxib	C4

Unique binding interactions of valdecoxib with COX - 2 translate into a fast rate of inactivation of COX - 2 ( 110,000 M / s compared with 7000 M / s for rofecoxib and 80 M / s for etoricoxib ) .
【GOLD_E】
rofecoxib	chem
valdecoxib	chem
etoricoxib	chem
COX-2	geneY
COX-2	geneY
【PRE_E】
valdecoxib	chem
COX-2	geneY
COX-2	geneY
rofecoxib	chem
etoricoxib	chem
【GOLD_R】
valdecoxib	COX-2	C4
【PRE_R】
valdecoxib	COX-2	C4
COX-2	rofecoxib	C4
COX-2	etoricoxib	C4

The overall saturation binding affinity for COX - 2 of valdecoxib is 2.6 nM ( compared with 1.6 nM for celecoxib , 51 nM for rofecoxib , and 260 nM for etoricoxib ) , with a slow off - rate ( t ( 1 / 2 ) approximately 98 min ) .
【GOLD_E】
COX-2	geneY
valdecoxib	chem
celecoxib	chem
rofecoxib	chem
etoricoxib	chem
【PRE_E】
COX-2	geneY
valdecoxib	chem
celecoxib	chem
rofecoxib	chem
etoricoxib	chem
【GOLD_R】
【PRE_R】

Valdecoxib inhibits COX - 1 in a competitive fashion only at very high concentrations ( IC ( 50 ) = 150 microM ) .
【GOLD_E】
COX-1	geneY
Valdecoxib	chem
【PRE_E】
Valdecoxib	chem
COX-1	geneY
【GOLD_R】
Valdecoxib	COX-1	C4
【PRE_R】
Valdecoxib	COX-1	C4

Collectively , these data provide a mechanistic basis for the potency and in vitro selectivity of valdecoxib for COX - 2 .
【GOLD_E】
COX-2	geneY
valdecoxib	chem
【PRE_E】
valdecoxib	chem
COX-2	geneY
【GOLD_R】
【PRE_R】
valdecoxib	COX-2	C4

Valdecoxib showed similar activity in the human whole - blood COX assay ( COX - 2 IC ( 50 ) = 0.24 microM ; COX - 1 IC ( 50 ) = 21.9 microM ) .
【GOLD_E】
humanwhole-bloodCOX	geneN
COX-2	geneY
COX-1	geneY
Valdecoxib	chem
【PRE_E】
Valdecoxib	chem
COX	geneN
COX-2	geneY
COX-1	geneY
【GOLD_R】
Valdecoxib	humanwhole-bloodCOX	C4
Valdecoxib	COX-2	C4
Valdecoxib	COX-1	C4
【PRE_R】
Valdecoxib	COX	C4
Valdecoxib	COX-2	C4
Valdecoxib	COX-1	C4

We also determined whether this in vitro potency and selectivity translated to significant potency in vivo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In rats , valdecoxib demonstrated marked potency in acute and chronic models of inflammation ( air pouch ED ( 50 ) = 0.06 mg / kg ; paw edema ED ( 50 ) = 5.9 mg / kg ; adjuvant arthritis ED ( 50 ) = 0.03 mg / kg ) .
【GOLD_E】
valdecoxib	chem
【PRE_E】
valdecoxib	chem
【GOLD_R】
【PRE_R】

In these same animals , COX - 1 was spared at doses greater than 200 mg / kg .
【GOLD_E】
COX-1	geneY
【PRE_E】
COX-1	geneY
【GOLD_R】
【PRE_R】

These data provide a basis for the observed potent anti - inflammatory activity of valdecoxib in humans .
【GOLD_E】
valdecoxib	chem
【PRE_E】
valdecoxib	chem
【GOLD_R】
【PRE_R】

An angiotensin II AT1 receptor antagonist , telmisartan augments glucose uptake and GLUT4 protein expression in 3T3 - L1 adipocytes .
【GOLD_E】
telmisartan	chem
glucose	chem
angiotensinIIAT1receptor	geneY
GLUT4	geneY
angiotensinII	chem
【PRE_E】
angiotensinIIAT1receptor	geneY
telmisartan	chem
glucose	chem
GLUT4	geneY
【GOLD_R】
telmisartan	GLUT4	C3
telmisartan	angiotensinIIAT1receptor	C6
glucose	GLUT4	C9
【PRE_R】

Evidence has accumulated that some of the angiotensin II AT1 receptor antagonists have insulin - sensitizing property .
【GOLD_E】
angiotensinIIAT1receptor	geneY
insulin	geneN
angiotensinII	chem
【PRE_E】
angiotensinIIAT1receptor	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

We thus examined the effect of telmisartan on insulin action using 3T3 - L1 adipocytes .
【GOLD_E】
insulin	geneN
telmisartan	chem
【PRE_E】
telmisartan	chem
insulin	geneY
【GOLD_R】
【PRE_R】

With standard differentiation inducers , a higher dose of telmisartan effectively facilitated differentiation of 3T3 - L1 preadipocytes .
【GOLD_E】
telmisartan	chem
【PRE_E】
telmisartan	chem
【GOLD_R】
【PRE_R】

Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose - dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin .
【GOLD_E】
PPARgamma	geneY
aP2	geneY
adiponectin	geneY
telmisartan	chem
【PRE_E】
telmisartan	chem
PPARgamma	geneY
aP2	geneY
adiponectin	geneY
【GOLD_R】
telmisartan	PPARgamma	C3
telmisartan	aP2	C3
telmisartan	adiponectin	C3
【PRE_R】
telmisartan	PPARgamma	C3
telmisartan	aP2	C3
telmisartan	adiponectin	C3

By contrast , telmisartan attenuated 11beta - hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes .
【GOLD_E】
11beta-hydroxysteroiddehydrogenasetype1	geneY
telmisartan	chem
11beta-hydroxysteroid	chem
【PRE_E】
telmisartan	chem
11beta-hydroxysteroiddehydrogenasetype1	geneY
【GOLD_R】
telmisartan	11beta-hydroxysteroiddehydrogenasetype1	C3
【PRE_R】
telmisartan	11beta-hydroxysteroiddehydrogenasetype1	C4

Of note , we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2 - deoxy glucose uptake both in basal and insulin - stimulated state of adipocytes , which may contribute , at least partly , to its insulin - sensitizing ability .
【GOLD_E】
GLUT4	geneY
insulin	geneN
insulin	geneN
telmisartan	chem
2-deoxyglucose	chem
【PRE_E】
telmisartan	chem
GLUT4	geneY
2-deoxyglucose	chem
insulin	geneY
insulin	geneN
【GOLD_R】
telmisartan	GLUT4	C3
2-deoxyglucose	GLUT4	C9
【PRE_R】
telmisartan	GLUT4	C3
telmisartan	insulin	C3
telmisartan	insulin	C3

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma .
【GOLD_E】
albuterol	chem
【PRE_E】
albuterol	chem
【GOLD_R】
【PRE_R】

BACKGROUND : In the United States , Puerto Ricans and Mexicans have the highest and lowest asthma prevalence , morbidity , and mortality , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ethnic - specific differences in the response to drug treatment may contribute to differences in disease outcomes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Genetic variants at the beta ( 2 ) - adrenergic receptor ( beta ( 2 ) AR ) may modify asthma severity and albuterol responsiveness .
【GOLD_E】
beta(2)-adrenergicreceptor	geneY
beta(2)AR	geneY
albuterol	chem
【PRE_E】
beta(2)-adrenergicreceptor	geneY
beta(2)AR	geneY
albuterol	chem
【GOLD_R】
【PRE_R】

We tested the association of beta ( 2 ) AR genotypes with asthma severity and bronchodilator response to albuterol in Puerto Ricans and Mexicans with asthma .
【GOLD_E】
beta(2)AR	geneY
albuterol	chem
【PRE_E】
beta(2)AR	geneY
albuterol	chem
【GOLD_R】
【PRE_R】

METHODS : We used both family - based and cross - sectional tests of association with 8 beta ( 2 ) AR single nucleotide polymorphisms in 684 Puerto Rican and Mexican families .
【GOLD_E】
beta(2)AR	geneY
nucleotide	chem
【PRE_E】
AR	geneY
nucleotide	chem
【GOLD_R】
【PRE_R】

Regression analyses were used to determine the interaction between genotype , asthma severity , and bronchodilator drug responsiveness .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Among Puerto Ricans with asthma , the arginine ( Arg ) 16 allele was associated with greater bronchodilator response using both family - based and cross - sectional tests ( p = 0.00001 - 0.01 ) .
【GOLD_E】
arginine	chem
Arg	chem
【PRE_E】
arginine	chem
【GOLD_R】
【PRE_R】

We found a strong interaction of baseline FEV ( 1 ) with the Arg16Glycine ( Gly ) polymorphism in predicting bronchodilator response .
【GOLD_E】
Gly	chem
Arg16Glycine	geneN
【PRE_E】
FEV(1)	chem
Arg16Glycine	chem
Gly	chem
【GOLD_R】
【PRE_R】

Among Puerto Ricans with asthma with baseline FEV ( 1 ) < 80 % of predicted , but not in those with FEV ( 1 ) > 80 % , there was a very strong association between the Arg16 genotype and greater bronchodilator responsiveness .
【GOLD_E】
【PRE_E】
FEV(1)	geneY
Arg16	geneY
【GOLD_R】
【PRE_R】

No association was observed between Arg16Gly genotypes and drug responsiveness among Mexicans with asthma .
【GOLD_E】
Arg16Gly	geneN
【PRE_E】
Arg16Gly	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS : Ethnic - specific pharmacogenetic differences exist between Arg16Gly genotypes , asthma severity , and bronchodilator response in Puerto Ricans and Mexicans with asthma .
【GOLD_E】
Arg16Gly	geneN
【PRE_E】
Arg16Gly	geneY
【GOLD_R】
【PRE_R】

These findings underscore the need for additional research on racial / ethnic differences in asthma morbidity and drug responsiveness .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Tyrosinase inhibitors from Rhododendron collettianum and their structure - activity relationship ( SAR ) studies .
【GOLD_E】
Tyrosinase	geneY
【PRE_E】
Tyrosinase	geneY
【GOLD_R】
【PRE_R】

A new coumarinolignoid 8 ' - epi - cleomiscosin A ( 1 ) together with the new glycoside 8 - O - beta - D - glucopyranosyl - 6 - hydroxy - 2 - methyl - 4H - 1 - benzopyrane - 4 - one ( 2 ) have been isolated from the aerial parts of Rhododendron collettianum and their structures determined on the basis of spectroscopic evidences .
【GOLD_E】
8'-epi-cleomiscosinA	chem
coumarinolignoid	chem
8-O-beta-D-glucopyranosyl-6-hydroxy-2-methyl-4H-1-benzopyrane-4-one	chem
【PRE_E】
coumarinolignoid8'-epi-cleomiscosinA	chem
glycoside8-O-beta-D-glucopyranosyl-6-hydroxy-2-methyl-4H-1-benzopyrane-4-one	chem
【GOLD_R】
【PRE_R】

Tyrosinase inhibition study of these compounds and their structure - activity relationship ( SAR ) were also investigated .
【GOLD_E】
Tyrosinase	geneY
【PRE_E】
Tyrosinase	geneY
【GOLD_R】
【PRE_R】

The compounds exhibited potent to mild inhibition activity against the enzyme .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Especially , the compound 1 showed strong inhibition ( IC50 = 1.33 microM ) against the enzyme tyrosinase , as compared to the standard tyrosinase inhibitors kojic acid ( IC50 = 16.67 microM ) and L - mimosine ( IC50 = 3.68 microM ) , indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes .
【GOLD_E】
kojicacid	chem
L-mimosine	chem
tyrosinase	geneY
【PRE_E】
tyrosinase	geneY
tyrosinase	geneY
kojicacid	chem
L-mimosine	chem
【GOLD_R】
kojicacid	tyrosinase	C4
L-mimosine	tyrosinase	C4
【PRE_R】
tyrosinase	kojicacid	C4
tyrosinase	kojicacid	C4
tyrosinase	L-mimosine	C4

In vivo activity of the potent oxytocin antagonist on uterine activity in the rat .
【GOLD_E】
oxytocin	chem
oxytocin	geneY
【PRE_E】
oxytocin	geneY
【GOLD_R】
【PRE_R】

Oxytocin antagonist ( OTA ) , TT - 235 , was developed by our group and shown to inhibit either spontaneous or oxytocin - induced uterine contractions in primates .
【GOLD_E】
Oxytocin	chem
TT-235	chem
Oxytocin	geneY
oxytocin	geneY
oxytocin	chem
【PRE_E】
Oxytocin	geneY
OTA	chem
TT-235	chem
oxytocin	geneY
【GOLD_R】
TT-235	oxytocin	C4
TT-235	Oxytocin	C6
【PRE_R】

The purpose of the present study was to confirm the duration of TT - 235 to block oxytocin - induced uterine contractions in estrous rats .
【GOLD_E】
TT-235	chem
oxytocin	chem
oxytocin	geneY
【PRE_E】
TT-235	chem
oxytocin	geneY
【GOLD_R】
TT-235	oxytocin	C4
【PRE_R】
TT-235	oxytocin	C4

In Experiment 1 , the time - response of the three OTAs on uterine contractility was examined .
【GOLD_E】
【PRE_E】
OTAs	geneN
【GOLD_R】
【PRE_R】

The rats were anesthetized and cannulas were placed in the jugular vein for infusing vehicle ( sterile saline ) , Antag I , Antag II and TT - 235 .
【GOLD_E】
AntagI	chem
AntagII	chem
TT-235	chem
【PRE_E】
AntagI	geneY
TT-235	chem
【GOLD_R】
【PRE_R】

The uterine activity was monitored through a water - filled balloon - tipped cannula placed in the uterine horn .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The uterine contractile activity was determined as the integrated area for 10 minutes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Each OTA was administered as a single bolus injection of 5 microg , followed by 100 mU of oxytocin 5 minutes later , also done as a single bolus .
【GOLD_E】
oxytocin	chem
oxytocin	geneY
【PRE_E】
OTA	chem
oxytocin5	geneY
【GOLD_R】
【PRE_R】

Oxytocin injection of the same dosage was repeated every hour for 5 hours .
【GOLD_E】
Oxytocin	chem
Oxytocin	geneY
【PRE_E】
Oxytocin	geneY
【GOLD_R】
【PRE_R】

Experiment 2 determined the effect of the three OTAs on uterine oxytocin receptor number ( Rn ) and binding affinity ( Kd ) .
【GOLD_E】
oxytocin	chem
oxytocinreceptor	geneY
【PRE_E】
OTAs	geneN
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

Rats treated with either OTA or vehicle were sacrificed at 0.5 and 4 hours for receptor assay .
【GOLD_E】
【PRE_E】
OTA	chem
【GOLD_R】
【PRE_R】

In Experiment 1 , Antag I , Antag II and TT - 235 inhibited the integrated uterine response to oxytocin at 5 minutes by 76 % , 77 % and 80 % , respectively , compared to controls ( p < 0.05 ) .
【GOLD_E】
oxytocin	geneY
AntagI	chem
AntagII	chem
TT-235	chem
oxytocin	chem
【PRE_E】
AntagI	geneY
oxytocin	geneY
【GOLD_R】
AntagI	oxytocin	C4
AntagII	oxytocin	C4
TT-235	oxytocin	C4
【PRE_R】

Two hours after injecting Antag I , inhibition of uterine contractility was 55 % lower than controls ( p < 0.05 ) .
【GOLD_E】
AntagI	chem
【PRE_E】
AntagI	geneY
【GOLD_R】
【PRE_R】

At 3 hours , uterine contractility was no longer affected in rats treated with Antag I compared with controls .
【GOLD_E】
AntagI	chem
【PRE_E】
AntagI	chem
【GOLD_R】
【PRE_R】

The suppressive uterine activity with Antag II continued up to 3 hours .
【GOLD_E】
AntagII	chem
【PRE_E】
AntagII	geneY
【GOLD_R】
【PRE_R】

However , uterine contractility remained lower ( 53 % ) in rats treated with TT - 235 5 hours later .
【GOLD_E】
TT-235	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In Experiment 2 , TT - 235 induced a significant decrease ( p < 0.05 ) in oxytocin receptor number and binding affinity at both 0.5 and 4 hours compared with controls .
【GOLD_E】
TT-235	chem
oxytocin	chem
oxytocinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
【GOLD_R】
TT-235	oxytocinreceptor	C4
【PRE_R】

Antag I and Antag II did not alter oxytocin receptor number or binding affinity significantly at each time point studied compared with controls .
【GOLD_E】
AntagI	chem
AntagII	chem
oxytocin	chem
oxytocinreceptor	geneY
【PRE_E】
AntagI	geneY
AntagII	geneY
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

In conclusion , TT - 235 may inhibit the uterine response to oxytocin by decreasing oxytocin receptor numbers and oxytocin binding affinity , which might explain the prolonged oxytocin antagonist activity of TT - 235 .
【GOLD_E】
TT-235	chem
oxytocin	chem
oxytocin	chem
oxytocin	chem
oxytocin	chem
TT-235	chem
oxytocin	geneY
oxytocinreceptor	geneY
oxytocin	geneY
oxytocin	geneY
【PRE_E】
TT-235	chem
oxytocin	geneY
oxytocinreceptor	geneY
oxytocin	geneY
oxytocin	geneY
TT-235	chem
【GOLD_R】
TT-235	oxytocinreceptor	C4
TT-235	oxytocin	C4
TT-235	oxytocin	C6
【PRE_R】
TT-235	oxytocin	C4
oxytocin	TT-235	C4

Preclinical pharmacology of lumiracoxib : a novel selective inhibitor of cyclooxygenase - 2 .
【GOLD_E】
lumiracoxib	chem
cyclooxygenase-2	geneY
【PRE_E】
lumiracoxib	chem
cyclooxygenase-2	geneY
【GOLD_R】
lumiracoxib	cyclooxygenase-2	C4
【PRE_R】
lumiracoxib	cyclooxygenase-2	C4

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This manuscript presents the preclinical profile of lumiracoxib , a novel cyclooxygenase - 2 ( COX - 2 ) selective inhibitor .
【GOLD_E】
lumiracoxib	chem
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
lumiracoxib	chem
cyclooxygenase-2	geneY
COX-2	geneY
【GOLD_R】
lumiracoxib	cyclooxygenase-2	C4
lumiracoxib	COX-2	C4
【PRE_R】
lumiracoxib	cyclooxygenase-2	C4
lumiracoxib	COX-2	C4

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lumiracoxib inhibited purified COX - 1 and COX - 2 with K ( i ) values of 3 and 0.06 microM , respectively .
【GOLD_E】
COX-1	geneY
COX-2	geneY
Lumiracoxib	chem
【PRE_E】
Lumiracoxib	chem
COX-1	geneY
COX-2	geneY
【GOLD_R】
Lumiracoxib	COX-1	C4
Lumiracoxib	COX-2	C4
【PRE_R】
Lumiracoxib	COX-1	C4
Lumiracoxib	COX-2	C4

In cellular assays , lumiracoxib had an IC ( 50 ) of 0.14 microM in COX - 2 - expressing dermal fibroblasts , but caused no inhibition of COX - 1 at concentrations up to 30 microM ( HEK 293 cells transfected with human COX - 1 ) .
【GOLD_E】
COX-2	geneY
COX-1	geneY
humanCOX-1	geneN
lumiracoxib	chem
【PRE_E】
lumiracoxib	chem
COX-2	geneY
COX-1	geneY
humanCOX-1	geneY
【GOLD_R】
lumiracoxib	COX-2	C4
【PRE_R】
lumiracoxib	COX-2	C4
lumiracoxib	COX-1	C4
lumiracoxib	humanCOX-1	C4

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In a human whole blood assay , IC ( 50 ) values for lumiracoxib were 0.13 microM for COX - 2 and 67 microM for COX - 1 ( COX - 1 / COX - 2 selectivity ratio 515 ) .
【GOLD_E】
COX-2	geneY
COX-1	geneY
COX-1	geneY
COX-2	geneY
lumiracoxib	chem
【PRE_E】
lumiracoxib	chem
COX-2	geneY
COX-1	geneY
COX-1	geneY
COX-2	geneY
【GOLD_R】
lumiracoxib	COX-2	C4
lumiracoxib	COX-1	C4
lumiracoxib	COX-1	C4
lumiracoxib	COX-2	C4
【PRE_R】
lumiracoxib	COX-2	C4
lumiracoxib	COX-1	C4
lumiracoxib	COX-1	C4
lumiracoxib	COX-2	C4

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lumiracoxib was rapidly absorbed following oral administration in rats with peak plasma levels being reached between 0.5 and 1 h .
【GOLD_E】
Lumiracoxib	chem
【PRE_E】
Lumiracoxib	chem
【GOLD_R】
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ex vivo , lumiracoxib inhibited COX - 1 - derived thromboxane B ( 2 ) ( TxB ( 2 ) ) generation with an ID ( 50 ) of 33 mg kg ( - 1 ) , whereas COX - 2 - derived production of prostaglandin E ( 2 ) ( PGE ( 2 ) ) in the lipopolysaccharide - stimulated rat air pouch was inhibited with an ID ( 50 ) value of 0.24 mg kg ( - 1 ) .
【GOLD_E】
lumiracoxib	chem
thromboxaneB(2)	chem
TxB(2)	chem
prostaglandinE(2)	chem
PGE(2)	chem
COX-1	geneY
COX-2	geneY
【PRE_E】
lumiracoxib	chem
COX-1	geneY
thromboxaneB(2)	chem
TxB(2)	chem
COX-2	geneY
prostaglandinE(2)	chem
PGE(2)	chem
【GOLD_R】
lumiracoxib	COX-1	C4
thromboxaneB(2)	COX-1	C9
TxB(2)	COX-1	C9
prostaglandinE(2)	COX-2	C9
PGE(2)	COX-2	C9
【PRE_R】
lumiracoxib	COX-1	C4
lumiracoxib	COX-2	C4

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Efficacy of lumiracoxib in rat models of hyperalgesia , oedema , pyresis and arthritis was dose - dependent and similar to diclofenac .
【GOLD_E】
lumiracoxib	chem
diclofenac	chem
【PRE_E】
lumiracoxib	chem
diclofenac	chem
【GOLD_R】
【PRE_R】

However , consistent with its low COX - 1 inhibitory activity , lumiracoxib at a dose of 100 mg kg ( - 1 ) orally caused no ulcers and was significantly less ulcerogenic than diclofenac ( P < 0.05 ) .
【GOLD_E】
COX-1	geneY
lumiracoxib	chem
diclofenac	chem
【PRE_E】
COX-1	geneY
lumiracoxib	chem
diclofenac	chem
【GOLD_R】
lumiracoxib	COX-1	C4
diclofenac	COX-1	C4
【PRE_R】
COX-1	lumiracoxib	C4
COX-1	diclofenac	C4

7 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lumiracoxib is a highly selective COX - 2 inhibitor with anti - inflammatory , analgesic and antipyretic activities comparable with diclofenac , the reference NSAID , but with much improved gastrointestinal safety .
【GOLD_E】
COX-2	geneY
Lumiracoxib	chem
diclofenac	chem
【PRE_E】
Lumiracoxib	chem
COX-2	geneY
diclofenac	chem
【GOLD_R】
Lumiracoxib	COX-2	C4
diclofenac	COX-2	C4
【PRE_R】
Lumiracoxib	COX-2	C4

Cloning , sequencing , structural and molecular biological characterization of placental protein 20 ( PP20 ) / human thiamin pyrophosphokinase ( hTPK ) .
【GOLD_E】
humanthiaminpyrophosphokinase	geneY
hTPK	geneY
placentalprotein20	geneY
PP20	geneY
thiamin	chem
【PRE_E】
placentalprotein20	geneY
PP20	geneN
humanthiaminpyrophosphokinase	geneY
hTPK	geneY
【GOLD_R】
【PRE_R】

Full - length cDNAs of placental protein 20 ( PP20 ) were cloned by screening a human placental cDNA library , which encode a 243 amino acid protein , identical to human thiamin pyrophosphokinase ( hTPK ) as confirmed by protein sequence analysis .
【GOLD_E】
humanthiaminpyrophosphokinase	geneY
hTPK	geneY
placentalprotein20	geneY
PP20	geneY
thiamin	chem
【PRE_E】
placentalprotein20	geneY
PP20	geneY
aminoacid	chem
humanthiaminpyrophosphokinase	geneY
hTPK	geneY
【GOLD_R】
【PRE_R】

Genomic alignment showed that the PP20 / hTPK gene contains 9 exons .
【GOLD_E】
PP20	geneY
hTPK	geneY
【PRE_E】
PP20	geneN
hTPK	geneY
【GOLD_R】
【PRE_R】

It is abundantly expressed in placenta , as numerous EST clones were identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As thiamine metabolism deficiencies have been seen in placental infarcts previously , these indicate that PP20 / hTPK may have a role in placental diseases .
【GOLD_E】
PP20	geneY
hTPK	geneY
thiamine	chem
【PRE_E】
thiamine	chem
PP20	geneN
hTPK	geneY
【GOLD_R】
thiamine	PP20	C9
thiamine	hTPK	C9
【PRE_R】

Analysis of the 1kb promoter region showed numerous putative transcription factor binding sites , which might be responsible for the ubiquitous PP20 / hTPK expression .
【GOLD_E】
PP20	geneY
hTPK	geneY
【PRE_E】
1kbpromoter	geneN
PP20	geneN
hTPK	geneY
【GOLD_R】
【PRE_R】

This may also be in accordance with the presence of the protein in tissues responsible for the regulation of the exquisite balance between cell division , differentiation and survival .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

TPK activity of the purified and recombinant protein was proved by mass spectrometry with electrospray ionization .
【GOLD_E】
TPK	geneY
【PRE_E】
TPK	geneN
【GOLD_R】
【PRE_R】

By Western blot , PP20 / hTPK was found in all human normal and tumorous adult and fetal tissues in nearly equal amounts , but not in sera .
【GOLD_E】
PP20	geneY
hTPK	geneY
【PRE_E】
PP20	geneY
hTPK	geneY
【GOLD_R】
【PRE_R】

By immunohistochemical and immunofluorescent confocal imaging methods , diffuse labelling in the cytoplasm of the syncytiotrophoblasts and weak staining of the trophoblasts were observed , and the amount of PP20 / hTPK decreased from the first trimester to the end of gestation .
【GOLD_E】
PP20	geneY
hTPK	geneY
【PRE_E】
syncytiotrophoblasts	geneN
PP20	geneY
hTPK	geneY
【GOLD_R】
【PRE_R】

A 3D model of PP20 / hTPK was computed ( PDB No . : 1OLY ) by homology modelling .
【GOLD_E】
hTPK	geneY
PP20	geneY
【PRE_E】
PP20	geneY
hTPK	geneY
1OLY	geneY
【GOLD_R】
【PRE_R】

A high degree of structural homology showed that the thiamin binding site was highly similar to that of the mouse enzyme , but highly different from the bacterial ones .
【GOLD_E】
thiamin	chem
【PRE_E】
thiaminbindingsite	geneN
【GOLD_R】
【PRE_R】

Comparison of the catalytic centre sequences revealed differences , raising the possibility of designing new drugs which specifically inhibit bacterial and fungal enzymes without affecting PP20 / hTPK and offering the possibility for safe antimicrobial therapy during pregnancy .
【GOLD_E】
PP20	geneY
hTPK	geneY
【PRE_E】
PP20	geneY
hTPK	geneY
【GOLD_R】
【PRE_R】

Safety and tolerability of denufosol tetrasodium inhalation solution , a novel P2Y2 receptor agonist : results of a phase 1 / phase 2 multicenter study in mild to moderate cystic fibrosis .
【GOLD_E】
denufosoltetrasodium	chem
P2Y2receptor	geneY
【PRE_E】
denufosoltetrasodium	chem
P2Y2	geneY
【GOLD_R】
denufosoltetrasodium	P2Y2receptor	C5
【PRE_R】

Denufosol tetrasodium ( INS37217 ) is a selective P2Y ( 2 ) agonist that stimulates ciliary beat frequency and Cl ( - ) secretion in normal and cystic fibrosis ( CF ) airway epithelia , and is being investigated as an inhaled treatment for CF .
【GOLD_E】
Denufosoltetrasodium	chem
P2Y(2)	geneY
Cl(-)	chem
INS37217	chem
【PRE_E】
Denufosoltetrasodium	chem
INS37217	chem
P2Y(2)	geneY
Cl(-)	chem
【GOLD_R】
Denufosoltetrasodium	P2Y(2)	C5
INS37217	P2Y(2)	C5
【PRE_R】

The Cl ( - ) secretory response is mediated via a non - CFTR pathway , and the driving force for Cl ( - ) secretion is enhanced by the effect of P2Y ( 2 ) activation to also inhibit epithelial Na ( + ) transport .
【GOLD_E】
Cl(-)	chem
Cl(-)	chem
Na(+)	chem
CFTR	geneY
P2Y(2)	geneY
【PRE_E】
Cl(-)	chem
CFTR	geneY
Cl(-)	chem
P2Y(2)	geneY
Na(+)	chem
【GOLD_R】
Cl(-)	CFTR	C9
【PRE_R】

Denufosol is metabolically more stable and better tolerated , and may enhance mucociliary clearance for a longer period of time than previously investigated P2Y ( 2 ) agonists .
【GOLD_E】
Denufosol	chem
P2Y(2)	geneY
【PRE_E】
Denufosol	chem
P2Y(2)	geneY
【GOLD_R】
Denufosol	P2Y(2)	C5
【PRE_R】

The goal of this phase 1 / phase 2 study was to assess the safety and tolerability of single and repeated doses of aerosolized denufosol in subjects with CF .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
CF	chem
【GOLD_R】
【PRE_R】

The study was a double - blind , placebo - controlled , multicenter comparison of ascending single doses of denufosol ( 10 , 20 , 40 , and 60 mg , administered by inhalation via the Pari LC Star nebulizer ) vs. placebo ( normal saline ) , followed by a comparison of twice - daily administration of the maximum tolerated dose ( MTD ) of denufosol or placebo for 5 days .
【GOLD_E】
denufosol	chem
denufosol	chem
【PRE_E】
denufosol	chem
denufosol	chem
【GOLD_R】
【PRE_R】

Thirty - seven adult ( 18 years of age or older ) and 24 pediatric ( 5 - 17 years of age ) subjects with CF were evaluated in five cohorts .
【GOLD_E】
【PRE_E】
CF	chem
【GOLD_R】
【PRE_R】

Subjects were randomized in a 3 : 1 ratio to receive either denufosol or placebo within each cohort .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

The percent of subjects experiencing adverse events was similar between the denufosol and placebo groups .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

The most common adverse event in subjects receiving denufosol was chest tightness in adult subjects ( 39 % ) and cough in pediatric subjects ( 56 % ) .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

Three ( 7 % ) subjects receiving denufosol and one ( 7 % ) subject receiving placebo experienced a serious adverse event .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

Forced expiratory volume in 1 sec ( FEV ( 1 ) ) profiles following dosing were similar across treatment groups , with some acute , reversible decline seen in both groups , most notably in subjects with lower lung function at baseline .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , doses up to 60 mg of denufosol inhalation solution were well - tolerated in most subjects .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

Some intolerability was noted among subjects with lower baseline lung function .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Based on the results of this phase 1 / phase 2 study , the Therapeutics Development Network ( TDN ) of the Cystic Fibrosis Foundation ( CFF ) and Inspire Pharmaceuticals , Inc. , recently completed a multicenter , 28 - day , phase 2 safety and efficacy clinical trial of denufosol inhalation solution in CF subjects with mild lung disease .
【GOLD_E】
denufosol	chem
【PRE_E】
denufosol	chem
【GOLD_R】
【PRE_R】

The dextromethorphan analog dimemorfan attenuates kainate - induced seizures via sigma1 receptor activation : comparison with the effects of dextromethorphan .
【GOLD_E】
dextromethorphan	chem
dimemorfan	chem
dextromethorphan	chem
sigma1receptor	geneY
【PRE_E】
dextromethorphan	chem
dimemorfan	chem
kainate	chem
sigma1receptor	geneY
dextromethorphan	chem
【GOLD_R】
dimemorfan	sigma1receptor	C3
dextromethorphan	sigma1receptor	C3
【PRE_R】

In a previous study , we demonstrated that a dextromethorphan analog , dimemorfan , has neuroprotective effects .
【GOLD_E】
dextromethorphan	chem
dimemorfan	chem
【PRE_E】
dextromethorphan	chem
dimemorfan	chem
【GOLD_R】
【PRE_R】

Dextromethorphan and dimemorfan are high - affinity ligands at sigma1 receptors .
【GOLD_E】
sigma1receptors	geneY
Dextromethorphan	chem
dimemorfan	chem
【PRE_E】
Dextromethorphan	chem
dimemorfan	chem
sigma1receptors	geneY
【GOLD_R】
【PRE_R】

Dextromethorphan has moderate affinities for phencyclidine sites , while dimemorfan has very low affinities for such sites , suggesting that these sites are not essential for the anticonvulsant actions of dimemorfan .
【GOLD_E】
Dextromethorphan	chem
phencyclidine	chem
dimemorfan	chem
dimemorfan	chem
【PRE_E】
Dextromethorphan	chem
phencyclidine	chem
dimemorfan	chem
dimemorfan	chem
【GOLD_R】
【PRE_R】

Kainate ( KA ) administration ( 10 mg kg ( - 1 ) , i.p . ) produced robust convulsions lasting 4 - 6 h in rats .
【GOLD_E】
Kainate	chem
KA	chem
【PRE_E】
Kainate	chem
KA	chem
【GOLD_R】
【PRE_R】

Pre - treatment with dimemorfan ( 12 or 24 mg kg ( - 1 ) ) reduced seizures in a dose - dependent manner .
【GOLD_E】
dimemorfan	chem
【PRE_E】
dimemorfan	chem
【GOLD_R】
【PRE_R】

Dimemorfan pre - treatment also attenuated the KA - induced increases in c - fos / c - jun expression , activator protein ( AP ) - 1 DNA - binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .
【GOLD_E】
Dimemorfan	chem
KA	chem
c-fos	geneY
c-jun	geneY
activatorprotein(AP)-1	geneY
【PRE_E】
Dimemorfan	chem
KA	chem
c-fos	geneY
c-jun	geneY
activatorprotein(AP)-1	geneY
【GOLD_R】
KA	activatorprotein(AP)-1	C3
KA	c-fos	C3
KA	c-jun	C3
Dimemorfan	c-fos	C4
Dimemorfan	c-jun	C4
Dimemorfan	activatorprotein(AP)-1	C4
【PRE_R】

These effects of dimemorfan were comparable to those of dextromethorphan .
【GOLD_E】
dimemorfan	chem
dextromethorphan	chem
【PRE_E】
dimemorfan	chem
dextromethorphan	chem
【GOLD_R】
【PRE_R】

The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor - activated modulation of AP - 1 transcription factors .
【GOLD_E】
BD1047	chem
dextromethorphan	chem
dextromethorphan	chem
dimemorfan	chem
sigma1receptor	geneY
AP-1	geneY
dimemorfan	chem
sigma1receptor	geneY
【PRE_E】
dextromethorphan	chem
dimemorfan	chem
sigma1receptor	geneY
BD1047	chem
dextromethorphan	chem
dimemorfan	chem
sigma1receptor	geneY
AP-1	geneY
【GOLD_R】
BD1047	sigma1receptor	C6
【PRE_R】
sigma1receptor	dimemorfan	C5

We asked whether dimemorfan produces the behavioral side effects seen with dextromethorphan or dextrorphan ( a phencyclidine - like metabolite of dextromethorphan ) .
【GOLD_E】
dextromethorphan	chem
dimemorfan	chem
dextromethorphan	chem
dextrorphan	chem
phencyclidine	chem
【PRE_E】
dimemorfan	chem
dextromethorphan	chem
dextrorphan	chem
phencyclidine	chem
dextromethorphan	chem
【GOLD_R】
【PRE_R】

Conditioned place preference and circling behaviors were significantly increased in mice treated with phencyclidine , dextrorphan or dextromethorphan , while mice treated with dimemorfan showed no behavioral side effects .
【GOLD_E】
phencyclidine	chem
dextrorphan	chem
dextromethorphan	chem
【PRE_E】
phencyclidine	chem
dextrorphan	chem
dextromethorphan	chem
dimemorfan	chem
【GOLD_R】
【PRE_R】

Our results suggest that dimemorfan is equipotent to dextromethorphan in preventing KA - induced seizures , while it may lack behavioral effects , such as psychotomimetic reactions .
【GOLD_E】
dimemorfan	chem
dextromethorphan	chem
KA	chem
【PRE_E】
dimemorfan	chem
dextromethorphan	chem
KA	chem
【GOLD_R】
【PRE_R】

Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin .
【GOLD_E】
oxytocin	chem
carbetocin	chem
oxytocin	chem
oxytocin	chem
barusiban	chem
oxytocin	geneY
oxytocinreceptor	geneY
oxytocinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
oxytocinreceptor	geneY
barusiban	chem
oxytocin	geneY
carbetocin	chem
【GOLD_R】
oxytocin	oxytocinreceptor	C5
carbetocin	oxytocinreceptor	C5
barusiban	oxytocinreceptor	C6
【PRE_R】

We have analyzed binding domains of the oxytocin receptor for barusiban , a highly selective oxytocin receptor antagonist , in comparison to the combined vasopressin V1A / oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin .
【GOLD_E】
vasopressin	chem
atosiban	chem
oxytocin	chem
carbetocin	chem
oxytocin	chem
barusiban	chem
oxytocin	chem
vasopressinV1A/oxytocinreceptor	geneN
oxytocin	geneY
oxytocinreceptor	geneY
oxytocinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
barusiban	chem
oxytocinreceptor	geneY
vasopressinV1A/oxytocinreceptor	geneN
atosiban	chem
oxytocin	geneY
carbetocin	chem
【GOLD_R】
oxytocin	vasopressinV1A/oxytocinreceptor	C5
carbetocin	vasopressinV1A/oxytocinreceptor	C5
atosiban	vasopressinV1A/oxytocinreceptor	C6
barusiban	oxytocinreceptor	C6
【PRE_R】

For this purpose , chimeric ' gain - in function ' oxytocin / vasopressin V2 receptors were expressed in COS - 7 cells .
【GOLD_E】
oxytocin	chem
vasopressin	chem
oxytocin/vasopressinV2receptors	geneN
【PRE_E】
oxytocin	geneY
vasopressinV2receptors	geneY
【GOLD_R】
【PRE_R】

These recombinant receptors have been produced by transfer of domains from the oxytocin receptor into the related vasopressin V2 receptor and have already been successfully employed for the identification of ligand binding domains at the oxytocin receptor ( Postina , R. , Kojro , E. , Fahrenholz , F. , 1996 .
【GOLD_E】
oxytocin	chem
vasopressin	chem
oxytocin	chem
oxytocinreceptor	geneY
vasopressinV2receptor	geneY
oxytocinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
vasopressinV2receptor	geneY
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor .
【GOLD_E】
oxytocin	chem
vasopressin	chem
oxytocinreceptor	geneY
V2vasopressinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
V2vasopressinreceptor	geneY
【GOLD_R】
【PRE_R】

J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Biol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

271 , 31593 - 31601 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In displacement studies with 10 chimeric receptor constructs , the binding profile of barusiban was compared with the binding profiles of the ligands oxytocin , [ Arg8 ] vasopressin , carbetocin , and atosiban .
【GOLD_E】
carbetocin	chem
atosiban	chem
barusiban	chem
oxytocin	chem
[Arg8]vasopressin	chem
vasopressin	geneY
oxytocin	geneY
【PRE_E】
barusiban	chem
oxytocin	geneY
[Arg8]vasopressin	chem
carbetocin	chem
atosiban	chem
【GOLD_R】
【PRE_R】

The binding profiles for the agonists oxytocin and carbetocin were found to be similar .
【GOLD_E】
oxytocin	chem
oxytocin	geneY
carbetocin	chem
【PRE_E】
oxytocin	geneY
carbetocin	chem
【GOLD_R】
【PRE_R】

For both agonists , important binding domains were the extracellular N - terminus ( = E1 ) and the extracellular loops E2 and E3 from the oxytocin receptor .
【GOLD_E】
oxytocinreceptor	geneY
N	chem
oxytocin	chem
【PRE_E】
N	chem
E2andE3	geneN
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

For the vasopressin V1A / oxytocin receptor antagonist atosiban , none of the receptor constructs were able to provide a binding with higher affinity than the starting vasopressin V2 receptor .
【GOLD_E】
vasopressin	chem
vasopressinV1A/oxytocinreceptor	geneN
vasopressinV2receptor	geneY
vasopressin	chem
oxytocin	chem
atosiban	chem
【PRE_E】
vasopressinV1A	geneY
oxytocinreceptor	geneY
atosiban	chem
vasopressinV2receptor	geneY
【GOLD_R】
atosiban	vasopressinV1A/oxytocinreceptor	C6
【PRE_R】

In contrast , the binding of barusiban was significantly improved when the transmembrane domains 1 and 2 were transferred from the oxytocin receptor to the vasopressin V2 receptor .
【GOLD_E】
barusiban	chem
oxytocin	chem
vasopressin	chem
vasopressinV2receptor	geneY
【PRE_E】
barusiban	chem
transmembranedomains1and2	geneN
oxytocinreceptor	geneY
vasopressinV2receptor	geneY
【GOLD_R】
【PRE_R】

The binding domain of barusiban differs from the binding domain of the agonists and the nonselective oxytocin receptor antagonist d ( CH2 ) 5 [ Tyr - ( Me ) 2 , Thr4 , Orn8 , Tyr9 ] vasotocin that has been used in previous studies .
【GOLD_E】
barusiban	chem
oxytocin	chem
d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin	chem
oxytocinreceptor	geneY
vasotocin	geneN
【PRE_E】
barusiban	chem
oxytocinreceptor	geneY
d(CH2)5	chem
Tyr-(Me)2	chem
Thr4	chem
Orn8	chem
Tyr9]vasotocin	chem
【GOLD_R】
d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin	oxytocinreceptor	C6
【PRE_R】

Overall , the data supported the concept of a central pocket site within the oxytocin receptor .
【GOLD_E】
oxytocin	chem
oxytocinreceptor	geneY
【PRE_E】
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox ( am ) ine 5 ' - phosphate oxidase .
【GOLD_E】
pyridox(am)ine5'-phosphate	chem
PNPO	geneY
pyridox(am)ine5'-phosphateoxidase	geneY
【PRE_E】
PNPO	geneY
pyridox(am)ine5'-phosphateoxidase	geneY
【GOLD_R】
【PRE_R】

In the mouse , neurotransmitter metabolism can be regulated by modulation of the synthesis of pyridoxal 5 ' - phosphate and failure to maintain pyridoxal phosphate ( PLP ) levels results in epilepsy .
【GOLD_E】
pyridoxalphosphate	chem
PLP	chem
pyridoxal5'-phosphate	chem
【PRE_E】
pyridoxal5'-phosphate	chem
pyridoxalphosphate	chem
PLP	chem
【GOLD_R】
【PRE_R】

This study of five patients with neonatal epileptic encephalopathy suggests that the same is true in man .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cerebrospinal fluid and urine analyses indicated reduced activity of aromatic L - amino acid decarboxylase and other PLP - dependent enzymes .
【GOLD_E】
aromaticL-aminoaciddecarboxylase	geneY
aromaticL-aminoacid	chem
PLP	chem
【PRE_E】
aromaticL-aminoaciddecarboxylase	geneN
PLP	chem
【GOLD_R】
【PRE_R】

Seizures ceased with the administration of PLP , having been resistant to treatment with pyridoxine , suggesting a defect of pyridox ( am ) ine 5 ' - phosphate oxidase ( PNPO ) .
【GOLD_E】
pyridox(am)ine5'-phosphateoxidase	geneY
PNPO	geneY
PLP	chem
pyridox(am)ine5'-phosphate	chem
【PRE_E】
PLP	chem
pyridoxine	chem
pyridox(am)ine5'-phosphateoxidase	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

Sequencing of the PNPO gene identified homozygous missense , splice site and stop codon mutations .
【GOLD_E】
PNPO	geneY
【PRE_E】
PNPO	geneY
【GOLD_R】
【PRE_R】

Expression studies in Chinese hamster ovary cells showed that the splice site ( IVS3 - 1g > a ) and stop codon ( X262Q ) mutations were null activity mutations and that the missense mutation ( R229W ) markedly reduced pyridox ( am ) ine phosphate oxidase activity .
【GOLD_E】
g>a	geneN
R229W	geneN
pyridox(am)inephosphateoxidase	geneY
pyridox(am)inephosphate	chem
【PRE_E】
X262Q	geneN
R229W	geneY
pyridox(am)inephosphateoxidase	geneY
【GOLD_R】
【PRE_R】

Maintenance of optimal PLP levels in the brain may be important in many neurological disorders in which neurotransmitter metabolism is disturbed ( either as a primary or as a secondary phenomenon ) .
【GOLD_E】
PLP	chem
【PRE_E】
PLP	chem
【GOLD_R】
【PRE_R】

Effect of 5 - azacytidine and procainamide on CD3 - zeta chain expression in Jurkat T cells .
【GOLD_E】
procainamide	chem
CD3-zetachain	geneY
5-azacytidine	chem
【PRE_E】
5-azacytidine	chem
procainamide	chem
CD3-zetachain	geneY
【GOLD_R】
【PRE_R】

It has been observed that decrease of DNA methyltransferase 1 ( DNMT1 ) activity is associated with low content of the CD3 - zeta ( zeta ) chain in T cell receptor ( TCR ) / CD3 complex of T cells in systemic lupus erythematosus ( SLE ) patients .
【GOLD_E】
CD3-zeta(zeta)chain	geneY
Tcellreceptor	geneN
TCR	geneN
CD3	geneN
DNAmethyltransferase1	geneY
DNMT1	geneY
【PRE_E】
DNAmethyltransferase1	geneY
DNMT1	geneY
CD3-zeta(zeta)chaininTcellreceptor	geneN
TCR	geneN
CD3	geneN
【GOLD_R】
【PRE_R】

The CD3 - zeta chain plays a pivotal role in intracellular signal transmission between TCR / CD3 complex and nuclei .
【GOLD_E】
CD3-zetachain	geneY
TCR	geneN
CD3	geneN
【PRE_E】
CD3-zetachain	geneN
TCR	geneN
CD3	geneN
【GOLD_R】
【PRE_R】

The compounds 5 ' - azacytidine ( AZC ) and procainamide ( PCA ) belong to inhibitors of DNMT1 , whose low activity correlates with increase in transcription of various genes .
【GOLD_E】
5'-azacytidine	chem
DNMT1	geneY
AZC	chem
procainamide	chem
PCA	chem
【PRE_E】
5'-azacytidine	chem
AZC	chem
procainamide	chem
PCA	chem
DNMT1	geneY
【GOLD_R】
5'-azacytidine	DNMT1	C4
AZC	DNMT1	C4
procainamide	DNMT1	C4
PCA	DNMT1	C4
【PRE_R】
5'-azacytidine	DNMT1	C4
AZC	DNMT1	C4
procainamide	DNMT1	C4
PCA	DNMT1	C4

Using the reverse - transcription and real - time quantitative PCR ( RQ - PCR ) analysis , we indicated that AZC and PCA did not profoundly affect on CD3 - zeta chain transcription in Jurkat T leukemia cells clone E6 - 1 .
【GOLD_E】
CD3-zetachain	geneY
AZC	chem
PCA	chem
【PRE_E】
AZC	chem
PCA	geneY
CD3-zetachain	geneY
E6-1	geneY
【GOLD_R】
【PRE_R】

However , the flowcytometric analysis revealed that AZC and PCA decreased intracellular contents of CD3 - zeta chain in these cells in dose dependent manner .
【GOLD_E】
CD3-zetachain	geneY
AZC	chem
PCA	chem
【PRE_E】
AZC	chem
PCA	geneY
CD3-zetachain	geneY
【GOLD_R】
AZC	CD3-zetachain	C4
PCA	CD3-zetachain	C4
【PRE_R】
AZC	CD3-zetachain	C3

Our results suggest that decrease of DNMT1 activity may alter intracellular signal transmission without effect on transcription level of CD3 - zeta chain .
【GOLD_E】
CD3-zetachain	geneY
DNMT1	geneY
【PRE_E】
DNMT1	geneY
CD3-zetachain	geneY
【GOLD_R】
【PRE_R】

Changes in gene expression associated with loss of function of the NSDHL sterol dehydrogenase in mouse embryonic fibroblasts .
【GOLD_E】
sterol	chem
NSDHL	geneY
steroldehydrogenase	geneN
【PRE_E】
NSDHL	geneY
steroldehydrogenase	geneN
【GOLD_R】
【PRE_R】

Seven human disorders of postsqualene cholesterol biosynthesis have been described .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
【GOLD_R】
【PRE_R】

One of these , congenital hemidysplasia with ichthyosiform nevus and limb defects ( CHILD ) syndrome , results from mutations in the X - linked gene NADH sterol dehydrogenase - like ( NSDHL ) encoding a sterol dehydrogenase .
【GOLD_E】
NADHsteroldehydrogenase-like	geneY
NSDHL	geneY
steroldehydrogenase	geneN
NADH	chem
sterol	chem
sterol	chem
【PRE_E】
X-linkedgeneNADHsteroldehydrogenase-like	geneY
NSDHL	geneY
steroldehydrogenase	geneY
【GOLD_R】
【PRE_R】

A series of mutant alleles of the murine Nsdhl gene are carried by bare patches ( Bpa ) mice , with Bpa ( 1H ) representing a null allele .
【GOLD_E】
Nsdhl	geneY
【PRE_E】
murineNsdhl	geneY
Bpa	chem
Bpa	chem
1H	chem
【GOLD_R】
【PRE_R】

Heterozygous Bpa ( 1H ) females display skin and skeletal abnormalities in a distribution reflecting random X inactivation , whereas hemizygous male embryos die before embryonic day 10.5 .
【GOLD_E】
【PRE_E】
Bpa	chem
1H	chem
【GOLD_R】
【PRE_R】

To investigate the molecular basis of defects associated with perturbations in cholesterol biosynthesis , microarray analysis was performed comparing gene expression in embryonic fibroblasts expressing the Bpa ( 1H ) allele versus wild - type ( wt ) cells .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
Bpa	chem
1H	chem
【GOLD_R】
【PRE_R】

Labeled cDNAs from cells grown in normal serum or lipid - depleted serum ( LDS ) were hybridized to microarrays containing 22,000 mouse genes .
【GOLD_E】
【PRE_E】
lipid-depletedserum	geneN
LDS	geneN
【GOLD_R】
【PRE_R】

Among 44 genes that showed higher expression in the Bpa ( 1H ) versus wt cells grown in LDS , 11 function in cholesterol biosynthesis , 7 are involved in fatty acid synthesis , 3 ( Srebp2 , Insig1 , and Orf11 ) encode sterol - regulatory proteins , and 2 ( Ldlr and StarD4 ) are lipid transporters .
【GOLD_E】
Srebp2	geneY
Insig1	geneY
Orf11	geneN
Ldlr	geneY
StarD4	geneY
cholesterol	chem
fattyacid	chem
sterol	chem
【PRE_E】
Bpa	chem
1H	chem
cholesterol	chem
fattyacid	chem
Srebp2	geneY
Insig1	geneY
Orf11	geneN
sterol-regulatoryproteins,and2	geneN
Ldlr	geneY
StarD4	geneY
【GOLD_R】
【PRE_R】
Bpa	Srebp2	C3
Bpa	Insig1	C3

Of the 21 remaining genes , 16 are known genes , some of which have been implicated previously in cholesterol homeostasis or lipid - mediated signaling , and 5 are uncharacterized cDNA clones .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
【GOLD_R】
【PRE_R】

Rapid quantitation of plasma 2 ' - deoxyuridine by high - performance liquid chromatography / atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients .
【GOLD_E】
2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

A novel method employing high - performance liquid chromatograph - mass spectrometry ( LC - MS ) has been developed and validated for the quantitation of plasma 2 ' - deoxyuridine ( UdR ) .
【GOLD_E】
UdR	chem
2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

It involves a plasma clean - up step with strong anion - exchange solid - phase extraction ( SAX - SPE ) followed by HPLC separation and atmospheric pressure chemical ionization mass spectrometry detection ( APCI - MS ) in a selected - ion monitoring ( SIM ) mode .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The ionization conditions were optimised in negative ion mode to give the best intensity of the dominant formate adduct [ M + HCOO ] - at m / z 273 .
【GOLD_E】
formate	chem
HCOO	chem
【PRE_E】
formate	chem
M+HCOO	chem
【GOLD_R】
【PRE_R】

Retention times were 7.5 and 12.5 min for 2 ' - deoxyuridine and 5 - iodo - 2 ' - deoxyuridine , an iodinated analogue internal standard ( IS ) , respectively .
【GOLD_E】
2'-deoxyuridine	chem
5-iodo-2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
5-iodo-2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

Peak area ratios of 2 ' - deoxyuridine to IS were used for regression analysis of the calibration curve .
【GOLD_E】
2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

The latter was linear from 5 to 400 nmol / l using 1 ml sample volume of plasma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The average recovery was 81.5 % and 78.6 % for 2 ' - deoxyuridine and 5 - iodo - deoxyuridine , respectively .
【GOLD_E】
2'-deoxyuridine	chem
5-iodo-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
5-iodo-deoxyuridine	chem
【GOLD_R】
【PRE_R】

The method provides sufficient sensitivity , precision , accuracy and selectivity for routine analysis of human plasma 2 ' - deoxyuridine concentration with the lowest limit of quantitation ( LLOQ ) of 5 nmol / l .
【GOLD_E】
2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

Clinical studies in cancer patients treated with the new fluoropyrimidine analogue capecitabine ( N4 - pentoxycarbonyl - 5 ' - 5 - fluorocytidine ) have shown that plasma 2 ' - deoxyuridine was significantly elevated after 1 week of treatment , consistent with inhibition of thymidylate synthase ( TS ) .
【GOLD_E】
thymidylatesynthase	geneY
TS	geneY
fluoropyrimidine	chem
capecitabine	chem
N4-pentoxycarbonyl-5'-5-fluorocytidine	chem
2'-deoxyuridine	chem
thymidylate	chem
【PRE_E】
fluoropyrimidine	chem
capecitabine	chem
N4-pentoxycarbonyl-5'-5-fluorocytidine	chem
2'-deoxyuridine	chem
thymidylatesynthase	geneY
TS	geneY
【GOLD_R】
fluoropyrimidine	thymidylatesynthase	C4
fluoropyrimidine	TS	C4
capecitabine	thymidylatesynthase	C4
capecitabine	TS	C4
N4-pentoxycarbonyl-5'-5-fluorocytidine	thymidylatesynthase	C4
N4-pentoxycarbonyl-5'-5-fluorocytidine	TS	C4
2'-deoxyuridine	thymidylatesynthase	C4
2'-deoxyuridine	TS	C4
【PRE_R】
fluoropyrimidine	TS	C4
capecitabine	TS	C4
N4-pentoxycarbonyl-5'-5-fluorocytidine	TS	C4
2'-deoxyuridine	TS	C4

These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5 - fluoro - 2 ' - deoxyuridine monophosphate ( FdUMP ) .
【GOLD_E】
FdUMP	chem
TS	geneY
capecitabine	chem
5-fluoro-2'-deoxyuridinemonophosphate	chem
【PRE_E】
capecitabine	chem
TS	geneY
5-fluoro-2'-deoxyuridinemonophosphate	chem
FdUMP	chem
【GOLD_R】
FdUMP	TS	C4
capecitabine	TS	C4
5-fluoro-2'-deoxyuridinemonophosphate	TS	C4
【PRE_R】
capecitabine	TS	C4
TS	5-fluoro-2'-deoxyuridinemonophosphate	C4
TS	FdUMP	C4

Monitoring of plasma UdR concentrations have the potential to help clinicians to guide scheduling of capecitabine or other TS inhibitors in clinical trials .
【GOLD_E】
UdR	chem
capecitabine	chem
TS	geneY
【PRE_E】
capecitabine	chem
TS	geneY
【GOLD_R】
【PRE_R】
capecitabine	TS	C4

Marked differences of plasma 2 ' - deoxyuridine between human and rodents have also been confirmed .
【GOLD_E】
2'-deoxyuridine	chem
【PRE_E】
2'-deoxyuridine	chem
【GOLD_R】
【PRE_R】

In conclusion , the LC - MS method developed is simple , highly selective and sensitive and permits pharmacodynamic studies of TS inhibitors in several species .
【GOLD_E】
TS	geneN
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

Induction of heparin - binding EGF - like growth factor and activation of EGF receptor in imatinib mesylate - treated squamous carcinoma cells .
【GOLD_E】
imatinibmesylate	chem
heparin-bindingEGF-likegrowthfactor	geneY
EGFreceptor	geneY
【PRE_E】
EGF-likegrowthfactor	geneY
EGFreceptor	geneY
imatinibmesylate	chem
【GOLD_R】
imatinibmesylate	EGFreceptor	C3
【PRE_R】

Imatinib mesylate is a tyrosine kinase inhibitor of the ABL , platelet - derived growth factor receptor ( PDGFR ) , and c - kit kinases .
【GOLD_E】
PDGFR	geneY
c-kit	geneY
Imatinibmesylate	chem
kinases	geneN
tyrosinekinase	geneN
ABL	geneY
platelet-derivedgrowthfactorreceptor	geneY
tyrosine	chem
【PRE_E】
Imatinibmesylate	chem
tyrosinekinase	geneN
ABL	geneY
platelet-derivedgrowthfactorreceptor	geneN
PDGFR	geneN
c-kitkinases	geneY
【GOLD_R】
Imatinibmesylate	PDGFR	C4
Imatinibmesylate	c-kit	C4
Imatinibmesylate	kinases	C4
Imatinibmesylate	tyrosinekinase	C4
Imatinibmesylate	ABL	C4
Imatinibmesylate	platelet-derivedgrowthfactorreceptor	C4
【PRE_R】
Imatinibmesylate	ABL	C4
Imatinibmesylate	platelet-derivedgrowthfactorreceptor	C4
Imatinibmesylate	PDGFR	C4
Imatinibmesylate	c-kitkinases	C4

Inhibition of BCR - ABL and c - kit accounts for its clinical activity in leukemia and sarcoma , respectively .
【GOLD_E】
BCR	geneY
ABL	geneY
c-kit	geneY
【PRE_E】
BCR	geneY
ABL	geneY
c-kit	geneY
【GOLD_R】
【PRE_R】

In this report , we describe other cellular targets for imatinib .
【GOLD_E】
imatinib	chem
【PRE_E】
imatinib	chem
【GOLD_R】
【PRE_R】

Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of imatinib - induced changes in cell morphology and growth similar to changes associated with epidermal growth factor receptor ( EGFR ) activation .
【GOLD_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
imatinib	chem
【PRE_E】
imatinib	chem
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【GOLD_R】
imatinib	epidermalgrowthfactorreceptor	C3
imatinib	EGFR	C3
【PRE_R】

Imatinib - induced changes were blocked with the EGFR antagonist cetuximab , which suggested direct involvement of EGFR in this process .
【GOLD_E】
Imatinib	chem
EGFR	geneY
EGFR	geneY
【PRE_E】
Imatinib	chem
EGFR	geneY
cetuximab	chem
EGFR	geneY
【GOLD_R】
Imatinib	EGFR	C3
【PRE_R】
EGFR	cetuximab	C4

Western blot analysis of cells incubated with imatinib demonstrated activation of EGFR and downstream signaling that was reduced by inhibition of mitogen - activated protein / extracellular signal - regulated kinase kinase 1 ( MEK1 ) and EGFR , but not Her2 / ErbB2 .
【GOLD_E】
imatinib	chem
EGFR	geneY
mitogen-activatedprotein/extracellularsignal-regulatedkinasekinase1	geneY
MEK1	geneY
EGFR	geneY
Her2	geneY
ErbB2	geneY
【PRE_E】
imatinib	chem
EGFR	geneY
mitogen-activatedprotein	geneN
extracellularsignal-regulatedkinasekinase1	geneY
MEK1	geneY
EGFR	geneY
Her2	geneY
ErbB2	geneY
【GOLD_R】
imatinib	EGFR	C3
imatinib	EGFR	C3
【PRE_R】
imatinib	EGFR	C4
imatinib	mitogen-activatedprotein	C4
imatinib	extracellularsignal-regulatedkinasekinase1	C4
imatinib	MEK1	C4
imatinib	EGFR	C4
imatinib	Her2	C4
imatinib	ErbB2	C4

An in vitro kinase assay showed that imatinib did not directly affect EGFR kinase activity , suggesting involvement of EGFR - activating molecules .
【GOLD_E】
imatinib	chem
kinase	geneN
EGFR	geneY
kinase	geneN
EGFR	geneY
【PRE_E】
kinase	geneN
imatinib	chem
EGFR	geneY
kinase	geneN
EGFR	geneY
【GOLD_R】
【PRE_R】

Inhibitors and neutralizing antibodies against heparin - binding epidermal growth factor - like growth factor ( HB - EGF ) , and to a lesser extent transforming growth factor - alpha , reduced imatinib - mediated mitogen activated protein kinase ( MAPK ) activation .
【GOLD_E】
heparin-bindingepidermalgrowthfactor-likegrowthfactor	geneY
HB-EGF	geneY
transforminggrowthfactor-alpha	geneY
mitogenactivatedproteinkinase	geneN
MAPK	geneN
imatinib	chem
【PRE_E】
epidermalgrowthfactor-likegrowthfactor	geneY
HB-EGF	geneY
transforminggrowthfactor-alpha	geneY
imatinib	chem
mitogenactivatedproteinkinase	geneN
MAPK	geneN
【GOLD_R】
imatinib	mitogenactivatedproteinkinase	C3
imatinib	MAPK	C3
【PRE_R】

Imatinib stimulated the rapid release of soluble HB - EGF and the subsequent induction of membrane - bound HB - EGF , which correlated with biphasic MAPK activation .
【GOLD_E】
HB-EGF	geneY
HB-EGF	geneY
MAPK	geneN
Imatinib	chem
【PRE_E】
Imatinib	chem
HB-EGF	geneY
HB-EGF	geneY
MAPK	geneN
【GOLD_R】
Imatinib	MAPK	C3
Imatinib	HB-EGF	C3
Imatinib	HB-EGF	C3
【PRE_R】
Imatinib	HB-EGF	C3
Imatinib	MAPK	C3

Together , these results suggested that imatinib affects EGFR activation and signaling pathways through rapid release and increased expression of endogenous EGFR - activating ligands .
【GOLD_E】
EGFR	geneY
EGFR	geneY
imatinib	chem
【PRE_E】
imatinib	chem
EGFR	geneY
EGFR	geneY
【GOLD_R】
imatinib	EGFR	C3
【PRE_R】
imatinib	EGFR	C3

Although , imatinib primarily inhibits tyrosine kinases , it also stimulates the activity of EGFR tyrosine kinase in head and neck squamous tumors .
【GOLD_E】
tyrosinekinases	geneN
EGFR	geneY
tyrosinekinase	geneN
imatinib	chem
tyrosine	chem
【PRE_E】
imatinib	chem
tyrosinekinases	geneN
EGFR	geneY
tyrosinekinase	geneN
【GOLD_R】
imatinib	EGFR	C3
imatinib	tyrosinekinase	C3
imatinib	tyrosinekinases	C4
【PRE_R】
imatinib	EGFR	C4

This finding demonstrates the need for careful use of this drug in cancer patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity .
【GOLD_E】
PDGFRA	geneY
【PRE_E】
PDGFRA	geneY
【GOLD_R】
【PRE_R】

The authors report a unique case of an intra - abdominal , epithelioid mesenchymal tumor that had an activating mutation of PDGFRA and a strong PDGFRA immunoreactivity but lacked both c - kit mutation and c - kit protein ( CD117 ) expression .
【GOLD_E】
c-kit	geneY
CD117	geneY
PDGFRA	geneY
PDGFRA	geneY
c-kit	geneY
【PRE_E】
PDGFRA	geneY
PDGFRA	geneY
c-kit	geneY
c-kitprotein	geneY
CD117	geneY
【GOLD_R】
【PRE_R】

IHC study showed that the tumor cells were diffusely and strongly positive for PDGFRA , vimentin , CD34 , and Bcl - 2 but completely negative for CD117 as well as for muscle , epithelial , endothelial , endocrine , mesothelial , neural , and melanocytic cell markers .
【GOLD_E】
PDGFRA	geneY
vimentin	geneY
CD34	geneY
Bcl-2	geneY
CD117	geneY
【PRE_E】
PDGFRA	geneY
vimentin	geneY
CD34	geneY
Bcl-2	geneY
CD117	geneY
【GOLD_R】
【PRE_R】

Molecular study revealed a mutation at the juxtamembrane domain of exon 12 in PDGFRA gene with GTC to GAC transition at codon 561 ( V561D ) , as shown in the previous mutational studies on gastrointestinal stromal tumor ( GIST ) .
【GOLD_E】
PDGFRA	geneY
GTCtoGAC	geneN
V561D	geneN
【PRE_E】
juxtamembranedomain	geneN
PDGFRA	geneY
GTC	chem
GACtransitionatcodon561	geneN
V561D	geneY
【GOLD_R】
【PRE_R】

This case likely represents an example of GIST with PDGFRA activating mutation and PDGFRA immunoreactivity without CD117 positivity , which has not been documented in the literature .
【GOLD_E】
PDGFRA	geneY
PDGFRA	geneY
CD117	geneY
【PRE_E】
PDGFRA	geneY
PDGFRA	geneY
CD117	geneY
【GOLD_R】
【PRE_R】

STI 571 ( imatinib mesylate [ Gleevec ] ) might be an effective therapy in this case , since Gleevec targets both PDGFRA and c - kit oncoproteins .
【GOLD_E】
STI571	chem
imatinibmesylate	chem
Gleevec	chem
Gleevec	chem
PDGFRA	geneY
c-kit	geneY
【PRE_E】
STI571	chem
imatinibmesylate	chem
Gleevec	chem
Gleevec	chem
PDGFRA	geneY
c-kit	geneY
【GOLD_R】
【PRE_R】
STI571	PDGFRA	C4
imatinibmesylate	PDGFRA	C4
Gleevec	PDGFRA	C4
Gleevec	PDGFRA	C4
Gleevec	c-kit	C4

Genetic polymorphism and activities of human lung alcohol and aldehyde dehydrogenases : implications for ethanol metabolism and cytotoxicity .
【GOLD_E】
ethanol	chem
alcohol	chem
aldehyde	chem
humanlungalcoholandaldehydedehydrogenases	geneN
【PRE_E】
alcohol	chem
aldehydedehydrogenases	geneN
ethanol	chem
【GOLD_R】
【PRE_R】

Alcohol dehydrogenase ( ADH ) and aldehyde dehydrogenase ( ALDH ) exhibit genetic polymorphism and tissue specificity .
【GOLD_E】
Alcoholdehydrogenase	geneN
Alcohol	chem
ADH	geneN
aldehydedehydrogenase	geneN
ALDH	geneN
aldehyde	chem
【PRE_E】
Alcoholdehydrogenase	geneY
ADH	geneY
aldehydedehydrogenase	geneY
ALDH	geneY
【GOLD_R】
【PRE_R】

ADH and ALDH isozyme phenotypes from 39 surgical Chinese lung specimens were identified by agarose isoelectric focusing .
【GOLD_E】
ADH	geneN
ALDH	geneN
【PRE_E】
ADH	geneY
ALDH	geneY
【GOLD_R】
【PRE_R】

The identity of the lung beta - ADHs was further demonstrated by their characteristic pH - activity profiles for ethanol oxidation , Km values for NAD and ethanol , and inhibition by 4 - methylpyrazole or 1,10 - phenanthroline .
【GOLD_E】
beta-ADHs	geneN
ethanol	chem
ethanol	chem
4-methylpyrazole	chem
1,10-phenanthroline	chem
【PRE_E】
beta-ADHs	geneN
ethanol	chem
NAD	chem
ethanol	chem
4-methylpyrazole	chem
1,10-phenanthroline	chem
【GOLD_R】
4-methylpyrazole	beta-ADHs	C4
1,10-phenanthroline	beta-ADHs	C4
ethanol	beta-ADHs	C9
ethanol	beta-ADHs	C9
【PRE_R】

The beta 2 allele , coding for beta 2 polypeptide , was found to be predominant in the lung specimens studied .
【GOLD_E】
polypeptide	chem
【PRE_E】
beta2	geneY
【GOLD_R】
【PRE_R】

The ADH activities in the lungs with the homozygous phenotype ADH2 2 - 2 ( exhibiting beta 2 beta 2 ) and ADH2 1 - 1 ( exhibiting beta 1 beta 1 ) and the heterozygous phenotype ADH2 2 - 1 ( exhibiting beta 2 beta 2 , beta 2 beta 1 , and beta 1 beta 1 ) were determined to be 999 + / - 77 , 48 + / - 17 , and 494 + / - 61 nmol / min / g tissue , respectively .
【GOLD_E】
ADH	geneN
ADH22-2	geneY
ADH21-1	geneY
ADH22-1	geneY
【PRE_E】
ADH	geneY
homozygousphenotypeADH22-2	geneY
beta2beta2	geneY
ADH21-1	geneY
exhibitingbeta1beta1	geneY
phenotypeADH22-1	geneY
exhibitingbeta2beta2	geneY
beta2beta1	geneY
beta1beta1	geneY
【GOLD_R】
【PRE_R】

Fifty - one percent of the specimens studied lacked the ALDH2 activity band on the isoelectric focusing gels .
【GOLD_E】
ALDH2	geneY
【PRE_E】
ALDH2	geneY
【GOLD_R】
【PRE_R】

The activities in the lung tissues with the ALDH2 - active phenotype and the inactive phenotype were determined to be 30 + / - 3 and 17 + / - 1 nmol / min / g tissue , respectively .
【GOLD_E】
ALDH2	geneY
【PRE_E】
ALDH2	geneY
【GOLD_R】
【PRE_R】

These findings indicate that human pulmonary ethanol - metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the ALDH2 loci .
【GOLD_E】
ADH2	geneY
ALDH2	geneY
ethanol	chem
【PRE_E】
ethanol	chem
ADH2	geneY
ALDH2	geneY
【GOLD_R】
ethanol	ADH2	C9
ethanol	ALDH2	C9
【PRE_R】

The results suggest that individuals with high Vmax beta 2 - ADH and deficient in low - Km mitochondrial ALDH2 , accounting for approximately 45 % of the Chinese population , may end up with acetaldehyde accumulation during alcohol consumption , rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite .
【GOLD_E】
beta2-ADH	geneY
ALDH2	geneY
acetaldehyde	chem
alcohol	chem
【PRE_E】
Vmaxbeta2-ADH	geneY
ALDH2	geneY
acetaldehyde	chem
alcohol	chem
【GOLD_R】
acetaldehyde	beta2-ADH	C9
acetaldehyde	ALDH2	C9
alcohol	beta2-ADH	C9
alcohol	ALDH2	C9
【PRE_R】
Vmaxbeta2-ADH	alcohol	C9
ALDH2	alcohol	C9

Simvastatin induces interleukin - 18 production in human peripheral blood mononuclear cells .
【GOLD_E】
Simvastatin	chem
interleukin-18	geneY
【PRE_E】
Simvastatin	chem
interleukin-18	geneY
【GOLD_R】
Simvastatin	interleukin-18	C3
【PRE_R】
Simvastatin	interleukin-18	C3

The effects of statins on immune response depend on the inhibition of 3 - hydroxy - 3 - methylglutaryl coenzyme - A ( HMG - CoA ) reductase and leukocyte function - associated antigen ( LFA ) - 1 , which is a ligand of intercellular adhesion molecule ( ICAM ) - 1 .
【GOLD_E】
leukocytefunction-associatedantigen(LFA)-1	geneY
intercellularadhesionmolecule(ICAM)-1	geneY
3-hydroxy-3-methylglutarylcoenzyme-A(HMG-CoA)reductase	geneY
HMG-CoA	chem
3-hydroxy-3-methylglutarylcoenzyme-A	chem
【PRE_E】
3-hydroxy-3-methylglutarylcoenzyme-A	geneY
HMG-CoA)reductase	geneY
leukocytefunction-associatedantigen(LFA)-1	geneY
intercellularadhesionmolecule(ICAM)-1	geneY
【GOLD_R】
【PRE_R】

Simvastatin , an HMG - CoA reductase inhibitor with mild inhibition of LFA - 1 , induced the production of interleukin ( IL ) - 18 , tumor necrosis factor ( TNF ) - alpha and interferon ( IFN ) - gamma in human peripheral blood mononuclear cells ( PBMC ) .
【GOLD_E】
HMG-CoAreductase	geneY
LFA-1	geneY
interleukin(IL)-18	geneY
tumornecrosisfactor(TNF)-alpha	geneY
interferon(IFN)-gamma	geneY
Simvastatin	chem
HMG-CoA	chem
【PRE_E】
Simvastatin	chem
HMG-CoAreductase	geneY
LFA-1	geneY
interleukin(IL)-18	geneY
tumornecrosisfactor(TNF)-alpha	geneY
interferon(IFN)-gamma	geneY
【GOLD_R】
Simvastatin	interleukin(IL)-18	C3
Simvastatin	tumornecrosisfactor(TNF)-alpha	C3
Simvastatin	interferon(IFN)-gamma	C3
Simvastatin	HMG-CoAreductase	C4
Simvastatin	LFA-1	C4
【PRE_R】
Simvastatin	LFA-1	C4
Simvastatin	interleukin(IL)-18	C4
Simvastatin	tumornecrosisfactor(TNF)-alpha	C4

The IL - 18 production is located upstream of the cytokine cascade activated by simvastatin .
【GOLD_E】
IL-18	geneY
cytokine	geneN
simvastatin	chem
【PRE_E】
IL-18	geneY
cytokine	geneN
simvastatin	chem
【GOLD_R】
simvastatin	cytokine	C3
simvastatin	IL-18	C3
【PRE_R】
IL-18	simvastatin	C4

Moreover , simvastatin concentration - dependently inhibited the expression of ICAM - 1 and induced the expression of CD40 on monocytes .
【GOLD_E】
ICAM-1	geneY
CD40	geneY
simvastatin	chem
【PRE_E】
simvastatin	chem
ICAM-1	geneY
CD40	geneY
【GOLD_R】
simvastatin	CD40	C3
simvastatin	ICAM-1	C4
【PRE_R】
simvastatin	ICAM-1	C4
simvastatin	CD40	C4

In the presence of IL - 18 , simvastatin suppressed the expression of ICAM - 1 and CD40 as well as the production of IL - 12 , TNF - alpha and IFN - gamma in PBMC , contributing to the anti - inflammatory effect of simvastatin .
【GOLD_E】
simvastatin	chem
simvastatin	chem
IL-18	geneY
ICAM-1	geneY
CD40	geneY
IL-12	geneN
TNF-alpha	geneY
IFN-gamma	geneY
【PRE_E】
IL-18	geneY
simvastatin	chem
ICAM-1	geneY
CD40	geneY
IL-12	geneY
TNF-alpha	geneY
IFN-gamma	geneY
simvastatin	chem
【GOLD_R】
simvastatin	IL-12	C3
simvastatin	TNF-alpha	C3
simvastatin	IFN-gamma	C3
simvastatin	ICAM-1	C4
simvastatin	CD40	C4
【PRE_R】
simvastatin	ICAM-1	C4
simvastatin	CD40	C4
simvastatin	IL-12	C4
IL-12	simvastatin	C4

The effects of simvastatin were abolished by the addition of the product of the HMG - CoA reductase , mevalonate , indicating the involvement of HMG - CoA reductase in the action of simvastatin .
【GOLD_E】
simvastatin	chem
HMG-CoA	chem
HMG-CoAreductase	geneY
mevalonate	chem
HMG-CoA	chem
HMG-CoAreductase	geneY
simvastatin	chem
【PRE_E】
simvastatin	chem
HMG-CoAreductase	geneY
mevalonate	geneN
HMG-CoAreductase	geneY
simvastatin	chem
【GOLD_R】
mevalonate	HMG-CoAreductase	C9
【PRE_R】

COX - 1 and COX - 2 inhibition in horse blood by phenylbutazone , flunixin , carprofen and meloxicam : an in vitro analysis .
【GOLD_E】
phenylbutazone	chem
flunixin	chem
carprofen	chem
meloxicam	chem
COX-1	geneY
COX-2	geneY
【PRE_E】
COX-1	geneY
COX-2	geneY
phenylbutazone	chem
flunixin	chem
carprofen	chem
meloxicam	chem
【GOLD_R】
phenylbutazone	COX-1	C4
phenylbutazone	COX-2	C4
flunixin	COX-1	C4
flunixin	COX-2	C4
carprofen	COX-1	C4
carprofen	COX-2	C4
meloxicam	COX-1	C4
meloxicam	COX-2	C4
【PRE_R】
COX-1	phenylbutazone	C4
COX-2	phenylbutazone	C4
COX-2	flunixin	C4
COX-2	carprofen	C4
COX-2	meloxicam	C4

We report on the inhibitory activity of the NSAIDs meloxicam , carprofen , phenylbutazone and flunixin , on blood cyclooxygenases in the horse using in vitro enzyme - linked assays .
【GOLD_E】
carprofen	chem
phenylbutazone	chem
flunixin	chem
cyclooxygenases	geneN
meloxicam	chem
【PRE_E】
meloxicam	chem
carprofen	chem
phenylbutazone	chem
flunixin	chem
cyclooxygenases	geneN
【GOLD_R】
carprofen	cyclooxygenases	C4
phenylbutazone	cyclooxygenases	C4
flunixin	cyclooxygenases	C4
meloxicam	cyclooxygenases	C4
【PRE_R】

As expected , comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX - 2 than phenylbutazone and flunixin ; meloxicam was the most advantageous for horses of four NSAIDs examined .
【GOLD_E】
COX-2	geneY
meloxicam	chem
carprofen	chem
phenylbutazone	chem
flunixin	chem
meloxicam	chem
【PRE_E】
meloxicam	chem
carprofen	chem
COX-2	geneY
phenylbutazone	chem
flunixin	chem
meloxicam	chem
【GOLD_R】
meloxicam	COX-2	C4
carprofen	COX-2	C4
phenylbutazone	COX-2	C4
flunixin	COX-2	C4
【PRE_R】
meloxicam	COX-2	C4
carprofen	COX-2	C4
COX-2	phenylbutazone	C4
COX-2	flunixin	C4
COX-2	meloxicam	C4

However at IC80 , phenylbutazone ( + 134.4 % ) and flunixin ( + 29.7 % ) had greater COX - 2 selectivity than at IC50 , and meloxicam ( - 41.2 % ) and carprofen ( - 12.9 % ) had lower COX - 2 selectivity than at IC50 .
【GOLD_E】
carprofen	chem
COX-2	geneY
COX-2	geneY
phenylbutazone	chem
flunixin	chem
meloxicam	chem
【PRE_E】
IC80	chem
phenylbutazone	chem
flunixin	chem
COX-2	geneY
meloxicam	chem
carprofen	chem
COX-2	geneY
【GOLD_R】
carprofen	COX-2	C4
phenylbutazone	COX-2	C4
flunixin	COX-2	C4
meloxicam	COX-2	C4
【PRE_R】
IC80	COX-2	C4
phenylbutazone	COX-2	C4
flunixin	COX-2	C4
COX-2	meloxicam	C4
carprofen	COX-2	C4

We therefore propose that the selectivity of NSAIDs should be assessed at the 80 % as well as 50 % inhibition level .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia - inducible factor - 1alpha and vascular endothelial growth factor in pressure - overloaded rat heart .
【GOLD_E】
Carvedilol	chem
hypoxia-induciblefactor-1alpha	geneY
vascularendothelialgrowthfactor	geneY
【PRE_E】
Carvedilol	chem
hypoxia-induciblefactor-1alpha	geneY
vascularendothelialgrowthfactor	geneY
【GOLD_R】
Carvedilol	hypoxia-induciblefactor-1alpha	C4
Carvedilol	vascularendothelialgrowthfactor	C4
【PRE_R】
Carvedilol	hypoxia-induciblefactor-1alpha	C4
Carvedilol	vascularendothelialgrowthfactor	C4

The use of beta - blockers has emerged as a beneficial treatment for cardiac hypertrophy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hypoxia - inducible factor - 1alpha ( HIF - 1alpha ) is tightly regulated in the ventricular myocardium .
【GOLD_E】
HIF-1alpha	geneY
Hypoxia-induciblefactor-1alpha	geneY
【PRE_E】
Hypoxia-induciblefactor-1alpha	geneY
HIF-1alpha	geneY
【GOLD_R】
【PRE_R】

However , the expression of HIF - 1alpha in cardiac hypertrophy due to pressure overload and after treatment with beta - blocker is little known .
【GOLD_E】
HIF-1alpha	geneY
【PRE_E】
HIF-1alpha	geneY
【GOLD_R】
【PRE_R】

To evaluate the effect of carvedilol on both myocardial HIF - 1alpha expression and cardiac hypertrophy , infra - renal aortic banding was performed for 4 weeks in adult Sprague - Dawley rats to induce cardiac hypertrophy .
【GOLD_E】
HIF-1alpha	geneY
carvedilol	chem
【PRE_E】
carvedilol	chem
HIF-1alpha	geneY
【GOLD_R】
【PRE_R】
carvedilol	HIF-1alpha	C4

Carvedilol at 50 mg / kg body weight per day after surgery was given .
【GOLD_E】
Carvedilol	chem
【PRE_E】
Carvedilol	chem
【GOLD_R】
【PRE_R】

Heart weight and the ratio of heart weight and body weight increased significantly after aortic banding for 4 weeks in the absence of drug treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mean arterial pressure increased from 80 + / - 9 mmHg in the sham group to 94 + / - 5 mmHg ( p < 0.001 ) in the banding group .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Echocardiography showed concentric hypertrophy after aortic banding .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mean arterial pressure decreased after treatment with carvedilol .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

The increased wall thickness and heart weight was reversed to normal by carvedilol .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

Western blot showed that HIF - 1alpha , vascular endothelial growth factor ( VEGF ) and brain natriuretic peptide ( BNP ) proteins were up - regulated and nerve growth factor - beta ( NGF - beta ) down - regulated in the banding group .
【GOLD_E】
HIF-1alpha	geneY
vascularendothelialgrowthfactor	geneY
VEGF	geneY
brainnatriureticpeptide	geneY
BNP	geneY
nervegrowthfactor-beta	geneY
NGF-beta	geneY
【PRE_E】
HIF-1alpha	geneY
vascularendothelialgrowthfactor	geneY
VEGF	geneY
brainnatriureticpeptide	geneY
BNP	geneY
nervegrowthfactor-beta	geneY
NGF-beta	geneY
【GOLD_R】
【PRE_R】

Treatment with valsartan , doxazosin , or N - acetylcysteine did not significantly affect HIF - 1alpha and VEGF proteins expression in the banding groups .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
valsartan	chem
doxazosin	chem
N-acetylcysteine	chem
【PRE_E】
valsartan	chem
doxazosin	chem
N-acetylcysteine	chem
HIF-1alpha	geneY
VEGF	geneY
【GOLD_R】
【PRE_R】
valsartan	VEGF	C4
doxazosin	VEGF	C4
N-acetylcysteine	VEGF	C4

Real - time polymerase chain reaction showed that mRNA of HIF - 1alpha , VEGF and BNP increased and mRNA of NGF - beta decreased in the banding group .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【PRE_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【GOLD_R】
【PRE_R】

Treatment with carvedilol reversed both protein and mRNA of HIF - 1alpha , VEGF , BNP , and NGF - beta to the baseline values .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
carvedilol	chem
【PRE_E】
carvedilol	chem
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【GOLD_R】
carvedilol	NGF-beta	C3
carvedilol	HIF-1alpha	C4
carvedilol	VEGF	C4
carvedilol	BNP	C4
【PRE_R】

Increased immunohistochemical labeling of HIF - 1alpha , VEGF , and BNP in the ventricular myocardium was observed in the banding group and carvedilol again normalized the labeling .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
carvedilol	chem
【PRE_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
carvedilol	chem
【GOLD_R】
carvedilol	HIF-1alpha	C4
carvedilol	VEGF	C4
carvedilol	BNP	C4
【PRE_R】
HIF-1alpha	carvedilol	C4
VEGF	carvedilol	C4
BNP	carvedilol	C4

In conclusion , HIF - 1alpha , VEGF , and BNP mRNA and protein expression were up - regulated , while NGF - beta mRNA and protein was downregulated in the rat model of pressure - overloaded cardiac hypertrophy .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【PRE_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【GOLD_R】
【PRE_R】

Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF - 1alpha , VEGF , BNP , and NGF - beta in the hypertrophic myocardium .
【GOLD_E】
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
carvedilol	chem
【PRE_E】
carvedilol	chem
HIF-1alpha	geneY
VEGF	geneY
BNP	geneY
NGF-beta	geneY
【GOLD_R】
carvedilol	HIF-1alpha	C4
carvedilol	VEGF	C4
carvedilol	BNP	C4
【PRE_R】
carvedilol	HIF-1alpha	C4
carvedilol	VEGF	C4
carvedilol	BNP	C4
carvedilol	NGF-beta	C4

Imatinib resistance in gastrointestinal stromal tumors .
【GOLD_E】
Imatinib	chem
【PRE_E】
Imatinib	chem
【GOLD_R】
【PRE_R】

Conventional chemotherapeutic drugs are ineffective in treatment of gastrointestinal stromal tumors ( GISTs ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Imatinib ( STI571 , Gleevec , Glivec ; Novartis Pharmaceuticals , East Hanover , NJ ) , a selective inhibitor of KIT , ABL , BCR - ABL , PDGFRA , and PDGFRB , represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs .
【GOLD_E】
KIT	geneY
ABL	geneY
BCR	geneY
ABL	geneY
PDGFRA	geneY
PDGFRB,	geneY
Imatinib	chem
STI571	chem
Gleevec	chem
Glivec	chem
【PRE_E】
Imatinib	chem
STI571	chem
Gleevec	chem
Glivec	chem
Novartis	chem
KIT	geneY
ABL	geneY
BCR	geneY
ABL	geneY
PDGFRA	geneY
PDGFRB	geneY
【GOLD_R】
Imatinib	KIT	C4
Imatinib	ABL	C4
Imatinib	BCR	C4
Imatinib	ABL	C4
Imatinib	PDGFRA	C4
Imatinib	PDGFRB,	C4
STI571	KIT	C4
STI571	ABL	C4
STI571	BCR	C4
STI571	ABL	C4
STI571	PDGFRA	C4
STI571	PDGFRB,	C4
Gleevec	KIT	C4
Gleevec	ABL	C4
Gleevec	BCR	C4
Gleevec	ABL	C4
Gleevec	PDGFRA	C4
Gleevec	PDGFRB,	C4
Glivec	KIT	C4
Glivec	ABL	C4
Glivec	BCR	C4
Glivec	ABL	C4
Glivec	PDGFRA	C4
Glivec	PDGFRB,	C4
【PRE_R】
Imatinib	KIT	C4
STI571	KIT	C4
Gleevec	KIT	C4
Glivec	KIT	C4
Novartis	KIT	C4
Novartis	ABL	C4
Novartis	BCR	C4
Novartis	ABL	C4
Novartis	PDGFRA	C4
Novartis	PDGFRB	C4

Unfortunately , imatinib resistance has emerged .
【GOLD_E】
imatinib	chem
【PRE_E】
imatinib	chem
【GOLD_R】
【PRE_R】

The reported mechanism of imatinib resistance in GISTs involves missense mutation in the kinase domain of KIT , including Thr670Ile , Tyr823Asp , and Val654Ala .
【GOLD_E】
kinasedomain	geneN
KIT,	geneN
Thr670Ile	geneN
Tyr823Asp	geneN
Val654Ala	geneN
imatinib	chem
【PRE_E】
imatinib	chem
GISTs	geneN
kinasedomain	geneN
KIT	geneY
Thr670Ile	geneY
Tyr823Asp	geneY
Val654Ala	geneY
【GOLD_R】
【PRE_R】

The established mechanisms and potential mechanisms of imatinib resistance in GISTs , the imaging studies indicative of early development of imatinib resistance , and the management of imatinib - resistant GISTs are discussed .
【GOLD_E】
imatinib	chem
imatinib	chem
imatinib	chem
【PRE_E】
imatinib	chem
imatinib	chem
imatinib	chem
【GOLD_R】
【PRE_R】

Evaluation of histamine H1 - , H2 - , and H3 - receptor ligands at the human histamine H4 receptor : identification of 4 - methylhistamine as the first potent and selective H4 receptor agonist .
【GOLD_E】
4-methylhistamine	chem
histamine	chem
histamine	chem
histamineH1-,H2-,andH3-receptor	geneN
H4receptor	geneY
humanhistamineH4receptor	geneY
【PRE_E】
histamineH1-,H2-,andH3-receptor	geneN
humanhistamineH4receptor	geneY
4-methylhistamine	chem
H4receptor	geneY
【GOLD_R】
4-methylhistamine	H4receptor	C5
【PRE_R】

The histamine H ( 4 ) receptor ( H ( 4 ) R ) is involved in the chemotaxis of leukocytes and mast cells to sites of inflammation and is suggested to be a potential drug target for asthma and allergy .
【GOLD_E】
H(4)R	geneY
histamineH(4)receptor	geneY
histamine	chem
【PRE_E】
histamineH(4)receptor	geneY
H(4)R	geneY
【GOLD_R】
【PRE_R】

So far , selective H ( 4 ) R agonists have not been identified .
【GOLD_E】
H(4)R	geneY
【PRE_E】
H(4)R	geneY
【GOLD_R】
【PRE_R】

In the present study , we therefore evaluated the human H ( 4 ) R ( hH ( 4 ) R ) for its interaction with various known histaminergic ligands .
【GOLD_E】
humanH(4)R	geneY
hH(4)R	geneY
【PRE_E】
humanH(4)R	geneY
hH(4)R	geneY
【GOLD_R】
【PRE_R】

Almost all of the tested H ( 1 ) R and H ( 2 ) R antagonists , including several important therapeutics , displaced less than 30 % of specific [ ( 3 ) H ] histamine binding to the hH ( 4 ) R at concentrations up to 10 microM .
【GOLD_E】
H(1)R	geneY
H(2)R	geneY
hH(4)R	geneY
[(3)H]histamine	chem
【PRE_E】
H(1)R	geneY
H(2)R	geneY
[(3)H]histamine	chem
hH(4)R	geneY
【GOLD_R】
【PRE_R】

Most of the tested H ( 2 ) R agonists and imidazole - based H ( 3 ) R ligands show micromolar - to - nanomolar range hH ( 4 ) R affinity , and these ligands exert different intrinsic hH ( 4 ) R activities , ranging from full agonists to inverse agonists .
【GOLD_E】
H(2)R	geneY
H(3)R	geneY
hH(4)R	geneY
hH(4)R	geneY
imidazole	chem
【PRE_E】
H(2)R	chem
imidazole	chem
H(3)R	chem
hH(4)R	geneY
hH(4)R	geneY
【GOLD_R】
imidazole	hH(4)R	C5
imidazole	hH(4)R	C5
【PRE_R】

Interestingly , we identified 4 - methylhistamine as a high - affinity H ( 4 ) R ligand ( K ( i ) = 50 nM ) that has a > 100 - fold selectivity for the hH ( 4 ) R over the other histamine receptor subtypes .
【GOLD_E】
H(4)R	geneY
hH(4)R	geneY
histaminereceptor	geneN
4-methylhistamine	chem
histamine	chem
【PRE_E】
4-methylhistamine	chem
H(4)R	geneN
hH(4)R	geneY
histaminereceptor	geneN
【GOLD_R】
【PRE_R】

Moreover , 4 - methylhistamine potently activated the hH ( 4 ) R ( pEC ( 50 ) = 7.4 + / - 0.1 ; alpha = 1 ) , and this response was competitively antagonized by the selective H ( 4 ) R antagonist JNJ 7777120 [ 1 - [ ( 5 - chloro - 1H - indol - 2 - yl ) - carbonyl ] - 4 - methylpiperazine ] ( pA ( 2 ) = 7.8 ) .
【GOLD_E】
hH(4)R	geneY
H(4)R	geneY
4-methylhistamine	chem
JNJ7777120	chem
1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine	chem
【PRE_E】
4-methylhistamine	chem
hH(4)R	geneY
pEC	chem
H(4)R	geneY
JNJ7777120	chem
1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine	chem
【GOLD_R】
4-methylhistamine	hH(4)R	C3
JNJ7777120	H(4)R	C6
1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine	H(4)R	C6
【PRE_R】
H(4)R	JNJ7777120	C5

The identification of 4 - methylhistamine as a potent H ( 4 ) R agonist is of major importance for future studies to unravel the physiological roles of the H ( 4 ) R .
【GOLD_E】
H(4)R	geneY
H(4)R	geneY
4-methylhistamine	chem
【PRE_E】
4-methylhistamine	chem
H(4)R	geneY
H(4)R	geneY
【GOLD_R】
4-methylhistamine	H(4)R	C5
【PRE_R】

Novel agents that potentially inhibit irinotecan - induced diarrhea .
【GOLD_E】
irinotecan	chem
【PRE_E】
irinotecan	chem
【GOLD_R】
【PRE_R】

Irinotecan ( CPT - 11 , 7 - ethyl - 10 - [ 4 - ( 1 - piperidino ) - 1 - piperidino ] carbonyloxycamptothecin ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I ( Topo I ) .
【GOLD_E】
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	chem
Irinotecan	chem
DNAtopoisomeraseI	geneY
TopoI	geneY
CPT-11	chem
【PRE_E】
Irinotecan	chem
CPT-11	chem
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	chem
DNAtopoisomeraseI	geneY
TopoI	geneY
【GOLD_R】
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	DNAtopoisomeraseI	C4
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	TopoI	C4
Irinotecan	DNAtopoisomeraseI	C4
Irinotecan	TopoI	C4
CPT-11	DNAtopoisomeraseI	C4
CPT-11	TopoI	C4
【PRE_R】
Irinotecan	DNAtopoisomeraseI	C4
CPT-11	DNAtopoisomeraseI	C4
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	DNAtopoisomeraseI	C4
7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin	TopoI	C4

However , severe and unpredictable dosing - limiting toxicities ( mainly myelosuppression and severe diarrhea ) hinder its clinical use .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The latter consists of early and late - onset diarrhea , occurring within 24 hr or > or = 24 hr after CPT - 11 administration , respectively .
【GOLD_E】
CPT-11	chem
【PRE_E】
CPT-11	chem
【GOLD_R】
【PRE_R】

This review highlights novel agents potentially inhibiting CPT - 11 - induced diarrhea , which are designed and tested under guidance of disposition pathways and potential toxicity mechanisms .
【GOLD_E】
CPT-11	chem
【PRE_E】
CPT-11	chem
【GOLD_R】
【PRE_R】

Early - onset diarrhea is observed immediately after CPT - 11 infusion and probably due to the inhibition of acetylcholinesterase activity , which can be eliminated by administration of atropine .
【GOLD_E】
CPT-11	chem
atropine	chem
acetylcholinesterase	geneY
【PRE_E】
CPT-11	chem
acetylcholinesterase	geneY
atropine	chem
【GOLD_R】
atropine	acetylcholinesterase	C3
CPT-11	acetylcholinesterase	C4
【PRE_R】
CPT-11	acetylcholinesterase	C4
acetylcholinesterase	atropine	C4

Late - onset diarrhea appears to be associated with intestinal exposure to SN - 38 ( 7 - ethyl - 10 - hydroxycamptothecin ) , the major active metabolite of CPT - 11 , which may bind to Topo I and induce apoptosis of intestinal epithelia , leading to the disturbance in the absorptive and secretory functions of mucosa .
【GOLD_E】
SN-38	chem
7-ethyl-10-hydroxycamptothecin	chem
CPT-11	chem
TopoI	geneY
【PRE_E】
SN-38(7-ethyl-10-hydroxycamptothecin	chem
CPT-11	chem
TopoI	geneY
【GOLD_R】
【PRE_R】

CPT - 11 and SN - 38 may also stimulate the production of pro - inflammatory cytokines and prostaglandins ( PGs ) , thus inducing the secretion of Na ( + ) and Cl ( - ) .
【GOLD_E】
cytokines	geneN
CPT-11	chem
SN-38	chem
prostaglandins	chem
PGs	chem
Na(+)	chem
Cl(-)	chem
【PRE_E】
CPT-11	chem
cytokines	geneN
prostaglandins	chem
PGs	chem
Na(+)	chem
Cl(-)	chem
【GOLD_R】
CPT-11	cytokines	C3
SN-38	cytokines	C3
【PRE_R】

Early treatment of severe late - onset diarrhea with oral high - dose loperamide has decreased patient morbidity .
【GOLD_E】
loperamide	chem
【PRE_E】
loperamide	chem
【GOLD_R】
【PRE_R】

Extensive studies have been conducted to identify other potential agents to ameliorate diarrhea in preclinical and clinical models .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These include intestinal alkalizing agents , oral antibiotics , enzyme inducers , P - glycoprotein ( PgP ) inhibitors , cyclooxygenase - 2 ( COX - 2 ) inhibitors , tumor necrosis factor - alpha ( TNF - alpha ) inhibitors , or blockers of biliary excretion of SN - 38 .
【GOLD_E】
SN-38	chem
P-glycoprotein	geneN
PgP	geneN
cyclooxygenase-2	geneY
COX-2	geneY
tumornecrosisfactor-alpha	geneY
TNF-alpha	geneY
【PRE_E】
P-glycoprotein	geneN
PgP	geneN
cyclooxygenase-2	geneY
COX-2	geneY
tumornecrosisfactor-alpha	geneY
TNF-alpha	geneY
SN-38	chem
【GOLD_R】
【PRE_R】

Further studies are needed to identify the molecular targets associated with CPT - 11 toxicity and safe and effective agents for alleviating CPT - 11 - induced diarrhea .
【GOLD_E】
CPT-11	chem
CPT-11	chem
【PRE_E】
CPT-11	chem
CPT-11	chem
【GOLD_R】
【PRE_R】

Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives .
【GOLD_E】
pyridoxal	chem
roscovitine	chem
pyridoxalkinase	geneY
【PRE_E】
pyridoxalkinase	geneN
roscovitine	chem
【GOLD_R】
【PRE_R】

Pyridoxal kinase ( PDXK ) catalyzes the phosphorylation of pyridoxal , pyridoxamine , and pyridoxine in the presence of ATP and Zn2 + .
【GOLD_E】
pyridoxal	chem
pyridoxamine	chem
Pyridoxal	chem
pyridoxine	chem
Pyridoxalkinase	geneY
PDXK	geneY
ATP	chem
Zn2+	chem
【PRE_E】
Pyridoxalkinase	geneY
PDXK	geneY
pyridoxal	chem
pyridoxamine	chem
pyridoxine	chem
ATP	chem
Zn2+	chem
【GOLD_R】
pyridoxal	Pyridoxalkinase	C9
pyridoxal	PDXK	C9
pyridoxamine	Pyridoxalkinase	C9
pyridoxamine	PDXK	C9
pyridoxine	Pyridoxalkinase	C9
pyridoxine	PDXK	C9
【PRE_R】
PDXK	pyridoxal	C9
PDXK	pyridoxamine	C9
PDXK	pyridoxine	C9
PDXK	ATP	C9
PDXK	Zn2+	C9

This constitutes an essential step in the synthesis of pyridoxal 5 ' - phosphate ( PLP ) , the active form of vitamin B6 , a cofactor for over 140 enzymes .
【GOLD_E】
vitaminB6	chem
pyridoxal5'-phosphate	chem
PLP	chem
【PRE_E】
pyridoxal5'-phosphate	chem
PLP	chem
vitaminB6	chem
【GOLD_R】
【PRE_R】

( R ) - Roscovitine ( CYC202 , Seliciclib ) is a relatively selective inhibitor of cyclin - dependent kinases ( CDKs ) , currently evaluated for the treatment of cancers , neurodegenerative disorders , renal diseases , and several viral infections .
【GOLD_E】
(R)-Roscovitine	chem
CYC202	chem
Seliciclib	chem
cyclin-dependentkinases	geneN
CDKs	geneN
【PRE_E】
(R)-Roscovitine	chem
CYC202	chem
Seliciclib	chem
cyclin-dependentkinases	geneN
CDKs	geneN
【GOLD_R】
(R)-Roscovitine	cyclin-dependentkinases	C4
(R)-Roscovitine	CDKs	C4
CYC202	cyclin-dependentkinases	C4
CYC202	CDKs	C4
Seliciclib	cyclin-dependentkinases	C4
Seliciclib	CDKs	C4
【PRE_R】
(R)-Roscovitine	cyclin-dependentkinases	C4
CYC202	cyclin-dependentkinases	C4
Seliciclib	cyclin-dependentkinases	C4
Seliciclib	CDKs	C4

Affinity chromatography investigations have shown that ( R ) - roscovitine also interacts with PDXK .
【GOLD_E】
(R)-roscovitine	chem
PDXK	geneY
【PRE_E】
(R)-roscovitine	chem
PDXK	geneN
【GOLD_R】
【PRE_R】

To understand this interaction , we determined the crystal structure of PDXK in complex with ( R ) - roscovitine , N6 - methyl - ( R ) - roscovitine , and O6 - ( R ) - roscovitine , the two latter derivatives being designed to bind to PDXK but not to CDKs .
【GOLD_E】
(R)-roscovitine	chem
N6-methyl-(R)-roscovitine	chem
O6-(R)-roscovitine	chem
PDXK	geneY
PDXK	geneY
CDKs	geneN
【PRE_E】
PDXK	geneN
(R)-roscovitine	chem
N6-methyl-(R)-roscovitine	chem
O6-(R)-roscovitine	chem
PDXK	geneN
CDKs	geneN
【GOLD_R】
【PRE_R】

Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal - binding site of PDXK rather than in the anticipated ATP - binding site .
【GOLD_E】
roscovitines	chem
pyridoxal	chem
ATP	chem
PDXK	geneY
【PRE_E】
roscovitines	chem
pyridoxal	chem
PDXK	geneN
ATP-bindingsite	geneN
【GOLD_R】
【PRE_R】

The pyridoxal pocket has thus an unexpected ability to accommodate molecules different from and larger than pyridoxal .
【GOLD_E】
pyridoxal	chem
pyridoxal	chem
【PRE_E】
pyridoxal	chem
pyridoxal	chem
【GOLD_R】
【PRE_R】

This work provides detailed structural information on the interactions between PDXK and roscovitine and analogs .
【GOLD_E】
PDXK	geneY
roscovitine	chem
【PRE_E】
PDXK	geneN
roscovitine	chem
【GOLD_R】
【PRE_R】

It could also aid in the design of roscovitine derivatives displaying strict selectivity for either PDXK or CDKs .
【GOLD_E】
PDXK	geneY
CDKs	geneN
roscovitine	chem
【PRE_E】
roscovitine	chem
PDXK	geneN
CDKs	geneN
【GOLD_R】
【PRE_R】
roscovitine	PDXK	C4
roscovitine	CDKs	C4

Gastric mucin secretion in response to beta - adrenergic G protein - coupled receptor activation is mediated by SRC kinase - dependent epidermal growth factor receptor transactivation .
【GOLD_E】
Gastricmucin	geneN
SRC	geneY
kinase	geneN
epidermalgrowthfactorreceptor	geneY
beta-adrenergicGprotein-coupledreceptor	geneN
【PRE_E】
mucin	geneN
beta-adrenergicGprotein-coupledreceptor	geneN
SRCkinase	geneN
epidermalgrowthfactorreceptor	geneY
【GOLD_R】
【PRE_R】

In many systems , the integration of converging regulatory signals that relay on G protein - coupled receptor ( GPCR ) activation into functional cellular pathways requires the involvement of receptor tyrosine kinase .
【GOLD_E】
GPCR	geneN
receptortyrosinekinase	geneN
Gprotein-coupledreceptor	geneN
tyrosine	chem
【PRE_E】
Gprotein-coupledreceptor	geneN
GPCR	geneN
tyrosinekinase	geneN
【GOLD_R】
【PRE_R】

In this report , we provide evidence that activation of GPCR by beta - adrenergic agonist leading to stimulation in gastric mucin secretion requires epidermal growth factor receptor ( EGFR ) participation .
【GOLD_E】
GPCR	geneN
gastricmucin	geneN
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【PRE_E】
GPCR	geneN
mucin	geneN
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

Using [ ( 3 ) H ] glucosamine - labeled gastric mucosal cells , we show that stimulatory effect of beta - adrenergic agonist , isoproterenol , on mucin secretion was inhibited by EGFR kinase inhibitor , PD153035 , as well as wortmannin , a specific inhibitor of PI3K .
【GOLD_E】
mucin	geneN
EGFR	geneY
kinase	geneN
PI3K	geneN
[(3)H]glucosamine	chem
PD153035	chem
wortmannin	chem
【PRE_E】
[(3)H]glucosamine	chem
isoproterenol	chem
mucin	geneY
EGFR	geneY
kinase	geneN
PD153035	chem
wortmannin	chem
PI3K	geneN
【GOLD_R】
PD153035	mucin	C4
wortmannin	mucin	C4
PD153035	EGFR	C4
PD153035	kinase	C4
wortmannin	PI3K	C4
【PRE_R】
mucin	PD153035	C4
EGFR	PD153035	C4
kinase	PD153035	C4
wortmannin	PI3K	C4

Both inhibitors , moreover , blunted the mucin secretory responses to beta - adrenergic agonist - generated second messenger , cAMP as well as adenylate cyclase activator , forskolin .
【GOLD_E】
forskolin	chem
mucin	geneN
adenylatecyclase	geneN
cAMP	chem
adenylate	chem
【PRE_E】
mucin	geneN
cAMP	chem
adenylatecyclaseactivator	geneN
forskolin	chem
【GOLD_R】
forskolin	adenylatecyclase	C3
forskolin	mucin	C4
cAMP	adenylatecyclase	C9
【PRE_R】

The gastric mucin secretory responses to isoproterenol , furthermore , were inhibited by PP2 , a selective inhibitor of tyrosine kinase Src responsible for ligand - independent EGFR autophosphorylation , but not by ERK inhibitor , PD98059 .
【GOLD_E】
isoproterenol	chem
PP2	chem
tyrosine	chem
EGFR	geneY
ERK	geneN
PD98059	chem
gastricmucin	geneN
tyrosinekinase	geneN
Src	geneY
【PRE_E】
mucin	geneN
isoproterenol	chem
PP2	chem
tyrosinekinaseSrc	geneN
EGFR	geneY
ERK	geneN
PD98059	chem
【GOLD_R】
PP2	EGFR	C3
PP2	gastricmucin	C4
PP2	tyrosinekinase	C4
PP2	Src	C4
PD98059	ERK	C4
【PRE_R】
mucin	isoproterenol	C4
mucin	PP2	C4
PP2	EGFR	C4
ERK	PD98059	C4

The inhibition of ERK , moreover , did not cause attenuation in mucin secretion in response to cAMP and forskolin .
【GOLD_E】
ERK	geneN
mucin	geneN
cAMP	chem
forskolin	chem
【PRE_E】
ERK	geneN
mucin	geneN
cAMP	chem
forskolin	chem
【GOLD_R】
cAMP	ERK	C4
forskolin	ERK	C4
【PRE_R】

The findings underline the role of EGFR as a convergence point in gastric mucin secretion triggered by beta - adrenergic GPCR activation , and demonstrate the requirement for Src kinase in EGFR transactivation .
【GOLD_E】
EGFR	geneY
gastricmucin	geneN
beta-adrenergicGPCR	geneN
Src	geneY
kinase	geneN
EGFR	geneY
【PRE_E】
EGFR	geneY
mucin	geneN
beta-adrenergicGPCR	geneN
Srckinase	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

Losartan : a selective angiotensin II type 1 ( AT1 ) receptor antagonist for the treatment of heart failure .
【GOLD_E】
Losartan	chem
angiotensinII	chem
angiotensinIItype1(AT1)receptor	geneY
【PRE_E】
Losartan	chem
angiotensinIItype1(AT1)receptor	geneY
【GOLD_R】
Losartan	angiotensinIItype1(AT1)receptor	C6
【PRE_R】

Losartan ( COZAAR ) is the prototype of a new class of potent and selective angiotensin II ( AII ) type 1 ( AT ( 1 ) ) receptor antagonists with the largest published preclinical and clinical data base .
【GOLD_E】
angiotensinII	chem
AII	chem
Losartan	chem
angiotensinII(AII)type1(AT(1))receptor	geneY
COZAAR	chem
【PRE_E】
Losartan	chem
COZAAR	chem
angiotensinII(AII)type1(AT(1))receptor	geneY
【GOLD_R】
Losartan	angiotensinII(AII)type1(AT(1))receptor	C6
COZAAR	angiotensinII(AII)type1(AT(1))receptor	C6
【PRE_R】

Since all of the AII antagonists are selective for the AT ( 1 ) receptor , these drugs should exhibit similar cardiovascular effects .
【GOLD_E】
AII	chem
AII	geneY
AT(1)receptor	geneY
【PRE_E】
AII	geneY
AT(1)receptor	geneY
【GOLD_R】
【PRE_R】

However , since the pharmacokinetic / pharmacodynamic profiles of these agents and their degree of affinity for the AT ( 1 ) receptor differ , it is likely that differences in clinical profiles between these drugs exist and will require investigation .
【GOLD_E】
AT(1)receptor	geneY
【PRE_E】
AT(1)receptor	geneY
【GOLD_R】
【PRE_R】

Losartan ( parent compound ) , has moderate affinity for the AT ( 1 ) receptor ( competitive inhibition ) .
【GOLD_E】
Losartan	chem
AT(1)receptor	geneY
【PRE_E】
Losartan	chem
AT(1)receptor	geneY
【GOLD_R】
【PRE_R】

Losartan is well - absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite ( designated E3174 ) with an affinity 20 - to 30 - times greater for the AT ( 1 ) receptor ( non - competitive inhibition ) .
【GOLD_E】
Losartan	chem
AT(1)receptor	geneY
【PRE_E】
Losartan	chem
E3174	chem
AT(1)receptor	geneY
【GOLD_R】
Losartan	AT(1)receptor	C4
【PRE_R】

E3174 has a half - life of 6 - 9 h ; elimination is via renal and hepatic routes .
【GOLD_E】
【PRE_E】
E3174	chem
【GOLD_R】
【PRE_R】

Antihypertensive and , in heart failure patients , haemodynamic activity is observed over a 24 h period with once daily dosing .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Over 6 million patients have been treated for hypertension with continued excellent tolerability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Clinical experience in heart failure is growing , and recent data suggest an improved survival with losartan versus captopril , a drug from the angiotensin - converting - enzyme inhibitor class with proven benefit in this population .
【GOLD_E】
angiotensin-converting-enzyme	geneY
losartan	chem
captopril	chem
angiotensin	chem
【PRE_E】
losartan	chem
captopril	chem
angiotensin-converting-enzyme	geneY
【GOLD_R】
losartan	angiotensin-converting-enzyme	C4
captopril	angiotensin-converting-enzyme	C4
【PRE_R】
losartan	angiotensin-converting-enzyme	C4
captopril	angiotensin-converting-enzyme	C4

The current comprehensive losartan clinical end - point programme ( 4 large scale morbidity / mortality trials ) should provide evidence regarding the efficacy of direct blockade of the AT ( 1 ) receptor with losartan compared to standard therapy : 1 ) The Losartan Heart Failure Survival Study - ELITE II , 2 ) The Losartan Post - Myocardial Infarction Survival Study - OPTIMAAL , 3 ) The Losartan Hypertension Survival Study - LIFE and 4 ) The Losartan Renal Protection Study - RENAAL .
【GOLD_E】
Losartan	chem
Losartan	chem
AT(1)receptor	geneY
losartan	chem
losartan	chem
Losartan	chem
Losartan	chem
【PRE_E】
losartan	chem
AT(1)receptor	geneY
losartan	chem
Losartan	chem
Losartan	chem
Losartan	chem
Losartan	chem
【GOLD_R】
losartan	AT(1)receptor	C4
【PRE_R】

Effect of amrinone on tumor necrosis factor production in endotoxic shock .
【GOLD_E】
amrinone	chem
tumornecrosisfactor	geneY
【PRE_E】
amrinone	chem
tumornecrosisfactor	geneY
【GOLD_R】
【PRE_R】

Tumor necrosis factor ( TNF ) is a macrophage - derived mediator responsible for many of the pathophysiologic manifestations of endotoxic shock .
【GOLD_E】
Tumornecrosisfactor	geneY
TNF	geneY
【PRE_E】
Tumornecrosisfactor	geneY
TNF	geneY
【GOLD_R】
【PRE_R】

We now demonstrate that amrinone , a noncatechol inotrope , strongly inhibits lipopolysaccharide ( LPS ) - induced TNF production at concentrations readily achieved in vivo .
【GOLD_E】
TNF	geneY
amrinone	chem
【PRE_E】
amrinone	chem
noncatechol	chem
TNF	geneY
【GOLD_R】
amrinone	TNF	C4
【PRE_R】
amrinone	TNF	C4
noncatechol	TNF	C4

This inhibition is apparent in murine macrophages , in macrophage cell lines , in vivo , and in cell lines containing a reporter gene construct that substitutes the chloramphenicol acetyl transferase ( CAT ) coding sequence for the TNF coding sequence and introns .
【GOLD_E】
TNF	geneY
【PRE_E】
chloramphenicolacetyltransferase	geneN
CAT	geneY
TNF	geneY
【GOLD_R】
【PRE_R】

Inhibition by amrinone ( like inhibition by pentoxifylline ) is manifested at the level of mRNA accumulation , in contrast to inhibition caused by dexamethasone .
【GOLD_E】
amrinone	chem
pentoxifylline	chem
dexamethasone	chem
【PRE_E】
amrinone	chem
pentoxifylline	chem
dexamethasone	chem
【GOLD_R】
【PRE_R】

Combined application of dexamethasone and amrinone caused additive inhibition of TNF biosynthesis in vitro .
【GOLD_E】
TNF	geneY
dexamethasone	chem
amrinone	chem
【PRE_E】
dexamethasone	chem
amrinone	chem
TNF	geneY
【GOLD_R】
dexamethasone	TNF	C4
amrinone	TNF	C4
【PRE_R】
dexamethasone	TNF	C4
amrinone	TNF	C4

Furthermore , treatment of mice with amrinone immediately prior to endotoxin challenge led to significantly improved survival .
【GOLD_E】
amrinone	chem
【PRE_E】
amrinone	chem
【GOLD_R】
【PRE_R】

These findings suggest that amrinone possesses antiinflammatory as well as inotropic properties that may make it an appropriate agent for use in septic shock or other serious bacterial infections .
【GOLD_E】
amrinone	chem
【PRE_E】
amrinone	chem
【GOLD_R】
【PRE_R】

Abrupt removal of amrinone or pentoxifylline from the culture medium prior to LPS stimulation , however , caused significantly augmented TNF production .
【GOLD_E】
TNF	geneY
amrinone	chem
pentoxifylline	chem
【PRE_E】
amrinone	chem
pentoxifylline	chem
TNF	geneY
【GOLD_R】
amrinone	TNF	C3
pentoxifylline	TNF	C3
【PRE_R】

Therefore , amrinone and other phosphodiesterase inhibitors may also enhance sensitivity to LPS during a period of time following discontinuation of therapy .
【GOLD_E】
phosphodiesterase	geneN
amrinone	chem
【PRE_E】
amrinone	chem
phosphodiesterase	geneN
【GOLD_R】
【PRE_R】
amrinone	phosphodiesterase	C4

Age - dependent changes of pyridoxal phosphate synthesizing enzymes immunoreactivities and activities in the gerbil hippocampal CA1 region .
【GOLD_E】
pyridoxalphosphate	chem
【PRE_E】
pyridoxalphosphate	chem
【GOLD_R】
【PRE_R】

In the present study , age - related changes of pyridoxal 5 ' - phosphate ( PLP ) synthesizing enzymes , pyridoxal kinase ( PLK ) and pyridoxine 5 ' - phosphate oxidase ( PNPO ) , their protein contents and activities were examined in the gerbil hippocampus proper .
【GOLD_E】
PLK	geneN
pyridoxine5'-phosphateoxidase	geneN
PNPO	geneN
pyridoxine5'-phosphate	chem
pyridoxalkinase	geneN
pyridoxal5'-phosphate	chem
PLP	chem
pyridoxal	chem
【PRE_E】
pyridoxal5'-phosphate(PLP)synthesizingenzymes	geneN
pyridoxalkinase	geneY
PLK	geneY
pyridoxine5'-phosphateoxidase	geneY
PNPO	geneY
【GOLD_R】
pyridoxal5'-phosphate	PLK	C9
pyridoxal5'-phosphate	pyridoxine5'-phosphateoxidase	C9
pyridoxal5'-phosphate	PNPO	C9
pyridoxal5'-phosphate	pyridoxalkinase	C9
PLP	PLK	C9
PLP	pyridoxine5'-phosphateoxidase	C9
PLP	PNPO	C9
PLP	pyridoxalkinase	C9
【PRE_R】

Significant age - dependent changes in PLK and PNPO immunoreactivities were found in the CA1 region , but not in the CA2 / 3 region .
【GOLD_E】
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

In the postnatal month 1 ( PM 1 ) group , PLK and PNPO immunoreactivities were detected mainly in the stratum pyramidale of the CA1 region .
【GOLD_E】
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

PLK and PNPO immunoreactivities and their protein contents were highest in the PM 6 group , showing that many CA1 pyramidal cells had strong PLK and PNPO immunoreactivities .
【GOLD_E】
PLK	geneN
PNPO	geneN
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

Thereafter , PLK and PNPO immunoreactivities started to decrease and were very low at PM 24 .
【GOLD_E】
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

Alterations in the change patterns in protein contents and total activities of PLK and PNPO corresponded to the immunohistochemical data , but their specific activities were not altered in any experimental group .
【GOLD_E】
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

Based on double immunofluorescence study , PLK and PNPO immunoreactive cells in the strata oriens and radiatum were identified as GABAergic cells .
【GOLD_E】
PLK	geneN
PNPO	geneN
【PRE_E】
PLK	geneY
PNPO	geneY
【GOLD_R】
【PRE_R】

Therefore , decreases of PLK and PNPO in the hippocampal CA1 region of aged brains may be involved in aging processes related with gamma - aminobutyric acid ( GABA ) function .
【GOLD_E】
PLK	geneN
PNPO	geneN
gamma-aminobutyricacid	chem
GABA	chem
【PRE_E】
PLK	geneY
PNPO	geneY
gamma-aminobutyricacid	chem
GABA	chem
【GOLD_R】
gamma-aminobutyricacid	PLK	C4
gamma-aminobutyricacid	PNPO	C4
GABA	PLK	C4
GABA	PNPO	C4
【PRE_R】
PNPO	gamma-aminobutyricacid	C9
PNPO	GABA	C9

Functional characteristics of H + - dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex .
【GOLD_E】
H+	chem
nicotinate	chem
【PRE_E】
H+	chem
nicotinate	chem
【GOLD_R】
【PRE_R】

In the present study , we report the characteristics of H ( + ) - coupled nicotinate transport in primary cultures of astrocytes from rat cerebral cortex .
【GOLD_E】
H(+)	chem
nicotinate	chem
【PRE_E】
H(+)	chem
nicotinate	chem
【GOLD_R】
【PRE_R】

The [ ( 3 ) H ] nicotinate transport in rat astrocytes increased up to a pH 5.5 .
【GOLD_E】
[(3)H]nicotinate	chem
【PRE_E】
[(3)H]nicotinate	chem
【GOLD_R】
【PRE_R】

The nicotinic acid uptake at pH 6.0 was both energy - dependent and saturable with a Michaelis constant ( K ( t ) ) of 2.8 + / - 0.4 mM and the maximal uptake rate ( V ( max ) ) of 31 + / - 3.2 nmol / mg protein / 10 min .
【GOLD_E】
nicotinicacid	chem
【PRE_E】
nicotinicacid	chem
【GOLD_R】
【PRE_R】

This process was reduced by a protonophore , carbonylcyanide p - trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha - cyano - 4 - hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H ( + ) - coupled monocarboxylate transport system .
【GOLD_E】
carbonylcyanidep-trifluoromethoxyphenylhydrazone	chem
monocarboxylate	chem
alpha-cyano-4-hydroxycinnamicacid	chem
nicotinate	chem
H(+)	chem
monocarboxylate	chem
monocarboxylatetransporter	geneN
MCT	geneN
monocarboxylatetransportsystem	geneN
【PRE_E】
protonophore	chem
carbonylcyanidep-trifluoromethoxyphenylhydrazone	chem
monocarboxylatetransporter	geneN
MCT	geneN
alpha-cyano-4-hydroxycinnamicacid	chem
nicotinate	chem
H(+)	chem
monocarboxylate	chem
【GOLD_R】
alpha-cyano-4-hydroxycinnamicacid	monocarboxylatetransporter	C4
alpha-cyano-4-hydroxycinnamicacid	MCT	C4
nicotinate	monocarboxylatetransportsystem	C9
【PRE_R】
protonophore	monocarboxylatetransporter	C4
carbonylcyanidep-trifluoromethoxyphenylhydrazone	monocarboxylatetransporter	C4
MCT	alpha-cyano-4-hydroxycinnamicacid	C4

[ ( 3 ) H ] Nicotinate transport in rat astrocytes was significantly inhibited by various monocarboxylic acids such as l - lactic acid and pyruvic acid with a relatively low affinity ( K ( i ) > 10 mM ) .
【GOLD_E】
[(3)H]Nicotinate	chem
monocarboxylicacids	chem
l-lacticacid	chem
pyruvicacid	chem
【PRE_E】
[(3)H]Nicotinate	chem
monocarboxylicacids	chem
l-lacticacid	chem
pyruvicacid	chem
【GOLD_R】
【PRE_R】

On the other hand , the uptake process of l - lactic acid was also saturable with a high - affinity component ( K ( t ) = 0.27 mM ) and a low - affinity component ( K ( t ) = 35.9 mM ) .
【GOLD_E】
l-lacticacid	chem
【PRE_E】
l-lacticacid	chem
【GOLD_R】
【PRE_R】

Reverse transcription - PCR and Western blot analyses revealed that three MCT subtypes , MCT1 / Slc16a1 , MCT2 / Slc16a7 , and MCT4 / Slc16a3 , were expressed in these cells .
【GOLD_E】
MCT	geneN
MCT1	geneY
Slc16a1	geneY
MCT2	geneY
Slc16a7	geneY
MCT4	geneY
Slc16a3	geneY
【PRE_E】
MCT	geneN
MCT1	geneY
Slc16a1	geneY
MCT2	geneY
Slc16a7	geneY
MCT4	geneY
Slc16a3	geneY
【GOLD_R】
【PRE_R】

Because l - lactate reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and / or MCT2 .
【GOLD_E】
l-lactate	chem
nicotinate	chem
MCT1	geneY
MCT2	geneY
nicotinate	chem
【PRE_E】
l-lactate	chem
nicotinate	chem
nicotinate	chem
MCT1	geneY
MCT2	geneY
【GOLD_R】
nicotinate	MCT1	C9
nicotinate	MCT2	C9
【PRE_R】
l-lactate	MCT1	C9
nicotinate	MCT1	C9
nicotinate	MCT1	C9
nicotinate	MCT2	C9

These results provide biochemical evidence of a H ( + ) - coupled and saturable transport system , presumed to be a low - affinity monocarboxylate transporter MCT4 or other unknown H ( + ) - coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .
【GOLD_E】
low-affinitymonocarboxylatetransporter	geneN
MCT4	geneY
H(+)-coupledmonocarboxylatetransportsystem	geneN
H(+)	chem
monocarboxylate	chem
H(+)	chem
monocarboxylate	chem
nicotinate	chem
【PRE_E】
H(+)	chem
monocarboxylatetransporterMCT4	geneN
H(+)	chem
monocarboxylate	chem
nicotinate	chem
【GOLD_R】
nicotinate	low-affinitymonocarboxylatetransporter	C9
nicotinate	MCT4	C9
nicotinate	H(+)-coupledmonocarboxylatetransportsystem	C9
【PRE_R】

A review of the structural and functional features of olmesartan medoxomil , an angiotensin receptor blocker .
【GOLD_E】
olmesartanmedoxomil	chem
angiotensinreceptor	geneN
【PRE_E】
olmesartanmedoxomil	chem
angiotensinreceptor	geneY
【GOLD_R】
olmesartanmedoxomil	angiotensinreceptor	C4
【PRE_R】

The angiotensin II ( A - II ) type 1 ( AT1 ) receptor - mediated effects of A - II play a key role in the pathophysiology of hypertension .
【GOLD_E】
angiotensinII(A-II)type1(AT1)receptor	geneY
A-II	geneY
A-II	chem
angiotensinII	chem
A-II	chem
【PRE_E】
angiotensinII(A-II)type1(AT1)receptor	geneN
A-II	geneY
【GOLD_R】
【PRE_R】

Effective inhibition of A - II is provided by the latest class of antihypertensive medications , the AT1 receptor blockers ( ARBs ) .
【GOLD_E】
A-II	geneY
AT1	geneY
A-II	chem
【PRE_E】
A-II	geneY
AT1	geneY
【GOLD_R】
【PRE_R】

These orally available agents were developed around a common imidazole - based structural core .
【GOLD_E】
【PRE_E】
imidazole	chem
【GOLD_R】
【PRE_R】

The most recent member of this drug class to be approved by the Food and Drug Administration , olmesartan medoxomil , contains unique features that may explain its clinical efficacy .
【GOLD_E】
olmesartanmedoxomil	chem
【PRE_E】
olmesartanmedoxomil	chem
【GOLD_R】
【PRE_R】

Key structural elements of olmesartan medoxomil include a hydroxyalkyl substituent at the imidazole 4 - position and a hydrolyzable ester group at the imidazole 5 - position .
【GOLD_E】
olmesartanmedoxomil	chem
【PRE_E】
olmesartanmedoxomil	chem
hydroxyalkyl	chem
imidazole	chem
hydrolyzableester	chem
imidazole	chem
【GOLD_R】
【PRE_R】

Inter - and intramolecular hydrogen bonding involving these groups may contribute to the potentiation of antagonist activity .
【GOLD_E】
【PRE_E】
Inter-andintramolecularhydrogen	chem
【GOLD_R】
【PRE_R】

After oral administration , olmesartan medoxomil is deesterified in the intestinal tract to produce the active metabolite olmesartan , which undergoes no additional metabolic change .
【GOLD_E】
olmesartanmedoxomil	chem
【PRE_E】
olmesartanmedoxomil	chem
olmesartan	chem
【GOLD_R】
【PRE_R】

The marked antihypertensive efficacy of olmesartan medoxomil may result from a unique pharmacological interaction of the drug with the AT1 receptor , resulting in a potent , long - lasting , dose - dependent blockade of A - II .
【GOLD_E】
AT1	geneY
A-II	geneY
olmesartanmedoxomil	chem
A-II	chem
【PRE_E】
olmesartanmedoxomil	chem
AT1	geneY
A-II	geneY
【GOLD_R】
olmesartanmedoxomil	A-II	C4
【PRE_R】
olmesartanmedoxomil	A-II	C4

This review article characterizes the structural features of olmesartan that may be responsible for its clinical efficacy .
【GOLD_E】
【PRE_E】
olmesartan	chem
【GOLD_R】
【PRE_R】

Inferential pharmacological studies compare and contrast the effects of olmesartan to those of other ARBs in comparable preclinical animal models .
【GOLD_E】
【PRE_E】
olmesartan	chem
【GOLD_R】
【PRE_R】

Effects of granulocyte colony - stimulating factor ( G - CSF ) and neutrophil elastase inhibitor ( ONO - 5046 ) on acid - induced lung injury in rats .
【GOLD_E】
granulocytecolony-stimulatingfactor	geneY
G-CSF	geneY
neutrophilelastase	geneY
ONO-5046	chem
【PRE_E】
granulocytecolony-stimulatingfactor	geneY
G-CSF	geneY
elastase	geneN
ONO-5046	chem
【GOLD_R】
ONO-5046	granulocytecolony-stimulatingfactor	C4
ONO-5046	G-CSF	C4
ONO-5046	neutrophilelastase	C4
【PRE_R】
granulocytecolony-stimulatingfactor	ONO-5046	C4
G-CSF	ONO-5046	C4
elastase	ONO-5046	C4

It has been suggested that neutrophils play an important role in acid - aspirated lung injury .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We examined the effects of the high dose of granulocyte - colony stimulating factor ( G - CSF ) , which is capable of increasing peripheral neutrophils , and a specific neutrophil elastase inhibitor ( ONO - 5046 ) on acid lung injury in rats .
【GOLD_E】
granulocyte-colonystimulatingfactor	geneY
G-CSF	geneY
neutrophilelastase	geneY
ONO-5046	chem
【PRE_E】
granulocyte-colonystimulatingfactor	geneY
G-CSF	geneY
elastase	geneN
ONO-5046	chem
【GOLD_R】
ONO-5046	neutrophilelastase	C4
【PRE_R】
G-CSF	ONO-5046	C4
elastase	ONO-5046	C4

Animals were anesthetized and normal saline ( NS , 2 mL kg ( - 1 ) ) or hydrochloric acid ( HCl , 0.1 N 2 mL kg ( - 1 ) ) was then instilled into trachea .
【GOLD_E】
hydrochloricacid	chem
HCl	chem
【PRE_E】
hydrochloricacid	chem
HCl	chem
【GOLD_R】
【PRE_R】

Thirty minutes before HCl instillation , G - CSF ( 150 microg kg ( - 1 ) ) was injected subcutaneously or ONO - 5046 ( 10 mg kg ( - 1 ) h ( - 1 ) ) was infused continuously into the right jugular vein .
【GOLD_E】
G-CSF	geneY
HCl	chem
ONO-5046	chem
【PRE_E】
HCl	chem
G-CSF	geneY
ONO-5046	chem
【GOLD_R】
【PRE_R】

Animals were ventilated during the experiments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Five hours after HCl or NS instillation , bronchoalveolar lavage fluid ( BALF ) and lung tissue samples were obtained .
【GOLD_E】
HCl	chem
【PRE_E】
HCl	chem
NS	chem
【GOLD_R】
【PRE_R】

Total nuclear cell count , absorbance , albumin , tumor necrosis factor ( TNF ) - alpha , interleukin ( IL ) - 6 , cytokine - induced neutrophil chemoattractant ( CINC ) , neutrophil elastase in BALF , wet - to - dry ( W / D ) ratio were measured .
【GOLD_E】
albumin	geneY
tumornecrosisfactor(TNF)-alpha	geneY
interleukin(IL)-6	geneY
cytokine-inducedneutrophilchemoattractant	geneN
CINC	geneN
neutrophilelastase	geneY
【PRE_E】
albumin	geneY
tumornecrosisfactor(TNF)-alpha	geneY
interleukin(IL)-6	geneY
cytokine-inducedneutrophilchemoattractant	geneY
CINC	geneY
【GOLD_R】
【PRE_R】

HCl aspiration markedly increased these values in BALF and W / D ratio .
【GOLD_E】
HCl	chem
【PRE_E】
HCl	chem
【GOLD_R】
【PRE_R】

Both ONO - 5046 and G - CSF attenuated the parameters increased by acid - induced lung injury in rats .
【GOLD_E】
G-CSF	geneY
ONO-5046	chem
【PRE_E】
ONO-5046	chem
G-CSF	geneY
【GOLD_R】
【PRE_R】

The data suggests that neutrophils play an important role in acid - induced lung injury .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , high - dose G - CSF does not exacerbate acid - aspirated lung injury in rats , although this agent causes an increase in peripheral neutrophils .
【GOLD_E】
G-CSF	geneY
【PRE_E】
G-CSF	geneY
【GOLD_R】
【PRE_R】

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease .
【GOLD_E】
miglustat	chem
【PRE_E】
miglustat	chem
【GOLD_R】
【PRE_R】

Type 1 Gaucher disease ( GD ) is a progressive lysosomal storage disorder due to an autosomal recessive deficiency of glucocerebrosidase .
【GOLD_E】
glucocerebrosidase	geneY
【PRE_E】
glucocerebrosidase	geneY
【GOLD_R】
【PRE_R】

Clinical manifestations include anemia , thrombocytopenia , hepatosplenomegaly , and bone and pulmonary disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Intravenous enzyme replacement ( ERT ) with imiglucerase is the accepted standard for treatment of symptomatic patients .
【GOLD_E】
【PRE_E】
imiglucerase	chem
【GOLD_R】
【PRE_R】

More than 3,500 patients worldwide have received ERT with well - documented beneficial effects on the hematological , visceral , skeletal , and pulmonary manifestations , and with resultant improvement in health - related quality of life .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Miglustat , an imino sugar that reversibly inhibits glucosylceramide synthase and reduces intracellular substrate burden , is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option .
【GOLD_E】
Miglustat	chem
iminosugar	chem
glucosylceramidesynthase	geneY
【PRE_E】
Miglustat	chem
iminosugar	chem
glucosylceramidesynthase	geneY
type1GD	chem
ERT	geneY
【GOLD_R】
Miglustat	glucosylceramidesynthase	C4
iminosugar	glucosylceramidesynthase	C4
【PRE_R】
Miglustat	glucosylceramidesynthase	C4
iminosugar	glucosylceramidesynthase	C4
iminosugar	ERT	C4

Because responses to miglustat are slower and less robust than those observed with ERT , and because miglustat is associated with significant side effects , clinicians who care for patients with GD should become familiar with the limited indications for miglustat use and the circumstances when it may be prescribed appropriately .
【GOLD_E】
miglustat	chem
miglustat	chem
miglustat	chem
【PRE_E】
miglustat	chem
ERT	geneY
miglustat	chem
GD	chem
miglustat	chem
【GOLD_R】
【PRE_R】

This review article and position statement represents the current opinion of American physicians with extensive expertise in GD regarding patient management in the context of the availability of standard imiglucerase treatment and the recent introduction of miglustat .
【GOLD_E】
miglustat	chem
【PRE_E】
miglustat	chem
【GOLD_R】
【PRE_R】

Nicotinic - receptor potentiator drugs , huprine X and galantamine , increase ACh release by blocking AChE activity but not acting on nicotinic receptors .
【GOLD_E】
galantamine	chem
ACh	chem
Nicotinic-receptor	geneN
nicotinicreceptors	geneN
AChE	geneY
【PRE_E】
Nicotinic-receptor	geneN
huprineX	chem
galantamine	chem
ACh	chem
AChE	geneY
nicotinicreceptors	geneN
【GOLD_R】
galantamine	AChE	C4
【PRE_R】
huprineX	AChE	C4
galantamine	AChE	C4

The main goal of the present study was to analyse the effects of ( + / - ) - huprine X ( ( + / - ) - HX ) and galantamine ( GAL ) , with potentiating action on nicotinic receptors , and huperzine A ( HPA ) , devoid of nicotinic activity , on [ 3H ] - acetylcholine ( [ 3H ] - ACh ) release in striatal slices of rat brain .
【GOLD_E】
nicotinicreceptors	geneN
[3H]-acetylcholine	chem
[3H]-ACh	chem
【PRE_E】
(+/-)-huprineX	chem
(+/-)-HX	chem
galantamine	chem
GAL	chem
nicotinicreceptors	geneN
huperzineA	chem
[3H]-acetylcholine	chem
[3H]-ACh	chem
【GOLD_R】
【PRE_R】

All compounds are non - covalent and reversible inhibitors of AChE .
【GOLD_E】
AChE	geneY
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

Addition of ( + / - ) - HX ( 0.01 microM ) , GAL ( 10 microM ) and HPA ( 0.1 microM ) to the superfusion medium decreased the release of the ACh neurotransmitter to a similar extent : 36 % , 30 % and 34 % , respectively ( P < 0.01 ) .
【GOLD_E】
ACh	chem
【PRE_E】
(+/-)-HX	chem
GAL	chem
ACh	chem
【GOLD_R】
【PRE_R】

This effect was reverted in the presence of atropine ( ATR ; 0.1 microM ) , which blocks the pre - synaptic muscarinic M2 receptor .
【GOLD_E】
atropine	chem
ATR	chem
muscarinicM2receptor	geneY
【PRE_E】
atropine	chem
ATR	chem
muscarinicM2receptor	geneY
【GOLD_R】
atropine	muscarinicM2receptor	C4
ATR	muscarinicM2receptor	C4
【PRE_R】

After that , a wide range of concentrations of drugs , concomitantly with ATR ( 0.1 microM ) , was studied in the presence of haloperidol ( HAL ; 0.01 microM ) , a dopamine D2 antagonist .
【GOLD_E】
ATR	chem
haloperidol	chem
HAL	chem
dopamine	chem
dopamineD2	geneY
【PRE_E】
ATR	geneY
haloperidol	chem
HAL	chem
dopamineD2	geneY
【GOLD_R】
haloperidol	dopamineD2	C6
HAL	dopamineD2	C6
【PRE_R】

In these conditions , a dose - dependent increase of [ 3H ] - ACh release was observed in the presence of ( + / - ) - HX , GAL and HPA .
【GOLD_E】
[3H]-ACh	chem
【PRE_E】
[3H]-ACh	chem
(+/-)-HX	chem
GAL	chem
【GOLD_R】
【PRE_R】

To test the role of nicotinic receptors in the drugs ' effects on [ 3H ] - ACh release , mecamylamine ( MEC ) 100 microM was used to block such receptors .
【GOLD_E】
[3H]-ACh	chem
nicotinicreceptors	geneN
mecamylamine	chem
MEC	chem
【PRE_E】
nicotinicreceptors	geneN
[3H]-ACh	chem
mecamylamine	chem
MEC	chem
【GOLD_R】
mecamylamine	nicotinicreceptors	C4
MEC	nicotinicreceptors	C4
【PRE_R】

MEC alone significantly decreased neurotransmitter release by 18 % ( P < 0.05 ) , but no change was obtained in the presence of both ATR and MEC .
【GOLD_E】
MEC	chem
ATR	chem
MEC	chem
【PRE_E】
MEC	chem
ATR	geneY
MEC	geneY
【GOLD_R】
【PRE_R】

Under these conditions , ( + / - ) - HX , GAL and HPA increased the release of [ 3H ] - ACh by 37 % , 25 % and 38 % , respectively ( P < 0.01 ) .
【GOLD_E】
[3H]-ACh	chem
【PRE_E】
(+/-)-HX	chem
GAL	chem
[3H]-ACh	chem
【GOLD_R】
【PRE_R】

Taking into account all of these data , the present results suggest that the effects induced by ( + / - ) - HX and GAL nicotinic - receptor potentiators seem to be mainly due to their ability in inhibiting acetylcholinesterase activity , but not by interaction on the nicotinic receptors .
【GOLD_E】
nicotinic-receptor	geneN
acetylcholinesterase	geneY
nicotinicreceptors	geneN
【PRE_E】
(+/-)-HX	chem
GALnicotinic-receptor	geneN
acetylcholinesterase	geneY
nicotinicreceptors	geneN
【GOLD_R】
【PRE_R】

Rat hepatic stellate cells become retinoid unresponsive during activation .
【GOLD_E】
retinoid	chem
【PRE_E】
retinoid	chem
【GOLD_R】
【PRE_R】

Hepatic stellate cells ( HSC ) play an essential role in fibrogenesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Many stimuli cause HSC to activate , lose their Vitamin A and produce collagen .
【GOLD_E】
collagen	geneN
VitaminA	chem
【PRE_E】
VitaminA	chem
collagen	geneN
【GOLD_R】
【PRE_R】

It is unclear whether Vitamin A loss causes activation , potentiates it or is simply an event in the cascade of activation changes .
【GOLD_E】
VitaminA	chem
【PRE_E】
VitaminA	chem
【GOLD_R】
【PRE_R】

We determine if exogenous retinoids prevent the activation of freshly isolated rat HSC activated by plating on plastic .
【GOLD_E】
retinoids	chem
【PRE_E】
retinoids	chem
ratHSC	geneY
【GOLD_R】
【PRE_R】
retinoids	ratHSC	C3

We also determine if retinoids : ( 1 ) reverse HSC activation ; ( 2 ) maintain / restore HSC intracellular retinoid levels ; ( 3 ) maintain expression of HSC nuclear receptors for retinoic acid ( RAR ) in HSC that are becoming activated or are chronically activated .
【GOLD_E】
nuclearreceptorsforretinoicacid	geneN
RAR	geneN
retinoids	chem
retinoid	chem
retinoicacid	chem
【PRE_E】
HSC	geneY
retinoid	chem
HSCnuclearreceptors	geneY
retinoicacid	chem
RAR	geneY
HSC	geneY
【GOLD_R】
【PRE_R】
HSC	retinoid	C3
retinoid	HSCnuclearreceptors	C3
HSCnuclearreceptors	retinoicacid	C3
retinoicacid	RAR	C3
retinoicacid	HSC	C3

Markers of activation in freshly isolated HSC were decreased by either retinol or retinoic acid without increases in HSC retinoid concentration . mRNA levels for RAR - alpha , RAR - beta and RAR - gamma , the nuclear receptors for retinoic acid , decreased during activation of freshly isolated HSC even with retinoid supplementation .
【GOLD_E】
retinol	chem
retinoicacid	chem
retinoid	chem
retinoicacid	chem
retinoid	chem
RAR-alpha	geneY
RAR-beta	geneY
RAR-gamma	geneY
nuclearreceptors	geneN
【PRE_E】
HSC	geneY
retinol	chem
retinoicacid	chem
retinoid	chem
RAR-alpha	geneY
RAR-beta	geneY
RAR-gamma	geneY
nuclearreceptors	geneN
retinoicacid	chem
HSC	geneN
retinoid	chem
【GOLD_R】
retinoid	RAR-alpha	C4
retinoid	RAR-beta	C4
retinoid	RAR-gamma	C4
retinoid	nuclearreceptors	C4
【PRE_R】
HSC	retinoicacid	C3
retinol	RAR-gamma	C9
retinoid	RAR-gamma	C9
retinoicacid	RAR-alpha	C3
retinoicacid	RAR-beta	C3
HSC	retinoid	C3

RAR - alpha , RAR - beta and RAR - gamma mRNA and RAR - beta protein was undetectable in chronically activated HSC and remained absent after retinoic acid supplementation .
【GOLD_E】
RAR-gamma	geneY
RAR-beta	geneN
retinoicacid	chem
RAR-alpha	geneY
RAR-beta	geneY
【PRE_E】
RAR-alpha	geneY
RAR-beta	geneY
RAR-gamma	geneY
RAR-beta	geneY
HSC	geneY
retinoicacid	chem
【GOLD_R】
【PRE_R】
HSC	retinoicacid	C3

Activation markers in chronically activated HSC were only slightly decreased after retinoid exposure .
【GOLD_E】
retinoid	chem
【PRE_E】
HSC	geneY
retinoid	chem
【GOLD_R】
【PRE_R】
HSC	retinoid	C4

We conclude that exposure of HSC to extracellular retinoids diminishes some markers of activation but does not prevent HSC activation .
【GOLD_E】
retinoids	chem
【PRE_E】
HSC	geneY
retinoids	chem
HSC	geneN
【GOLD_R】
【PRE_R】

Protein kinase C potentiates homologous desensitization of the beta2 - adrenoceptor in bovine tracheal smooth muscle .
【GOLD_E】
ProteinkinaseC	geneN
beta2-adrenoceptor	geneY
【PRE_E】
ProteinkinaseC	geneY
beta2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of fenoterol decreased isoprenaline - induced maximal relaxation ( E ( max ) ) of methacholine - contracted preparations in a concentration dependent fashion , indicating desensitization of the beta ( 2 ) - adrenoceptor .
【GOLD_E】
beta(2)-adrenoceptor	geneY
fenoterol	chem
isoprenaline	chem
methacholine	chem
【PRE_E】
fenoterol	chem
isoprenaline	chem
methacholine	chem
beta(2)-adrenoceptor	geneY
【GOLD_R】
fenoterol	beta(2)-adrenoceptor	C4
isoprenaline	beta(2)-adrenoceptor	C5
【PRE_R】
fenoterol	beta(2)-adrenoceptor	C4

Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12 - myristate 13 - acetate ( PMA ) caused a small but significant decrease in isoprenaline - induced E ( max ) , indicating activated PKC - mediated heterologous beta ( 2 ) - adrenoceptor desensitization .
【GOLD_E】
PMA	chem
isoprenaline	chem
proteinkinaseC	geneN
PKC	geneN
PKC	geneN
beta(2)-adrenoceptor	geneY
phorbol12-myristate13-acetate	chem
【PRE_E】
proteinkinaseC	geneN
PKC	geneN
phorbol12-myristate13-acetate	chem
PMA	chem
isoprenaline	chem
PKC	geneN
beta(2)-adrenoceptor	geneY
【GOLD_R】
PMA	proteinkinaseC	C3
PMA	PKC	C3
PMA	PKC	C3
phorbol12-myristate13-acetate	proteinkinaseC	C3
phorbol12-myristate13-acetate	PKC	C3
phorbol12-myristate13-acetate	PKC	C3
PMA	beta(2)-adrenoceptor	C4
phorbol12-myristate13-acetate	beta(2)-adrenoceptor	C4
isoprenaline	beta(2)-adrenoceptor	C5
【PRE_R】
proteinkinaseC	phorbol12-myristate13-acetate	C4
PKC	phorbol12-myristate13-acetate	C4
PKC	PMA	C4
isoprenaline	beta(2)-adrenoceptor	C3
PMA	PKC	C4

To investigate the capacity of activated PKC to regulate homologous desensitization , we incubated the smooth muscle strips with the combination of both 1 microM PMA and 1 microM fenoterol .
【GOLD_E】
fenoterol	chem
PKC	geneN
【PRE_E】
PKC	geneN
PMA	chem
fenoterol	chem
【GOLD_R】
【PRE_R】

This combined treatment synergistically decreased the isoprenaline - induced maximal relaxation , as compared to the individual effects of PMA and fenoterol alone , indicating a common pathway for heterologous and homologous desensitization .
【GOLD_E】
isoprenaline	chem
PMA	chem
fenoterol	chem
【PRE_E】
isoprenaline	chem
PMA	chem
fenoterol	chem
【GOLD_R】
【PRE_R】

Moreover , the specific PKC - inhibitor 2 - [ 1 - ( 3 - dimethylaminopropyl ) - 1H - indol - 3 - yl ] - 3 - ( 1H - indol - 3 - yl ) maleimide ( GF 109203X ) markedly increased the potency and E ( max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .
【GOLD_E】
PKC	geneN
2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide	chem
GF109203X	chem
isoprenaline	chem
PMA	chem
fenoterol	chem
【PRE_E】
PKC	geneN
2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide	chem
GF109203X	chem
isoprenaline	chem
PMA	chem
fenoterol	chem
【GOLD_R】
2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide	PKC	C4
GF109203X	PKC	C4
【PRE_R】
PKC	2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide	C4
PKC	GF109203X	C4

In conclusion , the present study demonstrates that homologous desensitization of the beta ( 2 ) - adrenergic receptor can be enhanced by PKC activation .
【GOLD_E】
beta(2)-adrenergicreceptor	geneY
PKC	geneN
【PRE_E】
beta(2)-adrenergicreceptor	geneY
PKC	geneN
【GOLD_R】
【PRE_R】

For the first time we have provided evidence that this concept is functionally operative in airway smooth muscle , and it may explain the reduced bronchodilator response to beta ( 2 ) - adrenoceptor agonists in patients with asthma during a severe exacerbation .
【GOLD_E】
beta(2)-adrenoceptor	geneY
【PRE_E】
beta(2)-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer .
【GOLD_E】
epidermalgrowthfactorreceptor	geneY
【PRE_E】
epidermalgrowthfactorreceptor	geneY
【GOLD_R】
【PRE_R】

The epidermal growth factor receptor ( EGFR ) provides survival signals and is overexpressed in the majority of colorectal cancers .
【GOLD_E】
EGFR	geneY
epidermalgrowthfactorreceptor	geneY
【PRE_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

As more is learned about the molecular details of EGFR signaling , antibodies can be designed to interfere with specific domains of the EGFR molecule .
【GOLD_E】
EGFR	geneY
EGFR	geneY
【PRE_E】
EGFR	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

In this review , we analyze preclinical and current clinical data on EGFR - targeting molecules and their potential role in the treatment of colorectal cancer .
【GOLD_E】
EGFR	geneY
【PRE_E】
EGFR	geneY
【GOLD_R】
【PRE_R】

Cetuximab binds to domain III of EGFR and hinders ligand binding .
【GOLD_E】
EGFR	geneY
【PRE_E】
Cetuximab	chem
domainIII	geneN
EGFR	geneY
【GOLD_R】
【PRE_R】

It is now approved by the US Food and Drug Administration for metastatic colorectal cancer treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Panitumumab is another widely studied anti - EGFR antibody with similar properties .
【GOLD_E】
EGFR	geneY
【PRE_E】
Panitumumab	chem
EGFR	geneY
【GOLD_R】
【PRE_R】

Bispecific antibodies are modified immunoglobulin molecules containing 2 different binding specificities .
【GOLD_E】
immunoglobulin	geneN
【PRE_E】
immunoglobulin	geneN
【GOLD_R】
【PRE_R】

These antibodies can redirect the immune response against tumor cells by tethering effector cells such as CD3e - expressing T cells or CD16 - expressing natural killer cells and granulocytes to the surface of cancer cells .
【GOLD_E】
CD3e	geneY
CD16	geneN
【PRE_E】
CD3e	geneY
CD16	geneY
【GOLD_R】
【PRE_R】

Tyrosine kinase inhibitors are quinazoline - derived , low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors , including EGFR , Erb2 , and vascular endothelial growth factor receptor , and thereby inhibit ligand - induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling .
【GOLD_E】
Tyrosine	chem
quinazoline	chem
tyrosine	chem
Tyrosinekinase	geneN
tyrosinekinasedomain	geneN
EGFR	geneY
Erb2	geneY
vascularendothelialgrowthfactorreceptor	geneN
EGFR	geneY
【PRE_E】
Tyrosinekinase	geneN
quinazoline	chem
tyrosinekinasedomain	geneN
EGFR	geneY
Erb2	geneY
vascularendothelialgrowthfactorreceptor	geneY
EGFR	geneY
【GOLD_R】
quinazoline	EGFR	C4
quinazoline	Tyrosinekinase	C4
quinazoline	tyrosinekinasedomain	C4
quinazoline	EGFR	C4
quinazoline	Erb2	C4
quinazoline	vascularendothelialgrowthfactorreceptor	C4
【PRE_R】

The presence of skin rash and EGFR gene amplification have been advanced as possible predictors of clinical effectiveness of targeted anti - EGFR therapies .
【GOLD_E】
EGFR	geneY
EGFR	geneY
【PRE_E】
EGFR	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

Isolation and function of the amino acid transporter PAT1 ( slc36a1 ) from rabbit and discrimination between transport via PAT1 and system IMINO in renal brush - border membrane vesicles .
【GOLD_E】
aminoacid	chem
PAT1	geneY
systemIMINO	geneN
aminoacidtransporterPAT1	geneY
slc36a1	geneY
【PRE_E】
aminoacidtransporterPAT1	geneY
slc36a1	geneY
PAT1	geneY
IMINO	chem
【GOLD_R】
【PRE_R】
slc36a1	IMINO	C9
PAT1	IMINO	C9

Reabsorption of amino acids is an important function of the renal proximal tubule . pH - dependent amino acid transport has been measured previously using rabbit renal brush - border membrane vesicles ( BBMV ) .
【GOLD_E】
aminoacid	chem
aminoacids	chem
【PRE_E】
Reabsorption	chem
aminoacids	chem
aminoacid	chem
【GOLD_R】
【PRE_R】

The purpose of this investigation was to determine whether this pH - dependent uptake represents H ( + ) / amino acid cotransport via a PAT1 - like transport system .
【GOLD_E】
aminoacid	chem
PAT1	geneY
H(+)	chem
【PRE_E】
H(+)	chem
aminoacid	chem
PAT1	geneY
【GOLD_R】
【PRE_R】

The rabbit PAT1 cDNA was isolated ( 2296bp including both 5 ' and 3 ' untranslated regions and poly ( A ) tail ) and the open reading frame codes for a protein of 475 amino acids ( 92 % identity to human PAT1 ) .
【GOLD_E】
aminoacids	chem
rabbitPAT1	geneY
poly(A)tail)	geneN
openreadingframe	geneN
humanPAT1	geneY
【PRE_E】
rabbitPAT1	geneY
aminoacids	chem
humanPAT1	geneY
【GOLD_R】
【PRE_R】

Rabbit PAT1 mRNA was found in all tissues investigated including kidney .
【GOLD_E】
RabbitPAT1	geneY
【PRE_E】
RabbitPAT1	geneY
【GOLD_R】
【PRE_R】

When expressed heterologously in a mammalian cell line , rabbit PAT1 mediates pH - dependent , Na ( + ) - independent uptake of proline , glycine , l - alanine and alpha - ( methylamino ) isobutyric acid .
【GOLD_E】
Na(+)	chem
proline	chem
glycine	chem
l-alanine	chem
alpha-(methylamino)isobutyricacid	chem
rabbitPAT1	geneY
【PRE_E】
PAT1	geneY
Na(+)	chem
proline	chem
glycine	chem
l-alanine	chem
alpha-(methylamino)isobutyricacid	chem
【GOLD_R】
proline	rabbitPAT1	C9
glycine	rabbitPAT1	C9
l-alanine	rabbitPAT1	C9
alpha-(methylamino)isobutyricacid	rabbitPAT1	C9
【PRE_R】
PAT1	Na(+)	C9
PAT1	proline	C9
PAT1	glycine	C9
PAT1	l-alanine	C9
PAT1	alpha-(methylamino)isobutyricacid	C9

Proline uptake was maximal at pH 5.0 ( K ( m ) 2.2 + / - 0.7 mM ) .
【GOLD_E】
Proline	chem
【PRE_E】
Proline	chem
【GOLD_R】
【PRE_R】

A transport system with identical characteristics ( ion dependency , substrate specificity ) was detected in rabbit renal BBMV where an overshoot was observed in the absence of Na + but in the presence of an inwardly directed H + gradient .
【GOLD_E】
Na+	chem
H+	chem
【PRE_E】
Na+	chem
H+	chem
【GOLD_R】
【PRE_R】

In the presence of Na + and under conditions in which PAT1 transport function was suppressed , a second proline uptake system was detected that exhibited functional characteristics similar to those of the IMINO system .
【GOLD_E】
PAT1	geneY
IMINOsystem	geneN
Na+	chem
proline	chem
【PRE_E】
Na+	chem
PAT1	geneY
proline	chem
IMINO	chem
【GOLD_R】
proline	PAT1	C9
【PRE_R】

The functional characteristics of rabbit PAT1 in either mammalian cells or renal BBMV suggest that PAT1 is the low - affinity transporter of proline , glycine and hydroxyproline believed to be defective in patients with iminoglycinuria .
【GOLD_E】
rabbitPAT1	geneY
PAT1	geneY
proline	chem
glycine	chem
hydroxyproline	chem
【PRE_E】
rabbitPAT1	geneY
PAT1	geneY
proline	chem
glycine	chem
hydroxyproline	chem
【GOLD_R】
proline	PAT1	C9
glycine	PAT1	C9
hydroxyproline	PAT1	C9
【PRE_R】
PAT1	proline	C9
PAT1	glycine	C9
PAT1	hydroxyproline	C9

Antidepressants suppress production of the Th1 cytokine interferon - gamma , independent of monoamine transporter blockade .
【GOLD_E】
monoamine	chem
cytokine	geneN
interferon-gamma	geneY
monoaminetransporter	geneN
【PRE_E】
Th1cytokineinterferon-gamma	geneY
monoaminetransporter	geneN
【GOLD_R】
【PRE_R】

In this study , antidepressants with selectivity for the noradrenaline transporter ( reboxetine and desipramine ) , or the serotonin transporter ( fluoxetine and clomipramine ) were examined in terms of their ability to promote an anti - inflammatory cytokine phenotype in human blood .
【GOLD_E】
noradrenaline	chem
reboxetine	chem
desipramine	chem
serotonintransporter	geneY
cytokine	geneN
serotonin	chem
noradrenalinetransporter	geneY
fluoxetine	chem
clomipramine	chem
【PRE_E】
noradrenalinetransporter	geneN
reboxetine	chem
desipramine	chem
serotonintransporter	geneY
fluoxetine	chem
clomipramine	chem
cytokine	geneN
【GOLD_R】
【PRE_R】

In addition , we examined the ability of trimipramine ; a tricyclic antidepressant that is devoid of monoamine reuptake inhibitory properties on cytokine production .
【GOLD_E】
tricyclic	chem
monoamine	chem
cytokine	geneN
trimipramine	chem
【PRE_E】
trimipramine	chem
tricyclic	chem
monoamine	chem
cytokine	geneN
【GOLD_R】
【PRE_R】
trimipramine	cytokine	C4
tricyclic	cytokine	C4

Lipopolysaccharide ( LPS ) was used to stimulate monocyte - derived pro - inflammatory ( IL - 1beta , TNF - alpha , IL - 12 ) and anti - inflammatory ( IL - 10 ) cytokines , whilst concanavalin A ( Con A ) was used to stimulate T - cell ( Th ( 1 ) : IFN - gamma and Th ( 2 / 3 ) : IL - 10 ) cytokines .
【GOLD_E】
IL-1beta	geneY
TNF-alpha	geneY
IL-12	geneN
IL-10	geneY
cytokines	geneN
IFN-gamma	geneY
IL-10	geneY
cytokines	geneN
【PRE_E】
monocyte-derivedpro-inflammatory	geneY
IL-1beta	geneY
TNF-alpha	geneY
IL-12	geneY
IL-10	geneY
cytokines	geneN
concanavalinA	geneY
ConA	geneY
T-cell	geneY
Th(1)	geneY
IFN-gamma	geneY
Th(2/3	geneY
IL-10	geneY
cytokines	geneN
【GOLD_R】
【PRE_R】

All of the antidepressants suppressed IFN - gamma production in the 10 - 50 microM concentration range , irrespective of their preference for serotonin or noradrenaline transporters .
【GOLD_E】
serotonin	chem
noradrenaline	chem
IFN-gamma	geneY
serotoninornoradrenalinetransporters	geneN
【PRE_E】
IFN-gamma	geneY
serotoninornoradrenalinetransporters	geneN
【GOLD_R】
【PRE_R】

This suppression of IFN - gamma production was paralleled by reduced T - cell proliferation , therefore we suggest that the ability of antidepressants to suppress IFN - gamma production may be related to their anti - proliferative properties .
【GOLD_E】
IFN-gamma	geneY
IFN-gamma	geneY
【PRE_E】
IFN-gamma	geneY
IFN-gamma	geneY
【GOLD_R】
【PRE_R】

The fact that trimipramine also suppressed IFN - gamma production and T - cell proliferation indicates that these immunomodulatory actions of antidepressants are most likely unrelated to inhibition of monoamine reuptake .
【GOLD_E】
IFN-gamma	geneY
trimipramine	chem
monoamine	chem
【PRE_E】
trimipramine	chem
IFN-gamma	geneY
monoamine	chem
【GOLD_R】
trimipramine	IFN-gamma	C4
【PRE_R】
trimipramine	IFN-gamma	C4

Interestingly , exposure to a lower concentration ( 1 microM ) of the antidepressants tended to increase T - cell - derived IL - 10 production , with significant effects elicited by the noradrenaline reuptake inhibitors reboxetine and desipramine .
【GOLD_E】
IL-10	geneY
noradrenaline	chem
reboxetine	chem
desipramine	chem
【PRE_E】
IL-10	geneY
noradrenaline	chem
reboxetine	chem
desipramine	chem
【GOLD_R】
【PRE_R】

In contrast to the robust actions of antidepressants on T - cell derived cytokine production , they failed to induce any consistent change in LPS - induced monocyte cytokine production .
【GOLD_E】
cytokine	geneN
cytokine	geneN
【PRE_E】
cytokine	geneN
monocytecytokine	geneN
【GOLD_R】
【PRE_R】

Overall , our results indicate that IFN - gamma producing T - cells ( Th ( 1 ) cells ) are the major target for the immunomodulatory actions of antidepressants , and provide evidence questioning the relationship between the monoaminergic reuptake properties of antidepressants and their immunomodulatory effects .
【GOLD_E】
IFN-gamma	geneY
【PRE_E】
IFN-gamma	geneY
Th	geneY
【GOLD_R】
【PRE_R】

The potential clinical significance of the anti - inflammatory actions of antidepressants is discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effect of cyproheptadine on serum leptin levels .
【GOLD_E】
cyproheptadine	chem
leptin	geneY
【PRE_E】
cyproheptadine	chem
leptin	geneY
【GOLD_R】
【PRE_R】

Leptin is a 167 amino acid protein encoded by the obesity gene that is synthesized in adipose tissue and interacts with receptors in the hypothalamus linked to the regulation of appetite and metabolism .
【GOLD_E】
Leptin	geneY
aminoacid	chem
【PRE_E】
Leptin	geneY
aminoacid	chem
【GOLD_R】
【PRE_R】

It is known to suppress appetite and increase energy expenditure .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cyproheptadine is a piperidine antihistamine that increases appetite through its antiserotonergic effect on 5 - HT2 receptors in the brain .
【GOLD_E】
5-HT2	geneY
Cyproheptadine	chem
piperidine	chem
antihistamine	chem
【PRE_E】
Cyproheptadine	chem
piperidine	chem
5-HT2receptors	geneN
【GOLD_R】
【PRE_R】

Although both leptin and cyproheptadine are effective in controlling appetite , their interaction has not been addressed in clinical studies .
【GOLD_E】
leptin	geneY
cyproheptadine	chem
【PRE_E】
leptin	geneY
cyproheptadine	chem
【GOLD_R】
【PRE_R】

This study evaluated serum leptin concentrations in patients who received cyproheptadine to treat a variety of disorders .
【GOLD_E】
cyproheptadine	chem
【PRE_E】
leptin	geneY
cyproheptadine	chem
【GOLD_R】
【PRE_R】

Sixteen patients aged 7 to 71 years ( mean , 26.25 years ) were given cyproheptadine 2 to 6 mg / day for a minimum of 7 days .
【GOLD_E】
cyproheptadine	chem
【PRE_E】
cyproheptadine	chem
【GOLD_R】
【PRE_R】

Body weight was measured and blood samples were obtained at baseline and after 1 week of treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Serum leptin levels were determined by leptin radioimmunoassay .
【GOLD_E】
leptin	geneY
leptin	geneY
【PRE_E】
leptin	geneY
leptin	geneY
【GOLD_R】
【PRE_R】

The mean body weight at baseline ( 52.59 kg ) did not differ significantly from that at 1 week after treatment ( 52.84 kg ; P > .05 ) , but the mean leptin level after 1 week of treatment with cyproheptadine ( 3.14 ng / mL ) was 14.2 % higher than that at baseline ( 2.75 ng / mL ; P < .05 ) .
【GOLD_E】
leptin	geneY
cyproheptadine	chem
【PRE_E】
leptin	geneY
cyproheptadine	chem
【GOLD_R】
cyproheptadine	leptin	C3
【PRE_R】

This increase may suggest that both leptin and cyproheptadine may affect appetite via similar receptors and that cyproheptadine does not impair leptin activity through these receptors .
【GOLD_E】
leptin	geneY
cyproheptadine	chem
cyproheptadine	chem
【PRE_E】
leptin	geneY
cyproheptadine	chem
cyproheptadine	chem
leptin	geneY
【GOLD_R】
【PRE_R】

Further study will be necessary to clarify this relationship .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Comparison of captopril and enalapril to study the role of the sulfhydryl - group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice .
【GOLD_E】
captopril	chem
methionine	chem
enalapril	chem
sulfhydryl	chem
ACE	geneY
【PRE_E】
captopril	chem
enalapril	chem
sulfhydryl	chem
ACE	geneY
methionine	chem
【GOLD_R】
captopril	ACE	C4
enalapril	ACE	C4
sulfhydryl	ACE	C4
【PRE_R】

To examine the role of sulfhydryl ( - SH ) group in improvement of endothelial dysfunction with angiotensin - converting enzyme ( ACE ) inhibitors in experimental high dose of methionine dieted rats .
【GOLD_E】
methionine	chem
sulfhydryl	chem
SH	chem
angiotensin	chem
ACE	geneY
angiotensin-convertingenzyme	geneY
【PRE_E】
sulfhydryl	chem
angiotensin-convertingenzyme	geneY
ACE	geneY
methionine	chem
【GOLD_R】
【PRE_R】

We compared the effects of Captopril ( an ACE inhibitor with - SH group ) , enalapril ( an ACE - inhibitor without - SH group ) , N - acetylcysteine ( only - SH group not ACE inhibitor ) on endothelial dysfunction injured by methionine - induced hyperhomocysteinemia ( HHcy ) in rats .
【GOLD_E】
Captopril	chem
SH	chem
enalapril	chem
SH	chem
N-acetylcysteine	chem
SH	chem
methionine	chem
ACE	geneY
ACE	geneY
ACE	geneY
【PRE_E】
Captopril	chem
ACE	geneY
enalapril	chem
ACE	geneY
N-acetylcysteine	chem
ACE	geneY
methionine	chem
【GOLD_R】
Captopril	ACE	C4
SH	ACE	C4
enalapril	ACE	C4
【PRE_R】
Captopril	ACE	C4
ACE	enalapril	C4
enalapril	ACE	C4
ACE	N-acetylcysteine	C4
N-acetylcysteine	ACE	C4

Male Sprague - Dawley rats were divided randomly into seven groups : control group , L - methionine group , low dose Captopril ( 15 mg / kg ) , middle dose Captopril ( 30 mg / kg ) , high dose Captopril ( 45 mg / kg ) , enalapril ( 20 mg / kg ) , N - acetylcysteine ( 200 mg / kg ) ; control group were intragastric gavaged by water and others groups were intragastric gavaged by L - methionine and drugs in water one time every day .
【GOLD_E】
L-methionine	chem
Captopril	chem
Captopril	chem
Captopril	chem
enalapril	chem
N-acetylcysteine	chem
L-methionine	chem
【PRE_E】
L-methionine	chem
Captopril	chem
Captopril	chem
Captopril	chem
enalapril	chem
N-acetylcysteine	chem
L-methionine	chem
【GOLD_R】
【PRE_R】

Acetylcholine ( ACh ) - induced endothelium - dependent relaxation ( EDR ) , sodium nitroprusside ( SNP ) - induced endothelium - independent relaxation of aortic rings were examined .
【GOLD_E】
Acetylcholine	chem
ACh	chem
sodiumnitroprusside	chem
SNP	chem
【PRE_E】
Acetylcholine	chem
ACh	chem
sodiumnitroprusside	chem
SNP	chem
【GOLD_R】
【PRE_R】

Paraoxonase1 ( PON1 ) and ACE activity , malondialdehyde ( MDA ) , nitric oxide ( NO ) , superoxide dismutase ( SOD ) in serum were analyzed .
【GOLD_E】
malondialdehyde	chem
MDA	chem
nitricoxide	chem
Paraoxonase1	geneY
NO	chem
PON1	geneY
ACE	geneY
superoxidedismutase	geneN
SOD	geneN
superoxide	chem
【PRE_E】
Paraoxonase1	geneY
PON1	geneY
ACE	geneY
malondialdehyde	chem
MDA	chem
nitricoxide	chem
NO	chem
superoxidedismutase	geneN
SOD	geneN
【GOLD_R】
【PRE_R】

It was found that a single intragastric gavage by L - methionine resulted in inhibition of endothelium - dependent relaxation , markedly increased the serum level of malondialdehyde and decreased the activity of PON1 and SOD , similarly decreased the level of NO in the serum ; but had no effects on endothelium - independent relaxation and angiotensin - converting enzyme activity compared with the control group .
【GOLD_E】
PON1	geneY
SOD	geneN
angiotensin-convertingenzyme	geneY
L-methionine	chem
malondialdehyde	chem
NO	chem
angiotensin	chem
【PRE_E】
L-methionine	chem
malondialdehyde	chem
PON1	geneN
SOD	geneN
NO	chem
angiotensin-convertingenzyme	geneY
【GOLD_R】
L-methionine	PON1	C4
L-methionine	SOD	C4
【PRE_R】
L-methionine	PON1	C4
L-methionine	SOD	C4

Given the treatment with three doses of Captopril ( 15 approximately 45 mg / kg ) markedly attenuated inhibition of vasodilator responses to ACh , and eliminated the increased level of malondialdehyde , the decreased level of NO , activity of PON1 and SOD in serum by single intragastric gavaged L - methionine .
【GOLD_E】
Captopril	chem
ACh	chem
malondialdehyde	chem
NO	chem
L-methionine	chem
PON1	geneY
SOD	geneN
【PRE_E】
Captopril	chem
ACh	chem
malondialdehyde	chem
NO	chem
PON1	geneY
SOD	geneN
L-methionine	chem
【GOLD_R】
Captopril	PON1	C3
Captopril	SOD	C3
【PRE_R】
Captopril	PON1	C4
PON1	L-methionine	C4
SOD	L-methionine	C4

However , there were some significant differences among Captopril ( 30 mg / kg or 45 mg / kg ) , enalapril ( 20 mg / kg ) , and N - acetylcysteine particular in the activity of PON1 and ACE .
【GOLD_E】
Captopril	chem
enalapril	chem
N-acetylcysteine	chem
PON1	geneY
ACE	geneY
【PRE_E】
Captopril	chem
enalapril	chem
N-acetylcysteine	chem
PON1	geneY
ACE	geneY
【GOLD_R】
【PRE_R】
Captopril	PON1	C4
enalapril	PON1	C4
N-acetylcysteine	PON1	C4
N-acetylcysteine	ACE	C4

These results suggested that Captopril can protect the vascular endothelium against the damages induced by L - methionine in rats , and the beneficial effects of Captopril may be related to attenuating the decrease in PON1 activity and NO levels .
【GOLD_E】
Captopril	chem
L-methionine	chem
Captopril	chem
NO	chem
PON1	geneY
【PRE_E】
Captopril	chem
L-methionine	chem
Captopril	chem
PON1	geneY
NO	chem
【GOLD_R】
Captopril	PON1	C3
L-methionine	PON1	C4
【PRE_R】
Captopril	PON1	C4
L-methionine	PON1	C4
Captopril	PON1	C4

Furthermore , this protective effect may be concerned with the sulfhydryl group .
【GOLD_E】
sulfhydryl	chem
【PRE_E】
sulfhydryl	chem
【GOLD_R】
【PRE_R】

Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment .
【GOLD_E】
sorafenib	chem
【PRE_E】
multikinase	geneN
sorafenib	chem
【GOLD_R】
【PRE_R】
multikinase	sorafenib	C4

Tumor survival , growth and metastasis depend on efficient tumor cell proliferation and tumor angiogenesis , and targeting both of these processes simultaneously could prove to be therapeutically relevant .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The RAS / RAF signaling pathway is an important mediator of tumor cell proliferation , and angiogenesis and is often aberrantly activated in human tumors due to the presence of activated Ras or mutant B - Raf , or elevation of growth factor receptors .
【GOLD_E】
RAS	geneN
RAF	geneY
Ras	geneN
B-Raf	geneY
growthfactorreceptors	geneN
【PRE_E】
RAS	geneN
RAF	geneN
Ras	geneN
B-Raf	geneY
growthfactorreceptors	geneN
【GOLD_R】
【PRE_R】

Sorafenib , which belongs chemically to a class that can be described as bis - aryl ureas , was selected for further pharmacologic characterization based on potent inhibition of Raf - 1 and its favorable kinase selectivity profile .
【GOLD_E】
Raf-1	geneY
kinase	geneN
Sorafenib	chem
bis-arylureas	chem
【PRE_E】
Sorafenib	chem
bis-arylureas	chem
Raf-1	geneY
kinase	geneN
【GOLD_R】
Sorafenib	Raf-1	C4
Sorafenib	kinase	C4
bis-arylureas	Raf-1	C4
bis-arylureas	kinase	C4
【PRE_R】
Sorafenib	Raf-1	C4
bis-arylureas	Raf-1	C4
bis-arylureas	kinase	C4

Further characterization showed that sorafenib suppresses both wild - type and V599E mutant B - Raf activity in vitro .
【GOLD_E】
sorafenib	chem
V599E	geneN
B-Raf	geneY
【PRE_E】
sorafenib	chem
V599E	geneY
B-Raf	geneY
【GOLD_R】
sorafenib	V599E	C4
sorafenib	B-Raf	C4
【PRE_R】
sorafenib	V599E	C4
sorafenib	B-Raf	C4

In addition , sorafenib demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression , including vascular - endothelial growth factor ( VEGFR ) - 2 , VEGFR - 3 , platelet - derived growth factor ( PDGFR ) - beta Flt - 3 , and c - KIT .
【GOLD_E】
sorafenib	chem
tyrosine	chem
VEGFR-3	geneY
platelet-derivedgrowthfactor(PDGFR)-beta	geneY
Flt-3	geneY
c-KIT	geneY
receptortyrosinekinases	geneN
vascular-endothelialgrowthfactor(VEGFR)-2	geneY
【PRE_E】
sorafenib	chem
tyrosinekinases	geneN
vascular-endothelialgrowthfactor(VEGFR)-2	geneY
VEGFR-3	geneY
platelet-derivedgrowthfactor(PDGFR)-betaFlt-3	geneY
c-KIT	geneY
【GOLD_R】
sorafenib	VEGFR-3	C3
sorafenib	platelet-derivedgrowthfactor(PDGFR)-beta	C3
sorafenib	Flt-3	C3
sorafenib	c-KIT	C3
sorafenib	receptortyrosinekinases	C3
sorafenib	vascular-endothelialgrowthfactor(VEGFR)-2	C3
【PRE_R】
sorafenib	vascular-endothelialgrowthfactor(VEGFR)-2	C4
sorafenib	VEGFR-3	C4
sorafenib	platelet-derivedgrowthfactor(PDGFR)-betaFlt-3	C4
sorafenib	c-KIT	C4

Preclinically , sorafenib showed broad - spectrum antitumor activity in colon , breast and non - small - cell lung cancer xenograft models .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

A total of four phase I studies using oral sorafenib as a single agent have been completed , and the compound showed a favorable safety profile with mild to moderate diarrhea being the most common treatment - related adverse event .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

The maximum tolerated dose was 400 mg b.i.d . continuous .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Single - agent phase II trials reported so far demonstrated antitumor activity of sorafenib in patients with hepatocellular carcinoma , sarcoma and renal cell cancer ( RCC ) .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

Based on phase II results in RCC patients , a placebo - controlled phase III study was performed , which randomized a total of 905 patients , most of whom were treated previously .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The partial response rate was 2 % for sorafenib and 0 % for placebo .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

Stable disease was observed in 78 % and 55 % of patients on sorafenib and placebo , respectively .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

Sorafenib significantly prolonged median progression - free survival ( 24 weeks ) compared with placebo ( 12 weeks ) in all subsets of patients evaluated .
【GOLD_E】
Sorafenib	chem
【PRE_E】
Sorafenib	chem
【GOLD_R】
【PRE_R】

Approval of sorafenib by the U.S .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

Food and Drug Administration for this indication is pending .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A first - line phase III study in RCC as well as phase III studies in hepatocellular carcinoma and metastatic melanoma have been initiated .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A selective retinoid X receptor agonist bexarotene ( LGD1069 , targretin ) inhibits angiogenesis and metastasis in solid tumours .
【GOLD_E】
retinoid	chem
bexarotene	chem
LGD1069	chem
targretin	chem
retinoidXreceptor	geneN
【PRE_E】
retinoidXreceptor	geneY
bexarotene	chem
LGD1069	chem
targretin	chem
【GOLD_R】
bexarotene	retinoidXreceptor	C5
LGD1069	retinoidXreceptor	C5
targretin	retinoidXreceptor	C5
【PRE_R】

The present study determined the influence of a retinoid X receptor agonist bexarotene on angiogenesis and metastasis in solid tumours .
【GOLD_E】
retinoidXreceptor	geneN
retinoid	chem
bexarotene	chem
【PRE_E】
retinoidXreceptor	geneY
bexarotene	chem
【GOLD_R】
bexarotene	retinoidXreceptor	C5
【PRE_R】

In the experimental lung metastasis xenograft models , treatment with bexarotene inhibited the development of the lung tumour nodule formation compared to control .
【GOLD_E】
bexarotene	chem
【PRE_E】
bexarotene	chem
【GOLD_R】
【PRE_R】

In vivo angiogenesis assay utilising gelfoam sponges , bexarotene reduced angiogenesis in sponges containing vascular endothelial growth factor , epidermal growth factor and basic fibroblast growth factor to various extent .
【GOLD_E】
vascularendothelialgrowthfactor	geneY
epidermalgrowthfactor	geneY
fibroblastgrowthfactor	geneN
bexarotene	chem
【PRE_E】
bexarotene	chem
vascularendothelialgrowthfactor	geneY
epidermalgrowthfactor	geneY
basicfibroblastgrowthfactor	geneY
【GOLD_R】
【PRE_R】
bexarotene	vascularendothelialgrowthfactor	C4
bexarotene	epidermalgrowthfactor	C4
bexarotene	basicfibroblastgrowthfactor	C4

To determine the basis of these observations , human breast and non - small - cell lung cancer cells were subjected to migration and invasion assays in the presence of bexarotene .
【GOLD_E】
bexarotene	chem
【PRE_E】
bexarotene	chem
【GOLD_R】
【PRE_R】

Our data showed that bexarotene decrease migration and invasiveness of tumour cells in a dose - dependent manner .
【GOLD_E】
bexarotene	chem
【PRE_E】
bexarotene	chem
【GOLD_R】
【PRE_R】

Furthermore , bexarotene inhibited angiogenesis by directly inhibiting human umbilical vein endothelial cell growth and indirectly inhibiting tumour cell - mediated migration of human umbilical vein endothelial cells through Matrigel matrix .
【GOLD_E】
bexarotene	chem
【PRE_E】
bexarotene	chem
【GOLD_R】
【PRE_R】

Analysis of tumour - conditioned medium indicated that bexarotene decreased the secretion of angiogenic factors and matrix metalloproteinases and increased the tissue inhibitor of matrix metalloproteinases .
【GOLD_E】
matrixmetalloproteinases	geneN
matrixmetalloproteinases	geneN
bexarotene	chem
【PRE_E】
bexarotene	chem
matrixmetalloproteinases	geneN
matrixmetalloproteinases	geneN
【GOLD_R】
bexarotene	matrixmetalloproteinases	C3
bexarotene	matrixmetalloproteinases	C4
【PRE_R】
bexarotene	matrixmetalloproteinases	C4
bexarotene	matrixmetalloproteinases	C4

The ability of bexarotene to inhibit angiogenesis and metastasis was dependent on activation of its heterodimerisation partner peroxisome proliferator - activated receptor gamma .
【GOLD_E】
peroxisomeproliferator-activatedreceptorgamma	geneY
bexarotene	chem
【PRE_E】
bexarotene	chem
peroxisomeproliferator-activatedreceptorgamma	geneY
【GOLD_R】
bexarotene	peroxisomeproliferator-activatedreceptorgamma	C3
【PRE_R】
bexarotene	peroxisomeproliferator-activatedreceptorgamma	C4

Collectively , our results suggest a role of bexarotene in treatment of angiogenesis and metastasis in solid tumours .
【GOLD_E】
bexarotene	chem
【PRE_E】
bexarotene	chem
【GOLD_R】
【PRE_R】

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first - episode schizophrenia patients .
【GOLD_E】
DRD2promoter	geneN
【PRE_E】
DRD2promoter	geneN
【GOLD_R】
【PRE_R】

OBJECTIVE : All antipsychotics act on the dopamine D ( 2 ) receptor .
【GOLD_E】
dopamine	chem
dopamineD(2)receptor	geneY
【PRE_E】
dopamineD(2)receptor	geneY
【GOLD_R】
【PRE_R】

The present study extends prior pharmacogenetic investigations of the D ( 2 ) receptor gene ( DRD2 ) by examining , in first - episode schizophrenia patients , promoter region variation as a predictor of response time to two first - line atypical antipsychotics .
【GOLD_E】
D(2)receptor	geneY
DRD2	geneY
【PRE_E】
D(2)receptor	geneY
DRD2	geneY
【GOLD_R】
【PRE_R】

METHOD : Patients experiencing their first episode of schizophrenia ( N = 61 ) were genotyped for two DRD2 promoter region polymorphisms ( A - 241G and - 141C Ins / Del ) and were randomly assigned to receive 16 weeks of treatment with either risperidone or olanzapine .
【GOLD_E】
risperidone	chem
olanzapine	chem
DRD2promoter	geneN
A-241G	geneN
【PRE_E】
DRD2promoter	geneN
risperidone	chem
olanzapine	chem
【GOLD_R】
【PRE_R】

Time until sustained response ( two consecutive ratings without significant positive symptoms ) for rare allele carriers versus wild types was examined by using Kaplan - Meier curves .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Relative to wild type homozygotes , G carriers ( A - 241G ) exhibited a significantly faster time until response , whereas - 141C Del carriers took a significantly longer time to respond .
【GOLD_E】
A-241G	geneN
【PRE_E】
A-241G	geneY
141C	geneY
【GOLD_R】
【PRE_R】

Diplotype analysis revealed similar results .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : These findings suggest that variation in the D ( 2 ) receptor gene can , in part , explain variation in the timing of clinical response to antipsychotics in patients with first - episode schizophrenia .
【GOLD_E】
D(2)receptor	geneY
【PRE_E】
D(2)receptor	geneY
【GOLD_R】
【PRE_R】

Intrauterine pressure , ischemia markers , and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin - induced dysmenorrhea .
【GOLD_E】
vasopressin	chem
vasopressin	chem
vasopressin	geneY
vasopressinV1areceptor	geneY
【PRE_E】
Intrauterine	chem
vasopressinV1areceptor	geneY
vasopressin	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : A model to study the effect of vasopressin V1a antagonist in dysmenorrhea .
【GOLD_E】
vasopressin	chem
vasopressinV1a	geneY
【PRE_E】
vasopressinV1a	geneY
【GOLD_R】
【PRE_R】

METHODS : A double - blind , randomized , placebo - controlled , cross - over trial was performed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Eight patients with primary dysmenorrhea and eight tuballigated , healthy subjects participated on days 1 - 2 of two consecutive menstruations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

At each menstruation a bolus injection of 10 pmol / kg of vasopressin was administered before and during infusion of either 300 microg / min of atosiban or placebo .
【GOLD_E】
atosiban	chem
vasopressin	geneY
vasopressin	chem
【PRE_E】
vasopressin	geneY
atosiban	chem
【GOLD_R】
【PRE_R】

Intrauterine pressure was measured as area under the curve throughout the experiments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ischemia markers in plasma and pain recorded by a visual analog scale were measured before and after each vasopressin injection as well as before and after the start of either atosiban or placebo infusion .
【GOLD_E】
vasopressin	chem
atosiban	chem
vasopressin	geneY
【PRE_E】
vasopressin	geneY
atosiban	chem
【GOLD_R】
【PRE_R】

RESULTS : Vasopressin injections elevated area under the curve in both healthy volunteers and dysmenorrhea subjects .
【GOLD_E】
Vasopressin	chem
Vasopressin	geneY
【PRE_E】
Vasopressin	geneY
【GOLD_R】
【PRE_R】

The vasopressin - induced rise in area under the curve was lower during atosiban administration than during infusion of placebo in both groups .
【GOLD_E】
vasopressin	chem
atosiban	chem
【PRE_E】
vasopressin	geneY
atosiban	chem
【GOLD_R】
【PRE_R】

None of the ischemia markers differed between or within groups at vasopressin injections or atosiban / placebo infusions .
【GOLD_E】
vasopressin	chem
atosiban	chem
【PRE_E】
vasopressin	geneY
atosiban	chem
【GOLD_R】
【PRE_R】

In subjects with dysmenorrhea the increase in pain following the administration of vasopressin was significantly lower during atosiban than during placebo infusion .
【GOLD_E】
vasopressin	geneY
vasopressin	chem
atosiban	chem
【PRE_E】
vasopressin	geneY
atosiban	chem
【GOLD_R】
atosiban	vasopressin	C4
【PRE_R】

Healthy volunteers experienced only slight discomfort after the vasopressin injections .
【GOLD_E】
vasopressin	geneY
vasopressin	chem
【PRE_E】
vasopressin	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS : Atosiban reduces vasopressin - induced intrauterine pressure in both healthy volunteers and dysmenorrheics , and reported pain in subjects with dysmenorrhea .
【GOLD_E】
vasopressin	geneY
Atosiban	chem
vasopressin	chem
【PRE_E】
Atosiban	chem
vasopressin	geneY
【GOLD_R】
Atosiban	vasopressin	C4
【PRE_R】

The ischemia markers are not a useful biomarker index in women with dysmenorrhea .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The dysmenorrhea pain evoked by vasopressin correlated poorly with area under the curve , which may suggest that the effect is mediated by more than one V1a - like receptor .
【GOLD_E】
vasopressin	geneY
V1a-likereceptor	geneY
vasopressin	chem
【PRE_E】
vasopressin	geneY
V1a-likereceptor	geneY
【GOLD_R】
【PRE_R】

We conclude that this model with recordings in healthy women is useful in the evaluation of drug candidates for primary dysmenorrhea .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thymidylate synthase expression in resectable and unresectable pancreatic cancer : role as predictive or prognostic marker ?
【GOLD_E】
Thymidylatesynthase	geneY
Thymidylate	chem
【PRE_E】
Thymidylatesynthase	geneY
【GOLD_R】
【PRE_R】

BACKGROUND AND AIMS : Thymidylate synthase ( TS ) is an important enzyme for DNA synthesis and the target for 5 - fluorouracil ( 5 - FU ) .
【GOLD_E】
Thymidylatesynthase	geneY
TS	geneY
5-fluorouracil	chem
5-FU	chem
Thymidylate	chem
【PRE_E】
Thymidylatesynthase	geneY
TS	geneY
5-fluorouracil	chem
5-FU	chem
【GOLD_R】
【PRE_R】
TS	5-fluorouracil	C9
TS	5-FU	C9

Its expression may determine the outcome of patients with gastrointestinal cancers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We examined the prognostic and predictive value of TS - protein expression in patients with ductal adenocarcinoma of the pancreas .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

METHODS : TS expression from 131 patients with ductal adenocarcinoma of the pancreas was analyzed by immunohistochemistry in paraffin - embedded primary tumour specimens or biopsies .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

RESULTS : The median disease - specific survival among all patients ( n = 131 ) was 13 months .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The invasion depth , the presence of metastases , grading and Union Internationale Contre le Cancer [ International Union Against Cancer ] ( UICC ) stage were associated with survival .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Among resected patients ( n = 98 ) , a difference in median survival was seen in the group receiving postoperative adjuvant treatment ( 21.1 months ) compared with the group treated by surgery alone ( 12.4 months ) ( p = 0.025 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Low - and high - TS immunoreactivity was present in 74 ( 56 % ) and 56 ( 43 % ) of the cancers , respectively .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

One sample was not evaluable .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

No difference in median survival was observed among low - and high - TS - expressing tumours .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

Among patients undergoing resection and receiving postoperative intra - arterial chemotherapy ( n = 23 ) , a marked trend to a longer median survival was seen for the group with low - TS - expressing tumours compared with the corresponding high - TS group ( 25.0 vs 16.0 months ) ( p = 0.3834 ) .
【GOLD_E】
TS	geneY
TS	geneY
【PRE_E】
TS	geneY
TS	geneY
【GOLD_R】
【PRE_R】

There was no difference in survival among all palliative treated patients with low - and high - TS - expressing tumours .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : Especially patients undergoing tumour resection with low - TS values seemed to have taken advantage from an intensified postoperative chemotherapeutic protocol .
【GOLD_E】
TS	geneY
【PRE_E】
TS	geneY
【GOLD_R】
【PRE_R】

However due to the heterogeneous group of patients in the present report , larger trials of more homogenous patient populations will be necessary to confirm this hypothesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Enzymatic and biochemical properties of a novel human serine dehydratase isoform .
【GOLD_E】
humanserinedehydratase	geneY
serine	chem
【PRE_E】
humanserinedehydratase	geneY
【GOLD_R】
【PRE_R】

A cDNA clone similar to human serine dehydratase ( SDH ) is deposited in the GenBank / EMBL databases , but its structural and functional bases remain unknown .
【GOLD_E】
humanserinedehydratase	geneY
SDH	geneY
serine	chem
【PRE_E】
humanserinedehydratase	geneY
SDH	geneY
【GOLD_R】
【PRE_R】

Despite the occurrence of mRNA , the expected protein level was found to be low in cultured cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To learn about physicochemical properties of the protein , we expressed the cDNA in Escherichia coli , and compared the expressed protein with that of a hepatic SDH .
【GOLD_E】
SDH	geneY
【PRE_E】
SDH	geneY
【GOLD_R】
【PRE_R】

The purified protein showed l - serine and l - threonine dehydratase activity , demonstrating to be an isoform of SDH .
【GOLD_E】
l-serineandl-threoninedehydratase	geneY
SDH	geneY
l-serine	chem
l-threonine	chem
【PRE_E】
l-serine	geneN
l-threoninedehydratase	geneY
SDH	geneY
【GOLD_R】
【PRE_R】

However , their Km and Vmax constants were different in a range of two - order .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Removal of Pro128 from the hepatic SDH consisting of 328 residues , which is missing in the corresponding position of the isoform consisting of 329 residues , significantly changed the Michaelis constants and Kd value for pyridoxal 5 ' - phosphate , whereas addition of a proline residue to the isoform was without effect .
【GOLD_E】
SDH	geneY
pyridoxal5'-phosphate	chem
proline	chem
【PRE_E】
Pro128	chem
SDH	geneY
pyridoxal5'-phosphate	chem
proline	chem
【GOLD_R】
【PRE_R】

These findings suggest the difference in the structures of the active sites of the two enzymes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Another striking feature was that the expressed level of the isoform in E. coli was 7 - fold lower than that of the hepatic SDH .
【GOLD_E】
SDH	geneY
【PRE_E】
SDH	geneY
【GOLD_R】
【PRE_R】

Substitution of Val for Leu287 in the isoform dramatically increased the protein level .
【GOLD_E】
ValforLeu287	geneN
【PRE_E】
Val	chem
Leu287	geneN
【GOLD_R】
【PRE_R】

The high yield of the mutated isoform was also confirmed by the in vitro transcription and translation experiment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The poor expression of the isoform could be explained by the more stable secondary structure of the mRNA than that of the hepatic SDH mRNA .
【GOLD_E】
SDH	geneY
【PRE_E】
SDH	geneY
【GOLD_R】
【PRE_R】

The present findings may provide a clue as to why the protein level in cultured cells is low .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents .
【GOLD_E】
histamine	chem
histamineH3receptor	geneY
【PRE_E】
histamineH3receptor	geneY
【GOLD_R】
【PRE_R】

Novel highly affine histamine H3 receptor ligands with additional inhibitory effects on the main histamine metabolizing enzyme in the brain , N - methyltransferase , chemically show structural elements of the acetylcholinesterase inhibitor tacrine .
【GOLD_E】
N-methyltransferase	geneN
histamineH3receptor	geneY
acetylcholinesterase	geneY
N	chem
histamine	chem
tacrine	chem
histamine	chem
【PRE_E】
histamineH3receptor	geneY
histamine	chem
N-methyltransferase	geneY
acetylcholinesterase	geneY
tacrine	chem
【GOLD_R】
tacrine	acetylcholinesterase	C4
histamine	N-methyltransferase	C9
【PRE_R】
acetylcholinesterase	tacrine	C4

H3 receptor antagonism , inhibition of metabolisation of neuronal histamine as well as inhibition of hydrolysis of acetylcholine are each one believed to improve reduced cognitive functions , which is useful for symptomatic treatment of Alzheimer 's disease .
【GOLD_E】
H3receptor	geneY
histamine	chem
acetylcholine	chem
【PRE_E】
H3receptor	geneY
histamine	chem
acetylcholine	chem
【GOLD_R】
【PRE_R】

Some of the new compounds proved in a slightly modified colorimetric Ellmann 's assay to be potent inhibitors of acetylcholinesterase and of butyrylcholinesterase which is another catalytic enzyme hydrolysing acetylcholine .
【GOLD_E】
acetylcholinesterase	geneY
butyrylcholinesterase	geneY
acetylcholine	chem
【PRE_E】
acetylcholinesterase	geneY
butyrylcholinesterase	geneY
acetylcholine	chem
【GOLD_R】
acetylcholine	acetylcholinesterase	C9
acetylcholine	butyrylcholinesterase	C9
【PRE_R】

Some compounds with ( sub ) nanomolar activities on the histamine - related targets are also active in the nanomolar concentration range on both cholinesterase targets being 5 - to 40 - times more potent than tacrine .
【GOLD_E】
cholinesterase	geneN
histamine	chem
tacrine	chem
【PRE_E】
histamine	chem
cholinesterase	geneY
tacrine	chem
【GOLD_R】
【PRE_R】
cholinesterase	tacrine	C4

Preliminary structure - activity relationships could already be drawn from the small number of compounds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The compounds acting as hybrid drugs simultaneously on four different targets to enhance cognitive functions via different pathways are promising lead structures for a new approach in the treatment of Alzheimer 's disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chemotherapy and targeted therapy combinations in advanced melanoma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For three decades , clinical trials with chemotherapy in melanoma have failed to show superiority of any one regimen over another .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Dacarbazine remains the only `` standard `` agent .
【GOLD_E】
Dacarbazine	chem
【PRE_E】
Dacarbazine	chem
【GOLD_R】
【PRE_R】

With response rates of < 10 % and median progression - free survival of 2 months or less in contemporary trials , there is a need to improve systemic therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Combination chemotherapy is associated with higher response rates than single - agent therapy but this has not translated into improved survival .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

An increasing number of potential therapeutic targets have been identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For some , pharmacologic inhibitors are available , including sorafenib for BRAF , farnesyltransferase inhibitors for NRAS , PD - 0325901 for mitogen - activated protein kinase / extracellular signal - regulated kinase kinase , rapamycin analogues for mammalian target of rapamycin , and agents that inhibit either vascular endothelial growth factor or its receptors .
【GOLD_E】
BRAF	geneY
farnesyltransferase	geneN
NRAS	geneY
mitogen-activatedproteinkinase	geneN
extracellularsignal-regulatedkinasekinase	geneN
mammaliantargetofrapamycin	geneY
vascularendothelialgrowthfactor	geneY
sorafenib	chem
PD-0325901	chem
rapamycin	chem
rapamycin	chem
【PRE_E】
sorafenib	chem
BRAF	geneY
farnesyltransferase	geneN
NRAS	geneY
PD-0325901	geneY
mitogen-activatedproteinkinase	geneN
extracellularsignal-regulatedkinasekinase	geneN
rapamycin	chem
rapamycin	chem
vascularendothelialgrowthfactor	geneY
【GOLD_R】
sorafenib	BRAF	C4
PD-0325901	mitogen-activatedproteinkinase	C4
PD-0325901	extracellularsignal-regulatedkinasekinase	C4
rapamycin	mammaliantargetofrapamycin	C4
【PRE_R】
sorafenib	BRAF	C4
sorafenib	farnesyltransferase	C4
sorafenib	NRAS	C4
PD-0325901	rapamycin	C4
mitogen-activatedproteinkinase	rapamycin	C4
extracellularsignal-regulatedkinasekinase	rapamycin	C4
rapamycin	vascularendothelialgrowthfactor	C4

Several multitargeted kinase inhibitors have potency against the fibroblast growth factor receptor , c - kit , and platelet - derived growth factor receptor .
【GOLD_E】
kinase	geneN
fibroblastgrowthfactorreceptor	geneN
c-kit	geneY
platelet-derivedgrowthfactorreceptor	geneN
【PRE_E】
multitargetedkinase	geneN
fibroblastgrowthfactorreceptor	geneN
c-kit	geneY
platelet-derivedgrowthfactorreceptor	geneN
【GOLD_R】
【PRE_R】

Small - molecule inhibitors of c - met and Akt are in preclinical development .
【GOLD_E】
c-met	geneY
Akt	geneN
【PRE_E】
c-met	geneY
Akt	geneN
【GOLD_R】
【PRE_R】

Another class of agents indirectly affect aberrant signaling , including inhibitors of chaperones and proteasomes .
【GOLD_E】
chaperones	geneN
proteasomes	geneN
【PRE_E】
proteasomes	geneN
【GOLD_R】
【PRE_R】

Several targeted agents seem to enhance the cytotoxicity of chemotherapy in preclinical models .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mechanism by which signaling inhibition might synergize with chemotherapy requires more study so that rational combinations move forward .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Very few targeted agents have been studied rigorously in this fashion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lipid specific activation of the murine P4 - ATPase Atp8a1 ( ATPase II ) .
【GOLD_E】
murineP4-ATPase	geneN
Atp8a1	geneY
ATPaseII	geneY
【PRE_E】
murineP4-ATPaseAtp8a1	geneY
ATPaseII	geneN
【GOLD_R】
【PRE_R】

The asymmetric transbilayer distribution of phosphatidylserine ( PS ) in the mammalian plasma membrane and secretory vesicles is maintained , in part , by an ATP - dependent transporter .
【GOLD_E】
ATP	chem
phosphatidylserine	chem
PS	chem
【PRE_E】
phosphatidylserine	chem
PS	chem
ATP-dependenttransporter	geneN
【GOLD_R】
【PRE_R】

This aminophospholipid `` flippase `` selectively transports PS to the cytosolic leaflet of the bilayer and is sensitive to vanadate , Ca ( 2 + ) , and modification by sulfhydryl reagents .
【GOLD_E】
ts	chem
tovanada	chem
e,Ca(2	chem
bysulfhydr	chem
`flippas	geneN
【PRE_E】
aminophospholipid	geneN
flippase	geneN
PS	chem
vanadate	chem
Ca(2+)	chem
sulfhydryl	chem
【GOLD_R】
ts	`flippas	C9
【PRE_R】
aminophospholipid	PS	C9
flippase	PS	C9
flippase	vanadate	C9
flippase	Ca(2+)	C9
flippase	sulfhydryl	C9

Although the flippase has not been positively identified , a subfamily of P - type ATPases has been proposed to function as transporters of amphipaths , including PS and other phospholipids .
【GOLD_E】
flippase	geneN
P-typeATPases	geneN
【PRE_E】
flippase	geneN
P-typeATPases	geneN
PS	chem
【GOLD_R】
【PRE_R】

A candidate PS flippase ATP8A1 ( ATPase II ) , originally isolated from bovine secretory vesicles , is a member of this subfamily based on sequence homology to the founding member of the subfamily , the yeast protein Drs2 , which has been linked to ribosomal assembly , the formation of Golgi - coated vesicles , and the maintenance of PS asymmetry .
【GOLD_E】
PS	chem
PSflippaseATP8A1	geneY
ATPaseII	geneY
yeastproteinDrs2	geneY
【PRE_E】
PSflippaseATP8A1	geneN
ATPaseII	geneN
yeastproteinDrs2	geneN
【GOLD_R】
【PRE_R】

To determine if ATP8A1 has biochemical characteristics consistent with a PS flippase , a murine homologue of this enzyme was expressed in insect cells and purified .
【GOLD_E】
PS	chem
ATP8A1	geneY
PSflippase	geneN
【PRE_E】
ATP8A1	geneN
PSflippase	geneN
【GOLD_R】
【PRE_R】

The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine , phosphatidic acid , or phosphatidylinositol , is minimally activated by phosphatidylglycerol or phosphatidylethanolamine ( PE ) , and is maximally activated by PS .
【GOLD_E】
phosphatidylcholine	chem
phosphatidicacid	chem
Atp8a1	geneY
phosphatidylinositol	chem
phosphatidylglycerol	chem
phosphatidylethanolamine	chem
PE	chem
PS	chem
【PRE_E】
Atp8a1	geneN
phosphatidylcholine	chem
phosphatidicacid	chem
phosphatidylinositol	chem
phosphatidylglycerol	chem
phosphatidylethanolamine	chem
PS	chem
【GOLD_R】
phosphatidylglycerol	Atp8a1	C3
phosphatidylethanolamine	Atp8a1	C3
PE	Atp8a1	C3
PS	Atp8a1	C3
【PRE_R】
Atp8a1	phosphatidylcholine	C9
Atp8a1	phosphatidicacid	C9
Atp8a1	phosphatidylinositol	C9
Atp8a1	phosphatidylglycerol	C9
Atp8a1	phosphatidylethanolamine	C9
Atp8a1	PS	C9

The selectivity for PS is dependent upon multiple elements of the lipid structure .
【GOLD_E】
PS	chem
【PRE_E】
PS	chem
【GOLD_R】
【PRE_R】

Similar to the plasma membrane PS transporter , Atp8a1 is activated only by the naturally occurring sn - 1,2 - glycerol isomer of PS and not the sn - 2,3 - glycerol stereoisomer .
【GOLD_E】
sn-1,2-glycerol	chem
sn-2,3-glycerol	chem
plasmamembranePStransporter	geneN
Atp8a1	geneY
PS	chem
【PRE_E】
PStransporter	geneN
Atp8a1	geneN
sn-1,2-glycerol	chem
PS	chem
sn-2,3-glycerol	chem
【GOLD_R】
sn-1,2-glycerol	plasmamembranePStransporter	C3
sn-1,2-glycerol	Atp8a1	C3
【PRE_R】
Atp8a1	sn-1,2-glycerol	C9
Atp8a1	PS	C9
Atp8a1	sn-2,3-glycerol	C9

Both flippase and Atp8a1 activities are insensitive to the stereochemistry of the serine headgroup .
【GOLD_E】
flippase	geneN
Atp8a1	geneY
【PRE_E】
flippase	geneN
Atp8a1	geneN
serine	chem
【GOLD_R】
【PRE_R】
flippase	serine	C9
Atp8a1	serine	C9

Most modifications of the PS headgroup structure decrease recognition by the plasma membrane PS flippase .
【GOLD_E】
PS	chem
PS	chem
PSflippase	geneN
【PRE_E】
PSflippase	geneN
【GOLD_R】
【PRE_R】

Activation of Atp8a1 is also reduced by these modifications ; phosphatidylserine - O - methyl ester , lysophosphatidylserine , glycerophosphoserine , and phosphoserine , which are not transported by the plasma membrane flippase , do not activate Atp8a1 .
【GOLD_E】
phosphatidylserine-O-methylester	chem
lysophosphatidylserine	chem
glycerophosphoserine	chem
phosphoserine	chem
Atp8a1	geneY
Atp8a1	geneY
【PRE_E】
Atp8a1	geneN
phosphatidylserine-O-methylester	chem
lysophosphatidylserine	chem
glycerophosphoserine	chem
phosphoserine	chem
flippase	geneN
Atp8a1	geneN
【GOLD_R】
phosphatidylserine-O-methylester	Atp8a1	C4
lysophosphatidylserine	Atp8a1	C4
glycerophosphoserine	Atp8a1	C4
phosphoserine	Atp8a1	C4
【PRE_R】

Weakly translocated lipids ( PE , phosphatidylhydroxypropionate , and phosphatidylhomoserine ) are also weak Atp8a1 activators .
【GOLD_E】
PE	chem
phosphatidylhydroxypropionate	chem
phosphatidylhomoserine	chem
Atp8a1	geneY
【PRE_E】
Atp8a1	geneN
【GOLD_R】
PE	Atp8a1	C3
phosphatidylhydroxypropionate	Atp8a1	C3
phosphatidylhomoserine	Atp8a1	C3
【PRE_R】

However , N - methyl - phosphatidylserine , which is transported by the plasma membrane flippase at a rate equivalent to PS , is incapable of activating Atp8a1 activity .
【GOLD_E】
N-methyl-phosphatidylserine	chem
PS	chem
flippase	geneN
Atp8a1	geneY
【PRE_E】
N-methyl-phosphatidylserine	chem
flippase	geneN
Atp8a1	geneN
【GOLD_R】
N-methyl-phosphatidylserine	flippase	C9
【PRE_R】
N-methyl-phosphatidylserine	Atp8a1	C3

These results indicate that the ATPase activity of the secretory granule Atp8a1 is activated by phospholipids binding to a specific site whose properties ( PS selectivity , dependence upon glycerol but not serine , stereochemistry , and vanadate sensitivity ) are similar to , but distinct from , the properties of the substrate binding site of the plasma membrane flippase .
【GOLD_E】
PS	chem
glycerol	chem
serine	chem
ATPase	geneN
Atp8a1	geneY
flippase	geneN
【PRE_E】
ATPase	geneN
Atp8a1	geneN
PS	geneN
glycerol	chem
serine	chem
vanadate	chem
flippase	geneN
【GOLD_R】
PS	ATPase	C3
PS	Atp8a1	C3
【PRE_R】

Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab , anti - tumor necrosis factor alpha neutralizing antibody .
【GOLD_E】
tumornecrosisfactoralpha	geneY
【PRE_E】
tumornecrosisfactoralpha	geneY
【GOLD_R】
【PRE_R】

We report that a - 63 - year - old woman developed Pneumocystis jiroveci pneumonia ( PCP ) as a complication from treatment with infliximab for rheumatoid arthritis .
【GOLD_E】
【PRE_E】
PCP	chem
【GOLD_R】
【PRE_R】

Although there was neither symptoms of dyspnea nor typical observations on a chest X - ray examination , low levels of oxygen saturation and findings of high - resolution chest computed tomographic scanning suggested a possibility of interstitial pneumonia .
【GOLD_E】
oxygen	chem
【PRE_E】
oxygen	chem
【GOLD_R】
【PRE_R】

A polymerase chain reaction - based detection of Pneumocystis jiroveci in induced sputum allowed an early diagnosis of PCP and subsequent effective treatment .
【GOLD_E】
【PRE_E】
Pneumocystisjiroveci	chem
PCP	chem
【GOLD_R】
【PRE_R】

High - mannose - type glycan modifications of dihydrofolate reductase using glycan - methotrexate conjugates .
【GOLD_E】
dihydrofolatereductase	geneY
dihydrofolate	chem
mannose	chem
methotrexate	chem
【PRE_E】
High-mannose	chem
dihydrofolatereductase	geneY
methotrexate	chem
【GOLD_R】
【PRE_R】

Various high - mannose - type glycan modifications of dihydrofolate reductase ( DHFR ) were achieved by ligand - based approach using glycan - methotrexate ( MTX ) conjugates as tight binding glycan bearing ligands for DHFR .
【GOLD_E】
DHFR	geneY
dihydrofolatereductase	geneY
DHFR	geneY
mannose	chem
methotrexate	chem
MTX	chem
dihydrofolate	chem
【PRE_E】
mannose	chem
dihydrofolatereductase	geneY
DHFR	geneY
methotrexate	chem
MTX	chem
DHFR	geneY
【GOLD_R】
【PRE_R】

The resulting glycan - MTX conjugates and the corresponding artificial glycoproteins could be useful as oligosaccharide - and glycoprotein - probes to perform quantitative analysis of glycan recognizing protein such as lectins , glycosyltransferases or glycosidases .
【GOLD_E】
glycanrecognizingprotein	geneN
lectins	geneN
glycosyltransferases	geneN
glycosidases	geneN
MTX	chem
【PRE_E】
MTX	chem
glycosyltransferases	geneN
glycosidases	geneN
【GOLD_R】
【PRE_R】

Moreover , artificial glycoproteins having two different high - mannose - type glycans were developed for the first time by a combination of two different types of glycan modification strategies .
【GOLD_E】
mannose	chem
【PRE_E】
high-mannose-typeglycans	geneN
【GOLD_R】
【PRE_R】

NMDA receptors are not alone : dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol - rich membrane domains leads to disease - specific nuances of glutamate - signalling .
【GOLD_E】
NMDA	chem
cholesterol	chem
glutamate	chem
NMDA	chem
NMDAreceptors	geneN
transientcholesterol-richmembranedomains	geneN
NMDAreceptor	geneN
neuregulins	geneN
【PRE_E】
NMDAreceptors	geneN
NMDAreceptor	geneN
neuregulins	geneN
cholesterol	chem
glutamate	chem
【GOLD_R】
【PRE_R】

Glutamate receptors of the N - methyl - D - asparate ( NMDA - ) subtype are tetrameric allosteric and ligand - gated calcium channels .
【GOLD_E】
NMDA	chem
Glutamatereceptors	geneN
Glutamate	chem
ligand-gatedcalciumchannels	geneN
N-methyl-D-asparate	chem
【PRE_E】
Glutamatereceptors	geneN
N-methyl-D-asparate	chem
NMDA	chem
ligand-gatedcalciumchannels	geneN
【GOLD_R】
【PRE_R】

They are modulated by a variety of endogenous ligands and ions and play a pivotal role in memory - related signal transduction due to a voltage - dependent block by magnesium , which makes them Hebbian coincidence detectors .
【GOLD_E】
magnesium	chem
【PRE_E】
magnesium	chem
【GOLD_R】
【PRE_R】

On the structural level NMDA receptors have an enormous flexibility due to seven genes ( NR1 , NR2A - D and NR3A - B ) , alternative splicing , RNA - editing and extensive posttranslational modifications , like phosphorylation and glycosylation .
【GOLD_E】
NMDAreceptors	geneN
NR1	geneY
NR2A-D	geneN
NR3A-B	geneN
NMDA	chem
【PRE_E】
NMDAreceptors	geneN
NR1	geneY
NR2A-D	geneY
NR3A-B	geneY
glycosylation	geneN
【GOLD_R】
【PRE_R】

NMDA receptors are thought to be responsible for excitotoxicity and subsequent downstream events like neuroinflammation and apoptosis and thus have been implicated in many important human pathologies , ranging from amyotrophic lateral sclerosis , Alzheimer 's and Parkinson ' disease , depression , epilepsy , trauma and stroke to schizophrenia .
【GOLD_E】
NMDA	chem
NMDAreceptors	geneN
【PRE_E】
NMDAreceptors	geneN
【GOLD_R】
【PRE_R】

This fundamental significance of NMDA receptor - related excitotoxicity is discussed in the context of the developing clinical success of Memantine , but moreover set into relation to various proteomic and genetic markers of said diseases .
【GOLD_E】
NMDA	chem
NMDAreceptor	geneN
Memantine	chem
【PRE_E】
NMDAreceptor	geneN
Memantine	chem
【GOLD_R】
【PRE_R】

The very complex localisational and functional regulation of NMDA receptors appears to be dependent on neuregulins and receptor tyrosine kinases in cholesterol - rich membrane domains ( lipid rafts ) , calcium - related mitochondrial feedback - loops and subsynaptic structural elements like PSD - 95 ( post - synaptic density protein of 95 kD ) .
【GOLD_E】
NMDAreceptors	geneN
neuregulins	geneN
receptortyrosinekinases	geneN
PSD-95	geneY
post-synapticdensityproteinof95kD	geneY
NMDA	chem
tyrosine	chem
cholesterol	chem
calcium	chem
【PRE_E】
NMDAreceptors	geneN
neuregulinsandreceptortyrosinekinases	geneN
cholesterol	chem
calcium	chem
【GOLD_R】
【PRE_R】

The flexibility and multitude of interaction partners and possibilities of these highly dynamic molecular systems are discussed in terms of drug development strategies , in particular comparing high affinity and sub - type specific ligands to currently successful or promising therapies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sorafenib : recent update on activity as a single agent and in combination with interferon - alpha2 in patients with advanced - stage renal cell carcinoma .
【GOLD_E】
interferon-alpha2	geneY
Sorafenib	chem
【PRE_E】
Sorafenib	chem
interferon-alpha2	geneY
【GOLD_R】
【PRE_R】

Metastatic renal cell carcinoma does not respond favorably to conventional treatment strategies and is not very responsive to cytokine therapy .
【GOLD_E】
【PRE_E】
cytokine	geneN
【GOLD_R】
【PRE_R】

Therefore , novel targeted treatment approaches have been explored for patients with renal cancer who have chemotherapy - refractory disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sorafenib ( BAY 43 - 9006 ) is a small - molecule inhibitor that has been shown to target members of multiple classes of tyrosine kinases that are known to be involved in tumor cell proliferation and tumor angiogenesis .
【GOLD_E】
Sorafenib	chem
BAY43-9006	chem
tyrosine	chem
tyrosinekinases	geneN
【PRE_E】
Sorafenib	chem
BAY43-9006	chem
tyrosinekinases	geneN
【GOLD_R】
Sorafenib	tyrosinekinases	C4
BAY43-9006	tyrosinekinases	C4
【PRE_R】

These kinases include vascular endothelial growth factor receptor ( VEGFR ) - 1 , VEGFR - 2 , VEGFR - 3 , platelet - derived growth factor receptor , Flt - 3 , c - kit , and Raf kinases .
【GOLD_E】
vascularendothelialgrowthfactorreceptor(VEGFR)-1	geneY
VEGFR-2	geneY
VEGFR-3	geneY
platelet-derivedgrowthfactorreceptor	geneY
Flt-3	geneY
c-kit	geneY
Raf	geneY
kinases	geneN
kinases	geneN
【PRE_E】
kinases	geneN
vascularendothelialgrowthfactorreceptor(VEGFR)-1	geneY
VEGFR-2	geneY
VEGFR-3	geneY
platelet-derivedgrowthfactorreceptor	geneY
Flt-3	geneY
c-kit	geneY
Rafkinases	geneN
【GOLD_R】
【PRE_R】

Based on the significant improvement in progression - free survival , sorafenib received Food and Drug Administration approval in December 2005 for the treatment of renal cell carcinoma .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

In combination studies , sorafenib with other antitumor agents has demonstrated significant clinical activity in patients with renal cell carcinoma .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

As discussed in this mini - review , the clinical potency of sorafenib as a single agent or in combination with other antitumor agents is being evaluated in several ongoing clinical trials in patients with renal carcinoma .
【GOLD_E】
sorafenib	chem
【PRE_E】
sorafenib	chem
【GOLD_R】
【PRE_R】

Hydrogen sulfide inhibits nitric oxide production and nuclear factor - kappaB via heme oxygenase - 1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide .
【GOLD_E】
Hydrogensulfide	chem
nitricoxide	chem
nuclearfactor-kappaB	geneN
hemeoxygenase-1	geneY
【PRE_E】
Hydrogensulfide	chem
nitricoxide	chem
nuclearfactor-kappaB	geneN
hemeoxygenase-1	geneY
【GOLD_R】
Hydrogensulfide	nuclearfactor-kappaB	C4
【PRE_R】
Hydrogensulfide	nuclearfactor-kappaB	C4
Hydrogensulfide	hemeoxygenase-1	C4

Hydrogen sulfide ( H ( 2 ) S ) , a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma - lyase ( CSE ) and / or cystathionine beta - synthase ( CBS ) from L - cysteine ( L - Cys ) metabolism , is a putative vasodilator , and its role in nitric oxide ( NO ) production is unexplored .
【GOLD_E】
L-cysteine	chem
L-Cys	chem
H(2)S	chem
Hydrogensulfide	chem
nitricoxide	chem
NO	chem
cystathionine	chem
CSE	geneY
cystathioninebeta-synthase	geneY
CBS	geneY
cystathionine	chem
cystathioninegamma-lyase	geneY
【PRE_E】
Hydrogensulfide	chem
H(2)S	chem
cystathioninegamma-lyase	geneY
CSE	geneY
cystathioninebeta-synthase	geneY
CBS	geneY
L-cysteine	chem
L-Cys	chem
nitricoxide	chem
NO	chem
【GOLD_R】
H(2)S	CSE	C9
H(2)S	cystathioninebeta-synthase	C9
H(2)S	CBS	C9
H(2)S	cystathioninegamma-lyase	C9
Hydrogensulfide	CSE	C9
Hydrogensulfide	cystathioninebeta-synthase	C9
Hydrogensulfide	CBS	C9
Hydrogensulfide	cystathioninegamma-lyase	C9
L-cysteine	CSE	C9
L-cysteine	cystathioninebeta-synthase	C9
L-cysteine	CBS	C9
L-cysteine	cystathioninegamma-lyase	C9
L-Cys	CSE	C9
L-Cys	cystathioninebeta-synthase	C9
L-Cys	CBS	C9
L-Cys	cystathioninegamma-lyase	C9
【PRE_R】
H(2)S	CSE	C9
CBS	L-cysteine	C9

Here , we show that at noncytotoxic concentrations , H ( 2 ) S was able to inhibit NO production and inducible NO synthase ( iNOS ) expression via heme oxygenase ( HO - 1 ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide ( LPS ) .
【GOLD_E】
H(2)S	chem
NO	chem
NO	chem
inducibleNOsynthase	geneY
iNOS	geneY
hemeoxygenase	geneN
HO-1	geneY
【PRE_E】
H(2)S	chem
NO	chem
inducibleNOsynthase	geneY
iNOS	geneY
hemeoxygenase	geneN
HO-1	geneY
【GOLD_R】
H(2)S	inducibleNOsynthase	C4
H(2)S	iNOS	C4
NO	inducibleNOsynthase	C9
NO	iNOS	C9
【PRE_R】
H(2)S	iNOS	C4
H(2)S	HO-1	C4

Both H ( 2 ) S solution prepared by bubbling pure H ( 2 ) S gas and NaSH , a H ( 2 ) S donor , dose dependently induced HO - 1 expression through the activation of the extracellular signal - regulated kinase ( ERK ) .
【GOLD_E】
H(2)S	chem
H(2)S	chem
NaSH	chem
H(2)S	chem
HO-1	geneY
extracellularsignal-regulatedkinase	geneN
ERK	geneN
【PRE_E】
H(2)S	chem
H(2)S	chem
H(2)S	chem
HO-1	geneY
extracellularsignal-regulatedkinase	geneN
ERK	geneN
【GOLD_R】
H(2)S	extracellularsignal-regulatedkinase	C3
H(2)S	ERK	C3
H(2)S	HO-1	C3
【PRE_R】
H(2)S	HO-1	C3
H(2)S	HO-1	C3
H(2)S	HO-1	C3
H(2)S	extracellularsignal-regulatedkinase	C3
H(2)S	ERK	C3

Pretreatment with H ( 2 ) S or NaHS significantly inhibited LPS - induced iNOS expression and NO production .
【GOLD_E】
H(2)S	chem
NaHS	chem
NO	chem
iNOS	geneY
【PRE_E】
H(2)S	chem
NaHS	chem
iNOS	geneY
NO	chem
【GOLD_R】
H(2)S	iNOS	C4
NaHS	iNOS	C4
NO	iNOS	C9
【PRE_R】
H(2)S	iNOS	C4
NaHS	iNOS	C4

Moreover , NO production in LPS - stimulated macrophages that are expressing CSE mRNA was significantly reduced by the addition of L - Cys , a substrate for H ( 2 ) S , but enhanced by the selective CSE inhibitor beta - cyano - L - alanine but not by the CBS inhibitor aminooxyacetic acid .
【GOLD_E】
beta-cyano-L-alanine	chem
NO	chem
L-Cys	chem
H(2)S	chem
CSE	geneY
CBS	geneY
aminooxyaceticacid	chem
CSE	geneY
【PRE_E】
NO	chem
CSE	geneY
L-Cys	chem
H(2)S	chem
CSE	geneY
beta-cyano-L-alanine	chem
CBS	geneY
aminooxyaceticacid	chem
【GOLD_R】
beta-cyano-L-alanine	CSE	C4
aminooxyaceticacid	CBS	C4
L-Cys	CSE	C9
【PRE_R】
L-Cys	CSE	C4
CSE	beta-cyano-L-alanine	C4
beta-cyano-L-alanine	CBS	C4
CBS	aminooxyaceticacid	C4

While either blockage of HO activity by the HO inhibitor , tin protoporphyrin IX , or down - regulation of HO - 1 expression by HO - 1 small interfering RNA ( siRNA ) reversed the inhibitory effects of H ( 2 ) S on iNOS expression and NO production , HO - 1 overexpression produced the same inhibitory effects of H ( 2 ) S .
【GOLD_E】
HO	geneY
HO	geneY
HO-1	geneY
HO-1	geneY
iNOS	geneY
HO-1	geneY
H(2)S	chem
NO	chem
H(2)S	chem
【PRE_E】
HO	geneY
HO	geneY
tinprotoporphyrinIX	chem
HO-1	geneY
HO-1	geneY
H(2)S	chem
iNOS	geneY
NO	chem
HO-1	geneY
H(2)S	chem
【GOLD_R】
H(2)S	iNOS	C4
NO	iNOS	C9
【PRE_R】
HO	tinprotoporphyrinIX	C4
tinprotoporphyrinIX	iNOS	C4

In addition , LPS - induced nuclear factor ( NF ) - kappaB activation was diminished in RAW264.7 macrophages preincubated with H ( 2 ) S .
【GOLD_E】
(NF)-kappaB	geneN
H(2)S	chem
【PRE_E】
nuclearfactor(NF)-kappaB	geneN
H(2)S	chem
【GOLD_R】
H(2)S	(NF)-kappaB	C4
【PRE_R】
nuclearfactor(NF)-kappaB	H(2)S	C3

Interestingly , the inhibitory effect of H ( 2 ) S on NF - kappaB activation was reversed by the transient transfection with HO - 1 siRNA , but was mimicked by either HO - 1 gene transfection or treatment with carbon monoxide ( CO ) , an end product of HO - 1 .
【GOLD_E】
carbonmonoxide	chem
CO	chem
NF-kappaB	geneN
HO-1	geneY
HO-1	geneY
HO-1	geneY
H(2)S	chem
【PRE_E】
H(2)S	chem
NF-kappaB	geneN
HO-1	geneY
HO-1	geneY
carbonmonoxide	chem
HO-1	geneY
【GOLD_R】
H(2)S	NF-kappaB	C4
carbonmonoxide	HO-1	C9
CO	HO-1	C9
【PRE_R】
carbonmonoxide	HO-1	C3

CO treatment also inhibited LPS - induced NO production and iNOS expression via its inactivation of NF - kappaB .
【GOLD_E】
CO	chem
NO	chem
iNOS	geneY
NF-kappaB	geneN
【PRE_E】
NO	chem
iNOS	geneY
NF-kappaB	geneN
【GOLD_R】
CO	iNOS	C4
CO	NF-kappaB	C4
NO	iNOS	C9
【PRE_R】

Collectively , our results suggest that H ( 2 ) S can inhibit NO production and NF - kappaB activation in LPS - stimulated macrophages through a mechanism that involves the action of HO - 1 / CO .
【GOLD_E】
H(2)S	chem
NO	chem
CO	chem
NF-kappaB	geneN
HO-1	geneY
【PRE_E】
H(2)S	chem
NO	chem
NF-kappaB	geneN
HO-1	geneY
【GOLD_R】
H(2)S	NF-kappaB	C4
CO	HO-1	C9
【PRE_R】
H(2)S	NF-kappaB	C4

Effect of chronic renal failure on arginase and argininosuccinate synthetase expression .
【GOLD_E】
argininosuccinate	chem
arginase	geneN
argininosuccinatesynthetase	geneY
【PRE_E】
arginase	geneN
argininosuccinatesynthetase	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : L - arginine ( L - arg ) participates in numerous biological functions including urea and nitric oxide synthesis .
【GOLD_E】
L-arg	chem
urea	chem
nitricoxide	chem
L-arginine	chem
【PRE_E】
L-arginine	chem
L-arg	chem
urea	chem
nitricoxide	chem
【GOLD_R】
【PRE_R】

Sources of L - arg include dietary proteins and endogenous synthesis by argininosuccinate synthetase and argininosuccinate lyase .
【GOLD_E】
argininosuccinate	chem
argininosuccinatesynthetase	geneY
argininosuccinatelyase	geneY
L-arg	chem
argininosuccinate	chem
【PRE_E】
L-arg	geneY
argininosuccinatesynthetase	geneY
argininosuccinatelyase	geneY
【GOLD_R】
L-arg	argininosuccinatesynthetase	C9
L-arg	argininosuccinatelyase	C9
【PRE_R】

L - arg is converted to urea by arginase I in the liver and arginase II in the kidney .
【GOLD_E】
L-arg	chem
urea	chem
arginaseI	geneY
arginaseII	geneY
【PRE_E】
L-arg	chem
urea	chem
arginaseI	geneY
arginaseII	geneY
【GOLD_R】
urea	arginaseI	C9
urea	arginaseII	C9
L-arg	arginaseI	C9
L-arg	arginaseII	C9
【PRE_R】
urea	arginaseI	C9

Normally , the liver fully consumes L - arg for urea generation and does not contribute to its circulating pool .
【GOLD_E】
L-arg	chem
urea	chem
【PRE_E】
L-arg	chem
urea	chem
【GOLD_R】
【PRE_R】

Instead , much of the circulating L - arg is produced by the kidney .
【GOLD_E】
L-arg	chem
【PRE_E】
L-arg	geneY
【GOLD_R】
【PRE_R】

If true , plasma L - arg should be severely reduced in chronic renal failure ( CRF ) ; however , plasma L - arg is frequently unchanged in CRF .
【GOLD_E】
L-arg	chem
L-arg	chem
【PRE_E】
L-arg	geneY
CRF	geneY
L-arg	geneY
CRF	geneY
【GOLD_R】
【PRE_R】

We hypothesized that preservation of plasma L - arg in CRF may be , partly , due to downregulation / inhibition of arginase .
【GOLD_E】
L-arg	chem
arginase	geneN
【PRE_E】
L-arg	geneY
CRF	geneY
arginase	geneN
【GOLD_R】
L-arg	arginase	C9
【PRE_R】

METHODS : Argininosuccinate synthetase , arginase I and II protein abundance and activity were measured in the liver and kidneys of rats 6 weeks after 5 / 6 nephrectomy or sham operation .
【GOLD_E】
Argininosuccinate	chem
Argininosuccinatesynthetase	geneY
arginaseIandII	geneN
【PRE_E】
Argininosuccinatesynthetase	geneY
arginaseIandIIprotein	geneN
【GOLD_R】
【PRE_R】

In addition , arginase activity was measured in the presence of different urea concentrations to simulate azotemia in vitro .
【GOLD_E】
urea	chem
arginase	geneN
【PRE_E】
arginase	geneN
urea	chem
【GOLD_R】
【PRE_R】

RESULTS : Arginases I and II protein abundance as well as arginase activity in the liver , measured in the physiological buffer , were similar among the CRF and control groups .
【GOLD_E】
ArginasesIandII	geneN
arginase	geneN
【PRE_E】
ArginasesIandIIprotein	geneN
arginase	geneN
CRF	geneY
【GOLD_R】
【PRE_R】

However , in vitro experiments simulating a uremic milieu revealed a marked concentration - dependent inhibition of arginase activity by urea in the tissue lysates .
【GOLD_E】
arginase	geneN
urea	chem
【PRE_E】
arginase	geneN
urea	chem
【GOLD_R】
urea	arginase	C4
【PRE_R】
arginase	urea	C4

CRF had no significant effect on argininosuccinate synthetase abundance in the kidney , liver , spleen or intestine .
【GOLD_E】
argininosuccinatesynthetase	geneY
argininosuccinate	chem
【PRE_E】
CRF	geneY
argininosuccinatesynthetase	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS : Although CRF does not change the abundance or intrinsic properties of arginase , the inherent rise in urea concentration inhibits its enzymatic activity .
【GOLD_E】
arginase	geneN
urea	chem
【PRE_E】
CRF	geneY
arginase	geneN
urea	chem
【GOLD_R】
urea	arginase	C4
【PRE_R】

The latter , in turn , attenuates L - arg catabolism and urea production and , thereby , mitigates the fall in plasma L - arg .
【GOLD_E】
L-arg	chem
L-arg	chem
【PRE_E】
urea	chem
L-arg	geneY
【GOLD_R】
【PRE_R】

Epratuzumab , a CD22 - targeting recombinant humanized antibody with a different mode of action from rituximab .
【GOLD_E】
CD22	geneY
【PRE_E】
Epratuzumab	chem
CD22	geneY
【GOLD_R】
【PRE_R】

Epratuzumab is a humanized anti - CD22 monoclonal antibody currently in clinical trials for treatment of non - Hodgkin lymphoma ( NHL ) and certain autoimmune diseases .
【GOLD_E】
CD22	geneY
【PRE_E】
Epratuzumab	chem
CD22	geneY
【GOLD_R】
【PRE_R】

Here we report the results of investigations of epratuzumab 's mode of action in comparison to and in combination with the anti - CD20 mAb , rituximab .
【GOLD_E】
CD20	geneY
【PRE_E】
CD20	geneY
【GOLD_R】
【PRE_R】

In vitro cell growth inhibition , induction of apoptosis , and the ability of the mAbs to mediate complement - dependent cytotoxicity ( CDC ) and antibody - dependent cellular cytotoxicity ( ADCC ) were evaluated .
【GOLD_E】
complement	geneN
【PRE_E】
mAbs	geneN
CDC	geneN
ADCC	geneN
【GOLD_R】
【PRE_R】

We also investigated the potential activity of epratuzumab in the regulation of B - cell antigen receptor ( BCR ) activation .
【GOLD_E】
B-cellantigenreceptor	geneN
BCR	geneN
【PRE_E】
epratuzumab	chem
B-cellantigenreceptor	geneY
BCR	geneY
【GOLD_R】
【PRE_R】
epratuzumab	BCR	C4

Epratuzumab and rituximab displayed very distinct modes of action ; epratuzumab acts as an immunomodulatory agent , while rituximab is an acutely cytotoxic therapeutic antibody .
【GOLD_E】
【PRE_E】
Epratuzumab	chem
epratuzumab	chem
【GOLD_R】
【PRE_R】

Epratuzumab has distinct effects on cell growth from rituximab .
【GOLD_E】
【PRE_E】
Epratuzumab	chem
【GOLD_R】
【PRE_R】

For example , rituximab + anti - human IgG Fcgamma yielded marked inhibition of proliferation in human NHL cell lines , while epratuzumab had little or no effect in this assay .
【GOLD_E】
IgGFcgamma	geneN
【PRE_E】
humanIgGFcgamma	geneN
epratuzumab	chem
【GOLD_R】
【PRE_R】

However , when cells were immobilized and stimulated with anti - IgM , epratuzumab , but not rituximab , caused a significant antiproliferative effect .
【GOLD_E】
IgM	geneN
【PRE_E】
IgM	geneN
epratuzumab	chem
【GOLD_R】
【PRE_R】

Unlike rituximab , no CDC could be detected , and ADCC was modest but significant with epratuzumab .
【GOLD_E】
【PRE_E】
ADCC	geneN
epratuzumab	chem
【GOLD_R】
【PRE_R】

Importantly , combining rituximab and epratuzumab did not decrease rituximab 's ability to induce apoptosis , CDC , and ADCC .
【GOLD_E】
【PRE_E】
epratuzumab	chem
ADCC	geneN
【GOLD_R】
【PRE_R】

In fact , the combination is more effective than rituximab alone in inhibiting proliferation of Daudi Burkitt lymphoma cells in the presence of second antibody , and at least equally effective to rituximab in the absence of crosslinking .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These observations suggest that it may be possible to enhance clinical efficacy by combination therapy comprised of anti - CD20 and anti - CD22 mAbs .
【GOLD_E】
CD20	geneY
CD22	geneY
【PRE_E】
CD20	geneY
CD22	geneY
【GOLD_R】
【PRE_R】

Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia .
【GOLD_E】
Vasopressin	chem
Vasopressin	geneY
【PRE_E】
Vasopressin	geneY
【GOLD_R】
【PRE_R】

Hyponatremia is the most frequent electrolyte disorder encountered in hospitalized patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It is a state of relative water excess due to stimulated arginine vasopressin ( AVP ) and fluid intake greater than obligatory losses .
【GOLD_E】
AVP	chem
argininevasopressin	geneY
AVP	geneY
argininevasopressin	chem
【PRE_E】
argininevasopressin	geneY
AVP	geneY
【GOLD_R】
【PRE_R】

This kind of hyponatremia occurs in the syndrome of inappropriate antidiuretic hormone secretion , congestive heart failure , and liver cirrhosis .
【GOLD_E】
antidiuretichormone	geneY
【PRE_E】
antidiuretichormone	geneY
【GOLD_R】
【PRE_R】

Fluid restriction is the presently recommended treatment for hyponatremia .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , fluid restriction may be very difficult for patients to achieve , is slow to work , and does not allow a graded therapeutic approach .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

More efficient and specific treatments of hyponatremia are needed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this respect , pharmacologic research has yielded a number of compounds exhibiting antagonistic qualities at the vasopressin V2 receptor .
【GOLD_E】
vasopressin	chem
vasopressinV2receptor	geneY
【PRE_E】
vasopressinV2receptor	geneY
【GOLD_R】
【PRE_R】

Among these agents , peptidic derivatives of AVP turned out to have intrinsic antidiuretic properties in vivo when given over days or weeks .
【GOLD_E】
AVP	chem
AVP	geneY
【PRE_E】
AVP	geneY
【GOLD_R】
【PRE_R】

The development of such agents for use in patients has not been pursued .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , several promising nonpeptide , vasopressin receptor antagonists have been described ; these agents are VPA - 985 ( lixivaptan ) , YM - 087 ( conivaptan ) , OPC - 41061 ( tolvaptan ) , and SR - 121463 .
【GOLD_E】
vasopressinreceptor	geneN
VPA-985	chem
lixivaptan	chem
YM-087	chem
conivaptan	chem
OPC-41061	chem
tolvaptan	chem
SR-121463	chem
【PRE_E】
vasopressinreceptor	geneY
VPA-985	chem
lixivaptan	chem
YM-087	chem
conivaptan	chem
OPC-41061	chem
tolvaptan	chem
SR-121463	chem
【GOLD_R】
VPA-985	vasopressinreceptor	C6
lixivaptan	vasopressinreceptor	C6
YM-087	vasopressinreceptor	C6
conivaptan	vasopressinreceptor	C6
OPC-41061	vasopressinreceptor	C6
tolvaptan	vasopressinreceptor	C6
SR-121463	vasopressinreceptor	C6
【PRE_R】

Prospective , randomized , placebo - controlled trials performed with these agents found that they corrected hyponatremia efficiently and safely .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Most of the studies were conducted over a 4 - to 28 - day period .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Long - term studies will be needed in the future to address such issues as the eventual benefit to patients and the effects of vasopressin antagonists on morbidity and mortality of patients with hyponatremia .
【GOLD_E】
vasopressin	chem
【PRE_E】
vasopressin	geneY
【GOLD_R】
【PRE_R】

Sedation and histamine H1 - receptor antagonism : studies in man with the enantiomers of chlorpheniramine and dimethindene .
【GOLD_E】
dimethindene	chem
histamine	chem
chlorpheniramine	chem
histamineH1-receptor	geneY
【PRE_E】
histamineH1-receptor	geneY
chlorpheniramine	chem
dimethindene	chem
【GOLD_R】
dimethindene	histamineH1-receptor	C6
chlorpheniramine	histamineH1-receptor	C6
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effects of 10 mg ( + ) - and ( - ) - chlorpheniramine and 5 mg ( + ) - and ( - ) - dimethindene on daytime sleep latencies , digit symbol substitution and subjective assessments of mood and well - being were studied in 6 healthy young adult humans .
【GOLD_E】
(+)-and(-)-chlorpheniramine	chem
(+)-and(-)-dimethindene	chem
【PRE_E】
(+)-and(-)-chlorpheniramine	chem
5mg(+)-and(-)-dimethindene	chem
【GOLD_R】
【PRE_R】

Each subject also took 5 mg triprolidine hydrochloride as an active control and two placebos .
【GOLD_E】
triprolidinehydrochloride	chem
【PRE_E】
triprolidinehydrochloride	chem
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Daytime sleep latencies were reduced with triprolidine , ( + ) - chlorpheniramine and ( - ) - dimethindene , and subjects also reported that they felt more sleepy after ( + ) - chlorpheniramine and ( - ) - dimethindene .
【GOLD_E】
triprolidine	chem
(+)-chlorpheniramine	chem
(-)-dimethindene	chem
(+)-chlorpheniramine	chem
(-)-dimethindene	chem
【PRE_E】
triprolidine	chem
(+)-chlorpheniramine	chem
(-)-dimethindene	chem
(+)-chlorpheniramine	chem
(-)-dimethindene	chem
【GOLD_R】
【PRE_R】

Performance on digit symbol substitution was impaired with ( + ) - chlorpheniramine .
【GOLD_E】
(+)-chlorpheniramine	chem
【PRE_E】
(+)-chlorpheniramine	chem
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Changes in measures with ( - ) - chlorpheniramine and ( + ) - dimethindene were not different from changes with placebo .
【GOLD_E】
(-)-chlorpheniramine	chem
(+)-dimethindene	chem
【PRE_E】
(-)-chlorpheniramine	chem
(+)-dimethindene	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present study , changes in measures of drowsiness and performance were limited to the enantiomers with high affinity for the histamine H1 - receptor .
【GOLD_E】
histamine	chem
histamineH1-receptor	geneY
【PRE_E】
histamineH1-receptor	geneY
【GOLD_R】
【PRE_R】

These findings strongly suggest that sedation can arise from H1 - receptor antagonism alone , and provide further support for the belief that the histaminergic system is concerned with the regulation of alertness in man .
【GOLD_E】
H1-receptor	geneY
【PRE_E】
H1-receptor	geneY
【GOLD_R】
【PRE_R】

Anti - clastogenic effect of beta - glucan extracted from barley towards chemically induced DNA damage in rodent cells .
【GOLD_E】
【PRE_E】
beta-glucan	chem
【GOLD_R】
【PRE_R】

beta - Glucan ( BG ) was tested in vitro to determine its potential clastogenic and / or anti - clastogenic activity , and attempts were made to elucidate its possible mechanism of action by using combinations with an inhibitor of DNA polymerase .
【GOLD_E】
DNApolymerase	geneN
【PRE_E】
beta-Glucan	chem
BG	chem
DNApolymerase	geneN
【GOLD_R】
【PRE_R】
beta-Glucan	DNApolymerase	C4
BG	DNApolymerase	C4

The study was carried out on cells deficient ( CHO - k1 ) and cells proficient ( HTC ) in phases I and II enzymes , and the DNA damage was assessed by the chromosomal aberration assay .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

BG did not show a clastogenic effect , but was anti - clastogenic in both cell lines used , and at all concentrations tested ( 2.5 , 5 and 10 microg / mL ) in combination with damage inducing agents ( methylmethane sulfonate in cell line CHO - k1 , and methylmethane sulfonate or 2 - aminoanthracene in cell line HTC ) .
【GOLD_E】
methylmethanesulfonate	chem
methylmethanesulfonate	chem
2-aminoanthracene	chem
【PRE_E】
BG	chem
methylmethanesulfonate	chem
methylmethanesulfonate	chem
2-aminoanthracene	chem
【GOLD_R】
【PRE_R】

BG also showed a protective effect in the presence of a DNA polymerase beta inhibitor ( cytosine arabinoside - 3 - phosphate , Ara - C ) , demonstrating that BG does not act through an anti - mutagenic mechanism of action involving DNA polymerase beta .
【GOLD_E】
cytosinearabinoside-3-phosphate	chem
Ara-C	chem
DNApolymerasebeta	geneY
DNApolymerasebeta	geneY
【PRE_E】
BG	chem
DNApolymerasebeta	geneN
cytosinearabinoside-3-phosphate	chem
Ara-C	chem
BG	chem
DNApolymerasebeta	geneN
【GOLD_R】
cytosinearabinoside-3-phosphate	DNApolymerasebeta	C4
Ara-C	DNApolymerasebeta	C4
【PRE_R】
DNApolymerasebeta	cytosinearabinoside-3-phosphate	C4

Association of DRD2 polymorphisms and chlorpromazine - induced extrapyramidal syndrome in Chinese schizophrenic patients .
【GOLD_E】
DRD2	geneY
chlorpromazine	chem
【PRE_E】
DRD2	geneY
chlorpromazine	chem
【GOLD_R】
【PRE_R】

AIM : Extrapyramidal syndrome ( EPS ) is most commonly affected by typical antipsychotic drugs that have a high affinity with the D2 receptor .
【GOLD_E】
D2receptor	geneY
【PRE_E】
D2receptor	geneY
【GOLD_R】
【PRE_R】

Recently , many research groups have reported on the positive relationship between the genetic variations in the DRD2 gene and the therapeutic response in schizophrenia patients as a result of the role of variations in the receptor in modulating receptor expression .
【GOLD_E】
DRD2	geneY
【PRE_E】
DRD2	geneY
【GOLD_R】
【PRE_R】

In this study , we evaluate the role DRD2 plays in chlorpromazine - induced EPS in schizophrenic patients .
【GOLD_E】
DRD2	geneY
chlorpromazine	chem
【PRE_E】
DRD2	geneY
chlorpromazine	chem
【GOLD_R】
【PRE_R】

METHODS : We identified seven SNP ( single nucleotide polymorphism ) ( - 141Cins > del , TaqIB , TaqID , Ser311Cys , rs6275 , rs6277 and TaqIA ) in the DRD2 gene in 146 schizophrenic inpatients ( 59 with EPS and 87 without EPS according to the Simpson - Angus Scale ) treated with chlorpromazine after 8 weeks .
【GOLD_E】
Ser311Cys	geneN
DRD2	geneY
nucleotide	chem
chlorpromazine	chem
【PRE_E】
SNP	chem
nucleotide	chem
TaqIB	geneY
TaqID	geneY
Ser311Cys	geneY
rs6275	geneY
rs6277	geneY
TaqIA	geneY
DRD2	geneY
chlorpromazine	chem
【GOLD_R】
【PRE_R】

The alleles of all loci were determined by PCR ( polymerase chain reaction ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Polymorphisms TaqID , Ser311Cys and rs6277 were not polymorphic in the population recruited in the present study .
【GOLD_E】
Ser311Cys	geneN
【PRE_E】
TaqID	geneY
Ser311Cys	geneY
rs6277	geneY
【GOLD_R】
【PRE_R】

No statistical significance was found in the allele distribution of - 141Cins > del , TaqIB , rs6275 and TaqIA or in the estimated haplotypes ( constituted by TaqIB , rs6275 and TaqIA ) in linkage disequilibrium between the two groups .
【GOLD_E】
【PRE_E】
141Cins	geneY
TaqIB	geneY
rs6275	geneY
TaqIA	geneY
TaqIB	geneY
rs6275	geneY
TaqIA	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : Our results did not lend strong support to the view that the genetic variation of the DRD2 gene plays a major role in the individually variable adverse effect induced by chlorpromazine , at least in Chinese patients with schizophrenia .
【GOLD_E】
chlorpromazine	chem
DRD2	geneY
【PRE_E】
DRD2	geneY
chlorpromazine	chem
【GOLD_R】
【PRE_R】

Our results confirmed a previous study on the relationship between DRD2 and EPS in Caucasians .
【GOLD_E】
DRD2	geneY
【PRE_E】
DRD2	geneY
EPS	geneY
【GOLD_R】
【PRE_R】

Activity - dependent cleavage of brain glutamic acid decarboxylase 65 by calpain .
【GOLD_E】
glutamicacid	chem
glutamicaciddecarboxylase65	geneY
calpain	geneN
【PRE_E】
brainglutamicaciddecarboxylase65	geneY
calpain	geneN
【GOLD_R】
【PRE_R】

Previously , we reported that l - glutamic acid decarboxylase isoform 65 ( GAD65 ) could be cleaved in vitro to release a stable truncated form which lacks amino acid 1 - 69 from the N - terminus , GAD65 ( Delta1 - 69 ) .
【GOLD_E】
GAD65(Delta1-69)	geneY
l-glutamicaciddecarboxylaseisoform65	geneY
aminoacid	chem
GAD65	geneY
N	chem
l-glutamicacid	chem
【PRE_E】
l-glutamicaciddecarboxylaseisoform65	geneY
GAD65	geneY
aminoacid	chem
N	chem
GAD65	geneY
Delta1-69	geneY
【GOLD_R】
【PRE_R】

However , whether such a truncated form is also present under certain physiological conditions remains elusive .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present study , we showed that , upon sustained neuronal stimulation , GAD65 could be cleaved into a truncated form in a rat synaptosomal preparation .
【GOLD_E】
GAD65	geneY
【PRE_E】
GAD65	geneY
【GOLD_R】
【PRE_R】

This truncated form had similar electrophoretic mobility to purified recombinant human GAD65 ( Delta1 - 69 ) .
【GOLD_E】
humanGAD65(Delta1-69	geneY
【PRE_E】
humanGAD65	geneY
Delta1-69	geneY
【GOLD_R】
【PRE_R】

Furthermore , we demonstrated that this conversion was calcium dependent .
【GOLD_E】
calcium	chem
【PRE_E】
calcium	chem
【GOLD_R】
【PRE_R】

Calcium - chelating reagents such as EDTA and 1,2 - bis - ( o - aminphenoxy ) - ethane - N , N , N ' , N ' - tetra - acetic acid tetra - acetoxy - methyl ester prevented the cleavage of GAD65 .
【GOLD_E】
GAD65	geneY
Calcium	chem
EDTA	chem
1,2-bis-(o-aminphenoxy)-ethane-N,N,N',N'-tetra-aceticacidtetra-acetoxy-methylester	chem
【PRE_E】
Calcium	chem
EDTA	chem
1,2-bis-(o-aminphenoxy)-ethane-N,N,N',N'-tetra-aceticacidtetra-acetoxy-methylester	chem
GAD65	geneY
【GOLD_R】
【PRE_R】

In addition , our data suggested that calpain , a calcium - dependent cysteine protease , is activated upon neuronal stimulation and could be responsible for the conversion of full - length GAD65 to truncated GAD65 in the brain .
【GOLD_E】
GAD65	geneY
calpain	geneN
calcium-dependentcysteineprotease	geneN
GAD65	geneY
calcium	chem
cysteine	chem
【PRE_E】
calpain	geneN
calcium-dependentcysteineprotease	geneN
GAD65	geneY
GAD65	geneY
【GOLD_R】
【PRE_R】

Moreover , calpain inhibitors such as calpain inhibitor I or calpastatin could block the cleavage .
【GOLD_E】
calpain	geneN
calpastatin	geneY
【PRE_E】
calpain	geneN
calpain	geneN
calpastatin	geneN
【GOLD_R】
【PRE_R】

Results of our in vitro cleavage assay using purified calpain and immunopurified rat GAD65 also supported the idea that GAD65 could be directly cleaved by calpain .
【GOLD_E】
calpain	geneN
ratGAD65	geneY
GAD65	geneY
calpain	geneN
【PRE_E】
calpain	geneN
immunopurifiedratGAD65	geneY
GAD65	geneY
calpain	geneN
【GOLD_R】
【PRE_R】

Therapeutic targets in melanoma : map kinase pathway .
【GOLD_E】
mapkinase	geneN
【PRE_E】
mapkinase	geneN
【GOLD_R】
【PRE_R】

Recent progress in our understanding of the genetic alterations that occur in the pathogenesis of melanoma provides exciting opportunities for therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most important signaling pathways in melanoma lie downstream of NRAS : the RAS - BRAF - MAPK pathway .
【GOLD_E】
NRAS	geneY
RAS	geneN
BRAF	geneY
MAPK	geneN
【PRE_E】
NRAS	geneY
RAS	geneN
BRAF	geneY
MAPK	geneN
【GOLD_R】
【PRE_R】

A great deal of attention has been focused on the high mutation rate in the BRAF oncogene , which approaches 60 % , because BRAF itself is an appealing drug substrate and because of the central contribution of BRAF function to melanoma development that the mutation rate signifies .
【GOLD_E】
BRAF	geneY
BRAF	geneY
BRAF	geneY
【PRE_E】
BRAF	geneY
BRAF	geneY
BRAF	geneY
【GOLD_R】
【PRE_R】

Agents that specifically target BRAF , such as sorafenib , as well as new molecules that function both upstream and downstream of BRAF , are being actively investigated .
【GOLD_E】
BRAF	geneY
sorafenib	chem
BRAF	geneY
【PRE_E】
BRAF	geneY
sorafenib	chem
BRAF	geneY
【GOLD_R】
【PRE_R】
BRAF	sorafenib	C4
sorafenib	BRAF	C4

Reduction of cerebral infarct size by the AT1 - receptor blocker candesartan , the HMG - CoA reductase inhibitor rosuvastatin and their combination . An experimental study in rats .
【GOLD_E】
rosuvastatin	chem
candesartan	chem
HMG-CoA	chem
AT1	geneN
HMG-CoAreductase	geneY
【PRE_E】
AT1-receptor	geneY
candesartan	chem
HMG-CoAreductase	geneY
rosuvastatin	chem
【GOLD_R】
rosuvastatin	HMG-CoAreductase	C4
candesartan	AT1	C4
【PRE_R】

Our purpose was to test the impact of single and / or combined treatment with the AT ( 1 ) - receptor blocker candesartan and the HMG - CoA reductase inhibitor rosuvastatin on infarct size and neuroscore in transient cerebral ischemia in rats .
【GOLD_E】
candesartan	chem
HMG-CoAreductase	geneY
AT(1)	geneN
HMG-CoA	chem
rosuvastatin	chem
【PRE_E】
AT(1)-receptor	geneY
candesartan	chem
HMG-CoAreductase	geneY
rosuvastatin	chem
【GOLD_R】
candesartan	AT(1)	C4
rosuvastatin	HMG-CoAreductase	C4
【PRE_R】

L - NAME was used to test whether any potential effect was due to activation of endothelial nitric oxide synthase ( eNOS ) .
【GOLD_E】
L-NAME	chem
nitricoxide	chem
endothelialnitricoxidesynthase	geneY
eNOS	geneY
【PRE_E】
L-NAME	chem
endothelialnitricoxidesynthase	geneY
eNOS	geneY
【GOLD_R】
【PRE_R】

Therefore , the middle cerebral artery was occluded for 1 h ( MCAO ) followed by 7 days reperfusion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rats received candesartan 2h before and daily after MCAO ( pretreatment ) or daily after MCAO ( posttreatment ) ; rosuvastatin was given daily for 7 days before MCAO without or with candesartan pre - and posttreatment .
【GOLD_E】
candesartan	chem
rosuvastatin	chem
candesartan	chem
【PRE_E】
candesartan2h	chem
MCAO	chem
MCAO	chem
rosuvastatin	chem
MCAO	chem
candesartan	chem
【GOLD_R】
【PRE_R】

In addition , candesartan and rosuvastatin were combined with L - NAME .
【GOLD_E】
candesartan	chem
rosuvastatin	chem
L-NAME	chem
【PRE_E】
candesartan	chem
rosuvastatin	chem
L-NAME	chem
【GOLD_R】
【PRE_R】

Infarct size and neuroscore at day 7 were compared to those of controls .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As result , compared to controls ( 109 + / - 12 mm ( 3 ) ) infarct size with candesartan ( pretreatment : 21 + / - 5 mm ( 3 ) ; posttreatment : 68 + / - 29 mm ( 3 ) ; P < 0.05 ) or rosuvastatin ( 69 + / - 14 mm ( 3 ) ; P < 0.05 ) was smaller .
【GOLD_E】
candesartan	chem
rosuvastatin	chem
【PRE_E】
candesartan	chem
rosuvastatin	chem
【GOLD_R】
【PRE_R】

Combined treatment also reduced infarct size ( pretreatment : 37 + / - 15 mm ( 3 ) ; posttreatment 57 + / - 20mm ( 3 ) ; P < 0.05 ) ; but there was no benefit of combined treatment over candesartan pretreatment alone .
【GOLD_E】
candesartan	chem
【PRE_E】
candesartan	chem
【GOLD_R】
【PRE_R】

Compared to controls ( 2.08 + / - 0.28 ) only candesartan pretreatment and combined treatment improved the neuroscore ( 0.97 + / - 0.05 , 1.10 + / - 0.33 ; P < 0.05 ) .
【GOLD_E】
candesartan	chem
【PRE_E】
candesartan	chem
【GOLD_R】
【PRE_R】

L - NAME abolished the reduction in infarct size and improvement in neuroscore .
【GOLD_E】
L-NAME	chem
【PRE_E】
L-NAME	chem
【GOLD_R】
【PRE_R】

In conclusion , both , candesartan or rosuvastatin treatment alone reduced infarct size in transient cerebral ischemia , and the best result was achieved with candesartan pretreatment .
【GOLD_E】
candesartan	chem
rosuvastatin	chem
candesartan	chem
【PRE_E】
candesartan	chem
rosuvastatin	chem
candesartan	chem
【GOLD_R】
【PRE_R】

Combined treatment was superior to rosuvastatin alone , but not to candesartan .
【GOLD_E】
rosuvastatin	chem
candesartan	chem
【PRE_E】
rosuvastatin	chem
candesartan	chem
【GOLD_R】
【PRE_R】

The therapeutic benefit of both agents was at least in parts mediated by eNOS - activation .
【GOLD_E】
eNOS	geneY
【PRE_E】
eNOS	geneY
【GOLD_R】
【PRE_R】

ABCA12 is the major harlequin ichthyosis gene .
【GOLD_E】
ABCA12	geneY
【PRE_E】
ABCA12	geneY
【GOLD_R】
【PRE_R】

Harlequin ichthyosis ( HI ) is the most severe form of autosomal - recessive , congenital ichthyosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Affected infants have markedly impaired barrier function and are more susceptible to infection .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Abnormalities in the localization of epidermal lipids as well as abnormal lamellar granule formation are features of HI skin .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Previously , we and others have shown that mutations in the ABCA12 gene encoding an adenosine triphosphate - binding cassette ( ABC ) transporter underlie the skin disease HI .
【GOLD_E】
adenosinetriphosphate	chem
ABCA12	geneY
adenosinetriphosphate-bindingcassette(ABC)transporter	geneN
【PRE_E】
ABCA12	geneY
adenosinetriphosphate-bindingcassette(ABC)transporter	geneY
【GOLD_R】
【PRE_R】

In this study , we have sequenced the ABCA12 gene in an additional 14 patients and show that all contain mutations , with the majority being either nonsense substitution or frameshift mutations .
【GOLD_E】
ABCA12	geneY
【PRE_E】
ABCA12	geneY
【GOLD_R】
【PRE_R】

Eleven HI patients had bi - allelic ABCA12 mutations , whereas in the remaining three HI patients in this study , ABCA12 mutations were detected on only one allele by sequencing .
【GOLD_E】
ABCA12	geneY
ABCA12	geneY
【PRE_E】
bi	geneY
ABCA12	geneY
ABCA12	geneY
【GOLD_R】
【PRE_R】

In addition , the one patient from the previous study where no sequence mutations were detected was screened for heterozygous deletions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A combination of oligonucleotide arrays , multiplex PCR analysis and single - nucleotide polymorphism genotyping revealed a heterozygous intragenic deletion in exon 8 .
【GOLD_E】
nucleotide	chem
【PRE_E】
nucleotide	chem
【GOLD_R】
【PRE_R】

These mutation data establish ABCA12 as the major HI gene .
【GOLD_E】
ABCA12	geneY
【PRE_E】
ABCA12	geneY
【GOLD_R】
【PRE_R】

Phosphorylation and up - regulation of diacylglycerol kinase gamma via its interaction with protein kinase C gamma .
【GOLD_E】
diacylglycerol	chem
diacylglycerolkinasegamma	geneY
proteinkinaseCgamma	geneY
【PRE_E】
diacylglycerolkinasegamma	geneY
proteinkinaseCgamma	geneY
【GOLD_R】
【PRE_R】

Diacylglycerol ( DAG ) acts as an allosteric activator of protein kinase C ( PKC ) and is converted to phosphatidic acid by DAG kinase ( DGK ) .
【GOLD_E】
phosphatidicacid	chem
DAGkinase	geneN
Diacylglycerol	chem
DGK	geneN
proteinkinaseC	geneN
DAG	chem
PKC	geneN
【PRE_E】
Diacylglycerol	chem
DAG	chem
proteinkinaseC	geneN
PKC	geneN
phosphatidicacid	chem
DAGkinase	geneN
DGK	geneN
【GOLD_R】
phosphatidicacid	DAGkinase	C9
phosphatidicacid	DGK	C9
Diacylglycerol	DAGkinase	C9
Diacylglycerol	DGK	C9
DAG	DAGkinase	C9
DAG	DGK	C9
【PRE_R】
DAG	DGK	C9
phosphatidicacid	DGK	C9

Therefore , DGK is thought to be a negative regulator of PKC activation .
【GOLD_E】
DGK	geneN
PKC	geneN
【PRE_E】
DGK	geneN
PKC	geneN
【GOLD_R】
【PRE_R】

Here we show molecular mechanisms of functional coupling of the two kinases . gammaPKC directly associated with DGKgamma through its accessory domain ( AD ) , depending on Ca2 + as well as phosphatidylserine / diolein in vitro .
【GOLD_E】
kinases	geneN
gammaPKC	geneY
DGKgamma	geneY
Ca2+	chem
phosphatidylserine	chem
diolein	chem
【PRE_E】
kinases	geneN
gammaPKC	geneY
DGKgamma	geneY
Ca2+	chem
phosphatidylserine	chem
diolein	chem
【GOLD_R】
【PRE_R】

Mass spectrometric analysis and mutation studies revealed that gammaPKC phosphorylated Ser - 776 and Ser - 779 in the AD of DGKgamma .
【GOLD_E】
gammaPKC	geneY
DGKgamma	geneY
phosphorylatedSer	chem
Ser	chem
【PRE_E】
gammaPKC	geneY
Ser-776	chem
Ser	chem
DGKgamma	geneY
【GOLD_R】
【PRE_R】

The phosphorylation by gammaPKC resulted in activation of DGKgamma because a DGKgamma mutant in which Ser - 776 and Ser - 779 were substituted with glutamic acid to mimic phosphorylation exhibited significantly higher activity compared with wild type DGKgamma and an unphosphorylatable DGKgamma mutant .
【GOLD_E】
glutamicacid	chem
gammaPKC	geneY
DGKgamma	geneY
DGKgamma	geneY
DGKgamma	geneY
DGKgamma	geneY
Ser	chem
Ser	chem
【PRE_E】
gammaPKC	geneY
DGKgamma	geneY
DGKgamma	geneY
Ser-776	chem
Ser-779	chem
glutamicacid	chem
DGKgamma	geneY
unphosphorylatable	geneY
DGKgamma	geneN
【GOLD_R】
【PRE_R】
gammaPKC	Ser-776	C3
DGKgamma	Ser-776	C3
DGKgamma	Ser-776	C3
DGKgamma	Ser-779	C3
DGKgamma	glutamicacid	C3

Importantly , the interaction of the two kinases and the phosphorylation of DGKgamma by gammaPKC could be confirmed in vivo , and overexpression of the AD of DGKgamma inhibited re - translocation of gammaPKC .
【GOLD_E】
DGKgamma	geneY
gammaPKC	geneY
kinases	geneN
DGKgamma	geneY
gammaPKC	geneY
【PRE_E】
kinases	geneN
DGKgamma	geneY
gammaPKC	geneY
DGKgamma	geneY
gammaPKC	geneY
【GOLD_R】
【PRE_R】

These results demonstrate that localization and activation of the functionally correlated kinases , gammaPKC and DGKgamma , are spatio - temporally orchestrated by their direct association and phosphorylation , contributing to subtype - specific regulation of DGKgamma and DAG signaling .
【GOLD_E】
kinases	geneN
gammaPKC	geneY
DGKgamma	geneY
DGKgamma	geneY
【PRE_E】
kinases	geneN
gammaPKC	geneY
DGKgamma	geneY
DGKgamma	geneY
DAG	geneN
【GOLD_R】
【PRE_R】

Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody .
【GOLD_E】
phosphorylatedacetylcholinesterase	geneY
【PRE_E】
phosphorylatedacetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Monoclonal antibody 25B1 generated against diisopropyl phosphorofluoridate inhibited fetal bovine serum acetylcholinesterase has been extensively characterized with respect to its anticholinesterase properties .
【GOLD_E】
anticholinesterase	geneY
bovineserumacetylcholinesterase	geneY
diisopropylphosphorofluoridate	chem
【PRE_E】
diisopropylphosphorofluoridate	chem
fetalbovineserumacetylcholinesterase	geneY
【GOLD_R】
diisopropylphosphorofluoridate	bovineserumacetylcholinesterase	C4
【PRE_R】
diisopropylphosphorofluoridate	fetalbovineserumacetylcholinesterase	C4

This antibody demonstrated considerably different properties from previously reported inhibitory antibodies raised against acetylcholinesterase in terms of the degree of inhibition ( greater than 98 % ) , the high degree of specificity , and the stability of the antigen - antibody complex .
【GOLD_E】
acetylcholinesterase	geneY
【PRE_E】
acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Monoclonal antibody 25B1 appears to be directed against a conformational epitope located in close proximity to the catalytic center of the enzyme and was found to be most suitable for studying the stabilization of the active site of acetylcholinesterase against denaturation by heat or guanidine following phosphorylation by organophosphorus anticholinesterase compounds .
【GOLD_E】
acetylcholinesterase	geneY
anticholinesterase	geneY
guanidine	chem
【PRE_E】
25B1	geneN
acetylcholinesterase	geneY
guanidine	chem
organophosphorus	chem
【GOLD_R】
guanidine	acetylcholinesterase	C4
【PRE_R】

This approach allowed the determination of stability rank order of various phosphorylated acetylcholinesterases .
【GOLD_E】
phosphorylatedacetylcholinesterases	geneN
【PRE_E】
phosphorylatedacetylcholinesterases	geneN
【GOLD_R】
【PRE_R】

Among all the organophosphates tested , the combination of a methyl group and a negatively charged oxygen attached to the P atom , CH3P ( O ) ( O - ) - AChE , conferred the greatest protection to the active site of aged or nonaged organophosphoryl conjugates of acetylcholinesterase .
【GOLD_E】
oxygen	chem
P	chem
CH3P(O)(O-)	chem
organophosphoryl	chem
organophosphates	chem
AChE	geneY
acetylcholinesterase	geneY
【PRE_E】
organophosphates	chem
methyl	chem
oxygen	chem
Patom,CH3P(O)	geneN
O-)-AChE	geneY
organophosphoryl	chem
acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation - induced micronuclei in human lymphocytes .
【GOLD_E】
folicacid	chem
MTHFR	geneY
C677T	geneN
【PRE_E】
folicacid	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

Folic acid plays a key role in the maintenance of genomic stability , providing methyl groups for the conversion of uracil to thymine and for DNA methylation .
【GOLD_E】
Folicacid	chem
uracil	chem
thymine	chem
【PRE_E】
Folicacid	chem
methyl	chem
uracil	chem
thymine	chem
【GOLD_R】
【PRE_R】

Besides dietary habits , folic acid metabolism is influenced by genetic polymorphism .
【GOLD_E】
folicacid	chem
【PRE_E】
folicacid	chem
【GOLD_R】
【PRE_R】

The C677T polymorphism of the methylene - tetrahydrofolate reductase ( MTHFR ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on folate status .
【GOLD_E】
methylene-tetrahydrofolate	chem
folate	chem
C677T	geneN
methylene-tetrahydrofolatereductase	geneY
MTHFR	geneY
【PRE_E】
C677T	geneY
methylene-tetrahydrofolatereductase	geneY
MTHFR	geneY
folate	chem
【GOLD_R】
【PRE_R】

In this work the effect of folic acid deficiency on genome stability and radiosensitivity has been investigated in cultured lymphocytes of 12 subjects with different MTHFR genotype ( four for each genotype ) .
【GOLD_E】
folicacid	chem
MTHFR	geneY
【PRE_E】
folicacid	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

Cells were grown for 9 days with 12 , 24 and 120 nM folic acid and analyzed in a comprehensive micronucleus test coupled with centromere characterization by CREST immunostaining .
【GOLD_E】
folicacid	chem
【PRE_E】
folicacid	chem
CREST	geneY
【GOLD_R】
【PRE_R】

In other experiments , cells were grown with various folic acid concentrations , irradiated with 0.5 Gy of gamma rays and analyzed in the micronucleus test .
【GOLD_E】
folicacid	chem
【PRE_E】
folicacid	chem
【GOLD_R】
【PRE_R】

The results obtained indicate that folic acid deficiency induces to a comparable extent chromosome loss and breakage , irrespective of the MTHFR genotype .
【GOLD_E】
MTHFR	geneY
folicacid	chem
【PRE_E】
folicacid	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

The effect of folic acid was highly significant ( P < 0.001 ) and explained > 50 % of variance of both types of micronuclei .
【GOLD_E】
folicacid	chem
【PRE_E】
folicacid	chem
【GOLD_R】
【PRE_R】

Also nucleoplasmic bridges and buds were significantly increased under low folate supply ; the increase in bridges was mainly observed in TT cells , highlighting a significant effect of the MTHFR genotype ( P = 0.006 ) on this biomarker .
【GOLD_E】
MTHFR	geneY
folate	chem
【PRE_E】
folate	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

Folic acid concentration significantly affected radiation - induced micronuclei ( P < 0.001 ) : the increased incidence of radiation - induced micronuclei with low folic acid was mainly accounted for by carriers of the variant MTHFR allele ( both homozygotes and heterozygotes ) , but the overall effect of genotype did not attain statistical significance .
【GOLD_E】
MTHFR	geneY
Folicacid	chem
folicacid	chem
【PRE_E】
Folicacid	chem
folicacid	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

Treatment with ionizing radiations also increased the frequency of nucleoplasmic bridges .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effect of folic acid level on this end - point was modulated by the MTHFR genotype ( P for interaction = 0.02 ) , with TT cells grown at low folic acid concentration apparently resistant to the induction of radiation - induced bridges .
【GOLD_E】
folicacid	chem
folicacid	chem
MTHFR	geneY
【PRE_E】
folicacid	chem
MTHFR	geneY
folicacid	chem
【GOLD_R】
【PRE_R】

Finally , the effect of in vitro folate deprivation on global DNA methylation was evaluated in lymphocytes of six homozygous subjects ( three CC and three TT ) .
【GOLD_E】
folate	chem
【PRE_E】
folate	chem
CC	geneY
【GOLD_R】
【PRE_R】

The results obtained suggest that , under the conditions of this work , folic acid deprivation is associated with global DNA hypermethylation .
【GOLD_E】
folicacid	chem
【PRE_E】
folicacid	chem
【GOLD_R】
【PRE_R】

Antifungal agents : mode of action in yeast cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Different kinds of mycoses , especially invasive , have become an important public health problem as their incidence has increased dramatically in the last decades in relation to AIDS , hematological malignancies , transplant recipients and other immunosuppressed individuals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Management of fungal infections is markedly limited by problems of drug safety , resistance and effectiveness profile .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Current therapy for invasive mycoses uses a relatively reduced number of antifungal drugs , such as amphotericin B , fluconazole and itraconazole .
【GOLD_E】
amphotericinB	chem
fluconazole	chem
itraconazole	chem
【PRE_E】
amphotericinB	chem
fluconazole	chem
itraconazole	chem
【GOLD_R】
【PRE_R】

Other new antifungal agents from old and new chemical families , like voriconazole , posaconazole , ravuconazole , caspofungin and micafungin , have been introduced into the armamentarium for fungal infections management .
【GOLD_E】
voriconazole	chem
posaconazole	chem
ravuconazole	chem
caspofungin	chem
micafungin	chem
【PRE_E】
voriconazole	chem
posaconazole	chem
ravuconazole	chem
caspofungin	chem
micafungin	chem
【GOLD_R】
【PRE_R】

This review is focused on the mode of action of those antifungal drugs used against pathogenic yeasts .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The interaction of amphotericin B with ergosterol and other membrane sterols results in the production of aqueous pores of drug and the ergosterol biosynthetic pathway is the target of the allylamines , phenylmorpholines and azole antifungal agents .
【GOLD_E】
allylamines	chem
phenylmorpholines	chem
amphotericinB	chem
ergosterol	chem
sterols	chem
ergosterol	chem
azole	chem
【PRE_E】
amphotericinB	chem
ergosterol	chem
sterols	chem
ergosterol	chem
allylamines	chem
phenylmorpholines	chem
azole	chem
【GOLD_R】
【PRE_R】

The main molecular target of azole antifungals is the cytochrome P - 450 protein Erg11p / Cyp51p .
【GOLD_E】
cytochromeP-450	geneN
Erg11p	geneN
Cyp51p	geneN
azole	chem
【PRE_E】
azole	chem
cytochromeP-450	geneY
Erg11p	geneY
Cyp51p	geneY
【GOLD_R】
【PRE_R】

Echinocandins , a new class of antifungal drugs , are fungal secondary metabolites that act against beta - 1 - 3 - D - glucan synthesis .
【GOLD_E】
【PRE_E】
Echinocandins	chem
beta-1-3-D-glucan	chem
【GOLD_R】
【PRE_R】

The phenylmorpholines , of which amorolfine is the sole representative in human therapy , affect two targets in the ergosterol pathway : Erg24p ( delta 14 reductase ) and Erg2p ( delta 8 - delta 7 isomerase ) .
【GOLD_E】
Erg24p	geneN
delta14reductase	geneN
Erg2p	geneN
delta8-delta7isomerase	geneN
phenylmorpholines	chem
amorolfine	chem
【PRE_E】
amorolfine	chem
ergosterol	chem
Erg24p(delta14reductase	geneY
Erg2p(delta8-delta7isomerase	geneY
【GOLD_R】
【PRE_R】

The sordarins group are protein synthesis inhibitors that work by blocking the function of fungal translation elongation factor 2 .
【GOLD_E】
fungaltranslationelongationfactor2	geneN
sordarins	chem
【PRE_E】
sordarins	chem
fungaltranslationelongationfactor2	geneY
【GOLD_R】
sordarins	fungaltranslationelongationfactor2	C4
【PRE_R】

Other protein inhibitors are zofimarin , BE31045 , SCH57504 , xylarin , hypoxysordarin and GR135402 .
【GOLD_E】
SCH57504	chem
xylarin	chem
hypoxysordarin	chem
GR135402	chem
zofimarin	chem
BE31045	chem
【PRE_E】
xylarin	chem
hypoxysordarin	chem
【GOLD_R】
【PRE_R】

In order to overcome the problems derived from the exploitation of azole drugs , macrolides and echinocandins , novel targets were explored .
【GOLD_E】
azole	chem
echinocandins	chem
【PRE_E】
azole	chem
macrolides	chem
echinocandins	chem
【GOLD_R】
【PRE_R】

Proposed antifungal drugs have been developed against potential targets like the N - myristylation of fungal proteins , with inhibitors like myristate and histidine analogues or myristoylpeptide derivatives , aminobenzothiazoles , quinolines and benzofurans .
【GOLD_E】
N	chem
myristate	chem
histidine	chem
aminobenzothiazoles	chem
quinolines	chem
benzofurans	chem
【PRE_E】
N-myristylation	geneN
fungalproteins	geneN
myristate	chem
histidine	chem
myristoylpeptide	chem
aminobenzothiazoles	chem
quinolines	chem
benzofurans	chem
【GOLD_R】
【PRE_R】
N-myristylation	benzofurans	C4
fungalproteins	benzofurans	C4

Polymerization of cell wall carbohydrates from uridine di - phospho sugars is another potential target .
【GOLD_E】
uridinedi-phosphosugars	chem
【PRE_E】
carbohydrates	chem
uridinedi-phospho	chem
【GOLD_R】
【PRE_R】

D - myo - inositol 1 - phosphate as a surrogate of D - myo - inositol 1,4,5 - tris phosphate to monitor G protein - coupled receptor activation .
【GOLD_E】
D-myo-inositol1-phosphate	chem
D-myo-inositol1,4,5-trisphosphate	chem
Gprotein-coupledreceptor	geneN
【PRE_E】
D-myo-inositol1-phosphate	chem
D-myo-inositol1,4,5-trisphosphate	chem
Gprotein-coupledreceptor	geneN
【GOLD_R】
【PRE_R】

Phospholipase C beta ( PLC - beta ) - coupled G protein - coupled receptor ( GPCR ) activities traditionally are assessed by measuring Ca2 + triggered by D - myo - inositol 1,4,5 - trisphosphate ( IP3 ) , a PLC - beta hydrolysis product , or by measuring the production of inositol phosphate using cumbersome radioactive assays .
【GOLD_E】
PhospholipaseCbeta	geneN
PLC-beta	geneN
PLC-beta	geneN
Gprotein-coupledreceptor	geneN
Ca2+	chem
GPCR	geneN
D-myo-inositol1,4,5-trisphosphate	chem
IP3	chem
inositolphosphate	chem
【PRE_E】
PhospholipaseCbeta	geneY
PLC-beta	geneN
Gprotein-coupledreceptor	geneN
GPCR	geneN
Ca2+	chem
D-myo-inositol1,4,5-trisphosphate	chem
IP3	geneN
PLC-beta	geneY
inositolphosphate	chem
【GOLD_R】
D-myo-inositol1,4,5-trisphosphate	PLC-beta	C9
IP3	PLC-beta	C9
inositolphosphate	PLC-beta	C9
【PRE_R】
PhospholipaseCbeta	D-myo-inositol1,4,5-trisphosphate	C9
PLC-beta	D-myo-inositol1,4,5-trisphosphate	C9
D-myo-inositol1,4,5-trisphosphate	IP3	C9
PLC-beta	inositolphosphate	C9

A specific detection of IP3 production was also established using IP3 binding proteins .
【GOLD_E】
IP3	chem
IP3	chem
【PRE_E】
IP3	geneN
IP3bindingproteins	geneN
【GOLD_R】
【PRE_R】

The short lifetime of IP3 makes this detection very challenging in measuring GPCR responses .
【GOLD_E】
IP3	chem
GPCR	geneN
【PRE_E】
IP3	geneN
GPCR	geneN
【GOLD_R】
【PRE_R】

Indeed , this IP3 rapidly enters the metabolic inositol phosphate cascade .
【GOLD_E】
IP3	chem
inositolphosphate	chem
【PRE_E】
IP3	geneN
inositolphosphate	chem
【GOLD_R】
【PRE_R】

It has been known for decades that lithium chloride ( LiCl ) leads to D - myo - inositol 1 - phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase , the final enzyme of the IP3 metabolic cascade .
【GOLD_E】
lithiumchloride	chem
LiCl	chem
D-myo-inositol1-phosphate	chem
IP3	chem
GPCR	geneN
inositolmonophosphatase	geneN
【PRE_E】
lithiumchloride	chem
LiCl	chem
D-myo-inositol1-phosphate	chem
GPCR	geneN
inositolmonophosphatase	chem
IP3	chem
【GOLD_R】
lithiumchloride	GPCR	C3
LiCl	GPCR	C3
lithiumchloride	inositolmonophosphatase	C4
LiCl	inositolmonophosphatase	C4
D-myo-inositol1-phosphate	inositolmonophosphatase	C9
IP3	inositolmonophosphatase	C9
【PRE_R】

We show here that IP1 can be used as a surrogate of IP3 to monitor GPCR activation .
【GOLD_E】
IP1	chem
IP3	chem
GPCR	geneN
【PRE_E】
IP1	chem
IP3	geneN
GPCR	geneN
【GOLD_R】
【PRE_R】
IP1	GPCR	C3

We developed a novel homogeneous time - resolved fluorescence ( HTRF ) assay that correlates perfectly with existing methods and is easily amenable to high - throughput screening .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The IP - One assay was validated on various GPCR models .
【GOLD_E】
GPCR	geneN
【PRE_E】
GPCR	geneN
【GOLD_R】
【PRE_R】

It has the advantage over the traditional Ca2 + assay of allowing the measurement of inverse agonist activity as well as the analysis of PLC - beta activity in any nontransfected primary cultures .
【GOLD_E】
Ca2+	chem
PLC-beta	geneN
【PRE_E】
Ca2+	chem
【GOLD_R】
【PRE_R】

Finally , the high assay specificity for D - myo - inositol 1 monophosphate ( IP1 ( 1 ) ) opens new possibilities in developing selective assays to study the functional roles of the various isoforms of inositol phosphates .
【GOLD_E】
D-myo-inositol1monophosphate	chem
IP1	chem
inositolphosphates	chem
【PRE_E】
D-myo-inositol1monophosphate	chem
IP1(1)	chem
inositolphosphates	chem
【GOLD_R】
【PRE_R】

Non - enzymatic interactions of glyoxylate with lysine , arginine , and glucosamine : a study of advanced non - enzymatic glycation like compounds .
【GOLD_E】
glyoxylate	chem
lysine	chem
arginine	chem
glucosamine	chem
【PRE_E】
glyoxylate	chem
lysine	chem
arginine	chem
glucosamine	chem
【GOLD_R】
【PRE_R】

Glyoxylate is a 2 carbon aldo acid that is formed in hepatic tissue from glycolate .
【GOLD_E】
Glyoxylate	chem
glycolate	chem
carbonaldoacid	chem
【PRE_E】
Glyoxylate	chem
carbonaldoacid	chem
glycolate	chem
【GOLD_R】
【PRE_R】

Once formed , the molecule can be converted to glycine by alanine - glyoxylate aminotransferase ( AGAT ) .
【GOLD_E】
alanine-glyoxylateaminotransferase	geneY
AGAT	geneY
glycine	chem
alanine	chem
glyoxylate	chem
【PRE_E】
glycine	chem
alanine-glyoxylateaminotransferase	geneY
AGAT	geneY
【GOLD_R】
glycine	alanine-glyoxylateaminotransferase	C9
glycine	AGAT	C9
【PRE_R】
glycine	AGAT	C9

In defects of AGAT , glyoxylate is transformed to oxalate , resulting in high levels of oxalate in the body .
【GOLD_E】
oxalate	chem
oxalate	chem
AGAT	geneY
glyoxylate	chem
【PRE_E】
AGAT	geneY
glyoxylate	geneN
oxalate	chem
oxalate	chem
【GOLD_R】
【PRE_R】
AGAT	oxalate	C9
glyoxylate	oxalate	C9
glyoxylate	oxalate	C9

The objective of this study was 2 - fold .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

First , it was to determine , if akin to D - glucose , D - fructose or DL - glyceraldehyde , glyoxylate was susceptible to non - enzymatic attack by amino containing molecules such as lysine , arginine or glucosamine .
【GOLD_E】
D-glucose	chem
D-fructose	chem
DL-glyceraldehyde	chem
glyoxylate	chem
amino	chem
lysine	chem
arginine	chem
glucosamine	chem
【PRE_E】
D-glucose	chem
D-fructose	chem
DL-glyceraldehyde	geneN
glyoxylate	geneN
amino	chem
lysine	chem
arginine	chem
glucosamine	chem
【GOLD_R】
【PRE_R】

Second , if by virtue of its molecular structure and size , glyoxylate was as reactive a reagent in non - enzymatic reactions as DL - glyceraldehyde ; i.e . , a glycose that we previously demonstrated to be a more effective glycating agent than D - glucose or D - fructose .
【GOLD_E】
glyoxylate	chem
DL-glyceraldehyde	chem
glycose	chem
D-glucose	chem
D-fructose	chem
【PRE_E】
glyoxylate	chem
DL-glyceraldehyde	chem
glycose	geneN
glycating	chem
D-glucose	chem
D-fructose	chem
【GOLD_R】
【PRE_R】

Using capillary electrophoresis ( CE ) , high performance liquid chromatography and UV and fluorescence spectroscopy , glyoxylate was found to be a highly reactive precursor of advanced glycation like end products ( AGLEs ) and a more effective promoter of non - enzymatic end products than D - glucose , D - fructose or DL - glyceraldehyde .
【GOLD_E】
glyoxylate	chem
D-glucose	chem
D-fructose	chem
DL-glyceraldehyde	chem
【PRE_E】
D-glucose	chem
D-fructose	chem
DL-glyceraldehyde	geneN
【GOLD_R】
【PRE_R】

Cortisol metabolism in hypertension .
【GOLD_E】
Cortisol	chem
【PRE_E】
Cortisol	chem
【GOLD_R】
【PRE_R】

Corticosteroids are critically involved in blood pressure regulation .
【GOLD_E】
Corticosteroids	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Lack of adrenal steroids in Addison 's disease causes life - threatening hypotension , whereas glucocorticoid excess in Cushing 's syndrome invariably results in high blood pressure .
【GOLD_E】
steroids	chem
【PRE_E】
steroids	chem
glucocorticoid	geneY
【GOLD_R】
【PRE_R】

At a pre - receptor level , glucocorticoid action is modulated by 11beta - hydroxysteroid dehydrogenases ( 11beta - HSDs ) .
【GOLD_E】
11beta-hydroxysteroiddehydrogenases	geneN
11beta-HSDs	geneN
11beta-hydroxysteroid	chem
【PRE_E】
11beta-hydroxysteroiddehydrogenases	geneY
11beta-HSDs	geneY
【GOLD_R】
【PRE_R】

11Beta - HSD1 activates cortisone to cortisol to facilitate glucocorticoid receptor ( GR ) - mediated action .
【GOLD_E】
11Beta-HSD1	geneY
glucocorticoidreceptor	geneY
GR	geneY
cortisone	chem
cortisol	chem
【PRE_E】
11Beta-HSD1	geneY
cortisone	chem
cortisol	chem
glucocorticoidreceptor	geneY
GR	geneY
【GOLD_R】
cortisol	11Beta-HSD1	C9
cortisone	11Beta-HSD1	C9
【PRE_R】
11Beta-HSD1	cortisone	C9
11Beta-HSD1	cortisol	C9
cortisol	GR	C9

By contrast , 11beta - HSD2 plays a pivotal role in aldosterone target tissues where it catalyses the opposite reaction ( i.e . inactivation of cortisol to cortisone ) to prevent activation of the mineralocorticoid receptor ( MR ) by cortisol .
【GOLD_E】
11beta-HSD2	geneY
mineralocorticoidreceptor	geneY
MR	geneY
aldosterone	chem
cortisol	chem
cortisone	chem
cortisol	chem
【PRE_E】
11beta-HSD2	geneY
aldosterone	chem
cortisol	chem
cortisone	chem
mineralocorticoidreceptor	geneY
MR	geneY
cortisol	chem
【GOLD_R】
cortisol	mineralocorticoidreceptor	C3
cortisol	MR	C3
cortisone	11beta-HSD2	C9
cortisol	11beta-HSD2	C9
【PRE_R】
11beta-HSD2	cortisol	C9
cortisone	MR	C9
MR	cortisol	C9

Mutations in the 11beta - HSD2 gene cause a rare form of inherited hypertension , the syndrome of apparent mineralocorticoid excess ( AME ) , in which cortisol activates the MR resulting in severe hypertension and hypokalemia .
【GOLD_E】
11beta-HSD2	geneY
MR	geneY
cortisol	chem
【PRE_E】
11beta-HSD2	geneY
cortisol	chem
MR	geneY
【GOLD_R】
cortisol	MR	C3
【PRE_R】

Ingestion of competitive inhibitors of 11beta - HSD2 such as liquorice and carbenoxolone result in a similar but milder clinical phenotype .
【GOLD_E】
carbenoxolone	chem
11beta-HSD2	geneY
【PRE_E】
11beta-HSD2	geneY
liquorice	chem
carbenoxolone	chem
【GOLD_R】
carbenoxolone	11beta-HSD2	C4
【PRE_R】
11beta-HSD2	liquorice	C4
11beta-HSD2	carbenoxolone	C4

Epidemiological data suggests that polymorphic variability in the HSD11B2 gene determines salt sensitivity in the general population , which is a key predisposing factor to adult onset hypertension in some patients .
【GOLD_E】
HSD11B2	geneY
【PRE_E】
HSD11B2	geneY
【GOLD_R】
【PRE_R】

Extrarenal sites of glucocorticoid action and metabolism that might impact on blood pressure include the vasculature and the central nervous system .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Intriguingly , increased exposure to glucocorticoids during fetal life promotes high blood pressure in adulthood suggesting an early programming effect .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , metabolism and action in many peripheral tissues might contribute to the pathophysiology of human hypertension .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells .
【GOLD_E】
retinoicacid	chem
PPARgamma	geneY
CD1d	geneY
【PRE_E】
PPARgamma	geneY
CD1d	geneY
retinoicacid	chem
【GOLD_R】
【PRE_R】

Dendritic cells ( DCs ) expressing CD1d , a molecule responsible for lipid antigen presentation , are capable of enhancing natural killer T ( iNKT ) cell proliferation .
【GOLD_E】
CD1d	geneY
【PRE_E】
CD1d	geneY
【GOLD_R】
【PRE_R】

The signals controlling CD1 expression and lipid antigen presentation are poorly defined .
【GOLD_E】
CD1	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

We have shown previously that stimulation of the lipid - activated transcription factor , peroxisome proliferator - activated receptor ( PPAR ) gamma , indirectly regulates CD1d expression .
【GOLD_E】
lipid-activatedtranscriptionfactor	geneN
peroxisomeproliferator-activatedreceptor(PPAR)gamma	geneY
CD1d	geneY
【PRE_E】
lipid-activatedtranscriptionfactor	geneN
peroxisomeproliferator-activatedreceptor(PPAR)gamma	geneY
CD1d	geneY
【GOLD_R】
【PRE_R】

Here we demonstrate that PPARgamma , turns on retinoic acid synthesis by inducing the expression of retinol and retinal metabolizing enzymes such as retinol dehydrogenase 10 and retinaldehyde dehydrogenase type 2 ( RALDH2 ) .
【GOLD_E】
PPARgamma	geneY
retinoldehydrogenase10	geneY
retinaldehydedehydrogenasetype2	geneY
RALDH2	geneY
retinoicacid	chem
retinol	chem
retinal	chem
retinol	chem
retinaldehyde	chem
【PRE_E】
PPARgamma	geneY
retinoicacid	chem
retinol	chem
retinal	chem
retinoldehydrogenase10	geneY
retinaldehydedehydrogenasetype2	geneY
RALDH2	geneY
【GOLD_R】
retinoicacid	retinoldehydrogenase10	C9
retinoicacid	retinaldehydedehydrogenasetype2	C9
retinoicacid	RALDH2	C9
retinol	retinoldehydrogenase10	C9
retinol	retinaldehydedehydrogenasetype2	C9
retinol	RALDH2	C9
retinal	retinoldehydrogenase10	C9
retinal	retinaldehydedehydrogenasetype2	C9
retinal	RALDH2	C9
【PRE_R】
retinol	RALDH2	C9
retinal	RALDH2	C9

PPARgamma - regulated expression of these enzymes leads to an increase in the intracellular generation of all - trans retinoic acid ( ATRA ) from retinol .
【GOLD_E】
retinol	chem
PPARgamma	geneY
all-transretinoicacid	chem
ATRA	chem
【PRE_E】
PPARgamma	geneY
all-transretinoicacid	chem
ATRA	chem
retinol	chem
【GOLD_R】
【PRE_R】

ATRA regulates gene expression via the activation of the retinoic acid receptor ( RAR ) alpha in human DCs , and RARalpha acutely regulates CD1d expression .
【GOLD_E】
ATRA	chem
retinoicacid	chem
retinoicacidreceptor(RAR)alpha	geneY
RARalpha	geneY
CD1d	geneY
【PRE_E】
ATRA	chem
retinoicacidreceptor(RAR)alpha	geneY
RARalpha	geneY
CD1d	geneY
【GOLD_R】
ATRA	retinoicacidreceptor(RAR)alpha	C3
ATRA	RARalpha	C3
ATRA	CD1d	C3
【PRE_R】
ATRA	RARalpha	C3
ATRA	CD1d	C3

The retinoic acid - induced elevated expression of CD1d is coupled to enhanced iNKT cell activation .
【GOLD_E】
retinoicacid	chem
CD1d	geneY
【PRE_E】
retinoicacid	chem
CD1d	geneY
iNKT	geneY
【GOLD_R】
retinoicacid	CD1d	C3
【PRE_R】
retinoicacid	CD1d	C3
retinoicacid	iNKT	C3

Furthermore , in vivo relevant lipids such as oxidized low - density lipoprotein can also elicit retinoid signaling leading to CD1d up - regulation .
【GOLD_E】
CD1d	geneY
retinoid	chem
【PRE_E】
low-densitylipoprotein	geneN
retinoid	chem
CD1d	geneY
【GOLD_R】
retinoid	CD1d	C3
【PRE_R】
retinoid	CD1d	C3

These data show that regulation of retinoid metabolism and signaling is part of the PPARgamma - controlled transcriptional events in DCs .
【GOLD_E】
PPARgamma	geneY
retinoid	chem
【PRE_E】
retinoid	chem
PPARgamma	geneY
【GOLD_R】
【PRE_R】

The uncovered mechanisms allow the DCs to respond to altered lipid homeostasis by changing CD1 gene expression .
【GOLD_E】
CD1	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Ramelteon : a novel hypnotic lacking abuse liability and sedative adverse effects .
【GOLD_E】
Ramelteon	chem
【PRE_E】
Ramelteon	chem
【GOLD_R】
【PRE_R】

CONTEXT : Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for insomnia treatment .
【GOLD_E】
Ramelteon	chem
MT1	geneY
MT2melatoninreceptor	geneY
【PRE_E】
Ramelteon	chem
MT1andMT2melatoninreceptor	geneN
【GOLD_R】
Ramelteon	MT1	C5
Ramelteon	MT2melatoninreceptor	C5
【PRE_R】
Ramelteon	MT1andMT2melatoninreceptor	C5

Most approved insomnia medications have potential for abuse and cause motor and cognitive impairment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVE : To evaluate the potential for abuse , subjective effects , and motor and cognitive - impairing effects of ramelteon compared with triazolam , a classic benzodiazepine sedative - hypnotic drug .
【GOLD_E】
ramelteon	chem
triazolam	chem
benzodiazepine	chem
【PRE_E】
ramelteon	chem
triazolam	chem
benzodiazepine	chem
【GOLD_R】
【PRE_R】

DESIGN : In this double - blind crossover study , each participant received oral doses of ramelteon ( 16 , 80 , or 160 mg ) , triazolam ( 0.25 , 0.5 , or 0.75 mg ) , and placebo during approximately 18 days .
【GOLD_E】
triazolam	chem
ramelteon	chem
【PRE_E】
ramelteon	chem
triazolam	chem
【GOLD_R】
【PRE_R】

All participants received each treatment on different days .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Most outcome measures were assessed at 0.5 hours before drug administration and repeatedly up to 24 hours after drug administration .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

SETTING : Residential research facility .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PARTICIPANTS : Fourteen adults with histories of sedative abuse .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

MAIN OUTCOME MEASURES : Subject - rated measures included items relevant to potential for abuse ( eg , drug liking , street value , and pharmacological classification ) , as well as assessments of a broad range of stimulant and sedative subjective effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Observer - rated measures included assessments of sedation and impairment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Motor and cognitive performance measures included psychomotor and memory tasks and a standing balance task .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Compared with placebo , ramelteon ( 16 , 80 , and 160 mg ) showed no significant effect on any of the subjective effect measures , including those related to potential for abuse .
【GOLD_E】
ramelteon	chem
【PRE_E】
ramelteon	chem
【GOLD_R】
【PRE_R】

In the pharmacological classification , 79 % ( 11 / 14 ) of subjects identified the highest dose of ramelteon as placebo .
【GOLD_E】
ramelteon	chem
【PRE_E】
ramelteon	chem
【GOLD_R】
【PRE_R】

Similarly , compared with placebo , ramelteon had no effect at any dose on any observer - rated or motor and cognitive performance measure .
【GOLD_E】
ramelteon	chem
【PRE_E】
ramelteon	chem
【GOLD_R】
【PRE_R】

In contrast , triazolam showed dose - related effects on a wide range of subject - rated , observer - rated , and motor and cognitive performance measures , consistent with its profile as a sedative drug with abuse liability .
【GOLD_E】
triazolam	chem
【PRE_E】
triazolam	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Ramelteon demonstrated no significant effects indicative of potential for abuse or motor and cognitive impairment at up to 20 times the recommended therapeutic dose and may represent a useful alternative to existing insomnia medications .
【GOLD_E】
Ramelteon	chem
【PRE_E】
Ramelteon	chem
【GOLD_R】
【PRE_R】

Inhibition of cardiac voltage - gated sodium channels by grape polyphenols .
【GOLD_E】
sodium	chem
voltage-gatedsodiumchannels	geneN
【PRE_E】
cardiacvoltage-gatedsodiumchannels	geneN
polyphenols	chem
【GOLD_R】
【PRE_R】

BACKGROUND AND PURPOSE : The cardiovascular benefits of red wine consumption are often attributed to the antioxidant effects of its polyphenolic constituents , including quercetin , catechin and resveratrol .
【GOLD_E】
quercetin	chem
catechin	chem
resveratrol	chem
【PRE_E】
quercetin	chem
catechin	chem
resveratrol	chem
【GOLD_R】
【PRE_R】

Inhibition of cardiac voltage - gated sodium channels ( VGSCs ) is antiarrhythmic and cardioprotective .
【GOLD_E】
sodium	chem
voltage-gatedsodiumchannels	geneN
VGSCs	geneN
【PRE_E】
cardiacvoltage-gatedsodiumchannels	geneN
VGSCs	geneN
【GOLD_R】
【PRE_R】

As polyphenols may also modulate ion channels , and possess structural similarities to several antiarrhythmic VGSC inhibitors , we hypothesised that VGSC inhibition may contribute to cardioprotection by these polyphenols .
【GOLD_E】
VGSC	geneN
VGSC	geneN
【PRE_E】
polyphenols	chem
ionchannels	geneN
VGSC	geneN
VGSC	geneN
polyphenols	chem
【GOLD_R】
【PRE_R】
polyphenols	ionchannels	C4
polyphenols	VGSC	C4
VGSC	polyphenols	C4

EXPERIMENTAL APPROACH : The whole - cell voltage - clamp technique was used to record peak and late VGSC currents ( INa ) from recombinant human heart NaV1.5 channels expressed in tsA201 cells .
【GOLD_E】
VGSC	geneN
humanheartNaV1.5	geneY
【PRE_E】
VGSC	geneY
humanheartNaV1.5	geneY
【GOLD_R】
【PRE_R】

Right ventricular myocytes from rat heart were isolated and single myocytes were field - stimulated .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Either calcium transients or contractility were measured using the calcium - sensitive dye Calcium - Green 1AM or video edge detection , respectively .
【GOLD_E】
calcium	chem
calcium	chem
Calcium	chem
【PRE_E】
calcium	chem
calcium	chem
Calcium	chem
【GOLD_R】
【PRE_R】

KEY RESULTS : The red grape polyphenols quercetin , catechin and resveratrol blocked peak INa with IC50s of 19.4 microM , 76.8 microM and 77.3 microM , respectively .
【GOLD_E】
quercetin	chem
catechin	chem
resveratrol	chem
【PRE_E】
polyphenolsquercetin	chem
catechin	chem
resveratrol	chem
【GOLD_R】
【PRE_R】

In contrast to lidocaine , resveratrol did not exhibit any frequency - dependence of peak INa block .
【GOLD_E】
lidocaine	chem
resveratrol	chem
【PRE_E】
lidocaine	chem
resveratrol	chem
【GOLD_R】
【PRE_R】

Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin .
【GOLD_E】
VGSC	geneN
R1623Q	geneN
resveratrol	chem
quercetin	chem
【PRE_E】
VGSClongQT	geneY
R1623Q	geneY
resveratrol	chem
quercetin	chem
【GOLD_R】
resveratrol	VGSC	C4
resveratrol	R1623Q	C4
quercetin	VGSC	C4
quercetin	R1623Q	C4
【PRE_R】
VGSClongQT	resveratrol	C4
R1623Q	resveratrol	C4
R1623Q	quercetin	C4

Resveratrol and quercetin also blocked late INa induced by the toxin , ATX II , with IC50s of 26.1 microM and 24.9 microM , respectively .
【GOLD_E】
Resveratrol	chem
quercetin	chem
【PRE_E】
Resveratrol	chem
quercetin	chem
ATXII	geneY
【GOLD_R】
【PRE_R】
Resveratrol	ATXII	C4
quercetin	ATXII	C4

In field - stimulated myocytes , ATXII - induced increases in diastolic calcium were prevented and reversed by resveratrol .
【GOLD_E】
resveratrol	chem
calcium	chem
【PRE_E】
ATXII	chem
calcium	chem
resveratrol	chem
【GOLD_R】
【PRE_R】

ATXII - induced contractile dysfunction was delayed and reduced by resveratrol .
【GOLD_E】
resveratrol	chem
【PRE_E】
ATXII	chem
resveratrol	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS AND IMPLICATIONS : Our results indicate that several red grape polyphenols inhibit cardiac VGSCs and that this effect may contribute to the documented cardioprotective efficacy of red grape products .
【GOLD_E】
VGSCs	geneN
【PRE_E】
polyphenols	chem
VGSCs	geneN
【GOLD_R】
【PRE_R】
polyphenols	VGSCs	C4

Enhancement of radiosensitivity by topoisomerase II inhibitor , amrubicin and amrubicinol , in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction .
【GOLD_E】
amrubicin	chem
amrubicinol	chem
topoisomeraseII	geneY
【PRE_E】
topoisomeraseII	geneY
amrubicin	chem
amrubicinol	chem
【GOLD_R】
amrubicin	topoisomeraseII	C4
amrubicinol	topoisomeraseII	C4
【PRE_R】
topoisomeraseII	amrubicin	C4
topoisomeraseII	amrubicinol	C4

The effects of amrubicin ( AMR ) and its active metabolite , amrubicinol ( AMROH ) , on the sensitivity of human lung adenocarcinoma A549 cells to ionizing radiation were investigated in vitro .
【GOLD_E】
AMR	chem
amrubicinol	chem
AMROH	chem
amrubicin	chem
【PRE_E】
amrubicin	chem
AMR	chem
amrubicinol	chem
AMROH	chem
【GOLD_R】
【PRE_R】

Further , the kinetics of apoptosis and necrosis induction were also analyzed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The cytocidal effects of X - ray irradiation on A549 cells resulted in a low level of radiosensitivity with a D0 value of 12 Gy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The slopes of the survival curves in the exponential phase were plotted on semilogarithmic paper for radiation combined with AMR ( 2.5 microg / ml ) and AMROH ( 0.02 microg / ml ) treatment , and were shown to be approximately parallel to treatment with irradiation alone .
【GOLD_E】
AMR	chem
AMROH	chem
【PRE_E】
AMROH	chem
【GOLD_R】
【PRE_R】

The initial shoulder - shape portion of the survival curve for radiation alone , indicating the repair of sublethal damage , was reduced as compared to that for sequential combined treatment with AMR or AMROH .
【GOLD_E】
AMR	chem
AMROH	chem
【PRE_E】
AMR	chem
AMROH	chem
【GOLD_R】
【PRE_R】

Sequential treatments with AMR or AMROH prior to ionizing radiation resulted in an additive radio - enhancement effect that reduced not only survival , but also the shoulder width .
【GOLD_E】
AMR	chem
AMROH	chem
【PRE_E】
AMROH	chem
【GOLD_R】
【PRE_R】

Fractionated irradiation with 2 Gy per fraction of A549 cells was carried out in vitro similar to that commonly performed in clinical radiotherapy and the radio - resistance of the cells was shown to be inhibited by AMR and AMROH .
【GOLD_E】
AMR	chem
AMROH	chem
【PRE_E】
AMR	chem
AMROH	chem
【GOLD_R】
【PRE_R】

Similar to AMR and AMROH , adriamycin and etoposide ( VP - 16 ) are DNA topoisomerase II inhibitors .
【GOLD_E】
DNAtopoisomeraseII	geneY
AMR	chem
AMROH	chem
adriamycin	chem
etoposide	chem
VP-16	chem
【PRE_E】
AMROH	chem
adriamycin	chem
etoposide	chem
VP-16	chem
DNAtopoisomeraseII	geneY
【GOLD_R】
AMR	DNAtopoisomeraseII	C4
AMROH	DNAtopoisomeraseII	C4
adriamycin	DNAtopoisomeraseII	C4
etoposide	DNAtopoisomeraseII	C4
VP-16	DNAtopoisomeraseII	C4
【PRE_R】
AMROH	DNAtopoisomeraseII	C4
adriamycin	DNAtopoisomeraseII	C4
etoposide	DNAtopoisomeraseII	C4
VP-16	DNAtopoisomeraseII	C4

The effects of these 4 agents on cells that received X - ray irradiation were compared and all of the agents exhibited comparable radio - enhancement effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The induction of apoptosis was investigated at 48 and 72 h after administration of AMROH , radiation or combined treatment , and apoptosis was not significantly induced after any of the treatments .
【GOLD_E】
AMROH	chem
【PRE_E】
AMROH	chem
【GOLD_R】
【PRE_R】

We also examined the induction of necrosis , and found that the incidence of necrosis following combined treatment was approximately 2 times higher than that with either of the single treatments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Interaction of nonsteroidal anti - inflammatory drugs ( NSAID ) with Helicobacter pylori in the stomach of humans and experimental animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Helicobacter pylori ( H. pylori ) and non - steroidal anti - inflammatory drugs ( NSAID ) are major pathogenic factors in peptic ulcer disease but whether these two factors exert synergistic or antagonistic action on the gastric mucosa has been a subject of controversy .
【GOLD_E】
steroidal	chem
【PRE_E】
steroidal	chem
【GOLD_R】
【PRE_R】

The classic concept states that there is an increased ulcer occurrence and bleeding in patients with both H. pylori infection and NSAID use .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , the question whether the H. pylori eradication therapy in NSAID users reduces the occurrence of peptic ulcer has not been fully addressed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Studies on secondary prevention of NSAID - associated ulcers in H. pylori patients have indicated that H. pylori eradication results in impaired ulcer healing with an effect on the rate of peptic ulcer occurrence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

On the other hand , the treatment of H. pylori in patients with no prior history of chronic NSAID therapy has been shown to decrease the risk of peptic ulcer .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Studies in experimental animals revealed for instance , that the H. pylori infection augments the gastric mucosal damage induced by NSAID in Mongolian gerbils .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In rats with preexisting chromic gastric ulcers , H. pylori infection attenuated significantly the aspirin - induced inhibition of ulcer healing and accompanying fall in the gastric blood flow at the margin of these ulcers , suggesting negative interaction between aspirin and H. pylori on ulcerogenesis .
【GOLD_E】
aspirin	chem
aspirin	chem
【PRE_E】
aspirin	chem
aspirin	chem
ulcerogenesis	chem
【GOLD_R】
【PRE_R】

Accumulated evidence in humans and animals shows that both aspirin and H. pylori upregulate the expression of cyclooxygenase ( COX ) - 2 both at mRNA and protein levels at the ulcer margin , but failed to influence significantly that of COX - 1 .
【GOLD_E】
aspirin	chem
cyclooxygenase(COX)-2	geneN
COX-1	geneN
【PRE_E】
aspirin	chem
cyclooxygenase(COX)-2	geneY
COX-1	geneY
【GOLD_R】
aspirin	cyclooxygenase(COX)-2	C3
【PRE_R】
aspirin	cyclooxygenase(COX)-2	C4

It was , therefore , proposed that H. pylori may in fact , antagonize , aspirin - induced delay of ulcer healing due to suppression of acid secretion by the enhancement in PGE ( 2 ) possibly derived from COX - 2 expression and activity and to the overexpression of growth factors such as TGF alpha and VEGF .
【GOLD_E】
TGFalpha	geneN
VEGF	geneN
aspirin	chem
PGE(2)	chem
COX-2	geneN
【PRE_E】
aspirin	chem
PGE(2)	chem
COX-2	geneY
TGFalpha	geneY
VEGF	geneY
【GOLD_R】
aspirin	COX-2	C3
aspirin	TGFalpha	C3
aspirin	VEGF	C3
aspirin	COX-2	C3
PGE(2)	COX-2	C9
【PRE_R】
aspirin	COX-2	C4
aspirin	TGFalpha	C4
aspirin	VEGF	C4

The present review summarizes and further addresses the issue of the interaction between these two major ulcer risk factors determined in the stomach of humans and experimental animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity .
【GOLD_E】
methylthioadenosine	chem
pemetrexed	chem
methylthioadenosinephosphorylase	geneY
【PRE_E】
methylthioadenosinephosphorylase	geneY
pemetrexed	chem
【GOLD_R】
【PRE_R】

Pemetrexed is a new - generation antifolate inhibitor of thymidylate synthase ( TS ) and a weaker inhibitor of glycinamide ribonucleotide transformylase ( GARFT ) required for de novo purine synthesis .
【GOLD_E】
thymidylate	chem
glycinamideribonucleotidetransformylase	geneY
GARFT	geneY
glycinamideribonucleotide	chem
thymidylatesynthase	geneY
TS	geneY
purine	chem
【PRE_E】
Pemetrexed	chem
thymidylatesynthase	geneY
TS	geneY
glycinamideribonucleotidetransformylase	geneY
GARFT	geneY
purine	chem
【GOLD_R】
【PRE_R】
Pemetrexed	thymidylatesynthase	C4
Pemetrexed	TS	C4
GARFT	purine	C4

Methylthioadenosine phosphorylase ( MTAP ) salvages purines by releasing adenine from methylthioadenosine and is often deleted in mesothelioma .
【GOLD_E】
purines	chem
adenine	chem
methylthioadenosine	chem
Methylthioadenosinephosphorylase	geneY
MTAP	geneY
Methylthioadenosine	chem
【PRE_E】
Methylthioadenosinephosphorylase	geneY
MTAP	geneY
purines	chem
adenine	chem
methylthioadenosine	chem
【GOLD_R】
adenine	Methylthioadenosinephosphorylase	C9
adenine	MTAP	C9
methylthioadenosine	Methylthioadenosinephosphorylase	C9
methylthioadenosine	MTAP	C9
【PRE_R】
MTAP	purines	C9
MTAP	adenine	C9
MTAP	methylthioadenosine	C9

The current study addresses the effect of MTAP on pemetrexed activity using a highly potent transition state inhibitor of MTAP , MT - DADMe - Immucillin A ( ImmA ; K ( i ) = 86 pmol / L ) in the MTAP ( + ) NCI - H28 and MTAP ( - ) NCI - H2052 mesothelioma cell lines .
【GOLD_E】
pemetrexed	chem
MTAP	geneY
MTAP	geneY
MTAP	geneY
MTAP	geneY
【PRE_E】
MTAP	geneY
pemetrexed	chem
MTAP	geneY
MT-DADMe-ImmucillinA	geneY
MTAP	geneY
MTAP	geneY
【GOLD_R】
【PRE_R】

Based on selective nucleoside protection , TS was found to be the primary pemetrexed target in both cell lines with GARFT inhibition requiring 20 - to 30 - fold higher pemetrexed concentrations .
【GOLD_E】
pemetrexed	chem
pemetrexed	chem
TS	geneY
GARFT	geneY
【PRE_E】
TS	geneY
pemetrexed	chem
GARFT	geneY
pemetrexed	chem
【GOLD_R】
pemetrexed	GARFT	C4
【PRE_R】
GARFT	pemetrexed	C4

ImmA had no effect on pemetrexed activity but , when thymidine was added , the pemetrexed IC ( 50 ) decreased by a factor of approximately 3 in MTAP ( + ) H28 cells with no effect in MTAP ( - ) H2052 cells .
【GOLD_E】
pemetrexed	chem
thymidine	chem
pemetrexed	chem
MTAP	geneY
MTAP	geneY
【PRE_E】
ImmA	chem
pemetrexed	chem
thymidine	chem
pemetrexed	chem
MTAP	geneY
MTAP	geneY
【GOLD_R】
【PRE_R】

Conversely , the transfection of MTAP into H2052 cells increased the pemetrexed IC ( 50 ) by nearly 3 - fold but only in the presence of thymidine ; this was reversed by ImmA .
【GOLD_E】
pemetrexed	chem
MTAP	geneY
thymidine	chem
【PRE_E】
pemetrexed	chem
thymidine	chem
【GOLD_R】
【PRE_R】

An MTAP - specific short interfering RNA produced a 2 - fold decrease in pemetrexed IC ( 50 ) in MTAP ( + ) HeLa cells in the presence of thymidine .
【GOLD_E】
MTAP	geneY
MTAP	geneY
pemetrexed	chem
thymidine	chem
【PRE_E】
MTAP	geneY
thymidine	chem
【GOLD_R】
【PRE_R】

These data indicate that suppression of constitutive MTAP has no effect on pemetrexed activity when the primary target is TS .
【GOLD_E】
MTAP	geneY
TS	geneY
pemetrexed	chem
【PRE_E】
constitutiveMTAP	geneY
pemetrexed	chem
TS	geneY
【GOLD_R】
【PRE_R】

There is a modest salutary effect when the pemetrexed target is GARFT alone .
【GOLD_E】
GARFT	geneY
pemetrexed	chem
【PRE_E】
pemetrexed	chem
GARFT	geneY
【GOLD_R】
【PRE_R】

Sulfonylureas and glinides exhibit peroxisome proliferator - activated receptor gamma activity : a combined virtual screening and biological assay approach .
【GOLD_E】
Sulfonylureas	chem
glinides	chem
peroxisomeproliferator-activatedreceptorgamma	geneY
【PRE_E】
Sulfonylureas	chem
glinides	chem
peroxisomeproliferator-activatedreceptorgamma	geneY
【GOLD_R】
【PRE_R】

Most drugs currently employed in the treatment of type 2 diabetes either target the sulfonylurea receptor stimulating insulin release ( sulfonylureas , glinides ) , or target the peroxisome proliferator - activated receptor ( PPARgamma ) improving insulin resistance ( thiazolidinediones ) .
【GOLD_E】
sulfonylurea	chem
insulin	geneY
peroxisomeproliferator-activatedreceptor	geneN
PPARgamma	geneY
insulin	geneY
sulfonylureareceptor	geneN
sulfonylureas	chem
glinides	chem
thiazolidinediones	chem
【PRE_E】
sulfonylureareceptor	geneN
insulin	geneY
sulfonylureas	chem
glinides	chem
peroxisomeproliferator-activatedreceptor	geneY
PPARgamma	geneY
insulin	geneY
thiazolidinediones	chem
【GOLD_R】
sulfonylureas	insulin	C3
glinides	insulin	C3
【PRE_R】

Our work shows that sulfonylureas and glinides additionally bind to PPARgamma and exhibit PPARgamma agonistic activity .
【GOLD_E】
PPARgamma	geneY
PPARgamma	geneY
sulfonylureas	chem
glinides	chem
【PRE_E】
sulfonylureas	chem
glinides	chem
PPARgamma	geneY
PPARgamma	geneY
【GOLD_R】
sulfonylureas	PPARgamma	C5
glinides	PPARgamma	C5
【PRE_R】

This activity was predicted in silico by virtual screening and confirmed in vitro in a binding assay , a transactivation assay , and by measuring the expression of PPARgamma target genes .
【GOLD_E】
PPARgamma	geneY
【PRE_E】
PPARgamma	geneY
【GOLD_R】
【PRE_R】

Among the measured compounds , gliquidone and glipizide ( two sulfonylureas ) , as well as nateglinide ( a glinide ) , exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment .
【GOLD_E】
gliquidone	chem
glipizide	chem
sulfonylureas	chem
nateglinide	chem
glinide	chem
PPARgamma	geneY
【PRE_E】
gliquidone	chem
glipizide	chem
sulfonylureas	chem
nateglinide	chem
glinide	chem
PPARgamma	geneY
【GOLD_R】
gliquidone	PPARgamma	C5
glipizide	PPARgamma	C5
sulfonylureas	PPARgamma	C5
nateglinide	PPARgamma	C5
glinide	PPARgamma	C5
【PRE_R】
nateglinide	PPARgamma	C6
glinide	PPARgamma	C6

The most active of these compounds , gliquidone , is shown to be as potent as pioglitazone at inducing PPARgamma target gene expression .
【GOLD_E】
gliquidone	chem
pioglitazone	chem
PPARgamma	geneY
【PRE_E】
gliquidone	chem
pioglitazone	chem
PPARgamma	geneY
【GOLD_R】
gliquidone	PPARgamma	C3
pioglitazone	PPARgamma	C3
【PRE_R】
gliquidone	PPARgamma	C3
pioglitazone	PPARgamma	C3

This dual mode of action of sulfonylureas and glinides may open new perspectives for the molecular pharmacology of antidiabetic drugs , because it provides evidence that drugs can be designed that target both the sulfonylurea receptor and PPARgamma .
【GOLD_E】
sulfonylureas	chem
glinides	chem
sulfonylurea	chem
sulfonylureareceptor	geneN
PPARgamma	geneY
【PRE_E】
sulfonylureas	chem
glinides	chem
sulfonylureareceptor	geneY
PPARgamma	geneY
【GOLD_R】
【PRE_R】

Targeting both receptors could increase pancreatic insulin secretion and improve insulin resistance .
【GOLD_E】
insulin	geneY
insulin	geneY
【PRE_E】
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Glinides , sulfonylureas , and other acidified sulfonamides may be promising leads in the development of new PPARgamma agonists .
【GOLD_E】
PPARgamma	geneY
Glinides	chem
sulfonylureas	chem
acidifiedsulfonamides	chem
【PRE_E】
Glinides	chem
sulfonylureas	chem
acidifiedsulfonamides	chem
PPARgamma	geneY
【GOLD_R】
Glinides	PPARgamma	C5
sulfonylureas	PPARgamma	C5
acidifiedsulfonamides	PPARgamma	C5
【PRE_R】

In addition , we provide a unified concept of the PPARgamma binding ability of seemingly disparate compound classes .
【GOLD_E】
PPARgamma	geneY
【PRE_E】
PPARgamma	geneY
【GOLD_R】
【PRE_R】

PGE ( 1 ) stimulation of HEK293 cells generates multiple contiguous domains with different [ cAMP ] : role of compartmentalized phosphodiesterases .
【GOLD_E】
PGE(1)	chem
cAMP	chem
【PRE_E】
PGE(1)	chem
cAMP	chem
compartmentalizedphosphodiesterases	geneN
【GOLD_R】
【PRE_R】

There is a growing appreciation that the cyclic adenosine monophosphate ( cAMP ) - protein kinase A ( PKA ) signaling pathway is organized to form transduction units that function to deliver specific messages .
【GOLD_E】
proteinkinaseA	geneN
PKA	geneN
cyclicadenosinemonophosphate	chem
cAMP	chem
【PRE_E】
cyclicadenosinemonophosphate(cAMP)-proteinkinaseA	geneN
PKA	geneN
【GOLD_R】
【PRE_R】

Such organization results in the local activation of PKA subsets through the generation of confined intracellular gradients of cAMP , but the mechanisms responsible for limiting the diffusion of cAMP largely remain to be clarified .
【GOLD_E】
PKA	geneN
cAMP	chem
cAMP	chem
【PRE_E】
PKA	geneN
cAMP	chem
cAMP	chem
【GOLD_R】
cAMP	PKA	C3
【PRE_R】

In this study , by performing real - time imaging of cAMP , we show that prostaglandin 1 stimulation generates multiple contiguous , intracellular domains with different cAMP concentration in human embryonic kidney 293 cells .
【GOLD_E】
cAMP	chem
prostaglandin1	chem
cAMP	chem
【PRE_E】
cAMP	chem
prostaglandin1	chem
cAMP	chem
【GOLD_R】
【PRE_R】

By using pharmacological and genetic manipulation of phosphodiesterases ( PDEs ) , we demonstrate that compartmentalized PDE4B and PDE4D are responsible for selectively modulating the concentration of cAMP in individual subcellular compartments .
【GOLD_E】
cAMP	chem
phosphodiesterases	geneN
PDEs	geneN
PDE4B	geneY
PDE4D	geneY
【PRE_E】
phosphodiesterases	geneN
PDEs	geneN
PDE4B	geneY
PDE4D	geneY
cAMP	chem
【GOLD_R】
cAMP	PDE4B	C9
cAMP	PDE4D	C9
【PRE_R】

We propose a model whereby compartmentalized PDEs , rather than representing an enzymatic barrier to cAMP diffusion , act as a sink to drain the second messenger from discrete locations , resulting in multiple and simultaneous domains with different cAMP concentrations irrespective of their distance from the site of cAMP synthesis .
【GOLD_E】
cAMP	chem
cAMP	chem
PDEs	geneN
cAMP	chem
【PRE_E】
PDEs	geneN
cAMP	chem
cAMP	chem
cAMP	chem
【GOLD_R】
cAMP	PDEs	C9
cAMP	PDEs	C9
【PRE_R】

DNA topoisomerase IIalpha ( TOP2A ) inhibitors up - regulate fatty acid synthase gene expression in SK - Br3 breast cancer cells : in vitro evidence for a ' functional amplicon ' involving FAS , Her - 2 / neu and TOP2A genes .
【GOLD_E】
DNAtopoisomeraseIIalpha	geneY
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
TOP2A	geneY
fattyacidsynthase	geneY
fattyacid	chem
【PRE_E】
DNAtopoisomeraseIIalpha	geneY
TOP2A	geneY
fattyacidsynthase	geneY
SK-Br3	geneY
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
【GOLD_R】
【PRE_R】

Fatty acid synthase ( FAS ) , the key metabolic multi - enzyme that is responsible for the terminal catalytic step in the de novo fatty acid biosynthesis , plays an active role in the development , maintenance , and enhancement of the malignant phenotype in a subset of breast carcinomas .
【GOLD_E】
Fattyacidsynthase	geneY
Fattyacid	chem
FAS	geneY
【PRE_E】
Fattyacidsynthase	geneY
FAS	geneY
fattyacid	chem
【GOLD_R】
【PRE_R】

We recently described that a molecular bi - directional cross - talk between FAS and the Her - 2 / neu ( erbB - 2 ) oncogene is taking place at the level of transcription , translation , and activity in breast cancer cells .
【GOLD_E】
FAS	geneY
Her-2	geneY
neu	geneY
erbB-2	geneY
【PRE_E】
FAS	geneY
Her-2/neu	geneY
erbB-2	geneY
【GOLD_R】
【PRE_R】

Because Her - 2 / neu has been linked with altered sensitivity to cytotoxic drugs , we envisioned that FAS gene expression may represent a novel predictive molecular factor for breast cancer response to chemotherapy in a Her - 2 / neu - related manner .
【GOLD_E】
Her-2	geneY
neu	geneY
FAS	geneY
Her-2	geneY
neu	geneY
【PRE_E】
Her-2	geneY
neu	geneY
FAS	geneY
Her-2	geneY
neu	geneY
【GOLD_R】
【PRE_R】

We herein evaluated whether chemotherapy - induced cell damage acts in an epigenetic fashion by inducing changes in the transcriptional activation of FAS gene in breast cancer cells .
【GOLD_E】
FAS	geneY
【PRE_E】
FAS	geneY
【GOLD_R】
【PRE_R】

To evaluate this option , FAS - and Her - 2 / neu - overexpressing SK - Br3 breast cancer cells were transiently transfected with a FAS promoter - reporter construct ( FAS - Luciferase ) harboring all the elements necessary for high level expression in cancer cells .
【GOLD_E】
FASpromoter	geneN
FAS	geneY
FAS	geneY
Her-2	geneY
neu	geneY
【PRE_E】
FAS	geneY
Her-2	geneY
neu	geneY
SK-Br3	geneY
FASpromoter	geneN
FAS	geneY
【GOLD_R】
【PRE_R】

SK - Br3 cells cultured in the presence of topoisomerase IIalpha ( TOP2A ) inhibitors doxorubicin and etopoxide ( VP - 16 ) demonstrated a 2 - to 3 - fold increase in FAS promoter activity when compared with control cells growing in drug - free culture conditions .
【GOLD_E】
topoisomeraseIIalpha	geneY
TOP2A	geneY
FASpromoter	geneN
doxorubicin	chem
etopoxide	chem
VP-16	chem
【PRE_E】
topoisomeraseIIalpha	geneY
TOP2A	geneY
doxorubicin	chem
etopoxide	chem
VP-16	chem
FASpromoter	geneN
【GOLD_R】
doxorubicin	FASpromoter	C3
etopoxide	FASpromoter	C3
VP-16	FASpromoter	C3
doxorubicin	topoisomeraseIIalpha	C4
doxorubicin	TOP2A	C4
etopoxide	topoisomeraseIIalpha	C4
etopoxide	TOP2A	C4
VP-16	topoisomeraseIIalpha	C4
VP-16	TOP2A	C4
【PRE_R】
topoisomeraseIIalpha	doxorubicin	C4
TOP2A	doxorubicin	C4
TOP2A	etopoxide	C4
VP-16	FASpromoter	C4

We failed to observe any significant activation of FAS promoter following exposure to the anti - metabolite 5 - fluorouracil , the alkylating drug cisplatin , or the microtubule interfering - agents paclitaxel and vincristine .
【GOLD_E】
FASpromoter	geneN
5-fluorouracil	chem
cisplatin	chem
paclitaxel	chem
vincristine	chem
【PRE_E】
FASpromoter	geneN
5-fluorouracil	chem
cisplatin	chem
microtubule	geneN
paclitaxel	chem
vincristine	chem
【GOLD_R】
【PRE_R】

Moreover , the up - regulatory effects of TOP2A inhibitors on the transcriptional activation of FAS gene expression were not significantly decreased when the FAS promoter was damaged at the sterol regulatory element binding protein ( SREBP ) - binding site .
【GOLD_E】
TOP2A	geneY
FAS	geneY
FASpromoter	geneN
sterolregulatoryelementbindingprotein	geneN
SREBP	geneN
【PRE_E】
TOP2A	geneY
FAS	geneY
FASpromoter	geneN
sterolregulatoryelementbindingprotein	geneN
SREBP	geneN
【GOLD_R】
【PRE_R】

Considering that FAS inhibition produces profound inhibition of DNA replication and S - phase progression in cancer cells , we finally asked whether a cross - talk between TOP2A and FAS could exhibit a Her - 2 / neu - related bi - directional nature .
【GOLD_E】
FAS	geneY
TOP2A	geneY
FAS	geneY
Her-2	geneY
neu	geneY
【PRE_E】
FAS	chem
TOP2A	geneY
FAS	geneY
neu	geneY
【GOLD_R】
【PRE_R】

TOP2A protein levels were decreased during treatment with the anti - Her - 2 / neu antibody trastuzumab while , concomitantly , FAS promoter activity and FAS protein expression were significantly reduced .
【GOLD_E】
TOP2A	geneY
Her-2	geneY
neu	geneY
FASpromoter	geneN
FAS	geneY
【PRE_E】
TOP2A	geneY
Her-2	geneY
neu	geneY
FASpromoter	geneN
FAS	geneY
【GOLD_R】
【PRE_R】

Of note , when the expression levels of TOP2A protein were analyzed following exposure of SK - Br3 cells to increasing concentrations of the novel slow - binding FAS inhibitor C75 , a dose - dependent reduction in TOP2A expression was observed .
【GOLD_E】
TOP2A	geneY
FAS	geneY
TOP2A	geneY
【PRE_E】
TOP2A	geneY
FAS	geneN
C75	chem
TOP2A	geneY
【GOLD_R】
【PRE_R】
FAS	C75	C4
C75	TOP2A	C4

Although FAS gene is not physically located in the Her - 2 / neu - TOP2A amplicon , our present findings strongly suggest that a tight functional association between FAS , Her - 2 / neu and TOP2A genes is taking place in a subset of breast carcinoma cells .
【GOLD_E】
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
【PRE_E】
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
FAS	geneY
Her-2	geneY
neu	geneY
TOP2A	geneY
【GOLD_R】
【PRE_R】

Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate .
【GOLD_E】
Mifepristone	chem
medroxyprogesteroneacetate	chem
steroid	chem
steroidreceptors	geneN
【PRE_E】
Mifepristone	chem
steroidreceptors	geneN
medroxyprogesteroneacetate	chem
【GOLD_R】
【PRE_R】

OBJECTIVE : To evaluate the effect of mifepristone on the expression of endometrial steroid receptors and their co - factors in depot medroxyprogesterone acetate ( DMPA ) users .
【GOLD_E】
medroxyprogesteroneacetate	chem
steroidreceptors	geneN
steroid	chem
【PRE_E】
mifepristone	chem
steroidreceptors	geneN
medroxyprogesteroneacetate	chem
DMPA	chem
【GOLD_R】
【PRE_R】

DESIGN : A prospective , randomized , placebo - controlled trial .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

SETTING : Reproductive research center .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PATIENT ( S ) : Fifty healthy women with regular menstrual cycle .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

INTERVENTION ( S ) : One hundred fifty milligrams of DMPA were given every 3 months .
【GOLD_E】
【PRE_E】
DMPA	chem
【GOLD_R】
【PRE_R】

Two pills ( 25 mg each ) of placebo or mifepristone were administered every 14 days during the DMPA therapy .
【GOLD_E】
mifepristone	chem
【PRE_E】
pills	chem
mifepristone	chem
DMPA	chem
【GOLD_R】
【PRE_R】

Four endometrial biopsy specimens were obtained from each patient .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

MAIN OUTCOME MEASURE ( S ) : The expression of estrogen receptor subtypes alpha and beta ( ERalpha and ERbeta ) , progesterone receptors A and B ( PRAB and PRB ) , and androgen receptor messenger RNA and protein was detected by real - time polymerase chain reaction and immunohistochemistry , respectively .
【GOLD_E】
estrogenreceptorsubtypesalphaandbeta	geneN
ERalpha	geneY
ERbeta	geneY
progesteronereceptorsAandB	geneN
PRAB	geneN
PRB	geneY
androgenreceptor	geneN
estrogen	chem
progesterone	chem
androgen	chem
【PRE_E】
estrogenreceptorsubtypesalphaandbeta	geneY
ERalpha	geneY
ERbeta	geneY
progesteronereceptorsAandB	geneN
PRAB	geneY
PRB	geneY
androgenreceptor	geneY
【GOLD_R】
【PRE_R】

Steroid receptor coactivator 1 ( SRC - 1 ) , silencing mediator for retinoid and thyroid - hormone receptors , and cell proliferation were evaluated by immunohistochemistry .
【GOLD_E】
Steroid	chem
retinoid	chem
thyroid-hormone	chem
Steroidreceptorcoactivator1	geneY
SRC-1	geneY
retinoidandthyroid-hormonereceptors	geneN
【PRE_E】
Steroidreceptorcoactivator1	geneY
SRC-1	geneY
retinoidandthyroid-hormonereceptors	geneN
【GOLD_R】
【PRE_R】

RESULT ( S ) : The expression of endometrial ERalpha , PRAB , PRB , and SRC - 1 was increased significantly after 1 week of mifepristone , but the increase was no longer seen after 10 weeks .
【GOLD_E】
ERalpha	geneY
PRAB	geneN
PRB	geneY
SRC-1	geneY
mifepristone	chem
【PRE_E】
ERalpha	geneY
PRAB	geneY
PRB	geneY
SRC-1	geneY
mifepristone	chem
【GOLD_R】
mifepristone	ERalpha	C3
mifepristone	PRAB	C3
mifepristone	PRB	C3
mifepristone	SRC-1	C3
【PRE_R】
ERalpha	mifepristone	C3
PRAB	mifepristone	C3
PRB	mifepristone	C3
SRC-1	mifepristone	C3

A positive correlation between endometrial ERalpha , PRAB , PRB , and SRC - 1 production and proliferation was demonstrated .
【GOLD_E】
ERalpha	geneY
PRAB	geneN
PRB	geneY
SRC-1	geneY
【PRE_E】
ERalpha	geneY
PRAB	geneY
PRB	geneY
SRC-1	geneY
【GOLD_R】
【PRE_R】

CONCLUSION ( S ) : Short - term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha , PRAB , PRB , and SRC - 1 and promotes cell proliferation .
【GOLD_E】
ERalpha	geneY
PRAB	geneN
PRB	geneY
SRC-1	geneY
mifepristone	chem
【PRE_E】
mifepristone	chem
DMPA	chem
ERalpha	geneY
PRAB	geneY
PRB	geneY
SRC-1	geneY
【GOLD_R】
mifepristone	ERalpha	C3
mifepristone	PRAB	C3
mifepristone	PRB	C3
mifepristone	SRC-1	C3
【PRE_R】
mifepristone	ERalpha	C3
DMPA	ERalpha	C3
DMPA	PRAB	C3
DMPA	PRB	C3
DMPA	SRC-1	C3

Prolonged exposure to mifepristone does not alter the suppression of these receptors that are caused by DMPA and continues to result in endometrial atrophy .
【GOLD_E】
mifepristone	chem
【PRE_E】
mifepristone	chem
DMPA	chem
【GOLD_R】
【PRE_R】

Characterization of the molecular mechanisms involved in the increased insulin secretion in rats with acute liver failure .
【GOLD_E】
insulin	geneN
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

To investigate the mechanism of hyperinsulinaemia in rats with acute liver failure induced by the administration of d - galactosamine ( GalN ) , we focused on the role of polyprimidine tract - binding protein ( PTB ) in islet insulin synthesis .
【GOLD_E】
polyprimidinetract-bindingprotein	geneY
PTB	geneY
insulin	geneN
d-galactosamine	chem
GalN	chem
【PRE_E】
d-galactosamine	chem
GalN	chem
polyprimidinetract-bindingprotein	geneY
PTB	geneN
isletinsulin	geneY
【GOLD_R】
【PRE_R】

Recent reports indicate that PTB binds and stabilizes mRNA encoding insulin and insulin secretory granule proteins , including islet cell autoantigen 512 ( ICA512 ) , prohormone convertase 1 / 3 ( PC1 / 3 ) , and PC2 .
【GOLD_E】
PTB	geneY
insulin	geneN
insulinsecretorygranuleproteins	geneN
isletcellautoantigen512	geneY
ICA512	geneY
prohormoneconvertase1/3	geneN
PC1/3	geneN
PC2	geneY
【PRE_E】
PTB	geneY
insulin	geneY
insulin	geneY
granuleproteins	geneN
isletcellautoantigen512	geneY
ICA512	geneN
prohormoneconvertase1/3	geneN
PC1/3	geneN
PC2	geneN
【GOLD_R】
【PRE_R】

In the present study , glucose - stimulated insulin secretion was significantly increased in GalN - treated rats compared to controls .
【GOLD_E】
insulin	geneN
glucose	chem
GalN	chem
【PRE_E】
glucose	chem
insulin	geneN
GalN	chem
【GOLD_R】
glucose	insulin	C3
GalN	insulin	C3
【PRE_R】
glucose	insulin	C3
insulin	GalN	C3

Levels of mRNA encoding insulin 1 , ICA512 , and PC1 / 3 were increased in the pancreatic islets of GalN - treated rats .
【GOLD_E】
insulin1	geneY
ICA512	geneY
PC1/3	geneN
GalN	chem
【PRE_E】
insulin1	geneY
ICA512	geneY
PC1/3	geneN
GalN	chem
【GOLD_R】
GalN	insulin1	C3
GalN	ICA512	C3
【PRE_R】
ICA512	GalN	C3

This mRNA level elevation was not prevented by pretreatment with actinomycin D .
【GOLD_E】
actinomycinD	chem
【PRE_E】
actinomycinD	chem
【GOLD_R】
【PRE_R】

When the PTB - binding site in insulin 1 mRNA was incubated with the islet cytosolic fraction , the RNA - protein complex level was increased in the cytosolic fraction obtained from GalN - treated rats compared to the level in control rats .
【GOLD_E】
PTB-bindingsite	geneN
insulin1	geneY
GalN	chem
【PRE_E】
PTB-bindingsite	geneN
insulin1	geneY
RNA-proteincomplex	geneN
GalN	chem
【GOLD_R】
GalN	PTB-bindingsite	C3
GalN	insulin1	C3
【PRE_R】

The cytosolic fraction obtained from pancreatic islets obtained from GalN - treated rats had an increased PTB level compared to the levels obtained from the pancreatic islets of control rats .
【GOLD_E】
GalN	chem
PTB	geneY
【PRE_E】
GalN	chem
PTB	geneY
【GOLD_R】
GalN	PTB	C3
【PRE_R】
GalN	PTB	C3

These findings suggest that , in rats with acute liver failure , cytosolic PTB binds and stabilizes mRNA encoding insulin and its secretory granule proteins .
【GOLD_E】
PTB	geneY
insulin	geneN
secretorygranuleproteins	geneN
【PRE_E】
cytosolicPTB	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Cysteinyl leukotriene receptor 1 is involved in N - methyl - D - aspartate - mediated neuronal injury in mice .
【GOLD_E】
Cysteinylleukotriene	chem
N-methyl-D-aspartate	chem
Cysteinylleukotrienereceptor1	geneY
【PRE_E】
Cysteinylleukotrienereceptor1	geneY
N-methyl-D-aspartate	chem
【GOLD_R】
【PRE_R】

AIM : To determine whether cysteinyl leukotriene receptor 1 ( CysLT1 receptor ) is involved in N - methyl - D - aspartate ( NMDA ) - induced excitotoxic injury in the mouse brain .
【GOLD_E】
N-methyl-D-aspartate	chem
cysteinylleukotrienereceptor1	geneY
CysLT1receptor	geneY
NMDA	chem
cysteinylleukotriene	chem
【PRE_E】
cysteinylleukotrienereceptor1	geneY
CysLT1	geneY
N-methyl-D-aspartate	chem
NMDA	chem
【GOLD_R】
【PRE_R】
CysLT1	N-methyl-D-aspartate	C9

METHODS : Brain injury was induced by NMDA microinjection ( 50 - 150 nmol in 0.5 microL ) into the cerebral cortex .
【GOLD_E】
NMDA	chem
【PRE_E】
NMDA	chem
【GOLD_R】
【PRE_R】

The changes in CysLT1 receptor expression 24 h after NMDA injection and the effects of a CysLT1 receptor antagonist , pranlukast ( 0.01 and 0.1 mg / kg ) , an NMDA receptor antagonist , ketamine ( 30 mg / kg ) , and an antioxidant , edaravone ( 9 mg / kg ) were observed .
【GOLD_E】
CysLT1receptor	geneY
CysLT1receptor	geneY
NMDAreceptor	geneN
NMDA	chem
pranlukast	chem
NMDA	chem
ketamine	chem
edaravone	chem
【PRE_E】
CysLT1	geneY
NMDA	chem
CysLT1	geneY
pranlukast	chem
NMDAreceptor	geneN
ketamine	chem
edaravone	chem
【GOLD_R】
pranlukast	CysLT1receptor	C6
ketamine	NMDAreceptor	C6
【PRE_R】
CysLT1	pranlukast	C6

RESULTS : In the NMDA - injured brain , the CysLT1 receptor mRNA , and protein expression were upregulated , and the receptor was mainly localized in the neurons and not in the astrocytes .
【GOLD_E】
NMDA	chem
CysLT1receptor	geneY
【PRE_E】
NMDA	chem
CysLT1	geneY
【GOLD_R】
NMDA	CysLT1receptor	C3
【PRE_R】

Pranlukast , ketamine and edaravone decreased NMDA - induced injury ; pranlukast ( 0.1 mg / kg ) and ketamine inhibited the upregulated expression of the CysLT1 receptor .
【GOLD_E】
Pranlukast	chem
ketamine	chem
edaravone	chem
NMDA	chem
pranlukast	chem
ketamine	chem
CysLT1receptor	geneY
【PRE_E】
Pranlukast	chem
ketamine	chem
edaravone	chem
NMDA	chem
pranlukast	chem
ketamine	chem
CysLT1	geneY
【GOLD_R】
pranlukast	CysLT1receptor	C4
ketamine	CysLT1receptor	C4
【PRE_R】
Pranlukast	CysLT1	C4
ketamine	CysLT1	C4
edaravone	CysLT1	C4
NMDA	CysLT1	C4
pranlukast	CysLT1	C4
ketamine	CysLT1	C4

CONCLUSION : CysLT1 receptor expression in neurons is upregulated after NMDA injection , and NMDA - induced responses are inhibited by CysLT1 receptor antagonists , indicating that the increased CysLT1 receptor is involved in NMDA excitotoxicity .
【GOLD_E】
NMDA	chem
NMDA	chem
NMDA	chem
CysLT1receptor	geneY
CysLT1receptor	geneY
CysLT1receptor	geneY
【PRE_E】
CysLT1	geneY
NMDA	chem
NMDA	chem
CysLT1	geneY
CysLT1	geneY
NMDA	chem
【GOLD_R】
NMDA	CysLT1receptor	C3
NMDA	CysLT1receptor	C3
【PRE_R】

Bcl - 2 phosphorylation has pathological significance in human breast cancer .
【GOLD_E】
Bcl-2	geneY
【PRE_E】
Bcl-2	geneY
【GOLD_R】
【PRE_R】

The anti - apoptotic molecule , Bcl - 2 , is well known to play an important role in the chemoresistance of breast cancer .
【GOLD_E】
Bcl-2	geneY
【PRE_E】
Bcl-2	geneY
【GOLD_R】
【PRE_R】

We have previously demonstrated that phosphorylation of Fas - associated death domain - containing protein ( FADD ) at 194 serine through c - jun NH2 - terminal kinase ( JNK ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2 / M , and that Bcl - 2 phosphorylation downstream of JNK / FADD plays an important role in cell growth suppression by paclitaxel .
【GOLD_E】
Fas-associateddeathdomain-containingprotein	geneY
FADD	geneY
c-junNH2-terminalkinase	geneN
JNK	geneN
Bcl-2	geneY
JNK	geneN
FADD	geneY
serine	chem
NH2	chem
paclitaxel	chem
【PRE_E】
Fas-associateddeathdomain-containingprotein	geneY
FADD	geneY
serine	chem
c-junNH2-terminalkinase	geneN
JNK	geneN
Bcl-2	geneY
JNK	geneN
FADD	geneY
paclitaxel	chem
【GOLD_R】
paclitaxel	Fas-associateddeathdomain-containingprotein	C3
paclitaxel	FADD	C3
paclitaxel	c-junNH2-terminalkinase	C3
paclitaxel	JNK	C3
paclitaxel	JNK	C3
paclitaxel	FADD	C3
【PRE_R】
FADD	paclitaxel	C4

In this study , the clinicopathological association of phosphorylated Bcl - 2 ( P - Bcl - 2 ) with estrogen , progesterone , c - erbB - 2 receptors , p53 expressions and phosphorylated FADD / JNK ( P - FADD / JNK ) was analyzed immunohistochemically using 107 human breast cancer specimens .
【GOLD_E】
phosphorylatedBcl-2	geneY
P-Bcl-2	geneY
estrogen,progesterone,c-erbB-2receptors	geneN
p53	geneY
phosphorylatedFADD	geneY
JNK	geneN
P-FADD	geneY
JNK	geneN
estrogen	chem
progesterone	chem
【PRE_E】
phosphorylatedBcl-2	geneY
P-Bcl-2	geneY
estrogen,progesterone,c-erbB-2receptors	geneN
p53	geneY
phosphorylatedFADD	geneY
JNK	geneN
P-FADD	geneY
JNK	geneN
【GOLD_R】
【PRE_R】

Expression of P - Bcl - 2 was found to significantly correlate with lymphatic invasion , lymph node metastasis , but not histological differentiation , tumor grade or vascular and fatty invasion .
【GOLD_E】
P-Bcl-2	geneY
【PRE_E】
P-Bcl-2	geneY
【GOLD_R】
【PRE_R】

The positivity of P - Bcl - 2 was also significantly correlated to that of P - FADD / JNK .
【GOLD_E】
P-Bcl-2	geneY
P-FADD	geneY
JNK	geneN
【PRE_E】
P-Bcl-2	geneY
P-FADD	geneY
JNK	geneN
【GOLD_R】
【PRE_R】

Thus , P - Bcl - 2 as well as the P - FADD / JNK parameter might be useful markers for cancer progression , independent of the hormone receptor status , in human breast cancers .
【GOLD_E】
JNK	geneN
P-Bcl-2	geneY
P-FADD	geneY
【PRE_E】
P-Bcl-2	geneY
P-FADD	geneN
JNK	geneN
hormonereceptor	geneN
【GOLD_R】
【PRE_R】

Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent , carvedilol .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

The mechanism ( s ) responsible for arterial vasodilation observed following acute administration of racemic carvedilol , a novel vasodilator / beta adrenoceptor antagonist , has been investigated in rats .
【GOLD_E】
racemiccarvedilol	chem
betaadrenoceptor	geneN
【PRE_E】
carvedilol	chem
betaadrenoceptor	geneN
【GOLD_R】
racemiccarvedilol	betaadrenoceptor	C6
【PRE_R】

In conscious spontaneously hypertensive rats , carvedilol ( 0.03 - 3.0 mg / kg , iv ) produced a dose - dependent reduction in blood pressure with no significant effect on heart rate .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

Because cardiac output was relatively unaffected , the antihypertensive response of carvedilol was associated with a dose - dependent reduction in total peripheral vascular resistance .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

Submaximal antihypertensive doses of carvedilol were chosen for mechanism of action studies in pithed rats .
【GOLD_E】
carvedilol	chem
【PRE_E】
carvedilol	chem
【GOLD_R】
【PRE_R】

Carvedilol ( 0.3 mg / kg , iv ) produced a significant inhibition of the beta 1 adrenoceptor mediated positive chronotropic response to isoproterenol .
【GOLD_E】
Carvedilol	chem
isoproterenol	chem
beta1adrenoceptor	geneY
【PRE_E】
Carvedilol	chem
beta1adrenoceptor	geneY
isoproterenol	chem
【GOLD_R】
isoproterenol	beta1adrenoceptor	C3
Carvedilol	beta1adrenoceptor	C4
【PRE_R】
Carvedilol	beta1adrenoceptor	C4
beta1adrenoceptor	isoproterenol	C4

This same dose of carvedilol also inhibited , but to a lesser degree , the beta 2 adrenoceptor mediated vasodepressor response to salbutamol in pithed rats whose blood pressure was elevated by a constant intravenous infusion of angiotensin II .
【GOLD_E】
carvedilol	chem
salbutamol	chem
angiotensinII	geneY
beta2adrenoceptor	geneY
【PRE_E】
carvedilol	chem
beta2adrenoceptor	geneY
salbutamol	chem
angiotensinII	geneY
【GOLD_R】
carvedilol	beta2adrenoceptor	C4
【PRE_R】
carvedilol	beta2adrenoceptor	C4
beta2adrenoceptor	salbutamol	C5

Thus , carvedilol blocks both beta 1 and beta 2 adrenoceptors at antihypertensive doses , with modest selectivity being observed for the beta 1 adrenoceptor subtype .
【GOLD_E】
carvedilol	chem
beta1andbeta2adrenoceptors	geneN
beta1adrenoceptor	geneY
【PRE_E】
carvedilol	chem
beta1andbeta2adrenoceptors	geneN
beta1adrenoceptor	geneN
【GOLD_R】
carvedilol	beta1adrenoceptor	C4
【PRE_R】

Carvedilol produced significant inhibition of the alpha 1 adrenoceptor mediated pressor response to cirazoline in the pithed rat , but had no effect on the alpha 2 adrenoceptor mediated pressor response to B - HT 933 , suggesting that carvedilol is also an alpha 1 adrenoceptor antagonist at antihypertensive doses .
【GOLD_E】
Carvedilol	chem
alpha1adrenoceptor	geneN
alpha2adrenoceptor	geneY
alpha1adrenoceptor	geneN
cirazoline	chem
B-HT933	chem
carvedilol	chem
【PRE_E】
Carvedilol	chem
alpha1adrenoceptor	geneY
cirazoline	chem
alpha2adrenoceptor	geneN
B-HT933	chem
carvedilol	chem
alpha1adrenoceptor	geneY
【GOLD_R】
Carvedilol	alpha1adrenoceptor	C4
carvedilol	alpha1adrenoceptor	C6
【PRE_R】
Carvedilol	alpha1adrenoceptor	C4
alpha1adrenoceptor	cirazoline	C5
alpha2adrenoceptor	B-HT933	C6
alpha1adrenoceptor	carvedilol	C5
B-HT933	alpha1adrenoceptor	C6

Carvedilol had no effect on the pressor response elicited by angiotensin II , indicating a lack of nonspecific vasodilator activity .
【GOLD_E】
angiotensinII	geneY
Carvedilol	chem
【PRE_E】
Carvedilol	chem
angiotensinII	geneY
【GOLD_R】
【PRE_R】

The vasopressor response to the calcium channel activator , BAY - K - 8644 , which is mediated through the opening of voltage dependent calcium channels and the subsequent translocation of extracellular calcium , was significantly inhibited by carvedilol ( 1 mg / kg , iv ) , suggesting that carvedilol is also a calcium channel antagonist , consistent with our previous in vitro studies .
【GOLD_E】
calcium	chem
carvedilol	chem
carvedilol	chem
calcium	chem
calciumchannel	geneN
voltagedependentcalciumchannels	geneN
calciumchannel	geneN
calcium	chem
BAY-K-8644	chem
calcium	chem
【PRE_E】
calciumchannel	geneN
BAY-K-8644	chem
voltagedependentcalciumchannels	geneN
calcium	chem
carvedilol	chem
carvedilol	chem
calciumchannel	geneN
【GOLD_R】
BAY-K-8644	calciumchannel	C3
BAY-K-8644	voltagedependentcalciumchannels	C3
carvedilol	voltagedependentcalciumchannels	C4
carvedilol	calciumchannel	C6
calcium	voltagedependentcalciumchannels	C9
【PRE_R】

In anesthetized spontaneously hypertensive rats , the antihypertensive activity of carvedilol was nearly abolished by combined pretreatment of the rats with high doses of the alpha 1 adrenoceptor antagonist , prazosin ( 1 mg / kg , iv ) , and the nonselective beta adrenoceptor antagonist , propranolol ( 3 mg / kg , iv ) , suggesting that the majority of the antihypertensive response produced by carvedilol may be accounted for by blockade of beta and alpha 1 adrenoceptors .
【GOLD_E】
carvedilol	chem
prazosin	chem
propranolol	chem
carvedilol	chem
alpha1adrenoceptor	geneN
betaadrenoceptor	geneN
betaandalpha1adrenoceptors	geneN
【PRE_E】
carvedilol	chem
alpha1adrenoceptor	geneN
prazosin	chem
betaadrenoceptor	geneN
propranolol	chem
carvedilol	chem
betaandalpha1adrenoceptors	geneN
【GOLD_R】
prazosin	alpha1adrenoceptor	C6
propranolol	betaadrenoceptor	C6
【PRE_R】
carvedilol	betaadrenoceptor	C4

We therefore conclude that carvedilol , at antihypertensive doses , is an antagonist of beta 1 , beta 2 , and alpha 1 adrenoceptors , and also of calcium channels in vascular smooth muscle . ( ABSTRACT TRUNCATED AT 400 WORDS )
【GOLD_E】
carvedilol	chem
calcium	chem
beta1,beta2,andalpha1adrenoceptors	geneN
calciumchannels	geneN
【PRE_E】
carvedilol	chem
beta1,beta2,andalpha1adrenoceptors	geneN
calciumchannels	geneN
【GOLD_R】
carvedilol	calciumchannels	C6
【PRE_R】

Clinical , biochemical and molecular diagnosis of a compound homozygote for the 254 bp deletion - 8 bp insertion of the APRT gene suffering from severe renal failure .
【GOLD_E】
APRT	geneY
【PRE_E】
APRT	geneY
【GOLD_R】
【PRE_R】

OBJECTIVE : To determine the type of mutation in a patient with clinical diagnosis of suspected APRT deficiency .
【GOLD_E】
APRT	geneY
【PRE_E】
APRT	geneY
【GOLD_R】
【PRE_R】

DESIGN AND METHODS : A 51 - year - old male patient , with a clinical history of two prior episodes of renal colic with urinary stone excretion ( reported as uric acid stones in the first episode and as calcium oxalate stones in the second ) , was admitted to the hospital with severe non - oliguric renal failure ( 1.06 mmol / L serum creatinine ) , severe hyponatremia ( 114 mmol / L Na ( + ) ) , metabolic acidosis ( 14 mmol / L HCO ( 3 ) ( - ) ) and uricemia in the normal range .
【GOLD_E】
uricacid	chem
calciumoxalate	chem
creatinine	chem
Na(+)	chem
HCO(3)(-)	chem
【PRE_E】
uricacid	chem
calciumoxalate	chem
creatinine	chem
Na(+)	chem
HCO(3)	chem
【GOLD_R】
【PRE_R】

Abnormalities at renal scan and persistency of severe renal failure required to start haemodialysis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results of renal biopsy prompted us to undertake a biochemical and molecular biological evaluation of the patient for suspected adenine phosphoribosyltransferase ( APRT ) deficiency .
【GOLD_E】
adeninephosphoribosyltransferase	geneY
APRT	geneY
adenine	chem
【PRE_E】
adeninephosphoribosyltransferase	geneY
APRT	geneY
【GOLD_R】
【PRE_R】

RESULTS : HPLC analysis of serum and urine , for determining purine derivative profile , showed the pathological presence of adenine in both biological fluids ( 3.57 micromol / L and 7.11 micromol / mmol creatinine in serum and urine , respectively ; not detectable in both fluids in healthy controls ) .
【GOLD_E】
adenine	chem
creatinine	chem
purine	chem
【PRE_E】
purine	chem
adenine	chem
creatinine	chem
【GOLD_R】
【PRE_R】

APRT assay in a sample of patient hemolysate showed no detectable activity of the enzyme ( 25.56 + / - 9.55 U / L red blood cells in control healthy subjects ) .
【GOLD_E】
APRT	geneY
【PRE_E】
APRT	geneY
hemolysate	chem
【GOLD_R】
【PRE_R】

Molecular biological analysis of the amplified APRT gene revealed that the patient harboured in exon 3 a homozygous 254 bp deletion - 8 bp insertion , previously described only once in a compound heterozygote .
【GOLD_E】
APRT	geneY
【PRE_E】
APRT	geneY
【GOLD_R】
【PRE_R】

Analysis of the patient family showed that heterozygotes for this APRT gene mutation , in spite of a 69 % lower APRT enzymatic activity than that of healthy subjects , had no detectable adenine concentrations in both serum and urine .
【GOLD_E】
APRT	geneY
APRT	geneY
adenine	chem
【PRE_E】
APRT	geneY
APRT	geneY
adenine	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : Results of the first patient harbouring the homozygous 254 bp deletion - 8 bp insertion of the APRT gene strongly indicated that definitive diagnosis of APRT deficiency ( often under or misdiagnosed ) would require a combined clinical , biochemical and molecular biological evaluation .
【GOLD_E】
APRT	geneY
APRT	geneY
【PRE_E】
APRT	geneY
APRT	geneY
【GOLD_R】
【PRE_R】

Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase - 1B .
【GOLD_E】
PhospholipaseCgamma1	geneY
Jak2	geneY
proteintyrosinephosphatase-1B	geneY
tyrosine	chem
growthhormone	geneY
【PRE_E】
PhospholipaseCgamma1	geneN
Jak2	geneY
proteintyrosinephosphatase-1B	geneY
【GOLD_R】
【PRE_R】

Growth hormone binds to its membrane receptor ( GHR ) , whereby it regulates many cellular functions , including proliferation , differentiation and chemotaxis .
【GOLD_E】
GHR	geneY
Growthhormone	geneY
【PRE_E】
Growthhormonebindstoitsmembranereceptor	geneY
GHR	geneY
【GOLD_R】
【PRE_R】

However , although the activation of growth hormone - mediated signalling is well understood , the precise mechanism responsible for its regulation has not been elucidated .
【GOLD_E】
growthhormone	geneY
【PRE_E】
growthhormone	geneN
【GOLD_R】
【PRE_R】

Here , we demonstrate that phospholipase Cgamma1 ( PLCgamma1 ) modulates the action of growth hormone - mediated signalling by interacting with tyrosine kinase Jak2 ( janus kinase 2 ) in a growth hormone - dependent manner .
【GOLD_E】
phospholipaseCgamma1	geneY
PLCgamma1	geneY
growthhormone	geneY
tyrosinekinaseJak2	geneY
tyrosine	chem
januskinase2	geneY
growthhormone	geneY
【PRE_E】
phospholipaseCgamma1	geneN
PLCgamma1	geneN
tyrosinekinaseJak2	geneN
januskinase2	geneY
【GOLD_R】
【PRE_R】

In the absence of PLCgamma1 ( PLCgamma1 ( - / - ) ) , growth hormone - induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts ( MEFs ) .
【GOLD_E】
PLCgamma1	geneY
PLCgamma1	geneY
growthhormone	geneY
JAK2	geneY
STAT5	geneY
【PRE_E】
PLCgamma1	geneN
PLCgamma1	geneY
JAK2	geneY
STAT5	geneY
【GOLD_R】
【PRE_R】

Furthermore , the re - expression of PLCgamma1 reduced growth hormone - induced Jak2 activation .
【GOLD_E】
PLCgamma1	geneY
growthhormone	geneY
Jak2	geneY
【PRE_E】
PLCgamma1	geneY
Jak2	geneY
【GOLD_R】
【PRE_R】

Growth hormone - induced Jak2 phosphorylation was enhanced by siRNA - specific knockdown of PLCgamma1 .
【GOLD_E】
Growthhormone	geneY
Jak2	geneY
PLCgamma1	geneY
【PRE_E】
Jak2	geneY
PLCgamma1	geneY
【GOLD_R】
【PRE_R】

Interestingly , PLCgamma1 physically linked Jak2 and protein tyrosine phosphatase - 1B ( PTP - 1B ) by binding to both using different domains , and this process was implicated in the modulation of cytokine signalling through Jak2 .
【GOLD_E】
tyrosine	chem
PLCgamma1	geneY
Jak2	geneY
proteintyrosinephosphatase-1B	geneN
PTP-1B	geneN
cytokine	geneN
Jak2	geneY
【PRE_E】
PLCgamma1	geneY
Jak2	geneY
proteintyrosinephosphatase-1B	geneY
PTP-1B	geneY
cytokine	geneN
Jak2	geneY
【GOLD_R】
【PRE_R】

In addition , in PLCgamma1 ( - / - ) MEFs , growth hormone - dependent c - Fos activation was upregulated and growth hormone - induced proliferation was potentiated .
【GOLD_E】
growthhormone	geneY
PLCgamma1	geneY
growthhormone	geneY
c-Fos	geneY
【PRE_E】
PLCgamma1	geneY
c-Fos	geneY
【GOLD_R】
【PRE_R】

These results suggest that PLCgamma1 has a key function in the regulation of growth hormone - mediated signalling by negatively regulating Jak2 activation .
【GOLD_E】
PLCgamma1	geneY
growthhormone	geneY
Jak2	geneY
【PRE_E】
PLCgamma1	geneN
Jak2	geneY
【GOLD_R】
【PRE_R】

Increased responsiveness of rat colonic splanchnic afferents to 5 - HT after inflammation and recovery .
【GOLD_E】
5-HT	chem
【PRE_E】
5-HT	chem
【GOLD_R】
【PRE_R】

5 - Hydroxytryptamine ( 5 - HT ) activates colonic splanchnic afferents , a mechanism by which it has been implicated in generating symptoms in postinfectious and postinflammatory states in humans .
【GOLD_E】
5-Hydroxytryptamine	chem
5-HT	chem
【PRE_E】
5-Hydroxytryptamine	chem
5-HT	chem
【GOLD_R】
【PRE_R】

Here we compared mechanisms of colonic afferent activation by 5 - HT and mechanical stimuli in normal and inflamed rat colon , and after recovery from inflammation .
【GOLD_E】
5-HT	chem
【PRE_E】
5-HT	chem
【GOLD_R】
【PRE_R】

Colonic inflammation was induced in rats by dextran sulphate sodium .
【GOLD_E】
dextransulphatesodium	chem
【PRE_E】
sulphatesodium	chem
【GOLD_R】
【PRE_R】

Single - fibre recordings of colonic lumbar splanchnic afferents revealed that 58 % of endings responded to 5 - HT ( 10 ( - 4 ) m ) in controls , 88 % in acute inflammation ( P < 0.05 ) and 75 % after 21 days recovery ( P < 0.05 versus control ) .
【GOLD_E】
5-HT	chem
【PRE_E】
5-HT	chem
【GOLD_R】
【PRE_R】

Maximal responses to 5 - HT were also larger , and the estimated EC50 was reduced from 3.2 x 10 ( - 6 ) to 8 x 10 ( - 7 ) m in acute inflammation and recovered to 2 x 10 ( - 6 ) m after recovery .
【GOLD_E】
5-HT	chem
【PRE_E】
5-HT	chem
【GOLD_R】
【PRE_R】

Responsiveness to mechanical stimulation was unaffected .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

5 - HT3 receptor antagonism with alosetron reduced responses to 5 - HT in controls but not during inflammation .
【GOLD_E】
alosetron	chem
5-HT	chem
5-HT3receptor	geneY
【PRE_E】
5-HT3	geneY
alosetron	chem
5-HT	chem
【GOLD_R】
alosetron	5-HT3receptor	C6
【PRE_R】

Responses to the mast cell degranulator 48 / 80 mimicked those to 5 - HT in inflamed tissue but not in controls , and more 5 - HT - containing mast cells were seen close to calcitonin gene - related peptide - containing fibres in inflamed serosa .
【GOLD_E】
calcitoningene-relatedpeptide	geneN
5-HT	chem
5-HT	chem
【PRE_E】
5-HT	chem
5-HT	chem
calcitoningene-relatedpeptide	geneY
【GOLD_R】
【PRE_R】

We conclude that colonic serosal and mesenteric endings exhibit increased sensitivity to 5 - HT in inflammation , with both an increase in proportion of responders and an increase in sensitivity , which is maintained after healing of inflammation .
【GOLD_E】
5-HT	chem
【PRE_E】
5-HT	chem
【GOLD_R】
【PRE_R】

This is associated with alterations in the roles of 5 - HT3 receptors and mast cells .
【GOLD_E】
5-HT3receptors	geneY
【PRE_E】
5-HT3	geneY
【GOLD_R】
【PRE_R】

The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle .
【GOLD_E】
progesterone	chem
progesterone	chem
progesteronereceptor	geneY
【PRE_E】
extranuclear	geneN
progesteronereceptor	geneY
progesterone	chem
【GOLD_R】
【PRE_R】

Human progesterone receptor ( PR ) contains a motif that interacts with the SH3 domain of Src and mediates rapid activation of Src and downstream MAPK ( Erk - 1 / - 2 ) without relying on the transcriptional activity of the receptor .
【GOLD_E】
Humanprogesteronereceptor	geneY
Src	geneY
MAPK	geneN
Erk-1/-2	geneN
PR	geneY
SH3domain	geneN
Src	geneY
progesterone	chem
【PRE_E】
Humanprogesteronereceptor	geneY
PR	geneY
SH3domain	geneN
Src	geneY
Src	geneY
MAPK	geneN
Erk-1/-2	geneN
【GOLD_R】
【PRE_R】

Here we investigated the role and intracellular location of this nontranscriptional activity of PR .
【GOLD_E】
PR	geneY
【PRE_E】
PR	geneN
【GOLD_R】
【PRE_R】

Progestin activation of Src / MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus , but not with PR - A that was predominantly nuclear .
【GOLD_E】
Src	geneY
MAPK	geneN
BisoformofPR	geneY
PR-A	geneY
Progestin	chem
【PRE_E】
Progestin	chem
Src	geneY
MAPK	geneN
BisoformofPR	geneY
PR-A	geneY
【GOLD_R】
Progestin	Src	C3
Progestin	MAPK	C3
【PRE_R】
Progestin	Src	C3
Progestin	MAPK	C3

Breast cancer cells stably expressing wild - type PR - B or PR - B with disrupting point mutations in the SH3 domain binding motif ( PR - BDeltaSH3 ) that do not affect the transcriptional activity of PR , were compared for effects of progestin on endogenous target gene expression and cell proliferation .
【GOLD_E】
PR-B	geneY
PR-B	geneY
SH3domainbindingmotif	geneN
PR-BDeltaSH3	geneN
PR	geneY
progestin	chem
【PRE_E】
PR-B	geneY
PR-B	geneY
SH3domainbindingmotif	geneN
PR-BDeltaSH3	geneY
PR	geneN
progestin	chem
【GOLD_R】
【PRE_R】

Progestin induction of the cyclin D1 gene , which lacks a progesterone response element , was dependent on PR activation of the Src / MAPK pathway , whereas induction of the Sgk ( serum and glucocorticoid regulated kinase ) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src .
【GOLD_E】
progesteroneresponseelement	geneN
PR	geneY
Src	geneY
progesterone	chem
cyclinD1	geneY
progesteroneresponseelement	geneN
PR	geneY
Src	geneY
MAPK	geneN
Sgk	geneY
serumandglucocorticoidregulatedkinase	geneY
Progestin	chem
progesterone	chem
【PRE_E】
Progestin	chem
cyclinD1	geneY
progesteroneresponseelement	geneN
PR	geneN
Src	geneY
MAPK	geneN
Sgk	geneN
serumandglucocorticoidregulatedkinase	geneN
progesteroneresponseelement	geneN
PR	geneN
Src	geneY
【GOLD_R】
Progestin	PR	C3
Progestin	Src	C3
Progestin	MAPK	C3
【PRE_R】

Progestin induction of cell cycle progression was also abrogated in cells expressing PR - BDeltaSH3 , and no effect of progestin on cyclin D1 expression and cell cycle was observed in the presence of PR - A .
【GOLD_E】
PR-BDeltaSH3	geneN
cyclinD1	geneY
PR-A	geneY
Progestin	chem
progestin	chem
【PRE_E】
Progestin	chem
PR-BDeltaSH3	geneY
progestin	chem
cyclinD1	geneY
PR-A	geneY
【GOLD_R】
【PRE_R】
Progestin	PR-BDeltaSH3	C3
PR-BDeltaSH3	progestin	C3

These results highlight the importance of PR activation of the Src / MAPK signaling pathway for progesterone - induced transcription of select target genes and cell cycle progression .
【GOLD_E】
PR	geneY
Src	geneY
MAPK	geneN
progesterone	chem
【PRE_E】
PR	geneY
Src	geneY
MAPK	geneN
progesterone	chem
【GOLD_R】
progesterone	PR	C3
progesterone	Src	C3
progesterone	MAPK	C3
【PRE_R】

Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Selected mutations in the human alpha4 or beta2 neuronal nicotinic acetylcholine receptor subunit genes cosegregate with a partial epilepsy syndrome known as autosomal dominant nocturnal frontal lobe epilepsy ( ADNFLE ) .
【GOLD_E】
humanalpha4orbeta2neuronalnicotinicacetylcholinereceptor	geneN
【PRE_E】
humanalpha4orbeta2neuronalnicotinicacetylcholinereceptor	geneN
ADNFLE	geneY
【GOLD_R】
【PRE_R】

To examine possible mechanisms underlying this inherited epilepsy , we engineered two ADNFLE mutations ( Chrna4 ( S252F ) and Chrna4 ( + L264 ) ) in mice .
【GOLD_E】
Chrna4	geneY
S252F	geneN
Chrna4	geneY
【PRE_E】
ADNFLE	geneY
Chrna4	geneY
S252F	geneY
Chrna4	geneY
L264	geneY
【GOLD_R】
【PRE_R】

Heterozygous ADNFLE mutant mice show persistent , abnormal cortical electroencephalograms with prominent delta and theta frequencies , exhibit frequent spontaneous seizures , and show an increased sensitivity to the proconvulsant action of nicotine .
【GOLD_E】
nicotine	chem
【PRE_E】
ADNFLE	geneY
proconvulsant	chem
nicotine	chem
【GOLD_R】
【PRE_R】

Relative to WT , electrophysiological recordings from ADNFLE mouse layer II / III cortical pyramidal cells reveal a > 20 - fold increase in nicotine - evoked inhibitory postsynaptic currents with no effect on excitatory postsynaptic currents . i.p . injection of a subthreshold dose of picrotoxin , a use - dependent gamma - aminobutyric acid receptor antagonist , reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice .
【GOLD_E】
gamma-aminobutyricacidreceptor	geneN
nicotine	chem
picrotoxin	chem
gamma-aminobutyricacid	chem
【PRE_E】
ADNFLE	geneY
nicotine	chem
picrotoxin	chem
gamma-aminobutyricacidreceptor	geneN
ADNFLE	geneY
【GOLD_R】
picrotoxin	gamma-aminobutyricacidreceptor	C6
【PRE_R】

Our studies suggest that the mechanism underlying ADNFLE seizures may involve inhibitory synchronization of cortical networks via activation of mutant alpha4 - containing nicotinic acetylcholine receptors located on the presynaptic terminals and somatodendritic compartments of cortical GABAergic interneurons .
【GOLD_E】
alpha4-containingnicotinicacetylcholinereceptors	geneY
【PRE_E】
ADNFLE	geneY
alpha4-containingnicotinicacetylcholinereceptors	geneN
【GOLD_R】
【PRE_R】

Molecular recognition of histidine tRNA by histidyl - tRNA synthetase from hyperthermophilic archaeon , Aeropyrum pernix K1 .
【GOLD_E】
histidyl-tRNAsynthetase	geneY
histidine	chem
【PRE_E】
histidine	chem
histidyl-tRNAsynthetase	geneN
AeropyrumpernixK1	geneN
【GOLD_R】
【PRE_R】

To investigate the recognition sites of histidine tRNA for histidyl - tRNA synthetase from an extreme hyperthermophilic archaeon , Aeropyrum pernix K1 , we examined histidylation activities by using overexpressed histidyl - tRNA synthetase and various histidine tRNA transcripts that were prepared by in vitro transcription system .
【GOLD_E】
histidyl	chem
histidine	chem
histidine	chem
histidyl-tRNAsynthetase	geneY
histidyl-tRNAsynthetase	geneY
【PRE_E】
histidine	chem
histidyl-tRNAsynthetase	geneN
AeropyrumpernixK1	geneN
histidyl-tRNAsynthetase	geneN
histidinetRNA	geneN
【GOLD_R】
【PRE_R】

Results indicated that anticodon was not recognized by the histidyl - tRNA synthetase similar to that of Escherichia coli histidine tRNA recognition system .
【GOLD_E】
histidyl	chem
histidine	chem
histidyl-tRNAsynthetase	geneY
【PRE_E】
histidyl-tRNAsynthetase	geneN
histidine	chem
【GOLD_R】
【PRE_R】

Discriminator base C73 was weekly recognized and an additional G residue was specifically recognized by the enzyme .
【GOLD_E】
【PRE_E】
C73	geneN
G	geneN
【GOLD_R】
【PRE_R】

Synthesis , radiosynthesis , and biological evaluation of carbon - 11 labeled 2beta - carbomethoxy - 3beta - ( 3 ' - ( ( Z ) - 2 - haloethenyl ) phenyl ) nortropanes : candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography .
【GOLD_E】
serotonin	chem
carbon-11labeled2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes	chem
serotonintransporter	geneY
【PRE_E】
radiosynthesis	chem
carbon	chem
2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes	chem
serotonintransporter	geneY
【GOLD_R】
【PRE_R】

2beta - carbomethoxy - 3beta - ( 3 ' - ( ( Z ) - 2 - iodoethenyl ) phenyl ) nortropane ( mZIENT , 1 ) and 2beta - carbomethoxy - 3beta - ( 3 ' - ( ( Z ) - 2 - bromoethenyl ) phenyl ) nortropane ( mZBrENT , 2 ) were synthesized and evaluated for binding to the human serotonin , dopamine , and norepinephrine transporters ( SERT , DAT , and NET , respectively ) using transfected cells .
【GOLD_E】
2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane	chem
humanserotonin,dopamine,andnorepinephrinetransporters	geneN
SERT	geneY
DAT	geneY
NET	geneY
2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane	chem
mZBrENT	chem
serotonin	chem
dopamine	chem
norepinephrine	chem
mZIENT	chem
【PRE_E】
2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane	chem
mZIENT,1)	chem
2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane	chem
mZBrENT,2)	chem
humanserotonin,dopamine,andnorepinephrinetransporters	geneN
SERT	geneY
DAT	geneY
NET	geneY
【GOLD_R】
【PRE_R】

Both 1 and 2 have a high affinity for the SERT ( Ki = 0.2 nM ) and are approximately 160 times more selective for the SERT than the DAT .
【GOLD_E】
SERT	geneY
SERT	geneY
DAT	geneY
【PRE_E】
SERT	geneY
SERT	geneY
DAT	geneY
【GOLD_R】
【PRE_R】

Compound 2 has a significantly higher affinity for the NET than 1 , and this may be a result of the different size and electronegativity of the halogen atoms .
【GOLD_E】
NET	geneY
halogen	chem
【PRE_E】
NET	geneY
halogen	chem
【GOLD_R】
【PRE_R】

MicroPET imaging in nonhuman primates with [ 11C ] 1 and [ 11C ] 2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the SERT - rich brain regions and peak uptake being achieved in about 55 min postinjection .
【GOLD_E】
SERT	geneN
11C	chem
11C	chem
【PRE_E】
MicroPET	chem
[11C]1	chem
[11C]2	chem
SERT	geneY
【GOLD_R】
11C	SERT	C9
11C	SERT	C9
【PRE_R】

Chase studies with citalopram and methylphenidate demonstrated that this uptake is the result of preferential binding to the SERT .
【GOLD_E】
citalopram	chem
methylphenidate	chem
SERT	geneN
【PRE_E】
citalopram	chem
methylphenidate	chem
SERT	geneY
【GOLD_R】
【PRE_R】

Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects .
【GOLD_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【PRE_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

BACKGROUND : Hypertension treatment guidelines recommend combination therapy with diuretics and other antihypertensive agents , including angiotensin II type 1 ( AT1 ) receptor antagonists .
【GOLD_E】
angiotensinIItype1(AT1)receptor	geneY
angiotensinII	chem
【PRE_E】
angiotensinIItype1(AT1)receptor	geneY
【GOLD_R】
【PRE_R】

This trial investigated the possibility of pharmacokinetic interactions between the AT1 receptor antagonist olmesartan medoxomil and the thiazide diuretic hydrochlorothiazide in healthy subjects .
【GOLD_E】
olmesartanmedoxomil	chem
thiazide	chem
hydrochlorothiazide	chem
AT1receptor	geneY
【PRE_E】
AT1	geneY
olmesartan	chem
medoxomil	chem
thiazide	chem
hydrochlorothiazide	chem
【GOLD_R】
olmesartanmedoxomil	AT1receptor	C6
【PRE_R】
AT1	olmesartan	C6
AT1	medoxomil	C6
AT1	thiazide	C6

METHODS : Twenty - four healthy normotensive adult male subjects underwent three consecutive 7 - day treatment periods ( A , B and C , respectively ) during which they were randomised to receive : olmesartan medoxomil 20 mg once daily ( regimen A ) , hydrochlorothiazide 25 mg once daily ( regimen B ) , or olmesartan medoxomil 20 mg once daily plus hydrochlorothiazide 25 mg once daily ( regimen C ) .
【GOLD_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【PRE_E】
olmesartan	chem
hydrochlorothiazide	chem
olmesartan	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Treatment periods were separated by washouts of 7 - 14 days .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The primary pharmacokinetic parameters evaluated were : the area under the plasma concentration versus time curve at steady state ( AUCss , tau ) , the maximum plasma concentration at steady state ( Css , max ) , and the time at which Css , max occurred ( tmax ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Complete data sets from 17 subjects were available for pharmacokinetic analyses .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mean concentration versus time profiles were similar for monotherapy and combination treatment for both olmesartan ( the active metabolite of olmesartan medoxomil ) and hydrochlorothiazide .
【GOLD_E】
olmesartan	chem
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【PRE_E】
olmesartan	chem
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

For olmesartan , comparison of monotherapy with combination therapy showed that for AUCss , tau and Css , max point estimates were close to unity , demonstrating bioequivalence .
【GOLD_E】
olmesartan	chem
【PRE_E】
olmesartan	chem
【GOLD_R】
【PRE_R】

For hydrochlorothiazide , combination therapy resulted in decreases in AUCss , tau and Css , max of approximately 10 % versus monotherapy ; nevertheless , since 90 % CIs were within the acceptance range , bioequivalence was proven .
【GOLD_E】
hydrochlorothiazide	chem
【PRE_E】
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Median tmax values for olmesartan and hydrochlorothiazide for periods A , B and C were identical , indicating bioequivalence .
【GOLD_E】
olmesartan	chem
hydrochlorothiazide	chem
【PRE_E】
olmesartan	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Both olmesartan medoxomil and hydrochlorothiazide were well tolerated .
【GOLD_E】
hydrochlorothiazide	chem
olmesartanmedoxomil	chem
【PRE_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

CONCLUSION : These results show that there is little or no potential for a clinically relevant pharmacokinetic interaction between olmesartan medoxomil 20 mg and hydrochlorothiazide 25 mg , and therefore dosage adjustment should not be necessary when they are co - administered .
【GOLD_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【PRE_E】
olmesartanmedoxomil	chem
hydrochlorothiazide	chem
【GOLD_R】
【PRE_R】

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models .
【GOLD_E】
S100P	geneY
【PRE_E】
cromolyn	chem
S100P	geneY
RAGE	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : We previously found that S100P , a member of the S100 protein family , is expressed in more than 90 % of pancreatic tumors and is associated with tumor growth and invasion .
【GOLD_E】
S100P	geneY
S100	geneN
【PRE_E】
S100P	geneY
S100	geneN
【GOLD_R】
【PRE_R】

In the current study , we investigated the ability of the antiallergy drug , cromolyn , to block S100P function .
【GOLD_E】
S100P	geneY
【PRE_E】
antiallergy	chem
cromolyn	chem
S100P	geneY
【GOLD_R】
【PRE_R】
antiallergy	S100P	C4
cromolyn	S100P	C4

METHODS : Interactions between cromolyn and S100P were investigated using a drug affinity column and by examining cromolyn 's effects on coimmunoprecipitation of S100P and receptor for advanced glycation end - products ( RAGE ) .
【GOLD_E】
S100P	geneY
S100P	geneY
【PRE_E】
cromolyn	chem
S100P	geneY
S100P	geneY
RAGE	geneY
【GOLD_R】
【PRE_R】

The effects of cromolyn on cell growth , invasion , and nuclear factor - kappaB ( NFkappaB ) activity of pancreatic cancer cells with ( BxPC - 3 and MPanc - 96 ) and without ( Panc - 1 ) endogenous S100P were investigated by cell proliferation assay , by cell invasion assay , and by luciferase reporter gene assay , respectively .
【GOLD_E】
nuclearfactor-kappaB	geneN
NFkappaB	geneN
S100P	geneY
【PRE_E】
cromolyn	chem
nuclearfactor-kappaB	geneN
NFkappaB	geneN
Panc-1	geneY
S100P	geneY
【GOLD_R】
【PRE_R】

The effects of cromolyn on tumor growth in vivo were investigated in three orthotopic models ( n = 20 mice per model ) by administration of cromolyn ( 5 mg / kg body weight , daily ) with and without gemcitabine ( 125 mg / kg body weight , biweekly ) , the drug currently used to treat pancreatic cancer .
【GOLD_E】
gemcitabine	chem
【PRE_E】
cromolyn	chem
cromolyn	chem
gemcitabine	chem
【GOLD_R】
【PRE_R】

Tumor growth was assayed by reporter gene expression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All statistical tests were two - sided .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : S100P was retained on a cromolyn affinity column .
【GOLD_E】
S100P	geneY
【PRE_E】
S100P	geneY
cromolyn	chem
【GOLD_R】
【PRE_R】

Cromolyn blocked the coimmunoprecipitation of S100P and RAGE .
【GOLD_E】
S100P	geneY
【PRE_E】
Cromolyn	chem
coimmunoprecipitation	geneY
S100P	geneY
RAGE	geneY
【GOLD_R】
【PRE_R】
Cromolyn	coimmunoprecipitation	C4
Cromolyn	S100P	C4
Cromolyn	RAGE	C4

In vitro , cromolyn ( 100 microM ) inhibited S100P - stimulated Panc - 1 cell proliferation ( S100P , mean = 0.93 U , versus S100P + cromolyn , mean = 0.56 U , difference = 0.37 U ; 95 % confidence interval [ CI ] = 0.24 to 0.49 U ; P = .001 , n = 3 ) , invasion ( S100P , mean = 58.0 % , versus S100P + cromolyn , mean = 9.4 % , difference = 48.6 % ; 95 % CI = 38.8 % to 58.8 % ; P < .001 , n = 3 ) , and NFkappaB activity ( S100P , mean = 14,460 , versus S100P + cromolyn , mean = 7360 photons / s , difference = 7100 photons / s ; 95 % CI = 3689 to 10 510 photons / s ; P = .005 , n = 3 ) .
【GOLD_E】
S100P	geneY
S100P	geneY
S100P	geneY
NFkappaB	geneN
S100P	geneY
S100P	geneY
S100P	geneY
S100P	geneY
【PRE_E】
cromolyn	chem
S100P	geneY
S100P	geneY
S100P	geneY
cromolyn	chem
S100P	geneY
S100P	geneY
cromolyn	chem
NFkappaB	geneN
S100P	geneY
S100P	geneY
cromolyn	chem
【GOLD_R】
【PRE_R】
cromolyn	S100P	C4
cromolyn	S100P	C4
S100P	cromolyn	C4
cromolyn	S100P	C4
S100P	cromolyn	C4
cromolyn	NFkappaB	C4
cromolyn	S100P	C4
S100P	cromolyn	C4

In vivo , cromolyn inhibited tumor growth in mice bearing tumor with endogenous S100P ( BxPC - 3 : control , mean = 1.6 x 10 ( 9 ) photons / s , versus cromolyn , mean = 4.4 x 10 ( 8 ) photons / s , difference = 1.2 x 10 ( 9 ) photons / s ; 95 % CI = 6.2 x 10 ( 8 ) to 1.6 x 10 ( 9 ) photons / s ; P < .001 , n = 5 ; MPanc - 96 : control , mean = 1.1 x 10 ( 10 ) photons / s , versus cromolyn , mean = 4.8 x 10 ( 9 ) photons / s , difference = 6.2 x 10 ( 9 ) photons / s ; 95 % CI = 1.9 x 10 ( 9 ) to 1.0 x 10 ( 10 ) photons / s ; P = .009 , n = 5 ) and increased the effectiveness of gemcitabine ( BxPC - 3 : gemcitabine , mean = 9.2 x 10 ( 8 ) photons / s , versus combination , mean = 1.8 x 10 ( 8 ) photons / s , difference = 7.4 x 10 ( 8 ) photons / s ; 95 % CI = 4.5 x 10 ( 8 ) to 1.0 x 10 ( 9 ) photons / s ; P < .001 ; MPanc - 96 : gemcitabine , mean = 4.1 x 10 ( 9 ) photons / s , versus combination , mean = 2.0 x 10 ( 9 ) photons / s , difference = 2.1 x 10 ( 9 ) photons / s ; 95 % CI = 4.4 x 10 ( 8 ) to 3.8 x 10 ( 9 ) photons / s ; P < .001 ) .
【GOLD_E】
S100P	geneY
gemcitabine	chem
gemcitabine	chem
gemcitabine	chem
【PRE_E】
cromolyn	chem
S100P	geneY
BxPC-3	geneY
cromolyn	chem
cromolyn	chem
【GOLD_R】
【PRE_R】
cromolyn	S100P	C4
BxPC-3	cromolyn	C4

However , cromolyn had no effect on growth of tumors lacking S100P ( Panc - 1 ) .
【GOLD_E】
S100P	geneY
【PRE_E】
cromolyn	chem
S100P	geneY
Panc-1	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : Cromolyn binds S100P , prevents activation of RAGE , inhibits tumor growth , and increases the effectiveness of gemcitabine in experimental models .
【GOLD_E】
S100P	geneY
gemcitabine	chem
【PRE_E】
Cromolyn	chem
S100P	geneY
RAGE	geneY
gemcitabine	chem
【GOLD_R】
【PRE_R】
Cromolyn	S100P	C4
RAGE	gemcitabine	C4

Genetic polymorphisms in the cyclooxygenase - 2 gene , use of nonsteroidal anti - inflammatory drugs , and breast cancer risk .
【GOLD_E】
cyclooxygenase-2	geneY
【PRE_E】
cyclooxygenase-2	geneY
【GOLD_R】
【PRE_R】

INTRODUCTION : The association between use of nonsteroidal anti - inflammatory drugs ( NSAIDs ) and breast cancer risk remains unclear .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Inconsistencies in previously reported findings may be partly due to differences in expression of cyclooxygenase ( COX ) - 2 .
【GOLD_E】
cyclooxygenase(COX)-2	geneY
【PRE_E】
cyclooxygenase(COX)-2	geneY
【GOLD_R】
【PRE_R】

We hypothesized that genetic polymorphisms ( COX - 2 .926 , COX - 2 .5209 , and COX - 2 .8473 ) may reduce overall breast cancer risk or risk for subtypes of breast cancer by modulating the inflammatory response and may interact with aspirin or any NSAID use .
【GOLD_E】
COX-2	geneY
COX-2	geneY
COX-2	geneY
【PRE_E】
COX-2	geneY
COX-2	geneY
COX-2	geneY
aspirin	chem
【GOLD_R】
【PRE_R】

METHODS : We conducted a population - based , case - control study in which we genotyped 1,067 breast cancer cases and 1,110 control individuals included in the Long Island Breast Cancer Study Project .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : No major effects of the three COX - 2 variant alleles on breast cancer risk were found .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

A total of eight distinct haplotypes and 18 diplotypes were observed in the population .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overall , no significant associations between COX - 2 haplotypes / diplotypes and breast cancer risk were observed .
【GOLD_E】
COX-2	geneN
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Among women who used aspirin or any NSAID there was little evidence for an interaction with the at - risk COX - 2 genotypes , with one exception .
【GOLD_E】
COX-2	geneY
【PRE_E】
aspirin	chem
COX-2	geneY
【GOLD_R】
【PRE_R】

Among women with hormone receptor positive breast cancer , the reduced risk for any NSAID use was only evident among those who had at least one variant C allele of COX - 2 .8473 ( odds ratio = 0.7 , 95 % confidence interval = 0.5 to 1.0 ; P for the interaction = 0.02 ) .
【GOLD_E】
COX-2	geneY
【PRE_E】
hormonereceptor	geneN
COX-2	geneY
【GOLD_R】
【PRE_R】

There was no corresponding interaction for aspirin use , possibly because of limited power .
【GOLD_E】
【PRE_E】
aspirin	chem
【GOLD_R】
【PRE_R】

CONCLUSION : These data provide modest evidence that the C allele of COX - 2 .8473 may interact with NSAIDs to reduce risk for hormone receptor positive breast cancer .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
hormonereceptor	geneN
【GOLD_R】
【PRE_R】

Biosynthesis of selenocysteine on its tRNA in eukaryotes .
【GOLD_E】
selenocysteine	chem
【PRE_E】
selenocysteine	chem
【GOLD_R】
【PRE_R】

Selenocysteine ( Sec ) is cotranslationally inserted into protein in response to UGA codons and is the 21st amino acid in the genetic code .
【GOLD_E】
Selenocysteine	chem
UGA	geneN
aminoacid	chem
Sec	chem
【PRE_E】
Selenocysteine	chem
UGA	geneN
aminoacid	chem
【GOLD_R】
【PRE_R】

However , the means by which Sec is synthesized in eukaryotes is not known .
【GOLD_E】
Sec	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Herein , comparative genomics and experimental analyses revealed that the mammalian Sec synthase ( SecS ) is the previously identified pyridoxal phosphate - containing protein known as the soluble liver antigen .
【GOLD_E】
mammalianSecsynthase	geneY
SecS	geneY
solubleliverantigen	geneY
Sec	chem
pyridoxalphosphate	chem
【PRE_E】
mammalianSecsynthase(SecS)	geneY
pyridoxalphosphate	chem
【GOLD_R】
【PRE_R】

SecS required selenophosphate and O - phosphoseryl - tRNA ( [ Ser ] Sec ) as substrates to generate selenocysteyl - tRNA ( [ Ser ] Sec ) .
【GOLD_E】
O-phosphoseryl	chem
selenocysteyl	chem
SecS	geneY
selenophosphate	chem
【PRE_E】
O-phosphoseryl-tRNA	chem
Ser	chem
selenocysteyl-tRNA	chem
Ser	chem
【GOLD_R】
selenocysteyl	SecS	C9
O-phosphoseryl	SecS	C9
selenophosphate	SecS	C9
【PRE_R】

Moreover , it was found that Sec was synthesized on the tRNA scaffold from selenide , ATP , and serine using tRNA ( [ Ser ] Sec ) , seryl - tRNA synthetase , O - phosphoseryl - tRNA ( [ Ser ] Sec ) kinase , selenophosphate synthetase , and SecS .
【GOLD_E】
Sec	chem
selenide	chem
ATP	chem
serine	chem
seryl	chem
O-phosphoseryl	chem
selenophosphate	chem
Sec	geneY
seryl-tRNAsynthetase	geneY
O-phosphoseryl-tRNA([Ser]Sec)kinase	geneY
selenophosphatesynthetase	geneN
SecS	geneY
【PRE_E】
selenide	chem
ATP	chem
serine	chem
tRNA([Ser]Sec	geneN
seryl-tRNAsynthetase	geneY
O-phosphoseryl-tRNA([Ser]Sec)kinase	geneN
selenophosphatesynthetase	geneY
【GOLD_R】
【PRE_R】

By identifying the pathway of Sec biosynthesis in mammals , this study not only functionally characterized SecS but also assigned the function of the O - phosphoseryl - tRNA ( [ Ser ] Sec ) kinase .
【GOLD_E】
Sec	chem
O-phosphoseryl	chem
SecS	geneY
O-phosphoseryl-tRNA([Ser]Sec)kinase	geneY
【PRE_E】
O-phosphoseryl-tRNA([Ser]Sec)kinase	geneN
【GOLD_R】
【PRE_R】

In addition , we found that selenophosphate synthetase 2 could synthesize monoselenophosphate in vitro but selenophosphate synthetase 1 could not .
【GOLD_E】
selenophosphate	chem
selenophosphatesynthetase1	geneY
monoselenophosphate	chem
selenophosphatesynthetase2	geneY
selenophosphate	chem
【PRE_E】
selenophosphatesynthetase2	geneY
monoselenophosphate	chem
selenophosphatesynthetase1	geneY
【GOLD_R】
monoselenophosphate	selenophosphatesynthetase2	C9
【PRE_R】

Conservation of the overall pathway of Sec biosynthesis suggests that this pathway is also active in other eukaryotes and archaea that synthesize selenoproteins .
【GOLD_E】
selenoproteins	geneN
【PRE_E】
selenoproteins	geneN
【GOLD_R】
【PRE_R】

Effects of triflusal and aspirin in a rat model of cerebral ischemia .
【GOLD_E】
triflusal	chem
aspirin	chem
【PRE_E】
triflusal	chem
aspirin	chem
【GOLD_R】
【PRE_R】

BACKGROUND AND PURPOSE : Neuroinflammation plays a critical role in the pathogenesis of cerebral ischemia .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Triflusal , a selective cyclooxygenase - 2 , and its active metabolite 3 - hydroxy - 4 - trifluoromethylbenzoic acid may inhibit apoptosis and inflammation after cerebral ischemia .
【GOLD_E】
cyclooxygenase-2	geneY
Triflusal	chem
3-hydroxy-4-trifluoromethylbenzoicacid	chem
【PRE_E】
Triflusal	chem
cyclooxygenase-2	geneY
3-hydroxy-4-trifluoromethylbenzoicacid	chem
【GOLD_R】
【PRE_R】
Triflusal	cyclooxygenase-2	C4
cyclooxygenase-2	3-hydroxy-4-trifluoromethylbenzoicacid	C4

An in vivo model of cerebral ischemia was used to investigate the effects of triflusal and aspirin treatment on infarct volume , and inflammation after cerebral ischemia in the rat .
【GOLD_E】
aspirin	chem
triflusal	chem
【PRE_E】
triflusal	chem
aspirin	chem
【GOLD_R】
【PRE_R】

METHODS : Male Wistar rats were subjected to a permanent right - sided middle cerebral artery occlusion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rats received oral administration of either triflusal or aspirin .
【GOLD_E】
triflusal	chem
aspirin	chem
【PRE_E】
triflusal	chem
aspirin	chem
【GOLD_R】
【PRE_R】

After 3 days after surgery , immunostaining was used to detect neuroinflammatory cells and molecules , and infarct volumes were measured .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Both triflusal and aspirin at a dose of 30 mg / kg but not 10 mg / kg significantly reduced infarct volume compared with vehicle treatment .
【GOLD_E】
triflusal	chem
aspirin	chem
【PRE_E】
triflusal	chem
aspirin	chem
【GOLD_R】
【PRE_R】

Middle cerebral artery occlusion resulted in increased astrocyte and heat shock protein - 27 ( Hsp27 ) immunostaining in the ipsilateral cortex .
【GOLD_E】
heatshockprotein-27	geneY
Hsp27	geneY
【PRE_E】
astrocyteandheatshockprotein-27	geneY
Hsp27	geneY
【GOLD_R】
【PRE_R】

Triflusal ( 30 mg / kg ) or aspirin treatment ( 30 mg / kg ) did not reduce the levels of GFAP or Hsp27 immunostaining .
【GOLD_E】
GFAP	geneY
Hsp27	geneY
Triflusal	chem
aspirin	chem
【PRE_E】
Triflusal	chem
aspirin	chem
GFAP	geneY
Hsp27	geneY
【GOLD_R】
【PRE_R】
Triflusal	GFAP	C4
aspirin	GFAP	C4
aspirin	Hsp27	C4

Triflusal ( 30 mg / kg ) also significantly decreased the protein levels of IL - Ibeta but not nuclear factor kappa B or tumor necrosis factor - alpha in the cortex ipsilateral to the middle cerebral artery occlusion .
【GOLD_E】
IL-Ibeta	geneY
nuclearfactorkappaB	geneN
tumornecrosisfactor-alpha	geneY
Triflusal	chem
【PRE_E】
Triflusal	chem
IL-Ibeta	geneY
nuclearfactorkappaB	geneN
tumornecrosisfactor-alpha	geneY
【GOLD_R】
Triflusal	IL-Ibeta	C4
【PRE_R】
Triflusal	IL-Ibeta	C4
Triflusal	nuclearfactorkappaB	C4
Triflusal	tumornecrosisfactor-alpha	C4

CONCLUSIONS : The results suggest that triflusal and aspirin appear to be equally neuroprotective against middle cerebral artery occlusion - induced cerebral ischemia .
【GOLD_E】
triflusal	chem
aspirin	chem
【PRE_E】
triflusal	chem
aspirin	chem
【GOLD_R】
【PRE_R】

Therefore , strong rationale exists to continue the neuroprotective examination of triflusal in brain injury .
【GOLD_E】
triflusal	chem
【PRE_E】
triflusal	chem
【GOLD_R】
【PRE_R】

Differential expression of glycans in the hippocampus of rats trained on an inhibitory learning paradigm .
【GOLD_E】
【PRE_E】
glycans	geneN
【GOLD_R】
【PRE_R】

The glycan chains of glycoconjugates play important roles in cell - cell and cell - matrix interactions .
【GOLD_E】
【PRE_E】
glycoconjugates	geneN
【GOLD_R】
【PRE_R】

In the CNS , previous studies on learning and memory suggest the importance of oligosaccharides attached to glycoconjugates in the modulation of synaptic connections .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We studied the hippocampal glycan distribution of rats subject to an inhibitory avoidance task .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The expression of glycans was examined by lectin - histochemistry using Vicia villosa lectin ( VVL ) for terminal alpha / beta N - acetylgalactosamine ( alpha / beta GalNAc ) ; Galanthus nivalus lectin ( GNL ) for terminal mannose alpha - 1,3 ( Man alpha - 1,3 ) ; Peanut agglutinin ( PNA ) for galactose beta - 1,3N - acetylgalactosamine ( Gal beta - 1,3 GalNAc ) ; Erythrina cristagalli lectin ( ECL ) for galactose beta - 1,4 N - acetylglucosamine ( Gal beta - 1,4 GlcNAc ) ; Sambucus nigra lectin ( SNA ) for sialic acid alpha - 2.6 galactose ( SA alpha - 2,6 Gal ) ; Maackia amurensis lectin II ( MAL II ) for sialic acid alpha - 2,3 ( SA alpha - 2,3 ) ; Wheat germ agglutinin ( WGA ) for terminal N - acetylglucosamine with / without sialic acid ( GlcNAc wo SA ) ; succynilated WGA ( sWGA ) for terminal N - acetylglucosamine without sialic acid ( terminal GlcNAc without SA ) ; Griffonia simplicifolia lectin II ( GSL II ) for terminal alpha / beta N - acetylglucosamine ( alpha / beta GlcNAc terminal ) ; and Lotus tetragonolobus lectin ( LTL ) alpha - fucose .
【GOLD_E】
alpha/betaGlcNAc	chem
alpha-fucose	chem
alpha/betaN-acetylgalactosamine	chem
alpha/betaGalNAc	chem
mannosealpha-1,3	chem
N-acetylglucosamine	chem
Manalpha-1,3	chem
galactosebeta-1,3N-acetylgalactosamine	chem
Galbeta-1,3GalNAc	chem
galactosebeta-1,4N-acetylglucosamine	chem
Galbeta-1,4GlcNAc	chem
sialicacidalpha-2.6galactose	chem
SAalpha-2,6Gal	chem
sialicacidalpha-2,3	chem
SAalpha-2,3	chem
GriffoniasimplicifolialectinII	geneN
sialicacid	chem
GSLII	geneN
Lotustetragonolobuslectin	geneY
LTL	geneY
lectin	geneN
Viciavillosalectin	geneN
VVL	geneN
Galanthusnivaluslectin	geneY
GlcNAc	chem
GNL	geneY
Peanutagglutinin	geneY
PNA	geneY
Erythrinacristagallilectin	geneY
ECL	geneY
Sambucusnigralectin	geneY
SNA	geneY
MaackiaamurensislectinII	geneN
MALII	geneN
Wheatgermagglutinin	geneN
SA	chem
WGA	geneN
N-acetylglucosamine	chem
sialicacid	chem
GlcNAc	chem
SA	chem
alpha/betaN-acetylglucosamine	chem
【PRE_E】
glycans	geneN
lectin-histochemistryusingViciavillosalectin	geneN
VVL	geneN
alpha/betaN-acetylgalactosamine(alpha/betaGalNAc	geneN
Galanthusnivaluslectin	geneN
GNL	geneY
mannosealpha-1,3	chem
alpha-1,3	chem
galactosebeta-1,3N-acetylgalactosamine	geneN
Galbeta-1,3GalNAc	geneY
Erythrinacristagallilectin	geneN
ECL	geneN
galactosebeta-1,4N-acetylglucosamine	chem
Galbeta-1,4GlcNAc	chem
Sambucusnigralectin	geneN
sialicacidalpha-2.6galactose	chem
SAalpha-2,6Gal	chem
MaackiaamurensislectinII	geneY
MAL	geneN
【GOLD_R】
【PRE_R】
mannosealpha-1,3	ECL	C9
ECL	galactosebeta-1,4N-acetylglucosamine	C9
Galbeta-1,4GlcNAc	Sambucusnigralectin	C9
Sambucusnigralectin	sialicacidalpha-2.6galactose	C9
SAalpha-2,6Gal	MaackiaamurensislectinII	C9

Two groups of 10 animals were examined : non - trained ( Control ) and Trained rats .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

ECL , sWGA and GSL II were negative for both groups in all the hippocampal subfields studied .
【GOLD_E】
ECL	geneN
sWGA	geneN
GSLII	geneN
【PRE_E】
sWGA	geneY
GSLII	geneY
【GOLD_R】
【PRE_R】

For both groups , VVL was negative in CA4 and granular cells of the Dentate Gyrus ( DG ) and LTL was negative in the CA4 subfield .
【GOLD_E】
【PRE_E】
VVL	geneN
CA4	chem
【GOLD_R】
【PRE_R】

Expression of alpha / beta GalNAc , alpha - fucose and GlcNAc in other hippocampal subflields was positive , with no differences between groups .
【GOLD_E】
GalNAc	chem
alpha-fucose	chem
GlcNAc	chem
【PRE_E】
alpha/betaGalNAc	geneN
alpha-fucose	chem
GlcNAc	chem
【GOLD_R】
【PRE_R】

However , expression of Man alpha - 1,3 was significantly higher in the CA1 , CA2 , CA3 , and CA4 subfields in the Trained group .
【GOLD_E】
Manalpha-1,3	chem
【PRE_E】
alpha-1,3	chem
CA2	chem
CA4	chem
【GOLD_R】
【PRE_R】

On the other hand , expression of Gal beta - 1,3 GalNAc was significantly low in CA4 and DG in the Trained group .
【GOLD_E】
Galbeta-1,3GalNAc	chem
【PRE_E】
Galbeta-1,3GalNAc	geneY
CA4	chem
DG	chem
【GOLD_R】
【PRE_R】

In conclusion , the results here presented indicate that the exposure of rats to an associative behavioral paradigm related to declarative memory , involves some regulatory mechanism / s for the differential patterns of glycan expression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin - proteasome system to regulate surface expression of GluR2 .
【GOLD_E】
Glutamate	chem
glutamate	chem
GluR2	geneY
glutamatereceptorinteractingprotein1	geneY
ubiquitin	geneN
proteasome	geneN
【PRE_E】
Glutamate	chem
glutamatereceptorinteractingprotein1	geneY
ubiquitin	geneN
proteasome	geneN
GluR2	geneY
【GOLD_R】
Glutamate	glutamatereceptorinteractingprotein1	C4
【PRE_R】

The glutamate receptor interacting protein 1 ( GRIP1 ) is a scaffolding protein in postsynaptic density ( PSD ) , tethering AMPA receptors to other signaling proteins .
【GOLD_E】
AMPA	chem
AMPAreceptors	geneN
glutamatereceptorinteractingprotein1	geneY
GRIP1	geneY
glutamate	chem
【PRE_E】
glutamatereceptorinteractingprotein1	geneY
GRIP1	geneY
AMPAreceptors	geneN
【GOLD_R】
【PRE_R】

Here we report that glutamate stimulation caused a rapid reduction in protein levels of GRIP1 , but not that of glutamate receptor ( GluR ) 1 , GluR2 and protein interacting with C kinase 1 ( PICK1 ) in rat primary cortical neuron cultures .
【GOLD_E】
GRIP1	geneY
(GluR)1	geneY
GluR2	geneY
proteininteractingwithCkinase1	geneY
PICK1	geneY
glutamate	chem
glutamate	chem
【PRE_E】
glutamate	chem
GRIP1	geneY
glutamatereceptor(GluR)1	geneN
GluR2	geneY
Ckinase1	geneY
PICK1	geneY
【GOLD_R】
glutamate	GRIP1	C4
【PRE_R】
glutamate	GRIP1	C3

Down - regulation of GRIP1 by glutamate was blocked by carbobenzoxyl - leucinyl - leucinyl - leucinal ( MG132 ) , a proteasome inhibitor and by expression of K48R - ubiquitin , a dominant negative form of ubiquitin .
【GOLD_E】
MG132	chem
GRIP1	geneY
proteasome	geneN
K48R	geneN
ubiquitin	geneN
ubiquitin	geneN
glutamate	chem
carbobenzoxyl-leucinyl-leucinyl-leucinal	chem
【PRE_E】
GRIP1	geneY
glutamate	chem
carbobenzoxyl-leucinyl-leucinyl-leucinal	chem
MG132	chem
proteasome	geneN
K48R	geneY
ubiquitin	geneN
ubiquitin	geneN
【GOLD_R】
glutamate	GRIP1	C4
MG132	proteasome	C4
carbobenzoxyl-leucinyl-leucinyl-leucinal	proteasome	C4
【PRE_R】
GRIP1	glutamate	C4
GRIP1	carbobenzoxyl-leucinyl-leucinyl-leucinal	C4
MG132	proteasome	C4
MG132	K48R	C4
MG132	ubiquitin	C4

The GRIP1 reduction was inhibited by MK - 801 , an N - methyl - d - aspartate ( NMDA ) receptor antagonist , but not by 6 - cyano - 7 - nitroquinoxaline - 2,3 - dione ( CNQX ) , an AMPA receptor antagonist .
【GOLD_E】
MK-801	chem
N-methyl-d-aspartate	chem
NMDA	chem
6-cyano-7-nitroquinoxaline-2,3-dione	chem
CNQX	chem
AMPA	chem
GRIP1	geneY
N-methyl-d-aspartate(NMDA)receptor	geneN
AMPAreceptor	geneN
【PRE_E】
GRIP1	geneY
MK-801	chem
N-methyl-d-aspartate(NMDA)receptor	geneN
6-cyano-7-nitroquinoxaline-2,3-dione	chem
CNQX	chem
AMPAreceptor	geneN
【GOLD_R】
MK-801	GRIP1	C3
MK-801	N-methyl-d-aspartate(NMDA)receptor	C6
6-cyano-7-nitroquinoxaline-2,3-dione	AMPAreceptor	C6
CNQX	AMPAreceptor	C6
【PRE_R】
GRIP1	6-cyano-7-nitroquinoxaline-2,3-dione	C4

EGTA and 1,2 - bis ( 2 - aminophenoxy ) ethane - N , N , N ' , N ' - tetra acetic acid tetrakis ( BAPTA ) , two Ca2 + chelators , but not nifedipine , an L - type Ca2 + channel blocker , prevented GRIP1 degradation .
【GOLD_E】
EGTA	chem
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraaceticacidtetrakis	chem
BAPTA	chem
Ca2+	chem
nifedipine	chem
Ca2+	chem
L-typeCa2+channel	geneN
GRIP1	geneY
【PRE_E】
EGTA	chem
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraaceticacidtetrakis	chem
BAPTA	chem
Ca2+	chem
nifedipine	chem
L-typeCa2+channel	geneN
GRIP1	geneY
【GOLD_R】
EGTA	GRIP1	C3
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraaceticacidtetrakis	GRIP1	C3
BAPTA	GRIP1	C3
nifedipine	L-typeCa2+channel	C4
【PRE_R】

Furthermore , MG132 prevented glutamate - stimulated reduction in surface amount of GluR2 , and knockdown of GRIP1 by RNAi against GRIP1 reduced surface GluR2 in neurons .
【GOLD_E】
MG132	chem
glutamate	chem
GluR2	geneY
GRIP1	geneY
GRIP1	geneY
GluR2	geneY
【PRE_E】
MG132	chem
glutamate	chem
GluR2	geneY
GRIP1	geneY
GRIP1	geneY
GluR2	geneY
【GOLD_R】
glutamate	GluR2	C4
【PRE_R】
MG132	GluR2	C3
glutamate	GluR2	C3
glutamate	GRIP1	C3

Our results suggest that glutamate induces GRIP1 degradation by proteasome through an NMDA receptor - Ca2 + pathway and that GRIP1 degradation may play an important role in regulating GluR2 surface expression .
【GOLD_E】
glutamate	chem
GRIP1	geneY
proteasome	geneN
NMDAreceptor	geneN
GRIP1	geneY
GluR2	geneY
NMDA	chem
Ca2+	chem
【PRE_E】
glutamate	chem
GRIP1	geneY
proteasome	geneN
NMDAreceptor	geneN
Ca2+	chem
GRIP1	geneY
GluR2	geneY
【GOLD_R】
glutamate	GRIP1	C4
glutamate	GRIP1	C4
【PRE_R】
glutamate	GRIP1	C3

Transgenic expression of the human Vitamin D receptor ( hVDR ) in the duodenum of VDR - null mice attenuates the age - dependent decline in calcium absorption .
【GOLD_E】
VitaminD	chem
humanVitaminDreceptor	geneY
hVDR	geneY
VDR	geneY
calcium	chem
【PRE_E】
humanVitaminDreceptor	geneY
hVDR	geneY
VDR	geneY
calcium	chem
【GOLD_R】
【PRE_R】

1,25 ( OH ) ( 2 ) D ( 3 ) regulates calcium homeostasis through its actions in the intestine , bone , and kidney .
【GOLD_E】
1,25(OH)(2)D(3)	chem
calcium	chem
【PRE_E】
1,25(OH)(2)D(3)	chem
calcium	chem
【GOLD_R】
【PRE_R】

These actions are mediated through the VDR .
【GOLD_E】
VDR	geneY
【PRE_E】
VDR	geneY
【GOLD_R】
【PRE_R】

To determine if VDR 's actions in the proximal small intestine can sufficiently restore calcium homeostasis , we generated transgenic mice expressing hVDR exclusively in the duodenum of mVDR - null mice by using the adenosine deaminase enhancer ( hVDR + / mVDR - null ) .
【GOLD_E】
VDR	geneY
hVDR	geneY
mVDR	geneY
adenosinedeaminaseenhancer	geneN
hVDR	geneY
mVDR	geneY
calcium	chem
adenosine	chem
【PRE_E】
VDR	geneY
calcium	chem
hVDR	geneY
mVDR	geneY
adenosinedeaminaseenhancer	geneY
hVDR	geneY
mVDR	geneY
【GOLD_R】
【PRE_R】

Unlike wild - type mice , hVDR + / mVDR - null mice express hVDR and VDR target genes only in the proximal small intestine .
【GOLD_E】
hVDR	geneY
mVDR	geneY
hVDR	geneY
VDR	geneY
【PRE_E】
hVDR	geneY
mVDR	geneY
hVDR	geneY
VDR	geneY
【GOLD_R】
【PRE_R】

Despite having functional hVDR in the proximal small intestine , hVDR + / mVDR - null mice were hypocalcaemic when fed a normal rodent diet at weaning , like mVDR - null mice fed the same diet .
【GOLD_E】
hVDR	geneY
hVDR	geneY
mVDR	geneY
mVDR	geneY
【PRE_E】
hVDR	geneY
hVDR	geneY
mVDR	geneY
mVDR	geneY
【GOLD_R】
【PRE_R】

The hypocalcemia in these mice is prevented if they are given the rescue diet before weaning .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , when 90 - day - old rachitic mice were fed a rescue diet , serum calcium improved in hVDR + / mVDR - null mice , but not in mVDR - null mice .
【GOLD_E】
hVDR	geneY
mVDR	geneY
mVDR	geneY
calcium	chem
【PRE_E】
calcium	chem
hVDR	geneY
mVDR	geneY
mVDR	geneY
【GOLD_R】
【PRE_R】
calcium	hVDR	C3

In conclusion , transgenic hVDR in the proximal small intestine of hVDR + / mVDR - null mice was transcriptionally active and regulated calcium absorption , but VDR actions elsewhere in the intestine are probably necessary to support adequate calcium homeostasis .
【GOLD_E】
hVDR	geneY
mVDR	geneY
VDR	geneY
calcium	chem
hVDR	geneY
calcium	chem
【PRE_E】
hVDR	geneY
hVDR	geneY
mVDR	geneY
calcium	chem
VDR	geneY
calcium	chem
【GOLD_R】
【PRE_R】

In addition , hVDR + / mVDR - null mice responded better to the late rescue diet suggesting that expression of VDR in the proximal small intestine protected the calcium absorbing machinery from age - dependent decline .
【GOLD_E】
hVDR	geneY
mVDR	geneY
VDR	geneY
calcium	chem
【PRE_E】
hVDR	geneY
mVDR	geneY
VDR	geneY
calcium	chem
【GOLD_R】
【PRE_R】

The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4 - induced MUC2 / 5AC gene expression and mucin secretion in human airway epithelial cells .
【GOLD_E】
leukotriene	chem
leukotrieneD4	chem
mucin	geneN
leukotrienereceptor	geneN
MUC2/5AC	geneN
【PRE_E】
leukotrienereceptor	geneN
leukotrieneD4	chem
MUC2	geneY
5AC	geneY
mucin	geneY
【GOLD_R】
leukotrieneD4	mucin	C3
leukotrieneD4	MUC2/5AC	C3
【PRE_R】

OBJECTIVES : Mucin gene expression and mucin production are markedly increased in inflammatory airway disorders such as asthma , chronic bronchitis and rhinosinusitis .
【GOLD_E】
Mucin	geneN
mucin	geneN
【PRE_E】
Mucin	geneY
mucin	geneY
【GOLD_R】
【PRE_R】

Cytokines , lipopolysaccharides and other inflammatory mediators such as prostaglandin and leukotriene are related to the secretion and production of mucin .
【GOLD_E】
Cytokines	geneN
mucin	geneN
prostaglandin	chem
leukotriene	chem
【PRE_E】
Cytokines	geneN
lipopolysaccharides	geneN
prostaglandin	chem
leukotriene	chem
mucin	geneN
【GOLD_R】
【PRE_R】

However , the relationship of leukotrienes with mucin genes expression is not clear .
【GOLD_E】
mucin	geneN
leukotrienes	chem
【PRE_E】
leukotrienes	chem
mucin	geneN
【GOLD_R】
【PRE_R】

The aim of this study is to evaluate MUC2 / 5AC gene expression and mucin secretion by the leukotriene receptor in human airway epithelial cells .
【GOLD_E】
MUC2/5AC	geneN
mucin	geneN
leukotrienereceptor	geneN
leukotriene	chem
【PRE_E】
MUC2	geneY
5AC	geneY
mucin	geneN
leukotrienereceptor	geneN
【GOLD_R】
【PRE_R】

METHODS : The effect of leukotriene D ( 4 ) and the leukotriene receptor antagonist , pranlukast hydrate ( ONO - 1078 ) on the regulation of MUC2 / 5AC gene expression and mucin secretion were observed in human airway NCI - H292 epithelial cells .
【GOLD_E】
leukotriene	chem
pranlukasthydrate	chem
ONO-1078	chem
leukotrienereceptor	geneN
MUC2/5AC	geneN
mucin	geneN
leukotrieneD(4)	chem
【PRE_E】
leukotrieneD(4)	chem
leukotrienereceptor	geneN
pranlukasthydrate	chem
ONO-1078	chem
MUC2	geneY
5AC	geneY
mucin	geneY
【GOLD_R】
pranlukasthydrate	leukotrienereceptor	C6
ONO-1078	leukotrienereceptor	C6
【PRE_R】
pranlukasthydrate	MUC2	C4
ONO-1078	MUC2	C4
ONO-1078	5AC	C4
ONO-1078	mucin	C4

The mRNA levels of MUC2 / 5AC and the amount of mucin were determined by reverse transcription - polymerase chain reaction ( RT - PCR ) and immunoassay .
【GOLD_E】
MUC2/5AC	geneN
mucin	geneN
【PRE_E】
MUC2	geneY
5AC	geneY
mucin	geneN
【GOLD_R】
【PRE_R】

RESULTS : Leukotriene D ( 4 ) upregulated MUC2 / 5AC gene expression and mucin secretion in a dose dependent pattern .
【GOLD_E】
LeukotrieneD(4)	chem
MUC2/5AC	geneN
mucin	geneN
【PRE_E】
LeukotrieneD(4)	chem
MUC2	geneY
5AC	geneY
mucin	geneY
【GOLD_R】
LeukotrieneD(4)	MUC2/5AC	C3
LeukotrieneD(4)	mucin	C3
【PRE_R】
LeukotrieneD(4)	MUC2	C3
LeukotrieneD(4)	5AC	C3
LeukotrieneD(4)	mucin	C3

Pranlukast hydrate ( ONO - 1078 , 100 microM ) downregulated the leukotriene D ( 4 ) - induced MUC2 / 5AC gene expression and mucin secretion .
【GOLD_E】
MUC2/5AC	geneN
mucin	geneN
Pranlukasthydrate	chem
ONO-1078	chem
leukotrieneD(4)	chem
【PRE_E】
Pranlukasthydrate	chem
ONO-1078	chem
leukotrieneD(4)	chem
MUC2	geneY
5AC	geneY
mucin	geneY
【GOLD_R】
leukotrieneD(4)	MUC2/5AC	C3
leukotrieneD(4)	mucin	C3
Pranlukasthydrate	MUC2/5AC	C4
Pranlukasthydrate	mucin	C4
ONO-1078	MUC2/5AC	C4
ONO-1078	mucin	C4
【PRE_R】
Pranlukasthydrate	MUC2	C4
ONO-1078	MUC2	C4
ONO-1078	5AC	C4
ONO-1078	mucin	C4

CONCLUSION : These results suggest that the leukotriene receptor system is one of the mechanisms related to MUC2 / 5AC gene expression and mucin secretion in the human airway epithelium .
【GOLD_E】
leukotrienereceptor	geneN
MUC2/5AC	geneN
mucin	geneN
leukotriene	chem
【PRE_E】
leukotrienereceptor	geneN
MUC2	geneY
5AC	geneY
mucin	geneN
【GOLD_R】
【PRE_R】

Effect of isolated isoflavone supplementation on ABCA1 - dependent cholesterol efflux potential in postmenopausal women .
【GOLD_E】
isoflavone	chem
cholesterol	chem
ABCA1	geneY
【PRE_E】
isoflavone	chem
ABCA1	geneY
cholesterol	chem
【GOLD_R】
【PRE_R】

OBJECTIVE : Isoflavones may display beneficial health effects in postmenopausal women .
【GOLD_E】
Isoflavones	chem
【PRE_E】
Isoflavones	chem
【GOLD_R】
【PRE_R】

We studied in a clinical trial whether isolated isoflavone treatment in postmenopausal women could affect reverse cholesterol transport as evaluated by adenosine triphosphate - binding cassette A1 - ( ABCA1 ) , dependent cholesterol efflux from macrophages .
【GOLD_E】
cholesterol	chem
adenosinetriphosphate	chem
cholesterol	chem
adenosinetriphosphate-bindingcassetteA1	geneY
ABCA1	geneY
isoflavone	chem
【PRE_E】
isoflavone	chem
cholesterol	chem
adenosinetriphosphate-bindingcassetteA1-	geneY
ABCA1	geneY
cholesterol	chem
【GOLD_R】
cholesterol	adenosinetriphosphate-bindingcassetteA1	C9
cholesterol	ABCA1	C9
【PRE_R】
ABCA1	cholesterol	C9

In addition , various serum lipid and lipoprotein parameters were investigated .
【GOLD_E】
lipoprotein	geneN
【PRE_E】
lipoprotein	geneN
【GOLD_R】
【PRE_R】

Furthermore , we separately assessed equol - producing and non - equol - producing women .
【GOLD_E】
【PRE_E】
equol	chem
equol	chem
【GOLD_R】
【PRE_R】

DESIGN : Postmenopausal women ( n = 56 ) were treated with either isoflavone or placebo tablets for 3 months in a crossover design , separated by a 2 - month washout period .
【GOLD_E】
isoflavone	chem
【PRE_E】
isoflavone	chem
【GOLD_R】
【PRE_R】

Fifteen women were classified as equol producers , and 15 women were classified as non - equol producers .
【GOLD_E】
【PRE_E】
equol	chem
equol	chem
【GOLD_R】
【PRE_R】

Serum samples were collected before and after each treatment period .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

[ H ] - Cholesterol - labeled J774 macrophage cells , with and without ABCA1 up - regulation , were incubated with the samples , and ABCA1 - dependent cholesterol efflux and serum lipid and lipoprotein levels were assessed .
【GOLD_E】
[H]-Cholesterol	chem
cholesterol	chem
lipoprotein	geneN
ABCA1	geneY
ABCA1	geneY
【PRE_E】
[H]-Cholesterol	chem
ABCA1	geneY
ABCA1	geneY
cholesterol	chem
lipoprotein	geneN
【GOLD_R】
cholesterol	ABCA1	C9
【PRE_R】

RESULTS : Serum promoted 3.1 % + / - 1.1 % and 3.2 % + / - 1.1 % cholesterol efflux from macrophages after isoflavone and placebo treatment , respectively .
【GOLD_E】
cholesterol	chem
isoflavone	chem
【PRE_E】
cholesterol	chem
isoflavone	chem
【GOLD_R】
【PRE_R】

Thus , isoflavone supplementation did not affect ABCA1 - dependent cholesterol efflux to serum .
【GOLD_E】
ABCA1	geneY
isoflavone	chem
cholesterol	chem
【PRE_E】
isoflavone	chem
ABCA1	geneY
cholesterol	chem
【GOLD_R】
cholesterol	ABCA1	C9
【PRE_R】

However , as a novel finding , isoflavone treatment increased a subclass of high - density lipoprotein , the pre - beta high - density lipoprotein levels by 18 % without affecting any other serum lipid concentrations .
【GOLD_E】
high-densitylipoprotein	geneN
pre-betahigh-densitylipoprotein	geneN
isoflavone	chem
【PRE_E】
isoflavone	chem
high-densitylipoprotein	geneN
pre-betahigh-densitylipoprotein	geneN
【GOLD_R】
isoflavone	high-densitylipoprotein	C3
isoflavone	pre-betahigh-densitylipoprotein	C3
【PRE_R】
isoflavone	high-densitylipoprotein	C3
isoflavone	pre-betahigh-densitylipoprotein	C3

ABCA1 - facilitated cholesterol efflux and lipid parameters did not differ between equol - producing and non - equol - producing women .
【GOLD_E】
equol	chem
ABCA1	geneY
cholesterol	chem
equol	chem
【PRE_E】
ABCA1	geneY
cholesterol	chem
equol	chem
equol	chem
【GOLD_R】
cholesterol	ABCA1	C9
【PRE_R】

CONCLUSION : In postmenopausal women , isolated isoflavone treatment does not affect ABCA1 - dependent cholesterol efflux potential from macrophages but increases circulating pre - beta high - density lipoprotein level , which could provide beneficial vascular effects .
【GOLD_E】
isoflavone	chem
cholesterol	chem
ABCA1	geneY
pre-betahigh-densitylipoprotein	geneN
【PRE_E】
isoflavone	chem
ABCA1	geneY
cholesterol	chem
pre-betahigh-densitylipoprotein	geneN
【GOLD_R】
isoflavone	pre-betahigh-densitylipoprotein	C3
cholesterol	ABCA1	C9
【PRE_R】

The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors .
【GOLD_E】
sorafenib	chem
PDGFRbeta	geneY
FLT3	geneY
【PRE_E】
sorafenib	chem
PDGFRbeta	geneY
FLT3	geneY
【GOLD_R】
sorafenib	PDGFRbeta	C4
sorafenib	FLT3	C4
【PRE_R】
sorafenib	PDGFRbeta	C4
sorafenib	FLT3	C4

BACKGROUND AND OBJECTIVES : Activated tyrosine kinases are implicated in the pathogenesis of chronic and acute leukemia , and represent attractive targets for therapy .
【GOLD_E】
tyrosine	chem
tyrosinekinases	geneN
【PRE_E】
tyrosinekinases	geneN
【GOLD_R】
【PRE_R】

Sorafenib ( BAY43 - 9006 , Nexavar ) is a small molecule B - RAF inhibitor that is used for the treatment of renal cell carcinoma , and has been shown to have activity against receptor tyrosine kinases from the platelet - derived growth factor receptor ( PDGFR ) and vascular endothelial growth factor receptor ( VEGFR ) families .
【GOLD_E】
tyrosine	chem
B-RAF	geneY
receptortyrosinekinases	geneN
platelet-derivedgrowthfactorreceptor	geneY
PDGFR	geneY
vascularendothelialgrowthfactorreceptor	geneN
VEGFR	geneN
Sorafenib	chem
BAY43-9006	chem
Nexavar	chem
【PRE_E】
Sorafenib	chem
BAY43-9006	chem
Nexavar	chem
B-RAF	geneY
tyrosinekinases	geneN
platelet-derivedgrowthfactorreceptor	geneN
PDGFR	geneN
vascularendothelialgrowthfactorreceptor	geneN
VEGFR	geneN
【GOLD_R】
Sorafenib	B-RAF	C4
BAY43-9006	B-RAF	C4
Nexavar	B-RAF	C4
【PRE_R】
Sorafenib	B-RAF	C4
BAY43-9006	B-RAF	C4
Nexavar	B-RAF	C4
Nexavar	platelet-derivedgrowthfactorreceptor	C4
Nexavar	PDGFR	C4
Nexavar	vascularendothelialgrowthfactorreceptor	C4
Nexavar	VEGFR	C4

We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta , KIT , and FLT3 , which are implicated in the pathogenesis of myeloid malignancies .
【GOLD_E】
sorafenib	chem
tyrosine	chem
receptortyrosinekinases	geneN
PDGFRbeta	geneY
KIT	geneY
FLT3	geneY
【PRE_E】
sorafenib	chem
tyrosinekinasesPDGFRbeta	geneN
KIT	geneY
FLT3	geneY
【GOLD_R】
sorafenib	receptortyrosinekinases	C4
sorafenib	PDGFRbeta	C4
sorafenib	KIT	C4
sorafenib	FLT3	C4
【PRE_R】
sorafenib	KIT	C4
sorafenib	FLT3	C4

DESIGN AND METHODS : We tested the effect of sorafenib on the proliferation of hematopoietic cells transformed by ETV6 - PDGFRbeta , FLT3 with an internal tandem duplication or D835Y point mutation , and the KIT ( D816V ) mutant .
【GOLD_E】
sorafenib	chem
ETV6	geneY
PDGFRbeta	geneY
FLT3	geneY
D835Y	geneN
KIT	geneY
D816V	geneN
【PRE_E】
sorafenib	chem
ETV6	geneY
PDGFRbeta	geneY
FLT3	geneY
D835Y	geneY
KIT	geneY
D816V	geneY
【GOLD_R】
【PRE_R】

The direct effect of sorafenib on the activity of these kinases and their downstream signaling was tested using phospho - specific antibodies .
【GOLD_E】
sorafenib	chem
phospho	chem
kinases	geneN
【PRE_E】
sorafenib	chem
kinases	geneN
phospho	chem
【GOLD_R】
【PRE_R】

RESULTS : We show that sorafenib is a potent inhibitor of ETV6 - PDGFRbeta and FLT3 mutants , including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors .
【GOLD_E】
ETV6	geneY
PDGFRbeta	geneY
FLT3	geneY
FLT3	geneY
sorafenib	chem
【PRE_E】
sorafenib	chem
ETV6	geneY
PDGFRbeta	geneY
FLT3	geneY
PKC412	chem
FLT3	geneY
【GOLD_R】
sorafenib	ETV6	C4
sorafenib	PDGFRbeta	C4
sorafenib	FLT3	C4
sorafenib	FLT3	C4
【PRE_R】
sorafenib	ETV6	C4
sorafenib	PDGFRbeta	C4
FLT3	PKC412	C4
PKC412	FLT3	C4

Sorafenib induced a cell cycle block and apoptosis in the acute myeloid leukemia cell lines MV4 - 11 and MOLM - 13 , both expressing FLT3 with an internal tandem duplication , whereas no effect was observed on four other acute myeloid leukemia cell lines .
【GOLD_E】
FLT3	geneY
Sorafenib	chem
【PRE_E】
Sorafenib	chem
FLT3	geneY
【GOLD_R】
Sorafenib	FLT3	C4
【PRE_R】
Sorafenib	FLT3	C4

The imatinib - resistant KIT ( D816V ) mutant , associated with systemic mastocytosis , was found to be resistant to sorafenib .
【GOLD_E】
KIT	geneY
D816V	geneN
imatinib	chem
sorafenib	chem
【PRE_E】
imatinib	chem
KIT	geneY
D816V	geneY
sorafenib	chem
【GOLD_R】
【PRE_R】
D816V	sorafenib	C4

INTERPRETATION AND CONCLUSIONS : These results warrant further clinical studies of sorafenib for the treatment of myeloid malignancies expressing activated forms of PDGFRbeta and FLT3 .
【GOLD_E】
PDGFRbeta	geneY
FLT3	geneY
sorafenib	chem
【PRE_E】
sorafenib	chem
PDGFRbeta	geneY
FLT3	geneY
【GOLD_R】
sorafenib	PDGFRbeta	C4
sorafenib	FLT3	C4
【PRE_R】
sorafenib	PDGFRbeta	C4
sorafenib	FLT3	C4

Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium .
【GOLD_E】
ENaC	geneN
【PRE_E】
ENaC	geneN
【GOLD_R】
【PRE_R】

Mammary epithelia produce an isotonic , low - Na ( + ) fluid that is rich in nutrients .
【GOLD_E】
Na(+)	chem
【PRE_E】
Na(+)	chem
【GOLD_R】
【PRE_R】

Mechanisms that account for the low electrolyte concentration have not been elucidated , although amiloride - sensitive ion transport has been reported in some situations .
【GOLD_E】
amiloride	chem
【PRE_E】
electrolyte	chem
amiloride	chem
【GOLD_R】
【PRE_R】

We hypothesized that corticosteroid exposure modulates epithelial Na ( + ) channel ( ENaC ) expression and / or activity in bovine mammary epithelial cells .
【GOLD_E】
epithelialNa(+)channel	geneN
ENaC	geneN
Na(+)	chem
【PRE_E】
corticosteroid	chem
Na(+)channel	geneN
ENaC	geneN
【GOLD_R】
【PRE_R】

BME - UV cells were grown to confluent monolayers on permeable supports with a standard basolateral medium and apical medium of low - electrolyte , high - lactose composition that resembles the ionic composition of milk .
【GOLD_E】
lactose	chem
【PRE_E】
BME	chem
electrolyte	chem
lactose	chem
【GOLD_R】
【PRE_R】

Ion transport was assessed in modified Ussing flux chambers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Exposure to glucocorticoids ( dexamethasone , cortisol , or prednisolone ) , but not aldosterone , increased short - circuit current ( I ( sc ) ) , a sensitive measure of net ion transport , whereas apical exposure to amiloride or benzamil reduced corticosteroid - induced I ( sc ) close to basal levels .
【GOLD_E】
dexamethasone	chem
cortisol	chem
prednisolone	chem
aldosterone	chem
amiloride	chem
benzamil	chem
【PRE_E】
dexamethasone	chem
cortisol	chem
prednisolone	chem
aldosterone	chem
net	chem
amiloride	chem
benzamil	chem
corticosteroid	chem
【GOLD_R】
【PRE_R】

Quantitative RT - PCR indicated a glucocorticoid - induced increase in mRNA for beta - and gamma - ENaC , whereas alpha - ENaC mRNA expression was only mildly affected .
【GOLD_E】
beta-andgamma-ENaC	geneN
alpha-ENaC	geneY
【PRE_E】
glucocorticoid	geneY
beta-andgamma-ENaC	geneN
alpha-ENaC	geneN
【GOLD_R】
【PRE_R】

Exposure to mifepristone ( a glucocorticoid receptor antagonist ) , but not spironolactone ( a mineralocorticoid receptor antagonist ) , precluded both the corticosteroid - induced elevation in amiloride - sensitive I ( sc ) and the induced changes in beta - and gamma - ENaC mRNA .
【GOLD_E】
glucocorticoidreceptor	geneY
mineralocorticoidreceptor	geneN
mifepristone	chem
beta-andgamma-ENaC	geneN
spironolactone	chem
amiloride	chem
【PRE_E】
mifepristone	chem
glucocorticoidreceptor	geneY
spironolactone	chem
mineralocorticoidreceptor	geneY
corticosteroid	chem
amiloride	chem
beta-andgamma-ENaC	geneN
【GOLD_R】
mifepristone	glucocorticoidreceptor	C6
spironolactone	mineralocorticoidreceptor	C6
【PRE_R】

We conclude that Na ( + ) movement across mammary epithelia is modulated by corticosteroids via a glucocorticoid receptor - mediated mechanism that regulates the expression of the beta - and gamma - subunits of ENaC .
【GOLD_E】
glucocorticoidreceptor	geneY
beta-andgamma-subunitsofENaC	geneN
Na(+)	chem
【PRE_E】
Na(+)	chem
glucocorticoidreceptor	geneY
beta-andgamma-subunitsofENaC	geneN
【GOLD_R】
【PRE_R】

ENaC expression and activity could account for the low Na ( + ) concentration that is typical of milk .
【GOLD_E】
ENaC	geneN
Na(+)	chem
【PRE_E】
ENaC	geneN
Na(+)	chem
【GOLD_R】
【PRE_R】

Salicylate - based anti - inflammatory drugs inhibit the early lesion of diabetic retinopathy .
【GOLD_E】
Salicylate	chem
【PRE_E】
Salicylate	chem
【GOLD_R】
【PRE_R】

It has been previously reported that aspirin inhibited the development of diabetic retinopathy in diabetic animals , raising the possibility that anti - inflammatory drugs may have beneficial effects on diabetic retinopathy .
【GOLD_E】
aspirin	chem
【PRE_E】
aspirin	chem
【GOLD_R】
【PRE_R】

To further explore this , we compared effects of oral consumption of three different salicylate - based drugs ( aspirin , sodium salicylate , and sulfasalazine ) on the development of early stages of diabetic retinopathy in rats .
【GOLD_E】
sodiumsalicylate	chem
sulfasalazine	chem
salicylate	chem
aspirin	chem
【PRE_E】
salicylate	chem
aspirin	chem
sodiumsalicylate	chem
sulfasalazine	chem
【GOLD_R】
【PRE_R】

These three drugs differ in their ability to inhibit cyclooxygenase but share an ability to inhibit nuclear factor - kappaB ( NF - kappaB ) .
【GOLD_E】
cyclooxygenase	geneN
nuclearfactor-kappaB	geneN
NF-kappaB	geneN
【PRE_E】
cyclooxygenase	geneN
nuclearfactor-kappaB	geneN
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

Diabetes of 9 - 10 months duration significantly increased the number of TUNEL ( transferase - mediated dUTP nick - end labeling ) - positive capillary cells and acellular ( degenerate ) capillaries in the retinal vasculature , and all three salicylate - based drugs inhibited this cell death and formation of acellular capillaries without altering the severity of hyperglycemia .
【GOLD_E】
salicylate	chem
【PRE_E】
dUTP	chem
retinal	chem
salicylate	chem
【GOLD_R】
【PRE_R】

In short - term diabetes ( 2 - 4 months ) , all three salicylates inhibited the diabetes - induced loss of neuronal cells from the ganglion cell layer .
【GOLD_E】
salicylates	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Oral aspirin ( as a representative of the salicylate family ) inhibited diabetes - induced increase in NF - kappaB DNA - binding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina .
【GOLD_E】
NF-kappaB	geneN
aspirin	chem
salicylate	chem
【PRE_E】
aspirin	chem
salicylate	chem
NF-kappaB	geneN
【GOLD_R】
aspirin	NF-kappaB	C4
salicylate	NF-kappaB	C4
【PRE_R】
aspirin	NF-kappaB	C4
salicylate	NF-kappaB	C4

All three salicylates inhibited the diabetes - induced translocation of p50 ( a subunit of NF - kappaB ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature , as well as of p50 and p65 into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole - retinal sections .
【GOLD_E】
p50	geneY
NF-kappaB	geneN
p50	geneY
p65	geneY
salicylates	chem
【PRE_E】
salicylates	chem
p50	geneY
NF-kappaB	geneN
retinal	chem
retinal	chem
p50	geneY
p65	geneY
retinal	chem
【GOLD_R】
salicylates	p50	C4
salicylates	p50	C4
salicylates	p65	C4
salicylates	NF-kappaB	C4
【PRE_R】
salicylates	p50	C4
salicylates	NF-kappaB	C4
salicylates	p50	C4
salicylates	p65	C4

Sulfasalazine ( also as a representative of the salicylates ) inhibited the diabetes - induced upregulation of several inflammatory gene products , which are regulated by NF - kappaB , including vascular cell adhesion molecule , intracellular adhesion molecule - 1 , inducible nitric oxide synthase , and cyclooxygenase - 2 in whole - retinal lysate .
【GOLD_E】
NF-kappaB	geneN
intracellularadhesionmolecule-1	geneY
induciblenitricoxidesynthase	geneY
cyclooxygenase-2	geneY
Sulfasalazine	chem
salicylates	chem
nitricoxide	chem
【PRE_E】
Sulfasalazine	chem
salicylates	chem
NF-kappaB	geneN
adhesionmolecule-1	geneY
induciblenitricoxidesynthase	geneY
cyclooxygenase-2	geneY
retinal	chem
【GOLD_R】
Sulfasalazine	NF-kappaB	C4
Sulfasalazine	intracellularadhesionmolecule-1	C4
Sulfasalazine	induciblenitricoxidesynthase	C4
Sulfasalazine	cyclooxygenase-2	C4
salicylates	NF-kappaB	C4
【PRE_R】
Sulfasalazine	NF-kappaB	C4
salicylates	NF-kappaB	C4
salicylates	adhesionmolecule-1	C4
salicylates	cyclooxygenase-2	C4

Salicylates , in doses administrated in our experiments , inhibited NF - kappaB and perhaps other transcription factors in the retina , were well tolerated , and offered new tools to investigate and inhibit the development of diabetic retinopathy .
【GOLD_E】
NF-kappa	geneN
Salicylates	chem
【PRE_E】
Salicylates	chem
NF-kappaB	geneN
【GOLD_R】
Salicylates	NF-kappa	C4
【PRE_R】
Salicylates	NF-kappaB	C4

Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron . Evidence for the existence of two species of dehydrogenase in the rat kidney .
【GOLD_E】
11betahydroxysteroid	chem
dehydrogenase	geneN
11betahydroxysteroiddehydrogenase	geneY
【PRE_E】
betahydroxysteroiddehydrogenase	geneY
dehydrogenase	geneN
【GOLD_R】
【PRE_R】

An 11 beta hydroxysteroid dehydrogenase ( 11 beta HSD ) activity has been localized in the rat kidney by a histochemical technique which links steroid metabolism with the production of a color reaction .
【GOLD_E】
11betahydroxysteroid	chem
11betahydroxysteroiddehydrogenase	geneY
11betaHSD	geneY
steroid	chem
【PRE_E】
betahydroxysteroiddehydrogenase	geneY
11betaHSD	geneY
steroid	chem
【GOLD_R】
【PRE_R】
11betaHSD	steroid	C9

Oxidation of 11 beta - hydroxyandrostenedione was observed in cortical distal convoluted tubules and in medullary collecting ducts .
【GOLD_E】
11beta-hydroxyandrostenedione	chem
【PRE_E】
beta-hydroxyandrostenedione	chem
【GOLD_R】
【PRE_R】

Carbenoxolone abolished staining , no reaction was obtained with androstenedione hydroxylated at the 17 or 19 position , and oxidation of 11 beta - hydroxyandrostenedione was nicotinamide - adenine dinucleotide ( NAD ) dependent .
【GOLD_E】
Carbenoxolone	chem
androstenedione	chem
11beta-hydroxyandrostenedione	chem
nicotinamide-adeninedinucleotide	chem
NAD	chem
【PRE_E】
Carbenoxolone	chem
androstenedionehydroxylated	chem
beta-hydroxyandrostenedione	chem
nicotinamide-adeninedinucleotide	geneY
NAD	geneN
【GOLD_R】
【PRE_R】

These results demonstrate the presence of a dehydrogenase activity separate from the nicotinamide - adenine dinucleotide phosphate ( NADP ) - dependent 11 beta hydroxysteroid dehydrogenase recently purified and cloned from rat liver .
【GOLD_E】
nicotinamide-adeninedinucleotidephosphate	chem
NADP	chem
11betahydroxysteroid	chem
dehydrogenase	geneN
11betahydroxysteroiddehydrogenase	geneY
【PRE_E】
dehydrogenase	geneN
nicotinamide-adeninedinucleotidephosphate(NADP)-dependent11betahydroxysteroiddehydrogenase	geneY
【GOLD_R】
【PRE_R】

We have named this activity 11 beta HSD2 to distinguish it from the NADP - dependent 11 beta HSD .
【GOLD_E】
NADP	chem
11betaHSD2	geneY
11betaHSD	geneY
【PRE_E】
betaHSD2	geneY
NADP-dependent11betaHSD	geneN
【GOLD_R】
【PRE_R】

Histological studies showed that 11 beta HSD2 activity does not correlate with the immunocytochemical localization of the previously defined 11 beta HSD enzyme , but rather the 11 beta HSD2 activity is localized in the distal tubules of the rat kidney .
【GOLD_E】
11betaHSD	geneY
11betaHSD2	geneY
11betaHSD2	geneY
【PRE_E】
betaHSD2	geneY
betaHSD	geneY
betaHSD2	geneY
【GOLD_R】
【PRE_R】

In this respect 11 beta HSD2 colocalizes with the mineralocorticoid receptor .
【GOLD_E】
11betaHSD2	geneY
mineralocorticoidreceptor	geneY
【PRE_E】
betaHSD2	geneY
mineralocorticoidreceptor	geneY
【GOLD_R】
【PRE_R】

No reaction product was obtained using cortisol or corticosterone as substrate with either NAD or NADP as cofactor .
【GOLD_E】
cortisol	chem
corticosterone	chem
NAD	chem
NADP	chem
【PRE_E】
cortisol	chem
corticosterone	chem
NAD	geneN
NADP	geneN
【GOLD_R】
【PRE_R】

Furthermore incubation of tissue sections with 11 beta androstenedione in the presence of deoxycorticosterone completely inhibited cytochemical staining .
【GOLD_E】
11betaandrostenedione	chem
deoxycorticosterone	chem
【PRE_E】
androstenedione	chem
deoxycorticosterone	chem
【GOLD_R】
【PRE_R】

We interpret these results as evidence of 20 reductase activity which uses the reduced cofactor at the expense of the color reaction .
【GOLD_E】
20reductase	geneN
【PRE_E】
20reductase	geneN
【GOLD_R】
【PRE_R】

These results support the crucial role played by an 11 beta hydroxysteroid dehydrogenase in the local protection of type I receptors in mineralocorticoid selective tissues .
【GOLD_E】
11betahydroxysteroiddehydrogenase	geneY
11betahydroxysteroid	chem
【PRE_E】
betahydroxysteroiddehydrogenase	geneY
typeIreceptors	geneN
mineralocorticoid	geneY
【GOLD_R】
【PRE_R】

Effect of long - term fluoxetine treatment on the human serotonin transporter in Caco - 2 cells .
【GOLD_E】
fluoxetine	chem
serotonin	chem
humanserotonintransporter	geneY
【PRE_E】
fluoxetine	chem
humanserotonintransporter	geneY
【GOLD_R】
【PRE_R】

Fluoxetine is a selective serotonin reuptake inhibitor ( SSRI ) broadly used in the treatment of human mood disorders and gastrointestinal diseases involving the serotoninergic system .
【GOLD_E】
Fluoxetine	chem
serotonin	chem
【PRE_E】
Fluoxetine	chem
serotonin	chem
【GOLD_R】
【PRE_R】

The effectiveness of this therapy depends on repeated long - term treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Most of the long - term studies in vivo of SSRI effects on serotoninergic activity have focused on their effects on autoreceptors or postsynaptic receptors .
【GOLD_E】
【PRE_E】
autoreceptorsorpostsynapticreceptors	geneN
【GOLD_R】
【PRE_R】

The chronic effect of SSRIs on the activity of the serotonin transporter ( SERT ) has been less studied and the results have been contradictory .
【GOLD_E】
serotonintransporter	geneY
SERT	geneY
serotonin	chem
【PRE_E】
serotonintransporter	geneY
SERT	geneY
【GOLD_R】
【PRE_R】

The aim of this study was to determine the specific effect of long - term fluoxetine treatment on human serotonin transporter ( hSERT ) in vitro , by using the human enterocyte - like cell line Caco - 2 .
【GOLD_E】
humanserotonintransporter	geneY
hSERT	geneY
fluoxetine	chem
serotonin	chem
【PRE_E】
fluoxetine	chem
humanserotonintransporter	geneY
hSERT	geneY
【GOLD_R】
【PRE_R】

Results show that fluoxetine diminished the 5 - HT uptake in a concentration - dependent way and that this effect was reversible .
【GOLD_E】
fluoxetine	chem
5-HT	chem
【PRE_E】
fluoxetine	chem
5-HT	chem
【GOLD_R】
【PRE_R】

Fluoxetine affected mainly the hSERT transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total hSERT protein content or the hSERT mRNA level .
【GOLD_E】
Fluoxetine	chem
hSERT	geneY
hSERT	geneY
hSERT	geneY
【PRE_E】
Fluoxetine	chem
hSERT	geneY
hSERT	geneY
hSERT	geneY
【GOLD_R】
【PRE_R】

These results suggest that the effect of fluoxetine on the expression of hSERT is post - translational and has shown itself to be independent of PKC and PKA activity .
【GOLD_E】
hSERT	geneY
PKC	geneN
PKA	geneN
fluoxetine	chem
【PRE_E】
fluoxetine	chem
hSERT	geneY
PKC	geneN
PKA	geneN
【GOLD_R】
【PRE_R】

This study may be useful to clarify the effect of the long - term fluoxetine therapy in both gastrointestinal and central nervous system disorders .
【GOLD_E】
fluoxetine	chem
【PRE_E】
fluoxetine	chem
【GOLD_R】
【PRE_R】

Roles played by lymphocyte function - associated antigen - 1 in the regulation of lymphocytic cholinergic activity .
【GOLD_E】
lymphocytefunction-associatedantigen-1	geneY
【PRE_E】
lymphocytefunction-associatedantigen-1	geneY
【GOLD_R】
【PRE_R】

Lymphocytes possess the essential components of a cholinergic system , including acetylcholine ( ACh ) ; choline acetyltransferase ( ChAT ) , its synthesizing enzyme ; and both muscarinic and nicotinic ACh receptors ( mAChRs and nAChRs , respectively ) .
【GOLD_E】
ACh	chem
cholineacetyltransferase	geneY
ChAT	geneY
choline	chem
muscarinicandnicotinicAChreceptors	geneN
mAChRs	geneN
nAChRs	geneN
ACh	chem
acetylcholine	chem
【PRE_E】
acetylcholine	chem
ACh	chem
cholineacetyltransferase	geneY
ChAT	geneY
muscarinicandnicotinicAChreceptors	geneN
mAChRs	geneN
nAChRs	geneN
【GOLD_R】
ACh	cholineacetyltransferase	C9
ACh	ChAT	C9
acetylcholine	cholineacetyltransferase	C9
acetylcholine	ChAT	C9
【PRE_R】

Stimulation of lymphocytes with phytohemagglutinin , which activates T cells via the T cell receptor / CD3 complex , enhances the synthesis and release of ACh and up - regulates expression of ChAT and M ( 5 ) mAChR mRNAs .
【GOLD_E】
phytohemagglutinin	geneN
Tcellreceptor	geneN
CD3	geneN
ChAT	geneY
M(5)mAChR	geneY
ACh	chem
【PRE_E】
Tcellreceptor	geneN
CD3	geneN
ACh	chem
ChAT	geneY
M(5)mAChR	geneY
【GOLD_R】
【PRE_R】
ACh	ChAT	C3
ACh	M(5)mAChR	C3

In addition , activation of protein kinase C and increases in intracellular cAMP also enhance cholinergic activity in T cells , and lymphocyte function associated antigen - 1 ( LFA - 1 ; CD11a / CD18 ) is an important mediator of leukocyte migration and T cell activation .
【GOLD_E】
proteinkinaseC	geneN
lymphocytefunctionassociatedantigen-1	geneY
LFA-1	geneY
CD11a	geneY
CD18	geneY
cAMP	chem
【PRE_E】
proteinkinaseC	geneY
cAMP	chem
lymphocytefunctionassociatedantigen-1	geneY
LFA-1	geneY
CD11a	geneY
CD18	geneY
【GOLD_R】
cAMP	lymphocytefunctionassociatedantigen-1	C3
cAMP	LFA-1	C3
cAMP	CD11a	C3
cAMP	CD18	C3
【PRE_R】
proteinkinaseC	cAMP	C3
cAMP	lymphocytefunctionassociatedantigen-1	C3
cAMP	LFA-1	C3
cAMP	CD11a	C3
cAMP	CD18	C3

Anti - CD11a monoclonal antibody ( mAb ) as well as antithymocyte globulin containing antibodies against CD2 , CD7 and CD11a all increase ChAT activity , ACh synthesis and release , and expression of ChAT and M ( 5 ) mAChR mRNAs in T cells .
【GOLD_E】
CD11a	geneY
globulin	geneN
CD2	geneY
CD7	geneY
CD11a	geneY
ChAT	geneY
ChAT	geneY
M(5)mAChR	geneY
ACh	chem
【PRE_E】
CD11a	geneN
antithymocyteglobulin	geneY
CD2	geneY
CD7	geneY
CD11a	geneY
ChAT	geneY
ACh	chem
ChAT	geneY
M(5)mAChR	geneY
【GOLD_R】
【PRE_R】
ChAT	ACh	C3
ACh	ChAT	C3
ACh	M(5)mAChR	C3

The cholesterol - lowering drug simvastatin inhibits LFA - 1 signaling by binding to an allosteric site on CD11a ( LFA - 1 alpha chain ) , which leads to immunomodulation .
【GOLD_E】
cholesterol	chem
LFA-1	geneY
CD11a	geneY
LFA-1alpha	geneY
【PRE_E】
cholesterol	chem
simvastatin	chem
LFA-1	geneY
CD11a	geneN
LFA-1alphachain	geneY
【GOLD_R】
【PRE_R】
cholesterol	LFA-1	C4
simvastatin	LFA-1	C4

We found that simvastatin abolishes anti - CD11a mAb - induced increases in lymphocytic cholinergic activity in a manner independent of its cholesterol - lowering activity .
【GOLD_E】
CD11a	geneY
simvastatin	chem
cholesterol	chem
【PRE_E】
simvastatin	chem
CD11amAb	geneN
cholesterol	chem
【GOLD_R】
simvastatin	CD11a	C4
【PRE_R】

Collectively then , these results indicate that LFA - 1 contributes to the regulation of lymphocytic cholinergic activity via CD11a - mediated pathways and suggest that simvastatin exerts its immunosuppressive effects in part via modification of lymphocytic cholinergic activity .
【GOLD_E】
LFA-1	geneY
CD11a	geneY
simvastatin	chem
【PRE_E】
LFA-1	geneY
CD11a	geneN
simvastatin	chem
【GOLD_R】
【PRE_R】

Association of estrogen receptor - alpha and progesterone receptor A expression with hormonal mammary carcinogenesis : role of the host microenvironment .
【GOLD_E】
estrogen	chem
progesterone	chem
estrogenreceptor-alpha	geneY
progesteronereceptor	geneY
【PRE_E】
estrogenreceptor-alpha	geneY
progesteronereceptorA	geneY
【GOLD_R】
【PRE_R】

INTRODUCTION : Medroxyprogesterone acetate ( MPA ) induces estrogen receptor ( ER ) - positive and progesterone receptor ( PR ) - positive ductal invasive mammary carcinomas in BALB / c mice .
【GOLD_E】
MPA	chem
estrogen	chem
progesterone	chem
PR	geneY
Medroxyprogesteroneacetate	chem
estrogenreceptor	geneY
ER	geneY
progesteronereceptor	geneY
【PRE_E】
Medroxyprogesteroneacetate	chem
MPA	chem
estrogenreceptor	geneY
ER	geneY
progesteronereceptor	geneY
PR	geneY
【GOLD_R】
MPA	PR	C3
MPA	estrogenreceptor	C3
MPA	ER	C3
Medroxyprogesteroneacetate	PR	C3
Medroxyprogesteroneacetate	estrogenreceptor	C3
Medroxyprogesteroneacetate	ER	C3
Medroxyprogesteroneacetate	progesteronereceptor	C3
【PRE_R】

We sought to reproduce this MPA cancer model in C57BL / 6 mice because of their widespread use in genetic engineering .
【GOLD_E】
MPA	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Within this experimental setting , we studied the carcinogenic effects of MPA , the morphologic changes in mammary glands that are induced by MPA and progesterone , and the levels of ER and PR expression in MPA - treated and progesterone - treated mammary glands .
【GOLD_E】
MPA	chem
progesterone	chem
MPA	chem
progesterone	chem
ER	geneY
PR	geneY
MPA	chem
【PRE_E】
MPA	chem
MPA	chem
progesterone	chem
ER	geneY
PR	geneY
MPA	chem
progesterone	chem
【GOLD_R】
【PRE_R】

Finally , we evaluated whether the differences found between BALB / c and C57BL / 6 mouse strains were due to intrinsic differences in epithelial cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS : The carcinogenic effect of MPA was evaluated in C57BL / 6 mice using protocols proven to be carcinogenic in BALB / c mice .
【GOLD_E】
MPA	chem
【PRE_E】
MPA	chem
【GOLD_R】
【PRE_R】

In addition , BALB / c and C57BL / 6 females were treated with progesterone or MPA for 1 or 2 months , and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of ER and PR .
【GOLD_E】
progesterone	chem
MPA	chem
ER	geneY
PR	geneY
【PRE_E】
progesterone	chem
ER	geneY
PR	geneY
【GOLD_R】
【PRE_R】

Hormone levels were determined by radioimmunoassay .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Isolated mammary epithelial cells were transplanted into cleared fat pads of 21 - day - old female Swiss nu / nu mice or control congenic animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : MPA failed to induce mammary carcinomas or significant morphologic changes in the mammary glands of C57BL / 6 mice .
【GOLD_E】
MPA	chem
【PRE_E】
【GOLD_R】
【PRE_R】

The expression of ER - alpha and PR isoform A in virgin mice was surprisingly much higher in BALB / c than in C57BL / 6 mammary glands , and both receptors were downregulated in progestin - treated BALB / c mice ( P < 0.05 ) .
【GOLD_E】
ER-alpha	geneY
PRisoformA	geneY
progestin	chem
【PRE_E】
ER-alpha	geneY
PRisoformA	geneY
progestin	chem
【GOLD_R】
progestin	ER-alpha	C4
progestin	PRisoformA	C4
【PRE_R】

PR isoform B levels were low in virgin control mice and increased after progestin treatment in both strains .
【GOLD_E】
PRisoformB	geneY
progestin	chem
【PRE_E】
PRisoformB	geneY
progestin	chem
【GOLD_R】
progestin	PRisoformB	C3
【PRE_R】

ER - beta expression followed a similar trend .
【GOLD_E】
ER-beta	geneY
【PRE_E】
ER-beta	geneY
【GOLD_R】
【PRE_R】

No differences in hormone levels were found between strains .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Surprisingly , the transplantation of the epithelial mammary gland cells of both strains into the cleared fat pads of Swiss ( nu / nu ) mice abolished the mammary gland morphologic differences and the ER and PR differences between strains .
【GOLD_E】
ER	geneY
PR	geneY
【PRE_E】
ER	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : C57BL / 6 mammary glands are resistant to MPA - induced carcinogenesis and to hormone action .
【GOLD_E】
MPA	chem
【PRE_E】
MPA	chem
【GOLD_R】
【PRE_R】

MPA and progesterone have different effects on mammary glands .
【GOLD_E】
MPA	chem
progesterone	chem
【PRE_E】
MPA	chem
progesterone	chem
【GOLD_R】
【PRE_R】

Low ER - alpha and PR - A levels in untreated mammary glands may be associated with a low - risk breast cancer profile .
【GOLD_E】
ER-alpha	geneY
PR-A	geneY
【PRE_E】
ER-alpha	geneY
PR-A	geneY
【GOLD_R】
【PRE_R】

Although we can not at this time rule out the participation of other , untested factors , our findings implicate the stroma as playing a crucial role in the strain - specific differential hormone receptor expression and hormone responsiveness .
【GOLD_E】
hormonereceptor	geneN
【PRE_E】
hormonereceptor	geneN
【GOLD_R】
【PRE_R】

Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism .
【GOLD_E】
estrogen	chem
steroid	chem
inorganicarsenic	chem
【PRE_E】
Transplacental	chem
arsenic	chem
hepatocarcinogenic	chem
estrogen	chem
steroid	chem
【GOLD_R】
【PRE_R】

Exposure to inorganic arsenic in utero in C3H mice produces hepatocellular carcinoma in male offspring when they reach adulthood .
【GOLD_E】
inorganicarsenic	chem
【PRE_E】
arsenic	chem
【GOLD_R】
【PRE_R】

To help define the molecular events associated with the fetal onset of arsenic hepatocarcinogenesis , pregnant C3H mice were given drinking water containing 0 ( control ) or 85 ppm arsenic from day 8 to 18 of gestation .
【GOLD_E】
arsenic	chem
arsenic	chem
【PRE_E】
arsenic	chem
arsenic	chem
【GOLD_R】
【PRE_R】

At the end of the arsenic exposure period , male fetal livers were removed and RNA isolated for microarray analysis using 22K oligo chips .
【GOLD_E】
arsenic	chem
【PRE_E】
arsenic	chem
【GOLD_R】
【PRE_R】

Arsenic exposure in utero produced significant ( p < 0.001 ) alterations in expression of 187 genes , with approximately 25 % of aberrantly expressed genes related to either estrogen signaling or steroid metabolism .
【GOLD_E】
Arsenic	chem
estrogen	chem
steroid	chem
【PRE_E】
Arsenic	chem
estrogen	chem
steroid	chem
【GOLD_R】
【PRE_R】

Real - time RT - PCR on selected genes confirmed these changes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Various genes controlled by estrogen , including X - inactive - specific transcript , anterior gradient - 2 , trefoil factor - 1 , CRP - ductin , ghrelin , and small proline - rich protein - 2A , were dramatically over - expressed .
【GOLD_E】
estrogen	chem
proline	chem
X-inactive-specifictranscript	geneY
anteriorgradient-2	geneY
trefoilfactor-1	geneY
CRP-ductin	geneY
ghrelin	geneY
smallproline-richprotein-2A	geneY
【PRE_E】
estrogen	chem
anteriorgradient-2	geneY
trefoilfactor-1	geneY
CRP-ductin	geneY
ghrelin	geneY
proline-richprotein-2A	geneY
【GOLD_R】
estrogen	X-inactive-specifictranscript	C3
estrogen	anteriorgradient-2	C3
estrogen	trefoilfactor-1	C3
estrogen	CRP-ductin	C3
estrogen	ghrelin	C3
estrogen	smallproline-richprotein-2A	C3
【PRE_R】
estrogen	anteriorgradient-2	C3
estrogen	trefoilfactor-1	C3
estrogen	CRP-ductin	C3

Estrogen - regulated genes including cytokeratin 1 - 19 and Cyp2a4 were over - expressed , although Cyp3a25 was suppressed .
【GOLD_E】
Estrogen	chem
Cyp2a4	geneY
Cyp3a25	geneY
cytokeratin1-19	geneY
【PRE_E】
Estrogen	chem
cytokeratin1-19	geneY
Cyp2a4	geneY
Cyp3a25	geneY
【GOLD_R】
Estrogen	Cyp2a4	C3
Estrogen	cytokeratin1-19	C3
Estrogen	Cyp3a25	C4
【PRE_R】
Estrogen	cytokeratin1-19	C3
Estrogen	Cyp2a4	C3
Estrogen	Cyp3a25	C3

Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of 17beta - hydroxysteroid dehydrogenase - 7 ( HSD17beta7 ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .
【GOLD_E】
steroid	chem
17beta-hydroxysteroid	chem
17beta-hydroxysteroiddehydrogenase-7	geneY
HSD17beta7	geneY
HSD17beta5	geneY
estradiol	chem
testosterone	chem
【PRE_E】
steroid	chem
17beta-hydroxysteroiddehydrogenase-7	geneY
HSD17beta7	geneY
estradiol	chem
HSD17beta5	geneN
testosterone	chem
【GOLD_R】
estradiol	17beta-hydroxysteroiddehydrogenase-7	C9
estradiol	HSD17beta7	C9
testosterone	HSD17beta5	C9
【PRE_R】
steroid	HSD17beta7	C9
HSD17beta7	estradiol	C9

The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase - 1a , betaine - homocysteine methyltransferase and thioether S - methyltransferase , were suppressed .
【GOLD_E】
thioether	chem
S	chem
methionineadenosyltransferase-1a	geneY
betaine-homocysteinemethyltransferase	geneY
thioetherS-methyltransferase	geneY
methionine	chem
methionine	chem
betaine	chem
homocysteine	chem
【PRE_E】
methionine	chem
methionineadenosyltransferase-1a	geneY
betaine-homocysteinemethyltransferase	geneY
thioetherS-methyltransferase	geneY
【GOLD_R】
methionine	methionineadenosyltransferase-1a	C9
methionine	betaine-homocysteinemethyltransferase	C9
methionine	thioetherS-methyltransferase	C9
【PRE_R】

Thus , exposure of mouse fetus to inorganic arsenic during a critical period in development significantly alters the expression of various genes encoding estrogen signaling and steroid or methionine metabolism .
【GOLD_E】
inorganicarsenic	chem
estrogen	chem
steroid	chem
methionine	chem
【PRE_E】
arsenic	chem
estrogen	chem
steroid	chem
methionine	chem
【GOLD_R】
【PRE_R】

These alterations could disrupt genetic programming at the very early life stage , which could impact tumor formation much later in adulthood .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A pilot study of IL - 1 inhibition by anakinra in acute gout .
【GOLD_E】
IL-1	geneN
【PRE_E】
IL-1	geneY
【GOLD_R】
【PRE_R】

Monosodium urate crystals stimulate monocytes and macrophages to release IL - 1beta through the NALP3 component of the inflammasome .
【GOLD_E】
NALP3	geneY
Monosodiumurate	chem
IL-1beta	geneY
【PRE_E】
Monosodium	chem
IL-1beta	geneY
NALP3	geneY
【GOLD_R】
Monosodiumurate	IL-1beta	C3
【PRE_R】

The effectiveness of IL - 1 inhibition in hereditary autoinflammatory syndromes with mutations in the NALP3 protein suggested that IL - 1 inhibition might also be effective in relieving the inflammatory manifestations of acute gout .
【GOLD_E】
IL-1	geneN
NALP3	geneY
IL-1	geneN
【PRE_E】
IL-1	geneY
NALP3	geneN
IL-1	geneY
【GOLD_R】
【PRE_R】

The effectiveness of IL - 1 inhibition was first evaluated in a mouse model of monosodium urate crystal - induced inflammation .
【GOLD_E】
monosodiumurate	chem
IL-1	geneN
【PRE_E】
IL-1	geneY
【GOLD_R】
【PRE_R】

IL - 1 inhibition prevented peritoneal neutrophil accumulation but TNF blockade had no effect .
【GOLD_E】
IL-1	geneN
TNF	geneY
【PRE_E】
IL-1	geneY
TNF	geneY
【GOLD_R】
【PRE_R】

Based on these findings , we performed a pilot , open - labeled study ( trial registration number ISRCTN10862635 ) in 10 patients with gout who could not tolerate or had failed standard antiinflammatory therapies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All patients received 100 mg anakinra daily for 3 days .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All 10 patients with acute gout responded rapidly to anakinra .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

No adverse effects were observed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

IL - 1 blockade appears to be an effective therapy for acute gouty arthritis .
【GOLD_E】
IL-1	geneN
【PRE_E】
IL-1	geneY
【GOLD_R】
【PRE_R】

The clinical findings need to be confirmed in a controlled study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Structural basis of inhibition of the human NAD + - dependent deacetylase SIRT5 by suramin .
【GOLD_E】
humanNAD+-dependentdeacetylaseSIRT5	geneY
NAD+	chem
suramin	chem
【PRE_E】
humanNAD+-dependentdeacetylaseSIRT5	geneY
suramin	chem
【GOLD_R】
suramin	humanNAD+-dependentdeacetylaseSIRT5	C4
【PRE_R】

Sirtuins are NAD ( + ) - dependent protein deacetylases and are emerging as molecular targets for the development of pharmaceuticals to treat human metabolic and neurological diseases and cancer .
【GOLD_E】
NAD(+)	chem
【PRE_E】
Sirtuins	geneN
NAD(+)-dependentproteindeacetylases	geneN
【GOLD_R】
【PRE_R】

To date , several sirtuin inhibitors and activators have been identified , but the structural mechanisms of how these compounds modulate sirtuin activity have not yet been determined .
【GOLD_E】
sirtuin	geneN
sirtuin	geneN
【PRE_E】
sirtuin	geneN
sirtuin	geneN
【GOLD_R】
【PRE_R】

We identified suramin as a compound that binds to human SIRT5 and showed that it inhibits SIRT5 NAD ( + ) - dependent deacetylase activity with an IC ( 50 ) value of 22 microM .
【GOLD_E】
humanSIRT5	geneY
SIRT5NAD(+)-dependentdeacetylase	geneY
suramin	chem
NAD(+)	chem
【PRE_E】
suramin	chem
humanSIRT5	geneY
SIRT5	geneY
NAD(+)-dependentdeacetylase	geneN
【GOLD_R】
suramin	SIRT5NAD(+)-dependentdeacetylase	C4
【PRE_R】
suramin	humanSIRT5	C4
suramin	SIRT5	C4

To provide insights into how sirtuin function is altered by inhibitors , we determined two crystal structures of SIRT5 , one in complex with ADP - ribose , the other bound to suramin .
【GOLD_E】
SIRT5	geneY
ADP	chem
suramin	chem
【PRE_E】
sirtuin	geneN
SIRT5	geneY
ADP-ribose	chem
suramin	chem
【GOLD_R】
【PRE_R】

Our structural studies provide a view of a synthetic inhibitory compound in a sirtuin active site revealing that suramin binds into the NAD ( + ) , the product , and the substrate - binding site .
【GOLD_E】
sirtuin	geneN
suramin	chem
NAD(+)	chem
【PRE_E】
sirtuin	geneN
suramin	chem
NAD(+)	chem
【GOLD_R】
【PRE_R】

Finally , our structures may enable the rational design of more potent inhibitors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase .
【GOLD_E】
methionine	chem
folate	chem
methionine	chem
methioninesynthasereductase	geneY
【PRE_E】
methionine	chem
folate	chem
methioninesynthasereductase	geneY
【GOLD_R】
【PRE_R】

Hyperhomocyst ( e ) inemia is a metabolic derangement that is linked to the distribution of folate pools , which provide one - carbon units for biosynthesis of purines and thymidylate and for remethylation of homocysteine to form methionine .
【GOLD_E】
thymidylate	chem
homocysteine	chem
methionine	chem
folate	chem
carbon	chem
purines	chem
【PRE_E】
Hyperhomocyst(e)inemia	chem
folate	chem
carbon	chem
purines	chem
thymidylate	chem
remethylation	chem
homocysteine	chem
methionine	chem
【GOLD_R】
【PRE_R】

In humans , methionine synthase deficiency results in the accumulation of methyltetrahydrofolate at the expense of folate derivatives required for purine and thymidylate biosynthesis .
【GOLD_E】
methionine	chem
methyltetrahydrofolate	chem
folate	chem
purine	chem
thymidylate	chem
methioninesynthase	geneY
【PRE_E】
methioninesynthase	geneY
methyltetrahydrofolate	chem
folate	chem
purine	chem
thymidylate	chem
【GOLD_R】
methyltetrahydrofolate	methioninesynthase	C9
【PRE_R】

Complete ablation of methionine synthase activity in mice results in embryonic lethality .
【GOLD_E】
methionine	chem
methioninesynthase	geneY
【PRE_E】
methioninesynthase	geneY
【GOLD_R】
【PRE_R】

Other mouse models for hyperhomocyst ( e ) inemia have normal or reduced levels of methyltetrahydrofolate and are not embryonic lethal , although they have decreased ratios of AdoMet / AdoHcy and impaired methylation .
【GOLD_E】
methyltetrahydrofolate	chem
AdoMet	chem
AdoHcy	chem
【PRE_E】
hyperhomocyst(e)inemia	chem
methyltetrahydrofolate	chem
AdoMet	chem
AdoHcy	chem
【GOLD_R】
【PRE_R】

We have constructed a mouse model with a gene trap insertion in the Mtrr gene specifying methionine synthase reductase , an enzyme essential for the activity of methionine synthase .
【GOLD_E】
methionine	chem
methionine	chem
Mtrr	geneY
methioninesynthasereductase	geneY
methioninesynthase	geneY
【PRE_E】
Mtrr	geneY
methioninesynthasereductase	geneY
methioninesynthase	geneY
【GOLD_R】
【PRE_R】

This model is a hypomorph , with reduced methionine synthase reductase activity , thus avoiding the lethality associated with the absence of methionine synthase activity .
【GOLD_E】
methionine	chem
methionine	chem
methioninesynthase	geneY
methioninesynthasereductase	geneY
【PRE_E】
methioninesynthasereductase	geneY
methioninesynthase	geneN
【GOLD_R】
【PRE_R】

Mtrr ( gt / gt ) mice have increased plasma homocyst ( e ) ine , decreased plasma methionine , and increased tissue methyltetrahydrofolate .
【GOLD_E】
homocyst(e)ine	chem
Mtrr	geneY
methionine	chem
methyltetrahydrofolate	chem
【PRE_E】
Mtrr	geneY
homocyst(e)ine	chem
methionine	chem
tissuemethyltetrahydrofolate	chem
【GOLD_R】
【PRE_R】

Unexpectedly , Mtrr ( gt / gt ) mice do not show decreases in the AdoMet / AdoHcy ratio in most tissues .
【GOLD_E】
Mtrr	geneY
AdoMet	chem
AdoHcy	chem
【PRE_E】
Mtrr	geneY
AdoMet	chem
AdoHcy	chem
【GOLD_R】
【PRE_R】

The different metabolite profiles in the various genetic mouse models for hyperhomocyst ( e ) inemia may be useful in understanding biological effects of elevated homocyst ( e ) ine .
【GOLD_E】
homocyst(e)ine	chem
【PRE_E】
hyperhomocyst(e)inemia	chem
homocyst(e)ine	chem
【GOLD_R】
【PRE_R】

Metformin and phenformin activate AMP - activated protein kinase in the heart by increasing cytosolic AMP concentration .
【GOLD_E】
Metformin	chem
AMP	chem
phenformin	chem
AMP	chem
AMP-activatedproteinkinase	geneN
【PRE_E】
Metformin	chem
phenformin	chem
AMP-activatedproteinkinase	geneN
AMP	chem
【GOLD_R】
Metformin	AMP-activatedproteinkinase	C3
phenformin	AMP-activatedproteinkinase	C3
【PRE_R】

AMP - activated protein kinase ( AMPK ) acts as a cellular energy sensor : it responds to an increase in AMP concentration ( [ AMP ] ) or the AMP - to - ATP ratio ( AMP / ATP ) .
【GOLD_E】
AMP	chem
ATP	chem
AMP	chem
AMP	chem
ATP	chem
AMP	chem
AMP-activatedproteinkinase	geneN
AMPK	geneN
AMP	chem
【PRE_E】
AMP-activatedproteinkinase	geneN
AMPK	geneN
AMP	chem
[AMP])	chem
AMP	chem
ATP	chem
AMP	chem
ATP	chem
【GOLD_R】
【PRE_R】

Metformin and phenformin , which are biguanides , have been reported to increase AMPK activity without increasing AMP / ATP .
【GOLD_E】
Metformin	chem
phenformin	chem
biguanides	chem
AMP	chem
ATP	chem
AMPK	geneN
【PRE_E】
Metformin	chem
phenformin	chem
biguanides	chem
AMPK	geneN
AMP	chem
ATP	chem
【GOLD_R】
Metformin	AMPK	C3
phenformin	AMPK	C3
biguanides	AMPK	C3
【PRE_R】
Metformin	AMPK	C4
phenformin	AMPK	C4
biguanides	AMPK	C4

This study tests the hypothesis that these biguanides increase AMPK activity in the heart by increasing cytosolic [ AMP ] .
【GOLD_E】
biguanides	chem
AMP	chem
AMPK	geneN
【PRE_E】
AMPK	geneN
AMP	chem
【GOLD_R】
【PRE_R】

Groups of isolated rat hearts ( n = 5 - 7 each ) were perfused with Krebs - Henseleit buffer with or without 0.2 mM phenformin or 10 mM metformin , and ( 31 ) P - NMR - measured phosphocreatine , ATP , and intracellular pH were used to calculate cytosolic [ AMP ] .
【GOLD_E】
phenformin	chem
metformin	chem
(31)P	chem
phosphocreatine	chem
ATP	chem
AMP	chem
【PRE_E】
phenformin	chem
metformin	chem
(31)P-NMR	chem
phosphocreatine	chem
ATP	chem
AMP	chem
【GOLD_R】
【PRE_R】

At various times , hearts were freeze - clamped and assayed for AMPK activity , phosphorylation of Thr ( 172 ) on AMPK - alpha , and phosphorylation of Ser ( 79 ) on acetyl - CoA carboxylase , an AMPK target .
【GOLD_E】
acetyl-CoA	chem
AMPK	geneN
AMPK-alpha	geneN
acetyl-CoAcarboxylase	geneN
AMPK	geneN
【PRE_E】
AMPK	geneN
Thr	chem
AMPK-alpha	geneY
Ser	chem
acetyl-CoAcarboxylase	geneN
AMPK	geneN
【GOLD_R】
【PRE_R】

In hearts treated with phenformin for 18 min and then perfused for 20 min with Krebs - Henseleit buffer , [ AMP ] began to increase at 26 min and AMPK activity was elevated at 36 min .
【GOLD_E】
phenformin	chem
AMP	chem
AMPK	geneN
【PRE_E】
phenformin	chem
AMP	chem
AMPK	geneN
【GOLD_R】
phenformin	AMPK	C3
【PRE_R】
phenformin	AMPK	C4

In hearts treated with metformin , [ AMP ] was increased at 50 min and AMPK activity , phosphorylated AMPK , and phosphorylated acetyl - CoA carboxylase were elevated at 61 min .
【GOLD_E】
metformin	chem
AMPK	geneN
AMPK	geneN
phosphorylatedacetyl-CoAcarboxylase	geneN
AMP	chem
acetyl-CoA	chem
【PRE_E】
metformin	chem
AMP	chem
AMPK	geneN
phosphorylatedAMPK	geneN
phosphorylatedacetyl-CoAcarboxylase	geneY
【GOLD_R】
metformin	AMPK	C3
metformin	AMPK	C3
metformin	phosphorylatedacetyl-CoAcarboxylase	C3
【PRE_R】
metformin	AMPK	C3
AMP	AMPK	C3
AMP	phosphorylatedAMPK	C3

In metformin - treated hearts , HPLC - measured total AMP content and total AMP / ATP did not increase .
【GOLD_E】
ATP	chem
metformin	chem
AMP	chem
AMP	chem
【PRE_E】
metformin	chem
AMP	chem
AMP	chem
ATP	chem
【GOLD_R】
【PRE_R】

In summary , phenformin and metformin increase AMPK activity and phosphorylation in the isolated heart .
【GOLD_E】
phenformin	chem
metformin	chem
AMPK	geneN
【PRE_E】
phenformin	chem
metformin	chem
AMPK	geneN
【GOLD_R】
phenformin	AMPK	C3
metformin	AMPK	C3
【PRE_R】
phenformin	AMPK	C4
metformin	AMPK	C4

The increase in AMPK activity was always preceded by and correlated with increased cytosolic [ AMP ] .
【GOLD_E】
AMP	chem
AMPK	geneN
【PRE_E】
AMPK	geneN
AMP	chem
【GOLD_R】
【PRE_R】
AMPK	AMP	C3

Total AMP content and total AMP / ATP did not change .
【GOLD_E】
AMP	chem
AMP	chem
ATP	chem
【PRE_E】
AMP	chem
AMP	chem
ATP	chem
【GOLD_R】
【PRE_R】

Cytosolic [ AMP ] reported metabolically active AMP , which triggered increased AMPK activity , but measures of total AMP did not .
【GOLD_E】
AMP	chem
AMP	chem
AMP	chem
AMPK	geneN
【PRE_E】
AMP	chem
AMP	chem
AMPK	geneN
AMP	chem
【GOLD_R】
AMP	AMPK	C3
【PRE_R】
AMP	AMPK	C3

The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population .
【GOLD_E】
glutathionetransferasesM1andT1	geneN
glutathione	chem
【PRE_E】
glutathionetransferasesM1andT1	geneN
【GOLD_R】
【PRE_R】

BACKGROUND : Susceptibility to bladder cancer is thought to depend on interplay between genetic factors and environmental chemical carcinogens .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

AIM : This study seeks to determine the role of the glutathione transferases M1 and T1 null genotypes ( GSTM1 * 0 and GSTT1 * 0 ) in individual susceptibility to bladder cancer in a Tunisian population .
【GOLD_E】
glutathione	chem
glutathionetransferasesM1andT1	geneN
GSTM1	geneY
GSTT1	geneY
【PRE_E】
glutathionetransferases	geneN
GSTM1	geneY
GSTT1	geneY
【GOLD_R】
【PRE_R】

METHOD : Sixty - two patients with transitional cell carcinoma of the bladder cancer and 79 controls were examined with respect to the frequency of GSTM1 and GSTT1 null genotypes .
【GOLD_E】
GSTM1	geneY
GSTT1	geneY
【PRE_E】
GSTM1	geneY
GSTT1	geneY
【GOLD_R】
【PRE_R】

RESULTS : The frequencies of the GSTT1 null in the total group of bladder cancer cases vs. controls did not differ statistically .
【GOLD_E】
GSTT1	geneY
【PRE_E】
GSTT1	geneY
【GOLD_R】
【PRE_R】

The proportion of GSTM1 null genotype in patients was 63 % compared to 45 % in controls group ( OR = 2.03 ; 95 % CI 0.97 - 4.24 ; p = 0.04 ) .
【GOLD_E】
GSTM1	geneY
【PRE_E】
GSTM1	geneY
【GOLD_R】
【PRE_R】

A significantly higher incidence of GSTM1 deletion genotype was found in smokers with bladder cancer compared to the controls ( 65.38 % vs .
【GOLD_E】
GSTM1	geneY
【PRE_E】
GSTM1	geneY
【GOLD_R】
【PRE_R】

45.5 % ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Smokers lacking the GSTM1 gene are at an approximately 2.2 - fold higher risk of bladder cancer ( OR = 2.23 , 95 % CI 1 - 5.15 ; p = 0.03 ) .
【GOLD_E】
GSTM1	geneY
【PRE_E】
GSTM1	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : This study suggests that in Tunisian subjects the GSTM1 null genotype may be associated with an increased risk of bladder cancer .
【GOLD_E】
GSTM1	geneY
【PRE_E】
GSTM1	geneY
【GOLD_R】
【PRE_R】

This association appears to depend upon smoking status .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Characterization of 5 - hydroxytryptamine1B receptors in rat spinal cord via [ 125I ] iodocyanopindolol binding and inhibition of [ 3H ] - 5 - hydroxytryptamine release .
【GOLD_E】
[3H]-5-hydroxytryptamine	chem
[125I]iodocyanopindolol	chem
5-hydroxytryptamine1B	geneY
【PRE_E】
5-hydroxytryptamine1Breceptors	geneY
[125I]iodocyanopindolol	chem
[3H]-5-hydroxytryptamine	chem
【GOLD_R】
【PRE_R】

The aim of the present study in rat spinal cord synaptosomes was to compare the pharmacological characteristics of the serotonin ( 5 - HT ) 1B receptor defined by [ 125I ] iodocyanopindolol [ ( 125I ] ICYP ) binding and the 5 - HT autoreceptor defined by inhibition of [ 3H ] - 5 - HT release .
【GOLD_E】
[125I]iodocyanopindolol	chem
[(125I]ICYP)	chem
5-HT	chem
serotonin	chem
[3H]-5-HT	chem
serotonin(5-HT)1Breceptor	geneY
5-HTautoreceptor	geneY
【PRE_E】
serotonin(5-HT)1Breceptor	geneY
[125I]iodocyanopindolol	chem
(125I]ICYP	chem
5-HTautoreceptor	geneN
[3H]-5-HT	chem
【GOLD_R】
【PRE_R】

In Percoll gradient Fractions 3 and 4 of spinal cord synaptosomes , a single saturable binding site for [ 125I ] ICYP with a maximum binding of 70 and 134 fmol / mg , respectively , was demonstrated in the presence of 30 microM isoproterenol .
【GOLD_E】
[125I]ICYP	chem
isoproterenol	chem
【PRE_E】
[125I]ICYP	chem
isoproterenol	chem
【GOLD_R】
【PRE_R】

The Kd of 0.16 nM did not vary between fractions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Competition for [ 125I ] ICYP binding by various 5 - HT agonists and antagonists also indicated a single site model based on a Hill coefficient of approximately 1.0 .
【GOLD_E】
[125I]ICYP	chem
5-HT	chem
【PRE_E】
[125I]ICYP	chem
5-HT	chem
【GOLD_R】
【PRE_R】

The most potent compounds at displacing [ 125I ] ICYP binding were RU 24969 ( 5 - methoxy - 3 - [ 1,2,3,6 - tetrahydropyridin - 4 - yl ] - 1H - indole ) , 5 - carboxyamidotryptamine HCl , 5 - methoxytryptamine , 5 - HT and CGS 12066B ( 7 - trifluoromethyl - 4 ( 4 methyl - 1 - pyrolo [ 1,2 - a ] - quinoxaline malate ) .
【GOLD_E】
[125I]ICYP	chem
RU24969	chem
5-methoxy-3-[1,2,3,6-tetrahydropyridin-4-yl]-1H-indole	chem
5-carboxyamidotryptamineHCl	chem
5-methoxytryptamine	chem
5-HT	chem
CGS12066B	chem
7-trifluoromethyl-4(4methyl-1-pyrolo[1,2-a]-quinoxalinemalate	chem
【PRE_E】
[125I]ICYP	chem
RU24969	chem
5-methoxy-3-[1,2,3,6-tetrahydropyridin-4-yl]-1H-indole	chem
5-carboxyamidotryptamineHCl	chem
5-methoxytryptamine	chem
5-HT	chem
CGS12066B	chem
7-trifluoromethyl-4(4methyl-1-pyrolo	chem
1,2-a]-quinoxalinemalate	chem
【GOLD_R】
【PRE_R】

[ 125I ] ICYP binding was not altered by compounds with activity at 5 - HT1A , 5 - HT1C , 5 - HT2 , 5 - HT3 or alpha - 2 receptor sites .
【GOLD_E】
[125I]ICYP	chem
5-HT1A	geneY
5-HT1C	geneY
5-HT2	geneY
5-HT3	geneY
【PRE_E】
[125I]ICYP	chem
5-HT1A	geneY
5-HT1C	geneY
5-HT2	geneY
5-HT3	geneY
alpha-2receptor	geneN
【GOLD_R】
【PRE_R】

Similar to the pharmacological characteristics of the 5HT1B site defined by [ 125I ] ICYP , compounds most active at inhibiting 15 mM K ( + ) - stimulated release of [ 3H ] - 5 - HT were RU24969 = 5 - carboxyamidotryptamine HCl = CGS 12066B greater than 5 - methoxytryptamine greater than 5 - HT .
【GOLD_E】
5-HT	chem
[125I]ICYP	chem
K(+)	chem
[3H]-5-HT	chem
5HT1B	geneY
RU24969	chem
5-carboxyamidotryptamine	chem
HCl	chem
CGS12066B	chem
5-methoxytryptamine	chem
【PRE_E】
5HT1B	geneY
[125I]ICYP	chem
K(+)	chem
[3H]-5-HT	chem
RU24969	chem
5-carboxyamidotryptamineHCl	chem
CGS12066B	chem
5-methoxytryptamine	chem
5-HT	chem
【GOLD_R】
【PRE_R】

Compounds with activity at 5 - HT1A , 5 - HT1C , 5 - HT2 or 5 - HT3 sites were inactive .
【GOLD_E】
5-HT1A	geneY
5-HT1C	geneY
5-HT2	geneY
5-HT3	geneY
【PRE_E】
5-HT1A	geneY
5-HT1C	geneY
5-HT2	geneY
5-HT3	geneY
【GOLD_R】
【PRE_R】

A correlation analysis of selective 5 - HT1B compounds comparing the pKD for displacement of [ 125I ] ICYP vs. the IC50 for inhibition of [ 3H ] - 5 - HT release demonstrated the pharmacological similarity of the presynaptic inhibitory 5 - HT autoreceptor and the 5 - HT receptor site defined by [ 125I ] ICYP binding in spinal cord synaptosomes ( r = 0.791 , P = .0193 ) .
【GOLD_E】
[125I]ICYP	chem
[3H]-5-HT	chem
5-HT	chem
5-HT	chem
[125I]ICYP	chem
5-HT1B	geneY
5-HTautoreceptor	geneY
5-HTreceptor	geneY
【PRE_E】
5-HT1B	geneY
pKD	geneY
[125I]ICYP	chem
[3H]-5-HT	chem
5-HTautoreceptor	geneN
5-HTreceptor	geneN
[125I]ICYP	chem
【GOLD_R】
【PRE_R】

Although [ 125I ] ICYP binding was unaltered , alpha - 2 agonists such as clonidine , norepinephrine and UK 14304 [ 5 - bromo - 6 - [ 2 - imidazolin - 2 - ylamino ] - quinoxaline ) as well as the alpha - 2 antagonists rauwolscine and yohimbine also decreased the K ( + ) - stimulated release of [ 3H ] - 5 - HT and phentolamine , an alpha - 2 antagonist increased release .
【GOLD_E】
[125I]ICYP	chem
clonidine	chem
norepinephrine	chem
UK14304	chem
[5-bromo-6-[2-imidazolin-2-ylamino]-quinoxaline	chem
rauwolscine	chem
yohimbine	chem
K(+)	chem
[3H]-5-HT	chem
phentolamine	chem
【PRE_E】
[125I]ICYP	chem
alpha-2	geneY
clonidine	chem
norepinephrine	chem
UK14304	chem
5-bromo-6-[2-imidazolin-2-ylamino]-quinoxaline	chem
alpha-2	geneY
rauwolscine	chem
yohimbine	chem
K(+)	chem
[3H]-5-HT	chem
phentolamine	chem
alpha-2	geneY
【GOLD_R】
【PRE_R】

The action of these alpha - 2 compounds to alter [ 3H ] - 5 - HT release suggests the presence of heteroreceptors localized on 5 - HT terminals in the spinal cord .
【GOLD_E】
[3H]-5-HT	chem
5-HT	chem
【PRE_E】
[3H]-5-HT	chem
5-HT	chem
【GOLD_R】
【PRE_R】

These results point out that [ 125I ] ICYP identifies the 5 - HT1B receptor , and affinity of compounds for this site predicts action at the 5 - HT1B autoreceptor . ( ABSTRACT TRUNCATED AT 400 WORDS )
【GOLD_E】
[125I]ICYP	chem
5-HT1B	geneY
5-HT1B	geneY
【PRE_E】
[125I]ICYP	chem
5-HT1B	geneY
5-HT1B	geneY
【GOLD_R】
【PRE_R】

Histamine H1 receptor involvement in prepulse inhibition and memory function : relevance for the antipsychotic actions of clozapine .
【GOLD_E】
Histamine	chem
clozapine	chem
HistamineH1receptor	geneY
【PRE_E】
HistamineH1receptor	geneY
clozapine	chem
【GOLD_R】
【PRE_R】

Histamine H ( 1 ) blockade is one of the more prominent actions of the multi - receptor acting antipsychotic clozapine .
【GOLD_E】
Histamine	chem
HistamineH(1)	geneY
clozapine	chem
【PRE_E】
HistamineH(1)	chem
clozapine	chem
【GOLD_R】
clozapine	HistamineH(1)	C4
【PRE_R】

It is currently not known how much this H ( 1 ) antagonism of clozapine contributes to the therapeutic or adverse side effects of clozapine .
【GOLD_E】
clozapine	chem
clozapine	chem
H(1)	geneY
【PRE_E】
H(1)	chem
clozapine	chem
clozapine	chem
【GOLD_R】
clozapine	H(1)	C6
【PRE_R】

The current studies with Sprague - Dawley rats were conducted to determine the participation of histaminergic H ( 1 ) receptor subtype in sensorimotor plasticity and memory function affected by clozapine using tests of prepulse inhibition ( PPI ) and radial - arm maze choice accuracy .
【GOLD_E】
clozapine	chem
histaminergicH(1)receptor	geneY
【PRE_E】
H(1)receptor	geneY
clozapine	chem
【GOLD_R】
【PRE_R】

The PPI impairment caused by the glutamate antagonist dizocilpine ( MK - 801 ) was significantly attenuated by clozapine .
【GOLD_E】
glutamate	chem
dizocilpine	chem
MK-801	chem
clozapine	chem
【PRE_E】
glutamate	chem
dizocilpine	chem
MK-801	chem
clozapine	chem
【GOLD_R】
【PRE_R】

In the current project , we found that the selective H ( 1 ) antagonist pyrilamine also reversed the dizocilpine - induced impairment in PPI of tactile startle with an auditory prepulse .
【GOLD_E】
pyrilamine	chem
dizocilpine	chem
H(1)	geneY
【PRE_E】
H(1)	geneY
pyrilamine	chem
dizocilpine	chem
【GOLD_R】
dizocilpine	H(1)	C3
pyrilamine	H(1)	C6
【PRE_R】
H(1)	dizocilpine	C5

In the radial - arm maze ( RAM ) , pyrilamine , like clozapine , impaired working memory and caused a significant dose - related slowing of response .
【GOLD_E】
pyrilamine	chem
clozapine	chem
【PRE_E】
pyrilamine	chem
clozapine	chem
【GOLD_R】
【PRE_R】

Pyrilamine , however , decreased the number of reference memory errors .
【GOLD_E】
Pyrilamine	chem
【PRE_E】
Pyrilamine	chem
【GOLD_R】
【PRE_R】

We have previously shown that nicotine effectively attenuates the clozapine - induced working memory impairment , but in the current study , nicotine did not significantly alter the effects of pyrilamine on the RAM .
【GOLD_E】
nicotine	chem
clozapine	chem
nicotine	chem
pyrilamine	chem
【PRE_E】
nicotine	chem
clozapine	chem
nicotine	chem
pyrilamine	chem
【GOLD_R】
【PRE_R】

In summary , the therapeutic effect of clozapine in reversing PPI impairment was mimicked by the H ( 1 ) antagonist pyrilamine , while pyrilamine had a mixed effect on cognition .
【GOLD_E】
H(1)	geneY
clozapine	chem
pyrilamine	chem
pyrilamine	chem
【PRE_E】
clozapine	chem
H(1)	geneY
pyrilamine	chem
pyrilamine	chem
【GOLD_R】
clozapine	H(1)	C4
pyrilamine	H(1)	C6
pyrilamine	H(1)	C6
【PRE_R】

Pyrilamine impaired working memory but improved reference memory in rats .
【GOLD_E】
Pyrilamine	chem
【PRE_E】
Pyrilamine	chem
【GOLD_R】
【PRE_R】

Thus , H ( 1 ) antagonism seems to play a role in part of the beneficial actions of antipsychotics , such as clozapine .
【GOLD_E】
clozapine	chem
H(1)	geneY
【PRE_E】
H(1)	chem
clozapine	chem
【GOLD_R】
clozapine	H(1)	C6
【PRE_R】

Inhibition of phosphatidylserine biosynthesis in developing rat brain by maternal exposure to ethanol .
【GOLD_E】
ethanol	chem
【PRE_E】
phosphatidylserine	chem
ethanol	chem
【GOLD_R】
【PRE_R】

Phosphatidylserine ( PtdSer ) , major acidic phospholipids in neuronal membranes , participate in important cell signaling processes .
【GOLD_E】
【PRE_E】
Phosphatidylserine	chem
PtdSer	chem
【GOLD_R】
【PRE_R】

The PtdSer in brain is highly enriched with docosahexaenoic acid ( DHA ; 22 : 6n - 3 ) , and the DHA status or ethanol exposure has been shown to influence the PtdSer level .
【GOLD_E】
docosahexaenoicacid	chem
DHA	chem
DHA	chem
ethanol	chem
【PRE_E】
PtdSer	chem
docosahexaenoicacid	chem
DHA	chem
DHA	chem
ethanol	chem
PtdSer	chem
【GOLD_R】
【PRE_R】

This study shows that ethanol exposure during prenatal and developmental period significantly attenuates microsomal PtdSer biosynthetic activities and reduces PtdSer , particularly 18 : 0 , 22 : 6 - PtdSer , in developing rat brain cortices .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
PtdSer	chem
PtdSer	chem
6-PtdSer	chem
【GOLD_R】
【PRE_R】

Brain microsomes were incubated with deuterium labeled exogenous substrates in vitro and the products formed were detected by reversed phase HPLC - electrospray ionization mass spectrometry ( ESI - MS ) .
【GOLD_E】
deuterium	chem
【PRE_E】
deuterium	chem
【GOLD_R】
【PRE_R】

These in vitro bioassays showed that 1 - stearoyl - 2 - docosahexaenoyl ( 18 : 0 , 22 : 6 ) species is the best substrate for PtdSer synthesis from both phosphatidylcholine ( PtdCho ) and phosphatidylethanolamine ( PtdEtn ) .
【GOLD_E】
1-stearoyl-2-docosahexaenoyl	chem
phosphatidylcholine	chem
PtdCho	chem
phosphatidylethanolamine	chem
PtdEtn	chem
【PRE_E】
1-stearoyl-2-docosahexaenoyl	chem
PtdSer	chem
phosphatidylcholine	chem
PtdCho	chem
phosphatidylethanolamine	chem
PtdEtn	chem
【GOLD_R】
【PRE_R】

The PtdSer biosynthetic activity of brain , especially for 18 : 0 , 22 : 6 - PtdSer production , was hampered significantly by maternal exposure to ethanol .
【GOLD_E】
ethanol	chem
【PRE_E】
PtdSer	chem
6-PtdSer	chem
ethanol	chem
【GOLD_R】
【PRE_R】

PtdSer levels were consistently reduced significantly in brain cortices of the pups from ethanol - exposed dams , due mainly to the depletion of 18 : 0 , 22 : 6 - PtdSer .
【GOLD_E】
ethanol	chem
【PRE_E】
PtdSer	chem
ethanol	chem
6-PtdSer	chem
【GOLD_R】
【PRE_R】

The mRNA expression of PtdSer synthase 1 ( PSS1 ) and PtdSer synthase 2 ( PSS2 ) was not reduced by ethanol .
【GOLD_E】
PtdSersynthase1	geneY
PSS1	geneY
PtdSersynthase2	geneY
PSS2	geneY
ethanol	chem
【PRE_E】
PtdSersynthase1	geneY
PSS1	geneY
PtdSersynthase2	geneY
PSS2	geneY
ethanol	chem
【GOLD_R】
【PRE_R】

Similarly , the PSS1 enzyme level did not change after ethanol exposure but PSS2 could not be probed with the antibody available currently .
【GOLD_E】
PSS1	geneY
PSS2	geneY
ethanol	chem
【PRE_E】
PSS1	geneY
ethanol	chem
PSS2	geneY
【GOLD_R】
【PRE_R】

Degradation of PtdSer by mitochondrial PtdSer decarboxylation was not enhanced but also inhibited .
【GOLD_E】
【PRE_E】
PtdSer	chem
PtdSer	chem
【GOLD_R】
【PRE_R】

Taken together , attenuated PtdSer biosynthetic activities are largely responsible for the PtdSer reduction observed in developing rat brains after maternal exposure to ethanol .
【GOLD_E】
ethanol	chem
【PRE_E】
PtdSer	chem
PtdSer	chem
ethanol	chem
【GOLD_R】
【PRE_R】

Regulation of gluconeogenesis by Kruppel - like factor 15 .
【GOLD_E】
Kruppel-likefactor15	geneY
【PRE_E】
gluconeogenesis	chem
Kruppel-likefactor15	geneY
【GOLD_R】
【PRE_R】

In the postabsorptive state , certain tissues , including the brain , require glucose as the sole source of energy .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

After an overnight fast , hepatic glycogen stores are depleted , and gluconeogenesis becomes essential for preventing life - threatening hypoglycemia .
【GOLD_E】
【PRE_E】
gluconeogenesis	chem
【GOLD_R】
【PRE_R】

Mice with a targeted deletion of KLF15 , a member of the Kruppel - like family of transcription factors , display severe hypoglycemia after an overnight ( 18 hr ) fast .
【GOLD_E】
KLF15	geneY
Kruppel-like	geneN
【PRE_E】
KLF15	geneY
Kruppel	geneN
【GOLD_R】
【PRE_R】

We provide evidence that defective amino acid catabolism promotes the development of fasting hypoglycemia in KLF15 - / - mice by limiting gluconeogenic substrate availability .
【GOLD_E】
KLF15	geneY
aminoacid	chem
【PRE_E】
aminoacid	chem
KLF15	geneY
【GOLD_R】
【PRE_R】

KLF15 - / - liver and skeletal muscle show markedly reduced mRNA expression of amino acid - degrading enzymes .
【GOLD_E】
KLF15	geneY
aminoacid	chem
【PRE_E】
KLF15	geneY
aminoacid-degradingenzymes	geneN
【GOLD_R】
【PRE_R】

Furthermore , the enzymatic activity of alanine aminotransferase ( ALT ) , which converts the critical gluconeogenic amino acid alanine into pyruvate , is decreased ( approximately 50 % ) in KLF15 - / - hepatocytes .
【GOLD_E】
alanineaminotransferase	geneN
ALT	geneN
KLF15	geneY
alanine	chem
aminoacid	chem
alanine	chem
pyruvate	chem
【PRE_E】
alanineaminotransferase	geneN
ALT	geneN
aminoacidalanine	chem
pyruvate	chem
KLF15	geneY
【GOLD_R】
pyruvate	alanineaminotransferase	C9
pyruvate	ALT	C9
aminoacid	alanineaminotransferase	C9
aminoacid	ALT	C9
alanine	alanineaminotransferase	C9
alanine	ALT	C9
【PRE_R】
ALT	aminoacidalanine	C9
ALT	pyruvate	C9

Consistent with this observation , intraperitoneal injection of pyruvate , but not alanine , rescues fasting hypoglycemia in KLF15 - / - mice .
【GOLD_E】
KLF15	geneY
pyruvate	chem
alanine	chem
【PRE_E】
pyruvate	chem
alanine	chem
KLF15	geneY
【GOLD_R】
【PRE_R】

We conclude that KLF15 plays an important role in the regulation of gluconeogenesis .
【GOLD_E】
KLF15	geneY
【PRE_E】
KLF15	geneY
gluconeogenesis	chem
【GOLD_R】
【PRE_R】

D - glucose stimulation of L - arginine transport and nitric oxide synthesis results from activation of mitogen - activated protein kinases p42 / 44 and Smad2 requiring functional type II TGF - beta receptors in human umbilical vein endothelium .
【GOLD_E】
D-glucose	chem
L-arginine	chem
nitricoxide	chem
mitogen-activatedproteinkinasesp42/44	geneN
Smad2	geneY
typeIITGF-betareceptors	geneY
【PRE_E】
D-glucose	chem
L-arginine	chem
nitricoxide	chem
mitogen-activatedproteinkinasesp42/44	geneN
Smad2	geneY
typeIITGF-betareceptors	geneY
【GOLD_R】
D-glucose	Smad2	C3
【PRE_R】
D-glucose	mitogen-activatedproteinkinasesp42/44	C3
D-glucose	Smad2	C3
D-glucose	typeIITGF-betareceptors	C3

Elevated extracellular D - glucose increases transforming growth factor beta1 ( TGF - beta1 ) release from human umbilical vein endothelium ( HUVEC ) .
【GOLD_E】
transforminggrowthfactorbeta1	geneY
TGF-beta1	geneY
D-glucose	chem
【PRE_E】
D-glucose	chem
transforminggrowthfactorbeta1	geneY
TGF-beta1	geneY
【GOLD_R】
D-glucose	transforminggrowthfactorbeta1	C3
D-glucose	TGF-beta1	C3
【PRE_R】

TGF - beta1 , via TGF - beta receptors I ( TbetaRI ) and TbetaRII , activates Smad2 and mitogen - activated protein kinases p44 and p42 ( p42 / 44 ( mapk ) ) .
【GOLD_E】
TGF-beta1	geneY
TGF-betareceptorsI	geneY
TbetaRI	geneY
TbetaRII	geneY
Smad2	geneY
mitogen-activatedproteinkinases	geneN
p44	geneY
p42	geneY
p42/44	geneN
mapk	geneN
【PRE_E】
TGF-beta1	geneY
TGF-betareceptorsI	geneY
TbetaRI	geneY
TbetaRII	geneY
Smad2	geneY
mitogen-activatedproteinkinasesp44	geneN
p42	geneN
p42/44	geneN
mapk	geneN
【GOLD_R】
【PRE_R】

We studied whether D - glucose - stimulation of L - arginine transport and nitric oxide synthesis involves TGF - beta1 in primary cultures of HUVEC .
【GOLD_E】
TGF-beta1	geneY
D-glucose	chem
L-arginine	chem
nitricoxide	chem
【PRE_E】
D-glucose	chem
L-arginine	chem
nitricoxide	chem
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

TGF - beta1 release was higher ( approximately 1.6 - fold ) in 25 mM ( high ) compared with 5 mM ( normal ) D - glucose .
【GOLD_E】
D-glucose	chem
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
D-glucose	chem
【GOLD_R】
D-glucose	TGF-beta1	C3
【PRE_R】

TGF - beta1 increases L - arginine transport ( half maximal effect approximately 1.6 ng / ml ) in normal D - glucose , but did not alter high D - glucose - increased L - arginine transport .
【GOLD_E】
L-arginine	chem
D-glucose	chem
D-glucose	chem
L-arginine	chem
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
L-arginine	chem
D-glucose	chem
D-glucose	chem
L-arginine	chem
【GOLD_R】
【PRE_R】
TGF-beta1	L-arginine	C9

TGF - beta1 and high D - glucose increased hCAT - 1 mRNA expression ( approximately 8 - fold ) and maximal transport velocity ( V ( max ) ) , L - [ ( 3 ) H ] citrulline formation from L - [ ( 3 ) H ] arginine ( index of NO synthesis ) and endothelial NO synthase ( eNOS ) protein abundance , but did not alter eNOS phosphorylation .
【GOLD_E】
D-glucose	chem
L-[(3)H]citrulline	chem
L-[(3)H]arginine	chem
NO	chem
NO	chem
TGF-beta1	geneY
hCAT-1	geneY
endothelialNOsynthase	geneY
eNOS	geneY
eNOS	geneY
【PRE_E】
TGF-beta1	geneY
D-glucose	chem
hCAT-1	geneY
L-[(3)H]citrulline	chem
L-[(3)H]arginine	chem
NO	chem
endothelialNOsynthase	geneY
eNOS	geneY
eNOS	geneY
【GOLD_R】
D-glucose	hCAT-1	C3
NO	endothelialNOsynthase	C9
NO	eNOS	C9
【PRE_R】
D-glucose	hCAT-1	C3
L-[(3)H]citrulline	eNOS	C9
L-[(3)H]arginine	eNOS	C9

TGF - beta1 and high D - glucose increased p42 / 44 ( mapk ) and Smad2 phosphorylation , an effect blocked by PD - 98059 ( MEK1 / 2 inhibitor ) .
【GOLD_E】
D-glucose	chem
TGF-beta1	geneY
p42/44	geneN
mapk	geneN
Smad2	geneY
MEK1/2	geneN
PD-98059	chem
【PRE_E】
TGF-beta1	geneY
D-glucose	chem
p42/44	geneN
mapk	geneN
Smad2	geneY
PD-98059	chem
MEK1/2	geneN
【GOLD_R】
D-glucose	Smad2	C3
PD-98059	Smad2	C4
【PRE_R】
D-glucose	p42/44	C3
D-glucose	mapk	C3
Smad2	PD-98059	C4
PD-98059	MEK1/2	C4

However , TGF - beta1 and high D - glucose were ineffective in cells expressing a truncated , negative dominant TbetaRII .
【GOLD_E】
TGF-beta1	geneY
TbetaRII	geneY
D-glucose	chem
【PRE_E】
TGF-beta1	geneY
D-glucose	chem
TbetaRII	geneY
【GOLD_R】
【PRE_R】

High D - glucose increases L - arginine transport and eNOS expression following TbetaRII activation by TGF - beta1 involving p42 / 44 ( mapk ) and Smad2 in HUVEC .
【GOLD_E】
eNOS	geneY
TbetaRII	geneY
TGF-beta1	geneY
p42/44	geneN
mapk	geneN
Smad2	geneY
D-glucose	chem
L-arginine	chem
【PRE_E】
D-glucose	chem
L-arginine	chem
eNOS	geneY
TbetaRII	geneY
TGF-beta1	geneY
p42/44	geneN
mapk	geneN
Smad2	geneY
【GOLD_R】
D-glucose	TbetaRII	C3
D-glucose	Smad2	C3
D-glucose	eNOS	C3
【PRE_R】
D-glucose	eNOS	C3
L-arginine	eNOS	C3
L-arginine	TbetaRII	C3
L-arginine	TGF-beta1	C3
L-arginine	p42/44	C3
L-arginine	mapk	C3
L-arginine	Smad2	C3

Thus , TGF - beta1 could play a crucial role under conditions of hyperglycemia , such as gestational diabetes mellitus , which is associated with fetal endothelial dysfunction .
【GOLD_E】
TGF-beta1	geneY
【PRE_E】
TGF-beta1	geneY
【GOLD_R】
【PRE_R】

n - 3 and n - 6 polyunsaturated fatty acids induce the expression of COX - 2 via PPARgamma activation in human keratinocyte HaCaT cells .
【GOLD_E】
n-3andn-6polyunsaturatedfattyacids	chem
COX-2	geneY
PPARgamma	geneY
【PRE_E】
n-3andn-6polyunsaturatedfattyacids	chem
COX-2	geneY
PPARgamma	geneY
【GOLD_R】
n-3andn-6polyunsaturatedfattyacids	PPARgamma	C3
n-3andn-6polyunsaturatedfattyacids	COX-2	C3
【PRE_R】
n-3andn-6polyunsaturatedfattyacids	COX-2	C3
n-3andn-6polyunsaturatedfattyacids	PPARgamma	C3

Polyunsaturated fatty acids ( PUFA ) n - 3 inhibit inflammation , in vivo and in vitro in keratinocytes .
【GOLD_E】
Polyunsaturatedfattyacids(PUFA)n-3	chem
【PRE_E】
Polyunsaturatedfattyacids	chem
PUFA	chem
【GOLD_R】
【PRE_R】

We examined in HaCaT keratinocyte cell line whether eicosapentaenoic acid ( EPA ) a n - 3 PUFA , gamma - linoleic acid ( GLA ) a n - 6 PUFA , and arachidic acid a saturated fatty acid , modulate expression of cyclooxygenase - 2 ( COX - 2 ) , an enzyme pivotal to skin inflammation and reparation .
【GOLD_E】
GLA	chem
n-6PUFA	chem
arachidicacid	chem
saturatedfattyacid	chem
cyclooxygenase-2	geneY
COX-2	geneY
eicosapentaenoicacid	chem
EPA	chem
n-3PUFA	chem
gamma-linoleicacid	chem
【PRE_E】
eicosapentaenoicacid	chem
EPA	chem
n-3PUFA	chem
gamma-linoleicacid	chem
GLA	chem
n-6PUFA	chem
arachidicacid	chem
fattyacid	chem
cyclooxygenase-2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand ( roziglitazone ) , induced COX - 2 expression ( protein and mRNA ) .
【GOLD_E】
GLA	chem
EPA	chem
roziglitazone	chem
PPARgamma	geneY
COX-2	geneY
【PRE_E】
HaCaT	geneY
GLA	geneY
EPA	chem
PPARgamma	geneY
COX-2	geneY
【GOLD_R】
GLA	COX-2	C3
EPA	COX-2	C3
roziglitazone	COX-2	C3
【PRE_R】

Moreover stimulation of COX - 2 promoter activity was increased by those PUFAs or rosiglitazone .
【GOLD_E】
PUFAs	chem
rosiglitazone	chem
COX-2promoter	geneN
【PRE_E】
COX-2	geneY
PUFAs	chem
rosiglitazone	chem
【GOLD_R】
PUFAs	COX-2promoter	C3
rosiglitazone	COX-2promoter	C3
【PRE_R】
COX-2	PUFAs	C3
COX-2	rosiglitazone	C3

The inhibitory effects of GW9662 and T0070907 ( PPARgamma antagonists ) , on COX - 2 expression and on stimulation of COX - 2 promoter activity by EPA and GLA suggest that PPARgamma is implicated in COX - 2 induction .
【GOLD_E】
GW9662	chem
T0070907	chem
EPA	chem
GLA	chem
PPARgamma	geneY
COX-2	geneY
COX-2promoter	geneN
PPARgamma	geneY
COX-2	geneY
【PRE_E】
GW9662	chem
T0070907	chem
PPARgamma	geneY
COX-2	geneY
COX-2	geneY
EPA	chem
GLA	geneY
PPARgamma	geneY
COX-2	geneY
【GOLD_R】
GW9662	PPARgamma	C6
T0070907	PPARgamma	C6
【PRE_R】
GW9662	PPARgamma	C6
T0070907	PPARgamma	C6

Finally , PLA2 inhibitor methyl arachidonyl fluorophosphonate blocked the PUFA effects on COX - 2 induction , promoter activity and arachidonic acid mobilization suggesting involvement of AA metabolites in PPAR activation .
【GOLD_E】
arachidonylfluorophosphonate	chem
PUFA	chem
arachidonicacid	chem
PPAR	geneN
AA	chem
PLA2	geneY
COX-2	geneY
【PRE_E】
PLA2	geneY
methylarachidonylfluorophosphonate	chem
PUFA	chem
COX-2	geneY
arachidonicacid	chem
PPAR	geneN
【GOLD_R】
AA	PPAR	C3
arachidonylfluorophosphonate	PLA2	C4
arachidonylfluorophosphonate	COX-2	C4
【PRE_R】
PLA2	methylarachidonylfluorophosphonate	C4
methylarachidonylfluorophosphonate	COX-2	C4

These findings demonstrate that n - 3 and n - 6 PUFA increased PPARgamma activity is necessary for the COX - 2 induction in HaCaT human keratinocyte cells .
【GOLD_E】
PPARgamma	geneY
COX-2	geneY
n-3andn-6PUFA	chem
【PRE_E】
n-3andn-6PUFA	chem
PPARgamma	geneY
COX-2	geneY
【GOLD_R】
n-3andn-6PUFA	PPARgamma	C3
n-3andn-6PUFA	COX-2	C3
【PRE_R】

Given the anti - inflammatory properties of EPA , we suggest that induction of COX - 2 in keratinocytes may be important in the anti - inflammatory and protective mechanism of action of PUFAs n - 3 or n - 6 .
【GOLD_E】
COX-2	geneY
EPA	chem
PUFAsn-3	chem
【PRE_E】
EPA	chem
COX-2	geneY
PUFAs	chem
【GOLD_R】
PUFAsn-3	COX-2	C3
【PRE_R】

Methylation - mediated silencing of genes is not altered by selenium treatment of prostate cancer cells .
【GOLD_E】
selenium	chem
【PRE_E】
selenium	chem
【GOLD_R】
【PRE_R】

BACKGROUND : The role of selenium in reducing the risk of multiple cancers has been described in the literature .
【GOLD_E】
selenium	chem
【PRE_E】
selenium	chem
【GOLD_R】
【PRE_R】

Although reports have described the antiproliferative and pro - apoptotic function of selenium by up - regulation of genes in these pathways , information is lacking on the target mechanisms of selenium on specific genes .
【GOLD_E】
selenium	chem
selenium	chem
【PRE_E】
selenium	chem
selenium	chem
【GOLD_R】
【PRE_R】

This study examines whether selenium treatment alters the methylation status of epigenetically silenced genes in prostate cancer cells .
【GOLD_E】
selenium	chem
【PRE_E】
selenium	chem
【GOLD_R】
【PRE_R】

MATERIALS AND METHODS : Methylation of glutathione sulfotransferase pi ( GSTP1 ) and Ras associated family 1A ( RASSF1A ) genes was studied using methylation sensitive PCR ( MS - PCR ) .
【GOLD_E】
GSTP1	geneY
Rasassociatedfamily1A	geneY
RASSF1A	geneY
glutathione	chem
glutathionesulfotransferasepi	geneY
【PRE_E】
glutathionesulfotransferasepi	geneY
GSTP1	geneY
Rasassociatedfamily1A	geneY
RASSF1A	geneY
【GOLD_R】
【PRE_R】

Gene expression was studied using Reverse Transcriptase PCR and Western Blotting .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS AND CONCLUSION : Treatment of prostate cancer cells with selenium did not alter the expression of genes that were silenced by DNA methylation .
【GOLD_E】
selenium	chem
【PRE_E】
selenium	chem
【GOLD_R】
【PRE_R】

Furthermore , the methylation status of these genes remained unaltered after treatment with seleno - DL - methionine .
【GOLD_E】
seleno-DL-methionine	chem
【PRE_E】
seleno-DL-methionine	chem
【GOLD_R】
【PRE_R】

Nebulized arformoterol in patients with COPD : a 12 - week , multicenter , randomized , double - blind , double - dummy , placebo - and active - controlled trial .
【GOLD_E】
arformoterol	chem
【PRE_E】
arformoterol	chem
【GOLD_R】
【PRE_R】

OBJECTIVE : The aim of this study was to assess the efficacy and tolerability of nebulized arformoterol tartrate ( a selective , long - acting beta ( 2 ) - adrenergic agonist that is the [ R , R ] isomer of formoterol ) and salmeterol xinafoate versus placebo in patients with chronic obstructive pulmonary disease ( COPD ) .
【GOLD_E】
beta(2)-adrenergic	geneY
[R,R]isomerofformoterol	chem
salmeterolxinafoate	chem
arformoteroltartrate	chem
【PRE_E】
arformoteroltartrate	chem
beta(2)-adrenergic	geneN
[R,R]isomerofformoterol	chem
salmeterolxinafoate	chem
【GOLD_R】
[R,R]isomerofformoterol	beta(2)-adrenergic	C5
arformoteroltartrate	beta(2)-adrenergic	C5
【PRE_R】

METHODS : This 12 - week , multicenter , randomized , double - blind , double - dummy , placebo - and active - controlled trial was conducted at 60 centers across the United States .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Male and female patients aged > or = 35 years with physician - diagnosed COPD received arformoterol ( 15 microg BID , 25 microg BID , or 50 microg QD via nebulizer ) , salmeterol ( 42 microg BID via metered dose inhaler ) , or placebo .
【GOLD_E】
arformoterol	chem
salmeterol	chem
【PRE_E】
arformoterol	chem
nebulizer	chem
salmeterol	chem
【GOLD_R】
【PRE_R】

Pulmonary function was assessed by spirometry ; dyspnea , by the Transitional Dyspnea Index ( TDI ) ; and health status , by the St .
【GOLD_E】
【PRE_E】
TDI	chem
【GOLD_R】
【PRE_R】

George 's Respiratory Questionnaire ( SGRQ ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Adverse events ( AEs ) were assessed by site personnel at all clinic visits ( screening , first dose at week 0 , and at weeks 3 , 6 , 9 , 12 , and follow - up ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

COPD exacerbations were defined as worsening respiratory status requiring a change in medication or an unscheduled provider visit .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : A total of 717 patients received study medication .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The demographic composition of all treatment arms was similar .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mean age was 62.9 years , 58 % were men , and mean baseline forced expiratory volume in 1 second ( FEV ( 1 ) ) was 1.2 L ( 41 % predicted ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mean improvement in trough FEV ( 1 ) over 12 weeks was significantly greater with all 3 arformoterol doses ( 15 microg BID , + 16.9 % ; 25 microg BID , + 18.9 % ; 50 microg QD , + 14.9 % ) and for salmeterol ( + 17.4 % ) relative to placebo ( + 6.0 % ; P < 0.001 ) .
【GOLD_E】
arformoterol	chem
salmeterol	chem
【PRE_E】
arformoterol	chem
salmeterol	chem
【GOLD_R】
【PRE_R】

There were significantly greater improvements in the mean percentage change in FEV ( 1 ) AUC ( 0 - 12h ) from the predose value over 12 weeks ( 15 microg BID , 12.7 % , 25 microg BID , 13.9 % , 50 microg QD , 18.9 % ; salmeterol , 9.8 % ) versus placebo ( 2.7 % ; P < or = 0.001 ) ; all doses of arformoterol were statistically different from salmeterol for this end point ( P < or = 0.024 ) .
【GOLD_E】
salmeterol	chem
【PRE_E】
salmeterol	chem
arformoterol	chem
salmeterol	chem
【GOLD_R】
【PRE_R】

At week 12 , TDI focal scores were significantly greater with all arformoterol doses compared with placebo ( mean [ 95 % CI ] : 15 microg BID , 0.97 [ 0.25 - 1.69 ] ; 25 microg BID , 1.08 [ 0.3 - 1.86 ] ; 50 microg QD , 1.04 [ 0.32 - 1.771 ) , suggesting treatment - associated improvement in dyspnea , however , the difference between salmeterol and placebo was not statistically significant ( 0.36 [ - 0.40 to 1.12 ] ) .
【GOLD_E】
【PRE_E】
TDI	chem
arformoterol	chem
salmeterol	chem
【GOLD_R】
【PRE_R】

Improvements in health status , as measured using SGRQ total scores , were - 2.6 to - 3.6 U in the arformoterol groups , - 4.4 U for salmeterol , and - 1.2 U for placebo ; 95 % CI of differences versus placebo suggested significant improvement for the arformoterol 25 microg BID and salmeterol groups .
【GOLD_E】
【PRE_E】
arformoterol	chem
salmeterol	chem
arformoterol	chem
salmeterol	chem
【GOLD_R】
【PRE_R】

There was a similar frequency of AEs and COPD exacerbations across all groups , including placebo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : In this trial , patients with moderate to severe COPD administered nebulized arformoterol over 12 weeks were observed to have significant and sustained improvements in airway function and dyspnea compared with placebo .
【GOLD_E】
【PRE_E】
arformoterol	chem
【GOLD_R】
【PRE_R】

The results also suggest that all doses of arformoterol , including the lowest dose ( 15 microg BID ) , were effective .
【GOLD_E】
【PRE_E】
arformoterol	chem
【GOLD_R】
【PRE_R】

Overall , nebulized arformoterol was well tolerated .
【GOLD_E】
【PRE_E】
arformoterol	chem
【GOLD_R】
【PRE_R】

Discovery of acetyl - coenzyme A carboxylase 2 inhibitors : comparison of a fluorescence intensity - based phosphate assay and a fluorescence polarization - based ADP Assay for high - throughput screening .
【GOLD_E】
phosphate	chem
acetyl-coenzymeA	chem
ADP	chem
acetyl-coenzymeAcarboxylase2	geneY
【PRE_E】
acetyl-coenzymeAcarboxylase2	geneY
phosphate	chem
ADP	chem
【GOLD_R】
【PRE_R】

Acetyl - coenzyme A carboxylase ( ACC ) enzymes exist as two isoforms , ACC1 and ACC2 , which play critical roles in fatty acid biosynthesis and oxidation .
【GOLD_E】
Acetyl-coenzymeAcarboxylase	geneN
Acetyl-coenzymeA	chem
ACC	geneN
ACC1	geneY
ACC2	geneY
fattyacid	chem
【PRE_E】
Acetyl-coenzymeAcarboxylase	geneN
ACC	geneN
ACC1	geneY
ACC2	geneY
fattyacid	chem
【GOLD_R】
fattyacid	Acetyl-coenzymeAcarboxylase	C9
fattyacid	ACC	C9
fattyacid	ACC1	C9
fattyacid	ACC2	C9
【PRE_R】

Though each isoform differs in tissue and subcellular localization , both catalyze the biotin - and ATP - dependent carboxylation of acetyl - coenzyme A to generate malonyl - coenzyme A , a key metabolite in the control of fatty acid synthesis and oxidation .
【GOLD_E】
fattyacid	chem
biotin	chem
ATP	chem
acetyl-coenzymeA	chem
malonyl-coenzymeA	chem
【PRE_E】
biotin	chem
ATP	chem
acetyl-coenzymeA	chem
malonyl-coenzymeA	geneY
fattyacid	chem
【GOLD_R】
【PRE_R】

The cytosolic ACC1 is expressed primarily in liver and adipose tissue , and uses malonyl - coenzyme A as a key building block in fatty acid biosynthesis .
【GOLD_E】
malonyl-coenzymeA	chem
fattyacid	chem
ACC1	geneY
【PRE_E】
ACC1	geneY
malonyl-coenzymeA	geneY
fattyacid	chem
【GOLD_R】
fattyacid	ACC1	C9
【PRE_R】
ACC1	fattyacid	C9

The mitochondrial ACC2 is primarily expressed in heart and skeletal muscle , where it is involved in the regulation of fatty acid oxidation .
【GOLD_E】
fattyacid	chem
ACC2	geneY
【PRE_E】
mitochondrialACC2	geneY
fattyacid	chem
【GOLD_R】
fattyacid	ACC2	C9
【PRE_R】

Inhibitors of ACC enzymes may therefore be useful therapeutics for diabetes , obesity , and metabolic syndrome .
【GOLD_E】
ACC	geneN
【PRE_E】
ACC	geneN
【GOLD_R】
【PRE_R】

Two assay formats for these ATP - utilizing enzymes amenable to high - throughput screening are compared : a fluorescence intensity - based assay to detect inorganic phosphate and a fluorescence polarization - based assay to detect ADP .
【GOLD_E】
ATP	chem
inorganicphosphate	chem
ADP	chem
【PRE_E】
ATP	chem
phosphate	chem
ADP	chem
【GOLD_R】
【PRE_R】

Acetyl - coenzyme A carboxylase inhibitors were identified by these high - throughput screening methods and were confirmed in a radiometric high performance liquid chromatography assay of malonyl - coenzyme A production .
【GOLD_E】
Acetyl-coenzymeAcarboxylase	geneN
Acetyl-coenzymeA	chem
malonyl-coenzymeA	chem
【PRE_E】
Acetyl-coenzymeAcarboxylase	geneY
malonyl-coenzymeA	geneY
【GOLD_R】
【PRE_R】

Retinoic acid is required for specification of the ventral eye field and for Rathke 's pouch in the avian embryo .
【GOLD_E】
Retinoicacid	chem
【PRE_E】
Retinoicacid	chem
【GOLD_R】
【PRE_R】

We have investigated the role of retinoic acid ( RA ) in eye development using the vitamin A deficient quail model system , which overcomes problems of retinoic acid synthesising enzyme redundancy in the embryo .
【GOLD_E】
retinoicacid	chem
retinoicacid	chem
RA	chem
vitaminA	chem
【PRE_E】
retinoicacid	chem
vitaminA	chem
retinoicacid	chem
【GOLD_R】
【PRE_R】

In the absence of retinoic acid , the ventral optic stalk and ventral retina are missing , whereas the dorsal optic stalk and dorsal retina develop appropriately .
【GOLD_E】
retinoicacid	chem
【PRE_E】
retinoicacid	chem
【GOLD_R】
【PRE_R】

Other ocular abnormalities observed were a thinner retina and the lack of differentiation of the lens .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In an attempt to explain this , we studied the expression of various dorsally and ventrally expressed genes such as Pax2 , Pax6 , Tbx6 , Vax2 , Raldh1 and Raldh3 and noted that they were unchanged in their expression patterns .
【GOLD_E】
Pax2	geneN
Pax6	geneY
Tbx6	geneN
Vax2	geneN
Raldh1	geneN
Raldh3	geneN
【PRE_E】
Pax2	geneY
Pax6	geneY
Tbx6	geneY
Vax2	geneY
Raldh1	geneY
Raldh3	geneY
【GOLD_R】
【PRE_R】

In contrast , the RA catabolising enzymes Cyp26A1 and Cyp26B1 which are known to be RA - responsive were not expressed at all in the developing eye .
【GOLD_E】
Cyp26A1	geneN
Cyp26B1	geneN
RA	chem
RA	chem
【PRE_E】
Cyp26A1	geneY
Cyp26B1	geneY
【GOLD_R】
RA	Cyp26A1	C9
RA	Cyp26B1	C9
【PRE_R】

At much earlier stages , the expression domain of Shh in the prechordal plate was reduced , as was Nkx2.1 and we suggest a model whereby the eye field is specified according to the concentration of SHH protein that is present .
【GOLD_E】
SHH	geneY
Shh	geneY
Nkx2.1	geneN
【PRE_E】
Nkx2.1	geneY
SHH	geneY
【GOLD_R】
【PRE_R】

We also describe another organ , Rathke 's pouch which fails to develop in the absence of retinoic acid .
【GOLD_E】
retinoicacid	chem
【PRE_E】
retinoicacid	chem
【GOLD_R】
【PRE_R】

We attribute this to the down - regulation of Bmp2 , Shh and Fgf8 which are known to be involved in the induction of this structure .
【GOLD_E】
Bmp2	geneN
Shh	geneY
Fgf8	geneN
【PRE_E】
Bmp2	geneY
Shh	geneY
Fgf8	geneY
【GOLD_R】
【PRE_R】

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia .
【GOLD_E】
【PRE_E】
AML	geneY
【GOLD_R】
【PRE_R】

Severe congenital neutropenia ( SCN ) is an inborn disorder of granulopoiesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Like most other bone marrow failure syndromes , it is associated with a marked propensity to transform into a myelodysplastic syndrome ( MDS ) or acute leukemia , with a cumulative rate of transformation to MDS / leukemia that exceeds 20 % .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The genetic ( and / or epigenetic ) changes that contribute to malignant transformation in SCN are largely unknown .
【GOLD_E】
【PRE_E】
SCN	geneN
【GOLD_R】
【PRE_R】

In this study , we performed mutational profiling of 14 genes previously implicated in leukemogenesis using 14 MDS / leukemia samples from patients with SCN .
【GOLD_E】
【PRE_E】
SCN	geneY
【GOLD_R】
【PRE_R】

We used high - throughput exon - based resequencing of whole - genome - amplified genomic DNA with a semiautomated method to detect mutations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The sensitivity and specificity of the sequencing pipeline was validated by determining the frequency of mutations in these 14 genes using 188 de novo AML samples .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As expected , mutations of tyrosine kinase genes ( FLT3 , KIT , and JAK2 ) were common in de novo AML , with a cumulative frequency of 30 % .
【GOLD_E】
JAK2	geneY
tyrosine	chem
tyrosinekinase	geneN
FLT3	geneY
KIT	geneY
【PRE_E】
tyrosinekinase	geneN
FLT3	geneY
KIT	geneY
JAK2	geneY
【GOLD_R】
【PRE_R】

In contrast , no mutations in these genes were detected in the SCN samples ; instead , mutations of CSF3R , encoding the G - CSF receptor , were common .
【GOLD_E】
CSF3R	geneY
G-CSFreceptor	geneY
【PRE_E】
SCN	geneN
CSF3R	geneY
G-CSFreceptor	geneY
【GOLD_R】
【PRE_R】

These data support the hypothesis that mutations of CSF3R may provide the `` activated tyrosine kinase signal `` that is thought to be important for leukemogenesis .
【GOLD_E】
dtyrosin	chem
CSF3R	geneY
dtyrosinekinas	geneN
【PRE_E】
CSF3R	geneY
tyrosinekinase	geneN
leukemogenesis	geneY
【GOLD_R】
【PRE_R】

Biology of incretins : GLP - 1 and GIP .
【GOLD_E】
incretins	geneN
GLP-1	geneY
GIP	geneY
【PRE_E】
incretins	geneN
GLP-1	geneY
GIP	geneY
【GOLD_R】
【PRE_R】

This review focuses on the mechanisms regulating the synthesis , secretion , biological actions , and therapeutic relevance of the incretin peptides glucose - dependent insulinotropic polypeptide ( GIP ) and glucagon - like peptide - 1 ( GLP - 1 ) .
【GOLD_E】
incretin	geneN
glucose-dependentinsulinotropicpolypeptide	geneY
GIP	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
glucose	chem
【PRE_E】
incretin	geneN
glucose-dependentinsulinotropicpolypeptide	geneY
GIP	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

The published literature was reviewed , with emphasis on recent advances in our understanding of the biology of GIP and GLP - 1 .
【GOLD_E】
GIP	geneY
GLP-1	geneY
【PRE_E】
GIP	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

GIP and GLP - 1 are both secreted within minutes of nutrient ingestion and facilitate the rapid disposal of ingested nutrients .
【GOLD_E】
GIP	geneY
GLP-1	geneY
【PRE_E】
GIP	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

Both peptides share common actions on islet beta - cells acting through structurally distinct yet related receptors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Incretin - receptor activation leads to glucose - dependent insulin secretion , induction of beta - cell proliferation , and enhanced resistance to apoptosis .
【GOLD_E】
Incretin-receptor	geneN
insulin	geneY
glucose	chem
【PRE_E】
Incretin-receptor	geneY
glucose	chem
insulin	geneY
【GOLD_R】
glucose	insulin	C3
【PRE_R】
glucose	insulin	C3

GIP also promotes energy storage via direct actions on adipose tissue , and enhances bone formation via stimulation of osteoblast proliferation and inhibition of apoptosis .
【GOLD_E】
GIP	geneY
【PRE_E】
GIP	geneY
【GOLD_R】
【PRE_R】

In contrast , GLP - 1 exerts glucoregulatory actions via slowing of gastric emptying and glucose - dependent inhibition of glucagon secretion .
【GOLD_E】
glucose	chem
GLP-1	geneY
glucagon	geneY
【PRE_E】
GLP-1	geneY
glucose	chem
glucagon	geneY
【GOLD_R】
【PRE_R】

GLP - 1 also promotes satiety and sustained GLP - 1 - receptor activation is associated with weight loss in both preclinical and clinical studies .
【GOLD_E】
GLP-1	geneY
GLP-1-receptor	geneN
【PRE_E】
GLP-1	geneY
GLP-1-receptor	geneY
【GOLD_R】
【PRE_R】

The rapid degradation of both GIP and GLP - 1 by the enzyme dipeptidyl peptidase - 4 has led to the development of degradation - resistant GLP - 1 - receptor agonists and dipeptidyl peptidase - 4 inhibitors for the treatment of type 2 diabetes .
【GOLD_E】
GLP-1-receptor	geneY
dipeptidylpeptidase-4	geneY
GIP	geneY
GLP-1	geneY
dipeptidylpeptidase-4	geneY
【PRE_E】
GIP	geneY
GLP-1	geneY
dipeptidylpeptidase-4	geneY
GLP-1-receptor	geneY
dipeptidylpeptidase-4	geneY
【GOLD_R】
【PRE_R】

These agents decrease hemoglobin A1c ( HbA1c ) safely without weight gain in subjects with type 2 diabetes .
【GOLD_E】
hemoglobinA1c	geneY
HbA1c	geneY
【PRE_E】
hemoglobinA1c	geneY
HbA1c	geneY
【GOLD_R】
【PRE_R】

GLP - 1 and GIP integrate nutrient - derived signals to control food intake , energy absorption , and assimilation .
【GOLD_E】
GLP-1	geneY
GIP	geneY
【PRE_E】
GLP-1	geneY
GIP	geneY
【GOLD_R】
【PRE_R】

Recently approved therapeutic agents based on potentiation of incretin action provide new physiologically based approaches for the treatment of type 2 diabetes .
【GOLD_E】
incretin	geneN
【PRE_E】
incretin	geneN
【GOLD_R】
【PRE_R】

[ Characteristics of A - interferon - generated dendritic cells in patients with pulmonary tuberculosis ] .
【GOLD_E】
A-interferon	geneN
【PRE_E】
A-interferon	geneN
【GOLD_R】
【PRE_R】

The phenotype of the dendritic cells ( DC ) generated from the adhesion fraction of mononuclear cells in the presence of GM - CSF and alpha - interferon was studied in patients with pulmonary tuberculosis .
【GOLD_E】
alpha-interferon	geneN
【PRE_E】
GM-CSF	geneY
alpha-interferon	geneY
【GOLD_R】
【PRE_R】

Despite the absence of significant differences in the count of mature CD83 + DCs in the groups of patients ( n = 38 ) and healthy donors ( n = 30 ) , elevated CD14 ( + ) - monocyte levels and few activated CD25 ( + ) - DCs were indicative of the impaired process of DC maturation / generation in patients with pulmonary tuberculosis , particularly in a subgroup of patients with a low T - cell proliferative response against PPD ( PPD - anergy , n = 10 ) .
【GOLD_E】
【PRE_E】
CD83	geneY
CD14(+)-monocyte	geneY
(+)	chem
【GOLD_R】
【PRE_R】

The patients with tuberculosis showed the lower relative levels of CD11c ( - ) - CD123 ( + ) - DC and the normal levels of myeloid CD11c ( + ) D123 ( - ) DCs .
【GOLD_E】
【PRE_E】
CD11c	geneY
CD123	geneY
(+)	chem
CD11c	geneY
D123	geneY
【GOLD_R】
【PRE_R】

However , in patients with PPD - anergy , the content of myeloid CD11c ( + ) CD123 ( - ) - DCs was significantly higher than that in PPD - reactive patients .
【GOLD_E】
【PRE_E】
CD11c	geneY
CD123	geneY
【GOLD_R】
【PRE_R】

Moreover , the patients with PPD - anergy were characterized by the elevated peripheral blood levels of CD14 + CD16 ( + ) - monocytes , which was associated with the high suppressive activity of monocytes ( r ( s ) = 0.53 ; p < 0.05 ) .
【GOLD_E】
【PRE_E】
CD14	geneY
CD16	geneY
【GOLD_R】
【PRE_R】

The impaired process of DC generation / maturation in patients with pulmonary tuberculosis is believed to be associated with the changes in the phenotypic and functional properties of monocytes and to be a cause of an inadequate antigen - specific response in tuberculous infection .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Aripiprazole acts as a selective dopamine D2 receptor partial agonist .
【GOLD_E】
dopamine	chem
dopamineD2receptor	geneY
【PRE_E】
Aripiprazole	chem
dopamineD2receptor	geneY
【GOLD_R】
【PRE_R】

Aripiprazole has made a significant contribution to the treatment of schizophrenia and related disorders with an improved safety and tolerability profile , which has been attributed to its unique pharmacological profile .
【GOLD_E】
Aripiprazole	chem
【PRE_E】
Aripiprazole	chem
【GOLD_R】
【PRE_R】

It has been claimed that partial agonism of the dopamine D ( 2 ) and 5 - HT ( 1A ) receptors and antagonism of the 5 - HT ( 2 ) receptor contribute to the clinical profile of aripiprazole , a so - called dopamine - and 5 - HT stabiliser .
【GOLD_E】
dopamineD(2)and5-HT(1A)receptors	geneN
5-HT(2)	geneY
dopamine	chem
aripiprazole	chem
dopamine	chem
5-HT	chem
【PRE_E】
dopamineD(2)	geneY
5-HT(1A)	geneY
5-HT(2)	geneY
aripiprazole	chem
dopamine	chem
5-HT	chem
【GOLD_R】
【PRE_R】

However , recent studies have questioned the role of the 5 - HT - mediated systems in the mechanism of action of aripiprazole .
【GOLD_E】
5-HT	chem
aripiprazole	chem
【PRE_E】
5-HT	chem
aripiprazole	chem
【GOLD_R】
【PRE_R】

This report reviews published and unpublished data that suggest that aripiprazole acts as a selective partial agonist at the dopamine D ( 2 ) receptor and does not affect 5 - HT receptors at therapeutic doses .
【GOLD_E】
5-HT	chem
dopamineD(2)receptor	geneY
5-HTreceptors	geneN
aripiprazole	chem
dopamine	chem
【PRE_E】
aripiprazole	chem
dopamineD(2)receptor	geneY
5-HTreceptors	geneN
【GOLD_R】
aripiprazole	dopamineD(2)receptor	C5
【PRE_R】

Pharmacological therapy of Cushing 's syndrome : drugs and indications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVE : To review the main pharmacological properties and clinical applications of the drugs used in the medical therapy of Cushing 's syndrome .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

DATA SOURCES : Search for articles were performed in the following dababases : MEDLINE , EMBASE , Cochrane Database of systematic Reviews and The Cochrane Central Register of Controlled Trials ( CENTRAL ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Search terms included Cushing 's syndrome and drug therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

DATA SYNTHESIS : Available data suggest that neuromodulatory compounds affect corticotropin ( ACTH ) or ACTH - releasing hormone ( CRH ) synthesis and release .
【GOLD_E】
corticotropin	geneY
ACTH	geneY
ACTH-releasinghormone	geneY
CRH	geneY
【PRE_E】
corticotropin	geneY
ACTH	geneY
ACTH-releasinghormone	geneY
CRH	geneY
【GOLD_R】
【PRE_R】

They include serotonin antagonists , dopaminergic agonists , valproic acid , reserpine , somatostatin analogs and thiazolidinediones .
【GOLD_E】
somatostatin	geneY
serotonin	chem
valproicacid	chem
reserpine	chem
thiazolidinediones	chem
【PRE_E】
serotonin	chem
valproicacid	chem
reserpine	chem
somatostatin	chem
thiazolidinediones	chem
【GOLD_R】
【PRE_R】

These agents have been effective in a limited number of patients with ACTH - dependent Cushing 's syndrome .
【GOLD_E】
ACTH	geneY
【PRE_E】
ACTH	geneY
【GOLD_R】
【PRE_R】

Inhibitors of steroidogenesis reduce cortisol production by blocking one ( metyrapone , trilostane ) or several ( aminoglutethimide , ketoconazole , fluconazole , etomidate ) enzymes involved in steroid biosynthesis .
【GOLD_E】
aminoglutethimide	chem
ketoconazole	chem
fluconazole	chem
etomidate	chem
metyrapone	chem
trilostane	chem
【PRE_E】
cortisol	chem
metyrapone	chem
trilostane	chem
aminoglutethimide	chem
ketoconazole	chem
fluconazole	chem
etomidate	chem
steroid	chem
【GOLD_R】
【PRE_R】

Mitotane is a steroidogenesis inhibitor with adrenolitic properties .
【GOLD_E】
Mitotane	chem
【PRE_E】
Mitotane	chem
【GOLD_R】
【PRE_R】

Mifepriston'e blocks glucocorticoid receptor activation without modifying cortisol synthesis .
【GOLD_E】
glucocorticoidreceptor	geneY
Mifepriston'e	chem
cortisol	chem
【PRE_E】
Mifepriston'e	geneY
glucocorticoidreceptor	geneY
cortisol	chem
【GOLD_R】
Mifepriston'e	glucocorticoidreceptor	C4
【PRE_R】
Mifepriston'e	cortisol	C3
glucocorticoidreceptor	cortisol	C3

CONCLUSION : Agents that inhibit steroidogenesis are useful in all forms of Cushing 's syndrome and are effective in about 70 % of patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Main indications for drug therapy include preparation for surgery , persistence or recurrence after surgery , while awaiting for the effect of radiation therapy , occult ectopic ACTH syndrome , severe hypercortisolism and malignancy related hypercortisolism .
【GOLD_E】
ACTH	geneY
【PRE_E】
ACTH	geneY
【GOLD_R】
【PRE_R】

Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection : immunocytochemistry , autoradiography and behavioral studies .
【GOLD_E】
Cannabinoid	chem
CannabinoidCB1receptors	geneY
【PRE_E】
CannabinoidCB1receptors	geneN
【GOLD_R】
【PRE_R】

[ N - ( piperidin - 1 - yl ) - 5 - ( 4 - chlorophenyl ) - 4 - methyl - 1H - pyrazole - 3 - carboxyamide ] ( SR 141716A ) , a selective cannabinoid CB1 receptor antagonist , injected into the paraventricular nucleus of the hypothalamus ( PVN ) of male rats , induces penile erection .
【GOLD_E】
SR141716A	chem
cannabinoidCB1receptor	geneY
cannabinoid	chem
N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide	chem
【PRE_E】
[N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide	chem
SR141716A	chem
CB1	geneY
【GOLD_R】
SR141716A	cannabinoidCB1receptor	C6
N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide	cannabinoidCB1receptor	C6
【PRE_R】
[N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide	CB1	C6

This effect is mediated by the release of glutamic acid , which in turn activates central oxytocinergic neurons mediating penile erection .
【GOLD_E】
glutamicacid	chem
【PRE_E】
glutamicacid	chem
【GOLD_R】
【PRE_R】

Double immunofluorescence studies with selective antibodies against CB1 receptors , glutamic acid transporters ( vesicular glutamate transporters 1 and 2 ( VGlut1 and VGlut2 ) , glutamic acid decarboxylase - 67 ( GAD67 ) and oxytocin itself , have shown that CB1 receptors in the PVN are located mainly in GABAergic terminals and fibers surrounding oxytocinergic cell bodies .
【GOLD_E】
glutamate	chem
glutamicacid	chem
oxytocin	chem
CB1receptors	geneY
glutamicacidtransporters	geneN
vesicularglutamatetransporters1and2	geneN
VGlut1	geneY
VGlut2	geneY
glutamicaciddecarboxylase-67	geneY
GAD67	geneY
oxytocin	geneY
CB1receptors	geneY
glutamicacid	chem
【PRE_E】
CB1	geneY
glutamicacidtransporters	geneN
vesicularglutamatetransporters1and2	geneN
VGlut1	geneY
VGlut2	geneY
glutamicaciddecarboxylase-67	geneY
GAD67	geneY
oxytocin	geneY
CB1	geneY
PVN	geneY
【GOLD_R】
【PRE_R】

As GABAergic synapses in the PVN impinge directly on oxytocinergic neurons or on excitatory glutamatergic synapses , which also impinge on oxytocinergic neurons , these results suggest that the blockade of CB1 receptors decreases GABA release in the PVN , increasing in turn glutamatergic neurotransmission to activate oxytocinergic neurons mediating penile erection .
【GOLD_E】
GABA	chem
CB1receptors	geneY
【PRE_E】
CB1	geneY
GABA	chem
PVN	geneY
【GOLD_R】
【PRE_R】

Autoradiography studies with [ ( 3 ) H ] ( - ) - CP 55,940 show that chronic treatment with SR 141716A for 15 days twice daily ( 1 mg / kg i.p . ) significantly increases the density of CB1 receptors in the PVN .
【GOLD_E】
CB1receptors	geneY
[(3)H](-)-CP55,940	chem
SR141716A	chem
【PRE_E】
[(3)H](-)-CP55,940	chem
SR141716A	chem
CB1	geneY
【GOLD_R】
【PRE_R】

This increase occurs concomitantly with an almost twofold increase in the pro - erectile effect of SR 141716A injected into the PVN as compared with control rats .
【GOLD_E】
SR141716A	chem
【PRE_E】
SR141716A	chem
【GOLD_R】
【PRE_R】

The present findings confirm that PVN CB1 receptors , localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses , exert an inhibitory control on penile erection , demonstrating for the first time that chronic blockade of CB1 receptors by SR 141716A increases the density of these receptors in the PVN .
【GOLD_E】
CB1receptors	geneY
CB1receptors	geneY
SR141716A	chem
【PRE_E】
PVNCB1	geneY
CB1	geneY
SR141716A	chem
【GOLD_R】
SR141716A	CB1receptors	C4
【PRE_R】

This increase is related to an enhanced pro - erectile effect of SR 141716A , which is still present 3 days after the end of the chronic treatment .
【GOLD_E】
SR141716A	chem
【PRE_E】
SR141716A	chem
【GOLD_R】
【PRE_R】

Activation of human platelets by misfolded proteins .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVE : Protein misfolding diseases result from the deposition of insoluble protein aggregates that often contain fibrils called amyloid .
【GOLD_E】
amyloid	geneY
【PRE_E】
amyloid	geneY
【GOLD_R】
【PRE_R】

Amyloids are found in Alzheimer disease , atherosclerosis , diabetes mellitus , and systemic amyloidosis , which are diseases where platelet activation might be implicated .
【GOLD_E】
Amyloids	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS AND RESULTS : We induced amyloid properties in 6 unrelated proteins and found that all induced platelet aggregation in contrast to fresh controls .
【GOLD_E】
amyloid	geneY
【PRE_E】
amyloid	geneY
【GOLD_R】
【PRE_R】

Amyloid - induced platelet aggregation was independent of thromboxane A2 formation and ADP secretion but enhanced by feedback stimulation through these pathways .
【GOLD_E】
Amyloid	geneY
thromboxaneA2	chem
ADP	chem
【PRE_E】
Amyloid	geneY
thromboxaneA2	chem
ADP	chem
【GOLD_R】
【PRE_R】

Treatments that raised cAMP ( iloprost ) , sequestered Ca2 + ( BAPTA - AM ) or prevented amyloid - platelet interaction ( sRAGE , tissue - type plasminogen activator [ tPA ] ) induced almost complete inhibition .
【GOLD_E】
amyloid	geneY
tissue-typeplasminogenactivator	geneY
tPA	geneY
cAMP	chem
iloprost	chem
Ca2+	chem
BAPTA-AM	chem
【PRE_E】
cAMP	chem
iloprost	chem
Ca2+	chem
BAPTA-AM	chem
amyloid-plateletinteraction	geneY
sRAGE	geneY
tissue-typeplasminogenactivator	geneY
tPA	geneY
【GOLD_R】
【PRE_R】

Modulation of the function of CD36 ( CD36 - / - mice ) , p38 ( MAPK ) ( SB203580 ) , COX - 1 ( indomethacin ) , and glycoprotein Ib alpha ( Nk - protease , 6D1 antibody ) induced approximately 50 % inhibition .
【GOLD_E】
CD36	geneN
p38	geneN
MAPK	geneN
COX-1	geneN
glycoproteinIbalpha	geneN
Nk-protease	geneN
SB203580	chem
indomethacin	chem
【PRE_E】
CD36	geneN
CD36	geneN
p38	geneN
MAPK	geneN
SB203580	geneN
COX-1	geneY
indomethacin	chem
glycoproteinIbalpha	geneY
Nk-protease	geneY
6D1	geneN
【GOLD_R】
SB203580	p38	C4
SB203580	MAPK	C4
indomethacin	COX-1	C4
【PRE_R】

Interference with fibrinogen binding ( RGDS ) revealed a major contribution of alphaIIb beta3 - independent aggregation ( agglutination ) .
【GOLD_E】
fibrinogen	geneN
alphaIIbbeta3	geneN
【PRE_E】
fibrinogenbinding	geneN
RGDS	geneN
alphaIIbbeta3	geneN
【GOLD_R】
【PRE_R】

CONCLUSIONS : Protein misfolding resulting in the appearance of amyloid induces platelet aggregation .
【GOLD_E】
amyloid	geneN
【PRE_E】
amyloid	geneY
【GOLD_R】
【PRE_R】

Amyloid activates platelets through 2 pathways : one is through CD36 , p38 ( MAPK ) , thromboxane A2 - mediated induction of aggregation ; the other is through glycoprotein Ib alpha - mediated aggregation and agglutination .
【GOLD_E】
Amyloid	geneN
CD36	geneN
p38	geneN
MAPK	geneN
glycoproteinIbalpha	geneN
thromboxaneA2	chem
【PRE_E】
Amyloid	geneY
CD36	geneN
p38	geneN
MAPK	geneN
thromboxaneA2	chem
Ibalpha	geneY
【GOLD_R】
【PRE_R】

The platelet stimulating properties of amyloid might explain the enhanced platelet activation observed in many diseases accompanied by the appearance of misfolded proteins with amyloid .
【GOLD_E】
【PRE_E】
amyloid	geneY
amyloid	geneY
【GOLD_R】
【PRE_R】

RDH12 , a retinol dehydrogenase causing Leber 's congenital amaurosis , is also involved in steroid metabolism .
【GOLD_E】
RDH12	geneY
retinoldehydrogenase	geneN
retinol	chem
【PRE_E】
RDH12	geneY
retinoldehydrogenase	geneN
steroid	chem
【GOLD_R】
【PRE_R】

Three retinol dehydrogenases ( RDHs ) were tested for steroid converting abilities : human and murine RDH 12 and human RDH13 .
【GOLD_E】
retinoldehydrogenases	geneN
humanandmurineRDH12	geneN
retinol	chem
humanRDH13	geneY
RDHs	geneN
【PRE_E】
retinoldehydrogenases	geneN
RDHs	geneN
steroid	chem
humanandmurineRDH12	geneY
humanRDH13	geneY
【GOLD_R】
【PRE_R】
RDHs	steroid	C9

RDH12 is involved in retinal degeneration in Leber 's congenital amaurosis ( LCA ) .
【GOLD_E】
RDH12	geneY
【PRE_E】
RDH12	geneY
retinal	chem
【GOLD_R】
【PRE_R】

We show that murine Rdh12 and human RDH13 do not reveal activity towards the checked steroids , but that human type 12 RDH reduces dihydrotestosterone to androstanediol , and is thus also involved in steroid metabolism .
【GOLD_E】
androstanediol	chem
murineRdh12	geneY
humanRDH13	geneY
humantype12RDH	geneY
【PRE_E】
Rdh12	geneY
humanRDH13	geneY
steroids	chem
humantype12RDH	geneN
dihydrotestosterone	chem
androstanediol	chem
steroid	chem
【GOLD_R】
androstanediol	humantype12RDH	C9
【PRE_R】
Rdh12	steroids	C9
humanRDH13	steroids	C9
steroids	humantype12RDH	C9
humantype12RDH	dihydrotestosterone	C9
humantype12RDH	androstanediol	C9
humantype12RDH	steroid	C9

Furthermore , we analyzed both expression and subcellular localization of these enzymes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine .
【GOLD_E】
sibutramine	chem
【PRE_E】
sibutramine	chem
【GOLD_R】
【PRE_R】

BACKGROUND & AIMS : It is unclear whether weight loss with the noradrenergic ( norepinephrine ) and serotonergic ( 5 - hydroxytryptamine ) reuptake inhibitor , sibutramine , is associated with altered stomach functions and whether genetics influence treatment response .
【GOLD_E】
norepinephrine	chem
5-hydroxytryptamine	chem
sibutramine	chem
【PRE_E】
norepinephrine	chem
5-hydroxytryptamine	chem
sibutramine	chem
【GOLD_R】
【PRE_R】

METHODS : Forty - eight overweight and obese but otherwise healthy participants were randomized to placebo or sibutramine ( 15 mg / day for 12 weeks ) .
【GOLD_E】
sibutramine	chem
【PRE_E】
sibutramine	chem
【GOLD_R】
【PRE_R】

At baseline and posttreatment we measured the following : gastric emptying for solids and liquids by scintigraphy , gastric volumes by single - photon emission computed tomography , maximum tolerated volume and 30 - minute postnutrient challenge symptoms , and selected gastrointestinal hormones .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All participants received structured behavior therapy for weight management .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The influence of candidate gene polymorphisms involved in norepinephrine and 5 - hydroxytryptamine or receptor function ( phenylethanolamine N - methyltransferase , guanine nucleotide binding protein beta polypeptide 3 , alpha2A adrenoreceptor , and solute carrier family 6 [ neurotransmitter transporter , serotonin ] member 4 [ homo sapiens ] [ SLC6A4 ] ) on weight loss and gastric functions was evaluated .
【GOLD_E】
norepinephrine	chem
5-hydroxytryptamine	chem
phenylethanolamine	chem
N	chem
guaninenucleotide	chem
solutecarrierfamily6[neurotransmittertransporter,serotonin]member4	geneY
SLC6A4	geneY
serotonin	chem
guaninenucleotidebindingproteinbetapolypeptide3	geneY
alpha2Aadrenoreceptor	geneY
【PRE_E】
norepinephrineand5-hydroxytryptamineorreceptor	geneN
phenylethanolamineN-methyltransferase	geneY
guaninenucleotidebindingproteinbetapolypeptide3	geneY
alpha2Aadrenoreceptor	geneY
solutecarrierfamily6[neurotransmittertransporter	geneY
serotonin]member4	geneY
homosapiens	geneY
SLC6A4	geneY
【GOLD_R】
【PRE_R】

RESULTS : The overall average weight loss posttreatment was 5.4 + / - 0.8 ( SEM ) kg with sibutramine and 0.9 + / - 0.9 kg with placebo ( P < .001 ) .
【GOLD_E】
sibutramine	chem
【PRE_E】
sibutramine	chem
【GOLD_R】
【PRE_R】

The sibutramine group showed significant retardation in gastric emptying of solids ( P = .03 ) , reduced maximum tolerated volume ( P = .03 ) , and increased postprandial peptide YY compared with the placebo group .
【GOLD_E】
peptideYY	geneY
sibutramine	chem
【PRE_E】
sibutramine	chem
YY	geneY
【GOLD_R】
sibutramine	peptideYY	C3
【PRE_R】

Obese females showed greater effects of sibutramine on weight loss and gastric emptying of solids and liquids .
【GOLD_E】
sibutramine	chem
【PRE_E】
sibutramine	chem
【GOLD_R】
【PRE_R】

Gastric volumes and postchallenge symptoms were not significantly different in the 2 treatment groups .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The LS / SS genotype of the promoter for SLC6A4 was associated with enhanced weight loss with sibutramine .
【GOLD_E】
SLC6A4	geneY
sibutramine	chem
【PRE_E】
SLC6A4	geneY
sibutramine	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : Weight reduction with sibutramine is associated with altered gastric functions and increased peptide YY and is significantly associated with SLC6A4 genotype .
【GOLD_E】
peptideYY	geneY
SLC6A4	geneY
sibutramine	chem
【PRE_E】
sibutramine	chem
YY	geneY
SLC6A4	geneY
【GOLD_R】
sibutramine	peptideYY	C3
【PRE_R】

The role of genetic variation in SLC6A4 on weight loss in response to sibutramine deserves further study .
【GOLD_E】
SLC6A4	geneY
sibutramine	chem
【PRE_E】
SLC6A4	geneY
sibutramine	chem
【GOLD_R】
【PRE_R】

Multiple rat brain calpastatin forms are produced by distinct starting points and alternative splicing of the N - terminal exons .
【GOLD_E】
ratbraincalpastatin	geneY
N	chem
【PRE_E】
ratbraincalpastatin	geneN
N	chem
【GOLD_R】
【PRE_R】

5 ' - RACE was performed on rat brain calpastatin mRNA and two new translation initiation ATG 's were found .
【GOLD_E】
ratbraincalpastatin	geneY
【PRE_E】
5'-RACE	geneY
ratbraincalpastatin	geneY
【GOLD_R】
【PRE_R】

The first one is upstream of the previously designed initiation translation site localized in the rat calpastatin L - domain .
【GOLD_E】
ratcalpastatinL-domain	geneN
【PRE_E】
ratcalpastatinL-domain	geneN
【GOLD_R】
【PRE_R】

The deduced protein sequence of this region is highly homologous to the XL - domain of calpastatin type I in other species .
【GOLD_E】
calpastatintypeI	geneN
XL-domain	geneN
【PRE_E】
XL-domain	geneN
calpastatintypeI	geneY
【GOLD_R】
【PRE_R】

The other ATG has not previously been reported and is localized in exon 8 , thus originating a calpastatin isoform constituted only by four repetitive inhibitory units without the XL - L - domains .
【GOLD_E】
calpastatin	geneY
XL-L-domains	geneN
【PRE_E】
ATG	geneN
calpastatin	geneN
XL-L-domains	geneN
【GOLD_R】
【PRE_R】

Transcripts from the rat brain calpastatin gene are also subjected to multiple splicing events involving exons 4 , 6 , 8 in different combinations .
【GOLD_E】
ratbraincalpastatin	geneY
【PRE_E】
ratbraincalpastatin	geneY
【GOLD_R】
【PRE_R】

A series of recombinant calpastatin forms was produced that differed in the exons present in the L - domain , and all the variants showed comparable inhibitory efficiency against calpain .
【GOLD_E】
calpastatin	geneY
L-domain	geneN
calpain	geneN
【PRE_E】
calpastatin	geneN
L-domain	geneN
calpain	geneN
【GOLD_R】
【PRE_R】

It was concluded that the presence of the XL - domain in these isoforms is not relevant for the formation of the calpain / calpastatin complex in the absence of calcium , that is the interaction of calpastatin with inactive calpain .
【GOLD_E】
XL-domain	geneN
calpain	geneN
calpastatin	geneY
calcium	chem
calpastatin	geneY
calpain	geneN
【PRE_E】
XL-domain	geneN
calpain	geneN
calpastatin	geneN
calcium	chem
calpastatin	geneN
calpain	geneN
【GOLD_R】
【PRE_R】

Using exon - specific antisera , specific calpastatin protein isoforms containing the XL - domain have been detected in rat brain homogenates .
【GOLD_E】
calpastatin	geneY
XL-domain	geneN
【PRE_E】
calpastatin	geneN
XL-domain	geneN
【GOLD_R】
【PRE_R】

An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT - 2331 using vibrational circular dichroism .
【GOLD_E】
histamine	chem
GT-2331	chem
histamineH3receptor	geneY
【PRE_E】
histamineH3receptor	geneY
GT-2331	chem
【GOLD_R】
GT-2331	histamineH3receptor	C6
【PRE_R】

GT - 2331 [ ( + ) - 1 ] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release of histamine by the histamine H3 receptor , and as such , is an important biomarker for pharmaceutical companies conducting research in this field .
【GOLD_E】
GT-2331	chem
histamine	chem
histamine	chem
histamineH3receptor	geneY
【PRE_E】
histamine	chem
histamineH3receptor	geneY
【GOLD_R】
【PRE_R】

In addition to overall structural features , the bioactivity of this molecule has also been found to be highly dependent on absolute stereochemistry , making the reliable assignment of this property a necessity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

X - ray diffraction studies have provided conflicting data , leaving its three - dimensional structure uncertain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In view of this , its absolute configuration was investigated by vibrational circular dichroism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results from this study provided independent assignment of this important molecule as the ( 1S,2S ) - enantiomer .
【GOLD_E】
【PRE_E】
(1S,2S)-enantiomer	chem
【GOLD_R】
【PRE_R】

Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors .
【GOLD_E】
vecuronium	chem
pancuronium	chem
humanmuscarinicM2receptors	geneY
【PRE_E】
vecuronium	chem
pancuronium	chem
humanmuscarinicM2receptors	geneY
【GOLD_R】
【PRE_R】

Neuromuscular blocking drugs produce muscle weakness by interaction with nicotinic - acetylcholine receptors .
【GOLD_E】
acetylcholine	chem
nicotinic-acetylcholinereceptors	geneN
【PRE_E】
nicotinic-acetylcholinereceptors	geneN
【GOLD_R】
【PRE_R】

Cardiovascular side effects have been reported .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study the neuromuscular blocking drug vecuronium and the controls gallamine and pancuronium slowed the rate of atropine induced [ ( 3 ) H ] N - methylscopolamine dissociation from Chinese hamster ovary cells expressing recombinant human muscarinic M2 receptors K ( off ) values min ( - 1 ) ; vecuronium ( 125 nM ) , atropine 0.45 + / - 0.07 + blocker 0.04 + / - 0.02 ; gallamine ( 21 nM ) , atropine 0.42 + / - 0.05 + blocker 0.15 + / - 0.04 ; pancuronium ( 21 nM ) , atropine 0.36 + / - 0.03 + blocker 0.03 + / - 0.01 ) .
【GOLD_E】
pancuronium	chem
atropine	chem
humanmuscarinicM2receptors	geneY
vecuronium	chem
gallamine	chem
pancuronium	chem
atropine	chem
[(3)H]N-methylscopolamine	chem
vecuronium	chem
atropine	chem
gallamine	chem
atropine	chem
【PRE_E】
vecuronium	chem
gallamine	chem
pancuronium	chem
atropine	chem
[(3)H]N-methylscopolamine	chem
humanmuscarinicM2receptorsK	geneY
vecuronium	chem
atropine	chem
gallamine	chem
atropine	chem
pancuronium	chem
atropine	chem
【GOLD_R】
vecuronium	humanmuscarinicM2receptors	C4
gallamine	humanmuscarinicM2receptors	C4
pancuronium	humanmuscarinicM2receptors	C4
【PRE_R】

These data indicate that vecuronium , gallamine and pancuronium interact with an allosteric site on the muscarinic M2 receptor ( located on the heart ) and this may explain some of their cardiac side effects .
【GOLD_E】
vecuronium	chem
gallamine	chem
pancuronium	chem
muscarinicM2receptor	geneY
【PRE_E】
vecuronium	chem
gallamine	chem
pancuronium	chem
M2receptor	geneY
【GOLD_R】
【PRE_R】

Hydrogen peroxide - mediated oxidative stress disrupts calcium binding on calmodulin : more evidence for oxidative stress in vitiligo .
【GOLD_E】
Hydrogenperoxide	chem
calcium	chem
calmodulin	geneY
【PRE_E】
Hydrogenperoxide	chem
calcium	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

Patients with acute vitiligo have low epidermal catalase expression / activities and accumulate 10 ( - 3 ) M H ( 2 ) O ( 2 ) .
【GOLD_E】
catalase	geneY
H(2)O(2)	chem
【PRE_E】
epidermalcatalase	geneY
H(2)O(2)	chem
【GOLD_R】
H(2)O(2)	catalase	C9
【PRE_R】

One consequence of this severe oxidative stress is an altered calcium homeostasis in epidermal keratinocytes and melanocytes .
【GOLD_E】
calcium	chem
【PRE_E】
calcium	chem
【GOLD_R】
【PRE_R】

Here , we show decreased epidermal calmodulin expression in acute vitiligo .
【GOLD_E】
calmodulin	geneY
【PRE_E】
epidermalcalmodulin	geneY
【GOLD_R】
【PRE_R】

Since 10 ( - 3 ) M H ( 2 ) O ( 2 ) oxidises methionine and tryptophan residues in proteins , we examined calcium binding to calmodulin in the presence and absence of H ( 2 ) O ( 2 ) utilising ( 45 ) calcium .
【GOLD_E】
calcium	chem
H(2)O(2)	chem
calcium	chem
calmodulin	geneY
H(2)O(2)	chem
methionine	chem
tryptophan	chem
【PRE_E】
H(2)O(2)	chem
methionine	chem
tryptophan	chem
calcium	chem
calmodulin	geneY
H(2)O(2)	chem
calcium	chem
【GOLD_R】
【PRE_R】

The results showed that all four calcium atoms exchanged per molecule of calmodulin .
【GOLD_E】
calcium	chem
calmodulin	geneY
【PRE_E】
calcium	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

Since oxidised calmodulin looses its ability to activate calcium ATPase , enzyme activities were followed in full skin biopsies from lesional skin of patients with acute vitiligo ( n = 6 ) and healthy controls ( n = 6 ) .
【GOLD_E】
calcium	chem
calmodulin	geneY
calciumATPase	geneN
【PRE_E】
oxidisedcalmodulin	geneY
calciumATPase	geneN
【GOLD_R】
【PRE_R】

The results yielded a 4 - fold decrease of ATPase activities in the patients .
【GOLD_E】
【PRE_E】
ATPase	geneN
【GOLD_R】
【PRE_R】

Computer simulation of native and oxidised calmodulin confirmed the loss of all four calcium ions from their specific EF - hand domains .
【GOLD_E】
calcium	chem
calmodulin	geneY
EF-handdomains	geneN
【PRE_E】
oxidisedcalmodulin	geneY
calcium	chem
EF-handdomains	geneN
【GOLD_R】
【PRE_R】

Taken together H ( 2 ) O ( 2 ) - mediated oxidation affects calcium binding in calmodulin leading to perturbed calcium homeostasis and perturbed l - phenylalanine - uptake in the epidermis of acute vitiligo .
【GOLD_E】
calmodulin	geneY
H(2)O(2)	chem
calcium	chem
calcium	chem
l-phenylalanine	chem
【PRE_E】
H(2)O(2)	chem
calcium	chem
calmodulin	geneY
calcium	chem
l-phenylalanine	chem
【GOLD_R】
【PRE_R】

The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol .
【GOLD_E】
VKORC1	geneY
c1173t	geneN
calumenin	geneY
a29809g	geneN
【PRE_E】
VKORC1	geneY
c1173t	geneN
calumenina29809g	geneY
acenocoumarol	chem
【GOLD_R】
【PRE_R】

BACKGROUND : The efficacy of oral anticoagulant therapy is largely conditioned by both environmental and genetic factors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVES : To attempt to define the genetic profile involved in the response to this treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PATIENTS AND METHODS : We selected 100 men younger than 75 years , with non - valvular atrial fibrillation , who started anticoagulation with acenocoumarol following the same protocol : 3 mg for three consecutive days .
【GOLD_E】
【PRE_E】
acenocoumarol	chem
【GOLD_R】
【PRE_R】

Then , doses were individually adjusted to achieve a steady International Normalized Ratio ( INR ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The basal plasma level and the level after 3 days were obtained , and the INR was determined .
【GOLD_E】
【PRE_E】
INR	geneN
【GOLD_R】
【PRE_R】

We studied five functional polymorphisms : FVII - 323 Del / Ins , CYP2C * 9 , VKORC1 c1173t , calumenin ( CALU ) R4Q and CALU a29809g .
【GOLD_E】
CALU	geneY
R4Q	geneN
CALU	geneY
a29809g	geneN
FVII	geneY
CYP2C*9	geneY
VKORC1	geneY
c1173t	geneN
calumenin	geneY
【PRE_E】
FVII-323Del/Ins	geneN
CYP2C*9	geneY
VKORC1	geneY
calumenin(CALU)R4Q	geneY
CALUa29809g	geneY
【GOLD_R】
【PRE_R】

The dose required for a steady INR was also recorded .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Only the VKORC1 genotype had significant impact on the efficacy of therapy .
【GOLD_E】
VKORC1	geneY
【PRE_E】
VKORC1	geneY
【GOLD_R】
【PRE_R】

Carriers of the 1173t allele were significantly more sensitive to therapy for 3 days [ INR 2.07 ( 1.59 - 2.87 ) vs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

1.74 ( 1.30 - 2.09 ) ; P = 0.015 ] and they needed lower acenocoumarol doses to stabilize their INR ( 15.8 + / - 5.6 vs .
【GOLD_E】
【PRE_E】
acenocoumarol	chem
【GOLD_R】
【PRE_R】

19.5 + / - 6.0 mg week ( - 1 ) ; P = 0.004 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Its effect was exacerbated by combination with the CALU a29809g polymorphism .
【GOLD_E】
CALU	geneY
a29809g	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Carriers of both variants ( 27 % of the sample ) achieved the highest INR [ 2.26 ( 1.70 - 3.32 ) ] and required the lowest dose ( 14.1 + / - 5.1 mg week ( - 1 ) ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This genetic profile was particularly relevant in patients with INR > or = 3.5 at the start of therapy ( P = 0.005 ; odds ratio = 6.67 , 95 % confidence interval = 1.32 - 37.43 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : Our results suggest that CALU a29809g might be a new genetic factor involved in the pharmacogenetics of anticoagulant therapy , and confirm that specific genetic profiles defined by different polymorphisms will determine the initial response and dose required to achieve a stable and safe INR .
【GOLD_E】
CALU	geneY
a29809g	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Characterization of the nitrosyl adduct of substrate - bound mouse cysteine dioxygenase by electron paramagnetic resonance : electronic structure of the active site and mechanistic implications .
【GOLD_E】
nitrosyl	chem
cysteine	chem
mousecysteinedioxygenase	geneY
【PRE_E】
nitrosyl	chem
mousecysteinedioxygenase	geneY
【GOLD_R】
【PRE_R】

Mammalian cysteine dioxygenase ( CDO ) is a non - heme iron metalloenzyme that catalyzes the first committed step in oxidative cysteine catabolism .
【GOLD_E】
cysteine	chem
iron	chem
Mammaliancysteinedioxygenase	geneY
CDO	geneY
cysteine	chem
【PRE_E】
Mammaliancysteinedioxygenase	geneY
CDO	geneY
ironmetalloenzyme	geneN
cysteine	chem
【GOLD_R】
cysteine	Mammaliancysteinedioxygenase	C9
cysteine	CDO	C9
【PRE_R】
CDO	cysteine	C9

The active site coordination of CDO comprises a mononuclear iron ligated by the Nepsilon atoms of three protein - derived histidines , thus representing a new variant on the 2 - histidine - 1 - carboxylate ( 2H1C ) facial triad motif .
【GOLD_E】
iron	chem
histidines	chem
2-histidine-1-carboxylate	chem
2H1C	chem
CDO	geneY
2-histidine-1-carboxylate(2H1C)facialtriadmotif	geneN
【PRE_E】
CDO	geneY
iron	chem
Nepsilon	chem
2-histidine-1-carboxylate	chem
2H1C	chem
【GOLD_R】
【PRE_R】

Nitric oxide was used as a spectroscopic probe in investigating the order of substrate - O2 binding by EPR spectroscopy .
【GOLD_E】
Nitricoxide	chem
O2	chem
【PRE_E】
Nitricoxide	chem
O2	chem
EPR	chem
【GOLD_R】
【PRE_R】

In these experiments , CDO exhibits an ordered binding of l - cysteine prior to NO ( and presumably O2 ) similar to that observed for the 2H1C class of non - heme iron enzymes .
【GOLD_E】
l-cysteine	chem
NO	chem
O2	chem
2H1C	chem
iron	chem
CDO	geneY
2H1Cclassofnon-hemeironenzymes	geneN
【PRE_E】
CDO	geneY
l-cysteine	chem
NO	chem
O2	chem
2H1C	geneN
iron	chem
【GOLD_R】
【PRE_R】

Moreover , the CDO active site is essentially unreactive toward NO in the absence of substrate , suggesting an obligate ordered binding of l - cysteine prior to NO .
【GOLD_E】
NO	chem
l-cysteine	chem
NO	chem
CDO	geneY
【PRE_E】
CDO	geneY
NO	chem
l-cysteine	chem
NO	chem
【GOLD_R】
【PRE_R】

Typically , addition of NO to a mononuclear non - heme iron center results in the formation of an { FeNO } 7 ( S = 3 / 2 ) species characterized by an axial EPR spectrum with gx , gy , and gz values of approximately 4 , approximately 4 , and approximately 2 , respectively .
【GOLD_E】
NO	chem
iron	chem
FeNO	chem
【PRE_E】
NO	chem
iron	chem
【GOLD_R】
【PRE_R】

However , upon addition of NO to CDO in the presence of substrate l - cysteine , a low - spin { FeNO } 7 ( S = 1 / 2 ) signal that accounts for approximately 85 % of the iron within the enzyme develops .
【GOLD_E】
NO	chem
l-cysteine	chem
CDO	geneY
FeNO	chem
iron	chem
【PRE_E】
NO	chem
CDO	geneY
l-cysteine	chem
FeNO}7	chem
iron	chem
【GOLD_R】
l-cysteine	CDO	C9
【PRE_R】

Similar { FeNO } 7 ( S = 1 / 2 ) EPR signals have been observed for a variety of octahedral mononuclear iron - nitrosyl synthetic complexes ; however , this type of iron - nitrosyl species is not commonly observed for non - heme iron enzymes .
【GOLD_E】
iron	chem
FeNO	chem
iron-nitrosyl	chem
iron-nitrosyl	chem
【PRE_E】
EPR	geneY
iron	chem
nitrosyl	chem
iron	chem
nitrosyl	chem
iron	chem
【GOLD_R】
【PRE_R】

Substitution of l - cysteine with isosteric substrate analogues cysteamine , 3 - mercaptopropionic acid , and propane thiol did not produce any analogous { FeNO } 7 signals ( S = 1 / 2 or 3 / 2 ) , thus reflecting the high substrate specificity of the enzyme observed by a number of researchers .
【GOLD_E】
l-cysteine	chem
cysteamine	chem
3-mercaptopropionicacid	chem
propanethiol	chem
FeNO	chem
【PRE_E】
l-cysteine	chem
cysteamine	chem
3-mercaptopropionicacid	chem
propanethiol	chem
FeNO}7	chem
【GOLD_R】
【PRE_R】

The unusual { FeNO } 7 ( S = 1 / 2 ) electronic configuration adopted by the substrate - bound iron - nitrosyl CDO ( termed { ES - NO } 7 ) is a result of the bidentate thiol / amine coordination of l - cysteine in the NO - bound CDO active site .
【GOLD_E】
FeNO	chem
iron-nitrosyl	chem
NO	chem
bidentatethiol/amine	chem
l-cysteine	chem
NO	chem
CDO	geneY
CDO	geneY
【PRE_E】
iron	chem
CDO	chem
{ES-NO}7	geneY
bidentatethiol	chem
amine	chem
l-cysteine	chem
NO	chem
CDO	geneN
【GOLD_R】
【PRE_R】

DFT computations were performed to further characterize this species .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The DFT - predicted geometric parameters for { ES - NO } 7 are in good agreement with the crystallographically determined substrate - bound active site configuration of CDO and are consistent with known iron - nitrosyl model complexes .
【GOLD_E】
NO	chem
iron-nitrosyl	chem
CDO	geneY
【PRE_E】
{ES-NO}7	chem
CDO	geneY
iron	chem
nitrosyl	chem
【GOLD_R】
【PRE_R】

Moreover , the computed EPR parameters ( g and A values ) are in excellent agreement with experimental results for this CDO species and those obtained from comparable synthetic { FeNO } 7 ( S = 1 / 2 ) iron - nitrosyl complexes .
【GOLD_E】
FeNO	chem
iron-nitrosyl	chem
CDO	geneY
【PRE_E】
CDO	geneY
{FeNO}7	chem
iron	chem
nitrosyl	chem
【GOLD_R】
【PRE_R】

Ligand - dependent transcriptional activities of four torafugu pufferfish Takifugu rubripes peroxisome proliferator - activated receptors .
【GOLD_E】
peroxisomeproliferator-activatedreceptors	geneN
【PRE_E】
peroxisomeproliferator-activatedreceptors	geneN
【GOLD_R】
【PRE_R】

Structural and functional properties were investigated for four peroxisome proliferator - activated receptors ( PPARs ) , PPARalpha1 , PPARalpha2 , PPARbeta , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the acyl - CoA oxidase PPAR response element .
【GOLD_E】
PPARs	geneN
PPARalpha1	geneY
PPARalpha2	geneY
PPARbeta	geneY
PPARgamma	geneY
acyl-CoAoxidasePPARresponseelement	geneN
peroxisomeproliferator-activatedreceptors	geneN
acyl-CoA	chem
【PRE_E】
peroxisomeproliferator-activatedreceptors	geneN
PPARs	geneN
PPARalpha1	geneY
PPARalpha2	geneY
PPARbeta	geneY
PPARgamma	geneY
acyl-CoAoxidasePPARresponseelement	geneN
【GOLD_R】
【PRE_R】

Although torafugu PPARs showed a high similarity in the primary structure to other vertebrate counterparts , torafugu PPARalpha2 and gamma contained additional sequences of 21 and 28 amino acids , respectively , as in the case of other teleost fish species when compared with African clawed frog counterparts .
【GOLD_E】
aminoacids	chem
AlthoughtorafuguPPARs	geneN
torafuguPPARalpha2andgamma	geneN
【PRE_E】
PPARs	geneN
PPARalpha2andgamma	geneN
aminoacids	chem
【GOLD_R】
【PRE_R】

The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5 - and 11.5 - fold by Wy - 14643 and 5,8,11,14 - eicosatetraynoic acid ( ETYA ) each at 10 microM , respectively , whereas that of PPARalpha2 , 4.5 - and 7.3 - fold at the same concentration of the respective ligands , respectively .
【GOLD_E】
Wy-14643	chem
5,8,11,14-eicosatetraynoicacid	chem
ETYA	chem
PPARalpha1	geneY
PPARalpha2	geneY
【PRE_E】
PPARalpha1	geneY
Wy-14643	chem
5,8,11,14-eicosatetraynoicacid	chem
ETYA	chem
PPARalpha2	geneY
【GOLD_R】
Wy-14643	PPARalpha1	C3
Wy-14643	PPARalpha2	C3
5,8,11,14-eicosatetraynoicacid	PPARalpha1	C3
5,8,11,14-eicosatetraynoicacid	PPARalpha2	C3
ETYA	PPARalpha1	C3
ETYA	PPARalpha2	C3
【PRE_R】

The activities of torafugu PPARalpha1 and alpha2 were also enhanced 5.6 - and 6.3 - fold by ETYA at 1 microM , respectively , but not by Wy - 14643 at this concentration .
【GOLD_E】
ETYA	chem
PPARalpha1andalpha2	geneN
Wy-14643	chem
【PRE_E】
torafuguPPARalpha1andalpha2	geneN
ETYA	chem
Wy-14643	chem
【GOLD_R】
【PRE_R】

Furthermore , the activities of the two torafugu PPARalphas were enhanced 4.3 - and 7.6 - fold by arachidonic acid , 4.4 - and 5.2 - fold by docosahexaenoic acid , and 6.7 - and 8.0 - fold by eicosapentaenoic acid each at 50 microM , respectively .
【GOLD_E】
torafuguPPARalphas	geneN
arachidonicacid	chem
docosahexaenoicacid	chem
eicosapentaenoicacid	chem
【PRE_E】
PPARalphas	geneN
arachidonicacid	chem
docosahexaenoicacid	chem
eicosapentaenoicacid	chem
【GOLD_R】
arachidonicacid	torafuguPPARalphas	C3
docosahexaenoicacid	torafuguPPARalphas	C3
eicosapentaenoicacid	torafuguPPARalphas	C3
【PRE_R】

On the other hand , the activities of torafugu PPARbeta and gamma were not changed by Wy - 14643 , ETYA , rosiglitazone , nor PUFAs .
【GOLD_E】
torafuguPPARbetaandgamma	geneN
Wy-14643	chem
ETYA	chem
rosiglitazone	chem
【PRE_E】
torafuguPPARbetaandgamma	geneN
Wy-14643	chem
ETYA	chem
rosiglitazone	chem
PUFAs	chem
【GOLD_R】
【PRE_R】

These results suggest that the activities of torafugu PPARbeta and gamma require undefined ligands .
【GOLD_E】
torafuguPPARbetaandgamma	geneN
【PRE_E】
torafuguPPARbetaandgamma	geneN
【GOLD_R】
【PRE_R】

Alternatively , the molecular mechanisms involved in their activation are different from those of other vertebrates .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Combination chemotherapy with a substance P receptor antagonist ( aprepitant ) and melarsoprol in a mouse model of human African trypanosomiasis .
【GOLD_E】
substanceP	chem
aprepitant	chem
melarsoprol	chem
substancePreceptor	geneY
【PRE_E】
substancePreceptor	geneN
aprepitant	chem
melarsoprol	chem
【GOLD_R】
aprepitant	substancePreceptor	C6
melarsoprol	substancePreceptor	C6
【PRE_R】

Drug therapy for late - stage ( encephalitic ) human African trypanosomiasis ( HAT ) is currently very unsatisfactory with the most commonly used drug , melarsoprol , having a 5 % overall mortality .
【GOLD_E】
melarsoprol	chem
【PRE_E】
melarsoprol	chem
【GOLD_R】
【PRE_R】

There is evidence in a mouse model of HAT that Substance P ( SP ) receptor antagonism reduces the neuroinflammatory reaction to CNS trypanosome infection .
【GOLD_E】
SubstanceP(SP)receptor	geneY
SubstanceP	chem
SP	chem
【PRE_E】
P(SP)receptor	geneY
【GOLD_R】
【PRE_R】

In this study we investigated the effects of combination chemotherapy with melarsoprol and a humanised SP receptor antagonist aprepitant ( EMEND ) in this mouse model .
【GOLD_E】
humanisedSPreceptor	geneY
melarsoprol	chem
SP	chem
aprepitant	chem
EMEND	chem
【PRE_E】
melarsoprol	chem
humanisedSPreceptor	geneN
aprepitant	chem
EMEND	chem
【GOLD_R】
aprepitant	humanisedSPreceptor	C6
EMEND	humanisedSPreceptor	C6
【PRE_R】

The melarsoprol / aprepitant drug combination did not produce any clinical signs of illness in mice with CNS trypanosome infection .
【GOLD_E】
melarsoprol	chem
aprepitant	chem
【PRE_E】
melarsoprol	chem
aprepitant	chem
【GOLD_R】
【PRE_R】

This lack of any additional or unexpected CNS toxicity in the mouse model of CNS HAT provides valuable safety data for the future possible use of this drug combination in patients with late - stage HAT .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Identification of the RLBP1 gene promoter .
【GOLD_E】
RLBP1genepromoter	geneN
【PRE_E】
RLBP1genepromoter	geneN
【GOLD_R】
【PRE_R】

PURPOSE : Cellular retinaldehyde - binding protein ( CRALBP ) , transcribed from the RLBP1 gene , is a 36 - kDa water - soluble protein with 316 amino acids found in the retinal pigment epithelium ( RPE ) and in retinal Muller cells .
【GOLD_E】
CRALBP	geneY
RLBP1	geneY
Cellularretinaldehyde-bindingprotein	geneY
36-kDawater-solubleprotein	geneN
aminoacids	chem
retinal	chem
retinaldehyde	chem
retinal	chem
【PRE_E】
retinaldehyde-bindingprotein	geneY
CRALBP	geneY
RLBP1	geneY
aminoacids	chem
retinal	chem
【GOLD_R】
【PRE_R】

It is thought to play a critical role in the visual cycle by functioning as an acceptor of 11 - cis - retinol from the isomerohydrolase reaction .
【GOLD_E】
isomerohydrolase	geneN
11-cis-retinol	chem
【PRE_E】
11-cis-retinol	chem
isomerohydrolase	geneN
【GOLD_R】
11-cis-retinol	isomerohydrolase	C9
【PRE_R】

The goal here was to evaluate the functional promoter of this gene .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS : 5 ' RACE analysis , promoter - reporter assays , and semiquantitative PCR with exon - specific primers were performed using human - derived RPE cells ( ARPE - 19 and D407 ) in culture to evaluate the 5 ' sequence flanking the RLBP1 gene .
【GOLD_E】
RLBP1	geneY
【PRE_E】
D407	geneY
RLBP1	geneY
【GOLD_R】
【PRE_R】

In addition , the murine , bovine , and porcine RLBP1 genes were evaluated in silico to identify likely proximal promoter / exon 1 sequences similar to the human gene .
【GOLD_E】
murine,bovine,andporcineRLBP1	geneN
【PRE_E】
porcineRLBP1	geneY
proximalpromoter/exon1	geneN
【GOLD_R】
【PRE_R】

RESULTS : 5 ' RACE analysis revealed the presence of a previously undescribed exon in the RLBP1 gene .
【GOLD_E】
RLBP1	geneY
【PRE_E】
RLBP1	geneY
【GOLD_R】
【PRE_R】

This was confirmed by analysis of the GenBank Human EST database , which revealed the presence of 18 sequences matching exon 1 .
【GOLD_E】
【PRE_E】
HumanEST	geneY
【GOLD_R】
【PRE_R】

Exon - specific PCR revealed that most CRALBP transcripts expressed in ARPE - 19 cells contain both exon 1 and the final exon , suggesting that the primary promoter of CRALBP exists 5 ' of the newly identified exon 1 .
【GOLD_E】
CRALBP	geneY
CRALBP	geneY
【PRE_E】
CRALBP	geneY
CRALBPexists5	geneN
【GOLD_R】
【PRE_R】

Highly homologous sequences in the murine , bovine , and porcine genes were also identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Finally , promoter - reporter constructs revealed a minimal sequence necessary for promoter function and indicated significantly greater promoter activity compared with previously described RLBP1 promoters .
【GOLD_E】
RLBP1promoters	geneN
【PRE_E】
RLBP1	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS : The findings presented here suggest that CRALBP transcripts in RPE cells contain a noncoding exon in addition to a newly described promoter and , by definition , an additional intron .
【GOLD_E】
CRALBP	geneY
【PRE_E】
CRALBP	geneY
【GOLD_R】
【PRE_R】

This finding sets the stage for a mechanistic understanding of the high degree of cell type - specific expression of RLBP1 .
【GOLD_E】
RLBP1	geneY
【PRE_E】
RLBP1	geneY
【GOLD_R】
【PRE_R】

Determination of dimethylarginine dimethylaminohydrolase activity in the kidney .
【GOLD_E】
dimethylarginine	chem
dimethylargininedimethylaminohydrolase	geneY
【PRE_E】
dimethylargininedimethylaminohydrolase	geneN
【GOLD_R】
【PRE_R】

Dimethylarginine dimethylaminohydrolase ( DDAH ) metabolizes asymmetric dimethylarginine to generate L - citrulline and is present in large quantities in the kidney .
【GOLD_E】
L-citrulline	chem
Dimethylargininedimethylaminohydrolase	geneY
Dimethylarginine	chem
DDAH	geneY
dimethylarginine	chem
【PRE_E】
Dimethylargininedimethylaminohydrolase	geneN
DDAH	geneN
dimethylarginine	chem
L-citrulline	chem
【GOLD_R】
L-citrulline	Dimethylargininedimethylaminohydrolase	C9
L-citrulline	DDAH	C9
dimethylarginine	Dimethylargininedimethylaminohydrolase	C9
dimethylarginine	DDAH	C9
【PRE_R】
DDAH	dimethylarginine	C9
DDAH	L-citrulline	C9

We present a new study that optimizes the Prescott - Jones colorimetric assay to measure DDAH - dependent L - citrulline generation in kidney homogenates .
【GOLD_E】
DDAH	geneY
L-citrulline	chem
【PRE_E】
DDAH	geneN
L-citrulline	chem
【GOLD_R】
L-citrulline	DDAH	C9
【PRE_R】
DDAH	L-citrulline	C9

We found that the removal of urea with urease is necessary since urea also produces a positive reaction .
【GOLD_E】
urease	geneN
urea	chem
urea	chem
【PRE_E】
urea	chem
urease	geneN
urea	chem
【GOLD_R】
urea	urease	C9
【PRE_R】
urea	urease	C9

Deproteinization with sulfosalicylic acid was found to be optimal and that protease inhibitors were not necessary .
【GOLD_E】
protease	geneN
sulfosalicylicacid	chem
【PRE_E】
sulfosalicylicacid	chem
protease	geneN
【GOLD_R】
【PRE_R】
sulfosalicylicacid	protease	C4

All assays were conducted in phosphate buffer , since other common additives can create false positive and false negative reactions .
【GOLD_E】
phosphate	chem
【PRE_E】
phosphate	chem
【GOLD_R】
【PRE_R】

Arginase or nitric oxide synthase isoenzymes were not found to influence L - citrulline production .
【GOLD_E】
Arginase	geneN
nitricoxidesynthase	geneN
nitricoxide	chem
L-citrulline	chem
【PRE_E】
Arginase	geneN
nitricoxidesynthase	geneN
L-citrulline	chem
【GOLD_R】
【PRE_R】

Our optimized L - citrulline production assay to measure DDAH activity correlated closely with the direct measure of the rate of asymmetric dimethylarginine consumption .
【GOLD_E】
L-citrulline	chem
dimethylarginine	chem
DDAH	geneY
【PRE_E】
L-citrulline	chem
DDAH	geneN
dimethylarginine	chem
【GOLD_R】
L-citrulline	DDAH	C9
dimethylarginine	DDAH	C9
【PRE_R】

Using this assay , we found that both superoxide and nitric oxide inhibit renal cortical DDAH activity in vitro .
【GOLD_E】
superoxide	chem
nitricoxide	chem
DDAH	geneY
【PRE_E】
superoxide	chem
nitricoxide	chem
DDAH	geneN
【GOLD_R】
superoxide	DDAH	C4
nitricoxide	DDAH	C4
【PRE_R】
superoxide	DDAH	C4

The role of trastuzumab in early stage breast cancer : current data and treatment recommendations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OPINION STATEMENT : Treatment of early stage breast cancer requires a multimodality approach in order to eradicate residual cancer and prevent recurrent disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Targeting the pathways that promote or sustain cancer cell growth and invasion is critical to the effective treatment of breast and other cancers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overexpression of the family of HER receptors have been associated with a variety of malignancies ; the first and best studied is the association of overexpression of the HER2 / neu receptor with a more aggressive breast cancer phenotype and poorer survival .
【GOLD_E】
HER	geneN
HER2	geneY
neureceptor	geneY
【PRE_E】
HERreceptors	geneN
HER2	geneY
neureceptor	geneY
【GOLD_R】
【PRE_R】

A humanized antibody to HER2 / neu , trastuzumab , is now FDA approved for the treatment of early stage , HER2 / neu overexpressing breast cancer sequenced with chemotherapy including doxorubicin , cyclophosphamide , and paclitaxel .
【GOLD_E】
HER2	geneY
neu	geneY
HER2	geneY
neu	geneY
doxorubicin	chem
cyclophosphamide	chem
paclitaxel	chem
【PRE_E】
HER2	geneY
neu	geneY
HER2	geneY
neu	geneY
doxorubicin	chem
cyclophosphamide	chem
paclitaxel	chem
【GOLD_R】
【PRE_R】
HER2	cyclophosphamide	C4
neu	cyclophosphamide	C4

Additional international and national studies support the significant impact of trastuzumab on both disease free and overall survival in women with this aggressive form of breast cancer .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Toxicity includes a low but clear risk of congestive heart failure , and the large phase III trials have helped to determine which patients are at higher risk for this complication .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Non - anthracycline containing regimens are an alternative therapy associated with reduced cardiac toxicity .
【GOLD_E】
anthracycline	chem
【PRE_E】
anthracycline	chem
【GOLD_R】
【PRE_R】

Trastuzumab therapy is now the standard of care for the treatment of early stage , HER2 / neu positive breast cancer given in combination with one of several chemotherapy regimens .
【GOLD_E】
HER2	geneY
neu	geneY
【PRE_E】
HER2	geneY
neu	geneY
【GOLD_R】
【PRE_R】

Ongoing questions include the appropriate duration of trastuzumab treatment as well as the optimal chemotherapy regimen and sequence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral tyrosine kinase inhibitor targeting HER2 / neu as well as the epidermal growth factor receptor ( EGFR ) , lapatinib .
【GOLD_E】
HER2	geneY
neu	geneY
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
tyrosine	chem
lapatinib	chem
【PRE_E】
tyrosinekinase	geneN
HER2	geneY
neu	geneY
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
lapatinib	chem
【GOLD_R】
lapatinib	HER2	C4
lapatinib	neu	C4
lapatinib	epidermalgrowthfactorreceptor	C4
lapatinib	EGFR	C4
【PRE_R】

Other trials are investigating differences in duration .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Studies in the neoadjuvant setting should help to define markers of trastuzumab and lapatinib sensitivity and resistance .
【GOLD_E】
lapatinib	chem
【PRE_E】
lapatinib	chem
【GOLD_R】
【PRE_R】

Preliminary data combining trastuzumab with the antiangiogenic antibody bevacizumab is encouraging ; this combination will be tested in both early stage and late stage disease .
【GOLD_E】
【PRE_E】
bevacizumab	chem
【GOLD_R】
【PRE_R】

Stimulation of N - methyl - D - aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin .
【GOLD_E】
N-methyl-D-aspartate	chem
N-methyl-D-aspartatereceptors	geneN
fibronectin	geneY
【PRE_E】
N-methyl-D-aspartatereceptors	geneN
fibronectin	geneY
【GOLD_R】
【PRE_R】

The aims of this study were to investigate the expression and the functional roles of N - methyl - d - aspartate ( NMDA ) receptors in leukemic Jurkat T cells .
【GOLD_E】
N-methyl-d-aspartate	chem
N-methyl-d-aspartate(NMDA)receptors	geneN
NMDA	chem
【PRE_E】
N-methyl-d-aspartate(NMDA)receptors	geneN
【GOLD_R】
【PRE_R】

RT - PCR and immunofluorescence / confocal microscopy analysis showed that Jurkat T cells express the NR1 and NR2B subunits of the NMDA receptors .
【GOLD_E】
NR1	geneY
NR2B	geneY
NMDAreceptors	geneN
NMDA	chem
【PRE_E】
NR1	geneY
NR2B	geneY
NMDAreceptors	geneN
【GOLD_R】
【PRE_R】

Exposure of Jurkat cells to either ( 5S,10R ) - ( + ) - 5 - methyl - 10,11 - dihydro - 5H - dibenzo [ a , b ] cyclohepten - 5,10 - imine [ ( + ) - MK 801 ] or D - ( - ) - 2 - amino - 5 - phosphonopentanoic acid ( D - AP5 ) , two selective NMDA receptor antagonists , limited cell growth by inhibiting cell cycle progression and inducing apoptosis , whereas l - glutamate ( 1 microM ) and NMDA ( 10 microM ) significantly increased ( 137.2 + / - 22.0 % ; P < 0.01 ) Jurkat T cell adhesion to fibronectin .
【GOLD_E】
NMDAreceptor	geneN
fibronectin	geneY
(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,b]cyclohepten-5,10-imine	chem
(+)-MK801	chem
D-(-)-2-amino-5-phosphonopentanoicacid	chem
D-AP5	chem
NMDA	chem
l-glutamate	chem
NMDA	chem
【PRE_E】
(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,b]cyclohepten-5,10-imine	chem
(+)-MK801	chem
D-(-)-2-amino-5-phosphonopentanoicacid	chem
D-AP5	chem
NMDAreceptor	geneN
l-glutamate	chem
NMDA	chem
fibronectin	geneY
【GOLD_R】
(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,b]cyclohepten-5,10-imine	NMDAreceptor	C6
(+)-MK801	NMDAreceptor	C6
D-(-)-2-amino-5-phosphonopentanoicacid	NMDAreceptor	C6
D-AP5	NMDAreceptor	C6
【PRE_R】

In conclusion , our results demonstrate that Jurkat T cells express NMDA receptors functionally active in controlling cell growth and adhesion to fibronectin .
【GOLD_E】
NMDA	chem
NMDAreceptors	geneN
fibronectin	geneY
【PRE_E】
NMDAreceptors	geneN
fibronectin	geneY
【GOLD_R】
【PRE_R】

Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter .
【GOLD_E】
Desvenlafaxinesuccinate	chem
norepinephrine	chem
humannorepinephrinetransporter	geneY
【PRE_E】
Desvenlafaxinesuccinate	chem
humannorepinephrinetransporter	geneY
【GOLD_R】
Desvenlafaxinesuccinate	humannorepinephrinetransporter	C6
【PRE_R】

Desvenlafaxine succinate ( DVS ) is a recently introduced antagonist of the human norepinephrine and serotonin transporters ( hNET and hSERT , respectively ) , currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause .
【GOLD_E】
norepinephrine	chem
Desvenlafaxinesuccinate	chem
serotonin	chem
hNET	geneY
hSERT	geneY
humannorepinephrineandserotonintransporters	geneN
DVS	chem
【PRE_E】
Desvenlafaxinesuccinate	chem
DVS	chem
humannorepinephrineandserotonintransporters	geneN
hNET	geneY
hSERT	geneY
【GOLD_R】
Desvenlafaxinesuccinate	hNET	C6
Desvenlafaxinesuccinate	hSERT	C6
DVS	hNET	C6
DVS	hSERT	C6
【PRE_R】
Desvenlafaxinesuccinate	hNET	C4
DVS	hNET	C4
DVS	hSERT	C4

Initial evaluation of the pharmacological properties of DVS ( J Pharmacol Exp Ther 318 : 657 - 665 , 2006 ) revealed significantly reduced potency for the hNET expressed in membranes compared with whole cells when competing for [ ( 3 ) H ] nisoxetine ( NIS ) binding .
【GOLD_E】
hNET	geneY
DVS	chem
[(3)H]nisoxetine	chem
NIS	chem
【PRE_E】
DVS(JPharmacolExpTher318	chem
hNET	geneY
[(3)H]nisoxetine	chem
NIS	geneY
【GOLD_R】
【PRE_R】
DVS(JPharmacolExpTher318	hNET	C4

Using hNET in transfected human embryonic kidney - 293 cells , this difference in potency for DVS at sites labeled by [ ( 3 ) H ] NIS was found to distinguish DVS , the DVS analog rac - ( 1 - [ 1 - ( 3 - chloro - phenyl ) - 2 - ( 4 - methylpiperazin - 1 - yl ) - ethyl ] cyclohexanol ( WY - 46824 ) , methylphenidate , and the cocaine analog 3beta - ( 4 - iodophenyl ) tropane - 2beta - carboxylic acid methyl ester ( RTI - 55 ) from other hNET antagonists , such as NIS , mazindol , tricyclic antidepressants , and cocaine .
【GOLD_E】
DVS	chem
rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol	chem
WY-46824	chem
methylphenidate	chem
cocaine	chem
3beta-(4-iodophenyl)tropane-2beta-carboxylicacidmethylester	chem
RTI-55	chem
NIS	chem
mazindol	chem
tricyclic	chem
cocaine	chem
hNET	geneY
hNET	geneY
DVS	chem
[(3)H]NIS	chem
DVS	chem
【PRE_E】
hNET	geneY
DVS	chem
[(3)H]NIS	chem
DVS	chem
DVS	chem
rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol	chem
WY-46824	chem
methylphenidate	chem
cocaine	chem
3beta-(4-iodophenyl)tropane-2beta-carboxylicacidmethylester	chem
RTI-55	chem
hNET	geneY
NIS	geneY
mazindol	chem
tricyclic	chem
cocaine	chem
【GOLD_R】
DVS	hNET	C6
rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol	hNET	C6
WY-46824	hNET	C6
methylphenidate	hNET	C6
cocaine	hNET	C6
3beta-(4-iodophenyl)tropane-2beta-carboxylicacidmethylester	hNET	C6
RTI-55	hNET	C6
NIS	hNET	C6
mazindol	hNET	C6
tricyclic	hNET	C6
cocaine	hNET	C6
DVS	hNET	C6
【PRE_R】
3beta-(4-iodophenyl)tropane-2beta-carboxylicacidmethylester	NIS	C4

These differences seem not to arise from preparation - specific perturbations of ligand intrinsic affinity or antagonist - specific surface trafficking but rather from protein conformational alterations that perturb the relationships between distinct hNET binding sites .
【GOLD_E】
hNET	geneY
【PRE_E】
hNET	geneY
【GOLD_R】
【PRE_R】

In an initial search for molecular features that differentially define antagonist binding determinants , we document that Val148 in hNET transmembrane domain 3 selectively disrupts NIS binding but not that of DVS .
【GOLD_E】
hNETtransmembranedomain3	geneN
NIS	chem
【PRE_E】
Val148	chem
hNETtransmembranedomain3	geneN
NIS	geneY
DVS	chem
【GOLD_R】
【PRE_R】

[ Lipoprotein ( a ) : a link between thrombogenesis and atherogenesis ] .
【GOLD_E】
Lipoprotein(a)	geneY
【PRE_E】
Lipoprotein(a)	geneY
【GOLD_R】
【PRE_R】

INTRODUCTION : It is well known that numerous mechanisms of thrombogenesis can participate in every stage of atherosclerotic disease .
【GOLD_E】
【PRE_E】
thrombogenesis	chem
【GOLD_R】
【PRE_R】

The discovery of Lp ( a ) lipoprotein and its structural similarity with plasminogen suggests another pathogenic link between atherogenesis and thrombogenesis .
【GOLD_E】
Lp(a)	geneY
lipoprotein	geneN
plasminogen	geneY
【PRE_E】
Lp(a)lipoprotein	geneN
plasminogen	geneN
【GOLD_R】
【PRE_R】

SOME CHARACTERISTICS OF LP ( A ) LIPOPROTEIN : This lipoprotein is present in the whole human population in a wide range of plasma concentrations .
【GOLD_E】
LP(A)	geneY
LIPOPROTEIN	geneN
【PRE_E】
LP(A)LIPOPROTEIN	geneY
lipoprotein	geneN
【GOLD_R】
【PRE_R】

It has numerous different isoforms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Its synthesis occurs in the liver , but it is practically metabolically independent from other lipoproteins .
【GOLD_E】
lipoproteins	geneN
【PRE_E】
lipoproteins	geneN
【GOLD_R】
【PRE_R】

Today , Lp ( a ) lipoprotein is considered to be an independent risk factor for heart and brain ischemic disease .
【GOLD_E】
Lp(a)	geneY
lipoprotein	geneN
【PRE_E】
Lp(a)lipoprotein	geneY
【GOLD_R】
【PRE_R】

FIBRINOLYTIC MECHANISMS : The primary role of the fibrinolytic mechanism is to prevent thrombus Jormation during circulation and to remove already formed ones .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Plasmin has a central role in this process , due to the inactive proenzyme plasminogen .
【GOLD_E】
Plasmin	geneY
plasminogen	geneY
【PRE_E】
Plasmin	geneY
proenzymeplasminogen	geneN
【GOLD_R】
【PRE_R】

Its basic activators are tissue - type plasminogen activator ( t - PA ) and urokinase plasminogen activator ( u - PA ) .
【GOLD_E】
urokinaseplasminogenactivator	geneY
tissue-typeplasminogenactivator	geneY
t-PA	geneY
u-PA	geneY
【PRE_E】
tissue-typeplasminogenactivator	geneY
t-PA	geneY
urokinaseplasminogenactivator	geneY
u-PA	geneY
【GOLD_R】
【PRE_R】

The most important inhibitors of plasminogen are alpha2 - antiplasmin and plasminogen activator inhibitors 1 and 2 ( PA - 1 and PAI - 2 ) .
【GOLD_E】
plasminogen	geneY
alpha2-antiplasmin	geneY
plasminogenactivatorinhibitors1and2	geneN
PA-1	geneY
PAI-2	geneY
【PRE_E】
plasminogen	geneN
alpha2-antiplasmin	geneN
plasminogenactivatorinhibitors1and2	geneN
PA-1	geneY
PAI-2	geneY
【GOLD_R】
【PRE_R】

Structural similarity of Lp ( a ) and plasminogen The apo ( a ) and plasminogen genes are very closely linked on the long arm of chromosome 6 .
【GOLD_E】
Lp(a)	geneY
plasminogen	geneY
apo(a)	geneN
plasminogen	geneY
【PRE_E】
Lp(a)	geneY
plasminogenTheapo(a)	geneY
plasminogen	geneN
【GOLD_R】
【PRE_R】

Because of that they are structuraly very similar and they have a cross immunological reactivity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Their common elements are so - called `` kringle `` structures .
【GOLD_E】
【PRE_E】
kringle	geneN
【GOLD_R】
【PRE_R】

The key difference in structure of Lp ( a ) and plasminogen is replacement of Arg with Ser at position 560 .
【GOLD_E】
Lp(a)	geneY
plasminogen	geneY
Arg	chem
Ser	chem
【PRE_E】
Lp(a)	geneY
plasminogen	geneN
Arg	chem
Ser	chem
【GOLD_R】
【PRE_R】

This prevents splitting of apo ( a ) by plasminogen activators .
【GOLD_E】
apo(a)	geneN
plasminogenactivators	geneN
【PRE_E】
apo(a)	geneY
plasminogen	geneN
【GOLD_R】
【PRE_R】

LP ( A ) AND FIBRINOLYSIS : Lp ( a ) lipoprotein inhibits activation of plasminogen by streptokinase .
【GOLD_E】
LP(A)	geneY
Lp(a)	geneY
lipoprotein	geneN
plasminogen	geneY
streptokinase	geneN
【PRE_E】
LP(A)	geneY
Lp(a)lipoprotein	geneY
plasminogen	geneN
streptokinase	chem
【GOLD_R】
【PRE_R】
Lp(a)lipoprotein	streptokinase	C4
plasminogen	streptokinase	C4

It is also a competitive inhibitor of plasminogen for its binding to plasminogen receptors .
【GOLD_E】
plasminogen	geneY
plasminogenreceptors	geneN
【PRE_E】
plasminogen	geneN
plasminogenreceptors	geneN
【GOLD_R】
【PRE_R】

Furthermore , it successfully achieves competitive inhibition of plasminogen for binding to tetranectin and thrombospondin .
【GOLD_E】
plasminogen	geneY
tetranectin	geneY
thrombospondin	geneY
【PRE_E】
plasminogen	geneN
tetranectin	geneN
thrombospondin	geneN
【GOLD_R】
【PRE_R】

Also , Lp ( a ) inhibits activation of transforming growth factor alpha ( TGF - alpha ) .
【GOLD_E】
Lp(a)	geneY
transforminggrowthfactoralpha	geneY
TGF-alpha	geneY
【PRE_E】
Lp(a)	geneY
transforminggrowthfactoralpha	geneY
TGF-alpha	geneY
【GOLD_R】
【PRE_R】

It positively correlates with PAI - 1 and it is assumed that it promotes release of tissue factor pathway inhibitor ( 17FPI ) from endothelial cell surfaces .
【GOLD_E】
PAI-1	geneY
tissuefactor	geneY
【PRE_E】
PAI-1	geneY
tissuefactor	geneN
【GOLD_R】
【PRE_R】

CONCLUSION : In regulation of the hemostatic system via apolipoprotein ( a ) antifibrinolytic effects , Lp ( a ) lipoprotein ojfers a molecular solution to the link between thrombogenesis and atherogenesis .
【GOLD_E】
apolipoprotein(a)	geneN
Lp(a)	geneY
lipoprotein	geneN
【PRE_E】
apolipoprotein(a)	geneY
Lp(a)lipoprotein	geneY
【GOLD_R】
【PRE_R】

Sunitinib , sorafenib and mTOR inhibitors in renal cancer .
【GOLD_E】
Sunitinib	chem
sorafenib	chem
mTOR	geneY
【PRE_E】
Sunitinib	chem
sorafenib	chem
mTOR	geneY
【GOLD_R】
【PRE_R】
Sunitinib	mTOR	C4
sorafenib	mTOR	C4

Understanding the alterations in cellular protein interactions and their relations to genetic mutations that cause renal cell carcinoma ( RCC ) provides a unique opportunity for the development of disease - specific therapy for patients with advanced forms of this disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

There is substantial evidence of an association between mutation on von Hippel - Lindau ( VHL ) gene and the earliest stages of tumorigenesis of RCC .
【GOLD_E】
vonHippel-Lindau	geneY
VHL	geneY
【PRE_E】
vonHippel-Lindau	geneY
VHL	geneY
RCC	geneY
【GOLD_R】
【PRE_R】

The main consequence of VHL loss is the upregulation of downstream proangiogenic factors leading to highly vascular tumors .
【GOLD_E】
VHL	geneY
【PRE_E】
VHL	geneY
【GOLD_R】
【PRE_R】

Overexpression of hypoxia inducible factor ( HIF ) is also caused by the mammalian target of rapamycin ( mTOR ) , a key component of signaling pathways inside the cell , involved in cell proliferation .
【GOLD_E】
rapamycin	chem
hypoxiainduciblefactor	geneN
HIF	geneN
mammaliantargetofrapamycin	geneY
mTOR	geneY
【PRE_E】
hypoxiainduciblefactor	geneN
HIF	geneN
mammaliantargetofrapamycin	geneY
mTOR	geneY
【GOLD_R】
【PRE_R】

The inhibition of proangiogenic factors and mTOR was the main idea behind the development of new targeted agents in advanced RCC .
【GOLD_E】
mTOR	geneY
【PRE_E】
mTOR	geneY
【GOLD_R】
【PRE_R】

Since December 2005 , 3 targeted agents have been approved by the U.S .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Food and Drug Administration ( FDA ) for the treatment of advanced RCC : sorafenib , sunitinib and temsirolimus .
【GOLD_E】
sorafenib	chem
sunitinib	chem
temsirolimus	chem
【PRE_E】
sorafenib	chem
sunitinib	chem
temsirolimus	chem
【GOLD_R】
【PRE_R】

Sorafenib and sunitinib are synthetic , orally active agents shown to directly inhibit vascular endothelial growth factor receptors - 2 and - 3 ( VEGFR - 2 , VEGFR - 3 ) and platelet - derived growth factor receptor beta ( PDGFR - beta ) , while temsirolimus is an mTOR inhibitor .
【GOLD_E】
vascularendothelialgrowthfactorreceptors-2and-3	geneN
VEGFR-2	geneY
VEGFR-3	geneY
platelet-derivedgrowthfactorreceptorbeta	geneY
PDGFR-beta	geneY
mTOR	geneY
Sorafenib	chem
sunitinib	chem
temsirolimus	chem
【PRE_E】
Sorafenib	chem
sunitinib	chem
vascularendothelialgrowthfactorreceptors-2and-3	geneY
VEGFR-2	geneY
VEGFR-3	geneY
platelet-derivedgrowthfactorreceptorbeta	geneN
PDGFR-beta	geneY
temsirolimus	chem
mTOR	geneY
【GOLD_R】
Sorafenib	VEGFR-2	C4
Sorafenib	VEGFR-3	C4
Sorafenib	platelet-derivedgrowthfactorreceptorbeta	C4
Sorafenib	PDGFR-beta	C4
sunitinib	VEGFR-2	C4
sunitinib	VEGFR-3	C4
sunitinib	platelet-derivedgrowthfactorreceptorbeta	C4
sunitinib	PDGFR-beta	C4
temsirolimus	mTOR	C4
【PRE_R】
Sorafenib	vascularendothelialgrowthfactorreceptors-2and-3	C4
sunitinib	vascularendothelialgrowthfactorreceptors-2and-3	C4
sunitinib	VEGFR-2	C4
sunitinib	VEGFR-3	C4
platelet-derivedgrowthfactorreceptorbeta	temsirolimus	C4
PDGFR-beta	temsirolimus	C4
temsirolimus	mTOR	C4

Recent clinical studies form the basis for new guidelines for the treatment of advanced RCC : sorafenib should be used as a second - line treatment , sunitinib as the first - line therapy for good and intermediate - risk patients , and temsirolimus should be considered as first - line treatment for poor - risk patients .
【GOLD_E】
sorafenib	chem
sunitinib	chem
temsirolimus	chem
【PRE_E】
sorafenib	chem
sunitinib	chem
temsirolimus	chem
【GOLD_R】
【PRE_R】

Future approaches to targeted therapy should focus on optimizing the use of current active drugs , exploring their combinations or investigating their sequential use .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , it is important to define the mechanisms of resistance on their use and to further investigate biomarkers and enhance treatment efficacy for the individual patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The development of these targeted therapies represents an exciting step forward in the treatment of advanced RCC .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Management of psoriasis : the position of retinoid drugs .
【GOLD_E】
retinoid	chem
【PRE_E】
retinoid	chem
【GOLD_R】
【PRE_R】

Oral synthetic retinoids have been established as effective systemic therapy for psoriasis since their introduction for clinical use in the 1970s ; a compound for topical use , tazarotene has been recently marketed .
【GOLD_E】
retinoids	chem
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Despite the demonstrated clinical success of retinoid therapy in psoriasis , its mechanism of action has not been fully elucidated , and investigators are confronted with two paradoxes .
【GOLD_E】
retinoid	chem
【PRE_E】
retinoid	chem
【GOLD_R】
【PRE_R】

One is that the binding of retinoids to nuclear retinoic acid receptors ( RARs ) does not match their therapeutic efficacy : acitretin activates the three receptor subtypes , RAR - alpha , - beta and - gamma , without measurable receptor binding , whereas tazarotene preferentially binds to and activates RAR - beta and - gamma in preference to RAR - alpha .
【GOLD_E】
retinoicacidreceptors	geneN
RARs	geneN
RAR-alpha,-betaand-gamma	geneN
RAR-betaand-gamma	geneN
RAR-alpha	geneY
retinoids	chem
retinoicacid	chem
acitretin	chem
tazarotene	chem
【PRE_E】
nuclearretinoicacidreceptors	geneN
RARs	geneN
acitretin	chem
RAR-alpha,-betaand-gamma	geneN
measurablereceptor	geneN
tazarotene	chem
RAR-betaand-gamma	geneN
RAR-alpha	geneY
【GOLD_R】
tazarotene	RAR-alpha	C3
【PRE_R】

The other is that there is already increased formation of retinoic acid in the psoriatic lesion .
【GOLD_E】
retinoicacid	chem
【PRE_E】
retinoicacid	chem
【GOLD_R】
【PRE_R】

Answering these questions should result in better use of these drugs in the treatment of psoriasis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Oral administration of acitretin remains one of the first therapeutic choices for severe psoriasis , particularly in association with ultraviolet light therapy , of which it may decrease the carcinogenic risk .
【GOLD_E】
acitretin	chem
【PRE_E】
acitretin	chem
【GOLD_R】
【PRE_R】

Topical tazarotene is suitable for moderate plaque psoriasis .
【GOLD_E】
tazarotene	chem
【PRE_E】
tazarotene	chem
【GOLD_R】
【PRE_R】

Its efficacy and tolerability can be enhanced by the addition of topical corticosteroids ; its irritative potential is counterbalanced by a sustained therapeutic effect after the treatment is stopped .
【GOLD_E】
corticosteroids	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Comprehensive review of rasagiline , a second - generation monoamine oxidase inhibitor , for the treatment of Parkinson 's disease .
【GOLD_E】
rasagiline	chem
monoamine	chem
monoamineoxidase	geneN
【PRE_E】
rasagiline	chem
monoamineoxidase	geneN
【GOLD_R】
rasagiline	monoamineoxidase	C4
【PRE_R】

BACKGROUND : Inhibitors of monoamine oxidase ( MAO ) with selectivity and specificity for MAO type B ( MAO - B ) prolong the duration of action of both endogenously and exogenously derived dopamine .
【GOLD_E】
monoamine	chem
monoamineoxidase	geneN
MAO	geneN
MAOtypeB	geneY
MAO-B	geneY
dopamine	chem
【PRE_E】
monoamineoxidase	geneN
MAO	geneN
MAOtypeB	geneY
MAO-B	geneY
dopamine	chem
【GOLD_R】
【PRE_R】
MAO-B	dopamine	C9

Rasagiline [ N - propargyl - l ( R ) - aminoindan ] is a second - generation propargylamine pharmacophore that selectively and irreversibly inhibits brain MAO - B and is specifically designed for the treatment of Parkinson 's disease ( PD ) .
【GOLD_E】
N-propargyl-l(R)-aminoindan	chem
propargylamine	chem
MAO-B	geneY
Rasagiline	chem
【PRE_E】
Rasagiline	chem
N-propargyl-l(R)-aminoindan	chem
propargylamine	chem
MAO-B	geneY
【GOLD_R】
N-propargyl-l(R)-aminoindan	MAO-B	C4
propargylamine	MAO-B	C4
Rasagiline	MAO-B	C4
【PRE_R】
Rasagiline	MAO-B	C4
N-propargyl-l(R)-aminoindan	MAO-B	C4
propargylamine	MAO-B	C4

OBJECTIVE : The aim of this study was to review the pharmacology , tolerability , and clinical efficacy of rasagiline in the treatment of PD .
【GOLD_E】
rasagiline	chem
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

METHODS : MEDLINE ( 1966 - April 2007 ) , the Cochrane Database of Systematic Reviews , and International Pharmaceutical Abstracts ( 1970 - April 2007 ) were searched for original research and review articles published in English .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The search terms were monoamine oxidase , neuroprotection , Parkinson disease , propargylamine , rasagiline , and selegiline .
【GOLD_E】
monoamine	chem
propargylamine	chem
rasagiline	chem
selegiline	chem
monoamineoxidase	geneN
【PRE_E】
monoamineoxidase	geneN
propargylamine	chem
rasagiline	chem
selegiline	chem
【GOLD_R】
【PRE_R】

The reference lists of articles were also consulted , as was information provided by the manufacturer of rasagiline .
【GOLD_E】
rasagiline	chem
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

RESULTS : Data from 63 clinical and laboratory studies were analyzed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Based on the results from those studies , we concluded that rasagiline PO QD , at the therapeutic dosage range of 0.5 to 1 rag / d , is effective and well tolerated and completely , selectively , and specifically inhibited MAO - B .
【GOLD_E】
MAO-B	geneY
rasagiline	chem
【PRE_E】
rasagiline	chem
PO	chem
MAO-B	geneY
【GOLD_R】
rasagiline	MAO-B	C4
【PRE_R】
rasagiline	MAO-B	C4
PO	MAO-B	C4

Pharmacologically , rasagiline was found to be < or = 10 - fold more potent than selegiline and was not metabolized to amphetamine derivatives .
【GOLD_E】
rasagiline	chem
selegiline	chem
amphetamine	chem
【PRE_E】
rasagiline	chem
selegiline	chem
amphetamine	chem
【GOLD_R】
【PRE_R】

Rasagiline was effective both as monotherapy in early PD and as adjunctive treatment in patients with advancing PD and motor fluctuations .
【GOLD_E】
Rasagiline	chem
【PRE_E】
Rasagiline	chem
【GOLD_R】
【PRE_R】

As monotherapy , rasagiline provided modest yet clinically meaningful benefit .
【GOLD_E】
rasagiline	chem
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

A randomized , double - blind , placebo - controlled study found that , after 26 weeks of treatment , the adjusted effect size for total Unified Parkinson 's Disease Rating Scale score was - 4.20 ( 95 % CI , - 5.66 to - 2.73 ) for rasagiline 1 mg / d versus placebo ( P < 0.001 ) .
【GOLD_E】
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

Preliminary long - term data from an open - label study suggest a sustained therapeutic advantage when rasagiline is initiated early ( before the need for dopaminergic agents ) rather than later .
【GOLD_E】
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

In patients with more advanced disease who received treatment with dopaminergic agents , rasagiline and entacapone were associated with reductions of `` off `` time significantly greater than placebo ( - 1.18 and - 1.2 vs 0.4 hour ; both , P < or = 0.001 ) .
【GOLD_E】
rasagiline	chem
entacapone	chem
【PRE_E】
rasagiline	chem
entacapone	chem
【GOLD_R】
【PRE_R】

Rasagiline was well tolerated in younger ( aged < ; 70 years ) and older ( aged > or = 70 years ) patients with early or advanced PD .
【GOLD_E】
Rasagiline	chem
【PRE_E】
Rasagiline	chem
【GOLD_R】
【PRE_R】

Pharmacologically , rasagiline has the potential to augment the vasopressor effects of diet - derived tyramine ( ie , the `` cheese reaction `` ) .
【GOLD_E】
tyramine	chem
【PRE_E】
rasagiline	chem
tyramine	chem
【GOLD_R】
【PRE_R】

However , clinical challenge studies of tyramine have found this unlikely to occur even with ingestion of supraphysiologic amounts of tyramine .
【GOLD_E】
tyramine	chem
tyramine	chem
【PRE_E】
tyramine	chem
tyramine	chem
【GOLD_R】
【PRE_R】

In experimental models , rasagiline has been found to have neuroprotective properties that may be independent of MAO - B inhibition .
【GOLD_E】
rasagiline	chem
MAO-B	geneY
【PRE_E】
rasagiline	chem
MAO-B	geneY
【GOLD_R】
【PRE_R】
rasagiline	MAO-B	C4

CONCLUSIONS : Based on this review , rasagiline has been found to be well tolerated and effective in the treatment of early PD and as adjunctive treatment in motor fluctuations .
【GOLD_E】
rasagiline	chem
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

Whether rasagiline is associated with clinically significant neuroprotection ( ie , disease modification ) in PD is the subject of ongoing clinical trials .
【GOLD_E】
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin .
【GOLD_E】
camptothecin	chem
DNAtopoisomeraseI	geneY
【PRE_E】
Gly721	geneN
DNAtopoisomeraseI	geneY
camptothecin	chem
【GOLD_R】
【PRE_R】

DNA topoisomerase I ( Top1p ) catalyzes the relaxation of supercoiled DNA via a concerted mechanism of DNA strand cleavage and religation .
【GOLD_E】
DNAtopoisomeraseI	geneY
Top1p	geneY
【PRE_E】
DNAtopoisomeraseI	geneY
Top1p	geneY
【GOLD_R】
【PRE_R】

Top1p is the cellular target of the anti - cancer drug camptothecin ( CPT ) , which reversibly stabilizes a covalent enzyme - DNA intermediate .
【GOLD_E】
camptothecin	chem
CPT	chem
Top1p	geneY
【PRE_E】
Top1p	geneN
camptothecin	chem
CPT	chem
【GOLD_R】
【PRE_R】

Top1p clamps around duplex DNA , wherein the core and C - terminal domains are connected by extended alpha - helices ( linker domain ) , which position the active site Tyr of the C - terminal domain within the catalytic pocket .
【GOLD_E】
C	chem
Tyr	chem
C	chem
Top1p	geneY
alpha-helices	geneN
linkerdomain	geneN
【PRE_E】
C	chem
Tyr	chem
C	chem
【GOLD_R】
【PRE_R】

The physical connection of the linker with the Top1p clamp as well as linker flexibility affect enzyme sensitivity to CPT .
【GOLD_E】
CPT	chem
Top1p	geneY
【PRE_E】
Top1p	geneN
CPT	chem
【GOLD_R】
【PRE_R】

Crystallographic data reveal that a conserved Gly residue ( located at the juncture between the linker and C - terminal domains ) is at one end of a short alpha - helix , which extends to the active site Tyr covalently linked to the DNA .
【GOLD_E】
Gly	chem
C	chem
Tyr	chem
alpha-helix	geneN
【PRE_E】
Gly	chem
C	chem
Tyr	chem
【GOLD_R】
【PRE_R】

In the presence of drug , the linker is rigid and this alpha - helix extends to include Gly and the preceding Leu .
【GOLD_E】
Gly	chem
Leu	chem
alpha-helix	geneN
【PRE_E】
Gly	chem
Leu	chem
【GOLD_R】
【PRE_R】

We report that mutation of this conserved Gly in yeast Top1p alters enzyme sensitivity to CPT .
【GOLD_E】
Gly	chem
CPT	chem
yeastTop1p	geneY
【PRE_E】
Gly	chem
CPT	chem
【GOLD_R】
【PRE_R】

Mutating Gly to Asp , Glu , Asn , Gln , Leu , or Ala enhanced enzyme CPT sensitivity , with the acidic residues inducing the greatest increase in drug sensitivity in vivo and in vitro .
【GOLD_E】
CPT	chem
Gly	chem
Asp	chem
Glu	chem
Asn	chem
Gln	chem
Leu	chem
Ala	chem
【PRE_E】
Gly	chem
Asp	chem
Glu	chem
Asn	chem
Gln	chem
Leu	chem
Ala	chem
CPT	chem
【GOLD_R】
【PRE_R】

By contrast , Val or Phe substituents rendered the enzyme CPT - resistant .
【GOLD_E】
Val	chem
Phe	chem
CPT	chem
【PRE_E】
Val	chem
Phe	chem
CPT	chem
【GOLD_R】
【PRE_R】

Mutation - induced alterations in enzyme architecture preceding the active site Tyr suggest these structural transitions modulate enzyme sensitivity to CPT , while enhancing the rate of DNA cleavage .
【GOLD_E】
Tyr	chem
CPT	chem
【PRE_E】
Tyr	chem
CPT	chem
【GOLD_R】
【PRE_R】

We postulate that this conserved Gly residue provides a flexible hinge within the Top1p catalytic pocket to facilitate linker dynamics and the structural alterations that accompany drug binding of the covalent enzyme - DNA intermediate .
【GOLD_E】
Gly	chem
Top1p	geneY
【PRE_E】
Gly	chem
【GOLD_R】
【PRE_R】

Characterization of the substrate mimic bound to engineered prostacyclin synthase in solution using high - resolution NMR spectroscopy and mutagenesis : implication of the molecular mechanism in biosynthesis of prostacyclin .
【GOLD_E】
prostacyclin	chem
prostacyclin	chem
prostacyclinsynthase	geneY
【PRE_E】
prostacyclinsynthase	geneY
prostacyclin	chem
【GOLD_R】
【PRE_R】

High - resolution NMR spectroscopy was used to determine the docking of a substrate ( prostaglandin H2 ) mimic ( U46619 ) to the engineered prostacyclin ( PGI2 ) synthase ( PGIS ) in solution .
【GOLD_E】
U46619	chem
prostaglandinH2	chem
prostacyclin(PGI2)synthase	geneY
PGIS	geneY
prostacyclin	chem
PGI2	chem
【PRE_E】
prostaglandinH2	chem
U46619	chem
prostacyclin(PGI2)synthase	geneY
PGIS	geneY
【GOLD_R】
【PRE_R】
U46619	PGIS	C4

The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration , and the significant perturbation of the chemical shifts of protons at C - 11 , H2C , and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration - dependent manner .
【GOLD_E】
U46619	chem
C-11	chem
H2C	chem
H20	chem
U46619	chem
U46619	chem
PGIS	geneY
PGIS	geneY
【PRE_E】
U46619	chem
PGIS	geneN
C-11	chem
H2C	chem
U46619	chem
U46619	chem
PGIS	geneN
【GOLD_R】
【PRE_R】

The detailed conformational change and 3D structure of the PGIS - bound U46619 were further demonstrated by 2D 1H NMR experiments using the transferred NOE technique .
【GOLD_E】
U46619	chem
1H	chem
PGIS	geneY
【PRE_E】
PGIS	geneN
U46619	chem
1H	chem
NOE	chem
【GOLD_R】
【PRE_R】

The distances between the protons H20 and H2 , H18 and H2 , and H18 and H4 are shorter following their binding to the PGIS in solution - down to within 5 A .
【GOLD_E】
H20	chem
H2	chem
H18	chem
H2	chem
H18	chem
H4	chem
PGIS	geneY
【PRE_E】
H20	chem
H18	chem
H18	chem
PGIS	geneN
【GOLD_R】
【PRE_R】

These shorter distances resulted in a widely open conformation , where the triangle shape of the unbound U46619 changed to a more compact conformation with an oval shape .
【GOLD_E】
U46619	chem
【PRE_E】
U46619	chem
【GOLD_R】
【PRE_R】

The bound conformation of U46619 fits the crystal structure of the PGIS substrate binding pocket considerably better than that of the unbound U46619 .
【GOLD_E】
U46619	chem
U46619	chem
PGIS	geneY
【PRE_E】
U46619	chem
PGIS	geneN
U46619	chem
【GOLD_R】
【PRE_R】

The residues important to the substrate binding in the active site pocket of PGIS were also predicted .
【GOLD_E】
PGIS	geneY
【PRE_E】
PGIS	geneN
【GOLD_R】
【PRE_R】

For example , Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function , which has been established by the docking studies using the NMR structure of the PGIS - bound form of U46619 and the PGIS crystal structure .
【GOLD_E】
PGIS	geneY
PGIS	geneY
U46619	chem
【PRE_E】
PGIS	geneN
U46619	chem
PGIS	geneN
【GOLD_R】
【PRE_R】

These studies have provided the structural information for the interaction of the PGIS with its substrate mimic .
【GOLD_E】
PGIS	geneY
【PRE_E】
PGIS	geneN
【GOLD_R】
【PRE_R】

The noted conformational changes where the C - 6 position is closer to the C - 9 position of U46619 provided the first experimental data for understanding the molecular mechanism of the catalytic function of PGIS in the isomerization of PGH2 to prostacyclin .
【GOLD_E】
prostacyclin	chem
PGIS	geneY
C-6	chem
C-9	chem
U46619	chem
PGH2	chem
【PRE_E】
C-6	geneY
C-9	geneY
U46619	chem
PGIS	geneN
PGH2	chem
prostacyclin	chem
【GOLD_R】
【PRE_R】

Type 2 diabetes and oral antihyperglycemic drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Type II diabetes is a heterogeneous disease where environment and genetics are important factors for the expression of the disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The high cost for treating complications of diabetes is a burden for public health systems and governments worldwide .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Type II diabetes has been causing debilitation worldwide for many decades , and a single drug that safely treats the disease has yet to be discovered .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sulfonylureas , biguanides , alpha - glucosidase , meglitinides , DPP - 4 inhibitors and thiazolidinediones are among the classes of oral hypoglycemic drugs available to treat Type II diabetes , but concerns exist regarding safety and efficacy of these drugs .
【GOLD_E】
Sulfonylureas	chem
biguanides	chem
meglitinides	chem
DPP-4	chem
thiazolidinediones	chem
alpha-glucosidase	geneN
DPP-4	geneY
【PRE_E】
Sulfonylureas	chem
biguanides	chem
alpha-glucosidase	geneN
meglitinides	geneN
DPP-4	geneY
thiazolidinediones	chem
【GOLD_R】
【PRE_R】
Sulfonylureas	alpha-glucosidase	C4
biguanides	alpha-glucosidase	C4
biguanides	meglitinides	C4
DPP-4	thiazolidinediones	C4

In this article we present the pros and cons of the six classes and discuss some of the latest advances towards the development of new drugs for the treatment of Type II diabetes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Asenapine : a novel psychopharmacologic agent with a unique human receptor signature .
【GOLD_E】
Asenapine	chem
【PRE_E】
Asenapine	chem
humanreceptor	geneY
【GOLD_R】
【PRE_R】

Asenapine is a novel psychopharmacologic agent under development for the treatment of schizophrenia and bipolar disorder .
【GOLD_E】
Asenapine	chem
【PRE_E】
Asenapine	chem
【GOLD_R】
【PRE_R】

We determined and compared the human receptor binding affinities and functional characteristics of asenapine and several antipsychotic drugs .
【GOLD_E】
asenapine	chem
【PRE_E】
humanreceptor	geneN
asenapine	chem
【GOLD_R】
【PRE_R】

Compounds were tested under comparable assay conditions using cloned human receptors .
【GOLD_E】
【PRE_E】
humanreceptors	geneN
【GOLD_R】
【PRE_R】

In comparison with the antipsychotics , asenapine showed high affinity and a different rank order of binding affinities ( pKi ) for serotonin receptors ( 5 - HT1A [ 8.6 ] , 5 - HT1B [ 8.4 ] , 5 - HT2A [ 10.2 ] , 5 - HT2B [ 9.8 ] , 5 - HT2C [ 10.5 ] , 5 - HT5 [ 8.8 ] , 5 - HT6 [ 9.6 ] and 5 - HT7 [ 9.9 ] ) , adrenoceptors ( alpha1 [ 8.9 ] , alpha2A [ 8.9 ] , alpha2B [ 9.5 ] and alpha2C [ 8.9 ] ) , dopamine receptors ( D1 [ 8.9 ] , D2 [ 8.9 ] , D3 [ 9.4 ] and D4 [ 9.0 ] ) and histamine receptors ( H1 [ 9.0 ] and H2 [ 8.2 ] ) .
【GOLD_E】
5-HT2A	geneY
5-HT2B	geneY
5-HT2C	geneY
5-HT5	geneY
5-HT6	geneY
5-HT7	geneY
adrenoceptors(alpha1	geneN
alpha2A	geneY
alpha2B	geneY
alpha2C	geneY
dopaminereceptors(D1	geneY
D2	geneY
D3	geneY
D4	geneY
histaminereceptors(H1	geneY
H2	geneY
serotonin	chem
dopamine	chem
histamine	chem
serotoninreceptors	geneN
5-HT1A	geneY
5-HT1B	geneY
【PRE_E】
asenapine	chem
serotoninreceptors	geneY
5-HT1A	geneY
5-HT1B	geneY
5-HT2A	geneY
5-HT2B	geneY
5-HT2C	geneY
5-HT5	geneY
5-HT6	geneY
5-HT7	geneY
adrenoceptors(alpha1[8.9],alpha2A[8.9],alpha2B[9.5]andalpha2C[8.9])	geneN
dopaminereceptors	geneY
D1	geneY
D2	geneY
D3	geneY
【GOLD_R】
【PRE_R】

It had much lower affinity ( pKi < or = 5 ) for muscarinic receptors and was the only agent with affinity for H2 receptors .
【GOLD_E】
【PRE_E】
muscarinicreceptors	geneN
H2receptors	geneN
【GOLD_R】
【PRE_R】

Relative to its D2 receptor affinity , asenapine had a higher affinity for 5 - HT2C , 5 - HT2A , 5 - HT2B , 5 - HT7 , 5 - HT6 , alpha2B and D3 receptors , suggesting stronger engagement of these targets at therapeutic doses .
【GOLD_E】
【PRE_E】
D2receptor	geneY
asenapine	chem
5-HT2C	geneY
5-HT2A	geneY
5-HT2B	geneY
5-HT7	geneY
5-HT6	geneY
alpha2B	geneY
D3receptors	geneY
【GOLD_R】
【PRE_R】

Asenapine behaved as a potent antagonist ( pKB ) at 5 - HT1A ( 7.4 ) , 5 - HT1B ( 8.1 ) , 5 - HT2A ( 9.0 ) , 5 - HT2B ( 9.3 ) , 5 - HT2C ( 9.0 ) , 5 - HT6 ( 8.0 ) , 5 - HT7 ( 8.5 ) , D2 ( 9.1 ) , D3 ( 9.1 ) , alpha2A ( 7.3 ) , alpha2B ( 8.3 ) , alpha2C ( 6.8 ) and H1 ( 8.4 ) receptors .
【GOLD_E】
【PRE_E】
Asenapine	chem
pKB	geneY
5-HT1A	geneY
5-HT1B	geneY
5-HT2A	geneY
5-HT2B	geneY
5-HT2C	geneY
5-HT6	geneY
5-HT7	geneY
D2(9.1)	geneY
D3(9.1)	geneY
alpha2A(7.3)	geneY
alpha2B(8.3)	geneY
alpha2C(6.8)	geneY
H1(8.4)	geneY
【GOLD_R】
【PRE_R】
Asenapine	pKB	C4

These functional effects differed from those of risperidone ( pKB < 5 for 5 - HT6 ) and olanzapine ( pKB < 5 for 5 - HT1A and alpha2 ) .
【GOLD_E】
【PRE_E】
risperidone	chem
5-HT6	geneY
olanzapine(pKB<5	geneN
5-HT1A	geneY
【GOLD_R】
【PRE_R】

Our results indicate that asenapine has a unique human receptor signature , with binding affinity and antagonistic properties that differ appreciably from those of antipsychotic drugs .
【GOLD_E】
【PRE_E】
asenapine	chem
humanreceptor	geneY
【GOLD_R】
【PRE_R】

Current and future prospects for anticoagulant therapy : inhibitors of factor Xa and factor IIa .
【GOLD_E】
factorIIa	geneY
factorXa	geneY
【PRE_E】
factorXa	geneY
factorIIa	geneY
【GOLD_R】
【PRE_R】

Indirect systemic and direct oral factor Xa and direct oral factor IIa inhibitors with improved pharmacologic profiles compared with heparins and vitamin K antagonists are currently in clinical development .
【GOLD_E】
vitaminK	chem
factorIIa	geneY
【PRE_E】
factorXa	geneY
factorIIa	geneY
vitaminK	chem
【GOLD_R】
【PRE_R】

This overview focuses on the indirect antithrombin dependent pentasaccharide derivatives of idraparinux and on the most advanced oral direct inhibitors to factor Xa ( rivaroxaban and apixaban ) and IIa ( dabigatran ) .
【GOLD_E】
pentasaccharide	chem
idraparinux	chem
rivaroxaban	chem
apixaban	chem
dabigatran	chem
factorXa	geneY
【PRE_E】
antithrombin	geneY
pentasaccharide	chem
idraparinux	chem
factorXa	geneY
rivaroxaban	chem
apixaban	chem
dabigatran	chem
【GOLD_R】
rivaroxaban	factorXa	C4
apixaban	factorXa	C4
【PRE_R】
antithrombin	pentasaccharide	C4
idraparinux	factorXa	C4
factorXa	rivaroxaban	C4
factorXa	apixaban	C4
factorXa	dabigatran	C4

Specifically , the results of dose - finding studies for the prevention of venous thromboembolism after elective orthopedic surgery , the results of dose - finding studies for treatment of acute venous thromboembolism including prolonged prophylaxis of recurrent events , and the designs of ongoing clinical trials are reviewed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Triple pharmacological blockade of the renin - angiotensin - aldosterone system in nondiabetic CKD : an open - label crossover randomized controlled trial .
【GOLD_E】
aldosterone	chem
renin	geneY
angiotensin	geneY
【PRE_E】
renin	geneY
angiotensin	geneY
aldosterone	chem
【GOLD_R】
【PRE_R】

BACKGROUND : Agents inhibiting the renin - angiotensin - aldosterone ( RAAS ) system have an important role in slowing the progression of chronic kidney disease .
【GOLD_E】
renin	geneY
angiotensin	geneY
aldosterone	chem
【PRE_E】
renin	geneY
angiotensin	geneY
aldosterone	chem
【GOLD_R】
【PRE_R】

We evaluated the hypothesis that the addition of an aldosterone receptor antagonist to an angiotensin - converting enzyme ( ACE ) inhibitor and angiotensin II type 1 ( AT - 1 ) receptor blocker ( ARB ) ( triple RAAS blockade ) may provide an additional benefit compared with an ACE inhibitor and ARB ( double RAAS blockade ) .
【GOLD_E】
aldosteronereceptor	geneY
angiotensin-convertingenzyme	geneY
ACE	geneY
angiotensinIItype1(AT-1)receptor	geneY
ACE	geneY
aldosterone	chem
angiotensinII	chem
【PRE_E】
aldosteronereceptor	geneN
angiotensin-convertingenzyme	geneY
ACE	geneY
angiotensinIItype1(AT-1)receptor	geneY
ACE	geneY
【GOLD_R】
【PRE_R】

DESIGN : Randomized open controlled crossover study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

SETTING & PARTICIPANTS : 18 whites ( 7 women , 11 men ) from the Outpatient Department of Nephrology with chronic nondiabetic proteinuric kidney diseases , mean age 42.4 + / - 1.9 years ( SEM ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

INTERVENTIONS : In the 8 - week run - in period , all participants received the ACE inhibitor cilazapril ( 5 mg ) , the ARB telmisartan ( 80 mg ) , and the diuretic hydrochlorothiazide ( 12.5 mg ) as double RAAS blockade to achieve the target blood pressure of less than 130 / 80 mm Hg .
【GOLD_E】
ACE	geneY
cilazapril	chem
telmisarta	chem
hydrochlorothiazide	chem
【PRE_E】
ACE	geneY
cilazapril	chem
telmisartan	chem
hydrochlorothiazide	chem
【GOLD_R】
cilazapril	ACE	C4
【PRE_R】
ACE	cilazapril	C4
ACE	telmisartan	C4
ACE	hydrochlorothiazide	C4

Participants were then randomly assigned to 2 treatment sequences , either the addition of spironolactone ( 25 mg ) ( triple RAAS blockade ) through 8 weeks followed by double RAAS blockade through 8 weeks ( sequence 1 ) or double RAAS blockade followed by triple RAAS blockade ( sequence 2 ) .
【GOLD_E】
spironolactone	chem
【PRE_E】
spironolactone	chem
【GOLD_R】
【PRE_R】

MAIN OUTCOME MEASURES : 24 - hour urine protein excretion ( primary end point ) and markers of tubular injury and fibrosis ( secondary end points ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Analysis was performed using analysis of variance for repeated measurements .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : At baseline , mean serum creatinine level was 1.16 + / - 0.09 mg / dL ( 103 + / - 8 micromol / L ) , estimated glomerular filtration rate was 107.8 mL / min ( 95 % confidence interval , 93 to 140.9 [ 1.8 mL / s ; 95 % confidence interval , 1.55 to 2.35 ; Cockcroft - Gault formula ) , and 24 - hour mean proteinuria was 0.97 + / - 0.18 g .
【GOLD_E】
【PRE_E】
creatinine	chem
【GOLD_R】
【PRE_R】

Mean urine protein excretion was 0.7 g / 24 h ( 95 % confidence interval , 0.48 to 0.92 ) less after triple RAAS blockade than after double RAAS blockade ( P = 0.01 ) , without change in blood pressure .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Urine excretion of N - acetyl - beta - d - glucosaminidase ( P = 0.02 ) and amino - terminal propeptide of type III procollagen ( P = 0.05 ) also significantly decreased .
【GOLD_E】
N-acetyl-beta-d-glucosaminidase	geneY
typeIIIprocollagen	geneN
【PRE_E】
N-acetyl-beta-d-glucosaminidase	chem
amino	chem
typeIIIprocollagen	geneN
【GOLD_R】
【PRE_R】

Potassium levels increased significantly after triple therapy ( P = 0.02 ) .
【GOLD_E】
Potassium	chem
【PRE_E】
Potassium	chem
【GOLD_R】
【PRE_R】

However , no patient was withdrawn because of adverse effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

LIMITATIONS : Absence of blinding , small sample size , short treatment period , absence of histological assessment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : Administration of an aldosterone receptor antagonist in addition to double RAAS blockade with an ACE inhibitor and ARB may slow the progression of chronic kidney disease .
【GOLD_E】
aldosteronereceptor	geneY
ACE	geneY
aldosterone	chem
【PRE_E】
aldosteronereceptor	geneY
ACE	geneY
【GOLD_R】
【PRE_R】

Additional studies are necessary to confirm this result .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand , imiquimod .
【GOLD_E】
TLR7	geneY
TLR7	geneY
TLR8	geneY
imiquimod	chem
【PRE_E】
PorcineTLR8	geneY
TLR7	geneY
TLR7	geneN
【GOLD_R】
imiquimod	TLR7	C3
imiquimod	TLR8	C3
【PRE_R】

Toll - like receptors ( TLRs ) are a family of highly conserved germline - encoded pattern - recognition receptors ( PRR ) , which are utilized by the innate immune system to recognize microbial components , known as pathogen - associated molecular patterns ( PAMP ) .
【GOLD_E】
TLRs	geneN
pattern-recognitionreceptors	geneN
Toll-likereceptors	geneN
PRR	geneN
【PRE_E】
Toll-likereceptors	geneN
TLRs	geneN
pattern-recognitionreceptors	geneN
PRR	geneN
pathogen-associatedmolecularpatterns	geneN
PAMP	geneN
【GOLD_R】
【PRE_R】

We cloned and characterized porcine TLR7 and TLR8 genes from pig lymph node tissue .
【GOLD_E】
TLR7	geneY
TLR8	geneY
【PRE_E】
porcineTLR7	geneY
TLR8	geneY
【GOLD_R】
【PRE_R】

Sequence analysis showed that the aa sequence identities of porcine TLR7 with human , mouse and bovine TLR7 are 85 , 78 and 90 % , respectively , whereas porcine TLR8 aa sequence identities with human , mouse and bovine TLR8 are 73 , 69 and 79 % , respectively .
【GOLD_E】
porcineTLR7	geneY
human,mouseandbovineTLR7	geneN
porcineTLR8	geneY
human,mouseandbovineTLR8	geneN
【PRE_E】
porcineTLR7	geneY
human,mouseandbovineTLR7	geneY
porcineTLR8	geneY
human,mouseandbovineTLR8	geneN
【GOLD_R】
【PRE_R】

Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N - glycosylated .
【GOLD_E】
porcineTLR7	geneN
TLR8	geneN
N	chem
【PRE_E】
porcineTLR7	geneY
TLR8	geneY
N-glycosylated	geneN
【GOLD_R】
【PRE_R】

The stimulatory activity of TLR7 and TLR8 ligands to porcine and human TLR7 and TLR8 in transiently transfected Cos - 7 and 293T cells were analyzed using a NF - kappaB reporter assay .
【GOLD_E】
TLR7	geneY
TLR8	geneY
porcineandhumanTLR7	geneN
TLR8	geneN
NF-kappaB	geneN
【PRE_E】
TLR7	geneY
TLR8	geneY
porcine	geneY
humanTLR7	geneY
TLR8	geneY
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

Two imidazoquinoline molecules , imiquimod and gardiquimod , markedly activated both porcine TLR7 and TLR8 whereas only human TLR7 , but not TLR8 , was activated by the ligands .
【GOLD_E】
porcineTLR7	geneY
TLR8	geneY
humanTLR7	geneY
TLR8	geneY
imidazoquinoline	chem
imiquimod	chem
gardiquimod	chem
【PRE_E】
imidazoquinoline	chem
imiquimod	chem
gardiquimod	chem
porcineTLR7	geneY
TLR8	geneY
humanTLR7	geneY
TLR8	geneY
【GOLD_R】
imidazoquinoline	porcineTLR7	C3
imidazoquinoline	TLR8	C3
imidazoquinoline	humanTLR7	C3
imiquimod	porcineTLR7	C3
imiquimod	TLR8	C3
imiquimod	humanTLR7	C3
gardiquimod	porcineTLR7	C3
gardiquimod	TLR8	C3
gardiquimod	humanTLR7	C3
【PRE_R】
imidazoquinoline	porcineTLR7	C4
imiquimod	porcineTLR7	C4
gardiquimod	porcineTLR7	C4
gardiquimod	TLR8	C4
gardiquimod	humanTLR7	C4

Therefore , receptor specificity for porcine TLR8 is clearly species specific .
【GOLD_E】
porcineTLR8	geneY
【PRE_E】
porcineTLR8	geneY
【GOLD_R】
【PRE_R】

We further showed that porcine TLR7 and TLR8 are located intracellularly and are mainly within the endoplasmic reticulum .
【GOLD_E】
porcineTLR7	geneY
TLR8	geneY
【PRE_E】
porcineTLR7	geneY
TLR8	geneY
【GOLD_R】
【PRE_R】

Moreover , activation of transfected cells and porcine PBMC by TLR7 ligands was inhibited by bafilomycin A ( 1 ) indicating the requirement of endosomal / lysosomal acidification for activation of the receptors .
【GOLD_E】
TLR7	geneY
bafilomycinA(1)	chem
【PRE_E】
TLR7	geneY
bafilomycinA(1)	chem
【GOLD_R】
bafilomycinA(1)	TLR7	C4
【PRE_R】
TLR7	bafilomycinA(1)	C4

High - affinity blockade of voltage - operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues .
【GOLD_E】
sodium	chem
halogenatedpropofol	chem
voltage-operatedskeletalmuscleandneuronalsodiumchannels	geneN
【PRE_E】
sodiumchannels	geneN
propofol	chem
【GOLD_R】
halogenatedpropofol	voltage-operatedskeletalmuscleandneuronalsodiumchannels	C4
【PRE_R】

BACKGROUND AND PURPOSE : Voltage - operated sodium channels constitute major target sites for local anaesthetic - like action .
【GOLD_E】
Voltage-operatedsodiumchannels	geneN
sodium	chem
【PRE_E】
Voltage-operatedsodiumchannels	geneN
【GOLD_R】
【PRE_R】

The clinical use of local anaesthetics is still limited by severe side effects , in particular , arrhythmias and convulsions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These side effects render the search for new local anaesthetics a matter of high interest .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

EXPERIMENTAL APPROACH : We have investigated the effects of three halogenated structural analogues of propofol on voltage - operated human skeletal muscle sodium channels ( Na ( V ) 1.4 ) and the effect of one compound ( 4 - chloropropofol ) on neuronal sodium channels ( Na ( V ) 1.2 ) heterologously expressed in human embryonic kidney cell line 293 .
【GOLD_E】
propofol	chem
sodium	chem
4-chloropropofol	chem
sodium	chem
voltage-operatedhumanskeletalmusclesodiumchannels	geneN
Na(V)1.4	geneY
neuronalsodiumchannels	geneN
Na(V)1.2	geneY
【PRE_E】
propofol	chem
voltage-operatedhumanskeletalmusclesodiumchannels	geneN
Na(V)1.4	chem
4-chloropropofol	chem
sodiumchannels	geneN
Na(V)1.2	geneY
【GOLD_R】
【PRE_R】

KEY RESULTS : 4 - Iodo - , 4 - bromo - and 4 - chloropropofol reversibly suppressed depolarization - induced whole - cell sodium inward currents with high potency .
【GOLD_E】
4-Iodo	chem
4-bromo	chem
4-chloropropofol	chem
sodium	chem
【PRE_E】
4-Iodo-,4-bromo-and4-chloropropofol	chem
sodium	chem
【GOLD_R】
【PRE_R】

The IC ( 50 ) for block of resting channels at - 150 mV was 2.3 , 3.9 and 11.3 microM in Na ( V ) 1.4 , respectively , and 29.2 microM for 4 - chloropropofol in Na ( V ) 1.2 .
【GOLD_E】
4-chloropropofol	chem
Na(V)1.4	geneY
Na(V)1.2	geneY
【PRE_E】
Na(V)	chem
4-chloropropofol	chem
Na(V)1.2	chem
【GOLD_R】
4-chloropropofol	Na(V)1.2	C4
【PRE_R】

Membrane depolarization inducing inactivation strongly increased the blocking potency of all compounds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Estimated affinities for the fast - inactivated channel state were 81 nM , 312 nM and 227 nM for 4 - iodopropofol , 4 - bromopropofol and 4 - chloropropofol in Na ( V ) 1.4 , and 450 nM for 4 - chloropropofol in Na ( V ) 1.2 .
【GOLD_E】
4-iodopropofol	chem
Na(V)1.4	geneY
Na(V)1.2	geneY
4-bromopropofol	chem
4-chloropropofol	chem
4-chloropropofol	chem
【PRE_E】
4-iodopropofol	chem
4-bromopropofol	chem
4-chloropropofol	chem
Na(V)	chem
4-chloropropofol	chem
Na(V)1.2	chem
【GOLD_R】
4-iodopropofol	Na(V)1.4	C4
4-bromopropofol	Na(V)1.4	C4
4-chloropropofol	Na(V)1.4	C4
4-chloropropofol	Na(V)1.2	C4
【PRE_R】

Recovery from fast inactivation was prolonged in the presence of drug leading to an accumulation of block during repetitive stimulation at high frequencies ( 100 Hz ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS AND IMPLICATIONS : Halogenated propofol analogues constitute a novel class of sodium channel - blocking drugs possessing almost 100 - fold higher potency compared with the local anaesthetic and anti - arrhythmic drug lidocaine .
【GOLD_E】
sodiumchannel	geneN
Halogenatedpropofol	chem
sodium	chem
lidocaine	chem
【PRE_E】
propofol	chem
sodiumchannel	geneN
lidocaine	chem
【GOLD_R】
Halogenatedpropofol	sodiumchannel	C4
【PRE_R】

Preferential drug binding to inactivated channel states suggests that halogenated propofol analogues might be especially effective in suppressing ectopic discharges in a variety of pathological conditions .
【GOLD_E】
halogenatedpropofol	chem
【PRE_E】
propofol	chem
【GOLD_R】
【PRE_R】

Irbesartan : a review of its use in hypertension and diabetic nephropathy .
【GOLD_E】
Irbesartan	chem
【PRE_E】
Irbesartan	chem
【GOLD_R】
【PRE_R】

Irbesartan ( Aprovel , Avapro , Irbetan , Karvea ) , an angiotensin II receptor type 1 antagonist , is approved in many countries worldwide for the treatment of hypertension .
【GOLD_E】
angiotensinIIreceptortype1	geneY
Irbesartan	chem
Aprovel	chem
Avapro	chem
Irbetan	chem
Karvea	chem
angiotensinII	chem
【PRE_E】
Irbesartan	chem
Aprovel	chem
Avapro	chem
Irbetan	chem
Karvea	chem
angiotensinIIreceptortype1	geneY
【GOLD_R】
Irbesartan	angiotensinIIreceptortype1	C6
Aprovel	angiotensinIIreceptortype1	C6
Avapro	angiotensinIIreceptortype1	C6
Irbetan	angiotensinIIreceptortype1	C6
Karvea	angiotensinIIreceptortype1	C6
【PRE_R】
Irbesartan	angiotensinIIreceptortype1	C6
Aprovel	angiotensinIIreceptortype1	C6
Avapro	angiotensinIIreceptortype1	C6
Irbetan	angiotensinIIreceptortype1	C6
Karvea	angiotensinIIreceptortype1	C6

It is also approved in some regions for the treatment of nephropathy in patients with hypertension and type 2 diabetes mellitus .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In adults with essential hypertension , irbesartan is effective at reducing blood pressure ( BP ) over a 24 - hour period with once - daily administration .
【GOLD_E】
irbesartan	chem
【PRE_E】
irbesartan	chem
【GOLD_R】
【PRE_R】

Irbesartan also slows the progression of renal disease in hypertensive patients with type 2 diabetes , with this effect partly independent of its BP - lowering effect .
【GOLD_E】
Irbesartan	chem
【PRE_E】
Irbesartan	chem
【GOLD_R】
【PRE_R】

In addition , irbesartan was generally well tolerated in clinical trials .
【GOLD_E】
irbesartan	chem
【PRE_E】
irbesartan	chem
【GOLD_R】
【PRE_R】

Thus , irbesartan is a useful treatment option for patients with hypertension , including those with type 2 diabetes and nephropathy .
【GOLD_E】
irbesartan	chem
【PRE_E】
irbesartan	chem
【GOLD_R】
【PRE_R】

DNA damage and homologous recombination signaling induced by thymidylate deprivation .
【GOLD_E】
thymidylate	chem
【PRE_E】
thymidylate	chem
【GOLD_R】
【PRE_R】

DNA damage is accepted as a consequence of thymidylate deprivation induced by chemotherapeutic inhibitors of thymidylate synthase ( TS ) , but the types of damage and signaling responses remain incompletely understood .
【GOLD_E】
thymidylate	chem
thymidylatesynthase	geneY
TS	geneY
thymidylate	chem
【PRE_E】
thymidylate	chem
thymidylatesynthase	geneY
TS	geneY
【GOLD_R】
thymidylate	thymidylatesynthase	C9
thymidylate	TS	C9
【PRE_R】
thymidylate	TS	C4

Thymidylate deprivation increases dUTP and uracil in DNA , which is removed by base excision repair ( BER ) .
【GOLD_E】
Thymidylate	chem
uracil	chem
【PRE_E】
Thymidylate	chem
dUTP	chem
uracil	chem
【GOLD_R】
【PRE_R】

Because BER requires a synthesis step , strand break intermediates presumably accumulate .
【GOLD_E】
【PRE_E】
BER	geneN
【GOLD_R】
【PRE_R】

Thymidylate deprivation also induces cell cycle arrest during replication .
【GOLD_E】
Thymidylate	chem
【PRE_E】
Thymidylate	chem
【GOLD_R】
【PRE_R】

Homologous recombination ( HR ) is a means of repairing persistent BER intermediates and collapsed replication forks .
【GOLD_E】
【PRE_E】
BER	geneY
【GOLD_R】
【PRE_R】

There are also intimate links between HR and S - phase checkpoint pathways .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , the goals were to determine the involvement of HR - associated proteins and DNA damage signaling responses to thymidylate deprivation .
【GOLD_E】
thymidylate	chem
【PRE_E】
thymidylate	chem
【GOLD_R】
【PRE_R】

When RAD51 , which is a central component of HR , was depleted by siRNA cells were sensitized to raltitrexed ( RTX ) , which specifically inhibits TS .
【GOLD_E】
raltitrexed	chem
RTX	chem
RAD51	geneY
TS	geneY
【PRE_E】
RAD51	geneY
raltitrexed	chem
RTX	chem
TS	geneY
【GOLD_R】
RTX	TS	C4
【PRE_R】
raltitrexed	TS	C4
RTX	TS	C4

To our knowledge , this is the first demonstration in mammalian cells that depletion of RAD51 causes sensitivity to thymidylate deprivation .
【GOLD_E】
RAD51	geneY
thymidylate	chem
【PRE_E】
RAD51	geneY
thymidylate	chem
【GOLD_R】
【PRE_R】
RAD51	thymidylate	C9

Activation of DNA damage signaling responses was examined following treatment with RTX .
【GOLD_E】
RTX	chem
【PRE_E】
RTX	chem
【GOLD_R】
【PRE_R】

Phosphorylation of replication protein A ( RPA2 subunit ) and formation of damage - induced foci were strikingly evident following IC ( 50 ) doses of RTX .
【GOLD_E】
replicationproteinA	geneN
RPA2	geneY
RTX	chem
【PRE_E】
replicationproteinA	geneY
RPA2	geneY
RTX	chem
【GOLD_R】
【PRE_R】
RPA2	RTX	C4

Induction was much more striking following RTX treatment than with hydroxyurea , which is commonly used to inhibit replication .
【GOLD_E】
RTX	chem
hydroxyurea	chem
【PRE_E】
RTX	geneY
hydroxyurea	chem
【GOLD_R】
【PRE_R】
RTX	hydroxyurea	C4

RTX treatment also induced foci of RAD51 , gamma - H2AX , phospho - Chk1 , and phospho - NBS1 , although the extent of co - localization with RPA2 foci varied .
【GOLD_E】
RAD51	geneY
gamma-H2AX	geneY
phospho-Chk1	geneY
phospho-NBS1	geneY
RPA2	geneY
RTX	chem
【PRE_E】
RTX	chem
RAD51	geneY
gamma-H2AX	geneY
phospho-Chk1	geneY
phospho-NBS1	geneY
RPA2	geneN
【GOLD_R】
RTX	RAD51	C3
RTX	gamma-H2AX	C3
RTX	phospho-Chk1	C3
RTX	phospho-NBS1	C3
【PRE_R】
RTX	RAD51	C3
RTX	gamma-H2AX	C3
RTX	phospho-Chk1	C3
RTX	phospho-NBS1	C3

Collectively , the results suggest that HR and S - phase checkpoint signaling processes are invoked by thymidylate deprivation and influence cellular resistance to thymidylate deprivation .
【GOLD_E】
thymidylate	chem
thymidylate	chem
【PRE_E】
thymidylate	chem
thymidylate	chem
【GOLD_R】
【PRE_R】

Corticosteroids and human recombinant activated protein C for septic shock .
【GOLD_E】
Corticosteroids	chem
humanrecombinantactivatedproteinC	geneY
【PRE_E】
humanrecombinantactivatedproteinC	geneY
【GOLD_R】
【PRE_R】

This article summarizes the current knowledge on the benefit / risk profile from the use of low - dose corticosteroids and activated protein C in treating septic shock .
【GOLD_E】
corticosteroids	chem
activatedproteinC	geneY
【PRE_E】
proteinC	geneY
【GOLD_R】
【PRE_R】

Physicians should consider using low - dose corticosteroids and drotrecogin alpha activated in the treatment of patients who have vasopressor - dependent septic shock with persistent signs of hypoperfusion , organ dysfunction , or hypotension .
【GOLD_E】
corticosteroids	chem
drotrecoginalpha	geneY
【PRE_E】
drotrecoginalpha	geneY
【GOLD_R】
【PRE_R】

The optimal timing for initiating these treatments is from 6 to 24 hours from onset of shock .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

When patients are receiving these drugs , physicians should systematically screen for superinfection and serious bleeding events .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Adipose tissue as a source of nicotinamide N - methyltransferase and homocysteine .
【GOLD_E】
nicotinamide	chem
N	chem
homocysteine	chem
nicotinamideN-methyltransferase	geneY
【PRE_E】
nicotinamideN-methyltransferase	geneY
homocysteine	chem
【GOLD_R】
【PRE_R】

Nicotinamide N - methyltransferase ( NNMT ) catalyses the conversion of nicotinamide to 1 - methylnicotinamide and plays an important role in hepatic detoxification reactions .
【GOLD_E】
1-methylnicotinamide	chem
NicotinamideN-methyltransferase	geneY
Nicotinamide	chem
NNMT	geneY
N	chem
nicotinamide	chem
【PRE_E】
NicotinamideN-methyltransferase	geneY
NNMT	geneY
nicotinamide	chem
1-methylnicotinamide	chem
【GOLD_R】
1-methylnicotinamide	NicotinamideN-methyltransferase	C9
1-methylnicotinamide	NNMT	C9
nicotinamide	NicotinamideN-methyltransferase	C9
nicotinamide	NNMT	C9
【PRE_R】
NNMT	nicotinamide	C9
NNMT	1-methylnicotinamide	C9

Here we show that , in addition to the liver , 3T3 - L1 adipocytes as well as human and murine adipose tissue explants express high amounts of enzymatically active NNMT .
【GOLD_E】
NNMT	geneY
【PRE_E】
NNMT	geneY
【GOLD_R】
【PRE_R】

NNMT mRNA levels and enzyme activity increased in 3T3 - L1 cells in a differentiation - dependent manner .
【GOLD_E】
NNMT	geneY
【PRE_E】
NNMT	geneY
【GOLD_R】
【PRE_R】

Homocysteine , the atherogenic product of the NNMT - catalyzed reaction , was secreted from 3T3 - L1 cells or adipose tissue cultures .
【GOLD_E】
NNMT	geneY
Homocysteine	chem
【PRE_E】
Homocysteine	chem
NNMT	geneY
【GOLD_R】
Homocysteine	NNMT	C9
【PRE_R】

Homocysteine release increased during 3T3 - L1 differentiation and was reduced when adipose tissue was treated with the NNMT inhibitor 1 - methylnicotinamide .
【GOLD_E】
NNMT	geneY
Homocysteine	chem
1-methylnicotinamide	chem
【PRE_E】
Homocysteine	chem
NNMT	geneY
1-methylnicotinamide	chem
【GOLD_R】
1-methylnicotinamide	NNMT	C4
【PRE_R】
NNMT	1-methylnicotinamide	C4

Nicotinic acid ( NA ) , a widely used drug to lower elevated plasma lipid levels , induced NNMT enzyme activity in white adipose tissue of mice .
【GOLD_E】
NA	chem
NNMT	geneY
Nicotinicacid	chem
【PRE_E】
Nicotinicacid	chem
NA	chem
NNMT	geneY
【GOLD_R】
NA	NNMT	C3
Nicotinicacid	NNMT	C3
【PRE_R】
NA	NNMT	C3

In tissue culture nicotinamide treatment led to an increase in adipose tissue homocysteine secretion .
【GOLD_E】
nicotinamide	chem
homocysteine	chem
【PRE_E】
nicotinamide	chem
homocysteine	chem
【GOLD_R】
【PRE_R】

These data support the concept that adipose tissue NNMT contributes to the increased plasma homocysteine levels in patients treated with NA .
【GOLD_E】
NNMT	geneY
homocysteine	chem
NA	chem
【PRE_E】
NNMT	geneY
homocysteine	chem
NA	chem
【GOLD_R】
homocysteine	NNMT	C9
【PRE_R】
NNMT	homocysteine	C9

Expression and 1,4 - dihydropyridine - binding properties of brain L - type calcium channel isoforms .
【GOLD_E】
calcium	chem
L-typecalciumchannel	geneN
1,4-dihydropyridine	chem
【PRE_E】
1,4-dihydropyridine	chem
brainL-typecalciumchannel	geneN
【GOLD_R】
【PRE_R】

The L - type calcium channel ( LTCC ) isoforms Ca ( v ) 1.2 and Ca ( v ) 1.3 display similar 1,4 - dihydropyridine ( DHP ) binding properties and are both expressed in mammalian brain .
【GOLD_E】
DHP	chem
LTCC	geneN
L-typecalciumchannel	geneN
Ca(v)1.2	geneY
Ca(v)1.3	geneY
calcium	chem
1,4-dihydropyridine	chem
【PRE_E】
L-typecalciumchannel	geneN
LTCC	geneY
Ca(v)1.2	geneY
Ca(v)1.3	geneY
1,4-dihydropyridine	chem
DHP	chem
【GOLD_R】
【PRE_R】
LTCC	1,4-dihydropyridine	C9

Recent work implicates Ca ( v ) 1.3 channels as interesting drug targets , but no isoform - selective modulators exist .
【GOLD_E】
Ca(v)1.3	geneY
【PRE_E】
Ca(v)1.3	geneY
【GOLD_R】
【PRE_R】

It is also unknown to what extent Ca ( v ) 1.1 and Ca ( v ) 1.4 contribute to L - type - specific DHP binding activity in brain .
【GOLD_E】
Ca(v)1.1	geneY
Ca(v)1.4	geneY
DHP	chem
【PRE_E】
Ca(v)1.1	chem
Ca(v)	geneY
DHP	chem
【GOLD_R】
【PRE_R】

To address this question and to determine whether DHPs can discriminate between Ca ( v ) 1.2 and Ca ( v ) 1.3 binding pockets , we combined radioreceptor assays and quantitative polymerase chain reaction ( qPCR ) .
【GOLD_E】
Ca(v)1.2	geneY
Ca(v)1.3	geneY
【PRE_E】
DHPs	geneY
Ca(v)1.2	geneY
Ca(v)1.3	geneY
【GOLD_R】
【PRE_R】

We bred double mutants ( Ca ( v ) - DM ) from mice expressing mutant Ca ( v ) 1.2 channels [ Ca ( v ) 1.2DHP ( - / - ) ] lacking high affinity for DHPs and from Ca ( v ) 1.3 knockouts [ Ca ( v ) 1.3 ( - / - ) ] .
【GOLD_E】
Ca(v)	geneN
Ca(v)1.2	geneY
Ca(v)1.2	geneY
Ca(v)1.3	geneY
Ca(v)1.3	geneY
【PRE_E】
Ca(v)	geneY
Ca(v)1.2	geneY
Ca(v)1.2DHP	geneY
DHPs	geneY
Ca(v)1.3	geneY
Ca(v)1.3	geneY
【GOLD_R】
【PRE_R】

( + ) - [ ( 3 ) H ] isradipine binding to Ca ( v ) 1.2DHP ( - / - ) and Ca ( v ) - DM brains was reduced to 15.1 and 4.4 % of wild type , respectively , indicating that Ca ( v ) 1.3 accounts for 10.7 % of brain LTCCs . qPCR revealed that Ca ( v ) 1.1 and Ca ( v ) 1.4 alpha ( 1 ) subunits comprised 0.08 % of the LTCC transcripts in mouse whole brain , suggesting that they can not account for the residual binding .
【GOLD_E】
LTCC	geneN
Ca(v)1.2	geneY
Ca(v)	geneN
Ca(v)1.3	geneY
LTCCs	geneN
Ca(v)1.1	geneY
Ca(v)1.4alpha(1)	geneY
(+)-[(3)H]isradipine	chem
【PRE_E】
(+)-[(3)H]isradipine	chem
Ca(v)1.2DHP	geneY
Ca(v)	geneY
Ca(v)1.3	geneY
LTCCs	geneN
Ca(v)1.1	geneY
Ca(v)1.4alpha(1)	geneY
LTCC	geneN
【GOLD_R】
【PRE_R】
(+)-[(3)H]isradipine	LTCCs	C3

Instead , this could be explained by low - affinity binding ( 127 - fold K ( d ) increase ) to the mutated Ca ( v ) 1.2 channels .
【GOLD_E】
Ca(v)1.2	geneY
【PRE_E】
Ca(v)1.2	geneY
【GOLD_R】
【PRE_R】

Inhibition of ( + ) - [ ( 3 ) H ] isradipine binding to Ca ( v ) 1.2DHP ( - / - ) ( predominantly Ca ( v ) 1.3 ) and wild - type ( predominantly Ca ( v ) 1.2 ) brain membranes by unlabeled DHPs revealed a 3 - to 4 - fold selectivity of nitrendipine and nifedipine for the Ca ( v ) 1.2 binding pocket , a finding further confirmed with heterologously expressed channels .
【GOLD_E】
Ca(v)1.2	geneY
Ca(v)1.3	geneY
Ca(v)1.2	geneY
Ca(v)1.2	geneY
(+)-[(3)H]isradipine	chem
nitrendipine	chem
nifedipine	chem
【PRE_E】
(+)-[(3)H]isradipine	chem
Ca(v)1.2DHP	geneY
Ca(v)1.3	geneY
Ca(v)1.2	geneY
DHPs	geneY
nitrendipine	chem
nifedipine	chem
Ca(v)1.2	geneY
【GOLD_R】
【PRE_R】
DHPs	nitrendipine	C9
nitrendipine	Ca(v)1.2	C9

This suggests that small differences in their binding pockets may allow development of isoform - selective modulators for LTCCs and that , because of their very low expression , Ca ( v ) 1.1 and Ca ( v ) 1.4 are unlikely to serve as drug targets to treat CNS diseases .
【GOLD_E】
LTCCs	geneN
Ca(v)1.1	geneY
Ca(v)1.4	geneY
【PRE_E】
LTCCs	geneN
Ca(v)1.1	geneY
Ca(v)	geneY
【GOLD_R】
【PRE_R】

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells .
【GOLD_E】
bosutinib	chem
kinase	geneN
【PRE_E】
kinase	geneN
bosutinib	chem
【GOLD_R】
bosutinib	kinase	C4
【PRE_R】
kinase	bosutinib	C4

The detailed molecular mechanism of action of second - generation BCR - ABL tyrosine kinase inhibitors , including perturbed targets and pathways , should contribute to rationalized therapy in chronic myeloid leukemia ( CML ) or in other affected diseases .
【GOLD_E】
BCR	geneY
ABL	geneY
tyrosinekinase	geneN
【PRE_E】
BCR	geneY
ABL	geneY
tyrosinekinase	geneN
【GOLD_R】
【PRE_R】

Here , we characterized the target profile of the dual SRC / ABL inhibitor bosutinib employing a two - tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel .
【GOLD_E】
SRC	geneY
ABL	geneY
kinase	geneN
kinase	geneN
bosutinib	chem
【PRE_E】
SRC	geneY
ABL	geneY
bosutinib	chem
kinase	geneN
kinase	geneN
【GOLD_R】
bosutinib	SRC	C4
bosutinib	ABL	C4
【PRE_R】
SRC	bosutinib	C4
ABL	bosutinib	C4

The combined strategy resulted in a global survey of bosutinib targets comprised of over 45 novel tyrosine and serine / threonine kinases .
【GOLD_E】
tyrosineandserine/threoninekinases	geneN
bosutinib	chem
tyrosine	chem
serine	chem
threonine	chem
【PRE_E】
bosutinib	chem
tyrosine	chem
serine/threoninekinases	geneN
【GOLD_R】
【PRE_R】

We have found clear differences in the target patterns of bosutinib in primary CML cells versus the K562 cell line .
【GOLD_E】
bosutinib	chem
【PRE_E】
bosutinib	chem
【GOLD_R】
【PRE_R】

A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping , but distinct , inhibition profiles .
【GOLD_E】
dasatinib	chem
kinase	geneN
bosutinib	chem
【PRE_E】
bosutinib	chem
dasatinib	chem
kinase	geneN
【GOLD_R】
dasatinib	kinase	C4
bosutinib	kinase	C4
【PRE_R】

Common among those were the SRC , ABL and TEC family kinases .
【GOLD_E】
SRC	geneY
ABL	geneY
TEC	geneY
kinases	geneN
【PRE_E】
SRC	geneY
ABL	geneY
TEC	geneY
kinases	geneN
【GOLD_R】
【PRE_R】

Bosutinib did not inhibit KIT or platelet - derived growth factor receptor , but prominently targeted the apoptosis - linked STE20 kinases .
【GOLD_E】
Bosutinib	chem
KIT	geneY
platelet-derivedgrowthfactorreceptor	geneN
STE20kinases	geneN
【PRE_E】
Bosutinib	chem
KIT	geneY
platelet-derivedgrowthfactorreceptor	geneY
STE20kinases	geneN
【GOLD_R】
【PRE_R】

Although in vivo bosutinib is inactive against ABL T315I , we found this clinically important mutant to be enzymatically inhibited in the mid - nanomolar range .
【GOLD_E】
ABL	geneY
T315I	geneN
bosutinib	chem
【PRE_E】
bosutinib	chem
ABL	geneY
T315I	geneN
【GOLD_R】
【PRE_R】
bosutinib	ABL	C4
bosutinib	T315I	C4

Finally , bosutinib is the first kinase inhibitor shown to target CAMK2G , recently implicated in myeloid leukemia cell proliferation .
【GOLD_E】
kinase	geneN
CAMK2G	geneY
bosutinib	chem
【PRE_E】
bosutinib	chem
kinase	geneN
CAMK2G	geneY
【GOLD_R】
bosutinib	kinase	C4
bosutinib	CAMK2G	C4
【PRE_R】
bosutinib	kinase	C4
bosutinib	CAMK2G	C4

The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent .
【GOLD_E】
estramustine	chem
【PRE_E】
estramustine	chem
microtubule	geneN
【GOLD_R】
【PRE_R】

Estramustine , and derivatives of estramustine with a charged substituent at position 17 on the estrogen moiety , have been investigated for their effects on bovine brain microtubules in vitro .
【GOLD_E】
estramustine	chem
estrogen	chem
Estramustine	chem
【PRE_E】
Estramustine	chem
estramustine	chem
estrogen	chem
bovinebrainmicrotubules	geneN
【GOLD_R】
【PRE_R】

The negatively charged estramustine phosphate has been found previously to be a microtubule - associated protein ( MAP ) - dependent microtubule inhibitor [ Wallin M , Deinum J and Friden B , FEBS Lett 179 : 289 - 293 , 1985 ] .
【GOLD_E】
estramustinephosphate	chem
microtubule-associatedprotein	geneN
MAP	geneN
【PRE_E】
estramustinephosphate	chem
microtubule-associatedprotein	geneN
microtubule	geneN
【GOLD_R】
【PRE_R】

In the present study the binding of estramustine phosphate to MAP2 and tau was investigated .
【GOLD_E】
estramustinephosphate	chem
MAP2	geneY
tau	geneY
【PRE_E】
estramustinephosphate	chem
MAP2	geneN
【GOLD_R】
【PRE_R】

Both these MAPs were found to have two to three binding sites for estramustine phosphate which is compatible with the reported number of basic amino acid repeats of these MAPs , considered to be the ultimate tubulin binding domains .
【GOLD_E】
estramustinephosphate	chem
aminoacid	chem
MAPs	geneN
MAPs	geneN
tubulin	geneN
【PRE_E】
estramustinephosphate	chem
aminoacid	chem
tubulinbindingdomains	geneN
【GOLD_R】
【PRE_R】

The Kd for the binding of estramustine phosphate to MAP2 was estimated to be 20 microM at 4 degrees , and for the binding of tau , 200 microM .
【GOLD_E】
estramustinephosphate	chem
MAP2	geneN
【PRE_E】
estramustinephosphate	chem
MAP2	geneY
【GOLD_R】
【PRE_R】

The rate of dissociation was very low ( T1 / 2 greater than 2 hr ) , which indicates that the binding of estramustine phosphate may stabilize the protein - drug complex by changing the protein conformation .
【GOLD_E】
estramustinephosphate	chem
【PRE_E】
estramustinephosphate	chem
【GOLD_R】
【PRE_R】

Two new negatively charged estramustine derivatives , estramustine sulphate and estramustine glucuronide , were found to be similar MAP - dependent microtubule inhibitors .
【GOLD_E】
MAP	geneN
estramustine	chem
estramustinesulphate	chem
estramustineglucuronide	chem
【PRE_E】
estramustine	chem
estramustinesulphate	chem
estramustineglucuronide	chem
microtubule	geneN
【GOLD_R】
【PRE_R】
estramustine	microtubule	C4
estramustinesulphate	microtubule	C4
estramustineglucuronide	microtubule	C4

The concentration for 50 % inhibition of assembly was 100 microM for the sulphate derivative , the same as found previously for estramustine phosphate , and 250 microM for the more bulky estramustine glucuronide .
【GOLD_E】
sulphate	chem
estramustinephosphate	chem
estramustineglucuronide	chem
【PRE_E】
sulphate	chem
estramustinephosphate	chem
estramustineglucuronide	chem
【GOLD_R】
【PRE_R】

A positively charged derivative , estramustine sarcosinate , did not inhibit microtubule assembly or alter the composition of the coassembled MAPs .
【GOLD_E】
MAPs	geneN
estramustinesarcosinate	chem
【PRE_E】
estramustinesarcosinate	chem
microtubule	geneN
【GOLD_R】
【PRE_R】

The morphology of the microtubules was , however , affected .
【GOLD_E】
【PRE_E】
microtubules	geneN
【GOLD_R】
【PRE_R】

The uncharged estramustine bound to both tubulin and MAPs , but no effects were seen on microtubule assembly , the composition of coassembled MAPs or the microtubule morphology .
【GOLD_E】
tubulin	geneN
MAPs	geneN
MAPs	geneN
estramustine	chem
【PRE_E】
estramustine	chem
tubulin	geneN
microtubule	geneN
【GOLD_R】
【PRE_R】

Our results suggest that only negatively charged estramustine derivatives have a MAP - dependent microtubule inhibitory effect .
【GOLD_E】
estramustine	chem
MAP	geneN
【PRE_E】
estramustine	chem
MAP	geneN
microtubule	geneN
【GOLD_R】
【PRE_R】
estramustine	MAP	C4
estramustine	microtubule	C4

The two new negatively charged derivatives could therefore be valuable tools in the study of tubulin - MAP interactions .
【GOLD_E】
tubulin	geneN
MAP	geneN
【PRE_E】
tubulin	geneN
【GOLD_R】
【PRE_R】

The results also confirm that these interactions between tubulin and MAPs are mainly electrostatic .
【GOLD_E】
tubulin	geneN
MAPs	geneN
【PRE_E】
tubulin	geneN
【GOLD_R】
【PRE_R】

Analysis of coenzyme binding by human placental 3 beta - hydroxy - 5 - ene - steroid dehydrogenase and steroid 5 - - - - 4 - ene - isomerase using 5 ' - [ p - ( fluorosulfonyl ) benzoyl ] adenosine , an affinity labeling cofactor analog .
【GOLD_E】
5'-[p-(fluorosulfonyl)benzoyl]adenosine	chem
3beta-hydroxy-5-ene-steroid	chem
humanplacental3beta-hydroxy-5-ene-steroiddehydrogenase	geneN
steroid5----4-ene-isomerase	geneN
【PRE_E】
humanplacental3beta-hydroxy-5-ene-steroiddehydrogenase	geneY
steroid5----4-ene-isomerase	chem
5'-[p-(fluorosulfonyl)benzoyl]adenosine	chem
【GOLD_R】
【PRE_R】

3 beta - Hydroxy - 5 - ene - steroid dehydrogenase and steroid 5 - - - - 4 - ene - isomerase copurify as a single , homogeneous protein from human placental microsomes .
【GOLD_E】
3beta-Hydroxy-5-ene-steroid	chem
3beta-Hydroxy-5-ene-steroiddehydrogenase	geneN
steroid5----4-ene-isomerase	geneN
【PRE_E】
3beta-Hydroxy-5-ene-steroiddehydrogenase	geneY
steroid5----4-ene-isomerasecopurify	geneY
【GOLD_R】
【PRE_R】

Affinity alkylation with 2 alpha - bromoacetoxyprogesterone suggests that the dehydrogenase and isomerase substrate steroids bind at different sites on the same protein .
【GOLD_E】
dehydrogenase	geneN
alpha-bromoacetoxyprogesterone	chem
steroids	chem
【PRE_E】
2alpha-bromoacetoxyprogesterone	chem
dehydrogenase	geneN
isomerase	geneN
steroids	chem
【GOLD_R】
steroids	dehydrogenase	C9
【PRE_R】
dehydrogenase	steroids	C9
isomerase	steroids	C9

However , the coenzyme , NADH , completely abolishes the alkylation of both enzyme activities by the progestin analog [ Thomas J .L . , Myers R .
【GOLD_E】
progestin	chem
NADH	chem
【PRE_E】
coenzyme	chem
NADH	chem
progestin	chem
【GOLD_R】
【PRE_R】

P. , Rosik L .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

O. and Strickler R .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

C. , J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Steroid Biochem .
【GOLD_E】
【PRE_E】
SteroidBiochem	chem
【GOLD_R】
【PRE_R】

36 ( 1990 ) 117 - 123 ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Unlike bacterial 3 - keto - 5 - ene - steroid isomerase , the human isomerase reaction is stimulated by diphosphopyridine nucleotides ( NADH , NAD + ) .
【GOLD_E】
3-keto-5-ene-steroid	chem
diphosphopyridinenucleotides	chem
NADH	chem
NAD+	chem
3-keto-5-ene-steroidisomerase	geneN
【PRE_E】
bacterial3-keto-5-ene-steroidisomerase	geneY
humanisomerase	geneN
diphosphopyridinenucleotides	chem
NADH	chem
NAD+)	chem
【GOLD_R】
【PRE_R】
humanisomerase	diphosphopyridinenucleotides	C9
humanisomerase	NADH	C9

The affinity labeling nucleotide analog , 5 ' - [ p - ( fluorosulfonyl ) benzoyl ] adenosine ( FSA ) , inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration ( 0.2 - 0.6 mM ) .
【GOLD_E】
nucleotide	chem
5'-[p-(fluorosulfonyl)benzoyl]adenosine	chem
FSA	chem
dehydrogenase	geneN
【PRE_E】
nucleotide	chem
5'-[p-(fluorosulfonyl)benzoyl]adenosine	chem
FSA	chem
dehydrogenase	geneN
isomerase	geneN
alkylator	chem
【GOLD_R】
nucleotide	dehydrogenase	C4
5'-[p-(fluorosulfonyl)benzoyl]adenosine	dehydrogenase	C4
FSA	dehydrogenase	C4
【PRE_R】
5'-[p-(fluorosulfonyl)benzoyl]adenosine	dehydrogenase	C4
FSA	dehydrogenase	C4
FSA	isomerase	C4

FSA is a cofactor site - directed reagent that binds with similar affinity as a competitive inhibitor of NAD + reduction by dehydrogenase ( Ki = 162 microM ) or as a stimulator of isomerase ( Km = 153 microM ) .
【GOLD_E】
dehydrogenase	geneN
NAD+	chem
【PRE_E】
NAD+	chem
dehydrogenase	geneN
isomerase	geneN
【GOLD_R】
【PRE_R】
NAD+	dehydrogenase	C4
NAD+	isomerase	C4

Parallel plots derived from Kitz and Wilson analysis indicate that FSA inactivates the two enzyme activities with equal alkylation efficiency ( k3 / Ki = 1 / slope = 0.51 / mol - s for both ) .
【GOLD_E】
FSA	chem
【PRE_E】
FSA	geneY
【GOLD_R】
【PRE_R】

The 3 beta - hydroxysteroid substrate , pregnenolone , protects isomerase as well as dehydrogenase from inactivation by FSA .
【GOLD_E】
dehydrogenase	geneN
3beta-hydroxysteroid	chem
pregnenolone	chem
FSA	chem
【PRE_E】
3beta-hydroxysteroid	chem
pregnenolone	chem
protectsisomerase	geneN
dehydrogenase	geneN
【GOLD_R】
FSA	dehydrogenase	C4
【PRE_R】
3beta-hydroxysteroid	dehydrogenase	C9
pregnenolone	dehydrogenase	C9

These observations are evidence for a single cofactor binding region which services both enzyme activities .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Tyrosine kinase blockers : new hope for successful cancer therapy .
【GOLD_E】
Tyrosine	chem
Tyrosinekinase	geneN
【PRE_E】
Tyrosinekinase	geneN
【GOLD_R】
【PRE_R】

Tyrosine kinases ( TKs ) are attractive targets for cancer therapy , as quite often their abnormal signaling has been linked with tumor development and growth .
【GOLD_E】
Tyrosine	chem
Tyrosinekinases	geneN
TKs	geneN
【PRE_E】
Tyrosinekinases	geneN
TKs	geneN
【GOLD_R】
【PRE_R】

Constitutive activated TKs stimulate multiple signaling pathways responsible for DNA repair , apoptosis , and cell proliferation .
【GOLD_E】
TKs	geneN
【PRE_E】
Constitutive	geneN
TKs	geneN
【GOLD_R】
【PRE_R】

During the last few years , thorough analysis of the mechanism underlying tyrosine kinase 's activity led to novel cancer therapy using TKs blockers .
【GOLD_E】
tyrosine	chem
tyrosinekinase	geneN
TKs	geneN
【PRE_E】
tyrosinekinase	geneN
TKs	geneN
【GOLD_R】
【PRE_R】

These drugs are remarkably effective in the treatment of various human tumors including head and neck , gastric , prostate and breast cancer and leukemias .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most successful example of kinase blockers is Imatinib ( Imatinib mesylate , Gleevec , STI571 ) , the inhibitor of Bcr / Abl oncoprotein , which has become a first - line therapy for chronic myelogenous leukemia .
【GOLD_E】
Imatinib	chem
Imatinibmesylate	chem
Gleevec	chem
STI571	chem
kinase	geneN
Bcr	geneY
Abl	geneY
【PRE_E】
kinase	geneN
Imatinib	chem
Imatinibmesylate	chem
Gleevec	chem
STI571	chem
Bcr	geneY
Abl	geneY
【GOLD_R】
Imatinib	kinase	C4
Imatinib	Bcr	C4
Imatinib	Abl	C4
Imatinibmesylate	kinase	C4
Imatinibmesylate	Bcr	C4
Imatinibmesylate	Abl	C4
Gleevec	kinase	C4
Gleevec	Bcr	C4
Gleevec	Abl	C4
STI571	kinase	C4
STI571	Bcr	C4
STI571	Abl	C4
【PRE_R】
kinase	Imatinib	C4
kinase	Imatinibmesylate	C4
Gleevec	Bcr	C4
STI571	Bcr	C4
STI571	Abl	C4

The introduction of STI571 for the treatment of leukemia in clinical oncology has had a dramatic impact on how this disease is currently managed .
【GOLD_E】
STI571	chem
【PRE_E】
STI571	chem
【GOLD_R】
【PRE_R】

Others kinase inhibitors used recently in cancer therapy include Dasatinib ( BMS - 354825 ) specific for ABL non - receptor cytoplasmic kinase , Gefitinib ( Iressa ) , Erlotinib ( OSI - 774 , Tarceva ) and Sunitinib ( SU 11248 , Sutent ) specific for VEGF receptor kinase , AMN107 ( Nilotinib ) and INNO - 406 ( NS - 187 ) specific for c - KIT kinase .
【GOLD_E】
SU11248	chem
Sutent	chem
AMN107	chem
Nilotinib	chem
INNO-406	chem
NS-187	chem
Dasatinib	chem
BMS-354825	chem
ABL	geneY
non-receptorcytoplasmickinase	geneN
VEGFreceptor	geneN
kinase	geneN
c-KIT	geneY
Gefitinib	chem
Iressa	chem
Erlotinib	chem
OSI-774	chem
Tarceva	chem
Sunitinib	chem
【PRE_E】
Otherskinase	geneN
Dasatinib	chem
BMS-354825	chem
ABL	geneY
-receptorcytoplasmickinase	geneN
Gefitinib	chem
Iressa	chem
Erlotinib	chem
OSI-774	chem
Tarceva	chem
Sunitinib	chem
SU11248	chem
Sutent	chem
VEGFreceptorkinase	geneN
AMN107	geneY
Nilotinib	chem
INNO-406	chem
NS-187	chem
c-KITkinase	geneY
【GOLD_R】
SU11248	VEGFreceptor	C4
SU11248	kinase	C4
Sutent	VEGFreceptor	C4
Sutent	kinase	C4
AMN107	c-KIT	C4
Nilotinib	c-KIT	C4
INNO-406	c-KIT	C4
NS-187	c-KIT	C4
Dasatinib	ABL	C4
Dasatinib	non-receptorcytoplasmickinase	C4
BMS-354825	ABL	C4
Gefitinib	VEGFreceptor	C4
Gefitinib	kinase	C4
Iressa	VEGFreceptor	C4
Iressa	kinase	C4
Erlotinib	VEGFreceptor	C4
Erlotinib	kinase	C4
OSI-774	VEGFreceptor	C4
OSI-774	kinase	C4
Tarceva	VEGFreceptor	C4
Tarceva	kinase	C4
Sunitinib	VEGFreceptor	C4
Sunitinib	kinase	C4
【PRE_R】
Otherskinase	Dasatinib	C4
BMS-354825	ABL	C4
-receptorcytoplasmickinase	Gefitinib	C4
-receptorcytoplasmickinase	Iressa	C4
-receptorcytoplasmickinase	Erlotinib	C4
-receptorcytoplasmickinase	OSI-774	C4
Tarceva	VEGFreceptorkinase	C4
Sunitinib	VEGFreceptorkinase	C4
SU11248	VEGFreceptorkinase	C4
Sutent	VEGFreceptorkinase	C4
AMN107	Nilotinib	C4
AMN107	INNO-406	C4
NS-187	c-KITkinase	C4

The following TK blockers for treatment of various human tumors are in clinical development : Lapatinib ( Lapatinib ditosylate , Tykerb , GW - 572016 ) , Canertinib ( CI - 1033 ) , Zactima ( ZD6474 ) , Vatalanib ( PTK787 / ZK 222584 ) , Sorafenib ( Bay 43 - 9006 , Nexavar ) , and Leflunomide ( SU101 , Arava ) .
【GOLD_E】
Lapatinib	chem
Lapatinibditosylate	chem
Tykerb	chem
GW-572016	chem
Canertinib	chem
CI-1033	chem
Zactima	chem
ZD6474	chem
Vatalanib	chem
PTK787	chem
ZK222584	chem
Sorafenib	chem
Bay43-9006	chem
Nexavar	chem
Leflunomide	chem
SU101	chem
Arava	chem
TK	geneN
【PRE_E】
TK	geneN
Lapatinib	chem
Lapatinibditosylate	chem
Tykerb	chem
GW-572016	chem
Canertinib	chem
CI-1033	chem
Zactima	chem
ZD6474	chem
Vatalanib	chem
PTK787	chem
ZK222584	chem
Sorafenib	chem
Bay43-9006	chem
Nexavar	chem
Leflunomide	chem
SU101	chem
Arava	chem
【GOLD_R】
Lapatinib	TK	C4
Lapatinibditosylate	TK	C4
Tykerb	TK	C4
GW-572016	TK	C4
Canertinib	TK	C4
CI-1033	TK	C4
Zactima	TK	C4
ZD6474	TK	C4
Vatalanib	TK	C4
PTK787	TK	C4
ZK222584	TK	C4
Sorafenib	TK	C4
Bay43-9006	TK	C4
Nexavar	TK	C4
Leflunomide	TK	C4
SU101	TK	C4
Arava	TK	C4
【PRE_R】
TK	Lapatinib	C4
TK	Lapatinibditosylate	C4
TK	Tykerb	C4
TK	GW-572016	C4
TK	Canertinib	C4
TK	CI-1033	C4
TK	Zactima	C4
TK	ZD6474	C4
TK	Vatalanib	C4
TK	PTK787	C4
TK	ZK222584	C4
TK	Sorafenib	C4
TK	Bay43-9006	C4
TK	Nexavar	C4
TK	Leflunomide	C4
TK	SU101	C4
TK	Arava	C4

Herein , we discuss the chemistry , biological activity and clinical potential of new drugs with tyrosine kinase blockers for cancer treatment .
【GOLD_E】
tyrosine	chem
tyrosinekinase	geneN
【PRE_E】
tyrosinekinase	geneN
【GOLD_R】
【PRE_R】

Transdermal selegiline for the treatment of major depressive disorder .
【GOLD_E】
selegiline	chem
【PRE_E】
selegiline	chem
【GOLD_R】
【PRE_R】

Non - selective inhibition of monoamine oxidase ( MAO ) enzymes ( ie , isoforms A and B ) in the brain are associated with clinically significant antidepressant effects .
【GOLD_E】
monoamineoxidase	geneN
MAO	geneN
monoamine	chem
【PRE_E】
monoamineoxidase	geneN
MAO	geneN
【GOLD_R】
【PRE_R】

In the US , the selegiline transdermal system ( STS ; EMSAM ) is the first antidepressant transdermal delivery system to receive Food and Drug Administration ( FDA ) approved labeling for the treatment of major depressive disorder ( MDD ) .
【GOLD_E】
selegiline	chem
【PRE_E】
selegiline	chem
EMSAM	chem
【GOLD_R】
【PRE_R】

Currently , the use of orally administered MAO inhibitor antidepressants ( eg , phenelzine , tranylcypromine ) is limited by the risk of tyramine - provoked events ( eg , acute hypertension and headache , also known as the `` cheese reaction `` ) when combined with dietary tyramine .
【GOLD_E】
MAO	geneN
phenelzine	chem
tranylcypromine	chem
tyramine	chem
rytyrami	chem
【PRE_E】
MAO	geneN
phenelzine	chem
tranylcypromine	chem
tyramine	chem
tyramine	chem
【GOLD_R】
phenelzine	MAO	C4
tranylcypromine	MAO	C4
【PRE_R】
MAO	phenelzine	C4
MAO	tranylcypromine	C4

The selegiline transdermal system is the only MAOI available in the US for the treatment of MDD that does not require dietary restriction at the clinically effective dose of 6 mg / 24 hours .
【GOLD_E】
selegiline	chem
【PRE_E】
selegiline	chem
MAOI	chem
【GOLD_R】
【PRE_R】

Delivery of selegiline transdermally ( EMSAM ( ( R ) ) ) bypasses hepatic first pass metabolism , thereby avoiding significant inhibition of gastrointestinal and hepatic MAO - A activity ( ie , reduced risk of tyramine - provoked events ) while still providing sufficient levels of selegiline in the brain to produce an antidepressant effect .
【GOLD_E】
MAO-A	geneY
tyramine	chem
selegiline	chem
【PRE_E】
selegilinetransdermally	chem
EMSAM((R)	chem
MAO-A	geneY
tyramine	chem
selegiline	chem
【GOLD_R】
【PRE_R】
selegilinetransdermally	MAO-A	C4
EMSAM((R)	MAO-A	C4
MAO-A	selegiline	C4

At dosages of 6 - 12 mg / 24 hours , EMSAM has been shown to improve symptoms of depression , have good tolerability , and have high rates of medication adherence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , at higher doses of EMSAM ( ie , 9 mg / 24 hours or more ) , dietary restriction of tyramine intake is recommended .
【GOLD_E】
tyramine	chem
【PRE_E】
EMSAM	chem
tyramine	chem
【GOLD_R】
【PRE_R】

The introduction of EMSAM overcomes many of the safety concerns affiliated with the conventional oral MAO inhibitors and EMSAM may be considered another strategy for the treatment of MDD , especially in patients who can not tolerate oral antidepressants , are poorly adherent , who present with atypical depressive symptoms , or have failed other antidepressants .
【GOLD_E】
MAO	geneN
【PRE_E】
EMSAM	chem
MAO	geneN
EMSAM	chem
【GOLD_R】
【PRE_R】
EMSAM	MAO	C4
MAO	EMSAM	C4

Atomoxetine : a review of its use in attention - deficit hyperactivity disorder in children and adolescents .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine ( Strattera ( R ) ) is a selective norepinephrine ( noradrenaline ) reuptake inhibitor that is not classified as a stimulant , and is indicated for use in patients with attention - deficit hyperactivity disorder ( ADHD ) .
【GOLD_E】
Atomoxetine	chem
norepinephrine	chem
noradrenaline	chem
Strattera	chem
【PRE_E】
Atomoxetine	chem
Strattera(R)	chem
norepinephrine	chem
noradrenaline	chem
【GOLD_R】
【PRE_R】

Atomoxetine is effective and generally well tolerated .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

It is significantly more effective than placebo and standard current therapy and does not differ significantly from or is noninferior to immediate - release methylphenidate ; however , it is significantly less effective than the extended - release methylphenidate formulation OROS ( R ) methylphenidate ( hereafter referred to as osmotically released methylphenidate ) and extended - release mixed amfetamine salts .
【GOLD_E】
methylphenidate	chem
methylphenidate	chem
methylphenidate	chem
methylphenidate	chem
amfetamine	chem
【PRE_E】
methylphenidate	chem
methylphenidate	chem
OROS(R)methylphenidate	chem
methylphenidate	chem
amfetaminesalts	chem
【GOLD_R】
【PRE_R】

Atomoxetine can be administered either as a single daily dose or split into two evenly divided doses , has a negligible risk of abuse or misuse , and is not a controlled substance in the US .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine is particularly useful for patients at risk of substance abuse , as well as those who have co - morbid anxiety or tics , or who do not wish to take a controlled substance .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Thus , atomoxetine is a useful option in the treatment of ADHD in children and adolescents .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

The mechanism of action of atomoxetine is unclear , but is thought to be related to its selective inhibition of presynaptic norepinephrine reuptake in the prefrontal cortex .
【GOLD_E】
atomoxetine	chem
norepinephrine	chem
【PRE_E】
atomoxetine	chem
norepinephrine	chem
【GOLD_R】
【PRE_R】

Atomoxetine has a high affinity and selectivity for norepinephrine transporters , but little or no affinity for various neurotransmitter receptors .
【GOLD_E】
norepinephrinetransporters	geneY
Atomoxetine	chem
neurotransmitterreceptors	geneN
norepinephrine	chem
【PRE_E】
Atomoxetine	chem
norepinephrinetransporters	geneN
【GOLD_R】
【PRE_R】

Atomoxetine has a demonstrated ability to selectively inhibit norepinephrine uptake in humans and animals , and studies have shown that it preferentially binds to areas of known high distribution of noradrenergic neurons , such as the fronto - cortical subsystem .
【GOLD_E】
Atomoxetine	chem
norepinephrine	chem
【PRE_E】
Atomoxetine	chem
norepinephrine	chem
【GOLD_R】
【PRE_R】

Atomoxetine was generally associated with statistically , but not clinically , significant increases in both heart rate and blood pressure in pediatric patients with ADHD .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

While there was an initial loss in expected height and weight among atomoxetine recipients , this eventually returned to normal in the longer term .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Data suggest that atomoxetine is unlikely to have any abuse potential .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine appeared less likely than methylphenidate to exacerbate disordered sleep in pediatric patients with ADHD .
【GOLD_E】
Atomoxetine	chem
methylphenidate	chem
【PRE_E】
Atomoxetine	chem
methylphenidate	chem
【GOLD_R】
【PRE_R】

Atomoxetine is rapidly absorbed , and demonstrates dose - proportional increases in plasma exposure .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

It undergoes extensive biotransformation , which is affected by poor metabolism by cytochrome P450 ( CYP ) 2D6 in a small percentage of the population ; these patients have greater exposure to and slower elimination of atomoxetine than extensive metabolizers .
【GOLD_E】
atomoxetine	chem
cytochromeP450(CYP)2D6	geneY
【PRE_E】
cytochromeP450(CYP)2D6	geneY
atomoxetine	chem
【GOLD_R】
atomoxetine	cytochromeP450(CYP)2D6	C9
【PRE_R】

Patients with hepatic insufficiency show an increase in atomoxetine exposure .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

CYP2D6 inhibitors , such as paroxetine , are associated with changes in atomoxetine pharmacokinetics similar to those observed among poor CYP2D6 metabolizers .
【GOLD_E】
paroxetine	chem
atomoxetine	chem
CYP2D6	geneY
CYP2D6	geneY
【PRE_E】
CYP2D6	geneY
paroxetine	chem
atomoxetine	chem
CYP2D6	geneY
【GOLD_R】
paroxetine	CYP2D6	C4
atomoxetine	CYP2D6	C9
【PRE_R】

Once - or twice - daily atomoxetine was effective in the short - term treatment of ADHD in children and adolescents , as observed in several well designed placebo - controlled trials .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine also demonstrated efficacy in the longer term treatment of these patients .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

A single morning dose was shown to be effective into the evening , and discontinuation of atomoxetine was not associated with symptom rebound .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine efficacy did not appear to differ between children and adolescents .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Stimulant - naive patients also responded well to atomoxetine treatment .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine did not differ significantly from or was noninferior to immediate - release methylphenidate in children and adolescents with ADHD with regard to efficacy , and was significantly more effective than standard current therapy ( any combination of medicines [ excluding atomoxetine ] and / or behavioral counseling , or no treatment ) .
【GOLD_E】
Atomoxetine	chem
methylphenidate	chem
atomoxetine	chem
【PRE_E】
Atomoxetine	chem
methylphenidate	chem
atomoxetine	chem
【GOLD_R】
【PRE_R】

However , atomoxetine was significantly less effective than osmotically released methylphenidate and extended - release mixed amfetamine salts .
【GOLD_E】
atomoxetine	chem
methylphenidate	chem
amfetamine	chem
【PRE_E】
atomoxetine	chem
methylphenidate	chem
amfetaminesalts	chem
【GOLD_R】
【PRE_R】

The efficacy of atomoxetine did not appear to be affected by the presence of co - morbid disorders , and symptoms of the co - morbid disorders were not affected or were improved by atomoxetine administration .
【GOLD_E】
atomoxetine	chem
atomoxetine	chem
【PRE_E】
atomoxetine	chem
atomoxetine	chem
【GOLD_R】
【PRE_R】

Health - related quality of life ( HR - QOL ) appeared to be positively affected by atomoxetine in both short - and long - term studies ; atomoxetine also improved HR - QOL to a greater extent than standard current therapy .
【GOLD_E】
atomoxetine	chem
atomoxetine	chem
【PRE_E】
atomoxetine	chem
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine was generally well tolerated in children and adolescents with ADHD .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Common adverse events included headache , abdominal pain , decreased appetite , vomiting , somnolence , and nausea .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The majority of adverse events were mild or moderate ; there was a very low incidence of serious adverse events .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Few patients discontinued atomoxetine treatment because of adverse events .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine discontinuation appeared to be well tolerated , with a low incidence of discontinuation - emergent adverse events .
【GOLD_E】
Atomoxetine	chem
【PRE_E】
Atomoxetine	chem
【GOLD_R】
【PRE_R】

Atomoxetine appeared better tolerated among extensive CYP2D6 metabolizers than among poor metabolizers .
【GOLD_E】
Atomoxetine	chem
CYP2D6	geneY
【PRE_E】
Atomoxetine	chem
CYP2D6	geneY
【GOLD_R】
Atomoxetine	CYP2D6	C9
【PRE_R】

Slight differences were evident in the adverse event profiles of atomoxetine and stimulants , both immediate - and extended - release .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Somnolence appeared more common among atomoxetine recipients and insomnia appeared more common among stimulant recipients .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

A black - box warning for suicidal ideation has been published in the US prescribing information , based on findings from a meta - analysis showing that atomoxetine is associated with a significantly higher incidence of suicidal ideation than placebo .
【GOLD_E】
atomoxetine	chem
【PRE_E】
atomoxetine	chem
【GOLD_R】
【PRE_R】

Rarely , atomoxetine may also be associated with serious liver injury ; postmarketing data show that three patients have had liver - related adverse events deemed probably related to atomoxetine treatment .
【GOLD_E】
atomoxetine	chem
atomoxetine	chem
【PRE_E】
atomoxetine	chem
atomoxetine	chem
【GOLD_R】
【PRE_R】

Treatment algorithms involving the initial use of atomoxetine appear cost effective versus algorithms involving initial methylphenidate ( immediate - or extended - release ) , dexamfetamine , tricyclic antidepressants , or no treatment in stimulant - naive , - failed , and - contraindicated children and adolescents with ADHD .
【GOLD_E】
atomoxetine	chem
methylphenidate	chem
dexamfetamine	chem
tricyclic	chem
【PRE_E】
atomoxetine	chem
methylphenidate	chem
dexamfetamine	chem
tricyclic	chem
【GOLD_R】
【PRE_R】

The incremental cost per quality - adjusted life - year is below commonly accepted cost - effectiveness thresholds , as shown in several Markov model analyses conducted from the perspective of various European countries , with a time horizon of 1 year .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Novel inhibitors complexed with glutamate dehydrogenase : allosteric regulation by control of protein dynamics .
【GOLD_E】
glutamate	chem
glutamatedehydrogenase	geneY
【PRE_E】
glutamatedehydrogenase	geneN
【GOLD_R】
【PRE_R】

Mammalian glutamate dehydrogenase ( GDH ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of l - glutamate to 2 - oxoglutarate using NAD ( P ) ( + ) as coenzyme .
【GOLD_E】
Mammalianglutamatedehydrogenase	geneN
GDH	geneN
glutamate	chem
l-glutamate	chem
2-oxoglutarate	chem
NAD(P)(+)	chem
【PRE_E】
Mammalianglutamatedehydrogenase	geneN
GDH	geneN
l-glutamate	chem
2-oxoglutarate	chem
NAD(P)(+)	chem
coenzyme	chem
【GOLD_R】
2-oxoglutarate	Mammalianglutamatedehydrogenase	C9
2-oxoglutarate	GDH	C9
l-glutamate	Mammalianglutamatedehydrogenase	C9
l-glutamate	GDH	C9
【PRE_R】
GDH	l-glutamate	C9
GDH	2-oxoglutarate	C9
GDH	NAD(P)(+)	C9
GDH	coenzyme	C9

Unlike its counterparts from other animal kingdoms , mammalian GDH is regulated by a host of ligands .
【GOLD_E】
mammalianGDH	geneN
【PRE_E】
mammalianGDH	geneN
【GOLD_R】
【PRE_R】

The recently discovered hyperinsulinism / hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin .
【GOLD_E】
GDH	geneY
insulin	geneY
GTP	chem
【PRE_E】
GDH	geneN
GTP	chem
insulin	geneN
【GOLD_R】
GTP	insulin	C3
【PRE_R】

Subsequent studies demonstrated that wild - type and hyperinsulinemia / hyperammonemia forms of GDH are inhibited by the green tea polyphenols , epigallocatechin gallate and epicatechin gallate .
【GOLD_E】
GDH	geneY
epigallocatechingallate	chem
epicatechingallate	chem
【PRE_E】
GDH	geneN
polyphenols	chem
epigallocatechingallate	chem
epicatechingallate	chem
【GOLD_R】
epigallocatechingallate	GDH	C4
epicatechingallate	GDH	C4
【PRE_R】
GDH	polyphenols	C4
GDH	epigallocatechingallate	C4
GDH	epicatechingallate	C4

This was followed by high throughput studies that identified more stable inhibitors , including hexachlorophene , GW5074 , and bithionol .
【GOLD_E】
hexachlorophene	chem
GW5074	chem
bithionol	chem
【PRE_E】
hexachlorophene	chem
GW5074	chem
bithionol	chem
【GOLD_R】
【PRE_R】

Shown here are the structures of GDH complexed with these three compounds .
【GOLD_E】
GDH	geneY
【PRE_E】
GDH	geneN
【GOLD_R】
【PRE_R】

Hexachlorophene forms a ring around the internal cavity in GDH through aromatic stacking interactions between the drug and GDH as well as between the drug molecules themselves .
【GOLD_E】
Hexachlorophene	chem
GDH	geneY
GDH	geneY
【PRE_E】
Hexachlorophene	chem
GDH	geneN
GDH	geneN
【GOLD_R】
【PRE_R】

In contrast , GW5074 and bithionol both bind as pairs of stacked compounds at hexameric 2 - fold axes between the dimers of subunits .
【GOLD_E】
GW5074	chem
bithionol	chem
【PRE_E】
GW5074	chem
bithionol	chem
【GOLD_R】
【PRE_R】

The internal core of GDH contracts when the catalytic cleft closes during enzymatic turnover .
【GOLD_E】
GDH	geneY
【PRE_E】
GDH	geneN
【GOLD_R】
【PRE_R】

None of the drugs cause conformational changes in the contact residues , but all bind to key interfaces involved in this contraction process .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , it seems likely that the drugs inhibit enzymatic turnover by inhibiting this transition .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Indeed , this expansion / contraction process may play a major role in the inter - subunit communication and allosteric regulation observed in GDH .
【GOLD_E】
GDH	geneY
【PRE_E】
GDH	geneN
【GOLD_R】
【PRE_R】

The effect of a peripheral block on inflammation - induced prostaglandin E2 and cyclooxygenase expression in rats .
【GOLD_E】
prostaglandinE2	chem
cyclooxygenase	geneN
【PRE_E】
prostaglandinE2	chem
cyclooxygenase	geneN
【GOLD_R】
【PRE_R】

BACKGROUND : Peripheral inflammatory pain is associated with an upregulation of spinal cord COX - 2 ( cyclooxygenase - 2 ) , with a subsequent increase in central prostaglandin E2 ( PGE2 ) levels associated with the development of hyperalgesia .
【GOLD_E】
COX-2	geneY
cyclooxygenase-2	geneY
prostaglandinE2	chem
PGE2	chem
【PRE_E】
cordCOX-2	geneY
cyclooxygenase-2	geneY
prostaglandinE2	chem
PGE2	chem
【GOLD_R】
prostaglandinE2	COX-2	C9
prostaglandinE2	cyclooxygenase-2	C9
PGE2	COX-2	C9
PGE2	cyclooxygenase-2	C9
【PRE_R】

In this study , we evaluated the effect of bupivacaine administered via a nerve block or via a systemic route on the spinal expression of PGE2 and COX in a model of peripheral inflammation in rats .
【GOLD_E】
COX	geneN
bupivacaine	chem
PGE2	chem
【PRE_E】
bupivacaine	chem
PGE2	chem
COX	geneN
【GOLD_R】
【PRE_R】
bupivacaine	COX	C4

METHODS : All rats randomly received three injections : 1 ) a left subcutaneous hindpaw injection ( 0.2 mL with either carrageenan 2 % w / v or saline ) , 2 ) a left sciatic block ( 0.2 mL with either bupivacaine 0.5 % or saline ) , and 3 ) a systemic injection ( subcutaneous interscapular with 0.2 mL with either bupivacaine 0.5 % or saline ) .
【GOLD_E】
bupivacaine	chem
bupivacaine	chem
【PRE_E】
bupivacaine	chem
bupivacaine	chem
【GOLD_R】
【PRE_R】

Local edema , thermal , and mechanical hyperalgesia as well as cerebrospinal fluid PGE2 concentration and COX - 1 and COX - 2 expression in the spinal cord in dorsal root ganglions were measured .
【GOLD_E】
COX-1	geneY
COX-2	geneY
PGE2	chem
【PRE_E】
PGE2	chem
COX-1	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

RESULTS : We confirmed that a bupivacaine block attenuates hyperalgesia and local inflammation in a model of inflammatory pain .
【GOLD_E】
bupivacaine	chem
【PRE_E】
bupivacaine	chem
【GOLD_R】
【PRE_R】

This effect was associated with an inhibition of the increase in COX - 2 expression induced by peripheral inflammation in dorsal root ganglions and cord .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

The subsequent production of PGE2 in cerebrospinal fluid was also impaired .
【GOLD_E】
PGE2	chem
【PRE_E】
PGE2	chem
【GOLD_R】
【PRE_R】

Systemic bupivacaine did not modify either the hyperalgesia and local inflammation or COX expression .
【GOLD_E】
COX	geneN
bupivacaine	chem
【PRE_E】
bupivacaine	chem
COX	geneN
【GOLD_R】
【PRE_R】

CONCLUSION : These results constitute a key element strongly suggesting that local anesthetics act at a different level when administered systematically or via a nerve block .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Two pharmacologically distinct alpha 1 - adrenoceptor subtypes in the contraction of rabbit aorta : each subtype couples with a different Ca2 + signalling mechanism and plays a different physiological role .
【GOLD_E】
Ca2+	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
Ca2+	chem
【GOLD_R】
【PRE_R】

Using the alpha 1 - adrenoceptor subtype - selective antagonists chlorethylclonidine ( CEC ) , WB4101 , and 5 - methyl - urapidil , we have examined the possible heterogeneity in the alpha 1 - adrenoceptor populations in rabbit aorta .
【GOLD_E】
5-methyl-urapidil	chem
chlorethylclonidine	chem
CEC	chem
WB4101	chem
alpha1-adrenoceptor	geneN
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
chlorethylclonidine	chem
CEC	chem
WB4101	chem
5-methyl-urapidil	chem
alpha1-adrenoceptor	geneN
【GOLD_R】
5-methyl-urapidil	alpha1-adrenoceptor	C6
chlorethylclonidine	alpha1-adrenoceptor	C6
CEC	alpha1-adrenoceptor	C6
WB4101	alpha1-adrenoceptor	C6
【PRE_R】
alpha1-adrenoceptor	chlorethylclonidine	C6
alpha1-adrenoceptor	CEC	C6
WB4101	alpha1-adrenoceptor	C6

The alpha 1 - adrenoceptor alkylating agent CEC selectively inhibited the phasic component of the norepinephrine - induced contractile response , with little effect on the tonic component .
【GOLD_E】
norepinephrine	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
CEC	chem
norepinephrine	chem
【GOLD_R】
【PRE_R】

The alpha 1 - adrenoceptor occupancy - response relationship defined by the phenoxybenzamine inactivation method was rectangular hyperbolic for the tonic response , whereas that for the phasic response was linear , indicating the different degree of receptor reserve for the two responses .
【GOLD_E】
phenoxybenzamine	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
phenoxybenzamine	chem
【GOLD_R】
【PRE_R】

Radioligand binding studies with the nonselective alpha 1 - adrenoceptor antagonist radioligand 125I - BE2254 showed that 73 - 87 % of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 ( pKd = 8.1 ) and for 5 - methylurapidil ( pKd = 7.1 ) .
【GOLD_E】
125I-BE2254	chem
CEC	chem
WB4101	chem
5-methylurapidil	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
125I-BE2254	chem
WB4101	chem
pKd	geneY
5-methylurapidil	chem
【GOLD_R】
125I-BE2254	alpha1-adrenoceptor	C6
【PRE_R】
alpha1-adrenoceptor	125I-BE2254	C6

Moreover , alpha 1 - adrenoceptor - mediated phosphatidylinositol ( PI ) hydrolysis was CEC sensitive , and fractional inactivation of alpha 1 receptors with CEC showed equivalent increments in the reduction of PI hydrolysis and phasic contractile response , suggesting that both responses are linearly related to the CEC - sensitive receptor sites .
【GOLD_E】
alpha1receptors	geneN
phosphatidylinositol	chem
alpha1-adrenoceptor	geneN
PI	chem
CEC	chem
CEC	chem
PI	chem
CEC	chem
【PRE_E】
alpha1-adrenoceptor	geneY
phosphatidylinositol	chem
PI	chem
CEC	chem
alpha1receptors	geneN
CEC	chem
PI	chem
CEC-sensitivereceptor	geneN
【GOLD_R】
【PRE_R】

The Schild plots for the competitive antagonists WB4101 and 5 - methyl - urapidil against alpha 1a - adrenoceptor - selective agonist methoxamine - induced contraction were linear and had slopes not significantly different from unity , with a pA2 of 9.07 + / - 0.07 ( n = 5 ) for WB4101 and 9.09 + / - 0.05 ( n = 3 ) for 5 - methyl - urapidil .
【GOLD_E】
methoxamine	chem
WB4101	chem
5-methyl-urapidil	chem
alpha1a-adrenoceptor	geneY
WB4101	chem
5-methyl-urapidil	chem
【PRE_E】
WB4101	chem
5-methyl-urapidil	chem
alpha1a-adrenoceptor	geneY
methoxamine	chem
WB4101	chem
5-methyl-urapidil	chem
【GOLD_R】
methoxamine	alpha1a-adrenoceptor	C5
WB4101	alpha1a-adrenoceptor	C6
5-methyl-urapidil	alpha1a-adrenoceptor	C6
WB4101	alpha1a-adrenoceptor	C6
5-methyl-urapidil	alpha1a-adrenoceptor	C6
【PRE_R】
WB4101	alpha1a-adrenoceptor	C6

However , the Schilod plots for these antagonists against norepinephrine were curvilinear .
【GOLD_E】
norepinephrine	chem
【PRE_E】
norepinephrine	chem
【GOLD_R】
【PRE_R】

Computer - assisted analysis of these curvilinear Schild plots in a two - receptor system indicated that alpha 1 - adrenoceptor populations responsible for the constrictive response are predominantly ( approximately 80 - 90 % ) low affinity sites for the two antagonists ( pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5 - methyl - urapidil ) and a small population ( approximately 10 - 20 % ) are high affinity sites ( pKd approximately 9.1 for both WB4101 and 5 - methyl - urapidil ) , which was in good agreement with radioligand binding studies . ( ABSTRACT TRUNCATED AT 400 WORDS )
【GOLD_E】
WB4101	chem
5-methyl-urapidil	chem
WB4101	chem
5-methyl-urapidil	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
pKd	geneY
WB4101	chem
pKd	geneY
5-methyl-urapidil	chem
WB4101	chem
5-methyl-urapidil	chem
【GOLD_R】
WB4101	alpha1-adrenoceptor	C6
5-methyl-urapidil	alpha1-adrenoceptor	C6
【PRE_R】

Ambrisentan for the treatment of pulmonary arterial hypertension .
【GOLD_E】
Ambrisentan	chem
【PRE_E】
Ambrisentan	chem
【GOLD_R】
【PRE_R】

Ambrisentan is an endothelin receptor antagonist ( ERA ) that was recently approved for treatment of pulmonary arterial hypertension ( PAH ) .
【GOLD_E】
Ambrisentan	chem
endothelinreceptor	geneN
【PRE_E】
Ambrisentan	chem
endothelinreceptor	geneY
【GOLD_R】
Ambrisentan	endothelinreceptor	C6
【PRE_R】

Endothelin ( ET ) is a potent vasoconstrictor with mitogenic , hypertrophic and pro - inflammatory properties that is upregulated in pulmonary hypertensive diseases .
【GOLD_E】
Endothelin	geneN
ET	geneN
【PRE_E】
Endothelin	geneY
ET	geneY
【GOLD_R】
【PRE_R】

The biologic effects of ET are mediated by 2 cell surface receptors termed ET ( A ) and ET ( B ) .
【GOLD_E】
ET	geneN
ET(A)	geneY
ET(B)	geneY
【PRE_E】
ET	chem
ET(A)	geneY
ET(B)	geneY
【GOLD_R】
【PRE_R】

ET ( A ) mediates the vasoconstrictor effect of ET on vascular smooth muscle , whereas ET ( B ) is expressed primarily on vascular endothelial cells where it induces nitric oxide synthesis and acts to clear ET from the circulation .
【GOLD_E】
ET(A)	geneY
ET	geneN
ET(B)	geneY
ET	geneN
nitricoxide	chem
【PRE_E】
ET(A)	geneY
ET(B)	geneY
nitricoxide	chem
【GOLD_R】
【PRE_R】

Ambrisentan is the first ET ( A ) selective ERA approved for use in the US .
【GOLD_E】
ET(A)	geneY
Ambrisentan	chem
【PRE_E】
Ambrisentan	chem
ET(A)	geneY
【GOLD_R】
Ambrisentan	ET(A)	C6
【PRE_R】

Recently published clinical trials in patients with PAH demonstrate improvement in functional capacity and pulmonary hemodynamics similar to other ET ( A ) selective and non - selective ERAs .
【GOLD_E】
ET(A)	geneY
【PRE_E】
PAH	chem
ET(A)	geneY
【GOLD_R】
【PRE_R】

Its once daily dosing and lower incidence of serum aminotransferase elevation offer potential advantages over other ERAs , but further experience with this agent is needed to fully understand its long - term efficacy and safety .
【GOLD_E】
aminotransferase	geneN
【PRE_E】
serumaminotransferase	geneY
【GOLD_R】
【PRE_R】

This review discusses the endothelin family of proteins and receptors and their role in the pathophysiology of pulmonary hypertensive diseases .
【GOLD_E】
endothelin	geneN
【PRE_E】
endothelin	geneN
【GOLD_R】
【PRE_R】

It also examines the development process , safety profile and clinical trials that have resulted in ambrisentan being approved for treatment of PAH .
【GOLD_E】
ambrisentan	chem
【PRE_E】
ambrisentan	chem
PAH	chem
【GOLD_R】
【PRE_R】

Design , synthesis , and in - vivo evaluation of 4,5 - diaryloxazole as novel nonsteroidal anti - inflammatory drug .
【GOLD_E】
4,5-diaryloxazole	chem
【PRE_E】
4,5-diaryloxazole	chem
【GOLD_R】
【PRE_R】

A series of 4,5 - diaryloxazole analogs were designed and the interaction between oxaprozin and cyclooxygenase - 2 studied by the docking method to improve the biological activity and reduce the gastrointestinal side effects of oxaprozin .
【GOLD_E】
oxaprozin	chem
cyclooxygenase-2	geneY
4,5-diaryloxazole	chem
oxaprozin	chem
【PRE_E】
4,5-diaryloxazole	chem
oxaprozin	chem
cyclooxygenase-2	geneY
oxaprozin	chem
【GOLD_R】
【PRE_R】
4,5-diaryloxazole	cyclooxygenase-2	C4
oxaprozin	cyclooxygenase-2	C4

Finally , 3 - ( 4 - ( 4 - fluorophenyl ) - 5 - ( 4 - aminosulfonyl - 3 - fluorophenyl ) - oxazole - 2 - yl ) propanoic acid ( NC - 2142 ) , the best candidate , was selected for synthesis and bioassay based on the screening result .
【GOLD_E】
3-(4-(4-fluorophenyl)-5-(4-aminosulfonyl-3-fluorophenyl)-oxazole-2-yl)propanoicacid	chem
NC-2142	chem
【PRE_E】
3-(4-(4-fluorophenyl)-5-(4-aminosulfonyl-3-fluorophenyl)-oxazole-2-yl)propanoicacid	chem
NC-2142	chem
【GOLD_R】
【PRE_R】

NC - 2142 could lower the tumefaction rates of back metatarsus in rats , as well as reduce the writhing times in mice .
【GOLD_E】
NC-2142	chem
【PRE_E】
NC-2142	chem
【GOLD_R】
【PRE_R】

NC - 2142 produced fewer gastric lesions than oxaprozin .
【GOLD_E】
NC-2142	chem
oxaprozin	chem
【PRE_E】
NC-2142	chem
oxaprozin	chem
【GOLD_R】
【PRE_R】

After the aminosulfonyl group was introduced into the benzene ring of oxaprozin , its analgesic and anti - inflammatory activities remained unchanged , and it reduced the number of gastric lesions .
【GOLD_E】
oxaprozin	chem
aminosulfonyl	chem
benzene	chem
【PRE_E】
aminosulfonyl	chem
benzene	chem
oxaprozin	chem
【GOLD_R】
【PRE_R】

This provided a feasible method for further structure modification and optimization of oxaprozin .
【GOLD_E】
oxaprozin	chem
【PRE_E】
oxaprozin	chem
【GOLD_R】
【PRE_R】

Breast cancer and steroid metabolizing enzymes : the role of progestogens .
【GOLD_E】
steroid	chem
progestogens	chem
【PRE_E】
steroid	chem
progestogens	chem
【GOLD_R】
【PRE_R】

It is well documented that breast tissue , both normal and cancerous , contains all the enzymatic systems necessary for the bioformation and metabolic transformation of estrogens , androgens and progesterone .
【GOLD_E】
estrogens	chem
androgens	chem
progesterone	chem
【PRE_E】
bioformation	chem
estrogens	chem
androgens	chem
progesterone	chem
【GOLD_R】
【PRE_R】

These include sulfatases , aromatase , hydroxysteroid - dehydrogenases , sulfotransferases , hydroxylases and glucuronidases .
【GOLD_E】
sulfatases	geneN
aromatase	geneY
hydroxysteroid-dehydrogenases	geneN
sulfotransferases	geneN
hydroxylases	geneN
glucuronidases	geneN
hydroxysteroid	chem
【PRE_E】
sulfatases	geneN
aromatase	geneY
hydroxysteroid-dehydrogenases	geneN
sulfotransferases	geneN
hydroxylases	geneN
glucuronidases	geneN
【GOLD_R】
【PRE_R】

The control of these enzymes plays an important role in the development and pathogenesis of hormone - dependent breast cancer .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As discussed in this review , various progestogens including dydrogesterone and its 20alpha - dihydro - derivative , medrogestone , promegestone , nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta - hydroxysteroid - dehydrogenase type 1 activities .
【GOLD_E】
promegestone	chem
nomegestrolacetate	chem
norelgestromin	chem
estradiol	chem
17beta-hydroxysteroid	chem
sulfatase	geneN
17beta-hydroxysteroid-dehydrogenasetype1	geneY
progestogens	chem
dydrogesterone	chem
medrogestone	chem
【PRE_E】
progestogens	chem
dydrogesterone	chem
20alpha-dihydro	chem
medrogestone	chem
promegestone	chem
nomegestrolacetate	chem
norelgestromin	chem
estradiol	chem
sulfatase	geneY
17beta-hydroxysteroid-dehydrogenasetype1	geneY
【GOLD_R】
promegestone	sulfatase	C4
promegestone	17beta-hydroxysteroid-dehydrogenasetype1	C4
nomegestrolacetate	sulfatase	C4
nomegestrolacetate	17beta-hydroxysteroid-dehydrogenasetype1	C4
norelgestromin	sulfatase	C4
norelgestromin	17beta-hydroxysteroid-dehydrogenasetype1	C4
progestogens	sulfatase	C4
progestogens	17beta-hydroxysteroid-dehydrogenasetype1	C4
dydrogesterone	sulfatase	C4
dydrogesterone	17beta-hydroxysteroid-dehydrogenasetype1	C4
medrogestone	sulfatase	C4
medrogestone	17beta-hydroxysteroid-dehydrogenasetype1	C4
estradiol	sulfatase	C9
estradiol	17beta-hydroxysteroid-dehydrogenasetype1	C9
【PRE_R】

A possible correlation has been postulated between breast cell proliferation and estrogen sulfotransferase activity .
【GOLD_E】
estrogen	chem
estrogensulfotransferase	geneY
【PRE_E】
estrogensulfotransferase	geneY
【GOLD_R】
【PRE_R】

Progesterone is largely transformed in the breast ; normal breast produces mainly 4 - ene derivatives , whereas 5alpha - derivatives are most common in breast cancer tissue .
【GOLD_E】
Progesterone	chem
【PRE_E】
Progesterone	chem
4-ene	chem
【GOLD_R】
【PRE_R】

It has been suggested that this specific conversion of progesterone may be involved in breast carcinogenesis .
【GOLD_E】
progesterone	chem
【PRE_E】
progesterone	chem
【GOLD_R】
【PRE_R】

In conclusion , treatment with anti - aromatases combined with anti - sulfatase or 17beta - hydroxysteroid - dehydrogenase type 1 could provide new therapeutic possibilities in the treatment of patients with hormone - dependent breast cancer .
【GOLD_E】
sulfatase	geneN
17beta-hydroxysteroid-dehydrogenasetype1	geneY
17beta-hydroxysteroid	chem
【PRE_E】
aromatases	geneN
sulfatase	geneY
17beta-hydroxysteroid-dehydrogenasetype1	geneY
【GOLD_R】
【PRE_R】

Mechanism of right precordial ST - segment elevation in structural heart disease : excitation failure by current - to - load mismatch .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

BACKGROUND : The Brugada sign has been associated with mutations in SCN5A and with right ventricular structural abnormalities .
【GOLD_E】
SCN5A	geneY
【PRE_E】
SCN5A	geneY
【GOLD_R】
【PRE_R】

Their role in the Brugada sign and the associated ventricular arrhythmias is unknown .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVE : The purpose of this study was to delineate the role of structural abnormalities and sodium channel dysfunction in the Brugada sign .
【GOLD_E】
sodium	chem
sodiumchannel	geneN
【PRE_E】
sodiumchannel	geneN
【GOLD_R】
【PRE_R】

METHODS : Activation and repolarization characteristics of the explanted heart of a patient with a loss - of - function mutation in SCN5A ( G752R ) and dilated cardiomyopathy were determined after induction of right - sided ST - segment elevation by ajmaline .
【GOLD_E】
ajmaline	chem
SCN5A	geneY
G752R	geneN
【PRE_E】
SCN5A	geneY
G752R	geneY
ajmaline	chem
【GOLD_R】
【PRE_R】

In addition , right ventricular structural discontinuities and sodium channel dysfunction were simulated in a computer model encompassing the heart and thorax .
【GOLD_E】
sodium	chem
sodiumchannel	geneN
【PRE_E】
sodiumchannel	geneN
【GOLD_R】
【PRE_R】

RESULTS : In the explanted heart , disappearance of local activation in unipolar electrograms at the basal right ventricular epicardium was followed by monophasic ST - segment elevation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The local origin of this phenomenon was confirmed by coaxial electrograms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Neither early repolarization nor late activation correlated with ST - segment elevation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

At sites of local ST - segment elevation , the subepicardium was interspersed with adipose tissue and contained more fibrous tissue than either the left ventricle or control hearts .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In computer simulations entailing right ventricular structural discontinuities , reduction of sodium channel conductance or size of the gaps between introduced barriers resulted in subepicardial excitation failure or delayed activation by current - to - load mismatch and in the Brugada sign on the ECG .
【GOLD_E】
sodium	chem
sodiumchannel	geneN
【PRE_E】
sodiumchannel	geneN
ECG	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Right ventricular excitation failure and activation delay by current - to - load mismatch in the subepicardium can cause the Brugada sign .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , current - to - load mismatch may underlie the ventricular arrhythmias in patients with the Brugada sign .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis .
【GOLD_E】
mitiglinide	chem
voglibose	chem
【PRE_E】
mitiglinide	chem
voglibose	chem
【GOLD_R】
【PRE_R】

OBJECTIVE : Mitiglinide , a rapid - and short - acting insulinotropic sulfonylurea receptor ligand , exhibits hypoglycemic action unlike other sulfonylureas .
【GOLD_E】
sulfonylurea	chem
Mitiglinide	chem
sulfonylureareceptor	geneN
sulfonylureas	chem
【PRE_E】
Mitiglinide	chem
insulinotropicsulfonylureareceptor	geneY
sulfonylureas	chem
【GOLD_R】
【PRE_R】

The efficacy of the combination of mitiglinide and alpha - glucosidase inhibitors for diabetic patients on hemodialysis ( HD ) has not been prospectively evaluated ; therefore , we evaluated the efficacy and safety of mitiglinide in these patients .
【GOLD_E】
mitiglinide	chem
mitiglinide	chem
alpha-glucosidase	geneY
【PRE_E】
mitiglinide	chem
alpha-glucosidase	geneN
mitiglinide	chem
【GOLD_R】
【PRE_R】

RESEARCH DESIGN AND METHODS : We performed an open - label randomized study with 36 type 2 diabetics with poor glycemic control on HD and receiving daily doses of voglibose ( 0.9 mg ) .
【GOLD_E】
voglibose	chem
【PRE_E】
voglibose	chem
【GOLD_R】
【PRE_R】

The patients were randomly assigned to two groups : a combination - therapy group ( mitiglinide group ) , mitiglinide initial dose 7.5 - 15 mg titrated to 30 mg daily and constant daily dose 0.9 mg of voglibose , and a monotherapy group ( control group ) , constant daily dose 0.9 mg of voglibose alone .
【GOLD_E】
mitiglinide	chem
mitiglinide	chem
voglibose	chem
voglibose	chem
【PRE_E】
mitiglinide	chem
mitiglinide	chem
voglibose	chem
voglibose	chem
【GOLD_R】
【PRE_R】

The efficacy of the treatment was determined by monitoring plasma glucose , hemoglobin A1c ( Hb ( A1c ) ) , and glycated albumin ( GA ) levels and using homeostasis model assessment of insulin resistance ( HOMA - IR ) .
【GOLD_E】
glucose	chem
insulin	geneY
hemoglobinA1c	geneY
Hb(A1c)	geneY
glycatedalbumin	geneY
GA	geneY
【PRE_E】
glucose	chem
hemoglobinA1c	geneY
Hb	geneY
A1c	geneY
glycatedalbumin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Safety and tolerance were determined by monitoring clinical and laboratory parameters .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : The final dose of mitiglinide was 22.9 + / - 8.9 ( mean + / - s.d . ) mg ( 0.41 mg / kg ) daily .
【GOLD_E】
mitiglinide	chem
【PRE_E】
mitiglinide	chem
【GOLD_R】
【PRE_R】

Mitiglinide reduced fasting plasma glucose and GA levels after 4 weeks and Hb ( A1c ) levels after 8 weeks .
【GOLD_E】
GA	geneY
Hb(A1c)	geneY
Mitiglinide	chem
glucose	chem
【PRE_E】
Mitiglinide	chem
glucose	chem
Hb	geneY
A1c	geneY
【GOLD_R】
Mitiglinide	GA	C4
Mitiglinide	Hb(A1c)	C4
【PRE_R】

Triglyceride levels and HOMA - IR values also decreased significantly after mitiglinide treatment .
【GOLD_E】
Triglyceride	chem
mitiglinide	chem
【PRE_E】
Triglyceride	chem
mitiglinide	chem
【GOLD_R】
【PRE_R】

No significant changes in blood pressure levels or serious adverse effects such as hypoglycemia or liver impairment were observed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSIONS : This study suggests a combination therapy of mitiglinide and voglibose may have potential for the treatment of diabetics on HD .
【GOLD_E】
mitiglinide	chem
voglibose	chem
【PRE_E】
mitiglinide	chem
voglibose	chem
【GOLD_R】
【PRE_R】

Due to the small sample size used , further studies should be performed , particularly to assess the safety of mitiglinide treatment .
【GOLD_E】
mitiglinide	chem
【PRE_E】
mitiglinide	chem
【GOLD_R】
【PRE_R】

A fluorescence resonance energy transfer - based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation .
【GOLD_E】
M2muscarinicreceptor	geneY
【PRE_E】
M2muscarinicreceptor	geneY
【GOLD_R】
【PRE_R】

Allosteric modulators have been identified for several G protein - coupled receptors , most notably muscarinic receptors .
【GOLD_E】
Gprotein-coupledreceptors	geneN
muscarinicreceptors	geneN
【PRE_E】
Gprotein-coupledreceptors	geneN
muscarinicreceptors	geneN
【GOLD_R】
【PRE_R】

To study their mechanism of action , we made use of a recently developed technique to generate fluorescence resonance energy transfer ( FRET ) - based sensors to monitor G protein - coupled receptor activation .
【GOLD_E】
Gprotein-coupledreceptor	geneN
【PRE_E】
Gprotein-coupledreceptor	geneN
【GOLD_R】
【PRE_R】

Cyan fluorescent protein was fused to the C terminus of the M ( 2 ) muscarinic receptor , and a specific binding sequence for the small fluorescent compound fluorescein arsenical hairpin binder , FlAsH , was inserted into the third intracellular loop ; the latter site was labeled in intact cells by incubation with FlAsH .
【GOLD_E】
M(2)muscarinicreceptor	geneY
C	chem
fluorescein	chem
【PRE_E】
C	chem
M(2)muscarinicreceptor	geneY
fluoresceinarsenical	chem
FlAsH	chem
【GOLD_R】
【PRE_R】

We then measured FRET between the donor cyan fluorescent protein and the acceptor FlAsH in intact cells and monitored its changes in real time .
【GOLD_E】
【PRE_E】
FRET	geneN
FlAsH	chem
【GOLD_R】
【PRE_R】

Agonists such as acetylcholine and carbachol induced rapid changes in FRET , indicative of agonist - induced conformational changes .
【GOLD_E】
carbachol	chem
acetylcholine	chem
【PRE_E】
acetylcholine	chem
carbachol	chem
【GOLD_R】
【PRE_R】

Removal of the agonists or addition of an antagonist caused a reversal of this signal with rate constants between 400 and 1100 ms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The allosteric ligands gallamine and dimethyl - W84 caused no changes in FRET when given alone , but increased FRET when given in the presence of an agonist , compatible with an inactivation of the receptors .
【GOLD_E】
gallamine	chem
dimethyl-W84	chem
【PRE_E】
gallamine	chem
dimethyl-W84	chem
FRET	geneN
FRET	geneY
【GOLD_R】
【PRE_R】

The kinetics of these effects were very rapid , with rate constants of 80 - 100 ms and approximately 200 ms for saturating concentrations of gallamine and dimethyl - W84 , respectively .
【GOLD_E】
gallamine	chem
dimethyl-W84	chem
【PRE_E】
gallamine	chem
dimethyl-W84	chem
【GOLD_R】
【PRE_R】

Because these speeds are significantly faster than the responses to antagonists , these data indicate that gallamine and dimethyl - W84 are allosteric ligands and actively induce a conformation of the M ( 2 ) receptor with a reduced affinity for its agonists .
【GOLD_E】
M(2)receptor	geneY
gallamine	chem
dimethyl-W84	chem
【PRE_E】
gallamine	chem
dimethyl-W84	chem
M(2)receptor	geneY
【GOLD_R】
【PRE_R】

A molecular mechanism for ibuprofen - mediated RhoA inhibition in neurons .
【GOLD_E】
ibuprofen	chem
RhoA	geneY
【PRE_E】
ibuprofen	chem
RhoA	geneY
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】
ibuprofen	RhoA	C4

Ibuprofen is a nonsteroidal anti - inflammatory drug widely used to relieve pain and inflammation in many disorders via inhibition of cyclooxygenases .
【GOLD_E】
cyclooxygenases	geneN
Ibuprofen	chem
【PRE_E】
Ibuprofen	chem
cyclooxygenases	geneN
【GOLD_R】
Ibuprofen	cyclooxygenases	C4
【PRE_R】
Ibuprofen	cyclooxygenases	C4

Recently , we have demonstrated that ibuprofen inhibits intracellular signaling of RhoA and promotes significant axonal growth and functional recovery following spinal cord lesions in rodents .
【GOLD_E】
RhoA	geneY
ibuprofen	chem
【PRE_E】
ibuprofen	chem
RhoA	geneY
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】
ibuprofen	RhoA	C4

In addition , another study suggests that ibuprofen reduces generation of amyloid - beta42 peptide via inactivation of RhoA signaling , although it may also regulate amyloid - beta42 formation by direct inhibition of the gamma - secretase complex .
【GOLD_E】
amyloid-beta42	geneY
RhoA	geneY
amyloid-beta42	geneY
gamma-secretasecomplex	geneN
ibuprofen	chem
【PRE_E】
ibuprofen	chem
amyloid-beta42	geneY
RhoA	geneY
amyloid-beta42	geneY
gamma-secretase	geneN
【GOLD_R】
ibuprofen	amyloid-beta42	C3
ibuprofen	amyloid-beta42	C4
ibuprofen	RhoA	C4
ibuprofen	gamma-secretasecomplex	C4
【PRE_R】
ibuprofen	amyloid-beta42	C4
ibuprofen	RhoA	C4
ibuprofen	gamma-secretase	C4

The molecular mechanisms by which ibuprofen inhibits the RhoA signal in neurons , however , remain unclear .
【GOLD_E】
RhoA	geneY
ibuprofen	chem
【PRE_E】
ibuprofen	chem
RhoA	geneY
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】
ibuprofen	RhoA	C4

Here , we report that the transcription factor peroxisome proliferator - activated receptor gamma ( PPARgamma ) is essential for coupling ibuprofen to RhoA inhibition and subsequent neurite growth promotion in neurons .
【GOLD_E】
ibuprofen	chem
peroxisomeproliferator-activatedreceptorgamma	geneY
PPARgamma	geneY
RhoA	geneY
【PRE_E】
peroxisomeproliferator-activatedreceptorgamma	geneY
PPARgamma	geneY
ibuprofen	chem
RhoA	geneY
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】
ibuprofen	RhoA	C4

Ibuprofen activates PPARgamma in neuron - like PC12 and B104 cells .
【GOLD_E】
Ibuprofen	chem
PPARgamma	geneY
【PRE_E】
Ibuprofen	chem
PPARgamma	geneY
【GOLD_R】
Ibuprofen	PPARgamma	C3
【PRE_R】
Ibuprofen	PPARgamma	C3

Activation of PPARgamma with traditional agonists mimics the RhoA - inhibiting properties of ibuprofen in PC12 cells and , like ibuprofen , promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors .
【GOLD_E】
RhoA	geneY
ibuprofen	chem
PPARgamma	geneY
ibuprofen	chem
【PRE_E】
PPARgamma	geneY
RhoA	geneY
ibuprofen	chem
ibuprofen	chem
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】
RhoA	ibuprofen	C4

Protein knockdown with small interfering RNA specific for PPARgamma blocks RhoA suppression of PPARgamma agonists in PC12 cells .
【GOLD_E】
PPARgamma	geneY
RhoA	geneY
PPARgamma	geneY
【PRE_E】
PPARgamma	geneY
RhoA	geneY
PPARgamma	geneY
【GOLD_R】
【PRE_R】

Moreover , the effect of ibuprofen on RhoA activity and neurite growth in neuronal cultures is prevented by selective PPARgamma inhibition .
【GOLD_E】
RhoA	geneY
PPARgamma	geneY
ibuprofen	chem
【PRE_E】
ibuprofen	chem
RhoA	geneN
PPARgamma	geneY
【GOLD_R】
【PRE_R】

These findings support that PPARgamma plays an essential role in mediating the RhoA - inhibiting effect of ibuprofen .
【GOLD_E】
PPARgamma	geneY
RhoA	geneY
ibuprofen	chem
【PRE_E】
PPARgamma	geneY
RhoA	geneY
ibuprofen	chem
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】

Elucidation of the novel molecular mechanisms linking ibuprofen to RhoA inhibition may provide additional therapeutic targets to the disorders characterized by RhoA activation , including spinal cord injuries and Alzheimer 's disease .
【GOLD_E】
RhoA	geneY
RhoA	geneY
ibuprofen	chem
【PRE_E】
ibuprofen	chem
RhoA	geneN
RhoA	geneY
【GOLD_R】
ibuprofen	RhoA	C4
【PRE_R】

Comparative efficacy and safety of the novel oral anticoagulants dabigatran , rivaroxaban and apixaban in preclinical and clinical development .
【GOLD_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【PRE_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【GOLD_R】
【PRE_R】

Therapeutic oral anticoagulation is still commonly achieved by administration of warfarin or other vitamin K antagonists that are associated with an untoward pharmacokinetic / pharmacodynamic ( PK / PD ) profile leading to a high incidence of bleeding complications or therapeutic failure .
【GOLD_E】
warfarin	chem
vitaminK	chem
【PRE_E】
warfarin	chem
vitaminK	chem
【GOLD_R】
【PRE_R】

Hence , there is an unmet medical need of novel easy - to - use oral anticoagulants with improved efficacy and safety .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recent developments include the identification of non - peptidic small - molecules that selectively inhibit certain serine proteases within the coagulation cascade .
【GOLD_E】
serineproteases	geneN
serine	chem
【PRE_E】
serineproteases	geneN
【GOLD_R】
【PRE_R】

Of these , the thrombin inhibitor dabigatran and factor Xa inhibitor rivaroxaban have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe .
【GOLD_E】
dabigatran	chem
rivaroxaban	chem
thrombin	geneY
factorXa	geneY
【PRE_E】
thrombin	geneY
dabigatran	chem
factorXa	geneY
rivaroxaban	chem
【GOLD_R】
dabigatran	thrombin	C4
rivaroxaban	factorXa	C4
【PRE_R】
thrombin	dabigatran	C4
dabigatran	factorXa	C4
factorXa	rivaroxaban	C4

In addition , the factor Xa inhibitor apixaban is in late - stage clinical development .
【GOLD_E】
apixaban	chem
factorXa	geneY
【PRE_E】
factorXa	geneY
apixaban	chem
【GOLD_R】
apixaban	factorXa	C4
【PRE_R】
factorXa	apixaban	C4

Each drug is prescribed at fixed doses without the need of anticoagulant monitoring .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Phase III trials in orthopaedic patients essentially resulted in non - inferior efficacy of dabigatran and superior efficacy of rivaroxaban over enoxaparin without any marked differences of drug safety , while apixaban data is still controversial .
【GOLD_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【PRE_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【GOLD_R】
【PRE_R】

However , alterations of rivaroxaban and apixaban pharmacokinetics upon interactions with inhibitors and inducers of CYP3A4 or P - glycoprotein may complicate the use of these compounds in daily practice , whereas dabigatran elimination largely depends on renal function .
【GOLD_E】
CYP3A4	geneY
P-glycoprotein	geneN
rivaroxaban	chem
apixaban	chem
dabigatran	chem
【PRE_E】
rivaroxaban	chem
apixaban	chem
CYP3A4	geneY
P-glycoprotein	geneN
dabigatran	chem
【GOLD_R】
【PRE_R】
rivaroxaban	CYP3A4	C4
apixaban	CYP3A4	C4
apixaban	P-glycoprotein	C4

Hence , this review reports PK / PD , efficacy and safety data of dabigatran , rivaroxaban and apixaban throughout preclinical and clinical development .
【GOLD_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【PRE_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
【GOLD_R】
【PRE_R】

Captopril directly inhibits matrix metalloproteinase - 2 activity in continuous ambulatory peritoneal dialysis therapy .
【GOLD_E】
matrixmetalloproteinase-2	geneY
Captopril	chem
【PRE_E】
Captopril	chem
matrixmetalloproteinase-2	geneY
【GOLD_R】
Captopril	matrixmetalloproteinase-2	C4
【PRE_R】
Captopril	matrixmetalloproteinase-2	C4

BACKGROUND : Matrix metalloproteinase ( MMP ) - 2 plays an important role in tissue remodeling related to inflammation during continuous ambulatory peritoneal dialysis ( CAPD ) therapy .
【GOLD_E】
Matrixmetalloproteinase(MMP)-2	geneY
【PRE_E】
Matrixmetalloproteinase(MMP)-2	geneY
【GOLD_R】
【PRE_R】

But its inhibitors were not applied clinically .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We determined whether an angiotensin - converting enzyme ( ACE ) inhibitor , captopril , inhibits MMP - 2 activity in peritoneal effluents from patients on CAPD , and simulated molecular models of the MMP - 2 - captopril complex .
【GOLD_E】
angiotensin-convertingenzyme	geneY
ACE	geneY
MMP-2	geneY
MMP-2	geneY
angiotensin	chem
captopril	chem
captopril	chem
【PRE_E】
angiotensin-convertingenzyme	geneY
ACE	geneY
captopril	chem
MMP-2	geneY
CAPD	chem
MMP-2-captopril	chem
【GOLD_R】
captopril	angiotensin-convertingenzyme	C4
captopril	ACE	C4
【PRE_R】
ACE	captopril	C4
captopril	MMP-2	C4
MMP-2	CAPD	C4

METHODS : The inhibitory effect of captopril on MMP - 2 activity was measured in peritoneal effluents from 17 patients on CAPD .
【GOLD_E】
MMP-2	geneY
captopril	chem
【PRE_E】
captopril	chem
MMP-2	geneY
CAPD	chem
【GOLD_R】
captopril	MMP-2	C4
【PRE_R】
captopril	MMP-2	C4

Molecular models of the MMP - 2 - captopril complex were simulated by 1000 iterations of random docking and energy minimization .
【GOLD_E】
MMP-2	geneY
captopril	chem
【PRE_E】
MMP-2-captopril	chem
【GOLD_R】
【PRE_R】

RESULTS : Captopril directly inhibited MMP - 2 activity in peritoneal effluents from patients on CAPD ( IC50 ; 48 micromol / l ) , and that captopril binding to the MMP - 2 active site could be formed in each complex model without molecular distortion .
【GOLD_E】
MMP-2	geneY
MMP-2	geneY
Captopril	chem
captopril	chem
【PRE_E】
Captopril	chem
MMP-2	geneY
CAPD	chem
captopril	chem
MMP-2	geneY
【GOLD_R】
Captopril	MMP-2	C4
【PRE_R】
Captopril	MMP-2	C4
MMP-2	CAPD	C4
captopril	MMP-2	C4

CONCLUSION : ACE inhibitors , such as captopril , may be applied as important compounds for MMP - 2 inhibition in inflammation caused by CAPD .
【GOLD_E】
MMP-2	geneY
ACE	geneY
captopril	chem
【PRE_E】
ACE	geneY
captopril	chem
MMP-2	geneY
CAPD	chem
【GOLD_R】
captopril	MMP-2	C4
captopril	ACE	C4
【PRE_R】
ACE	captopril	C4
captopril	MMP-2	C4
MMP-2	CAPD	C4

Phenformin has a direct inhibitory effect on the ATP - sensitive potassium channel .
【GOLD_E】
Phenformin	chem
ATP	chem
potassium	chem
ATP-sensitivepotassiumchannel	geneN
【PRE_E】
Phenformin	chem
ATP-sensitivepotassiumchannel	geneN
【GOLD_R】
Phenformin	ATP-sensitivepotassiumchannel	C4
【PRE_R】

The biguanides , phenformin and metformin , are used in the treatment of type II diabetes mellitus , as well as being routinely used in studies investigating AMPK activity .
【GOLD_E】
metformin	chem
biguanides	chem
AMPK	geneN
phenformin	chem
【PRE_E】
biguanides	chem
phenformin	chem
metformin	chem
AMPK	geneN
【GOLD_R】
【PRE_R】
biguanides	AMPK	C4
phenformin	AMPK	C4
metformin	AMPK	C4

We used the patch - clamp technique and rubidium flux assays to determine the role of these drugs in ATP - sensitive K + channel ( K ( ATP ) ) regulation in cell lines expressing the cloned components of K ( ATP ) and the current natively expressed in vascular smooth muscle cells ( VSMCs ) .
【GOLD_E】
rubidium	chem
ATP	chem
K+	chem
K	chem
ATP	chem
K	chem
ATP	chem
ATP-sensitiveK+channel	geneN
K(ATP)	geneN
K(ATP)	geneN
【PRE_E】
rubidium	chem
ATP-sensitiveK+channel	geneN
K	chem
ATP	chem
K	chem
ATP	chem
【GOLD_R】
【PRE_R】

Phenformin but not metformin inhibits a number of variants of K ( ATP ) including the cloned equivalents of currents present in vascular and non - vascular smooth muscle ( Kir6.1 / SUR2B and Kir6.2 / SUR2B ) and pancreatic beta - cells ( Kir6.2 / SUR1 ) .
【GOLD_E】
Phenformin	chem
metformin	chem
K	chem
ATP	chem
K(ATP)	geneN
Kir6.1	geneY
SUR2B	geneY
Kir6.2	geneY
SUR2B	geneY
Kir6.2	geneY
SUR1	geneY
【PRE_E】
Phenformin	chem
metformin	chem
K	chem
ATP	chem
Kir6.1	geneY
SUR2B	geneY
Kir6.2	geneY
SUR2B	geneY
Kir6.2	geneY
SUR1	geneY
【GOLD_R】
Phenformin	K(ATP)	C4
Phenformin	Kir6.1	C4
Phenformin	SUR2B	C4
Phenformin	Kir6.2	C4
Phenformin	SUR2B	C4
Phenformin	Kir6.2	C4
Phenformin	SUR1	C4
【PRE_R】
Phenformin	Kir6.1	C4
metformin	Kir6.1	C4
metformin	SUR2B	C4
metformin	Kir6.2	C4
metformin	SUR2B	C4
metformin	Kir6.2	C4
metformin	SUR1	C4

However it does not inhibit the current potentially present in cardiac myocytes ( Kir6.2 / SUR2A ) .
【GOLD_E】
Kir6.2	geneY
SUR2A	geneY
【PRE_E】
Kir6.2	geneY
SUR2A	geneY
【GOLD_R】
【PRE_R】

The highest affinity interaction is seen with Kir6.1 / SUR2B ( IC50 = 0.55 mM ) and it also inhibits the current in native vascular smooth muscle cells .
【GOLD_E】
Kir6.1	geneY
SUR2B	geneY
【PRE_E】
Kir6.1	geneY
SUR2B	geneY
【GOLD_R】
【PRE_R】

The extent and rate of inhibition are similar to that seen with the known K ( ATP ) blocker PNU 37883A .
【GOLD_E】
K	chem
K(ATP)	geneN
ATP	chem
PNU37883A	chem
【PRE_E】
K	chem
ATP	chem
PNU37883A	chem
【GOLD_R】
PNU37883A	K(ATP)	C4
【PRE_R】

Additionally , phenformin inhibited the current elicited through the Kir6.2DeltaC26 ( functional without SUR ) channel with an IC50 of 1.78 mM .
【GOLD_E】
Kir6.2DeltaC26	geneY
SUR	geneY
phenformin	chem
【PRE_E】
phenformin	chem
Kir6.2DeltaC26	geneY
SUR	geneY
【GOLD_R】
phenformin	Kir6.2DeltaC26	C4
【PRE_R】
phenformin	Kir6.2DeltaC26	C4
phenformin	SUR	C4

Phenformin reduced the open probability of Kir6.1 / SUR2B channels by approximately 90 % in inside - out patches .
【GOLD_E】
Kir6.1	geneY
SUR2B	geneY
Phenformin	chem
【PRE_E】
Phenformin	chem
Kir6.1	geneY
SUR2B	geneY
【GOLD_R】
Phenformin	Kir6.1	C4
Phenformin	SUR2B	C4
【PRE_R】
Phenformin	Kir6.1	C4
Phenformin	SUR2B	C4

These findings suggest that phenformin interacts directly with the pore - forming Kir6.0 subunit however the sulphonylurea receptor is able to significantly modulate the affinity .
【GOLD_E】
Kir6.0	geneN
sulphonylureareceptor	geneY
phenformin	chem
sulphonylurea	chem
【PRE_E】
phenformin	chem
Kir6.0	geneN
sulphonylureareceptor	geneN
【GOLD_R】
【PRE_R】

It is likely to block from the intracellular side of the channel in a manner analogous to that of PNU 37883A .
【GOLD_E】
PNU37883A	chem
【PRE_E】
PNU37883A	chem
【GOLD_R】
【PRE_R】

Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis .
【GOLD_E】
paricalcitol	chem
doxercalciferol	chem
【PRE_E】
paricalcitol	chem
doxercalciferol	chem
【GOLD_R】
【PRE_R】

Vitamin D receptor agonists ( VDRAs ) directly suppress parathyroid hormone ( PTH ) mRNA expression .
【GOLD_E】
VitaminD	chem
VitaminDreceptor	geneY
parathyroidhormone	geneY
PTH	geneY
【PRE_E】
VitaminDreceptor	geneY
VDRAs	geneY
parathyroidhormone	geneY
PTH	geneY
【GOLD_R】
【PRE_R】

Different VDRAs are known to have differential effects on serum calcium ( Ca ) , which may also affect serum PTH levels since serum Ca regulates PTH secretion mediated by the Ca - sensing receptor ( CaSR ) .
【GOLD_E】
PTH	geneY
PTH	geneY
Ca-sensingreceptor	geneY
CaSR	geneY
calcium	chem
Ca	chem
Ca	chem
Ca	chem
【PRE_E】
VDRAs	geneY
calcium	chem
Ca)	geneY
PTH	geneY
Ca	geneN
PTH	geneY
Ca-sensingreceptor	geneY
CaSR	geneY
【GOLD_R】
Ca	PTH	C3
【PRE_R】
calcium	Ca	C3

In this study , we compared the effects of paricalcitol and doxercalciferol on regulating serum Ca and PTH , and also the expression of PTH , VDR , and CaSR mRNA .
【GOLD_E】
doxercalciferol	chem
Ca	chem
PTH	geneY
PTH	geneY
VDR	geneY
CaSR	geneY
paricalcitol	chem
【PRE_E】
paricalcitol	chem
doxercalciferol	chem
Ca	geneN
PTH	geneY
PTH	geneY
VDR	geneY
CaSR	geneY
【GOLD_R】
【PRE_R】
paricalcitol	Ca	C3
doxercalciferol	Ca	C3
doxercalciferol	PTH	C3

The 5 / 6 nephrectomized ( NX ) Sprague - Dawley rats on a normal or hyperphosphatemia - inducing diet were treated with vehicle , paricalcitol , or doxercalciferol for two weeks .
【GOLD_E】
paricalcitol	chem
doxercalciferol	chem
【PRE_E】
nephrectomized	chem
NX	chem
hyperphosphatemia	chem
paricalcitol	chem
doxercalciferol	chem
【GOLD_R】
【PRE_R】

Both drugs at the tested doses ( 0.042 - 0.33 mug / kg ) suppressed PTH mRNA expression and serum PTH effectively in the 5 / 6 NX rats , but paricalcitol was less potent in raising serum Ca than doxercalciferol .
【GOLD_E】
paricalcitol	chem
Ca	chem
doxercalciferol	chem
PTH	geneY
PTH	geneY
【PRE_E】
PTH	geneY
PTH	geneY
paricalcitol	chem
Ca	geneN
doxercalciferol	chem
【GOLD_R】
paricalcitol	PTH	C4
doxercalciferol	PTH	C4
paricalcitol	PTH	C4
doxercalciferol	PTH	C4
【PRE_R】
PTH	paricalcitol	C4
PTH	doxercalciferol	C3
Ca	doxercalciferol	C3

In pig parathyroid cells , paricalcitol and the active form of doxercalciferol induced VDR translocation from the cytoplasm into the nucleus , suppressed PTH mRNA expression and inhibited cell proliferation in a similar manner , although paricalcitol induced the expression of CaSR mRNA more effectively .
【GOLD_E】
paricalcitol	chem
doxercalciferol	chem
CaSR	geneY
paricalcitol	chem
VDR	geneY
PTH	geneY
【PRE_E】
paricalcitol	chem
doxercalciferol	chem
VDR	geneY
PTH	geneY
paricalcitol	chem
CaSR	geneY
【GOLD_R】
paricalcitol	CaSR	C3
paricalcitol	PTH	C4
doxercalciferol	PTH	C4
【PRE_R】
paricalcitol	VDR	C3
doxercalciferol	VDR	C3
PTH	paricalcitol	C3
paricalcitol	CaSR	C3

The multiple effects of VDRAs on modulating serum Ca , parathyroid cell proliferation , and the expression of CaSR and PTH mRNA reflect the complex involvement of the vitamin D axis in regulating the mineral homeostasis system .
【GOLD_E】
CaSR	geneN
PTH	geneN
Ca	chem
vitaminD	chem
【PRE_E】
VDRAs	geneY
Ca	geneN
CaSR	geneY
PTH	geneY
vitaminD	chem
【GOLD_R】
【PRE_R】

Identification of a primary target of thalidomide teratogenicity .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

Half a century ago , thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic , causing multiple birth defects .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

Today , thalidomide is still used in the treatment of leprosy and multiple myeloma , although how it causes limb malformation and other developmental defects is unknown .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

Here , we identified cereblon ( CRBN ) as a thalidomide - binding protein .
【GOLD_E】
thalidomide-bindingprotein	geneN
thalidomide	chem
cereblon	geneN
CRBN	geneN
【PRE_E】
cereblon	geneY
CRBN	geneY
thalidomide-bindingprotein	geneN
【GOLD_R】
【PRE_R】

CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 ( DDB1 ) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks .
【GOLD_E】
CRBN	geneN
E3ubiquitinligasecomplex	geneN
damagedDNAbindingprotein1	geneN
DDB1	geneN
Cul4A	geneN
fibroblastgrowthfactor	geneN
Fgf8	geneN
【PRE_E】
CRBN	geneY
E3ubiquitinligase	geneN
DNAbindingprotein1	geneY
DDB1	geneY
Cul4A	geneY
fibroblastgrowthfactorFgf8	geneN
【GOLD_R】
【PRE_R】

Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity .
【GOLD_E】
CRBN	geneN
ubiquitinligase	geneN
Thalidomide	chem
【PRE_E】
Thalidomide	chem
CRBN	geneY
ubiquitinligase	geneN
【GOLD_R】
Thalidomide	ubiquitinligase	C4
【PRE_R】

This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity .
【GOLD_E】
thalidomide	chem
thalidomide	chem
【PRE_E】
thalidomide	chem
thalidomide	chem
【GOLD_R】
【PRE_R】

A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin - actin binding .
【GOLD_E】
troponinC	geneY
myosin	geneN
actin	geneN
【PRE_E】
troponinC	geneY
myosin-actin	geneN
【GOLD_R】
【PRE_R】

In this study we explore the mechanisms by which a double mutation ( E59D / D75Y ) in cardiac troponin C ( CTnC ) associated with dilated cardiomyopathy reduces the Ca ( 2 + ) - activated maximal tension of cardiac muscle .
【GOLD_E】
Ca(2+)	chem
E59D	geneN
D75Y	geneN
cardiactroponinC	geneY
CTnC	geneY
【PRE_E】
E59D	geneN
D75Y	geneN
cardiactroponinC	geneY
CTnC	geneN
Ca(2+)	chem
【GOLD_R】
【PRE_R】

Studying the single mutants ( i.e .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

E59D or D75Y ) indicates that D75Y , but not E59D , causes a reduction in the calcium affinity of CTnC in troponin complex , regulated thin filaments ( RTF ) , and the Ca ( 2 + ) sensitivity of contraction and ATPase in cardiac muscle preparations .
【GOLD_E】
E59D	geneN
D75Y	geneN
D75Y	geneN
E59D	geneN
CTnC	geneY
troponin	geneN
regulatedthinfilaments	geneN
RTF	geneN
ATPase	geneN
Ca(2+)	chem
【PRE_E】
E59D	geneN
D75Y	geneN
D75Y	geneN
E59D	geneN
calcium	chem
CTnC	geneN
troponin	geneN
Ca(2+)	chem
ATPase	geneN
【GOLD_R】
【PRE_R】

However , both D75Y and E59D are required to reduce the actomyosin ATPase activity and maximal force in muscle fibers , indicating that E59D enhances the effects of D75Y .
【GOLD_E】
D75Y	geneN
E59D	geneN
actomyosin	geneN
ATPase	geneN
E59D	geneN
D75Y	geneN
【PRE_E】
D75Y	geneN
E59D	geneN
actomyosinATPase	geneN
E59D	geneN
D75Y	geneN
【GOLD_R】
【PRE_R】

Part of the reduction in force / ATPase may be due to a defect in the interactions between CTnC and cardiac troponin T , which are known to be necessary for ATPase activation .
【GOLD_E】
ATPase	geneN
CTnC	geneY
cardiactroponinT	geneY
ATPase	geneN
【PRE_E】
ATPase	geneN
CTnC	geneN
cardiactroponinT	geneN
ATPase	geneN
【GOLD_R】
【PRE_R】

An additional mechanism for the reduction in force / ATPase comes from measurements of the binding stoichiometry of myosin subfragment - 1 ( S - 1 ) to the RTF .
【GOLD_E】
ATPase	geneN
myosinsubfragment-1	geneN
S-1	geneN
RTF	geneN
【PRE_E】
ATPase	geneN
myosinsubfragment-1	geneY
RTF	geneN
【GOLD_R】
【PRE_R】

Using wild type RTFs , 4.8 mol S - 1 was bound per mol filament ( seven actins ) , whereas with E59D / D75Y RTFs , the number of binding sites was reduced by approximately 23 % to 3.7 .
【GOLD_E】
RTFs	geneN
S-1	geneN
E59D	geneN
D75Y	geneN
RTFs	geneN
【PRE_E】
E59D	geneN
D75Y	geneN
【GOLD_R】
【PRE_R】

Altogether , these results suggest that the reduction in force and ATPase activation is possibly due to a thin filament conformation that promotes fewer accessible S - 1 - binding sites .
【GOLD_E】
ATPase	geneN
S-1-bindingsites	geneN
【PRE_E】
ATPase	geneN
【GOLD_R】
【PRE_R】

In the absence of any family segregation data , the functional results presented here support the concept that this is likely a dilated cardiomyopathy - causing mutation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Zolmitriptan and human aggression : interaction with alcohol .
【GOLD_E】
Zolmitriptan	chem
alcohol	chem
【PRE_E】
Zolmitriptan	chem
alcohol	chem
【GOLD_R】
【PRE_R】

RATIONALE : The serotonin 1 ( B / D ) ( 5 - HT1 ( B / D ) ) receptor has shown potential as a target for decreasing aggression .
【GOLD_E】
serotonin1(B/D)	geneN
5-HT1(B/D)	geneN
serotonin	chem
【PRE_E】
serotonin1(B/D)(5-HT1(B/D))receptor	geneN
【GOLD_R】
【PRE_R】

The 5 - HT1 ( B / D ) agonist zolmitriptan 's ability to reduce aggressive behavior in humans and its interaction with the well - known aggression - enhancing drug alcohol were examined .
【GOLD_E】
alcohol	chem
5-HT1(B/D)	geneN
【PRE_E】
5-HT1	geneY
B/D	geneN
alcohol	chem
【GOLD_R】
【PRE_R】

OBJECTIVES : Our objective was to investigate zolmitriptan 's potential to modify human aggression in a laboratory paradigm across a range of alcohol doses .
【GOLD_E】
alcohol	chem
【PRE_E】
alcohol	chem
【GOLD_R】
【PRE_R】

Alcohol has been consistently associated with aggression and violence , thus we hoped to expand current understanding of alcohol 's role in aggressive behavior via manipulation of the serotonin ( 5 - HT ) system .
【GOLD_E】
Alcohol	chem
serotonin	chem
5-HT	chem
【PRE_E】
Alcohol	chem
serotonin	chem
5-HT	chem
【GOLD_R】
【PRE_R】

METHODS : Eleven social drinkers , seven male , were recruited to participate in a research study lasting 3 - 4 weeks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Aggression was measured using the point - subtraction aggression paradigm ( PSAP ) , a laboratory model widely used in human aggression studies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Subjects were administered 5 - mg zolmitriptan and placebo capsules along with alcohol doses of 0.0 , 0.4 and 0.8 g / kg in a within - subject , counterbalanced dosing design .
【GOLD_E】
zolmitriptan	chem
alcohol	chem
【PRE_E】
5-mgzolmitriptan	chem
alcohol	chem
【GOLD_R】
【PRE_R】

Data were analyzed as the ratio of aggressive / monetary - earning responses , to account for possible changes in overall motor function due to alcohol .
【GOLD_E】
alcohol	chem
【PRE_E】
alcohol	chem
【GOLD_R】
【PRE_R】

RESULTS : There was a significant alcohol by zolmitriptan interaction on the aggressive / monetary response ratio .
【GOLD_E】
alcohol	chem
zolmitriptan	chem
【PRE_E】
alcohol	chem
zolmitriptan	chem
【GOLD_R】
【PRE_R】

Specifically , compared to placebo , zolmitriptan decreased the aggressive / monetary ratio at the 0.4 - and 0.8 - g / kg alcohol doses .
【GOLD_E】
zolmitriptan	chem
alcohol	chem
【PRE_E】
zolmitriptan	chem
alcohol	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : A 5 - mg dose of zolmitriptan effectively reduced alcohol - related aggression in an acute dosing protocol , demonstrating an interaction of 5 - HT and alcohol in human aggressive behavior .
【GOLD_E】
alcohol	chem
zolmitriptan	chem
alcohol	chem
5-HT	chem
【PRE_E】
zolmitriptan	chem
alcohol	chem
5-HT	chem
alcohol	chem
【GOLD_R】
【PRE_R】

New standards in hypertension and cardiovascular risk management : focus on telmisartan .
【GOLD_E】
telmisartan	chem
【PRE_E】
telmisartan	chem
【GOLD_R】
【PRE_R】

Blockade of the renin - angiotensin system is an important approach in managing high blood pressure , and has increasingly been shown to affect cardiovascular disease processes mediated by angiotensin II throughout the cardiovascular and renal continua .
【GOLD_E】
renin	geneY
angiotensinII	geneY
angiotensin	geneY
angiotensinII	chem
angiotensin	chem
【PRE_E】
renin	geneY
angiotensin	geneY
angiotensinII	geneY
【GOLD_R】
【PRE_R】

Telmisartan is an angiotensin II receptor blocker ( ARB ) displaying unique pharmacologic properties , including a longer half life than any other ARB , that result in large and sustained reductions of blood pressure .
【GOLD_E】
angiotensinIIreceptor	geneN
Telmisartan	chem
angiotensinII	chem
【PRE_E】
Telmisartan	chem
angiotensinIIreceptor	geneY
【GOLD_R】
Telmisartan	angiotensinIIreceptor	C4
【PRE_R】

In patients with mild - to - moderate hypertension , telmisartan has proved superior to other antihypertensive agents ( valsartan , losartan , ramipril , perindopril , and atenolol ) in controlling blood pressure particularly towards the end of the dosing interval .
【GOLD_E】
losartan	chem
ramipril	chem
perindopril	chem
atenolol	chem
telmisartan	chem
valsartan	chem
【PRE_E】
telmisartan	chem
valsartan	chem
losartan	chem
ramipril	chem
perindopril	chem
atenolol	chem
【GOLD_R】
【PRE_R】

There is also clinical evidence that telmisartan reduces left ventricular hypertrophy , reduces arterial stiffness and the recurrence of atrial fibrillation , and confers renoprotection .
【GOLD_E】
telmisartan	chem
【PRE_E】
telmisartan	chem
【GOLD_R】
【PRE_R】

The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial ( ONTARGET ) study has demonstrated that telmisartan has similar cardiovascular protective effects to ramipril in a large , high - risk patient population but was better tolerated .
【GOLD_E】
Telmisartan	chem
Ramipril	chem
telmisartan	chem
ramipril	chem
【PRE_E】
Telmisartan	chem
Ramipril	chem
telmisartan	chem
ramipril	chem
【GOLD_R】
【PRE_R】

The powerful and sustained blood pressure control apparent in clinical trials , together with cardiovascular protection and tolerability demonstrated in ONTARGET means that telmisartan may be a preferred option for patients with hypertension .
【GOLD_E】
telmisartan	chem
【PRE_E】
telmisartan	chem
【GOLD_R】
【PRE_R】

Jostling for position : optimizing linker location in the design of estrogen receptor - targeting PROTACs .
【GOLD_E】
estrogen	chem
estrogenreceptor	geneN
【PRE_E】
estrogenreceptor	geneY
PROTACs	geneN
【GOLD_R】
【PRE_R】

Estrogen receptor - alpha ( ER ) antagonists have been widely used for breast cancer therapy .
【GOLD_E】
Estrogenreceptor-alpha	geneN
Estrogen	chem
ER	geneN
【PRE_E】
Estrogenreceptor-alpha	geneY
ER	geneY
【GOLD_R】
【PRE_R】

Despite initial responsiveness , hormone - sensitive ER - positive cancer cells eventually develop resistance to ER antagonists .
【GOLD_E】
ER	geneN
ER	geneN
【PRE_E】
ER	geneY
ER	geneY
【GOLD_R】
【PRE_R】

It has been shown that in most of these resistant tumor cells , the ER is expressed and continues to regulate tumor growth .
【GOLD_E】
ER	geneN
【PRE_E】
ER	geneY
【GOLD_R】
【PRE_R】

Recent studies indicate that tamoxifen initially acts as an antagonist , but later functions as an ER agonist , promoting tumor growth .
【GOLD_E】
ER	geneN
tamoxifen	chem
【PRE_E】
tamoxifen	chem
ER	geneY
【GOLD_R】
tamoxifen	ER	C5
tamoxifen	ER	C6
【PRE_R】

This suggests that targeted ER degradation may provide an effective therapeutic approach for breast cancers , even those that are resistant to conventional therapies .
【GOLD_E】
ER	geneN
【PRE_E】
ER	geneY
【GOLD_R】
【PRE_R】

With this in mind , we previously demonstrated that proteolysis targeting chimeras ( PROTACs ) effectively induce degradation of the ER as a proof - of - concept experiment .
【GOLD_E】
ER	geneN
【PRE_E】
PROTACs	geneN
ER	geneY
【GOLD_R】
【PRE_R】

Herein we further refined the PROTAC approach to target the ER for degradation .
【GOLD_E】
ER	geneN
【PRE_E】
PROTAC	geneY
ER	geneY
【GOLD_R】
【PRE_R】

The ER - targeting PROTACs are composed of an estradiol on one end and a hypoxia - inducing factor 1alpha ( HIF - 1alpha ) - derived synthetic pentapeptide on the other .
【GOLD_E】
ER	geneN
hypoxia-inducingfactor1alpha	geneN
HIF-1alpha	geneN
estradiol	chem
【PRE_E】
ER	geneY
PROTACs	geneN
estradiol	chem
hypoxia-inducingfactor1alpha	geneY
HIF-1alpha	geneY
pentapeptide	chem
【GOLD_R】
【PRE_R】

The pentapeptide is recognized by an E3 ubiquitin ligase called the von Hippel Lindau tumor suppressor protein ( pVHL ) , thereby recruiting the ER to this E3 ligase for ubiquitination and degradation .
【GOLD_E】
E3ubiquitinligase	geneN
vonHippelLindautumorsuppressorprotein	geneN
pVHL	geneN
ER	geneN
E3ligase	geneN
【PRE_E】
pentapeptide	geneN
E3	geneN
ubiquitinligase	geneN
vonHippelLindautumorsuppressorprotein	geneY
pVHL	geneY
ER	geneY
E3ligase	geneN
【GOLD_R】
【PRE_R】

Specifically , the pentapeptide is attached at three different locations on estradiol to generate three different PROTAC types .
【GOLD_E】
estradiol	chem
【PRE_E】
pentapeptide	geneN
estradiol	chem
PROTAC	geneN
【GOLD_R】
【PRE_R】

With the pentapeptide linked through the C7alpha position of estradiol , the resulting PROTAC shows the most effective ER degradation and highest affinity for the estrogen receptor .
【GOLD_E】
ER	geneN
estrogenreceptor	geneN
estradiol	chem
estrogen	chem
【PRE_E】
pentapeptide	chem
C7alpha	chem
estradiol	chem
PROTAC	geneN
ER	geneY
estrogenreceptor	geneY
【GOLD_R】
estradiol	ER	C4
【PRE_R】

This result provides an opportunity to develop a novel type of ER antagonist that may overcome the resistance of breast tumors to conventional drugs such as tamoxifen and fulvestrant ( Faslodex ) .
【GOLD_E】
ER	geneN
tamoxifen	chem
fulvestrant	chem
Faslodex	chem
【PRE_E】
ER	geneY
tamoxifen	chem
fulvestrant	chem
Faslodex	chem
【GOLD_R】
【PRE_R】

C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid , vitamin B12 , and homocysteine serum levels in Turkish children with neural tube defects .
【GOLD_E】
homocysteine	chem
methylenetetrahydrofolate	chem
folicacid	chem
vitaminB12	chem
C677T	geneN
methylenetetrahydrofolatereductase	geneY
【PRE_E】
C677T	geneY
methylenetetrahydrofolatereductase	geneY
folicacid	chem
vitaminB12	chem
homocysteine	chem
【GOLD_R】
【PRE_R】

Association between neural tube defects ( NTDs ) and C677T polymorphism of the methylenetetrahydrofolate reductase ( MTHFR ) gene was suspected , because the MTHFR gene codes for a key enzyme in folate metabolism .
【GOLD_E】
methylenetetrahydrofolate	chem
MTHFR	geneY
MTHFR	geneY
C677T	geneN
methylenetetrahydrofolatereductase	geneY
folate	chem
【PRE_E】
C677T	geneY
methylenetetrahydrofolatereductase	geneY
MTHFR	geneY
MTHFR	geneY
folate	chem
【GOLD_R】
【PRE_R】

Its deficiency usually leads to significant reductions in plasma concentrations of folate , vitamin B ( 12 ) and methionine , whereas homocysteine levels are increased .
【GOLD_E】
folate	chem
vitaminB(12)	chem
methionine	chem
homocysteine	chem
【PRE_E】
folate	chem
vitaminB(12)	chem
methionine	chem
homocysteine	chem
【GOLD_R】
【PRE_R】

We examined folate , vitamin B ( 12 ) and homocysteine serum concentrations and polymorphism of the C677T MTHFR gene in Turkish children with neural tube defects .
【GOLD_E】
folate	chem
vitaminB(12)	chem
homocysteine	chem
C677T	geneN
MTHFR	geneY
【PRE_E】
folate	chem
vitaminB(12)	chem
homocysteine	chem
C677T	geneN
MTHFR	geneY
【GOLD_R】
【PRE_R】

Thirty - three children with NTDs , 26 mothers and 48 healthy individuals were studied .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

C677T MTHFR polymorphism was determined by melting curve analyses ( LightCycler ) .
【GOLD_E】
C677T	geneN
MTHFR	geneY
【PRE_E】
C677T	geneN
MTHFR	geneY
【GOLD_R】
【PRE_R】

The levels of folate , vitamin B ( 12 ) and homocysteine serum concentrations in NTDs were evaluated and compared , along with information concerning alleles of the MTHFR gene .
【GOLD_E】
folate	chem
vitaminB(12)	chem
homocysteine	chem
MTHFR	geneY
【PRE_E】
folate	chem
vitaminB(12)	chem
homocysteine	chem
MTHFR	geneY
【GOLD_R】
【PRE_R】

C677T allele frequencies in NTD children and their mothers were similar to those found in controls .
【GOLD_E】
C677T	geneN
【PRE_E】
C677T	geneY
【GOLD_R】
【PRE_R】

Serum folate and vitamin B ( 12 ) concentrations were significantly higher in NTD children than that of controls .
【GOLD_E】
folate	chem
vitaminB(12)	chem
【PRE_E】
folate	chem
vitaminB(12)	chem
【GOLD_R】
【PRE_R】

Serum homocysteine concentrations were not significantly higher in NTD children and mothers .
【GOLD_E】
homocysteine	chem
【PRE_E】
homocysteine	chem
【GOLD_R】
【PRE_R】

We concluded that C677T MTHFR gene polymorphism does not affect folic acid , vitamin B ( 12 ) and homocysteine metabolism in Turkish children with NTDs .
【GOLD_E】
C677T	geneN
MTHFR	geneY
folicacid	chem
vitaminB(12)	chem
homocysteine	chem
【PRE_E】
C677TMTHFR	geneY
folicacid	chem
vitaminB(12)	chem
homocysteine	chem
【GOLD_R】
【PRE_R】

C677T polymorphism of the MTHFR gene can not be regarded as a major risk factor for NTDs in Turkish children .
【GOLD_E】
C677T	geneN
MTHFR	geneY
【PRE_E】
C677T	geneY
MTHFR	geneY
【GOLD_R】
【PRE_R】

The selectivity of beta - adrenoceptor agonists at human beta1 - , beta2 - and beta3 - adrenoceptors .
【GOLD_E】
beta-adrenoceptor	geneN
humanbeta1-,beta2-andbeta3-adrenoceptors	geneN
【PRE_E】
beta-adrenoceptor	geneY
humanbeta1-,beta2-andbeta3-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

BACKGROUND AND PURPOSE : There are two important properties of receptor - ligand interactions : affinity ( the ability of the ligand to bind to the receptor ) and efficacy ( the ability of the receptor - ligand complex to induce a response ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ligands are classified as agonists or antagonists depending on whether or not they have efficacy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In theory , it is possible to develop selective agonists based on selective affinity , selective intrinsic efficacy or both .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study examined the affinity and intrinsic efficacy of 31 beta - adrenoceptor agonists at the three human beta - adrenoceptors to determine whether the current agonists are subtype selective because of affinity or intrinsic efficacy .
【GOLD_E】
beta-adrenoceptor	geneN
humanbeta-adrenoceptors	geneN
【PRE_E】
beta-adrenoceptor	geneN
humanbeta-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

EXPERIMENTAL APPROACH : Stable clonal CHO - K1 cell lines , transfected with either the human beta ( 1 ) , beta ( 2 ) or beta ( 3 ) - adrenoceptor , were used , and whole - cell [ ( 3 ) H ] - CGP 12177 radioligand binding and [ ( 3 ) H ] - cAMP accumulation were measured .
【GOLD_E】
[(3)H]-CGP12177	chem
[(3)H]-cAMP	chem
humanbeta(1),beta(2)orbeta(3)-adrenoceptor	geneN
【PRE_E】
humanbeta(1)	geneY
beta(2)	geneY
beta(3)-adrenoceptor	geneN
[(3)H]-CGP12177	chem
[(3)H]-cAMP	chem
【GOLD_R】
【PRE_R】

KEY RESULTS : Several agonists were found to be highly subtype selective because of selective affinity ( e.g . salmeterol and formoterol , for the beta ( 2 ) - adrenoceptor over the beta ( 1 ) or beta ( 3 ) ) , while others ( e.g . isoprenaline ) had little affinity - selectivity .
【GOLD_E】
beta(2)-adrenoceptor	geneY
beta(1)	geneY
beta(3)	geneY
salmeterol	chem
formoterol	chem
isoprenaline	chem
【PRE_E】
salmeterol	chem
formoterol	chem
beta(2)-adrenoceptor	geneY
beta(3)	geneY
isoprenaline	chem
【GOLD_R】
salmeterol	beta(2)-adrenoceptor	C5
salmeterol	beta(1)	C5
formoterol	beta(2)-adrenoceptor	C5
formoterol	beta(3)	C5
isoprenaline	beta(2)-adrenoceptor	C5
isoprenaline	beta(1)	C5
isoprenaline	beta(3)	C5
【PRE_R】

However , the intrinsic efficacy of salmeterol , formoterol and isoprenaline was similar across all three receptor subtypes .
【GOLD_E】
salmeterol	chem
formoterol	chem
isoprenaline	chem
【PRE_E】
salmeterol	chem
formoterol	chem
isoprenaline	chem
【GOLD_R】
【PRE_R】

Other ligands ( e.g . denopamine for beta ( 1 ) ; clenbuterol , AZ 40140d , salbutamol for beta ( 2 ) ) were found to have subtype - selective intrinsic efficacy .
【GOLD_E】
salbutamol	chem
beta(1)	geneY
beta(2)	geneY
denopamine	chem
clenbuterol	chem
AZ40140d	chem
【PRE_E】
denopamine	chem
beta(1)	chem
clenbuterol	chem
AZ40140d	chem
salbutamol	chem
beta(2)	geneY
【GOLD_R】
【PRE_R】

Several ligands appeared to activate two agonist conformations of the beta ( 1 ) - and beta ( 3 ) - adrenoceptors .
【GOLD_E】
beta(1)-andbeta(3)-adrenoceptors	geneN
【PRE_E】
beta(1)-andbeta(3)-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

CONCLUSIONS AND IMPLICATIONS : There are agonists with subtype selectivity based upon both selective affinity and selective intrinsic efficacy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , there is scope to develop better selective agonists based upon both selective affinity and selective intrinsic efficacy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rasagiline : a novel anti - Parkinsonian monoamine oxidase - B inhibitor with neuroprotective activity .
【GOLD_E】
Rasagiline	chem
monoamine	chem
monoamineoxidase-B	geneY
【PRE_E】
Rasagiline	chem
Parkinsonianmonoamineoxidase-B	geneY
【GOLD_R】
Rasagiline	monoamineoxidase-B	C4
【PRE_R】

Rasagiline ( N - propargyl - 1 - ( R ) - aminoindan ) is a novel , highly potent irreversible monoamine oxidase ( MAO ) - B inhibitor , anti - Parkinsonian drug .
【GOLD_E】
monoamine	chem
monoamineoxidase(MAO)-B	geneY
Rasagiline	chem
N-propargyl-1-(R)-aminoindan	chem
【PRE_E】
Rasagiline	chem
N-propargyl-1-(R)-aminoindan	chem
monoamineoxidase(MAO)-B	geneY
【GOLD_R】
Rasagiline	monoamineoxidase(MAO)-B	C4
N-propargyl-1-(R)-aminoindan	monoamineoxidase(MAO)-B	C4
【PRE_R】

Rasagiline is effective as monotherapy or adjunct to L - Dopa for patients with early and late Parkinson 's disease ( PD ) .
【GOLD_E】
Rasagiline	chem
L-Dopa	chem
【PRE_E】
Rasagiline	chem
L-Dopa	chem
【GOLD_R】
【PRE_R】

Its S - isomer , TVP1022 is thousand times less potent as an MAO - B inhibitor .
【GOLD_E】
MAO-B	geneY
TVP1022	chem
【PRE_E】
TVP1022	chem
MAO-B	geneY
【GOLD_R】
TVP1022	MAO-B	C4
【PRE_R】
TVP1022	MAO-B	C4

However , both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models , indicating that the neuroprotective effect of rasagiline does not depend on inhibition of MAO - B , but rather is associated with the N - propargyl moiety , which promotes mitochondrial viability and stabilizes permeability transition by regulating Bcl - 2 family proteins .
【GOLD_E】
MAO-B	geneY
Bcl-2	geneY
rasagiline	chem
N-propargyl	chem
【PRE_E】
rasagiline	chem
MAO-B	geneY
N-propargyl	chem
Bcl-2	geneY
【GOLD_R】
N-propargyl	Bcl-2	C3
rasagiline	MAO-B	C4
【PRE_R】

Novel findings demonstrated that the major metabolite of rasagiline , 1 - ( R ) - aminoindan has antioxidant and neuroprotective capabilities and thus , may contribute to the overt activity of its parent compound , rasagiline .
【GOLD_E】
1-(R)-aminoindan	chem
rasagiline	chem
rasagiline	chem
【PRE_E】
rasagiline	chem
1-(R)-aminoindan	chem
rasagiline	chem
【GOLD_R】
【PRE_R】

This paper will review the earlier and present studies in the development of rasagiline for treatment of PD and discuss its pharmacology and applicable mechanism of action .
【GOLD_E】
rasagiline	chem
【PRE_E】
rasagiline	chem
【GOLD_R】
【PRE_R】

Resistance to thyroid hormone due to a novel thyroid hormone receptor mutant in a patient with hypothyroidism secondary to lingual thyroid and functional characterization of the mutant receptor .
【GOLD_E】
thyroidhormonereceptor	geneN
【PRE_E】
thyroidhormonereceptor	geneN
【GOLD_R】
【PRE_R】

BACKGROUND : We describe a rare case of congenital hypothyroidism and an extremely high serum thyrotropin ( TSH ) level caused by a combination of resistance to thyroid hormone ( RTH ) and a lingual thyroid .
【GOLD_E】
TSH	geneN
thyrotropin	geneN
【PRE_E】
serumthyrotropin	geneY
TSH	geneN
thyroidhormone	geneY
RTH	geneY
【GOLD_R】
【PRE_R】

As the RTH mutant , R316C , was new , the optimum dose of levothyroxine was unclear .
【GOLD_E】
R316C	geneN
levothyroxine	chem
【PRE_E】
RTH	geneY
R316C	geneY
levothyroxine	chem
【GOLD_R】
【PRE_R】

To aid in assessment of the therapy , we characterized the mutant R316C thyroid hormone receptor ( TR ) and compared it with a common mutant , R316H , using in vitro studies .
【GOLD_E】
R316C	geneN
thyroidhormonereceptor	geneN
TR	geneN
R316H	geneN
【PRE_E】
R316Cthyroidhormonereceptor	geneN
TR	geneN
R316H	geneY
【GOLD_R】
【PRE_R】

SUMMARY : The patient was a newborn female having severe hypothyroidism with a free thyroxine level of 0.36 ng / dL and a serum TSH level of 177 microU / mL .
【GOLD_E】
TSH	geneN
thyroxine	chem
【PRE_E】
thyroxine	chem
TSH	geneN
【GOLD_R】
【PRE_R】

A scintiscan showed ectopic lingual thyroid tissue without a normal thyroid gland .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Supplementation with levothyroxine at a dose of > 350 microg / day did not normalize the serum TSH level ; however , the patient showed normal growth and intelligence at 14 years of age .
【GOLD_E】
TSH	geneN
levothyroxine	chem
【PRE_E】
levothyroxine	chem
TSH	geneN
【GOLD_R】
【PRE_R】

Consistent with the results of a computer analysis , the binding of R316C to triiodothyronine ( T3 ) was significantly decreased to 38 % that of the wild type .
【GOLD_E】
T3	chem
R316C	geneN
triiodothyronine	chem
【PRE_E】
R316C	geneY
triiodothyronine	chem
【GOLD_R】
【PRE_R】

Electrophoretic mobility shift assay demonstrated that like R316H , R316C did not form a homodimer , but formed a heterodimer with RXR .
【GOLD_E】
R316H	geneN
R316C	geneN
RXR	geneN
【PRE_E】
R316H	geneY
R316C	geneY
RXR	geneN
【GOLD_R】
【PRE_R】

However , a glutathione - S - transferase pull - down assay showed reduced binding of R316C with NCoR in the absence of T3 and impaired release in the presence of T3 .
【GOLD_E】
R316C	geneN
NCoR	geneY
glutathione	chem
S	chem
T3	chem
T3	chem
【PRE_E】
glutathione-S-transferase	geneN
R316C	geneY
NCoR	geneY
【GOLD_R】
【PRE_R】

In addition , transient transfection experiments demonstrated that unlike R316H , R316C had severe impairment of transcriptional activity on genes both positively and negatively regulated by thyroid hormone .
【GOLD_E】
R316H	geneN
R316C	geneN
【PRE_E】
R316H	geneY
R316C	geneY
【GOLD_R】
【PRE_R】

It also had a clear dominant negative effect on genes negatively , but not positively , regulated by thyroid hormone , including the TSH - releasing hormone and TSHbeta genes .
【GOLD_E】
TSH-releasinghormone	geneY
TSHbeta	geneY
【PRE_E】
TSH-releasinghormone	geneY
TSHbeta	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : This is the first reported case of a R316C TR mutation .
【GOLD_E】
R316C	geneN
TR	geneN
【PRE_E】
R316C	geneY
TR	geneN
【GOLD_R】
【PRE_R】

The characteristics of the R316C mutant differed from those of the R316H mutant .
【GOLD_E】
R316C	geneN
R316H	geneN
【PRE_E】
R316C	geneY
R316H	geneY
【GOLD_R】
【PRE_R】

Our findings suggest that R316C causes reduced association with and impaired release of NCoR , resulting in RTH predominantly at the pituitary level , and that slightly elevated serum TSH level with high dose of levothyroxine might be optimum for normal growth .
【GOLD_E】
R316C	geneN
NCoR	geneY
TSH	geneN
levothyroxine	chem
【PRE_E】
R316C	geneY
NCoR	geneY
RTH	geneY
TSH	geneN
levothyroxine	chem
【GOLD_R】
levothyroxine	TSH	C3
【PRE_R】
TSH	levothyroxine	C3

Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In order to shorten the list of candidate drugs with anticonvulsant potential against nerve agents , critical subreceptors in seizure controlling brain regions should be specified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Epileptiform activity does not spread randomly throughout the brain , but appears to be generated and propagated by specific anatomical routes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Nerve agents evoke seizure activity in the forebrain that progresses to the hind brain resulting in tonic - clonic convulsions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In some recent studies , it was shown that lesion of the area tempestas ( AT ) , medial septum ( MS ) , perirhinal cortex ( PRC ) , or posterior piriform cortex ( PPC ) produces anticonvulsant effects ( prevention of convulsions or delayed onset of convulsions ) in rats exposed to soman , whereas damage to nucleus accumbens , nucleus basalis magnocellularis , amygdala , hippocampus , or entorhinal cortex does not cause anticonvulsant impact .
【GOLD_E】
soman	chem
【PRE_E】
soman	chem
【GOLD_R】
【PRE_R】

These results are in compliance with findings that seizures can be generated in AT , MS , PRC , and PPC by means of nerve agents , chemoconvulsants , or kindling .
【GOLD_E】
【PRE_E】
chemoconvulsants	chem
kindling	chem
【GOLD_R】
【PRE_R】

Results from microinfusion studies show that anticonvulsant efficacy is obtained by GABA ( A ) modulators or cholinergic antagonists ( M1 - M5 ) in AT , cholinergic antagonists ( M1 - M5 ) in MS , combined glutamatergic ( NMDA ) and cholinergic antagonist ( M1 - M4 ) , AMPA antagonist , or modulators of metabotropic glutamate receptors ( mGluR5 , mGluR2 / 3 ) in PRC , and cholinergic antagonist ( M1 - M5 ) or GABA ( A ) agonist in PPC .
【GOLD_E】
GABA(A)	geneN
M1	geneY
M5	geneY
M1	geneY
M5	geneY
M1	geneY
M4	geneY
metabotropicglutamatereceptors	geneN
mGluR5	geneY
GABA	chem
mGluR2/3	geneN
M1	geneY
M5	geneY
GABA(A)	geneN
NMDA	chem
AMPA	chem
glutamate	chem
【PRE_E】
microinfusion	chem
GABA(A)	geneN
M1-M5	chem
M1-M5	chem
NMDA	chem
M1-M4	chem
AMPA	chem
metabotropicglutamatereceptors	geneN
mGluR5	geneY
mGluR2/3	geneN
M1-M5	chem
GABA(A)	geneN
【GOLD_R】
【PRE_R】

Calculation of impact factors for the most potent drugs ( percentage of positive effects in the seizure controlling sites ) showed that scopolamine and procyclidine were ranking highest ( 75 ) followed by muscimol ( 50 ) , NBQX ( 33 ) , and caramiphen ( 33 ) .
【GOLD_E】
scopolamine	chem
procyclidine	chem
muscimol	chem
NBQX	chem
caramiphen	chem
【PRE_E】
scopolamine	chem
procyclidine	chem
muscimol	chem
NBQX	chem
caramiphen	chem
【GOLD_R】
【PRE_R】

Potential strategies for prophylactic and post - exposure treatments are discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Selective cyclooxygenase - 2 ( COX - 2 ) inhibitors and breast cancer risk .
【GOLD_E】
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
cyclooxygenase-2	geneY
COX-2	geneY
【GOLD_R】
【PRE_R】

BACKGROUND : Recent epidemiologic and laboratory studies have suggested that non - steroidal anti - inflammatory drugs ( NSAIDs ) may reduce the risk of breast cancer through inhibition of cyclooxygenase - 2 ( COX - 2 ) .
【GOLD_E】
cyclooxygenase-2	geneY
COX-2	geneY
steroidal	chem
【PRE_E】
steroidal	chem
cyclooxygenase-2	geneY
COX-2	geneY
【GOLD_R】
steroidal	cyclooxygenase-2	C4
steroidal	COX-2	C4
【PRE_R】
steroidal	cyclooxygenase-2	C4
steroidal	COX-2	C4

METHODS : We conducted a case - control study to measure the association between selective cox - 2 inhibitors , particularly celecoxib , rofecoxib , valdecoxib and non - specific NSAID subgroups , and breast cancer risk .
【GOLD_E】
cox-2	geneY
celecoxib	chem
rofecoxib	chem
valdecoxib	chem
【PRE_E】
cox-2	geneY
celecoxib	chem
rofecoxib	chem
valdecoxib	chem
【GOLD_R】
celecoxib	cox-2	C4
rofecoxib	cox-2	C4
valdecoxib	cox-2	C4
【PRE_R】
cox-2	celecoxib	C4
cox-2	rofecoxib	C4
cox-2	valdecoxib	C4

Between 2003 and 2006 , a total of 18,368 incident breast cancer cases were identified in the Ingenix / Lab Rx insurance database , which contains clinical encounter and drug prescription data .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Four controls per case were randomly selected , matched on age and time in database .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Odds ratios ( OR ) and 95 % confidence intervals ( CI ) were estimated using conditional logistic regression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Breast cancer risk was inversely associated with both non - specific NSAID and selective COX - 2 inhibitor use .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Greater than 12 months ' duration of use of Celecoxib at a standard dose ( 200mg / day ) was associated with a 16 % decrease in breast cancer risk ( OR = 0.84 , 95 % CI = 0.73 , 0.97 ) .
【GOLD_E】
Celecoxib	chem
【PRE_E】
Celecoxib	chem
【GOLD_R】
【PRE_R】

We observed the greatest risk reduction in association with > 2 years of rofecoxib exposure ( OR = 0.54 , 95 % CI = 0.37 , 0.80 ) .
【GOLD_E】
rofecoxib	chem
【PRE_E】
rofecoxib	chem
【GOLD_R】
【PRE_R】

Acetaminophen , a compound with less biological plausibility for chemoprevention , showed no significant association with the risk of developing breast cancer .
【GOLD_E】
Acetaminophen	chem
【PRE_E】
Acetaminophen	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Consistent with animal models and laboratory investigations , higher doses of selective COX - 2 inhibitors were more protective against breast cancer than non - specific NSAIDs .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

With exposure to rofecoxib , a selective COX - 2 inhibitor , breast cancer risk reduction was appreciable ( 46 % ) , suggesting a possible role for selective COX - 2 inhibitors in breast cancer prophylaxis .
【GOLD_E】
COX-2	geneY
COX-2	geneY
rofecoxib	chem
【PRE_E】
rofecoxib	chem
COX-2	geneY
COX-2	geneY
【GOLD_R】
rofecoxib	COX-2	C4
rofecoxib	COX-2	C4
【PRE_R】
rofecoxib	COX-2	C4

Barrel rotation in rats induced by SMS 201 - 995 : suppression by ceruletide .
【GOLD_E】
SMS201-995	chem
ceruletide	chem
【PRE_E】
SMS201-995	chem
ceruletide	chem
【GOLD_R】
【PRE_R】

Intracerebroventricular administration of SMS 201 - 995 ( 5 micrograms / rat ) , a somatostatin analogue , induced barrel rotation in rats .
【GOLD_E】
somatostatin	chem
somatostatin	geneY
SMS201-995	chem
【PRE_E】
201-995	chem
somatostatin	geneY
【GOLD_R】
【PRE_R】

Pretreatment with ceruletide ( 40 micrograms / 100 g b. wt . , IP ) 3 days or 7 days prior to the injection of SMS 201 - 995 significantly inhibited the response rate of barrel rotation induced by SMS 201 - 995 , but not that induced by arginine - vasopressin ( 1 microgram / rat , ICV ) .
【GOLD_E】
arginine-vasopressin	geneY
ceruletide	chem
SMS201-995	chem
SMS201-995	chem
arginine-vasopressin	chem
【PRE_E】
ceruletide	chem
201-995	chem
201-995	chem
arginine-vasopressin(1microgram	geneY
【GOLD_R】
【PRE_R】

The suppressive effect of ceruletide on barrel rotation could be partially countered by MK - 329 , a selective peripheral CCK ( CCK - A ) receptor antagonist .
【GOLD_E】
CCK	geneY
(CCK-A)receptor	geneY
ceruletide	chem
MK-329	chem
【PRE_E】
ceruletide	chem
MK-329	chem
CCK(CCK-A)receptor	geneY
【GOLD_R】
ceruletide	CCK	C4
ceruletide	(CCK-A)receptor	C4
MK-329	CCK	C6
MK-329	(CCK-A)receptor	C6
【PRE_R】

Desulfated cerulein did not affect the barrel rotation induced by SMS 201 - 995 .
【GOLD_E】
SMS201-995	chem
【PRE_E】
Desulfatedcerulein	chem
201-995	chem
【GOLD_R】
【PRE_R】

These findings suggest that ceruletide specifically suppresses the barrel rotation evoked by SMS 201 - 995 in a long - lasting manner possibly acting through CCK - A receptor .
【GOLD_E】
SMS201-995	chem
CCK-Areceptor	geneY
ceruletide	chem
【PRE_E】
ceruletide	chem
201-995	chem
CCK-A	geneY
【GOLD_R】
ceruletide	CCK-Areceptor	C4
【PRE_R】

Effects of the histamine H1 antagonist chlorcyclizine on rat fetal palate development .
【GOLD_E】
histamineH1	geneY
histamine	chem
chlorcyclizine	chem
【PRE_E】
histamineH1	geneY
chlorcyclizine	chem
【GOLD_R】
chlorcyclizine	histamineH1	C6
【PRE_R】

BACKGROUND : The effects of histamine H1 antagonist chlorcyclizine on rat palate development were characterized following in utero exposure .
【GOLD_E】
histamineH1	geneY
histamine	chem
chlorcyclizine	chem
【PRE_E】
histamineH1	geneY
chlorcyclizine	chem
【GOLD_R】
chlorcyclizine	histamineH1	C6
【PRE_R】

METHODS : To identify the optimum dose for inducing cleft palate , pregnant rats were administered 30 , 60 , or 90 mg / kg chlorcyclizine on Gestation Days 11 to 14 .
【GOLD_E】
chlorcyclizine	chem
【PRE_E】
chlorcyclizine	chem
【GOLD_R】
【PRE_R】

Fetal palate gene expression was also assessed after 90 mg / kg chlorcyclizine at 8 , 15 and 30 hours post - dose on Gestation Day 14 using microarray and qRT - PCR .
【GOLD_E】
chlorcyclizine	chem
【PRE_E】
chlorcyclizine	chem
【GOLD_R】
【PRE_R】

RESULTS : Rats in the 60 - and 90 - mg / kg groups exhibited adverse clinical signs and body weight loss .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rats in the 90 - mg / kg group also demonstrated increases in late resorptions and decreases in fetal weight .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effects in the low - dose group were limited to decreases in body weight gain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Fetal assessment on Gestation Day 21 revealed that findings were limited to the 60 - and 90 - mg / kg groups , and included cleft palate ( 80 % of litters for both groups ) , high arched palate , small nose , micrognathia , high domed head , digits shortened / absent and small limb .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The fetal incidence of cleft palate was higher at 90 mg / kg , thus this dose was selected to assess palate gene expression .
【GOLD_E】
【PRE_E】
palate	geneY
【GOLD_R】
【PRE_R】

The altered genes associated with chlorcyclizine - induced cleft palate included Wnt5a , Bmp2 , Bmp4 , Fgf10 , Fgfr2 , Msx1 , and Insig1 but the magnitude of the change was relatively small ( 1.5 - to 2 - fold ) .
【GOLD_E】
Bmp2	geneY
Bmp4	geneY
Fgf10	geneY
Fgfr2	geneY
Msx1	geneY
Insig1	geneY
chlorcyclizine	chem
Wnt5a	geneY
【PRE_E】
chlorcyclizine	chem
Wnt5a	geneY
Bmp2	geneY
Bmp4	geneY
Fgf10	geneY
Fgfr2	geneY
Msx1	geneY
Insig1	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS : Expression of several genes involved in palate , limb and digit development was altered in the fetal palate following in utero exposure to chlorcyclizine .
【GOLD_E】
chlorcyclizine	chem
【PRE_E】
chlorcyclizine	chem
【GOLD_R】
【PRE_R】

The subtle perturbation and interplay of these genes may have profound effects on the dynamics of fetal palate development .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

GABA ( A ) receptors as molecular targets of general anesthetics : identification of binding sites provides clues to allosteric modulation .
【GOLD_E】
GABA(A)receptors	geneN
【PRE_E】
GABA(A)receptors	geneN
【GOLD_R】
【PRE_R】

PURPOSE : The purpose of this review is to summarize current knowledge of detailed biochemical evidence for the role of gamma - aminobutyric acid type A receptors ( GABA ( A ) - Rs ) in the mechanisms of general anesthesia .
【GOLD_E】
gamma-aminobutyricacidtypeAreceptors	geneN
GABA(A)-Rs	geneN
gamma-aminobutyricacid	chem
【PRE_E】
gamma-aminobutyricacidtypeAreceptors	geneY
GABA(A)-Rs	geneY
【GOLD_R】
【PRE_R】

PRINCIPAL FINDINGS : With the knowledge that all general anesthetics positively modulate GABA ( A ) - R - mediated inhibitory transmission , site - directed mutagenesis comparing sequences of GABA ( A ) - R subunits of varying sensitivity led to identification of amino acid residues in the transmembrane domain that are critical for the drug actions in vitro .
【GOLD_E】
GABA(A)-R	geneN
GABA(A)-R	geneN
aminoacid	chem
【PRE_E】
GABA(A)-R	geneY
GABA(A)-R	geneN
aminoacid	chem
【GOLD_R】
【PRE_R】

Using a photo incorporable analogue of the general anesthetic , R ( + ) etomidate , we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA ( A ) - R .
【GOLD_E】
aminoacids	chem
bovinebrainGABA(A)-R	geneN
R(+)etomidate	chem
【PRE_E】
R(+)etomidate	chem
aminoacids	chem
bovinebrainGABA(A)-R	geneY
【GOLD_R】
【PRE_R】

Homology protein structural modelling positions these two residues , alphaM1 - 11 ' and betaM3 - 4 ' , close to each other in a single type of intersubunit etomidate binding pocket at the beta / alpha interface .
【GOLD_E】
etomidate	chem
intersubunitetomidatebindingpocket	geneN
beta/alphainterface	geneN
【PRE_E】
alphaM1	chem
betaM3	chem
etomidate	chem
【GOLD_R】
【PRE_R】

This position would be appropriate for modulation of agonist channel gating .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overall , available information suggests that these two etomidate binding residues are allosterically coupled to sites of action of steroids , barbiturates , volatile agents , and propofol , but not alcohols .
【GOLD_E】
etomidate	chem
steroids	chem
barbiturates	chem
propofol	chem
alcohols	chem
【PRE_E】
etomidate	chem
steroids	chem
barbiturates	chem
propofol	chem
alcohols	chem
【GOLD_R】
【PRE_R】

Residue alpha / betaM2 - 15 ' is probably not a binding site but allosterically coupled to action of volatile agents , alcohols , and intravenous agents , and alpha / betaM1 - ( - 2 ' ) is coupled to action of intravenous agents .
【GOLD_E】
alcohols	chem
【PRE_E】
alcohols	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : Establishment of a coherent and consistent structural model of the GABA ( A ) - R lends support to the conclusion that general anesthetics can modulate function by binding to appropriate domains on the protein .
【GOLD_E】
GABA(A)-R	geneN
【PRE_E】
GABA(A)-R	geneN
【GOLD_R】
【PRE_R】

Genetic engineering of mice with mutation in some of these GABA ( A ) - R residues are insensitive to general anesthetics in vivo , suggesting that further analysis of these domains could lead to development of more potent and specific drugs .
【GOLD_E】
GABA(A)-R	geneN
【PRE_E】
GABA(A)-R	geneN
【GOLD_R】
【PRE_R】

Role of extracellular calcium and calmodulin in prolactin secretion induced by hyposmolarity , thyrotropin - releasing hormone , and high K + in GH4C1 cells .
【GOLD_E】
K+	chem
calcium	chem
calmodulin	geneY
prolactin	geneY
thyrotropin-releasinghormone	geneY
【PRE_E】
calcium	chem
calmodulin	geneY
prolactin	geneY
hyposmolarity	chem
thyrotropin-releasinghormone	geneY
K+	chem
【GOLD_R】
【PRE_R】

The mechanism by which 30 % medium hyposmolarity induces PRL secretion by GH4C1 cells was compared with that induced by 100 nmol / l TRH or 30 mmol / l K + .
【GOLD_E】
TRH	geneY
PRL	geneY
K+	chem
【PRE_E】
TRH	geneY
【GOLD_R】
【PRE_R】

Removing medium Ca2 + , blocking Ca2 + channels with 50 mumol / l verapamil , or inhibiting calmodulin activation with 20 mumol / l trifluoperazine , 10 mumol / l chlorpromazine or 10 mumol / l pimozide almost completely blocked hyposmolarity - induced secretion .
【GOLD_E】
Ca2+channels	geneN
calmodulin	geneY
Ca2+	chem
Ca2+	chem
verapamil	chem
trifluoperazine	chem
chlorpromazine	chem
pimozide	chem
【PRE_E】
Ca2+	chem
Ca2+channels	geneN
verapamil	chem
calmodulin	geneY
trifluoperazine	chem
chlorpromazine	chem
pimozide	chem
hyposmolarity	chem
【GOLD_R】
verapamil	Ca2+channels	C4
trifluoperazine	calmodulin	C4
chlorpromazine	calmodulin	C4
pimozide	calmodulin	C4
【PRE_R】
calmodulin	trifluoperazine	C4
calmodulin	chlorpromazine	C4
calmodulin	pimozide	C4

The smooth muscle relaxant , W - 7 , which is believed relatively specific in inhibiting the Ca2 ( + ) - calmodulin interaction , depressed hyposmolarity - induced PRL secretion in a dose - dependent manner ( r = - 0.991 , p less than 0.01 ) .
【GOLD_E】
Ca2(+)	chem
calmodulin	geneY
PRL	geneY
W-7	chem
【PRE_E】
Ca2(+)-calmodulin	geneN
【GOLD_R】
W-7	PRL	C4
【PRE_R】

The above drugs also blocked or decreased high K ( + ) - induced secretion , but had much less effect on TRH - induced secretion .
【GOLD_E】
K(+)	chem
TRH	geneY
【PRE_E】
K(+)	chem
TRH	geneY
【GOLD_R】
【PRE_R】

Secretion induced by TRH , hyposmolarity , or high K + was optimal at pH 7.3 - 7.65 and was significantly depressed at pH 6.0 or 8.0 , indicating that release of hormone induced by all 3 stimuli is due to an active cell process requiring a physiologic extracellular pH and is not produced by nonspecific cell toxicity .
【GOLD_E】
K+	chem
TRH	geneY
【PRE_E】
TRH	geneY
hyposmolarity	chem
K+	chem
【GOLD_R】
【PRE_R】

The data suggest hyposmolarity and high K + may share some similarities in their mechanism of stimulating secretion , which is different from that of TRH .
【GOLD_E】
TRH	geneY
K+	chem
【PRE_E】
hyposmolarity	chem
K+	chem
TRH	geneY
【GOLD_R】
【PRE_R】

Use of ( Gyro ) Gy and spermine synthase transgenic mice to study functions of spermine .
【GOLD_E】
spermine	chem
spermine	chem
sperminesynthase	geneY
【PRE_E】
sperminesynthase	geneY
spermine	chem
【GOLD_R】
【PRE_R】

The polyamines putrescine , spermidine , and spermine are essential for mammalian cell growth , - differentiation , and cell death and have important physiological roles in all tissues .
【GOLD_E】
putrescine	chem
spermidine	chem
polyamines	chem
spermine	chem
【PRE_E】
polyamines	chem
putrescine	chem
spermidine	chem
spermine	chem
【GOLD_R】
【PRE_R】

Many of the properties of polyamines that can be demonstrated in vitro are common to all three molecules with differences only in potency .
【GOLD_E】
polyamines	chem
【PRE_E】
polyamines	chem
【GOLD_R】
【PRE_R】

Loss of any of the enzymes needed to make either putrescine or spermidine ( which also - prevent the production of spermine ) is lethal , but male mice lacking spermine synthase ( SpmS ) due to a deletion of part of the X chromosome are viable on the B6C3H background .
【GOLD_E】
spermine	chem
sperminesynthase	geneY
SpmS	geneY
putrescine	chem
spermidine	chem
spermine	chem
【PRE_E】
putrescine	chem
spermidine	chem
spermine	chem
sperminesynthase	geneY
SpmS	geneY
B6C3H	geneY
【GOLD_R】
【PRE_R】

These mice are termed Gyro ( Gy ) due to their circling behavior .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

They have a variety of abnormalities including deafness , neurological problems , small size , and a tendency to early death .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

They can therefore be used to evaluate the physiological function ( s ) uniquely provided by spermine .
【GOLD_E】
spermine	chem
【PRE_E】
spermine	chem
【GOLD_R】
【PRE_R】

They also provide a potential animal model for Snyder - Robinson syndrome ( SRS ) , a rare human inherited disease due to a loss of SpmS activity .
【GOLD_E】
SpmS	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

An essential control in experiments using Gy mice is to demonstrate that the abnormal phenotypes exhibited by these mice are abolished by providing replacement spermine and this can be accomplished by breeding with CAG - SMS mice that express SpmS from a ubiquitous promoter .
【GOLD_E】
SMS	geneY
SpmS	geneY
spermine	chem
【PRE_E】
spermine	chem
CAG	geneY
【GOLD_R】
spermine	SMS	C9
spermine	SpmS	C9
【PRE_R】

Techniques for identifying , characterizing , and using these mouse strains and limitations of this approach are described in this chapter .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cabozantinib ( XL184 ) , a novel MET and VEGFR2 inhibitor , simultaneously suppresses metastasis , angiogenesis , and tumor growth .
【GOLD_E】
MET	geneY
VEGFR2	geneY
Cabozantinib	chem
XL184	chem
【PRE_E】
Cabozantinib	chem
XL184	chem
MET	chem
VEGFR2	geneY
【GOLD_R】
Cabozantinib	MET	C4
Cabozantinib	VEGFR2	C4
XL184	MET	C4
XL184	VEGFR2	C4
【PRE_R】
Cabozantinib	VEGFR2	C4
XL184	VEGFR2	C4
MET	VEGFR2	C4

The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor ( HGF ) is important for cell growth , survival , and motility and is functionally linked to the signaling pathway of VEGF , which is widely recognized as a key effector in angiogenesis and cancer progression .
【GOLD_E】
VEGF	geneY
receptortyrosinekinaseMET	geneY
hepatocytegrowthfactor	geneY
HGF	geneY
【PRE_E】
receptortyrosinekinaseMET	geneN
hepatocytegrowthfactor	geneY
HGF	geneY
VEGF	geneY
【GOLD_R】
【PRE_R】

Dysregulation of the MET / VEGF axis is found in a number of human malignancies and has been associated with tumorigenesis .
【GOLD_E】
MET	geneY
VEGF	geneY
【PRE_E】
MET	chem
VEGF	geneY
【GOLD_R】
【PRE_R】

Cabozantinib ( XL184 ) is a small - molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 ( VEGFR2 ) , as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology , including RET , KIT , AXL , and FLT3 .
【GOLD_E】
kinase	geneN
MET	geneY
VEGFreceptor2	geneY
VEGFR2	geneY
receptortyrosinekinases	geneN
RET	geneY
KIT	geneY
AXL	geneY
FLT3	geneY
Cabozantinib	chem
XL184	chem
tyrosine	chem
【PRE_E】
Cabozantinib	chem
XL184	chem
kinase	geneN
MET	geneY
VEGFreceptor2	geneY
VEGFR2	geneY
tyrosinekinases	geneN
RET	geneY
KIT	geneY
AXL	geneY
FLT3	geneY
【GOLD_R】
Cabozantinib	kinase	C4
Cabozantinib	MET	C4
Cabozantinib	VEGFreceptor2	C4
Cabozantinib	VEGFR2	C4
Cabozantinib	receptortyrosinekinases	C4
Cabozantinib	RET	C4
Cabozantinib	KIT	C4
Cabozantinib	AXL	C4
Cabozantinib	FLT3	C4
XL184	kinase	C4
XL184	MET	C4
XL184	VEGFreceptor2	C4
XL184	VEGFR2	C4
XL184	receptortyrosinekinases	C4
XL184	RET	C4
XL184	KIT	C4
XL184	AXL	C4
XL184	FLT3	C4
【PRE_R】
Cabozantinib	kinase	C4
XL184	kinase	C4
XL184	MET	C4
XL184	VEGFreceptor2	C4
XL184	VEGFR2	C4
XL184	RET	C4
XL184	KIT	C4
XL184	AXL	C4
XL184	FLT3	C4

Treatment with cabozantinib inhibited MET and VEGFR2 phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro .
【GOLD_E】
MET	geneY
VEGFR2	geneY
cabozantinib	chem
【PRE_E】
cabozantinib	chem
MET	chem
VEGFR2	geneY
【GOLD_R】
cabozantinib	MET	C4
cabozantinib	VEGFR2	C4
【PRE_R】
cabozantinib	VEGFR2	C4
MET	VEGFR2	C4

In mouse models , cabozantinib dramatically altered tumor pathology , resulting in decreased tumor and endothelial cell proliferation coupled with increased apoptosis and dose - dependent inhibition of tumor growth in breast , lung , and glioma tumor models .
【GOLD_E】
cabozantinib	chem
【PRE_E】
cabozantinib	chem
【GOLD_R】
【PRE_R】

Importantly , treatment with cabozantinib did not increase lung tumor burden in an experimental model of metastasis , which has been observed with inhibitors of VEGF signaling that do not target MET .
【GOLD_E】
VEGF	geneY
MET	geneY
cabozantinib	chem
【PRE_E】
cabozantinib	chem
VEGF	geneY
MET	chem
【GOLD_R】
cabozantinib	VEGF	C4
【PRE_R】
cabozantinib	VEGF	C4

Collectively , these data suggest that cabozantinib is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated MET and VEGFR signaling .
【GOLD_E】
MET	geneY
VEGFR	geneN
cabozantinib	chem
【PRE_E】
cabozantinib	chem
MET	geneY
VEGFR	geneN
【GOLD_R】
cabozantinib	MET	C4
cabozantinib	VEGFR	C4
【PRE_R】
cabozantinib	MET	C4
cabozantinib	VEGFR	C4

Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways : a new use for an old drug .
【GOLD_E】
RANKL	geneY
Thiocolchicoside	chem
【PRE_E】
Thiocolchicoside	chem
RANKL	geneY
【GOLD_R】
【PRE_R】
Thiocolchicoside	RANKL	C4

BACKGROUND AND PURPOSE : Most patients with cancer die not because of the tumour in the primary site , but because it has spread to other sites .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Common tumours , such as breast , multiple myeloma , and prostate tumours , frequently metastasize to the bone .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To search for an inhibitor of cancer - induced bone loss , we investigated the effect of thiocolchicoside , a semi - synthetic colchicoside derived from the plant Gloriosa superba and clinically used as a muscle relaxant , on osteoclastogenesis induced by receptor activator of NF - kappaB ligand ( RANKL ) and tumour cells .
【GOLD_E】
receptoractivatorofNF-kappaBligand	geneY
RANKL	geneY
thiocolchicoside	chem
colchicoside	chem
【PRE_E】
thiocolchicoside	chem
colchicoside	chem
NF-kappaB	geneN
RANKL	geneY
【GOLD_R】
【PRE_R】
thiocolchicoside	NF-kappaB	C4
colchicoside	NF-kappaB	C4
colchicoside	RANKL	C4

EXPERIMENTAL APPROACH : We used RAW 264.7 ( murine macrophage ) cells , a well - established system for osteoclastogenesis , and evaluated the effect of thiocolchicoside on RANKL - induced NF - kappaB signalling and osteoclastogenesis as well as on osteoclastogenesis induced by tumour cells .
【GOLD_E】
RANKL	geneY
NF-kappaB	geneN
thiocolchicoside	chem
【PRE_E】
thiocolchicoside	chem
RANKL	geneY
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

KEY RESULTS : Thiocolchicoside suppressed osteoclastogenesis induced by RANKL , and by breast cancer and multiple myeloma cells .
【GOLD_E】
RANKL	geneY
Thiocolchicoside	chem
【PRE_E】
Thiocolchicoside	chem
RANKL	geneY
【GOLD_R】
【PRE_R】
Thiocolchicoside	RANKL	C4

Inhibition of the NF - kappaB pathway was responsible for this effect since the colchicoside inhibited RANKL - induced NF - kappaB activation , activation of IkappaB kinase ( IKK ) and suppressed inhibitor of NF - kappaBalpha ( IkappaBalpha ) phosphorylation and degradation , an inhibitor of NF - kappaB .
【GOLD_E】
NF-kappaB	geneN
IkappaBkinase	geneN
IKK	geneN
NF-kappaBalpha	geneY
IkappaBalpha	geneY
NF-kappaB	geneN
colchicoside	chem
NF-kappaB	geneN
RANKL	geneY
【PRE_E】
NF-kappaB	geneN
colchicoside	chem
RANKL	geneY
NF-kappaB	geneN
IkappaBkinase	geneN
IKK	geneN
NF-kappaBalpha	geneN
IkappaBalpha	geneY
NF-kappaB	geneN
【GOLD_R】
colchicoside	NF-kappaB	C4
colchicoside	IkappaBkinase	C4
colchicoside	IKK	C4
colchicoside	NF-kappaBalpha	C4
colchicoside	IkappaBalpha	C4
colchicoside	NF-kappaB	C4
colchicoside	RANKL	C4
【PRE_R】
colchicoside	RANKL	C4
colchicoside	NF-kappaB	C4
colchicoside	IkappaBkinase	C4
colchicoside	IKK	C4
colchicoside	NF-kappaBalpha	C4
colchicoside	IkappaBalpha	C4
colchicoside	NF-kappaB	C4

Furthermore , an inhibitor of the IkappaBalpha kinase gamma or NF - kappaB essential modulator , the regulatory component of the IKK complex , demonstrated that the NF - kappaB signalling pathway is mandatory for osteoclastogenesis induced by RANKL .
【GOLD_E】
IkappaBalpha	geneY
kinase	geneN
NF-kappaB	geneN
IKK	geneN
NF-kappaB	geneN
RANKL	geneY
【PRE_E】
IkappaBalphakinasegamma	geneY
NF-kappaB	geneN
IKK	geneN
NF-kappaB	geneN
RANKL	geneY
【GOLD_R】
【PRE_R】

CONCLUSIONS AND IMPLICATIONS : Together , these data suggest that thiocolchicoside significantly suppressed osteoclastogenesis induced by RANKL and tumour cells via the NF - kappaB signalling pathway .
【GOLD_E】
RANKL	geneY
NF-kappaB	geneN
thiocolchicoside	chem
【PRE_E】
thiocolchicoside	chem
RANKL	geneY
NF-kappaB	geneN
【GOLD_R】
thiocolchicoside	RANKL	C4
thiocolchicoside	NF-kappaB	C4
【PRE_R】
thiocolchicoside	RANKL	C4
thiocolchicoside	NF-kappaB	C4

Thus , thiocolchicoside , a drug that has been used for almost half a century to treat muscle pain , may also be considered as a new treatment for bone loss .
【GOLD_E】
thiocolchicoside	chem
【PRE_E】
thiocolchicoside	chem
【GOLD_R】
【PRE_R】

Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction .
【GOLD_E】
Endothelialnitricoxidesynthase	geneY
nitricoxide	chem
sildenafil	chem
【PRE_E】
Endothelialnitricoxidesynthase	geneY
sildenafil	chem
【GOLD_R】
【PRE_R】

Erectile dysfunction ( ED ) is usually treated with sildenafil .
【GOLD_E】
sildenafil	chem
【PRE_E】
sildenafil	chem
【GOLD_R】
【PRE_R】

Although genetic polymorphisms in the endothelial nitric oxide synthase ( eNOS ) gene may impair endogenous NO formation , there is little information about how eNOS polymorphisms and haplotypes affect the responses to sildenafil .
【GOLD_E】
eNOS	geneY
eNOS	geneY
nitricoxide	chem
NO	chem
sildenafil	chem
endothelialnitricoxidesynthase	geneY
【PRE_E】
endothelialnitricoxidesynthase	geneY
eNOS	geneY
NO	chem
eNOS	geneY
sildenafil	chem
【GOLD_R】
NO	eNOS	C9
NO	endothelialnitricoxidesynthase	C9
【PRE_R】

We studied 118 patients ; 63 patients had ED secondary to radical prostatectomy ( PED ) and 55 had organic , clinical ED . eNOS genotypes for three eNOS polymorphisms ( T ( - 786 ) C , rs2070744 ; a variable number of tandem repeats ( VNTR ) in intron 4 ; and Glu298Asp , rs1799983 ) were determined , and eNOS haplotypes were estimated using PHASE 2.1 .
【GOLD_E】
eNOS	geneY
eNOS	geneY
eNOS	geneY
【PRE_E】
eNOS	geneY
eNOS	geneY
Glu298Asp	geneY
eNOS	geneY
【GOLD_R】
【PRE_R】

The clinical responses to sildenafil were evaluated and the patients were classified as good responders ( GR ) or poor responders ( PR ) when their changes in five - item version of International Index for Erectile Function questionnaire were above or below the median value .
【GOLD_E】
sildenafil	chem
【PRE_E】
sildenafil	chem
GR	geneY
PR)	geneY
【GOLD_R】
【PRE_R】
sildenafil	GR	C4
sildenafil	PR)	C4

The TC / CC genotypes and the C allele for the T ( - 786 ) C polymorphism were more common in GR , compared with PR patients with PED .
【GOLD_E】
【PRE_E】
CC	geneY
T(-786)C	geneY
GR	geneY
PR	geneY
【GOLD_R】
【PRE_R】

However , the 4b4a / 4a4a genotypes and the 4a allele for the VNTR polymorphism in intron 4 were more common in GR , compared with PR patients with clinical ED .
【GOLD_E】
【PRE_E】
VNTR	geneY
GR	geneY
PR	geneY
【GOLD_R】
【PRE_R】

The C - 4a - Glu haplotype was more common in GR than in PR patients with PED .
【GOLD_E】
【PRE_E】
C-4a-Glu	chem
GR	geneY
【GOLD_R】
【PRE_R】

Conversely , the T - 4b - Asp haplotype was less common in GR than in PR patients with PED .
【GOLD_E】
【PRE_E】
T-4b-Asp	chem
GR	geneY
PR	geneY
【GOLD_R】
【PRE_R】

No other significant differences were found .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our findings show evidence that eNOS polymorphisms affect the responses of PED and clinical ED patients to sildenafil .
【GOLD_E】
eNOS	geneY
sildenafil	chem
【PRE_E】
eNOS	geneY
sildenafil	chem
【GOLD_R】
【PRE_R】

Mercury induces the expression of cyclooxygenase - 2 and inducible nitric oxide synthase .
【GOLD_E】
cyclooxygenase-2	geneY
induciblenitricoxidesynthase	geneY
Mercury	chem
nitricoxide	chem
【PRE_E】
Mercury	chem
cyclooxygenase-2	geneY
induciblenitricoxidesynthase	geneY
【GOLD_R】
Mercury	cyclooxygenase-2	C3
Mercury	induciblenitricoxidesynthase	C3
【PRE_R】

Nuclear factor - κB ( NF - κB ) is a transcription factor that mediates the inducible expression of a variety of genes involved in immune and inflammatory responses .
【GOLD_E】
NF-κB	geneN
Nuclearfactor-κB	geneN
【PRE_E】
Nuclearfactor-κB	geneN
NF-κB	geneN
【GOLD_R】
【PRE_R】

NF - κB activation induces numerous proinflammatory gene products including cytokines , cyclooxygenase - 2 ( COX - 2 ) , and inducible nitric oxide synthase ( iNOS ) .
【GOLD_E】
cytokines	geneN
cyclooxygenase-2	geneY
COX-2	geneY
induciblenitricoxidesynthase	geneY
iNOS	geneY
nitricoxide	chem
NF-κB	geneN
【PRE_E】
NF-κB	geneN
cytokines	geneN
cyclooxygenase-2	geneY
COX-2	geneY
induciblenitricoxidesynthase	geneY
iNOS	geneY
【GOLD_R】
【PRE_R】

The divalent heavy metal mercury has been used for thousands of years .
【GOLD_E】
mercury	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Although mercury is clearly toxic to most mammalian organ systems , especially the immune system , exposure has still increased in some areas of the world .
【GOLD_E】
mercury	chem
【PRE_E】
【GOLD_R】
【PRE_R】

However , the underlying toxic mechanism is not clearly identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we report biochemical evidence that mercury alone induces NF - κB activation , resulting in the induced expression of COX - 2 and iNOS .
【GOLD_E】
NF-κB	geneN
COX-2	geneY
iNOS	geneY
mercury	chem
【PRE_E】
mercury	chem
NF-κB	geneN
COX-2	geneY
iNOS	geneY
【GOLD_R】
mercury	NF-κB	C3
mercury	COX-2	C3
mercury	iNOS	C3
【PRE_R】

The results suggest that mercury can induce inflammatory diseases by lowering host defense .
【GOLD_E】
mercury	chem
【PRE_E】
mercury	chem
【GOLD_R】
【PRE_R】

Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal - related cholinergic laterodorsal tegmental neurons .
【GOLD_E】
glutamate	chem
metabotrophicglutamatereceptors	geneN
【PRE_E】
metabotrophicglutamatereceptors	geneN
【GOLD_R】
【PRE_R】

Cholinergic neurons of the pontine laterodorsal tegmentum ( LDT ) are importantly involved in neurobiological mechanisms governing states of arousal such as sleep and wakefulness as well as other appetitive behaviors , such as drug - seeking .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Accordingly , mechanisms controlling their excitability are important to elucidate if we are to understand how these LDT neurons generate arousal states .
【GOLD_E】
【PRE_E】
LDT	chem
【GOLD_R】
【PRE_R】

Glutamate mediates the vast majority of excitatory synaptic transmission in the vertebrate CNS and while presence of glutamate input in the LDT has been shown and ionotropic responses to glutamate have been reported in the LDT , characterization of metabotropic responses is lacking .
【GOLD_E】
Glutamate	chem
glutamate	chem
glutamate	chem
【PRE_E】
Glutamate	chem
glutamate	chem
LDT	geneN
ionotropic	chem
glutamate	chem
LDT	geneN
metabotropic	geneN
【GOLD_R】
【PRE_R】

Therefore , electrophysiological responses and changes in levels of intracellular Ca ( 2 + ) in mouse cholinergic LDT neurons following application of specific mGluR agonists and antagonists were examined .
【GOLD_E】
Ca(2+)	chem
mGluR	geneN
【PRE_E】
Ca(2+)	chem
LDT	chem
mGluR	geneN
【GOLD_R】
【PRE_R】

Unexpectedly , both the mGluR ( 5 ) specific agonist , CHPG , and the group II mGluR ( mGlu ( 2 / 3 ) ) agonist , LY379268 ( LY ) , induced a TTX - insensitive outward current / hyperpolarization .
【GOLD_E】
CHPG	chem
LY379268	chem
TTX	chem
mGluR(5)	geneY
groupIImGluR	geneN
mGlu(2/3)	geneN
【PRE_E】
mGluR(5)	geneY
CHPG	chem
groupIImGluR	geneN
mGlu(2/3)	geneN
LY379268	chem
LY	chem
TTX	chem
【GOLD_R】
CHPG	mGluR(5)	C5
LY379268	groupIImGluR	C5
【PRE_R】

Both outward currents were significantly reduced by the mGluR antagonist MCPG and the CHPG - induced current was blocked by the specific mGluR ( 5 ) antagonist MTEP .
【GOLD_E】
MCPG	chem
mGluR	geneN
mGluR(5)	geneY
CHPG	chem
MTEP	chem
【PRE_E】
mGluR	geneY
MCPG	chem
CHPG	chem
mGluR(5)	geneY
MTEP	chem
【GOLD_R】
MCPG	mGluR	C6
MTEP	mGluR(5)	C6
【PRE_R】
mGluR	MCPG	C6
CHPG	mGluR(5)	C5
mGluR	MTEP	C6

Concurrent Ca ( 2 + ) imaging revealed that while CHPG actions did include release of Ca ( 2 + ) from CPA / thapsigargin - sensitive intracellular stores , actions of LY did not .
【GOLD_E】
Ca(2+)	chem
CHPG	chem
Ca(2+)	chem
CPA	chem
thapsigargin	chem
【PRE_E】
Ca(2+)	chem
CHPG	chem
Ca(2+)	chem
CPA	chem
thapsigargin	chem
LY	geneN
【GOLD_R】
【PRE_R】

Both CHPG - and LY - induced outward currents were mediated by a TEA - sensitive potassium conductance .
【GOLD_E】
TEA	chem
potassium	chem
CHPG	chem
【PRE_E】
CHPG	chem
LY	chem
TEA	chem
potassium	chem
【GOLD_R】
【PRE_R】

The large - conductance , Ca ( 2 + ) - dependent potassium ( BK ) channel blocker , iberiotoxin , attenuated CHPG actions .
【GOLD_E】
Ca(2+)	chem
potassium	chem
CHPG	chem
Ca(2+)-dependentpotassium(BK)channel	geneN
【PRE_E】
Ca(2+)	chem
potassium(BK)channel	geneN
iberiotoxin	chem
CHPG	chem
【GOLD_R】
【PRE_R】

Consistent with actions on the BK conductance , CHPG enhanced the amplitude of the fast component of the after hyperpolarizing potential , concurrent with a reduction in the firing rate .
【GOLD_E】
CHPG	chem
【PRE_E】
BK	geneN
CHPG	chem
【GOLD_R】
【PRE_R】

We conclude that stimulation of mGluR ( 5 ) and group II ( mGluR ( 2 / 3 ) ) elicits postsynaptically - mediated outward currents / hyperpolarizations in cholinergic LDT neurons .
【GOLD_E】
mGluR(5)	geneY
mGluR(2/3)	geneN
【PRE_E】
mGluR(5)	geneY
mGluR(2/3)	geneN
【GOLD_R】
【PRE_R】

Effects of glutamatergic input would be , thus , expected not only to be excitation via stimulation of ionotropic glutamate receptors and mGluR ( 1 ) , but also inhibition via actions at mGluR ( 5 ) and mGluR ( 2 / 3 ) on these neurons .
【GOLD_E】
glutamate	chem
ionotropicglutamatereceptors	geneN
mGluR(1)	geneY
mGluR(5)	geneY
mGluR(2/3)	geneN
【PRE_E】
ionotropicglutamatereceptors	geneN
mGluR(1)	geneY
mGluR(5)	geneY
mGluR(2/3	geneN
【GOLD_R】
【PRE_R】

As these two processes counteract each other , these surprising findings necessitate revision of predictions regarding the net level of excitation generated by glutamate input to cholinergic LDT cells and , by extension , the functional outcome of glutamate transmission on processes which these neurons regulate .
【GOLD_E】
glutamate	chem
glutamate	chem
【PRE_E】
net	geneY
glutamate	chem
glutamate	chem
【GOLD_R】
【PRE_R】

This article is part of a Special Issue entitled ' Metabotropic Glutamate Receptors ' .
【GOLD_E】
Glutamate	chem
MetabotropicGlutamateReceptors	geneN
【PRE_E】
MetabotropicGlutamateReceptors	geneN
【GOLD_R】
【PRE_R】

A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneY
【GOLD_R】
【PRE_R】

There are few effective treatments for metastatic melanoma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Checkpoint kinase 1 ( Chk1 ) inhibitors are being trialled for their efficacy in enhancing conventional chemotherapeutic agents , but their effectiveness as single agents is not known .
【GOLD_E】
Checkpointkinase1	geneY
Chk1	geneY
【PRE_E】
Checkpointkinase1	geneY
Chk1	geneY
【GOLD_R】
【PRE_R】

We have examined the effectiveness of two novel Chk1 selective inhibitors , AR323 and AR678 , in a panel of melanoma cell lines and normal cell types .
【GOLD_E】
AR323	chem
AR678	chem
Chk1	geneY
【PRE_E】
Chk1	geneN
AR678	geneN
【GOLD_R】
AR323	Chk1	C4
AR678	Chk1	C4
【PRE_R】

We demonstrate that these drugs display single - agent activity , with IC50s in the low nanomolar range .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The drugs produce cytotoxic effects in cell lines that are most sensitive to these drugs , whereas normal cells are only sensitive to these drugs at the higher concentrations where they have cytostatic activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The cytotoxic effect is the consequence of inhibition of S - phase Chk1 , which drives cells prematurely from late S phase into an aberrant mitosis and results in either failure of cytokinesis or cell death through an apoptotic mechanism .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneN
【GOLD_R】
【PRE_R】

The sensitivity to the Chk1 inhibitors was correlated with the level of endogenous DNA damage indicating replicative stress .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneY
【GOLD_R】
【PRE_R】

Chk1 inhibitors are viable single - agent therapies that target melanoma cells with high levels of endogenous DNA damage .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneY
【GOLD_R】
【PRE_R】

This sensitivity suggests that Chk1 is a critical component of an adaptation to replicative stress in these cells .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneY
【GOLD_R】
【PRE_R】

It also suggests that markers of DNA damage may be useful in identifying the melanomas and potentially other tumour types that are more likely to be sensitive to Chk1 inhibitors as single agents .
【GOLD_E】
Chk1	geneY
【PRE_E】
Chk1	geneY
【GOLD_R】
【PRE_R】

Aspirin inhibits mTOR signaling , activates AMP - activated protein kinase , and induces autophagy in colorectal cancer cells .
【GOLD_E】
Aspirin	chem
mTOR	chem
AMP	chem
mTOR	geneY
AMP-activatedproteinkinase	geneN
【PRE_E】
Aspirin	chem
mTOR	geneY
AMP-activatedproteinkinase	geneN
【GOLD_R】
Aspirin	AMP-activatedproteinkinase	C3
Aspirin	mTOR	C4
【PRE_R】
Aspirin	mTOR	C4

BACKGROUND & AIMS : Aspirin reduces the incidence of and mortality from colorectal cancer ( CRC ) by unknown mechanisms .
【GOLD_E】
Aspirin	chem
【PRE_E】
Aspirin	chem
【GOLD_R】
【PRE_R】

Cancer cells have defects in signaling via the mechanistic target of rapamycin ( mTOR ) , which regulates proliferation .
【GOLD_E】
rapamycin	chem
mTOR	chem
mechanistictargetofrapamycin	geneY
mTOR	geneY
【PRE_E】
mechanistictargetofrapamycin	geneY
mTOR	geneY
【GOLD_R】
【PRE_R】

We investigated whether aspirin affects adenosine monophosphate - activated protein kinase ( AMPK ) and mTOR signaling in CRC cells .
【GOLD_E】
aspirin	chem
adenosinemonophosphate	chem
mTOR	chem
adenosinemonophosphate-activatedproteinkinase	geneN
AMPK	geneN
mTOR	geneY
【PRE_E】
aspirin	chem
adenosinemonophosphate-activatedproteinkinase	geneN
AMPK	geneN
mTOR	geneY
【GOLD_R】
【PRE_R】
aspirin	AMPK	C4
aspirin	mTOR	C4

METHODS : The effects of aspirin on mTOR signaling , the ribosomal protein S6 , S6 kinase 1 ( S6K1 ) , and eukaryotic translation initiation factor 4E binding protein 1 ( 4E - BP1 ) were examined in CRC cells by immunoblotting .
【GOLD_E】
aspirin	chem
mTOR	chem
mTOR	geneY
ribosomalproteinS6	geneY
S6kinase1	geneY
S6K1	geneY
eukaryotictranslationinitiationfactor4Ebindingprotein1	geneY
4E-BP1	geneY
【PRE_E】
aspirin	chem
mTOR	geneY
ribosomalproteinS6	geneN
S6kinase1	geneY
S6K1	geneY
eukaryotictranslationinitiationfactor4Ebindingprotein1	geneY
4E-BP1	geneY
【GOLD_R】
【PRE_R】

Phosphorylation of AMPK was measured ; the effects of loss of AMPKalpha on the aspirin - induced effects of mTOR were determined using small interfering RNA ( siRNA ) in CRC cells and in AMPK ( alpha1 / alpha2 - / - ) mouse embryonic fibroblasts .
【GOLD_E】
aspirin	chem
mTOR	chem
AMPK	geneN
AMPKalpha	geneN
mTOR	geneY
AMPK(alpha1/alpha2	geneN
【PRE_E】
AMPK	geneN
AMPKalpha	geneN
aspirin	chem
mTOR	geneY
AMPK	geneN
alpha1/alpha2	geneN
【GOLD_R】
【PRE_R】

LC3 and ULK1 were used as markers of autophagy .
【GOLD_E】
LC3	geneN
ULK1	geneY
【PRE_E】
LC3	geneN
ULK1	geneY
【GOLD_R】
【PRE_R】

We analyzed rectal mucosa samples from patients given 600 mg aspirin , once daily for 1 week .
【GOLD_E】
aspirin	chem
【PRE_E】
aspirin	chem
【GOLD_R】
【PRE_R】

RESULTS : Aspirin reduced mTOR signaling in CRC cells by inhibiting the mTOR effectors S6K1 and 4E - BP1 .
【GOLD_E】
mTOR	chem
Aspirin	chem
mTOR	chem
mTOR	geneY
S6K1	geneY
4E-BP1	geneY
mTOR	geneY
【PRE_E】
Aspirin	chem
mTOR	geneY
mTOR	geneY
S6K1	geneY
4E-BP1	geneY
【GOLD_R】
Aspirin	mTOR	C4
Aspirin	mTOR	C4
Aspirin	S6K1	C4
Aspirin	4E-BP1	C4
【PRE_R】
Aspirin	mTOR	C4
Aspirin	mTOR	C4
Aspirin	S6K1	C4
Aspirin	4E-BP1	C4

Aspirin changed nucleotide ratios and activated AMPK in CRC cells . mTOR was still inhibited by aspirin in CRC cells after siRNA knockdown of AMPKalpha , indicating AMPK - dependent and AMPK - independent mechanisms of aspirin - induced inhibition of mTOR .
【GOLD_E】
Aspirin	chem
AMPK	geneN
mTOR	geneY
AMPKalpha	geneN
AMPK	geneN
AMPK	geneN
mTOR	geneY
mTOR	chem
aspirin	chem
aspirin	chem
mTOR	chem
【PRE_E】
Aspirin	chem
nucleotide	chem
AMPK	geneN
CRC	geneY
mTOR	geneY
aspirin	chem
AMPKalpha	geneY
AMPK	geneN
AMPK	geneN
aspirin	chem
mTOR	geneY
【GOLD_R】
Aspirin	AMPK	C3
aspirin	mTOR	C4
aspirin	mTOR	C4
【PRE_R】
Aspirin	AMPK	C4
CRC	aspirin	C4
mTOR	aspirin	C4
aspirin	AMPKalpha	C4
AMPK	aspirin	C4
aspirin	mTOR	C4

Aspirin induced autophagy , a feature of mTOR inhibition .
【GOLD_E】
mTOR	geneY
Aspirin	chem
mTOR	chem
【PRE_E】
Aspirin	chem
mTOR	geneY
【GOLD_R】
Aspirin	mTOR	C4
【PRE_R】
Aspirin	mTOR	C4

Aspirin and metformin ( an activator of AMPK ) increased inhibition of mTOR and Akt , as well as autophagy in CRC cells .
【GOLD_E】
metformin	chem
mTOR	chem
AMPK	geneN
mTOR	geneY
Akt	geneN
Aspirin	chem
【PRE_E】
Aspirin	chem
metformin	chem
AMPK	geneN
mTOR	geneY
Akt	geneN
【GOLD_R】
metformin	AMPK	C3
Aspirin	AMPK	C3
metformin	mTOR	C4
metformin	Akt	C4
Aspirin	mTOR	C4
Aspirin	Akt	C4
【PRE_R】
Aspirin	AMPK	C4
metformin	AMPK	C4
metformin	mTOR	C4
metformin	Akt	C4

Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6K1 and S6 .
【GOLD_E】
aspirin	chem
S6K1	geneY
S6	geneY
【PRE_E】
aspirin	chem
S6K1	geneY
S6	geneN
【GOLD_R】
aspirin	S6K1	C4
aspirin	S6	C4
【PRE_R】
aspirin	S6K1	C4
aspirin	S6	C4

CONCLUSIONS : Aspirin is an inhibitor of mTOR and an activator of AMPK , targeting regulators of intracellular energy homeostasis and metabolism .
【GOLD_E】
Aspirin	chem
mTOR	chem
mTOR	geneY
AMPK	geneN
【PRE_E】
Aspirin	chem
mTOR	geneY
AMPK	geneN
【GOLD_R】
Aspirin	AMPK	C3
Aspirin	mTOR	C4
【PRE_R】
Aspirin	mTOR	C4
Aspirin	AMPK	C4

These could contribute to its protective effects against development of CRC .
【GOLD_E】
【PRE_E】
CRC	geneY
【GOLD_R】
【PRE_R】

Oncogenic K - ras expression is associated with derangement of the cAMP / PKA pathway and forskolin - reversible alterations of mitochondrial dynamics and respiration .
【GOLD_E】
cAMP	chem
forskolin	chem
K-ras	geneY
PKA	geneN
【PRE_E】
K-ras	geneN
cAMP	chem
PKA	geneN
forskolin	chem
【GOLD_R】
【PRE_R】

The Warburg effect in cancer cells has been proposed to involve several mechanisms , including adaptation to hypoxia , oncogenes activation or loss of oncosuppressors and impaired mitochondrial function .
【GOLD_E】
【PRE_E】
oncosuppressors	geneY
【GOLD_R】
【PRE_R】

In previous papers , it has been shown that K - ras transformed mouse cells are much more sensitive as compared with normal cells to glucose withdrawal ( undergoing apoptosis ) and present a high glycolytic rate and a strong reduction of mitochondrial complex I .
【GOLD_E】
K-ras	geneY
mitochondrialcomplexI	geneN
glucose	chem
【PRE_E】
K-ras	geneN
glucose	chem
mitochondrialcomplexI	geneY
【GOLD_R】
【PRE_R】

Recent observations suggest that transformed cells have a derangement in the cyclic adenosine monophosphate / cAMP - dependent protein kinase ( cAMP / PKA ) pathway , which is known to regulate several mitochondrial functions .
【GOLD_E】
cAMP-dependentproteinkinase	geneN
PKA	geneN
cyclicadenosinemonophosphate	chem
cAMP	chem
cAMP	chem
【PRE_E】
cyclicadenosinemonophosphate	chem
cAMP-dependentproteinkinase	geneN
cAMP/PKA	geneN
【GOLD_R】
【PRE_R】

Herein , the derangement of the cAMP / PKA pathway and its impact on transformation - linked changes of mitochondrial functions is investigated .
【GOLD_E】
cAMP	chem
PKA	geneN
【PRE_E】
cAMP	chem
PKA	geneN
【GOLD_R】
【PRE_R】

Exogenous stimulation of PKA activity , achieved by forskolin treatment , protected K - ras - transformed cells from apoptosis induced by glucose deprivation , enhanced complex I activity , intracellular adenosine triphosphate ( ATP ) levels , mitochondrial fusion and decreased intracellular reactive oxygen species ( ROS ) levels .
【GOLD_E】
forskolin	chem
glucose	chem
adenosinetriphosphate	chem
PKA	geneN
K-ras	geneY
complexI	geneN
ATP	chem
oxygen	chem
【PRE_E】
PKA	geneN
forskolin	chem
K-ras	geneN
glucose	chem
adenosinetriphosphate	chem
ATP	chem
oxygen	chem
【GOLD_R】
forskolin	PKA	C3
forskolin	complexI	C3
glucose	K-ras	C4
【PRE_R】
PKA	forskolin	C3
forskolin	K-ras	C3
K-ras	glucose	C3

Several of these effects were almost completely prevented by inhibiting the PKA activity .
【GOLD_E】
PKA	geneN
【PRE_E】
PKA	geneN
【GOLD_R】
【PRE_R】

Short - time treatment with compounds favoring mitochondrial fusion strongly decreased the cellular ROS levels especially in transformed cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These findings support the notion that glucose shortage - induced apoptosis , specific of K - ras - transformed cells , is associated to a derangement of PKA signaling that leads to mitochondrial complex I decrease , reduction of ATP formation , prevalence of mitochondrial fission over fusion , and thereby opening new approaches for development of anticancer drugs .
【GOLD_E】
K-ras	geneY
PKA	geneN
mitochondrialcomplexI	geneN
glucose	chem
ATP	chem
【PRE_E】
glucose	chem
K-ras	geneN
PKA	geneN
mitochondrialcomplexI	geneN
ATP	chem
【GOLD_R】
【PRE_R】
glucose	K-ras	C3
glucose	PKA	C3
glucose	mitochondrialcomplexI	C3

Berberine inhibits myofibroblast differentiation in nasal polyp - derived fibroblasts via the p38 pathway .
【GOLD_E】
p38	geneN
Berberine	chem
【PRE_E】
Berberine	chem
p38	geneN
【GOLD_R】
【PRE_R】
Berberine	p38	C4

The purposes of this study were to determine whether berberine has any effect on phenotype changes and extracellular matrix ( ECM ) production in nasal polyp - derived fibroblasts ( NPDFs ) and to investigate the underlying molecular mechanism .
【GOLD_E】
berberine	chem
【PRE_E】
berberine	chem
【GOLD_R】
【PRE_R】

NPDFs were pre - treated with berberine prior to induction by transforming growth factor ( TGF ) - β1 .
【GOLD_E】
transforminggrowthfactor(TGF)-β1	geneY
berberine	chem
【PRE_E】
berberine	chem
transforminggrowthfactor(TGF)-β1	geneY
【GOLD_R】
【PRE_R】
berberine	transforminggrowthfactor(TGF)-β1	C4

The expression of α - smooth muscle actin ( SMA ) and collagen type I mRNA was determined by a reverse transcription - polymerase chain reaction , and the expression of α - SMA protein and collagen type I was determined by western blotting and / or immunofluorescent staining .
【GOLD_E】
α-smoothmuscleactin	geneY
SMA	geneY
collagentypeI	geneN
α-SMA	geneY
collagentypeI	geneN
【PRE_E】
α-smoothmuscleactin	geneY
SMA	geneY
collagentypeI	geneY
α-SMA	geneY
collagentypeI	geneN
【GOLD_R】
【PRE_R】

The total soluble collagen production was analysed by the SirCol collagen assay .
【GOLD_E】
collagen	geneN
【PRE_E】
collagen	geneN
SirColcollagen	geneN
【GOLD_R】
【PRE_R】

The expression of several signaling molecules of the TGF - β1 pathway was evaluated by western blot analysis .
【GOLD_E】
TGF-β1	geneY
【PRE_E】
TGF-β1	geneY
【GOLD_R】
【PRE_R】

In TGF - β1 - induced NPDFs , berberine significantly inhibited the expression of α - SMA and collagen type I mRNA and reduced α - SMA and collagen protein levels .
【GOLD_E】
TGF-β1	geneY
α-SMA	geneY
collagentypeI	geneN
α-SMA	geneY
collagen	geneN
berberine	chem
【PRE_E】
TGF-β1	geneY
NPDFs	chem
berberine	chem
α-SMA	geneY
collagentypeI	geneY
α-SMA	geneY
collagenprotein	geneN
【GOLD_R】
berberine	TGF-β1	C4
berberine	α-SMA	C4
berberine	collagentypeI	C4
berberine	α-SMA	C4
berberine	collagen	C4
【PRE_R】
TGF-β1	NPDFs	C4
berberine	α-SMA	C4
berberine	collagentypeI	C4
berberine	α-SMA	C4
berberine	collagenprotein	C4

Berberine only suppressed the expression of pp38 among the evaluated signaling molecules .
【GOLD_E】
pp38	geneN
Berberine	chem
【PRE_E】
Berberine	chem
pp38	geneN
【GOLD_R】
Berberine	pp38	C4
【PRE_R】
Berberine	pp38	C4

SB203580 ( a specific inhibitor of p38 kinase ) markedly suppressed the increased expression of collagen type I and α - SMA in TGF - β1 - induced NPDFs .
【GOLD_E】
collagentypeI	geneN
α-SMA	geneY
TGF-β1	geneY
SB203580	chem
p38	geneN
kinase	geneN
【PRE_E】
SB203580	chem
p38kinase	geneN
collagentypeI	geneY
α-SMA	geneY
TGF-β1	geneY
NPDFs	geneY
【GOLD_R】
SB203580	collagentypeI	C4
SB203580	α-SMA	C4
SB203580	TGF-β1	C4
SB203580	p38	C4
SB203580	kinase	C4
【PRE_R】
SB203580	p38kinase	C4
SB203580	collagentypeI	C4
SB203580	α-SMA	C4
SB203580	TGF-β1	C4
SB203580	NPDFs	C4

Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference .
【GOLD_E】
p38	geneN
Berberine	chem
【PRE_E】
Berberine	chem
NPDFs	geneY
p38	geneN
【GOLD_R】
【PRE_R】
Berberine	NPDFs	C4
Berberine	p38	C4

The findings provide new therapeutic options for ECM production in nasal polyps .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Glaucogenin E , a new C21 steroid from Cynanchum stauntonii .
【GOLD_E】
GlaucogeninE	chem
C21	chem
steroid	chem
【PRE_E】
GlaucogeninE	chem
C21steroid	chem
【GOLD_R】
【PRE_R】

Glaucogenin E ( 1 ) , a new C ( 21 ) steroid sapogenin , along with three known ones ( 2 - 4 ) were isolated from the rhizomes of Cynanchum stauntonii ( Decne . ) Schltr . ex Levl .
【GOLD_E】
GlaucogeninE	chem
C(21)	chem
steroid	chem
【PRE_E】
GlaucogeninE(1)	chem
C(21)steroidsapogenin	chem
【GOLD_R】
【PRE_R】

Their structures were established mainly by the spectroscopic analysis , including 2D NMR .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All the isolated compounds were evaluated for their cytotoxicity against human cancer cell lines HeLa , Bel - 7402 , SGC - 7901 and BGC - 823 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

New triterpenoids from the stem bark of Hypodaphnis zenkeri .
【GOLD_E】
triterpenoids	chem
【PRE_E】
triterpenoids	chem
【GOLD_R】
【PRE_R】

A new pentacyclic triterpenoid and three new derivatives based on the taraxer - 14 - ene skeleton with a C - 28 attached a carboxylic acid group have been isolated from the stem bark of Hypodaphnis zenkeri , together with six known compounds .
【GOLD_E】
pentacyclictriterpenoid	chem
taraxer-14-ene	chem
carboxylicacid	chem
【PRE_E】
pentacyclictriterpenoid	chem
taraxer-14-ene	chem
C-28	chem
carboxylicacid	chem
【GOLD_R】
【PRE_R】

The new product was identified as 2α,3α - dihydroxytaraxer - 14 - en - 28 - oic acid ( 1 ) .
【GOLD_E】
2α,3α-dihydroxytaraxer-14-en-28-oicacid	chem
【PRE_E】
2α,3α-dihydroxytaraxer-14-en-28-oicacid	chem
【GOLD_R】
【PRE_R】

Its derivatives , 2α,3α - diacetyltaraxer - 14 - en - 28 - oic acid ( 2 ) , 2α,3α - di - O - carbonyl - 2α,3α - dihydroxytaraxer - 14 - en - 28 - oic acid ( 3 ) and 2α,3α - dipropionyltaraxer - 14 - en - 28 - oic acid ( 4 ) were obtained by semisynthesis .
【GOLD_E】
2α,3α-dipropionyltaraxer-14-en-28-oicacid	chem
2α,3α-diacetyltaraxer-14-en-28-oicacid	chem
2α,3α-di-O-carbonyl-2α,3α-dihydroxytaraxer-14-en-28-oicacid	chem
【PRE_E】
2α,3α-diacetyltaraxer-14-en-28-oicacid	chem
2α,3α-di-O-carbonyl-2α,3α-dihydroxytaraxer-14-en-28-oicacid	chem
2α,3α-dipropionyltaraxer-14-en-28-oicacid	chem
【GOLD_R】
【PRE_R】

The known compounds were identified as 3β - hydroxytaraxer - 14 - en - 28 - oic acid or aleuritolic acid ( 5 ) ( McPhail , A.T. , McPhail , D.R . , Wani , M.C . , Wall , M.E .
【GOLD_E】
3β-hydroxytaraxer-14-en-28-oicacid	chem
aleuritolicacid	chem
【PRE_E】
3β-hydroxytaraxer-14-en-28-oicacid	chem
aleuritolicacid	chem
McPhail	chem
McPhail	chem
【GOLD_R】
【PRE_R】

& A.W . , Nicholas , A.W .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 1989 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Identity of maprounic acid with aleuritolic acid .
【GOLD_E】
maprounicacid	chem
aleuritolicacid	chem
【PRE_E】
maprounicacid	chem
aleuritolicacid	chem
【GOLD_R】
【PRE_R】

Revision of the structure of maprounic acid : X - ray crystal structure of p - bromobenzyl acetylmaprounate .
【GOLD_E】
maprounicacid	chem
p-bromobenzylacetylmaprounate	chem
【PRE_E】
maprounicacid	chem
p-bromobenzylacetylmaprounate	chem
【GOLD_R】
【PRE_R】

Journal Natural Products , 52 , 212 ) , 3α - hydroxytaraxer - 14 - en - 28 - oic acid or isoaleuritolic acid ( 6 ) , 3α - acetyltaraxer - 14 - en - 28 - oic acid acetate or aleuritolic acid acetate ( 7 ) ( Chaudhuri , S.K . , Fullas , F. , Brown , D.M . , Wani , M.C . , Wall , M.E . , Cai , L. , … Kinghorn , A.D .
【GOLD_E】
3α-hydroxytaraxer-14-en-28-oicacid	chem
aleuritolicacidacetate	chem
isoaleuritolicacid	chem
3α-acetyltaraxer-14-en-28-oicacidacetate	chem
【PRE_E】
3α-hydroxytaraxer-14-en-28-oicacid	chem
isoaleuritolicacid	chem
3α-acetyltaraxer-14-en-28-oicacidacetate	chem
aleuritolicacidacetate	chem
【GOLD_R】
【PRE_R】

( 1995 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Isolation and structural elucidation of pentacyclic triterpenoids from Maprounea africana .
【GOLD_E】
【PRE_E】
pentacyclictriterpenoids	chem
【GOLD_R】
【PRE_R】

Journal of Natural Products , 58 , 1 - 9 ) , 3 - oxo - taraxer - 14 - ene or taraxerone ( 8 ) β - sitosterol ( 9 ) and stigmasterol ( 10 ) ( Kamboj & Saluja , 2011 ) , together with fatty acids .
【GOLD_E】
3-oxo-taraxer-14-ene	chem
taraxerone	chem
β-sitosterol	chem
stigmasterol	chem
【PRE_E】
3-oxo-taraxer-14-ene	chem
taraxerone(8)β-sitosterol	chem
stigmasterol	chem
Kamboj	chem
fattyacids	chem
【GOLD_R】
【PRE_R】

Their structures were established on the basis of spectroscopic studies and chemical transformations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Two new C - 15 enolic acyl phragmalin - type limonoids from Chukrasia tabularis var . velutina .
【GOLD_E】
enolicacylphragmalin	chem
limonoids	chem
【PRE_E】
C-15enolicacylphragmalin	chem
【GOLD_R】
【PRE_R】

Two new C - 15 enolic acyl phragmalin - type limonoid orthoesters , chukvelutilide G ( 1 ) and chukrasine F ( 2 ) , were isolated from the stem barks of Chukrasia tabularis var . velutina .
【GOLD_E】
enolicacylphragmalin	chem
limonoidorthoesters	chem
chukvelutilideG	chem
chukrasineF	chem
【PRE_E】
C-15enolicacylphragmalin	chem
limonoidorthoesters	chem
chukvelutilideG(1)	chem
chukrasineF(2)	chem
【GOLD_R】
【PRE_R】

Their structures were elucidated by their extensive high resolution - electrospray ionization mass spectrometry ( HR - ESI - MS ) , one - and two - dimensional spectroscopic analysis , including heteronuclear single quantum coherence ( HSQC ) , HMBC and NOESY experiments .
【GOLD_E】
【PRE_E】
HMBC	chem
【GOLD_R】
【PRE_R】

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide .
【GOLD_E】
pomalidomide	chem
lenalidomide	chem
Cereblon	geneY
【PRE_E】
Cereblon	geneY
lenalidomide	chem
pomalidomide	chem
【GOLD_R】
【PRE_R】

Thalidomide and the immunomodulatory drug , lenalidomide , are therapeutically active in hematological malignancies .
【GOLD_E】
lenalidomide	chem
Thalidomide	chem
【PRE_E】
Thalidomide	chem
lenalidomide	chem
【GOLD_R】
【PRE_R】

The ubiquitously expressed E3 ligase protein cereblon ( CRBN ) has been identified as the primary teratogenic target of thalidomide .
【GOLD_E】
cereblon	geneY
CRBN	geneY
thalidomide	chem
【PRE_E】
E3ligaseproteincereblon	geneY
CRBN	geneY
thalidomide	chem
【GOLD_R】
【PRE_R】

Our studies demonstrate that thalidomide , lenalidomide and another immunomodulatory drug , pomalidomide , bound endogenous CRBN and recombinant CRBN - DNA damage binding protein - 1 ( DDB1 ) complexes .
【GOLD_E】
pomalidomide	chem
CRBN	geneY
CRBN	geneY
DNAdamagebindingprotein-1	geneY
DDB1	geneY
thalidomide	chem
lenalidomide	chem
【PRE_E】
thalidomide	chem
lenalidomide	chem
pomalidomide	chem
CRBN	geneY
CRBN	geneY
DNAdamagebindingprotein-1	geneY
DDB1	geneY
【GOLD_R】
【PRE_R】

CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells , as well as lenalidomide - and pomalidomide - induced cytokine production in T cells .
【GOLD_E】
lenalidomide	chem
pomalidomide	chem
lenalidomide	chem
pomalidomide	chem
CRBN	geneY
cytokine	geneN
【PRE_E】
CRBN	geneY
lenalidomide	chem
pomalidomide	chem
lenalidomide	chem
pomalidomide	chem
cytokine	geneN
【GOLD_R】
lenalidomide	cytokine	C3
pomalidomide	cytokine	C3
【PRE_R】
lenalidomide	cytokine	C4
pomalidomide	cytokine	C4
lenalidomide	cytokine	C4
pomalidomide	cytokine	C4

Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide - binding competent wild - type CRBN , but not thalidomide - binding defective CRBN ( YW / AA ) .
【GOLD_E】
Lenalidomide	chem
pomalidomide	chem
thalidomide	chem
thalidomide	chem
CRBN	geneY
CRBN	geneY
CRBN	geneY
【PRE_E】
Lenalidomide	chem
pomalidomide	chem
CRBN	geneY
thalidomide	chem
CRBN	geneY
thalidomide	chem
CRBN	geneY
【GOLD_R】
Lenalidomide	CRBN	C4
Lenalidomide	CRBN	C4
pomalidomide	CRBN	C4
pomalidomide	CRBN	C4
【PRE_R】
Lenalidomide	CRBN	C4
pomalidomide	CRBN	C4

Overexpression of CRBN wild - type protein , but not CRBN ( YW / AA ) mutant protein , in KMS12 myeloma cells , amplified pomalidomide - mediated reductions in c - myc and IRF4 expression and increases in p21 ( WAF - 1 ) expression .
【GOLD_E】
pomalidomide	chem
WAF-1	geneY
CRBN	geneY
CRBN	geneY
c-myc	geneY
IRF4	geneY
p21	geneY
【PRE_E】
CRBN	geneY
CRBN	geneY
YW	geneY
pomalidomide	chem
c-myc	geneY
IRF4	geneY
p21	geneY
WAF-1	geneY
【GOLD_R】
pomalidomide	WAF-1	C3
pomalidomide	p21	C3
pomalidomide	c-myc	C4
pomalidomide	IRF4	C4
【PRE_R】
pomalidomide	p21	C3
pomalidomide	WAF-1	C3

Long - term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a reduction in CRBN , while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide , CRBN protein was undetectable .
【GOLD_E】
CRBN	geneY
CRBN	geneY
lenalidomide	chem
pomalidomide	chem
lenalidomide	chem
【PRE_E】
lenalidomide	chem
CRBN	geneY
pomalidomide	chem
lenalidomide	chem
CRBN	geneY
【GOLD_R】
lenalidomide	CRBN	C4
【PRE_R】
lenalidomide	CRBN	C4
CRBN	pomalidomide	C4
lenalidomide	CRBN	C4

Our biophysical , biochemical and gene silencing studies show that CRBN is a proximate , therapeutically important molecular target of lenalidomide and pomalidomide .
【GOLD_E】
CRBN	geneY
lenalidomide	chem
pomalidomide	chem
【PRE_E】
CRBN	geneY
lenalidomide	chem
pomalidomide	chem
【GOLD_R】
【PRE_R】

Evaluation of food - drug interaction of guava leaf tea .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Guava leaf tea ( GLT ) contains guava leaf polyphenol ( Gvpp ) , which regulates the absorption of dietary carbohydrate from the intestines .
【GOLD_E】
carbohydrate	chem
polyphenol	chem
【PRE_E】
GLT	geneY
polyphenol	chem
Gvpp	chem
carbohydrate	chem
【GOLD_R】
【PRE_R】

Borderline diabetics , who are at high risk of development of diabetes , take GLT to suppress a rapid increase of blood sugar level after meals .
【GOLD_E】
sugar	chem
【PRE_E】
GLT	geneY
sugar	chem
【GOLD_R】
【PRE_R】
GLT	sugar	C3

However , patients with diabetes in whom diabetic drugs or warfarin as a blood thinner are prescribed also take GLT with the expectation of glycemic control .
【GOLD_E】
warfarin	chem
【PRE_E】
warfarin	chem
GLT	geneY
【GOLD_R】
【PRE_R】
warfarin	GLT	C3

Therefore , we studied whether GLT had potential for inhibition or induction of cytochrome P450 ( CYP ) and an influence on the action of warfarin .
【GOLD_E】
cytochromeP450	geneN
CYP	geneN
warfarin	chem
【PRE_E】
GLT	geneY
cytochromeP450	geneN
CYP	geneN
warfarin	chem
【GOLD_R】
【PRE_R】

Extract of guava leaf ( GvEx ) consists of carbohydrate and polyphenols , which are Gvpp , quercetin , and ellagic acid .
【GOLD_E】
quercetin	chem
ellagicacid	chem
carbohydrate	chem
polyphenols	chem
【PRE_E】
carbohydrate	chem
polyphenols	chem
Gvpp	chem
quercetin	chem
ellagicacid	chem
【GOLD_R】
【PRE_R】

These polyphenols , but not GvEx , showed a certain level of inhibition of human - cDNA - expressed CYPs .
【GOLD_E】
polyphenols	chem
CYPs	geneN
【PRE_E】
polyphenols	chem
GvEx	chem
human-cDNA-expressedCYPs	geneN
【GOLD_R】
polyphenols	CYPs	C4
【PRE_R】
polyphenols	human-cDNA-expressedCYPs	C4
GvEx	human-cDNA-expressedCYPs	C4

In a comparison of GLT and grapefruit juice , GLT showed weaker inhibition of CYP activities and of midazolam 1 ' - hydroxylation than grapefruit juice .
【GOLD_E】
midazolam	chem
CYP	geneN
【PRE_E】
GLT	geneY
grapefruit	chem
GLT	geneY
CYP	geneN
midazolam1	chem
grapefruit	chem
【GOLD_R】
【PRE_R】
GLT	grapefruit	C4
grapefruit	GLT	C4
CYP	midazolam1	C4
CYP	grapefruit	C4

Furthermore , neither liver weight nor CYP3A expression in the liver was changed in rats that received GvEx for 90 days compared with the control group .
【GOLD_E】
CYP3A	geneN
【PRE_E】
CYP3A	geneN
GvEx	chem
【GOLD_R】
【PRE_R】

When rats were concomitantly treated with GLT and warfarin , the prolongation of clotting time of blood by warfarin was not influenced .
【GOLD_E】
warfarin	chem
warfarin	chem
【PRE_E】
GLT	chem
warfarin	chem
warfarin	chem
【GOLD_R】
【PRE_R】

These data suggest that GLT is unlikely to interact with drugs .
【GOLD_E】
【PRE_E】
GLT	geneY
【GOLD_R】
【PRE_R】

Crizotinib in the treatment of non - small - cell lung cancer .
【GOLD_E】
Crizotinib	chem
【PRE_E】
Crizotinib	chem
【GOLD_R】
【PRE_R】

INTRODUCTION : Recent progress in identifying distinct subsets of lung cancer , based on critical driver mutations , has led to increasingly focused efforts in the development of selectively targeted therapies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The fusion oncogene , echinoderm microtubule - associated protein - like 4 - anaplastic lymphoma kinase ( EML4 - ALK ) , is present in approximately 5 % of non - small - cell lung cancer ( NSCLC ) tumors .
【GOLD_E】
echinodermmicrotubule-associatedprotein-like4	geneY
anaplasticlymphomakinase	geneY
EML4	geneN
ALK	geneY
【PRE_E】
echinodermmicrotubule-associatedprotein-like4-anaplasticlymphomakinase	geneY
EML4	geneY
ALK	geneY
【GOLD_R】
【PRE_R】

Crizotinib is an oral tyrosine kinase inhibitor ( TKI ) , which silences the protein product of the ALK fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing ALK .
【GOLD_E】
tyrosinekinase	geneN
ALK	geneY
ALK	geneY
Crizotinib	chem
tyrosine	chem
【PRE_E】
Crizotinib	chem
tyrosinekinase	geneN
TKI	geneY
ALK	geneY
ALK	geneY
【GOLD_R】
Crizotinib	ALK	C4
Crizotinib	tyrosinekinase	C4
【PRE_R】
Crizotinib	TKI	C4
Crizotinib	ALK	C4
Crizotinib	ALK	C4

Emerging data suggest that crizotinib may also have activity in other subsets of lung cancer , including tumors demonstrating amplification or mutation of the MET oncogene , or translocation of the ROS1 oncogene .
【GOLD_E】
MET	geneY
ROS1	geneY
crizotinib	chem
【PRE_E】
crizotinib	chem
MET	geneY
ROS1	geneY
【GOLD_R】
【PRE_R】

AREAS COVERED : This paper gives an overview of the molecular pathogenesis of ALK - associated NSCLC .
【GOLD_E】
ALK	geneY
【PRE_E】
ALK	geneY
【GOLD_R】
【PRE_R】

It also reviews the pharmacokinetic and pharmacodynamic data on crizotinib and outlines the preclinical and clinical studies leading to the approval of crizotinib .
【GOLD_E】
crizotinib	chem
crizotinib	chem
【PRE_E】
crizotinib	chem
crizotinib	chem
【GOLD_R】
【PRE_R】

In addition , it discusses its role in the treatment of NSCLC expressing ALK .
【GOLD_E】
ALK	geneY
【PRE_E】
ALK	geneY
【GOLD_R】
【PRE_R】

EXPERT OPINION : Crizotinib represents the newest example of a focused strategy for drug development in lung cancer , based on identification and targeted inhibition of critical tumor - specific driver mutations .
【GOLD_E】
Crizotinib	chem
【PRE_E】
Crizotinib	chem
【GOLD_R】
【PRE_R】

Crizotinib has demonstrated efficacy against ALK - rearranged NSCLC , and has potential for broader application in select subsets of lung cancer .
【GOLD_E】
ALK	geneY
Crizotinib	chem
【PRE_E】
Crizotinib	chem
ALK	geneY
【GOLD_R】
【PRE_R】

Central adenosinergic system involvement in ethanol - induced motor incoordination in mice .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
【GOLD_R】
【PRE_R】

To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change , the effect of i.c.v . adenosine agonists , N6 - ( R - phenylisopropyl ) adenosine ( R - PIA ) , N6 - ( S - phenylisopropyl ) adenosine , 5 ' - ( N - cyclopropyl ) - carboxamidoadenosine , antagonists , theophylline and 8 - p - ( sulfophenyl ) theophylline as well as enprofylline on ethanol - ( i.p . ) - induced motor incoordination was evaluated by rotorod .
【GOLD_E】
adenosine	chem
N6-(R-phenylisopropyl)adenosine	chem
R-PIA	chem
N6-(S-phenylisopropyl)adenosine	chem
5'-(N-cyclopropyl)-carboxamidoadenosine	chem
theophylline	chem
8-p-(sulfophenyl)theophylline	chem
enprofylline	chem
ethanol	chem
ethanol	chem
adenosine	chem
adenosine	geneN
adenosine	geneN
【PRE_E】
ethanol	chem
adenosine	chem
adenosine	chem
N6-(R-phenylisopropyl)adenosine	chem
R-PIA	chem
N6-(S-phenylisopropyl)adenosine	chem
5'-(N-cyclopropyl)-carboxamidoadenosine	chem
theophylline	chem
8-p-(sulfophenyl)theophylline	chem
enprofylline	chem
ethanol	chem
【GOLD_R】
N6-(R-phenylisopropyl)adenosine	adenosine	C5
R-PIA	adenosine	C5
N6-(S-phenylisopropyl)adenosine	adenosine	C5
5'-(N-cyclopropyl)-carboxamidoadenosine	adenosine	C5
theophylline	adenosine	C6
8-p-(sulfophenyl)theophylline	adenosine	C6
enprofylline	adenosine	C6
【PRE_R】

Adenosine agonists and antagonists dose dependently accentuated and attenuated , respectively , ethanol - induced motor incoordination , thereby suggesting a central mechanism of adenosine modulation of this effect of ethanol and confirmed our previous reports in which adenosine agonists and antagonists were given i.p .
【GOLD_E】
Adenosine	chem
ethanol	chem
adenosine	chem
ethanol	chem
adenosine	chem
Adenosine	geneN
adenosine	geneN
adenosine	geneN
【PRE_E】
Adenosine	chem
ethanol	chem
adenosine	chem
ethanol	chem
adenosine	chem
【GOLD_R】
【PRE_R】

Enprofylline , a weak adenosine antagonist but potent inhibitor of cyclic AMP phosphodiesterase , did not alter ethanol 's motor incoordination , further supporting involvement of brain adenosine receptor mechanism ( s ) in ethanol - adenosine interactions .
【GOLD_E】
adenosine	chem
Enprofylline	chem
adenosine	chem
cyclicAMP	chem
ethanol	chem
adenosine	geneN
adenosine	geneN
cyclicAMPphosphodiesterase	geneN
adenosinereceptor	geneN
【PRE_E】
Enprofylline	chem
adenosine	chem
cyclicAMPphosphodiesterase	geneN
adenosinereceptor	geneY
ethanol	chem
adenosine	chem
【GOLD_R】
Enprofylline	cyclicAMPphosphodiesterase	C4
Enprofylline	adenosine	C6
【PRE_R】

Results from R - PIA and N6 - ( S - phenylisopropyl ) adenosine experiments showed nearly a 40 - fold greater potency of R - vs .
【GOLD_E】
N6-(S-phenylisopropyl)adenosine	chem
【PRE_E】
R-PIA	chem
N6-(S-phenylisopropyl)adenosine	chem
【GOLD_R】
【PRE_R】

S - diastereoisomer , suggesting predominance of adenosine A1 subtype .
【GOLD_E】
adenosineA1	geneY
adenosine	chem
【PRE_E】
S-diastereoisomer	chem
adenosineA1	geneY
【GOLD_R】
【PRE_R】

However , 5 ' - ( N - cyclopropyl ) - carboxamidoadenosine data indicate complexity of the mechanism ( s ) and point toward an additional involvement of a yet unknown subtype of adenosine A2 .
【GOLD_E】
adenosineA2	geneN
5'-(N-cyclopropyl)-carboxamidoadenosine	chem
adenosine	chem
【PRE_E】
5'-(N-cyclopropyl)-carboxamidoadenosine	chem
adenosineA2	chem
【GOLD_R】
【PRE_R】

No effect of ethanol on blood or brain levels of [ 3H ] R - PIA was noted and sufficient amount of the latter entered the brain to suggest adenosine receptor activation adequate to produce behavioral interaction with ethanol .
【GOLD_E】
adenosinereceptor	geneN
[3H]R-PIA	chem
adenosine	chem
ethanol	chem
【PRE_E】
ethanol	chem
[3H]R-PIA	chem
adenosinereceptor	geneY
ethanol	chem
【GOLD_R】
【PRE_R】

There was no escape of i.c.v . - administered [ 3H ] R - PIA from brain to the peripheral circulation ruling out a peripheral and supporting a central mechanism of ethanol - adenosine interaction . ( ABSTRACT TRUNCATED AT 250 WORDS )
【GOLD_E】
ethanol	chem
adenosine	chem
adenosine	geneN
[3H]R-PIA	chem
【PRE_E】
[3H]R-PIA	chem
ethanol	chem
adenosine	chem
【GOLD_R】
【PRE_R】

TGF - β and NF - κB signal pathway cross - talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers .
【GOLD_E】
TGF-β	geneY
NF-κB	geneN
TAK1	geneY
SMAD7	geneY
【PRE_E】
TGF-β	geneY
NF-κB	geneN
TAK1	geneY
SMAD7	geneY
【GOLD_R】
【PRE_R】

Transforming growth factor - beta ( TGF - β ) has a dual role in epithelial malignancies , including head and neck squamous cell carcinoma ( HNSCC ) .
【GOLD_E】
TGF-β	geneY
Transforminggrowthfactor-beta	geneY
【PRE_E】
Transforminggrowthfactor-beta	geneY
TGF-β	geneY
【GOLD_R】
【PRE_R】

Attenuation of canonical TGF - β signaling enhances de novo tumor development , whereas TGF - β overexpression and signaling paradoxically promotes malignant progression .
【GOLD_E】
TGF-β	geneY
TGF-β	geneY
【PRE_E】
TGF-β	geneY
TGF-β	geneY
【GOLD_R】
【PRE_R】

We recently observed that TGF - β - induced growth arrest response is attenuated , in association with aberrant activation of nuclear factor - κB ( NF - κB ) , a transcription factor , which promotes malignant progression in HNSCC .
【GOLD_E】
TGF-β	geneY
nuclearfactor-κB	geneN
NF-κB	geneN
【PRE_E】
TGF-β	geneY
nuclearfactor-κB	geneN
NF-κB	geneN
【GOLD_R】
【PRE_R】

However , what role cross - talk between components of the TGF - β and NF - κB pathways plays in altered activation of these pathways has not been established .
【GOLD_E】
TGF-β	geneY
NF-κB	geneN
【PRE_E】
TGF-β	geneN
NF-κB	geneN
【GOLD_R】
【PRE_R】

Here , we show TGF - β receptor II and TGF - β - activated kinase 1 ( TAK1 ) are predominantly expressed in a subset of HNSCC tumors with nuclear activation of NF - κB family member RELA ( p65 ) .
【GOLD_E】
TGF-βreceptorII	geneY
TGF-β-activatedkinase1	geneY
TAK1	geneY
NF-κB	geneN
RELA	geneY
p65	geneY
【PRE_E】
TGF-βreceptorII	geneY
TGF-β-activatedkinase1	geneY
TAK1	geneY
NF-κB	geneN
RELA	geneY
p65	geneY
【GOLD_R】
【PRE_R】

Further , TGF - β1 treatment induced sequential phosphorylation of TAK1 , IKK , IκBα and RELA in human HNSCC lines .
【GOLD_E】
TGF-β1	geneY
TAK1	geneY
IKK	geneN
IκBα	geneY
RELA	geneY
【PRE_E】
TGF-β1	geneY
TAK1	geneY
IKK	geneY
IκBα	geneY
RELA	geneY
【GOLD_R】
【PRE_R】

TAK1 enhances TGF - β - induced NF - κB activation , as TAK1 siRNA knockdown decreased TGF - β1 - induced phosphorylation of IKK , IκB and RELA , degradation of IκBα , RELA nuclear translocation and DNA binding , and NF - κB - induced reporter and target gene transcription .
【GOLD_E】
RELA	geneY
IκBα	geneY
RELA	geneY
NF-κB	geneN
NF-κB	geneN
TAK1	geneY
TGF-β	geneY
TAK1	geneY
TGF-β1	geneY
IKK	geneN
IκB	geneY
【PRE_E】
TAK1	geneN
TGF-β	geneY
NF-κB	geneN
TAK1	geneY
TGF-β1	geneY
IKK	geneN
IκB	geneY
RELA	geneY
IκBα	geneY
RELA	geneY
NF-κB	geneN
【GOLD_R】
【PRE_R】

Functionally , TAK1 siRNA inhibited cell proliferation , migration and invasion .
【GOLD_E】
TAK1	geneY
【PRE_E】
TAK1	geneY
【GOLD_R】
【PRE_R】

Celastrol , a TAK1 inhibitor and anti - inflammatory compound used in traditional Chinese medicine , also decreased TGF - β1 - induced phosphorylation of TAK1 and RELA , and suppressed basal , TGF - β1 - and tumor necrosis factor - alpha ( TNF - α ) - induced NF - κB reporter gene activity .
【GOLD_E】
TAK1	geneY
TGF-β1	geneY
TAK1	geneY
RELA	geneY
TGF-β1	geneY
Celastrol	chem
tumornecrosisfactor-alpha	geneY
TNF-α	geneY
NF-κB	geneN
【PRE_E】
Celastrol	chem
TAK1	geneN
TGF-β1	geneY
TAK1	geneY
RELA	geneY
TGF-β1	geneY
tumornecrosisfactor-alpha	geneY
TNF-α	geneY
NF-κB	geneN
【GOLD_R】
Celastrol	TGF-β1	C4
Celastrol	TGF-β1	C4
Celastrol	tumornecrosisfactor-alpha	C4
Celastrol	TAK1	C4
Celastrol	TAK1	C4
Celastrol	RELA	C4
Celastrol	NF-κB	C4
【PRE_R】
Celastrol	TAK1	C4
Celastrol	TGF-β1	C4
Celastrol	TAK1	C4
Celastrol	RELA	C4
Celastrol	TGF-β1	C4
Celastrol	NF-κB	C4

Celastrol also inhibited cell proliferation , while increasing sub - G0 DNA fragmentation and Annexin V markers of apoptosis .
【GOLD_E】
AnnexinV	geneY
Celastrol	chem
【PRE_E】
Celastrol	chem
【GOLD_R】
Celastrol	AnnexinV	C3
【PRE_R】

Furthermore , TGF - β and RELA activation promoted SMAD7 expression .
【GOLD_E】
TGF-β	geneY
RELA	geneY
SMAD7	geneY
【PRE_E】
TGF-β	geneY
RELA	geneY
SMAD7	geneY
【GOLD_R】
【PRE_R】

In turn , SMAD7 preferentially suppressed TGF - β - induced SMAD and NF - κB reporters when compared with constitutive or TNF - α - induced NF - κB reporter gene activation .
【GOLD_E】
SMAD7	geneY
TGF-β	geneY
SMAD	geneN
NF-κB	geneN
TNF-α	geneY
NF-κB	geneN
【PRE_E】
SMAD7	geneY
TGF-β	geneY
SMAD	geneY
NF-κB	geneN
TNF-α	geneY
NF-κB	geneN
【GOLD_R】
【PRE_R】

Thus , cross - talk by TGF - β via TAK1 and NF - κB promotes the malignant phenotype of HNSCC .
【GOLD_E】
TGF-β	geneY
TAK1	geneY
NF-κB	geneN
【PRE_E】
TGF-β	geneY
TAK1	geneY
NF-κB	geneN
HNSCC	geneY
【GOLD_R】
【PRE_R】

Moreover , NF - κB may contribute to the downstream attenuation of canonical TGF - β signaling through increased SMAD7 expression .
【GOLD_E】
NF-κB	geneN
TGF-β	geneY
SMAD7	geneY
【PRE_E】
NF-κB	geneN
TGF-β	geneN
SMAD7	geneY
【GOLD_R】
【PRE_R】

Celastrol highlights the therapeutic potential of agents targeting TAK1 as a key node in this pro - oncogenic TGF - β - NF - κB signal pathway .
【GOLD_E】
Celastrol	chem
TAK1	geneY
TGF-β	geneY
NF-κB	geneN
【PRE_E】
Celastrol	chem
TAK1	geneN
TGF-β	geneN
NF-κB	geneN
【GOLD_R】
Celastrol	TAK1	C4
【PRE_R】

Dendritic cell migration assay : a potential prediction model for identification of contact allergens .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This manuscript describes methodology and a prediction model for the MUTZ - LC migration assay .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The assay represents the physiological change in Langerhans cell ( LC ) behavior after exposure to a sensitizing chemical , resulting in LC migration from the epidermis to the dermis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

MUTZ - LC are derived from the commercially available MUTZ - 3 cell line .
【GOLD_E】
【PRE_E】
MUTZ-LC	chem
【GOLD_R】
【PRE_R】

Upon exposure to a sensitizer MUTZ - LC migrate preferentially towards CXCL12 whereas upon exposure to a non - sensitizer MUTZ - LC migrate towards CCL5 .
【GOLD_E】
CXCL12	geneY
CCL5	geneY
【PRE_E】
MUTZ-LC	chem
CXCL12	geneY
MUTZ-LC	chem
CCL5	geneY
【GOLD_R】
【PRE_R】
MUTZ-LC	CXCL12	C3
CXCL12	MUTZ-LC	C3
MUTZ-LC	CCL5	C3

A CXCL12 / CCL5 ratio > 1.10 in 2 / 3 independent experiments is indicative of a sensitizer , whereas a CXCL12 / CCL5 ratio ≤ 1.10 is indicative of a non - sensitizer .
【GOLD_E】
CXCL12	geneY
CCL5	geneY
CXCL12	geneY
CCL5	geneY
【PRE_E】
CXCL12	geneY
CCL5	geneY
CXCL12	geneY
CCL5	geneY
【GOLD_R】
【PRE_R】

At non cytotoxic chemical concentrations 9 sensitizers ( 2,4 - dinitrochlorobenzene , paraphenylendiamine , cinnamaldehyde , isoeugenol , nickel - sulfate , tetramethylthiuram disulfide , eugenol , cinnamic - alcohol , ammonium - hexachloroplatinate ) were distinguished from 4 non sensitizers ( sodium lauryl sulfate , salicylic acid , phenol , octanoic acid ) .
【GOLD_E】
sodiumlaurylsulfate	chem
salicylicacid	chem
phenol	chem
octanoicacid	chem
2,4-dinitrochlorobenzene	chem
paraphenylendiamine	chem
cinnamaldehyde	chem
isoeugenol	chem
nickel-sulfate	chem
tetramethylthiuramdisulfide	chem
eugenol	chem
cinnamic-alcohol	chem
ammonium-hexachloroplatinate	chem
【PRE_E】
2,4-dinitrochlorobenzene	chem
paraphenylendiamine	chem
cinnamaldehyde	chem
isoeugenol	chem
nickel-sulfate	chem
tetramethylthiuramdisulfide	chem
eugenol	chem
cinnamic-alcohol	chem
ammonium-hexachloroplatinate	chem
sodiumlaurylsulfate	chem
salicylicacid	chem
phenol	chem
octanoicacid	chem
【GOLD_R】
【PRE_R】

Critical points in assay performance are ( i ) MUTZ - 3 passage number after thawing ( p6 - p40 ) ; ( ii ) cell viability ( > 80 % ) ; ( iii ) standard curve to optimize correlation of fluorescence with cell number ; and ( iv ) optimization of the concentration of rhCXCL12 and rhCCL5 in transwell .
【GOLD_E】
rhCXCL12	geneY
rhCCL5	geneY
【PRE_E】
p6-p40	geneY
【GOLD_R】
【PRE_R】

The protocol has been tested in three European laboratories and results suggest that it may provide working conditions for performing the DC migration assay which is aimed at distinguishing sensitizers from non sensitizers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The atypical antidepressant mianserin exhibits agonist activity at kappa - opioid receptors .
【GOLD_E】
mianserin	chem
kappa-opioidreceptors	geneY
【PRE_E】
mianserin	chem
kappa-opioidreceptors	geneN
【GOLD_R】
mianserin	kappa-opioidreceptors	C5
【PRE_R】

BACKGROUND AND PURPOSE : Antidepressants are known to interact with the opioid system through mechanisms not completely understood .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We previously reported that tricyclic antidepressants act as agonists at distinct opioid receptors .
【GOLD_E】
tricyclic	chem
opioidreceptors	geneN
【PRE_E】
tricyclic	chem
opioidreceptors	geneN
【GOLD_R】
tricyclic	opioidreceptors	C5
【PRE_R】

Here , we investigated the effect of the atypical antidepressant mianserin at cloned and native opioid receptors .
【GOLD_E】
mianserin	chem
opioidreceptors	geneN
【PRE_E】
mianserin	chem
opioidreceptors	geneN
【GOLD_R】
【PRE_R】

EXPERIMENTAL APPROACH : Effects of mianserin were examined in CHO cells transfected with human opioid receptors , C6 glioma cells and rat brain membranes by the use of radioligand binding and functional assays including the stimulation of [ ( 35 ) S ] GTPgammaS binding and MAPK phosphorylation .
【GOLD_E】
mianserin	chem
[(35)S]GTPgammaS	chem
humanopioidreceptors	geneN
MAPK	geneN
【PRE_E】
mianserin	chem
humanopioidreceptors	geneY
[(35)S]GTPgammaS	chem
MAPK	geneN
【GOLD_R】
【PRE_R】

KEY RESULTS : Mianserin displayed 12 - and 18 - fold higher affinity for kappa - than micro - and delta - opioid receptors respectively .
【GOLD_E】
Mianserin	chem
kappa-thanmicro-anddelta-opioidreceptors	geneN
【PRE_E】
Mianserin	chem
kappa-thanmicro-anddelta-opioidreceptors	geneN
【GOLD_R】
【PRE_R】

In [ ( 35 ) S ] GTPgammaS assays , mianserin selectively activated kappa - opioid receptors .
【GOLD_E】
[(35)S]GTPgammaS	chem
mianserin	chem
kappa-opioidreceptors	geneY
【PRE_E】
[(35)S]GTPgammaS	chem
mianserin	chem
kappa-opioidreceptors	geneN
【GOLD_R】
mianserin	kappa-opioidreceptors	C3
【PRE_R】

The agonist activity was antagonized by the selective kappa - opioid blocker nor - binaltorphimine ( nor - BNI ) .
【GOLD_E】
nor-binaltorphimine	chem
nor-BNI	chem
kappa-opioid	geneY
【PRE_E】
kappa-opioid	geneN
nor-binaltorphimine	chem
nor-BNI	chem
【GOLD_R】
nor-binaltorphimine	kappa-opioid	C4
nor-BNI	kappa-opioid	C4
nor-binaltorphimine	kappa-opioid	C6
nor-BNI	kappa-opioid	C6
【PRE_R】
kappa-opioid	nor-binaltorphimine	C6
kappa-opioid	nor-BNI	C6

The mianserin analogue mirtazapine also displayed kappa - opioid agonist activity .
【GOLD_E】
mianserin	chem
mirtazapine	chem
kappa-opioid	geneY
【PRE_E】
mianserin	chem
mirtazapine	chem
kappa-opioid	geneN
【GOLD_R】
mianserin	kappa-opioid	C5
mirtazapine	kappa-opioid	C5
【PRE_R】

Mianserin and mirtazapine increased ERK1 / 2 phosphorylation in CHO cells expressing kappa - opioid receptors and C6 cells , and these effects were antagonized by nor - BNI .
【GOLD_E】
Mianserin	chem
ERK1/2	geneN
kappa-opioidreceptors	geneY
mirtazapine	chem
nor-BNI	chem
【PRE_E】
Mianserin	chem
mirtazapine	chem
ERK1/2	geneN
kappa-opioidreceptors	geneN
nor-BNI	chem
【GOLD_R】
【PRE_R】
Mianserin	ERK1/2	C4
mirtazapine	ERK1/2	C4

In rat striatum and nucleus accumbens , mianserin stimulated [ 35S ] GTPgammaS binding in a nor - BNI - sensitive manner with maximal effects lower than those of the full kappa - opioid agonists ( - ) - U50,488 and dynorphin A .
【GOLD_E】
kappa-opioid	geneY
dynorphinA	geneY
mianserin	chem
[35S]GTPgammaS	chem
nor-BNI	chem
(-)-U50,488	chem
dynorphinA	chem
【PRE_E】
mianserin	chem
[35S]GTPgammaS	chem
nor-BNI	chem
kappa-opioid	geneN
(-)-U50,488	chem
dynorphinA	chem
【GOLD_R】
(-)-U50,488	kappa-opioid	C5
dynorphinA	kappa-opioid	C5
【PRE_R】
kappa-opioid	(-)-U50,488	C6

When combined , mianserin antagonized the effects of the full kappa - opioid receptor agonists in [ ( 35 ) S ] GTPgammaS assays and reduced the stimulation of p38 MAPK and ERK1 / 2 phosphorylation by dynorphin A .
【GOLD_E】
[(35)S]GTPgammaS	chem
dynorphinA	chem
kappa-opioidreceptor	geneY
p38	geneN
MAPK	geneN
ERK1/2	geneN
dynorphinA	geneY
mianserin	chem
【PRE_E】
mianserin	chem
kappa-opioidreceptor	geneN
[(35)S]GTPgammaS	chem
p38	geneN
MAPK	geneN
ERK1/2	geneN
dynorphinA	geneY
【GOLD_R】
dynorphinA	p38	C3
dynorphinA	MAPK	C3
mianserin	p38	C4
mianserin	MAPK	C4
mianserin	kappa-opioidreceptor	C6
【PRE_R】
mianserin	kappa-opioidreceptor	C4
kappa-opioidreceptor	[(35)S]GTPgammaS	C4
[(35)S]GTPgammaS	p38	C4
[(35)S]GTPgammaS	MAPK	C4
[(35)S]GTPgammaS	ERK1/2	C4

CONCLUSIONS AND IMPLICATIONS : In different cell systems , mianserin directly activates kappa - opioid receptors , displaying partial agonist activity at brain receptors .
【GOLD_E】
mianserin	chem
kappa-opioidreceptors	geneY
【PRE_E】
mianserin	chem
kappa-opioidreceptors	geneN
【GOLD_R】
mianserin	kappa-opioidreceptors	C3
mianserin	kappa-opioidreceptors	C5
【PRE_R】

Thus , this property appears to be a common feature of different classes of antidepressants .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lipid biomarkers of oxidative stress in a genetic mouse model of Smith - Lemli - Opitz syndrome .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

7 - Dehydrocholesterol ( 7 - DHC ) accumulates in tissues and fluids of patients with Smith - Lemli - Opitz syndrome ( SLOS ) , which is caused by mutations in the gene encoding 3β - hydroxysterol - Δ ( 7 ) - reductase ( DHCR7 ) .
【GOLD_E】
3β-hydroxysterol	chem
7-DHC	chem
7-Dehydrocholesterol	chem
3β-hydroxysterol-Δ(7)-reductase	geneY
DHCR7	geneY
【PRE_E】
7-Dehydrocholesterol	chem
7-DHC	chem
SLOS	geneY
3β-hydroxysterol-Δ(7)-reductase	geneY
DHCR7	geneY
【GOLD_R】
【PRE_R】
7-DHC	DHCR7	C9

We recently reported that 7 - DHC is the most reactive lipid molecule toward free radical oxidation ( lipid peroxidation ) and 14 oxysterols have been identified as products of oxidation of 7 - DHC in solution .
【GOLD_E】
7-DHC	chem
oxysterols	chem
7-DHC	chem
【PRE_E】
7-DHC	chem
oxysterols	chem
7-DHC	chem
【GOLD_R】
【PRE_R】

As the high oxidizability of 7 - DHC may lead to systemic oxidative stress in SLOS patients , we report here lipid biomarkers of oxidative stress in a Dhcr7 - KO mouse model of SLOS , including oxysterols , isoprostanes ( IsoPs ) , and neuroprostanes ( NeuroPs ) that are formed from the oxidation of 7 - DHC , arachidonic acid and docosahexaenoic acid , respectively .
【GOLD_E】
7-DHC	chem
oxysterols	chem
isoprostanes	chem
IsoPs	chem
neuroprostanes	chem
NeuroPs	chem
7-DHC	chem
arachidonicacid	chem
docosahexaenoicacid	chem
Dhcr7	geneY
【PRE_E】
oxidizability	chem
7-DHC	chem
Dhcr7	geneY
SLOS	geneY
oxysterols	chem
isoprostanes	chem
IsoPs	chem
neuroprostanes	chem
NeuroPs	chem
7-DHC	chem
arachidonicacid	chem
docosahexaenoicacid	chem
【GOLD_R】
【PRE_R】

In addition to a previously described oxysterol , 3β,5α - dihydroxycholest - 7 - en - 6 - one ( DHCEO ) , we provide evidence for the chemical structures of three new oxysterols in the brain and / or liver tissue of Dhcr7 - KO mice , two of which were quantified .
【GOLD_E】
oxysterol	chem
3β,5α-dihydroxycholest-7-en-6-one	chem
DHCEO	chem
oxysterols	chem
Dhcr7	geneY
【PRE_E】
oxysterol	chem
3β,5α-dihydroxycholest-7-en-6-one	chem
DHCEO	chem
oxysterols	chem
Dhcr7	geneY
【GOLD_R】
【PRE_R】

We find that levels of IsoPs and NeuroPs are also elevated in brain and / or liver tissues of Dhcr7 - KO mice relative to matching WT mice .
【GOLD_E】
Dhcr7	geneY
IsoPs	chem
NeuroPs	chem
【PRE_E】
IsoPs	chem
NeuroPs	chem
Dhcr7	geneY
【GOLD_R】
【PRE_R】

While IsoPs and NeuroPs have been established as a reliable measurement of lipid peroxidation and oxidative stress in vivo , we show that in this genetic SLOS mouse model , 7 - DHC - derived oxysterols are present at much higher levels than IsoPs and NeuroPs and thus are better markers of lipid oxidation and related oxidative stress .
【GOLD_E】
IsoPs	chem
NeuroPs	chem
7-DHC	chem
oxysterols	chem
IsoPs	chem
NeuroPs	chem
【PRE_E】
IsoPs	chem
NeuroPs	chem
SLOS	geneY
7-DHC	chem
oxysterols	chem
IsoPs	chem
NeuroPs	chem
【GOLD_R】
【PRE_R】

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus .
【GOLD_E】
Smad1	geneY
【PRE_E】
Smad1	geneY
【GOLD_R】
【PRE_R】

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration ( GHF ) in type 2 diabetes mellitus ( T2DM ) , and to explore the factors related to the urinary Smad1 in T2DM .
【GOLD_E】
Smad1	geneY
Smad1	geneY
【PRE_E】
Smad1	geneY
glomerularhyperfiltration	geneY
GHF	geneY
Smad1	geneY
【GOLD_R】
【PRE_R】

The reference value of the estimated glomerular filtration rate ( eGFR ) was determined in 248 healthy individuals .
【GOLD_E】
【PRE_E】
eGFR	geneY
【GOLD_R】
【PRE_R】

30 patients with GHF , 58 patients with norm - GFR T2DM , and 24 healthy patients who served as controls were recruited .
【GOLD_E】
【PRE_E】
GHF	geneY
【GOLD_R】
【PRE_R】

Urinary Smad1 , fasting plasma glucose ( FPG ) , fasting serum C - Peptide ( C - P ) , hemoglobin A1C ( HbA1c ) , cystatin C , and other chemistry laboratory parameters of T2DM participants and controls were measured .
【GOLD_E】
HbA1c	geneY
cystatinC	geneY
glucose	chem
Smad1	geneY
C-Peptide	geneY
C-P	geneY
hemoglobinA1C	geneY
【PRE_E】
Smad1	geneY
glucose	chem
C-Peptide	geneY
C-P	geneY
hemoglobinA1C	geneY
HbA1c	geneY
cystatinC	geneY
【GOLD_R】
【PRE_R】

Patients with GHF had higher levels of urinary Smad1 than the control group , and those with norm - GFR .
【GOLD_E】
Smad1	geneY
【PRE_E】
GHF	geneY
Smad1	geneY
【GOLD_R】
【PRE_R】

For T2DM patients with body mass index , age , and gender adjustments , urinary Smad1 was positively correlated with FPG , HbA1C , and eGFR , but negatively correlated with fasting serum C - P .
【GOLD_E】
Smad1	geneY
HbA1C	geneY
C-P	geneN
【PRE_E】
Smad1	geneY
HbA1C	geneY
eGFR	geneY
C-P	geneY
【GOLD_R】
【PRE_R】

Multivariate linear regression analysis demonstrated that eGFR , HbA1C , and fasting serum C - P were independently associated with urinary Smad1 .
【GOLD_E】
HbA1C	geneY
C-P	geneY
Smad1	geneY
【PRE_E】
eGFR	geneY
HbA1C	geneY
C-P	geneY
Smad1	geneY
【GOLD_R】
【PRE_R】

High levels of urinary Smad1 were found in GHF patients with T2DM , which may be another potential mechanism of GHF in relation to diabetic nephropathy .
【GOLD_E】
Smad1	geneY
【PRE_E】
Smad1	geneY
GHF	geneY
【GOLD_R】
【PRE_R】

Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence - accelerated mouse model .
【GOLD_E】
amyloid	geneY
Tau	geneY
Propranolol	chem
【PRE_E】
Propranolol	chem
amyloid	geneY
Tau	geneY
【GOLD_R】
【PRE_R】
Propranolol	amyloid	C3
Propranolol	Tau	C3

Ageing is associated with a deterioration of cognitive performance and with increased risk of neurodegenerative disorders .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hypertension is the most - prevalent modifiable risk factor for cardiovascular morbidity and mortality worldwide , and clinical data suggest that hypertension is a risk factor for Alzheimer 's disease ( AD ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present study we tested whether propranolol , a β - receptor antagonist commonly used as antihypertensive drug , could ameliorate the cognitive impairments and increases in AD - related markers shown by the senescence - accelerated mouse prone - 8 ( SAMP8 ) .
【GOLD_E】
β-receptor	geneN
propranolol	chem
【PRE_E】
propranolol	chem
β-receptor	geneN
senescence-acceleratedmouseprone-8	geneY
【GOLD_R】
propranolol	β-receptor	C6
【PRE_R】

Propranolol administration ( 5 mg / kg for 3 weeks ) to 6 - month - old SAMP8 mice attenuated cognitive memory impairments shown by these mice in the novel object recognition test .
【GOLD_E】
Propranolol	chem
【PRE_E】
Propranolol	chem
【GOLD_R】
【PRE_R】

In the hippocampus of SAMP8 mice it has been found increases in Aβ ( 42 ) levels , the principal constituent of amyloid plaques observed in AD , accompanied by both an increased expression of the cleaving enzyme BACE1 and a decreased expression of the degrading enzyme IDE .
【GOLD_E】
Aβ(42)	geneY
amyloid	geneY
BACE1	geneY
IDE	geneY
【PRE_E】
Aβ(42)	geneY
amyloid	geneY
BACE1	geneY
IDE	geneY
【GOLD_R】
【PRE_R】

All these effects were reversed by propranolol treatment .
【GOLD_E】
propranolol	chem
【PRE_E】
propranolol	chem
【GOLD_R】
【PRE_R】

Tau hyperphosphorylation ( PHF - 1 epitope ) shown by SAMP8 mice at this age was also decreased in the hippocampus of propranolol - treated mice , an effect probably related to a decrease in JNK1 expression .
【GOLD_E】
Tau	geneY
JNK1	geneY
propranolol	chem
【PRE_E】
Tauhyperphosphorylation	geneY
PHF-1	geneY
propranolol	chem
JNK1	geneY
【GOLD_R】
【PRE_R】
PHF-1	propranolol	C3

Interestingly , propranolol also phosphorylated Akt in SAMP8 mice , which was associated with an increase of glycogen synthase kinase - 3β phosphorylation , contributing therefore to the reductions in Tau hyperphosphorylation .
【GOLD_E】
Akt	geneN
glycogensynthasekinase-3β	geneY
Tau	geneY
propranolol	chem
【PRE_E】
propranolol	chem
phosphorylatedAkt	geneN
glycogensynthasekinase-3β	geneY
Tauhyperphosphorylation	geneY
【GOLD_R】
【PRE_R】
propranolol	glycogensynthasekinase-3β	C3

Synaptic pathology in SAMP8 mice , as shown by decreases in synaptophysin and BDNF , was also counteracted by propranolol treatment .
【GOLD_E】
synaptophysin	geneY
BDNF	geneY
propranolol	chem
【PRE_E】
synaptophysin	geneY
BDNF	geneY
propranolol	chem
【GOLD_R】
【PRE_R】
synaptophysin	propranolol	C4
BDNF	propranolol	C4

Overall , propranolol might be beneficial in age - related brain dysfunction and could be an emerging candidate for the treatment of other neurodegenerative diseases .
【GOLD_E】
propranolol	chem
【PRE_E】
propranolol	chem
【GOLD_R】
【PRE_R】

This article is part of a Special Issue entitled ' Cognitive Enhancers ' .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women : report of two cases .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Leydig cell hyperplasia and Leydig cell tumours of the ovary are rare .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We present two cases in which patients had increased blood levels of testosterone and frank hirsutism .
【GOLD_E】
testosterone	chem
【PRE_E】
testosterone	chem
【GOLD_R】
【PRE_R】

Imaging showed minimal abnormalities .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

After adrenal disease had been ruled out , they underwent a bilateral oophorectomy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

One case showed a Leydig cell hyperplasia , the other a Leydig cell tumour .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

An androgen producing tumour should be excluded in every woman with evidence of hirsutism or frank virilization and markedly elevated testosterone levels .
【GOLD_E】
androgen	chem
testosterone	chem
【PRE_E】
androgen	chem
testosterone	chem
【GOLD_R】
【PRE_R】

Adrenal disease with androgen hypersecretion can be suspected by detailed clinical , laboratory and radiologic imaging .
【GOLD_E】
androgen	chem
【PRE_E】
androgen	chem
【GOLD_R】
【PRE_R】

Although DHEAS has a good sensitivity in the detection of adrenal origin of hyperandrogenism ( and hence a good negative predictive value ) it is not specific ( specificity ranging from 85 to 98 % ) .
【GOLD_E】
DHEAS	chem
【PRE_E】
DHEAS	geneY
【GOLD_R】
【PRE_R】

Imaging of the ovaries can be helpful but does not rule out ovarian disease if normal .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Indeed , diffuse stromal Leydig cell hyperplasia and Leydig cell tumours ( usually small ) may escape imaging and in some cases diagnosis can only be made on pathology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As these clinical entities represent a diagnostic and therapeutic challenge , oophorectomy should be considered in postmenopausal women with hirsutism and elevated testosterone levels , after the exclusion of adrenal causes .
【GOLD_E】
testosterone	chem
【PRE_E】
testosterone	chem
【GOLD_R】
【PRE_R】

The procedure is relatively safe and effective .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Follow - up remains indicated .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Incretin and pancreatic hormone secretion in Caucasian non - diabetic carriers of the TCF7L2 rs7903146 risk T allele .
【GOLD_E】
Incretin	geneY
TCF7L2	geneY
【PRE_E】
Incretin	geneN
TCF7L2	geneY
【GOLD_R】
【PRE_R】

We characterised 62 non - diabetic , middle - aged , Caucasians with and without the T risk allele of rs7903146 in transcription factor 7 - like 2 ( TCF7L2 ) with regard to secretion of insulin , glucagon , glucose - dependent insulinotropic polypeptide ( GIP ) , glucagon - like peptide - 1 ( GLP - 1 ) as well as insulin sensitivity and endogenous glucose production .
【GOLD_E】
transcriptionfactor7-like2	geneY
TCF7L2	geneY
insulin	geneY
glucagon	geneY
glucose-dependentinsulinotropicpolypeptide	geneY
GIP	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
insulin	geneY
glucose	chem
glucose	chem
【PRE_E】
factor7-like2	geneY
TCF7L2	geneY
insulin	geneY
glucagon	geneY
glucose-dependentinsulinotropicpolypeptide	geneY
GIP	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
insulin	geneY
glucose	chem
【GOLD_R】
【PRE_R】

All participants had a 3 - h oral glucose tolerance test ( OGTT ) , an intravenous glucose tolerance test and a euglycaemic , hyperinsulinaemic clamp .
【GOLD_E】
glucose	chem
glucose	chem
【PRE_E】
glucose	chem
glucose	chem
【GOLD_R】
【PRE_R】

After adjustment for age and sex , risk T allele carriers had higher haemoglobin A1c levels ( p = 0.030 ) , reduced first - phase insulin response ( p = 0.048 ) , higher peripheral insulin sensitivity ( p = 0.050 ) and lower fasting GIP concentrations ( p = 0.003 ) than CC allele carriers .
【GOLD_E】
haemoglobinA1c	geneY
insulin	geneY
insulin	geneY
GIP	geneY
【PRE_E】
haemoglobinA1c	geneY
insulin	geneY
insulin	geneY
GIP	geneY
CC	geneY
【GOLD_R】
【PRE_R】

The latter was also reflected by lower total GIP secretion during the OGTT ( p = 0.018 ) .
【GOLD_E】
GIP	geneY
【PRE_E】
GIP	geneY
OGTT	geneY
【GOLD_R】
【PRE_R】

We found no significant differences in endogenous glucose production , hepatic insulin sensitivity or fasting concentrations of glucose , insulin , glucagon and GLP - 1 between the groups .
【GOLD_E】
insulin	geneY
insulin	geneY
glucose	chem
glucose	chem
glucagon	geneY
GLP-1	geneY
【PRE_E】
glucose	chem
insulin	geneY
glucose	chem
insulin	geneY
glucagon	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

The findings suggest that the effect of TCF7L2 on diabetes risk may include reduced secretion of GIP .
【GOLD_E】
GIP	geneY
TCF7L2	geneY
【PRE_E】
TCF7L2	geneY
GIP	geneY
【GOLD_R】
【PRE_R】

Anti - inflammatory trends of 1 , 3 - diphenyl - 2 - propen - 1 - one derivatives .
【GOLD_E】
1,3-diphenyl-2-propen-1-one	chem
【PRE_E】
1,3-diphenyl-2-propen-1-one	chem
【GOLD_R】
【PRE_R】

Chalcones ( 1 , 3 - Diphenyl - 2 - propen - 1 - one ) are constituted by a three carbon α , β - unsaturated carbonyl system .
【GOLD_E】
α,β-unsaturatedcarbonyl	chem
Chalcones	chem
1,3-Diphenyl-2-propen-1-one	chem
carbon	chem
【PRE_E】
Chalcones	chem
1,3-Diphenyl-2-propen-1-one	chem
carbonα	chem
β-unsaturatedcarbonyl	chem
【GOLD_R】
【PRE_R】

The biosynthesis of flavonoids and isoflavonoids is initiated by chalcones .
【GOLD_E】
flavonoids	chem
isoflavonoids	chem
chalcones	chem
【PRE_E】
flavonoids	chem
isoflavonoids	chem
chalcones	chem
【GOLD_R】
【PRE_R】

Notable pharmacological activities of chalcones and its derivatives include anti - inflammatory , antifungal , antibacterial , antimalarial , antituberculosis , antitumor , antimicrobial and antiviral effects respectively .
【GOLD_E】
chalcones	chem
【PRE_E】
chalcones	chem
antituberculosis	chem
antimicrobial	chem
【GOLD_R】
【PRE_R】

Owing to simplicity of the chemical structures and a huge variety of pharmacological actions exhibited , the entities derived from chalcones are subjected to extensive consideration .
【GOLD_E】
chalcones	chem
【PRE_E】
chalcones	chem
【GOLD_R】
【PRE_R】

This review article is an effort to sum up the anti - inflammatory activities of chalcone derived chemical entities .
【GOLD_E】
chalcone	chem
【PRE_E】
chalcone	chem
【GOLD_R】
【PRE_R】

Effect of chalcones on lipid peroxidation , heme oxygenase 1 ( HO - 1 ) , cyclooxygenase ( COX ) , interleukin 5 ( IL - 5 ) , nitric oxide ( NO ) and expression of cell adhesion molecules ( CAM ) is summarized stepwise .
【GOLD_E】
chalcones	chem
heme	chem
nitricoxide	chem
NO	chem
hemeoxygenase1	geneY
HO-1	geneY
cyclooxygenase	geneN
COX	geneN
interleukin5	geneY
IL-5	geneY
【PRE_E】
chalcones	chem
hemeoxygenase1	geneY
HO-1	geneY
cyclooxygenase	geneN
COX	geneN
interleukin5	geneY
IL-5	geneY
nitricoxide	chem
NO	chem
celladhesionmolecules	geneN
CAM	geneN
【GOLD_R】
【PRE_R】

Oxysterol generation and liver X receptor - dependent reverse cholesterol transport : not all roads lead to Rome .
【GOLD_E】
Oxysterol	chem
cholesterol	chem
liverXreceptor	geneN
【PRE_E】
Oxysterol	chem
liverXreceptor	geneY
cholesterol	chem
【GOLD_R】
【PRE_R】

Cell cholesterol metabolism is a tightly regulated process , dependent in part on activation of nuclear liver X receptors ( LXRs ) to increase expression of genes mediating removal of excess cholesterol from cells in the reverse cholesterol transport pathway .
【GOLD_E】
LXRs	geneN
cholesterol	chem
nuclearliverXreceptors	geneN
cholesterol	chem
cholesterol	chem
【PRE_E】
cholesterol	chem
nuclearliverXreceptors	geneN
LXRs	geneN
cholesterol	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

LXRs are thought to be activated predominantly by oxysterols generated enzymatically from cholesterol in different cell organelles .
【GOLD_E】
LXRs	geneN
oxysterols	chem
cholesterol	chem
【PRE_E】
LXRs	geneN
oxysterols	chem
cholesterol	chem
【GOLD_R】
oxysterols	LXRs	C3
【PRE_R】

Defects resulting in slowed release of cholesterol from late endosomes and lysosomes or reduction in sterol - 27 - hydroxylase activity lead to specific blocks in oxysterol production and impaired LXR - dependent gene activation .
【GOLD_E】
sterol-27-hydroxylase	geneY
LXR	geneN
cholesterol	chem
sterol	chem
oxysterol	chem
【PRE_E】
cholesterol	chem
sterol-27-hydroxylase	geneY
oxysterol	chem
LXR	geneY
【GOLD_R】
oxysterol	sterol-27-hydroxylase	C9
【PRE_R】
oxysterol	LXR	C3

This block does not appear to be compensated by oxysterol production in other cell compartments .
【GOLD_E】
oxysterol	chem
【PRE_E】
oxysterol	chem
【GOLD_R】
【PRE_R】

The purpose of this review is to summarize current knowledge about oxysterol - dependent activation by LXR of genes involved in reverse cholesterol transport , and what these defects of cell cholesterol homeostasis can teach us about the critical pathways of oxysterol generation for expression of LXR - dependent genes .
【GOLD_E】
oxysterol	chem
cholesterol	chem
cholesterol	chem
oxysterol	chem
LXR	geneN
LXR	geneN
【PRE_E】
oxysterol	chem
LXR	geneY
cholesterol	chem
cholesterol	chem
oxysterol	chem
LXR	geneY
【GOLD_R】
oxysterol	LXR	C3
【PRE_R】

Assessment of developmental delay in the zebrafish embryo teratogenicity assay .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study we analyzed some aspects of the assessment of developmental delay in the zebrafish embryotoxicity / teratogenicity test and explored the suitability of acetylcholinesterase ( AChE ) activity as a biochemical marker and as a higher throughput alternative to morphological endpoints such as head - trunk angle , tail length and morphological score .
【GOLD_E】
acetylcholinesterase	geneY
AChE	geneY
【PRE_E】
embryotoxicity	chem
acetylcholinesterase	geneY
AChE	geneY
【GOLD_R】
【PRE_R】

Embryos were exposed from 4 to 52 h post - fertilization ( hpf ) to a selection of known embryotoxic / teratogen compounds ( valproic acid , retinoic acid , caffeine , sodium salicylate , glucose , hydroxyurea , methoxyacetic acid , boric acid and paraoxon - methyl ) over a concentration range .
【GOLD_E】
valproicacid	chem
retinoicacid	chem
caffeine	chem
sodiumsalicylate	chem
glucose	chem
hydroxyurea	chem
methoxyaceticacid	chem
boricacid	chem
paraoxon-methyl	chem
【PRE_E】
embryotoxic	chem
valproicacid	chem
retinoicacid	chem
caffeine	chem
sodiumsalicylate	chem
glucose	chem
hydroxyurea	chem
methoxyaceticacid	chem
boricacid	chem
paraoxon-methyl	chem
【GOLD_R】
【PRE_R】

They were evaluated for AChE activity , head - trunk angle , tail length and several qualitative parameters integrated in a morphological score .
【GOLD_E】
AChE	geneY
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

In general , the different patterns of the concentration - response curves allowed distinguishing between chemicals that produced growth retardation ( valproic and methoxyacetic acid ) and chemicals that produced non - growth - delay related malformations .
【GOLD_E】
valproicandmethoxyaceticacid	chem
【PRE_E】
valproic	chem
methoxyaceticacid	chem
【GOLD_R】
【PRE_R】

An acceptable correlation between the morphological score , AChE activity and head - trunk angle as markers of developmental delay was observed , being AChE activity particularly sensitive to detect delay in the absence of malformations .
【GOLD_E】
AChE	geneY
AChE	geneY
【PRE_E】
AChE	geneY
AChE	geneY
【GOLD_R】
【PRE_R】

Cresyl saligenin phosphate makes multiple adducts on free histidine , but does not form an adduct on histidine 438 of human butyrylcholinesterase .
【GOLD_E】
Cresylsaligeninphosphate	chem
histidine	chem
histidine	chem
humanbutyrylcholinesterase	geneY
【PRE_E】
Cresylsaligeninphosphate	chem
histidine	chem
histidine	chem
humanbutyrylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Cresyl saligenin phosphate ( CBDP ) is a suspected causative agent of `` aerotoxic syndrome `` , affecting pilots , crew members and passengers .
【GOLD_E】
Cresylsaligeninphosphate	chem
CBDP	chem
【PRE_E】
Cresylsaligeninphosphate	chem
CBDP	chem
【GOLD_R】
【PRE_R】

CBDP is produced in vivo from ortho - containing isomers of tricresyl phosphate ( TCP ) , a component of jet engine lubricants and hydraulic fluids .
【GOLD_E】
CBDP	chem
tricresylphosphate	chem
TCP	chem
【PRE_E】
CBDP	chem
ortho	chem
tricresylphosphate	chem
TCP	chem
【GOLD_R】
【PRE_R】

CBDP irreversibly inhibits butyrylcholinesterase ( BChE ) in human plasma by forming adducts on the active site serine ( Ser - 198 ) .
【GOLD_E】
butyrylcholinesterase	geneY
BChE	geneY
CBDP	chem
serine	chem
Ser	chem
【PRE_E】
CBDP	chem
butyrylcholinesterase	geneY
BChE	geneY
serine	chem
Ser	chem
【GOLD_R】
CBDP	butyrylcholinesterase	C4
CBDP	BChE	C4
【PRE_R】
CBDP	butyrylcholinesterase	C4
CBDP	BChE	C4

Inhibited BChE undergoes aging to release saligenin and o - cresol .
【GOLD_E】
saligenin	chem
o-cresol	chem
BChE	geneY
【PRE_E】
BChE	geneY
saligenin	chem
o-cresol	chem
【GOLD_R】
【PRE_R】

The active site histidine ( His - 438 ) was hypothesized to abstract o - hydroxybenzyl moiety from the initial adduct on Ser - 198 .
【GOLD_E】
histidine	chem
His	chem
o-hydroxybenzyl	chem
Ser	chem
【PRE_E】
histidine	chem
His	chem
o-hydroxybenzyl	chem
Ser-198	chem
【GOLD_R】
【PRE_R】

Our goal was to test this hypothesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mass spectral analysis of CBDP - inhibited BChE digested with Glu - C showed an o - hydroxybenzyl adduct ( + 106amu ) on lysine 499 , a residue far from the active site , but not on His - 438 .
【GOLD_E】
CBDP	chem
Glu	chem
o-hydroxybenzyl	chem
lysine	chem
His	chem
BChE	geneY
【PRE_E】
CBDP	chem
BChE	geneY
Glu-C	chem
o-hydroxybenzyl	chem
(+106amu	chem
lysine499	chem
His	chem
【GOLD_R】
CBDP	BChE	C4
【PRE_R】

Nevertheless , the nitrogen of the imidazole ring of free l - histidine formed a variety of adducts upon reaction with CBDP , including the o - hydroxybenzyl adduct , suggesting that histidine - CBDP adducts may form on other proteins .
【GOLD_E】
nitrogen	chem
imidazole	chem
l-histidine	chem
CBDP	chem
o-hydroxybenzyl	chem
histidine	chem
CBDP	chem
【PRE_E】
nitrogen	chem
imidazole	chem
l-histidine	chem
CBDP	chem
o-hydroxybenzyl	chem
histidine	chem
CBDP	chem
【GOLD_R】
【PRE_R】

The role of long chain omega - 3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment : a case - control study .
【GOLD_E】
omega-3polyunsaturatedfattyacids	chem
【PRE_E】
polyunsaturatedfattyacids	chem
【GOLD_R】
【PRE_R】

The present work explores the effect of dietary omega - 3 polyunsaturated fatty acids ( PUFAs ) intake on lipid peroxidation among mild cognitive impairment ( MCI ) patients .
【GOLD_E】
PUFAs	chem
omega-3polyunsaturatedfattyacids	chem
【PRE_E】
omega-3polyunsaturatedfattyacids	chem
PUFAs	chem
【GOLD_R】
【PRE_R】

The plasma lipid hydroperoxide ( LPO ) levels in 67 MCI patients were compared to those of 134 healthy elderly controls .
【GOLD_E】
hydroperoxide	chem
【PRE_E】
hydroperoxide	chem
LPO	chem
【GOLD_R】
【PRE_R】

Omega - 3 PUFA intake was assessed using an interviewer - administered food frequency questionnaire .
【GOLD_E】
Omega-3PUFA	chem
【PRE_E】
Omega-3PUFA	chem
【GOLD_R】
【PRE_R】

Apolipoprotein E genotyping was performed using polymerase chain reaction and restriction enzyme digestion .
【GOLD_E】
ApolipoproteinE	geneY
【PRE_E】
ApolipoproteinE	geneY
【GOLD_R】
【PRE_R】

The association between various confounders and lipid peroxidation was evaluated using regression analysis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The influence of docosahexaenoic acid ( DHA ) and eicosapentaenoic acid ( EPA ) intake on LPO level was investigated .
【GOLD_E】
docosahexaenoicacid	chem
DHA	chem
eicosapentaenoicacid	chem
EPA	chem
【PRE_E】
docosahexaenoicacid	chem
DHA	chem
eicosapentaenoicacid	chem
EPA	chem
LPO	chem
【GOLD_R】
【PRE_R】

The results revealed that LPO levels were significantly higher in the MCI group than in the control group .
【GOLD_E】
【PRE_E】
MCI	chem
【GOLD_R】
【PRE_R】

Inverse correlations were found between DHA and EPA intake and LPO level among the MCI group .
【GOLD_E】
DHA	chem
EPA	chem
【PRE_E】
DHA	chem
EPA	chem
MCI	chem
【GOLD_R】
【PRE_R】

LPO levels decreased significantly with increasing DHA and EPA intake .
【GOLD_E】
DHA	chem
EPA	chem
【PRE_E】
DHA	chem
EPA	chem
【GOLD_R】
【PRE_R】

In summary , the findings revealed that DHA and EPA can play a role in alleviating oxidative stress and reducing the risk of neurodegenerative diseases .
【GOLD_E】
DHA	chem
EPA	chem
【PRE_E】
DHA	chem
EPA	chem
【GOLD_R】
【PRE_R】

Vitamin E deficiency impairs the somatostatinergic receptor - effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus .
【GOLD_E】
VitaminE	chem
phosphotyrosine	chem
somatostatinergicreceptor	geneN
phosphotyrosinephosphatase	geneN
【PRE_E】
VitaminE	chem
somatostatinergicreceptor	geneN
phosphotyrosinephosphatase	geneN
【GOLD_R】
【PRE_R】

Vitamin E plays an essential role in maintaining the structure and function of the nervous system , and its deficiency , commonly associated with fat malabsorption diseases , may reduce neuronal survival .
【GOLD_E】
VitaminE	chem
【PRE_E】
VitaminE	chem
【GOLD_R】
【PRE_R】

We previously demonstrated that the somatostatinergic system , implicated in neuronal survival control , can be modulated by α - tocopherol in the rat dentate gyrus , increasing cyclic adenosine monophosphate response element binding protein phosphorylation .
【GOLD_E】
α-tocopherol	chem
cyclicadenosinemonophosphate	chem
cyclicadenosinemonophosphateresponseelementbindingprotein	geneN
【PRE_E】
α-tocopherol	chem
cyclicadenosinemonophosphateresponseelementbindingprotein	geneN
【GOLD_R】
α-tocopherol	cyclicadenosinemonophosphateresponseelementbindingprotein	C3
【PRE_R】

To gain a better understanding of the molecular actions of tocopherols and examine the link among vitamin E , somatostatin and neuronal survival , we have investigated the effects of a deficiency and subsequent administration of tocopherol on the somatostatin signaling pathway and neuronal survival in the rat hippocampus .
【GOLD_E】
tocopherols	chem
vitaminE	chem
somatostatin	chem
tocopherol	chem
somatostatin	chem
somatostatin	geneY
somatostatin	geneY
【PRE_E】
tocopherols	chem
vitaminE	chem
somatostatin	geneY
tocopherol	chem
somatostatin	geneY
【GOLD_R】
【PRE_R】

No changes in somatostatin expression were detected in vitamin - E - deficient rats .
【GOLD_E】
somatostatin	chem
vitamin-E	chem
somatostatin	geneY
【PRE_E】
somatostatin	geneY
vitamin-E	chem
【GOLD_R】
【PRE_R】

These rats , however , showed a significant increase in the somatostatin receptor density and dissociation constant , which correlated with a significant increase in the protein levels of somatostatin receptors .
【GOLD_E】
somatostatin	chem
somatostatinreceptors	geneN
somatostatin	chem
somatostatinreceptor	geneN
【PRE_E】
somatostatinreceptor	geneY
somatostatinreceptors	geneY
【GOLD_R】
【PRE_R】

Nevertheless , vitamin E deficiency impaired the ability of the somatostatin receptors to couple to the effectors adenylyl cyclase and phosphotyrosine phosphatase by diminishing Gi protein functionality .
【GOLD_E】
somatostatinreceptors	geneN
phosphotyrosinephosphatase	geneN
Giprotein	geneN
vitaminE	chem
somatostatin	chem
adenylyl	chem
phosphotyrosine	chem
【PRE_E】
vitaminE	chem
somatostatinreceptors	geneN
adenylylcyclase	geneN
phosphotyrosinephosphatase	geneN
Giprotein	geneN
【GOLD_R】
【PRE_R】

Furthermore , vitamin E deficiency significantly increased phosphotyrosine phosphatase activity and PTPη expression , as well as PKC δ activation , and decreased extracellular - signal - regulated kinase phosphorylation .
【GOLD_E】
phosphotyrosinephosphatase	geneN
PTPη	geneY
PKCδ	geneY
extracellular-signal-regulatedkinase	geneN
vitaminE	chem
phosphotyrosine	chem
【PRE_E】
vitaminE	chem
phosphotyrosinephosphatase	geneN
PTPη	geneY
PKC	geneN
extracellular-signal-regulatedkinase	geneN
【GOLD_R】
【PRE_R】

All these changes were accompanied by an increase in neuronal cell death .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Subsequent α - tocopherol administration partially or completely reversed all these values to control levels .
【GOLD_E】
α-tocopherol	chem
【PRE_E】
α-tocopherol	chem
【GOLD_R】
【PRE_R】

Altogether , our results prove the importance of vitamin E homeostasis in the somatostatin receptor - effector system and suggest a possible mechanism by which this vitamin may regulate the neuronal cell survival in the adult hippocampus .
【GOLD_E】
vitaminE	chem
somatostatin	chem
somatostatinreceptor	geneN
【PRE_E】
vitaminE	chem
somatostatinreceptor	geneY
vitamin	chem
【GOLD_R】
【PRE_R】

CCAAT / Enhancer - binding protein - homologous protein sensitizes to SU5416 by modulating p21 and PI3K / Akt signal pathway in FRO anaplastic thyroid carcinoma cells .
【GOLD_E】
SU5416	chem
CCAAT/Enhancer-bindingprotein-homologousprotein	geneY
p21	geneY
PI3K	geneN
Akt	geneN
【PRE_E】
CCAAT/Enhancer-bindingprotein-homologousprotein	geneY
SU5416	chem
p21	geneY
PI3K	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

SU5416 , vascular endothelial cell growth factor receptor inhibitor , suppresses hypoxia - induced angiogenesis , growth , proliferation , and metastasis in cancer cells .
【GOLD_E】
SU5416	chem
【PRE_E】
SU5416	chem
vascularendothelialcellgrowthfactorreceptor	geneY
【GOLD_R】
【PRE_R】
SU5416	vascularendothelialcellgrowthfactorreceptor	C4

CCAAT / enhancer - binding protein - homologous protein ( CHOP ) has pivotal roles in regulation of growth and survival .
【GOLD_E】
CCAAT/enhancer-bindingprotein-homologousprotein	geneY
CHOP	geneY
【PRE_E】
CCAAT/enhancer-bindingprotein-homologousprotein	geneY
CHOP	geneY
【GOLD_R】
【PRE_R】

In the present study , we evaluated the effects of SU5416 on cell survival , p21 , and PI3K / Akt signal pathway in FRO anaplastic thyroid carcinoma ( ATC ) cells .
【GOLD_E】
p21	geneY
PI3K	geneN
Akt	geneN
SU5416	chem
【PRE_E】
SU5416	chem
p21	geneY
PI3K	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

Moreover , we investigated the roles of CHOP in cell survival under condition of SU5416 treatment in FRO ATC cells .
【GOLD_E】
CHOP	geneY
SU5416	chem
【PRE_E】
CHOP	geneY
SU5416	chem
【GOLD_R】
【PRE_R】

After SU5416 treatment , cell viability , PARP - 1 , and caspase - 3 protein levels were not changed . p53 and p27 protein levels decreased while p21 protein levels increased .
【GOLD_E】
PARP-1	geneY
caspase-3	geneY
p53	geneY
p27	geneY
p21	geneY
SU5416	chem
【PRE_E】
SU5416	chem
PARP-1	geneY
caspase-3	geneY
p53	geneY
p27	geneY
p21	geneY
【GOLD_R】
【PRE_R】
SU5416	PARP-1	C3
SU5416	caspase-3	C3
SU5416	p53	C3
SU5416	p27	C3

Phospho - Akt protein levels were not altered .
【GOLD_E】
Phospho-Akt	geneN
Phospho	chem
【PRE_E】
Phospho-Akt	geneN
【GOLD_R】
【PRE_R】

In SU5416 - treated situation , cell viability was not different before and after administration of either p21 siRNA or LY294002 whereas it was lessened after co - administration of p21 siRNA and LY294002 .
【GOLD_E】
LY294002	chem
LY294002	chem
p21	geneY
p21	geneY
SU5416	chem
【PRE_E】
SU5416	chem
p21	geneY
LY294002	chem
p21	geneY
LY294002	chem
【GOLD_R】
【PRE_R】
SU5416	p21	C4
LY294002	p21	C4
p21	LY294002	C4

Compared to SU5416 treatment alone , cell viability was reduced with CHOP plasmid but it was unchanged with CHOP siRNA .
【GOLD_E】
SU5416	chem
CHOP	geneY
CHOP	geneY
【PRE_E】
SU5416	chem
CHOP	geneY
CHOP	geneY
【GOLD_R】
【PRE_R】
SU5416	CHOP	C4

PARP - 1 and caspase - 3 protein levels with CHOP plasmid were elevated whereas the protein levels with CHOP siRNA were similar .
【GOLD_E】
PARP-1	geneN
caspase-3	geneN
CHOP	geneY
CHOP	geneY
【PRE_E】
PARP-1	geneY
caspase-3	geneY
CHOP	geneY
CHOP	geneY
【GOLD_R】
【PRE_R】

While CHOP plasmid transfection diminished p21 and phospho - Akt protein levels , CHOP siRNA transfection did not alter the protein levels .
【GOLD_E】
CHOP	geneY
p21	geneY
phospho-Akt	geneN
CHOP	geneY
phospho	chem
【PRE_E】
CHOP	geneY
p21	geneY
phospho-Akt	geneY
CHOP	geneY
【GOLD_R】
【PRE_R】

In conclusion , these results suggest that CHOP may sensitize FRO ATC cells to SU5416 thereby inhibiting cell survival by modulating p21 and PI3K / Akt signal pathway .
【GOLD_E】
CHOP	geneY
p21	geneY
PI3K	geneN
Akt	geneN
SU5416	chem
【PRE_E】
CHOP	geneY
SU5416	chem
p21	geneY
PI3K	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

Furthermore , these findings imply that CHOP may be a possible candidate as the chemosensitizing factor for induction of cytotoxicity in ATC cells exposed to SU5416 .
【GOLD_E】
CHOP	geneY
SU5416	chem
【PRE_E】
CHOP	geneY
chemosensitizingfactor	geneY
SU5416	chem
【GOLD_R】
【PRE_R】

An overview of transcriptional regulation in response to toxicological insult .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The completion of the human genome project and the subsequent advent of DNA microarray and high - throughput sequencing technologies have led to a renaissance in molecular toxicology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Toxicogenomic data sets , from both in vivo and in vitro studies , are growing exponentially , providing a wealth of information on regulation of stress pathways at the transcriptome level .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Through such studies , we are now beginning to appreciate the diversity and complexity of biological responses to xenobiotics .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this review , we aim to consolidate and summarise the major toxicologically relevant transcription factor - governed molecular pathways .
【GOLD_E】
【PRE_E】
toxicologically	chem
【GOLD_R】
【PRE_R】

It is becoming clear that different chemical entities can cause oxidative , genotoxic and proteotoxic stress , which induce cellular responses in an effort to restore homoeostasis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Primary among the response pathways involved are NFE2L2 ( Nrf2 ) , NFE2L1 ( Nrf1 ) , p53 , heat shock factor and the unfolded protein response .
【GOLD_E】
Nrf2	geneY
NFE2L1	geneY
Nrf1	geneY
p53	geneY
heatshockfactor	geneN
NFE2L2	geneY
【PRE_E】
NFE2L2	geneY
Nrf2	geneY
NFE2L1	geneY
Nrf1	geneY
p53	geneY
heatshockfactor	geneN
【GOLD_R】
【PRE_R】

Additionally , more specific mechanisms exist where xenobiotics act as ligands , including the aryl hydrocarbon receptor , metal - responsive transcription factor - 1 and the nuclear receptor family of transcription factors .
【GOLD_E】
arylhydrocarbon	chem
arylhydrocarbonreceptor	geneY
metal-responsivetranscriptionfactor-1	geneY
nuclearreceptor	geneN
【PRE_E】
arylhydrocarbonreceptor	geneY
metal-responsivetranscriptionfactor-1	geneY
nuclearreceptor	geneN
【GOLD_R】
【PRE_R】

Other pathways including the immunomodulatory transcription factors NF - κB and STAT together with the hypoxia - inducible transcription factor HIF are also implicated in cellular responses to xenobiotic exposure .
【GOLD_E】
NF-κB	geneN
STAT	geneN
hypoxia-inducibletranscriptionfactor	geneN
HIF	geneN
【PRE_E】
NF-κB	geneN
STAT	geneN
hypoxia-inducibletranscriptionfactorHIF	geneN
【GOLD_R】
【PRE_R】

A less specific but equally important aspect to cellular injury controlled by transcriptional activity is loss of tissue - specific gene expression , resulting in dedifferentiation of target cells and compromise of tissue function .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we review these pathways and the genes they regulate in order to provide an overview of this growing field of molecular toxicology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cholinergic modulation by opioid receptor ligands : potential application to Alzheimer 's disease .
【GOLD_E】
opioidreceptor	geneN
【PRE_E】
opioidreceptor	geneN
【GOLD_R】
【PRE_R】

Morphinans have a storied history in medicinal chemistry as pain management drugs but have received attention as modulators of cholinergic signaling for the treatment of Alzheimer 's Disease ( AD ) .
【GOLD_E】
Morphinans	chem
【PRE_E】
Morphinans	chem
【GOLD_R】
【PRE_R】

Galantamine is a reversible , competitive acetylcholinesterase ( AChE ) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors ( nAChR - APL ) that shares many common structural elements with morphinan - based opioids .
【GOLD_E】
nicotinicacetylcholinereceptors	geneN
nAChR	geneN
Galantamine	chem
acetylcholine	chem
morphinan	chem
acetylcholinesterase	geneY
AChE	geneY
【PRE_E】
Galantamine	chem
acetylcholinesterase	geneY
AChE	geneY
nicotinicacetylcholinereceptors	geneN
nAChR-APL	geneY
morphinan	chem
【GOLD_R】
Galantamine	acetylcholinesterase	C4
Galantamine	AChE	C4
【PRE_R】
Galantamine	acetylcholinesterase	C4
Galantamine	AChE	C4
Galantamine	nAChR-APL	C4

The structurally diverse opioids codeine and eseroline , like galantamine , are also nAChR - APL that have greatly diminished affinity for AChE , representing potential lead compounds for selective nAChR - APL development .
【GOLD_E】
nAChR	geneN
AChE	geneY
nAChR	geneN
codeine	chem
eseroline	chem
galantamine	chem
【PRE_E】
codeine	chem
eseroline	chem
galantamine	chem
nAChR-APL	geneY
AChE	geneY
nAChR	geneN
【GOLD_R】
【PRE_R】
codeine	nAChR-APL	C4
eseroline	nAChR-APL	C4
galantamine	nAChR-APL	C4

In accordance with the emerging repurposing trend of evaluating known compounds for novel pharmacological activity , ongoing research on augmentation of cholinergic signaling that has been aided by the use of opioids will be reviewed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Adhesion of osteoblasts to a vertically aligned TiO2 nanotube surface .
【GOLD_E】
TiO2	chem
【PRE_E】
TiO2	chem
【GOLD_R】
【PRE_R】

The adhesion of cells to vertically aligned TiO2 nanotubes is reviewed .
【GOLD_E】
TiO2	chem
【PRE_E】
TiO2	chem
【GOLD_R】
【PRE_R】

The attraction between a negatively charged nanotube surface and a negatively charged osteoblast is facilitated by charged protein - mediators like proteins with a quadrupolar internal charge distribution , fibronectin and vitronectin .
【GOLD_E】
fibronectin	geneY
vitronectin	geneY
【PRE_E】
fibronectin	geneY
vitronectin	geneN
【GOLD_R】
【PRE_R】

It is shown that adhesion and spreading of osteoblasts on vertically aligned TiO2 nanotube surfaces depend on the diameter of the nanotubes .
【GOLD_E】
TiO2	chem
【PRE_E】
TiO2	chem
【GOLD_R】
【PRE_R】

Apparently , a small diameter nanotube surface has on average more sharp convex edges per unit area than a large one , leading to stronger binding affinity on its surface .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Abnormal uterine bleeding ( AUB ) , which is defined as excessively heavy , prolonged and / or frequent bleeding of uterine origin , is a frequent cause of visits to the Emergency Department and / or health care provider .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

While there are many etiologies of AUB , the one most likely among otherwise healthy adolescents is dysfunctional uterine bleeding ( DUB ) , which is characterizing any AUB when all possible underlying pathologic causes have been previously excluded .
【GOLD_E】
【PRE_E】
AUB	geneN
【GOLD_R】
【PRE_R】

The most common cause of DUB in adolescence is anovulation , which is very frequent in the first 2 - 3 post - menarchal years and is associated with immaturity of the hypothalamic - pituitary - ovarian axis .
【GOLD_E】
【PRE_E】
DUB	geneY
【GOLD_R】
【PRE_R】

Management of AUB is based on the underlying etiology and the severity of the bleeding and primary goals are prevention of complications , such as anemia and reestablishment of regular cyclical bleeding , while the management of DUB can in part be directed by the amount of flow , the degree of associated anemia , as well as patient and family comfort with different treatment modalities .
【GOLD_E】
【PRE_E】
AUB	geneY
DUB	geneY
【GOLD_R】
【PRE_R】

Treatment options for DUB are : combined oral contraceptives ( COCs ) , progestogens , non steroidal anti inflammatory drugs ( NSAIDs ) , tranexamic acid ( anti - fibrinolytic ) , GnRH analogues , Danazol and Levonorgestrel releasing intra uterine system ( LNG IUS ) .
【GOLD_E】
progestogens	chem
tranexamicacid	chem
GnRH	chem
Danazol	chem
Levonorgestrel	chem
GnRH	geneY
【PRE_E】
DUB	geneY
COCs	chem
progestogens	chem
steroidal	chem
tranexamicacid	chem
GnRH	geneY
Danazol	chem
Levonorgestrel	chem
LNGIUS	chem
【GOLD_R】
【PRE_R】

Role of oestrogen receptors on the modulation of NADPH - diaphorase - positive cell number in supraoptic and paraventricular nuclei of ovariectomised female rats .
【GOLD_E】
NADPH	chem
oestrogen	chem
NADPH-diaphorase	geneN
oestrogenreceptors	geneY
【PRE_E】
oestrogenreceptors	geneN
NADPH-diaphorase	geneN
【GOLD_R】
【PRE_R】

Modulation of the nitric oxide producing system ( demonstrated via the NADPH - diaphorase histochemical reaction ) by oestradiol has been established in several structures of the rat brain .
【GOLD_E】
NADPH	chem
oestradiol	chem
NADPH-diaphorase	geneN
nitricoxide	chem
【PRE_E】
nitricoxide	chem
NADPH	chem
oestradiol	chem
【GOLD_R】
nitricoxide	NADPH-diaphorase	C9
【PRE_R】

The present study aimed to explore the possible regulation of NADPH - diaphorase activity by oestradiol in neurones of the supraoptic ( SON ) and paraventricular ( PVN ) nuclei and the role of oestrogen receptors ( ERα and ERβ ) in this regulation .
【GOLD_E】
NADPH-diaphorase	geneN
oestrogenreceptors	geneY
ERα	geneY
ERβ	geneY
NADPH	chem
oestradiol	chem
oestrogen	chem
【PRE_E】
NADPH-diaphorase	geneN
oestradiol	chem
SON	geneN
paraventricular	geneN
PVN	geneN
oestrogenreceptors	geneY
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol , a selective ERα agonist - PPT [ 4,4',4″ - ( 4 - propyl - [ 1H ] - pyrazole - 1,3,5 - triyl ) trisphenol ] , a selective ERβ agonist - DPN [ 2,3 - bis ( 4 - hydroxyphenyl ) - propionitrile ] , a selective ERα antagonist - MPP [ 1,3 - bis ( 4 - hydroxyphenyl ) - 4 - methyl - 5 - [ 4 - ( 2 - piperidinylethoxy ) phenol ] - 1H - pyrazole dihydrochloride ] or a selective ERβ antagonist - PHTPP ( 4 - [ 2 - phenyl - 5,7 - bis ( trifluoromethyl ) pyrazolo [ 1,5 - a ] pyrimidin - 3 - yl ] phenol ) .
【GOLD_E】
DPN	chem
2,3-bis(4-hydroxyphenyl)-propionitrile	chem
MPP	chem
1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol	chem
1H-pyrazoledihydrochloride	chem
PHTPP	chem
4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol	chem
ERα	geneY
ERβ	geneY
ERα	geneY
ERβ	geneY
oestradiol	chem
PPT	chem
4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol	chem
【PRE_E】
oestradiol	chem
ERα	geneY
PPT	chem
4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol	chem
ERβ	geneY
-DPN	chem
2,3-bis(4-hydroxyphenyl)-propionitrile	chem
ERα	geneY
MPP	chem
1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazoledihydrochloride	chem
ERβ	geneY
-PHTPP	chem
4-[2-phenyl-5,7	chem
【GOLD_R】
DPN	ERβ	C5
2,3-bis(4-hydroxyphenyl)-propionitrile	ERβ	C5
PPT	ERα	C5
4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol	ERα	C5
MPP	ERα	C6
1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol	ERα	C6
1H-pyrazoledihydrochloride	ERα	C6
PHTPP	ERβ	C6
4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol	ERβ	C6
【PRE_R】
oestradiol	ERα	C5
ERα	PPT	C5
4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol	ERβ	C5
-DPN	ERα	C6
ERβ	2,3-bis(4-hydroxyphenyl)-propionitrile	C5
ERβ	MPP	C5
ERβ	1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazoledihydrochloride	C5
ERβ	-PHTPP	C6
ERβ	4-[2-phenyl-5,7	C5

The number of NADPH - diaphorase positive elements in the SON and the PVN was modulated by both ERs but , depending on the nucleus , ERα and ERβ ligands induced different effects .
【GOLD_E】
NADPH	chem
ERs	geneY
ERα	geneY
ERβ	geneY
NADPH-diaphorase	geneN
【PRE_E】
NADPH-diaphorasepositiveelements	geneN
SON	geneY
PVN	geneN
ERs	geneY
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

These results suggest that the regulation of nitrergic system by ERs may play a role in the control of oestrogen - dependent physiological mechanisms regulated by the SON and the PVN .
【GOLD_E】
ERs	geneY
oestrogen	chem
【PRE_E】
ERs	geneN
oestrogen	chem
SON	geneY
PVN	geneY
【GOLD_R】
【PRE_R】

Human plasma - derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning .
【GOLD_E】
Humanplasma-derivedBuChE	geneY
【PRE_E】
Humanplasma-derivedBuChE	geneY
【GOLD_R】
【PRE_R】

Potent organophosphorous ( OP ) agents , such as VX , are hazardous by absorption through the skin and are resistant to conventional pharmacological antidotal treatments .
【GOLD_E】
organophosphorous	chem
【PRE_E】
organophosphorous	chem
OP	chem
VX	chem
antidotal	chem
【GOLD_R】
【PRE_R】

The residence time of a stoichiometric bioscavenger , human butyrylcholinesterase ( huBuChE ) , in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs ( oxime , anti - muscarinic , anticonvulsant ) .
【GOLD_E】
huBuChE	geneY
oxime	chem
humanbutyrylcholinesterase	geneY
【PRE_E】
humanbutyrylcholinesterase	geneY
huBuChE	geneY
VX	chem
oxime	chem
【GOLD_R】
【PRE_R】
humanbutyrylcholinesterase	VX	C4
huBuChE	VX	C4
huBuChE	oxime	C4

Intramuscular ( i.m . ) huBuChE afforded almost complete protection when administered prior to the onset of observable cholinergic signs of VX poisoning , but once signs of poisoning became evident the efficacy of i.m . huBuChE decreased .
【GOLD_E】
huBuChE	geneY
huBuChE	geneY
【PRE_E】
huBuChE	chem
VX	chem
huBuChE	chem
【GOLD_R】
【PRE_R】

A combination of nerve agent therapy drugs ( oxime , anti - muscarinic , anticonvulsant ) with huBuChE ( i.m . ) protected 100 % ( 8 / 8 ) of guinea - pigs from a lethal dose of VX ( 0.74mg / kg ) to 48h , even when administered on signs of poisoning .
【GOLD_E】
huBuChE	geneY
oxime	chem
【PRE_E】
oxime	chem
huBuChE	chem
VX	chem
【GOLD_R】
【PRE_R】

Survival was presumed to be due to immediate alleviation of the cholinergic crisis by the conventional pharmacological treatment drugs , in conjunction with bioscavenger that prevented further absorbed agent reaching the AChE targets .
【GOLD_E】
AChE	geneY
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

Evidence to support this proposed mechanism of action was obtained from PKPD experiments in which multiple blood samples and microdialysate samples were collected from individual conscious ambulatory animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Plasma concentrations of intramuscularly - administered atropine , diazepam and HI - 6 reached a peak within 15min and were eliminated rapidly within 4h .
【GOLD_E】
atropine	chem
diazepam	chem
HI-6	chem
【PRE_E】
atropine	chem
diazepam	chem
【GOLD_R】
【PRE_R】

Plasma concentrations of huBuChE administered by the i.m . route took approximately 24h to reach a peak , but were well - maintained over the subsequent 7days .
【GOLD_E】
huBuChE	geneY
【PRE_E】
huBuChE	chem
【GOLD_R】
【PRE_R】

Thus , the pharmacological therapy rapidly treated the initial signs of poisoning , whilst the bioscavenger provided prolonged protection by neutralising further nerve agent entering the bloodstream and preventing it from reaching the target organs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Verrucarin A sensitizes TRAIL - induced apoptosis via the upregulation of DR5 in an eIF2α / CHOP - dependent manner .
【GOLD_E】
TRAIL	geneY
DR5	geneY
eIF2α	geneY
CHOP	geneY
VerrucarinA	chem
【PRE_E】
VerrucarinA	chem
TRAIL	geneY
DR5	geneY
eIF2α	geneY
CHOP	geneY
【GOLD_R】
VerrucarinA	DR5	C3
VerrucarinA	eIF2α	C3
VerrucarinA	CHOP	C3
【PRE_R】

Tumor necrosis factor - related apoptosis - inducing ligand ( TRAIL ) is one of the most promising candidates for new cancer therapeutics .
【GOLD_E】
TRAIL	geneY
Tumornecrosisfactor-relatedapoptosis-inducingligand	geneY
【PRE_E】
Tumornecrosisfactor	geneY
apoptosis-inducingligand	geneY
TRAIL	geneY
【GOLD_R】
【PRE_R】

However , resistance to TRAIL in some cancers remains a current problem in recent .
【GOLD_E】
TRAIL	geneY
【PRE_E】
TRAIL	geneY
【GOLD_R】
【PRE_R】

The protein - folding compartment of the endoplasmic reticulum ( ER ) is particularly sensitive to disturbances , which , if severe , may trigger apoptosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , we examined whether verrucarin A ( VA ) sensitize TRAIL - induced apoptosis in cancer cells by induction of ER stress .
【GOLD_E】
TRAIL	geneY
verrucarinA	chem
【PRE_E】
verrucarinA	chem
TRAIL	geneY
【GOLD_R】
【PRE_R】

We first found that VA induces a major molecule of ER stress , CCAAT / enhancer binding protein homologous protein ( CHOP ) - dependent DR5 induction and subsequently increases TRAIL - induced cleavage of caspases and PARP in TRAIL - resistant Hep3B cells .
【GOLD_E】
CCAAT/enhancerbindingproteinhomologousprotein	geneY
CHOP	geneY
DR5	geneN
TRAIL	geneY
caspases	geneN
PARP	geneN
TRAIL	geneY
【PRE_E】
ER	geneY
CCAAT/enhancerbindingproteinhomologousprotein	geneY
CHOP	geneY
DR5	geneY
TRAIL	geneY
caspases	geneN
PARP	geneN
TRAIL	geneY
【GOLD_R】
【PRE_R】

Importantly , the transient knockdown using siRNA for CHOP abrogated VA - induced DR5 expression and attenuated TRAIL - induced apoptosis .
【GOLD_E】
CHOP	geneY
DR5	geneY
TRAIL	geneY
【PRE_E】
CHOP	geneY
VA	geneY
DR5	geneY
TRAIL	geneY
【GOLD_R】
【PRE_R】

Treatment with VA also increased the levels of phosphorylation of eukaryotic translation initiation factor - 2α ( eIF2α ) , which is a common cellular response of ER stress .
【GOLD_E】
eukaryotictranslationinitiationfactor-2α	geneY
eIF2α	geneY
【PRE_E】
eukaryotictranslationinitiationfactor-2α	geneY
eIF2α	geneY
【GOLD_R】
【PRE_R】

Furthermore , salubrinal , a specific eIF2α phosphorylation - inducing agent , increased CHOP and DR5 expression in the presence of VA .
【GOLD_E】
salubrinal	chem
eIF2α	geneY
CHOP	geneY
DR5	geneY
【PRE_E】
salubrinal	chem
eIF2α	geneY
CHOP	geneY
DR5	geneY
【GOLD_R】
salubrinal	eIF2α	C3
salubrinal	CHOP	C3
salubrinal	DR5	C3
【PRE_R】
salubrinal	eIF2α	C3
salubrinal	CHOP	C3
salubrinal	DR5	C3

In contrast , transfection of mutant - eIF2α significantly reversed VA - induced apoptosis with downregulation of CHOP - dependent DR5 expression .
【GOLD_E】
CHOP	geneY
DR5	geneY
eIF2α	geneY
【PRE_E】
eIF2α	geneY
CHOP	geneY
DR5	geneY
【GOLD_R】
【PRE_R】

Therefore , VA - induced eIF2α phosphorylation seemed to be important for CHOP and DR5 upregulation and TRAIL - induced apoptosis .
【GOLD_E】
eIF2α	geneY
CHOP	geneY
DR5	geneY
TRAIL	geneY
【PRE_E】
eIF2α	geneY
CHOP	geneY
DR5	geneY
TRAIL	geneY
【GOLD_R】
【PRE_R】

In addition , generation of reactive oxygen species ( ROS ) is an effector molecular in sensitization of VA - induced ER stress .
【GOLD_E】
oxygen	chem
【PRE_E】
oxygen	chem
VA	geneY
【GOLD_R】
【PRE_R】

We concluded that VA triggers TRAIL - induced apoptosis by eIF2α / CHOP - dependent DR5 induction via ROS generation .
【GOLD_E】
TRAIL	geneY
eIF2α	geneY
CHOP	geneY
DR5	geneY
【PRE_E】
TRAIL	geneY
eIF2α	geneY
CHOP	geneY
DR5	geneY
【GOLD_R】
【PRE_R】

Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone , the murine model of X - linked hypophosphatemia .
【GOLD_E】
osteopontin	geneY
PHEX	geneY
osteopontin	geneY
【PRE_E】
osteopontin	geneY
PHEX	geneY
osteopontin	geneY
【GOLD_R】
【PRE_R】

X - linked hypophosphatemia ( XLH / HYP ) - with renal phosphate wasting , hypophosphatemia , osteomalacia , and tooth abscesses - is caused by mutations in the zinc - metallopeptidase PHEX gene ( phosphate - regulating gene with homologies to endopeptidase on the X chromosome ) .
【GOLD_E】
zinc-metallopeptidase	geneN
zinc	chem
PHEX	geneY
endopeptidase	geneN
phosphate	chem
phosphate	chem
【PRE_E】
X-linkedhypophosphatemia	geneY
XLH	geneY
HYP	geneY
phosphate	chem
zinc-metallopeptidasePHEX	geneN
phosphate	chem
endopeptidase	geneN
【GOLD_R】
【PRE_R】
XLH	phosphate	C9
HYP	phosphate	C9

PHEX is highly expressed by mineralized tissue cells .
【GOLD_E】
PHEX	geneY
【PRE_E】
PHEX	geneY
【GOLD_R】
【PRE_R】

Inactivating mutations in PHEX lead to distal renal effects ( implying accumulation of a secreted , circulating phosphaturic factor ) and accumulation in bone and teeth of mineralization - inhibiting , acidic serine - and aspartate - rich motif ( ASARM ) - containing peptides , which are proteolytically derived from the mineral - binding matrix proteins of the SIBLING family ( small , integrin - binding ligand N - linked glycoproteins ) .
【GOLD_E】
PHEX	geneY
acidicserine-andaspartate-richmotif	geneN
ASARM	geneN
SIBLING	geneN
small,integrin-bindingligandN-linkedglycoproteins	geneN
serine	chem
aspartate	chem
N	chem
【PRE_E】
PHEX	geneY
phosphaturicfactor	geneY
acidicserine-andaspartate-richmotif	geneN
ASARM	geneY
SIBLING	geneN
integrin	geneN
N	chem
【GOLD_R】
【PRE_R】

Although the latter observation suggests a local , direct matrix effect for PHEX , its physiologically relevant substrate protein ( s ) have not been identified .
【GOLD_E】
PHEX	geneY
【PRE_E】
PHEX	geneY
【GOLD_R】
【PRE_R】

Here , we investigated two SIBLING proteins containing the ASARM motif - osteopontin ( OPN ) and bone sialoprotein ( BSP ) - as potential substrates for PHEX .
【GOLD_E】
SIBLING	geneN
ASARMmotif	geneN
osteopontin	geneY
OPN	geneY
bonesialoprotein	geneY
BSP	geneY
PHEX	geneY
【PRE_E】
ASARMmotif	geneN
osteopontin	geneY
OPN	geneY
bonesialoprotein	geneN
BSP	geneN
PHEX	geneY
【GOLD_R】
【PRE_R】

Using cleavage assays , gel electrophoresis , and mass spectrometry , we report that OPN is a full - length protein substrate for PHEX .
【GOLD_E】
PHEX	geneY
OPN	geneY
【PRE_E】
OPN	geneY
PHEX	geneY
【GOLD_R】
【PRE_R】

Degradation of OPN was essentially complete , including hydrolysis of the ASARM motif , resulting in only very small residual fragments .
【GOLD_E】
OPN	geneY
ASARMmotif	geneN
【PRE_E】
OPN	geneY
ASARMmotif	geneN
【GOLD_R】
【PRE_R】

Western blotting of Hyp ( the murine homolog of human XLH ) mouse bone extracts having no PHEX activity clearly showed accumulation of an ∼ 35 kDa OPN fragment that was not present in wild - type mouse bone .
【GOLD_E】
Hyp	geneY
humanXLH	geneY
PHEX	geneY
PNf	geneY
【PRE_E】
Hyp	geneY
humanXLH	geneY
PHEX	geneY
OPN	geneY
【GOLD_R】
【PRE_R】

Immunohistochemistry and immunogold labeling ( electron microscopy ) for OPN in Hyp bone likewise showed an accumulation of OPN and / or its fragments compared with normal wild - type bone .
【GOLD_E】
OPN	geneY
OPN	geneY
【PRE_E】
OPN	geneY
OPN	geneY
【GOLD_R】
【PRE_R】

Incubation of Hyp mouse bone extracts with PHEX resulted in the complete degradation of these fragments .
【GOLD_E】
PHEX	geneY
【PRE_E】
PHEX	geneY
【GOLD_R】
【PRE_R】

In conclusion , these results identify full - length OPN and its fragments as novel , physiologically relevant substrates for PHEX , suggesting that accumulation of mineralization - inhibiting OPN fragments may contribute to the mineralization defect seen in the osteomalacic bone characteristic of XLH / HYP .
【GOLD_E】
OPN	geneY
PHEX	geneY
OPN	geneY
【PRE_E】
OPN	geneY
PHEX	geneY
OPN	geneY
XLH	geneY
HYP	geneY
【GOLD_R】
【PRE_R】

Targeted disruption of inducible nitric oxide synthase protects against aging , S - nitrosation , and insulin resistance in muscle of male mice .
【GOLD_E】
induciblenitricoxidesynthase	geneY
insulin	geneN
nitricoxide	chem
S	chem
【PRE_E】
induciblenitricoxidesynthase	geneY
S-nitrosation	chem
insulin	geneY
【GOLD_R】
【PRE_R】

Accumulating evidence has demonstrated that S - nitrosation of proteins plays a critical role in several human diseases .
【GOLD_E】
S	chem
【PRE_E】
S-nitrosation	chem
【GOLD_R】
【PRE_R】

Here , we explored the role of inducible nitric oxide synthase ( iNOS ) in the S - nitrosation of proteins involved in the early steps of the insulin - signaling pathway and insulin resistance in the skeletal muscle of aged mice .
【GOLD_E】
induciblenitricoxidesynthase	geneY
iNOS	geneY
insulin	geneN
insulin	geneN
nitricoxide	chem
S	chem
【PRE_E】
induciblenitricoxidesynthase	geneY
iNOS	geneY
S-nitrosation	chem
insulin	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

Aging increased iNOS expression and S - nitrosation of major proteins involved in insulin signaling , thereby reducing insulin sensitivity in skeletal muscle .
【GOLD_E】
iNOS	geneY
insulin	geneN
insulin	geneN
S	chem
【PRE_E】
iNOS	geneY
S-nitrosation	chem
insulin	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

Conversely , aged iNOS - null mice were protected from S - nitrosation - induced insulin resistance .
【GOLD_E】
iNOS	geneY
insulin	geneN
S	chem
【PRE_E】
iNOS	geneY
S-nitrosation	chem
insulin	geneY
【GOLD_R】
【PRE_R】
S-nitrosation	insulin	C3

Moreover , pharmacological treatment with an iNOS inhibitor and acute exercise reduced iNOS - induced S - nitrosation and increased insulin sensitivity in the muscle of aged animals .
【GOLD_E】
iNOS	geneY
iNOS	geneY
insulin	geneN
S	chem
【PRE_E】
iNOS	geneY
iNOS	geneY
S-nitrosation	chem
insulin	geneY
【GOLD_R】
【PRE_R】

These findings indicate that the insulin resistance observed in aged mice is mainly mediated through the S - nitrosation of the insulin - signaling pathway .
【GOLD_E】
insulin	geneN
insulin	geneN
S	chem
【PRE_E】
insulin	geneN
S-nitrosation	chem
insulin	geneN
【GOLD_R】
【PRE_R】

Genetic correlate of cognitive training response in schizophrenia .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Intensive computerized auditory training results in improved cognition for schizophrenia patients , but participants show variation in their cognitive gains and the biological factors that affect the response to training are unknown .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Single nucleotide polymorphisms ( SNPs ) in the catechol - O - methyltransferase ( COMT ) gene have been related to cognitive function .
【GOLD_E】
catechol	chem
O	chem
catechol-O-methyltransferase	geneY
COMT	geneY
【PRE_E】
nucleotide	chem
catechol-O-methyltransferase	geneY
COMT	geneY
【GOLD_R】
【PRE_R】

Here we asked if functional variation in this gene has an impact on the response of schizophrenia patients to cognitive training .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We genotyped 48 schizophrenia patients who completed 50 h of computerized cognitive training and analyzed the association between DNA variants in the COMT gene and the improvement in global cognition .
【GOLD_E】
COMT	geneY
【PRE_E】
COMT	geneY
【GOLD_R】
【PRE_R】

Although conventional analyses did not reveal any significant associations , a set - based analysis examining the aggregate effect of common variation in the COMT gene ( 42 SNPs ) suggested association with improvement in global cognition .
【GOLD_E】
COMT	geneY
【PRE_E】
COMT	geneY
【GOLD_R】
【PRE_R】

Eight SNPs , mostly located in the 3 ' end of the COMT gene , were nominally associated with improvement in cognition .
【GOLD_E】
COMT	geneY
【PRE_E】
COMT	geneY
【GOLD_R】
【PRE_R】

These data suggest that genotype influences the response to intensive cognitive training in schizophrenia , and may indicate that cognitive training regimens need to be personalized to the underlying biosignatures of each individual patient .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This article is part of a Special Issue entitled ' Cognitive Enhancers ' .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Microtubule network is required for insulin - induced signal transduction and actin remodeling .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
actin	geneN
【GOLD_R】
【PRE_R】

Both microtubule and actin are required for insulin - induced glucose uptake .
【GOLD_E】
insulin	geneY
glucose	chem
actin	geneN
【PRE_E】
microtubule	geneN
actin	geneN
insulin	geneN
glucose	chem
【GOLD_R】
【PRE_R】

However , the roles of these two cytoskeletons and their relationship in insulin action still remain unclear .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

In this work , we examined the morphological change of microtubule / actin and their involvement in insulin signal transduction using rat skeletal muscle cells .
【GOLD_E】
insulin	geneN
actin	geneN
【PRE_E】
microtubule	geneN
actin	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

Insulin rapidly led to microtubule clustering from ventral to dorsal surface of the cell .
【GOLD_E】
Insulin	geneN
【PRE_E】
Insulin	geneY
【GOLD_R】
【PRE_R】

Microtubule filaments were rearranged to create space where new actin structures formed .
【GOLD_E】
actin	geneN
【PRE_E】
Microtubule	geneN
actin	geneN
【GOLD_R】
【PRE_R】

Disruption of microtubule prevented insulin - induced actin remodeling and distal insulin signal transduction , with reduction in surface glucose transporter isoform 4 ( GLUT4 ) and glucose uptake .
【GOLD_E】
insulin	geneN
actin	geneN
insulin	geneN
glucosetransporterisoform4	geneY
GLUT4	geneY
glucose	chem
glucose	chem
【PRE_E】
microtubule	geneN
insulin	geneY
actin	geneN
insulin	geneN
glucosetransporterisoform4	geneY
GLUT4	geneY
glucose	chem
【GOLD_R】
glucose	glucosetransporterisoform4	C9
glucose	GLUT4	C9
【PRE_R】
GLUT4	glucose	C9

Though microtubule mediated actin remodeling through PKCζ , reorganization of microtubule depended on tyrosine phosphorylation of insulin receptor , the mechanism is different from insulin - induced actin remodeling , which relied on the activity of PI3 - kinase and PKCζ .
【GOLD_E】
actin	geneN
PKCζ	geneY
insulinreceptor	geneY
insulin	geneN
actin	geneN
PI3-kinase	geneN
PKCζ	geneY
tyrosine	chem
【PRE_E】
actin	geneN
PKCζ	geneY
microtubule	geneN
tyrosine	chem
insulinreceptor	geneY
insulin	geneN
actin	geneN
PI3-kinase	geneN
PKCζ	geneY
【GOLD_R】
【PRE_R】

We propose that microtubule network is required for insulin - induced signal transduction and actin remodeling in skeletal muscle cells .
【GOLD_E】
insulin	geneN
actin	geneN
【PRE_E】
insulin	geneY
actin	geneN
【GOLD_R】
【PRE_R】

The influence of chronic fluorosis on mitochondrial dynamics morphology and distribution in cortical neurons of the rat brain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The present study was designed to evaluate the effects of chronic fluorosis on the dynamics ( including fusion and fission proteins ) , fragmentation , and distribution of mitochondria in the cortical neurons of the rat brain in an attempt to elucidate molecular mechanisms underlying the brain damage associated with excess accumulation of fluoride .
【GOLD_E】
fluoride	chem
【PRE_E】
fluoride	chem
【GOLD_R】
【PRE_R】

Sixty Sprague - Dawley rats were divided randomly into three groups of 20 each , that is , the untreated control group ( drinking water naturally containing < 0.5 mg fluoride / l , NaF ) , the low - fluoride group ( whose drinking water was supplemented with 10 mg fluoride / l ) and the high - fluoride group ( 50 mg fluoride / l ) .
【GOLD_E】
luoride/	chem
aF)	chem
luorideg	chem
uoride/l	chem
uoridegr	chem
oride/l)	chem
【PRE_E】
fluoride	chem
NaF	chem
fluoride	chem
fluoride	chem
fluoride	chem
fluoride	chem
【GOLD_R】
【PRE_R】

After 6 months of exposure , the expression of mitofusin - 1 ( Mfn1 ) , fission - 1 ( Fis1 ) , and dynamin - related protein - 1 ( Drp1 ) at both the protein and mRNA levels were detected by Western blotting , immunohistochemistry , and real - time PCR , respectively .
【GOLD_E】
itofusin-1(	geneY
fn1)	geneY
ission-1(	geneY
is1)	geneY
ynamin-relatedprotein-1(	geneY
rp1)	geneY
【PRE_E】
mitofusin-1	geneY
Mfn1	geneY
fission-1	geneY
Fis1	geneY
dynamin-relatedprotein-1	geneY
Drp1	geneY
【GOLD_R】
【PRE_R】

Moreover , mitochondrial morphology and distribution in neurons were observed by transmission electron or fluorescence microscopy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the cortices of the brains of rats with chronic fluorosis , the level of Mfn1 protein was clearly reduced , whereas the levels of Fis1 and Drp1 were elevated .
【GOLD_E】
Drp1	geneY
Mfn1	geneY
Fis1	geneY
【PRE_E】
Mfn1	geneY
Fis1	geneY
Drp1	geneY
【GOLD_R】
【PRE_R】

The alternations of expression of the mRNAs encoding all three of these proteins were almost the same as the corresponding changes at the protein levels .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mitochondria were fragmented and the redistributed away from the axons of the cortical neurons .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These findings indicate that chronic fluorosis induces abnormal mitochondrial dynamics , which might in turn result in a high level of oxidative stress .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Quantitative analysis of the interaction of constitutive androstane receptor with chemicals and steroid receptor coactivator 1 using surface plasmon resonance biosensor systems : a case study of the Baikal seal ( Pusa sibirica ) and the mouse .
【GOLD_E】
steroid	chem
constitutiveandrostanereceptor	geneN
steroidreceptorcoactivator1	geneN
androstane	chem
【PRE_E】
constitutiveandrostanereceptor	geneY
steroidreceptorcoactivator1	geneY
【GOLD_R】
【PRE_R】

The constitutive androstane receptor ( CAR ) not only displays a high basal transcriptional activity but also acts as a ligand - dependent transcriptional factor .
【GOLD_E】
CAR	geneY
constitutiveandrostanereceptor	geneY
androstane	chem
【PRE_E】
constitutiveandrostanereceptor	geneY
CAR	geneY
【GOLD_R】
【PRE_R】

It is known that CAR exhibits different ligand profiles across species .
【GOLD_E】
CAR	geneY
【PRE_E】
CAR	geneY
【GOLD_R】
【PRE_R】

However , the mechanisms underlying CAR activation by chemicals and the species - specific responses are not fully understood .
【GOLD_E】
CAR	geneY
【PRE_E】
CAR	geneY
【GOLD_R】
【PRE_R】

The objectives of this study are to establish a high - throughput tool to screen CAR ligands and to clarify how CAR proteins from the Baikal seal ( bsCAR ) and the mouse ( mCAR ) interact with chemicals and steroid receptor coactivator 1 ( SRC1 ) .
【GOLD_E】
CAR	geneN
CAR	geneN
bsCAR	geneY
mCAR	geneY
steroidreceptorcoactivator1	geneN
SRC1	geneN
steroid	chem
【PRE_E】
CAR	geneY
CAR	geneY
bsCAR	geneY
mCAR	geneY
steroidreceptorcoactivator1	geneY
SRC1	geneY
【GOLD_R】
【PRE_R】

We developed the surface plasmon resonance ( SPR ) system to assess quantitatively the interaction of CAR with potential ligands and SRC1 .
【GOLD_E】
CAR	geneN
SRC1	geneN
【PRE_E】
CAR	geneY
SRC1	geneY
【GOLD_R】
【PRE_R】

The ligand - binding domain ( LBD ) of bsCAR and mCAR was synthesized in a wheat germ cell - free system .
【GOLD_E】
bsCAR	geneY
mCAR	geneY
【PRE_E】
ligand-bindingdomain	geneN
LBD	geneN
bsCAR	geneY
mCAR	geneY
【GOLD_R】
【PRE_R】

The purified CAR LBD was then immobilized on the sensor chip for the SPR assay , and the kinetics of direct interaction of CARs with ligand candidates was measured .
【GOLD_E】
CARLBD	geneN
CARs	geneN
【PRE_E】
CAR	geneY
LBD	geneN
【GOLD_R】
【PRE_R】

Androstanol and androstenol , estrone , 17β - estradiol , TCPOBOP , and CITCO showed compound - specific but similar affinities for both CARs .
【GOLD_E】
CARs	geneN
androstenol	chem
estrone	chem
17β-estradiol	chem
TCPOBOP	chem
CITCO	chem
Androstanol	chem
【PRE_E】
Androstanol	chem
androstenol	chem
estrone	chem
17β-estradiol	chem
TCPOBOP	chem
CITCO	chem
【GOLD_R】
【PRE_R】

The CAR - SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse .
【GOLD_E】
CAR	geneN
SRC1	geneN
【PRE_E】
CAR	geneY
SRC1	geneY
【GOLD_R】
【PRE_R】

The results of SRC1 interaction assay accounted for those of our previous in vitro CAR - mediated transactivation assay .
【GOLD_E】
SRC1	geneN
CAR	geneN
【PRE_E】
SRC1	geneY
CAR	geneY
【GOLD_R】
【PRE_R】

In silico analyses also supported the results of CAR - SRC1 interaction ; there is little structural difference in the ligand - binding pocket of bsCAR and mCAR , but there is a distinct discrimination in the helix 11 and 12 of these receptors , suggesting that the interaction of ligand - bound CAR and SRC1 is critical for determining species - specific and ligand - dependent transactivation over the basal activity .
【GOLD_E】
CAR	geneN
SRC1	geneN
bsCAR	geneY
mCAR	geneY
CAR	geneN
SRC1	geneN
【PRE_E】
CAR	geneY
SRC1	geneY
bsCAR	geneY
mCAR	geneY
CAR	geneY
SRC1	geneY
【GOLD_R】
【PRE_R】

The SPR assays demonstrated a potential as a high - throughput screening tool of CAR ligands .
【GOLD_E】
CAR	geneN
【PRE_E】
SPR	geneY
CAR	geneY
【GOLD_R】
【PRE_R】

Studies on the antioxidant potential of flavones of Allium vineale isolated from its water - soluble fraction .
【GOLD_E】
flavones	chem
【PRE_E】
flavones	chem
Allium	chem
【GOLD_R】
【PRE_R】

The aim of this work was to examine the chemical constituents and antioxidant potential of water - soluble fractions from the commonly consumed vegetable , Allium vineale .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The water - soluble fraction , containing phenolic compounds , was extracted with ethyl acetate to obtain flavonoids which were separated and purified by repeated column chromatography over Sephadex LH - 20 , RP C18 and silica gel .
【GOLD_E】
ethylacetate	chem
flavonoids	chem
silicagel	chem
【PRE_E】
phenolic	chem
ethylacetate	chem
flavonoids	chem
LH	geneN
C18	chem
silica	chem
【GOLD_R】
【PRE_R】

The isolated compounds were identified according to their physicochemical properties and spectral data ( UV , HPLC - TOF / MS , ( 1 ) H NMR , ( 13 ) C NMR and 2D NMR ) .
【GOLD_E】
(13)C	chem
(1)H	chem
【PRE_E】
(1)H	chem
(13)C	chem
【GOLD_R】
【PRE_R】

Three flavonoids were isolated and identified as chrysoeriol - 7 - O - [ 2″ - O - E - feruloyl ] - β - d - glucoside ( 1 ) , chrysoeriol ( 2 ) , and isorhamnetin - 3 - β - d - glucoside ( 3 ) .
【GOLD_E】
chrysoeriol-7-O-[2″-O-E-feruloyl]-β-d-glucoside	chem
chrysoeriol	chem
isorhamnetin-3-β-d-glucoside	chem
【PRE_E】
flavonoids	chem
chrysoeriol-7-O-[2″-O-E-feruloyl]-β-d-glucoside	chem
chrysoeriol	chem
isorhamnetin-3-β-d-glucoside	chem
【GOLD_R】
【PRE_R】

Antioxidant studies of the aqueous extract and three isolated compounds , 1 , 2 , 3 , were undertaken and they were found to have significant antioxidant activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Antioxidant activities were evaluated for total antioxidant activity by the ferric thiocyanate method , ferric ion ( Fe ( 3 + ) ) reducing antioxidant power assay ( FRAP ) , ferrous ion ( Fe ( 2 + ) ) metal chelating activity , and DPPH free radical - scavenging activity .
【GOLD_E】
ferricthiocyanate	chem
ferric	chem
Fe(3+)	chem
ferrous	chem
Fe(2+)	chem
DPPH	chem
【PRE_E】
ferricthiocyanate	chem
ferricion	chem
Fe(3+)	chem
ferrousion	chem
Fe(2+)	chem
DPPH	chem
【GOLD_R】
【PRE_R】

The water - soluble ethyl acetate and methanol extraction methods were also compared using HPLC - TOF / MS .
【GOLD_E】
ethylacetate	chem
methanol	chem
【PRE_E】
ethylacetate	chem
methanol	chem
【GOLD_R】
【PRE_R】

Amino acid composition , antinutrients and allergens in the peanut protein fraction obtained by an aqueous enzymatic process .
【GOLD_E】
Aminoacid	chem
【PRE_E】
Aminoacid	chem
【GOLD_R】
【PRE_R】

Enzyme - assisted aqueous extraction ( EAE ) of peanut kernel was used to extract oil and protein .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The aqueous fraction ( AF ) obtained by EAE had a better essential amino acid profile than the residues obtained by solvent extraction ( Rs ) and cold pressing ( Rc ) .
【GOLD_E】
aminoacid	chem
【PRE_E】
EAE	geneY
aminoacid	chem
【GOLD_R】
【PRE_R】

No major difference in the trypsin inhibitor activity among AF , Rs and Rc was observed ; however , the trypsin inhibitor activity was drastically reduced in the residue obtained after EAE .
【GOLD_E】
trypsin	geneN
trypsin	geneN
【PRE_E】
trypsin	geneN
trypsin	geneN
【GOLD_R】
【PRE_R】

AF was subjected to MALDI - TOF / MS , revealing it to be rich in peptides ( 107 ) with molecular masses from m / z 700 to 2369Da .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

AF had an extremely low phytate content and was rich in peptides , which could be used as a food supplement .
【GOLD_E】
phytate	chem
【PRE_E】
AF	chem
phytate	chem
【GOLD_R】
【PRE_R】

ESI - MS / MS data were used for the identification of major peanut allergens , viz . , Ara h1 , h3 , h6 - 8 .
【GOLD_E】
peanutallergens	geneN
Arah1,h3,h6-8	geneN
【PRE_E】
Arah1,h3	geneN
h6-8	geneY
【GOLD_R】
【PRE_R】

Their allergenic potential needs to be established .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

NMDA receptor blockade impairs the muscarinic conversion of sub - threshold transient depression into long - lasting LTD in the hippocampus - prefrontal cortex pathway in vivo : correlation with gamma oscillations .
【GOLD_E】
NMDA	chem
NMDAreceptor	geneN
【PRE_E】
NMDAreceptor	geneN
【GOLD_R】
【PRE_R】

Cholinergic fibers from the brainstem and basal forebrain innervate the medial prefrontal cortex ( mPFC ) modulating neuronal activity and synaptic plasticity responses to hippocampal inputs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we investigated the muscarinic and glutamatergic modulation of long - term depression ( LTD ) in the intact projections from CA1 to mPFC in vivo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cortical - evoked responses were recorded in urethane - anesthetized rats for 30 min during baseline and 4 h following LTD .
【GOLD_E】
urethane	chem
【PRE_E】
urethane	chem
【GOLD_R】
【PRE_R】

In order to test the potentiating effects of pilocarpine ( PILO ) , independent groups of rats received either a microinjection of PILO ( 40 nmol ; i.c.v . ) or vehicle , immediately before or 20 min after a sub - threshold LTD protocol ( 600 pulses , 1 Hz ; LFS600 ) .
【GOLD_E】
PILO	chem
pilocarpine	chem
PILO	chem
【PRE_E】
pilocarpine	chem
PILO	chem
PILO	chem
LFS600	chem
【GOLD_R】
【PRE_R】

Other groups received either an infusion of the selective NMDA receptor antagonist ( AP7 ; 10 nmol ; intra - mPFC ) or vehicle , 10 min prior to PILO preceding LFS600 , or prior to a supra - threshold LTD protocol ( 900 pulses , 1 Hz ; LFS900 ) .
【GOLD_E】
NMDA	chem
AP7	chem
PILO	chem
NMDAreceptor	geneN
【PRE_E】
NMDAreceptor	geneN
AP7	chem
LFS600	chem
【GOLD_R】
AP7	NMDAreceptor	C6
【PRE_R】

Our results show that PILO converts a transient cortical depression induced by LFS600 into a robust LTD , stable for at least 4 h .
【GOLD_E】
PILO	chem
【PRE_E】
PILO	geneY
LFS600	chem
【GOLD_R】
【PRE_R】

When applied after LFS600 , PILO does not change either mPFC basal neurotransmission or late LTD .
【GOLD_E】
PILO	chem
【PRE_E】
LFS600	chem
PILO	chem
【GOLD_R】
【PRE_R】

Our data also indicate that NMDA receptor pre - activation is essential to the muscarinic enhancement of mPFC synaptic depression , since AP7 microinjection into the mPFC blocked the conversion of transient depression into long - lasting LTD produced by PILO .
【GOLD_E】
NMDAreceptor	geneN
NMDA	chem
AP7	chem
PILO	chem
【PRE_E】
NMDAreceptor	geneN
AP7	chem
【GOLD_R】
AP7	NMDAreceptor	C4
【PRE_R】

In addition , AP7 effectively blocked the long - lasting LTD induced by LFS900 .
【GOLD_E】
AP7	chem
【PRE_E】
AP7	chem
LFS900	chem
【GOLD_R】
【PRE_R】

Therefore , our findings suggest that the glutamatergic co - activation of prefrontal neurons is important for the effects of PILO on mPFC synaptic depression , which could play an important role in the control of executive and emotional functions .
【GOLD_E】
PILO	chem
【PRE_E】
PILO	chem
【GOLD_R】
【PRE_R】

Metabolism of triethylenetetramine and 1,12 - diamino - 3,6,9 - triazadodecane by the spermidine / spermine - N ( 1 ) - acetyltransferase and thialysine acetyltransferase .
【GOLD_E】
thialysine	chem
triethylenetetramine	chem
1,12-diamino-3,6,9-triazadodecane	chem
spermidine	chem
spermine	chem
thialysineacetyltransferase	geneN
spermidine/spermine-N(1)-acetyltransferase	geneY
【PRE_E】
triethylenetetramine	chem
1,12-diamino-3,6,9-triazadodecane	chem
spermidine/spermine-N(1)-acetyltransferase	geneN
thialysineacetyltransferase	geneY
【GOLD_R】
triethylenetetramine	thialysineacetyltransferase	C9
triethylenetetramine	spermidine/spermine-N(1)-acetyltransferase	C9
1,12-diamino-3,6,9-triazadodecane	thialysineacetyltransferase	C9
1,12-diamino-3,6,9-triazadodecane	spermidine/spermine-N(1)-acetyltransferase	C9
【PRE_R】

Triethylenetetramine ( TETA ; Syprine ; Merck Rahway , NJ ) , a drug for Wilson 's disease , is a copper chelator and a charge - deficient analog of polyamine spermidine .
【GOLD_E】
TETA	chem
Syprine	chem
Triethylenetetramine	chem
copper	chem
polyamine	chem
spermidine	chem
【PRE_E】
Triethylenetetramine	chem
TETA	chem
Syprine	chem
MerckRahway	chem
copperchelator	chem
polyaminespermidine	chem
【GOLD_R】
【PRE_R】

We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine / spermine - N ( 1 ) - acetyltransferase ( SSAT1 ) and by thialysine acetyltransferase ( SSAT2 ) to its monoacetylated derivative ( MAT ) .
【GOLD_E】
spermidine	chem
spermine	chem
thialysine	chem
spermidine/spermine-N(1)-acetyltransferase	geneY
SSAT1	geneY
thialysineacetyltransferase	geneY
SSAT2	geneY
TETA	chem
polyamine	chem
【PRE_E】
TETA	geneY
polyamine	chem
spermidine/spermine-N(1)-acetyltransferase	geneY
SSAT1	geneY
thialysineacetyltransferase	geneY
SSAT2	geneY
monoacetylated	chem
【GOLD_R】
TETA	spermidine/spermine-N(1)-acetyltransferase	C9
TETA	SSAT1	C9
TETA	thialysineacetyltransferase	C9
TETA	SSAT2	C9
polyamine	spermidine/spermine-N(1)-acetyltransferase	C9
polyamine	SSAT1	C9
【PRE_R】
TETA	polyamine	C9
polyamine	SSAT1	C9
SSAT2	monoacetylated	C9

The acetylation of TETA is increased in SSAT1 - overexpressing mice compared with wild - type mice .
【GOLD_E】
TETA	chem
SSAT1	geneY
【PRE_E】
TETA	geneY
SSAT1	geneY
【GOLD_R】
TETA	SSAT1	C9
【PRE_R】

However , SSAT1 - deficient mice metabolize TETA at the same rate as the wild - type mice , indicating the existence of another N - acetylase respons 2ible for its metabolism in mice .
【GOLD_E】
TETA	chem
SSAT1	geneY
N-acetylase	geneN
【PRE_E】
SSAT1	geneY
TETA	geneY
N-acetylaserespons2ible	geneY
【GOLD_R】
TETA	N-acetylase	C9
【PRE_R】

Here , we show that siRNA - mediated knockdown of SSAT2 in HEPG2 cells and in primary hepatocytes from the SSAT1 - deficient or wild - type mice reduced the metabolism of TETA to MAT .
【GOLD_E】
TETA	chem
SSAT2	geneY
SSAT1	geneY
【PRE_E】
SSAT2	geneY
SSAT1	geneY
TETA	chem
【GOLD_R】
TETA	SSAT2	C9
【PRE_R】

By contrast , 1,12 - diamino - 3,6,9 - triazadodecane ( SpmTrien ) , a charge - deficient spermine analog , was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild - type primary hepatocytes .
【GOLD_E】
1,12-diamino-3,6,9-triazadodecane	chem
SpmTrien	chem
spermine	chem
SSAT1	geneY
humanrecombinantSSAT2	geneY
【PRE_E】
1,12-diamino-3,6,9-triazadodecane	chem
SpmTrien	chem
spermine	chem
humanrecombinantSSAT2	geneY
SSAT1	geneY
【GOLD_R】
1,12-diamino-3,6,9-triazadodecane	SSAT1	C9
1,12-diamino-3,6,9-triazadodecane	humanrecombinantSSAT2	C9
SpmTrien	SSAT1	C9
SpmTrien	humanrecombinantSSAT2	C9
spermine	SSAT1	C9
spermine	humanrecombinantSSAT2	C9
【PRE_R】
SpmTrien	humanrecombinantSSAT2	C9
SpmTrien	SSAT1	C9

Thus , despite the similar structures of TETA and SpmTrien , SSAT2 is the main acetylator of TETA , whereas SpmTrien is primarily acetylated by SSAT1 .
【GOLD_E】
SSAT2	geneY
SSAT1	geneY
TETA	chem
SpmTrien	chem
TETA	chem
SpmTrien	chem
【PRE_E】
TETA	geneN
SpmTrien	geneY
SSAT2	geneY
TETA	geneY
SpmTrien	chem
SSAT1	geneY
【GOLD_R】
TETA	SSAT2	C9
SpmTrien	SSAT1	C9
【PRE_R】
TETA	SpmTrien	C9
SpmTrien	SpmTrien	C9
SSAT2	SpmTrien	C9
TETA	SpmTrien	C9
SpmTrien	SSAT1	C9

In vitro metabolism of the 5 - hydroxytryptamine1B receptor antagonist elzasonan .
【GOLD_E】
elzasonan	chem
5-hydroxytryptamine1B	geneY
【PRE_E】
5-hydroxytryptamine1Breceptor	geneY
elzasonan	chem
【GOLD_R】
elzasonan	5-hydroxytryptamine1B	C6
【PRE_R】

The metabolism of elzasonan has been examined in vitro using hepatic microsomes from human and recombinant heterologously expressed P450 enzymes ( rCYP ) .
【GOLD_E】
P450enzymes	geneN
rCYP	geneN
elzasonan	chem
【PRE_E】
elzasonan	chem
humanandrecombinantheterologouslyexpressedP450enzymes	geneN
rCYP	geneY
【GOLD_R】
【PRE_R】
elzasonan	rCYP	C9

Metabolism occurs primarily via oxidative N - demethylation to form M4 and oxidation reactions to form elzasonan N - oxide ( M5 ) and 5 - hydroxyelzasonan metabolite ( M3 ) .
【GOLD_E】
N	chem
elzasonanN-oxide	chem
5-hydroxyelzasonan	chem
【PRE_E】
N	chem
M4	chem
elzasonanN-oxide	chem
M5	chem
5-hydroxyelzasonan	chem
【GOLD_R】
【PRE_R】

Additionally , elzasonan was shown to be metabolized to the novel cyclized indole metabolite ( M6 ) which undergoes subsequent oxidation to form the iminium ion metabolite ( M3a ) .
【GOLD_E】
elzasonan	chem
indole	chem
iminium	chem
【PRE_E】
elzasonan	chem
cyclizedindole	chem
M6	chem
iminium	chem
【GOLD_R】
【PRE_R】

The rCYP data was normalized relative to the levels of each CYP form in native human liver microsomes to better assess the contribution of each rCYP in the metabolism of elzasonan .
【GOLD_E】
rCYP	geneN
CYP	geneN
rCYP	geneN
elzasonan	chem
【PRE_E】
rCYP	geneY
CYP	geneN
rCYP	geneN
elzasonan	chem
【GOLD_R】
elzasonan	rCYP	C9
【PRE_R】
rCYP	elzasonan	C9
rCYP	elzasonan	C9

Results demonstrated the involvement of CYP3A4 in the pathways leading to M3a , M3 , M5 and M6 and CYP2C8 in the formation of M4 .
【GOLD_E】
CYP3A4	geneY
CYP2C8	geneY
【PRE_E】
CYP3A4	geneY
M3a,M3,M5andM6	geneN
CYP2C8	geneY
【GOLD_R】
【PRE_R】

Kinetic constants for the formation of M3 were determined and correlation and inhibition studies suggested that CYP3A4 is primarily responsible for the formation of M3 and CYP2C19 plays a very minor role in its formation .
【GOLD_E】
CYP3A4	geneY
CYP2C19	geneY
【PRE_E】
CYP3A4	geneY
CYP2C19	geneY
【GOLD_R】
【PRE_R】

Cytochrome b5 has shown to be an essential component in P450 3A4 catalyzed 5 - hydroxyelzasonan formation and provides insights on the disconnect between human liver microsomes data and that of rCYP .
【GOLD_E】
Cytochromeb5	geneY
P4503A4	geneY
rCYP	geneN
5-hydroxyelzasonan	chem
【PRE_E】
Cytochromeb5	geneY
P4503A4	geneY
5-hydroxyelzasonan	chem
rCYP	geneY
【GOLD_R】
5-hydroxyelzasonan	P4503A4	C9
【PRE_R】
Cytochromeb5	5-hydroxyelzasonan	C9
P4503A4	5-hydroxyelzasonan	C9
5-hydroxyelzasonan	rCYP	C9

Furthermore , rCYP3A4 containing b5 are useful models for predicting the rates for liver microsomes P450 - dependent drug oxidations and should be utilized routinely .
【GOLD_E】
rCYP3A4	geneY
P450	geneN
【PRE_E】
rCYP3A4containingb5	geneY
P450	geneN
oxidations	chem
【GOLD_R】
【PRE_R】
rCYP3A4containingb5	oxidations	C9

Effective phagocytosis of low Her2 tumor cell lines with engineered , aglycosylated IgG displaying high FcγRIIa affinity and selectivity .
【GOLD_E】
FcγRIIa	geneY
Her2	geneY
aglycosylatedIgG	geneN
【PRE_E】
Her2	geneY
aglycosylatedIgG	geneN
FcγRIIa	geneY
【GOLD_R】
【PRE_R】

Glycans anchored to residue N297 of the antibody IgG Fc domain are critical in mediating binding toward FcγRs to direct both adaptive and innate immune responses .
【GOLD_E】
FcγRs	geneN
IgGFcdomain	geneN
【PRE_E】
Glycans	geneN
N297	geneN
IgGFcdomain	geneN
FcγRs	geneN
【GOLD_R】
【PRE_R】

However , using a full length bacterial IgG display system , we have isolated aglycosylated Fc domains with mutations that confer up to a 160 - fold increase in the affinity toward the low affinity FcγRIIa - R131 allele as well as high selectivity against binding to the remarkably homologous human inhibitory receptor , FcγRIIb .
【GOLD_E】
bacterialIgG	geneN
aglycosylatedFcdomains	geneN
FcγRIIa	geneY
FcγRIIb	geneY
【PRE_E】
IgG	geneN
aglycosylatedFcdomains	geneN
FcγRIIa	geneY
R131	geneN
humaninhibitoryreceptor	geneN
FcγRIIb	geneY
【GOLD_R】
【PRE_R】

The mutant Fc domain ( AglycoT - Fc1004 ) contained a total of 5 amino acid substitutions that conferred an activating to inhibitory ratio of 25 ( A / I ratio ; FcyRIIa - R131 : FcγRIIb ) .
【GOLD_E】
AglycoT-Fc1004	geneN
FcyRIIa	geneY
FcγRIIb	geneY
aminoacid	chem
Fcdomain	geneN
【PRE_E】
Fcdomain	geneN
AglycoT	geneN
Fc1004	geneN
5aminoacid	chem
FcyRIIa-R131	geneY
FcγRIIb	geneY
【GOLD_R】
【PRE_R】

Incorporation of this engineered Fc into trastuzumab , an anti - Her2 antibody , resulted in a 75 % increase in tumor cell phagocytosis by macrophages compared to that of the parental glycosylated trastuzumab with both medium and low Her2 - expressing cancer cells .
【GOLD_E】
Fc	geneN
Her2	geneY
Her2	geneY
【PRE_E】
Her2	geneY
glycosylated	geneN
Her2	geneY
【GOLD_R】
【PRE_R】

A mathematical model has been developed to help explain how receptor affinity and the A / I ratio relate to improved antibody dependent cell - mediated phagocytosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our model provides guidelines for the future engineering of Fc domains with enhanced effector function .
【GOLD_E】
Fcdomains	geneN
【PRE_E】
Fcdomains	geneN
【GOLD_R】
【PRE_R】

Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid - organogenesis mouse limbs .
【GOLD_E】
valproicacid	chem
【PRE_E】
valproicacid	chem
【GOLD_R】
【PRE_R】

In utero exposure to valproic acid ( VPA ) , a histone deacetylase ( HDAC ) inhibitor , causes neural tube , heart , and limb defects .
【GOLD_E】
histonedeacetylase	geneN
HDAC	geneN
valproicacid	chem
VPA	chem
【PRE_E】
valproicacid	chem
VPA	chem
histonedeacetylase	geneN
HDAC	geneN
【GOLD_R】
valproicacid	histonedeacetylase	C4
valproicacid	HDAC	C4
VPA	histonedeacetylase	C4
VPA	HDAC	C4
【PRE_R】
valproicacid	histonedeacetylase	C4
VPA	histonedeacetylase	C4
VPA	HDAC	C4

Valpromide ( VPD ) , the amide derivative of VPA , does not inhibit HDAC activity and is a weak teratogen in vivo .
【GOLD_E】
HDAC	geneN
Valpromide	chem
VPD	chem
amide	chem
VPA	chem
【PRE_E】
Valpromide	chem
VPD	chem
amide	chem
VPA	chem
HDAC	geneN
【GOLD_R】
【PRE_R】

The detailed mechanism of action of VPA as a teratogen is not known .
【GOLD_E】
VPA	chem
【PRE_E】
VPA	chem
【GOLD_R】
【PRE_R】

The goal of this study was to test the hypothesis that VPA disrupts regulation of the expression of genes that are critical in chondrogenesis and osteogenesis during limb development .
【GOLD_E】
VPA	chem
【PRE_E】
VPA	geneY
【GOLD_R】
【PRE_R】

Murine gestation day - 12 embryonic forelimbs were excised and exposed to VPA or VPD in a limb bud culture system .
【GOLD_E】
VPA	chem
VPD	chem
【PRE_E】
VPA	chem
VPD	chem
【GOLD_R】
【PRE_R】

VPA caused a significant concentration - dependent increase in limb abnormalities , which was correlated with its HDAC inhibitory effect .
【GOLD_E】
VPA	chem
HDAC	geneN
【PRE_E】
VPA	chem
HDAC	geneN
【GOLD_R】
VPA	HDAC	C4
【PRE_R】

The signaling of both Sox9 and Runx2 , key regulators of chondrogenesis , was downregulated by VPA .
【GOLD_E】
VPA	chem
Sox9	geneY
Runx2	geneY
【PRE_E】
Sox9	geneY
Runx2	geneY
VPA	chem
【GOLD_R】
VPA	Sox9	C4
VPA	Runx2	C4
【PRE_R】

In contrast , VPD had little effect on limb morphology and no significant effect on HDAC activity or the expression of marker genes .
【GOLD_E】
VPD	chem
HDAC	geneN
【PRE_E】
HDAC	geneN
【GOLD_R】
【PRE_R】

Thus , VPA exposure dysregulated the expression of target genes directly involved in chondrogenesis and osteogenesis in the developing limb .
【GOLD_E】
VPA	chem
【PRE_E】
VPA	chem
【GOLD_R】
【PRE_R】

Disturbances in these signaling pathways are likely to be a consequence of HDAC inhibition because VPD did not affect their expressions .
【GOLD_E】
HDAC	geneN
VPD	chem
【PRE_E】
HDAC	geneN
VPD	chem
【GOLD_R】
【PRE_R】

Tumor necrosis factor - alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells : roles of caspase activation and oxidative stress .
【GOLD_E】
amiodarone	chem
Tumornecrosisfactor-alpha	geneY
caspase	geneN
【PRE_E】
Tumornecrosisfactor-alpha	geneY
amiodarone	chem
caspase	geneN
【GOLD_R】
【PRE_R】
amiodarone	caspase	C3

Amiodarone ( AMD ) , a class III antiarrhythmic drug , causes idiosyncratic hepatotoxicity in human patients .
【GOLD_E】
Amiodarone	chem
AMD	chem
【PRE_E】
Amiodarone	chem
AMD	chem
【GOLD_R】
【PRE_R】

We demonstrated previously that tumor necrosis factor - alpha ( TNF - α ) plays an important role in a rat model of AMD - induced hepatotoxicity under inflammatory stress .
【GOLD_E】
AMD	chem
tumornecrosisfactor-alpha	geneY
TNF-α	geneY
【PRE_E】
tumornecrosisfactor-alpha	geneY
TNF-α	geneY
【GOLD_R】
【PRE_R】

In this study , we developed a model in vitro to study the roles of caspase activation and oxidative stress in TNF potentiation of AMD cytotoxicity .
【GOLD_E】
AMD	chem
caspase	geneN
TNF	geneY
【PRE_E】
caspase	geneN
TNF	geneY
【GOLD_R】
【PRE_R】

AMD caused cell death in Hepa1c1c7 cells , and TNF cotreatment potentiated its toxicity .
【GOLD_E】
AMD	chem
TNF	geneY
【PRE_E】
TNF	geneY
【GOLD_R】
【PRE_R】

Activation of caspases 9 and 3 / 7 was observed in AMD / TNF - cotreated cells , and caspase inhibitors provided minor protection from cytotoxicity .
【GOLD_E】
AMD	chem
caspases9and3/7	geneN
TNF	geneY
【PRE_E】
caspases9and3/7	geneN
AMD	geneY
TNF	geneY
caspase	geneN
【GOLD_R】
【PRE_R】

Intracellular reactive oxygen species ( ROS ) generation and lipid peroxidation were observed after treatment with AMD and were further elevated by TNF cotreatment .
【GOLD_E】
oxygen	chem
AMD	chem
TNF	geneY
【PRE_E】
oxygen	chem
AMD	chem
TNF	geneY
【GOLD_R】
【PRE_R】

Adding water - soluble antioxidants ( trolox , N - acetylcysteine , glutathione , or ascorbate ) produced only minor attenuation of AMD / TNF - induced cytotoxicity and did not influence the effect of AMD alone .
【GOLD_E】
trolox	chem
N-acetylcysteine	chem
glutathione	chem
ascorbate	chem
AMD	chem
AMD	chem
TNF	geneY
【PRE_E】
trolox	chem
N-acetylcysteine	chem
glutathione	chem
ascorbate	chem
AMD	geneN
TNF	geneY
AMD	chem
【GOLD_R】
【PRE_R】

On the other hand , α - tocopherol ( TOCO ) , which reduced lipid peroxidation and ROS generation , prevented AMD toxicity and caused pronounced reduction in cytotoxicity from AMD / TNF cotreatment .
【GOLD_E】
TNF	geneY
α-tocopherol	chem
TOCO	chem
AMD	chem
AMD	chem
【PRE_E】
α-tocopherol	chem
TOCO	chem
AMD	geneY
TNF	geneY
【GOLD_R】
【PRE_R】
TOCO	AMD	C4

α - TOCO plus a pancaspase inhibitor completely abolished AMD / TNF - induced cytotoxicity .
【GOLD_E】
pancaspase	geneN
TNF	geneY
α-TOCO	chem
AMD	chem
【PRE_E】
α-TOCO	chem
pancaspase	chem
AMD	geneY
TNF	geneY
【GOLD_R】
α-TOCO	pancaspase	C4
【PRE_R】
α-TOCO	AMD	C4
pancaspase	AMD	C4
pancaspase	TNF	C4

In summary , activation of caspases and oxidative stress were observed after AMD / TNF cotreatment , and caspase inhibitors and a lipid - soluble free - radical scavenger attenuated AMD / TNF - induced cytotoxicity .
【GOLD_E】
AMD	chem
caspases	geneN
TNF	geneY
caspase	geneN
TNF	geneN
AMD	chem
【PRE_E】
caspases	geneN
TNF	geneY
caspase	geneN
AMD	chem
TNF	geneY
【GOLD_R】
AMD	caspases	C3
【PRE_R】

Amino acid residues at the N - and C - termini are essential for the folding of active human butyrylcholinesterase polypeptide .
【GOLD_E】
humanbutyrylcholinesterase	geneY
Aminoacid	chem
【PRE_E】
Aminoacid	chem
N	chem
C	chem
humanbutyrylcholinesterasepolypeptide	geneY
【GOLD_R】
【PRE_R】

Human serum butyrylcholinesterase ( HuBChE ) is currently the most suitable bioscavenger for the prophylaxis of highly toxic organophosphate ( OP ) nerve agents .
【GOLD_E】
HuBChE	geneY
organophosphate	chem
Humanserumbutyrylcholinesterase	geneY
【PRE_E】
Humanserumbutyrylcholinesterase	geneY
HuBChE	geneY
organophosphate	chem
【GOLD_R】
organophosphate	HuBChE	C9
organophosphate	Humanserumbutyrylcholinesterase	C9
【PRE_R】

A dose of 200mg of HuBChE is envisioned as a prophylactic treatment that can protect humans from an exposure of up to 2×LD50 of soman .
【GOLD_E】
HuBChE	geneY
【PRE_E】
HuBChE	chem
soman	chem
【GOLD_R】
【PRE_R】

The limited availability and administration of multiple doses of this stoichiometric bioscavenger make this pretreatment difficult .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , the goal of this study was to produce a smaller enzymatically active HuBChE polypeptide ( HBP ) that could bind to nerve agents with high affinity thereby reducing the dose of enzyme .
【GOLD_E】
HuBChE	geneY
【PRE_E】
HuBChEpolypeptide	geneY
HBP	geneN
【GOLD_R】
【PRE_R】

Studies have indicated that the three - dimensional structure and the domains of HuBChE ( acyl pocket , lip of the active center gorge , and the anionic substrate - binding domain ) that are critical for the binding of substrate are also essential for the selectivity and binding of inhibitors including OPs .
【GOLD_E】
HuBChE	geneY
acyl	chem
【PRE_E】
HuBChE	chem
acyl	chem
【GOLD_R】
【PRE_R】

Therefore , we designed three HBPs by deleting some N - and C - terminal residues of HuBChE by maintaining the folds of the active site core that includes the three active site residues ( S198 , E325 , and H438 ) .
【GOLD_E】
HuBChE	geneY
【PRE_E】
HBPs	geneN
N	chem
C	chem
HuBChE	geneN
S198	geneN
E325	geneN
【GOLD_R】
【PRE_R】

HBP - 4 that lacks 45 residues from C - terminus but known to have BChE activity was used as a control .
【GOLD_E】
HBP-4	geneN
BChE	geneY
【PRE_E】
HBP-4	geneY
C	chem
BChE	geneY
【GOLD_R】
【PRE_R】

The cDNAs for the HBPs containing signal sequences were synthesized , cloned into different mammalian expression vectors , and recombinant polypeptides were transiently expressed in different cell lines .
【GOLD_E】
【PRE_E】
HBPs	geneN
【GOLD_R】
【PRE_R】

No BChE activity was detected in the culture media of cells transfected with any of the newly designed HBPs , and the inactive polypeptides remained inside the cells .
【GOLD_E】
BChE	geneY
【PRE_E】
BChE	geneY
HBPs	geneN
【GOLD_R】
【PRE_R】

Only enzymatically active HBP - 4 was secreted into the culture medium .
【GOLD_E】
HBP-4	geneN
【PRE_E】
HBP-4	geneY
【GOLD_R】
【PRE_R】

These results suggest that residues at the N - and C - termini are required for the folding and / or maintenance of HBP into an active stable , conformation .
【GOLD_E】
【PRE_E】
N	chem
C	chem
HBP	chem
【GOLD_R】
【PRE_R】

Claudin - 3 and claudin - 4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1 .
【GOLD_E】
cisplatin	chem
cisplatin	chem
copper	chem
Claudin-3	geneY
CTR1	geneY
claudin-4	geneY
copperandcisplatininfluxtransporter	geneN
【PRE_E】
Claudin-3	geneY
claudin-4	geneY
cisplatin	chem
copperandcisplatininfluxtransporterCTR1	geneN
【GOLD_R】
【PRE_R】

Claudin - 3 ( CLDN3 ) and claudin - 4 ( CLDN4 ) are the major structural molecules that form tight junctions ( TJs ) between epithelial cells .
【GOLD_E】
Claudin-3	geneY
CLDN3	geneY
claudin-4	geneY
CLDN4	geneY
【PRE_E】
Claudin-3	geneY
CLDN3	geneY
claudin-4	geneY
CLDN4	geneY
TJs	geneN
【GOLD_R】
【PRE_R】

We found that knockdown of the expression of either CLDN3 or CLDN4 produced marked changes in the phenotype of ovarian cancer cells , including an increase in resistance to cisplatin ( cDDP ) .
【GOLD_E】
CLDN3	geneY
CLDN4	geneY
cisplatin	chem
【PRE_E】
CLDN3	geneY
CLDN4	geneY
cisplatin	chem
cDDP	chem
【GOLD_R】
【PRE_R】

The effect of CLND3 and CLDN4 on cDDP cytotoxicity , cDDP cellular accumulation , and DNA adduct formation was compared in the CLDN3 - and CLDN4 - expressing parental human ovarian carcinoma 2008 cells and CLDN3 and CLDN4 knockdown sublines ( CLDN3KD and CLDN4KD , respectively ) .
【GOLD_E】
CLND3	geneY
CLDN4	geneY
CLDN3	geneY
CLDN4	geneY
CLDN3	geneY
CLDN4	geneY
CLDN3	geneY
CLDN4	geneY
【PRE_E】
CLND3	geneY
CLDN4	geneY
cDDP	chem
cDDP	chem
CLDN3	geneY
CLDN4	geneY
CLDN3	geneY
CLDN4	geneY
CLDN4KD	chem
【GOLD_R】
【PRE_R】
CLDN4	CLDN4KD	C3

Knockdown of CLDN3 or CLDN4 rendered human ovarian carcinoma 2008 cells resistant to cDDP in both in vitro culture and in vivo xenograft model .
【GOLD_E】
CLDN3	geneY
CLDN4	geneY
【PRE_E】
CLDN3	geneY
CLDN4	geneY
cDDP	chem
【GOLD_R】
【PRE_R】

The net accumulation of platinum ( Pt ) and the Pt - DNA adduct levels were reduced in CLDN3KD and CLDN4KD cells .
【GOLD_E】
Pt	chem
Pt	chem
CLDN3	geneY
CLDN4	geneY
platinum	chem
【PRE_E】
platinum	chem
Pt	chem
Pt	chem
【GOLD_R】
【PRE_R】

The endogenous mRNA levels of copper influx transporter CTR1 were found to be significantly reduced in the knockdown cells , and exogenous expression of CTR1 restored their sensitivity to cDDP .
【GOLD_E】
copper	chem
CTR1	geneY
copperinfluxtransporter	geneN
CTR1	geneY
【PRE_E】
copperinfluxtransporterCTR1	geneN
CTR1	geneY
cDDP	chem
【GOLD_R】
【PRE_R】

Reexpression of an shRNAi - resistant CLDN3 or CLDN4 up - regulated CTR1 levels , reversed the cDDP resistance , and enhanced TJ formation in the knockdown cells .
【GOLD_E】
CLDN3	geneY
CLDN4	geneY
CTR1	geneY
【PRE_E】
shRNAi	geneY
CLDN3	geneY
CLDN4	geneY
CTR1	geneY
cDDP	chem
【GOLD_R】
【PRE_R】
shRNAi	cDDP	C3
CLDN3	cDDP	C3
CLDN4	cDDP	C3
CTR1	cDDP	C3

Baseline copper ( Cu ) level , Cu uptake , and Cu cytotoxicity were also reduced in CLDN3KD and CLDN4KD cells .
【GOLD_E】
copper	chem
CLDN3	geneY
CLDN4	geneY
Cu	chem
Cu	chem
Cu	chem
【PRE_E】
copper	chem
Cu	chem
Cu	chem
Cu	chem
CLDN4KD	chem
【GOLD_R】
【PRE_R】

Cu - dependent tyrosinase activity was also markedly reduced in both types of CLDN knockdown cells when incubated with the substrate l - DOPA .
【GOLD_E】
tyrosinase	geneY
CLDN	geneN
Cu	chem
l-DOPA	chem
【PRE_E】
Cu	chem
tyrosinase	geneY
CLDN	geneY
l-DOPA	chem
【GOLD_R】
l-DOPA	tyrosinase	C9
【PRE_R】

These results indicate that CLDN3 and CLDN4 affect sensitivity of the ovarian cancer cells to the cytotoxic effect of cDDP by regulating expression of the Cu transporter CTR1 .
【GOLD_E】
CLDN3	geneY
CLDN4	geneY
Cutransporter	geneN
CTR1	geneY
Cu	chem
【PRE_E】
CLDN3	geneY
CLDN4	geneY
cDDP	chem
CutransporterCTR1	geneN
【GOLD_R】
【PRE_R】

Regulation of hepatic phase II metabolism in pregnant mice .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Phase II enzymes , including Ugts , Sults , and Gsts , are critical for the disposition and detoxification of endo - and xenobiotics .
【GOLD_E】
Ugts	geneN
Sults	geneN
Gsts	geneN
【PRE_E】
Sults	geneN
Gsts	geneN
【GOLD_R】
【PRE_R】

In this study , the mRNA and protein expression of major phase II enzymes , as well as key regulatory transcription factors , were quantified in livers of time - matched pregnant and virgin control C57BL / 6 mice on gestation days ( GD ) 7 , 11 , 14 , 17 , and postnatal days ( PND ) 1 , 15 , and 30 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Compared with virgin controls , the mRNA expression of Ugt1a1 , 1a6 , 1a9 , 2a3 , 2b1 , 2b34 , and 2b35 decreased 40 to 80 % in pregnant dams .
【GOLD_E】
Ugt1a1,1a6,1a9,2a3,2b1,2b34,and2b35	geneN
【PRE_E】
Ugt1a1,1a6,1a9,2a3,2b1,2b34,and2b35	geneN
【GOLD_R】
【PRE_R】

Protein expression of Ugt1a6 also decreased and corresponded with reduced in vitro glucuronidation of bisphenol A in S9 fractions from livers of pregnant mice .
【GOLD_E】
Ugt1a6	geneY
bisphenolA	chem
【PRE_E】
Ugt1a6	geneY
bisphenolA	chem
S9	chem
【GOLD_R】
bisphenolA	Ugt1a6	C4
【PRE_R】
Ugt1a6	bisphenolA	C3
Ugt1a6	S9	C3

Similar to Ugts levels , Gsta1 and a4 mRNAs were reduced in pregnant dams in mid to late gestation ; however no change in protein expression was observed .
【GOLD_E】
Ugts	geneN
Gsta1anda4	geneN
【PRE_E】
Gsta1anda4	geneN
【GOLD_R】
【PRE_R】

Conversely , Sult1a1 , 2a1 / 2 , and 3a1 mRNAs increased 100 to 500 % at various time points in pregnant and lactating mice and corresponded with enhanced in vitro sulfation of acetaminophen in liver S9 fractions .
【GOLD_E】
acetaminophen	chem
Sult1a1,2a1/2,and3a1	geneN
【PRE_E】
Sult1a1,2a1/2,and3a1	geneN
acetaminophen	chem
【GOLD_R】
【PRE_R】

Coinciding with maximal decreases in Ugts as well as increases in Sults , the expression of transcription factors CAR , PPARα , and PXR and their target genes were downregulated , whereas ERα mRNA was upregulated .
【GOLD_E】
Ugts	geneN
Sults	geneN
CAR	geneY
PPARα	geneY
PXR	geneY
ERα	geneY
【PRE_E】
Sults	geneN
CAR	geneY
PPARα	geneY
PXR	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

Collectively , these data demonstrate altered regulation of hepatic phase II metabolism in mice during pregnancy and suggest that CAR , PPARα , PXR , and ERα signaling pathways may be candidate signaling pathways responsible for these changes .
【GOLD_E】
PPARα	geneY
PXR	geneY
ERα	geneY
CAR	geneY
【PRE_E】
CAR	geneY
PPARα	geneY
PXR	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

Dimethylfumarate attenuates renal fibrosis via NF - E2 - related factor 2 - mediated inhibition of transforming growth factor - beta / Smad signaling .
【GOLD_E】
Dimethylfumarate	chem
Smad	geneN
NF-E2-relatedfactor2	geneY
transforminggrowthfactor-beta	geneY
【PRE_E】
Dimethylfumarate	chem
NF-E2	geneY
factor2	geneY
transforminggrowthfactor-beta	geneY
Smad	geneY
【GOLD_R】
Dimethylfumarate	Smad	C4
Dimethylfumarate	transforminggrowthfactor-beta	C4
【PRE_R】
Dimethylfumarate	NF-E2	C4
Dimethylfumarate	factor2	C4
Dimethylfumarate	transforminggrowthfactor-beta	C4
Dimethylfumarate	Smad	C4

TGF - beta plays a key role in the development of renal fibrosis .
【GOLD_E】
TGF-beta	geneY
【PRE_E】
TGF-beta	geneY
【GOLD_R】
【PRE_R】

Suppressing the TGF - beta signaling pathway is a possible therapeutic approach for preventing this disease , and reports have suggested that Nrf2 protects against renal fibrosis by inhibiting TGF - beta signaling .
【GOLD_E】
Nrf2	geneY
TGF-beta	geneY
TGF-beta	geneY
【PRE_E】
TGF-beta	geneY
Nrf2	geneY
TGF-beta	geneY
【GOLD_R】
【PRE_R】

This study examines whether dimethylfumarate ( DMF ) , which stimulates Nrf2 , prevents renal fibrosis via the Nrf2 - mediated suppression of TGF - beta signaling .
【GOLD_E】
Nrf2	geneY
Nrf2	geneY
TGF-beta	geneY
dimethylfumarate	chem
DMF	chem
【PRE_E】
dimethylfumarate	chem
DMF	chem
Nrf2	geneY
Nrf2	geneY
TGF-beta	geneY
【GOLD_R】
【PRE_R】
dimethylfumarate	Nrf2	C3
DMF	Nrf2	C3
DMF	Nrf2	C3

Results showed that DMF increased nuclear levels of Nrf2 , and both DMF and adenovirus - mediated overexpression of Nrf2 ( Ad - Nrf2 ) decreased PAI - 1 , alpha - smooth muscle actin ( alpha - SMA ) , fibronectin and type 1 collagen expression in TGF - beta - treated rat mesangial cells ( RMCs ) and renal fibroblast cells ( NRK - 49F ) .
【GOLD_E】
DMF	chem
DMF	chem
Nrf2	geneY
Nrf2	geneY
Nrf2	geneY
PAI-1	geneY
alpha-smoothmuscleactin	geneY
alpha-SMA	geneY
fibronectin	geneY
type1collagen	geneN
TGF-beta	geneY
【PRE_E】
DMF	chem
Nrf2	geneY
DMF	chem
Nrf2	geneY
Nrf2	geneY
PAI-1	geneY
alpha-smoothmuscleactin	geneY
alpha-SMA	geneY
fibronectin	geneY
type1collagen	geneN
TGF-beta	geneY
【GOLD_R】
DMF	Nrf2	C3
DMF	Nrf2	C3
DMF	PAI-1	C4
DMF	alpha-smoothmuscleactin	C4
DMF	alpha-SMA	C4
DMF	fibronectin	C4
DMF	type1collagen	C4
【PRE_R】
DMF	Nrf2	C3
Nrf2	DMF	C3
DMF	Nrf2	C3
DMF	Nrf2	C3
DMF	PAI-1	C3
DMF	alpha-smoothmuscleactin	C3
DMF	fibronectin	C3
DMF	type1collagen	C3
DMF	TGF-beta	C3

Additionally , DMF and Ad - Nrf2 repressed TGF - beta - stimulated Smad3 activity by inhibiting Smad3 phosphorylation , which was restored by siRNA - mediated knockdown of Nrf2 expression .
【GOLD_E】
DMF	chem
Nrf2	geneY
TGF-beta	geneY
Smad3	geneY
Smad3	geneY
Nrf2	geneY
【PRE_E】
DMF	chem
Nrf2	geneY
TGF-beta	geneY
Smad3	geneY
Smad3	geneY
Nrf2	geneY
【GOLD_R】
DMF	TGF-beta	C4
DMF	Smad3	C4
DMF	Smad3	C4
【PRE_R】
DMF	Nrf2	C3
DMF	TGF-beta	C3
DMF	Smad3	C3

However , downregulation of the antioxidant response element ( ARE ) - driven Nrf2 target genes such as NQO1 , HO - 1 and glutathione S - transferase ( GST ) did not reverse the inhibitory effect of DMF on TGF - beta - induced upregulation of profibrotic genes or extracellular matrix proteins , suggesting an ARE - independent anti - fibrotic activity of DMF .
【GOLD_E】
NQO1	geneY
HO-1	geneY
glutathioneS-transferase	geneN
GST	geneN
TGF-beta	geneY
glutathione	chem
ARE	geneN
S	chem
DMF	chem
DMF	chem
antioxidantresponseelement	geneN
ARE	geneN
Nrf2	geneY
【PRE_E】
antioxidantresponseelement	geneN
Nrf2	geneY
NQO1	geneY
HO-1	geneY
glutathioneS-transferase	geneN
GST	geneN
DMF	chem
TGF-beta	geneY
extracellularmatrixproteins	geneN
DMF	chem
【GOLD_R】
DMF	TGF-beta	C4
【PRE_R】
Nrf2	DMF	C3
NQO1	DMF	C3
HO-1	DMF	C3

Finally , DMF suppressed unilateral ureteral obstruction ( UUO ) - induced renal fibrosis and alpha - SMA , fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice , along with increased and decreased expression of Nrf2 and phospho - Smad3 , respectively .
【GOLD_E】
alpha-SMA	geneY
fibronectin	geneY
type1collagen	geneN
Nrf2	geneY
phospho-Smad3	geneY
DMF	chem
【PRE_E】
DMF	chem
alpha-SMA	geneY
fibronectin	geneY
type1collagen	geneN
Nrf2	geneY
phospho-Smad3	geneY
【GOLD_R】
DMF	Nrf2	C3
DMF	alpha-SMA	C4
DMF	fibronectin	C4
DMF	type1collagen	C4
DMF	phospho-Smad3	C4
【PRE_R】
DMF	Nrf2	C3

In summary , DMF attenuated renal fibrosis via the Nrf2 - mediated inhibition of TGF - beta / Smad3 signaling in an ARE - independent manner , suggesting that DMF could be used to treat renal fibrosis .
【GOLD_E】
Nrf2	geneY
TGF-beta	geneY
Smad3	geneY
ARE	geneN
DMF	chem
DMF	chem
【PRE_E】
DMF	chem
Nrf2	geneY
TGF-beta	geneY
Smad3	geneY
DMF	chem
【GOLD_R】
DMF	TGF-beta	C4
DMF	Smad3	C4
【PRE_R】
DMF	Nrf2	C4
DMF	TGF-beta	C4
DMF	Smad3	C4

The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice .
【GOLD_E】
CCL3	geneY
CCR1	geneY
【PRE_E】
CCL3	geneY
CCR1	geneY
【GOLD_R】
【PRE_R】

Bone remodeling is affected by mechanical loading and inflammatory mediators , including chemokines .
【GOLD_E】
chemokines	geneN
【PRE_E】
chemokines	geneN
【GOLD_R】
【PRE_R】

The chemokine ( C - C motif ) ligand 3 ( CCL3 ) is involved in bone remodeling by binding to C - C chemokine receptors 1 and 5 ( CCR1 and CCR5 ) expressed on osteoclasts and osteoblasts .
【GOLD_E】
CCL3	geneY
C-Cchemokinereceptors1and5	geneN
CCR1	geneY
CCR5	geneY
chemokine(C-Cmotif)ligand3	geneY
【PRE_E】
chemokine	geneN
C-Cmotif)ligand3	geneN
CCL3	geneY
C-Cchemokinereceptors1and5	geneN
CCR1	geneY
CCR5	geneY
【GOLD_R】
【PRE_R】

Our group has previously demonstrated that CCR5 down - regulates mechanical loading - induced bone resorption .
【GOLD_E】
CCR5	geneY
【PRE_E】
CCR5	geneY
【GOLD_R】
【PRE_R】

Thus , the present study aimed to investigate the role of CCR1 and CCL3 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice .
【GOLD_E】
CCR1	geneY
CCL3	geneY
【PRE_E】
CCR1	geneY
CCL3	geneY
【GOLD_R】
【PRE_R】

Our results showed that bone remodeling was significantly decreased in CCL3 ( - / - ) and CCR1 ( - / - ) mice and in animals treated with Met - RANTES ( an antagonist of CCR5 and CCR1 ) . mRNA levels of receptor activator of nuclear factor kappa - B ( RANK ) , its ligand RANKL , tumor necrosis factor alpha ( TNF - α ) and RANKL / osteoprotegerin ( OPG ) ratio were diminished in the periodontium of CCL3 ( - / - ) mice and in the group treated with Met - RANTES .
【GOLD_E】
CCL3	geneY
CCR1	geneY
CCR5	geneY
CCR1	geneY
receptoractivatorofnuclearfactorkappa-B	geneY
RANK	geneY
Met	chem
RANKL	geneY
tumornecrosisfactoralpha	geneY
TNF-α	geneY
RANKL	geneY
osteoprotegerin	geneY
OPG	geneY
CCL3	geneY
Met	chem
【PRE_E】
CCL3	geneY
CCR1	geneY
Met-RANTES	geneY
CCR5	geneY
CCR1	geneY
receptoractivatorofnuclearfactorkappa-B	geneY
RANK	geneN
RANKL	geneY
tumornecrosisfactoralpha	geneY
TNF-α	geneY
RANKL	geneY
osteoprotegerin	geneY
OPG	geneY
CCL3	geneY
Met-RANTES	geneY
【GOLD_R】
Met	receptoractivatorofnuclearfactorkappa-B	C4
Met	RANK	C4
Met	RANKL	C4
Met	tumornecrosisfactoralpha	C4
Met	TNF-α	C4
Met	RANKL	C4
Met	osteoprotegerin	C4
Met	OPG	C4
Met	CCR5	C6
Met	CCR1	C6
【PRE_R】

Met - RANTES treatment also reduced the levels of cathepsin K and metalloproteinase 13 ( MMP13 ) .
【GOLD_E】
Met	chem
cathepsinK	geneY
metalloproteinase13	geneY
MMP13	geneY
【PRE_E】
Met	chem
RANTES	geneY
cathepsinK	geneY
metalloproteinase13	geneY
MMP13	geneY
【GOLD_R】
Met	cathepsinK	C4
Met	metalloproteinase13	C4
Met	MMP13	C4
【PRE_R】
Met	RANTES	C4
Met	metalloproteinase13	C4
Met	MMP13	C4

The expression of the osteoblast markers runt - related transcription factor 2 ( RUNX2 ) and periostin was decreased , while osteocalcin ( OCN ) was augmented in CCL3 ( - / - ) and Met - RANTES - treated mice .
【GOLD_E】
RUNX2	geneY
periostin	geneY
osteocalcin	geneY
OCN	geneY
CCL3	geneY
Met	chem
runt-relatedtranscriptionfactor2	geneY
【PRE_E】
osteoblastmarkersrunt-relatedtranscriptionfactor2	geneY
RUNX2	geneY
periostin	geneY
osteocalcin	geneY
OCN	geneY
CCL3	geneY
Met	geneY
RANTES	geneY
【GOLD_R】
Met	osteocalcin	C3
Met	OCN	C3
Met	RUNX2	C4
Met	periostin	C4
Met	runt-relatedtranscriptionfactor2	C4
【PRE_R】

Altogether , these findings show that CCR1 is pivotal for bone remodeling induced by mechanical loading during orthodontic tooth movement and these actions depend , at least in part , on CCL3 .
【GOLD_E】
CCR1	geneY
CCL3	geneY
【PRE_E】
CCR1	geneY
CCL3	geneY
【GOLD_R】
【PRE_R】

Nano - graphene in biomedicine : theranostic applications .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

Owing to their unique physical and chemical properties , graphene and its derivatives such as graphene oxide ( GO ) , reduced graphene oxide ( RGO ) and GO - nanocomposites have attracted tremendous interest in many different fields including biomedicine in recent years .
【GOLD_E】
grapheneoxide	chem
reducedgrapheneoxide	chem
RGO	chem
graphene	chem
【PRE_E】
graphene	chem
grapheneoxide	chem
GO	chem
grapheneoxide	chem
RGO	chem
GO	chem
【GOLD_R】
【PRE_R】

With every atom exposed on its surface , single - layered graphene shows ultra - high surface area available for efficient molecular loading and bioconjugation , and has been widely explored as novel nano - carriers for drug and gene delivery .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

Utilizing the intrinsic near - infrared ( NIR ) optical absorbance , in vivo graphene - based photothermal therapy has been realized , achieving excellent anti - tumor therapeutic efficacy in animal experiments .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

A variety of inorganic nanoparticles can be grown on the surface of nano - graphene , obtaining functional graphene - based nanocomposites with interesting optical and magnetic properties useful for multi - modal imaging and imaging - guided cancer therapy .
【GOLD_E】
graphene	chem
graphene	chem
【PRE_E】
graphene	chem
graphene	chem
【GOLD_R】
【PRE_R】

Moreover , significant efforts have also been devoted to study the behaviors and toxicology of functionalized nano - graphene in animals .
【GOLD_E】
graphene	chem
【PRE_E】
nano-graphene	chem
【GOLD_R】
【PRE_R】

It has been uncovered that both surface chemistry and sizes play key roles in controlling the biodistribution , excretion , and toxicity of nano - graphene .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

Biocompatibly coated nano - graphene with ultra - small sizes can be cleared out from body after systemic administration , without rendering noticeable toxicity to the treated mice .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

In this review article , we will summarize the latest progress in this rapidly growing field , and discuss future prospects and challenges of using graphene - based materials for theranostic applications .
【GOLD_E】
graphene	chem
【PRE_E】
graphene	chem
【GOLD_R】
【PRE_R】

Human ether - a - go - go - related gene channel blockers and its structural analysis for drug design .
【GOLD_E】
ether	chem
Humanether-a-go-go-relatedgene	geneY
【PRE_E】
Humanether-a-go-go-relatedgenechannel	geneY
【GOLD_R】
【PRE_R】

The human ether - a - go - go - related gene ( hERG ) is a K + channel protein mainly expressed in the heart and the nervous systems and its blockade by non - cardiovascular acting drugs resulted in tachycardia and sudden death .
【GOLD_E】
hERG	geneY
humanether-a-go-go-relatedgene	geneY
K+channel	geneN
ether	chem
K+	chem
【PRE_E】
humanether-a-go-go-relatedgene	geneY
hERG	geneY
K+channel	geneN
【GOLD_R】
【PRE_R】

In this present review , we have focused the physicochemical properties responsible for the hERG blocking activity of structurally different compounds .
【GOLD_E】
hERG	geneY
【PRE_E】
hERG	geneY
【GOLD_R】
【PRE_R】

The reported research works showed that the hydrophobicity on the van der Waals ( vdW ) surface of the molecules ( aroused from the aromatic ring ) necessary for the hERG blocking activity along with topological and electronic properties .
【GOLD_E】
hERG	geneY
【PRE_E】
hERG	geneY
【GOLD_R】
【PRE_R】

The quinolizidine alkaloids ( natural products ) such as oxymatrine , sophoridine , sophocarpine and matrine carry the common molecular structure of O = C = N - C - C - C - N that possessed positive ionotropic effect and hERG blocking activity .
【GOLD_E】
matrine	chem
O=C=N-C-C-C-N	chem
hERG	geneY
quinolizidinealkaloids	chem
oxymatrine	chem
sophoridine	chem
sophocarpine	chem
【PRE_E】
quinolizidine	chem
oxymatrine	chem
sophoridine	chem
sophocarpine	chem
matrine	chem
O=C=N-C-C-C-N	chem
hERG	geneY
【GOLD_R】
matrine	hERG	C4
O=C=N-C-C-C-N	hERG	C4
quinolizidinealkaloids	hERG	C4
oxymatrine	hERG	C4
sophoridine	hERG	C4
sophocarpine	hERG	C4
【PRE_R】
quinolizidine	hERG	C4
oxymatrine	hERG	C4
sophoridine	hERG	C4
sophocarpine	hERG	C4
matrine	hERG	C4
O=C=N-C-C-C-N	hERG	C4

Acehytisine hydrochloride ( previously named Guangfu base A ) was isolated from the root of Aconitum coreanum ( Levl . ) , is an anti - arrhythmic drug in phase IV clinical trial .
【GOLD_E】
Acehytisinehydrochloride	chem
GuangfubaseA	chem
【PRE_E】
Acehytisinehydrochloride	chem
Guangfu	chem
【GOLD_R】
【PRE_R】

The isoquinoline alkaloid , neferine ( Nef ) induces a concentration - dependent decrease in current amplitude ( IC50 of 7.419 MM ) .
【GOLD_E】
isoquinolinealkaloid	chem
neferine	chem
Nef	chem
【PRE_E】
isoquinoline	chem
neferine	chem
Nef	geneN
【GOLD_R】
【PRE_R】
isoquinoline	Nef	C4
neferine	Nef	C4

Most of these natural product compounds contain non - flexible aromatic structures but have significant activity due to the presence of optimum hydrophobicity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recent research works revealed that Eag and hERG channels are expressed by a variety of cancer cell lines and tissues .
【GOLD_E】
Eag	geneY
hERG	geneY
【PRE_E】
Eag	geneY
hERG	geneY
【GOLD_R】
【PRE_R】

The Eag channel showed an oncogenic potential while hERG channels are associated with more aggressive tumors and have a role in mediating invasion .
【GOLD_E】
Eag	geneY
hERG	geneY
【PRE_E】
Eagchannel	geneN
hERG	geneY
【GOLD_R】
【PRE_R】

This review concluded that the consideration of physicochemical properties necessary for the hERG blocking activity will guide to develop novel drugs with less cardiotoxicity .
【GOLD_E】
hERG	geneY
【PRE_E】
hERG	geneY
【GOLD_R】
【PRE_R】

Multifunctional targets of dietary polyphenols in disease : a case for the chemokine network and energy metabolism .
【GOLD_E】
chemokine	geneN
polyphenols	chem
【PRE_E】
polyphenols	chem
chemokine	geneN
【GOLD_R】
【PRE_R】

Chronic , non - acute inflammation is behind conditions that represent most of the disease burden in humans and is clearly linked to immune and metabolic mechanisms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The convergence of pathways involving the immune response , oxidative stress , increased circulating lipids and aberrant insulin signaling results in CCL2 - associated macrophage recruitment and altered energy metabolism .
【GOLD_E】
insulin	geneY
CCL2	geneY
【PRE_E】
insulin	geneN
CCL2	geneY
【GOLD_R】
【PRE_R】

The CCL2 / CCR2 pathway and the energy sensor AMP - activated protein kinase ( AMPK ) are attractive therapeutic targets as a part of preventive management of disease .
【GOLD_E】
AMPK	geneY
AMP	chem
CCL2	geneY
CCR2	geneY
AMP-activatedproteinkinase	geneY
【PRE_E】
CCL2	geneY
CCR2	geneY
AMP-activatedproteinkinase	geneN
AMPK	geneN
【GOLD_R】
【PRE_R】

Several effects of polyphenols are useful in this scenario , including a reduction in the activities of cytokines and modulation of cellular metabolism through histone deacetylase inhibitors , AMPK activators , calorie - restriction mimetics or epigenetic regulators .
【GOLD_E】
cytokines	geneN
histonedeacetylase	geneN
AMPK	geneY
polyphenols	chem
【PRE_E】
polyphenols	chem
cytokines	geneN
histonedeacetylase	geneN
AMPK	geneN
【GOLD_R】
polyphenols	AMPK	C3
polyphenols	cytokines	C4
polyphenols	histonedeacetylase	C4
【PRE_R】
polyphenols	cytokines	C4
polyphenols	histonedeacetylase	C4
polyphenols	AMPK	C4

Research is currently underway to develop orally active drugs with these effects , but it is convenient to examine more closely what we are eating .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

If a lack of relevance in terms of toxicity and substantial effectiveness are confirmed , plant - derived components may provide useful druggable components and dietary supplements .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We consider therapeutic actions as a combination of synergistic and / or antagonistic interactions in a multi - target strategy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hence , improvement in food through enrichment with polyphenols with demonstrated activity may represent a major advance in the design of diets with both industrial and sanitary value .
【GOLD_E】
polyphenols	chem
【PRE_E】
polyphenols	chem
【GOLD_R】
【PRE_R】

Inhibition of EGF / EGFR activation with naphtho [ 1,2 - b ] furan - 4,5 - dione blocks migration and invasion of MDA - MB - 231 cells .
【GOLD_E】
naphtho[1,2-b]furan-4,5-dione	chem
EGF	geneY
EGFR	geneY
【PRE_E】
EGF	geneY
EGFR	geneY
naphtho[1,2-b]furan-4,5-dione	chem
【GOLD_R】
naphtho[1,2-b]furan-4,5-dione	EGF	C4
naphtho[1,2-b]furan-4,5-dione	EGFR	C4
【PRE_R】
EGF	naphtho[1,2-b]furan-4,5-dione	C4
EGFR	naphtho[1,2-b]furan-4,5-dione	C4

Naphtho [ 1,2 - b ] furan - 4,5 - dione ( NFD ) , a bioactive component of Avicennia marina , has been demonstrated to display anti - cancer activity .
【GOLD_E】
Naphtho[1,2-b]furan-4,5-dione	chem
NFD	chem
【PRE_E】
Naphtho[1,2-b]furan-4,5-dione	chem
NFD	chem
【GOLD_R】
【PRE_R】

Activation of epidermal growth factor receptor ( EGFR ) - induced signaling pathway has been correlated with cancer metastasis in various tumors , including breast carcinoma .
【GOLD_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【PRE_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

We use EGF as a metastatic inducer of MDA - MB - 231 cells to investigate the effect of NFD on cell migration and invasion .
【GOLD_E】
EGF	geneY
NFD	chem
【PRE_E】
EGF	geneY
NFD	chem
【GOLD_R】
【PRE_R】

NFD suppressed EGF - mediated protein levels of c - Jun and c - Fos , and reduced MMP - 9 expression and activity , concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity .
【GOLD_E】
EGF	geneY
c-Jun	geneY
c-Fos	geneY
MMP-9	geneY
NFD	chem
【PRE_E】
NFD	chem
EGF	geneY
c-Jun	geneY
c-Fos	geneY
MMP-9	geneY
【GOLD_R】
NFD	EGF	C4
NFD	c-Jun	C4
NFD	c-Fos	C4
NFD	MMP-9	C4
NFD	MMP-9	C4
【PRE_R】
NFD	EGF	C4
NFD	c-Jun	C4
NFD	c-Fos	C4
NFD	MMP-9	C4

NFD abrogated EGF - induced phosphorylation of EGF receptor ( EGFR ) and phosphatidylinositol 3 - kinase ( PI3K ) / Akt .
【GOLD_E】
EGF	geneY
EGFreceptor	geneY
EGFR	geneY
phosphatidylinositol3-kinase	geneN
PI3K	geneN
Akt	geneN
NFD	chem
phosphatidylinositol	chem
【PRE_E】
NFD	chem
EGF	geneY
EGFreceptor	geneY
EGFR	geneY
phosphatidylinositol3-kinase	geneN
PI3K	geneN
Akt	geneN
【GOLD_R】
NFD	EGF	C4
NFD	EGFreceptor	C4
NFD	EGFR	C4
NFD	phosphatidylinositol3-kinase	C4
NFD	PI3K	C4
NFD	Akt	C4
【PRE_R】
NFD	EGFR	C4
NFD	PI3K	C4

The specific PI3K inhibitor , wortmannin , blocked significantly EGF - induced cell migration and invasion .
【GOLD_E】
PI3K	geneN
EGF	geneY
wortmannin	chem
【PRE_E】
PI3K	geneN
wortmannin	chem
EGF	geneY
【GOLD_R】
wortmannin	PI3K	C4
wortmannin	EGF	C4
【PRE_R】
PI3K	wortmannin	C4
wortmannin	EGF	C4

Furthermore , the EGFR inhibitor AG1478 inhibited EGF - induced MMP - 9 expression , cell migration and invasion , as well as the activation of PI3K / Akt , suggesting that PI3K / Akt activation occur downstream of EGFR activation .
【GOLD_E】
AG1478	chem
PI3K	geneN
Akt	geneN
EGFR	geneY
EGFR	geneY
EGF	geneY
MMP-9	geneY
PI3K	geneN
Akt	geneN
【PRE_E】
EGFR	geneY
AG1478	chem
EGF	geneY
MMP-9	geneY
PI3K	geneN
Akt	geneN
PI3K	geneN
Akt	geneN
EGFR	geneY
【GOLD_R】
AG1478	MMP-9	C4
AG1478	PI3K	C4
AG1478	Akt	C4
AG1478	EGFR	C4
AG1478	EGFR	C4
AG1478	EGF	C4
AG1478	PI3K	C4
AG1478	Akt	C4
【PRE_R】
AG1478	EGF	C4
AG1478	MMP-9	C4

These findings suggest that NFD inhibited the EGF - induced invasion and migration of MDA - MB - 231 cells via EGFR - dependent PI3K / Akt signaling , leading to the down - regulation of MMP - 9 expression .
【GOLD_E】
EGF	geneY
EGFR	geneY
PI3K	geneN
Akt	geneN
MMP-9	geneY
NFD	chem
【PRE_E】
NFD	chem
EGF	geneY
EGFR	geneY
PI3K	geneN
Akt	geneN
MMP-9	geneY
【GOLD_R】
NFD	PI3K	C4
NFD	Akt	C4
NFD	MMP-9	C4
NFD	EGF	C4
NFD	EGFR	C4
【PRE_R】
NFD	EGF	C4
NFD	PI3K	C4
NFD	Akt	C4
NFD	MMP-9	C4

These results provide a novel mechanism to explain the role of NFD as a potent anti - metastatic agent in MDA - MB - 231 cells .
【GOLD_E】
NFD	chem
【PRE_E】
NFD	chem
【GOLD_R】
【PRE_R】

A novel EPAC - specific inhibitor suppresses pancreatic cancer cell migration and invasion .
【GOLD_E】
EPAC	geneY
【PRE_E】
EPAC	geneY
【GOLD_R】
【PRE_R】

Exchange protein directly activated by cAMP ( EPAC ) and cAMP - dependent protein kinase ( PKA ) are two intracellular receptors that mediate the effects of the prototypic second messenger cAMP .
【GOLD_E】
cAMP-dependentproteinkinase	geneN
cAMP	chem
PKA	geneN
cAMP	chem
cAMP	chem
ExchangeproteindirectlyactivatedbycAMP	geneY
EPAC	geneY
【PRE_E】
cAMP	chem
EPAC	geneY
cAMP-dependentproteinkinase	geneN
PKA	geneN
cAMP	chem
【GOLD_R】
【PRE_R】

Identifying pharmacological probes for selectively modulating EPAC activity represents a significant unmet need within the research field .
【GOLD_E】
EPAC	geneY
【PRE_E】
EPAC	geneY
【GOLD_R】
【PRE_R】

Herein , we report the identification and characterization of 3 - ( 5 - tert - butyl - isoxazol - 3 - yl ) - 2 - [ ( 3 - chloro - phenyl ) - hydrazono ] - 3 - oxo - propionitrile ( ESI - 09 ) , a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC - mediated Rap1 activation and Akt phosphorylation , as well as EPAC - mediated insulin secretion in pancreatic β cells .
【GOLD_E】
EPAC	geneY
EPAC	geneY
Rap1	geneY
Akt	geneN
EPAC	geneY
insulin	geneY
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	chem
ESI-09	chem
nucleotide	chem
【PRE_E】
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	chem
ESI-09	chem
nucleotide	chem
EPAC	geneY
EPAC	geneY
Rap1	geneY
Akt	geneN
EPAC	geneY
insulin	geneY
【GOLD_R】
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	insulin	C4
ESI-09	insulin	C4
nucleotide	insulin	C4
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	EPAC	C4
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	Rap1	C4
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	Akt	C4
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	EPAC	C4
ESI-09	EPAC	C4
ESI-09	Rap1	C4
ESI-09	Akt	C4
ESI-09	EPAC	C4
nucleotide	EPAC	C4
nucleotide	Rap1	C4
nucleotide	Akt	C4
nucleotide	EPAC	C4
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	EPAC	C6
ESI-09	EPAC	C6
nucleotide	EPAC	C6
【PRE_R】
3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile	EPAC	C4
ESI-09	EPAC	C4
nucleotide	EPAC	C4

Using this novel EPAC - specific inhibitor , we have probed the functional roles of overexpression of EPAC1 in pancreatic cancer cells .
【GOLD_E】
EPAC	geneY
EPAC1	geneY
【PRE_E】
EPAC	geneY
EPAC1	geneY
【GOLD_R】
【PRE_R】

Our studies show that EPAC1 plays an important role in pancreatic cancer cell migration and invasion , and thus represents a potential target for developing novel therapeutic strategies for pancreatic cancer .
【GOLD_E】
EPAC1	geneY
【PRE_E】
EPAC1	geneY
【GOLD_R】
【PRE_R】

Metformin directly inhibits ghrelin secretion through AMP - activated protein kinase in rat primary gastric cells .
【GOLD_E】
Metformin	chem
AMP	chem
ghrelin	geneY
AMP-activatedproteinkinase	geneY
【PRE_E】
Metformin	chem
ghrelin	geneY
AMP-activatedproteinkinase	geneN
【GOLD_R】
Metformin	ghrelin	C4
【PRE_R】
Metformin	ghrelin	C4

The antidiabetic drug Metformin causes weight loss in both diabetic and non - diabetic individuals .
【GOLD_E】
Metformin	chem
【PRE_E】
Metformin	chem
【GOLD_R】
【PRE_R】

Metformin treatment is also associated with lower circulating levels of the orexigenic hormone ghrelin .
【GOLD_E】
Metformin	chem
orexigenichormone	geneN
ghrelin	geneY
【PRE_E】
Metformin	chem
orexigenichormoneghrelin	geneY
【GOLD_R】
Metformin	orexigenichormone	C4
Metformin	ghrelin	C4
【PRE_R】
Metformin	orexigenichormoneghrelin	C3

To test whether Metformin directly affects ghrelin cells , rat primary stomach cells were treated with Metformin and the levels of ghrelin secretion , proghrelin gene expression and activation of adenosine monophosphate - activated protein kinase ( AMPK ) were examined .
【GOLD_E】
ghrelin	geneY
ghrelin	geneY
proghrelin	geneY
adenosinemonophosphate-activatedproteinkinase	geneY
AMPK	geneY
Metformin	chem
Metformin	chem
adenosinemonophosphate	chem
【PRE_E】
Metformin	chem
Metformin	chem
ghrelin	geneY
proghrelin	geneY
adenosinemonophosphate-activatedproteinkinase	geneN
AMPK	geneN
【GOLD_R】
【PRE_R】
Metformin	ghrelin	C3
Metformin	ghrelin	C3
Metformin	proghrelin	C3
Metformin	AMPK	C3

Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by co - incubation with the AMPK inhibitor compound C .
【GOLD_E】
ghrelin	geneY
proghrelin	geneY
AMPK	geneY
Metformin	chem
compoundC	chem
【PRE_E】
Metformin	chem
ghrelin	geneY
proghrelin	geneY
AMPK	geneN
【GOLD_R】
compoundC	ghrelin	C3
compoundC	proghrelin	C3
Metformin	ghrelin	C4
Metformin	proghrelin	C4
compoundC	AMPK	C4
【PRE_R】
Metformin	ghrelin	C3
Metformin	proghrelin	C4
Metformin	AMPK	C4

Furthermore , the AMPK activator 5 - amino - 1 - β - D - ribofuranosyl - imidazole - 4 - carboxamide ( AICAR ) significantly inhibited ghrelin secretion .
【GOLD_E】
AMPK	geneY
ghrelin	geneY
5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide	chem
AICAR	chem
【PRE_E】
AMPK	geneN
5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide	chem
AICAR	chem
ghrelin	geneY
【GOLD_R】
5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide	AMPK	C3
AICAR	AMPK	C3
AICAR	ghrelin	C4
【PRE_R】
AMPK	5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide	C4
AICAR	ghrelin	C4

Additionally , ghrelin cells were shown to express AMPK .
【GOLD_E】
ghrelin	geneY
AMPK	geneY
【PRE_E】
AMPK	geneN
【GOLD_R】
【PRE_R】

Finally , Metformin treatment caused a significant increase in the level of phosphorylated ( active ) AMPK .
【GOLD_E】
Metformin	chem
phosphorylated(active)AMPK	geneY
【PRE_E】
Metformin	chem
phosphorylated(active)AMPK	geneN
【GOLD_R】
Metformin	phosphorylated(active)AMPK	C3
【PRE_R】
Metformin	phosphorylated(active)AMPK	C3

Our results show that Metformin directly inhibits stomach ghrelin production and secretion through AMPK .
【GOLD_E】
Metformin	chem
AMPK	geneY
ghrelin	geneY
【PRE_E】
Metformin	chem
ghrelin	geneY
AMPK	geneN
【GOLD_R】
Metformin	ghrelin	C4
【PRE_R】
Metformin	ghrelin	C4
Metformin	AMPK	C4

This reduction in ghrelin secretion may be one of the key components in Metformin 's mechanism of weight loss .
【GOLD_E】
Metformin	chem
【PRE_E】
ghrelin	geneY
【GOLD_R】
【PRE_R】

Fungicide prochloraz and environmental pollutant dioxin induce the ABCG2 transporter in bovine mammary epithelial cells by the arylhydrocarbon receptor signaling pathway .
【GOLD_E】
prochloraz	chem
arylhydrocarbon	chem
dioxin	chem
arylhydrocarbonreceptor	geneY
ABCG2	geneY
【PRE_E】
Fungicideprochloraz	chem
dioxin	chem
ABCG2	geneY
arylhydrocarbonreceptor	geneY
【GOLD_R】
prochloraz	ABCG2	C3
dioxin	ABCG2	C3
【PRE_R】
Fungicideprochloraz	ABCG2	C3
dioxin	ABCG2	C3

The molecular mechanisms by which environmental pollutants including 2,3,7,8 - tetrachlorodibenzo - p - dioxin ( TCDD ) or widely used imidazole fungicide prochloraz display their toxic effects in vertebrates are still not well understood .
【GOLD_E】
2,3,7,8-tetrachlorodibenzo-p-dioxin	chem
TCDD	chem
imidazole	chem
prochloraz	chem
【PRE_E】
2,3,7,8-tetrachlorodibenzo-p-dioxin	chem
TCDD	chem
imidazole	chem
prochloraz	chem
【GOLD_R】
【PRE_R】

Using computer analysis , we recently identified nuclear aryl hydrocarbon receptor ( AhR ) binding sites termed `` dioxin response elements `` ( DREs ) in the 5 ' - untranslated region ( 5 ' - UTR ) of efflux transporter ABCG2 ( Accession No .
【GOLD_E】
`dioxi	chem
arylhydrocarbonreceptor	geneY
AhR	geneY
`dioxinresponseelement	geneN
`(DR	geneN
ofeffluxtransport	geneN
erABC	geneY
arylhydrocarbon	chem
【PRE_E】
nucleararylhydrocarbonreceptor	geneY
AhR	geneY
dioxinresponseelements	geneN
DREs	geneN
5'-untranslatedregion	geneN
5'-UTR	geneY
effluxtransporterABCG2	geneN
Accession	geneY
【GOLD_R】
【PRE_R】

EU570105 ) from the bovine mammary gland .
【GOLD_E】
EU570105	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

As these regulatory motifs mediate regulation of target genes by AhR agonists including TCDD and prochloraz , we have systematically investigated the effect of both contaminants on functional ABCG2 transport activity in primary bovine mammary epithelial cells .
【GOLD_E】
TCDD	chem
prochloraz	chem
AhR	geneY
ABCG2	geneY
【PRE_E】
AhR	geneY
TCDD	chem
prochloraz	chem
ABCG2	geneY
【GOLD_R】
TCDD	AhR	C5
prochloraz	AhR	C5
【PRE_R】

TCDD or prochloraz doubled ABCG2 - mediated Hoechst H33342 secretion .
【GOLD_E】
TCDD	chem
prochloraz	chem
HoechstH33342	chem
ABCG2	geneY
【PRE_E】
TCDD	chem
prochloraz	chem
ABCG2	geneY
【GOLD_R】
HoechstH33342	ABCG2	C9
【PRE_R】
TCDD	ABCG2	C3
prochloraz	ABCG2	C3

This effect was almost completely reversed by specific ABCG2 inhibitor Ko143 .
【GOLD_E】
Ko143	chem
ABCG2	geneY
【PRE_E】
ABCG2	geneY
Ko143	chem
【GOLD_R】
Ko143	ABCG2	C4
【PRE_R】
ABCG2	Ko143	C4

In further mechanistic studies , we showed that this induction was due to binding of activated AhR to DRE sequences in the ABCG2 5 ' - UTR .
【GOLD_E】
DRE	geneN
ABCG2	geneY
AhR	geneY
【PRE_E】
AhR	geneY
DRE	geneY
ABCG2	geneY
5'-UTR	geneN
【GOLD_R】
【PRE_R】

Receptor binding was significantly reduced by specific AhR antagonist salicyl amide .
【GOLD_E】
AhR	geneY
salicylamide	chem
【PRE_E】
AhR	geneY
salicylamide	chem
【GOLD_R】
salicylamide	AhR	C6
【PRE_R】

Induction of AhR by TCDD and prochloraz resulted in a time - and dose - dependent increase of ABCG2 gene expression and transporter protein levels .
【GOLD_E】
AhR	geneY
ABCG2	geneY
TCDD	chem
prochloraz	chem
【PRE_E】
AhR	geneY
TCDD	chem
prochloraz	chem
ABCG2	geneY
【GOLD_R】
TCDD	ABCG2	C3
prochloraz	ABCG2	C3
TCDD	AhR	C3
prochloraz	AhR	C3
【PRE_R】
AhR	TCDD	C3
prochloraz	ABCG2	C3

As ABCG2 represents the main mammary transporter for xenobiotics including drugs and toxins , exposure to prevalent AhR agonists may enhance transporter - mediated secretion of potential harmful compounds into milk .
【GOLD_E】
ABCG2	geneY
AhR	geneY
【PRE_E】
ABCG2	geneY
AhR	geneY
【GOLD_R】
【PRE_R】

Through identification of mammary ABCG2 as a novel target gene of pesticide prochloraz and dioxin , our results may therefore help to improve the protection of breast - feeding infants and the consumer of dairy products .
【GOLD_E】
ABCG2	geneY
prochloraz	chem
dioxin	chem
【PRE_E】
ABCG2	geneY
prochloraz	chem
dioxin	chem
【GOLD_R】
【PRE_R】

Molecular analyses of dinosaur osteocytes support the presence of endogenous molecules .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The discovery of soft , transparent microstructures in dinosaur bone consistent in morphology with osteocytes was controversial .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We hypothesize that , if original , these microstructures will have molecular features in common with extant osteocytes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We present immunological and mass spectrometry evidence for preservation of proteins comprising extant osteocytes ( Actin , Tubulin , PHEX , Histone H4 ) in osteocytes recovered from two non - avian dinosaurs .
【GOLD_E】
Actin	geneN
Tubulin	geneN
PHEX	geneN
HistoneH4	geneN
【PRE_E】
Actin	geneN
Tubulin	geneN
PHEX	geneY
HistoneH4	geneY
【GOLD_R】
【PRE_R】

Furthermore , antibodies to DNA show localized binding to these microstructures , which also react positively with DNA intercalating stains propidium iodide ( PI ) and 4',6 ' - diamidino - 2 - phenylindole dihydrochloride ( DAPI ) .
【GOLD_E】
propidiumiodide	chem
4',6'-diamidino-2-phenylindoledihydrochloride	chem
DAPI	chem
【PRE_E】
propidiumiodide	chem
PI)	chem
4',6'-diamidino-2-phenylindoledihydrochloride	chem
DAPI	chem
【GOLD_R】
【PRE_R】

Each antibody binds dinosaur cells in patterns similar to extant cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These data are the first to support preservation of multiple proteins and to present multiple lines of evidence for material consistent with DNA in dinosaurs , supporting the hypothesis that these structures were part of the once living animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We propose mechanisms for preservation of cells and component molecules , and discuss implications for dinosaurian cellular biology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effects of silver nanoparticles on the liver and hepatocytes in vitro .
【GOLD_E】
silver	chem
【PRE_E】
【GOLD_R】
【PRE_R】

With the increasing use and incorporation of nanoparticles ( NPs ) into consumer products , screening for potential toxicity is necessary to ensure customer safety .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

NPs have been shown to translocate to the bloodstream following inhalation and ingestion , and such studies demonstrate that the liver is an important organ for accumulation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Silver ( Ag ) NPs are highly relevant for human exposure due to their use in food contact materials , dietary supplements , and antibacterial wound treatments .
【GOLD_E】
Silver	chem
Ag	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Due to the large number of different NPs already used in various products and being developed for new applications , it is essential that relevant , quick , and cheap methods of in vitro risk assessment suitable for these new materials are established .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , this study used a simple hepatocytes model combined with an in vivo injection model to simulate the passage of a small amount of NPs into the bloodstream following exposure , e.g . , via ingestion or inhalation , and examined the potential of Ag NPs of 20 nm diameter to cause toxicity , inflammation , and oxidative stress in the liver following in vivo exposures of female Wistar rats via iv injection to 50 μg of NPs and in vitro exposures using the human hepatocyte cell line C3A .
【GOLD_E】
Ag	chem
【PRE_E】
【GOLD_R】
【PRE_R】

We found that Ag NPs were highly cytotoxic to hepatocytes ( LC ( 50 ) lactate dehydrogenase : 2.5 μg / cm ( 2 ) ) and affected hepatocyte homeostasis by reducing albumin release .
【GOLD_E】
lactatedehydrogenase	geneN
albumin	geneY
Ag	chem
lactate	chem
【PRE_E】
Ag	chem
lactatedehydrogenase	geneY
albumin	geneY
【GOLD_R】
Ag	albumin	C4
【PRE_R】

At sublethal concentrations with normal cell or tissue morphology , Ag NPs were detected in cytoplasm and nuclei of hepatocytes .
【GOLD_E】
Ag	chem
【PRE_E】
【GOLD_R】
【PRE_R】

We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin - 8 ( IL - 8 ) / macrophage inflammatory protein 2 , IL - 1RI , and tumor necrosis factor - α expression in both models and increased IL - 8 protein release in vitro .
【GOLD_E】
interleukin-8	geneY
IL-8	geneY
macrophageinflammatoryprotein2	geneN
IL-1RI	geneY
tumornecrosisfactor-α	geneY
IL-8	geneY
Ag	chem
【PRE_E】
Ag	chem
interleukin-8	geneY
IL-8	geneY
macrophageinflammatoryprotein2	geneY
IL-1RI	geneY
tumornecrosisfactor-α	geneY
IL-8	geneY
【GOLD_R】
Ag	interleukin-8	C3
Ag	IL-8	C3
Ag	macrophageinflammatoryprotein2	C3
Ag	IL-1RI	C3
Ag	tumornecrosisfactor-α	C3
Ag	IL-8	C3
【PRE_R】

This article presents evidence of the potential toxicity and inflammogenic potential of Ag NPs in the liver following ingestion .
【GOLD_E】
Ag	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , the similarities between in vitro and in vivo responses are striking and encouraging for future reduction , refinement , and replacement of animal studies by the use of hepatocyte cell lines in particle risk assessment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor .
【GOLD_E】
GTP	chem
prostaglandin	chem
ExtracellularloopII	geneN
prostaglandinEP3receptor	geneY
【PRE_E】
ExtracellularloopII	geneN
GTP	chem
prostaglandinEP3receptor	geneY
【GOLD_R】
【PRE_R】

Unlike the majority of G protein - coupled receptors , the prostaglandin E ( 2 ) ( PGE ( 2 ) ) E - prostanoid 3 ( EP3 ) receptor binds agonist with high affinity that is insensitive to the presence of guanosine 5 [ prime ] - O - ( 3 - thio ) triphosphate ( GTPγS ) .
【GOLD_E】
PGE(2)	chem
E-prostanoid	chem
Gprotein-coupledreceptors	geneN
prostaglandinE(2)(PGE(2))E-prostanoid3(EP3)receptor	geneY
guanosine5[prime]-O-(3-thio)triphosphate	chem
GTPγS	chem
prostaglandinE(2)	chem
【PRE_E】
Gprotein-coupledreceptors	geneN
prostaglandinE(2)	geneY
PGE(2)	geneY
E-prostanoid3(EP3)receptor	geneY
guanosine5[prime]-O-(3-thio)triphosphate	chem
GTPγS	chem
【GOLD_R】
【PRE_R】

We report the identification of mutations that confer GTPγS sensitivity to agonist binding .
【GOLD_E】
GTPγS	chem
【PRE_E】
GTPγS	chem
【GOLD_R】
【PRE_R】

Seven point mutations were introduced into the conserved motif in the second extracellular loop ( ECII ) of EP3 , resulting in acquisition of GTP - sensitive agonist binding .
【GOLD_E】
secondextracellularloop	geneN
ECII	geneN
EP3	geneY
GTP	chem
【PRE_E】
ECII	geneN
EP3	geneN
GTP	chem
【GOLD_R】
【PRE_R】

One receptor mutation W203A was studied in detail .
【GOLD_E】
W203A	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the W203A receptor , conditions where high GTP levels are present ; however , high affinity binding [ ( 3 ) H ] PGE ( 2 ) was observed in broken cell preparations washed free of GTP .
【GOLD_E】
[(3)H]PGE(2)	chem
GTP	chem
W203A	geneN
GTP	chem
【PRE_E】
W203Areceptor	geneY
GTP	chem
[(3)H]PGE(2)	chem
GTP	chem
【GOLD_R】
【PRE_R】

The [ ( 3 ) H ] PGE ( 2 ) binding of W203A in broken cell membrane fractions was inhibited by addition of GTPγS ( IC ( 50 ) 21 ± 1.8 nM ) .
【GOLD_E】
[(3)H]PGE(2)	chem
GTPγS	chem
W203A	geneN
【PRE_E】
[(3)H]PGE(2)	chem
W203A	geneN
GTPγS	chem
【GOLD_R】
【PRE_R】

Taken together , these results suggest that the wild - type EP3 receptor displays unusual characteristics of the complex coupled equilibria between agonist - receptor and receptor - G protein interaction .
【GOLD_E】
Gprotein	geneN
EP3	geneY
【PRE_E】
EP3receptor	geneY
receptor-G	geneN
【GOLD_R】
【PRE_R】

Moreover , mutation of ECII can alter this coupled equilibrium from GTP - insensitive agonist binding to more conventional GTP - sensitive binding .
【GOLD_E】
ECII	geneN
GTP	chem
GTP	chem
【PRE_E】
ECII	geneN
GTP	chem
GTP	chem
【GOLD_R】
【PRE_R】

This suggests that for the mutant receptors , ECII plays a critical role in linking the agonist bound receptor conformation to the G protein nucleotide bound state .
【GOLD_E】
ECII	geneN
Gprotein	geneN
nucleotide	chem
【PRE_E】
ECII	geneN
nucleotide	chem
【GOLD_R】
【PRE_R】

Identification of Dlk1 - Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion .
【GOLD_E】
Dlk1	geneY
Dio3	geneY
【PRE_E】
Dlk1	geneY
Dio3	geneY
【GOLD_R】
【PRE_R】

The molecular events during nongenotoxic carcinogenesis and their temporal order are poorly understood but thought to include long - lasting perturbations of gene expression .
【GOLD_E】
【PRE_E】
nongenotoxic	chem
【GOLD_R】
【PRE_R】

Here , we have investigated the temporal sequence of molecular and pathological perturbations at early stages of phenobarbital ( PB ) mediated liver tumor promotion in vivo .
【GOLD_E】
phenobarbital	chem
【PRE_E】
phenobarbital	chem
PB	chem
【GOLD_R】
【PRE_R】

Molecular profiling ( mRNA , microRNA [ miRNA ] , DNA methylation , and proteins ) of mouse liver during 13 weeks of PB treatment revealed progressive increases in hepatic expression of long noncoding RNAs and miRNAs originating from the Dlk1 - Dio3 imprinted gene cluster , a locus that has recently been associated with stem cell pluripotency in mice and various neoplasms in humans .
【GOLD_E】
Dlk1	geneY
Dio3	geneY
【PRE_E】
microRNA	geneY
miRNA	geneY
PB	chem
Dlk1	geneY
Dio3	geneY
【GOLD_R】
【PRE_R】

PB induction of the Dlk1 - Dio3 cluster noncoding RNA ( ncRNA ) Meg3 was localized to glutamine synthetase - positive hypertrophic perivenous hepatocytes , suggesting a role for β - catenin signaling in the dysregulation of Dlk1 - Dio3 ncRNAs .
【GOLD_E】
Dlk1	geneY
Dio3	geneY
glutaminesynthetase	geneN
β-catenin	geneN
Dlk1	geneY
Dio3	geneY
glutamine	chem
【PRE_E】
PB	chem
Dlk1	geneY
Dio3	geneY
ncRNA	geneY
Meg3	geneY
glutaminesynthetase	geneY
β-catenin	geneY
Dlk1	geneY
Dio3	geneY
ncRNAs	geneN
【GOLD_R】
【PRE_R】

The carcinogenic relevance of Dlk1 - Dio3 locus ncRNA induction was further supported by in vivo genetic dependence on constitutive androstane receptor and β - catenin pathways .
【GOLD_E】
Dlk1	geneY
Dio3	geneY
androstane	chem
constitutiveandrostanereceptor	geneN
β-catenin	geneN
【PRE_E】
Dlk1	geneY
Dio3	geneY
ncRNA	geneY
constitutiveandrostanereceptor	geneY
β-catenin	geneY
【GOLD_R】
【PRE_R】

Our data identify Dlk1 - Dio3 ncRNAs as novel candidate early biomarkers for mouse liver tumor promotion and provide new opportunities for assessing the carcinogenic potential of novel compounds .
【GOLD_E】
Dlk1	geneY
Dio3	geneY
【PRE_E】
Dlk1	geneY
Dio3	geneY
【GOLD_R】
【PRE_R】

GH improves spatial memory and reverses certain anabolic androgenic steroid - induced effects in intact rats .
【GOLD_E】
GH	geneY
【PRE_E】
GH	geneY
steroid	chem
【GOLD_R】
【PRE_R】

GH has previously been shown to promote cognitive functions in GH - deficient rodents .
【GOLD_E】
GH	geneY
GH	geneY
【PRE_E】
GH	geneY
GH	geneY
【GOLD_R】
【PRE_R】

In this study we report the effects of GH on learning and memory in intact rats pretreated with the anabolic androgenic steroid nandrolone .
【GOLD_E】
steroid	chem
nandrolone	chem
GH	geneY
【PRE_E】
GH	geneY
steroidnandrolone	chem
【GOLD_R】
【PRE_R】

Male Wistar rats received nandrolone decanoate ( 15 mg / kg ) or peanut oil every third day for 3 weeks and were subsequently treated with recombinant human GH ( 1.0 IU / kg ) or saline for 10 consecutive days .
【GOLD_E】
humanGH	geneY
nandrolonedecanoate	chem
【PRE_E】
nandrolonedecanoate	chem
humanGH	geneY
【GOLD_R】
【PRE_R】

During the GH / saline treatment spatial learning and memory were tested in the Morris water maze ( MWM ) .
【GOLD_E】
GH	geneY
【PRE_E】
GH	geneY
【GOLD_R】
【PRE_R】

Also , plasma levels of IGF1 were assessed and the gene expression of the GH receptors ( Ghr ) , Igf1 and Igf2 , in hippocampus and frontal cortex was analyzed .
【GOLD_E】
IGF1	geneY
GHreceptors	geneY
Ghr	geneY
Igf1	geneY
Igf2	geneY
【PRE_E】
IGF1	geneY
GHreceptors	geneY
Ghr	geneY
Igf1	geneY
Igf2	geneY
【GOLD_R】
【PRE_R】

The results demonstrated a significant positive effect of GH on memory functions and increased gene expression of Igf1 in the hippocampus was found in the animals treated with GH .
【GOLD_E】
GH	geneY
Igf1	geneY
GH	geneY
【PRE_E】
GH	geneY
Igf1	geneY
GH	geneY
【GOLD_R】
【PRE_R】

In addition , GH was demonstrated to increase the body weight gain and was able to attenuate the reduced body weight seen in nandrolone - treated animals .
【GOLD_E】
GH	geneY
nandrolone	chem
【PRE_E】
GH	geneY
nandrolone	chem
【GOLD_R】
【PRE_R】

In general , the rats treated with nandrolone alone did not exhibit any pronounced alteration in memory compared with controls in the MWM , and in many cases GH did not induce any alteration .
【GOLD_E】
nandrolone	chem
GH	geneY
【PRE_E】
nandrolone	chem
GH	geneY
【GOLD_R】
【PRE_R】

Regarding target zone crossings , considered to be associated with spatial memory , the difference between GH - and steroid - treated animals was significant and administration of GH improved this parameter in the latter group .
【GOLD_E】
GH	geneY
GH	geneY
【PRE_E】
GH	geneY
steroid	chem
GH	geneY
【GOLD_R】
【PRE_R】

In conclusion , GH improves spatial memory in intact rats and can reverse certain effects induced by anabolic androgenic steroid .
【GOLD_E】
GH	geneY
steroid	chem
【PRE_E】
GH	geneY
steroid	chem
【GOLD_R】
【PRE_R】

Phosphoinositide - dependent kinase - 1 and protein kinase C δ contribute to endothelin - 1 constriction and elevated blood pressure in intermittent hypoxia .
【GOLD_E】
Phosphoinositide-dependentkinase-1	geneY
proteinkinaseCδ	geneY
endothelin-1	geneY
【PRE_E】
Phosphoinositide-dependentkinase-1	geneY
proteinkinaseC	geneY
endothelin-1	geneY
【GOLD_R】
【PRE_R】

Obstructive sleep apnea ( OSA ) is associated with cardiovascular complications including hypertension .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Previous findings from our laboratory indicate that exposure to intermittent hypoxia ( IH ) , to mimic sleep apnea , increases blood pressure in rats .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

IH also increases endothelin - 1 ( ET - 1 ) constrictor sensitivity in a protein kinase C ( PKC ) δ - dependent manner in mesenteric arteries .
【GOLD_E】
endothelin-1	geneY
ET-1	geneY
proteinkinaseC(PKC)δ	geneY
【PRE_E】
IH	chem
endothelin-1	geneY
ET-1	geneY
proteinkinaseC	geneN
PKC	geneN
【GOLD_R】
【PRE_R】
IH	endothelin-1	C3
IH	ET-1	C3

Because phosphoinositide - dependent kinase - 1 ( PDK - 1 ) regulates PKC δ activity , we hypothesized that PDK - 1 contributes to the augmented ET - 1 constrictor sensitivity and elevated blood pressure following IH .
【GOLD_E】
phosphoinositide-dependentkinase-1	geneY
PDK-1	geneY
PKCδ	geneY
PDK-1	geneY
ET-1	geneY
【PRE_E】
phosphoinositide-dependentkinase-1	geneY
PDK-1	geneY
PKC	geneN
PDK-1	geneY
ET-1	geneY
【GOLD_R】
【PRE_R】

Male Sprague - Dawley rats were exposed to either sham or IH ( cycles between 21 % O ( 2 ) / 0 % CO ( 2 ) and 5 % O ( 2 ) / 5 % CO ( 2 ) ) conditions for 7 h / day for 14 or 21 days .
【GOLD_E】
O(2)	chem
CO(2)	chem
O(2)	chem
CO(2)	chem
【PRE_E】
IH	chem
O(2)	chem
CO(2)	chem
O(2)	chem
CO(2)	chem
【GOLD_R】
【PRE_R】

The contribution of PKC δ and PDK - 1 to ET - 1 - mediated vasoconstriction was assessed in mesenteric arteries using pharmacological inhibitors .
【GOLD_E】
PKCδ	geneY
PDK-1	geneY
ET-1	geneY
【PRE_E】
PKC	geneN
PDK-1	geneY
ET-1	geneY
【GOLD_R】
【PRE_R】

Constrictor sensitivity to ET - 1 was enhanced in arteries from IH - exposed rats .
【GOLD_E】
ET-1	geneY
【PRE_E】
ET-1	geneY
【GOLD_R】
【PRE_R】

Inhibition of PKC δ or PDK - 1 blunted ET - 1 constriction in arteries from IH but not sham group rats .
【GOLD_E】
PKCδ	geneY
PDK-1	geneY
ET-1	geneY
【PRE_E】
PKC	geneN
PDK-1	geneY
ET-1	geneY
【GOLD_R】
【PRE_R】

Western analysis revealed similar levels of total and phosphorylated PDK - 1 in arteries from sham and IH group rats but decreased protein - protein interaction between PKC δ and PDK - 1 in arteries from IH - compared with sham - exposed rats .
【GOLD_E】
phosphorylatedPDK-1	geneY
PKCδ	geneY
PDK-1	geneY
【PRE_E】
phosphorylatedPDK-1	geneY
PKC	geneN
PDK-1	geneY
【GOLD_R】
【PRE_R】

Blood pressure was increased in rats exposed to IH , and treatment with the PDK - 1 inhibitor OSU - 03012 [ 2 - amino - N - { 4 - [ 5 - ( 2 - phenanthrenyl ) - 3 - ( trifluoromethyl ) - 1H - pyrazol - 1 - yl ] - phenyl } - acetamide ] ( 33 mg / day ) lowered blood pressure in IH but not sham group rats .
【GOLD_E】
PDK-1	geneY
OSU-03012	chem
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide	chem
【PRE_E】
IH	chem
PDK-1	geneY
OSU-03012	chem
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide	chem
【GOLD_R】
OSU-03012	PDK-1	C4
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide	PDK-1	C4
【PRE_R】
IH	PDK-1	C4
PDK-1	OSU-03012	C4
PDK-1	2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide	C4

Our results suggest that exposure to IH unmasks a role for PDK - 1 in regulating ET - 1 constrictor sensitivity and blood pressure that is not present under normal conditions .
【GOLD_E】
PDK-1	geneY
ET-1	geneY
【PRE_E】
IH	geneY
PDK-1	geneY
ET-1	geneY
【GOLD_R】
【PRE_R】

These novel findings suggest that PDK - 1 may be a uniquely effective antihypertensive therapy for OSA patients .
【GOLD_E】
PDK-1	geneY
【PRE_E】
PDK-1	geneY
【GOLD_R】
【PRE_R】

Intercellular adhesion molecule - 2 is involved in apical ectoplasmic specialization dynamics during spermatogenesis in the rat .
【GOLD_E】
Intercellularadhesionmolecule-2	geneY
【PRE_E】
Intercellularadhesionmolecule-2	geneY
【GOLD_R】
【PRE_R】

In this study , we investigated the role of intercellular adhesion molecule - 2 ( ICAM2 ) in the testis .
【GOLD_E】
intercellularadhesionmolecule-2	geneY
ICAM2	geneY
【PRE_E】
intercellularadhesionmolecule-2	geneY
ICAM2	geneY
【GOLD_R】
【PRE_R】

ICAM2 is a cell adhesion protein having important roles in cell migration , especially during inflammation when leukocytes cross the endothelium .
【GOLD_E】
ICAM2	geneY
【PRE_E】
ICAM2	geneY
【GOLD_R】
【PRE_R】

Herein , we showed ICAM2 to be expressed by germ and Sertoli cells in the rat testis .
【GOLD_E】
ICAM2	geneY
【PRE_E】
ICAM2	geneY
【GOLD_R】
【PRE_R】

When a monospecific antibody was used for immunolocalization experiments , ICAM2 was found to surround the heads of elongating / elongated spermatids in all stages of the seminiferous epithelial cycle .
【GOLD_E】
ICAM2	geneY
【PRE_E】
ICAM2	geneY
【GOLD_R】
【PRE_R】

To determine whether ICAM2 is a constituent of apical ectoplasmic specialization ( ES ) , co - immunoprecipitation and dual immunofluorescence staining were performed .
【GOLD_E】
ICAM2	geneY
【PRE_E】
ICAM2	geneY
【GOLD_R】
【PRE_R】

Interestingly , ICAM2 was found to associate with β1 - integrin , nectin - 3 , afadin , Src , proline - rich tyrosine kinase 2 , annexin II , and actin .
【GOLD_E】
ICAM2	geneY
β1-integrin	geneY
nectin-3	geneY
afadin	geneY
Src	geneY
proline-richtyrosinekinase2	geneY
annexinII	geneY
actin	geneN
tyrosine	chem
【PRE_E】
ICAM2	geneY
β1-integrin	geneY
nectin-3	geneY
afadin	geneY
Src	geneY
proline-richtyrosinekinase2	geneY
annexinII	geneY
actin	geneN
【GOLD_R】
【PRE_R】

Following CdCl₂ treatment , ICAM2 was found to be upregulated during restructuring of the seminiferous epithelium , with round spermatids becoming increasingly immunoreactive for ICAM2 by 6 - 16 h .
【GOLD_E】
ICAM2	geneY
CdCl₂	chem
ICAM2	geneY
【PRE_E】
CdCl₂	chem
ICAM2	geneY
ICAM2	geneY
【GOLD_R】
CdCl₂	ICAM2	C3
【PRE_R】
CdCl₂	ICAM2	C3

Interestingly , there was a loss in the binding of ICAM2 to actin during CdCl₂ - induced germ cell loss , suggesting that a loss of ICAM2 - actin interactions might have facilitated junction restructuring .
【GOLD_E】
CdCl₂	chem
ICAM2	geneY
actin	geneN
ICAM2	geneY
actin	geneN
【PRE_E】
ICAM2	geneY
actin	geneN
CdCl₂	chem
ICAM2	geneY
actin	geneN
【GOLD_R】
CdCl₂	actin	C4
【PRE_R】

Taken collectively , these results illustrate that ICAM2 plays an important role in apical ES dynamics during spermatogenesis .
【GOLD_E】
ICAM2	geneY
【PRE_E】
ICAM2	geneY
【GOLD_R】
【PRE_R】

The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5 - methoxytryptamine in the brain : an in vitro study .
【GOLD_E】
serotonin	chem
5-methoxytryptamine	chem
cytochromeP450	geneN
【PRE_E】
cytochromeP450	geneN
serotonin	chem
5-methoxytryptamine	chem
【GOLD_R】
serotonin	cytochromeP450	C9
5-methoxytryptamine	cytochromeP450	C9
【PRE_R】
cytochromeP450	serotonin	C9
cytochromeP450	5-methoxytryptamine	C9

Brain serotonin has been implicated in the pathophysiology of a wide spectrum of psychiatric disorders , as well as in the mechanism of action of psychotropic drugs .
【GOLD_E】
serotonin	chem
【PRE_E】
serotonin	chem
【GOLD_R】
【PRE_R】

The aim of present study was to identify rat cytochrome P450 ( CYP ) isoforms which can catalyze the O - demethylation of 5 - methoxytryptamine to serotonin , and to find out whether that alternative pathway of serotonin synthesis may take place in the brain .
【GOLD_E】
serotonin	chem
serotonin	chem
ratcytochromeP450	geneN
CYP	geneN
O	chem
5-methoxytryptamine	chem
【PRE_E】
ratcytochromeP450	geneN
CYP	geneN
O	chem
5-methoxytryptamine	chem
serotonin	chem
serotonin	chem
【GOLD_R】
【PRE_R】
CYP	O	C9
CYP	5-methoxytryptamine	C9
CYP	serotonin	C9
CYP	serotonin	C9

The study was conducted on cDNA - expressed CYPs ( rat CYP1A1 / 2 , 2A1 / 2 , 2B1 , 2C6 / 11 / 13 , 2D1 / 2 / 4 / 18 , 2E1 , 3A2 and human CYP2D6 ) , on rat brain and liver microsomes and on human liver microsomes ( the wild - type CYP2D6 or the allelic variant 2D6 * 4 * 4 ) .
【GOLD_E】
CYPs	geneN
ratCYP1A1/2,2A1/2,2B1,2C6/11/13,2D1/2/4/18,2E1,3A2	geneN
humanCYP2D6	geneY
CYP2D6	geneN
2D6	geneN
【PRE_E】
CYPs	geneN
ratCYP1A1/2,2A1/2,2B1,2C6/11/13,2D1/2/4/18,2E1,3A2	geneN
humanCYP2D6	geneY
CYP2D6	geneY
2D6*4*4)	geneY
【GOLD_R】
【PRE_R】

Of the rat CYP isoforms studied , CYP2D isoforms were the most efficient in catalyzing the O - demethylation of 5 - methoxytryptamine to serotonin , but they were less effective than the human isoform CYP2D6 .
【GOLD_E】
O	chem
5-methoxytryptamine	chem
serotonin	chem
ratCYP	geneN
CYP2D	geneN
humanisoformCYP2D6	geneY
【PRE_E】
ratCYP	geneN
CYP2D	geneN
O	chem
5-methoxytryptamine	chem
serotonin	chem
humanisoformCYP2D6	geneY
【GOLD_R】
serotonin	CYP2D	C9
serotonin	humanisoformCYP2D6	C9
O	CYP2D	C9
O	humanisoformCYP2D6	C9
5-methoxytryptamine	CYP2D	C9
5-methoxytryptamine	humanisoformCYP2D6	C9
【PRE_R】
ratCYP	O	C9
CYP2D	O	C9
CYP2D	5-methoxytryptamine	C9
CYP2D	serotonin	C9

Microsomes from different brain regions were capable of metabolizing 5 - methoxytryptamine to serotonin .
【GOLD_E】
5-methoxytryptamine	chem
serotonin	chem
【PRE_E】
5-methoxytryptamine	chem
serotonin	chem
【GOLD_R】
【PRE_R】

The reaction was inhibited by the specific CYP2D inhibitors quinine and fluoxetine .
【GOLD_E】
quinine	chem
CYP2D	geneN
fluoxetine	chem
【PRE_E】
CYP2D	geneN
quinine	chem
fluoxetine	chem
【GOLD_R】
quinine	CYP2D	C4
fluoxetine	CYP2D	C4
【PRE_R】
CYP2D	quinine	C4
CYP2D	fluoxetine	C4

Human liver microsomes of the wild - type CYP2D6 metabolized 5 - methoxytryptamine to serotonin more effectively than did the defective CYP2D6 * 4 * 4 ones .
【GOLD_E】
CYP2D6	geneY
CYP2D6	geneY
5-methoxytryptamine	chem
serotonin	chem
【PRE_E】
CYP2D6	geneY
5-methoxytryptamine	chem
serotonin	chem
CYP2D6*4*4	geneY
【GOLD_R】
serotonin	CYP2D6	C9
serotonin	CYP2D6	C9
5-methoxytryptamine	CYP2D6	C9
5-methoxytryptamine	CYP2D6	C9
【PRE_R】
CYP2D6	5-methoxytryptamine	C9
serotonin	CYP2D6*4*4	C9

The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5 - methoxytryptamine , and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain .
【GOLD_E】
ratbrainCYP2D	geneN
CYP2D	geneN
serotonin	chem
5-methoxytryptamine	chem
serotonin	chem
【PRE_E】
ratbrainCYP2D	geneN
serotonin	chem
5-methoxytryptamine	chem
CYP2D	geneN
serotonin	chem
【GOLD_R】
serotonin	ratbrainCYP2D	C9
serotonin	CYP2D	C9
5-methoxytryptamine	ratbrainCYP2D	C9
【PRE_R】
ratbrainCYP2D	serotonin	C9
5-methoxytryptamine	CYP2D	C9
CYP2D	serotonin	C9

The results are discussed in the context of their possible physiological and pharmacological significance in vivo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Estrogen receptor signaling as a target for novel breast cancer therapeutics .
【GOLD_E】
Estrogenreceptor	geneY
Estrogen	chem
【PRE_E】
Estrogenreceptor	geneY
【GOLD_R】
【PRE_R】

In breast cancer ( BC ) epithelial cells , the mitogenic action of estradiol is transduced through binding to two receptors , ERα and ERβ , which act as transcription factors .
【GOLD_E】
ERα	geneY
ERβ	geneY
estradiol	chem
【PRE_E】
estradiol	chem
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Anti - estrogens ( AEs ) and aromatase inhibitors ( AIs ) are used clinically to arrest the estrogen - dependent growth of BC .
【GOLD_E】
aromatase	geneY
estrogens	chem
estrogen	chem
【PRE_E】
estrogens	chem
aromatase	geneY
estrogen	chem
【GOLD_R】
【PRE_R】

In the case of AE or AI resistance , Herceptin or lapatinib may be used to inhibit growth factors .
【GOLD_E】
lapatinib	chem
【PRE_E】
AE	chem
Herceptin	chem
lapatinib	chem
【GOLD_R】
【PRE_R】

Estrogen effects are mediated not only through nuclear ERs but also through cytoplasmic / membrane ERs and G - protein - coupled ERs .
【GOLD_E】
ERs	geneY
ERs	geneY
G-protein	geneN
ERs	geneY
Estrogen	chem
【PRE_E】
Estrogen	chem
ERs	geneN
ERs	geneN
G-protein	geneN
ERs	geneN
【GOLD_R】
【PRE_R】

These estrogen - binding systems associate with various proteins that direct cell cycle signaling , proliferation and survival .
【GOLD_E】
estrogen	chem
【PRE_E】
estrogen	chem
【GOLD_R】
【PRE_R】

The partners of nuclear ER include SRC1 - 3 , HDACs and ERβ itself as well as newly identified proteins , such as E6 - AP , LKB1 , PELP1 , PAX - 2 and FOXA1 .
【GOLD_E】
ER	geneY
SRC1-3	geneN
HDACs	geneN
ERβ	geneY
E6-AP	geneY
LKB1	geneY
PELP1	geneY
PAX-2	geneY
FOXA1	geneY
【PRE_E】
ER	geneY
SRC1-3	geneY
HDACs	geneN
ERβ	geneY
E6-AP	geneY
LKB1	geneY
PELP1	geneY
PAX-2	geneY
FOXA1	geneY
【GOLD_R】
【PRE_R】

The partners of extra - nuclear ERα include PI3K and the tyrosine kinase Src .
【GOLD_E】
ERα	geneY
PI3K	geneN
tyrosinekinase	geneN
Src	geneY
tyrosine	chem
【PRE_E】
ERα	geneY
PI3K	geneN
tyrosinekinaseSrc	geneN
【GOLD_R】
【PRE_R】

These various factors are all potential targets for therapeutic intervention .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , BC proliferation is enhanced by insulin and EGF , which stimulate signaling through the MAPK and PI3K / AKT pathways by activation of the IGF - 1R and EGFR axes , respectively .
【GOLD_E】
MAPK	geneN
PI3K	geneN
AKT	geneN
IGF-1R	geneY
EGFR	geneY
insulin	geneY
EGF	geneY
【PRE_E】
insulin	geneY
EGF	geneY
MAPK	geneN
PI3K	geneN
AKT	geneN
IGF-1R	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

These pathways are tightly interconnected with ER - activated signaling , and membrane ERα forms complexes with Src and PI3K .
【GOLD_E】
ER	geneY
ERα	geneY
Src	geneY
PI3K	geneN
【PRE_E】
ER	geneY
ERα	geneY
Src	geneY
PI3K	geneN
【GOLD_R】
【PRE_R】

Chemokine - mediated signaling also modulates the estrogen response .
【GOLD_E】
estrogen	chem
Chemokine	geneN
【PRE_E】
Chemokine	geneN
estrogen	chem
【GOLD_R】
【PRE_R】

Inhibiting these pathways with specific inhibitors or activating some of the pathways by gene manipulation may be therapeutically valuable for arresting BC cell cycle progression and for inducing apoptosis to antagonize hormone - resistance .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we review some newly identified putatively targetable ER partners and highlight the need to develop tumor - targeting drug carrier systems affecting both the tumor cells and the tumor environment .
【GOLD_E】
ER	geneY
【PRE_E】
ER	geneY
【GOLD_R】
【PRE_R】

Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL - 60 cells .
【GOLD_E】
Toosendanin	chem
JNK	geneN
【PRE_E】
Toosendanin	chem
JNK	geneN
【GOLD_R】
Toosendanin	JNK	C4
【PRE_R】

Toosendanin ( TSN ) , a triterpenoid isolated from Melia toosendan Sieb . et Zucc . , has been found to suppress proliferation and induce apoptosis in a variety of human cancer cells .
【GOLD_E】
Toosendanin	chem
TSN	chem
triterpenoid	chem
【PRE_E】
Toosendanin	chem
TSN	chem
triterpenoid	chem
【GOLD_R】
【PRE_R】

However , the mechanism how TSN induces apoptosis remains poorly understood .
【GOLD_E】
TSN	chem
【PRE_E】
TSN	chem
【GOLD_R】
【PRE_R】

In this study , we examined the effects of TSN on the growth , cell cycle arrest , induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL - 60 cells .
【GOLD_E】
TSN	chem
【PRE_E】
TSN	chem
【GOLD_R】
【PRE_R】

Proliferation of HL - 60 cells was inhibited in a dose - dependent manner with the IC ( 50 ( 48 h ) ) of 28 ng / mL .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The growth inhibition was due primarily to the S phase arrest and cell apoptosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cell apoptosis induced by TSN was confirmed by Annexin V - FITC / propidium iodide staining .
【GOLD_E】
TSN	chem
FITC	chem
propidiumiodide	chem
【PRE_E】
TSN	chem
AnnexinV-FITC	chem
propidiumiodide	chem
【GOLD_R】
【PRE_R】

The increase of the pro - apoptotic protein Bax , cleaved PARP and caspase - 3 , and the decrease of anti - apoptotic protein Bcl - 2 were observed .
【GOLD_E】
Bax	geneY
PARP	geneN
caspase-3	geneY
Bcl-2	geneY
【PRE_E】
Bax	geneY
PARP	geneN
caspase-3	geneY
Bcl-2	geneY
【GOLD_R】
【PRE_R】

Western blot analysis indicated that TSN inhibits the CDC42 / MEKK1 / JNK pathway .
【GOLD_E】
TSN	chem
CDC42	geneY
MEKK1	geneY
JNK	geneN
【PRE_E】
TSN	chem
CDC42	geneY
MEKK1	geneY
JNK	geneN
【GOLD_R】
TSN	CDC42	C4
TSN	MEKK1	C4
TSN	JNK	C4
【PRE_R】
TSN	CDC42	C4
TSN	MEKK1	C4
TSN	JNK	C4

Taken together , our study suggested , for the first time , that the pro - apoptotic effects of TSN on HL - 60 cells were mediated through JNK signaling pathway .
【GOLD_E】
JNK	geneN
TSN	chem
【PRE_E】
TSN	chem
JNK	geneN
【GOLD_R】
【PRE_R】

Novel insights on the effect of nicotine in a murine colitis model .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

Studies showed that nicotine has a positive influence on symptoms of ulcerative colitis .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

In the present study , we explored the effect of nicotine treatment using different routes of administration in the dextran sodium sulfate ( DSS ) colitis mouse model .
【GOLD_E】
nicotine	chem
sodiumsulfate	chem
【PRE_E】
nicotine	chem
sodiumsulfate	chem
【GOLD_R】
【PRE_R】

We also investigated the effects of cotinine , a major metabolite of nicotine , in the model .
【GOLD_E】
nicotine	chem
cotinine	chem
【PRE_E】
cotinine	chem
nicotine	chem
【GOLD_R】
【PRE_R】

C57BL6 adult male mice were given DSS solution freely in the drinking water for seven consecutive days , and tap water was given thereafter .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Disease severity , length of the colon , colon tissue histology , and inflammatory markers , including colonic myeloperoxidase activity and colonic tumor necrosis factor - α levels , were evaluated .
【GOLD_E】
colonicmyeloperoxidase	geneY
colonictumornecrosisfactor-α	geneY
【PRE_E】
myeloperoxidase	geneY
tumornecrosisfactor-α	geneY
【GOLD_R】
【PRE_R】

The effect of nicotine and cotinine treatments via various different routes of administration were examined the DSS model .
【GOLD_E】
nicotine	chem
cotinine	chem
【PRE_E】
nicotine	chem
cotinine	chem
【GOLD_R】
【PRE_R】

In addition , we measured the plasma levels of nicotine and cotinine in our treatment protocols .
【GOLD_E】
nicotine	chem
cotinine	chem
【PRE_E】
nicotine	chem
cotinine	chem
【GOLD_R】
【PRE_R】

Administration of low , but not high , doses of oral nicotine in DSS - treated mice resulted in a significant decrease in disease severity , histologic damage scores , as well as colonic level of tumor necrosis factor - α .
【GOLD_E】
nicotine	chem
tumornecrosisfactor-α	geneY
【PRE_E】
nicotine	chem
tumornecrosisfactor-α	geneY
【GOLD_R】
nicotine	tumornecrosisfactor-α	C3
【PRE_R】
nicotine	tumornecrosisfactor-α	C3

However , the anti - inflammatory effect of nicotine was not seen after chronic s.c. or minipump infusion of the drug .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
minipump	chem
【GOLD_R】
【PRE_R】

Differences in plasma levels of nicotine and cotinine do not seem to account for this lack of effect .
【GOLD_E】
nicotine	chem
cotinine	chem
【PRE_E】
nicotine	chem
cotinine	chem
【GOLD_R】
【PRE_R】

Finally , oral cotinine alone failed to show a significant effect in the DSS model of colitis .
【GOLD_E】
cotinine	chem
【PRE_E】
cotinine	chem
【GOLD_R】
【PRE_R】

These results highlight that dose and route of administration play a critical role in the protective effect of nicotine in the DSS mouse colitis model .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

The S349T mutation of SQSTM1 links Keap1 / Nrf2 signalling to Paget 's disease of bone .
【GOLD_E】
SQSTM1	geneY
Keap1	geneY
Nrf2	geneY
S349T	geneN
【PRE_E】
S349T	geneY
SQSTM1	geneY
Keap1	geneY
Nrf2	geneY
【GOLD_R】
【PRE_R】

Mutations affecting the Sequestosome 1 ( SQSTM1 ) gene commonly occur in patients with the skeletal disorder Paget 's disease of bone ( PDB ) , a condition characterised by defective osteoclast differentiation and function .
【GOLD_E】
Sequestosome1	geneY
SQSTM1	geneY
【PRE_E】
Sequestosome1	geneY
SQSTM1	geneY
【GOLD_R】
【PRE_R】

Whilst most mutations cluster within the ubiquitin - associated ( UBA ) domain of the SQSTM1 protein , and are associated with dysregulated NFκB signalling , several non - UBA domain mutations have also been identified .
【GOLD_E】
ubiquitin-associated(UBA)domain	geneN
SQSTM1	geneY
NFκB	geneN
UBAdomain	geneN
【PRE_E】
ubiquitin-associated(UBA)domain	geneN
SQSTM1	geneY
NFκB	geneN
UBA	geneN
【GOLD_R】
【PRE_R】

Keap1 is a SQSTM1 - interacting protein that regulates the levels and activity of the Nrf2 transcription factor .
【GOLD_E】
Keap1	geneY
SQSTM1	geneY
Nrf2	geneY
【PRE_E】
Keap1	geneY
SQSTM1	geneY
Nrf2	geneY
【GOLD_R】
【PRE_R】

This in turn controls the expression of numerous cytoprotective genes that contribute to the cell 's capacity to defend itself against chemical and oxidative stress , through binding to the antioxidant response element ( ARE ) .
【GOLD_E】
antioxidantresponseelement	geneN
ARE	geneN
【PRE_E】
antioxidantresponseelement	geneN
【GOLD_R】
【PRE_R】

The PDB - associated S349T mutation maps to the Keap1 - interacting region ( KIR ) of SQSTM1 , however the effects of PDB mutant SQSTM1 on Keap1 function have not been investigated .
【GOLD_E】
S349T	geneN
Keap1-interactingregion	geneN
KIR	geneN
SQSTM1	geneY
SQSTM1	geneY
Keap1	geneY
【PRE_E】
PDB	geneN
S349T	geneN
Keap1	geneY
KIR	geneN
SQSTM1	geneY
PDB	geneN
SQSTM1	geneY
Keap1	geneY
【GOLD_R】
【PRE_R】

Here we show that unlike other SQSTM1 mutations , the S349T mutation results in neither impaired ubiquitin - binding function in pull - down assays , nor dysregulated NFκB signalling in luciferase reporter assays .
【GOLD_E】
ubiquitin	geneN
SQSTM1	geneY
S349T	geneN
NFκB	geneN
【PRE_E】
SQSTM1	geneY
S349T	geneN
ubiquitin	geneN
NFκB	geneN
【GOLD_R】
【PRE_R】

Keap1 is expressed in differentiating osteoclast - like cells and the S349T mutation selectively impairs the SQSTM1 - Keap1 interaction in co - immunoprecipitations , which molecular modelling indicates results from effects on critical hydrogen bonds required to stabilise the KIR - Keap1 complex .
【GOLD_E】
hydrogen	chem
Keap1	geneY
S349T	geneN
SQSTM1	geneY
Keap1	geneY
KIR	geneN
Keap1	geneY
【PRE_E】
Keap1	geneY
S349T	geneN
SQSTM1	geneY
Keap1	geneY
hydrogen	chem
KIR	geneN
Keap1	geneY
【GOLD_R】
【PRE_R】

Further , S349T mutant SQSTM1 , but not other PDB - associated mutants , showed reduced ability to activate Nrf2 signalling as assessed by ARE - luciferase reporter assays .
【GOLD_E】
S349T	geneN
SQSTM1	geneY
Nrf2	geneY
ARE	geneN
【PRE_E】
S349T	geneY
SQSTM1	geneY
PDB	geneN
Nrf2	geneY
【GOLD_R】
【PRE_R】

Thus , SQSTM1 - mediated dysregulation of the Keap1 - Nrf2 axis , which could potentially lead to aberrant production of oxidative response genes , may contribute to disease aetiology in a subset of PDB patients .
【GOLD_E】
SQSTM1	geneY
Keap1	geneY
Nrf2	geneY
【PRE_E】
SQSTM1	geneY
Keap1	geneY
Nrf2	geneY
【GOLD_R】
【PRE_R】

Orexin - A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain - derived neurotrophic factor .
【GOLD_E】
Orexin-A	geneY
brain-derivedneurotrophicfactor	geneY
glucose	chem
【PRE_E】
Orexin-A	geneY
glucose	chem
brain-derivedneurotrophicfactor	geneY
【GOLD_R】
【PRE_R】

Orexin - A ( a glucose - sensing neuropeptide in the hypothalamus ) and brain - derived neurotrophic factor ( BDNF ; a member of the neurotrophin family ) play roles in many physiologic functions , including regulation of glucose metabolism .
【GOLD_E】
Orexin-A	geneY
BDNF	geneY
neurotrophin	geneN
brain-derivedneurotrophicfactor	geneY
glucose	chem
glucose	chem
【PRE_E】
Orexin-A	geneY
glucose-sensingneuropeptide	geneN
brain-derivedneurotrophicfactor	geneY
BDNF	geneY
neurotrophin	geneN
glucose	chem
【GOLD_R】
【PRE_R】

We previously showed that the development of postischemic glucose intolerance is one of the triggers of ischemic neuronal damage .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

The aim of this study was to determine whether there was an interaction between orexin - A and BDNF functions in the hypothalamus after cerebral ischemic stress .
【GOLD_E】
orexin-A	geneY
BDNF	geneY
【PRE_E】
orexin-A	geneY
BDNF	geneY
【GOLD_R】
【PRE_R】

Male ddY mice were subjected to 2 hours of middle cerebral artery occlusion ( MCAO ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Neuronal damage was estimated by histologic and behavioral analyses .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Expression of protein levels was analyzed by Western blot .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Small interfering RNA directed BDNF , orexin - A , and SB334867 [ N - ( 2 - methyl - 6 - benzoxazolyl ) - N ' - 1,5 - naphthyridin - 4 - yl urea ; a specific orexin - 1 receptor antagonist ] were administered directly into the hypothalamus .
【GOLD_E】
BDNF	geneY
orexin-A	geneY
orexin-1receptor	geneY
SB334867	chem
N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-ylurea	chem
【PRE_E】
BDNF	geneY
orexin-A	chem
SB334867	chem
N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-ylurea	chem
orexin-1receptor	geneY
【GOLD_R】
SB334867	orexin-1receptor	C6
N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-ylurea	orexin-1receptor	C6
【PRE_R】
orexin-A	orexin-1receptor	C6

The level of hypothalamic orexin - A , detected by immunohistochemistry , was decreased on day 1 after MCAO .
【GOLD_E】
orexin-A	geneY
【PRE_E】
orexin-A	geneY
【GOLD_R】
【PRE_R】

Intrahypothalamic administration of orexin - A ( 1 or 5 pmol / mouse ) significantly and dose - dependently suppressed the development of postischemic glucose intolerance on day 1 and development of neuronal damage on day 3 .
【GOLD_E】
orexin-A	geneY
glucose	chem
【PRE_E】
Intrahypothalamic	chem
orexin-A	geneY
glucose	chem
【GOLD_R】
【PRE_R】

The MCAO - induced decrease in insulin receptor levels in the liver and skeletal muscle on day 1 was recovered to control levels by orexin - A , and this effect of orexin - A was reversed by the administration of SB334867 as well as by hypothalamic BDNF knockdown .
【GOLD_E】
insulinreceptor	geneY
orexin-A	geneY
orexin-A	geneY
BDNF	geneY
SB334867	chem
【PRE_E】
MCAO	chem
insulinreceptor	geneY
orexin-A	geneY
orexin-A	geneY
SB334867	chem
BDNF	geneY
【GOLD_R】
SB334867	orexin-A	C4
SB334867	insulinreceptor	C4
【PRE_R】
MCAO	insulinreceptor	C3
orexin-A	SB334867	C3

These results suggest that suppression of postischemic glucose intolerance by orexin - A assists in the prevention of cerebral ischemic neuronal damage .
【GOLD_E】
orexin-A	geneY
glucose	chem
【PRE_E】
glucose	chem
orexin-A	geneY
【GOLD_R】
【PRE_R】
glucose	orexin-A	C3

In addition , hypothalamic BDNF may play an important role in this effect of orexin - A .
【GOLD_E】
BDNF	geneY
orexin-A	geneY
【PRE_E】
BDNF	geneY
orexin-A	geneY
【GOLD_R】
【PRE_R】

Mesalamine modulates intercellular adhesion through inhibition of p - 21 activated kinase - 1 .
【GOLD_E】
Mesalamine	chem
p-21activatedkinase-1	geneY
【PRE_E】
Mesalamine	chem
p-21	geneY
kinase-1	geneY
【GOLD_R】
Mesalamine	p-21activatedkinase-1	C4
【PRE_R】
Mesalamine	p-21	C4
Mesalamine	kinase-1	C4

Mesalamine ( 5 - ASA ) is widely used for the treatment of ulcerative colitis , a remitting condition characterized by chronic inflammation of the colon .
【GOLD_E】
Mesalamine	chem
5-ASA	chem
【PRE_E】
Mesalamine	chem
5-ASA	chem
【GOLD_R】
【PRE_R】

Knowledge about the molecular and cellular targets of 5 - ASA is limited and a clear understanding of its activity in intestinal homeostasis and interference with neoplastic progression is lacking .
【GOLD_E】
5-ASA	chem
【PRE_E】
5-ASA	chem
【GOLD_R】
【PRE_R】

We sought to identify molecular pathways interfered by 5 - ASA , using CRC cell lines with different genetic background .
【GOLD_E】
5-ASA	chem
【PRE_E】
5-ASA	chem
【GOLD_R】
【PRE_R】

Microarray was performed for gene expression profile of 5 - ASA - treated and untreated cells ( HCT116 and HT29 ) .
【GOLD_E】
5-ASA	chem
【PRE_E】
5-ASA	chem
【GOLD_R】
【PRE_R】

Filtering and analysis of data identified three oncogenic pathways interfered by 5 - ASA : MAPK / ERK pathway , cell adhesion and β - catenin / Wnt signaling .
【GOLD_E】
5-ASA	chem
MAPK	geneN
ERK	geneN
β-catenin	geneY
Wnt	geneN
【PRE_E】
5-ASA	chem
MAPK	geneN
ERK	geneN
β-catenin	geneN
Wnt	geneN
【GOLD_R】
【PRE_R】

PAK1 emerged as a consensus target of 5 - ASA , orchestrating these pathways .
【GOLD_E】
5-ASA	chem
PAK1	geneY
【PRE_E】
PAK1	geneY
5-ASA	chem
【GOLD_R】
【PRE_R】

We further investigated the effect of 5 - ASA on cell adhesion .
【GOLD_E】
5-ASA	chem
【PRE_E】
5-ASA	chem
【GOLD_R】
【PRE_R】

5 - ASA increased cell adhesion which was measured by cell adhesion assay and transcellular - resistance measurement .
【GOLD_E】
5-ASA	chem
【PRE_E】
5-ASA	chem
【GOLD_R】
【PRE_R】

Moreover , 5 - ASA treatment restored membranous expression of adhesion molecules E - cadherin and β - catenin .
【GOLD_E】
5-ASA	chem
E-cadherin	geneY
β-catenin	geneY
【PRE_E】
5-ASA	chem
E-cadherin	geneY
β-catenin	geneY
【GOLD_R】
5-ASA	E-cadherin	C3
5-ASA	β-catenin	C3
【PRE_R】
5-ASA	E-cadherin	C3
5-ASA	β-catenin	C3

Role of PAK1 as a mediator of mesalamine activity was validated in vitro and in vivo .
【GOLD_E】
PAK1	geneY
【PRE_E】
PAK1	geneY
mesalamine	chem
【GOLD_R】
【PRE_R】

Inhibition of PAK1 by RNA interference also increased cell adhesion .
【GOLD_E】
PAK1	geneY
【PRE_E】
PAK1	geneY
【GOLD_R】
【PRE_R】

PAK1 expression was elevated in APC ( min ) polyps and 5 - ASA treatment reduced its expression .
【GOLD_E】
PAK1	geneY
5-ASA	chem
【PRE_E】
PAK1	geneY
5-ASA	chem
【GOLD_R】
5-ASA	PAK1	C4
【PRE_R】

Our data demonstrates novel pharmacological mechanism of mesalamine in modulation of cell adhesion and role of PAK1 in APC ( min ) polyposis .
【GOLD_E】
PAK1	geneY
mesalamine	chem
【PRE_E】
mesalamine	chem
PAK1	geneY
APC	geneY
【GOLD_R】
【PRE_R】

We propose that inhibition of PAK1 expression by 5 - ASA can impede with neoplastic progression in colorectal carcinogenesis .
【GOLD_E】
PAK1	geneY
5-ASA	chem
【PRE_E】
PAK1	geneY
5-ASA	chem
【GOLD_R】
5-ASA	PAK1	C4
【PRE_R】
PAK1	5-ASA	C4

The mechanism of PAK1 inhibition and induction of membranous translocation of adhesion proteins by 5 - ASA might be independent of its known anti - inflammatory action .
【GOLD_E】
PAK1	geneY
5-ASA	chem
【PRE_E】
PAK1	geneY
5-ASA	chem
【GOLD_R】
5-ASA	PAK1	C4
【PRE_R】
PAK1	5-ASA	C4

Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2 .
【GOLD_E】
epigallocatechingallate	chem
Mrp2	geneY
【PRE_E】
epigallocatechingallate	chem
Mrp2	geneY
【GOLD_R】
【PRE_R】
epigallocatechingallate	Mrp2	C4

Epigallocatechin gallate ( EGCG ) has been shown to be protective in various experimental models of liver injury , although opposite effects have also been reported .
【GOLD_E】
EGCG	chem
Epigallocatechingallate	chem
【PRE_E】
Epigallocatechingallate	chem
EGCG	chem
【GOLD_R】
【PRE_R】

Since its effect on biliary physiology has not been thoroughly investigated , the present study evaluated effect of EGCG on bile flow and bile acid homeostasis in rats .
【GOLD_E】
EGCG	chem
bileacid	chem
【PRE_E】
EGCG	chem
bileacid	chem
【GOLD_R】
【PRE_R】

Compared to controls , EGCG treatment decreased bile flow by 23 % .
【GOLD_E】
EGCG	chem
【PRE_E】
EGCG	chem
【GOLD_R】
【PRE_R】

Hepatic paracellular permeability and biliary bile acid excretion were not altered by EGCG administration , but biliary glutathione excretion was reduced by 70 % .
【GOLD_E】
bileacid	chem
EGCG	chem
glutathione	chem
【PRE_E】
bileacid	chem
EGCG	chem
glutathione	chem
【GOLD_R】
【PRE_R】

Accordingly , the main glutathione transporter on the hepatocyte canalicular membrane , multidrug resistance - associated protein 2 ( Mrp2 ) , was significantly decreased at the protein level .
【GOLD_E】
glutathione	chem
glutathionetransporter	geneN
multidrugresistance-associatedprotein2	geneY
Mrp2	geneY
【PRE_E】
glutathionetransporter	geneN
multidrugresistance-associatedprotein2	geneY
Mrp2	geneY
【GOLD_R】
【PRE_R】

EGCG administration also doubled plasma bile acid levels compared to controls .
【GOLD_E】
EGCG	chem
bileacid	chem
【PRE_E】
EGCG	chem
bileacid	chem
【GOLD_R】
【PRE_R】

While protein levels of the main hepatic bile acid transporters were unchanged , the rate - limiting enzyme in the bile acid synthesis , Cyp7a1 , was significantly increased by EGCG .
【GOLD_E】
bileacid	chem
bileacid	chem
EGCG	chem
hepaticbileacidtransporters	geneY
Cyp7a1	geneY
【PRE_E】
bileacidtransporters	geneN
Cyp7a1	geneY
EGCG	chem
【GOLD_R】
【PRE_R】
Cyp7a1	EGCG	C9

Enhanced bile acid synthesis in these animals was also confirmed by a 2 - fold increase in plasma marker 7α - hydroxy - 4 - cholesten - 3 - one .
【GOLD_E】
bileacid	chem
7α-hydroxy-4-cholesten-3-one	chem
【PRE_E】
bileacid	chem
7α-hydroxy-4-cholesten-3-one	chem
【GOLD_R】
【PRE_R】

In contrast , EGCG markedly downregulated major bile acid transporters ( Asbt and Ostα ) and regulatory molecules ( Shp and Fgf15 ) in the ileum .
【GOLD_E】
bileacidtransporters	geneN
Asbt	geneY
Ostα	geneY
Shp	geneY
Fgf15	geneY
EGCG	chem
bileacid	chem
【PRE_E】
EGCG	chem
bileacidtransporters	geneN
Asbt	geneY
Ostα	geneY
Shp	geneY
Fgf15	geneY
【GOLD_R】
EGCG	bileacidtransporters	C4
EGCG	Asbt	C4
EGCG	Ostα	C4
EGCG	Shp	C4
EGCG	Fgf15	C4
【PRE_R】
EGCG	Asbt	C4
EGCG	Ostα	C4
EGCG	Shp	C4
EGCG	Fgf15	C4

When EGCG was coadministered with ethinylestradiol , a potent cholestatic agent , it did not show any additional effect on the induced cholestasis .
【GOLD_E】
EGCG	chem
ethinylestradiol	chem
【PRE_E】
EGCG	chem
ethinylestradiol	chem
【GOLD_R】
【PRE_R】

This study shows ability of EGCG to raise plasma bile acid concentrations , mainly through Cyp7a1 upregulation , and to decrease bile production through reduction in Mrp2 - mediated bile acid - independent bile flow .
【GOLD_E】
bileacid	chem
Cyp7a1	geneY
Mrp2	geneY
EGCG	chem
bileacid	chem
【PRE_E】
EGCG	chem
Cyp7a1	geneY
Mrp2	geneY
bileacid	chem
【GOLD_R】
EGCG	Cyp7a1	C3
【PRE_R】
EGCG	Cyp7a1	C3
EGCG	Mrp2	C3

In conclusion , our data demonstrate that under certain conditions EGCG may induce cholestasis .
【GOLD_E】
EGCG	chem
【PRE_E】
EGCG	chem
【GOLD_R】
【PRE_R】

Effects - based marine ecological risk assessment at a polychlorinated biphenyl - contaminated site in Saglek , Labrador , Canada .
【GOLD_E】
polychlorinatedbiphenyl	chem
【PRE_E】
polychlorinatedbiphenyl	chem
【GOLD_R】
【PRE_R】

Although the presence and distribution of polychlorinated biphenyls ( PCBs ) in Arctic marine environments has been well documented , the implications for the health of biota are poorly understood .
【GOLD_E】
polychlorinatedbiphenyls	chem
PCBs	chem
【PRE_E】
polychlorinatedbiphenyls	chem
PCBs	chem
【GOLD_R】
【PRE_R】

In the present study , multiple lines of evidence , including site - specific effects data , were used to assess PCB - related risks to marine biota at a contaminated military site in Saglek Bay , Labrador , Canada , from 1997 to 1999 .
【GOLD_E】
PCB	chem
【PRE_E】
PCB	chem
1997	chem
【GOLD_R】
【PRE_R】

Risks were evaluated for three components of the ecosystem : benthic invertebrates , a bottom - feeding fish ( shorthorn sculpin , Myoxocephalus scorpius ) , and a diving seabird ( black guillemot , Cepphus grylle ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Average sediment PCB concentrations exceeded the Canadian interim sediment quality guideline level by 41 - fold .
【GOLD_E】
PCB	chem
【PRE_E】
PCB	chem
【GOLD_R】
【PRE_R】

However , sediment toxicity testing and a benthic community survey showed no evidence of adverse effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast , shorthorn sculpin and black guillemot PCB exposures ( measured as sum of 55 congeners ) were elevated enough to pose risks to survival or reproduction .
【GOLD_E】
PCB	chem
【PRE_E】
PCB	chem
【GOLD_R】
【PRE_R】

Based on the collective evidence , the authors estimated that risks were posed by sediment PCB concentrations greater than 77 ng / g dry weight for black guillemots and 750 ng / g dry weight for shorthorn sculpins .
【GOLD_E】
PCB	chem
【PRE_E】
PCB	chem
【GOLD_R】
【PRE_R】

The present study , along with two parallel studies , provided information to support the management decisions concerning potential remedial action on the contaminated sediments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This ecological risk assessment describes the steps and rationale taken to evaluate the risk posed by an area of PCB - contaminated marine sediments in an otherwise relatively pristine northern coastal environment .
【GOLD_E】
PCB	chem
【PRE_E】
PCB	chem
【GOLD_R】
【PRE_R】

Ablation of Egr2 - positive cells in male mouse anterior pituitary leads to atypical isolated GH deficiency .
【GOLD_E】
Egr2	geneY
【PRE_E】
Egr2	geneY
GH	geneY
【GOLD_R】
【PRE_R】

In this study , we have investigated the expression and function of the transcription factor early growth response factor 2 ( Egr2 ) / Krox20 in the developing anterior pituitary .
【GOLD_E】
earlygrowthresponsefactor2	geneY
Egr2	geneY
Krox20	geneY
【PRE_E】
transcriptionfactorearlygrowthresponsefactor2	geneY
Egr2	geneY
Krox20	geneY
【GOLD_R】
【PRE_R】

Egr2 is initially expressed in all differentiating hormonal cells types , but its expression is mostly restricted to the somatotroph lineage after birth .
【GOLD_E】
Egr2	geneY
【PRE_E】
Egr2	geneY
【GOLD_R】
【PRE_R】

Egr2 knockout results in anterior pituitary hypoplasia .
【GOLD_E】
Egr2	geneY
【PRE_E】
Egr2	geneY
【GOLD_R】
【PRE_R】

However , the analysis of a conditional mutant demonstrates that this phenotype does not originate from a lack of Egr2 expression in the pituitary .
【GOLD_E】
Egr2	geneY
【PRE_E】
Egr2	geneY
【GOLD_R】
【PRE_R】

Using an Egr2 allele driving a Cre - activable toxin gene , we performed a genetic ablation of Egr2 - positive cells in the pituitary .
【GOLD_E】
Egr2	geneY
Egr2	geneY
【PRE_E】
Egr2	geneY
Cre-activabletoxin	geneN
Egr2	geneY
【GOLD_R】
【PRE_R】

During the postnatal period , this ablation leads to specific and progressive depletion of the somatotroph population , creating a novel model of early - onset isolated GH deficiency ( GHD ) .
【GOLD_E】
【PRE_E】
GH	geneY
【GOLD_R】
【PRE_R】

Mutant animals were subjected to a complete metabolic analysis , revealing atypical and expected features .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Consistent with an adult - onset isolated GHD model , mutant animals are hypoglycemic and display increased insulin sensitivity and glucose clearance .
【GOLD_E】
glucose	chem
insulin	geneN
【PRE_E】
insulin	geneY
glucose	chem
【GOLD_R】
【PRE_R】

This latter phenotype is in contrast to the glucose intolerance observed in another early - onset GHD model .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

Surprisingly , increased insulin sensitivity is not accompanied by a modified balance between fat and lean tissues , but by reduced metabolic adaptability between glucose and lipid oxidation conditions .
【GOLD_E】
glucose	chem
【PRE_E】
insulin	geneY
glucose	chem
【GOLD_R】
【PRE_R】

This suggests that the relationship between these metabolic features and insulin sensitivity should be reconsidered .
【GOLD_E】
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

In conclusion , our mutant may be a valuable genetic model with which to study the effects of long - term GH deficiency , in conditions of normal pancreatic function and unaffected balance between fat and glucose metabolism .
【GOLD_E】
glucose	chem
【PRE_E】
GH	geneY
glucose	chem
【GOLD_R】
【PRE_R】

The scintigraphic evaluation and genetic correlation of joint involvements in pediatric patients with familial Mediterranean fever .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Purpose : We aimed to evaluate the articular involvements in pediatric patients with familial Mediterranean fever ( FMF ) with joint symptoms by bone scintigraphy and to correlate the involved joints with the gene mutations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Materials and methods : A total of 41 newly diagnosed patients in pediatric age group ( 28 girls and 13 boys ; mean age 9.14 ± 2.91 years ) with joint involvement symptoms were included in this study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Scintigraphic images were obtained at 5th min ( blood pool or early phase ) and starting at 3 h ( late phase ) after ( after tracer injection ) intravenous administration of technetium - 99m ( 99mTc ) - methylendiphosphonate ( MDP ) .
【GOLD_E】
technetium-99m	chem
99mTc	chem
methylendiphosphonate	chem
MDP	chem
【PRE_E】
technetium-99m(99mTc)-methylendiphosphonate	chem
MDP	chem
【GOLD_R】
【PRE_R】

Genomic DNA was isolated from leukocytes using standard salting out procedure .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The sequencing data were analyzed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results : Of the 41 patients , arthritis was found in 21 ( 51.2 % ) patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Of the 21 patients , there was single joint involvement in 15 ( 71.4 % ) patients and multiple joint involvement in six ( 28.6 % ) patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mean age of patients with joint involvement ( 8 ± 2.3 years ) were considerably lower than the patients without joint involvement ( 10.35 ± 3.04 years ) , and this was statistically significant ( p = 0.008 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most commonly involved joints were ankles and knees .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Multiple joint involvements were most frequently observed in the M694V and M694I gene mutations ( 16.7 % ) .
【GOLD_E】
M694V	geneN
M694I	geneN
【PRE_E】
M694V	geneY
M694I	geneY
【GOLD_R】
【PRE_R】

Conclusions : We use and recommend the bone scintigraphy in patients with FMF to determine the presence and distribution of arthritis , since bone scintigraphy is inexpensive , noninvasive , easy - to - use , and also is more sensitive in the diagnosis and distribution of arthritis than conventional radiological methods and clinical examination .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Serotonin receptors of type 6 ( 5 - HT6 ) : from neuroscience to clinical pharmacology .
【GOLD_E】
Serotoninreceptors	geneN
5-HT6	geneY
Serotonin	chem
【PRE_E】
Serotoninreceptorsoftype6	geneY
5-HT6	chem
【GOLD_R】
【PRE_R】

The serotonin ( 5 - HT ) receptors of type 6 ( 5 - HT6 ) are quite different from all other 5 - HT receptors , as they include a short third cytoplasmatic loop and a long C - terminal tail , and one intron located in the middle of the third cytoplasmatic loop .
【GOLD_E】
5-HTreceptors	geneN
5-HT	chem
C	chem
serotonin	chem
5-HT	chem
5-HT6	geneY
serotonin(5-HT)receptors	geneN
【PRE_E】
serotonin(5-HT)receptors	geneN
5-HT6	geneY
5-HTreceptors	geneN
C	chem
【GOLD_R】
【PRE_R】

A lot of controversies still exist regarding their binding affinity , effects of 5 - HT6 ligands on brain catecholamines , behavioral syndromes regulated by them , and brain distribution .
【GOLD_E】
catecholamines	chem
5-HT6	geneY
【PRE_E】
5-HT6	chem
catecholamines	chem
【GOLD_R】
【PRE_R】

In spite of the lack of information on metabolic pattern of the various compounds , some of 5 - HT6 receptor ligands entered the clinical development as potential anti - dementia , antipsychotic , antidepressant and anti - obese drugs .
【GOLD_E】
5-HT6	geneY
【PRE_E】
5-HT6	geneY
【GOLD_R】
【PRE_R】

The present paper is a comprehensive review on the state of art of the 5 - HT6 receptors , while highlighting the potential clinical applications of 5 - HT6 receptor agonists / antagonists .
【GOLD_E】
5-HT6	geneY
5-HT6	geneY
【PRE_E】
5-HT6	geneY
5-HT6	geneY
【GOLD_R】
【PRE_R】

Expression of cAMP - responsive element binding proteins ( CREBs ) in fast - and slow - twitch muscles : A signaling pathway to account for the synaptic expression of collagen - tailed subunit ( ColQ ) of acetylcholinesterase at the rat neuromuscular junction .
【GOLD_E】
cAMP-responsiveelementbindingproteins	geneN
collagen-tailedsubunit	geneY
ColQ	geneY
acetylcholinesterase	geneY
CREBs	geneN
cAMP	chem
【PRE_E】
cAMP-responsiveelementbindingproteins	geneN
CREBs	geneN
collagen-tailedsubunit	geneN
ColQ	geneN
acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

The gene encoding the collagen - tailed subunit ( ColQ ) of acetylcholinesterase ( AChE ) contains two distinct promoters that drive the production of two ColQ mRNAs , ColQ - 1 and ColQ - 1a , in slow - and fast - twitch muscles , respectively .
【GOLD_E】
collagen-tailedsubunit	geneY
ColQ	geneY
acetylcholinesterase	geneY
AChE	geneY
ColQ	geneY
ColQ-1	geneY
ColQ-1a	geneY
【PRE_E】
collagen-tailedsubunit	geneN
ColQ	geneY
acetylcholinesterase	geneY
AChE	geneY
ColQ	geneN
ColQ-1	geneY
ColQ-1a	geneY
【GOLD_R】
【PRE_R】

ColQ - 1a is expressed at the neuromuscular junction ( NMJ ) in fast - twitch muscle , and this expression depends on trophic factors supplied by motor neurons signaling via a cAMP - dependent pathway in muscle .
【GOLD_E】
ColQ-1a	geneY
cAMP	chem
【PRE_E】
ColQ-1a	geneY
neuromuscularjunction	geneN
NMJ	geneN
cAMP	chem
【GOLD_R】
【PRE_R】

To further elucidate the molecular basis of ColQ - 1a 's synaptic expression , here we investigated the expression and localization of cAMP - responsive element binding protein ( CREB ) at the synaptic and extra - synaptic regions of fast - and slow - twitch muscles from adult rats .
【GOLD_E】
ColQ-1a's	geneY
cAMP-responsiveelementbindingprotein	geneN
CREB	geneN
cAMP	chem
【PRE_E】
ColQ	geneN
cAMP-responsiveelementbindingprotein	geneN
CREB	geneN
【GOLD_R】
【PRE_R】

The total amount of active , phosphorylated CREB ( P - CREB ) present in slow - twitch soleus muscle was higher than that in fast - twitch tibialis muscle , but P - CREB was predominantly expressed in the fast - twitch muscle at NMJs .
【GOLD_E】
phosphorylatedCREB	geneN
P-CREB	geneN
P-CREB	geneN
【PRE_E】
phosphorylatedCREB	geneN
P-CREB	geneN
P-CREB	geneN
【GOLD_R】
【PRE_R】

In contrast , P - CREB was detected in both synaptic and extra - synaptic regions of slow - twitch muscle .
【GOLD_E】
P-CREB	geneN
【PRE_E】
P-CREB	geneN
【GOLD_R】
【PRE_R】

These results reveal , for the first time , the differential distribution of P - CREB in fast - and slow - twitch muscles , which might support the crucial role of cAMP - dependent signaling in controlling the synapse - specific expression of ColQ - 1a in fast - twitch muscles .
【GOLD_E】
cAMP	chem
P-CREB	geneN
ColQ-1a	geneY
【PRE_E】
P-CREB	geneN
cAMP	chem
ColQ-1a	geneY
【GOLD_R】
【PRE_R】

Analysis of mammalian alcohol dehydrogenase 5 ( ADH5 ) : characterisation of rat ADH5 with comparisons to the corresponding human variant .
【GOLD_E】
mammalianalcoholdehydrogenase5	geneY
ADH5	geneY
ratADH5	geneY
alcohol	chem
【PRE_E】
mammalianalcoholdehydrogenase5	geneY
ADH5	geneY
ratADH5	geneY
【GOLD_R】
【PRE_R】

Alcohol dehydrogenase 5 ( ADH5 ) is a member of the mammalian alcohol dehydrogenase family of yet undefined functions .
【GOLD_E】
ADH5	geneY
mammalianalcoholdehydrogenase	geneN
Alcohol	chem
alcohol	chem
Alcoholdehydrogenase5	geneY
【PRE_E】
Alcoholdehydrogenase5	geneY
ADH5	geneY
mammalianalcoholdehydrogenase	geneN
【GOLD_R】
【PRE_R】

ADH5 was first identified at the DNA level in human and deer mouse .
【GOLD_E】
ADH5	geneY
【PRE_E】
ADH5	geneY
【GOLD_R】
【PRE_R】

A rat alcohol dehydrogenase structure of similar type has been isolated at the cDNA level using human ADH5 as a screening probe , where the rat cDNA structure displayed several atypical properties . mRNA for rat ADH5 was found in multiple tissues , especially in the kidney .
【GOLD_E】
ratalcoholdehydrogenase	geneN
humanADH5	geneY
ratADH5	geneY
alcohol	chem
【PRE_E】
ratalcoholdehydrogenase	geneY
humanADH5	geneY
ratADH5	geneY
【GOLD_R】
【PRE_R】

In vitro translation experiments indicated that rat ADH5 is expressed as efficiently as ADH1 and furthermore , rat ADH5 was readily expressed in COS cells fused to Green Fluorescent Protein .
【GOLD_E】
ratADH5	geneY
ADH1	geneY
ratADH5	geneY
【PRE_E】
ratADH5	geneY
ADH1	geneY
ratADH5	geneY
【GOLD_R】
【PRE_R】

However , no soluble ADH5 protein could be heterologously expressed in Escherichia coli cells with expression systems successfully used for other mammalian ADHs , including fused to glutathione - S - transferase .
【GOLD_E】
ADH5	geneY
mammalianADHs	geneN
glutathione	chem
S	chem
【PRE_E】
ADH5	geneY
mammalianADHs	geneN
glutathione-S-transferase	geneN
【GOLD_R】
【PRE_R】

Molecular modelling of the enzyme indicated that the protein does not fold in a productive way , which can be the explanation why no stable and active ADH5 has been isolated .
【GOLD_E】
ADH5	geneY
【PRE_E】
ADH5	geneY
【GOLD_R】
【PRE_R】

These results indicate that ADH5 , while readily expressed at the mRNA level , does not behave similarly to other mammalian ADHs investigated .
【GOLD_E】
mammalianADHs	geneN
ADH5	geneY
【PRE_E】
ADH5	geneY
mammalianADHs	geneN
【GOLD_R】
【PRE_R】

The results , in vitro and in silico , suggest an unstable ADH5 structure , which can explain for why no active and stable protein can be isolated .
【GOLD_E】
ADH5	geneY
【PRE_E】
ADH5	geneY
【GOLD_R】
【PRE_R】

Further possibilities are conceivable : the ADH5 protein may have to interact with a stabiliser , or the gene is actually a pseudogene .
【GOLD_E】
ADH5	geneY
【PRE_E】
ADH5	geneY
pseudogene	geneN
【GOLD_R】
【PRE_R】

Combining quantum mechanical ligand conformation analysis and protein modeling to elucidate GPCR - ligand binding modes .
【GOLD_E】
GPCR	geneN
【PRE_E】
GPCR	geneN
【GOLD_R】
【PRE_R】

SAR beyond protein - ligand interactions : By combining structure - affinity relationships , protein - ligand modeling studies , and quantum mechanical calculations , we show that ligand conformational energies and basicity play critical roles in ligand binding to the histamine H4 receptor , a GPCR that plays a key role in inflammation .
【GOLD_E】
histamine	chem
histamineH4receptor	geneY
GPCR	geneN
【PRE_E】
histamineH4receptor	geneN
GPCR	geneN
【GOLD_R】
【PRE_R】

Catalpol inhibits LPS plus IFN - γ - induced inflammatory response in astrocytes primary cultures .
【GOLD_E】
Catalpol	chem
IFN-γ	geneY
【PRE_E】
Catalpol	chem
IFN-γ	geneY
【GOLD_R】
Catalpol	IFN-γ	C4
【PRE_R】
Catalpol	IFN-γ	C4

A large body of evidence suggests that the inflammatory reaction plays an important role in the pathogenesis of neurodegenerative diseases .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our previous studies described the neuroprotective effects of catalpol in lipopolysaccharide ( LPS ) - induced inflammatory models , in which catalpol was shown to prevent mesencephalic neuron death and ameliorate cognitive ability animals .
【GOLD_E】
catalpol	chem
catalpol	chem
【PRE_E】
catalpol	chem
catalpol	chem
【GOLD_R】
【PRE_R】

To further investigate the protective effect and underlying mechanism of catalpol , astrocytes were pretreated with low ( 0.1mM ) and high dose ( 0.5mM ) catalpol for 1h prior to LPS plus interferon - γ stimulation .
【GOLD_E】
interferon-γ	geneY
catalpol	chem
catalpol	chem
【PRE_E】
catalpol	chem
catalpol	chem
interferon-γ	geneY
【GOLD_R】
【PRE_R】
catalpol	interferon-γ	C4

Biochemical analyses showed that NO and ROS production and iNOS activity were significantly reduced by catalpol .
【GOLD_E】
iNOS	geneY
NO	chem
catalpol	chem
【PRE_E】
NO	chem
iNOS	geneY
catalpol	chem
【GOLD_R】
catalpol	iNOS	C4
【PRE_R】
iNOS	catalpol	C4

Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation , such as iNOS , COX - 2 and TLR4 .
【GOLD_E】
iNOS	geneY
COX-2	geneY
TLR4	geneY
catalpol	chem
【PRE_E】
catalpol	chem
iNOS	geneY
COX-2	geneY
TLR4	geneY
【GOLD_R】
catalpol	iNOS	C4
catalpol	COX-2	C4
catalpol	TLR4	C4
【PRE_R】
catalpol	iNOS	C4
catalpol	COX-2	C4
catalpol	TLR4	C4

In addition , our exploration further revealed that the suppressive action of catalpol on inflammation was mediated via inhibiting nuclear factor - κB ( NF - κB ) activation .
【GOLD_E】
catalpol	chem
NF-κB	geneN
nuclearfactor-κB	geneN
【PRE_E】
catalpol	chem
nuclearfactor-κB	geneN
NF-κB	geneN
【GOLD_R】
catalpol	NF-κB	C4
catalpol	nuclearfactor-κB	C4
【PRE_R】
catalpol	nuclearfactor-κB	C4
catalpol	NF-κB	C4

Collectively , these results suggest that catalpol can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of NF - κB could be the major determinant for its anti - inflammatory mechanism .
【GOLD_E】
NF-κB	geneN
catalpol	chem
【PRE_E】
catalpol	chem
NF-κB	geneN
【GOLD_R】
catalpol	NF-κB	C4
【PRE_R】
catalpol	NF-κB	C4

Therefore , catalpol may potentially be a highly effective therapeutic agent in treating neurodegenerative diseases associated with inflammation .
【GOLD_E】
catalpol	chem
【PRE_E】
catalpol	chem
【GOLD_R】
【PRE_R】

Cardiolipin - dependent reconstitution of respiratory supercomplexes from purified Saccharomyces cerevisiae complexes III and IV .
【GOLD_E】
Cardiolipin	chem
【PRE_E】
Cardiolipin	chem
【GOLD_R】
【PRE_R】

Here , we report for the first time in vitro reconstitution of the respiratory supercomplexes from individual complexes III and IV .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Complexes III and IV were purified from Saccharomyces cerevisiae mitochondria .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Complex III contained eight molecules of cardiolipin , and complex IV contained two molecules of cardiolipin , as determined by electrospray ionization - mass spectrometry .
【GOLD_E】
cardiolipin	chem
cardiolipin	chem
【PRE_E】
cardiolipin	chem
complexIV	geneN
cardiolipin	chem
【GOLD_R】
【PRE_R】

Complex IV also contained Rcf1p .
【GOLD_E】
Rcf1p	geneY
【PRE_E】
ComplexIV	geneN
【GOLD_R】
【PRE_R】

No supercomplexes were formed upon mixing of the purified complexes , and low amounts of the supercomplex trimer III ( 2 ) IV ( 1 ) were formed after reconstitution into proteoliposomes containing only phosphatidylcholine and phosphatidylethanolamine .
【GOLD_E】
phosphatidylcholine	chem
phosphatidylethanolamine	chem
【PRE_E】
supercomplextrimerIII(2)IV(1)	geneN
phosphatidylcholine	chem
phosphatidylethanolamine	chem
【GOLD_R】
【PRE_R】

Further addition of cardiolipin to the proteoliposome reconstitution mixture resulted in distinct formation of both the III ( 2 ) IV ( 1 ) supercomplex trimer and III ( 2 ) IV ( 2 ) supercomplex tetramer .
【GOLD_E】
【PRE_E】
cardiolipin	chem
III(2)IV(1)supercomplextrimerandIII(2)IV(2)supercomplex	geneN
【GOLD_R】
【PRE_R】

No other anionic phospholipid was as effective as cardiolipin in supporting tetramer formation .
【GOLD_E】
cardiolipin	chem
【PRE_E】
cardiolipin	chem
【GOLD_R】
【PRE_R】

Phospholipase treatment of complex IV prevented trimer formation in the absence of cardiolipin .
【GOLD_E】
Phospholipase	geneN
cardiolipin	chem
【PRE_E】
Phospholipase	geneN
complexIV	geneN
【GOLD_R】
【PRE_R】

Both trimer and tetramer formations were restored by cardiolipin .
【GOLD_E】
cardiolipin	chem
【PRE_E】
cardiolipin	chem
【GOLD_R】
【PRE_R】

Analysis of the reconstituted tetramer by single particle electron microscopy confirmed native organization of individual complexes within the supercomplex .
【GOLD_E】
【PRE_E】
supercomplex	geneN
【GOLD_R】
【PRE_R】

In conclusion , although some trimer formation occurred dependent only on tightly bound cardiolipin , tetramer formation required additional cardiolipin .
【GOLD_E】
cardiolipin	chem
cardiolipin	chem
【PRE_E】
cardiolipin	chem
【GOLD_R】
【PRE_R】

This is consistent with the high cardiolipin content in the native tetramer .
【GOLD_E】
cardiolipin	chem
【PRE_E】
cardiolipin	chem
【GOLD_R】
【PRE_R】

The dependence on cardiolipin for supercomplex formation suggests that changes in cardiolipin levels resulting from changes in physiological conditions may control the equilibrium between individual respiratory complexes and supercomplexes in vivo .
【GOLD_E】
cardiolipin	chem
cardiolipin	chem
【PRE_E】
cardiolipin	chem
supercomplex	geneN
【GOLD_R】
【PRE_R】

Protein tyrosine phosphatase 1B inhibitory effect by dammarane - type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins .
【GOLD_E】
Proteintyrosinephosphatase1B	geneY
saponins	chem
dammarane	chem
triterpenes	chem
tyrosine	chem
【PRE_E】
Proteintyrosinephosphatase1B	geneY
dammarane-typetriterpenes	chem
Gynostemmapentaphyllumsaponins	chem
【GOLD_R】
saponins	Proteintyrosinephosphatase1B	C4
dammarane	Proteintyrosinephosphatase1B	C4
triterpenes	Proteintyrosinephosphatase1B	C4
【PRE_R】

Protein tyrosine phosphatase 1B ( PTP1B ) is an important factor in non - insulin - dependent diabetes mellitus ( type - 2 diabetes ) , and a promising target for treatment of diabetes and obesity .
【GOLD_E】
insulin	geneY
tyrosine	chem
Proteintyrosinephosphatase1B	geneY
PTP1B	geneY
【PRE_E】
Proteintyrosinephosphatase1B	geneY
PTP1B	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Therefore , the aim of this study is to investigate the inhibitory activities of constituents ( three new together with twelve known triterpenes compounds ) isolated from the hydrolyzate of total saponins from Gynostemma pentaphyllum .
【GOLD_E】
triterpenes	chem
saponins	chem
【PRE_E】
triterpenes	chem
hydrolyzate	chem
saponins	chem
Gynostemmapentaphyllum	chem
【GOLD_R】
【PRE_R】

Their structures were accomplished mainly base on the spectroscopic methods , and then were further confirmed by X - ray crystal diffraction .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All the compounds were evaluated for inhibitory activity against PTP1B .
【GOLD_E】
PTP1B	geneY
【PRE_E】
PTP1B	geneY
【GOLD_R】
【PRE_R】

Current data suggested that the compounds 1 , 3 , 12 , 13 and 14 were considered to be potential as antidiabetic agents , in which they could significantly inhibit the PTP1B enzyme activity in a dose - dependent manner .
【GOLD_E】
PTP1B	geneY
【PRE_E】
PTP1B	geneY
【GOLD_R】
【PRE_R】

Disrupted cytoskeletal homeostasis , astrogliosis and apoptotic cell death in the cerebellum of preweaning rats injected with diphenyl ditelluride .
【GOLD_E】
diphenylditelluride	chem
【PRE_E】
diphenylditelluride	chem
【GOLD_R】
【PRE_R】

In the present report 15 day - old rats were injected with 0.3μmol of diphenyl ditelluride ( PhTe ) ( 2 ) / kg body weight and parameters of neurodegeneration were analyzed in slices from cerebellum 3 and 6 days afterwards .
【GOLD_E】
(PhTe)(2)	chem
diphenylditelluride	chem
【PRE_E】
diphenylditelluride	chem
PhTe	chem
【GOLD_R】
【PRE_R】

The earlier responses , at day 3 after injection , included hyperphosphorylation of intermediate filament ( IF ) proteins from astrocyte ( glial fibrillary acidic protein - GFAP - and vimentin ) and neuron ( low - , medium - and high molecular weight neurofilament subunits : NF - L , NF - M and NF - H ) ; increased mitogen - activated protein kinase ( MAPK ) ( Erk and p38MAPK ) and cAMP - dependent protein kinase ( PKA ) activities .
【GOLD_E】
glialfibrillaryacidicprotein	geneY
GFAP	geneY
vimentin	geneY
low-,medium-andhighmolecularweightneurofilamentsubunits	geneN
NF-L	geneY
NF-M	geneY
NF-H	geneY
mitogen-activatedproteinkinase	geneN
MAPK	geneN
Erk	geneN
p38MAPK	geneN
cAMP-dependentproteinkinase	geneN
PKA	geneN
cAMP	chem
【PRE_E】
glialfibrillaryacidicprotein	geneY
GFAP	geneY
vimentin	geneN
NF-L	geneN
NF-M	geneY
NF-H	geneY
mitogen-activatedproteinkinase	geneN
MAPK	geneN
Erk	geneN
p38MAPK	geneN
cAMP-dependentproteinkinase	geneN
PKA	geneN
【GOLD_R】
【PRE_R】

Also , reactive astrogliosis takes part of the early responses to the insult with ( PhTe ) ( 2 ) , evidenced by upregulated GFAP in Western blot , PCR and immunofluorescence analysis .
【GOLD_E】
(PhTe)(2)	chem
GFAP	geneY
【PRE_E】
PhTe)(2)	chem
GFAP	geneY
【GOLD_R】
(PhTe)(2)	GFAP	C3
【PRE_R】
PhTe)(2)	GFAP	C3

Six days after ( PhTe ) ( 2 ) injection we found persistent astrogliosis , increased propidium iodide ( PI ) positive cells in NeuN positive population evidenced by flow cytometry and reduced immunofluorescence for NeuN , suggesting that the in vivo exposure to ( PhTe ) ( 2 ) progressed to neuronal death .
【GOLD_E】
(PhTe)(2)	chem
propidiumiodide	chem
NeuN	geneY
(PhTe)(2)	chem
NeuN	geneY
【PRE_E】
PhTe)(2)	chem
propidiumiodide	chem
PI	chem
PhTe)(2)	chem
【GOLD_R】
(PhTe)(2)	NeuN	C4
【PRE_R】

Moreover , activated caspase 3 suggested apoptotic neuronal death .
【GOLD_E】
caspase3	geneY
【PRE_E】
caspase3	geneY
【GOLD_R】
【PRE_R】

Neurodegeneration was related with decreased [ ( 3 ) H ] glutamate uptake and decreased Akt immunoreactivity , however phospho - GSK - 3 - β ( Ser9 ) was not altered in ( PhTe ) ( 2 ) injected rat .
【GOLD_E】
Akt	geneN
phospho-GSK-3-β	geneY
[(3)H]glutamate	chem
Ser	chem
(PhTe)(2)	chem
【PRE_E】
[(3)H]glutamate	chem
Akt	geneN
phospho-GSK-3-β	geneY
Ser9	geneY
PhTe)(2)	chem
【GOLD_R】
(PhTe)(2)	Akt	C4
【PRE_R】
Akt	PhTe)(2)	C3
phospho-GSK-3-β	PhTe)(2)	C3

Therefore , the present results show that the earlier cerebellar responses to ( PhTe ) ( 2 ) include disruption of cytoskeletal homeostasis that could be related with MAPK and PKA activation and reactive astrogliosis .
【GOLD_E】
MAPK	geneN
PKA	geneN
(PhTe)(2)	chem
【PRE_E】
PhTe)(2)	chem
MAPK	geneN
PKA	geneN
【GOLD_R】
(PhTe)(2)	MAPK	C3
(PhTe)(2)	PKA	C3
【PRE_R】

Akt inhibition observed at this time could also play a role in the neuronal death evidenced afterwards .
【GOLD_E】
Akt	geneN
【PRE_E】
Akt	geneN
【GOLD_R】
【PRE_R】

The later events of the neurodegenerative process are characterized by persistent astrogliosis and activation of apoptotic neuronal death through caspase 3 mediated mechanisms , which could be related with glutamate excitotoxicity .
【GOLD_E】
caspase3	geneY
glutamate	chem
【PRE_E】
caspase3	geneY
glutamate	chem
【GOLD_R】
【PRE_R】

The progression of these responses are therefore likely to be critical for the outcome of the neurodegeneration provoked by ( PhTe ) ( 2 ) in rat cerebellum .
【GOLD_E】
(PhTe)(2)	chem
【PRE_E】
PhTe)(2)	chem
【GOLD_R】
【PRE_R】

The presence of D - fagomine in the human diet from buckwheat - based foodstuffs .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

Buckwheat ( Fagopyrum esculentum Moench ) groats contain the iminosugar D - fagomine as a minor component that might contribute to the alleged health benefits of this pseudo - cereal .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

This study presents analysis of D - fagomine in buckwheat - based foodstuffs by liquid chromatography coupled to mass spectrometry and an estimation of its presence in the human diet based on a published population - based cross - sectional nutrition survey .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

D - fagomine is present in common buckwheat - based foodstuffs in amounts ranging from 1 to 25 mg / kg or mg / L , it is stable during boiling , baking , frying and fermentation , and it is biosynthesised upon sprouting .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

The estimated total intake of D - fagomine resulting from a diet that includes such foodstuffs would be between 3 and 17 mg per day ( mean for both genders ; range from P5 to P95 ) .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

A diet rich in buckwheat products would provide a daily amount of D - fagomine that may in part explain the beneficial properties traditionally attributed to buckwheat consumption .
【GOLD_E】
D-fagomine	chem
【PRE_E】
D-fagomine	chem
【GOLD_R】
【PRE_R】

Profluorogenic reductase substrate for rapid , selective , and sensitive visualization and detection of human cancer cells that overexpress NQO1 .
【GOLD_E】
NQO1	geneY
【PRE_E】
Profluorogenicreductase	geneY
NQO1	geneY
【GOLD_R】
【PRE_R】

Achieving the vision of identifying and quantifying cancer - related events and targets for future personalized oncology is predicated on the existence of synthetically accessible and economically viable probe molecules fully able to report the presence of these events and targets in a rapid and highly selective and sensitive fashion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Delineated here are the design and evaluation of a newly synthesized turn - on probe whose intense fluorescent reporter signature is revealed only through probe activation by a specific intracellular enzyme present in tumor cells of multiple origins .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Quenching of molecular probe fluorescence is achieved through unique photoinduced electron transfer between the naphthalimide dye reporter and a covalently attached , quinone - based enzyme substrate .
【GOLD_E】
naphthalimide	chem
quinone	chem
【PRE_E】
naphthalimide	chem
quinone	chem
【GOLD_R】
【PRE_R】

Fluorescence of the reporter dye is turned on by rapid removal of the quinone quencher , an event that immediately occurs only after highly selective , two - electron reduction of the sterically and conformationally restricted quinone substrate by the cancer - associated human NAD ( P ) H : quinone oxidoreductase isozyme 1 ( hNQO1 ) .
【GOLD_E】
quinone	chem
quinone	chem
quinone	chem
humanNAD(P)H:quinoneoxidoreductaseisozyme1	geneY
hNQO1	geneY
【PRE_E】
quinone	chem
quinone	chem
humanNAD(P)H:quinoneoxidoreductaseisozyme1	geneY
hNQO1	geneY
【GOLD_R】
quinone	humanNAD(P)H:quinoneoxidoreductaseisozyme1	C9
quinone	hNQO1	C9
【PRE_R】
quinone	hNQO1	C9
quinone	hNQO1	C9

Successes of the approach include rapid differentiation of NQO1 - expressing and - nonexpressing cancer cell lines via the unaided eye , flow cytometry , fluorescence imaging , and two - photon microscopy .
【GOLD_E】
NQO1	geneY
【PRE_E】
NQO1	geneY
【GOLD_R】
【PRE_R】

The potential for use of the turn - on probe in longer - term cellular studies is indicated by its lack of influence on cell viability and its in vitro stability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synthesis , biological evaluation , and molecular modeling of glycyrrhizin derivatives as potent high - mobility group box - 1 inhibitors with anti - heart - failure activity in vivo .
【GOLD_E】
high-mobilitygroupbox-1	geneY
glycyrrhizin	chem
【PRE_E】
glycyrrhizin	chem
box-1	geneY
【GOLD_R】
glycyrrhizin	high-mobilitygroupbox-1	C4
【PRE_R】
glycyrrhizin	box-1	C4

Novel glycyrrhizin ( GL ) derivatives were designed and synthesized by introducing various amine or amino acid residues into the carbohydrate chain and at C - 30 .
【GOLD_E】
carbohydrate	chem
glycyrrhizin	chem
amine	chem
aminoacid	chem
【PRE_E】
glycyrrhizin	chem
GL	chem
amine	chem
aminoacid	chem
carbohydrate	chem
【GOLD_R】
【PRE_R】

Their inhibitory effects on high - mobility group box 1 ( HMGB1 ) were evaluated using a cell - based lipopolysaccharide ( LPS ) induced tumor necrosis factor α ( TNF - α ) release study .
【GOLD_E】
high-mobilitygroupbox1	geneY
HMGB1	geneY
tumornecrosisfactorα	geneY
TNF-α	geneY
【PRE_E】
high-mobilitygroupbox1	geneY
HMGB1	geneY
tumornecrosisfactorα	geneY
TNF-α	geneY
【GOLD_R】
【PRE_R】

Compounds 10 , 12 , 18 - 20 , 23 , and 24 , which had substituents introduced at C - 30 , demonstrated moderate HMGB1 inhibition with ED₅₀ values ranging from 337 to 141 μM , which are values comparable to that of the leading GL compound ( 1 ) ( ED₅₀ = 70 μM ) .
【GOLD_E】
HMGB1	geneY
【PRE_E】
HMGB1	geneY
【GOLD_R】
【PRE_R】

Compounds 23 and 24 emerged as novel and interesting HMGB1 inhibitors .
【GOLD_E】
HMGB1	geneY
【PRE_E】
HMGB1	geneY
【GOLD_R】
【PRE_R】

These compounds were able to extend the survival of mice with chronic heart failure ( CHF ) and acute heart failure ( AHF ) , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , molecular modeling studies were performed to support the biological data .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Further exploration of M₁ allosteric agonists : subtle structural changes abolish M₁ allosteric agonism and result in pan - mAChR orthosteric antagonism .
【GOLD_E】
mAChR	geneN
【PRE_E】
M₁	geneY
M₁	geneY
mAChR	geneY
【GOLD_R】
【PRE_R】

This letter describes the further exploration of two series of M ( 1 ) allosteric agonists , TBPB and VU0357017 , previously reported from our lab .
【GOLD_E】
TBPB	chem
VU0357017	chem
【PRE_E】
M(1)	chem
TBPB	geneN
VU0357017	geneY
【GOLD_R】
【PRE_R】

Within the TPBP scaffold , either electronic or steric perturbations to the central piperidine ring led to a loss of selective M ( 1 ) allosteric agonism and afforded pan - mAChR antagonism , which was demonstrated to be mediated via the orthosteric site .
【GOLD_E】
TPBP	chem
piperidine	chem
mAChR	geneN
【PRE_E】
TPBP	chem
piperidine	chem
pan-mAChR	geneN
【GOLD_R】
TPBP	mAChR	C6
piperidine	mAChR	C6
【PRE_R】

Additional SAR around a related M ( 1 ) allosteric agonist family ( VU0357017 ) identified similar , subtle ' molecular switches ' that modulated modes of pharmacology from allosteric agonism to pan - mAChR orthosteric antagonism .
【GOLD_E】
VU0357017	chem
mAChR	geneN
【PRE_E】
mAChR	geneY
【GOLD_R】
VU0357017	mAChR	C6
【PRE_R】

Therefore , all of these ligands are best classified as bi - topic ligands that possess high affinity binding at an allosteric site to engender selective M ( 1 ) activation , but all bind , at higher concentrations , to the orthosteric ACh site , leading to non - selective orthosteric site binding and mAChR antagonism .
【GOLD_E】
mAChR	geneN
【PRE_E】
M(1)	geneY
ACh	chem
mAChR	geneY
【GOLD_R】
【PRE_R】

Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite , 9 - hydroxyrisperidone in rats .
【GOLD_E】
9-hydroxyrisperidone	chem
risperidone	chem
【PRE_E】
silymarin	chem
risperidone	chem
9-hydroxyrisperidone	chem
【GOLD_R】
【PRE_R】

1 . The interactions between herbal dietary supplements and therapeutic drugs have emerged as an important issue and P - glycoprotein ( P - gp ) has been reported as one of the significant factors of these interactions .
【GOLD_E】
-glycoprotein(	geneY
-gp)	geneY
【PRE_E】
P-glycoprotein	geneN
P-gp	geneN
【GOLD_R】
【PRE_R】

2 . The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a P - gp substrate , risperidone , and its major metabolite , 9 - hydroxyrisperidone , in rats .
【GOLD_E】
-gps	geneY
isperidone,	chem
-hydroxyrisperidone,	chem
【PRE_E】
silymarin	chem
P-gp	geneN
risperidone	chem
9-hydroxyrisperidone	chem
【GOLD_R】
isperidone,	-gps	C9
-hydroxyrisperidone,	-gps	C9
【PRE_R】

3 . To determine the plasma levels of risperidone and 9 - hydroxyrisperidone in rats , a HPLC method was developed using a liquid - liquid acid back extraction .
【GOLD_E】
isperidonea	chem
-hydroxyrisperidonei	chem
【PRE_E】
risperidone	chem
9-hydroxyrisperidone	chem
【GOLD_R】
【PRE_R】

When risperidone ( 6 mg / kg ) was co - administered with silymarin ( 40 mg / kg ) to rats orally , the C ( max ) of 9 - hydroxyrisperidone was significantly increased to1.3 - fold ( p < 0.05 ) , while the other pharmacokinetic parameters did not show any significant differences .
【GOLD_E】
risperidone	chem
hydroxyrisperidonewa	chem
【PRE_E】
risperidone	chem
silymarin	chem
9-hydroxyrisperidone	chem
【GOLD_R】
【PRE_R】

Expanding the experiment where rats were repeatedly administered with silymarin for 5 days prior to giving risperidone , the C ( max ) of risperidone and 9 - hydroxyrisperidone were significantly increased to 2.4 - fold ( p < 0.001 ) and 1.7 - fold ( p < 0.001 ) , respectively , and the AUC ( 0 - t ) , as well to 1.7 - fold ( p < 0.05 ) and 2.1 - fold ( p < 0.01 ) , respectively .
【GOLD_E】
risperidone	chem
risperidone	chem
9-hydroxyrisperidone	chem
【PRE_E】
silymarin	chem
risperidone	chem
risperidone	chem
9-hydroxyrisperidone	chem
【GOLD_R】
【PRE_R】

4 . The repeated exposures of silymarin , compared to single administration of silymarin , increased oral bioavailability and affected the pharmacokinetics of risperidone and 9 - hydroxyrisperidone , by inhibiting P - gp .
【GOLD_E】
-gp.	geneY
isperidonea	chem
-hydroxyrisperidone,	chem
【PRE_E】
silymarin	chem
silymarin	chem
risperidone	chem
9-hydroxyrisperidone	chem
P-gp	geneN
【GOLD_R】
【PRE_R】
silymarin	P-gp	C4
silymarin	P-gp	C4
risperidone	P-gp	C4
9-hydroxyrisperidone	P-gp	C4

Design , synthesis and structure - activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2 .
【GOLD_E】
proline	chem
argininevasopressin	chem
argininevasopressin	geneY
【PRE_E】
argininevasopressin	geneY
proline	chem
【GOLD_R】
【PRE_R】

In this study , we present the synthesis and pharmacological properties of new analogues of arginine vasopressin modified in the N - terminal part of the molecule with proline derivatives : indoline - 2 - carboxylic acid ( Ica ) and ( 2S,4R ) - 4 - ( naphthalene - 2 - ylmethyl ) pyrrolidine - 2 - carboxylic acid .
【GOLD_E】
argininevasopressin	chem
argininevasopressin	geneY
N	chem
proline	chem
indoline-2-carboxylicacid	chem
Ica	chem
(2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylicacid	chem
【PRE_E】
argininevasopressin	geneY
N	chem
proline	chem
indoline-2-carboxylicacid	chem
(2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylicacid	chem
【GOLD_R】
【PRE_R】

All the peptides were tested for pressor , antidiuretic and in vitro uterotonic activities .
【GOLD_E】
【PRE_E】
antidiuretic	chem
【GOLD_R】
【PRE_R】

We also determined their binding affinity to the human oxytocin receptor .
【GOLD_E】
humanoxytocinreceptor	geneY
oxytocin	chem
【PRE_E】
humanoxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

The Ica ( 2 ) substitution resulted in two moderately potent and selective antioxytocic agents : [ Mpa ( 1 ) , Ica ( 2 ) , D - Arg ( 8 ) ] VP and [ Mpa ( 1 ) , Ica ( 2 ) , Val ( 4 ) , D - Arg ( 8 ) ] VP ( pA ( 2 ) = 7.09 and 7.50 , respectively ) .
【GOLD_E】
Ica	chem
[Mpa(1),Ica(2),D-Arg(8)]VP	chem
[Mpa(1),Ica(2),Val(4),D-Arg(8)]VP	chem
【PRE_E】
Ica(2)	chem
antioxytocic	chem
D-Arg(8)]VP	chem
Val	chem
D-Arg(8)]VP	chem
【GOLD_R】
【PRE_R】

On the other hand , peptides modified with ( 2S,4R ) - 4 - ( naphthalene - 2 - ylmethyl ) pyrrolidine - 2 - carboxylic acid , apart from their moderate antioxytocic activity , turned out to be weak antagonists of the pressor response to arginine vasopressin .
【GOLD_E】
(2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylicacid	chem
argininevasopressin	chem
argininevasopressin	geneY
【PRE_E】
(2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylicacid	chem
antioxytocic	chem
argininevasopressin	geneY
【GOLD_R】
(2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylicacid	argininevasopressin	C6
【PRE_R】

The results of this study provide useful information about the structure - activity relationship of arginine vasopressin analogues and can help to design compounds with desired biological properties .
【GOLD_E】
argininevasopressin	chem
argininevasopressin	geneY
【PRE_E】
argininevasopressin	geneY
【GOLD_R】
【PRE_R】

Liver X Receptors and female reproduction : when cholesterol meets fertility !
【GOLD_E】
cholesterol	chem
LiverXReceptors	geneN
【PRE_E】
LiverXReceptors	geneY
cholesterol	chem
【GOLD_R】
【PRE_R】

The role of cholesterol in female reproductive physiology has been suspected for a long time , while the molecular bases were unknown .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
【GOLD_R】
【PRE_R】

Cholesterol is the precursor of ovarian steroid biosynthesis and is also essential for fertility .
【GOLD_E】
Cholesterol	chem
steroid	chem
【PRE_E】
Cholesterol	chem
steroid	chem
【GOLD_R】
【PRE_R】

In the uterus , cholesterol is essential to achieve correct contractions at term , but an excessive uterine cholesterol concentration has been associated with contractility defects .
【GOLD_E】
cholesterol	chem
cholesterol	chem
【PRE_E】
cholesterol	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

Liver X Receptor ( LXR ) α and LXR β are nuclear receptors activated by oxysterols , oxidized derivatives of cholesterol .
【GOLD_E】
LiverXReceptor(LXR)α	geneY
LXRβ	geneY
oxysterols	chem
cholesterol	chem
【PRE_E】
LiverXReceptor(LXR)α	geneY
LXRβ	geneY
nuclearreceptors	geneN
oxysterols	chem
cholesterol	chem
【GOLD_R】
oxysterols	LiverXReceptor(LXR)α	C3
oxysterols	LXRβ	C3
【PRE_R】

Since their discovery , the role of LXR in the control of cholesterol homeostasis has been widely described .
【GOLD_E】
LXR	geneN
cholesterol	chem
【PRE_E】
LXR	geneY
cholesterol	chem
【GOLD_R】
【PRE_R】

Beyond their cholesterol - lowering role , more recent data have linked these nuclear receptors to various physiological processes .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
nuclearreceptors	geneN
【GOLD_R】
【PRE_R】

In particular , they control ovarian endocrine and exocrine functions , as well as uterine contractility .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Their contribution to female reproductive cancers will also be discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This review will try to enlighten on the LXR as a molecular link between dietary cholesterol and reproductive diseases in women .
【GOLD_E】
LXR	geneN
cholesterol	chem
【PRE_E】
LXR	geneY
cholesterol	chem
【GOLD_R】
【PRE_R】

In the future , a better comprehension of the various physiological processes regulated by the LXR will help to develop new ligands to prevent or to cure these pathologies in women .
【GOLD_E】
LXR	geneN
【PRE_E】
LXR	geneY
【GOLD_R】
【PRE_R】

β - catenin regulates GnRH - induced FSHβ gene expression .
【GOLD_E】
GnRH	chem
β-catenin	geneY
GnRH	geneY
FSHβ	geneY
【PRE_E】
β-catenin	geneY
GnRH	geneY
FSHβ	geneY
【GOLD_R】
GnRH	FSHβ	C3
【PRE_R】

The regulation of gonadotropin synthesis by GnRH plays an essential role in the neuroendocrine control of reproduction .
【GOLD_E】
gonadotropin	geneN
GnRH	geneY
GnRH	chem
【PRE_E】
gonadotropin	geneN
GnRH	geneY
【GOLD_R】
【PRE_R】

The known signaling mechanisms involved in gonadotropin synthesis have been expanding .
【GOLD_E】
gonadotropin	geneN
【PRE_E】
gonadotropin	geneN
【GOLD_R】
【PRE_R】

For example , involvement of β - catenin in LHβ induction by GnRH has been discovered .
【GOLD_E】
β-catenin	geneY
GnRH	geneY
GnRH	chem
【PRE_E】
β-catenin	geneY
LHβ	geneY
GnRH	geneY
【GOLD_R】
【PRE_R】

We examined the role of β - catenin in FSHβ gene expression in LβT2 gonadotrope cells .
【GOLD_E】
β-catenin	geneY
FSHβ	geneY
【PRE_E】
β-catenin	geneY
FSHβ	geneY
【GOLD_R】
【PRE_R】

GnRH caused a sustained increase in nuclear β - catenin levels , which was significantly reduced by c - Jun N - terminal kinase ( JNK ) inhibition .
【GOLD_E】
GnRH	geneY
β-catenin	geneY
c-JunN-terminalkinase	geneN
JNK	geneN
GnRH	chem
N	chem
【PRE_E】
GnRH	geneY
β-catenin	geneY
c-JunN-terminalkinase	geneN
JNK	geneN
【GOLD_R】
GnRH	β-catenin	C3
【PRE_R】

Small interfering RNA - mediated knockdown of β - catenin mRNA demonstrated that induction of FSHβ mRNA by GnRH depended on β - catenin and that regulation of FSHβ by β - catenin occurred independently of the JNK - c - jun pathway .
【GOLD_E】
β-catenin	geneY
FSHβ	geneY
GnRH	geneY
β-catenin	geneY
FSHβ	geneY
β-catenin	geneY
JNK	geneN
c-jun	geneY
GnRH	chem
【PRE_E】
β-catenin	geneY
FSHβ	geneY
GnRH	geneY
β-catenin	geneY
FSHβ	geneY
β-catenin	geneY
JNK	geneN
c-jun	geneN
【GOLD_R】
GnRH	FSHβ	C3
【PRE_R】

β - Catenin depletion had no impact on FSHβ mRNA stability .
【GOLD_E】
β-Catenin	geneY
FSHβ	geneY
【PRE_E】
β-Catenin	geneY
FSHβ	geneY
【GOLD_R】
【PRE_R】

In LβT2 cells transfected with FSHβ promoter luciferase fusion constructs , GnRH responsiveness was conferred by the proximal promoter ( - 944 / - 1 ) and was markedly decreased by β - catenin knockdown .
【GOLD_E】
FSHβpromoter	geneN
GnRH	geneY
β-catenin	geneY
GnRH	chem
【PRE_E】
FSHβpromoter	geneN
GnRH	geneY
β-catenin	geneY
【GOLD_R】
【PRE_R】

However , none of the T - cell factor / lymphoid enhancer factor binding sites in that region were required for promoter activation by GnRH .
【GOLD_E】
T-cellfactor/lymphoidenhancerfactorbindingsites	geneN
GnRH	geneY
GnRH	chem
【PRE_E】
T-cellfactor	geneN
lymphoidenhancerfactor	geneN
GnRH	geneY
【GOLD_R】
【PRE_R】

Chromatin immunoprecipitation further corroborated the absence of direct interaction between β - catenin and the 1.8 - kb FSHβ promoter .
【GOLD_E】
β-catenin	geneY
FSHβpromoter	geneN
【PRE_E】
β-catenin	geneY
1.8-kbFSHβpromoter	geneN
【GOLD_R】
【PRE_R】

To elucidate the mechanism for the β - catenin effect , we analyzed approximately 1 billion reads of next - generation RNA sequencing β - catenin knockdown assays and selected the nuclear cofactor breast cancer metastasis - suppressor 1 - like ( Brms1L ) as one candidate for further study .
【GOLD_E】
β-catenin	geneY
β-catenin	geneY
breastcancermetastasis-suppressor1-like	geneY
Brms1L	geneY
【PRE_E】
β-catenin	geneY
β-catenin	geneY
breastcancermetastasis-suppressor1-like	geneY
Brms1L	geneY
【GOLD_R】
【PRE_R】

Subsequent experiments confirmed that Brms1L mRNA expression was decreased by β - catenin knockdown as well as by JNK inhibition .
【GOLD_E】
Brms1L	geneY
β-catenin	geneY
JNK	geneN
【PRE_E】
Brms1L	geneY
β-catenin	geneY
JNK	geneN
【GOLD_R】
【PRE_R】

Furthermore , knockdown of Brms1L significantly attenuated GnRH - induced FSHβ expression .
【GOLD_E】
Brms1L	geneY
GnRH	geneY
FSHβ	geneY
GnRH	chem
【PRE_E】
Brms1L	geneY
GnRH	geneY
FSHβ	geneY
【GOLD_R】
GnRH	FSHβ	C3
【PRE_R】

Thus , our findings indicate that the expression of Brms1L depends on β - catenin activity and contributes to FSHβ induction by GnRH .
【GOLD_E】
Brms1L	geneY
β-catenin	geneY
FSHβ	geneY
GnRH	geneY
GnRH	chem
【PRE_E】
Brms1L	geneY
β-catenin	geneY
FSHβ	geneY
GnRH	geneY
【GOLD_R】
GnRH	FSHβ	C3
【PRE_R】

Doxorubicin decreases paraquat accumulation and toxicity in Caco - 2 cells .
【GOLD_E】
Doxorubicin	chem
paraquat	chem
【PRE_E】
Doxorubicin	chem
paraquat	chem
【GOLD_R】
【PRE_R】

P - glycoprotein ( P - gp ) is an efflux pump belonging to the ATP - binding cassette transporter superfamily expressed in several organs .
【GOLD_E】
ATP	chem
P-glycoprotein	geneN
P-gp	geneN
effluxpump	geneN
ATP-bindingcassettetransporter	geneN
【PRE_E】
P-glycoprotein	geneN
P-gp	geneN
ATP-bindingcassettetransporter	geneN
【GOLD_R】
【PRE_R】

Considering its potential protective effects , the induction of de novo synthesis of P - gp could be used therapeutically in the treatment of intoxications by its substrates .
【GOLD_E】
P-gp	geneN
【PRE_E】
P-gp	geneN
【GOLD_R】
【PRE_R】

The herbicide paraquat ( PQ ) is a P - gp substrate responsible for thousands of fatal intoxications worldwide that still lacks an effective antidote .
【GOLD_E】
P-gp	geneN
paraquat	chem
【PRE_E】
paraquat	chem
PQ	chem
P-gp	geneN
【GOLD_R】
paraquat	P-gp	C9
【PRE_R】
paraquat	P-gp	C9

The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether doxorubicin ( DOX ) , a known P - gp inducer , could efficiently protect Caco - 2 cells against PQ cytotoxicity , 6 h after the incubation with the herbicide , reflecting a real - life intoxication scenario .
【GOLD_E】
P-gp	geneN
doxorubicin	chem
DOX	chem
【PRE_E】
doxorubicin	chem
DOX	chem
P-gp	geneN
PQ	chem
【GOLD_R】
doxorubicin	P-gp	C3
DOX	P-gp	C3
【PRE_R】

Cytotoxicity was evaluated by the MTT assay and PQ intracellular concentrations were measured by gas chromatography - ion trap - mass spectrometry ( GC - IT - MS ) .
【GOLD_E】
MTT	chem
【PRE_E】
MTT	chem
PQ	chem
【GOLD_R】
【PRE_R】

Also , the DOX modulatory effect on choline uptake transport system was assessed by measuring the uptake of [ ³H ] - choline .
【GOLD_E】
DOX	chem
choline	chem
[³H]-choline	chem
【PRE_E】
DOX	chem
choline	chem
[³H]-choline	chem
【GOLD_R】
【PRE_R】

The results show that DOX exerts protective effects against PQ cytotoxicity , preventing the intracellular accumulation of the herbicide .
【GOLD_E】
DOX	chem
【PRE_E】
DOX	chem
PQ	chem
【GOLD_R】
【PRE_R】

These protective effects were not completely prevented by the incubation with the UIC2 antibody , a specific P - gp inhibitor , suggesting the involvement of alternative protection mechanisms .
【GOLD_E】
P-gp	geneN
【PRE_E】
UIC2	chem
P-gp	geneN
【GOLD_R】
【PRE_R】

In fact , DOX also efficiently inhibited the choline transport system that influences PQ cellular uptake .
【GOLD_E】
DOX	chem
choline	chem
【PRE_E】
DOX	chem
choline	chem
PQ	chem
【GOLD_R】
【PRE_R】

In conclusion , in this cellular model , DOX effectively protects against PQ toxicity by inducing P - gp and through the interaction with the choline transporter , suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications .
【GOLD_E】
P-gp	geneN
cholinetransporter	geneN
DOX	chem
choline	chem
【PRE_E】
DOX	chem
PQ	chem
P-gp	geneN
cholinetransporter	geneY
PQ	chem
【GOLD_R】
DOX	P-gp	C3
【PRE_R】

Sirtuins as emerging anti - parasitic targets .
【GOLD_E】
Sirtuins	geneN
【PRE_E】
Sirtuins	geneN
【GOLD_R】
【PRE_R】

Silent information regulator 2 ( Sir2 ) enzymes or sirtuins are a family of NAD ( + ) - dependent protein N ( ε ) - acetyl - lysine ( AcK ) deacetylases .
【GOLD_E】
NAD(+)-dependentproteinN(ε)-acetyl-lysine(AcK)deacetylases	geneN
AcK	chem
NAD(+)	chem
N(ε)-acetyl-lysine	chem
Silentinformationregulator2	geneY
Sir2	geneY
sirtuins	geneN
【PRE_E】
Silentinformationregulator2	geneN
Sir2	geneN
sirtuins	geneN
NAD(+)-dependentproteinN(ε)-acetyl-lysine(AcK)deacetylases	geneN
【GOLD_R】
【PRE_R】

Sirtuins are also evolutionarily conserved proteins that are present in all kingdoms of life ranging from bacteria to humans .
【GOLD_E】
Sirtuins	geneN
【PRE_E】
Sirtuins	geneN
【GOLD_R】
【PRE_R】

Interestingly , it was recently found that the sirtuins found in various human parasites ( especially the Plasmodium , Trypanosoma , and Leishmania species ) were pro - survival for the parasites under various conditions .
【GOLD_E】
sirtuins	geneN
【PRE_E】
sirtuins	geneN
Plasmodium	geneN
Trypanosoma	geneN
Leishmania	geneN
【GOLD_R】
【PRE_R】

Therefore , these parasitic sirtuins have emerged as novel anti - parasitic therapeutic targets .
【GOLD_E】
parasiticsirtuins	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

This article reviews the currently available structural , biochemical , pharmacological , and medicinal chemistry studies on these enzymes , and discusses the perspectives of selectively targeting the parasitic sirtuins as a novel therapeutic strategy for the human parasitic diseases .
【GOLD_E】
parasiticsirtuins	geneN
【PRE_E】
sirtuins	geneN
【GOLD_R】
【PRE_R】

The selective SYK inhibitor P505 - 15 ( PRT062607 ) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia .
【GOLD_E】
P505-15	chem
PRT062607	chem
SYK	geneY
fludarabine	chem
【PRE_E】
SYK	geneY
P505-15	chem
PRT062607	chem
fludarabine	chem
【GOLD_R】
P505-15	SYK	C4
PRT062607	SYK	C4
【PRE_R】
SYK	P505-15	C4
SYK	PRT062607	C4
SYK	fludarabine	C4

B - cell receptor ( BCR ) associated kinases including spleen tyrosine kinase ( SYK ) contribute to the pathogenesis of B - cell malignancies .
【GOLD_E】
B-cellreceptor	geneN
BCR	geneN
kinases	geneN
spleentyrosinekinase	geneY
SYK	geneY
tyrosine	chem
【PRE_E】
B-cellreceptor	geneY
BCR	geneY
kinases	geneN
spleentyrosinekinase	geneY
SYK	geneY
【GOLD_R】
【PRE_R】

SYK is persistently phosphorylated in a subset of non - Hodgkin lymphoma ( NHL ) and chronic lymphocytic leukemia ( CLL ) , and SYK inhibition results in abrogation of downstream kinase activity and apoptosis .
【GOLD_E】
SYK	geneY
SYK	geneY
kinase	geneN
【PRE_E】
SYK	geneY
SYK	geneY
kinase	geneN
【GOLD_R】
【PRE_R】

P505 - 15 ( also known as PRT062607 ) is a novel , highly selective , and orally bioavailable small molecule SYK inhibitor ( SYK IC ( 50 ) = 1 nM ) with anti - SYK activity that is at least 80 - fold greater than its affinity for other kinases .
【GOLD_E】
SYK	geneY
SYK	geneY
SYK	geneY
kinases	geneN
P505-15	chem
PRT062607	chem
【PRE_E】
P505-15	geneY
PRT062607	chem
SYK	geneY
SYK	geneY
SYK	geneN
kinases	geneN
【GOLD_R】
P505-15	SYK	C4
P505-15	SYK	C4
P505-15	SYK	C4
PRT062607	SYK	C4
PRT062607	SYK	C4
PRT062607	SYK	C4
【PRE_R】
PRT062607	SYK	C4
PRT062607	SYK	C4

We evaluated the preclinical characteristics of P505 - 15 in models of NHL and CLL .
【GOLD_E】
P505-15	chem
【PRE_E】
P505-15	geneY
【GOLD_R】
【PRE_R】

P505 - 15 successfully inhibited SYK - mediated B - cell receptor signaling and decreased cell viability in NHL and CLL .
【GOLD_E】
SYK	geneY
B-cellreceptor	geneN
P505-15	chem
【PRE_E】
P505-15	chem
SYK	geneY
B-cellreceptor	geneN
【GOLD_R】
P505-15	B-cellreceptor	C4
P505-15	SYK	C4
【PRE_R】
P505-15	SYK	C4
P505-15	B-cellreceptor	C4

Oral dosing in mice prevented BCR - mediated splenomegaly and significantly inhibited NHL tumor growth in a xenograft model .
【GOLD_E】
BCR	geneN
【PRE_E】
BCR	geneY
【GOLD_R】
【PRE_R】

In addition , combination treatment of primary CLL cells with P505 - 15 plus fludarabine produced synergistic enhancement of activity at nanomolar concentrations .
【GOLD_E】
P505-15	chem
fludarabine	chem
【PRE_E】
P505-15	geneY
fludarabine	chem
【GOLD_R】
【PRE_R】

Our findings support the ongoing development of P505 - 15 as a therapeutic agent for B - cell malignancies .
【GOLD_E】
P505-15	chem
【PRE_E】
P505-15	geneY
【GOLD_R】
【PRE_R】

A dose finding study in healthy volunteers has been completed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The fidelity of transcription : RPB1 ( RPO21 ) mutations that increase transcriptional slippage in S. cerevisiae .
【GOLD_E】
RPB1	geneY
RPO21	geneY
【PRE_E】
RPB1	geneN
RPO21	geneY
【GOLD_R】
【PRE_R】

The fidelity of RNA synthesis depends on both accurate template - mediated nucleotide selection and proper maintenance of register between template and RNA .
【GOLD_E】
nucleotide	chem
【PRE_E】
nucleotide	chem
【GOLD_R】
【PRE_R】

Loss of register , or transcriptional slippage , is particularly likely on homopolymeric runs in the template .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Transcriptional slippage can alter the coding capacity of mRNAs and is used as a regulatory mechanism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here we describe mutations in the largest subunit of Saccharomyces cerevisiae RNA polymerase II that substantially increase the level of transcriptional slippage .
【GOLD_E】
SaccharomycescerevisiaeRNApolymeraseII	geneN
【PRE_E】
SaccharomycescerevisiaeRNApolymeraseII	geneY
【GOLD_R】
【PRE_R】

Alleles of RPB1 ( RPO21 ) with elevated slippage rates were identified among 6 - azauracil - sensitive mutants and were also isolated using a slippage - dependent reporter gene .
【GOLD_E】
6-azauracil	chem
RPB1	geneY
RPO21	geneY
【PRE_E】
RPB1	geneY
RPO21	geneY
6-azauracil	chem
【GOLD_R】
【PRE_R】

Biochemical characterization of polymerase II isolated from these mutants confirms elevated levels of transcriptional slippage .
【GOLD_E】
polymeraseII	geneN
【PRE_E】
polymeraseII	geneN
【GOLD_R】
【PRE_R】

Effect of nuclear vibrations , temperature , co - adsorbed water , and dye orientation on light absorption , charge injection and recombination conditions in organic dyes on TiO2 .
【GOLD_E】
TiO2	chem
【PRE_E】
TiO2	chem
【GOLD_R】
【PRE_R】

We study the effect of nuclear motions at different temperatures , including the effect of a dye molecule 's orientation with respect to the oxide surface , on factors determining the performance of dye sensitized solar cells : light absorption , electron injection , and back - donation .
【GOLD_E】
oxide	chem
【PRE_E】
oxide	chem
【GOLD_R】
【PRE_R】

We perform ab initio molecular dynamics simulations of aminophenyl acid dyes NK1 and NK7 , differing by the electron donating group , in a vacuum and adsorbed in mono - and bi - dentate modes on a dry and a water - covered anatase ( 101 ) surface of TiO ( 2 ) , at 300 and 350 K .
【GOLD_E】
aminophenylacid	chem
NK1	chem
NK7	chem
anatase(101)	chem
TiO(2)	chem
【PRE_E】
aminophenylacid	chem
NK1	chem
NK7	chem
anatase	chem
TiO(2)	chem
【GOLD_R】
【PRE_R】

Nuclear vibrations and an increase of temperature cause a red shift in the absorption spectra of free dyes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This effect is preserved in dyes on dry TiO ( 2 ) but largely disappears in the presence of water .
【GOLD_E】
TiO(2)	chem
【PRE_E】
TiO(2)	chem
【GOLD_R】
【PRE_R】

Averaged over nuclear vibrations , the driving force to injection , Δ G , differs from the static estimate .
【GOLD_E】
【PRE_E】
ΔG	geneY
【GOLD_R】
【PRE_R】

It depends on the adsorption mode and the presence of H ( 2 ) O but is almost the same for 300 and 350 K .
【GOLD_E】
H(2)O	chem
【PRE_E】
H(2)O	chem
【GOLD_R】
【PRE_R】

Recombination to the dye cation is expected to be much enhanced by the approach of the dye oxidation equivalent hole to the surface during dye wagging around TiO ( 2 ) .
【GOLD_E】
TiO(2)	chem
【PRE_E】
TiO(2)	chem
【GOLD_R】
【PRE_R】

This effect is somewhat mitigated by the co - adsorbed water .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The dynamics of Δ G ( t ) are explained by uncorrelated evolution of the energies of the dye excited state and the conduction band minimum of the oxide due to their respective vibrations , and are almost independent of dye orientation .
【GOLD_E】
oxide	chem
【PRE_E】
ΔG(t)	geneY
oxide	chem
【GOLD_R】
【PRE_R】

It may therefore be possible to independently control the conditions of recombination and of injection .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Proteomic and metabolomic responses to connexin43 silencing in primary hepatocyte cultures .
【GOLD_E】
connexin43	geneY
【PRE_E】
connexin43	geneY
【GOLD_R】
【PRE_R】

Freshly established cultures of primary hepatocytes progressively adopt a foetal - like phenotype and display increased production of connexin43 .
【GOLD_E】
connexin43	geneY
【PRE_E】
connexin43	geneY
【GOLD_R】
【PRE_R】

The latter is a multifaceted cellular entity with variable subcellular locations , including the mitochondrial compartment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cx43 forms hemichannels and gap junctions that are involved in a plethora of physiological and pathological processes , such as apoptosis .
【GOLD_E】
Cx43	geneY
hemichannels	geneN
【PRE_E】
Cx43	geneY
hemichannels	geneY
【GOLD_R】
【PRE_R】

The present study was conducted with the goal of shedding more light onto the role of connexin43 in primary hepatocyte cultures .
【GOLD_E】
connexin43	geneY
【PRE_E】
connexin43	geneY
【GOLD_R】
【PRE_R】

Connexin43 expression was suppressed by means of RNA interference technology , and the overall outcome of this treatment on the hepatocellular proteome and metabolome was investigated using tandem mass tag - based differential protein profiling and ( 1 ) H NMR spectroscopy , respectively .
【GOLD_E】
Connexin43	geneY
(1)H	chem
【PRE_E】
Connexin43	geneY
(1)H	chem
【GOLD_R】
【PRE_R】

Global protein profiling revealed a number of targets of the connexin43 knock - down procedure , including mitochondrial proteins ( heat shock protein 60 , glucose - regulated protein 75 , thiosulphate sulphurtransferase and adenosine triphosphate synthase ) and detoxifying enzymes ( glutathione S - transferase μ 2 and cytochrome P450 2C70 ) .
【GOLD_E】
cytochromeP4502C70	geneN
connexin43	geneY
adenosinetriphosphate	chem
heatshockprotein60	geneY
glucose-regulatedprotein75	geneY
thiosulphatesulphurtransferase	geneY
glutathione	chem
S	chem
glucose	chem
thiosulphate	chem
adenosinetriphosphatesynthase	geneN
glutathioneS-transferaseμ2	geneY
【PRE_E】
connexin43	geneY
mitochondrialproteins	geneN
heatshockprotein60	geneY
glucose-regulatedprotein75	geneY
thiosulphatesulphurtransferase	geneN
adenosinetriphosphatesynthase	geneN
glutathioneS-transferaseμ2	geneY
cytochromeP4502C70	geneY
【GOLD_R】
【PRE_R】

At the metabolomic level , connexin43 silencing caused no overt changes , though there was some evidence for a subtle increase in intracellular glycine quantities .
【GOLD_E】
connexin43	geneY
glycine	chem
【PRE_E】
connexin43	geneY
glycine	chem
【GOLD_R】
【PRE_R】

Collectively , these data could further substantiate the established existence of a mitochondrial connexin pool and could be reconciled with the previously reported involvement of connexin43 signalling in spontaneously occurring apoptosis in primary hepatocyte cultures .
【GOLD_E】
connexin	geneN
connexin43	geneN
【PRE_E】
connexin	geneN
connexin43	geneY
【GOLD_R】
【PRE_R】

Aryl hydrocarbon receptor is a target of 17 - Allylamino - 17 - demethoxygeldanamycin and enhances its anticancer activity in lung adenocarcinoma cells .
【GOLD_E】
Arylhydrocarbon	chem
17-Allylamino-17-demethoxygeldanamycin	chem
Arylhydrocarbonreceptor	geneY
【PRE_E】
Arylhydrocarbonreceptor	geneY
17-Allylamino-17-demethoxygeldanamycin	chem
【GOLD_R】
【PRE_R】

We have demonstrated that aryl hydrocarbon receptor ( AhR ) is overexpressed in lung adenocarcinoma ( AD ) .
【GOLD_E】
arylhydrocarbon	chem
arylhydrocarbonreceptor	geneY
AhR	geneY
【PRE_E】
arylhydrocarbonreceptor	geneY
AhR	geneY
【GOLD_R】
【PRE_R】

AhR is usually associated with heat shock protein 90 ( Hsp90 ) in the cytoplasm .
【GOLD_E】
AhR	geneY
heatshockprotein90	geneN
Hsp90	geneN
【PRE_E】
AhR	geneY
heatshockprotein90	geneN
Hsp90	geneN
【GOLD_R】
【PRE_R】

17 - Allylamino - 17 - demethoxygeldanamycin ( 17 - AAG ) , an Hsp90 inhibitor , is currently under evaluation for its anticancer activity in clinical trials .
【GOLD_E】
17-Allylamino-17-demethoxygeldanamycin	chem
17-AAG	chem
Hsp90	geneN
【PRE_E】
17-Allylamino-17-demethoxygeldanamycin	chem
17-AAG	chem
Hsp90	geneN
【GOLD_R】
17-Allylamino-17-demethoxygeldanamycin	Hsp90	C4
17-AAG	Hsp90	C4
【PRE_R】
17-Allylamino-17-demethoxygeldanamycin	Hsp90	C4
17-AAG	Hsp90	C4

Here we investigated whether AhR plays a role in 17 - AAG - mediated anticancer activity by functioning as a downstream target or by modulating its anticancer efficacy .
【GOLD_E】
17-AAG	chem
AhR	geneY
【PRE_E】
AhR	geneY
17-AAG	chem
【GOLD_R】
【PRE_R】

AhR expression in lung AD cells was modulated by siRNA interference or overexpression .
【GOLD_E】
AhR	geneY
【PRE_E】
AhR	geneY
【GOLD_R】
【PRE_R】

Tumor growth was determined with colony formation in vitro or in vivo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Anticancer activity of 17 - AAG was determined by measuring cell viability , cell cycle distribution , and expression of cell cycle regulators .
【GOLD_E】
17-AAG	chem
【PRE_E】
17-AAG	chem
【GOLD_R】
【PRE_R】

Proteins and mRNA levels were examined by immunoblotting and the real - time reverse transcription - polymerase chain reaction , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , AhR overexpression positively modulated growth of lung AD cells , at least partially , via RelA - dependent mechanisms .
【GOLD_E】
RelA	geneY
AhR	geneY
【PRE_E】
AhR	geneY
RelA	geneY
【GOLD_R】
【PRE_R】

Although treatment with 17 - AAG reduced AhR levels and AhR - regulated gene expression in lung AD cells , AhR expression increased anticancer activity of 17 - AAG .
【GOLD_E】
AhR	geneY
17-AAG	chem
AhR	geneY
AhR	geneY
17-AAG	chem
【PRE_E】
17-AAG	chem
AhR	geneY
AhR	geneY
AhR	geneY
17-AAG	chem
【GOLD_R】
17-AAG	AhR	C4
17-AAG	AhR	C4
【PRE_R】
AhR	17-AAG	C3
AhR	17-AAG	C3
AhR	17-AAG	C3

In addition , 17 - AAG treatment reduced cell viability , CDK2 , CDK4 , cyclin E , cyclin D1 , and phosphorylated Rb levels in AhR - expressing lung AD cells .
【GOLD_E】
CDK2	geneY
CDK4	geneY
cyclinE	geneN
cyclinD1	geneY
phosphorylatedRb	geneY
AhR	geneY
17-AAG	chem
【PRE_E】
17-AAG	chem
CDK2	geneY
CDK4	geneY
cyclinE	geneY
cyclinD1	geneY
phosphorylatedRb	geneY
AhR	geneY
【GOLD_R】
17-AAG	CDK2	C4
17-AAG	CDK4	C4
17-AAG	cyclinE	C4
17-AAG	cyclinD1	C4
17-AAG	phosphorylatedRb	C4
【PRE_R】
17-AAG	CDK2	C4
17-AAG	CDK4	C4
17-AAG	cyclinE	C4
17-AAG	cyclinD1	C4
17-AAG	phosphorylatedRb	C4

NAD ( P ) H : quinone oxidoreductase ( NQO1 ) , which is regulated by AhR , was shown to increase anticancer activity of 17 - AAG in cells .
【GOLD_E】
NAD(P)H:quinoneoxidoreductase	geneY
NQO1	geneY
AhR	geneY
NAD(P)H	chem
quinone	chem
17-AAG	chem
【PRE_E】
NAD(P)H	geneY
quinoneoxidoreductase	geneY
NQO1	geneY
AhR	geneY
17-AAG	chem
【GOLD_R】
【PRE_R】
NAD(P)H	17-AAG	C9
NQO1	17-AAG	C9
AhR	17-AAG	C9

Knockdown of NQO1 expression attenuated the reduction of cell cycle regulators by 17 - AAG treatment in AhR overexpressed cells .
【GOLD_E】
NQO1	geneY
AhR	geneY
17-AAG	chem
【PRE_E】
NQO1	geneY
17-AAG	chem
AhR	geneY
【GOLD_R】
【PRE_R】

We demonstrated that AhR protein not only functions as a downstream target of 17 - AAG , but also enhances anticancer activity of 17 - AAG in lung AD cells .
【GOLD_E】
AhR	geneY
17-AAG	chem
17-AAG	chem
【PRE_E】
AhR	geneY
17-AAG	chem
17-AAG	chem
【GOLD_R】
【PRE_R】

Pharmacogenomics of gemcitabine metabolism : functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase .
【GOLD_E】
deoxycytidine	chem
gemcitabine	chem
cytidine	chem
deoxycytidinekinase	geneY
cytidinedeaminase	geneY
【PRE_E】
gemcitabine	chem
cytidinedeaminase	geneY
deoxycytidinekinase	geneY
【GOLD_R】
【PRE_R】

Gemcitabine ( dFdC , 2',2 ' - difluorodeoxycytidine ) is metabolized by cytidine deaminase ( CDA ) and deoxycytidine kinase ( DCK ) , but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear .
【GOLD_E】
cytidine	chem
Gemcitabine	chem
deoxycytidine	chem
DCK	geneY
cytidinedeaminase	geneY
CDA	geneY
deoxycytidinekinase	geneY
dFdC	chem
2',2'-difluorodeoxycytidine	chem
【PRE_E】
Gemcitabine	chem
dFdC	chem
2',2'-difluorodeoxycytidine	chem
cytidinedeaminase	geneY
CDA	geneY
deoxycytidinekinase	geneY
DCK	geneY
【GOLD_R】
Gemcitabine	DCK	C9
Gemcitabine	cytidinedeaminase	C9
Gemcitabine	CDA	C9
Gemcitabine	deoxycytidinekinase	C9
dFdC	DCK	C9
dFdC	cytidinedeaminase	C9
dFdC	CDA	C9
dFdC	deoxycytidinekinase	C9
2',2'-difluorodeoxycytidine	DCK	C9
2',2'-difluorodeoxycytidine	cytidinedeaminase	C9
2',2'-difluorodeoxycytidine	CDA	C9
2',2'-difluorodeoxycytidine	deoxycytidinekinase	C9
【PRE_R】

Wild - type enzymes and variants of CDA ( Lys27Gln and Ala70Thr ) and DCK ( Ile24Val , Ala119Gly , and Pro122Ser ) were expressed in and purified from Escherichia coli , and enzyme kinetic parameters were estimated for cytarabine ( Ara - C ) , dFdC , and its metabolite 2',2 ' - difluorodeoxyuridine ( dFdU ) as substrates .
【GOLD_E】
Ara-C	chem
dFdC	chem
2',2'-difluorodeoxyuridine	chem
dFdU	chem
CDA	geneY
Lys27Gln	geneN
Ala70Thr	geneN
DCK	geneY
Ile24Val	geneN
Ala119Gly	geneN
Pro122Ser	geneN
cytarabine	chem
【PRE_E】
CDA	geneN
Lys27Gln	geneN
Ala70Thr	geneN
DCK	geneY
Ile24Val	geneN
Ala119Gly	geneN
Pro122Ser	geneN
cytarabine	chem
Ara-C	chem
dFdC	chem
2',2'-difluorodeoxyuridine	chem
dFdU	chem
【GOLD_R】
Ara-C	CDA	C9
Ara-C	Lys27Gln	C9
Ara-C	Ala70Thr	C9
Ara-C	DCK	C9
Ara-C	Ile24Val	C9
Ara-C	Ala119Gly	C9
Ara-C	Pro122Ser	C9
dFdC	CDA	C9
dFdC	Lys27Gln	C9
dFdC	Ala70Thr	C9
dFdC	DCK	C9
dFdC	Ile24Val	C9
dFdC	Ala119Gly	C9
dFdC	Pro122Ser	C9
2',2'-difluorodeoxyuridine	CDA	C9
2',2'-difluorodeoxyuridine	Lys27Gln	C9
2',2'-difluorodeoxyuridine	Ala70Thr	C9
2',2'-difluorodeoxyuridine	DCK	C9
2',2'-difluorodeoxyuridine	Ile24Val	C9
2',2'-difluorodeoxyuridine	Ala119Gly	C9
2',2'-difluorodeoxyuridine	Pro122Ser	C9
dFdU	CDA	C9
cytarabine	CDA	C9
cytarabine	Lys27Gln	C9
cytarabine	Ala70Thr	C9
cytarabine	DCK	C9
cytarabine	Ile24Val	C9
cytarabine	Ala119Gly	C9
cytarabine	Pro122Ser	C9
【PRE_R】

All three CDA proteins showed similar K ( m ) and V ( max ) for Ara - C and dFdC deamination , except for CDA70Thr , which had a 2.5 - fold lower K ( m ) and 6 - fold lower V ( max ) for Ara - C deamination .
【GOLD_E】
Ara-C	chem
dFdC	chem
Ara-C	chem
CDA	geneY
CDA	geneY
【PRE_E】
CDA	geneN
Ara-C	chem
dFdC	chem
CDA70Thr	geneN
Ara-C	chem
【GOLD_R】
Ara-C	CDA	C9
dFdC	CDA	C9
Ara-C	CDA	C9
【PRE_R】

All four DCK proteins yielded comparable metabolic activity for Ara - C and dFdC monophosphorylation , except for DCK24Val , which demonstrated an approximately 2 - fold increase ( P < 0.05 ) in the intrinsic clearance of dFdC monophosphorylation due to a 40 % decrease in K ( m ) ( P < 0.05 ) .
【GOLD_E】
Ara-C	chem
dFdC	chem
dFdC	chem
DCK	geneY
DCK	geneY
【PRE_E】
DCK	geneY
Ara-C	chem
dFdC	chem
DCK24Val	geneY
dFdC	chem
【GOLD_R】
Ara-C	DCK	C9
dFdC	DCK	C9
dFdC	DCK	C9
【PRE_R】

DCK did not significantly contribute to dFdU monophosphorylation .
【GOLD_E】
DCK	geneY
dFdU	chem
【PRE_E】
DCK	geneY
dFdUmonophosphorylation	geneY
【GOLD_R】
【PRE_R】

In conclusion , the Lys27Gln substitution does not significantly modulate CDA activity toward dFdC , and therefore would not contribute to interindividual variability in response to gemcitabine .
【GOLD_E】
Lys27Gln	geneN
CDA	geneY
dFdC	chem
gemcitabine	chem
【PRE_E】
Lys27Gln	geneN
CDA	geneN
dFdC	chem
gemcitabine	chem
【GOLD_R】
dFdC	Lys27Gln	C9
dFdC	CDA	C9
【PRE_R】

The higher in vitro catalytic efficiency of DCK24Val toward dFdC monophosphorylation may be relevant to dFdC clinical response .
【GOLD_E】
DCK	geneY
dFdC	chem
dFdC	chem
【PRE_E】
DCK24Val	geneY
dFdC	chem
dFdC	chem
【GOLD_R】
dFdC	DCK	C9
dFdC	DCK	C9
【PRE_R】
DCK24Val	dFdC	C9
DCK24Val	dFdC	C9

The substrate - dependent alterations in activities of CDA70Thr and DCK24Val in vitro were observed for the first time , and demonstrate that the in vivo consequences of these genetic variations should not be extrapolated from one substrate of these enzymes to another .
【GOLD_E】
CDA	geneY
DCK	geneY
【PRE_E】
CDA70Thr	geneN
DCK24Val	geneN
【GOLD_R】
【PRE_R】

Discovery of 4 - phenyl - 2 - phenylaminopyridine based TNIK inhibitors .
【GOLD_E】
TNIK	geneY
4-phenyl-2-phenylaminopyridine	chem
【PRE_E】
4-phenyl-2-phenylaminopyridine	chem
TNIK	geneY
【GOLD_R】
4-phenyl-2-phenylaminopyridine	TNIK	C4
【PRE_R】
4-phenyl-2-phenylaminopyridine	TNIK	C4

A series of compounds based on a 4 - phenyl - 2 - phenylaminopyridine scaffold that are potent and selective inhibitors of Traf2 - and Nck - interacting kinase ( TNIK ) activity are described .
【GOLD_E】
4-phenyl-2-phenylaminopyridine	chem
Traf2-andNck-interactingkinase	geneY
TNIK	geneY
【PRE_E】
4-phenyl-2-phenylaminopyridine	chem
Traf2	geneY
Nck-interactingkinase	geneN
TNIK	geneY
【GOLD_R】
4-phenyl-2-phenylaminopyridine	Traf2-andNck-interactingkinase	C4
4-phenyl-2-phenylaminopyridine	TNIK	C4
【PRE_R】
4-phenyl-2-phenylaminopyridine	Traf2	C4
4-phenyl-2-phenylaminopyridine	Nck-interactingkinase	C4
4-phenyl-2-phenylaminopyridine	TNIK	C4

These compounds were used as tools to test the importance of TNIK kinase activity in signaling and proliferation in Wnt - activated colorectal cancer cells .
【GOLD_E】
TNIK	geneY
kinase	geneN
Wnt	geneN
【PRE_E】
TNIK	geneY
kinase	geneN
Wnt	geneN
【GOLD_R】
【PRE_R】

The results indicate that pharmacological inhibition of TNIK kinase activity has minimal effects on either Wnt / TCF4 / β - catenin - driven transcription or viability .
【GOLD_E】
Wnt	geneN
TCF4	geneY
β-catenin	geneY
TNIK	geneY
kinase	geneN
【PRE_E】
TNIK	geneY
kinase	geneN
Wnt	geneN
TCF4	geneY
β-catenin	geneY
【GOLD_R】
【PRE_R】

The findings suggest that the kinase activity of TNIK may be less important to Wnt signaling than other aspects of TNIK function , such as its putative role in stabilizing the TCF4 / β - catenin transcriptional complex .
【GOLD_E】
kinase	geneN
TNIK	geneY
Wnt	geneN
TNIK	geneY
TCF4	geneY
β-catenin	geneY
【PRE_E】
kinase	geneN
TNIK	geneY
Wnt	geneN
TNIK	geneN
TCF4	geneY
β-catenin	geneY
【GOLD_R】
【PRE_R】

Hybrid carbon nanotube networks as efficient hole extraction layers for organic photovoltaics .
【GOLD_E】
carbon	chem
【PRE_E】
carbon	chem
【GOLD_R】
【PRE_R】

Transparent , highly percolated networks of regioregular poly ( 3 - hexylthiophene ) ( rr - P3HT ) - wrapped semiconducting single - walled carbon nanotubes ( s - SWNTs ) are deposited , and the charge transfer processes of these nanohybrids are studied using spectroscopic and electrical measurements .
【GOLD_E】
carbon	chem
poly(3-hexylthiophene)	chem
P3HT	chem
【PRE_E】
regioregularpoly(3-hexylthiophene)	chem
rr-P3HT	chem
carbon	chem
s-SWNTs	chem
【GOLD_R】
【PRE_R】

The data disclose hole doping of s - SWNTs by the polymer , challenging the prevalent electron - doping hypothesis .
【GOLD_E】
【PRE_E】
s-SWNTs	chem
【GOLD_R】
【PRE_R】

Through controlled fabrication , high - to low - density nanohybrid networks are achieved , with low - density hybrid carbon nanotube networks tested as hole transport layers ( HTLs ) for bulk heterojunction ( BHJ ) organic photovoltaics ( OPV ) .
【GOLD_E】
carbon	chem
【PRE_E】
carbon	chem
OPV	chem
【GOLD_R】
【PRE_R】

OPVs incorporating these rr - P3HT / s - SWNT networks as the HTL demonstrate the best large area ( 70 mm ( 2 ) ) carbon nanotube incorporated organic solar cells to date with a power conversion efficiency of 7.6 % .
【GOLD_E】
P3HT	chem
carbon	chem
【PRE_E】
rr-P3HT	chem
s-SWNT	chem
(2))carbon	chem
【GOLD_R】
【PRE_R】

This signifies the strong capability of nanohybrids as an efficient hole extraction layer , and we believe that dense nanohybrid networks have the potential to replace expensive and material scarce inorganic transparent electrodes in large area electronics toward the realization of low - cost flexible electronics .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chemical assessment and antioxidant capacity of pepper ( Capsicum annuum L. ) seeds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Capsicum annuum L. is reported to be the most widely cultivated species .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recently , waste of vegetable processing , like seeds , has been the subject of many studies as an attempt to find new , alternative and cheap resources of bioactive compounds with application in several industries .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Despite their chemical , biological and ecological importance , C. annuum seeds are still poorly studied .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To improve the knowledge on the metabolic profile of this matrix , a targeted metabolite analysis was performed in `` sweet Italian `` and `` Reus long pairal `` pepper seeds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sterols , triterpenes , organic acids , fatty acids and volatile compounds were determined by different chromatographic methods .
【GOLD_E】
Sterols	chem
triterpenes	chem
fattyacids	chem
【PRE_E】
Sterols	chem
triterpenes	chem
organicacids	chem
fattyacids	chem
volatile	chem
【GOLD_R】
【PRE_R】

The antioxidant activity was assessed against DPPH ( · ) , superoxide and nitric oxide radicals .
【GOLD_E】
DPPH(·)	chem
superoxide	chem
nitricoxide	chem
【PRE_E】
DPPH(·)	chem
superoxide	chem
nitricoxide	chem
【GOLD_R】
【PRE_R】

A concentration - dependent activity was noticed against all radicals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Acetylcholinesterase inhibitory capacity was also evaluated , but no effect was found .
【GOLD_E】
Acetylcholinesterase	geneY
【PRE_E】
Acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

Data provide evidence of great similarities between `` sweet Italian `` and `` Reus long pairal `` pepper seeds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The present study indicates that C. annuum seeds are a potential source of valuable bioactive compounds that could be used in food industry .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Boron - based inhibitors of acyl protein thioesterases 1 and 2 .
【GOLD_E】
acylproteinthioesterases1and2	geneN
Boron	chem
acyl	chem
【PRE_E】
Boron	chem
acylproteinthioesterases1and2	geneN
【GOLD_R】
Boron	acylproteinthioesterases1and2	C4
【PRE_R】

Ras proteins are of importance in cell proliferation , and hence their mutated forms play causative roles in many kinds of cancer in different tissues .
【GOLD_E】
Ras	geneN
【PRE_E】
Ras	geneN
【GOLD_R】
【PRE_R】

Inhibition of the Ras - depalmitoylating enzyme acyl protein thioesterases APT1 and - 2 is a new approach to modulating the Ras cycle .
【GOLD_E】
acyl	chem
Ras	geneN
acylproteinthioesterasesAPT1and-2	geneN
Ras	geneN
【PRE_E】
Ras	geneN
depalmitoylating	geneN
acylproteinthioesterasesAPT1and-2	geneN
Ras	geneN
【GOLD_R】
【PRE_R】

Here we present boronic and borinic acid derivatives as a new class of potent and nontoxic APT inhibitors .
【GOLD_E】
APT	geneN
boronic	chem
borinicacid	chem
【PRE_E】
borinicacid	chem
APT	geneN
【GOLD_R】
boronic	APT	C4
borinicacid	APT	C4
【PRE_R】
borinicacid	APT	C4

These compounds were detected by extensive library screening using chemical arrays and turned out to inhibit human APT1 and - 2 in a competitive mode .
【GOLD_E】
humanAPT1and-2	geneN
【PRE_E】
humanAPT1and-2	geneN
【GOLD_R】
【PRE_R】

Furthermore , one of the molecules was demonstrated to inhibit Erk1 / 2 phosphorylation significantly .
【GOLD_E】
Erk1/2	geneN
【PRE_E】
Erk1/2	geneN
【GOLD_R】
【PRE_R】

Three - Dimensional CdS - Titanate Composite Nanomaterials for Enhanced Visible - Light - Driven Hydrogen Evolution .
【GOLD_E】
CdS	chem
Titanate	chem
Hydrogen	chem
【PRE_E】
CdS	chem
Hydrogen	chem
【GOLD_R】
【PRE_R】

3D Hierarchical echinus - like titanate spheres ( HETSs ) , serving as the supporting material for CdS nanoparticles , are synthesized via a fast one - step hydrothermal method .
【GOLD_E】
titanate	chem
CdS	chem
【PRE_E】
CdS	chem
【GOLD_R】
【PRE_R】

The obtained 3D CdS - HETS composite materials show enhanced H2 generation under visible light irradiation .
【GOLD_E】
CdS	chem
H2	chem
【PRE_E】
CdS	chem
【GOLD_R】
【PRE_R】

UPLC - Q - TOF / HSMS / MS ( E ) - based metabonomics for adenine - induced changes in metabolic profiles of rat faeces and intervention effects of ergosta - 4,6,8 ( 14 ) , 22 - tetraen - 3 - one .
【GOLD_E】
ergosta-4,6,8(14),22-tetraen-3-one	chem
adenine	chem
【PRE_E】
adenine	chem
ergosta-4,6,8(14)	chem
22-tetraen-3-one	chem
【GOLD_R】
【PRE_R】

Ergosta - 4,6,8 ( 14 ) , 22 - tetraen - 3 - one ( ergone ) , isolated from the medicinal fungus Polyporus umbellatus , has been proven to prevent the progression of renal injury and the subsequent renal fibrosis .
【GOLD_E】
Ergosta-4,6,8(14),22-tetraen-3-one	chem
ergone	chem
【PRE_E】
Ergosta-4,6,8	chem
22-tetraen-3-one	chem
ergone	chem
【GOLD_R】
【PRE_R】

Ultra performance liquid chromatography coupled with quadrupole time - of - flight high - sensitivity mass spectrometry and a novel mass spectrometry ( Elevated Energy ) ( MS ( E ) ) data collection technique was employed to investigate metabonomic characters of chronic renal failure ( CRF ) induced adenine and the protective effects of ergosta - 4,6,8 ( 14 ) , 22 - tetraen - 3 - one ( ergone ) .
【GOLD_E】
adenine	chem
ergosta-4,6,8(14),22-tetraen-3-one	chem
ergone	chem
【PRE_E】
CRF	geneY
adenine	chem
ergosta-4,6,8	chem
22-tetraen-3-one	chem
ergone	chem
【GOLD_R】
【PRE_R】

Coupled with blood biochemistry and kidney histopathology results , the significant difference in metabolic profiling between adenine - induced CRF group and ergone - treated CRF group by using pattern recognition analysis indicated that changes in global faecal metabolites were occurred .
【GOLD_E】
adenine	chem
ergone	chem
【PRE_E】
adenine	chem
CRF	geneY
ergone	chem
CRF	geneY
【GOLD_R】
【PRE_R】
adenine	CRF	C3
CRF	ergone	C3

Seven endogenous metabolites were identified by using metabonomic method combined with multivariate data analysis , the accurate mass , isotopic pattern , MS ( E ) fragments information and MassLynx i - FIT algorithm .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These biochemical changes in faecal metabolites are related to the perturbations of bile acid metabolism and phospholipid metabolism , which may be helpful to further understand the CRF and therapeutic mechanisms of ergone .
【GOLD_E】
bileacid	chem
ergone	chem
【PRE_E】
bileacid	chem
CRF	geneY
ergone	chem
【GOLD_R】
【PRE_R】

This research proved that MS ( E ) can simultaneous acquire precursor ion information and fragment ion data at high and low collision energy in one analytical run , which facilitated the fast structural characterization of metabolites .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Selective separation of similarly sized proteins with tunable nanoporous block copolymer membranes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

An integral asymmetric membrane was fabricated in a fast and one - step process by combining the self - assembly of an amphiphilic block copolymer ( PS - b - P4VP ) with nonsolvent - induced phase separation .
【GOLD_E】
PS-b-P4VP	chem
【PRE_E】
PS-b-P4VP	chem
nonsolvent	chem
【GOLD_R】
【PRE_R】

The structure was found to be composed of a thin layer of densely packed highly ordered cylindrical channels with uniform pore sizes perpendicular to the surface on top of a nonordered sponge - like layer .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The as - assembled membrane obtained a water flux of more than 3200 L m ( - 2 ) h ( - 1 ) bar ( - 1 ) , which was at least an order of magnitude higher than the water fluxes of commercially available membranes with comparable pore sizes , making this membrane particularly well suited to size - selective and charge - based separation of biomolecules .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To test the performance of the membrane , we conducted diffusion experiments at the physiological pH of 7.4 using bovine serum albumin ( BSA ) and globulin - γ , two proteins with different diameters but too close in size ( 2 - fold difference in molecular mass ) to be efficiently separated via conventional dialysis membrane processes .
【GOLD_E】
BSA	geneY
globulin-γ	geneN
bovineserumalbumin	geneY
【PRE_E】
bovineserumalbumin	geneY
BSA	geneY
globulin-γ	geneY
【GOLD_R】
【PRE_R】

The diffusion rate differed by a factor of 87 , the highest value reported to date .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We also analyzed charge - based diffusive transport and separation of two proteins of similar molecular weight ( BSA and bovine hemoglobin ( BHb ) ) through the membrane as a function of external pH .
【GOLD_E】
BSA	geneY
bovinehemoglobin	geneN
BHb	geneN
【PRE_E】
BSA	geneY
bovinehemoglobin	geneY
BHb	geneN
【GOLD_R】
【PRE_R】

The membrane achieved a selectivity of about 10 at pH 4.7 , the isoelectric point ( pI ) of BSA .
【GOLD_E】
BSA	geneY
【PRE_E】
BSA	geneY
【GOLD_R】
【PRE_R】

We then positively charged the membrane to improve the separation selectivity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

With the modified membrane BSA was completely blocked when the pH was 7.0 , the pI of BHb , while BHb was completely blocked at pH 4.7 .
【GOLD_E】
BSA	geneY
BHb	geneN
BHb	geneN
【PRE_E】
BSA	geneY
BHb	chem
BHb	chem
【GOLD_R】
【PRE_R】

Our results demonstrate the potential of our asymmetric membrane to efficiently separate biological substances / pharmaceuticals in bioscience , biotechnology , and biomedicine applications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA - mediated suppression of RhoA signaling .
【GOLD_E】
genistein	chem
PKA	geneN
RhoA	geneY
【PRE_E】
Phytoestrogengenistein	chem
RhoA	geneY
【GOLD_R】
【PRE_R】
Phytoestrogengenistein	RhoA	C4

The soy - derived phytoestrogen genistein has received attention for its potential to improve vascular function , but its mechanism remains unclear .
【GOLD_E】
genistein	chem
【PRE_E】
phytoestrogengenistein	chem
【GOLD_R】
【PRE_R】

Here , we report that genistein at physiologically relevant concentrations ( 0.1 - 10 μM ) significantly inhibited thrombin - induced increase in endothelial monolayer permeability .
【GOLD_E】
thrombin	geneY
genistein	chem
【PRE_E】
genistein	chem
thrombin	geneY
【GOLD_R】
genistein	thrombin	C4
【PRE_R】
genistein	thrombin	C4

Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin - induced phosphorylation of myosin light chain ( MLC ) on Ser ( 19 ) / Thr ( 18 ) in endothelial cells ( ECs ) .
【GOLD_E】
thrombin	geneY
thrombin	geneY
myosinlightchain	geneN
MLC	geneN
Genistein	chem
Ser	chem
Thr	chem
【PRE_E】
Genistein	chem
thrombin	geneY
thrombin	geneY
myosinlightchain	geneY
MLC	geneY
Ser	chem
Thr	chem
【GOLD_R】
Genistein	thrombin	C4
Genistein	thrombin	C4
Genistein	myosinlightchain	C4
Genistein	MLC	C4
【PRE_R】
Genistein	thrombin	C4
Genistein	thrombin	C4
Genistein	MLC	C4

Genistein had no effect on resting intracellular [ Ca ( 2 + ) ] or thrombin - induced increase in Ca ( 2 + ) mobilization .
【GOLD_E】
Genistein	chem
Ca(2+)	chem
Ca(2+)	chem
thrombin	geneY
【PRE_E】
Genistein	chem
Ca(2+)	chem
thrombin	geneY
Ca(2+)	chem
【GOLD_R】
【PRE_R】

Addition of the inhibitors of endothelial nitric oxide synthase or estrogen receptor did not alter the protective effect of genistein .
【GOLD_E】
nitricoxide	chem
estrogen	chem
genistein	chem
endothelialnitricoxidesynthase	geneY
estrogenreceptor	geneY
【PRE_E】
endothelialnitricoxidesynthase	geneN
estrogenreceptor	geneY
genistein	chem
【GOLD_R】
【PRE_R】

RhoA is a small GTPase that plays an important role in actin - myosin contraction and endothelial barrier dysfunction .
【GOLD_E】
RhoA	geneY
GTPase	geneN
actin	geneN
myosin	geneN
【PRE_E】
RhoA	geneY
GTPase	geneN
actin	geneN
myosin	geneN
【GOLD_R】
【PRE_R】

RhoA inhibitor blocked the protective effect of genistein on endothelial permeability and also ablated thrombin - induced MLC - phosphorylation in ECs .
【GOLD_E】
genistein	chem
RhoA	geneY
thrombin	geneY
MLC	geneN
【PRE_E】
RhoA	geneY
genistein	chem
thrombin	geneY
MLC	geneN
【GOLD_R】
【PRE_R】

Inhibition of PKA significantly attenuated the effect of genistein on thrombin - induced EC permeability , MLC phosphorylation , and RhoA membrane translocation in ECs .
【GOLD_E】
PKA	geneN
thrombin	geneY
genistein	chem
MLC	geneN
RhoA	geneY
【PRE_E】
PKA	geneN
genistein	chem
thrombin	geneY
MLC	geneY
RhoA	geneY
【GOLD_R】
【PRE_R】
PKA	genistein	C4
genistein	MLC	C4
genistein	RhoA	C4

Furthermore , thrombin diminished cAMP production in ECs , which were prevented by treatment with genistein .
【GOLD_E】
thrombin	geneY
cAMP	chem
genistein	chem
【PRE_E】
thrombin	geneY
cAMP	chem
ECs	geneY
genistein	chem
【GOLD_R】
genistein	thrombin	C4
【PRE_R】
thrombin	genistein	C4
ECs	genistein	C4

These findings demonstrated that genistein improves thrombin - induced endothelial barrier dysfunction in ECs through PKA - mediated suppression of RhoA signaling .
【GOLD_E】
thrombin	geneY
PKA	geneN
RhoA	geneY
genistein	chem
【PRE_E】
genistein	chem
thrombin	geneY
RhoA	geneY
【GOLD_R】
【PRE_R】
genistein	thrombin	C3

Metabolic effects of honey in type 1 diabetes mellitus : a randomized crossover pilot study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The aim of this study was to evaluate the metabolic effects of 12 - week honey consumption on patients suffering from type 1 diabetes mellitus ( DM ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This was a randomized crossover clinical trial done in the National Institute for Diabetes and Endocrinology , Cairo , Egypt .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Twenty patients of both sexes aged 4 - 18 years with type 1 DM and HbA1C < 10 % participated in the study .
【GOLD_E】
HbA1C	geneY
【PRE_E】
type1DM	geneY
HbA1C	geneY
【GOLD_R】
【PRE_R】

They were randomized into two equal groups ( intervention to control and control to intervention ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The dietary intervention was 12 - week honey consumption in a dose of 0.5 mL / kg body weight per day .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The main outcome measures were serum glucose , lipids , and C - peptide , and anthropometric measurements .
【GOLD_E】
C-peptide	geneY
glucose	chem
【PRE_E】
glucose	chem
C-peptide	geneY
【GOLD_R】
【PRE_R】

None of participants were lost in follow - up .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The intervention resulted in significant decreases in subscapular skin fold thickness ( SSFT ; P = .002 ) , fasting serum glucose ( FSG ; P = .001 ) , total cholesterol ( P = .0001 ) , serum triglycerides ( TG ; P = .0001 ) , and low - density lipoprotein ( P = .0009 ) , and significant increases in fasting C - peptide ( FCP ; P = .0004 ) and 2 - h postprandial C - peptide ( PCP ; P = .002 ) .
【GOLD_E】
low-densitylipoprotein	geneN
fastingC-peptide	geneY
glucose	chem
cholesterol	chem
triglycerides	chem
FCP	geneY
postprandialC-peptide	geneY
PCP	geneY
【PRE_E】
glucose	chem
cholesterol	chem
triglycerides	chem
low-densitylipoprotein	geneN
C-peptide	geneY
C-peptide	geneY
【GOLD_R】
【PRE_R】

As possible long - term effects of honey after its withdrawal , statistically significant reductions in midarm circumference ( P = .000 ) , triceps skin fold thickness ( P = .006 ) , SSFT ( P = .003 ) , FSG ( P = .005 ) , 2 - h postprandial serum glucose ( P = .000 ) , TG ( P = .003 ) , and HbA1C ( P = .043 ) , and significant increases in FCP ( P = .002 ) and PCP ( P = .003 ) were observed .
【GOLD_E】
FCP	geneY
PCP	geneY
glucose	chem
HbA1C	geneY
【PRE_E】
glucose	chem
HbA1C	geneY
【GOLD_R】
【PRE_R】

This small clinical trial suggests that long - term consumption of honey might have positive effects on the metabolic derangements of type 1 DM .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Evaluation of drug interactions of GSK1292263 ( a GPR119 agonist ) with statins : from in vitro data to clinical study design .
【GOLD_E】
GSK1292263	chem
GPR119	geneY
【PRE_E】
GSK1292263	chem
GPR119	geneY
【GOLD_R】
GSK1292263	GPR119	C5
【PRE_R】
GSK1292263	GPR119	C6

1 . This work investigated the drug interaction potential of GSK1292263 , a novel GPR119 agonist , with the HMG - coA reductase inhibitors simvastatin and rosuvastatin .
【GOLD_E】
SK1292263,	chem
MG-coAreductasei	geneY
PR119a	geneY
imvastatina	chem
osuvastatin.	chem
【PRE_E】
GSK1292263	chem
GPR119	geneY
HMG-coAreductase	geneY
simvastatin	chem
rosuvastatin	chem
【GOLD_R】
imvastatina	MG-coAreductasei	C4
osuvastatin.	MG-coAreductasei	C4
SK1292263,	PR119a	C5
【PRE_R】
GSK1292263	GPR119	C6

2 . In vitro experiments assessed the inhibition of transporters and CYP enzymes by GSK1292263 , and a clinical drug interaction study investigated the effect of GSK1292263 ( 300 mg BID ) on the pharmacokinetic profile of simvastatin ( 40 mg single dose ) and rosuvastatin ( 10 mg single dose ) .
【GOLD_E】
SK1292263(	chem
mvastatin(4	chem
uvastatin(10	chem
ransportersa	geneN
YPe	geneN
SK1292263,	chem
【PRE_E】
CYP	geneN
GSK1292263	chem
GSK1292263	chem
simvastatin	chem
rosuvastatin	chem
【GOLD_R】
SK1292263,	ransportersa	C4
SK1292263,	YPe	C4
【PRE_R】
CYP	GSK1292263	C4

3 . In vitro , GSK1292263 demonstrated little / weak inhibition ( IC50 values > 30 μM ) towards CYPs ( CYP1A2 , 2C9 , 2C19 , 2D6 , 3A4 ) , Pgp , OATP1B3 , or OCT2 .
【GOLD_E】
SK1292263d	chem
YPs(	geneN
YP1A2,	geneY
C9,	geneY
C19,	geneY
D6,	geneY
A4)	geneY
gp,	geneN
ATP1B3,	geneY
CT2.	geneY
【PRE_E】
GSK1292263	chem
CYPs(CYP1A2,2C9,2C19,2D6,3A4	geneN
Pgp	geneY
OATP1B3	geneY
OCT2	geneY
【GOLD_R】
SK1292263d	YPs(	C4
SK1292263d	YP1A2,	C4
SK1292263d	C9,	C4
SK1292263d	C19,	C4
SK1292263d	D6,	C4
SK1292263d	A4)	C4
SK1292263d	gp,	C4
SK1292263d	ATP1B3,	C4
SK1292263d	CT2.	C4
【PRE_R】
GSK1292263	Pgp	C4
GSK1292263	OATP1B3	C4
GSK1292263	OCT2	C4

However , GSK1292263 inhibited BCRP and OATP1B1 , which are transporters involved in statin disposition .
【GOLD_E】
GSK1292263	chem
BCRP	geneY
OATP1B1	geneY
【PRE_E】
GSK1292263	chem
BCRP	geneY
OATP1B1	geneY
【GOLD_R】
GSK1292263	BCRP	C4
GSK1292263	OATP1B1	C4
【PRE_R】
GSK1292263	BCRP	C4
GSK1292263	OATP1B1	C4

4 . In the clinical study , small increases in the AUC ( 0 - inf ) of simvastatin [ mean ratio ( 90 % CI ) of 1.34 ( 1.22 , 1.48 ) ] and rosuvastatin [ mean ratio ( 90 % CI ) of 1.39 ( 1.30 , 1.49 ) ] were observed when co - administered with GSK1292263 , which is consistent with an inhibitory effect on intestinal BCRP and CYP3A4 .
【GOLD_E】
imvastatin[	chem
osuvastatin[	chem
SK1292263,	chem
YP3A4.	geneY
CRPa	geneY
【PRE_E】
simvastatin	chem
rosuvastatin	chem
GSK1292263	chem
BCRP	geneY
CYP3A4	geneY
【GOLD_R】
SK1292263,	YP3A4.	C4
SK1292263,	CRPa	C4
【PRE_R】
simvastatin	CYP3A4	C4
rosuvastatin	CYP3A4	C4
GSK1292263	CYP3A4	C4

In contrast , GSK1292263 did not inhibit OATP1B1 based on the lack of changes in simvastatin acid exposure [ mean AUC ( 0 - inf ) ratio ( 90 % CI ) of 1.05 ( 0.91 , 1.21 ) ] .
【GOLD_E】
GSK1292263	chem
OATP1B1	geneY
simvastatin	chem
【PRE_E】
GSK1292263	chem
OATP1B1	geneY
simvastatinacid	chem
【GOLD_R】
【PRE_R】

5 . GSK1292263 has a weak drug interaction with simvastatin and rosuvastain .
【GOLD_E】
SK1292263h	chem
imvastatina	chem
osuvastain.	chem
【PRE_E】
GSK1292263	chem
simvastatin	chem
rosuvastain	chem
【GOLD_R】
【PRE_R】

This study provides a mechanistic understanding of the in vivo inhibition of transporters and enzymes by GSK1292263 .
【GOLD_E】
transporters	geneN
GSK1292263	chem
【PRE_E】
GSK1292263	chem
【GOLD_R】
GSK1292263	transporters	C4
【PRE_R】

Antioxidants and mucolytics in COPD management : when ( if ever ) and in whom ?
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chronic obstructive pulmonary disease ( COPD ) is a major cause of morbidity and mortality worldwide .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Oxidative stress is an important mechanism in the pathogenesis of this disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The oxidant / antioxidant imbalance occurring in smokers and patients with COPD is well established .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , therapeutic strategies targeting oxidative stress with pharmacological antioxidant agents or boosting the endogenous levels of antioxidants is likely to be beneficial as an adjunctive tool in the treatment of COPD patients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thiol compounts such as N - acetyl - L - cysteine ( NAC ) , carbocysteine , erdosteine , and fudosteine have been extensively studied .
【GOLD_E】
Thiol	chem
N-acetyl-L-cysteine	chem
NAC	chem
carbocysteine	chem
erdosteine	chem
fudosteine	chem
【PRE_E】
Thiol	chem
N-acetyl-L-cysteine	chem
NAC	chem
carbocysteine	chem
erdosteine	chem
fudosteine	chem
【GOLD_R】
【PRE_R】

Although some results remain controversial , NAC and carbocysteine seem to have beneficial effect in patients not receiving inhaled corticosteroids who suffer from frequent exacerbations .
【GOLD_E】
carbocysteine	chem
corticosteroids	chem
NAC	chem
【PRE_E】
NAC	chem
carbocysteine	chem
【GOLD_R】
【PRE_R】

In addition , other antioxidants like superoxide dismutase ( SOD ) mimetics and nuclear factor - erythroid 2 related factor 2 ( Nrf2 ) are shown to decrease markers of oxidative stress in patients with emphysema , while others like glutathione peroxidase ( GPx ) mimetics and NO synthase ( iNOS ) can prevent both inflammation and oxidative stress in clinical trials in vivo ( or in mouse models ) .
【GOLD_E】
superoxide	chem
glutathioneperoxidase	geneN
GPx	geneN
NOsynthase	geneN
iNOS	geneY
superoxidedismutase	geneN
SOD	geneN
nuclearfactor-erythroid2relatedfactor2	geneY
glutathione	chem
Nrf2	geneY
NO	chem
【PRE_E】
superoxidedismutase	geneN
SOD	geneN
nuclearfactor-erythroid2relatedfactor2	geneY
Nrf2	geneY
glutathioneperoxidase	geneN
GPx	geneN
NOsynthase	geneY
iNOS	geneY
【GOLD_R】
【PRE_R】

In this article we review the effectiveness of various antioxidant factors in COPD and their potential beneficial effect in the treatment of the disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Steroid toxicity and detoxification in ascomycetous fungi .
【GOLD_E】
Steroid	chem
【PRE_E】
Steroid	chem
【GOLD_R】
【PRE_R】

In the last couple of decades fungal infections have become a significant clinical problem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A major interest into fungal steroid action has been provoked since research has proven that steroid hormones are toxic to fungi and affect the host / fungus relationship .
【GOLD_E】
steroid	chem
steroid	chem
【PRE_E】
steroid	chem
steroid	chem
【GOLD_R】
【PRE_R】

Steroid hormones were found to differ in their antifungal activity in ascomycetous fungi Hortaea werneckii , Saccharomyces cerevisiae and Aspergillus oryzae .
【GOLD_E】
Steroid	chem
【PRE_E】
Steroid	chem
【GOLD_R】
【PRE_R】

Dehydroepiandrosterone was shown to be the strongest inhibitor of growth in all three varieties of fungi followed by androstenedione and testosterone .
【GOLD_E】
androstenedione	chem
testosterone	chem
【PRE_E】
Dehydroepiandrosterone	chem
androstenedione	chem
testosterone	chem
【GOLD_R】
【PRE_R】

For their protection , fungi use several mechanisms to lower the toxic effects of steroids .
【GOLD_E】
steroids	chem
【PRE_E】
steroids	chem
【GOLD_R】
【PRE_R】

The efficiency of biotransformation in detoxification depended on the microorganism and steroid substrate used .
【GOLD_E】
steroid	chem
【PRE_E】
steroid	chem
【GOLD_R】
【PRE_R】

Biotransformation was a relatively slow process as it also depended on the growth phase of the fungus .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition to biotransformation , steroid extrusion out of the cells contributed to the lowering of the active intracellular steroid concentration .
【GOLD_E】
steroid	chem
steroid	chem
【PRE_E】
steroid	chem
steroid	chem
【GOLD_R】
【PRE_R】

Plasma membrane Pdr5 transporter was found to be the most effective , followed by Snq2 transporter and vacuolar transporters Ybt1 and Ycf1 .
【GOLD_E】
Pdr5	geneN
Snq2	geneN
Ybt1	geneN
Ycf1	geneN
【PRE_E】
Pdr5	geneY
Snq2transporter	geneY
vacuolartransportersYbt1	geneN
Ycf1	geneY
【GOLD_R】
【PRE_R】

Proteins Aus1 and Dan1 were not found to be involved in steroid import .
【GOLD_E】
Aus1	geneN
Dan1	geneN
steroid	chem
【PRE_E】
Aus1	geneY
Dan1	geneY
steroid	chem
【GOLD_R】
【PRE_R】

The research of possible targets of steroid hormone action in fungi suggests that steroid hormones inhibit ergosterol biosynthesis in S. cerevisiae and H. werneckii .
【GOLD_E】
steroid	chem
steroid	chem
ergosterol	chem
【PRE_E】
steroidhormone	chem
steroid	chem
ergosterol	chem
【GOLD_R】
【PRE_R】

Results of this inhibition caused changes in the sterol content of the cellular membrane .
【GOLD_E】
sterol	chem
【PRE_E】
sterol	chem
【GOLD_R】
【PRE_R】

The presence of steroid hormones most probably causes the degradation of the Tat2 permease and impairment of tryptophan import .
【GOLD_E】
Tat2	geneN
steroid	chem
tryptophan	chem
【PRE_E】
steroid	chem
Tat2permease	geneN
tryptophan	chem
【GOLD_R】
steroid	Tat2	C4
【PRE_R】

Cell - cycle and DNA damage regulation of the DNA mismatch repair protein Msh2 occurs at the transcriptional and post - transcriptional level .
【GOLD_E】
DNAmismatchrepairproteinMsh2	geneY
【PRE_E】
Msh2	geneY
【GOLD_R】
【PRE_R】

DNA mismatch repair during replication is a conserved process essential for maintaining genomic stability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mismatch repair is also implicated in cell - cycle arrest and apoptosis after DNA damage .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Because yeast and human mismatch repair systems are well conserved , we have employed the budding yeast Saccharomyces cerevisiae to understand the regulation and function of the mismatch repair gene MSH2 .
【GOLD_E】
MSH2	geneY
【PRE_E】
MSH2	geneY
【GOLD_R】
【PRE_R】

Using a luciferase - based transcriptional reporter , we defined a 218 - bp region upstream of MSH2 that contains cell - cycle and DNA damage responsive elements .
【GOLD_E】
MSH2	geneY
cell-cycleandDNAdamageresponsiveelements	geneN
【PRE_E】
MSH2	geneY
【GOLD_R】
【PRE_R】

The 5 ' end of the MSH2 transcript was mapped by primer extension and was found to encode a small upstream open reading frame ( uORF ) .
【GOLD_E】
MSH2	geneY
upstreamopenreadingframe	geneN
uORF	geneN
【PRE_E】
MSH2	geneY
smallupstreamopenreadingframe	geneN
uORF	geneY
【GOLD_R】
【PRE_R】

Mutagenesis of the uORF start codon or of the uORF stop codon , which creates a continuous reading frame with MSH2 , increased Msh2 steady - state protein levels ∼ 2 - fold .
【GOLD_E】
uORFstartcodon	geneN
uORFstopcodon	geneN
MSH2	geneY
Msh2	geneY
【PRE_E】
uORF	geneY
uORF	geneY
MSH2	geneY
Msh2	geneY
【GOLD_R】
【PRE_R】

Furthermore , we found that the cell - cycle transcription factors Swi6 , Swi4 , and Mbp1 - along with SCB / MCB cell - cycle binding sites upstream of MSH2 - are all required for full basal expression of MSH2 .
【GOLD_E】
Swi6	geneY
Swi4	geneY
Mbp1	geneY
SCB/MCBcell-cyclebindingsite	geneN
MSH2	geneY
MSH2	geneY
【PRE_E】
Swi6	geneN
Swi4	geneN
Mbp1	geneY
MSH2	geneY
MSH2	geneY
【GOLD_R】
【PRE_R】

Mutagenesis of the cell - cycle boxes resulted in a minor reduction in basal Msh2 levels and a 3 - fold defect in mismatch repair .
【GOLD_E】
cell-cycleboxes	geneN
Msh2	geneY
【PRE_E】
Msh2	geneY
【GOLD_R】
【PRE_R】

Disruption of the cell - cycle boxes also affected growth in a DNA polymerase - defective strain background where mismatch repair is essential , particularly in the presence of the DNA damaging agent methyl methane sulfonate ( MMS ) .
【GOLD_E】
methylmethanesulfonate	chem
MMS	chem
cell-cycleboxes	geneN
DNApolymerase	geneN
【PRE_E】
DNApolymerase	geneN
methylmethanesulfonate	chem
MMS	chem
【GOLD_R】
【PRE_R】

Promoter replacements conferring constitutive expression of MSH2 revealed that the transcriptional induction in response to MMS is required to maintain induced levels of Msh2 .
【GOLD_E】
MSH2	geneY
Msh2	geneY
MMS	chem
【PRE_E】
Promoter	geneN
MSH2	geneY
MMS	chem
Msh2	geneY
【GOLD_R】
【PRE_R】

Turnover experiments confirmed an elevated rate of degradation in the presence of MMS .
【GOLD_E】
MMS	chem
【PRE_E】
MMS	chem
【GOLD_R】
【PRE_R】

Taken together , the data show that the DNA damage regulation of Msh2 occurs at the transcriptional and post - transcriptional levels .
【GOLD_E】
Msh2	geneY
【PRE_E】
Msh2	geneY
【GOLD_R】
【PRE_R】

The transcriptional and translational control elements identified are conserved in mammalian cells , underscoring the use of yeast as a model system to examine the regulation of MSH2 .
【GOLD_E】
MSH2	geneY
【PRE_E】
MSH2	geneY
【GOLD_R】
【PRE_R】

Inhibition of Th1 / Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin .
【GOLD_E】
icariin	chem
STAT1	geneY
STAT3	geneY
flavonoid	chem
【PRE_E】
STAT1	geneY
STAT3	geneY
flavonoidglucosideicariin	chem
【GOLD_R】
icariin	STAT1	C4
icariin	STAT3	C4
flavonoid	STAT1	C4
flavonoid	STAT3	C4
【PRE_R】
STAT1	flavonoidglucosideicariin	C4
STAT3	flavonoidglucosideicariin	C4

Inflammatory bowel disease ( IBD ) is a chronic inflammatory disorder in the intestine which involves overproduction of pro - inflammatory cytokines and excessive functions of inflammatory cells .
【GOLD_E】
cytokines	geneN
【PRE_E】
cytokines	geneN
【GOLD_R】
【PRE_R】

However , current treatments for IBD may have potential adverse effects including steroid dependence , infections and lymphoma .
【GOLD_E】
steroid	chem
【PRE_E】
steroid	chem
【GOLD_R】
【PRE_R】

Therefore new therapies or drug candidates for the treatment of IBD are desperately needed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present study we found that icariin , a major bioactive compound from plants in Epimedium family , exerted protective effect on intestinal inflammation in mice induced by dextran sulfate sodium .
【GOLD_E】
icariin	chem
sulfate	chem
sodium	chem
【PRE_E】
icariin	chem
Epimedium	chem
sulfatesodium	chem
【GOLD_R】
【PRE_R】

Oral administration of icariin significantly attenuated the disease progression and alleviated the pathological changes of colitis .
【GOLD_E】
icariin	chem
【PRE_E】
icariin	chem
【GOLD_R】
【PRE_R】

It also inhibited the production of pro - inflammatory cytokines and expression of p - p65 , p - STAT1 and p - STAT3 in colon tissues .
【GOLD_E】
cytokines	geneN
p-p65	geneY
p-STAT1	geneY
p-STAT3	geneY
【PRE_E】
cytokines	geneN
p-p65	geneY
p-STAT1	geneY
p-STAT3	geneY
【GOLD_R】
【PRE_R】

Further study showed that icariin dose - dependently inhibited the proliferation and activation of T lymphocytes , and suppressed pro - inflammatory cytokine levels of activated T cells .
【GOLD_E】
cytokine	geneN
icariin	chem
【PRE_E】
icariin	chem
cytokine	geneN
【GOLD_R】
icariin	cytokine	C4
【PRE_R】
icariin	cytokine	C4

Moreover , icariin treatment inhibited the phosphorylations of STAT1 and STAT3 in CD4 ( + ) T cells , which were the crucial transcription factors for Th1 and Th17 respectively .
【GOLD_E】
STAT1	geneY
STAT3	geneY
icariin	chem
【PRE_E】
icariin	chem
phosphorylations	geneN
STAT1	geneY
STAT3	geneY
【GOLD_R】
icariin	STAT1	C4
icariin	STAT3	C4
【PRE_R】
icariin	phosphorylations	C4
icariin	STAT1	C4
icariin	STAT3	C4

Taken together , these results indicate that icariin is a potential therapeutic agent for IBD .
【GOLD_E】
icariin	chem
【PRE_E】
icariin	chem
【GOLD_R】
【PRE_R】

Stimulatory effect of insulin on theca - interstitial cell proliferation and cell cycle regulatory proteins through MTORC1 dependent pathway .
【GOLD_E】
MTORC1	geneN
insulin	geneY
【PRE_E】
insulin	geneY
MTORC1	geneN
【GOLD_R】
【PRE_R】

The present study examined the effect of insulin - mediated activation of the mammalian target of rapamycin complex 1 ( MTORC1 ) signaling network on the proliferation of primary culture of theca - interstitial ( T - I ) cells .
【GOLD_E】
mammaliantargetofrapamycincomplex1	geneN
rapamycin	chem
MTORC1	geneN
insulin	geneY
【PRE_E】
insulin	geneN
mammaliantargetofrapamycincomplex1	geneN
MTORC1	geneN
【GOLD_R】
【PRE_R】

Our results show that insulin treatment increased proliferation of the T - I cells through the MTORC1 - dependent signaling pathway by increasing cell cycle regulatory proteins .
【GOLD_E】
MTORC1	geneN
【PRE_E】
insulin	geneY
MTORC1	geneN
【GOLD_R】
【PRE_R】

Inhibition of ERK1 / 2 signaling caused partial reduction of insulin - induced phosphorylation of RPS6KB1 and RPS6 whereas inhibition of PI3 - kinase signaling completely blocked the insulin response .
【GOLD_E】
insulin	geneY
RPS6KB1	geneY
RPS6	geneY
PI3-kinase	geneN
insulin	geneY
ERK1/2	geneN
【PRE_E】
ERK1/2	geneN
insulin	geneY
RPS6KB1	geneY
RPS6	geneY
PI3-kinase	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

Pharmacological inhibition of MTORC1 with rapamycin abrogated the insulin - induced phosphorylation of EIF4EBP1 , RPS6KB1 and its downstream effector , RPS6 .
【GOLD_E】
MTORC1	geneN
insulin	geneY
EIF4EBP1	geneY
RPS6KB1	geneY
RPS6	geneY
rapamycin	chem
【PRE_E】
MTORC1	geneN
rapamycin	chem
insulin	geneY
EIF4EBP1	geneY
RPS6KB1	geneY
RPS6	geneY
【GOLD_R】
rapamycin	insulin	C4
rapamycin	MTORC1	C4
rapamycin	EIF4EBP1	C4
rapamycin	RPS6KB1	C4
rapamycin	RPS6	C4
【PRE_R】
MTORC1	rapamycin	C4
rapamycin	insulin	C4
rapamycin	EIF4EBP1	C4
rapamycin	RPS6KB1	C4
rapamycin	RPS6	C4

These results were further confirmed by demonstrating that knockdown of Mtor using siRNA reduced the insulin - stimulated MTORC1 signaling .
【GOLD_E】
Mtor	geneY
insulin	geneY
MTORC1	geneN
【PRE_E】
Mtor	geneY
insulin	geneY
MTORC1	geneN
【GOLD_R】
【PRE_R】

Furthermore , insulin - stimulated T - I cell proliferation and the expression of cell cycle regulatory proteins CDK4 , CCND3 and PCNA were also blocked by rapamycin .
【GOLD_E】
rapamycin	chem
insulin	geneY
cellcycleregulatoryproteins	geneN
CDK4	geneY
CCND3	geneY
PCNA	geneY
【PRE_E】
insulin	geneY
CDK4	geneY
CCND3	geneY
PCNA	geneY
rapamycin	chem
【GOLD_R】
rapamycin	insulin	C4
rapamycin	cellcycleregulatoryproteins	C4
rapamycin	CDK4	C4
rapamycin	CCND3	C4
rapamycin	PCNA	C4
【PRE_R】
CDK4	rapamycin	C4
CCND3	rapamycin	C4
PCNA	rapamycin	C4

Taken together , the present studies show that insulin stimulates cell proliferation and cell cycle regulatory proteins in T - I cells via activation of the MTORC1 signaling pathway .
【GOLD_E】
MTORC1	geneN
【PRE_E】
insulin	geneY
MTORC1	geneN
【GOLD_R】
【PRE_R】

The conserved PHD1 - PHD2 domain of ZFP - 1 / AF10 is a discrete functional module essential for viability in Caenorhabditis elegans .
【GOLD_E】
PHD1-PHD2domain	geneN
ZFP-1	geneY
AF10	geneY
【PRE_E】
PHD1-PHD2domain	geneN
ZFP-1	geneY
AF10	geneY
【GOLD_R】
【PRE_R】

Plant homeodomain ( PHD ) - type zinc fingers play an important role in recognizing chromatin modifications and recruiting regulatory proteins to specific genes .
【GOLD_E】
zinc	chem
Planthomeodomain(PHD)-typezincfingers	geneN
【PRE_E】
Planthomeodomain	geneN
PHD	geneN
zinc	chem
【GOLD_R】
【PRE_R】

A specific module containing a conventional PHD finger followed by an extended PHD finger exists in the mammalian AF10 protein , among a few others .
【GOLD_E】
PHDfinger	geneN
PHDfinger	geneN
AF10	geneN
【PRE_E】
PHD	geneN
PHDfinger	geneN
mammalianAF10	geneY
【GOLD_R】
【PRE_R】

AF10 has mostly been studied in the context of the leukemic MLL - AF10 fusion protein , which lacks the N - terminal PHD fingers of AF10 .
【GOLD_E】
AF10	geneY
MLL	geneY
AF10	geneY
N-terminalPHDfingers	geneN
AF10	geneY
N	chem
【PRE_E】
AF10	geneY
leukemicMLL	geneY
AF10	geneY
N	chem
PHD	geneN
AF10	geneY
【GOLD_R】
【PRE_R】

Although this domain of AF10 is the most conserved region of the protein , its biological significance has not been elucidated .
【GOLD_E】
AF10	geneY
【PRE_E】
AF10	geneY
【GOLD_R】
【PRE_R】

In this study , we used genetic and biochemical approaches to examine the PHD1 - PHD2 region of the Caenorhabditis elegans ortholog of AF10 , zinc finger protein 1 ( ZFP - 1 ) .
【GOLD_E】
PHD1-PHD2	geneN
AF10	geneY
zincfingerprotein1	geneY
ZFP-1	geneY
zinc	chem
【PRE_E】
PHD1	geneY
PHD2	geneY
AF10	geneY
zincfingerprotein1	geneY
ZFP-1	geneY
【GOLD_R】
【PRE_R】

We demonstrate that the PHD1 - PHD2 region is essential for viability and that the first PHD finger contributes to the preferred binding of PHD1 - PHD2 to lysine 4 - methylated histone H3 tails .
【GOLD_E】
PHD1-PHD2	geneN
PHDfinger	geneN
PHD1-PHD2	geneN
lysine	chem
【PRE_E】
PHD1	geneY
PHD2	geneY
PHDfinger	geneN
PHD1	geneY
PHD2	geneY
lysine4-methylatedhistoneH3	geneN
【GOLD_R】
【PRE_R】

Moreover , we show that ZFP - 1 localization peaks overlap with H3K4 methylation - enriched promoters of actively expressed genes genomewide and that H3K4 methylation is important for ZFP - 1 localization to promoters in the embryo .
【GOLD_E】
ZFP-1	geneY
ZFP-1	geneY
【PRE_E】
ZFP-1	geneY
H3K4	geneY
H3K4	geneY
ZFP-1	geneY
【GOLD_R】
【PRE_R】

We predict that the essential biological role of the PHD1 - PHD2 module of ZFP - 1 / AF10 is connected to the regulation of actively expressed genes during early development .
【GOLD_E】
PHD1-PHD2	geneN
ZFP-1	geneY
AF10	geneY
【PRE_E】
PHD1	geneY
PHD2	geneY
ZFP-1	geneY
AF10	geneY
【GOLD_R】
【PRE_R】

Novel limonene and citral based 2,5 - disubstituted - 1,3,4 - oxadiazoles : a natural product coupled approach to semicarbazones for antiepileptic activity .
【GOLD_E】
semicarbazones	chem
citral	chem
2,5-disubstituted-1,3,4-oxadiazoles	chem
limonene	chem
【PRE_E】
limonene	chem
citral	chem
2,5-disubstituted-1,3,4-oxadiazoles	chem
semicarbazones	chem
【GOLD_R】
【PRE_R】

Two novel series of N ( 4 ) - ( 5 - ( 2 / 3 / 4 - substituted - phenyl ) - 1,3,4 - oxadiazol - 2 - yl ) - N ( 1 ) - ( 2 - methyl - 5 - ( prop - 1 - en - 2 - yl ) cyclohex - 2 - enylidene ) semicarbazide and N ( 4 ) - ( 5 - ( 2 / 3 / 4 - substituted - phenyl ) - 1,3,4 - oxadiazol - 2 - yl ) - N ( 1 ) - ( 3,7 - dimethylocta - 3,6 - dienylidene ) - semicarbazide were synthesized to meet structural prerequisite indispensable for anticonvulsant activity .
【GOLD_E】
N(4)-(5-(2/3/4-substituted-phenyl)-1,3,4-oxadiazol-2-yl)-N(1)-(3,7-dimethylocta-3,6-dienylidene)-semicarbazide	chem
N(4)-(5-(2/3/4-substituted-phenyl)-1,3,4-oxadiazol-2-yl)-N(1)-(2-methyl-5-(prop-1-en-2-yl)cyclohex-2-enylidene)semicarbazide	chem
【PRE_E】
N(4)-(5-(2/3/4-substituted-phenyl)-1,3,4-oxadiazol-2-yl)-N(1)-(2-methyl-5-(prop-1-en-2-yl)cyclohex-2-enylidene)semicarbazide	chem
N(4)	chem
5-(2/3/4-substituted-phenyl)-1,3,4-oxadiazol-2-yl)-N(1)-(3,7-dimethylocta-3,6-dienylidene)-semicarbazide	chem
【GOLD_R】
【PRE_R】

The anticonvulsant activities of the compounds were investigated using maximal electroshock seizure ( MES ) , subcutaneous pentylenetrtrazole ( scPTZ ) and subcutaneous strychnine ( scSTY ) models .
【GOLD_E】
pentylenetrtrazole	chem
strychnine	chem
【PRE_E】
scPTZ	chem
strychnine	chem
scSTY	chem
【GOLD_R】
【PRE_R】

The rotorod test was conducted to evaluate neurotoxicity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Some of the selected active compounds were subjected to GABA assay to confirm their mode of action .
【GOLD_E】
GABA	chem
【PRE_E】
GABA	chem
【GOLD_R】
【PRE_R】

The outcome of the present investigations proved that the four binding sites pharmacophore model is vital for anticonvulsant activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The efforts were also made to establish structure - activity relationships among test compounds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synthesis and evaluation of 8 - oxoadenine derivatives as potent Toll - like receptor 7 agonists with high water solubility .
【GOLD_E】
Toll-likereceptor7	geneY
8-oxoadenine	chem
【PRE_E】
8-oxoadenine	chem
Toll-likereceptor7	geneY
【GOLD_R】
8-oxoadenine	Toll-likereceptor7	C5
【PRE_R】
8-oxoadenine	Toll-likereceptor7	C5

We report the discovery of novel series of highly potent TLR7 agonists based on 8 - oxoadenines , 1 and 2 by introducing and optimizing various tertiary amines onto the N ( 9 ) - position of the adenine moiety .
【GOLD_E】
tertiaryamines	chem
N	chem
adenine	chem
8-oxoadenines	chem
TLR7	geneY
【PRE_E】
TLR7	geneY
8-oxoadenines	chem
amines	chem
N(9)	chem
adenine	chem
【GOLD_R】
tertiaryamines	TLR7	C5
N	TLR7	C5
adenine	TLR7	C5
8-oxoadenines	TLR7	C5
【PRE_R】

The introduction of the amino group resulted in not only improved water solubility but also enhanced TLR7 agonistic activity .
【GOLD_E】
amino	chem
TLR7	geneY
【PRE_E】
amino	chem
TLR7	geneY
【GOLD_R】
amino	TLR7	C5
【PRE_R】

In particular compound 20 ( DSR - 6434 ) indicated an optimal balance between the agonistic potency and high water solubility .
【GOLD_E】
DSR-6434	chem
【PRE_E】
【GOLD_R】
【PRE_R】

It also demonstrated a strong antitumor effect in vivo by intravenous administration in a tumor bearing mice model .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Discovery of liver - targeted inhibitors of stearoyl - CoA desaturase ( SCD1 ) .
【GOLD_E】
stearoyl-CoA	chem
stearoyl-CoAdesaturase	geneY
SCD1	geneY
【PRE_E】
stearoyl-CoAdesaturase	geneY
SCD1	geneY
【GOLD_R】
【PRE_R】

Inhibitors based on a benzo - fused spirocyclic oxazepine scaffold were discovered for stearoyl - coenzyme A ( CoA ) desaturase 1 ( SCD1 ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model .
【GOLD_E】
stearoyl-coenzymeA	chem
SCD1	geneY
stearoyl-coenzymeA(CoA)desaturase1	geneY
CoA	chem
benzo-fusedspirocyclicoxazepine	chem
【PRE_E】
benzo-fusedspirocyclicoxazepine	chem
stearoyl-coenzymeA(CoA)desaturase1	geneY
SCD1	geneY
【GOLD_R】
benzo-fusedspirocyclicoxazepine	SCD1	C4
benzo-fusedspirocyclicoxazepine	stearoyl-coenzymeA(CoA)desaturase1	C4
【PRE_R】
benzo-fusedspirocyclicoxazepine	SCD1	C4

Initial optimization revealed potency preferences for the oxazepine core and benzylic positions , while substituents on the piperidine portions were more tolerant and allowed for tuning of potency and PK properties .
【GOLD_E】
oxazepine	chem
benzylic	chem
piperidine	chem
【PRE_E】
oxazepine	chem
benzylic	chem
piperidine	chem
【GOLD_R】
【PRE_R】

After preparation and testing of a range of functional groups on the piperidine nitrogen , three classes of analogs were identified with single digit nanomolar potency : glycine amides , heterocycle - linked amides , and thiazoles .
【GOLD_E】
amides	chem
thiazoles	chem
piperidine	chem
nitrogen	chem
glycineamides	chem
【PRE_E】
piperidinenitrogen	chem
glycineamides	chem
heterocycle	chem
amides	chem
thiazoles	chem
【GOLD_R】
【PRE_R】

Responding to concerns about target localization and potential mechanism - based side effects , an initial effort was also made to improve liver concentration in an available rat PK model .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

An advanced compound 17m with a 5 - carboxy - 2 - thiazole substructure appended to the spirocyclic piperidine scaffold was developed which satisfied the in vitro and in vivo requirements for more detailed studies .
【GOLD_E】
5-carboxy-2-thiazole	chem
spirocyclicpiperidine	chem
【PRE_E】
5-carboxy-2-thiazole	chem
spirocyclicpiperidine	chem
【GOLD_R】
【PRE_R】

N - acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver .
【GOLD_E】
N-acetylgalactosamine	chem
【PRE_E】
N-acetylgalactosamine	chem
【GOLD_R】
【PRE_R】

Due to its efficient and specific gene silencing ability , RNA interference has shown great potential in the treatment of liver diseases .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , achieving in vivo delivery of siRNA to critical liver cells remains the biggest obstacle for this technique to be a real clinic therapeutic modality .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we describe a promising liver targeting siRNA delivery system based on N - acetylgalactosamine functionalized mixed micellar nanoparticles ( Gal - MNP ) , which can efficiently deliver siRNA to hepatocytes and silence the target gene expression after systemic administration .
【GOLD_E】
N-acetylgalactosamine	chem
【PRE_E】
N-acetylgalactosamine	chem
Gal-MNP	chem
【GOLD_R】
【PRE_R】

The Gal - MNP were assembled in aqueous solution from mixed N - acetylgalactosamine functionalized poly ( ethylene glycol ) - b - poly ( ε - caprolactone ) and cationic poly ( ε - caprolactone ) - b - poly ( 2 - aminoethyl ethylene phosphate ) ( PCL - b - PPEEA ) ; the properties of nanoparticles , including particle size , zeta potential and the density of poly ( ethylene glycol ) could be easily regulated .
【GOLD_E】
N-acetylgalactosamine	chem
poly(ethyleneglycol)-b-poly(ε-caprolactone)	chem
poly(ε-caprolactone)-b-poly(2-aminoethylethylenephosphate)	chem
PCL-b-PPEEA	chem
poly(ethyleneglycol)	chem
【PRE_E】
Gal-MNP	chem
N-acetylgalactosamine	chem
poly(ethyleneglycol)-b-poly(ε-caprolactone	chem
poly(ε-caprolactone)-b-poly(2-aminoethylethylenephosphate)	chem
PCL-b-PPEEA	chem
poly(ethyleneglycol)	chem
【GOLD_R】
【PRE_R】

The hepatocyte - targeting effect of Gal - MNP was demonstrated by significant enriching of fluorescent siRNA in primary hepatocytes in vitro and in vivo .
【GOLD_E】
【PRE_E】
Gal-MNP	chem
【GOLD_R】
【PRE_R】

Successful down - regulation of liver - specific apolipoprotein B ( apoB ) expression was achieved in mouse liver , at both the transcriptional and protein level , following intravenous injection of Gal - MNP / siapoB to BALB / c mice .
【GOLD_E】
apoB	geneY
apolipoproteinB	geneY
apoB	geneY
【PRE_E】
apolipoproteinB	geneY
apoB	geneY
Gal	chem
【GOLD_R】
【PRE_R】

Systemic delivery of Gal - MNP / siRNA did not induce the innate immune response or positive hepatotoxicity .
【GOLD_E】
【PRE_E】
Gal	chem
MNP	chem
【GOLD_R】
【PRE_R】

The results of this study suggested therapeutic potential for the Gal - MNP / siRNA system in liver disease .
【GOLD_E】
【PRE_E】
Gal	chem
MNP	chem
【GOLD_R】
【PRE_R】

Effects of Yerba Mate tea ( Ilex paraguariensis ) on vascular endothelial function and liver lipoprotein receptor gene expression in hyperlipidemic rats .
【GOLD_E】
lipoproteinreceptor	geneN
【PRE_E】
Yerba	chem
liverlipoproteinreceptor	geneY
【GOLD_R】
【PRE_R】

Yerba Mate tea ( Mate ) , an infusion made from the leaves of the tree Ilex paraguariensis , is a widely consumed beverage in South America .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study was performed to investigate the effect of Mate tea on vascular endothelial dysfunction and liver lipoprotein receptor gene expression in hyperlipidemic rats , with the aim of gaining insight into its known lipid - lowering protective mechanisms .
【GOLD_E】
lipoproteinreceptor	geneN
【PRE_E】
liverlipoproteinreceptor	geneY
【GOLD_R】
【PRE_R】

Sixty male Sprague - Dawley rats were randomly divided into five groups : a normal control group ( NC ) , a high - fat diet group ( HC ) , and three Mate tea - treated groups .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the NC group , rats were fed with standard diet while in the other groups the rats were fed a high - fat diet for 8weeks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the Mate tea - treated groups , the rats were fed a high - fat diet supplemented with low , moderate or high concentrations of aqueous Mate tea extract for the final 4weeks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Compared to the HC group , aqueous Mate tea extract significantly reduced endothelin ( ET ) and thromboxane B ( 2 ) ( TXB ( 2 ) ) levels and increased nitric oxide ( NO ) and 6 - keto prostaglandin F ( 1α ) ( 6 - keto - PGF ( 1α ) ) levels in the blood , reduced the pathological damage of vascular endothelial cells , decreased intercellular adhesion molecule - 1 ( ICAM - 1 ) protein expression in the thoracic aorta , and upregulated mRNA expression of hepatic low density lipoprotein receptor ( LDLR ) and scavenger receptor B1 ( SR - B1 ) .
【GOLD_E】
LDLR	geneY
scavengerreceptorB1	geneY
SR-B1	geneY
endothelin	geneN
ET	geneN
NO	chem
6-ketoprostaglandinF(1α)	chem
6-keto-PGF(1α)	chem
thromboxaneB(2)	chem
TXB(2)	chem
nitricoxide	chem
intercellularadhesionmolecule-1	geneY
ICAM-1	geneY
lowdensitylipoproteinreceptor	geneY
【PRE_E】
endothelin(ET)	geneY
thromboxaneB(2)	chem
TXB(2)	geneY
nitricoxide	chem
NO	chem
6-ketoprostaglandinF	chem
1α)	chem
6-keto-PGF(1α)	chem
intercellularadhesionmolecule-1	geneY
ICAM-1	geneY
lowdensitylipoproteinreceptor	geneY
LDLR	geneY
scavengerreceptorB1	geneY
SR-B1	geneY
【GOLD_R】
【PRE_R】
endothelin(ET)	6-ketoprostaglandinF	C4
6-ketoprostaglandinF	intercellularadhesionmolecule-1	C4
1α)	intercellularadhesionmolecule-1	C4
6-keto-PGF(1α)	intercellularadhesionmolecule-1	C4

These findings indicate that Mate tea administration might have a regulatory effect on blood fat and endothelial function in hyperlipidemia rats .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mechanism may involve protecting vascular endothelial cell function and upregulating the expression of LDLR and SR - B1 genes , thereby inhibiting the occurrence of atherosclerosis .
【GOLD_E】
LDLR	geneY
SR-B1	geneY
【PRE_E】
LDLR	geneY
SR-B1	geneY
【GOLD_R】
【PRE_R】

Development of hypoxia - inducible factor ( HIF ) - 1α inhibitors : effect of ortho - carborane substituents on HIF transcriptional activity under hypoxia .
【GOLD_E】
HIF	geneN
hypoxia-induciblefactor(HIF)-1α	geneY
ortho-carborane	chem
【PRE_E】
hypoxia-induciblefactor(HIF)-1α	geneY
ortho-carborane	chem
HIF	geneN
【GOLD_R】
【PRE_R】

A series of substituted ortho - carboranylphenoxyacetanilides were synthesized and evaluated for their ability to inhibit hypoxia - induced HIF - 1 transcriptional activity using a cell - based reporter assay in HeLa cells expressing the HRE - dependent firefly luciferase reporter construct ( HRE - Luc ) and constitutively expressing CMV - driven Renilla luciferase reporter , and their ability to inhibit cell growth ( GI ( 50 ) ) using the MTT assay .
【GOLD_E】
ortho-carboranylphenoxyacetanilides	chem
MTT	chem
HIF-1	geneN
HRE	geneN
HRE	geneN
【PRE_E】
ortho-carboranylphenoxyacetanilides	chem
HIF-1	geneN
HRE	geneY
HRE	geneY
CMV	geneY
Renilla	geneY
MTT	chem
【GOLD_R】
【PRE_R】
ortho-carboranylphenoxyacetanilides	HIF-1	C4
ortho-carboranylphenoxyacetanilides	HRE	C4
ortho-carboranylphenoxyacetanilides	HRE	C4
Renilla	MTT	C4

Among the compounds synthesized , 1g and 1l showed significant inhibition of hypoxia - induced HIF - 1 transcriptional activity ( IC ( 50 ) : 1.9 ± 0.4 and 1.4 ± 0.2 μM , respectively ) .
【GOLD_E】
HIF-1	geneN
【PRE_E】
HIF-1	geneN
【GOLD_R】
【PRE_R】

Both compounds suppressed HIF - 1α accumulation in a concentration - dependent manner .
【GOLD_E】
HIF-1α	geneY
【PRE_E】
HIF-1α	geneY
【GOLD_R】
【PRE_R】

The porcine heart malate dehydrogenase ( MDH ) refolding assay revealed that compound 1l inhibited human Hsp60 chaperone activity ( IC ( 50 ) : 6.80 ± 0.25 μM ) and this inhibition activity was higher than that of ETB ( IC ( 50 ) : 10.9 ± 0.63 μM ) .
【GOLD_E】
porcineheartmalatedehydrogenase	geneN
MDH	geneN
humanHsp60	geneY
malate	chem
ETB	chem
【PRE_E】
porcineheartmalatedehydrogenase	geneY
MDH	geneN
humanHsp60chaperone	geneN
ETB	geneY
【GOLD_R】
ETB	humanHsp60	C4
【PRE_R】

Apocynin and raisanberine alleviate intermittent hypoxia induced abnormal StAR and 3β - HSD and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes .
【GOLD_E】
Apocynin	chem
raisanberine	chem
testosterone	chem
p66Shc	geneY
StAR	geneY
3β-HSD	geneN
【PRE_E】
Apocynin	chem
raisanberine	chem
StAR	geneN
3β-HSD	geneY
testosterone	chem
p66Shc	geneY
【GOLD_R】
Apocynin	p66Shc	C4
raisanberine	p66Shc	C4
raisanberine	3β-HSD	C9
【PRE_R】
Apocynin	StAR	C3
raisanberine	StAR	C3
raisanberine	3β-HSD	C3
raisanberine	p66Shc	C3

We hypothesized that hypoxia induced testicular damage is mediated by an activated NADPH oxidase ( NOX ) , therefore , APO ( apocynin ) an inhibitor of NOX and raisanberine ( RS ) , a calcium influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis .
【GOLD_E】
NOX	geneN
APO	chem
NADPHoxidase	geneN
NOX	geneN
apocynin	chem
raisanberine	chem
calcium	chem
NADPH	chem
【PRE_E】
NADPHoxidase	geneN
NOX	geneN
APO	geneN
apocynin	chem
NOX	geneN
raisanberine	chem
RS	chem
calcium	chem
【GOLD_R】
APO	NOX	C4
apocynin	NOX	C4
【PRE_R】

Male Sprague - Dawley rats were exposed to hypoxia ( 10±0.5 % O2 ) for 17d and intervened with APO and RS in the last 6d .
【GOLD_E】
APO	chem
【PRE_E】
O2	chem
APO	geneN
【GOLD_R】
【PRE_R】

Histological changes and expression of pro - inflammation factors were evaluated in vivo .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Biomarkers in isolated Leydig cells incubated with H2O2 were also assayed in vitro .
【GOLD_E】
H2O2	chem
【PRE_E】
H2O2	chem
【GOLD_R】
【PRE_R】

Hypoxic rats displayed lower serum testosterone and higher LH and FSH .
【GOLD_E】
LH	geneN
FSH	geneN
testosterone	chem
【PRE_E】
testosterone	chem
LH	geneN
FSH	geneN
【GOLD_R】
【PRE_R】

Upregulation of p22 / p47 ( phox ) , NOX2 , MMP9 , PERK and p66Shc was associated with downregulation of StAR , 3β - HSD and Cx43 in the hypoxia testis , revealed by Western blot and immunohistochemical assay , respectively .
【GOLD_E】
p22/p47(phox)	geneN
NOX2	geneY
MMP9	geneY
PERK	geneY
p66Shc	geneY
StAR	geneY
3β-HSD	geneN
Cx43	geneY
【PRE_E】
p22/p47	geneY
phox	geneY
NOX2	geneY
MMP9	geneY
PERK	geneY
p66Shc	geneY
StAR	geneY
3β-HSD	geneY
Cx43	geneY
【GOLD_R】
【PRE_R】

APO and RS at least partially normalize hypoxia caused male hypogonadism by suppressing ER stress , and p66Shc in testes .
【GOLD_E】
p66Shc	geneY
APO	chem
【PRE_E】
APOandRS	geneN
p66Shc	geneY
【GOLD_R】
APO	p66Shc	C4
【PRE_R】

Coming full circle : contributions of central and peripheral oxytocin actions to energy balance .
【GOLD_E】
oxytocin	geneY
oxytocin	chem
【PRE_E】
oxytocin	geneY
【GOLD_R】
【PRE_R】

The neuropeptide oxytocin has emerged as an important anorexigen in the regulation of energy balance .
【GOLD_E】
oxytocin	chem
anorexigen	chem
oxytocin	geneY
【PRE_E】
oxytocin	geneY
【GOLD_R】
【PRE_R】

Its effects on food intake have largely been attributed to limiting meal size through interactions in key regulatory brain regions such as the hypothalamus and hindbrain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Pharmacologic and pair - feeding studies indicate that its ability to reduce body mass extends beyond that of food intake , affecting multiple factors that determine energy balance such as energy expenditure , lipolysis , and glucose regulation .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

Systemic administration of oxytocin recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating oxytocin contributes to energy regulation .
【GOLD_E】
oxytocin	geneY
oxytocin	chem
oxytocin	chem
oxytocin	geneY
【PRE_E】
oxytocin	geneY
oxytocin	geneY
【GOLD_R】
【PRE_R】

Its therapeutic potential to treat metabolic conditions remains to be determined , but data from diet - induced and genetically obese rodent models as well as application of oxytocin in humans in other areas of research have revealed promising results thus far .
【GOLD_E】
oxytocin	geneY
oxytocin	chem
【PRE_E】
oxytocin	geneY
【GOLD_R】
【PRE_R】

Arsenic suppresses cell survival via Pirh2 - mediated proteasomal degradation of Δ Np63 protein .
【GOLD_E】
Pirh2	geneY
ΔNp63	geneY
Arsenic	chem
【PRE_E】
Arsenic	chem
Pirh2	geneY
ΔNp63	geneY
【GOLD_R】
【PRE_R】
Arsenic	Pirh2	C3
Arsenic	ΔNp63	C3

Transcription factor p63 , a member of the p53 family , shares a high degree of sequence similarity with p53 .
【GOLD_E】
p53	geneY
p53	geneY
Transcriptionfactorp63	geneY
【PRE_E】
p63	geneY
p53	geneY
p53	geneY
【GOLD_R】
【PRE_R】

Because of transcription from two distinct promoters , the p63 gene encodes two isoforms , TAp63 and Δ Np63 .
【GOLD_E】
p63	geneN
TAp63	geneY
ΔNp63	geneY
【PRE_E】
p63	geneN
TAp63	geneY
ΔNp63	geneY
【GOLD_R】
【PRE_R】

Although TAp63 acts as a tumor suppressor , Δ Np63 functions as an oncogene and is often overexpressed in squamous cell carcinomas .
【GOLD_E】
TAp63	geneY
ΔNp63	geneY
【PRE_E】
TAp63	geneY
ΔNp63	geneY
【GOLD_R】
【PRE_R】

Thus , therapeutic agents targeting Δ Np63 might be used to manage tumors that overexpress Δ Np63 .
【GOLD_E】
ΔNp63	geneY
ΔNp63	geneY
【PRE_E】
ΔNp63	geneY
ΔNp63	geneY
【GOLD_R】
【PRE_R】

Here we found that arsenic trioxide , a frontline agent for acute promyelocytic leukemia , inhibits Δ Np63 but not TAp63 expression in time - and dose - dependent manners .
【GOLD_E】
ΔNp63	geneY
TAp63	geneY
arsenictrioxide	chem
【PRE_E】
arsenictrioxide	chem
ΔNp63	geneY
TAp63	geneY
【GOLD_R】
arsenictrioxide	ΔNp63	C4
【PRE_R】
arsenictrioxide	ΔNp63	C4
arsenictrioxide	TAp63	C4

In addition , we found that arsenic trioxide decreases the stability of Δ Np63 protein via a proteasome - dependent pathway but has little effect on the level of Δ Np63 transcript .
【GOLD_E】
ΔNp63	geneY
proteasome	geneN
ΔNp63	geneY
arsenictrioxide	chem
【PRE_E】
arsenictrioxide	chem
ΔNp63	geneY
proteasome	geneN
ΔNp63	geneY
【GOLD_R】
arsenictrioxide	ΔNp63	C4
【PRE_R】
arsenictrioxide	ΔNp63	C4
arsenictrioxide	proteasome	C4

Furthermore , we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression .
【GOLD_E】
Pirh2promoter	geneN
Pirh2	geneY
arsenictrioxide	chem
【PRE_E】
arsenictrioxide	chem
Pirh2promoter	geneN
Pirh2	geneY
【GOLD_R】
arsenictrioxide	Pirh2promoter	C3
arsenictrioxide	Pirh2	C3
【PRE_R】
arsenictrioxide	Pirh2promoter	C3
arsenictrioxide	Pirh2	C3

Consistent with this , we found that knockdown of Pirh2 inhibits , whereas ectopic expression of Pirh2 enhances , arsenic - induced degradation of Δ Np63 protein .
【GOLD_E】
ΔNp63	geneY
arsenic	chem
Pirh2	geneY
Pirh2	geneY
【PRE_E】
Pirh2	geneY
Pirh2	geneY
arsenic	chem
ΔNp63	geneY
【GOLD_R】
arsenic	ΔNp63	C4
【PRE_R】
arsenic	ΔNp63	C3

Importantly , we found that knockdown of Δ Np63 sensitizes , whereas ectopic expression of Δ Np63 inhibits , growth suppression induced by arsenic .
【GOLD_E】
ΔNp63	geneY
ΔNp63	geneY
arsenic	chem
【PRE_E】
ΔNp63	geneY
ΔNp63	geneY
arsenic	chem
【GOLD_R】
【PRE_R】
ΔNp63	arsenic	C4

Together , these data suggest that arsenic degrades Δ Np63 protein at least in part via Pirh2 - dependent proteolysis and that inhibition of Δ Np63 expression facilitates tumor cells to arsenic - induced death .
【GOLD_E】
ΔNp63	geneY
Pirh2	geneY
ΔNp63	geneY
arsenic	chem
arsenic	chem
【PRE_E】
arsenic	chem
ΔNp63	geneY
Pirh2	geneY
ΔNp63	geneY
arsenic	chem
【GOLD_R】
arsenic	ΔNp63	C4
arsenic	ΔNp63	C4
【PRE_R】

Jaceosidin , isolated from dietary mugwort ( Artemisia princeps ) , induces G2 / M cell cycle arrest by inactivating cdc25C - cdc2 via ATM - Chk1 / 2 activation .
【GOLD_E】
Jaceosidin	chem
cdc25C	geneY
cdc2	geneY
ATM	geneY
Chk1/2	geneN
【PRE_E】
Jaceosidin	chem
mugwort	chem
Artemisia	chem
cdc25C-cdc2	geneY
ATM	geneY
Chk1/2	geneN
【GOLD_R】
Jaceosidin	ATM	C3
Jaceosidin	cdc25C	C4
Jaceosidin	cdc2	C4
【PRE_R】
Jaceosidin	cdc25C-cdc2	C4
mugwort	cdc25C-cdc2	C4
Artemisia	cdc25C-cdc2	C4
Artemisia	ATM	C4
Artemisia	Chk1/2	C4

Jaceosidin , a flavonoid derived from Artemisia princeps ( Japanese mugwort ) , has been shown to inhibit the growth of several human cancer cells , However , the exact mechanism for the cytotoxic effect of jaceosidin is not completely understood .
【GOLD_E】
Jaceosidin	chem
flavonoid	chem
jaceosidin	chem
【PRE_E】
Jaceosidin	chem
flavonoid	chem
jaceosidin	chem
【GOLD_R】
【PRE_R】

In this study , we investigated the molecular mechanism involved in the antiproliferative effect of jaceosidin in human endometrial cancer cells .
【GOLD_E】
jaceosidin	chem
【PRE_E】
jaceosidin	chem
【GOLD_R】
【PRE_R】

We demonstrated that jaceosidin is a more potent inhibitor of cell growth than cisplatin in human endometrial cancer cells .
【GOLD_E】
jaceosidin	chem
cisplatin	chem
【PRE_E】
jaceosidin	chem
cisplatin	chem
【GOLD_R】
【PRE_R】

In contrast , jaceosidin - induced cytotoxicity in normal endometrial cells was lower than that observed for cisplatin .
【GOLD_E】
jaceosidin	chem
cisplatin	chem
【PRE_E】
jaceosidin	chem
cisplatin	chem
【GOLD_R】
【PRE_R】

Jaceosidin induced G2 / M phase cell cycle arrest and modulated the levels of cyclin B and p - Cdc2 in Hec1A cells .
【GOLD_E】
Jaceosidin	chem
cyclinB	geneY
p-Cdc2	geneY
【PRE_E】
Jaceosidin	chem
cyclinB	geneY
p-Cdc2	geneY
【GOLD_R】
【PRE_R】
Jaceosidin	p-Cdc2	C4

Knockdown of p21 using specific siRNAs partially abrogated jaceosidin - induced cell growth inhibition .
【GOLD_E】
jaceosidin	chem
p21	geneY
【PRE_E】
p21	geneY
jaceosidin	chem
【GOLD_R】
【PRE_R】

Additional mechanistic studies revealed that jaceosidin treatment resulted in an increase in phosphorylation of Cdc25C and ATM - Chk1 / 2 .
【GOLD_E】
jaceosidin	chem
Cdc25C	geneY
ATM	geneY
Chk1/2	geneN
【PRE_E】
jaceosidin	chem
Cdc25C	geneY
ATM-Chk1/2	geneN
【GOLD_R】
jaceosidin	Cdc25C	C3
jaceosidin	ATM	C3
【PRE_R】

Ku55933 , an ATM inhibitor , reversed jaceosidin - induced cell growth inhibition , in part .
【GOLD_E】
jaceosidin	chem
ATM	geneY
【PRE_E】
Ku55933	chem
ATM	geneY
jaceosidin	chem
【GOLD_R】
【PRE_R】
Ku55933	ATM	C4
ATM	jaceosidin	C4

Moreover , jaceosidin treatment resulted in phosphorylation of ERK , and pretreatment with the ERK inhibitor , PD98059 , attenuated cell growth inhibition by jaceosidin .
【GOLD_E】
ERK	geneN
ERK	geneN
jaceosidin	chem
PD98059	chem
jaceosidin	chem
【PRE_E】
jaceosidin	chem
ERK	geneN
ERK	geneN
PD98059	chem
jaceosidin	chem
【GOLD_R】
PD98059	ERK	C4
【PRE_R】
jaceosidin	ERK	C4
ERK	PD98059	C4
ERK	jaceosidin	C4

These data suggest that jaceosidin , isolated from Japanese mugwort , modulates the ERK / ATM / Chk1 / 2 pathway , leading to inactivation of the Cdc2 - cyclin B1 complex , followed by G2 / M cell cycle arrest in endometrial cancer cells .
【GOLD_E】
ERK	geneN
ATM	geneY
Chk1/2	geneN
Cdc2	geneY
cyclinB1	geneY
jaceosidin	chem
【PRE_E】
jaceosidin	chem
ERK	geneN
ATM	geneY
Chk1/2	geneN
Cdc2	geneY
cyclinB1	geneY
【GOLD_R】
jaceosidin	Cdc2	C4
jaceosidin	cyclinB1	C4
【PRE_R】
jaceosidin	ERK	C4
jaceosidin	ATM	C4
jaceosidin	Chk1/2	C4
jaceosidin	Cdc2	C4
jaceosidin	cyclinB1	C4

EphA5 - EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine / glutamate balance during hypoglycemia .
【GOLD_E】
glutamine	chem
glutamate	chem
EphA5	geneY
EphrinA5	geneY
【PRE_E】
EphA5	geneY
EphrinA5	geneY
counterregulatoryhormone	geneY
glutamine	chem
glutamate	chem
【GOLD_R】
【PRE_R】

Activation of β - cell EphA5 receptors by its ligand ephrinA5 from adjacent β - cells has been reported to decrease insulin secretion during hypoglycemia .
【GOLD_E】
EphA5receptors	geneY
ephrinA5	geneY
【PRE_E】
β-cellEphA5	geneY
ephrinA5	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Given the similarities between islet and ventromedial hypothalamus ( VMH ) glucose sensing , we tested the hypothesis that the EphA5 / ephrinA5 system might function within the VMH during hypoglycemia to stimulate counterregulatory hormone release as well .
【GOLD_E】
EphA5	geneY
ephrinA5	geneY
glucose	chem
【PRE_E】
VMH	chem
glucose	chem
EphA5	geneY
ephrinA5	geneY
counterregulatoryhormone	geneY
【GOLD_R】
【PRE_R】

Counterregulatory responses and glutamine / glutamate concentrations in the VMH were assessed during a hyperinsulinemic - hypoglycemic glucose clamp study in chronically catheterized awake male Sprague - Dawley rats that received an acute VMH microinjection of ephrinA5 - Fc , chronic VMH knockdown , or overexpression of ephrinA5 using an adenoassociated viral construct .
【GOLD_E】
glucose	chem
ephrinA5	geneY
ephrinA5	geneY
glutamine	chem
glutamate	chem
【PRE_E】
glutamine	chem
glutamate	chem
VMH	geneY
glucose	chem
VMH	geneY
ephrinA5-Fc	geneY
VMH	geneY
ephrinA5	geneY
【GOLD_R】
【PRE_R】
glucose	VMH	C3
glucose	ephrinA5-Fc	C3

Local stimulation of VMH EphA5 receptors by ephrinA5 - Fc or ephrinA5 overexpression increased , whereas knockdown of VMH ephrinA5 reduced counterregulatory responses during hypoglycemia .
【GOLD_E】
EphA5receptors	geneY
ephrinA5-Fc	geneY
ephrinA5	geneY
ephrinA5	geneY
【PRE_E】
VMHEphA5receptors	geneN
ephrinA5	geneY
Fc	geneY
ephrinA5	geneY
VMH	geneN
ephrinA5	geneY
【GOLD_R】
【PRE_R】

Overexpression of VMH ephrinA5 transiently increased local glutamate concentrations , whereas ephrinA5 knockdown produced profound suppression of VMH interstitial fluid glutamine concentrations in the basal state and during hypoglycemia .
【GOLD_E】
ephrinA5	geneY
glutamate	chem
ephrinA5	geneY
glutamine	chem
【PRE_E】
VMH	geneY
ephrinA5	geneY
glutamate	chem
ephrinA5	geneY
VMH	geneY
glutamine	chem
【GOLD_R】
【PRE_R】
VMH	glutamate	C3
ephrinA5	glutamate	C3
glutamate	ephrinA5	C3
VMH	glutamine	C3

Changes in ephrinA5 / EphA5 interactions within the VMH , a key brain glucose - sensing region , act in concert with islets to restore glucose homeostasis during acute hypoglycemia , and its effect on counterregulation may be mediated by changes in glutamate / glutamine cycling .
【GOLD_E】
ephrinA5	geneY
EphA5	geneY
glucose	chem
glucose	chem
glutamate	chem
glutamine	chem
【PRE_E】
ephrinA5	geneY
EphA5	geneY
VMH	geneY
glucose	chem
glucose	chem
glutamate	chem
glutamine	chem
【GOLD_R】
【PRE_R】

Electrical Stimuli Release ATP to Increase GLUT4 Translocation and Glucose Uptake via PI3Kγ - Akt - AS160 in Skeletal Muscle Cells .
【GOLD_E】
ATP	chem
Glucose	chem
GLUT4	geneY
PI3Kγ	geneY
Akt	geneN
AS160	geneY
【PRE_E】
ATP	chem
GLUT4	geneY
Glucose	chem
PI3Kγ	geneN
Akt	geneN
AS160	geneY
【GOLD_R】
Glucose	GLUT4	C9
【PRE_R】
ATP	GLUT4	C3
GLUT4	Glucose	C3
Glucose	PI3Kγ	C3
Glucose	Akt	C3
Glucose	AS160	C3

Skeletal muscle glucose uptake in response to exercise is preserved in insulin - resistant conditions , but the signals involved are debated .
【GOLD_E】
insulin	geneY
glucose	chem
【PRE_E】
glucose	chem
insulin	geneY
【GOLD_R】
【PRE_R】

ATP is released from skeletal muscle by contractile activity and can autocrinely signal through purinergic receptors , and we hypothesized it may influence glucose uptake .
【GOLD_E】
purinergicreceptors	geneN
ATP	chem
glucose	chem
【PRE_E】
ATP	chem
purinergicreceptors	geneN
glucose	chem
【GOLD_R】
【PRE_R】

Electrical stimulation , ATP , and insulin each increased fluorescent 2 - NBD - Glucose ( 2 - NBDG ) uptake in primary myotubes , but only electrical stimulation and ATP - dependent 2 - NBDG uptake were inhibited by adenosine - phosphate phosphatase and by purinergic receptor blockade ( suramin ) .
【GOLD_E】
2-NBD-Glucose	chem
2-NBDG	chem
ATP	chem
2-NBDG	chem
adenosine-phosphate	chem
suramin	chem
insulin	geneY
adenosine-phosphatephosphatase	geneN
purinergicreceptor	geneN
ATP	chem
【PRE_E】
ATP	chem
insulin	geneY
2-NBD-Glucose	chem
2-NBDG	chem
ATP	chem
2-NBDG	chem
adenosine-phosphatephosphatase	geneN
purinergicreceptor	geneN
suramin	chem
【GOLD_R】
suramin	adenosine-phosphatephosphatase	C4
suramin	purinergicreceptor	C4
【PRE_R】

Electrical stimulation transiently elevated extracellular ATP and caused Akt phosphorylation that was additive to insulin and inhibited by suramin .
【GOLD_E】
ATP	chem
suramin	chem
Akt	geneN
insulin	geneY
【PRE_E】
ATP	chem
Akt	geneN
insulin	geneY
suramin	chem
【GOLD_R】
suramin	Akt	C4
【PRE_R】
insulin	suramin	C4

Exogenous ATP transiently activated Akt and , inhibiting phosphatidylinositol 3 - kinase ( PI3K ) or Akt as well as dominant - negative Akt mutant , reduced ATP - dependent 2 - NBDG uptake and Akt phosphorylation .
【GOLD_E】
ATP	chem
ATP	chem
2-NBDG	chem
Akt	geneN
phosphatidylinositol3-kinase	geneN
PI3K	geneN
Akt	geneN
Akt	geneN
Akt	geneN
【PRE_E】
ATP	chem
Akt	geneN
phosphatidylinositol3-kinase	geneN
PI3K	geneN
Akt	geneN
Akt	geneN
ATP	chem
2-NBDG	chem
Akt	geneN
【GOLD_R】
ATP	Akt	C3
【PRE_R】
ATP	Akt	C3
Akt	ATP	C3
2-NBDG	Akt	C3

ATP - dependent 2 - NBDG uptake was also inhibited by the G protein βγ subunit - interacting peptide βark - ct and by the phosphatidylinositol 3 - kinase - γ ( PI3Kγ ) inhibitor AS605240 .
【GOLD_E】
AS605240	chem
ATP	chem
2-NBDG	chem
phosphatidylinositol3-kinase-γ	geneY
PI3Kγ	geneY
Gproteinβγ	geneN
【PRE_E】
ATP	chem
2-NBDG	chem
Gproteinβγ	geneN
βark-ct	chem
phosphatidylinositol3-kinase-γ	geneY
PI3Kγ	geneN
AS605240	chem
【GOLD_R】
AS605240	phosphatidylinositol3-kinase-γ	C4
AS605240	PI3Kγ	C4
【PRE_R】
Gproteinβγ	βark-ct	C4
βark-ct	phosphatidylinositol3-kinase-γ	C4
PI3Kγ	AS605240	C4

ATP caused translocation of GLUT4myc - eGFP to the cell surface , mechanistically mediated by increased exocytosis involving AS160 / Rab8A reduced by dominant - negative Akt or PI3Kγ kinase - dead mutants , and potentiated by myristoylated PI3Kγ .
【GOLD_E】
GLUT4	geneY
AS160	geneY
Rab8A	geneY
ATP	chem
Akt	geneN
PI3Kγ	geneY
kinase	geneN
myristoylatedPI3Kγ	geneY
【PRE_E】
ATP	chem
GLUT4myc	geneY
AS160	geneY
Rab8A	geneY
Akt	geneN
PI3Kγ	geneY
kinase	geneN
myristoylatedPI3Kγ	geneY
【GOLD_R】
【PRE_R】
ATP	GLUT4myc	C3
ATP	AS160	C3
ATP	Rab8A	C3
ATP	PI3Kγ	C3
ATP	kinase	C3

ATP stimulated 2 - NBDG uptake in normal and insulin - resistant adult muscle fibers , resembling the reported effect of exercise .
【GOLD_E】
insulin	geneY
ATP	chem
2-NBDG	chem
【PRE_E】
ATP	chem
2-NBDG	chem
insulin	geneN
【GOLD_R】
【PRE_R】

Hence , the ATP - induced pathway may be tapped to bypass insulin resistance .
【GOLD_E】
insulin	geneY
ATP	chem
【PRE_E】
ATP	chem
insulin	geneY
【GOLD_R】
【PRE_R】

The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability .
【GOLD_E】
COP9signalosome	geneN
interferonregulatoryfactor5protein	geneY
【PRE_E】
COP9signalosome	geneN
interferonregulatoryfactor5	geneY
【GOLD_R】
【PRE_R】

The transcription factor interferon regulatory factor 5 ( IRF5 ) exerts crucial functions in the regulation of host immunity against extracellular pathogens , DNA damage - induced apoptosis , death receptor signaling , and macrophage polarization .
【GOLD_E】
deathreceptor	geneN
interferonregulatoryfactor5	geneY
IRF5	geneY
【PRE_E】
interferonregulatoryfactor5	geneY
IRF5	geneY
【GOLD_R】
【PRE_R】

Tight regulation of IRF5 is thus warranted for an efficient response toward extracellular stressors and for limiting autoimmune and inflammatory responses .
【GOLD_E】
IRF5	geneY
【PRE_E】
IRF5	geneY
【GOLD_R】
【PRE_R】

Here we report that the COP9 signalosome ( CSN ) , a general modulator of diverse cellular and developmental processes , associates constitutively with IRF5 and promotes its protein stability .
【GOLD_E】
COP9signalosome	geneN
CSN	geneN
IRF5	geneY
【PRE_E】
COP9signalosome	geneN
CSN	geneN
IRF5	geneY
【GOLD_R】
【PRE_R】

The constitutive CSN / IRF5 interaction was identified using proteomics and confirmed by endogenous immunoprecipitations .
【GOLD_E】
CSN	geneN
IRF5	geneY
【PRE_E】
constitutiveCSN	geneN
IRF5	geneY
【GOLD_R】
【PRE_R】

The CSN / IRF5 interaction occurred on the carboxyl and amino termini of IRF5 ; a single internal deletion from amino acids 455 to 466 ( Δ 455 - 466 ) was found to significantly reduce IRF5 protein stability .
【GOLD_E】
carboxyl	chem
CSN	geneN
IRF5	geneY
amino	chem
IRF5	geneY
IRF5	geneY
aminoacids	chem
【PRE_E】
CSN	geneN
IRF5	geneY
carboxyl	chem
amino	chem
IRF5	geneY
aminoacids	chem
Δ455-466	chem
IRF5	geneY
【GOLD_R】
【PRE_R】

CSN subunit 3 ( CSN3 ) was identified as a direct interacting partner of IRF5 , and knockdown of this subunit with small interfering RNAs resulted in enhanced degradation .
【GOLD_E】
CSNsubunit3	geneY
CSN3	geneY
IRF5	geneY
【PRE_E】
CSNsubunit3	geneY
CSN3	geneY
IRF5	geneY
【GOLD_R】
【PRE_R】

Degradation was further augmented by knockdown of CSN1 and CSN3 together .
【GOLD_E】
CSN1	geneY
CSN3	geneY
【PRE_E】
CSN1	geneY
CSN3	geneY
【GOLD_R】
【PRE_R】

The ubiquitin E1 inhibitor UBEI - 41 or the proteasome inhibitor MG132 prevented IRF5 degradation , supporting the idea that its stability is regulated by the ubiquitin - proteasome system .
【GOLD_E】
proteasome	geneN
ubiquitinE1	geneN
proteasome	geneN
IRF5	geneY
ubiquitin	geneN
【PRE_E】
ubiquitinE1	geneN
UBEI-41	chem
proteasome	geneN
MG132	chem
IRF5	geneY
ubiquitin	geneN
proteasome	geneN
【GOLD_R】
【PRE_R】
ubiquitinE1	UBEI-41	C4
UBEI-41	proteasome	C4
proteasome	MG132	C4
MG132	IRF5	C4

Importantly , activation of IRF5 by the death receptor ligand tumor necrosis factor - related apoptosis - inducing ligand ( TRAIL ) resulted in enhanced degradation via loss of the CSN / IRF5 interaction .
【GOLD_E】
IRF5	geneY
deathreceptor	geneN
tumornecrosisfactor-relatedapoptosis-inducingligand	geneY
TRAIL	geneY
CSN	geneN
IRF5	geneY
【PRE_E】
IRF5	geneY
tumornecrosisfactor	geneY
apoptosis-inducingligand	geneY
TRAIL	geneY
CSN	geneN
IRF5	geneY
【GOLD_R】
【PRE_R】

This study defines CSN to be a new interacting partner of IRF5 that controls its stability .
【GOLD_E】
CSN	geneN
IRF5	geneY
【PRE_E】
CSN	geneN
IRF5	geneY
【GOLD_R】
【PRE_R】

Structure - based design , synthesis and evaluation of novel anthra [ 1,2 - d ] imidazole - 6,11 - dione derivatives as telomerase inhibitors and potential for cancer polypharmacology .
【GOLD_E】
anthra[1,2-d]imidazole-6,11-dione	chem
telomerase	geneY
【PRE_E】
anthra[1,2-d]imidazole-6,11-dione	chem
telomerase	geneY
【GOLD_R】
anthra[1,2-d]imidazole-6,11-dione	telomerase	C4
【PRE_R】
anthra[1,2-d]imidazole-6,11-dione	telomerase	C4

A series of anthra [ 1,2 - d ] imidazole - 6,11 - dione derivatives were synthesized and evaluated for telomerase inhibition , hTERT expression and suppression of cancer cell growth in vitro .
【GOLD_E】
anthra[1,2-d]imidazole-6,11-dione	chem
hTERT	geneY
telomerase	geneY
【PRE_E】
anthra[1,2-d]imidazole-6,11-dione	chem
telomerase	geneY
hTERT	geneY
【GOLD_R】
anthra[1,2-d]imidazole-6,11-dione	telomerase	C4
【PRE_R】
anthra[1,2-d]imidazole-6,11-dione	telomerase	C4
anthra[1,2-d]imidazole-6,11-dione	hTERT	C4

All of the compounds tested , except for compounds 4 , 7 , 16 , 24 , 27 and 28 were selected by the NCI screening system .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Among them , compounds 16 , 39 , and 40 repressed hTERT expression without greatly affecting cell growth , suggesting for the selectivity toward hTERT expression .
【GOLD_E】
hTERT	geneY
hTERT	geneY
【PRE_E】
hTERT	geneY
hTERT	geneY
【GOLD_R】
【PRE_R】

Taken together , our findings indicated that the analysis of cytotoxicity and telomerase inhibition might provide information applicable for further developing potential telomerase and polypharmacological targeting strategy .
【GOLD_E】
telomerase	geneY
telomerase	geneY
【PRE_E】
telomerase	geneN
telomerase	geneN
【GOLD_R】
【PRE_R】

Zinc sulphate and vitamin E alleviate reproductive toxicity caused by aluminium sulphate in male albino rats .
【GOLD_E】
Zincsulphate	chem
vitaminE	chem
aluminiumsulphate	chem
【PRE_E】
Zincsulphate	chem
vitaminE	chem
aluminiumsulphate	chem
【GOLD_R】
【PRE_R】

This study was designed to investigate the reproductive toxicity of aluminium sulphate and the therapeutic effects of administration of zinc sulphate and vitamin E individually or in combination against the toxic effect caused by aluminium ( Al ) in male albino rats .
【GOLD_E】
aluminium	chem
Al	chem
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
【PRE_E】
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
aluminium	chem
Al	chem
【GOLD_R】
【PRE_R】

The animals were divided into five groups : group 1 received distilled water and served as control ; group 2 received only aluminium sulphate ( 50 mg / kg body weight ( b.w . ) ) ; group 3 received aluminium sulphate ( 50 mg / kg b.w . ) plus zinc sulphate ( 50 mg / kg b.w . ) ; group 4 received aluminium sulphate ( 50 mg / kg b.w . ) and vitamin E ( 15 mg / kg b.w . ) ; group 5 received aluminium sulphate plus a combination of zinc sulphate and vitamin E in similar doses as above .
【GOLD_E】
aluminiumsulphate	chem
aluminiumsulphate	chem
zincsulphate	chem
aluminiumsulphate	chem
vitaminE	chem
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
【PRE_E】
aluminiumsulphate	chem
aluminiumsulphate	chem
zincsulphate	chem
aluminiumsulphate	chem
vitaminE	chem
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
【GOLD_R】
【PRE_R】

Doses were administered orally once daily for 45 consecutive days .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The results revealed that aluminium sulphate induced significant decrease in body weight gain and testis weight and significant increase in Al level in both serum and testes of male rats .
【GOLD_E】
aluminiumsulphate	chem
Al	chem
【PRE_E】
aluminiumsulphate	chem
【GOLD_R】
【PRE_R】

Biochemical analysis showed significant decrease in serum total protein and phospholipids levels , while serum total lipid was significantly elevated post Al treatment .
【GOLD_E】
Al	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , significant decrease in total protein , phospholipids and cholesterol levels in the testes of Al - treated rats was recorded .
【GOLD_E】
cholesterol	chem
Al	chem
【PRE_E】
cholesterol	chem
Al	chem
【GOLD_R】
【PRE_R】

The data also showed significant decrease in the levels of serum testosterone , leutinizing hormone and follicle stimulating hormone and significant increase in the level of serum prolactin in Al - intoxicated rats .
【GOLD_E】
leutinizinghormone	geneN
folliclestimulatinghormone	geneN
prolactin	geneY
testosterone	chem
Al	chem
【PRE_E】
testosterone	chem
leutinizinghormone	geneY
folliclestimulatinghormone	geneN
serumprolactin	geneY
【GOLD_R】
【PRE_R】

Moreover , histological examination showed that aluminium sulphate caused apparent alterations in the testicular structure of the treated animals .
【GOLD_E】
aluminiumsulphate	chem
【PRE_E】
aluminiumsulphate	chem
【GOLD_R】
【PRE_R】

Treatment with zinc sulphate and vitamin E individually or in combination ameliorated the harmful effects of Al , which was proved histopathologically by the noticeable improvement in the testicular tissues .
【GOLD_E】
vitaminE	chem
Al	chem
zincsulphate	chem
【PRE_E】
zincsulphate	chem
vitaminE	chem
Al	chem
【GOLD_R】
【PRE_R】

We can conclude that the tested dose of aluminium sulphate induced toxic effect on the reproductive system of male albino rats and the treatment with zinc sulphate and / or vitamin E alleviated these toxic effects .
【GOLD_E】
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
【PRE_E】
aluminiumsulphate	chem
zincsulphate	chem
vitaminE	chem
【GOLD_R】
【PRE_R】

In some cases , vitamin E exerted a more potent effect , while in other cases , the more potent effect is related to zinc sulphate and the combination of both at most of the recorded data .
【GOLD_E】
vitaminE	chem
zincsulphate	chem
【PRE_E】
vitaminE	chem
zincsulphate	chem
【GOLD_R】
【PRE_R】

Trichostatin A inhibits transforming growth factor - β - induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF - E2 - related factor 2 - antioxidant response element signaling .
【GOLD_E】
TrichostatinA	chem
oxygen	chem
NF-E2-relatedfactor2	geneY
antioxidantresponseelement	geneN
transforminggrowthfactor-β	geneY
【PRE_E】
TrichostatinA	chem
transforminggrowthfactor-β	geneY
oxygen	chem
NF-E2	geneN
factor2	geneY
antioxidantresponseelement	geneN
【GOLD_R】
TrichostatinA	NF-E2-relatedfactor2	C3
TrichostatinA	antioxidantresponseelement	C3
TrichostatinA	transforminggrowthfactor-β	C4
【PRE_R】
TrichostatinA	transforminggrowthfactor-β	C4

Trichostatin A ( TSA ) has been shown to prevent fibrosis in vitro and in vivo .
【GOLD_E】
TSA	chem
TrichostatinA	chem
【PRE_E】
TrichostatinA	chem
TSA	chem
【GOLD_R】
【PRE_R】

The present study aimed at investigating the role of reactive oxygen species ( ROS ) scavenging by TSA on transforming growth factor - β ( TGF - β ) - induced myofibroblast differentiation of corneal fibroblasts in vitro .
【GOLD_E】
TSA	chem
transforminggrowthfactor-β	geneY
TGF-β)	geneY
oxygen	chem
【PRE_E】
oxygen	chem
TSA	chem
transforminggrowthfactor-β	geneY
TGF-β	geneY
【GOLD_R】
【PRE_R】

Human immortalized corneal fibroblasts were treated with TGF - β in the presence of TSA , the NAD ( P ) H oxidase inhibitor diphenyleneiodonium ( DPI ) , the antioxidant N - acetyl - cysteine ( NAC ) , the NF - E2 - related factor 2 - antioxidant response element ( Nrf2 - ARE ) activator sulforaphane , or small interfering RNA .
【GOLD_E】
TSA	chem
NAD(P)H	chem
diphenyleneiodonium	chem
DPI	chem
N-acetyl-cysteine	chem
NAC	chem
sulforaphane	chem
TGF-β	geneY
NAD(P)Hoxidase	geneN
NF-E2-relatedfactor2	geneY
antioxidantresponseelement	geneN
Nrf2	geneY
ARE	geneN
【PRE_E】
TGF-β	geneY
TSA	chem
NAD(P)Hoxidase	geneY
diphenyleneiodonium	chem
DPI	chem
N-acetyl-cysteine	chem
NAC	chem
NF-E2-relatedfactor2	geneY
antioxidantresponseelement	geneN
Nrf2-ARE	geneY
sulforaphane	chem
【GOLD_R】
sulforaphane	NF-E2-relatedfactor2	C3
sulforaphane	antioxidantresponseelement	C3
sulforaphane	Nrf2	C3
sulforaphane	ARE	C3
diphenyleneiodonium	NAD(P)Hoxidase	C4
DPI	NAD(P)Hoxidase	C4
【PRE_R】
diphenyleneiodonium	antioxidantresponseelement	C4
DPI	antioxidantresponseelement	C4
N-acetyl-cysteine	Nrf2-ARE	C9

Myofibroblast differentiation was assessed by α - smooth muscle actin ( α - SMA ) expression , F - actin bundle formation , and collagen gel contraction .
【GOLD_E】
α-smoothmuscleactin	geneY
α-SMA	geneY
F-actin	geneN
collagen	geneN
【PRE_E】
α-smoothmuscleactin	geneY
α-SMA	geneY
F-actin	geneN
collagen	geneN
【GOLD_R】
【PRE_R】

ROS , H ( 2 ) O ( 2 ) , intracellular glutathione ( GSH ) level , cellular total antioxidant capacity , and the activation of Nrf2 - ARE signaling were determined with various assays .
【GOLD_E】
H(2)O(2)	chem
glutathione	chem
GSH	chem
Nrf2	geneY
ARE	geneN
【PRE_E】
H(2)O(2)	chem
glutathione	chem
GSH	chem
Nrf2	geneY
【GOLD_R】
【PRE_R】
H(2)O(2)	Nrf2	C3
glutathione	Nrf2	C3

Treatment with TSA and the Nrf2 - ARE activator resulted in increased inhibition of the TGF - β - induced myofibroblast differentiation as compared with treatment with DPI or NAC .
【GOLD_E】
TSA	chem
DPI	chem
NAC	chem
Nrf2	geneY
ARE	geneN
TGF-β	geneY
【PRE_E】
TSA	chem
Nrf2-ARE	geneY
TGF-β	geneY
DPI	chem
NAC	chem
【GOLD_R】
TSA	TGF-β	C4
【PRE_R】
Nrf2-ARE	DPI	C4
TGF-β	DPI	C4
TGF-β	NAC	C4

Furthermore , TSA also decreased cellular ROS and H ( 2 ) O ( 2 ) accumulation induced by TGF - β , whereas it elevated intracellular GSH level and cellular total antioxidant capacity .
【GOLD_E】
TGF-β	geneY
TSA	chem
H(2)O(2)	chem
GSH	chem
【PRE_E】
TSA	chem
H(2)O(2)	chem
TGF-β	geneY
GSH	chem
【GOLD_R】
TSA	TGF-β	C4
【PRE_R】
TSA	TGF-β	C3

In addition , TSA induced Nrf2 nuclear translocation and up - regulated the expression of Nrf2 - ARE downstream antioxidant genes , whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation .
【GOLD_E】
Nrf2	geneY
Nrf2	geneY
ARE	geneN
Nrf2	geneY
TSA	chem
TSA	chem
【PRE_E】
TSA	chem
Nrf2	geneY
Nrf2	geneY
Nrf2	geneY
TSA	chem
【GOLD_R】
TSA	Nrf2	C3
TSA	ARE	C3
【PRE_R】
TSA	Nrf2	C3
TSA	Nrf2	C3
TSA	Nrf2	C3

In conclusion , this study provides the first evidence implicating that TSA inhibits TGF - β - induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2 - ARE signaling .
【GOLD_E】
TSA	chem
TGF-β	geneY
Nrf2	geneY
ARE	geneN
【PRE_E】
TSA	chem
TGF-β	geneY
Nrf2	geneY
【GOLD_R】
TSA	Nrf2	C3
TSA	ARE	C3
TSA	TGF-β	C4
【PRE_R】
TSA	TGF-β	C4
TSA	Nrf2	C4

Cannabinoid discrimination and antagonism by CB ( 1 ) neutral and inverse agonist antagonists .
【GOLD_E】
Cannabinoid	chem
CB(1)	geneN
【PRE_E】
Cannabinoid	chem
【GOLD_R】
【PRE_R】

Cannabinoid receptor 1 ( CB ( 1 ) ) inverse agonists ( e.g . , rimonabant ) have been reported to produce adverse effects including nausea , emesis , and anhedonia that limit their clinical applications .
【GOLD_E】
Cannabinoidreceptor1	geneN
CB(1)	geneN
Cannabinoid	chem
rimonabant	chem
【PRE_E】
Cannabinoidreceptor1	geneY
CB(1)	geneY
rimonabant	chem
【GOLD_R】
rimonabant	Cannabinoidreceptor1	C5
rimonabant	CB(1)	C5
【PRE_R】

Recent laboratory studies suggest that the effects of CB ( 1 ) neutral antagonists differ from those of such inverse agonists , raising the possibility of improved clinical utility .
【GOLD_E】
CB(1)	geneN
【PRE_E】
CB(1)	chem
【GOLD_R】
【PRE_R】

However , little is known regarding the antagonist properties of neutral antagonists .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present studies , the CB ( 1 ) inverse agonist SR141716A ( rimonabant ) and the CB ( 1 ) neutral antagonist AM4113 were compared for their ability to modify CB ( 1 ) receptor - mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB ( 1 ) full agonist AM4054 .
【GOLD_E】
AM4113	chem
AM4054	chem
CB(1)	geneN
CB(1)	geneN
CB(1)receptor	geneN
CB(1)	geneN
SR141716A	chem
rimonabant	chem
【PRE_E】
CB(1)	geneY
SR141716A	chem
rimonabant	chem
CB(1)	geneY
AM4113	chem
CB(1)receptor	geneY
CB(1)	geneY
AM4054	chem
【GOLD_R】
AM4054	CB(1)	C5
SR141716A	CB(1)	C5
rimonabant	CB(1)	C5
AM4113	CB(1)	C6
【PRE_R】
CB(1)	SR141716A	C6
SR141716A	CB(1)	C6
CB(1)receptor	AM4054	C6
CB(1)	AM4054	C6

Results indicate that AM4054 serves as an effective CB ( 1 ) discriminative stimulus , with an onset and time course of action comparable with that of the CB ( 1 ) agonist Δ ( 9 ) - tetrahydrocannabinol , and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose - related rightward shifts in the AM4054 dose - effect curve , indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054 .
【GOLD_E】
AM4054	chem
Δ(9)-tetrahydrocannabinol	chem
rimonabant	chem
CB(1)	geneN
CB(1)	geneN
AM4113	chem
AM4054	chem
AM4054	chem
【PRE_E】
AM4054	chem
CB(1)	geneY
Δ(9)-tetrahydrocannabinol	chem
rimonabant	chem
AM4113	chem
AM4054	chem
AM4054	chem
【GOLD_R】
AM4054	CB(1)	C3
Δ(9)-tetrahydrocannabinol	CB(1)	C5
AM4054	CB(1)	C5
AM4054	CB(1)	C5
rimonabant	CB(1)	C5
AM4113	CB(1)	C6
【PRE_R】
CB(1)	rimonabant	C6
CB(1)	AM4113	C6

Schild analyses further show that rimonabant and AM4113 produce highly similar antagonist effects , as evident in comparable pA ( 2 ) values ( 6.9 ) .
【GOLD_E】
rimonabant	chem
AM4113	chem
【PRE_E】
rimonabant	chem
AM4113	chem
pA(2)	geneY
【GOLD_R】
【PRE_R】

Taken together with previous studies , the present data suggest that the improved safety profile suggested for CB ( 1 ) neutral antagonists over inverse agonists is not accompanied by a loss of antagonist action at CB ( 1 ) receptors .
【GOLD_E】
CB(1)	geneN
CB(1)receptors	geneN
【PRE_E】
CB(1)receptors	geneY
【GOLD_R】
【PRE_R】

Marked decline in beta cell function during pregnancy leads to the development of glucose intolerance in Japanese women .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

The aim of this study is to investigate glucose metabolism longitudinally during pregnancy to explore mechanisms underlying gestational diabetes mellitus ( GDM ) .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

We reviewed a total of 62 pregnant Japanese women who underwent a 75g oral glucose tolerance test ( OGTT ) twice during pregnancy ( median : early , 13 ; late , 28 weeks ' gestation ) because of positive GDM screening .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

All showed normal OGTT results in early pregnancy .
【GOLD_E】
【PRE_E】
OGTT	geneY
【GOLD_R】
【PRE_R】

Based on late OGTT , 15 had GDM ( late - onset GDM ) and 47 normal glucose tolerance ( NGT ) .
【GOLD_E】
glucose	chem
【PRE_E】
OGTT	geneY
glucose	chem
【GOLD_R】
【PRE_R】

In early pregnancy , there were no significant differences in insulin sensitivity ( insulin sensitivity index derived from OGTT [ ISOGTT ] and homeostasis model assessment for insulin resistance [ HOMA - IR ] ) and insulin secretion ( a ratio of the total area - under - the - insulin - curve to the total area - under - the - glucose - curve [ AUCins / glu ] and insulinogenic index [ IGI ] ) between the NGT and late - onset GDM groups .
【GOLD_E】
insulin	geneY
insulin	geneY
insulin	geneY
insulin	geneY
insulin	geneY
glucose	chem
【PRE_E】
insulin	geneY
insulin	geneY
OGTT	geneY
ISOGTT	geneY
insulin	geneY
insulin	geneY
insulin	geneY
glucose	chem
AUCins	geneY
glu	chem
【GOLD_R】
【PRE_R】

In each group , insulin sensitivity significantly decreased from early to late pregnancy , most in the late - onset GDM group ( each p < 0.05 ) .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

The insulin secretion showed no significant changes with advancing pregnancy in both of the groups , although late - onset GDM showed significantly lower IGI compared with NGT in late OGTT ( p < 0.05 ) .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
NGT	geneY
OGTT	geneY
【GOLD_R】
【PRE_R】

When assessed beta cell function by OGTT - derived disposition index ( i.e .
【GOLD_E】
【PRE_E】
OGTT	geneY
【GOLD_R】
【PRE_R】

Insulin Secretion - Sensitivity Index - 2 and IGI / fasting insulin ) , the indices significantly decreased from early to late pregnancy in the both groups ( each p < 0.05 ) .
【GOLD_E】
Insulin	geneY
insulin	geneY
【PRE_E】
Insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Women with late - onset GDM showed significantly lower indices compared with NGT ( each p < 0.05 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The failure of beta cell to compensate for decreased insulin sensitivity could contribute to the development of the late - onset GDM .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

New oral anticoagulants : comparative pharmacology with vitamin K antagonists .
【GOLD_E】
vitaminK	chem
【PRE_E】
vitaminK	chem
【GOLD_R】
【PRE_R】

New oral anticoagulants ( OACs ) that directly inhibit Factor Xa ( FXa ) or thrombin have been developed for the long - term prevention of thromboembolic disorders .
【GOLD_E】
FactorXa	geneY
FXa	geneY
thrombin	geneY
【PRE_E】
anticoagulants	chem
OACs	chem
FactorXa	geneY
FXa	geneY
thrombin	geneY
【GOLD_R】
【PRE_R】
anticoagulants	FactorXa	C4
OACs	FactorXa	C4
OACs	FXa	C4
OACs	thrombin	C4

These novel agents provide numerous benefits over older vitamin K antagonists ( VKAs ) due to major pharmacological differences .
【GOLD_E】
vitaminK	chem
【PRE_E】
vitaminK	chem
VKAs	chem
【GOLD_R】
【PRE_R】

VKAs are economical and very well characterized , but have important limitations that can outweigh these advantages , such as slow onset of action , narrow therapeutic window and unpredictable anticoagulant effect .
【GOLD_E】
【PRE_E】
VKAs	chem
【GOLD_R】
【PRE_R】

VKA - associated dietary precautions , monitoring and dosing adjustments to maintain international normalized ratio ( INR ) within therapeutic range , and bridging therapy , are inconvenient for patients , expensive , and may result in inappropriate use of VKA therapy .
【GOLD_E】
【PRE_E】
VKA	chem
【GOLD_R】
【PRE_R】

This may lead to increased bleeding risk or reduced anticoagulation and increased risk of thrombotic events .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The new OACs have rapid onset of action , low potential for food and drug interactions , and predictable anticoagulant effect that removes the need for routine monitoring .
【GOLD_E】
【PRE_E】
OACs	chem
【GOLD_R】
【PRE_R】

FXa inhibitors , e.g . rivaroxaban and apixaban , are potent , oral direct inhibitors of prothrombinase - bound , clot - associated or free FXa .
【GOLD_E】
rivaroxaban	chem
FXa	geneY
prothrombinase	geneN
FXa	geneY
apixaban	chem
【PRE_E】
FXa	geneY
rivaroxaban	chem
apixaban	chem
prothrombinase	geneN
FXa	geneY
【GOLD_R】
rivaroxaban	FXa	C4
rivaroxaban	prothrombinase	C4
rivaroxaban	FXa	C4
apixaban	FXa	C4
apixaban	prothrombinase	C4
apixaban	FXa	C4
【PRE_R】
FXa	rivaroxaban	C4
FXa	apixaban	C4

Both agents have a rapid onset of action , a wide therapeutic window , little or no interaction with food and other drugs , minimal inter - patient variability , and display similar pharmacokinetics in different patient populations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Since both are substrates , co - administration of rivaroxaban and apixaban with strong cytochrome P450 ( CYP ) 3A4 and permeability glycoprotein ( P - gp ) inhibitors and inducers can result in substantial changes in plasma concentrations due to altered clearance rates ; consequently , their concomitant use is contraindicated and caution is required when used concomitantly with strong CYP3A4 and P - gp inducers .
【GOLD_E】
cytochromeP450(CYP)3A4	geneY
permeabilityglycoprotein	geneY
P-gp	geneY
CYP3A4	geneY
P-gp	geneY
rivaroxaban	chem
apixaban	chem
【PRE_E】
rivaroxaban	chem
apixaban	chem
cytochromeP450(CYP)3A4	geneN
permeabilityglycoprotein	geneN
P-gp	geneN
CYP3A4	geneY
P-gp	geneN
【GOLD_R】
【PRE_R】
rivaroxaban	cytochromeP450(CYP)3A4	C4
apixaban	cytochromeP450(CYP)3A4	C4
apixaban	permeabilityglycoprotein	C4
apixaban	P-gp	C4

Although parenteral oral direct thrombin inhibitors ( DTIs ) , such as argatroban and bivalirudin , have been on the market for years , DTIs such as dabigatran are novel synthetic thrombin antagonists .
【GOLD_E】
thrombin	geneY
thrombin	geneY
argatroban	chem
dabigatran	chem
【PRE_E】
thrombin	geneY
DTIs	geneN
argatroban	chem
bivalirudin	chem
DTIs	chem
dabigatran	chem
thrombin	geneY
【GOLD_R】
argatroban	thrombin	C4
dabigatran	thrombin	C6
【PRE_R】
thrombin	argatroban	C4
DTIs	argatroban	C4
DTIs	bivalirudin	C4
DTIs	thrombin	C6
dabigatran	thrombin	C6

Dabigatran etexilate is a low - molecular - weight non - active pro - drug that is administered orally and converted rapidly to its active form , dabigatran - - a potent , competitive and reversible DTI .
【GOLD_E】
Dabigatranetexilate	chem
dabigatran	chem
【PRE_E】
Dabigatranetexilate	chem
dabigatran	chem
【GOLD_R】
【PRE_R】

Dabigatran has an advantage over the indirect thrombin inhibitors , unfractionated heparin and low - molecular - weight heparin , in that it inhibits free and fibrin - bound thrombin .
【GOLD_E】
Dabigatran	chem
thrombin	geneY
fibrin	geneN
thrombin	geneY
【PRE_E】
Dabigatran	chem
thrombin	geneY
fibrin	geneN
thrombin	geneY
【GOLD_R】
Dabigatran	thrombin	C4
Dabigatran	fibrin	C4
Dabigatran	thrombin	C4
【PRE_R】
Dabigatran	thrombin	C4
Dabigatran	thrombin	C4

The reversible binding of dabigatran may provide safer and more predictable anticoagulant treatment than seen with irreversible , non - covalent thrombin inhibitors , e.g . hirudin .
【GOLD_E】
dabigatran	chem
thrombin	geneY
【PRE_E】
dabigatran	chem
thrombin	geneY
hirudin	chem
【GOLD_R】
dabigatran	thrombin	C4
【PRE_R】
dabigatran	thrombin	C4
thrombin	hirudin	C4

Dabigatran shows a very low potential for drug - drug interactions .
【GOLD_E】
Dabigatran	chem
【PRE_E】
Dabigatran	chem
【GOLD_R】
【PRE_R】

However , co - administration of dabigatran etexilate with other anticoagulants and antiplatelet agents can increase the bleeding risk .
【GOLD_E】
dabigatranetexilate	chem
【PRE_E】
dabigatran	chem
etexilate	chem
【GOLD_R】
【PRE_R】

Although the new agents are pharmacologically better than VKAs - - particularly in terms of fixed dosing , rapid onset of action , no INR monitoring and lower risk of drug interactions - - there are some differences between them : the bioavailability of dabigatran is lower than rivaroxaban and apixaban , and so the dabigatran dosage required is higher ; lower protein binding of dabigatran reduces the variability related to albuminaemia .
【GOLD_E】
dabigatran	chem
rivaroxaban	chem
apixaban	chem
dabigatran	chem
dabigatran	chem
【PRE_E】
VKAs	chem
INR	chem
dabigatran	chem
rivaroxaban	chem
apixaban	chem
dabigatran	chem
dabigatran	chem
【GOLD_R】
【PRE_R】

The risk of metabolic drug - drug interactions also appears to differ between OACs : VKAs > rivaroxaban > apixaban > dabigatran .
【GOLD_E】
rivaroxaban	chem
apixaban	chem
dabigatran	chem
【PRE_E】
OACs	chem
VKAs	chem
rivaroxaban	chem
apixaban	chem
dabigatran	chem
【GOLD_R】
【PRE_R】

The convenience of the new OACs has translated into improvements in efficacy and safety as shown in phase III randomized trials .
【GOLD_E】
【PRE_E】
OACs	chem
【GOLD_R】
【PRE_R】

The new anticoagulants so far offer the greatest promise and opportunity for the replacement of VKAs .
【GOLD_E】
【PRE_E】
VKAs	chem
【GOLD_R】
【PRE_R】

Effects of smoking on the oxidant / antioxidant balance and the blood lipids in pesticide sprayers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The present study was conducted on 80 pesticide male sprayers ( 42 nonsmokers and 38 smokers ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our aim was to estimate the smoking effects on blood lipids and oxidant / antioxidant status in pesticide sprayers .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results revealed that cholesterol , low - density lipoprotein ( LDL ) and glutathion peroxidase ( GPx ) enzyme were significantly higher in the 38 smoker sprayers than in the 42 nonsmoker sprayers .
【GOLD_E】
low-densitylipoprotein	geneN
LDL	geneN
glutathionperoxidase	geneN
GPx	geneN
cholesterol	chem
glutathion	chem
【PRE_E】
cholesterol	chem
low-densitylipoprotein	geneN
LDL	geneN
glutathionperoxidase	geneN
GPx	geneN
【GOLD_R】
【PRE_R】

Cholesterol and LDL were correlated with smoking index and high - density lipoprotein ( HDL ) , superoxide dismutase ( SOD ) enzyme and zinc ( Zn ) were inversely correlated with duration of pesticides ' exposure .
【GOLD_E】
LDL	geneN
high-densitylipoprotein	geneN
HDL	geneN
superoxidedismutase	geneN
SOD	geneN
Cholesterol	chem
superoxide	chem
zinc	chem
Zn	chem
【PRE_E】
Cholesterol	chem
LDL	geneN
high-densitylipoprotein	geneN
HDL	geneN
superoxidedismutase	geneN
SOD	geneN
zinc	chem
Zn	chem
【GOLD_R】
【PRE_R】

In nonsmokers , LDL and cholesterol were negatively correlated with SOD and correlated with malondialdehyde ( MDA ) , and cholesterol was negatively correlated with Zn .
【GOLD_E】
cholesterol	chem
malondialdehyde	chem
MDA	chem
cholesterol	chem
Zn	chem
LDL	geneN
SOD	geneN
【PRE_E】
LDL	geneN
cholesterol	chem
SOD	geneN
malondialdehyde	chem
MDA	chem
cholesterol	chem
Zn	chem
【GOLD_R】
【PRE_R】

HDL was negatively correlated with MDA in all the sprayers , but was correlated with GPx in smokers and with Zn in nonsmokers .
【GOLD_E】
MDA	chem
Zn	chem
HDL	geneN
GPx	geneN
【PRE_E】
HDL	geneN
MDA	chem
GPx	geneN
Zn	chem
【GOLD_R】
【PRE_R】

In smokers , LDL was negatively correlated with GPx , HDL was negatively correlated with MDA and triglycerides and very - low - density lipoprotein were negatively correlated with Zn .
【GOLD_E】
MDA	chem
triglycerides	chem
very-low-densitylipoprotein	geneN
Zn	chem
LDL	geneN
GPx	geneN
HDL	geneN
【PRE_E】
LDL	geneN
GPx	geneN
HDL	geneN
MDA	chem
triglycerides	chem
very-low-densitylipoprotein	geneN
Zn	chem
【GOLD_R】
【PRE_R】

MDA was negatively correlated with SOD , GPx and Zn .
【GOLD_E】
SOD	geneN
GPx	geneN
MDA	chem
Zn	chem
【PRE_E】
MDA	chem
SOD	geneN
GPx	geneN
Zn	chem
【GOLD_R】
【PRE_R】

Smoking and pesticide exposure could be responsible for hyperlipidemia and oxidative stress .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , improvement in the antioxidant status is mandatory for pesticide sprayers especially the ones who smoke .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Fluorescence lifetime analysis and effect of magnesium ions on binding of NADH to human aldehyde dehydrogenase 1 .
【GOLD_E】
magnesium	chem
NADH	chem
aldehyde	chem
humanaldehydedehydrogenase1	geneY
【PRE_E】
magnesium	chem
NADH	chem
humanaldehydedehydrogenase1	geneY
【GOLD_R】
【PRE_R】

Aldehyde dehydrogenase 1 ( ALDH1A1 ) catalyzes the oxidation of toxic aldehydes to carboxylic acids .
【GOLD_E】
Aldehyde	chem
aldehydes	chem
carboxylicacids	chem
Aldehydedehydrogenase1	geneY
ALDH1A1	geneY
【PRE_E】
Aldehydedehydrogenase1	geneY
ALDH1A1	geneY
aldehydes	chem
carboxylicacids	chem
【GOLD_R】
carboxylicacids	Aldehydedehydrogenase1	C9
carboxylicacids	ALDH1A1	C9
aldehydes	Aldehydedehydrogenase1	C9
aldehydes	ALDH1A1	C9
【PRE_R】
ALDH1A1	aldehydes	C9
ALDH1A1	carboxylicacids	C9

Physiologic levels of Mg ( 2 + ) ions decrease ALDH1 activity in part by increasing NADH binding affinity to the enzyme .
【GOLD_E】
NADH	chem
ALDH1	geneY
Mg(2+)	chem
【PRE_E】
Mg(2+)	chem
ALDH1	geneY
NADH	chem
【GOLD_R】
Mg(2+)	ALDH1	C4
【PRE_R】

By using time - resolved fluorescence spectroscopy , we have resolved the fluorescent lifetimes ( τ ) of free NADH in solution ( τ = 0.4 ns ) and two enzyme - bound NADH states ( τ = 2.0 ns and τ = 7.7 ns ) .
【GOLD_E】
NADH	chem
NADH	chem
【PRE_E】
NADH	chem
NADH	chem
【GOLD_R】
【PRE_R】

We used this technique to investigate the effects of Mg ( 2 + ) ions on the ALDH1A1 - NADH binding characteristics and enzyme catalysis .
【GOLD_E】
Mg(2+)	chem
NADH	chem
ALDH1A1	geneY
【PRE_E】
Mg(2+)	chem
ALDH1A1	geneY
NADH	chem
【GOLD_R】
【PRE_R】

From the resolved free and bound NADH fluorescence signatures , the KD values for both NADH conformations in ALDH1A1 ranged from about 24 μM to 1 μM for Mg ( 2 + ) ion concentrations of 0 - 6000 μM , respectively .
【GOLD_E】
NADH	chem
NADH	chem
Mg(2+)	chem
ALDH1A1	geneY
【PRE_E】
NADH	chem
NADH	chem
ALDH1A1	geneY
Mg(2+)	chem
【GOLD_R】
【PRE_R】

The rate constants for dissociation of the enzyme - NADH complex ranged from 0.03 s ( - 1 ) ( 6000 μM Mg ( 2 + ) ) to 0.30s ( - 1 ) ( 0 μM Mg ( 2 + ) ) as determined by addition of excess NAD ( + ) to prevent re - association of NADH and resolving the real - time NADH fluorescence signal .
【GOLD_E】
NADH	chem
Mg(2+)	chem
Mg(2+)	chem
NAD(+)	chem
NADH	chem
NADH	chem
【PRE_E】
NADH	chem
Mg(2+)	chem
Mg(2+)	chem
NAD(+)	chem
NADH	chem
NADH	chem
【GOLD_R】
【PRE_R】

During the initial reaction of enzyme with NAD ( + ) and butyraldehyde , there was an immediate rise in the NADH fluorescence , due to the formation of bound NADH complexes , with a constant steady - state rate of production of free NADH .
【GOLD_E】
NAD(+)	chem
butyraldehyde	chem
NADH	chem
NADH	chem
NADH	chem
【PRE_E】
NAD(+)	chem
butyraldehyde	chem
NADH	chem
NADH	chem
NADH	chem
【GOLD_R】
【PRE_R】

As the Mg ( 2 + ) ion concentration was increased , there was a consistent decrease of the enzyme catalytic turnover from 0.31 s ( - 1 ) ( 0 μM Mg ( 2 + ) ) to 0.050 s ( - 1 ) ( 6000 μM Mg ( 2 + ) ) and a distinct shift in steady - state conformational population from one that favors the ALDH1 - NADH complex with the shorter fluorescence lifetime ( 33 % excess ) in the absence of magnesium ion to one that favors the ALDH1 - NADH complex with the longer fluorescence lifetime ( 13 % excess ) at 6000 μM Mg ( 2 + ) .
【GOLD_E】
Mg(2+)	chem
NADH	chem
magnesium	chem
NADH	chem
Mg(2+)	chem
ALDH1	geneY
ALDH1	geneY
Mg(2+)	chem
Mg(2+)	chem
【PRE_E】
Mg(2+)	chem
Mg(2+)	chem
Mg(2+)	chem
ALDH1-NADH	geneY
magnesium	chem
ALDH1	geneY
NADH	chem
Mg(2+)	chem
【GOLD_R】
Mg(2+)	ALDH1	C4
【PRE_R】
ALDH1-NADH	magnesium	C9
magnesium	ALDH1	C9
ALDH1	NADH	C9

This shift in conformational population at higher Mg ( 2 + ) ion concentrations and to lower enzyme activity may be due to longer residence time of the NADH in the ALDH1 pocket .
【GOLD_E】
Mg(2+)	chem
NADH	chem
ALDH1	geneY
【PRE_E】
Mg(2+)	chem
NADH	chem
ALDH1	geneY
【GOLD_R】
Mg(2+)	ALDH1	C4
【PRE_R】

The results from monitoring enzyme catalysis in the absence of magnesium suggests that the ALDH1 - NADH complex with the shorter fluorescence lifetime is the form initially produced , and the complex with the longer fluorescence lifetime is produced through isomerization .
【GOLD_E】
magnesium	chem
NADH	chem
ALDH1	geneY
【PRE_E】
magnesium	chem
ALDH1	geneY
NADH	chem
【GOLD_R】
【PRE_R】

Acrolein induces Alzheimer 's disease - like pathologies in vitro and in vivo .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

The pathologic mechanisms of Alzheimer 's disease ( AD ) have not been fully uncovered .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Acrolein , a ubiquitous dietary pollutant and by - product of oxidative stress , can induce cytotoxicity in neurons , which might play an important role in the etiology of AD .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

Here , we examined the effects of Acrolein on the AD pathologies in vitro and in vivo .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

We found Acrolein induced HT22 cells death in concentration - and time - dependent manners .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

Interestingly , Acrolein increased proteins ' levels of amyloid precursor protein ( APP ) , β - secretase ( BACE - 1 ) and the amyloid β - peptide transporter receptor for advanced glycation end products , and decreased A - disintegrin and metalloprotease ( ADAM ) 10 levels .
【GOLD_E】
amyloidprecursorprotein	geneY
APP	geneY
β-secretase	geneN
BACE-1	geneY
amyloidβ-peptidetransporter	geneY
receptorforadvancedglycationendproducts	geneY
A-disintegrinandmetalloprotease(ADAM)10	geneY
Acrolein	chem
【PRE_E】
Acrolein	chem
amyloidprecursorprotein	geneY
APP	geneY
β-secretase	geneY
BACE-1	geneY
amyloidβ-peptidetransporterreceptor	geneY
A-disintegrin	geneN
metalloprotease(ADAM)	geneY
【GOLD_R】
Acrolein	amyloidprecursorprotein	C3
Acrolein	β-secretase	C3
Acrolein	BACE-1	C3
Acrolein	amyloidβ-peptidetransporter	C3
Acrolein	receptorforadvancedglycationendproducts	C3
Acrolein	A-disintegrinandmetalloprotease(ADAM)10	C4
【PRE_R】
Acrolein	amyloidprecursorprotein	C3
Acrolein	APP	C3
Acrolein	β-secretase	C3
Acrolein	BACE-1	C3
Acrolein	amyloidβ-peptidetransporterreceptor	C3

In vivo , chronic oral exposure to Acrolein ( 2.5 mg / kg / day by intragastric gavage for 8 weeks ) induced mild cognitive declination and pyknosis / atrophy of hippocampal neurons .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

The activity of superoxide dismutase was down - regulated while the level of malondialdehyde was up - regulated in rat brain .
【GOLD_E】
superoxidedismutase	geneN
superoxide	chem
malondialdehyde	chem
【PRE_E】
superoxidedismutase	geneN
malondialdehyde	chem
【GOLD_R】
【PRE_R】

Moreover , Acrolein resulted in activation of astrocytes , up - regulation of BACE - 1 in cortex and down - regulation of ADAM - 10 in hippocampus and cortex .
【GOLD_E】
Acrolein	chem
BACE-1	geneY
ADAM-10	geneY
【PRE_E】
Acrolein	chem
BACE-1	geneY
ADAM-10	geneY
【GOLD_R】
Acrolein	BACE-1	C3
Acrolein	ADAM-10	C4
【PRE_R】
Acrolein	BACE-1	C3
Acrolein	ADAM-10	C3

Taken together , our findings suggest that exposure to Acrolein induces AD - like pathology in vitro and in vivo .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

Scavenging Acrolein might be beneficial for the therapy of AD .
【GOLD_E】
Acrolein	chem
【PRE_E】
Acrolein	chem
【GOLD_R】
【PRE_R】

Membrane - initiated estradiol signaling in immortalized hypothalamic N - 38 neurons .
【GOLD_E】
estradiol	chem
【PRE_E】
estradiol	chem
N	chem
【GOLD_R】
【PRE_R】

Regulation of sexual reproduction by estradiol involves the activation of estrogen receptors ( ERs ) in the hypothalamus .
【GOLD_E】
estrogenreceptors	geneY
ERs	geneY
estradiol	chem
estrogen	chem
【PRE_E】
estradiol	chem
estrogenreceptors	geneY
ERs	geneN
【GOLD_R】
estradiol	estrogenreceptors	C3
estradiol	ERs	C3
【PRE_R】
estradiol	ERs	C3

Of the two classical ERs involved in reproduction , ERα appears to be the critical isoform .
【GOLD_E】
ERs	geneY
ERα	geneY
【PRE_E】
ERs	geneN
ERα	geneY
【GOLD_R】
【PRE_R】

The role of ERα in reproduction has been found to involve a nuclear ERα that induces a genomic mechanism of action .
【GOLD_E】
ERα	geneY
ERα	geneY
【PRE_E】
ERα	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

More recently , a plasma membrane ERα has been shown to trigger signaling pathways involved in reproduction .
【GOLD_E】
ERα	geneY
【PRE_E】
ERα	geneY
【GOLD_R】
【PRE_R】

Mechanisms underlying membrane - initiated estradiol signaling are emerging , including evidence that activation of plasma membrane ERα involves receptor trafficking .
【GOLD_E】
ERα	geneY
【PRE_E】
estradiol	chem
ERα	geneY
【GOLD_R】
【PRE_R】

The present study examined the insertion of ERα into the plasma membrane of N - 38 neurons , an immortalized murine hypothalamic cell line .
【GOLD_E】
ERα	geneY
【PRE_E】
ERα	geneY
N	chem
【GOLD_R】
【PRE_R】

We identified , using western blotting and PCR that N - 38 neurons express full - length 66kDa ERα and a 52kDa ERα spliced variant missing the fourth exon - ERα Δ 4 .
【GOLD_E】
ERα	geneY
ERα	geneY
ERαΔ4	geneY
【PRE_E】
N	chem
66kDa	geneN
ERα	geneY
52kDa	geneN
ERα	geneY
ERαΔ4	geneY
【GOLD_R】
【PRE_R】

Using surface biotinylation , we observed that treatment of N - 38 neurons with estradiol or with a membrane impermeant estradiol elevated plasma membrane ERα protein levels , indicating that membrane signaling increased receptor insertion into the cell membrane .
【GOLD_E】
ERα	geneY
estradiol	chem
estradiol	chem
【PRE_E】
N	chem
estradiol	chem
estradiol	chem
ERα	geneY
【GOLD_R】
estradiol	ERα	C3
estradiol	ERα	C3
【PRE_R】
estradiol	ERα	C3
estradiol	ERα	C3

Insertion of ERα was blocked by the ER antagonist ICI 182,780 or with the protein kinase C ( PKC ) pathway inhibitor bisindolylmaleimide ( BIS ) .
【GOLD_E】
ERα	geneY
ER	geneY
proteinkinaseC	geneN
PKC	geneN
ICI182,780	chem
bisindolylmaleimide	chem
BIS	chem
【PRE_E】
ERα	geneY
ER	geneY
ICI182,780	chem
proteinkinaseC	geneN
PKC	geneN
bisindolylmaleimide(BIS)	chem
【GOLD_R】
ICI182,780	ERα	C4
bisindolylmaleimide	ERα	C4
bisindolylmaleimide	proteinkinaseC	C4
bisindolylmaleimide	PKC	C4
BIS	ERα	C4
BIS	proteinkinaseC	C4
BIS	PKC	C4
ICI182,780	ER	C6
【PRE_R】
ERα	ICI182,780	C6
ER	ICI182,780	C6
proteinkinaseC	bisindolylmaleimide(BIS)	C4
PKC	bisindolylmaleimide(BIS)	C4

Downstream membrane - initiated signaling was confirmed by estradiol activation of PKC - theta ( PKCθ ) and the release of intracellular calcium .
【GOLD_E】
PKC-theta	geneY
PKCθ	geneY
estradiol	chem
【PRE_E】
estradiol	chem
PKC-theta	geneY
PKCθ	geneY
calcium	chem
【GOLD_R】
【PRE_R】
estradiol	PKC-theta	C3
estradiol	PKCθ	C3

These results indicate that membrane ERα levels in N - 38 neurons are dynamically autoregulated by estradiol .
【GOLD_E】
ERα	geneY
estradiol	chem
【PRE_E】
ERα	geneY
N	chem
estradiol	chem
【GOLD_R】
estradiol	ERα	C3
【PRE_R】

Neuroprotective and anti - inflammatory properties of a coffee component in the MPTP model of Parkinson 's disease .
【GOLD_E】
MPTP	chem
【PRE_E】
MPTP	chem
【GOLD_R】
【PRE_R】

Consumption of coffee is associated with reduced risk of Parkinson 's disease ( PD ) , an effect that has largely been attributed to caffeine .
【GOLD_E】
【PRE_E】
caffeine	chem
【GOLD_R】
【PRE_R】

However , coffee contains numerous components that may also be neuroprotective .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

One of these compounds is eicosanoyl - 5 - hydroxytryptamide ( EHT ) , which ameliorates the phenotype of α - synuclein transgenic mice associated with decreased protein aggregation and phosphorylation , improved neuronal integrity and reduced neuroinflammation .
【GOLD_E】
α-synuclein	geneY
eicosanoyl-5-hydroxytryptamide	chem
EHT	chem
【PRE_E】
eicosanoyl-5-hydroxytryptamide	chem
EHT	chem
α-synuclein	geneY
【GOLD_R】
【PRE_R】
eicosanoyl-5-hydroxytryptamide	α-synuclein	C4
EHT	α-synuclein	C4

Here , we sought to investigate if EHT has an effect in the MPTP model of PD .
【GOLD_E】
EHT	chem
MPTP	chem
【PRE_E】
EHT	geneY
MPTP	chem
【GOLD_R】
【PRE_R】

Mice fed a diet containing EHT for four weeks exhibited dose - dependent preservation of nigral dopaminergic neurons following MPTP challenge compared to animals given control feed .
【GOLD_E】
EHT	chem
MPTP	chem
【PRE_E】
EHT	geneY
MPTP	chem
【GOLD_R】
【PRE_R】

Reductions in striatal dopamine and tyrosine hydroxylase content were also less pronounced with EHT treatment .
【GOLD_E】
dopamine	chem
tyrosine	chem
EHT	chem
tyrosinehydroxylase	geneY
【PRE_E】
dopamineandtyrosinehydroxylase	geneN
【GOLD_R】
EHT	tyrosinehydroxylase	C3
【PRE_R】

The neuroinflammatory response to MPTP was markedly attenuated , and indices of oxidative stress and JNK activation were significantly prevented with EHT .
【GOLD_E】
MPTP	chem
EHT	chem
JNK	geneN
【PRE_E】
MPTP	chem
JNK	geneN
EHT	geneY
【GOLD_R】
EHT	JNK	C4
【PRE_R】
MPTP	JNK	C4
MPTP	EHT	C4

In cultured primary microglia and astrocytes , EHT had a direct anti - inflammatory effect demonstrated by repression of lipopolysaccharide - induced NFκB activation , iNOS induction , and nitric oxide production .
【GOLD_E】
EHT	chem
NFκB	geneN
iNOS	geneY
nitricoxide	chem
【PRE_E】
EHT	geneY
NFκB	geneN
iNOS	geneY
nitricoxide	chem
【GOLD_R】
EHT	NFκB	C4
EHT	iNOS	C4
【PRE_R】

EHT also exhibited a robust anti - oxidant activity in vitro .
【GOLD_E】
EHT	chem
【PRE_E】
EHT	geneY
【GOLD_R】
【PRE_R】

Additionally , in SH - SY5Y cells , MPP ( + ) - induced demethylation of phosphoprotein phosphatase 2A ( PP2A ) , the master regulator of the cellular phosphoregulatory network , and cytotoxicity were ameliorated by EHT .
【GOLD_E】
phosphoproteinphosphatase2A	geneN
PP2A	geneN
MPP(+)	chem
EHT	chem
【PRE_E】
MPP(+)	chem
phosphoproteinphosphatase2A	geneN
PP2A	geneN
【GOLD_R】
EHT	phosphoproteinphosphatase2A	C3
EHT	PP2A	C3
MPP(+)	phosphoproteinphosphatase2A	C4
MPP(+)	PP2A	C4
【PRE_R】
MPP(+)	phosphoproteinphosphatase2A	C3
MPP(+)	PP2A	C3

These findings indicate that the neuroprotective effect of EHT against MPTP is through several mechanisms including its anti - inflammatory and antioxidant activities as well as its ability to modulate the methylation and hence activity of PP2A .
【GOLD_E】
PP2A	geneN
EHT	chem
MPTP	chem
【PRE_E】
EHT	chem
MPTP	chem
PP2A	geneN
【GOLD_R】
【PRE_R】

Our data , therefore , reveal a strong beneficial effect of a novel component of coffee in multiple endpoints relevant to PD .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hydrogen sulfide , the next potent preventive and therapeutic agent in aging and age - associated diseases .
【GOLD_E】
Hydrogensulfide	chem
【PRE_E】
Hydrogensulfide	chem
【GOLD_R】
【PRE_R】

Hydrogen sulfide ( H ( 2 ) S ) is the third endogenous signaling gasotransmitter , following nitric oxide and carbon monoxide .
【GOLD_E】
nitricoxide	chem
Hydrogensulfide	chem
carbonmonoxide	chem
H(2)S	chem
【PRE_E】
Hydrogensulfide	chem
H(2)S	chem
nitricoxide	chem
carbonmonoxide	chem
【GOLD_R】
【PRE_R】

It is physiologically generated by cystathionine - γ - lyase , cystathionine - β - synthase , and 3 - mercaptopyruvate sulfurtransferase .
【GOLD_E】
cystathionine-γ-lyase	geneY
cystathionine-β-synthase	geneY
3-mercaptopyruvatesulfurtransferase	geneY
cystathionine	chem
cystathionine	chem
3-mercaptopyruvate	chem
【PRE_E】
cystathionine-γ-lyase	geneY
cystathionine-β-synthase	geneY
3-mercaptopyruvatesulfurtransferase	geneY
【GOLD_R】
【PRE_R】

H ( 2 ) S has been gaining increasing attention as an important endogenous signaling molecule because of its significant effects on the cardiovascular and nervous systems .
【GOLD_E】
H(2)S	chem
【PRE_E】
H(2)S	chem
【GOLD_R】
【PRE_R】

Substantial evidence shows that H ( 2 ) S is involved in aging by inhibiting free - radical reactions , activating SIRT1 , and probably interacting with the age - related gene Klotho .
【GOLD_E】
SIRT1	geneY
Klotho	geneY
H(2)S	chem
【PRE_E】
H(2)S	chem
SIRT1	geneY
Klotho	geneY
【GOLD_R】
H(2)S	SIRT1	C3
【PRE_R】

Moreover , H ( 2 ) S has been shown to have therapeutic potential in age - associated diseases .
【GOLD_E】
H(2)S	chem
【PRE_E】
H(2)S	chem
【GOLD_R】
【PRE_R】

This article provides an overview of the physiological functions and effects of H ( 2 ) S in aging and age - associated diseases , and proposes the potential health and therapeutic benefits of H ( 2 ) S .
【GOLD_E】
H(2)S	chem
H(2)S	chem
【PRE_E】
H(2)S	chem
H(2)S	chem
【GOLD_R】
【PRE_R】

Induction of HO - 1 through p38 MAPK / Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS - activated RAW 264.7 cells and CLP - induced septic mice .
【GOLD_E】
HO-1	geneY
p38	geneN
MAPK	geneN
Nrf2	geneY
ethanol	chem
【PRE_E】
HO-1	geneY
p38	geneN
MAPK	geneN
Nrf2	geneY
ethanol	chem
【GOLD_R】
ethanol	HO-1	C3
ethanol	p38	C3
ethanol	MAPK	C3
【PRE_R】
HO-1	ethanol	C3
p38	ethanol	C3
MAPK	ethanol	C3
Nrf2	ethanol	C3

High mobility group box 1 ( HMGB1 ) plays a crucial mediator in the pathogenesis of many inflammatory diseases .
【GOLD_E】
HMGB1	geneY
Highmobilitygroupbox1	geneY
【PRE_E】
Highmobilitygroupbox1	geneY
HMGB1	geneY
【GOLD_R】
【PRE_R】

We recently proposed that heme oxygenase - 1 ( HO - 1 ) negatively regulates HMGB1 in inflammatory conditions .
【GOLD_E】
hemeoxygenase-1	geneY
HO-1	geneY
HMGB1	geneY
heme	chem
【PRE_E】
hemeoxygenase-1	geneY
HO-1	geneY
HMGB1	geneY
【GOLD_R】
【PRE_R】

We investigated whether ethanol extract of Inula helenium L .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
【GOLD_R】
【PRE_R】

( EIH ) activates p38 MAPK / Nrf2 / HO - 1 pathways in RAW264.7 cells and reduces inflammation in CLP - induced septic mice .
【GOLD_E】
p38	geneN
MAPK	geneN
Nrf2	geneY
HO-1	geneY
【PRE_E】
p38	geneN
MAPK	geneN
Nrf2	geneY
HO-1	geneY
【GOLD_R】
【PRE_R】

EIH induced expression of HO - 1 protein in a time - and concentration - dependent manner .
【GOLD_E】
HO-1	geneY
【PRE_E】
EIH	chem
HO-1	geneY
【GOLD_R】
【PRE_R】
EIH	HO-1	C3

EIH significantly diminished HO - 1 expression in siNrf2 RNA - transfected cells .
【GOLD_E】
HO-1	geneY
siNrf2	geneY
【PRE_E】
EIH	chem
HO-1	geneY
siNrf2	chem
【GOLD_R】
【PRE_R】
EIH	HO-1	C4
HO-1	siNrf2	C4

As expected , the inhibited expression of iNOS / NO , COX - 2 / PGE2 , HMGB1 release by EIH in LPS - activated RAW264.7 cells was significantly reversed by siHO - 1RNA transfection .
【GOLD_E】
iNOS	geneY
COX-2	geneY
HMGB1	geneY
siHO-1	geneY
【PRE_E】
iNOS	geneY
NO	chem
COX-2	geneY
PGE2	chem
HMGB1	geneY
【GOLD_R】
【PRE_R】

Furthermore , EIH not only inhibited NF - κB luciferase activity , phosphorylation of IκBα in LPS - activated cells but also significantly suppressed expression of adhesion molecules ( ICAM - 1 and VCAM - 1 ) in TNF - α activated human umbilical vein endothelial cells .
【GOLD_E】
NF-κB	geneN
IκBα	geneY
ICAM-1	geneY
VCAM-1	geneY
TNF-α	geneY
【PRE_E】
EIH	chem
NF-κB	geneN
IκBα	geneY
adhesionmolecules	geneN
ICAM-1	geneY
VCAM-1	geneY
TNF-α	geneY
【GOLD_R】
【PRE_R】
EIH	NF-κB	C4
EIH	IκBα	C4

The induction of HO - 1 by EIH was inhibited by SB203580 but not by SP600125 , PD98059 , nor LY294002 .
【GOLD_E】
SB203580	chem
SP600125	chem
HO-1	geneY
PD98059	chem
LY294002	chem
【PRE_E】
HO-1	geneY
EIH	chem
SB203580	chem
SP600125	chem
PD98059	chem
LY294002	chem
【GOLD_R】
SB203580	HO-1	C4
【PRE_R】
HO-1	EIH	C4
HO-1	SB203580	C4
HO-1	SP600125	C4
HO-1	PD98059	C4
HO-1	LY294002	C4

Most importantly , administration of EIH significantly reduced not only increase in blood HMGB1 , ALT , AST , BUN , creatinine levels but also decrease macrophage infiltrate in the liver of septic mice , which were reversed by ZnPPIX , a HO - 1 inhibitor .
【GOLD_E】
HMGB1	geneY
ALT,	geneN
AST	geneN
HO-1	geneY
creatinine	chem
【PRE_E】
EIH	chem
HMGB1	geneY
ALT	geneN
AST	geneY
BUN	geneY
creatinine	chem
ZnPPIX	chem
HO-1	geneY
【GOLD_R】
【PRE_R】
EIH	HMGB1	C3
EIH	ALT	C3
EIH	AST	C3
ZnPPIX	HO-1	C4

We concluded that EIH has anti - inflammatory effect via the induction of p38 MAPK - dependent HO - 1 signaling pathway .
【GOLD_E】
p38	geneN
MAPK	geneN
HO-1	geneY
【PRE_E】
EIH	chem
p38	geneN
MAPK	geneN
HO-1	geneY
【GOLD_R】
【PRE_R】

Protease - activated receptor ( PAR ) 1 and PAR4 differentially regulate factor V expression from human platelets .
【GOLD_E】
Protease-activatedreceptor(PAR)1	geneY
PAR4	geneY
factorV	geneY
【PRE_E】
Protease-activatedreceptor(PAR)1	geneY
PAR4	geneY
factorV	geneY
【GOLD_R】
【PRE_R】

With the recent interest of protease - activated receptors ( PAR ) 1 and PAR4 as possible targets for the treatment of thrombotic disorders , we compared the efficacy of protease - activated receptor ( PAR ) 1 and PAR4 in the generation of procoagulant phenotypes on platelet membranes .
【GOLD_E】
protease-activatedreceptor(PAR)1	geneY
PAR4	geneY
protease-activatedreceptors(PAR)1	geneY
PAR4	geneY
【PRE_E】
protease-activatedreceptors(PAR)1	geneY
PAR4	geneY
protease-activatedreceptor(PAR)1	geneY
PAR4	geneY
【GOLD_R】
【PRE_R】

PAR4 - activating peptide ( AP ) - stimulated platelets promoted thrombin generation in plasma up to 5 minutes earlier than PAR1 - AP - stimulated platelets .
【GOLD_E】
PAR4	geneY
thrombin	geneY
PAR1	geneY
【PRE_E】
PAR4-activatingpeptide	geneY
AP	geneY
thrombin	geneY
PAR1-AP	geneY
【GOLD_R】
【PRE_R】

PAR4 - AP - mediated factor V ( FV ) association with the platelet surface was 1.6 - fold greater than for PAR1 - AP .
【GOLD_E】
PAR4	geneY
factorV	geneY
FV	geneY
PAR1	geneY
【PRE_E】
PAR4-AP-mediatedfactorV	geneY
FV	geneY
PAR1-AP	geneY
【GOLD_R】
【PRE_R】

Moreover , PAR4 stimulation resulted in a 3 - fold greater release of microparticles , compared with PAR1 stimulation .
【GOLD_E】
PAR4	geneY
PAR1	geneY
【PRE_E】
PAR4	geneY
PAR1	geneY
【GOLD_R】
【PRE_R】

More robust FV secretion and microparticle generation with PAR4 - AP was attributable to stronger and more sustained phosphorylation of myosin light chain at serine 19 and threonine 18 .
【GOLD_E】
serine	chem
FV	geneY
PAR4	geneY
threonine	chem
【PRE_E】
PAR4-AP	geneY
myosinlightchain	geneY
serine	chem
threonine	chem
【GOLD_R】
【PRE_R】

Inhibition of Rho - kinase reduced PAR4 - AP - mediated FV secretion and microparticle generation to PAR1 - AP - mediated levels .
【GOLD_E】
Rho-kinase	geneN
PAR4	geneY
FV	geneY
PAR1	geneY
【PRE_E】
Rho-kinase	geneN
PAR4-AP	geneY
PAR1-AP	geneY
【GOLD_R】
【PRE_R】

Thrombin generation assays measuring prothrombinase complex activity demonstrated 1.5 - fold higher peak thrombin levels on PAR4 - AP - stimulated platelets , compared with PAR1 - AP - stimulated platelets .
【GOLD_E】
Thrombin	geneY
prothrombinase	geneN
thrombin	geneY
PAR4	geneY
PAR1	geneY
【PRE_E】
Thrombin	geneY
prothrombinase	geneN
thrombin	geneY
PAR4-AP	geneY
PAR1-AP	geneY
【GOLD_R】
【PRE_R】

Rho - kinase inhibition reduced PAR4 - AP - mediated peak thrombin generation by 25 % but had no significant effect on PAR1 - AP - mediated thrombin generation .
【GOLD_E】
Rho-kinase	geneN
PAR4	geneY
PAR1	geneY
thrombin	geneY
【PRE_E】
Rho-kinase	geneN
PAR4-AP	geneY
thrombin	geneY
PAR1-AP	geneY
thrombin	geneY
【GOLD_R】
【PRE_R】

In conclusion , stimulation of PAR4 on platelets leads to faster and more robust thrombin generation , compared with PAR1 stimulation .
【GOLD_E】
PAR4	geneY
PAR1	geneY
【PRE_E】
PAR4	geneY
thrombin	geneY
PAR1	geneY
【GOLD_R】
【PRE_R】

The greater procoagulant potential is related to more efficient FV release from intracellular stores and microparticle production driven by stronger and more sustained myosin light chain phosphorylation .
【GOLD_E】
FV	geneY
【PRE_E】
myosinlightchain	geneY
【GOLD_R】
【PRE_R】

These data have implications about the role of PAR4 during hemostasis and are clinically relevant in light of recent efforts to develop PAR antagonists to treat thrombotic disorders .
【GOLD_E】
PAR4	geneY
PAR	geneN
【PRE_E】
PAR4	geneY
PAR	geneN
【GOLD_R】
【PRE_R】

Diels - Alder mediated controlled release from a poly ( ethylene glycol ) based hydrogel .
【GOLD_E】
poly(ethyleneglycol)	chem
【PRE_E】
Diels-Alder	chem
poly(ethyleneglycol)	chem
【GOLD_R】
【PRE_R】

A synthetic amino acid bearing a furan functionality was developed and incorporated into peptide sequences using solid phase synthesis .
【GOLD_E】
aminoacid	chem
furan	chem
【PRE_E】
aminoacid	chem
furan	chem
【GOLD_R】
【PRE_R】

Peptides expressing the furan moiety were attached to poly ( ethylene glycol ) ( PEG ) hydrogels through a thermally reversible covalent bond formed by a Diels - Alder reaction .
【GOLD_E】
furan	chem
poly(ethyleneglycol)	chem
PEG	chem
【PRE_E】
furan	chem
poly(ethyleneglycol)	chem
PEG	chem
Diels-Alder	chem
【GOLD_R】
【PRE_R】

Reactions of thiol and maleimide PEG macromers in an off - stoichiometric Michael addition were performed , such that the maleimide moiety was in excess , to create hydrogel networks with pendant Diels - Alder compatible tethering sites , that is , the maleimide .
【GOLD_E】
maleimide	chem
maleimide	chem
thiol	chem
maleimidePEG	chem
【PRE_E】
thiol	chem
maleimidePEG	chem
maleimide	chem
Diels-Alder	chem
maleimide	chem
【GOLD_R】
【PRE_R】

By making use of the Diels - Alder reaction , it was possible to control the release rate of reversibly bound moieties from the hydrogel by changing the temperature ; higher temperatures favor a faster retro - Diels - Alder reaction and , therefore , a faster release from the polymer network .
【GOLD_E】
【PRE_E】
Diels-Alder	chem
retro-Diels-Alder	chem
【GOLD_R】
【PRE_R】

This concept was demonstrated by incorporating a fluorescently labeled furan - RGDS sequence into a hydrogel possessing excess maleimide functionalities and monitoring the subsequent liberation of RGDS at various temperatures , illustrating a Diels - Alder mediated release mechanism .
【GOLD_E】
furan	chem
maleimide	chem
【PRE_E】
furan-RGDS	chem
maleimide	chem
RGDS	chem
Diels-Alder	chem
【GOLD_R】
【PRE_R】

The release profile was quantified at temperatures ranging from physiological ( 37 °C ) to 80 °C .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

By changing the temperature , varying extents of release were attained over the time course of several days , ranging from 40 % release for lower temperatures to complete release for the highest temperature considered .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Further confirmation of a reaction - diffusion controlled release mechanism was obtained through comparison of experimental release data to a reaction - diffusion model of the release .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition to thermal modulation , tuning of the release rate was accomplished by altering the number of possible Diels - Alder tethering sites present in the hydrogel .
【GOLD_E】
【PRE_E】
Diels-Alder	chem
【GOLD_R】
【PRE_R】

Increasing the amount of free maleimide and , therefore , the number of potential Diels - Alder reaction sites , effectively slowed the release of peptide from the polymer .
【GOLD_E】
maleimide	chem
【PRE_E】
maleimide	chem
Diels-Alder	chem
【GOLD_R】
【PRE_R】

For instance , doubling the amount of maleimide sites present in the hydrogel system decreased the amount of peptide released from approximately 60 % to about 40 % in the same span of time .
【GOLD_E】
maleimide	chem
【PRE_E】
maleimide	chem
【GOLD_R】
【PRE_R】

Trimethylamine - N - oxide , a metabolite associated with atherosclerosis , exhibits complex genetic and dietary regulation .
【GOLD_E】
Trimethylamine-N-oxide	chem
【PRE_E】
Trimethylamine-N-oxide	chem
【GOLD_R】
【PRE_R】

Circulating trimethylamine - N - oxide ( TMAO ) levels are strongly associated with atherosclerosis .
【GOLD_E】
trimethylamine-N-oxide	chem
TMAO	chem
【PRE_E】
trimethylamine-N-oxide	chem
TMAO	chem
【GOLD_R】
【PRE_R】

We now examine genetic , dietary , and hormonal factors regulating TMAO levels .
【GOLD_E】
TMAO	chem
【PRE_E】
TMAO	chem
【GOLD_R】
【PRE_R】

We demonstrate that two flavin mono - oxygenase family members , FMO1 and FMO3 , oxidize trimethylamine ( TMA ) , derived from gut flora metabolism of choline , to TMAO .
【GOLD_E】
flavinmono-oxygenase	geneN
FMO1	geneY
FMO3	geneY
flavin	chem
trimethylamine	chem
TMA	chem
choline	chem
TMAO	chem
【PRE_E】
flavinmono-oxygenase	geneN
FMO1	geneY
FMO3	geneY
trimethylamine	chem
TMA	chem
choline	chem
TMAO	chem
【GOLD_R】
TMAO	flavinmono-oxygenase	C9
TMAO	FMO1	C9
TMAO	FMO3	C9
trimethylamine	flavinmono-oxygenase	C9
trimethylamine	FMO1	C9
trimethylamine	FMO3	C9
TMA	flavinmono-oxygenase	C9
TMA	FMO1	C9
TMA	FMO3	C9
choline	flavinmono-oxygenase	C9
choline	FMO1	C9
choline	FMO3	C9
【PRE_R】
flavinmono-oxygenase	trimethylamine	C9
FMO1	trimethylamine	C9
FMO3	trimethylamine	C9
FMO3	TMA	C9
FMO3	choline	C9
FMO3	TMAO	C9

Further , we show that FMO3 exhibits 10 - fold higher specific activity than FMO1 .
【GOLD_E】
FMO3	geneY
FMO1	geneY
【PRE_E】
FMO3	geneY
FMO1	geneY
【GOLD_R】
【PRE_R】

FMO3 overexpression in mice significantly increases plasma TMAO levels while silencing FMO3 decreases TMAO levels .
【GOLD_E】
TMAO	chem
FMO3	geneY
FMO3	geneY
TMAO	chem
【PRE_E】
FMO3	geneY
TMAO	chem
FMO3	geneY
TMAO	chem
【GOLD_R】
TMAO	FMO3	C9
TMAO	FMO3	C9
【PRE_R】
FMO3	TMAO	C9
TMAO	FMO3	C9
FMO3	TMAO	C9

In both humans and mice , hepatic FMO3 expression is reduced in males compared to females .
【GOLD_E】
FMO3	geneY
【PRE_E】
FMO3	geneY
【GOLD_R】
【PRE_R】

In mice , this reduction in FMO3 expression is due primarily to downregulation by androgens .
【GOLD_E】
androgens	chem
FMO3	geneY
【PRE_E】
FMO3	geneY
androgens	chem
【GOLD_R】
androgens	FMO3	C4
【PRE_R】
FMO3	androgens	C3

FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor ( FXR ) , a bile acid - activated nuclear receptor .
【GOLD_E】
bileacids	chem
bileacid	chem
FMO3	geneY
farnesoidXreceptor	geneY
FXR	geneY
【PRE_E】
FMO3	geneY
bileacids	chem
farnesoidXreceptor	geneY
FXR	geneY
bileacid-activatednuclearreceptor	geneN
【GOLD_R】
bileacid	farnesoidXreceptor	C3
bileacid	FXR	C3
bileacids	FMO3	C3
【PRE_R】
FMO3	bileacids	C3

Analysis of natural genetic variation among inbred strains of mice indicates that FMO3 and TMAO are significantly correlated , and TMAO levels explain 11 % of the variation in atherosclerosis .
【GOLD_E】
TMAO	chem
TMAO	chem
FMO3	geneY
【PRE_E】
FMO3	geneY
TMAO	geneY
TMAO	geneN
【GOLD_R】
TMAO	FMO3	C9
【PRE_R】

Tricycloalternarenes F - H : three new mixed terpenoids produced by an endolichenic fungus Ulocladium sp . using OSMAC method .
【GOLD_E】
TricycloalternarenesF-H	chem
terpenoids	chem
【PRE_E】
TricycloalternarenesF-H	chem
terpenoids	chem
【GOLD_R】
【PRE_R】

Three new mixed terpenoids , tricycloalternarenes ( TCAs ) F - H ( 1 - 3 ) , together with ten known tricycloalternarenes ( 4 - 13 ) , were isolated from the Czapek 's culture of an endophytic fungus Ulocladium sp .
【GOLD_E】
terpenoids	chem
tricycloalternarenes	chem
TCAs	chem
tricycloalternarenes	chem
【PRE_E】
terpenoids	chem
tricycloalternarenes	chem
TCAs	chem
F-H	chem
tricycloalternarenes	chem
【GOLD_R】
【PRE_R】

Their structures were identified by extensive spectroscopic experiments ( NMR and MS ) and comparison with literature data .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

TCA 1b ( 5 ) showed weak activity against the Bacille Calmette - Guerin strain with the MIC of 125μg / mL .
【GOLD_E】
TCA	chem
【PRE_E】
TCA1b(5)	chem
【GOLD_R】
【PRE_R】

TCA 9b ( 10 ) exhibited strong cytotoxic activity against Hela cell line with IC50 of 8.58μM .
【GOLD_E】
TCA	chem
【PRE_E】
TCA9b	chem
【GOLD_R】
【PRE_R】

What are the physiological estrogens ?
【GOLD_E】
estrogens	chem
【PRE_E】
estrogens	chem
【GOLD_R】
【PRE_R】

Estradiol ( E2 ) is the principal physiological estrogen in mammals .
【GOLD_E】
Estradiol	chem
【PRE_E】
Estradiol	chem
E2	chem
estrogen	chem
【GOLD_R】
【PRE_R】

E2 and its active metabolites , estrone and estriol have a characteristic phenolic A ring , unlike progesterone , testosterone , cortisol and aldosterone , which have an A ring containing a C3 - ketone , a Δ ( 4 ) bond and a C19 methyl group .
【GOLD_E】
estrone	chem
estriol	chem
progesterone	chem
testosterone	chem
cortisol	chem
aldosterone	chem
ketone	chem
methyl	chem
【PRE_E】
E2	chem
estrone	chem
estriol	chem
phenolicA	chem
progesterone	chem
testosterone	chem
cortisol	chem
aldosterone	chem
C3-ketone	chem
Δ(4)	chem
C19methyl	chem
【GOLD_R】
【PRE_R】

Crystal structures of E2 in the estrogen receptor ( ER ) confirm the importance of the A ring in stabilizing E2 in the ER .
【GOLD_E】
estrogenreceptor	geneY
ER	geneY
ER	geneY
estrogen	chem
【PRE_E】
E2	chem
estrogenreceptor	geneY
ER	geneY
E2	chem
【GOLD_R】
【PRE_R】
ER	E2	C9

However , other steroids , including Δ ( 5 ) - androstenediol , 5α - androstanediol and 27 - hydroxycholesterol , which have a saturated A ring containing a 3β - hydroxyl and a C19 methyl group , also mediate physiological responses through binding to estrogen receptor - α ( ERα ) and ERβ .
【GOLD_E】
steroids	chem
Δ(5)-androstenediol	chem
5α-androstanediol	chem
27-hydroxycholesterol	chem
3β-hydroxyl	chem
methyl	chem
estrogen	chem
estrogenreceptor-α	geneY
ERα	geneY
ERβ	geneY
【PRE_E】
steroids	chem
Δ(5)-androstenediol	chem
5α-androstanediol	chem
27-hydroxycholesterol	chem
3β-hydroxyl	chem
C19methyl	chem
estrogenreceptor-α	geneY
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Moreover , selective estrogen response modulators ( SERMs ) with diverse structures also regulate transcription of ERα and ERβ .
【GOLD_E】
estrogen	chem
ERα	geneY
ERβ	geneY
【PRE_E】
estrogenresponsemodulators	geneN
SERMs	geneN
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Our understanding of the physiological responses mediated by these `` alternative `` estrogens is in its infancy .
【GOLD_E】
``estroge	chem
【PRE_E】
estrogens	chem
【GOLD_R】
【PRE_R】

Further studies of the role of these steroids and SERMs in regulating responses mediated by ERα and ERβ a variety of tissues , during different stages of development , are likely to uncover additional estrogenic activities .
【GOLD_E】
steroids	chem
ERα	geneY
ERβ	geneY
【PRE_E】
steroids	chem
SERMs	geneN
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Synthesis of quinoline derivatives : discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer 's disease .
【GOLD_E】
phosphodiesterase5	geneY
quinoline	chem
【PRE_E】
quinoline	chem
phosphodiesterase5	geneY
【GOLD_R】
quinoline	phosphodiesterase5	C4
【PRE_R】
quinoline	phosphodiesterase5	C4

Phosphodiesterase type 5 ( PDE5 ) mediates the degradation of cGMP in a variety of tissues including brain .
【GOLD_E】
PDE5	geneY
cGMP	chem
Phosphodiesterasetype5	geneY
【PRE_E】
Phosphodiesterasetype5	geneY
PDE5	geneY
cGMP	chem
【GOLD_R】
cGMP	PDE5	C9
cGMP	Phosphodiesterasetype5	C9
【PRE_R】
Phosphodiesterasetype5	cGMP	C9
PDE5	cGMP	C9

Recent studies have demonstrated the importance of the nitric oxide / cGMP / cAMP - responsive element - binding protein ( CREB ) pathway to the process of learning and memory .
【GOLD_E】
CREB	geneN
nitricoxide	chem
cGMP	chem
cAMP	chem
cAMP-responsiveelement-bindingprotein	geneN
【PRE_E】
nitricoxide	chem
cGMP/cAMP-responsiveelement-bindingprotein	geneN
CREB	geneN
【GOLD_R】
【PRE_R】

Thus , PDE5 inhibitors ( PDE5Is ) are thought to be promising new therapeutic agents for the treatment of Alzheimer 's disease ( AD ) , a neurodegenerative disorder characterized by memory loss .
【GOLD_E】
PDE5	geneY
【PRE_E】
PDE5	geneY
【GOLD_R】
【PRE_R】

To explore this possibility , a series of quinoline derivatives were synthesized and evaluated .
【GOLD_E】
quinoline	chem
【PRE_E】
quinoline	chem
【GOLD_R】
【PRE_R】

We found that compound 7a selectively inhibits PDE5 with an IC ( 50 ) of 0.27 nM and readily crosses the blood brain barrier .
【GOLD_E】
PDE5	geneY
【PRE_E】
PDE5	geneY
【GOLD_R】
【PRE_R】

In an in vivo mouse model of AD , compound 7a rescues synaptic and memory defects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Quinoline - based , CNS - permeant PDE5Is have potential for AD therapeutic development .
【GOLD_E】
Quinoline	chem
【PRE_E】
Quinoline	chem
PDE5Is	chem
【GOLD_R】
【PRE_R】

Fragment - based design , synthesis , and biological evaluation of N - substituted - 5 - ( 4 - isopropylthiophenol ) - 2 - hydroxynicotinamide derivatives as novel Mcl - 1 inhibitors .
【GOLD_E】
N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide	chem
Mcl-1	geneN
【PRE_E】
N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide	chem
Mcl-1	geneY
【GOLD_R】
N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide	Mcl-1	C4
【PRE_R】
N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide	Mcl-1	C4

We have previously reported a nanomolar inhibitor of antiapoptotic Mcl - 1 protein , 3 - thiomorpholin - 8 - oxo - 8H - acenaphtho [ 1,2 - b ] pyrrole - 9 - carbonitrile ( S1 ) .
【GOLD_E】
3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile	chem
Mcl-1	geneY
【PRE_E】
Mcl-1	geneY
3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile	chem
【GOLD_R】
3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile	Mcl-1	C4
【PRE_R】
Mcl-1	3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile	C4

S1 plays its function by binding to the BH3 groove of Mcl - 1 .
【GOLD_E】
Mcl-1	geneY
【PRE_E】
BH3	geneN
Mcl-1	geneY
【GOLD_R】
【PRE_R】

Basing on this spacial structural characteristic , we developed a novel class of Mcl - 1 inhibitor using fragment - based drug discovery approach .
【GOLD_E】
Mcl-1	geneY
【PRE_E】
Mcl-1	geneY
【GOLD_R】
【PRE_R】

By dissecting S1 , we identified the compound 4 with a 2 - hydroxypyridine core as the starting fragment .
【GOLD_E】
2-hydroxypyridine	chem
【PRE_E】
2-hydroxypyridine	chem
【GOLD_R】
【PRE_R】

In the following molecular growth , we used the ligand efficiency evaluation and fit quality score to assess the fragments .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A novel potent compound , N - benzyl - 5 - ( 4 - isopropylthiophenol ) - 2 - hydroxyl nicotinamide ( 12c ) , which binds Mcl - 1 with an IC ( 50 ) value of 54 nM was obtained .
【GOLD_E】
N-benzyl-5-(4-isopropylthiophenol)-2-hydroxylnicotinamide	chem
Mcl-1	geneY
【PRE_E】
N-benzyl-5-(4-isopropylthiophenol)-2-hydroxylnicotinamide	chem
12c	chem
Mcl-1	geneY
【GOLD_R】
N-benzyl-5-(4-isopropylthiophenol)-2-hydroxylnicotinamide	Mcl-1	C4
【PRE_R】

Compound 12c demonstrated a better aqueous solubility than S1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Transaldolase deficiency : report of 12 new cases and further delineation of the phenotype .
【GOLD_E】
Transaldolase	geneY
【PRE_E】
Transaldolase	geneN
【GOLD_R】
【PRE_R】

PURPOSE : Transaldolase deficiency is a recently described inborn error of pentose phosphate pathway .
【GOLD_E】
pentosephosphate	chem
Transaldolase	geneY
【PRE_E】
Transaldolase	geneN
pentosephosphate	chem
【GOLD_R】
【PRE_R】
Transaldolase	pentosephosphate	C9

We conducted this study to further delineate the associated phenotype .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS AND RESULTS : We report on 12 new cases representing six families with this metabolic defect that were observed over an 8 year span .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

None of these cases received the correct diagnosis initially because of significant overlap in the presenting symptoms ( growth retardation , dysmorphic features , cutis laxa , congenital heart disease , hepatosplenomegaly , pancytopenia , and bleeding tendency ) with a wide range of genetic disorders .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , the consanguineous nature of these families allowed us to pursue autozygome analysis , which highlighted TALDO as the likely candidate gene and sequencing confirmed segregation of a novel homozygous mutation with the disease in all the studied families .
【GOLD_E】
TALDO	geneY
【PRE_E】
TALDO	geneY
【GOLD_R】
【PRE_R】

Biochemical analysis was also consistent with transaldolase deficiency .
【GOLD_E】
transaldolase	geneY
【PRE_E】
transaldolase	geneN
【GOLD_R】
【PRE_R】

CONCLUSION : This study expands the clinical definition of transaldolase deficiency , and adds to its allelic heterogeneity .
【GOLD_E】
transaldolase	geneY
【PRE_E】
transaldolase	geneN
【GOLD_R】
【PRE_R】

In addition , we emphasize the diagnostic challenge posed by this rare and pleiotropic metabolic disorder .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cellular signaling crosstalk between multiple receptors for investigation of pathophysiology in multifactorial diseases - - what is clinically - relevant crosstalk ?
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recently , genomics and proteomics have been utilized as advanced tools for investigation of cellular signaling pathways and molecular interactions , and elucidated promiscuous networks composed of numerous interactions among pathways .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , some of these interactions are considered to be simply contributing to background ' noise ' and others are as ' crosstalk ' biologically - relevant to cellular physiology , leading to synergy effects more than additive responses in an entire organism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effort is now required to determine which interactions truly contribute to final physiological output .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A receptor is the prime example of connectors among the networks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It functions , not simply as a signaling gateway , but also as an active trader by forming inter - receptor dimers .
【GOLD_E】
【PRE_E】
inter-receptor	geneN
【GOLD_R】
【PRE_R】

Furthermore , various receptors can modulate the function of the other receptors by input to common intracellular signaling pathways , establishing functional crosstalk among networks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our findings by combined analyses of gene polymorphisms of two separate genes present evidences that such is the case with human body in a clinical setting : 1 ) an integrated effect of epidermal growth factor receptor ( EGFR ) and protease activated receptor - 1 ( PAR - 1 ) on susceptibility to airway hyperresponsiveness ( AHR ) , and 2 ) a crosstalk effect between muscarinic acetylcholine receptor ( mAChRs ) and β ( 2 ) adrenoceptor ( β ( 2 ) AR ) on bronchodilatory response to anticholinergic agents in patients with COPD .
【GOLD_E】
acetylcholine	chem
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
proteaseactivatedreceptor-1	geneY
PAR-1	geneY
muscarinicacetylcholinereceptor	geneN
mAChRs	geneN
β(2)adrenoceptor	geneY
β(2)AR	geneY
【PRE_E】
epidermalgrowthfactorreceptor	geneY
EGFR	geneY
proteaseactivatedreceptor-1	geneY
PAR-1	geneY
AHR	geneY
muscarinicacetylcholinereceptor	geneN
mAChRs	geneY
β(2)adrenoceptor	geneY
β(2)AR	geneY
【GOLD_R】
【PRE_R】

These results indicate that these interactions are unlikely to be ' noise ' but functionally - relevant ' crosstalk ' in a human body .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This review attempts to highlight the clinically - relevant ' crosstalk ' paradigm in a human body which provides us a novel insight necessary to investigate pathophysiology in common multifactorial diseases and to develop new drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Peginesatide clearance , distribution , metabolism , and excretion in monkeys following intravenous administration .
【GOLD_E】
Peginesatide	chem
【PRE_E】
Peginesatide	chem
【GOLD_R】
【PRE_R】

Peginesatide , a polyethylene glycol ( PEG ) ylated peptide - based erythropoiesis - stimulating agent , stimulates the erythropoietin receptor dimer that governs erythropoiesis .
【GOLD_E】
erythropoietinreceptor	geneN
Peginesatide	chem
polyethyleneglycol	chem
PEG	chem
【PRE_E】
Peginesatide	chem
polyethyleneglycol	chem
PEG	chem
erythropoiesis	geneN
erythropoietinreceptor	geneY
【GOLD_R】
Peginesatide	erythropoietinreceptor	C3
polyethyleneglycol	erythropoietinreceptor	C3
PEG	erythropoietinreceptor	C3
【PRE_R】

Studies were designed to determine the erythropoietic response , pharmacokinetics ( PK ) , tissue distribution , metabolism , and excretion of peginesatide in nonhuman primates following a single i.v . dose .
【GOLD_E】
peginesatide	chem
【PRE_E】
peginesatide	chem
【GOLD_R】
【PRE_R】

The PK profile of peginesatide ( 0.1 - 5 mg / kg ) is characterized by low , dose - dependent plasma clearance ; small volume of distribution ; and long half - life .
【GOLD_E】
peginesatide	chem
【PRE_E】
peginesatide	chem
【GOLD_R】
【PRE_R】

The peginesatide PK profile following a single i.v . dose is consistent with the sustained erythropoiesis .
【GOLD_E】
peginesatide	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Biodistribution quantitative whole - body autoradiography demonstrated high peginesatide levels in bone marrow ( i.e . , primary hematopoietic site ) as well as other known hematopoietic sites persisting through at least 3 weeks at 2.1 mg / kg .
【GOLD_E】
peginesatide	chem
【PRE_E】
Biodistribution	chem
peginesatide	chem
【GOLD_R】
【PRE_R】

Microautoradiography analysis at 48 hours postdose revealed uniform and high distribution of radioactivity in the bone marrow and splenic red pulp with less extensive distribution in the renal cortex ( glomeruli , associated ducts , interstitial cells ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Radioactivity in the kidney was most prominent in the outer medullary and papillary interstitium .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

At 2 weeks after dosing , cumulative radioactivity recovery in the urine and feces was 60 and 7 % of the administered dose , respectively , with most of the radioactivity associated with the parent molecule .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , the PK characteristics are consistent with a PEGylated peptide of a 45 - kDa molecular mass , specifically low volume of distribution and long half - life .
【GOLD_E】
【PRE_E】
PEGylated	geneN
【GOLD_R】
【PRE_R】

Drug was localized principally to hematopoietic sites , and nonspecific tissue retention was not observed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The nonhuman primate data indicate that peginesatide is metabolically stable and primarily excreted in the urine .
【GOLD_E】
peginesatide	chem
【PRE_E】
peginesatide	chem
【GOLD_R】
【PRE_R】

Comparison of orientation and rotational motion of skeletal muscle cross - bridges containing phosphorylated and dephosphorylated myosin regulatory light chain .
【GOLD_E】
phosphorylatedanddephosphorylatedmyosinregulatorylightchain	geneY
【PRE_E】
dephosphorylatedmyosinregulatorylightchain	geneY
【GOLD_R】
【PRE_R】

Calcium binding to thin filaments is a major element controlling active force generation in striated muscles .
【GOLD_E】
Calcium	chem
【PRE_E】
Calcium	chem
【GOLD_R】
【PRE_R】

Recent evidence suggests that processes other than Ca ( 2 + ) binding , such as phosphorylation of myosin regulatory light chain ( RLC ) also controls contraction of vertebrate striated muscle ( Cooke , R .
【GOLD_E】
Ca(2+)	chem
myosinregulatorylightchain	geneY
RLC	geneY
【PRE_E】
Ca(2+)	chem
myosinregulatorylightchain	geneY
RLC	geneY
【GOLD_R】
【PRE_R】

( 2011 ) Biophys .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rev .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

3 , 33 - 45 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Electron paramagnetic resonance ( EPR ) studies using nucleotide analog spin label probes showed that dephosphorylated myosin heads are highly ordered in the relaxed fibers and have very low ATPase activity .
【GOLD_E】
ATPase	geneN
nucleotide	chem
dephosphorylatedmyosin	geneN
【PRE_E】
nucleotide	chem
dephosphorylatedmyosin	geneN
ATPase	geneN
【GOLD_R】
【PRE_R】

This ordered structure of myosin cross - bridges disappears with the phosphorylation of RLC ( Stewart , M .
【GOLD_E】
myosin	geneN
【PRE_E】
myosin	geneN
RLC	geneN
【GOLD_R】
【PRE_R】

( 2010 ) Proc .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Natl .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Acad .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Sci .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

U.S.A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

107 , 430 - 435 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The slower ATPase activity in the dephosporylated moiety has been defined as a new super - relaxed state ( SRX ) .
【GOLD_E】
ATPase	geneN
【PRE_E】
ATPase	geneN
SRX	geneY
【GOLD_R】
【PRE_R】

It can be observed in both skeletal and cardiac muscle fibers ( Hooijman , P. , Stewart , M .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A. , and Cooke , R .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 2011 ) Biophys .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

100 , 1969 - 1976 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Given the importance of the finding that suggests a novel pathway of regulation of skeletal muscle , we aim to examine the effects of phosphorylation on cross - bridge orientation and rotational motion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We find that : ( i ) relaxed cross - bridges , but not active ones , are statistically better ordered in muscle where the RLC is dephosporylated compared with phosphorylated RLC ; ( ii ) relaxed phosphorylated and dephosphorylated cross - bridges rotate equally slowly ; and ( iii ) active phosphorylated cross - bridges rotate considerably faster than dephosphorylated ones during isometric contraction but the duty cycle remained the same , suggesting that both phosphorylated and dephosphorylated muscles develop the same isometric tension at full Ca ( 2 + ) saturation .
【GOLD_E】
Ca(2+)	chem
RLC	geneY
phosphorylatedRLC	geneY
【PRE_E】
RLC	geneN
phosphorylatedRLC	geneY
Ca(2+)	chem
【GOLD_R】
【PRE_R】

A simple theory was developed to account for this fact .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

LPA1 - induced cytoskeleton reorganization drives fibrosis through CTGF - dependent fibroblast proliferation .
【GOLD_E】
LPA1	geneY
CTGF	geneY
【PRE_E】
LPA1	geneY
CTGF	geneY
【GOLD_R】
【PRE_R】

There has been much recent interest in lysophosphatidic acid ( LPA ) signaling through one of its receptors , LPA1 , in fibrotic diseases , but the mechanisms by which LPA - LPA1 signaling promotes pathological fibrosis remain to be fully elucidated .
【GOLD_E】
LPA1	geneY
LPA	chem
lysophosphatidicacid	chem
LPA	chem
LPA1	geneY
【PRE_E】
lysophosphatidicacid	chem
LPA	geneN
LPA1	geneY
LPA	geneN
LPA1	geneY
【GOLD_R】
【PRE_R】

Using a mouse peritoneal fibrosis model , we demonstrate central roles for LPA and LPA1 in fibroblast proliferation .
【GOLD_E】
LPA1	geneY
LPA	chem
【PRE_E】
LPA	geneN
LPA1	geneY
【GOLD_R】
【PRE_R】

Genetic deletion or pharmacological antagonism of LPA1 protected mice from peritoneal fibrosis , blunting the increases in peritoneal collagen by 65.4 and 52.9 % , respectively , compared to control animals and demonstrated that peritoneal fibroblast proliferation was highly LPA1 dependent .
【GOLD_E】
LPA1	geneY
collagen	geneN
LPA1	geneY
【PRE_E】
LPA1	geneY
collagen	geneN
LPA1	geneY
【GOLD_R】
【PRE_R】

Activation of LPA1 on mesothelial cells induced these cells to express connective tissue growth factor ( CTGF ) , driving fibroblast proliferation in a paracrine fashion .
【GOLD_E】
LPA1	geneY
connectivetissuegrowthfactor	geneY
CTGF	geneY
【PRE_E】
LPA1	geneY
connectivetissuegrowthfactor	geneY
CTGF	geneY
【GOLD_R】
【PRE_R】

Activation of mesothelial cell LPA1 induced CTGF expression by inducing cytoskeleton reorganization in these cells , causing nuclear translocation of myocardin - related transcription factor ( MRTF ) - A and MRTF - B .
【GOLD_E】
LPA1	geneY
CTGF	geneY
myocardin-relatedtranscriptionfactor(MRTF)-A	geneY
MRTF-B	geneY
【PRE_E】
mesothelialcellLPA1	geneY
CTGF	geneY
myocardin-relatedtranscriptionfactor(MRTF)-A	geneY
MRTF-B	geneY
【GOLD_R】
【PRE_R】

Pharmacological inhibition of MRTF - induced transcription also diminished CTGF expression and fibrosis in the peritoneal fibrosis model , mitigating the increase in peritoneal collagen content by 57.9 % compared to controls .
【GOLD_E】
collagen	geneN
MRTF	geneN
CTGF	geneY
【PRE_E】
MRTF	geneY
CTGF	geneY
collagen	geneN
【GOLD_R】
【PRE_R】

LPA1 - induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of LPA by driving MRTF - dependent CTGF expression , which , in turn , drives fibroblast proliferation . - Sakai , N. , Chun , J. , Duffield , J .
【GOLD_E】
LPA1	geneY
MRTF	geneN
CTGF	geneY
LPA	chem
【PRE_E】
LPA1	geneY
LPA	geneN
MRTF	geneY
CTGF	geneY
【GOLD_R】
LPA	CTGF	C3
【PRE_R】

S. , Wada , T. , Luster , A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

D. , Tager , A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

M .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

LPA1 - induced cytoskeleton reorganization drives fibrosis through CTGF - dependent fibroblast proliferation .
【GOLD_E】
LPA1	geneY
CTGF	geneY
【PRE_E】
LPA1	geneY
CTGF	geneY
【GOLD_R】
【PRE_R】

Cooperative effects for CYP2E1 differ between styrene and its metabolites .
【GOLD_E】
styrene	chem
CYP2E1	geneY
【PRE_E】
CYP2E1	geneY
styrene	chem
【GOLD_R】
【PRE_R】

Abstract 1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cooperative interactions are frequently observed in the metabolism of drugs and pollutants by cytochrome P450s ; nevertheless , the molecular determinants for cooperativity remain elusive .
【GOLD_E】
cytochromeP450s	geneN
【PRE_E】
cytochromeP450s	geneN
【GOLD_R】
【PRE_R】

Previously , we demonstrated that steady - state styrene metabolism by CYP2E1 exhibits positive cooperativity .
【GOLD_E】
CYP2E1	geneY
【PRE_E】
styrene	chem
CYP2E1	geneY
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We hypothesized that styrene metabolites have lower affinity than styrene toward CYP2E1 and limited ability to induce cooperative effects during metabolism .
【GOLD_E】
CYP2E1	geneY
styrene	chem
styrene	chem
【PRE_E】
styrene	chem
styrene	chem
CYP2E1	geneY
【GOLD_R】
【PRE_R】

To test the hypothesis , we determined the potency and mechanism of inhibition for styrene and its metabolites toward oxidation of 4 - nitrophenol using CYP2E1 Supersomes ® and human liver microsomes .
【GOLD_E】
CYP2E1	geneY
styrene	chem
4-nitrophenol	chem
【PRE_E】
styrene	chem
4-nitrophenol	chem
CYP2E1	geneY
【GOLD_R】
【PRE_R】
4-nitrophenol	CYP2E1	C9

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Styrene inhibited the reaction through a mixed cooperative mechanism with high affinity for the catalytic site ( 67 µM ) and lower affinity for the cooperative site ( 1100 µM ) , while increasing substrate turnover at high concentrations .
【GOLD_E】
Styrene	chem
【PRE_E】
Styrene	chem
【GOLD_R】
【PRE_R】

Styrene oxide and 4 - vinylphenol possessed similar affinity for CYP2E1 .
【GOLD_E】
4-vinylphenol	chem
CYP2E1	geneY
Styreneoxide	chem
【PRE_E】
Styreneoxide	chem
4-vinylphenol	chem
CYP2E1	geneY
【GOLD_R】
【PRE_R】

Styrene oxide behaved cooperatively like styrene , but 4 - vinylphenol decreased turnover at high concentrations .
【GOLD_E】
Styreneoxide	chem
styrene	chem
4-vinylphenol	chem
【PRE_E】
Styreneoxide	chem
styrene	chem
4-vinylphenol	chem
【GOLD_R】
【PRE_R】

Styrene glycol was a very poor competitive inhibitor .
【GOLD_E】
Styreneglycol	chem
【PRE_E】
Styreneglycol	chem
【GOLD_R】
【PRE_R】

Among all compounds , there was a positive correlation with binding and hydrophobicity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Taken together , these findings for CYP2E1 further validate contributions of cooperative mechanisms to metabolic processes , demonstrate the role of molecular structure on those mechanisms and underscore the potential for heterotropic cooperative effects between different compounds .
【GOLD_E】
CYP2E1	geneY
【PRE_E】
CYP2E1	geneY
【GOLD_R】
【PRE_R】

Nonalcoholic fatty liver disease : current issues and novel treatment approaches .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Nonalcoholic fatty liver disease ( NAFLD ) is considered the most common liver disorder in the Western world .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It is commonly associated with insulin resistance , obesity , dyslipidaemia , type 2 diabetes mellitus ( T2DM ) and cardiovascular disease .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

Nonalcoholic steatohepatitis ( NASH ) is characterized by steatosis with necroinflammation and eventual fibrosis , which can lead to end - stage liver disease and hepatocellular carcinoma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Its pathogenesis is complex , and involves a state of ' lipotoxicity ' in which insulin resistance , with increased free fatty acid release from adipose tissue to the liver , play a key role in the onset of a ' lipotoxic liver disease ' and its progression to NASH .
【GOLD_E】
freefattyacid	chem
insulin	geneY
【PRE_E】
insulin	geneY
fattyacid	chem
【GOLD_R】
【PRE_R】

The diagnosis of NASH is challenging , as most affected patients are symptom free and the role of routine screening is not clearly established .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A complete medical history is important to rule out other causes of fatty liver disease ( alcohol abuse , medications , other ) .
【GOLD_E】
alcohol	chem
【PRE_E】
fatty	chem
alcohol	chem
【GOLD_R】
【PRE_R】

Plasma aminotransferase levels and liver ultrasound are helpful in the diagnosis of NAFLD / NASH , but a liver biopsy is often required for a definitive diagnosis .
【GOLD_E】
Plasmaaminotransferase	geneN
【PRE_E】
aminotransferase	geneN
【GOLD_R】
【PRE_R】

However , there is an active search for plasma biomarkers and imaging techniques that may non - invasively aid in the diagnosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The treatment of NASH requires a multifaceted approach .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The goal is to reverse obesity - associated lipotoxicity and insulin resistance via lifestyle intervention .
【GOLD_E】
insulin	geneY
【PRE_E】
lipotoxicity	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Although there is no pharmacological agent approved for the treatment of NAFLD , vitamin E ( in patients without T2DM ) and the thiazolidinedione pioglitazone ( in patients with and without T2DM ) have shown the most consistent results in randomized controlled trials .
【GOLD_E】
vitaminE	chem
pioglitazone	chem
【PRE_E】
NAFLD	geneY
vitaminE	chem
thiazolidinedione	chem
pioglitazone	chem
【GOLD_R】
【PRE_R】

This review concentrates on our current understanding of the disease , with a focus on the existing therapeutic approaches and potential future pharmacological developments for NAFLD and NASH .
【GOLD_E】
【PRE_E】
NAFLD	geneY
【GOLD_R】
【PRE_R】

Nuclear receptors in bile acid metabolism .
【GOLD_E】
Nuclearreceptors	geneN
bileacid	chem
【PRE_E】
Nuclearreceptors	geneN
bileacid	chem
【GOLD_R】
【PRE_R】

Bile acids are signaling molecules that activate nuclear receptors , such as farnesoid X receptor , pregnane X receptor , constitutive androstane receptor , and vitamin D receptor , and play a critical role in the regulation of lipid , glucose , energy , and drug metabolism .
【GOLD_E】
constitutiveandrostanereceptor	geneY
vitaminDreceptor	geneY
nuclearreceptors	geneN
farnesoidXreceptor	geneY
pregnaneXreceptor	geneY
Bileacids	chem
androstane	chem
vitaminD	chem
glucose	chem
pregnane	chem
【PRE_E】
Bileacids	chem
nuclearreceptors	geneN
farnesoidXreceptor	geneY
pregnaneXreceptor	geneY
constitutiveandrostanereceptor	geneY
vitaminDreceptor	geneY
glucose	chem
【GOLD_R】
Bileacids	constitutiveandrostanereceptor	C3
Bileacids	vitaminDreceptor	C3
Bileacids	nuclearreceptors	C3
Bileacids	farnesoidXreceptor	C3
Bileacids	pregnaneXreceptor	C3
【PRE_R】

These xenobiotic / endobiotic - sensing nuclear receptors regulate phase I oxidation , phase II conjugation , and phase III transport in bile acid and drug metabolism in the digestive system .
【GOLD_E】
xenobiotic/endobiotic-sensingnuclearreceptors	geneN
bileacid	chem
【PRE_E】
endobiotic-sensingnuclearreceptors	geneN
bileacid	chem
【GOLD_R】
【PRE_R】

Integration of bile acid metabolism with drug metabolism controls absorption , transport , and metabolism of nutrients and drugs to maintain metabolic homeostasis and also protects against liver injury , inflammation , and related metabolic diseases , such as nonalcoholic fatty liver disease , diabetes , and obesity .
【GOLD_E】
bileacid	chem
【PRE_E】
bileacid	chem
【GOLD_R】
【PRE_R】

Bile - acid - based drugs targeting nuclear receptors are in clinical trials for treating cholestatic liver diseases and fatty liver disease .
【GOLD_E】
Bile-acid	chem
【PRE_E】
Bile-acid	chem
nuclearreceptors	geneN
【GOLD_R】
【PRE_R】

Green tea catechin leads to global improvement among Alzheimer 's disease - related phenotypes in NSE / hAPP - C105 Tg mice .
【GOLD_E】
C105	geneN
NSE	geneY
hAPP	geneY
catechin	chem
【PRE_E】
catechin	chem
NSE	geneY
hAPP	geneY
C105	geneY
【GOLD_R】
【PRE_R】

Amyloid β ( Αβ ) has been reported to be responsible for the functional and structural abnormalities of Alzheimer 's disease ( AD ) through the induction of oxidative stress .
【GOLD_E】
Amyloidβ	geneY
Αβ	geneY
【PRE_E】
Amyloidβ	geneY
Αβ	geneY
【GOLD_R】
【PRE_R】

The aim of this study was to determine whether or not treatment of transgenic ( Tg ) mice with green tea catechin ( GTC ) , a radical scavenger , improves AD phenotypes .
【GOLD_E】
catechin	chem
【PRE_E】
catechin	chem
GTC	chem
【GOLD_R】
【PRE_R】

To test this , 7 - month - old Tg mice were treated with a low ( 1 mg ) or high ( 10 mg ) dose of GTC for 6 months .
【GOLD_E】
【PRE_E】
GTC	chem
【GOLD_R】
【PRE_R】

Surprisingly , GTC - treated Tg mice exhibited significant decreases in behavioral impairment , Aβ - 42 production , APP - C99 / 89 expression , γ - secretase component and Wnt protein levels , γ - secretase activity and MAPK activation .
【GOLD_E】
C99/89	geneN
γ-secretase	geneY
Wnt	geneN
γ-secretase	geneY
MAPK	geneN
Aβ-42	geneY
APP	geneY
【PRE_E】
GTC	chem
Aβ-42	geneY
APP	geneY
C99	geneY
γ-secretase	geneY
Wnt	geneN
γ-secretase	geneY
MAPK	geneN
【GOLD_R】
【PRE_R】
GTC	Aβ-42	C3
GTC	C99	C3
GTC	γ-secretase	C3

In contrast , the levels of APP - C83 protein and enzyme activities ( α - secretase , neprilysin and Pin1 ) were elevated in the GTC - treated groups .
【GOLD_E】
APP	geneY
C83	geneN
α-secretase	geneY
neprilysin	geneY
Pin1	geneY
【PRE_E】
APP	geneY
C83	geneY
α-secretase	geneY
neprilysin	geneY
Pin1	geneY
GTC	chem
【GOLD_R】
【PRE_R】

Moreover , GTC - treated groups showed lower levels of total cholesterol and low - density lipoprotein cholesterol , whereas the level of high - density lipoprotein cholesterol increased .
【GOLD_E】
low-densitylipoprotein	geneN
high-densitylipoprotein	geneN
cholesterol	chem
cholesterol	chem
cholesterol	chem
【PRE_E】
GTC	chem
cholesterol	chem
low-densitylipoproteincholesterol	geneN
high-densitylipoproteincholesterol	geneN
【GOLD_R】
【PRE_R】

These results provide the first experimental evidence that GTC improves AD phenotypes , thereby suggesting that GTC can be used in the prevention of AD or treatment of AD patients .
【GOLD_E】
【PRE_E】
GTC	chem
GTC	chem
【GOLD_R】
【PRE_R】

RIF1 is essential for 53BP1 - dependent nonhomologous end joining and suppression of DNA double - strand break resection .
【GOLD_E】
RIF1	geneY
53BP1	geneY
【PRE_E】
RIF1	geneY
53BP1	geneY
nonhomologousendjoining	geneN
【GOLD_R】
【PRE_R】

The appropriate execution of DNA double - strand break ( DSB ) repair is critical for genome stability and tumor avoidance .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

53BP1 and BRCA1 directly influence DSB repair pathway choice by regulating 5 ' end resection , but how this is achieved remains uncertain .
【GOLD_E】
53BP1	geneY
BRCA1	geneY
【PRE_E】
53BP1	geneY
BRCA1	geneY
DSB	geneY
【GOLD_R】
【PRE_R】

Here we report that Rif1 ( - / - ) mice are severely compromised for 53BP1 - dependent class switch recombination ( CSR ) and fusion of dysfunctional telomeres .
【GOLD_E】
Rif1	geneY
53BP1	geneY
【PRE_E】
Rif1	geneY
53BP1-dependentclassswitchrecombination	geneN
CSR	geneN
【GOLD_R】
【PRE_R】

The inappropriate accumulation of RIF1 at DSBs in S phase is antagonized by BRCA1 , and deletion of Rif1 suppresses toxic nonhomologous end joining ( NHEJ ) induced by PARP inhibition in Brca1 - deficient cells .
【GOLD_E】
PARP	geneN
Brca1	geneY
RIF1	geneY
BRCA1	geneY
Rif1	geneY
【PRE_E】
RIF1	geneY
DSBs	geneY
BRCA1	geneY
Rif1	geneY
nonhomologousendjoining	geneN
NHEJ	geneN
PARP	geneN
Brca1	geneY
【GOLD_R】
【PRE_R】

Mechanistically , RIF1 is recruited to DSBs via the N - terminal phospho - SQ / TQ domain of 53BP1 , and DSBs generated by ionizing radiation or during CSR are hyperresected in the absence of RIF1 .
【GOLD_E】
RIF1	geneY
N-terminalphospho-SQ/TQdomain	geneN
53BP1	geneY
RIF1	geneY
N	chem
phospho	chem
【PRE_E】
RIF1	geneY
DSBs	geneY
N	chem
phospho-SQ/TQdomain	geneN
53BP1	geneY
DSBs	geneN
CSR	geneN
RIF1	geneY
【GOLD_R】
【PRE_R】

Thus , RIF1 and 53BP1 cooperate to block DSB resection to promote NHEJ in G1 , which is antagonized by BRCA1 in S phase to ensure a switch of DSB repair mode to homologous recombination .
【GOLD_E】
RIF1	geneY
53BP1	geneY
BRCA1	geneY
【PRE_E】
RIF1	geneY
53BP1	geneY
NHEJ	geneN
BRCA1	geneY
DSB	geneN
【GOLD_R】
【PRE_R】

RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF - κB activation and down regulating inflammatory cytokines .
【GOLD_E】
RANKL	geneY
NF-κB	geneN
cytokines	geneN
【PRE_E】
RANKL	geneY
NF-κB	geneN
cytokines	geneN
【GOLD_R】
【PRE_R】

Peptides designed from osteoprotegerin ( OPG ) have previously been shown to inhibit receptor activator of NF - κB ligand ( RANKL ) and prevent bone loss without significantly inhibiting inflammation .
【GOLD_E】
RANKL	geneY
receptoractivatorofNF-κBligand	geneY
【PRE_E】
osteoprotegerin	geneN
OPG	geneY
NF-κB	geneN
RANKL	geneY
【GOLD_R】
【PRE_R】

The objective of this study was to develop a novel peptide with dual inhibitory activity against bone loss and inflammation using site - directed mutagenesis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Out of the three putative sites ( i.e . , Tyr70 - Asp78 , Tyr82 - Glu96 , and Leu113 - Arg122 ) available on OPG for RANKL binding , Leu113 - Arg122 was used as a template for peptide synthesis .
【GOLD_E】
Leu	chem
Arg	chem
Leu	chem
Arg	chem
RANKL	geneY
Tyr	chem
Asp	chem
Tyr	chem
Glu	chem
【PRE_E】
Tyr70	chem
Asp78	chem
Tyr82	chem
Glu96	chem
Leu113	chem
Arg122	chem
OPG	geneY
RANKL	geneY
Leu113	chem
Arg122	chem
【GOLD_R】
【PRE_R】

Peptide mutants of the template sequence ( 112YLEIEFCLKHR122 ) were synthesized and initially screened for their inhibitory effect on RANK - RANKL binding by competitive ELISA .
【GOLD_E】
RANK	geneY
RANKL	geneY
【PRE_E】
112YLEIEFCLKHR122	geneN
RANK	geneN
RANKL	geneY
【GOLD_R】
【PRE_R】

The most active peptide was further evaluated in vitro for RANKL induced osteoclastogenesis in mouse macrophage cells , and in vivo for Freund 's complete adjuvant induced arthritis ( AIA ) in Lewis rats .
【GOLD_E】
RANKL	geneY
【PRE_E】
RANKL	geneY
【GOLD_R】
【PRE_R】

The efficacy of the candidate peptide was compared with that of the standard drug celecoxib .
【GOLD_E】
celecoxib	chem
【PRE_E】
celecoxib	chem
【GOLD_R】
【PRE_R】

The peptide YR - 11 ( YLEIEFSLKHR ) , obtained by direct substitution of cysteine with a serine residue in the template sequence , significantly ( p < 0.05 ) inhibited RANK - RANKL binding , and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity .
【GOLD_E】
RANK	geneY
RANKL	geneY
RANKL	geneY
TRAP	geneY
YR-11	chem
cysteine	chem
serine	chem
【PRE_E】
YLEIEFSLKHR	geneY
cysteine	chem
serine	chem
RANKL	geneY
RANKL	geneY
TRAP	geneY
【GOLD_R】
YR-11	RANKL	C4
YR-11	TRAP	C4
cysteine	RANKL	C4
cysteine	TRAP	C4
serine	RANKL	C4
serine	TRAP	C4
【PRE_R】

Administration of YR - 11 peptide at the dose of 30mg / kg ( i.p . ) ameliorated both bone loss and inflammation in AIA rats .
【GOLD_E】
YR-11	chem
【PRE_E】
【GOLD_R】
【PRE_R】

To elucidate the mechanism for inhibition of inflammation in arthritic rats , serum and tissue cytokines ( TNF - α , IL - 1β , and IL - 6 ) were analyzed by ELISA and RT - PCR methods .
【GOLD_E】
cytokines	geneN
TNF-α	geneY
IL-1β	geneY
IL-6	geneY
【PRE_E】
tissuecytokines	geneN
TNF-α	geneY
IL-1β	geneY
IL-6	geneY
【GOLD_R】
【PRE_R】

Results confirmed that YR - 11 peptide inhibited pro - inflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of NF - κB .
【GOLD_E】
cytokines	geneN
RANKL	geneY
NF-κB	geneN
YR-11	chem
【PRE_E】
cytokines	geneN
RANKL	geneY
NF-κB	geneN
【GOLD_R】
YR-11	NF-κB	C4
YR-11	cytokines	C4
YR-11	RANKL	C4
【PRE_R】

The results obtained in this study substantiate the therapeutic benefit of this novel peptide in the prevention of bone loss and inflammation in rheumatoid arthritis with reduced side effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Activation of Rac1 GTPase by nanoparticulate structures in human macrophages .
【GOLD_E】
Rac1	geneY
GTPase	geneN
【PRE_E】
Rac1	geneY
GTPase	geneN
【GOLD_R】
【PRE_R】

Inflammatory activation of alveolar macrophages by ambient particles can be facilitated via Toll - like receptors ( TLR ) .
【GOLD_E】
Toll-likereceptors	geneN
TLR	geneN
【PRE_E】
Toll-likereceptors	geneN
TLR	geneN
【GOLD_R】
【PRE_R】

The action of TLR agonists and antagonists has been reported to depend on the formation of nanoparticulate structures .
【GOLD_E】
TLR	geneN
【PRE_E】
TLR	geneN
【GOLD_R】
【PRE_R】

Aim of the present study was to identify the signaling pathways induced by nanoparticulate structures in human macrophages , which might be critical for inflammatory cell activation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS : Studies were performed in primary human alveolar macrophages or in differentiated THP - 1 macrophages .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Silica nanoparticles were prepared by Stöber synthesis and characterized by dynamic light scattering and scanning electron microscopy .
【GOLD_E】
Silica	chem
【PRE_E】
Silica	chem
【GOLD_R】
【PRE_R】

Mycobacterial DNA was isolated from Mycobacterium bovis BCG , and nanoparticle formation was assessed by atomic force microscopy and dynamic light scattering .
【GOLD_E】
【PRE_E】
BCG	chem
【GOLD_R】
【PRE_R】

Actin polymerization was measured by phalloidin - TRITC staining , and cell activation was determined by reverse transcription quantitative PCR analysis , L929 cytotoxicity assay ( cytokine induction ) , and pull - down assays ( Rho GTPases ) .
【GOLD_E】
Actin	geneN
cytokine	geneN
phalloidin	chem
TRITC	chem
Rho	geneN
GTPases	geneN
【PRE_E】
Actin	geneN
phalloidin	chem
cytokine	geneN
Rho	geneN
GTPases	geneN
【GOLD_R】
【PRE_R】

RESULTS : In contrast to immune stimulatory sequence ISS 1018 , BCG DNA spontaneously formed nanoparticulate structures and induced actin polymerization as did synthetic silica nanoparticles .
【GOLD_E】
actin	geneN
silica	chem
【PRE_E】
ISS1018	geneN
actin	geneN
silica	chem
【GOLD_R】
【PRE_R】

Co - incubation with silica nanoparticles amplified the responsiveness of macrophages toward the TLR9 ligand ISS 1018 .
【GOLD_E】
TLR9	geneY
silica	chem
【PRE_E】
silica	chem
TLR9	geneY
ISS1018	geneY
【GOLD_R】
【PRE_R】

The activation of Rac1 was induced by silica nanoparticles as well as BCG DNA and is suggested as the critical signaling event inducing both cytoskeleton changes as well as inflammatory cell activation .
【GOLD_E】
Rac1	geneY
silica	chem
【PRE_E】
Rac1	geneY
silica	chem
【GOLD_R】
silica	Rac1	C3
【PRE_R】
Rac1	silica	C3

CONCLUSION : Nanoparticles can induce signaling pathways , which amplify an inflammatory response in macrophages .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Enhancing macrocyclic diterpenes as multidrug - resistance reversers : structure - activity studies on jolkinol D derivatives .
【GOLD_E】
diterpenes	chem
jolkinolD	chem
【PRE_E】
macrocyclicditerpenes	chem
multidrug-resistancereversers	geneN
jolkinolD	chem
【GOLD_R】
【PRE_R】

The phytochemical study of Euphorbia piscatoria yielded jolkinol D ( 1 ) in a large amount , whose derivatization gave rise to 12 ester derivatives ( 2 - 13 ) and hydrolysis to compound 14 .
【GOLD_E】
ester	chem
jolkinolD	chem
【PRE_E】
jolkinolD(1)	chem
【GOLD_R】
【PRE_R】

The in vitro modulation of P - gp of compounds 1 - 14 was evaluated through a combination of transport and chemosensitivity assays , using the L5178 mouse T lymphoma cell line transfected with the human MDR1 gene .
【GOLD_E】
P-gp	geneN
humanMDR1	geneY
【PRE_E】
P-gp	geneN
humanMDR1	geneY
【GOLD_R】
【PRE_R】

Apart from jolkinol D , all derivatives ( 2 - 14 ) showed potential as MDR reversal agents .
【GOLD_E】
jolkinolD	chem
【PRE_E】
jolkinolD	chem
MDR	geneY
【GOLD_R】
【PRE_R】

In this small library of novel bioactive macrocyclic lathyrane diterpene derivatives , designed to evaluate structure - activity relationships essential in overcoming multidrug resistance ( MDR ) , some correlations between MDR reversal and molecular weight , accessible solvent areas , and octanol / water partition coefficient were identified that can contribute to the development of new selective P - gp reversal agents .
【GOLD_E】
P-gp	geneN
lathyranediterpene	chem
octanol	chem
【PRE_E】
macrocycliclathyranediterpene	chem
multidrugresistance	geneN
MDR	geneN
MDR	geneN
octanol	chem
P-gp	geneN
【GOLD_R】
【PRE_R】
macrocycliclathyranediterpene	multidrugresistance	C4
macrocycliclathyranediterpene	MDR	C4

Osteoblasts survive the arsenic trioxide treatment by activation of ATM - mediated pathway .
【GOLD_E】
ATM	geneY
arsenictrioxide	chem
【PRE_E】
arsenictrioxide	chem
ATM	geneY
【GOLD_R】
arsenictrioxide	ATM	C3
【PRE_R】

Arsenic trioxide ( ATO ) is widely used in tumor treatment , but excessive arsenic exposure can have adverse effects .
【GOLD_E】
Arsenictrioxide	chem
ATO	chem
arsenic	chem
【PRE_E】
Arsenictrioxide	chem
ATO	chem
arsenic	chem
【GOLD_R】
【PRE_R】

We recently found that , in primary osteoblasts , ATO produces oxidative stress and causes DNA tailing , but does not induce apoptosis .
【GOLD_E】
ATO	chem
【PRE_E】
ATO	chem
【GOLD_R】
【PRE_R】

We further examined the signaling pathway by which osteoblasts survive ATO treatment , and found that they were arrested at G2 / M phase of the cell cycle at 30h and overrode the G2 / M boundary at 48h .
【GOLD_E】
ATO	chem
【PRE_E】
ATO	chem
【GOLD_R】
【PRE_R】

After treatment for 30h , there was increased Cdc2 phosphorylation and expression of Wee1 , a Cdc2 kinase , and expression of the cell cycle inhibitor , p21 ( waf1 / cip1 ) , which interacts with Cdc2 .
【GOLD_E】
Cdc2	geneY
Wee1	geneY
Cdc2	geneY
kinase	geneN
p21	geneY
waf1	geneY
cip1	geneY
Cdc2	geneY
【PRE_E】
Cdc2	geneY
Wee1	geneY
Cdc2	geneY
kinase	geneN
p21	geneY
waf1	geneY
cip1	geneY
Cdc2	geneY
【GOLD_R】
【PRE_R】

Furthermore , levels of the phosphatase Cdc25C , which activates Cdc2 , were decreased , while the ratio of its phosphorylated / inactivated form to the total amount was increased .
【GOLD_E】
phosphataseCdc25C	geneY
Cdc2	geneY
【PRE_E】
phosphatase	geneN
Cdc25C	geneY
Cdc2	geneY
【GOLD_R】
【PRE_R】

Moreover , phosphorylation / activation of the checkpoint kinases Chk1 , Chk2 and p53 levels were increased , as were levels of activated ATM and γ - H2AX .
【GOLD_E】
Chk1	geneY
Chk2	geneY
p53	geneY
ATM	geneY
H2AX	geneY
【PRE_E】
checkpointkinasesChk1	geneN
Chk2	geneY
p53	geneY
ATM	geneY
γ-H2AX	geneY
【GOLD_R】
【PRE_R】

The cell viability was decreased as an ATM inhibitor was added .
【GOLD_E】
ATM	geneY
【PRE_E】
ATM	geneY
【GOLD_R】
【PRE_R】

Additionally , these effects of ATO on γ - H2AX , Chk1 , Chk2 , p53 , and p21 ( waf1 / cip1 ) were reduced by an ATM inhibitor .
【GOLD_E】
Chk1	geneY
Chk2	geneY
p53	geneY
p21	geneY
waf1	geneY
cip1	geneY
ATM	geneY
ATO	chem
H2AX	geneY
【PRE_E】
ATO	chem
γ-H2AX	geneY
Chk1	geneY
Chk2	geneY
p53	geneY
p21	geneY
waf1	geneY
cip1	geneY
ATM	geneY
【GOLD_R】
ATO	ATM	C3
ATO	Chk1	C3
ATO	Chk2	C3
ATO	p53	C3
ATO	p21	C3
ATO	waf1	C3
ATO	cip1	C3
ATO	H2AX	C3
【PRE_R】
ATO	γ-H2AX	C4
ATO	Chk1	C4
ATO	Chk2	C4
ATO	p53	C4
ATO	p21	C4
ATO	waf1	C4
ATO	cip1	C4
ATO	ATM	C4

These findings suggest that G2 / M phase arrest of osteoblasts is mediated by Chk1 / Chk2 activation via an ATM - dependent pathway by which osteoblasts survive .
【GOLD_E】
Chk1	geneY
Chk2	geneY
ATM	geneY
【PRE_E】
Chk1	geneY
Chk2	geneY
ATM	geneY
【GOLD_R】
【PRE_R】

Structure prediction of binary pernitride MN2 compounds ( M = Ca , Sr , Ba , La , and Ti ) .
【GOLD_E】
pernitride	chem
MN2	chem
Ca	chem
Sr	chem
Ba	chem
La	chem
Ti	chem
【PRE_E】
pernitrideMN2	chem
【GOLD_R】
【PRE_R】

Metal - pernitride compounds belong to a class of chemical systems in which both the complex ions and the non - bonding electrons may play roles in the formation of their modified crystalline structures .
【GOLD_E】
Metal-pernitride	chem
【PRE_E】
pernitride	chem
【GOLD_R】
【PRE_R】

To investigate this issue , the energy landscapes of pernitrides of metals with different maximum valence ( M = Ca , Sr , Ba , La , and Ti ) were globally explored on the ab initio level at standard and high pressures , thereby yielding possible ( meta ) stable modifications in these systems together with information on how the landscape changed as function of the valence of the metal cation .
【GOLD_E】
pernitrides	chem
Ca	chem
Sr	chem
Ba	chem
La	chem
Ti	chem
【PRE_E】
【GOLD_R】
【PRE_R】

For all of the systems in which no compounds had been synthesized so far , we predicted the existence of kinetically stable modifications that should , in principle , be experimentally accessible .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In particular , TiN2 should crystallize in a new structure type , TiN2 - I .
【GOLD_E】
TiN2	chem
TiN2	chem
【PRE_E】
TiN2	geneY
TiN2-I	geneY
【GOLD_R】
【PRE_R】

25 - Hydroxyvitamin D in Obese Youth Across the Spectrum of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes .
【GOLD_E】
25-HydroxyvitaminD	chem
Glucose	chem
【PRE_E】
25-HydroxyvitaminD	geneY
Glucose	chem
【GOLD_R】
【PRE_R】

OBJECTIVETo 1 ) determine if plasma 25 - hydroxyvitamin D ( 25 [ OH ] D ) concentrations differ among obese youth with normal glucose tolerance ( NGT ) versus prediabetes versus type 2 diabetes , and 2 ) assess the relationships between 25 ( OH ) D and in vivo insulin sensitivity and β - cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma 25 ( OH ) D concentrations were examined in banked specimens in 9 - to 20 - year - old obese youth ( n = 175 ; male 42.3 % , black 46.3 % ) ( NGT , n = 105 ; impaired glucose tolerance [ IGT ] , n = 43 ; type 2 diabetes , n = 27 ) who had in vivo insulin sensitivity and secretion measured by hyperinsulinemic - euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal adiposity.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg / m ( 2 ) , respectively .
【GOLD_E】
glucose	chem
25[OH]D	chem
insulin	geneY
insulin	geneY
glucose	chem
25(OH)D	chem
25(OH)D	chem
25-hydroxyvitaminD	chem
【PRE_E】
25-hydroxyvitaminD(25[OH]D	chem
glucose	chem
25(OH)D	chem
insulin	geneY
25(OH)D	chem
glucose	chem
【GOLD_R】
【PRE_R】

BMI , plasma 25 ( OH ) D , and the proportion of vitamin D - deficient and - insufficient children did not differ across the three groups .
【GOLD_E】
25(OH)D	chem
vitaminD	chem
【PRE_E】
25(OH)D	chem
vitaminD	chem
【GOLD_R】
【PRE_R】

Furthermore , there was no association between 25 ( OH ) D and in vivo insulin sensitivity or β - cell function relative to insulin sensitivity ( disposition index ) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1 ) no differences in plasma 25 ( OH ) D concentrations across the glucose tolerance groups , and 2 ) no relationship between 25 ( OH ) D and in vivo insulin sensitivity and β - cell function relative to insulin sensitivity in any of the groups .
【GOLD_E】
insulin	geneY
insulin	geneY
insulin	geneY
insulin	geneY
25(OH)D	chem
25(OH)D	chem
glucose	chem
25(OH)D	chem
【PRE_E】
25(OH)D	chem
insulin	geneY
insulin	geneY
25(OH)D	chem
glucose	chem
25(OH)D	chem
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

It remains uncertain if enhancement of the vitamin D status could improve pathophysiological mechanisms of prediabetes and type 2 diabetes in obese youth .
【GOLD_E】
vitaminD	chem
【PRE_E】
vitaminD	chem
【GOLD_R】
【PRE_R】

Binary diffusion coefficients for mixtures of ionic liquids [ EMIM ] [ N ( CN ) 2 ] , [ EMIM ] [ NTf2 ] , and [ HMIM ] [ NTf2 ] with acetone and ethanol by dynamic light scattering ( DLS ) .
【GOLD_E】
acetone	chem
ethanol	chem
[EMIM][N(CN)2]	chem
[EMIM][NTf2]	chem
[HMIM][NTf2]	chem
【PRE_E】
EMIM]	chem
N(CN)2	chem
[EMIM]	chem
NTf2	chem
[HMIM]	chem
NTf2	chem
acetone	chem
ethanol	chem
【GOLD_R】
【PRE_R】

Mutual diffusivities for binary mixtures of the ionic liquids ( ILs ) [ EMIM ] [ N ( CN ) 2 ] ( 1 - ethyl - 3 - methylimidazolium dicyanimide ) , [ EMIM ] [ NTf2 ] ( 1 - ethyl - 3 - methylimidazolium bis ( trifluoromethylsulfonyl ) imide ) , and [ HMIM ] [ NTf2 ] ( 1 - hexyl - 3 - methylimidazolium bis ( trifluoromethylsulfonyl ) imide ) with acetone and ethanol were studied in dependence on composition in the temperature range from 283.15 to 323.15 K , applying dynamic light scattering ( DLS ) .
【GOLD_E】
1-hexyl-3-methylimidazoliumbis(trifluoromethylsulfonyl)imide	chem
acetone	chem
ethanol	chem
[EMIM][N(CN)2]	chem
1-ethyl-3-methylimidazoliumdicyanimide	chem
[EMIM][NTf2]	chem
1-ethyl-3-methylimidazoliumbis(trifluoromethylsulfonyl)imide	chem
[HMIM][NTf2]	chem
【PRE_E】
EMIM	chem
N(CN)2](1-ethyl-3-methylimidazoliumdicyanimide	chem
[EMIM][NTf2](1-ethyl-3-methylimidazoliumbis(trifluoromethylsulfonyl)imide	chem
[HMIM][NTf2](1-hexyl-3-methylimidazoliumbis(trifluoromethylsulfonyl)imide	chem
acetone	chem
ethanol	chem
【GOLD_R】
【PRE_R】

The influence of experimental parameters on the achievable uncertainties was analyzed to ensure the acquisition of accurate data in adequate measurement times .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For all probed systems , increasing binary diffusion coefficients were found for increasing temperatures .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The systematic variation of anion and cation of the investigated ILs as well as a comparison with the literature data demonstrates the considerable influence of different ions on the resulting binary diffusion coefficients .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mutual diffusivities were found to be lower for the mixtures with ethanol than for those with acetone , which could be related to the formation of hydrogen bonds between ethanol and the ions .
【GOLD_E】
ethanol	chem
acetone	chem
hydrogen	chem
ethanol	chem
【PRE_E】
ethanol	chem
acetone	chem
hydrogen	chem
ethanol	chem
【GOLD_R】
【PRE_R】

Most of the investigated IL solvent mixtures show increasing binary diffusion coefficients with increasing solvent concentration .
【GOLD_E】
【PRE_E】
IL	geneN
【GOLD_R】
【PRE_R】

For the mixtures of [ EMIM ] [ NTf2 ] with ethanol , however , a minimum of the mutual diffusivities was found in the ethanol mole fraction range from 0.7 to 0.8 , which may hint at the vicinity of a critical demixing point .
【GOLD_E】
[EMIM][NTf2]	chem
ethanol	chem
ethanol	chem
【PRE_E】
EMIM]	chem
NTf2	chem
ethanol	chem
ethanol	chem
【GOLD_R】
【PRE_R】

The viscosity of the pure ILs turned out to be no reliable indicator for the mutual diffusivity in mixtures with the same solvent .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Quercetin - loaded microcapsules ameliorate experimental colitis in mice by anti - inflammatory and antioxidant mechanisms .
【GOLD_E】
Quercetin	chem
【PRE_E】
Quercetin	chem
【GOLD_R】
【PRE_R】

Quercetin ( 1 ) is an anti - inflammatory and antioxidant flavonoid .
【GOLD_E】
Quercetin	chem
flavonoid	chem
【PRE_E】
Quercetin(1)	chem
flavonoid	chem
【GOLD_R】
【PRE_R】

However , the oral administration of 1 did not lead to beneficial effects in experimental animal colitis models , which involve cytokines and oxidative stress .
【GOLD_E】
cytokines	geneN
【PRE_E】
cytokines	geneN
【GOLD_R】
【PRE_R】

A possible explanation is that the absorption profile of 1 prevents its activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , it was reasoned that the controlled release of 1 would improve its therapeutic effect .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , the therapeutic effect and mechanisms of 1 - loaded microcapsules in acetic acid - induced colitis in mice were evaluated .
【GOLD_E】
aceticacid	chem
【PRE_E】
aceticacid	chem
【GOLD_R】
【PRE_R】

Microcapsules were prepared using pectin / casein polymer and 1 .
【GOLD_E】
casein	geneN
【PRE_E】
pectin	chem
【GOLD_R】
【PRE_R】

The oral administration of 1 - loaded microcapsules decreased neutrophil recruitment , attenuated histological alterations , and reduced macroscopical damage , edema , and IL - 1β and IL - 33 production in the colon samples .
【GOLD_E】
IL-1β	geneY
IL-33	geneY
【PRE_E】
IL-1β	geneY
IL-33	geneY
【GOLD_R】
【PRE_R】

Microcapsules loaded with 1 also prevented the reduction of anti - inflammatory cytokine IL - 10 and the antioxidant capacity of the colon .
【GOLD_E】
cytokine	geneN
IL-10	geneY
【PRE_E】
cytokine	geneN
IL-10	geneY
【GOLD_R】
【PRE_R】

These preclinical data indicate that pectin / casein polymer microcapsules loaded with 1 improved the anti - inflammatory and antioxidant effects of 1 compared to the nonencapsulated drug .
【GOLD_E】
casein	geneN
【PRE_E】
pectin	chem
casein	geneN
【GOLD_R】
【PRE_R】

Therefore , quercetin seems to be a promising active molecule in inflammatory bowel disease if provided with adequate controlled release .
【GOLD_E】
quercetin	chem
【PRE_E】
quercetin	chem
【GOLD_R】
【PRE_R】

Dietary relevant mixtures of phytoestrogens inhibit adipocyte differentiation in vitro .
【GOLD_E】
【PRE_E】
phytoestrogens	chem
【GOLD_R】
【PRE_R】

Phytoestrogens ( PEs ) are naturally occurring plant components , with the ability to induce biological responses in vertebrates by mimicking or modulating the action of endogenous hormones .
【GOLD_E】
【PRE_E】
Phytoestrogens	chem
PEs	chem
【GOLD_R】
【PRE_R】

Single isoflavones have been shown to affect adipocyte differentiation , but knowledge on the effect of dietary relevant mixtures of PEs , including for instance lignans , is lacking .
【GOLD_E】
isoflavones	chem
【PRE_E】
isoflavones	chem
PEs	chem
lignans	chem
【GOLD_R】
【PRE_R】

In the current study dietary relevant mixtures of isoflavones and their metabolites , lignans and their metabolites , coumestrol , and a mixture containing all of them , were examined for effects on adipogenesis in 3T3 - L1 adipocytes , as well as tested for their PPARγ activating abilities .
【GOLD_E】
PPARγ	geneY
isoflavones	chem
lignans	chem
coumestrol	chem
【PRE_E】
isoflavones	chem
lignans	chem
coumestrol	chem
PPARγ	geneY
【GOLD_R】
【PRE_R】

The results showed that mixtures of isoflavonoid parent compounds and metabolites , respectively , a mixture of lignan metabolites , as well as coumestrol concentration - dependently inhibited adipocyte differentiation .
【GOLD_E】
isoflavonoid	chem
lignan	chem
coumestrol	chem
【PRE_E】
isoflavonoid	chem
lignan	chem
coumestrol	chem
【GOLD_R】
【PRE_R】

Furthermore , a mixture of isoflavonoid parent compounds , and a mixture of isoflavonoid metabolites were found to have PPARγ activating abilities .
【GOLD_E】
PPARγ	geneY
isoflavonoid	chem
isoflavonoid	chem
【PRE_E】
isoflavonoid	chem
isoflavonoid	chem
PPARγ	geneY
【GOLD_R】
isoflavonoid	PPARγ	C3
isoflavonoid	PPARγ	C3
【PRE_R】

These results suggest that PEs can affect pathways known to play a role in obesity development , and indicate that the inhibitory effect on adipocyte differentiation does not appear to be strictly associated with PPARγ activation / inhibition .
【GOLD_E】
PPARγ	geneY
【PRE_E】
PEs	chem
PPARγ	geneY
【GOLD_R】
【PRE_R】

The current study support the hypothesis that compounds with endocrine activity can affect pathways playing a role in the development obesity and obesity related diseases .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Anti - inflammatory activity of patchouli alcohol in RAW264.7 and HT - 29 cells .
【GOLD_E】
patchoulialcohol	chem
【PRE_E】
patchoulialcohol	chem
【GOLD_R】
【PRE_R】

Patchouli alcohol ( PA ) is a chemical compound extracted from patchouli which belongs to the genus Pogostemon , herb of mint family .
【GOLD_E】
Patchoulialcohol	chem
【PRE_E】
Patchoulialcohol	chem
PA	chem
patchouli	chem
【GOLD_R】
【PRE_R】

Recently , it has been reported that PA inhibits the production of inflammatory mediators .
【GOLD_E】
【PRE_E】
PA	geneN
【GOLD_R】
【PRE_R】

However , the biological mechanisms of PA for anti - inflammatory activities have not been studied .
【GOLD_E】
【PRE_E】
PA	geneN
【GOLD_R】
【PRE_R】

In this study , we investigated whether PA decreases the production of inflammatory mediators through downregulation of the NF - κB and ERK pathway .
【GOLD_E】
NF-κB	geneN
ERK	geneN
【PRE_E】
PA	geneN
NF-κB	geneN
ERK	geneN
【GOLD_R】
【PRE_R】

Our data indicated that PA inhibits the over - expression of iNOS and IL - 6 in protein and mRNA levels in LPS - stimulated RAW264.7 and TNF - α stimulated HT - 29 cells .
【GOLD_E】
iNOS	geneN
IL-6	geneN
TNF-α	geneY
【PRE_E】
PA	geneN
iNOS	geneY
IL-6	geneY
TNF-α	geneY
【GOLD_R】
【PRE_R】

PA inhibited IκB - α degradation and p65 nuclear translocation , and subsequently suppressed transcriptional activity of NF - κB in LPS - stimulated RAW264.7 and TNF - α - stimulated HT - 29 cells .
【GOLD_E】
IκB-α	geneN
p65	geneN
NF-κB	geneN
TNF-α	geneY
【PRE_E】
PA	geneN
IκB-α	geneY
p65	geneY
NF-κB	geneN
TNF-α	geneY
【GOLD_R】
【PRE_R】

In addition , PA inhibited LPS - or TNF - α - stimulated ERK1 / 2 activation by decreasing phosphorylation of ERK1 / 2 .
【GOLD_E】
TNF-α	geneY
ERK1/2	geneN
ERK1/2	geneN
【PRE_E】
PA	geneN
TNF-α	geneY
ERK1/2	geneN
ERK1/2	geneN
【GOLD_R】
【PRE_R】

These findings suggest that PA shows anti - inflammatory activities through suppressing ERK - mediated NF - κB pathway in mouse macrophage and human colorectal cancer cells .
【GOLD_E】
ERK	geneN
NF-κB	geneN
【PRE_E】
PA	geneN
ERK	geneN
NF-κB	geneN
【GOLD_R】
【PRE_R】

Evaluation of suppressive and pro - resolving effects of EPA and DHA in human primary monocytes and T - helper cells .
【GOLD_E】
EPA	chem
DHA	chem
【PRE_E】
EPA	chem
DHA	chem
【GOLD_R】
【PRE_R】

Despite their beneficial anti - inflammatory properties , eicosapentaenoic acid ( EPA ) and docosahexaenoic acid ( DHA ) may increase the infection risk at high doses , likely by generating an immune - depressed state .
【GOLD_E】
eicosapentaenoicacid	chem
EPA	chem
docosahexaenoicacid	chem
DHA	chem
【PRE_E】
eicosapentaenoicacid	chem
EPA	chem
docosahexaenoicacid	chem
DHA	chem
【GOLD_R】
【PRE_R】

To assess the contribution of different immune cell populations to the immunomodulatory fatty acid effect , we comparatively investigated several aspects of inflammation in human T - helper ( Th ) cells and monocytes .
【GOLD_E】
fattyacid	chem
【PRE_E】
fattyacid	chem
humanT-helper	geneN
Th	geneY
【GOLD_R】
【PRE_R】

Both fatty acids , but DHA to a lesser extent compared with EPA , selectively and dose - dependently reduced the percentage of cytokine - expressing Th cells in a peroxisome proliferator - activated receptor ( PPAR ) γ - dependent fashion , whereas the expression of the cell surface marker CD69 was unaltered on activated T cells .
【GOLD_E】
fattyacids	chem
DHA	chem
EPA	chem
cytokine	geneN
peroxisomeproliferator-activatedreceptor(PPAR)γ	geneY
CD69	geneY
【PRE_E】
fattyacids	chem
DHA	chem
EPA	chem
cytokine	geneN
Th	geneY
peroxisomeproliferator-activatedreceptor(PPAR)γ	geneY
CD69	geneY
【GOLD_R】
fattyacids	cytokine	C4
DHA	cytokine	C4
EPA	cytokine	C4
【PRE_R】
fattyacids	cytokine	C4
DHA	cytokine	C4
EPA	cytokine	C4
EPA	Th	C4
EPA	CD69	C4

In monocytes , both EPA and DHA increased interleukin ( IL ) - 10 without affecting tumor necrosis factor ( TNF ) - α and IL - 6 .
【GOLD_E】
EPA	chem
DHA	chem
interleukin(IL)-10	geneY
tumornecrosisfactor(TNF)-α	geneY
IL-6	geneY
【PRE_E】
EPA	chem
DHA	chem
interleukin(IL)-10	geneY
tumornecrosisfactor(TNF)-α	geneY
IL-6	geneY
【GOLD_R】
EPA	interleukin(IL)-10	C3
DHA	interleukin(IL)-10	C3
【PRE_R】
EPA	interleukin(IL)-10	C3
DHA	interleukin(IL)-10	C3
DHA	tumornecrosisfactor(TNF)-α	C3
DHA	IL-6	C3

Cellular incorporation of EPA and DHA occurred mainly at the expense of arachidonic acid .
【GOLD_E】
EPA	chem
DHA	chem
arachidonicacid	chem
【PRE_E】
EPA	chem
DHA	chem
arachidonicacid	chem
【GOLD_R】
【PRE_R】

Concomitantly , thromboxane B ( TXB ) 2 and leukotriene B ( LTB ) 4 in supernatants decreased , while levels of TXB3 and LTB5 increased .
【GOLD_E】
(LTB)4	chem
thromboxaneB	chem
(TXB)2	chem
leukotrieneB	chem
TXB3	chem
LTB5	chem
【PRE_E】
thromboxaneB(TXB)2	chem
leukotrieneB(LTB)4	chem
TXB3	chem
LTB5	chem
【GOLD_R】
【PRE_R】

This increase was independent of activation and in accordance with cyclooxygenase expression patterns in monocytes .
【GOLD_E】
cyclooxygenase	geneN
【PRE_E】
cyclooxygenase	geneN
【GOLD_R】
【PRE_R】

Moreover , EPA and DHA gave rise to a variety of mono - and trihydroxy derivatives of highly anti - inflammatory potential , such as resolvins and their precursors .
【GOLD_E】
EPA	chem
DHA	chem
mono-andtrihydroxy	chem
resolvins	chem
【PRE_E】
EPA	chem
DHA	chem
mono-andtrihydroxy	chem
resolvins	chem
【GOLD_R】
【PRE_R】

Our results suggest that EPA and DHA do not generally affect immune cell functions in an inhibitory manner but rather promote pro - resolving responses .
【GOLD_E】
DHA	chem
EPA	chem
【PRE_E】
EPA	chem
DHA	chem
【GOLD_R】
【PRE_R】

Cell penetrating peptide tethered bi - ligand liposomes for delivery to brain in vivo : Biodistribution and transfection .
【GOLD_E】
【PRE_E】
Biodistribution	chem
【GOLD_R】
【PRE_R】

Targeted nano - particulate systems hold extraordinary potential for delivery of therapeutics across blood brain barrier ( BBB ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this work , we investigated the potential of novel bi - ligand ( transferrin - poly - l - arginine ) liposomal vector for delivery of desired gene to brain , in vivo .
【GOLD_E】
poly-l-arginine	chem
【PRE_E】
transferrin-poly-l-arginine	chem
【GOLD_R】
【PRE_R】

The in vivo evaluation of the delivery vectors is essential for clinical translation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We followed an innovative approach of combining transferrin receptor targeting with enhanced cell penetration to design liposomal vectors for improving the transport of molecules into brain .
【GOLD_E】
【PRE_E】
transferrinreceptor	geneY
【GOLD_R】
【PRE_R】

The biodistribution profile of 1 , 1 ' - dioctadecyl - 3,3,3',3 ' - tetramethyl - indocarbocyanine iodide ( DiR ) - labeled liposomes was evaluated in adult rats after single intravenous injection at dose of 15.2μmoles of phospholipids / kg body weight .
【GOLD_E】
1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanineiodide	chem
DiR	chem
【PRE_E】
1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanineiodide	chem
DiR	chem
【GOLD_R】
【PRE_R】

We demonstrated that bi - ligand liposomes accumulated in rat brain at significantly ( p < 0.05 ) higher concentrations as compared to the single - ligand ( transferrin ) or plain liposomes .
【GOLD_E】
transferrin	geneY
【PRE_E】
bi	geneN
transferrin	geneN
【GOLD_R】
【PRE_R】

In addition , the bi - ligand liposomes resulted in increased expression of β - galactosidase ( β - gal ) plasmid in rat brain tissue in comparison to the single - ligand liposomes .
【GOLD_E】
β-galactosidase	geneY
β-gal	geneY
【PRE_E】
β-galactosidase	geneY
β-gal)	geneY
【GOLD_R】
【PRE_R】

Histological examination of the transfected tissues did not show any signs of tissue necrosis or inflammation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hemolysis assay further authenticated the biocompatibility of bi - ligand liposomes in blood up to 600 nmoles of phospholipids / 1.4×10 ( 7 ) erythrocytes .
【GOLD_E】
【PRE_E】
bi	geneN
【GOLD_R】
【PRE_R】

The findings of this study provide important and detailed information regarding the distribution of bi - ligand liposomes in vivo and accentuate their ability to demonstrate improved brain penetration and transfection potential over single - ligand liposomes .
【GOLD_E】
【PRE_E】
bi	geneN
【GOLD_R】
【PRE_R】

Encapsulation of Nod1 and Nod2 receptor ligands into poly ( lactic acid ) nanoparticles potentiates their immune properties .
【GOLD_E】
Nod1	geneY
Nod2	geneY
poly(lacticacid)	chem
【PRE_E】
Nod1	geneY
Nod2	geneY
poly(lacticacid)	chem
【GOLD_R】
【PRE_R】

Most successful vaccines are able to induce persistent antibody responses that can last a lifetime .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Emerging evidences indicate that activation of immune cells through pattern recognition receptors ( PRRs ) such as Toll - like receptors ( TLRs ) or Nod - like receptors ( NLRs ) may be critical mechanisms .
【GOLD_E】
patternrecognitionreceptors	geneN
PRRs	geneN
Toll-likereceptors	geneN
TLRs	geneN
Nod-likereceptors	geneN
NLRs	geneN
【PRE_E】
patternrecognitionreceptors	geneN
PRRs	geneN
Toll-likereceptors	geneN
TLRs	geneN
Nod-likereceptors	geneN
NLRs	geneN
【GOLD_R】
【PRE_R】

Among PRRs , the use of TLR ligands as adjuvants is already largely described whereas the use of NLRs ligands remains largely unexplored .
【GOLD_E】
PRRs	geneN
TLR	geneN
NLRs	geneN
【PRE_E】
PRRs	geneN
TLR	geneN
NLRs	geneN
【GOLD_R】
【PRE_R】

As activation of intracytoplasmic NLRs is able to induce proinflammatory molecules , the added value of encapsulation of Nod1 and Nod2 receptor ligands into Poly ( Lactic Acid ) ( PLA ) biodegradable nanocarriers to modulate their immune properties on human dendritic cells ( DCs ) maturation has been evaluated .
【GOLD_E】
NLRs	geneN
Nod1	geneY
Nod2	geneY
Poly(LacticAcid)	chem
PLA	chem
【PRE_E】
intracytoplasmicNLRs	geneN
Nod1	geneY
Nod2receptor	geneY
Poly(LacticAcid)	chem
PLA	geneN
【GOLD_R】
【PRE_R】

Their ability to induce systemic immune responses in mice was also measured and compared to free ligands and the Alum adjuvant .
【GOLD_E】
【PRE_E】
Alum	chem
【GOLD_R】
【PRE_R】

Nod ligands encapsulated into PLA NPs were efficiently taken up by DCs and subsequently induced a strong up - regulation of maturation markers and the enhancement of proinflammatory cytokine secretion by DCs .
【GOLD_E】
Nod	geneN
PLA	chem
cytokine	geneN
【PRE_E】
PLA	geneN
cytokine	geneN
【GOLD_R】
【PRE_R】

Furthermore , co - injection of encapsulated Nod - ligands with PLA particles carrying Gag p24 HIV - 1 antigen allowed a 100 fold increase in antibody responses in comparison to Alum .
【GOLD_E】
PLA	chem
Nod	geneN
Gagp24	geneN
【PRE_E】
Nod	geneY
PLA	geneN
Gagp24HIV-1	geneY
【GOLD_R】
【PRE_R】

These results suggest that encapsulation of Nod ligands into PLA - NPs could be an effective way to improve vaccine efficiency .
【GOLD_E】
Nod	geneN
PLA	chem
【PRE_E】
Nod	geneY
PLA	geneN
【GOLD_R】
【PRE_R】

In vitro permeability analysis , pharmacokinetic and brain distribution study in mice of imperatorin , isoimperatorin and cnidilin in Radix Angelicae Dahuricae .
【GOLD_E】
isoimperatorin	chem
cnidilin	chem
imperatorin	chem
【PRE_E】
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【GOLD_R】
【PRE_R】

Coumarins are important constituents of Radix Angelicae Dahuricae , a well - known traditional Chinese medicine possess several known bioactivities with potentials in the treatment of central nervous system diseases .
【GOLD_E】
Coumarins	chem
【PRE_E】
Coumarins	chem
【GOLD_R】
【PRE_R】

By using an HPLC - MS / MS method , we analyzed the in vivo plasma and brain pharmacokinetics of three ingredients of coumarins , including imperatorin , isoimperatorin and cnidilin in mice after oral administration of Dahuricae extract at doses of 800mg / kg .
【GOLD_E】
coumarins	chem
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【PRE_E】
coumarins	chem
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【GOLD_R】
【PRE_R】

The biosamples were prepared using acetonitrile precipitation and the separation was achieved on an XDB - C18 column by gradient elution .
【GOLD_E】
acetonitrile	chem
【PRE_E】
acetonitrile	chem
XDB-C18	chem
【GOLD_R】
【PRE_R】

The BBB permeability and P - gp - mediated efflux were further examined in Madin Canine kidney cells transfected with full length cDNA for human multidrug resistance gene1 ( MDCKII - MDR1 ) .
【GOLD_E】
P-gp	geneN
humanmultidrugresistancegene1	geneY
MDR1	geneY
【PRE_E】
P-gp	geneN
humanmultidrugresistancegene1	geneY
MDCKII	geneY
MDR1	geneY
【GOLD_R】
【PRE_R】

Our results demonstrate that the method has excellent and satisfactory selectivity , sensitivity , linearity , precision , and accuracy for simultaneous determination of imperatorin , isoimperatorin and cnidilin .
【GOLD_E】
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【PRE_E】
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【GOLD_R】
【PRE_R】

The pharmacokinetics parameters were determined by using noncompartmental analyses , including the AUC ( 0 - t ) in plasma ( 1695.22 , 1326.45 and 636.98mg * h / L ) , the AUC ( 0 - t ) in brain ( 1812.35 , 2125.17 and 1145.83ng * h / g ) as well as the T1 / 2 in plasma ( 0.66 , 0.82 , 0.97h ) and brain ( 0.96 , 1.1 , 0.99h ) for imperatorin , isoimperatorin and cnidilin , respectively , suggesting that the three coumarins could easily pass through the BBB in vivo .
【GOLD_E】
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
coumarins	chem
【PRE_E】
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
coumarins	chem
【GOLD_R】
【PRE_R】

In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the P - gp - mediated efflux ratios of 0.53 and 0.06 , as well as medium permeability of cnidilin with 0.82 .
【GOLD_E】
P-gp	geneN
imperatorin	chem
isoimperatorin	chem
cnidilin	chem
【PRE_E】
imperatorin	chem
isoimperatorin	chem
P-gp	geneN
cnidilin	chem
【GOLD_R】
imperatorin	P-gp	C9
isoimperatorin	P-gp	C9
cnidilin	P-gp	C9
【PRE_R】
imperatorin	P-gp	C4
isoimperatorin	P-gp	C4
P-gp	cnidilin	C4

All data suggest that these three coumarins have high BBB permeability and have pharmacokinetic potentials for the treatment of central nervous system diseases .
【GOLD_E】
coumarins	chem
【PRE_E】
coumarins	chem
【GOLD_R】
【PRE_R】

Involvement of Src and the actin cytoskeleton in the antitumorigenic action of adenosine dialdehyde .
【GOLD_E】
adenosinedialdehyde	chem
Src	geneY
actin	geneN
【PRE_E】
Src	geneY
actin	geneN
adenosinedialdehyde	chem
【GOLD_R】
【PRE_R】

Transmethylation is an important reaction that transfers a methyl group in S - adenosylmethionine ( SAM ) to substrates such as DNA , RNA , and proteins .
【GOLD_E】
methyl	chem
S-adenosylmethionine	chem
SAM	chem
【PRE_E】
Transmethylation	chem
methyl	chem
S-adenosylmethionine	chem
SAM	chem
【GOLD_R】
【PRE_R】

It is known that transmethylation plays critical roles in various cellular responses .
【GOLD_E】
【PRE_E】
transmethylation	chem
【GOLD_R】
【PRE_R】

In this study , we examined the effects of transmethylation on tumorigenic responses and its regulatory mechanism using an upregulation strategy of adenosylhomocysteine ( SAH ) acting as a negative feedback inhibitor .
【GOLD_E】
adenosylhomocysteine	chem
SAH	chem
【PRE_E】
transmethylation	chem
adenosylhomocysteine	chem
SAH	chem
【GOLD_R】
【PRE_R】

Treatment with adenosine dialdehyde ( AdOx ) , an inhibitor of transmethylation - suppressive adenosylhomocysteine ( SAH ) hydrolase ( SAHH ) , enhanced the level of SAH and effectively blocked the proliferation , migration , and invasion of cancer cells ; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose - dependent manner .
【GOLD_E】
adenosylhomocysteine	chem
SAH	chem
SAH	chem
adenosylhomocysteine(SAH)hydrolase	geneY
SAHH	geneY
adenosinedialdehyde	chem
AdOx	chem
【PRE_E】
adenosinedialdehyde	chem
AdOx	chem
transmethylation-suppressiveadenosylhomocysteine(SAH)hydrolase	geneY
SAHH	geneY
SAH	chem
【GOLD_R】
adenosinedialdehyde	adenosylhomocysteine(SAH)hydrolase	C4
adenosinedialdehyde	SAHH	C4
AdOx	adenosylhomocysteine(SAH)hydrolase	C4
AdOx	SAHH	C4
SAH	adenosylhomocysteine(SAH)hydrolase	C9
SAH	SAHH	C9
【PRE_R】
adenosinedialdehyde	transmethylation-suppressiveadenosylhomocysteine(SAH)hydrolase	C4
AdOx	transmethylation-suppressiveadenosylhomocysteine(SAH)hydrolase	C4
SAHH	SAH	C4

Through immunoblotting analysis , it was found that AdOx was capable of indirectly diminishing the phosphorylation of oncogenic Src and its kinase activity .
【GOLD_E】
AdOx	chem
Src	geneY
kinase	geneN
【PRE_E】
AdOx	chem
Src	geneY
kinase	geneN
【GOLD_R】
AdOx	Src	C4
AdOx	kinase	C4
【PRE_R】
AdOx	Src	C3
AdOx	kinase	C3

Interestingly , AdOx disrupted actin cytoskeleton structures , leading to morphological changes , and suppressed the formation of a signaling complex composed of Src and p85 / PI3K , which is linked to various tumorigenic responses .
【GOLD_E】
actin	geneN
Src	geneY
AdOx	chem
p85	geneN
PI3K	geneN
【PRE_E】
AdOx	geneY
actin	geneN
Src	geneY
p85	geneN
PI3K	geneN
【GOLD_R】
AdOx	Src	C4
AdOx	p85	C4
AdOx	PI3K	C4
AdOx	actin	C4
【PRE_R】

In agreement with these data , the exogenous treatment of SAH or inhibition of SAHH by specific siRNA or another type of inhibitor , 3 - deazaadenosine ( DAZA ) , similarly resulted in antitumorigenic responses , suppressive activity on Src , the alteration of actin cytoskeleton , and a change of the colocalization pattern between actin and Src .
【GOLD_E】
SAHH	geneY
Src	geneY
actin	geneN
actin	geneN
Src	geneY
SAH	chem
3-deazaadenosine	chem
DAZA	chem
【PRE_E】
SAH	chem
SAHH	geneY
3-deazaadenosine	chem
DAZA	chem
Src	geneY
actin	geneN
actin	geneN
Src	geneY
【GOLD_R】
SAH	Src	C4
3-deazaadenosine	SAHH	C4
DAZA	SAHH	C4
【PRE_R】
SAH	SAHH	C4
SAHH	3-deazaadenosine	C4
DAZA	Src	C4

Taken together , these results suggest that SAH / SAHH - mediated transmethylation could be linked to the tumorigenic processes through cross - regulation between the actin cytoskeleton and Src kinase activity .
【GOLD_E】
SAHH	geneY
actin	geneN
Src	geneY
kinase	geneN
SAH	chem
【PRE_E】
SAH	chem
SAHH	geneY
transmethylation	chem
actin	geneN
Srckinase	geneN
【GOLD_R】
【PRE_R】
SAHH	transmethylation	C9

Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase - 1 ( MMP - 1 ) .
【GOLD_E】
methylrosmarinate	chem
MMP-1	geneY
matrixmetalloproteinase-1	geneY
【PRE_E】
methylrosmarinate	chem
matrixmetalloproteinase-1	geneY
MMP-1	geneY
【GOLD_R】
methylrosmarinate	MMP-1	C4
methylrosmarinate	matrixmetalloproteinase-1	C4
【PRE_R】
methylrosmarinate	matrixmetalloproteinase-1	C4
methylrosmarinate	MMP-1	C4

A series of MMP - 1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure - based drug design methods .
【GOLD_E】
methylrosmarinate	chem
MMP-1	geneY
【PRE_E】
MMP-1	geneY
methylrosmarinate	chem
【GOLD_R】
methylrosmarinate	MMP-1	C4
【PRE_R】
MMP-1	methylrosmarinate	C4

The best compound in the series showed an IC50 value of 0.4 μM .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A docking study was conducted for compound ( S ) - 10n in order to investigate its binding interactions with MMP - 1 .
【GOLD_E】
MMP-1	geneY
【PRE_E】
(S)-10n	chem
MMP-1	geneY
【GOLD_R】
【PRE_R】

The structure - activity relationships ( SAR ) were also briefly discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Useful SAR was established which provides important guidelines for the design of future generations of potent inhibitors against MMP - 1 .
【GOLD_E】
MMP-1	geneY
【PRE_E】
MMP-1	geneY
【GOLD_R】
【PRE_R】

Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti - tumor agents .
【GOLD_E】
resveratrolamide	chem
【PRE_E】
resveratrolamide	chem
【GOLD_R】
【PRE_R】

Three series of novel resveratrol amide derivatives ( 1a - q , 2a - h , 3a - l ) were synthesized and evaluated for their biological activities .
【GOLD_E】
resveratrolamide	chem
【PRE_E】
resveratrolamide	chem
【GOLD_R】
【PRE_R】

All compounds were characterized by ( 1 ) H NMR , ( 13 ) C NMR , MS and elemental analysis .
【GOLD_E】
(1)H	chem
(13)C	chem
【PRE_E】
(1)H	chem
(13)C	chem
【GOLD_R】
【PRE_R】

Furthermore , compound 3e was also characterized by X - ray crystallography .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All the compounds were evaluated for their anti - tumor activity against MCF - 7 , A549 and B16 - F10 tumor cell lines as well as cyclooxygenase - 2 ( COX - 2 ) - derived prostaglandin E2 ( PGE2 ) inhibitory activity of murine macrophage RAW 264.7 cell line .
【GOLD_E】
prostaglandinE2	chem
PGE2	chem
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
cyclooxygenase-2	geneY
COX-2	geneY
prostaglandinE2	chem
PGE2	chem
【GOLD_R】
prostaglandinE2	cyclooxygenase-2	C9
prostaglandinE2	COX-2	C9
PGE2	cyclooxygenase-2	C9
PGE2	COX-2	C9
【PRE_R】
cyclooxygenase-2	prostaglandinE2	C4
COX-2	prostaglandinE2	C4
COX-2	PGE2	C4

Among them , compounds 1c , 1g and 3e displayed the most potent COX - 2 inhibitory activity with the IC50 values of 1.02 , 1.27 and 1.98 μM , respectively .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Molecular docking studies were performed to position compounds 1c and 3e into the active site of COX - 2 to determine the probable binding modes .
【GOLD_E】
COX-2	geneY
【PRE_E】
COX-2	geneY
【GOLD_R】
【PRE_R】

Cystathionase mediates senescence evasion in melanocytes and melanoma cells .
【GOLD_E】
Cystathionase	geneY
【PRE_E】
Cystathionase	geneY
【GOLD_R】
【PRE_R】

The development of malignant melanoma is a highly complex process , which is still poorly understood .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A majority of human melanomas are found to express a few oncogenic proteins , such as mutant RAS and BRAF variants .
【GOLD_E】
RAS	geneN
BRAF	geneY
【PRE_E】
RAS	geneN
BRAF	geneY
【GOLD_R】
【PRE_R】

However , these oncogenes are also found in nevi , and it is now a well - accepted fact that their expression alone leads to senescence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This renders the understanding of senescence escape mechanisms an important point to understand tumor development .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we approached the question of senescence evasion by expressing the transcription factor v - myc myelocytomatosis viral oncogene homolog ( c - MYC ) , which is known to act synergistically with many oncogenes , in melanocytes .
【GOLD_E】
v-mycmyelocytomatosisviraloncogenehomolog	geneY
c-MYC	geneY
【PRE_E】
v-mycmyelocytomatosisviraloncogenehomolog	geneY
c-MYC	geneY
【GOLD_R】
【PRE_R】

We observed that MYC drives the evasion of reactive - oxygen stress - induced melanocyte senescence , caused by activated receptor tyrosine kinase signaling .
【GOLD_E】
MYC	geneY
receptortyrosinekinase	geneN
oxygen	chem
tyrosine	chem
【PRE_E】
MYC	geneY
oxygen	chem
tyrosinekinase	geneN
【GOLD_R】
【PRE_R】

Conversely , MIZ1 , the growth suppressing interaction partner of MYC , is involved in mediating melanocyte senescence .
【GOLD_E】
MIZ1	geneY
MYC	geneY
【PRE_E】
MIZ1	geneY
MYC	geneY
【GOLD_R】
【PRE_R】

Both , MYC overexpression and Miz1 knockdown led to a strong reduction of endogenous reactive - oxygen species ( ROS ) , DNA damage and senescence .
【GOLD_E】
oxygen	chem
MYC	geneY
Miz1	geneY
【PRE_E】
MYC	geneY
Miz1	geneY
oxygen	chem
【GOLD_R】
【PRE_R】

We identified the cystathionase ( CTH ) gene product as mediator of the ROS - related MYC and MIZ1 effects .
【GOLD_E】
cystathionase	geneY
CTH	geneY
MYC	geneY
MIZ1	geneY
【PRE_E】
cystathionase	geneY
CTH	geneY
MYC	geneY
MIZ1	geneY
【GOLD_R】
【PRE_R】

Blocking CTH enzymatic activity in MYC - overexpressing and Miz1 knockdown cells increased intracellular stress and senescence .
【GOLD_E】
MYC	geneY
Miz1	geneY
CTH	geneY
【PRE_E】
CTH	geneY
MYC	geneY
Miz1	geneY
【GOLD_R】
【PRE_R】

Importantly , pharmacological inhibition of CTH in human melanoma cells also reconstituted senescence in the majority of cell lines , and CTH knockdown reduced tumorigenic effects such as proliferation , H ( 2 ) O ( 2 ) resistance and soft agar growth .
【GOLD_E】
CTH	geneY
CTH	geneY
H(2)O(2)	chem
【PRE_E】
CTH	geneY
CTH	geneY
H(2)O(2)	chem
【GOLD_R】
【PRE_R】

Thus , we identified CTH as new MYC target gene with an important function in senescence evasion.Oncogene advance online publication , 28 January 2013 ; doi : 10.1038 / onc.2012.641 .
【GOLD_E】
CTH	geneY
MYC	geneY
【PRE_E】
CTH	geneY
MYC	geneY
doi	chem
【GOLD_R】
【PRE_R】

Investigational anti - hyperglycemic agents : the future of type 2 diabetes therapy ?
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As the pandemic of type 2 diabetes spreads globally , clinicians face many challenges in treating an increasingly diverse patient population varying in age , comorbidities , and socioeconomic status .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Current therapies for type 2 diabetes are often unable to alter the natural course of the disease and provide durable glycemic control , and side effects in the context of individual patient characteristics often limit treatment choices .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This often results in the progression to insulin use and complex regimens that are difficult to maintain .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

Therefore , a number of agents are being developed to better address the pathogenesis of type 2 diabetes and to overcome limitations of current therapies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The hope is to provide more options for glucose lowering and complication reduction with less risk for hypoglycemia and other adverse effects .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

These agents include newer incretin - based therapies and PPAR agonists , as well as new therapeutic classes such as sodium - coupled glucose cotransporter 2 inhibitors , free fatty acid receptor agonists , 11 - β - hydroxysteroid dehydrogenase type 1 inhibitors , glucokinase activators , and several others that may enter clinical use over the next decade .
【GOLD_E】
incretin	geneN
PPAR	geneN
sodium-coupledglucosecotransporter2	geneY
fattyacid	chem
11-β-hydroxysteroid	chem
sodium	chem
glucose	chem
freefattyacidreceptor	geneN
11-β-hydroxysteroiddehydrogenasetype1	geneY
glucokinase	geneY
【PRE_E】
incretin	geneN
PPAR	geneY
sodium	chem
glucosecotransporter2	geneY
fattyacidreceptor	geneN
11-β-hydroxysteroiddehydrogenasetype1	geneY
glucokinase	geneY
【GOLD_R】
【PRE_R】

Herein we review these agents that are advancing through clinical trials and describe the rationale behind their use , mechanisms of action , and potential for glucose lowering , as well as what is known of their limitations .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

3 - Methylglutaconic aciduria - lessons from 50 genes and 977 patients .
【GOLD_E】
3-Methylglutaconic	chem
【PRE_E】
3-Methylglutaconic	chem
【GOLD_R】
【PRE_R】

Elevated urinary excretion of 3 - methylglutaconic acid is considered rare in patients suspected of a metabolic disorder .
【GOLD_E】
3-methylglutaconicacid	chem
【PRE_E】
3-methylglutaconicacid	chem
【GOLD_R】
【PRE_R】

In 3 - methylglutaconyl - CoA hydratase deficiency ( mutations in AUH ) , it derives from leucine degradation .
【GOLD_E】
3-methylglutaconyl-CoAhydratase	geneY
AUH	geneY
3-methylglutaconyl-CoA	chem
leucine	chem
【PRE_E】
3-methylglutaconyl-CoAhydratase	geneY
AUH	geneY
leucine	chem
【GOLD_R】
【PRE_R】

In all other disorders with 3 - methylglutaconic aciduria the origin is unknown , yet mitochondrial dysfunction is thought to be the common denominator .
【GOLD_E】
3-methylglutaconic	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

We investigate the biochemical , clinical and genetic data of 388 patients referred to our centre under suspicion of a metabolic disorder showing 3 - methylglutaconic aciduria in routine metabolic screening .
【GOLD_E】
3-methylglutaconic	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

Furthermore , we investigate 591 patients with 50 different , genetically proven , mitochondrial disorders for the presence of 3 - methylglutaconic aciduria .
【GOLD_E】
3-methylglutaconic	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

Three percent of all urine samples of the patients referred showed 3 - methylglutaconic aciduria , often in correlation with disorders not reported earlier in association with 3 - methylglutaconic aciduria ( e.g . organic acidurias , urea cycle disorders , haematological and neuromuscular disorders ) .
【GOLD_E】
3-methylglutaconic	chem
3-methylglutaconic	chem
urea	chem
【PRE_E】
3-methylglutaconic	chem
3-methylglutaconic	chem
urea	chem
【GOLD_R】
【PRE_R】

In the patient cohort with genetically proven mitochondrial disorders 11 % presented 3 - methylglutaconic aciduria .
【GOLD_E】
-methylglutaconica	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

It was more frequently seen in ATPase related disorders , with mitochondrial DNA depletion or deletion , but not in patients with single respiratory chain complex deficiencies .
【GOLD_E】
ATPase	geneN
respiratorychaincomplex	geneN
【PRE_E】
ATPase	geneN
【GOLD_R】
【PRE_R】

Besides , it was a consistent feature of patients with mutations in TAZ , SERAC1 , OPA3 , DNAJC19 and TMEM70 accounting for mitochondrial membrane related pathology .
【GOLD_E】
TAZ	geneY
SERAC1	geneY
OPA3	geneY
DNAJC19	geneY
TMEM70	geneY
【PRE_E】
TAZ	geneY
SERAC1	geneY
OPA3	geneY
DNAJC19	geneY
TMEM70	geneY
【GOLD_R】
【PRE_R】

3 - methylglutaconic aciduria is found quite frequently in patients suspected of a metabolic disorder , and mitochondrial dysfunction is indeed a common denominator .
【GOLD_E】
3-methylglutaconic	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

It is only a discriminative feature of patients with mutations in AUH , TAZ , SERAC1 , OPA3 , DNAJC19 TMEM70 .
【GOLD_E】
AUH	geneY
TAZ	geneY
SERAC1	geneY
OPA3	geneY
DNAJC19	geneY
TMEM70	geneY
【PRE_E】
AUH	geneY
TAZ	geneY
SERAC1	geneY
OPA3	geneY
DNAJC19	geneY
TMEM70	geneN
【GOLD_R】
【PRE_R】

These conditions should therefore be referred to as inborn errors of metabolism with 3 - methylglutaconic aciduria as discriminative feature .
【GOLD_E】
3-methylglutaconic	chem
【PRE_E】
3-methylglutaconic	chem
【GOLD_R】
【PRE_R】

Bioactives and nutraceutical phytochemicals naturally occurring in virgin olive oil . The case study of the Nocellara del Belice Italian olive cultivar .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This work reports on the composition and bionutritional value of organic virgin olive oil from the Nocellara del Belice variety , one cultivated in the olive areas of the Sicily region , Italy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Destoned oils obtained by processing olives with a destoning - based procedure were compared with conventional oils .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This innovative technique , consisting in removing the stone from fruits prior to processing , strongly enhanced the already high - quality level of the conventional product .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

An in - depth analytical investigation from 2008 to 2010 showed how this innovative olive extraction process led to an excellent peculiar final product , mainly attributable to the improved biophenol and volatile composition , as well as higher concentrations of the lipophilic and vitamin antioxidants ( tocopherols and tocotrienols ) .
【GOLD_E】
tocopherols	chem
tocotrienols	chem
【PRE_E】
biophenol	chem
vitamin	chem
tocopherols	chem
tocotrienols	chem
【GOLD_R】
【PRE_R】

It had higher levels of oleocanthal ( p - HPEA - EDA ) , a nutraceutical compound exerting actions against COX1 and COX2 ( cycloxygenases ) .
【GOLD_E】
oleocanthal	chem
p-HPEA-EDA	chem
COX1	geneY
COX2	geneY
cycloxygenases	geneN
【PRE_E】
oleocanthal	chem
p-HPEA-EDA	chem
COX1	geneY
COX2	geneY
cycloxygenases	geneN
【GOLD_R】
【PRE_R】
oleocanthal	COX1	C4
p-HPEA-EDA	COX1	C4
p-HPEA-EDA	COX2	C4
p-HPEA-EDA	cycloxygenases	C4

Its head - space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase ( LOX ) - pathway ( one having as precursors the polyunsaturated fatty acids containing a cis - cis - 1,4 - pentadiene system ) .
【GOLD_E】
lipoxygenase	geneN
LOX	geneN
polyunsaturatedfattyacids	chem
cis-cis-1,4-pentadiene	chem
【PRE_E】
lipoxygenase	geneN
LOX	geneN
polyunsaturatedfattyacids	chem
cis-cis-1,4-pentadiene	chem
【GOLD_R】
polyunsaturatedfattyacids	lipoxygenase	C9
polyunsaturatedfattyacids	LOX	C9
cis-cis-1,4-pentadiene	lipoxygenase	C9
cis-cis-1,4-pentadiene	LOX	C9
【PRE_R】
lipoxygenase	polyunsaturatedfattyacids	C9
LOX	polyunsaturatedfattyacids	C9
LOX	cis-cis-1,4-pentadiene	C9

Among the other bioactives , we highlight its significant levels of trans - β - carotene and xanthophylls ( lutein , violaxanthin , neoxanthin and other carotenoids ) .
【GOLD_E】
trans-β-carotene	chem
xanthophylls	chem
lutein	chem
violaxanthin	chem
neoxanthin	chem
【PRE_E】
trans-β-carotene	chem
xanthophylls	chem
violaxanthin	chem
neoxanthin	chem
【GOLD_R】
【PRE_R】

Its enhanced nutritional value was also attributable to the increased intensity of valuable tasting notes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synthesis , DNA binding and antitumor evaluation of styelsamine and cystodytin analogues .
【GOLD_E】
styelsamine	chem
cystodytin	chem
【PRE_E】
styelsamine	chem
cystodytin	chem
【GOLD_R】
【PRE_R】

A series of N - 14 sidechain substituted analogues of styelsamine ( pyrido [ 4,3,2 - mn ] acridine ) and cystodytin ( pyrido [ 4,3,2 - mn ] acridin - 4 - one ) alkaloids have been prepared and evaluated for their DNA binding affinity and antiproliferative activity towards a panel of human tumor cell lines .
【GOLD_E】
pyrido[4,3,2-mn]acridin-4-one	chem
styelsamine	chem
pyrido[4,3,2-mn]acridine	chem
cystodytin	chem
【PRE_E】
N-14sidechain	chem
styelsamine	chem
pyrido[4,3,2-mn]acridine	chem
cystodytin	chem
pyrido[4,3,2-mn]acridin-4-one	chem
【GOLD_R】
【PRE_R】

Overall it was found that styelsamine analogues were stronger DNA binders , with the natural products styelsamines B and D having particularly high affinity ( K ( app ) 5.33 × 10 ( 6 ) and 3.64 × 10 ( 6 ) M ( - 1 ) , respectively ) .
【GOLD_E】
styelsamine	chem
styelsaminesBandD	chem
【PRE_E】
styelsamine	chem
styelsaminesB	chem
【GOLD_R】
【PRE_R】

In comparison , the cystodytin iminoquinone alkaloids showed lower affinity for DNA , but were typically just as active as styelsamine analogues at inhibiting proliferation of tumor cells in vitro .
【GOLD_E】
cystodytiniminoquinonealkaloids	chem
styelsamine	chem
【PRE_E】
cystodytiniminoquinone	chem
styelsamine	chem
【GOLD_R】
【PRE_R】

Sub - panel selectivity towards non - small cell lung , melanoma and renal cancer cell lines were observed for a number of the analogues .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Correlation was observed between whole cell activity and clogP , with the most potent antiproliferative activity being observed for 3 - phenylpropanamide analogues 37 and 41 ( NCI panel average GI ( 50 ) 0.4 μM and 0.32 μM , respectively ) with clogP ~ 4.0 - 4.5 .
【GOLD_E】
3-phenylpropanamide	chem
【PRE_E】
3-phenylpropanamide	chem
【GOLD_R】
【PRE_R】

Intercalation pathway in many - particle LiFePO4 electrode revealed by nanoscale state - of - charge mapping .
【GOLD_E】
LiFePO4	chem
【PRE_E】
LiFePO4	chem
【GOLD_R】
【PRE_R】

The intercalation pathway of lithium iron phosphate ( LFP ) in the positive electrode of a lithium - ion battery was probed at the ∼ 40 nm length scale using oxidation - state - sensitive X - ray microscopy .
【GOLD_E】
lithiumironphosphate	chem
LFP	chem
lithium	chem
【PRE_E】
lithium	chem
ironphosphate	chem
LFP	chem
lithium	chem
【GOLD_R】
【PRE_R】

Combined with morphological observations of the same exact locations using transmission electron microscopy , we quantified the local state - of - charge of approximately 450 individual LFP particles over nearly the entire thickness of the porous electrode .
【GOLD_E】
LFP	chem
【PRE_E】
【GOLD_R】
【PRE_R】

With the electrode charged to 50 % state - of - charge in 0.5 h , we observed that the overwhelming majority of particles were either almost completely delithiated or lithiated .
【GOLD_E】
【PRE_E】
lithiated	chem
【GOLD_R】
【PRE_R】

Specifically , only ∼ 2 % of individual particles were at an intermediate state - of - charge .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

From this small fraction of particles that were actively undergoing delithiation , we conclude that the time needed to charge a particle is ∼ 1 / 50 the time needed to charge the entire particle ensemble .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Surprisingly , we observed a very weak correlation between the sequence of delithiation and the particle size , contrary to the common expectation that smaller particles delithiate before larger ones .
【GOLD_E】
【PRE_E】
delithiation	chem
【GOLD_R】
【PRE_R】

Our quantitative results unambiguously confirm the mosaic ( particle - by - particle ) pathway of intercalation and suggest that the rate - limiting process of charging is initiating the phase transformation by , for example , a nucleation - like event .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , strategies for further enhancing the performance of LFP electrodes should not focus on increasing the phase - boundary velocity but on the rate of phase - transformation initiation .
【GOLD_E】
LFP	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Silica precipitation by synthetic minicollagens .
【GOLD_E】
Silica	chem
【PRE_E】
Silica	chem
【GOLD_R】
【PRE_R】

Oligomeric Pro - Hyp - Gly - ( POG - ) peptides , wherein the collagenous triple helix is supported by C - terminal capping , exhibit silica precipitation properties ( O , Hyp = ( 2S,4R ) hydroxyproline ) .
【GOLD_E】
C	chem
collagenoustriplehelix	geneN
Pro-Hyp-Gly	chem
silica	chem
Hyp	chem
(2S,4R)hydroxyproline	chem
【PRE_E】
Pro-Hyp-Gly	chem
POG	chem
C	chem
silica	chem
O	chem
Hyp	chem
2S,4R)hydroxyproline	chem
【GOLD_R】
【PRE_R】

As quantified by a molybdate assay , the length of the covalently tethered triple helix ( number of POG units ) determines the amount of amorphous silica obtained from silicic acid solution .
【GOLD_E】
triplehelix	geneN
silica	chem
silicicacid	chem
【PRE_E】
molybdate	chem
POG	chem
silica	chem
silicicacid	chem
【GOLD_R】
【PRE_R】

Although lacking charged side chains , the synthetic collagens precipitate large quantities of silicic acid resulting in micrometer - sized spheres of varying surface morphologies as analyzed by scanning electron microscopy .
【GOLD_E】
collagens	geneN
silicicacid	chem
【PRE_E】
silicicacid	chem
【GOLD_R】
【PRE_R】

Similar precipitation efficiencies on a fast time scale of less than 10 min were previously described only for biogenic diatom proteins and sponge collagen , respectively , which have a considerably higher structural complexity and limited accessibility .
【GOLD_E】
spongecollagen	geneN
【PRE_E】
biogenicdiatomproteins	geneN
collagen	geneN
【GOLD_R】
【PRE_R】

The minicollagens described here provide an unexpected alternative to the widely used precipitation conditions , which generally depend on ( poly - ) amines in phosphate buffer .
【GOLD_E】
(poly-)amines	chem
phosphate	chem
【PRE_E】
poly-)amines	chem
phosphate	chem
【GOLD_R】
【PRE_R】

Collagen can form intimate connections with inorganic matter .
【GOLD_E】
Collagen	geneN
【PRE_E】
Collagen	geneN
【GOLD_R】
【PRE_R】

Hence , silica - enclosed collagens have promising perspectives as composite materials .
【GOLD_E】
collagens	geneN
silica	chem
【PRE_E】
silica	chem
collagens	geneN
【GOLD_R】
【PRE_R】

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin .
【GOLD_E】
metformin	chem
【PRE_E】
lixisenatide	chem
metformin	chem
【GOLD_R】
【PRE_R】

AIM : Assess the pharmacodynamics of lixisenatide once daily ( QD ) versus liraglutide QD in type 2 diabetes insufficiently controlled on metformin .
【GOLD_E】
metformin	chem
【PRE_E】
lixisenatide	chem
metformin	chem
【GOLD_R】
【PRE_R】

METHODS : In this 28 - day , randomized , open - label , parallel - group , multicentre study ( NCT01175473 ) , patients ( mean HbA1c 7.3 % ) received subcutaneous lixisenatide QD ( 10 µg weeks 1 - 2 , then 20 µg ; n = 77 ) or liraglutide QD ( 0.6 mg week 1 , 1.2 mg week 2 , then 1.8 mg ; n = 71 ) 30 min before breakfast .
【GOLD_E】
HbA1c	geneY
【PRE_E】
HbA1c	geneY
lixisenatide	chem
【GOLD_R】
【PRE_R】

Primary endpoint was change in postprandial plasma glucose ( PPG ) exposure from baseline to day 28 during a breakfast test meal .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

RESULTS : Lixisenatide reduced PPG significantly more than liraglutide [ mean change in AUC ( 0 ) ( : 30 - 4 : 30h ) : - 12.6 vs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

- 4.0 h / mmol / l , respectively ; p < 0.0001 ( 0 : 30 h = start of meal ) ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Change in maximum PPG excursion was - 3.9 mmol / l vs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

- 1.4 mmol / l , respectively ( p < 0.0001 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

More lixisenatide - treated patients achieved 2 - h PPG < 7.8 mmol / l ( 69 % vs .
【GOLD_E】
【PRE_E】
lixisenatide	chem
【GOLD_R】
【PRE_R】

29 % ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Changes in fasting plasma glucose were greater with liraglutide ( - 0.3 vs .
【GOLD_E】
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

- 1.3 mmol / l , p < 0.0001 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lixisenatide provided greater decreases in postprandial glucagon ( p < 0.05 ) , insulin ( p < 0.0001 ) and C - peptide ( p < 0.0001 ) .
【GOLD_E】
glucagon	geneY
sulin(p	geneY
ptide(p<0	geneY
【PRE_E】
Lixisenatide	chem
glucagon	geneY
insulin	geneY
C-peptide	geneY
【GOLD_R】
【PRE_R】

Mean HbA1c decreased in both treatment groups ( from 7.2 % to 6.9 % with lixisenatide vs .
【GOLD_E】
HbA1c	geneN
【PRE_E】
HbA1c	geneY
lixisenatide	chem
【GOLD_R】
【PRE_R】
HbA1c	lixisenatide	C4

7.4 % to 6.9 % with liraglutide ) as did body weight ( - 1.6 kg vs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

- 2.4 kg , respectively ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overall incidence of adverse events was lower with lixisenatide ( 55 % ) versus liraglutide ( 65 % ) , with no serious events or hypoglycaemia reported .
【GOLD_E】
【PRE_E】
lixisenatide	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : Once daily prebreakfast lixisenatide provided a significantly greater reduction in PPG ( AUC ) during a morning test meal versus prebreakfast liraglutide .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lixisenatide provided significant decreases in postprandial insulin , C - peptide ( vs. an increase with liraglutide ) and glucagon , and better gastrointestinal tolerability than liraglutide .
【GOLD_E】
glucagon	geneY
insulin	geneY
C-peptide	geneY
【PRE_E】
Lixisenatide	chem
insulin	geneY
C-peptide	geneY
liraglutide)	geneY
glucagon	geneY
【GOLD_R】
【PRE_R】
Lixisenatide	insulin	C4
Lixisenatide	C-peptide	C4
Lixisenatide	liraglutide)	C4
Lixisenatide	glucagon	C4

The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo - and imino - pyridine anticancer complexes : control of cell selectivity , cross - resistance , p53 dependence , and apoptosis pathway .
【GOLD_E】
iodido	chem
chloridoruthenium	chem
osmiumareneazo-andimino-pyridine	chem
p53	geneY
【PRE_E】
iodidoversuschloridoruthenium	chem
osmiumareneazo	chem
imino-pyridine	chem
p53	geneY
【GOLD_R】
【PRE_R】

Organometallic half - sandwich complexes [ M ( p - cymene ) ( azo / imino - pyridine ) X ] ( + ) where M = Ru ( II ) or Os ( II ) and X ═ Cl or I , exhibit potent antiproliferative activity toward a range of cancer cells .
【GOLD_E】
M=Ru(II)orOs(II)	chem
X═ClorI	chem
Cl	chem
I	chem
[M(p-cymene)(azo/imino-pyridine)X](+)	chem
【PRE_E】
Organometallic	chem
[M(p-cymene)	chem
azo/imino-pyridine)X](+)	chem
Ru(II)	chem
Os(II)	chem
【GOLD_R】
【PRE_R】

Not only are the iodido complexes more potent than the chlorido analogues , but they are not cross - resistant with the clinical platinum drugs cisplatin and oxaliplatin .
【GOLD_E】
iodido	chem
chlorido	chem
platinum	chem
cisplatin	chem
oxaliplatin	chem
【PRE_E】
iodido	chem
chlorido	chem
platinum	chem
cisplatin	chem
oxaliplatin	chem
【GOLD_R】
【PRE_R】

They are also more selective for cancer cells versus normal cells ( fibroblasts ) and show high accumulation in cell membranes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

They arrest cell growth in G1 phase in contrast to cisplatin ( S phase ) with a high incidence of late - stage apoptosis .
【GOLD_E】
cisplatin	chem
【PRE_E】
cisplatin	chem
【GOLD_R】
【PRE_R】

The iodido complexes retain potency in p53 mutant colon cells .
【GOLD_E】
iodido	chem
p53	geneY
【PRE_E】
iodido	chem
p53	geneY
【GOLD_R】
【PRE_R】

All complexes activate caspase 3 .
【GOLD_E】
caspase3	geneY
【PRE_E】
caspase3	geneY
【GOLD_R】
【PRE_R】

In general , antiproliferative activity is greatly enhanced by low levels of the glutathione synthase inhibitor l - buthionine sulfoxime .
【GOLD_E】
glutathione	chem
l-buthioninesulfoxime	chem
glutathionesynthase	geneY
【PRE_E】
glutathionesynthase	geneN
l-buthioninesulfoxime	chem
【GOLD_R】
l-buthioninesulfoxime	glutathionesynthase	C4
【PRE_R】

The work illustrates how subtle changes to the design of low - spin d ( 6 ) metal complexes can lead to major changes in cellular metabolism and to potent complexes with novel mechanisms of anticancer activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Zinc - dependent lysosomal enlargement in TRPML1 - deficient cells involves MTF - 1 transcription factor and ZnT4 ( Slc30a4 ) transporter .
【GOLD_E】
Zinc	chem
ZnT4	geneY
Slc30a4	geneY
TRPML1	geneY
MTF-1	geneY
【PRE_E】
Zinc	chem
TRPML1	geneY
MTF-1	geneY
ZnT4(Slc30a4)transporter	geneY
【GOLD_R】
【PRE_R】

Zinc is critical for a multitude of cellular processes , including gene expression , secretion and enzymatic activities .
【GOLD_E】
Zinc	chem
【PRE_E】
Zinc	chem
【GOLD_R】
【PRE_R】

Cellular zinc is controlled by zinc - chelating proteins and by zinc transporters .
【GOLD_E】
zinc-chelatingproteins	geneN
zinctransporters	geneN
zinc	chem
zinc	chem
zinc	chem
【PRE_E】
zinc	chem
zinc-chelatingproteins	geneN
zinctransporters	geneN
【GOLD_R】
zinc	zinc-chelatingproteins	C9
zinc	zinctransporters	C9
【PRE_R】

The recent identification of zinc permeability of the lysosomal ion channel TRPML1 ( transient receptor potential mucolipin 1 ) , and the evidence of abnormal zinc levels in cells deficient in TRPML1 , suggested a role for TRPML1 in zinc transport .
【GOLD_E】
zinc	chem
zinc	chem
inct	chem
ionchannel	geneN
TRPML1	geneY
transientreceptorpotentialmucolipin1	geneY
TRPML1	geneY
TRPML1	geneY
【PRE_E】
zinc	chem
TRPML1(transientreceptorpotentialmucolipin1	geneY
zinc	chem
TRPML1	geneY
TRPML1	geneY
zinc	chem
【GOLD_R】
zinc	TRPML1	C9
zinc	transientreceptorpotentialmucolipin1	C9
inct	TRPML1	C9
【PRE_R】

In the present study we provide new evidence for such a role and identify additional cellular components responsible for it .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In agreement with the previously published data , an acute siRNA ( small interfering RNA ) - driven TRPML1 KD ( knockdown ) leads to the build - up of large cytoplasmic vesicles positive for LysoTracker ™ and zinc staining , when cells are exposed to high concentrations of zinc .
【GOLD_E】
zinc	chem
zinc	chem
TRPML1	geneY
【PRE_E】
TRPML1	geneY
LysoTracker™	chem
zinc	chem
zinc	chem
【GOLD_R】
【PRE_R】

We now show that lysosomal enlargement and zinc build - up in TRPML1 - KD cells exposed to zinc are ameliorated by KD of the zinc - sensitive transcription factor MTF - 1 ( metal - regulatory - element - binding transcription factor - 1 ) or the zinc transporter ZnT4 .
【GOLD_E】
zinc	chem
zinc	chem
zinc	chem
metal-regulatory-element-bindingtranscriptionfactor-1	geneY
zinctransporterZnT4	geneY
zinc	chem
TRPML1	geneY
zinc-sensitivetranscriptionfactor	geneN
MTF-1	geneY
【PRE_E】
zinc	chem
TRPML1	geneY
zinc	chem
zinc	chem
MTF-1	geneY
metal-regulatory-element-bindingtranscriptionfactor-1	geneY
zinctransporterZnT4	geneN
【GOLD_R】
【PRE_R】

TRPML1 KD is associated with a build - up of cytoplasmic zinc and with enhanced transcriptional response of mRNA for MT2a ( metallothionein 2a ) .
【GOLD_E】
TRPML1	geneY
MT2a	geneY
metallothionein2a	geneY
zinc	chem
【PRE_E】
TRPML1	geneY
zinc	chem
MT2a	geneY
metallothionein2a	geneY
【GOLD_R】
【PRE_R】

TRPML1 KD did not suppress lysosomal secretion , but it did delay zinc leak from the lysosomes into the cytoplasm .
【GOLD_E】
TRPML1	geneY
zinc	chem
【PRE_E】
TRPML1	geneY
zinc	chem
【GOLD_R】
【PRE_R】

These results underscore a role for TRPML1 in zinc metabolism .
【GOLD_E】
TRPML1	geneY
incm	chem
【PRE_E】
TRPML1	geneY
zinc	chem
【GOLD_R】
incm	TRPML1	C9
【PRE_R】

Furthermore , they suggest that TRPML1 works in concert with ZnT4 to regulate zinc translocation between the cytoplasm and lysosomes .
【GOLD_E】
TRPML1	geneY
ZnT4	geneY
zinc	chem
【PRE_E】
TRPML1	geneY
ZnT4	geneY
zinc	chem
【GOLD_R】
zinc	TRPML1	C9
zinc	ZnT4	C9
【PRE_R】

Evaluation of in vivo anti - hyperglycemic and antioxidant potentials of α - santalol and sandalwood oil .
【GOLD_E】
α-santalol	chem
【PRE_E】
α-santalol	chem
【GOLD_R】
【PRE_R】

Sandalwood finds numerous mentions across diverse traditional medicinal systems in use worldwide .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The objective of this study was to evaluate the in vivo anti - hyperglycemic and antioxidant potential of sandalwood oil and its major constituent α - santalol .
【GOLD_E】
α-santalol	chem
【PRE_E】
α-santalol	chem
【GOLD_R】
【PRE_R】

The in vivo anti - hyperglycemic experiment was conducted in alloxan - induced diabetic male Swiss albino mice models .
【GOLD_E】
alloxan	chem
【PRE_E】
alloxan	chem
【GOLD_R】
【PRE_R】

The in vivo antioxidant experiment was performed in d - galactose mediated oxidative stress induced male Swiss albino mice models .
【GOLD_E】
d-galactose	chem
【PRE_E】
d-galactose	chem
【GOLD_R】
【PRE_R】

Intraperitoneal administration of α - santalol ( 100mg / kg BW ) and sandalwood oil ( 1g / kg BW ) for an week modulated parameters such as body weight , blood glucose , serum bilirubin , liver glycogen , and lipid peroxides contents to normoglycemic levels in the alloxan - induced diabetic mice .
【GOLD_E】
α-santalol	chem
glucose	chem
bilirubin	chem
peroxides	chem
alloxan	chem
【PRE_E】
α-santalol	chem
glucose	chem
bilirubin	chem
peroxides	chem
alloxan	chem
【GOLD_R】
【PRE_R】

Similarly , intraperitoneal administration of α - santalol ( 100mg / kg BW ) and sandalwood oil ( 1g / kg BW ) for two weeks modulated parameters such as serum aminotransferases , alkaline phosphatase , bilirubin , superoxide dismutase , catalase , free sulfhydryl , protein carbonyl , nitric oxide , liver lipid peroxide contents , and antioxidant capacity in d - galactose mediated oxidative stress induced mice .
【GOLD_E】
α-santalol	chem
bilirubin	chem
superoxide	chem
catalase	geneY
sulfhydryl	chem
aminotransferases	geneN
alkalinephosphatase	geneN
superoxidedismutase	geneN
carbonyl	chem
nitricoxide	chem
peroxide	chem
d-galactose	chem
【PRE_E】
α-santalol	chem
serumaminotransferases	geneN
alkalinephosphatase	geneN
bilirubin	chem
superoxidedismutase	geneN
catalase	geneY
sulfhydryl	chem
carbonyl	chem
nitricoxide	chem
peroxide	chem
d-galactose	chem
【GOLD_R】
【PRE_R】
bilirubin	catalase	C9
catalase	sulfhydryl	C9
catalase	carbonyl	C9
catalase	d-galactose	C9

Besides , it was observed that the beneficial effects of α - santalol were well complimented , differentially by other constituents present in sandalwood oil , thus indicating synergism in biological activity of this traditionally used bioresource .
【GOLD_E】
α-santalol	chem
【PRE_E】
α-santalol	chem
【GOLD_R】
【PRE_R】

Serum amyloid A upsurge precedes standard biomarkers of hepatotoxicity in ritodrine - injected mice .
【GOLD_E】
ritodrine	chem
SerumamyloidA	geneN
【PRE_E】
amyloidA	geneY
ritodrine	chem
【GOLD_R】
ritodrine	SerumamyloidA	C3
【PRE_R】

The tocolytic agent ritodrine acts on the β2 - adrenoceptor and is an effective treatment option for preterm labor .
【GOLD_E】
ritodrine	chem
β2-adrenoceptor	geneY
【PRE_E】
ritodrine	chem
β2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

However , several adverse effects of ritodrine therapy , including liver damage , have been noted .
【GOLD_E】
ritodrine	chem
【PRE_E】
ritodrine	chem
【GOLD_R】
【PRE_R】

To elucidate the underlying mechanisms of ritodrine - induced adverse effects , development of sensitive biomarkers of these adverse events is necessary .
【GOLD_E】
ritodrine	chem
【PRE_E】
ritodrine	chem
【GOLD_R】
【PRE_R】

Here , we report the development and analysis of an animal model of ritodrine - induced liver damage .
【GOLD_E】
ritodrine	chem
【PRE_E】
ritodrine	chem
【GOLD_R】
【PRE_R】

Female mice received daily ritodrine injections for 2 weeks ; liver samples were then collected and subjected to DNA microarray analysis .
【GOLD_E】
ritodrine	chem
【PRE_E】
ritodrine	chem
【GOLD_R】
【PRE_R】

Ritodrine significantly altered the expression of genes related to steroid and lipid metabolism , as well as the metabolism of ritodrine itself .
【GOLD_E】
Ritodrine	chem
steroid	chem
ritodrine	chem
【PRE_E】
Ritodrine	chem
steroid	chem
ritodrine	chem
【GOLD_R】
【PRE_R】

Importantly , expression of the acute - phase reactant serum amyloid A ( SAA ) significantly increased after ritodrine injection , with values indicating the largest fold - change .
【GOLD_E】
ritodrine	chem
serumamyloidA	geneN
SAA	geneN
【PRE_E】
amyloidA	geneY
SAA	geneY
ritodrine	chem
【GOLD_R】
ritodrine	serumamyloidA	C3
ritodrine	SAA	C3
【PRE_R】
amyloidA	ritodrine	C3
SAA	ritodrine	C3

This large increase in blood SAA levels serves as a more sensitive biomarker than conventional liver enzymes , such as aspartate aminotransferase and alanine aminotransferase .
【GOLD_E】
aspartate	chem
aspartateaminotransferase	geneY
alanineaminotransferase	geneN
alanine	chem
SAA	geneN
【PRE_E】
SAA	geneY
aspartateaminotransferase	geneN
alanineaminotransferase	geneN
【GOLD_R】
【PRE_R】

The increase in SAA expression is specific to ritodrine - induced liver damage , because SAA expression was not induced by other hepatotoxic drugs such as acetaminophen , valproic acid , or metformin .
【GOLD_E】
SAA	geneN
SAA	geneN
ritodrine	chem
acetaminophen	chem
valproicacid	chem
metformin	chem
【PRE_E】
SAA	geneY
ritodrine	chem
SAA	geneN
acetaminophen	chem
valproicacid	chem
metformin	chem
【GOLD_R】
ritodrine	SAA	C3
【PRE_R】
SAA	ritodrine	C3
ritodrine	SAA	C3

Our in vitro studies showed that cyclic adenosine 3',5 ' - monophosphate ( cAMP ) accumulation was not a primary cause of the ritodrine - induced SAA increase .
【GOLD_E】
SAA	geneN
cyclicadenosine3',5'-monophosphate	chem
cAMP	chem
ritodrine	chem
【PRE_E】
cyclicadenosine3',5'-monophosphate	chem
cAMP	chem
ritodrine	chem
SAA	geneN
【GOLD_R】
ritodrine	SAA	C3
【PRE_R】
ritodrine	SAA	C3

Instead , SAA expression was enhanced by indirect phosphorylation of the signal transducer and activator of transcription - 3 ( STAT3 ) mediated by interleukin - 6 .
【GOLD_E】
SAA	geneN
signaltransducerandactivatoroftranscription-3	geneY
STAT3	geneY
interleukin-6	geneY
【PRE_E】
SAA	geneY
signaltransducerandactivatoroftranscription-3	geneY
STAT3	geneY
interleukin-6	geneY
【GOLD_R】
【PRE_R】

Therefore , our study provides a method for sensitive and early detection of hepatic injury , and may thus help preclude serious liver damage due to ritodrine use in preterm labor .
【GOLD_E】
ritodrine	chem
【PRE_E】
ritodrine	chem
【GOLD_R】
【PRE_R】

Ceftazidime - avibactam : a novel cephalosporin / β - lactamase inhibitor combination .
【GOLD_E】
Ceftazidime	chem
avibactam	chem
cephalosporin	chem
β-lactamase	geneN
【PRE_E】
Ceftazidime-avibactam	chem
cephalosporin	chem
β-lactamase	geneN
【GOLD_R】
Ceftazidime	β-lactamase	C4
avibactam	β-lactamase	C4
【PRE_R】
Ceftazidime-avibactam	β-lactamase	C4
cephalosporin	β-lactamase	C4

Avibactam ( formerly NXL104 , AVE1330A ) is a synthetic non - β - lactam , β - lactamase inhibitor that inhibits the activities of Ambler class A and C β - lactamases and some Ambler class D enzymes .
【GOLD_E】
NXL104	chem
Avibactam	chem
AVE1330A	chem
β-lactam	chem
AmblerclassAandCβ-lactamases	geneN
AmblerclassD	geneN
β-lactamase	geneN
【PRE_E】
Avibactam	chem
formerlyNXL104	chem
AVE1330A	chem
β-lactam	chem
β-lactamase	geneY
AmblerclassA	geneY
Cβ-lactamases	geneY
AmblerclassD	geneY
【GOLD_R】
NXL104	AmblerclassD	C4
NXL104	β-lactamase	C4
Avibactam	AmblerclassD	C4
Avibactam	β-lactamase	C4
AVE1330A	AmblerclassD	C4
AVE1330A	β-lactamase	C4
【PRE_R】
Avibactam	β-lactamase	C4
formerlyNXL104	β-lactamase	C4
AVE1330A	β-lactamase	C4
β-lactam	β-lactamase	C4
β-lactam	AmblerclassA	C4
β-lactam	Cβ-lactamases	C4
β-lactam	AmblerclassD	C4

This review summarizes the existing data published for ceftazidime - avibactam , including relevant chemistry , mechanisms of action and resistance , microbiology , pharmacokinetics , pharmacodynamics , and efficacy and safety data from animal and human trials .
【GOLD_E】
ceftazidime	chem
avibactam	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
【GOLD_R】
【PRE_R】

Although not a β - lactam , the chemical structure of avibactam closely resembles portions of the cephem bicyclic ring system , and avibactam has been shown to bond covalently to β - lactamases .
【GOLD_E】
β-lactam	chem
avibactam	chem
cephem	chem
avibactam	chem
β-lactamases	geneN
【PRE_E】
β-lactam	chem
avibactam	chem
cephem	chem
avibactam	chem
β-lactamases	geneY
【GOLD_R】
【PRE_R】

Very little is known about the potential for avibactam to select for resistance .
【GOLD_E】
avibactam	chem
【PRE_E】
avibactam	chem
【GOLD_R】
【PRE_R】

The addition of avibactam greatly ( 4 - 1024 - fold minimum inhibitory concentration [ MIC ] reduction ) improves the activity of ceftazidime versus most species of Enterobacteriaceae depending on the presence or absence of β - lactamase enzyme ( s ) .
【GOLD_E】
avibactam	chem
ceftazidime	chem
β-lactamase	geneN
【PRE_E】
avibactam	chem
4-1024	geneY
MIC	chem
ceftazidime	chem
β-lactamase	chem
【GOLD_R】
avibactam	β-lactamase	C4
ceftazidime	β-lactamase	C4
【PRE_R】
4-1024	MIC	C4

Against Pseudomonas aeruginosa , the addition of avibactam also improves the activity of ceftazidime ( ~ fourfold MIC reduction ) .
【GOLD_E】
ceftazidime	chem
avibactam	chem
【PRE_E】
Pseudomonas	geneN
avibactam	chem
ceftazidime	chem
MIC	chem
【GOLD_R】
【PRE_R】
Pseudomonas	avibactam	C4
Pseudomonas	ceftazidime	C4
Pseudomonas	MIC	C4

Limited data suggest that the addition of avibactam does not improve the activity of ceftazidime versus Acinetobacter species or most anaerobic bacteria ( exceptions : Bacteroides fragilis , Clostridium perfringens , Prevotella spp . and Porphyromonas spp . ) .
【GOLD_E】
avibactam	chem
ceftazidime	chem
【PRE_E】
avibactam	chem
ceftazidime	chem
Acinetobacter	chem
Clostridiumperfringens	geneN
Prevotellaspp	geneY
Porphyromonasspp	geneN
【GOLD_R】
【PRE_R】
ceftazidime	Clostridiumperfringens	C9
Acinetobacter	Clostridiumperfringens	C9
Acinetobacter	Prevotellaspp	C9

The pharmacokinetics of avibactam follow a two - compartment model and do not appear to be altered by the co - administration of ceftazidime .
【GOLD_E】
avibactam	chem
ceftazidime	chem
【PRE_E】
avibactam	chem
ceftazidime	chem
【GOLD_R】
【PRE_R】

The maximum plasma drug concentration ( C ( max ) ) and area under the plasma concentration - time curve ( AUC ) of avibactam increase linearly with doses ranging from 50 mg to 2,000 mg .
【GOLD_E】
avibactam	chem
【PRE_E】
avibactam	chem
【GOLD_R】
【PRE_R】

The mean volume of distribution and half - life of 22 L ( ~ 0.3 L / kg ) and ~ 2 hours , respectively , are similar to ceftazidime .
【GOLD_E】
ceftazidime	chem
【PRE_E】
ceftazidime	chem
【GOLD_R】
【PRE_R】

Like ceftazidime , avibactam is primarily renally excreted , and clearance correlates with creatinine clearance .
【GOLD_E】
avibactam	chem
creatinine	chem
ceftazidime	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
creatinine	chem
【GOLD_R】
【PRE_R】

Pharmacodynamic data suggest that ceftazidime - avibactam is rapidly bactericidal versus β - lactamase - producing Gram - negative bacilli that are not inhibited by ceftazidime alone.Clinical trials to date have reported that ceftazidime - avibactam is as effective as standard carbapenem therapy in complicated intra - abdominal infection and complicated urinary tract infection , including infection caused by cephalosporin - resistant Gram - negative isolates .
【GOLD_E】
ceftazidime	chem
avibactam	chem
ceftazidime	chem
ceftazidime	chem
avibactam	chem
carbapenem	chem
cephalosporin	chem
β-lactamase	geneN
【PRE_E】
ceftazidime-avibactam	chem
β-lactamase	geneY
Gram	geneN
ceftazidimealone.Clinical	chem
ceftazidime	chem
avibactam	chem
carbapenem	chem
cephalosporin	chem
【GOLD_R】
ceftazidime	β-lactamase	C4
avibactam	β-lactamase	C4
【PRE_R】
ceftazidime-avibactam	β-lactamase	C4
Gram	ceftazidimealone.Clinical	C4

The safety and tolerability of ceftazidime - avibactam has been reported in three phase I pharmacokinetic studies and two phase II clinical studies .
【GOLD_E】
ceftazidime	chem
avibactam	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
【GOLD_R】
【PRE_R】

Ceftazidime - avibactam appears to be well tolerated in healthy subjects and hospitalized patients , with few serious drug - related treatment - emergent adverse events reported to date.In conclusion , avibactam serves to broaden the spectrum of ceftazidime versus ß - lactamase - producing Gram - negative bacilli .
【GOLD_E】
Ceftazidime	chem
avibactam	chem
avibactam	chem
ceftazidime	chem
ß-lactamase	geneN
【PRE_E】
Ceftazidime-avibactam	chem
avibactam	chem
ceftazidime	chem
ß-lactamase	chem
【GOLD_R】
avibactam	ß-lactamase	C4
ceftazidime	ß-lactamase	C4
【PRE_R】

The exact roles for ceftazidime - avibactam will be defined by efficacy and safety data from further clinical trials .
【GOLD_E】
ceftazidime	chem
avibactam	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
【GOLD_R】
【PRE_R】

Potential future roles for ceftazidime - avibactam include the treatment of suspected or documented infections caused by resistant Gram - negative - bacilli producing extended - spectrum ß - lactamase ( ESBL ) , Klebsiella pneumoniae carbapenemases ( KPCs ) and / or AmpC ß - lactamases .
【GOLD_E】
ceftazidime	chem
avibactam	chem
extended-spectrumß-lactamase	geneN
ESBL	geneN
Klebsiellapneumoniaecarbapenemases	geneN
KPCs	geneN
AmpCß-lactamases	geneN
【PRE_E】
ceftazidime-avibactam	chem
bacilliproducingextended-spectrumß-lactamase	geneY
ESBL	geneN
Klebsiellapneumoniaecarbapenemases	geneY
KPCs	geneY
AmpCß-lactamases	geneY
【GOLD_R】
【PRE_R】

In addition , ceftazidime - avibactam may be used in combination ( with metronidazole ) for suspected polymicrobial infections .
【GOLD_E】
ceftazidime	chem
avibactam	chem
metronidazole	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
metronidazole	chem
【GOLD_R】
【PRE_R】

Finally , the increased activity of ceftazidime - avibactam versus P. aeruginosa may be of clinical benefit in patients with suspected or documented P. aeruginosa infections .
【GOLD_E】
ceftazidime	chem
avibactam	chem
【PRE_E】
ceftazidime	chem
avibactam	chem
【GOLD_R】
【PRE_R】

Increased human dermal microvascular endothelial cell survival induced by cysteamine .
【GOLD_E】
cysteamine	chem
【PRE_E】
cysteamine	chem
【GOLD_R】
【PRE_R】

BACKGROUND : Cystinosis is an autosomal recessive disease caused by intralysosomal cystine accumulation , treated with cysteamine .
【GOLD_E】
cysteamine	chem
【PRE_E】
Cystinosis	geneY
intralysosomalcystine	chem
cysteamine	chem
【GOLD_R】
【PRE_R】

Recently , new adverse effects of cysteamine were reported .
【GOLD_E】
cysteamine	chem
【PRE_E】
cysteamine	chem
【GOLD_R】
【PRE_R】

Skin biopsies showed microvascular proliferation ( angioendotheliomatosis ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To examine the mechanism of angioendotheliomatosis associated with cysteamine toxicity , we examined the effect of cysteamine on human dermal microvascular endothelial cells ( HDMVEC ) .
【GOLD_E】
cysteamine	chem
cysteamine	chem
【PRE_E】
cysteamine	chem
cysteamine	chem
【GOLD_R】
【PRE_R】

METHODS : After cysteamine exposure ( range 0 - 3.0 mM ) during 24 h , cell viability was measured using water soluble tetrazolium salt - 1 ( WST - 1 ) in both control HDMVEC and fibroblasts .
【GOLD_E】
cysteamine	chem
trazoliumsalt-1(W	chem
【PRE_E】
cysteamine	chem
tetrazolium	chem
【GOLD_R】
【PRE_R】

Cell proliferation and apoptosis rate were measured in HDMVEC by bromodeoxyuridine ( BrdU ) incorporation and caspase 3 and caspase 7 activity , respectively .
【GOLD_E】
bromodeoxyuridine	chem
BrdU	chem
caspase3	geneY
caspase7	geneY
【PRE_E】
bromodeoxyuridine	chem
BrdU	chem
caspase3	geneY
caspase7	geneY
【GOLD_R】
【PRE_R】

Intracellular glutathione ( GSH ) was measured in HDMVEC after cysteamine exposure of 0 , 0.1 or 1.0 mM .
【GOLD_E】
glutathione	chem
GSH	chem
cysteamine	chem
【PRE_E】
glutathione	chem
GSH	chem
HDMVEC	chem
cysteamine	chem
【GOLD_R】
【PRE_R】

Medium and cysteamine were refreshed every 6 h to mimic the in vivo situation .
【GOLD_E】
cysteamine	chem
【PRE_E】
cysteamine	chem
【GOLD_R】
【PRE_R】

Next , cell viability in HDMVEC was measured after 24 h of GSH exposure ( range 0 - 10.0 mM ) .
【GOLD_E】
SHe	chem
【PRE_E】
HDMVEC	chem
GSH	chem
【GOLD_R】
【PRE_R】

RESULTS : HDMVEC viability and proliferation increased after cysteamine exposure 0.03 - 3.0 mM ( p < 0.01 ) and 0.03 - 1.0 mM ( p = 0.01 ) respectively ; cell viability in fibroblasts was not affected by incubation with cysteamine .
【GOLD_E】
cysteamine	chem
mine.	chem
【PRE_E】
HDMVEC	chem
cysteamine	chem
cysteamine	chem
【GOLD_R】
【PRE_R】

Apoptosis remained unaffected by incubation with 0 - 1.0 mM cysteamine , 3.0 mM caused increased apoptosis .
【GOLD_E】
ysteamine,	chem
【PRE_E】
cysteamine	chem
【GOLD_R】
【PRE_R】

Intracellular GSH was significantly increased after incubation with cysteamine 0.1 mM ( p = 0.02 ) and 1.0 mM ( p < 0.01 ) .
【GOLD_E】
GSH	chem
cysteamine	chem
【PRE_E】
GSH	chem
cysteamine	chem
【GOLD_R】
【PRE_R】

HDMVEC viability increased after exposure to GSH 1.0 - 5.0 mM ( p < 0.01 ) .
【GOLD_E】
GSH	chem
【PRE_E】
HDMVEC	chem
GSH	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Cysteamine concentrations , similar to those described in plasma of cystinosis patients , stimulate HDMVEC viability and proliferation and increase intracellular GSH content .
【GOLD_E】
GSH	chem
Cysteamine	chem
【PRE_E】
Cysteamine	chem
HDMVEC	chem
GSH	chem
【GOLD_R】
【PRE_R】

We postulate that this mechanism might underlie angioendotheliomatosis induced by cysteamine .
【GOLD_E】
cysteamine	chem
【PRE_E】
cysteamine	chem
【GOLD_R】
【PRE_R】

Novel locus including FGF21 is associated with dietary macronutrient intake .
【GOLD_E】
FGF21	geneY
【PRE_E】
FGF21	geneY
【GOLD_R】
【PRE_R】

Dietary intake of macronutrients ( carbohydrate , protein , and fat ) has been associated with risk of chronic conditions such as obesity and diabetes .
【GOLD_E】
carbohydrate	chem
【PRE_E】
macronutrients	chem
carbohydrate	chem
【GOLD_R】
【PRE_R】

Family studies have reported a moderate contribution of genetics to variation in macronutrient intake .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In a genome - wide meta - analysis of a population - based discovery cohort ( n = 33 533 ) , rs838133 in FGF21 ( 19q13.33 ) , rs197273 near TRAF family member - associated NF - kappa - B activator ( TANK ) ( 2p24.2 ) , and rs10163409 in FTO ( 16q12.2 ) were among the top associations ( P < 10 ( - 5 ) ) for percentage of total caloric intake from protein and carbohydrate . rs838133 was replicated in silico in an independent sample from the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium ( CHARGE ) Nutrition Working Group ( n = 38 360 ) and attained genome - wide significance in combined analysis ( Pjoint = 7.9 × 10 ( - 9 ) ) .
【GOLD_E】
carbohydrate	chem
FGF21	geneY
TRAFfamilymember-associatedNF-kappa-Bactivator	geneY
TANK	geneY
FTO	geneY
【PRE_E】
FGF21	geneY
TRAF	geneN
NF-kappa-Bactivator	geneY
rs10163409	geneY
FTO	geneY
16q12.2	geneY
carbohydrate	chem
【GOLD_R】
【PRE_R】

A cytokine involved in cellular metabolism , FGF21 is a potential susceptibility gene for obesity and type 2 diabetes .
【GOLD_E】
cytokine	geneN
FGF21	geneY
【PRE_E】
cytokine	geneN
FGF21	geneY
【GOLD_R】
【PRE_R】

Our results highlight the potential of genetic variation for determining dietary macronutrient intake .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Investigation of astatine ( III ) hydrolyzed species : experiments and relativistic calculations .
【GOLD_E】
astatine(III)	chem
【PRE_E】
astatine(III)	chem
【GOLD_R】
【PRE_R】

This work aims to resolve some controversies about astatine ( III ) hydroxide species present in oxidant aqueous solution .
【GOLD_E】
astatine(III)hydroxide	chem
【PRE_E】
astatine(III)hydroxide	chem
【GOLD_R】
【PRE_R】

AtO ( + ) is the dominant species existing under oxidizing and acidic pH conditions .
【GOLD_E】
AtO(+)	chem
【PRE_E】
AtO(+)	chem
【GOLD_R】
【PRE_R】

This is consistent with high - performance ion - exchange chromatography data showing the existence of one species holding one positive charge .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A change in speciation occurs as the pH changes from 1 to 4 , while remaining under oxidizing conditions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Dynamic experiments with ion - exchange resins evidence the existence of a neutral species witnessed by its elution in the void volume .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Batch - experiments using a competition method show the exchange of one proton indicating the formation of the AtO ( OH ) species .
【GOLD_E】
AtO(OH)	chem
【PRE_E】
AtO	chem
OH	chem
【GOLD_R】
【PRE_R】

The hydrolysis thermodynamic constant , extrapolated to zero ionic strength , was determined to be 10 ( - 1.9 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This value is supported by two - component relativistic quantum calculations and therefore allows disclosing unambiguously the structure of the formed species .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Trim24 - repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA .
【GOLD_E】
Trim24	geneY
VL30retrotransposons	geneN
【PRE_E】
Trim24	geneY
VL30	geneY
【GOLD_R】
【PRE_R】

Trim24 ( Tif1α ) and Trim33 ( Tif1γ ) interact to form a co - repressor complex that suppresses murine hepatocellular carcinoma .
【GOLD_E】
Tif1α	geneY
Trim24	geneY
Trim33	geneY
Tif1γ	geneY
【PRE_E】
Trim24	geneY
Tif1α	geneY
Trim33	geneY
Tif1γ	geneY
【GOLD_R】
【PRE_R】

Here we show that Trim24 and Trim33 cooperatively repress retinoic acid receptor - dependent activity of VL30 - class endogenous retroviruses ( ERVs ) in liver .
【GOLD_E】
retinoicacid	chem
Trim24	geneY
Trim33	geneY
retinoicacidreceptor	geneN
VL30	geneN
【PRE_E】
Trim24	geneY
Trim33	geneY
retinoicacidreceptor	geneN
VL30-classendogenousretroviruses	geneN
ERVs	geneN
【GOLD_R】
【PRE_R】

In Trim24 - knockout hepatocytes , VL30 derepression leads to accumulation of reverse - transcribed VL30 cDNA in the cytoplasm that correlates with activation of the viral - defense interferon responses mimicking the preneoplastic inflammatory state seen in human liver following exogenous viral infection .
【GOLD_E】
VL30	geneN
VL30	geneN
interferon	geneN
Trim24	geneY
【PRE_E】
Trim24	geneY
VL30	geneY
VL30	geneY
【GOLD_R】
【PRE_R】

Furthermore , upon derepression , VL30 long terminal repeats ( LTRs ) act as promoter and enhancer elements deregulating expression of neighboring genes and generating enhancer RNAs that are required for LTR enhancer activity in hepatocytes in vivo .
【GOLD_E】
VL30longterminalrepeats	geneN
LTRs	geneN
promoterandenhancerelements	geneN
LTRenhancer	geneN
【PRE_E】
VL30longterminalrepeats	geneN
LTRs	geneN
LTR	geneN
【GOLD_R】
【PRE_R】

These data reinforce the role of the TRIM family of proteins in retroviral restriction and antiviral defense and provide an example of an ERV - derived oncogenic regulatory network .
【GOLD_E】
TRIM	geneN
【PRE_E】
TRIM	geneN
ERV	geneN
【GOLD_R】
【PRE_R】

Apelin inhibits diet - induced obesity by enhancing lymphatic and blood vessel integrity .
【GOLD_E】
Apelin	geneY
【PRE_E】
Apelin	geneY
【GOLD_R】
【PRE_R】

Angiogenesis is tightly associated with the outgrowth of adipose tissue , leading to obesity , which is a risk factor for type 2 diabetes and hypertension , mainly because expanding adipose tissue requires an increased nutrient supply from blood vessels .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , induction of vessel abnormality by adipokines has been well studied , whereas how altered vascular function promotes obesity is relatively unexplored .
【GOLD_E】
adipokines	geneN
【PRE_E】
adipokines	geneN
【GOLD_R】
【PRE_R】

Also , surviving Prox1 heterozygous mice showed abnormal lymphatic patterning and adult - onset obesity , indicating that accumulation of adipocytes could be closely linked with lymphatic function .
【GOLD_E】
Prox1	geneY
【PRE_E】
Prox1	geneY
【GOLD_R】
【PRE_R】

Here we propose a new anti - obesity strategy based on enhancement of lymphatic and blood vessel integrity with apelin .
【GOLD_E】
apelin	geneY
【PRE_E】
apelin	geneY
【GOLD_R】
【PRE_R】

Apelin - knockout mice given a high - fat diet showed an obese phenotype associated with abnormal lymphatic and blood vessel enlargement .
【GOLD_E】
Apelin	geneY
【PRE_E】
Apelin	geneY
【GOLD_R】
【PRE_R】

Fatty acids present in the high - fat diet induced hyperpermeability of endothelial cells , causing adipocyte differentiation , whereas apelin promoted vascular stabilization .
【GOLD_E】
Fattyacids	chem
【PRE_E】
Fattyacids	chem
apelin	geneY
【GOLD_R】
【PRE_R】

Moreover , treatment of high - fat - diet - fed apelin - knockout mice with a selective cyclooxygenase - 2 inhibitor , celecoxib , improved vascular function , and also attenuated obesity .
【GOLD_E】
celecoxib	chem
apelin	geneY
cyclooxygenase-2	geneY
【PRE_E】
apelin	geneY
cyclooxygenase-2	geneY
celecoxib	chem
【GOLD_R】
celecoxib	cyclooxygenase-2	C4
【PRE_R】
cyclooxygenase-2	celecoxib	C4

Finally , apelin transgenic mice showed decreased subcutaneous adipose tissue owing to inhibition of high - fat - diet - induced hyperpermeability of vessels .
【GOLD_E】
apelin	geneY
【PRE_E】
apelin	geneY
【GOLD_R】
【PRE_R】

These results indicate that apelin inhibits high - fat - diet - induced obesity by enhancing vessel integrity .
【GOLD_E】
【PRE_E】
apelin	geneY
【GOLD_R】
【PRE_R】

Apelin could serve as a therapeutic target for treating obesity and related diseases .
【GOLD_E】
Apelin	geneY
【PRE_E】
Apelin	geneY
【GOLD_R】
【PRE_R】

Activation of the anti - cancer agent upamostat by the mARC enzyme system .
【GOLD_E】
upamostat	chem
mARC	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Abstract 1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Upamostat ( Mesupron ® ) is a new small molecule serine protease inhibitor .
【GOLD_E】
serine	chem
serineprotease	geneN
Upamostat	chem
Mesupron	chem
【PRE_E】
Upamostat	chem
Mesupron	chem
serineprotease	geneN
【GOLD_R】
Upamostat	serineprotease	C4
Mesupron	serineprotease	C4
【PRE_R】

The drug candidate was developed to inhibit the urokinase - type plasminogen activator ( uPA ) system , which plays a major role in tumor invasion and metastasis .
【GOLD_E】
urokinase-typeplasminogenactivator	geneY
uPA	geneY
【PRE_E】
urokinase-typeplasminogenactivator	geneY
uPA	geneY
【GOLD_R】
【PRE_R】

Upamostat is currently in clinical development as an anti - metastatic and non - cytotoxic agent against pancreatic and breast cancer .
【GOLD_E】
Upamostat	chem
【PRE_E】
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Upamostat is the orally available amidoxime - ( i.e . hydroxyamidine - ) prodrug of the pharmacologically active form , WX - UK1 .
【GOLD_E】
Upamostat	chem
amidoxime	chem
hydroxyamidine	chem
WX-UK1	chem
【PRE_E】
amidoxime	chem
hydroxyamidine	chem
WX-UK1	chem
【GOLD_R】
【PRE_R】

In this study , the reductive enzymatic activation of upamostat to its corresponding amidine WX - UK1 was analyzed .
【GOLD_E】
WX-UK1	chem
upamostat	chem
【PRE_E】
amidine	chem
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The recently discovered molybdenum enzyme `` mitochondrial Amidoxime Reducing Component `` ( mARC ) catalyses together with its electron transport proteins cytochrome b ( 5 ) and NADH cytochrome b ( 5 ) reductase the reduction of N - hydroxylated prodrugs .
【GOLD_E】
molybdenum	chem
lAmidoxim	chem
ndNA	chem
o	chem
`mitochondrialAmidoximeReducingComponen	geneN
`(mA	geneN
tselectrontransportprotei	geneN
nscytochromeb(	geneY
ndNADHcytochromeb(5)reducta	geneN
【PRE_E】
molybdenum	chem
Amidoxime	chem
cytochromeb(5)	geneY
NADHcytochromeb(5)reductase	geneY
N-hydroxylated	chem
【GOLD_R】
【PRE_R】
molybdenum	cytochromeb(5)	C9
Amidoxime	cytochromeb(5)	C9
NADHcytochromeb(5)reductase	N-hydroxylated	C9

In vitro biotransformation assays with porcine subcellular fractions and the reconstituted human enzymes demonstrate an mARC - dependent N - reduction of upamostat .
【GOLD_E】
N	chem
upamostat	chem
mARC	geneN
【PRE_E】
N	chem
【GOLD_R】
【PRE_R】

Differential autophagic cell death under stress with ectopic cytoplasmic and mitochondrial - specific PPP2R2B in human neuroblastoma cells .
【GOLD_E】
PPP2R2B	geneY
【PRE_E】
PPP2R2B	geneY
【GOLD_R】
【PRE_R】

Protein phosphatase 2A is one of four major classes of serine / threonine phosphatases .
【GOLD_E】
serine/threoninephosphatases	geneN
serine	chem
threonine	chem
Proteinphosphatase2A	geneN
【PRE_E】
Proteinphosphatase2A	geneY
serine/threoninephosphatases	geneN
【GOLD_R】
【PRE_R】

Overexpression of brain - specific regulatory subunit PPP2R2 in neuron cells is implicated in pathogenesis .
【GOLD_E】
PPP2R2	geneN
【PRE_E】
PPP2R2	geneY
【GOLD_R】
【PRE_R】

The alternative splicing of PPP2R2B encodes two isoforms .
【GOLD_E】
PPP2R2B	geneY
【PRE_E】
PPP2R2B	geneY
【GOLD_R】
【PRE_R】

They are subunit of cytoplasmic specific Bβ1 and mitochondria - targeted Bβ2 .
【GOLD_E】
Bβ1	geneY
Bβ2	geneY
【PRE_E】
Bβ1	geneN
Bβ2	geneN
【GOLD_R】
【PRE_R】

The two constructs were transfected into human neuroblastoma cells , SK - N - SH , respectively , and the stable clones overexpressing either Bβ1 or Bβ2 established .
【GOLD_E】
Bβ1	geneY
Bβ2	geneY
【PRE_E】
Bβ1	geneY
Bβ2	geneY
【GOLD_R】
【PRE_R】

We have reported that Bβ2 clones are sensitive to reactive oxygen species ( ROS ) treatment by inducing autophagic cell death .
【GOLD_E】
Bβ2	geneY
oxygen	chem
【PRE_E】
Bβ2	chem
oxygen	chem
【GOLD_R】
【PRE_R】

To study more on the onset of neuropathogenesis under strain , both clones were exposed to different environmental stress , e.g . starvation and endoplasmic reticulum ( ER ) stress .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To learn how PPP2R2B overexpression responds to starvation , cells were incubated in Hank 's buffered salt solution of deprived nutrient .
【GOLD_E】
PPP2R2B	geneN
【PRE_E】
PPP2R2B	geneY
【GOLD_R】
【PRE_R】

Cell death was induced in Bβ1 clones after 6 h starvation , but not in Bβ2 clones .
【GOLD_E】
Bβ1	geneY
β2c	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

The pharmacological inhibitor , Bafilomycin A1 , rescued the cell death while suppressing autophagy .
【GOLD_E】
BafilomycinA1	chem
【PRE_E】
BafilomycinA1	geneY
【GOLD_R】
【PRE_R】

On the other hand , to assess how cells respond to ER stress , the cells were treated with 0.1 μM of N - glycosylation inhibitor , tunicamycin ( TM ) .
【GOLD_E】
-	chem
unicamycin(	chem
【PRE_E】
N-glycosylation	geneN
tunicamycin	chem
【GOLD_R】
【PRE_R】

In contrast with Bβ1 , the apoptotic cell death appeared in Bβ2 after 48 h treatment .
【GOLD_E】
Bβ2	geneY
Bβ1	geneY
【PRE_E】
Bβ1	geneY
【GOLD_R】
【PRE_R】

The formation of autophagolysosome was detected in Bβ2 following 12 h treatment with TM as evidenced by lysotracker and GFP - LC3 staining for fluorescence microscopy analysis .
【GOLD_E】
Bβ2	geneN
【PRE_E】
LC3	geneN
【GOLD_R】
【PRE_R】

The autophagy inhibitor , 3 - methyladenine , salvaged the final apoptosis .
【GOLD_E】
3-methyladenine	chem
【PRE_E】
3-methyladenine	chem
【GOLD_R】
【PRE_R】

The stable cell lines with ectopically transfected PPP2R2B genes encoding isoforms of brain - specific regulatory subunit exhibit distinct apoptosis under different stressors .
【GOLD_E】
PPP2R2B	geneY
【PRE_E】
PPP2R2B	geneY
【GOLD_R】
【PRE_R】

The induced autophagic apoptotic cell death is related to mitochondrial membrane potential drop and ROS generation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Disturbance of autophagy alleviates the induced cell death .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The results promised a good model for understanding the onset in pathogenesis under stress in neuron cells with aberrant PPP2R2B expression .
【GOLD_E】
PPP2R2B	geneY
【PRE_E】
PPP2R2B	geneY
【GOLD_R】
【PRE_R】

Population pharmacokinetics of atorvastatin and its active metabolites in children and adolescents with heterozygous familial hypercholesterolemia : selective use of informative prior distributions from adults .
【GOLD_E】
atorvastatin	chem
【PRE_E】
atorvastatin	chem
【GOLD_R】
【PRE_R】

The population pharmacokinetics ( PPK ) of atorvastatin and its principal active metabolite , o - hydroxyatorvastatin , were described in 6 - 17 years old pediatric hypercholesterolemia patients with a 2 - compartment model for both parent and metabolite .
【GOLD_E】
atorvastatin	chem
o-hydroxyatorvastatin	chem
【PRE_E】
atorvastatin	chem
o-hydroxyatorvastatin	chem
【GOLD_R】
【PRE_R】

Informative prior distributions on selected parameters , based on adult data , were required to stabilize the model and were implemented using a Bayesian penalty term on the likelihood function in the nonlinear mixed effects model ( NONMEM VI with PRIOR ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Concentrations below the limit of quantitation were treated as censored data using a conditional likelihood function .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Atorvastatin apparent oral clearance ( CL / F ) was described as a function of body weight using an allometric equation .
【GOLD_E】
Atorvastatin	chem
【PRE_E】
Atorvastatin	chem
CL/F	chem
【GOLD_R】
【PRE_R】

Based on the final model , the typical CL / F estimates for a Tanner Stage 1 patient ( 35 kg weight ) and Tanner Stage ≥ 2 ( 50 kg weight ) , would be 553 and 543 L / hour , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

When scaled allometrically , CL / F was similar to values reported for adults .
【GOLD_E】
【PRE_E】
CL/F	chem
【GOLD_R】
【PRE_R】

Variability in atorvastatin PK was primarily affected by weight .
【GOLD_E】
atorvastatin	chem
【PRE_E】
atorvastatinPK	chem
【GOLD_R】
【PRE_R】

A high - confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex .
【GOLD_E】
SIRT1	geneY
USP22	geneY
SAGA	geneN
【PRE_E】
SIRT1	geneY
USP22	geneY
SAGAcoactivator	geneN
【GOLD_R】
【PRE_R】

Although many functions and targets have been attributed to the histone and protein deacetylase SIRT1 , a comprehensive analysis of SIRT1 binding proteins yielding a high - confidence interaction map has not been established .
【GOLD_E】
histone	geneN
proteindeacetylase	geneN
SIRT1	geneY
SIRT1	geneY
【PRE_E】
histone	geneN
proteindeacetylaseSIRT1	geneN
SIRT1	geneY
【GOLD_R】
【PRE_R】

Using a comparative statistical analysis of binding partners , we have assembled a high - confidence SIRT1 interactome .
【GOLD_E】
SIRT1	geneY
【PRE_E】
SIRT1	geneY
【GOLD_R】
【PRE_R】

Employing this method , we identified the deubiquitinating enzyme ubiquitin - specific protease 22 ( USP22 ) , a component of the deubiquitinating module ( DUBm ) of the SAGA transcriptional coactivating complex , as a SIRT1 - interacting partner .
【GOLD_E】
ubiquitin-specificprotease22	geneY
USP22	geneY
SAGA	geneN
SIRT1	geneY
【PRE_E】
deubiquitinating	geneN
ubiquitin-specificprotease22	geneY
USP22	geneY
deubiquitinatingmodule	geneN
DUBm	geneN
SAGA	geneN
SIRT1	geneY
【GOLD_R】
【PRE_R】

We found that this interaction is highly specific , requires the ZnF - UBP domain of USP22 , and is disrupted by the inactivating H363Y mutation within SIRT1 .
【GOLD_E】
ZnF-UBPdomain	geneN
USP22	geneY
H363Y	geneN
SIRT1	geneY
ZnF	chem
【PRE_E】
ZnF	geneY
UBP	geneN
USP22	geneY
H363Y	geneY
SIRT1	geneY
【GOLD_R】
【PRE_R】

Moreover , we show that USP22 is acetylated on multiple lysine residues and that alteration of a single lysine ( K129 ) within the ZnF - UBP domain is sufficient to alter interaction of the DUBm with the core SAGA complex .
【GOLD_E】
USP22	geneY
ZnF-UBPdomain	geneN
DUBm	geneN
SAGA	geneN
lysine	chem
lysine	chem
ZnF	chem
【PRE_E】
USP22	geneY
lysine	chem
lysine	chem
K129	geneN
ZnF	geneN
UBP	geneN
DUBm	geneN
SAGA	geneN
【GOLD_R】
【PRE_R】

Furthermore , USP22 - mediated recruitment of SIRT1 activity promotes the deacetylation of individual SAGA complex components .
【GOLD_E】
USP22	geneY
SIRT1	geneY
SAGA	geneN
【PRE_E】
USP22	geneY
SIRT1	geneY
SAGA	geneN
【GOLD_R】
【PRE_R】

Our results indicate an important role of SIRT1 - mediated deacetylation in regulating the formation of DUBm subcomplexes within the larger SAGA complex .
【GOLD_E】
SIRT1	geneY
DUBm	geneN
SAGA	geneN
【PRE_E】
SIRT1	geneY
DUBmsubcomplexes	geneN
SAGA	geneN
【GOLD_R】
【PRE_R】

Characterization of cytosolic glutathione peroxidase and phospholipid - hydroperoxide glutathione peroxidase genes in rainbow trout ( Oncorhynchus mykiss ) and their modulation by in vitro selenium exposure .
【GOLD_E】
selenium	chem
glutathione	chem
hydroperoxide	chem
glutathione	chem
cytosolicglutathioneperoxidase	geneY
phospholipid-hydroperoxideglutathioneperoxidase	geneN
【PRE_E】
cytosolicglutathioneperoxidase	geneN
phospholipid-hydroperoxideglutathioneperoxidase	geneN
selenium	chem
【GOLD_R】
【PRE_R】

Selenium ( Se ) is an oligonutrient with both essential biological functions and recognized harmful effects .
【GOLD_E】
Selenium	chem
Se	chem
【PRE_E】
Selenium	chem
Se	chem
【GOLD_R】
【PRE_R】

As the selenocysteine ( SeCys ) amino acid , selenium is integrated in several Se - containing proteins ( selenoproteins ) , many of which are fundamental for cell homeostasis .
【GOLD_E】
aminoacid	chem
selenium	chem
Se	chem
selenocysteine	chem
SeCys	chem
【PRE_E】
selenocysteine	chem
SeCys	chem
aminoacid	chem
selenium	chem
Se-containingproteins	geneN
selenoproteins	geneN
【GOLD_R】
【PRE_R】

Nevertheless , selenium may exert toxic effects at levels marginally above those required , mainly through the generation of reactive oxygen species ( ROS ) .
【GOLD_E】
oxygen	chem
【PRE_E】
selenium	chem
oxygen	chem
【GOLD_R】
【PRE_R】

The selenium chemical speciation can strongly affect the bioavailability of this metal and its impact on metabolism , dictating the levels that can be beneficial or detrimental towards an organism .
【GOLD_E】
selenium	chem
【PRE_E】
selenium	chem
【GOLD_R】
【PRE_R】

Glutathione peroxidase ( GPxs ) is the largest and the most studied selenoprotein family .
【GOLD_E】
Glutathione	chem
Glutathioneperoxidase	geneN
GPxs	geneN
selenoprotein	geneN
【PRE_E】
Glutathioneperoxidase	geneN
GPxs	geneN
selenoprotein	geneN
【GOLD_R】
【PRE_R】

Cytosolic glutathione peroxidase ( cGPx , GPx1 ) and phospholipid hydroperoxide glutathione peroxidase ( PHGPx , GPx4 ) are widely distributed throughout tissues , and play a pivotal role in regulating the oxidative status in the cell .
【GOLD_E】
glutathione	chem
hydroperoxide	chem
glutathione	chem
Cytosolicglutathioneperoxidase	geneY
cGPx	geneY
GPx1	geneY
phospholipidhydroperoxideglutathioneperoxidase	geneN
PHGPx	geneN
GPx4	geneN
【PRE_E】
Cytosolicglutathioneperoxidase	geneN
cGPx	geneY
GPx1	geneY
phospholipidhydroperoxideglutathioneperoxidase	geneN
PHGPx	geneN
GPx4	geneN
【GOLD_R】
【PRE_R】

In this study we have cloned GPx1 and GPx4 genes in rainbow trout ( Oncorhynchus mykiss ) .
【GOLD_E】
GPx1	geneY
GPx4	geneN
【PRE_E】
GPx1	geneY
GPx4	geneY
【GOLD_R】
【PRE_R】

The constitutive mRNA expression of these GPx genes was examined in 18 trout tissues and their responsiveness to Se availability was analysed using a rainbow trout liver cell line ( RTL ) .
【GOLD_E】
GPx	geneN
【PRE_E】
GPx	geneN
Se	chem
【GOLD_R】
【PRE_R】

An inorganic ( sodium selenite , Na2SeO3 ) and organic ( selenocysteine , Cys - Se - Se - Cys ) selenocompound have been used as Se sources .
【GOLD_E】
sodiumselenite	chem
Na2SeO3	chem
selenocysteine	chem
Cys-Se-Se-Cys	chem
Se	chem
【PRE_E】
sodiumselenite	chem
Na2SeO3	chem
selenocysteine	chem
Cys-Se-Se-Cys	chem
selenocompound	chem
Se	chem
【GOLD_R】
【PRE_R】

GPx1 activity was also tested to verify the impact of transcript changes on the enzymatic function of these molecules .
【GOLD_E】
GPx1	geneY
【PRE_E】
GPx1	geneY
【GOLD_R】
【PRE_R】

To understand if the results obtained from the transcript expression analysis were due to Se bioavailability or generation of ROS , the cytoxicity of the two selenocompounds was tested by measuring the impact of Se on cell membrane integrity .
【GOLD_E】
Se	chem
Se	chem
【PRE_E】
Se	chem
selenocompounds	chem
Se	chem
【GOLD_R】
【PRE_R】

Lastly , Se availability was quantified by mass spectrophotometry to determine the amount of Se in the cell culture media , the Se background due to the foetal calf serum supplement and the contribution from the two selenocompounds used in the treatments .
【GOLD_E】
Se	chem
Se	chem
Se	chem
【PRE_E】
Se	chem
Se	chem
Se	chem
selenocompounds	chem
【GOLD_R】
【PRE_R】

Three isoforms of genes for both GPx1 ( GPx1a , 1b1 and 1b2 ) and GPx4 ( GPx4a1 , a2 and b ) have been identified .
【GOLD_E】
GPx1	geneY
GPx1a,1b1and1b2	geneN
GPx4	geneN
GPx4a1,a2andb	geneN
【PRE_E】
GPx1	geneY
GPx1a,1b1and1b2	geneN
GPx4	geneN
GPx4a1,a2andb)	geneN
【GOLD_R】
【PRE_R】

The discovery of a third gene encoding for GPx1 and GPx4 hints that salmonids may have the biggest selenoproteome amongst all vertebrates .
【GOLD_E】
GPx1	geneY
GPx4	geneN
【PRE_E】
GPx1	geneY
GPx4	geneY
【GOLD_R】
【PRE_R】

Transcripts of GPx4 genes were more highly expressed in most tissues examined in vivo ( except blood , head kidney and spleen ) , whereas those of the GPx1 genes were more responsive to selenium exposure in vitro , especially to the organic form .
【GOLD_E】
selenium	chem
GPx4	geneN
GPx1	geneY
【PRE_E】
GPx4	geneY
GPx1	geneY
selenium	chem
【GOLD_R】
【PRE_R】

Interestingly , GPx1a was the most sensitive to selenium availability in non stressful conditions , whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells .
【GOLD_E】
selenium	chem
selenium	chem
GPx1a	geneY
GPx1b1	geneY
GPx1b2	geneY
【PRE_E】
GPx1a	geneY
selenium	chem
GPx1b1	geneN
GPx1b2	geneN
selenium	chem
【GOLD_R】
selenium	GPx1b1	C3
selenium	GPx1b2	C3
【PRE_R】

Although the different concentrations tested of the two selenocompounds modulate GPx1 transcript expression to various degrees , no significant change of GPx1 enzymatic activity was detectable .
【GOLD_E】
GPx1	geneY
GPx1	geneY
【PRE_E】
selenocompounds	chem
GPx1	geneY
GPx1	geneY
【GOLD_R】
【PRE_R】

Our results lead us to conclude that trout GPx1 transcripts expression level may represent a sensitive biomarker for selenium intake , helping to evaluate if selenium concentration and chemical speciation impact on cell homeostasis .
【GOLD_E】
selenium	chem
selenium	chem
GPx1	geneY
【PRE_E】
GPx1	geneY
selenium	chem
selenium	chem
【GOLD_R】
【PRE_R】

Manganese - exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox .
【GOLD_E】
Manganese	chem
Trolox	chem
【PRE_E】
Manganese	chem
Trolox	chem
【GOLD_R】
【PRE_R】

While manganese ( Mn ) is essential for proper central nervous system ( CNS ) development , excessive Mn exposure may lead to neurotoxicity .
【GOLD_E】
Mn	chem
manganese	chem
Mn	chem
【PRE_E】
manganese	chem
Mn	chem
Mn	chem
【GOLD_R】
【PRE_R】

Mn preferentially accumulates in the basal ganglia , and in adults it may cause Parkinson 's disease - like disorder .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

Compared to adults , younger individuals accumulate greater Mn levels in the CNS and are more vulnerable to its toxicity .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

Moreover , the mechanisms mediating developmental Mn - induced neurotoxicity are not completely understood .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

The present study investigated the developmental neurotoxicity elicited by Mn exposure ( 5 , 10 and 20 mg / kg ; i.p . ) from postnatal day 8 to PN27 in rats .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

Neurochemical analyses were carried out on PN29 , with a particular focus on striatal alterations in intracellular signaling pathways ( MAPKs , Akt and DARPP - 32 ) , oxidative stress generation and cell death .
【GOLD_E】
MAPKs	geneN
Akt	geneN
DARPP-32	geneY
【PRE_E】
PN29	geneY
MAPKs	geneN
Akt	geneN
DARPP-32	geneY
【GOLD_R】
【PRE_R】

Motor alterations were evaluated later in life at 3 , 4 or 5 weeks of age .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mn exposure ( 20 mg / kg ) increased p38 ( MAPK ) and Akt phosphorylation , but decreased DARPP - 32 - Thr - 34 phosphorylation .
【GOLD_E】
Mn	chem
38(	geneN
APK)	geneN
ktp	geneN
ARPP-32-	geneY
【PRE_E】
Mn	chem
p38	geneN
MAPK	geneN
Akt	geneN
DARPP-32	geneY
Thr-34	geneY
【GOLD_R】
Mn	38(	C3
Mn	APK)	C3
Mn	ktp	C3
Mn	ARPP-32-	C4
【PRE_R】
Mn	p38	C3
Mn	DARPP-32	C3
Mn	Thr-34	C3

Mn ( 10 and 20 mg / kg ) increased caspase activity and F ( 2 ) - isoprostane production ( a biological marker of lipid peroxidation ) .
【GOLD_E】
Mn	chem
aspasea	geneN
(2)-isoprostanep	chem
【PRE_E】
Mn	chem
caspase	geneN
F(2)-isoprostane	chem
【GOLD_R】
Mn	aspasea	C3
【PRE_R】

Paralleling the changes in striatal biochemical parameters , Mn ( 20 mg / kg ) also caused motor impairment , evidenced by increased falling latency in the rotarod test , decreased distance traveled and motor speed in the open - field test .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

Notably , the antioxidant Trolox ™ reversed the Mn ( 20 mg / kg ) - dependent augmentation in p38 ( MAPK ) phosphorylation and reduced the Mn ( 20 mg / kg ) - induced caspase activity and F ( 2 ) - isoprostane production .
【GOLD_E】
38(	geneN
APK)	geneN
spaseac	geneN
Trolox	chem
Mn	chem
n(	chem
2)-isoprostanepr	chem
【PRE_E】
Trolox	chem
Mn	chem
p38	geneN
MAPK	geneN
Mn	chem
caspase	geneN
F(2)-isoprostane	chem
【GOLD_R】
Mn	38(	C3
Mn	APK)	C3
n(	spaseac	C3
Trolox	38(	C4
Trolox	APK)	C4
Trolox	spaseac	C4
【PRE_R】
Trolox	caspase	C3
Mn	caspase	C3
Mn	caspase	C3

Trolox ™ also reversed the Mn - induced motor coordination deficits .
【GOLD_E】
Mn	chem
Trolox	chem
【PRE_E】
Trolox™	chem
Mn	chem
【GOLD_R】
【PRE_R】

These findings are the first to show that long - term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers , p38 ( MAPK ) phosphorylation and caspase activity in the striatum .
【GOLD_E】
Mn	chem
p38	geneN
MAPK	geneN
caspase	geneN
【PRE_E】
Mn	chem
p38	geneN
MAPK	geneN
caspase	geneN
【GOLD_R】
Mn	p38	C3
Mn	MAPK	C3
Mn	caspase	C3
【PRE_R】

Moreover , we establish Trolox ™ as a potential neuroprotective agent given its efficacy in reversing the Mn - induced neurodevelopmental effects .
【GOLD_E】
Trolox	chem
Mn	chem
【PRE_E】
Trolox™	chem
Mn	chem
【GOLD_R】
【PRE_R】

Nocapyrones H - J , 3,6 - Disubstituted α - Pyrones from the Marine Actinomycete Nocardiopsis sp . KMF - 001 .
【GOLD_E】
NocapyronesH-J	chem
3,6-Disubstitutedα-Pyrones	chem
【PRE_E】
NocapyronesH-J,3,6-Disubstitutedα-Pyrones	chem
【GOLD_R】
【PRE_R】

Three new 3,6 - disubstituted α - pyrones , nocapyrones H - J ( 1 - 3 ) , were isolated from the marine actinomycete Nocardiopsis sp .
【GOLD_E】
3,6-disubstitutedα-pyrones	chem
nocapyronesH-J	chem
【PRE_E】
3,6-disubstitutedα-pyrones	chem
nocapyronesH-J	chem
【GOLD_R】
【PRE_R】

KMF - 001 .
【GOLD_E】
【PRE_E】
KMF-001	chem
【GOLD_R】
【PRE_R】

Their structures were assigned to be 3 - alkylated 6 - ( 1 - methyl - 1 - propenyl ) - 2H - pyran - 2 - ones on the basis of UV , MS , NMR , and high resolution ( HR ) - FAB - MS analyses .
【GOLD_E】
3-alkylated6-(1-methyl-1-propenyl)-2H-pyran-2-ones	chem
【PRE_E】
3-alkylated6-(1-methyl-1-propenyl)-2H-pyran-2-ones	chem
【GOLD_R】
【PRE_R】

Nocapyrone H ( 1 ) reduced the pro - inflammatory factor such as nitric oxide ( NO ) , prostaglandin E2 ( PGE2 ) and interleukin - 1β ( IL - 1β ) .
【GOLD_E】
interleukin-1β	geneY
IL-1β	geneY
NocapyroneH	chem
nitricoxide	chem
NO	chem
prostaglandinE2	chem
PGE2	chem
【PRE_E】
NocapyroneH(1)	chem
nitricoxide	chem
NO	chem
prostaglandinE2	chem
PGE2	chem
interleukin-1β	geneY
IL-1β	geneY
【GOLD_R】
NocapyroneH	interleukin-1β	C4
NocapyroneH	IL-1β	C4
【PRE_R】

Moreover , nocapyrone H showed 5.82 % stronger inhibitory effect on NO production than chrysin at a concentration of 10 µm in lipopolysaccharide ( LPS ) - stimulated BV - 2 microglial cells .
【GOLD_E】
NO	chem
nocapyroneH	chem
【PRE_E】
nocapyroneH	chem
NO	chem
chrysin	chem
【GOLD_R】
【PRE_R】

Investigating the enteroenteric recirculation of apixaban , a factor Xa inhibitor : administration of activated charcoal to bile duct - cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats .
【GOLD_E】
apixaban	chem
factorXa	geneN
【PRE_E】
apixaban	chem
factorXa	geneY
【GOLD_R】
apixaban	factorXa	C4
【PRE_R】
apixaban	factorXa	C4

The study described here investigated the impact of intestinal excretion ( IE ; excretion of drug directly from circulation to intestinal lumen ) , enteroenteric recirculation ( EER ) , and renal tubule recirculation ( RTR ) on apixaban pharmacokinetics and disposition .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

The experimental approaches involve integrating apixaban elimination pathways with pharmacokinetic profiles obtained from bile duct - cannulated ( BDC ) rats and dogs receiving i.v . doses together with oral administration of activated charcoal ( AC ) .
【GOLD_E】
apixaban	chem
charcoal	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

Additionally , the role of P - gp ( P - glycoprotein ; abcb1 ) and BCRP ( breast cancer resistance protein ; abcg2 ) in apixaban disposition was evaluated in experiments using transporter inhibitors and transporter knockout ( KO ) rats .
【GOLD_E】
apixaban	chem
P-gp	geneY
P-glycoprotein	geneY
abcb1	geneY
BCRP	geneY
breastcancerresistanceprotein	geneY
abcg2	geneY
【PRE_E】
P-gp	geneN
P-glycoprotein	geneN
abcb1	geneY
BCRP	geneY
breastcancerresistanceprotein	geneY
abcg2	geneY
apixaban	chem
【GOLD_R】
【PRE_R】

Approximately 20 - 50 % of an apixaban i.v . dose was found in feces of BDC rats and dogs , suggesting IE leading to fecal elimination and intestinal clearance ( IC ) .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

The fecal elimination , IC , and systemic clearance of apixaban were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with GF - 120918 , a dual BCRP and P - gp inhibitor ) .
【GOLD_E】
apixaban	chem
BCRP	geneY
P-gp	geneN
GF-120918	chem
【PRE_E】
apixaban	chem
GF-120918	chem
BCRP	geneY
P-gp	geneN
【GOLD_R】
GF-120918	BCRP	C4
GF-120918	P-gp	C4
【PRE_R】
apixaban	BCRP	C4
GF-120918	BCRP	C4
GF-120918	P-gp	C4

BCRP appeared to play a more important role for absorption and intestinal and renal elimination of apixaban than P - gp in transporter - KO rats after oral and i.v . dosing , which led to a higher level of active renal excretion in rat than other species .
【GOLD_E】
BCRP	geneY
P-gp	geneN
apixaban	chem
【PRE_E】
BCRP	geneY
apixaban	chem
P-gp	geneN
【GOLD_R】
apixaban	BCRP	C9
apixaban	P-gp	C9
【PRE_R】

These data demonstrate that apixaban undergoes IE , EER , and RTR that are facilitated by efflux transporters .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
effluxtransporters	geneN
【GOLD_R】
【PRE_R】

Intestinal reabsorption of apixaban could be interrupted by AC even at 3 hours post - drug dose in dogs ( late charcoal effect ) .
【GOLD_E】
apixaban	chem
charcoal	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

This study demonstrates that the intestine is an organ for direct clearance and redistribution of apixaban .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

The IE , EER , and RTR contribute to overall pharmacokinetic profiles of apixaban .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

IE as a clearance pathway , balanced with metabolism and renal excretion , helps decrease the impacts of intrinsic ( renal or hepatic impairment ) and extrinsic ( drug - drug interactions ) factors on apixaban disposition .
【GOLD_E】
apixaban	chem
【PRE_E】
apixaban	chem
【GOLD_R】
【PRE_R】

Cloning , Characterization , and Sulfonamide and Thiol Inhibition Studies of an α - Carbonic Anhydrase from Trypanosoma cruzi , the Causative Agent of Chagas Disease .
【GOLD_E】
α-CarbonicAnhydrase	geneY
Sulfonamide	chem
Thiol	chem
【PRE_E】
Sulfonamide	chem
Thiol	chem
α-CarbonicAnhydrase	geneN
【GOLD_R】
Sulfonamide	α-CarbonicAnhydrase	C4
Thiol	α-CarbonicAnhydrase	C4
【PRE_R】
Sulfonamide	α-CarbonicAnhydrase	C4
Thiol	α-CarbonicAnhydrase	C4

An α - carbonic anhydrase ( CA , EC 4.2.1.1 ) has been identified , cloned , and characterized from the unicellular protozoan Trypanosoma cruzi , the causative agent of Chagas disease .
【GOLD_E】
CA	geneY
EC4.2.1.1	geneY
α-carbonicanhydrase	geneY
【PRE_E】
α-carbonicanhydrase	geneN
CA	geneN
EC4.2.1.1	geneY
unicellularprotozoanTrypanosomacruzi	geneN
【GOLD_R】
【PRE_R】

The enzyme ( TcCA ) has a very high catalytic activity for the CO ( 2 ) hydration reaction , being similar kinetically to the human ( h ) isoform hCA II , although it is devoid of the His64 proton shuttle .
【GOLD_E】
hCAII	geneY
CO(2)	chem
His	chem
TcCA	geneY
【PRE_E】
TcCA	chem
CO(2)	chem
hCAII	geneY
His64	geneN
【GOLD_R】
CO(2)	hCAII	C9
CO(2)	TcCA	C9
【PRE_R】

A large number of aromatic / heterocyclic sulfonamides and some 5 - mercapto - 1,3,4 - thiadiazoles were investigated as TcCA inhibitors .
【GOLD_E】
TcCA	geneY
aromatic/heterocyclicsulfonamides	chem
5-mercapto-1,3,4-thiadiazoles	chem
【PRE_E】
aromatic/heterocyclicsulfonamides	chem
5-mercapto-1,3,4-thiadiazoles	chem
TcCA	geneN
【GOLD_R】
aromatic/heterocyclicsulfonamides	TcCA	C4
5-mercapto-1,3,4-thiadiazoles	TcCA	C4
【PRE_R】
aromatic/heterocyclicsulfonamides	TcCA	C4
5-mercapto-1,3,4-thiadiazoles	TcCA	C4

The aromatic sulfonamides were weak inhibitors ( K ( I ) values of 192 nM to 84 μM ) , whereas some heterocyclic compounds inhibited the enzyme with K ( I ) values in the range 61.6 - 93.6 nM .
【GOLD_E】
aromaticsulfonamides	chem
【PRE_E】
aromaticsulfonamides	chem
heterocyclic	chem
【GOLD_R】
【PRE_R】

The thiols were the most potent in vitro inhibitors ( K ( I ) values of 21.1 - 79.0 nM ) , and some of them also inhibited the epimastigotes growth of two T. cruzi strains in vivo .
【GOLD_E】
thiols	chem
【PRE_E】
thiols	chem
【GOLD_R】
【PRE_R】

The increased number of Leydig cells by di ( 2 - ethylhexyl ) phthalate comes from the differentiation of stem cells into Leydig cell lineage in the adult rat testis .
【GOLD_E】
di(2-ethylhexyl)phthalate	chem
【PRE_E】
di(2-ethylhexyl)phthalate	chem
【GOLD_R】
【PRE_R】

The objective of the present study is to determine whether di ( 2 - ethylhexyl ) phthalate ( DEHP ) exposure at adulthood increases rat Leydig cell number and to investigate the possible mechanism .
【GOLD_E】
di(2-ethylhexyl)phthalate	chem
DEHP	chem
【PRE_E】
di(2-ethylhexyl)phthalate	chem
DEHP	chem
【GOLD_R】
【PRE_R】

90 - day - old Long - Evans rats were randomly divided into 3 groups , and were gavaged with the corn oil ( control ) or 10 or 750mg / kg DEHP daily for 7 days , and then received an intraperitoneal injection of 75mg / kg ethane dimethanesulfonate ( EDS ) to eliminate Leydig cells .
【GOLD_E】
EDS	chem
DEHP	chem
ethanedimethanesulfonate	chem
【PRE_E】
DEHP	chem
ethanedimethanesulfonate	chem
EDS	chem
【GOLD_R】
【PRE_R】

Serum testosterone concentrations were assessed by RIA , and the mRNA levels of Leydig cell genes were measured by qPCR .
【GOLD_E】
testosterone	chem
【PRE_E】
testosterone	chem
【GOLD_R】
【PRE_R】

EDS eliminated all Leydig cells in the control testis on day 4 post - EDS , as judged by undetectable serum testosterone level and no 3β - hydroxysteroid dehydrogenase positive ( 3β - HSD ( pos ) ) cells in the interstitium .
【GOLD_E】
EDS	chem
EDS	chem
testosterone	chem
3β-hydroxysteroid	chem
3β-hydroxysteroiddehydrogenase	geneN
3β-HSD	geneN
【PRE_E】
testosterone	chem
3β-hydroxysteroiddehydrogenase	geneY
3β-HSD	geneY
pos)	geneY
【GOLD_R】
【PRE_R】

However , in DEHP - treated groups , there were detectable serum testosterone concentrations and some oval - shaped 3β - HSD ( pos ) cells in the interstitium .
【GOLD_E】
DEHP	chem
testosterone	chem
3β-HSD	geneN
【PRE_E】
DEHP	chem
testosterone	chem
3β-HSD	geneY
【GOLD_R】
【PRE_R】

These 3β - HSD ( pos ) cells were not stained by the antibody against 11β - hydroxysteroid dehydrogenase 1 ( 11β - HSD1 ) , a marker for Leydig cells at a more advanced stage .
【GOLD_E】
11β-hydroxysteroid	chem
11β-hydroxysteroiddehydrogenase1	geneY
11β-HSD	geneY
3β-HSD	geneN
【PRE_E】
3β-HSD	geneY
11β-hydroxysteroiddehydrogenase1	geneY
11β-HSD1	geneY
【GOLD_R】
【PRE_R】

The disappearance of mRNAs of Leydig cell biomarkers including Lhcgr , Cyp11a1 , Cyp17a1 , Insl3 and Hsd11b1 in the control testis was observed on day 4 post - EDS .
【GOLD_E】
EDS	chem
【PRE_E】
Lhcgr	geneY
Cyp11a1	geneY
Cyp17a1	geneY
Insl3	geneY
Hsd11b1	geneY
【GOLD_R】
【PRE_R】

However , there were detectable concentrations of Lhcgr , Cyp11a1 and Cyp17a1 mRNAs but undetectable concentrations of Insl3 , Hsd17b3 and Hsd11b1 in the DEHP - treated testes , indicating that these 3β - HSD ( pos ) cells were newly formed progenitor Leydig cells .
【GOLD_E】
Lhcgr	geneY
Cyp11a1	geneY
Cyp17a1	geneY
Insl3	geneY
Hsd17b3	geneY
Hsd11b1	geneY
3β-HSD	geneN
DEHP	chem
【PRE_E】
Lhcgr	geneY
Cyp11a1	geneY
Cyp17a1	geneY
Insl3	geneY
Hsd17b3	geneY
Hsd11b1	geneY
DEHP	chem
3β-HSD	geneY
【GOLD_R】
【PRE_R】
Cyp11a1	DEHP	C3
Cyp17a1	DEHP	C3
Hsd11b1	DEHP	C3

The mRNA level for nestin ( Nes , biomarker for stem Leydig cells ) was significantly increased in the control testis on day 4 post - EDS , but not in the DEHP treated testes , suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP - treated testes .
【GOLD_E】
nestin	geneY
Nes	geneY
nestin	geneY
EDS	chem
DEHP	chem
DEHP	chem
【PRE_E】
nestin	geneY
Nes	geneY
DEHP	chem
DEHP	chem
【GOLD_R】
EDS	nestin	C3
EDS	Nes	C3
【PRE_R】

The present study suggests that DEHP increases the differentiation of stem cells into progenitor Leydig cells .
【GOLD_E】
DEHP	chem
【PRE_E】
DEHP	chem
【GOLD_R】
【PRE_R】

GnRH pulse frequency - dependent stimulation of FSHβ transcription is mediated via activation of PKA and CREB .
【GOLD_E】
GnRH	chem
GnRH	geneN
CREB	geneN
FSHβ	geneY
PKA	geneN
【PRE_E】
GnRH	geneY
FSHβ	geneY
PKA	geneN
CREB	geneN
【GOLD_R】
GnRH	CREB	C3
GnRH	PKA	C3
GnRH	FSHβ	C3
【PRE_R】

Expression of pituitary FSH and LH , under the control of pulsatile GnRH , is essential for fertility . cAMP response element - binding protein ( CREB ) has been implicated in the regulation of FSHβ gene expression , but the molecular mechanisms by which pulsatile GnRH regulates CREB activation remain poorly understood .
【GOLD_E】
GnRH	chem
cAMPresponseelement-bindingprotein	geneN
cAMP	chem
CREB	geneN
FSHβ	geneY
FSH	geneN
GnRH	geneN
CREB	geneN
LH	geneN
GnRH	geneN
GnRH	chem
【PRE_E】
FSH	geneN
LH	geneN
pulsatileGnRH	geneY
cAMPresponseelement-bindingprotein	geneN
CREB	geneN
FSHβ	geneY
GnRH	geneY
CREB	geneN
【GOLD_R】
GnRH	CREB	C3
【PRE_R】

We hypothesized that CREB is activated by a distinct signaling pathway in response to pulsatile GnRH in a frequency - dependent manner to dictate the FSHβ transcriptional response .
【GOLD_E】
CREB	geneN
GnRH	geneN
FSHβ	geneY
GnRH	chem
【PRE_E】
CREB	geneN
GnRH	geneY
FSHβ	geneY
【GOLD_R】
GnRH	CREB	C3
【PRE_R】

GnRH stimulation of CREB phosphorylation ( pCREB ) in the gonadotrope - derived LβT2 cell line was attenuated by a protein kinase A ( PKA ) inhibitor , H89 .
【GOLD_E】
GnRH	geneN
CREB	geneN
pCREB	geneN
proteinkinaseA	geneN
PKA	geneN
GnRH	chem
H89	chem
【PRE_E】
GnRH	geneY
CREB	geneN
pCREB	geneY
gonadotrope	geneY
proteinkinaseA	geneN
PKA	geneN
H89	chem
【GOLD_R】
GnRH	CREB	C3
GnRH	pCREB	C3
H89	CREB	C4
H89	pCREB	C4
H89	proteinkinaseA	C4
H89	PKA	C4
【PRE_R】
proteinkinaseA	H89	C4
PKA	H89	C4

A dominant negative PKA ( DNPKA ) reduced GnRH - stimulated pCREB and markedly decreased GnRH stimulation of FSHβ mRNA and FSHβLUC activity , but had little effect on LHβLUC activity , indicating relative specificity of this pathway .
【GOLD_E】
GnRH	chem
GnRH	chem
dominantnegativePKA	geneN
DNPKA	geneN
GnRH	geneN
pCREB	geneN
GnRH	geneN
FSHβ	geneY
FSHβ	geneY
LHβ	geneY
【PRE_E】
PKA	geneN
GnRH	geneY
pCREB	geneY
GnRH	geneY
FSHβ	geneY
FSHβLUC	geneY
LHβLUC	geneY
【GOLD_R】
GnRH	pCREB	C3
GnRH	FSHβ	C3
GnRH	FSHβ	C3
【PRE_R】

In perifusion studies , FSHβ mRNA levels and FSHβLUC activities were increased by pulsatile GnRH , with significantly greater increases at low compared with high pulse frequencies .
【GOLD_E】
GnRH	chem
FSHβ	geneY
FSHβ	geneY
GnRH	geneN
【PRE_E】
FSHβ	geneY
FSHβLUC	geneY
pulsatileGnRH	geneY
【GOLD_R】
GnRH	FSHβ	C3
GnRH	FSHβ	C3
【PRE_R】

DNPKA markedly reduced these GnRH - stimulated FSHβ responses at both low and high pulse frequencies .
【GOLD_E】
DNPKA	geneN
GnRH	geneN
FSHβ	geneY
GnRH	chem
【PRE_E】
GnRH	geneY
FSHβ	geneY
【GOLD_R】
GnRH	FSHβ	C3
【PRE_R】

Correlating with FSHβ activation , both PKA activity and levels of pCREB were increased to a greater extent by low compared with high GnRH pulse frequencies , and the induction of pCREB was also attenuated by overexpression of DNPKA at both low and high pulse frequencies .
【GOLD_E】
FSHβ	geneY
PKA	geneN
pCREB	geneN
GnRH	geneN
pCREB	geneN
DNPKA	geneN
GnRH	chem
【PRE_E】
FSHβ	geneY
PKA	geneN
pCREB	geneY
GnRH	geneY
pCREB	geneY
DNPKA	geneY
【GOLD_R】
GnRH	FSHβ	C3
GnRH	PKA	C3
GnRH	pCREB	C3
GnRH	pCREB	C3
【PRE_R】

Taken together , these data indicate that a PKA - mediated signaling pathway mediates GnRH activation of CREB at low - pulse frequencies , playing a significant role in the decoding of the hypothalamic GnRH signal to result in frequency - dependent FSHβ activation .
【GOLD_E】
PKA	geneN
GnRH	geneN
CREB	geneN
GnRH	geneN
FSHβ	geneY
GnRH	chem
GnRH	chem
【PRE_E】
PKA	geneN
GnRH	geneY
CREB	geneN
GnRH	geneY
FSHβ	geneY
【GOLD_R】
GnRH	CREB	C3
GnRH	FSHβ	C3
【PRE_R】

Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway .
【GOLD_E】
AMPK	geneY
Sophocarpine	chem
【PRE_E】
Sophocarpine	chem
AMPK	geneN
【GOLD_R】
Sophocarpine	AMPK	C3
【PRE_R】
Sophocarpine	AMPK	C3

Sophocarpine , an effective compound derived from foxtail - like sophora herb and seed , has been reported that it can alleviate non - alcoholic steatohepatitis ( NASH ) in rats and affect adipocytokine synthesis .
【GOLD_E】
adipocytokine	geneN
Sophocarpine	chem
【PRE_E】
Sophocarpine	chem
adipocytokine	geneY
【GOLD_R】
【PRE_R】

Meanwhile , adipocytokines could adjust hepatic lipid metabolism through AMPK signaling pathway .
【GOLD_E】
adipocytokines	geneN
AMPK	geneY
【PRE_E】
AMPK	geneN
【GOLD_R】
【PRE_R】

In the work presented here , primary hepatocytes were isolated from specific pathogen - free male SD rats and incubated with 200 μmol / L oleic acid for 24h to induce steatotic model , then treated with sophocarpine for 72 h .
【GOLD_E】
oleicacid	chem
sophocarpine	chem
【PRE_E】
oleicacid	chem
sophocarpine	chem
【GOLD_R】
【PRE_R】

Oil red staining was performed to evaluate steatosis , total RNA and protein of primary hepatocytes were extracted for real - time RT - PCR and western blot analysis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A cluster of aberrances were observed in the model group , including hepatocyte steatosis , increased leptin and decreased adiponectin mRNA expressions .
【GOLD_E】
leptin	geneY
adiponectin	geneY
【PRE_E】
leptin	geneY
adiponectin	geneY
【GOLD_R】
【PRE_R】

While sophocarpine treatment resulted in : significant improvement of steatosis ( > 50 % decrease ) , decrease of leptin expression ( < 0.57 - fold ) and increase of adiponectin expression ( > 1.48 - fold ) .
【GOLD_E】
leptin	geneY
adiponectin	geneY
sophocarpine	chem
【PRE_E】
sophocarpine	chem
leptin	geneY
adiponectin	geneY
【GOLD_R】
sophocarpine	adiponectin	C3
sophocarpine	leptin	C4
【PRE_R】
sophocarpine	leptin	C4
sophocarpine	adiponectin	C4

Moreover , compared with the model group , sophocarpine could significantly increase P - AMPKα ( > 5.82 - fold ) , AMPKα ( > 1.29 - fold ) and ACC ( > 3.27 - fold ) protein expressions , and reduce P - ACC ( < 0.30 - fold ) and HNF - 4α ( < 0.20 - fold ) protein expression .
【GOLD_E】
ACC	geneN
P-ACC	geneN
HNF-4α	geneY
sophocarpine	chem
P-AMPKα	geneN
AMPKα	geneN
【PRE_E】
sophocarpine	chem
P-AMPKα	geneY
AMPKα	geneY
ACC(>3.27	geneN
P-ACC	geneN
HNF-4α	geneY
【GOLD_R】
sophocarpine	ACC	C3
sophocarpine	P-AMPKα	C3
sophocarpine	AMPKα	C3
sophocarpine	P-ACC	C4
sophocarpine	HNF-4α	C4
【PRE_R】

The mRNA expression of Srebp - 1c was downregulated significantly simultaneously ( < 0.68 - fold ) .
【GOLD_E】
Srebp-1c	geneY
【PRE_E】
Srebp-1c	geneY
【GOLD_R】
【PRE_R】

We concluded that sophocarpine could alleviate hepatocyte steatosis and the potential mechanism might be the activated signaling pathway of AMPK .
【GOLD_E】
AMPK	geneY
sophocarpine	chem
【PRE_E】
sophocarpine	chem
AMPK	geneN
【GOLD_R】
sophocarpine	AMPK	C3
【PRE_R】
sophocarpine	AMPK	C3

Elevation of 4 - hydroxynonenal and malondialdehyde modified protein levels in cerebral cortex with cognitive dysfunction in rats exposed to 1 - bromopropane .
【GOLD_E】
4-hydroxynonenal	chem
1-bromopropane	chem
malondialdehyde	chem
【PRE_E】
4-hydroxynonenal	chem
malondialdehyde	chem
1-bromopropane	chem
【GOLD_R】
【PRE_R】

1 - Bromopropane ( 1 - BP ) , an alternative to ozone - depleting solvents ( ODS ) , exhibits central nervous system ( CNS ) toxicity in animals and humans .
【GOLD_E】
1-BP	chem
ozone	chem
1-Bromopropane	chem
【PRE_E】
1-Bromopropane	chem
1-BP	chem
ozone	chem
ODS	chem
【GOLD_R】
【PRE_R】

This study was designed to relate CNS damage by Morris water maze ( MWM ) test and oxidative stress to 1 - BP exposure in the rat .
【GOLD_E】
1-BP	chem
【PRE_E】
1-BP	chem
【GOLD_R】
【PRE_R】

Male Wistar rats were randomly divided into 4 groups ( n = 10 ) , and treated with 0 , 200 , 400 and 800mg / kgbw 1 - BP for consecutive 12 days , respectively .
【GOLD_E】
1-BP	chem
【PRE_E】
【GOLD_R】
【PRE_R】

From day 8 to day 12 of the experiment , MWM test was employed to assess the cognitive function of rats .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The cerebral cortex of rats was obtained immediately following the 24h after MWM test conclusion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Glutathione ( GSH ) , oxidized glutathione ( GSSG ) and total thiol ( total - SH ) content , GSH reductase ( GR ) and GSH peroxidase ( GSH - Px ) activities , malondialdehyde ( MDA ) level , as well as 4 - hydroxynonenal ( 4 - HNE ) and MDA modified proteins in homogenates of cerebral cortex were measured .
【GOLD_E】
Glutathione	chem
GSH	chem
oxidizedglutathione	chem
GSSG	chem
thiol	chem
SH	chem
GSH	chem
GSH	chem
GSH	chem
malondialdehyde	chem
MDA	chem
4-hydroxynonenal	chem
4-HNE	chem
MDA	chem
GSHreductase	geneY
GR	geneY
GSHperoxidase	geneN
GSH-Px	geneN
【PRE_E】
Glutathione	chem
GSH	chem
glutathione	chem
GSSG	chem
thiol	chem
SH	chem
GSHreductase	geneY
GR	geneY
GSHperoxidase	geneN
GSH-Px	geneN
malondialdehyde	chem
MDA	chem
4-hydroxynonenal	chem
4-HNE	chem
MDA	chem
【GOLD_R】
【PRE_R】

The obtained results showed that 1 - BP led to cognitive dysfunction of rats , which was evidenced by delayed escape latency time and swimming distances in MWM performance .
【GOLD_E】
1-BP	chem
【PRE_E】
1-BP	chem
【GOLD_R】
【PRE_R】

GSH and total - SH content , GSH / GSSG ratio , GR activity significantly decreased in cerebral cortex of rats , coupling with the increase of MDA level .
【GOLD_E】
GSH	chem
GR	geneY
SH	chem
GSH	chem
GSSG	chem
MDA	chem
【PRE_E】
GSH	chem
SH	chem
GSH	chem
GSSG	chem
GR	geneY
MDA	chem
【GOLD_R】
【PRE_R】

4 - HNE and MDA modified protein levels obviously elevated after 1 - BP exposure .
【GOLD_E】
4-HNE	chem
MDA	chem
1-BP	chem
【PRE_E】
4-HNE	chem
MDA	chem
1-BP	chem
【GOLD_R】
【PRE_R】

GSH - Px activities in cerebral cortex of rats also increased .
【GOLD_E】
GSH	chem
GSH-Px	geneN
【PRE_E】
GSH	chem
Px	geneN
【GOLD_R】
【PRE_R】

These data suggested that 1 - BP resulted in enhanced lipid peroxidation of brain , which might play an important role in CNS damage induced by 1 - BP .
【GOLD_E】
1-BP	chem
1-BP	chem
【PRE_E】
1-BP	chem
1-BP	chem
【GOLD_R】
【PRE_R】

Site dependent intestinal absorption of darunavir and its interaction with ketoconazole .
【GOLD_E】
darunavir	chem
ketoconazole	chem
【PRE_E】
darunavir	chem
ketoconazole	chem
【GOLD_R】
【PRE_R】

The expression of P - gp increases from proximal to distal parts of the small intestine , whereas for P450 enzymes the expression is reported to be highest in duodenum and jejunum , decreasing to more distal sites .
【GOLD_E】
P-gp	geneN
P450enzymes	geneN
【PRE_E】
P-gp	geneN
P450	geneN
【GOLD_R】
【PRE_R】

To evaluate to what extent the regional differences in expression of P - gp and P450 enzymes affect the absorption of a dual substrate , we investigated the transport of darunavir across different small intestinal segments ( duodenum , proximal jejunum and ileum ) .
【GOLD_E】
P-gp	geneN
P450enzymes	geneN
darunavir	chem
【PRE_E】
P-gp	geneN
P450	geneN
darunavir	chem
【GOLD_R】
darunavir	P-gp	C9
darunavir	P450enzymes	C9
【PRE_R】

Moreover , the effect of ketoconazole on the intestinal absorption of darunavir was explored , since these drugs are commonly co - administered .
【GOLD_E】
ketoconazole	chem
darunavir	chem
【PRE_E】
ketoconazole	chem
darunavir	chem
【GOLD_R】
【PRE_R】

Performing the rat in situ intestinal perfusion technique with mesenteric blood sampling , we found no significant differences in the transport of darunavir at the different intestinal segments .
【GOLD_E】
darunavir	chem
【PRE_E】
darunavir	chem
【GOLD_R】
【PRE_R】

The involvement of P - gp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the P - gp inhibitor zosuquidar .
【GOLD_E】
darunavir	chem
darunavir	chem
zosuquidar	chem
P-gp	geneN
P-gp	geneN
【PRE_E】
P-gp	geneN
darunavir	chem
darunavir	chem
P-gp	geneN
zosuquidar	chem
【GOLD_R】
zosuquidar	P-gp	C4
darunavir	P-gp	C9
【PRE_R】
darunavir	P-gp	C4
darunavir	P-gp	C4
P-gp	zosuquidar	C4

In presence of zosuquidar , a 2.2 - , 4.2 - and 5.7 - fold increase in Papp values were measured for duodenum , proximal jejunum and ileum , respectively .
【GOLD_E】
zosuquidar	chem
【PRE_E】
zosuquidar	chem
【GOLD_R】
【PRE_R】

Involvement of P450 mediated metabolism in the absorption of darunavir could not be demonstrated in this rat model .
【GOLD_E】
P450	geneN
darunavir	chem
【PRE_E】
P450	geneN
darunavir	chem
【GOLD_R】
darunavir	P450	C9
【PRE_R】

Upon studying the drug - drug interaction of darunavir with ketoconazole , data were indicative for an inhibitory effect of ketoconazole on P - gp as the main mechanism for the increased transport of darunavir across the small intestine .
【GOLD_E】
P-gp	geneN
darunavir	chem
ketoconazole	chem
ketoconazole	chem
darunavir	chem
【PRE_E】
darunavir	chem
ketoconazole	chem
ketoconazole	chem
P-gp	geneN
darunavir	chem
【GOLD_R】
ketoconazole	P-gp	C4
darunavir	P-gp	C9
【PRE_R】
darunavir	P-gp	C4
ketoconazole	P-gp	C4
ketoconazole	P-gp	C4

Protective effect of Codium fragile against UVB - induced pro - inflammatory and oxidative damages in HaCaT cells and BALB / c mice .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Acute exposure to ultraviolet ( UV ) radiation causes pro - inflammatory responses via diverse mechanisms including oxidative stress .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Codium fragile is a green alga of Codiales family and has been reported to exhibit anti - edema , anti - allergic , anti - protozoal and anti - mycobacterial activities .
【GOLD_E】
【PRE_E】
Codiales	geneN
【GOLD_R】
【PRE_R】

In this study , we have investigated a novel anti - inflammatory potential of C. fragile using in vitro cell culture as well as in vivo animal models .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In HaCaT cells , buthanol and ethylacetate fractions of 80 % methanol C. fragile extract ( CFB or CFE ) and a single compound , clerosterol ( CLS ) isolated from CFE attenuated UVB ( 60mJ / cm ( 2 ) ) - induced cytotoxicity and reduced expression of pro - inflammatory proteins including cyclooxygenase - 2 ( COX - 2 ) , inducible nitric oxide synthase ( iNOS ) , and tumor necrosis factor - α ( TNF - α ) .
【GOLD_E】
cyclooxygenase-2	geneY
COX-2	geneY
induciblenitricoxidesynthase	geneY
iNOS	geneY
tumornecrosisfactor-α	geneY
TNF-α	geneY
buthanol	chem
ethylacetate	chem
methanol	chem
clerosterol	chem
CLS	chem
nitricoxide	chem
【PRE_E】
buthanol	chem
ethylacetate	chem
methanol	chem
clerosterol	chem
cyclooxygenase-2	geneY
COX-2	geneY
induciblenitricoxidesynthase	geneY
iNOS	geneY
tumornecrosisfactor-α	geneY
TNF-α	geneY
【GOLD_R】
buthanol	cyclooxygenase-2	C4
buthanol	COX-2	C4
buthanol	induciblenitricoxidesynthase	C4
buthanol	iNOS	C4
buthanol	tumornecrosisfactor-α	C4
buthanol	TNF-α	C4
ethylacetate	cyclooxygenase-2	C4
ethylacetate	COX-2	C4
ethylacetate	induciblenitricoxidesynthase	C4
ethylacetate	iNOS	C4
ethylacetate	tumornecrosisfactor-α	C4
ethylacetate	TNF-α	C4
methanol	cyclooxygenase-2	C4
methanol	COX-2	C4
methanol	induciblenitricoxidesynthase	C4
methanol	iNOS	C4
methanol	tumornecrosisfactor-α	C4
methanol	TNF-α	C4
clerosterol	cyclooxygenase-2	C4
clerosterol	COX-2	C4
clerosterol	induciblenitricoxidesynthase	C4
clerosterol	iNOS	C4
clerosterol	tumornecrosisfactor-α	C4
clerosterol	TNF-α	C4
CLS	cyclooxygenase-2	C4
CLS	COX-2	C4
CLS	induciblenitricoxidesynthase	C4
CLS	iNOS	C4
CLS	tumornecrosisfactor-α	C4
CLS	TNF-α	C4
【PRE_R】
buthanol	cyclooxygenase-2	C4
ethylacetate	cyclooxygenase-2	C4
methanol	cyclooxygenase-2	C4
clerosterol	cyclooxygenase-2	C4
clerosterol	COX-2	C4
clerosterol	iNOS	C4
clerosterol	tumornecrosisfactor-α	C4
clerosterol	TNF-α	C4

Moreover , CFB , CFE and CLS effectively suppressed UVB - induced production of pro - inflammatory mediators such as prostaglandin E2 ( PGE2 ) and nitric oxide ( NO ) .
【GOLD_E】
prostaglandinE2	chem
PGE2	chem
nitricoxide	chem
NO	chem
CLS	chem
【PRE_E】
CFB	geneY
CFE	chem
prostaglandinE2	chem
PGE2	chem
nitricoxide	chem
NO	chem
【GOLD_R】
【PRE_R】
CFB	prostaglandinE2	C9
CFB	PGE2	C9

In another experiment , topical application of CFB , CFE or CLS prior to UVB irradiation ( 200mJ / cm ( 2 ) ) on BALB / c mice , inhibited the UVB - elevated protein levels of COX - 2 , iNOS , and TNF - α .
【GOLD_E】
COX-2	geneY
iNOS	geneY
TNF-α	geneY
CLS	chem
【PRE_E】
CFE	chem
COX-2	geneY
iNOS	geneY
TNF-α	geneY
【GOLD_R】
CLS	COX-2	C4
CLS	iNOS	C4
CLS	TNF-α	C4
【PRE_R】
CFE	COX-2	C4
CFE	iNOS	C4
CFE	TNF-α	C4

Furthermore , CFB , CFE and CLS suppressed oxidative damages caused by UVB irradiation for example lipid peroxidation and / or protein carbonylation , which seemed to be mediated by up - regulation of antioxidant defense enzymes .
【GOLD_E】
CLS	chem
【PRE_E】
CFB	geneY
CFE	chem
【GOLD_R】
【PRE_R】

These results suggest that C. fragile could be an effective therapeutic agent providing protection against UVB - induced inflammatory and oxidative skin damages .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Strong effects of cluster size and air exposure on oxygen reduction and carbon oxidation electrocatalysis by size - selected Pt ( n ) ( n ≤ 11 ) on glassy carbon electrodes .
【GOLD_E】
Pt(n)	chem
glassycarbon	chem
oxygen	chem
carbon	chem
【PRE_E】
oxygen	chem
carbon	chem
Pt(n)	chem
carbon	chem
【GOLD_R】
【PRE_R】

Model Pt ( n ) / glassy carbon electrodes ( Pt ( n ) / GCE ) were prepared by deposition of mass - selected Pt ( n ) ( + ) ( n ≤ 11 ) on GCE substrates in ultrahigh vacuum .
【GOLD_E】
Pt(n)(+)	chem
glassycarbon	chem
Pt(n)	chem
Pt(n)	chem
【PRE_E】
Pt	chem
carbon	chem
Pt(n)	chem
GCE	chem
Pt(n)(+)	chem
GCE	chem
【GOLD_R】
【PRE_R】

Electrocatalysis under conditions appropriate for the oxygen reduction reaction ( ORR ) was studied , for samples both in situ with no exposure to laboratory air and with air exposure prior to electrochemical measurements .
【GOLD_E】
oxygen	chem
【PRE_E】
oxygen	chem
【GOLD_R】
【PRE_R】

Of the small clusters , only a few cluster sizes show the expected ORR activity , and in those cases , the activity per Pt atom is similar to that seen under identical conditions with a conventionally prepared electrode with Pt nanoparticles grown on a GCE .
【GOLD_E】
Pt	chem
Pt	chem
【PRE_E】
ORR	geneN
Pt	chem
Pt	chem
GCE	chem
【GOLD_R】
【PRE_R】

For other small Pt ( n ) on GCE , any ORR signal is overwhelmed by large oxidative currents attributed to catalysis of carbon oxidation by water .
【GOLD_E】
Pt(n)	chem
carbon	chem
【PRE_E】
Pt(n)	chem
GCE	chem
ORR	chem
carbon	chem
【GOLD_R】
【PRE_R】

If the samples are exposed to air prior to electrochemistry , both ORR and carbon oxidation signals are absent , and instead only small capacitive currents or currents attributed to redox chemistry of adventitious organic adsorbates are observed , indicating that air exposure results in passivation of the small Pt clusters .
【GOLD_E】
carbon	chem
Pt	chem
【PRE_E】
ORR	chem
carbon	chem
Pt	chem
【GOLD_R】
【PRE_R】

Inhibition of ghrelin O - acyltransferase attenuates food deprivation - induced increases in ingestive behavior .
【GOLD_E】
ghrelinO-acyltransferase	geneY
O	chem
【PRE_E】
ghrelinO-acyltransferase	geneY
【GOLD_R】
【PRE_R】

Ghrelin is an orexigenic hormone produced by the stomach in direct proportion to the time since the last meal and has therefore been called a ' hunger signal ' .
【GOLD_E】
Ghrelin	geneY
orexigenichormone	geneN
【PRE_E】
Ghrelin	geneY
orexigenichormone	geneY
【GOLD_R】
【PRE_R】

The octanoylation of ghrelin is critical for its orexigenic functions and is dependent upon ghrelin O - acyltransferase ( GOAT ) catalyzation .
【GOLD_E】
GOAT	geneY
O	chem
ghrelin	geneY
ghrelinO-acyltransferase	geneY
【PRE_E】
octanoylation	geneN
ghrelin	geneY
ghrelinO-acyltransferase(GOAT)catalyzation	geneY
【GOLD_R】
【PRE_R】

The GOAT inhibitor , GO - CoA - Tat , decreases the circulating concentrations of octanoylated ghrelin and attenuates weight gain on a high fat diet in mice .
【GOLD_E】
GOAT	geneY
octanoylatedghrelin	geneY
【PRE_E】
GOAT	geneN
GO-CoA-Tat	geneN
octanoylatedghrelin	geneY
【GOLD_R】
【PRE_R】

Unlike rats and mice , Siberian hamsters and humans do not increase food intake after food deprivation , but increase food hoarding after food deprivation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In Siberian hamsters , exogenous ghrelin increases ingestive behaviors similarly to 48 - 56h food deprivation .
【GOLD_E】
ghrelin	geneY
【PRE_E】
ghrelin	geneY
【GOLD_R】
【PRE_R】

Therefore , we tested the necessity of increased ghrelin in food - deprived Siberian hamsters to stimulate ingestive behaviors .
【GOLD_E】
ghrelin	geneY
【PRE_E】
ghrelin	geneY
【GOLD_R】
【PRE_R】

To do so we used our simulated natural housing system that allows hamsters to forage for and hoard food .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Animals were given an injection of GO - CoA - Tat ( i.p . , 11μmol / kg ) every 6h because that is the duration of its effective inhibition of octanoylated ghrelin concentrations during a 48h food deprivation .
【GOLD_E】
octanoylatedghrelin	geneN
【PRE_E】
GO-CoA	chem
octanoylatedghrelin	geneY
【GOLD_R】
【PRE_R】

We found that GO - CoA - Tat attenuated food foraging ( 0 - 1h ) , food intake ( 0 - 1 and 2 - 4h ) , and food hoarding ( 0 - 1h and 2 and 3days ) post - refeeding compared with saline treated animals .
【GOLD_E】
【PRE_E】
GO-CoA	chem
【GOLD_R】
【PRE_R】

This suggests that increased octanoylated ghrelin concentrations play a role in the food deprivation - induced increases in ingestive behavior .
【GOLD_E】
octanoylatedghrelin	geneN
【PRE_E】
octanoylatedghrelin	geneY
【GOLD_R】
【PRE_R】

Therefore , ghrelin is a critical aspect of the multi - faceted mechanisms that stimulate ingestive behaviors , and might be a critical point for a successful clinical intervention scheme in humans .
【GOLD_E】
ghrelin	geneY
【PRE_E】
ghrelin	geneY
【GOLD_R】
【PRE_R】

The accumulation of metal ( Co , Cr , Cu , Mn and Zn ) in freshwater Ulva ( Chlorophyta ) and its habitat .
【GOLD_E】
Co	chem
Cr	chem
Cu	chem
Mn	chem
Zn	chem
【PRE_E】
Cr	chem
Cu	chem
Mn	chem
Zn	chem
【GOLD_R】
【PRE_R】

The possibility of using freshwater Ulva ( Chlorophyta ) as a bioaccumulator of metals ( Co , Cr , Cu , Mn and Zn ) in lake and river water was examined weekly in the summer of 2010 in three types of samples : the water , the sediment and the thalli of Ulva .
【GOLD_E】
Co	chem
Cr	chem
Cu	chem
Mn	chem
Zn	chem
【PRE_E】
Cr	chem
Cu	chem
Mn	chem
Zn	chem
【GOLD_R】
【PRE_R】

Samples of freshwater Ulva were collected from two aqueous ecosystems lie 250 km away from the basin of the Baltic Sea and 53 km from each other .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A flow lake located in the centre of the big city was the first water reservoir ( ten sites ) and second , the suburban river ( six sites ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The mean metal concentrations in the Ulva tissue from the river and the lake decreased in the following order : Mn > Zn > Cr > Cu > Co and Mn > Cr > Zn > Cu > Co , respectively .
【GOLD_E】
Cu	chem
Co	chem
Mn	chem
Cr	chem
Zn	chem
Cu	chem
Co	chem
Mn	chem
Zn	chem
Cr	chem
【PRE_E】
Mn	chem
Zn	chem
Cr	chem
Cu	chem
Co	chem
Mn	chem
Cr	chem
Zn	chem
Cu	chem
【GOLD_R】
【PRE_R】

Moreover , a negative and statistically significant correlation between Mn concentrations in the Ulva thalli and the river water was observed .
【GOLD_E】
Mn	chem
【PRE_E】
Mn	chem
【GOLD_R】
【PRE_R】

Additionally , numerous correlations were noted between the different concentrations of metals within the Ulva thalli , in the water and in the sediment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The great concentrations of Mn and Zn and the smallest of Co were found in thalli of Ulva , irrespective of the type of the ecosystem from which samples of algal thalli originated .
【GOLD_E】
Mn	chem
Zn	chem
Co	chem
【PRE_E】
Mn	chem
Zn	chem
【GOLD_R】
【PRE_R】

Freshwater Ulva populations examined in this study were clearly characterized a dozen or so times by the higher Mn and Cr accumulation than taxa from that genera coming from sea ecosystems .
【GOLD_E】
Mn	chem
Cr	chem
【PRE_E】
Mn	chem
Cr	chem
【GOLD_R】
【PRE_R】

The calculated bioconcentration factor confirm the high potential for freshwater Ulva to be a bioaccumulator of trace metals in freshwater ecosystems .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Exploring the Interplay Between Ligand Derivatisation and Cation Type in the Assembly of Hybrid Polyoxometalate Mn - Andersons .
【GOLD_E】
Mn	chem
Polyoxometalate	chem
【PRE_E】
Derivatisation	chem
Cation	chem
PolyoxometalateMn-Andersons	chem
【GOLD_R】
【PRE_R】

Herein a library of hybrid Mn - Anderson polyoxometalates anions are presented : 1 , [ ( MnMo ( 6 ) O ( 18 ) ) ( ( OCH ( 2 ) ) ( 3 ) - C - ( CH ( 2 ) ) ( 7 ) CHCH ( 2 ) ) ( 2 ) ] ( 3 - ) ; compound 2 , [ ( MnMo ( 6 ) O ( 18 ) ) ( ( OCH ( 2 ) ) ( 3 ) C - NHCH ( 2 ) C ( 16 ) H ( 9 ) ) ( 2 ) ] ( 3 - ) ; compound 3 , [ ( MnMo ( 6 ) O ( 18 ) ) ( ( OCH ( 2 ) ) ( 3 ) C - ( CH ( 2 ) ) ( 7 ) CHCH ( 2 ) ) ( 1 ) ( ( OCH ( 2 ) ) ( 3 ) C - NHCH ( 2 ) C ( 16 ) H ( 9 ) ) ( 1 ) ] ( 3 - ) ; compound 4 , [ ( MnMo ( 6 ) O ( 18 ) ) ( ( OCH ( 2 ) ) ( 3 ) C - NHC ( O ) CH ( 2 ) CHCH ( 2 ) ) ( 2 ) ] ( 3 - ) and compounds 5 - 9 , [ ( MnMo ( 6 ) O ( 18 ) ) ( ( OCH ( 2 ) ) ( 3 ) C - NHC ( O ) ( CH ( 2 ) ) ( x ) CH ( 3 ) ) ( 2 ) ] ) , where x = 4 , 10 , 12 , 14 , and 18 respectively .
【GOLD_E】
[(MnMo(6)O(18))((OCH(2))(3)-C-(CH(2))(7)CHCH(2))(2)](3-)	chem
[(MnMo(6)O(18))((OCH(2))(3)C-NHCH(2)C(16)H(9))(2)](3-)	chem
[(MnMo(6)O(18))((OCH(2))(3)C-(CH(2))(7)CHCH(2))(1)((OCH(2))(3)C-NHCH(2)C(16)H(9))(1)](3-)	chem
Mn	chem
[(MnMo(6)O(18))((OCH(2))(3)C-NHC(O)CH(2)CHCH(2))(2)](3-)	chem
polyoxometalates	chem
[(MnMo(6)O(18))((OCH(2))(3)C-NHC(O)(CH(2))(x)CH(3))(2)]	chem
【PRE_E】
Mn-Andersonpolyoxometalates	chem
[(MnMo(6)O(18)	chem
OCH(2)	chem
(3)-C	chem
CH(2)	chem
CHCH(2)	chem
MnMo(6)O(18)	chem
OCH(2)	chem
(3)C-NHCH(2)	chem
[(MnMo(6)O	chem
【GOLD_R】
【PRE_R】

The compounds resulting from the cation exchange of the anions 1 - 9 to give TBA ( a ) and DMDOA ( b ) salts , and additionally for compounds 1 , 2 and 3 , tetraphenylphosphonium ( PPh ( 4 ) ) ( c ) salts , are explored at the air / water interface using scanning force microscopy , showing a range of architectures including hexagonal structures , nanofibers and other supramolecular forms .
【GOLD_E】
PPh(4)	chem
TBA	chem
DMDOA	chem
tetraphenylphosphonium	chem
【PRE_E】
TBA(a)	chem
DMDOA(b)salts	chem
tetraphenylphosphonium	chem
PPh(4))(c)salts	chem
【GOLD_R】
【PRE_R】

Additionally the solid - state structures for compounds 1c , 2c , 4a , 6a , 9a , are presented for the first time and these investigations demonstrate the delicate interplay between the structure of the covalently derivatised hybrid organo - clusters as well as the ion - exchange cation types .
【GOLD_E】
【PRE_E】
ion-exchangecationtypes	geneN
【GOLD_R】
【PRE_R】

Interaction of silymarin flavonolignans with organic anion - transporting polypeptides .
【GOLD_E】
flavonolignans	chem
organicanion-transportingpolypeptides	geneN
【PRE_E】
silymarinflavonolignans	chem
organicanion-transportingpolypeptides	geneN
【GOLD_R】
【PRE_R】

Organic anion - transporting polypeptides ( OATPs ) are multispecific transporters mediating the uptake of endogenous compounds and xenobiotics in tissues that are important for drug absorption and elimination , including the intestine and liver .
【GOLD_E】
Organicanion-transportingpolypeptides	geneN
OATPs	geneN
multispecifictransporters	geneN
【PRE_E】
Organicanion-transportingpolypeptides	geneN
OATPs	geneN
multispecifictransporters	geneN
【GOLD_R】
【PRE_R】

Silymarin is a popular herbal supplement often used by patients with chronic liver disease ; higher oral doses than those customarily used ( 140 mg three times / day ) are being evaluated clinically .
【GOLD_E】
【PRE_E】
Silymarin	chem
【GOLD_R】
【PRE_R】

The present study examined the effect of silymarin flavonolignans on OATP1B1 - , OATP1B3 - , and OATP2B1 - mediated transport in cell lines stably expressing these transporters and in human hepatocytes .
【GOLD_E】
OATP1B1	geneY
OATP1B3	geneY
OATP2B1	geneY
flavonolignans	chem
【PRE_E】
silymarinflavonolignans	chem
OATP1B1	geneY
OATP1B3	geneY
OATP2B1	geneY
【GOLD_R】
【PRE_R】

In overexpressing cell lines , OATP1B1 - and OATP1B3 - mediated estradiol - 17β - glucuronide uptake and OATP2B1 - mediated estrone - 3 - sulfate uptake were inhibited by most of the silymarin flavonolignans investigated .
【GOLD_E】
estradiol-17β-glucuronide	chem
estrone-3-sulfate	chem
flavonolignans	chem
OATP1B1	geneY
OATP1B3	geneY
OATP2B1	geneY
【PRE_E】
OATP1B1	geneY
OATP1B3	geneY
estradiol-17β-glucuronide	chem
OATP2B1	geneY
estrone-3-sulfate	chem
silymarin	chem
【GOLD_R】
flavonolignans	OATP1B1	C4
flavonolignans	OATP1B3	C4
flavonolignans	OATP2B1	C4
estradiol-17β-glucuronide	OATP1B1	C9
estradiol-17β-glucuronide	OATP1B3	C9
estrone-3-sulfate	OATP2B1	C9
【PRE_R】
OATP1B1	estradiol-17β-glucuronide	C9
OATP1B3	estradiol-17β-glucuronide	C9
estradiol-17β-glucuronide	OATP2B1	C9
OATP2B1	estrone-3-sulfate	C9

OATP1B1 - , OATP1B3 - , and OATP2B1 - mediated substrate transport was inhibited efficiently by silymarin ( IC50 values of 1.3 , 2.2 and 0.3 µM , respectively ) , silybin A ( IC50 values of 9.7 , 2.7 and 4.5 µM , respectively ) , silybin B ( IC50 values of 8.5 , 5.0 and 0.8 µM , respectively ) , and silychristin ( IC50 values of 9.0 , 36.4 , and 3.6 µM , respectively ) .
【GOLD_E】
silybinA	chem
silybinB	chem
OATP1B1	geneY
OATP1B3	geneY
OATP2B1	geneY
silychristin	chem
【PRE_E】
OATP1B1	geneY
OATP1B3	geneY
OATP2B1	geneY
silymarin	chem
silybinA	chem
silybinB	chem
silychristin	chem
【GOLD_R】
silybinA	OATP1B1	C4
silybinA	OATP1B3	C4
silybinA	OATP2B1	C4
silybinB	OATP1B1	C4
silybinB	OATP1B3	C4
silybinB	OATP2B1	C4
silychristin	OATP1B1	C4
silychristin	OATP1B3	C4
silychristin	OATP2B1	C4
【PRE_R】

Furthermore , silymarin , silybin A , and silybin B ( 100 µM ) significantly inhibited OATP - mediated estradiol - 17β - glucuronide and rosuvastatin uptake into human hepatocytes .
【GOLD_E】
OATP	geneN
silybinA	chem
silybinB	chem
estradiol-17β-glucuronide	chem
rosuvastatin	chem
【PRE_E】
silymarin	chem
silybinA	chem
silybinB	chem
OATP	geneN
estradiol-17β-glucuronide	chem
rosuvastatin	chem
【GOLD_R】
silybinA	OATP	C4
silybinB	OATP	C4
estradiol-17β-glucuronide	OATP	C9
rosuvastatin	OATP	C9
【PRE_R】
silymarin	OATP	C4
silybinA	OATP	C4
silybinB	OATP	C4

Calculation of the maximal unbound portal vein concentrations / IC50 values indicated a low risk for silymarin - drug interactions in hepatic uptake with a customary silymarin dose .
【GOLD_E】
【PRE_E】
silymarin	chem
silymarin	chem
【GOLD_R】
【PRE_R】

The extent of silymarin - drug interactions depends on OATP isoform specificity and concentrations of flavonolignans at the site of drug transport .
【GOLD_E】
OATP	geneN
flavonolignans	chem
【PRE_E】
silymarin	chem
OATP	geneN
flavonolignans	chem
【GOLD_R】
【PRE_R】

Higher than customary doses of silymarin , or formulations with improved bioavailability , may increase the risk of flavonolignan interactions with OATP substrates in patients .
【GOLD_E】
OATP	geneN
flavonolignan	chem
【PRE_E】
silymarin	chem
OATP	geneN
【GOLD_R】
【PRE_R】

Oxidation of tertiary amine - derivatized surfaces to control protein adhesion .
【GOLD_E】
tertiaryamine	chem
【PRE_E】
amine	chem
【GOLD_R】
【PRE_R】

Selective oxidation of ω - tertiary amine self - assembled thiol monolayers to tertiary amine N - oxides is shown to transform the adhesion of model proteins lysozyme and fibrinogen upon them .
【GOLD_E】
tertiaryamineN-oxides	chem
lysozyme	geneY
fibrinogen	geneN
ω-tertiaryamine	chem
thiol	chem
【PRE_E】
ω-tertiaryamine	chem
thiol	chem
N-oxides	chem
fibrinogen	geneN
【GOLD_R】
【PRE_R】

Efficient preparation of both secondary and tertiary linker amides as judged by X - ray photoelectron spectroscopy ( XPS ) and water droplet contact angle was achieved with an improved amide bond formation on gold quartz crystal microbalance ( QCM ) sensors using 2 - ( 1H - 7 - azabenzotriazol - 1 - yl ) - 1,1,3,3 - tetramethyl hexafluorophosphate methanaminium uronium ( HATU ) .
【GOLD_E】
secondaryandtertiarylinkeramides	chem
amide	chem
quartz	chem
2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethylhexafluorophosphatemethanaminiumuronium	chem
HATU	chem
【PRE_E】
amides	chem
XPS	chem
amide	chem
quartz	chem
QCM	chem
2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethylhexafluorophosphatemethanaminiumuronium	chem
HATU	chem
【GOLD_R】
【PRE_R】

Oxidation with hydrogen peroxide was similarly assessed , and adhesion of lysozyme and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM .
【GOLD_E】
phosphate	chem
lysozyme	geneY
fibrinogen	geneN
hydrogenperoxide	chem
【PRE_E】
hydrogenperoxide	chem
fibrinogen	geneN
phosphate	chem
QCM	chem
【GOLD_R】
【PRE_R】

Tertiary amine - functionalized sensors adsorbed multilayers of aggregated lysozyme , whereas tertiary amine N - oxides and triethylene glycol - terminated monolayers are consistent with small protein aggregates .
【GOLD_E】
Tertiaryamine	chem
tertiaryamineN-oxides	chem
triethyleneglycol	chem
lysozyme	geneY
【PRE_E】
Tertiaryamine	chem
N-oxides	chem
triethyleneglycol	chem
【GOLD_R】
【PRE_R】

The surface containing a dimethylamine N - oxide headgroup and ethyl secondary amide linker showed the largest difference in adsorption of both proteins .
【GOLD_E】
dimethylamineN-oxide	chem
ethylsecondaryamide	chem
【PRE_E】
dimethylamineN-oxide	chem
ethylsecondaryamide	chem
【GOLD_R】
【PRE_R】

Oxidation of tertiary amine decorated surfaces therefore holds the potential for selective deposition of proteins and cells through masking and other patterning techniques .
【GOLD_E】
tertiaryamine	chem
【PRE_E】
amine	chem
【GOLD_R】
【PRE_R】

Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , the stabilization effects of three polymers on four model drugs ( felodipine , fenofibrate , carbamazepine , and celecoxib ) under saturated humidity were investigated .
【GOLD_E】
carbamazepine	chem
celecoxib	chem
felodipine	chem
fenofibrate	chem
【PRE_E】
felodipine	chem
fenofibrate	chem
carbamazepine	chem
celecoxib	chem
【GOLD_R】
【PRE_R】

Three different types of thin films ( solid dispersions , drug films with a polymer film coating and drug films laid on top of polymer coated surfaces ) were prepared and compared with films containing the drug alone .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

ATR - FTIR spectroscopy , polarised light microscopy ( PLM ) , scanning electron microscopy ( SEM ) and nano - thermal analysis ( nano - TA ) were performed on the model systems after storage under saturated humidity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The recrystallisation tendency of the drug in the drug containing thin films was found to be strongly related to the intrinsic crystallization tendency of the drug film alone and the strength of drug - polymer interactions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Additionally , under high humidity , the glass transition temperature of the polymer is no longer an indicator of its drug stabilization capability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Instead , it is the hygroscobicity of the polymer that appears to be the most important parameter .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Amongst the polymers tested in this study , EUDRAGIT E PO was found to have the greatest inhibitory effect on crystallization , whilst PVP K30 was found to have the least protective effect ; presumably because of its hygroscopic nature .
【GOLD_E】
EUDRAGITEPO	chem
PVPK30	chem
【PRE_E】
EUDRAGITEPO	chem
PVPK30	chem
【GOLD_R】
【PRE_R】

Neuroprotective effects of mercaptoethylleonurine and mercaptoethylguanidine analogs on hydrogen peroxide - induced apoptosis in human neuronal SH - SY5Y cells .
【GOLD_E】
mercaptoethylleonurine	chem
mercaptoethylguanidine	chem
hydrogenperoxide	chem
【PRE_E】
mercaptoethylleonurine	chem
mercaptoethylguanidine	chem
hydrogenperoxide	chem
【GOLD_R】
【PRE_R】

A series of mercaptoethylleonurine and mercaptoethylguanidine derivatives were designed and synthesized .
【GOLD_E】
mercaptoethylleonurine	chem
mercaptoethylguanidine	chem
【PRE_E】
mercaptoethylleonurine	chem
mercaptoethylguanidine	chem
【GOLD_R】
【PRE_R】

Their neuroprotective effects toward H2O2 - induced apoptosis were investigated in human SH - SY5Y cells .
【GOLD_E】
H2O2	chem
【PRE_E】
H2O2	chem
【GOLD_R】
【PRE_R】

The results from these studies identified several potent compounds , with compound 8k emerging as the most effective .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Further investigation demonstrated that 8k reduced H2O2 - induced activation of mitochondrial apoptosis by inhibiting the expression of Bax and elevating the expression of Bcl - 2 .
【GOLD_E】
H2O2	chem
Bax	geneN
Bcl-2	geneN
【PRE_E】
H2O2	chem
Bax	geneY
Bcl-2	geneY
【GOLD_R】
H2O2	Bax	C3
H2O2	Bcl-2	C4
【PRE_R】
H2O2	Bcl-2	C3

Moreover , the molecular mechanism underlying the observed neuroprotective effects of 8k was exerted via the Akt and JNK pathways .
【GOLD_E】
Akt	geneN
JNK	geneN
【PRE_E】
Akt	geneN
JNK	geneN
【GOLD_R】
【PRE_R】

Compound 8k can be a lead compound for further discovery of neuroprotective medicine .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

AIMS / HYPOTHESIS : We examined the effects of serum insulin levels on vagal control over the heart and tested the hypothesis that higher fasting insulin levels are associated with lower vagal control .
【GOLD_E】
insulin	geneY
seruminsulin	geneY
【PRE_E】
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

We also examined whether experimentally induced increases in insulin by beta cell secretagogues , including glucagon - like peptide - 1 ( GLP - 1 ) , will decrease vagal control .
【GOLD_E】
insulin	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
【PRE_E】
insulin	geneY
glucagon-likepeptide-1	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

METHODS : Respiration and ECGs were recorded for 130 healthy participants undergoing clamps .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Three variables of cardiac vagal effects ( the root mean square of successive differences [ rMSSD ] in the interbeat interval of the heart rate [ IBI ] , heart - rate variability [ HRV ] caused by peak - valley respiratory sinus arrhythmia [ pvRSA ] , and high - frequency power [ HF ] ) and heart rate ( HR ) were obtained at seven time points during the clamps , characterised by increasing levels of insulin ( achieved by administering insulin plus glucose , glucose only , glucose and GLP - 1 , and glucose and GLP - 1 combined with arginine ) .
【GOLD_E】
insulin	geneY
insulin	geneY
GLP-1	geneY
GLP-1	geneY
glucose	chem
glucose	chem
glucose	chem
glucose	chem
arginine	chem
【PRE_E】
insulin	geneY
insulin	geneY
glucose	chem
glucose	chem
glucose	chem
GLP-1	geneY
glucose	chem
GLP-1	geneY
arginine	chem
【GOLD_R】
glucose	insulin	C3
glucose	insulin	C3
glucose	insulin	C3
glucose	insulin	C3
arginine	insulin	C3
【PRE_R】

RESULTS : Serum insulin level was positively associated with HR at all time points during the clamps except the first - phase hyperglycaemic clamp .
【GOLD_E】
Seruminsulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

Insulin levels were negatively correlated with variables of vagal control , reaching significance for rMSSD and log ( 10 ) HF , but not for pvRSA , during the last four phases of the hyperglycaemic clamp ( hyperglycaemic second phase , GLP - 1 first and second phases , and arginine ) .
【GOLD_E】
arginine	chem
Insulin	geneY
GLP-1	geneY
【PRE_E】
Insulin	geneY
GLP-1	geneY
arginine	chem
【GOLD_R】
【PRE_R】

These associations disappeared when adjusted for age , BMI and insulin sensitivity .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

Administration of the beta cell secretagogues GLP - 1 and arginine led to a significant increase in HR , but this was not paired with a significant reduction in HRV measures .
【GOLD_E】
GLP-1	geneY
arginine	chem
【PRE_E】
GLP-1	geneY
arginine	chem
【GOLD_R】
【PRE_R】

CONCLUSION / INTERPRETATION : Experimentally induced hyperinsulinaemia is not correlated with cardiac vagal control or HR when adjusting for age , BMI and insulin sensitivity index .
【GOLD_E】
insulin	geneY
【PRE_E】
hyperinsulinaemia	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Our findings suggest that exposure to a GLP - 1 during hyperglycaemia leads to a small acute increase in HR but not to an acute decrease in cardiac vagal control .
【GOLD_E】
GLP-1	geneY
【PRE_E】
GLP-1	geneY
【GOLD_R】
【PRE_R】

The propeptides of VEGF - D determine heparin binding , receptor heterodimerization , and effects on tumor biology .
【GOLD_E】
VEGF-D	geneY
【PRE_E】
propeptides	geneN
VEGF-D	geneY
【GOLD_R】
【PRE_R】

VEGF - D is an angiogenic and lymphangiogenic glycoprotein that can be proteolytically processed generating various forms differing in subunit composition due to the presence or absence of N - and C - terminal propeptides .
【GOLD_E】
N	chem
C	chem
VEGF-D	geneY
【PRE_E】
VEGF-D	geneY
lymphangiogenicglycoprotein	geneN
N	chem
C	chem
【GOLD_R】
【PRE_R】

These propeptides flank the central VEGF homology domain , that contains the binding sites for VEGF receptors ( VEGFRs ) , but their biological functions were unclear .
【GOLD_E】
VEGFhomologydomain	geneN
VEGFreceptors	geneN
VEGFRs	geneN
【PRE_E】
propeptides	geneN
VEGFhomologydomain	geneN
VEGFreceptors	geneN
VEGFRs	geneN
【GOLD_R】
【PRE_R】

Characterization of propeptide function will be important to clarify which forms of VEGF - D are biologically active and therefore clinically relevant .
【GOLD_E】
VEGF-D	geneY
【PRE_E】
propeptide	geneN
VEGF-D	geneY
【GOLD_R】
【PRE_R】

Here we use VEGF - D mutants deficient in either propeptide , and in the capacity to process the remaining propeptide , to monitor the functions of these domains .
【GOLD_E】
VEGF-D	geneY
【PRE_E】
VEGF-D	geneY
propeptide	geneN
propeptide	geneN
【GOLD_R】
【PRE_R】

We report for the first time that VEGF - D binds heparin , and that the C - terminal propeptide significantly enhances this interaction ( removal of this propeptide from full - length VEGF - D completely prevents heparin binding ) .
【GOLD_E】
VEGF-D	geneY
VEGF-D	geneY
C	chem
【PRE_E】
VEGF-D	geneY
C	chem
propeptide	geneN
VEGF	geneY
【GOLD_R】
【PRE_R】

We also show that removal of either the N - or C - terminal propeptide is required for VEGF - D to drive formation of VEGFR - 2 / VEGFR - 3 heterodimers which have recently been shown to positively regulate angiogenic sprouting .
【GOLD_E】
VEGF-D	geneY
N	chem
C	chem
VEGFR-2	geneY
VEGFR-3	geneY
【PRE_E】
N	chem
C	chem
propeptide	geneN
VEGF-D	geneY
VEGFR-2	geneY
VEGFR-3	geneY
【GOLD_R】
【PRE_R】

The mature form of VEGF - D , lacking both propeptides , can also promote formation of these receptor heterodimers .
【GOLD_E】
VEGF-D	geneY
【PRE_E】
VEGF-D	geneY
propeptides	geneN
【GOLD_R】
【PRE_R】

In a mouse tumor model , removal of only the C - terminal propeptide from full - length VEGF - D was sufficient to enhance angiogenesis and tumor growth .
【GOLD_E】
VEGF-D	geneY
C	chem
【PRE_E】
C	chem
VEGF-D	geneY
【GOLD_R】
【PRE_R】

In contrast , removal of both propeptides is required for high rates of lymph node metastasis .
【GOLD_E】
【PRE_E】
propeptides	geneN
【GOLD_R】
【PRE_R】

The findings reported here show that the propeptides profoundly influence molecular interactions of VEGF - D with VEGF receptors , co - receptors , and heparin , and its effects on tumor biology .
【GOLD_E】
VEGF-D	geneY
VEGFreceptors	geneN
【PRE_E】
propeptides	geneN
VEGF-D	geneY
VEGF	geneY
co-receptors	geneN
【GOLD_R】
【PRE_R】

Switchable Elastin - Like Polypeptides that Respond to Chemical Inducers of Dimerization .
【GOLD_E】
Elastin-LikePolypeptides	geneN
【PRE_E】
Elastin	geneY
【GOLD_R】
【PRE_R】

Elastin - like polypeptides ( ELPs ) are protein polymers that reversibly phase separate in response to increased temperature , pressure , concentration , ionic strength , and molecular weight .
【GOLD_E】
Elastin-likepolypeptides	geneN
ELPs	geneN
【PRE_E】
Elastin-likepolypeptides	geneN
ELPs	geneN
【GOLD_R】
【PRE_R】

If it were possible to engineer their phase separation to respond to specific molecular substrates , ELP fusion proteins might be engineered as biosensors , smart biomaterials , diagnostic imaging agents , and targeted therapies .
【GOLD_E】
ELP	geneN
【PRE_E】
ELP	geneN
【GOLD_R】
【PRE_R】

What has been lacking is a strategy to design ELPs to respond to specific substrates .
【GOLD_E】
ELPs	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

To address this deficiency , we report that ELP fusion proteins phase separate in response to chemical inducers of dimerization ( CID ) .
【GOLD_E】
ELP	geneN
【PRE_E】
ELP	geneY
【GOLD_R】
【PRE_R】

The rationale is that ELP phase separation depends on molecular weight , concentration , and local hydrophobicity ; therefore , processes that affect these properties , including noncovalent dimerization , can be tuned to produce isothermal phase separation .
【GOLD_E】
ELP	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

To test this hypothesis , constructs were evaluated consisting of an immunophilin : human FK - 506 binding protein 12 ( FKBP ) attached to an ELP .
【GOLD_E】
immunophilin	geneN
humanFK-506bindingprotein12	geneY
FK-506	chem
FKBP	geneY
ELP	geneN
【PRE_E】
immunophilin	geneN
humanFK-506bindingprotein12	geneY
FKBP	geneY
ELP	geneY
【GOLD_R】
【PRE_R】

Under stoichiometric binding of a CID , the fusion protein homodimerizes and triggers phase separation .
【GOLD_E】
【PRE_E】
proteinhomodimerizes	geneN
【GOLD_R】
【PRE_R】

This dimerization is reversible upon saturation with excess CID or competitive binding of a small lipophilic macrolide to FKBP .
【GOLD_E】
【PRE_E】
CID	chem
macrolide	chem
FKBP	geneN
【GOLD_R】
【PRE_R】
macrolide	FKBP	C4

By modulating the ELP molecular weight , phase separation was tuned for isothermal response to CID at physiological ionic strength and temperature ( 37 °C ) .
【GOLD_E】
ELP	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

To interpret the relationship between transition temperature and equilibrium binding constants , an empirical mathematical model was employed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To the best of our knowledge , this report is the first demonstration of reversible ELP switching in response to controlled dimerization .
【GOLD_E】
ELP	geneN
【PRE_E】
ELP	geneY
【GOLD_R】
【PRE_R】

Due to its simplicity , this strategy may be useful to design ELP fusion proteins that respond to specific dimeric biological entities .
【GOLD_E】
ELP	geneN
【PRE_E】
ELP	geneY
【GOLD_R】
【PRE_R】

Protective role of L - carnitine and vitamin E on the testis of atherosclerotic rats .
【GOLD_E】
L-carnitine	chem
vitaminE	chem
【PRE_E】
L-carnitine	chem
vitaminE	chem
【GOLD_R】
【PRE_R】

Atherosclerosis is a condition caused by lipid build - up and inflammation in the arteries , so hyperlipidemia is the major reason for atherosclerosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Testis was found to be negatively affected by hyperlipidemia which leads to its impaired functions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Vitamin E and < sc > l < / sc > - carnitine have well - known lipid - lowering and antioxidative activities .
【GOLD_E】
VitaminE	chem
<sc>l</sc>-carnitine	chem
【PRE_E】
VitaminE	chem
>-carnitine	chem
【GOLD_R】
【PRE_R】

Triton WR 1339 is a non - ionic detergent , which induces severe hyperlipidemia by inhibition of lipoprotein lipase .
【GOLD_E】
TritonWR1339	chem
【PRE_E】
TritonWR1339	chem
lipoproteinlipase	geneY
【GOLD_R】
【PRE_R】
TritonWR1339	lipoproteinlipase	C4

The present study evaluates the protective role of vitamin E and < sc > l < / sc > - carnitine on the testis in atherosclerosis and detects the most effective choice for protection against atherosclerosis ; vitamin E , < sc > l < / sc > - carnitine or a combination of both .
【GOLD_E】
vitaminE	chem
<sc>l</sc>-carnitine	chem
vitaminE	chem
<sc>l</sc>-carnitine	chem
【PRE_E】
vitaminE	chem
>-carnitine	chem
vitaminE	chem
>-carnitine	chem
【GOLD_R】
【PRE_R】

A total of 80 albino male rats were divided into eight groups ( 10 rats for each group ) : control ( G ( 1 ) ) , triton ( G ( 2 ) ) , < sc > l < / sc > - carnitine ( G ( 3 ) ) , triton + < sc > l < / sc > - carnitine ( G ( 4 ) ) , vitamin E ( G ( 5 ) ) , triton + vitamin E ( G ( 6 ) ) , < sc > l < / sc > - carnitine + vitamin E ( G ( 7 ) ) and triton + < sc > l < / sc > - carnitine + vitamin E ( G ( 8 ) ) .
【GOLD_E】
vitaminE	chem
triton	chem
<sc>l</sc>-carnitine	chem
triton	chem
<sc>l</sc>-carnitine	chem
vitaminE	chem
triton	chem
vitaminE	chem
<sc>l</sc>-carnitine	chem
vitaminE	chem
triton	chem
<sc>l</sc>-carnitine	chem
【PRE_E】
triton	chem
carnitine	chem
G(3)	geneY
carnitine	chem
G(4)	chem
vitaminE	chem
G(5)	chem
triton+vitaminE	chem
G(6)	chem
carnitine+vitaminE	chem
G(7)	geneY
triton+	chem
【GOLD_R】
【PRE_R】

Data showed a significant increase in the levels of total cholesterol ( TC ) , triglycerides ( TGs ) , low - density lipoprotein cholesterol ( LDL - C ) , 17 beta hydroxysteroid dehydrogenase ( 17 β HSD ) , testicular catalase and malondialdehyde ( MDA ) in G ( 2 ) when compared with G ( 1 ) , whereas high - density lipoprotein cholesterol ( HDL - C ) , serum testosterone , testicular 17 ketosteroid reductase ( 17 KSR ) , total thiol and glutathione - S - transferase ( GST ) data showed a significant decrease in G ( 2 ) when compared with G ( 1 ) .
【GOLD_E】
ketosteroid	chem
thiol	chem
glutathione	chem
S	chem
cholesterol	chem
triglycerides	chem
cholesterol	chem
17betahydroxysteroid	chem
malondialdehyde	chem
MDA	chem
cholesterol	chem
testosterone	chem
【PRE_E】
cholesterol	chem
TC	chem
triglycerides	chem
TGs	chem
low-densitylipoproteincholesterol	geneN
LDL	geneN
17betahydroxysteroiddehydrogenase	geneY
17βHSD	geneY
catalase	geneY
malondialdehyde	chem
MDA	chem
G(2)	geneY
G(1)	geneY
high-densitylipoproteincholesterol	geneN
HDL	geneN
testosterone	chem
testicular17ketosteroidreductase	geneY
17KSR	geneY
thiol	chem
glutathione-S-transferase	geneN
GST	geneN
G(2)	chem
G(1)	geneY
【GOLD_R】
【PRE_R】
thiol	GST	C9

Treatment with < sc > l < / sc > - carnitine or / and vitamin E helps in improving the adverse effect of triton ; also the histological changes confirm this finding .
【GOLD_E】
<sc>l</sc>-carnitine	chem
vitaminE	chem
triton	chem
【PRE_E】
carnitine	chem
vitaminE	chem
triton	chem
【GOLD_R】
【PRE_R】

So the present study recommends all people to include < sc > l < / sc > - carnitine and vitamin E in their diet to be protected against atherosclerosis .
【GOLD_E】
<sc>l</sc>-carnitine	chem
vitaminE	chem
【PRE_E】
carnitine	chem
vitaminE	chem
【GOLD_R】
【PRE_R】

The CRF ( 1 ) receptor antagonist SSR125543 prevents stress - induced cognitive deficit associated with hippocampal dysfunction : Comparison with paroxetine and D - cycloserine .
【GOLD_E】
paroxetine	chem
D-cycloserine	chem
SSR125543	chem
CRF(1)receptor	geneY
【PRE_E】
CRF(1)	geneY
SSR125543	chem
paroxetine	chem
D-cycloserine	chem
【GOLD_R】
SSR125543	CRF(1)receptor	C6
【PRE_R】
CRF(1)	SSR125543	C5

RATIONALE : The selective CRF ( 1 ) ( corticotropin releasing factor type 1 ) receptor antagonist SSR125543 has been previously shown to attenuate the long - term cognitive deficit produced by traumatic stress exposure .
【GOLD_E】
SSR125543	chem
CRF(1)(corticotropinreleasingfactortype1)receptor	geneY
【PRE_E】
CRF(1)	geneY
corticotropinreleasingfactortype1)receptor	geneY
SSR125543	chem
【GOLD_R】
SSR125543	CRF(1)(corticotropinreleasingfactortype1)receptor	C6
【PRE_R】

Memory disturbances described in post - traumatic stress disorder ( PTSD ) patients are believed to be associated with changes in neuronal activity , in particular at the level of the hippocampus .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

OBJECTIVES : The present study aims at investigating whether the effects of SSR125543 ( 10 mg / kg / day for 2 weeks ) on cognitive impairment induced by traumatic stress exposure are associated with changes in hippocampal excitability .
【GOLD_E】
SSR125543	chem
【PRE_E】
SSR125543	chem
【GOLD_R】
【PRE_R】

Effects of SSR125543 were compared to those of the 5 - HT reuptake inhibitor , paroxetine ( 10 mg / kg / day ) , and the partial N - methyl - D - aspartate ( NMDA ) receptor agonist , D - cycloserine ( 10 mg / kg / day ) , two compounds which have demonstrated clinical efficacy against PTSD .
【GOLD_E】
MDA)	chem
-cycloserine(	chem
-methyl-D-aspartate(NMDA)receptora	geneN
SSR125543	chem
5-HT	chem
paroxetine	chem
-methyl-D-aspartate(	chem
【PRE_E】
SSR125543	chem
5-HT	chem
paroxetine	chem
N-methyl-D-aspartate(NMDA)receptor	geneN
D-cycloserine	chem
【GOLD_R】
-cycloserine(	-methyl-D-aspartate(NMDA)receptora	C5
【PRE_R】

METHODS : Mice received two unavoidable electric foot - shocks .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Then , 1 or 16 days after stress , they were tested for their memory performance using the object recognition test .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Neuronal excitability was recorded during the third week post - stress in the CA1 area of the hippocampus .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Drugs were administered from day 1 post - stress to the day preceding the electrophysiological study .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : Application of electric shocks produced cognitive impairment 16 , but not 1 day after stress , an effect which was associated with a decrease in hippocampal neuronal excitability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Both stress - induced effects were prevented by repeated administration of SSR125543 , paroxetine and D - cycloserine .
【GOLD_E】
SSR125543	chem
paroxetine	chem
D-cycloserine	chem
【PRE_E】
SSR125543	chem
paroxetine	chem
D-cycloserine	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : These findings confirm that the CRF ( 1 ) receptor antagonist SSR125543 is able to attenuate the behavioral effects of traumatic stress exposure and indicate that these effects are associated with a normalization of hippocampal neuronal excitability impaired by stress .
【GOLD_E】
CRF(1)receptor	geneY
SSR125543	chem
【PRE_E】
CRF(1)	geneY
SSR125543	chem
【GOLD_R】
SSR125543	CRF(1)receptor	C6
【PRE_R】
CRF(1)	SSR125543	C5

Synthesis and structure - activity relationships of indazole arylsulfonamides as allosteric CC - chemokine receptor 4 ( CCR4 ) antagonists .
【GOLD_E】
indazolearylsulfonamides	chem
CCR4	geneY
CC-chemokinereceptor4	geneY
【PRE_E】
indazolearylsulfonamides	chem
CC-chemokinereceptor4	geneY
CCR4	geneY
【GOLD_R】
【PRE_R】

A series of indazole arylsulfonamides were synthesized and examined as human CCR4 antagonists .
【GOLD_E】
humanCCR4	geneY
indazolearylsulfonamides	chem
【PRE_E】
indazolearylsulfonamides	chem
humanCCR4	geneY
【GOLD_R】
indazolearylsulfonamides	humanCCR4	C6
【PRE_R】
indazolearylsulfonamides	humanCCR4	C4

Methoxy - or hydroxyl - containing groups were the more potent indazole C4 substituents .
【GOLD_E】
Methoxy	chem
hydroxyl	chem
indazole	chem
【PRE_E】
Methoxy	chem
hydroxyl	chem
indazoleC4	chem
【GOLD_R】
【PRE_R】

Only small groups were tolerated at C5 , C6 , or C7 , with the C6 analogues being preferred .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most potent N3 - substituent was 5 - chlorothiophene - 2 - sulfonamide .
【GOLD_E】
5-chlorothiophene-2-sulfonamide	chem
【PRE_E】
5-chlorothiophene-2-sulfonamide	chem
【GOLD_R】
【PRE_R】

N1 meta - substituted benzyl groups possessing an α - amino - 3 - [ ( methylamino ) acyl ] - group were the most potent N1 - substituents .
【GOLD_E】
benzyl	chem
3-[(methylamino)acyl]	chem
【PRE_E】
N1meta-substitutedbenzyl	chem
α-amino-3-[(methylamino)acyl	chem
【GOLD_R】
【PRE_R】

Strongly basic amino groups had low oral absorption in vivo .
【GOLD_E】
amino	chem
【PRE_E】
amino	chem
【GOLD_R】
【PRE_R】

Less basic analogues , such as morpholines , had good oral absorption ; however , they also had high clearance .
【GOLD_E】
morpholines	chem
【PRE_E】
morpholines	chem
【GOLD_R】
【PRE_R】

The most potent compound with high absorption in two species was analogue 6 ( GSK2239633A ) , which was selected for further development .
【GOLD_E】
GSK2239633A	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Aryl sulfonamide antagonists bind to CCR4 at an intracellular allosteric site denoted site II .
【GOLD_E】
Arylsulfonamide	chem
CCR4	geneY
【PRE_E】
Arylsulfonamide	chem
CCR4	geneY
【GOLD_R】
【PRE_R】

X - ray diffraction studies on two indazole sulfonamide fragments suggested the presence of an important intramolecular interaction in the active conformation .
【GOLD_E】
indazolesulfonamide	chem
【PRE_E】
indazolesulfonamide	chem
【GOLD_R】
【PRE_R】

Comparative analysis of nutritional compositions of transgenic high iron rice with its non - transgenic counterpart .
【GOLD_E】
iron	chem
【PRE_E】
iron	chem
【GOLD_R】
【PRE_R】

Iron is an essential micronutrient for human nutrition and polished rice contains very low amount of iron .
【GOLD_E】
Iron	chem
iron	chem
【PRE_E】
Iron	chem
iron	chem
【GOLD_R】
【PRE_R】

Rice with high iron content in seed endosperm has been developed by insertion of soybean ferritin gene under the control of the endosperm specific glutelin promoter into the genome of indica rice line IR68144 .
【GOLD_E】
iron	chem
soybeanferritin	geneN
glutelinpromoter	geneN
【PRE_E】
iron	chem
ferritin	geneY
glutelinpromoter	geneN
【GOLD_R】
【PRE_R】

The nutritional composition of the brown and milled rice grain has been compared with that of the non - transgenic rice of the same variety .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , the nutritional components , as well as the anti - nutrient levels , were measured .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Our studies established that apart from the increased level of iron and zinc in transgenic seeds , the nutritional quality of both the brown and milled rice grains from the transgenic line was substantially equivalent to that of the non - transgenic rice plants .
【GOLD_E】
iron	chem
zinc	chem
【PRE_E】
iron	chem
zinc	chem
【GOLD_R】
【PRE_R】

The result clearly shows that the measured amounts of the nutritional components are well within the range of values reported for other commercial lines .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects .
【GOLD_E】
Monoacylglycerol	chem
JZL184	chem
MonoacylglycerolLipase	geneY
CB1	geneY
【PRE_E】
MonoacylglycerolLipase	geneY
JZL184RetainsCB1Receptor	geneY
Gastroprotective	chem
【GOLD_R】
JZL184	MonoacylglycerolLipase	C4
【PRE_R】

The monoacylglycerol lipase ( MAGL ) inhibitor JZL184 produces antinociceptive and anti - inflammatory effects .
【GOLD_E】
monoacylglycerol	chem
JZL184	chem
MAGL	geneY
monoacylglycerollipase	geneY
【PRE_E】
monoacylglycerollipase	geneY
MAGL	geneN
JZL184	chem
【GOLD_R】
JZL184	MAGL	C4
JZL184	monoacylglycerollipase	C4
【PRE_R】
MAGL	JZL184	C4

However , repeated administration of high dose JZL184 ( 40 mg / kg ) causes dependence , antinociceptive tolerance , cross - tolerance to the pharmacological effects of cannabinoid receptor agonists , and CB ( 1 ) receptor downregulation and desensitization .
【GOLD_E】
cannabinoidreceptor	geneN
CB(1)	geneY
JZL184	chem
【PRE_E】
JZL184	chem
cannabinoidreceptor	geneN
CB(1)receptor	geneY
【GOLD_R】
【PRE_R】

This functional CB ( 1 ) receptor tolerance poses a hurdle in the development of MAGL inhibitors for therapeutic use .
【GOLD_E】
CB(1)	geneY
MAGL	geneY
【PRE_E】
CB(1)receptor	geneY
MAGL	geneN
【GOLD_R】
【PRE_R】

Consequently , the present study tested whether repeated administration of low dose JZL184 maintains its antinociceptive actions in the chronic constrictive injury ( CCI ) of the sciatic nerve neuropathic pain model and protective effects in a model of NSAlD - induced gastric hemorrhages .
【GOLD_E】
JZL184	chem
【PRE_E】
JZL184	chem
【GOLD_R】
【PRE_R】

Mice given daily injections of high dose JZL184 ( ≥ 16 mg / kg ) for six days displayed decreased CB ( 1 ) receptor density and function in brain , as assessed in [ ( 3 ) H ] SR141716A binding and CP55,940 - stimulated [ ( 35 ) S ] GTPγS binding assays , respectively .
【GOLD_E】
JZL184	chem
[(3)H]SR141716A	chem
CP55,940	chem
(35)S	chem
CB(1)	geneY
【PRE_E】
JZL184	chem
CB(1)receptor	geneY
[(3)H]SR141716A	chem
CP55,940	chem
[(35)S]GTPγS	chem
【GOLD_R】
JZL184	CB(1)	C4
【PRE_R】
JZL184	CB(1)receptor	C3

In contrast , normal CB ( 1 ) receptor expression and function were maintained following repeated administration of low dose JZL184 ( ≤ 8 mg / kg ) .
【GOLD_E】
CB(1)	geneY
JZL184	chem
【PRE_E】
CB(1)receptor	geneY
JZL184	chem
【GOLD_R】
【PRE_R】

Likewise , the antinociceptive and gastroprotective effects of high dose JZL184 underwent tolerance following repeated administration , but these effects were maintained following repeated low dose JZL184 treatment .
【GOLD_E】
JZL184	chem
JZL184	chem
【PRE_E】
JZL184	chem
JZL184	chem
【GOLD_R】
【PRE_R】

Consistent with these observations , repeated high dose JZL184 , but not repeated low dose JZL184 , elicited cross - tolerance to the common pharmacological effects of Δ ( 9 ) - tetrahydrocannabinol ( THC ) .
【GOLD_E】
JZL184	chem
JZL184	chem
Δ(9)-tetrahydrocannabinol	chem
THC	chem
【PRE_E】
JZL184	chem
JZL184	chem
Δ(9)-tetrahydrocannabinol	chem
THC	chem
【GOLD_R】
【PRE_R】

This same pattern of effects was found in a rimonabant - precipitated withdrawal model of cannabinoid dependence .
【GOLD_E】
rimonabant	chem
【PRE_E】
rimonabant	chem
【GOLD_R】
【PRE_R】

Taken together , these results indicate that prolonged , partial MAGL inhibition maintains potentially beneficial antinociceptive and anti - inflammatory effects , without producing functional CB ( 1 ) receptor tachyphylaxsis / tolerance or cannabinoid dependence .
【GOLD_E】
MAGL	geneY
CB(1)	geneY
【PRE_E】
MAGL	geneN
CB(1)receptor	geneY
【GOLD_R】
【PRE_R】

Differential gene expression in ERα - positive and ERα - negative breast cancer cells upon leptin stimulation .
【GOLD_E】
ERα	geneY
ERα	geneY
leptin	geneY
【PRE_E】
ERα	geneY
ERα	geneY
leptin	geneY
【GOLD_R】
【PRE_R】

In postmenopausal women , adipositas represents a serious risk factor for cancer development and progression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

White adipose tissue secretes the 16 kDa hormone leptin which plays a key role in the regulation of appetite and metabolism .
【GOLD_E】
eptinw	geneY
【PRE_E】
leptin	geneY
【GOLD_R】
【PRE_R】

An increasing number of reports indicate that leptin also interferes with signal transduction pathways implicated in the development of breast cancer .
【GOLD_E】
leptin	geneY
【PRE_E】
leptin	geneY
【GOLD_R】
【PRE_R】

In our previous study , we identified the estrogen receptor alpha ( ERα ) as a relevant enhancer of leptin - induced signal transduction leading to transactivation of signal transducer and activator of transcription 3 ( Stat3 ) .
【GOLD_E】
estrogenreceptoralpha	geneY
ERα	geneY
leptin	geneY
signaltransducerandactivatoroftranscription3	geneY
Stat3	geneY
estrogen	chem
【PRE_E】
estrogenreceptoralpha	geneY
ERα	geneY
leptin	geneY
signaltransducerandactivatoroftranscription3	geneY
Stat3	geneY
【GOLD_R】
【PRE_R】

The purpose of this study is the investigation of specific target gene expression in response to leptin - mediated Stat3 signaling .
【GOLD_E】
leptin	geneY
Stat3	geneN
【PRE_E】
leptin	geneY
Stat3	geneY
【GOLD_R】
【PRE_R】

We performed a comprehensive microarray analysis of ERα - positive and ERα - negative MDA - MB - 231 cells upon leptin treatment and identified 49 genes which showed a significant ERα - dependent regulation in leptin - treated MDA - MB - 231 cells .
【GOLD_E】
ERα	geneY
ERα	geneY
leptin	geneY
ERα	geneY
leptin	geneY
【PRE_E】
ERα	geneY
ERα	geneY
leptin	geneY
ERα	geneY
leptin	geneY
【GOLD_R】
【PRE_R】

There was no intersection with genes which were merely up - or downregulated by ERα expression and only 9 and 11 genes overlapping targets which were regulated by leptin stimulation either in ERα - expressing or ERα - negative MDA - MB - 231 cells , respectively .
【GOLD_E】
ERα	geneY
leptin	geneY
ERα	geneY
ERα	geneY
【PRE_E】
ERα	geneY
leptin	geneY
ERα	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

To demonstrate the specificity , expression of three target genes was validated by quantitative real - time PCR .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , these data imply that leptin can induce a different set of target genes dependent on ERα expression , which might contribute to the development and progression of cancer diseases .
【GOLD_E】
leptin	geneY
ERα	geneY
【PRE_E】
leptin	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF - FVIIa inhibitors .
【GOLD_E】
TF	geneY
FVIIa	geneY
bicyclicpyrazinoneandpyrimidinoneamides	chem
【PRE_E】
bicyclicpyrazinone	chem
pyrimidinoneamides	chem
TF-FVIIa	geneY
【GOLD_R】
bicyclicpyrazinoneandpyrimidinoneamides	TF	C4
bicyclicpyrazinoneandpyrimidinoneamides	FVIIa	C4
【PRE_R】
bicyclicpyrazinone	TF-FVIIa	C4
pyrimidinoneamides	TF-FVIIa	C4

Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF - FVIIa inhibitors .
【GOLD_E】
FVIIa	geneY
Bicyclicpyrazinoneandpyrimidinoneamides	chem
TF	geneY
【PRE_E】
Bicyclicpyrazinone	chem
pyrimidinoneamides	chem
TF	geneY
FVIIa	geneN
【GOLD_R】
Bicyclicpyrazinoneandpyrimidinoneamides	FVIIa	C4
Bicyclicpyrazinoneandpyrimidinoneamides	TF	C4
【PRE_R】
Bicyclicpyrazinone	TF	C4
pyrimidinoneamides	TF	C4
pyrimidinoneamides	FVIIa	C4

SAR demonstrated that the S2 and S3 pockets of FVIIa prefer to bind small , lipophilic groups .
【GOLD_E】
FVIIa	geneY
【PRE_E】
FVIIa	geneN
【GOLD_R】
【PRE_R】

An X - ray crystal structure of optimized compound 9b bound in the active site of FVIIa showed that the bicyclic scaffold provides 5 hydrogen bonding interactions in addition to projecting groups for interactions within the S1 , S2 and S3 pockets .
【GOLD_E】
hydrogen	chem
FVIIa	geneY
【PRE_E】
FVIIa	geneN
hydrogen	chem
【GOLD_R】
【PRE_R】

Compound 9b showed excellent FVIIa potency , good selectivity against FIXa , Xa , XIa and chymotrypsin , and good clotting activity .
【GOLD_E】
FVIIa	geneY
FIXa,Xa,XIa	geneN
chymotrypsin	geneN
【PRE_E】
FVIIa	geneN
FIXa	geneN
Xa	geneN
XIa	geneN
chymotrypsin	geneN
【GOLD_R】
【PRE_R】

A multivalent peptide as an activator of hypoxia inducible factor - 1α .
【GOLD_E】
hypoxiainduciblefactor-1α	geneY
【PRE_E】
hypoxiainduciblefactor-1α	geneY
【GOLD_R】
【PRE_R】

Hypoxia inducible factor - 1α ( HIF - 1α ) is a transcription factor found in mammalian cells under hypoxia .
【GOLD_E】
HIF-1α	geneN
Hypoxiainduciblefactor-1α	geneN
【PRE_E】
Hypoxiainduciblefactor-1α	geneY
HIF-1α	geneY
【GOLD_R】
【PRE_R】

While HIF - 1α in hypoxia translocates to the nucleus where it transcribes the target genes including vascular endothelial growth factor ( VEGF ) mRNA , HIF - 1α is degraded under normoxia , which involves its proline hydroxylation and subsequent binding to the von Hippel - Lindau protein - Elongin B - Elogin C ( VBC ) complex .
【GOLD_E】
vonHippel-Lindauprotein	geneY
ElonginB	geneY
EloginC	geneY
VBC	geneN
proline	chem
HIF-1α	geneY
vascularendothelialgrowthfactor	geneY
VEGF	geneY
HIF-1α	geneY
【PRE_E】
HIF-1α	geneY
vascularendothelialgrowthfactor	geneY
VEGF	geneY
HIF-1α	geneY
proline	chem
vonHippel	geneY
Lindau	geneY
Elongin	geneN
B-EloginC	geneY
VBC	geneN
【GOLD_R】
【PRE_R】

Previously , peptide inhibitors against this interaction between hydroxylated HIF - 1α and VBC have been developed to stabilize the transcriptional activity of HIF - 1α by preventing the degradation of the protein even under normoxia .
【GOLD_E】
HIF-1α	geneY
VBC	geneN
HIF-1α	geneY
【PRE_E】
HIF-1α	geneY
VBC	geneN
HIF-1α	geneY
【GOLD_R】
【PRE_R】

Despite the specific inhibition by these peptides , their poor inhibition potency needs to be improved for further clinical application .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this work , we have designed and prepared a streptavidin - based multivalent peptide inhibitor against the HIF - 1α - VBC complexation .
【GOLD_E】
HIF-1α	geneY
VBC	geneN
【PRE_E】
HIF	geneN
1α-VBC	geneY
【GOLD_R】
【PRE_R】

We have evaluated the potency of the multivalent peptide in terms of stabilization of HIF - 1α and the downstream effect .
【GOLD_E】
HIF-1α	geneY
【PRE_E】
HIF-1α	geneY
【GOLD_R】
【PRE_R】

As the result , we have found that the inhibitor showed about 13 - fold lowered IC50 value compared with that of the corresponding monovalent peptide , thereby activating HIF - 1α and leading to up - regulation of VEGF protein at the cellular level .
【GOLD_E】
HIF-1α	geneY
VEGF	geneY
【PRE_E】
HIF-1α	geneY
VEGF	geneY
【GOLD_R】
【PRE_R】

Glucagon - induced acetylation of Foxa2 regulates hepatic lipid metabolism .
【GOLD_E】
Glucagon	geneY
Foxa2	geneY
【PRE_E】
Glucagon	geneY
Foxa2	geneY
【GOLD_R】
【PRE_R】

Circulating levels of insulin and glucagon reflect the nutritional state of animals and elicit regulatory responses in the liver that maintain glucose and lipid homeostasis .
【GOLD_E】
glucagon	geneY
glucose	chem
insulin	geneY
【PRE_E】
insulin	geneY
glucagon	geneY
glucose	chem
【GOLD_R】
【PRE_R】

The transcription factor Foxa2 activates lipid metabolism and ketogenesis during fasting and is inhibited via insulin - PI3K - Akt signaling - mediated phosphorylation at Thr156 and nuclear exclusion .
【GOLD_E】
Foxa2	geneY
insulin	geneY
PI3K	geneN
Akt	geneN
【PRE_E】
Foxa2	geneY
insulin	geneN
PI3K	geneN
Akt	geneN
Thr156	geneN
【GOLD_R】
【PRE_R】

Here we show that , in addition , Foxa2 is acetylated at the conserved residue Lys259 following inhibition of histone deacetylases ( HDACs ) class I - III and the cofactors p300 and SirT1 are involved in Foxa2 acetylation and deacetylation , respectively .
【GOLD_E】
Foxa2	geneY
histonedeacetylases(HDACs)classI-III	geneN
p300	geneY
SirT1	geneY
Foxa2	geneY
【PRE_E】
Foxa2	geneY
histonedeacetylases(HDACs)classI-III	geneY
p300	geneY
SirT1	geneY
Foxa2	geneY
【GOLD_R】
【PRE_R】

Physiologically , fasting states and glucagon stimulation are sufficient to induce Foxa2 acetylation .
【GOLD_E】
glucagon	geneY
Foxa2	geneY
【PRE_E】
glucagon	geneY
Foxa2	geneY
【GOLD_R】
【PRE_R】

Introduction of the acetylation - mimicking ( K259Q ) or - deficient ( K259R ) mutations promotes or inhibits Foxa2 activity , respectively , and adenoviral expression of Foxa2 - K259Q augments expression of genes involved in fatty acid oxidation and ketogenesis .
【GOLD_E】
K259Q	geneN
K259R	geneN
Foxa2	geneY
Foxa2	geneY
K259Q	geneN
fattyacid	chem
【PRE_E】
K259Q	geneN
K259R	geneN
Foxa2	geneY
Foxa2	geneY
K259Q	geneY
fattyacid	chem
【GOLD_R】
【PRE_R】

Our study reveals a molecular mechanism by which glucagon signaling activates a fasting response through acetylation of Foxa2 .
【GOLD_E】
glucagon	geneY
Foxa2	geneY
【PRE_E】
glucagon	geneY
Foxa2	geneY
【GOLD_R】
【PRE_R】

Antitumor and immunomodulatory activity of a water - soluble low molecular weight polysaccharide from Schisandra chinensis ( Turcz . ) Baill .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A water - soluble low molecular weight polysaccharide ( SCPP11 ) was extracted and purified using DEAE - cellulose and Sephadex G - 100 column from Schisandra chinensis ( Turcz . ) Baill .
【GOLD_E】
【PRE_E】
DEAE	chem
【GOLD_R】
【PRE_R】

Its in vivo and in vitro antitumor and immunomodulatory activity were investigated .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The results showed that SCPP11 with a molecular weight of 3.4×10 ( 3 ) Da exhibited indirect cyctotoxic activity against tumor cells in vitro , but could significantly inhibit the growth of Heps cells in vivo at dose of 50mg / kg , and its inhibition rate is higher than that in the positive group .
【GOLD_E】
【PRE_E】
SCPP11	geneY
3.4×10(3)Da	chem
【GOLD_R】
【PRE_R】

Moreover , SCPP11 could ameliorate the hematological and biochemical parameters to almost normal and no significant changes in organ weight , and could increase the body weight .
【GOLD_E】
【PRE_E】
SCPP11	chem
【GOLD_R】
【PRE_R】

In addition , SCPP11 ( at 50mg / kg ) could also increased in thymus indexes as well as IL - 2 and TNF - α levels in serum in vivo and significantly enhance the phagocytosis activity and the productions of NO of RAW264.7 in vitro .
【GOLD_E】
NO	chem
IL-2	geneY
TNF-α	geneY
【PRE_E】
SCPP11	chem
IL-2	geneY
TNF-α	geneY
NO	chem
【GOLD_R】
【PRE_R】
SCPP11	IL-2	C3
SCPP11	TNF-α	C3

The results indicated that antitumor properties of SCPP11 might be achieved by improving immune response .
【GOLD_E】
【PRE_E】
SCPP11	chem
【GOLD_R】
【PRE_R】

It could be explored as a potential adjuvant against cancer used in the health food and pharmaceutical therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Fragment - based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy .
【GOLD_E】
STAT3	geneY
HJC0123	chem
【PRE_E】
HJC0123	chem
STAT3	geneY
【GOLD_R】
HJC0123	STAT3	C4
【PRE_R】
HJC0123	STAT3	C4

Fragment - based drug design ( FBDD ) is a promising approach for the generation of lead molecules with enhanced activity and especially drug - like properties against therapeutic targets .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Herein , we report the fragment - based drug design , systematic chemical synthesis and pharmacological evaluation of novel scaffolds as potent anticancer agents by utilizing six privileged fragments from known STAT3 inhibitors .
【GOLD_E】
STAT3	geneY
【PRE_E】
STAT3	geneY
【GOLD_R】
【PRE_R】

Several new molecules such as compounds 5 , 12 , and 19 that may act as advanced chemical leads have been identified .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most potent compound 5 ( HJC0123 ) has demonstrated to inhibit STAT3 promoter activity , downregulate phosphorylation of STAT3 , increase the expression of cleaved caspase - 3 , inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values .
【GOLD_E】
HJC0123	chem
STAT3promoter	geneN
STAT3	geneY
caspase-3	geneY
【PRE_E】
HJC0123	chem
STAT3	geneY
STAT3	geneY
caspase-3	geneY
【GOLD_R】
HJC0123	caspase-3	C3
HJC0123	STAT3promoter	C4
HJC0123	STAT3	C4
【PRE_R】
HJC0123	STAT3	C4
HJC0123	STAT3	C4

Furthermore , compound 5 significantly suppressed estrogen receptor ( ER ) - negative breast cancer MDA - MB - 231 xenograft tumor growth in vivo ( p.o . ) , indicating its great potential as an efficacious and orally bioavailable drug candidate for human cancer therapy .
【GOLD_E】
estrogen	chem
estrogenreceptor	geneY
ER	geneY
【PRE_E】
estrogenreceptor	geneY
ER	geneY
【GOLD_R】
【PRE_R】

Transcription forms and remodels supercoiling domains unfolding large - scale chromatin structures .
【GOLD_E】
supercoilingdomains	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

DNA supercoiling is an inherent consequence of twisting DNA and is critical for regulating gene expression and DNA replication .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , DNA supercoiling at a genomic scale in human cells is uncharacterized .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To map supercoiling , we used biotinylated trimethylpsoralen as a DNA structure probe to show that the human genome is organized into supercoiling domains .
【GOLD_E】
biotinylatedtrimethylpsoralen	chem
supercoilingdomains	geneN
【PRE_E】
trimethylpsoralen	chem
【GOLD_R】
【PRE_R】

Domains are formed and remodeled by RNA polymerase and topoisomerase activities and are flanked by GC - AT boundaries and CTCF insulator protein - binding sites .
【GOLD_E】
RNApolymerase	geneN
topoisomerase	geneN
CTCF	geneY
【PRE_E】
RNApolymerase	geneN
topoisomerase	geneN
CTCF	geneY
insulatorprotein-bindingsites	geneN
【GOLD_R】
【PRE_R】

Underwound domains are transcriptionally active and enriched in topoisomerase I , ' open ' chromatin fibers and DNase I sites , but they are depleted of topoisomerase II .
【GOLD_E】
Underwounddomains	geneN
topoisomeraseI	geneY
DNaseI	geneY
topoisomeraseII	geneY
【PRE_E】
topoisomeraseI	geneY
DNaseI	geneN
topoisomeraseII	geneY
【GOLD_R】
【PRE_R】

Furthermore , DNA supercoiling affects additional levels of chromatin compaction as underwound domains are cytologically decondensed , topologically constrained and decompacted by transcription of short RNAs .
【GOLD_E】
underwounddomains	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

We suggest that supercoiling domains create a topological environment that facilitates gene activation , providing an evolutionary purpose for clustering genes along chromosomes .
【GOLD_E】
【PRE_E】
supercoilingdomains	geneN
【GOLD_R】
【PRE_R】

Four new eudesmane - type sesquiterpenoid lactones from atractylenolide II by biotransformation of rat hepatic microsomes .
【GOLD_E】
eudesmane	chem
sesquiterpenoidlactones	chem
atractylenolideII	chem
【PRE_E】
eudesmane-typesesquiterpenoidlactones	chem
atractylenolideII	chem
【GOLD_R】
【PRE_R】

The biotransformation of atractylenolide II , a major bioactive principle of the rhizomes of Atractylodes macrocephala Koidz . , was investigated in vitro by incubation with rat hepatic microsomes pretreated with sodium phenobarbital .
【GOLD_E】
sodiumphenobarbital	chem
atractylenolideII	chem
【PRE_E】
atractylenolideII	geneY
sodiumphenobarbital	chem
【GOLD_R】
【PRE_R】

The biotransformation products were extracted and purified by chromatographic methods .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Seven biotransformation products ( BP1 - BP7 ) were obtained and their structures were elucidated by NMR and MS data analyses and by comparison with the previously reported values , including four new compounds , namely 4 ( R ) , 15 - epoxy - atractylenolide II ( BP1 ) , 4 ( R ) , 15 - epoxy - 13 - hydroxyatractylenolide II ( BP5 ) , 4 ( R ) , 15 - epoxy - 1β - hydroxyatractylenolide II ( BP6 ) , and 4 ( R ) , 15 - dihydroxyatractylenolide II ( BP7 ) .
【GOLD_E】
4(R),15-epoxy-atractylenolideII	chem
4(R),15-epoxy-13-hydroxyatractylenolideII	chem
4(R),15-epoxy-1β-hydroxyatractylenolideII	chem
4(R),15-dihydroxyatractylenolideII	chem
【PRE_E】
BP1-BP7	geneY
4(R),15-epoxy-atractylenolideII	chem
4(R),15-epoxy-13-hydroxyatractylenolideII	chem
4(R)	chem
15-epoxy-1β-hydroxyatractylenolideII	chem
BP6	chem
【GOLD_R】
【PRE_R】

The biotransformation pathway of atractylenolide II by hepatic microsomes was deducted based on the structure resolution of the products .
【GOLD_E】
atractylenolideII	chem
【PRE_E】
atractylenolideII	geneY
【GOLD_R】
【PRE_R】

The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults : a behavioral - electroencephalography study .
【GOLD_E】
phosphodiesterasetype5	geneY
vardenafil	chem
【PRE_E】
phosphodiesterasetype5	geneN
vardenafil	chem
【GOLD_R】
vardenafil	phosphodiesterasetype5	C4
【PRE_R】
phosphodiesterasetype5	vardenafil	C4

Phosphodiesterase type 5 inhibitors ( PDE5 - Is ) improve cognitive performance of rodents , but the few human studies investigating their effects did not systematically investigate cognitive effects and the results have been quite contradictory .
【GOLD_E】
Phosphodiesterasetype5	geneY
PDE5	geneY
【PRE_E】
Phosphodiesterasetype5	geneY
PDE5	geneY
【GOLD_R】
【PRE_R】

Therefore , we examined whether the PDE5 - I vardenafil improves memory and executive functioning and affect electroencephalography ( EEG ) in healthy young adults .
【GOLD_E】
PDE5	geneY
vardenafil	chem
【PRE_E】
PDE5	geneY
vardenafil	chem
【GOLD_R】
vardenafil	PDE5	C4
【PRE_R】

Participants were selected out of a group of volunteers , based on their performance on a memory screening and they were orally treated with vardenafil ( 10 - 20 mg or placebo ) .
【GOLD_E】
vardenafil	chem
【PRE_E】
vardenafil	chem
【GOLD_R】
【PRE_R】

Memory and executive functioning were tested while EEG activity was recorded .
【GOLD_E】
【PRE_E】
EEG	geneY
【GOLD_R】
【PRE_R】

Additionally , a simple reaction time task and questionnaires addressing various complaints were presented .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

No prominent effects of vardenafil on cognition were found : participants only made more mistakes on a reaction time task after 20 mg vardenafil .
【GOLD_E】
vardenafil	chem
vardenafil	chem
【PRE_E】
vardenafil	chem
vardenafil	chem
【GOLD_R】
【PRE_R】

During encoding of words , the P300 was generally smaller after vardenafil treatment .
【GOLD_E】
vardenafil	chem
【PRE_E】
P300	geneY
vardenafil	chem
【GOLD_R】
【PRE_R】

Furthermore , the N400 was larger after vardenafil 10 mg than placebo treatment in a spatial memory task at Fz .
【GOLD_E】
vardenafil	chem
【PRE_E】
vardenafil	chem
【GOLD_R】
【PRE_R】

Finally , headache and feeling weak were reported more after vardenafil treatment .
【GOLD_E】
vardenafil	chem
【PRE_E】
vardenafil	chem
【GOLD_R】
【PRE_R】

Vardenafil did not affect cognitive performance of healthy adults and showed only some incidental effects on ERPs .
【GOLD_E】
Vardenafil	chem
【PRE_E】
Vardenafil	chem
【GOLD_R】
【PRE_R】

These findings in humans do not corroborate the cognition - enhancing effects of PDE5 - Is in healthy animals .
【GOLD_E】
PDE5	geneY
【PRE_E】
PDE5	geneY
【GOLD_R】
【PRE_R】

Atorvastatin withdrawal elicits oxidative / nitrosative damage in the rat cerebral cortex .
【GOLD_E】
Atorvastatin	chem
【PRE_E】
Atorvastatin	chem
【GOLD_R】
【PRE_R】

Statins are inhibitors of the enzyme 3 - hydroxy - 3 - methylglutaryl coenzyme A reductase , the rate - limiting step in cholesterol biosynthesis .
【GOLD_E】
3-hydroxy-3-methylglutarylcoenzymeA	chem
3-hydroxy-3-methylglutarylcoenzymeAreductase	geneY
cholesterol	chem
【PRE_E】
3-hydroxy-3-methylglutarylcoenzymeAreductase	geneY
cholesterol	chem
【GOLD_R】
cholesterol	3-hydroxy-3-methylglutarylcoenzymeAreductase	C9
【PRE_R】

Statins effectively prevent and reduce the risk of coronary artery disease through lowering serum cholesterol , and also exert anti - thrombotic , anti - inflammatory and antioxidant effects independently of changes in cholesterol levels .
【GOLD_E】
cholesterol	chem
cholesterol	chem
【PRE_E】
cholesterol	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

On the other hand , clinical and experimental evidence suggests that abrupt cessation of statin treatment ( i.e . statin withdrawal ) is associated with a deleterious rebound phenomenon .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In fact , statin withdrawal increases the risk of thrombotic vascular events , causes impairment of endothelium - dependent relaxation and facilitates experimental seizures .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

However , evidence for statin withdrawal - induced detrimental effects to the brain parenchyma is still lacking .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the present study adult male Wistar rats were treated with atorvastatin for seven days ( 10mg / kg / day ) and neurochemical assays were performed in the cerebral cortex 30min ( atorvastatin treatment ) or 24h ( atorvastatin withdrawal ) after the last atorvastatin administration .
【GOLD_E】
atorvastatin	chem
atorvastatin	chem
atorvastatin	chem
atorvastatin	chem
【PRE_E】
atorvastatin	chem
atorvastatin	chem
atorvastatin	chem
atorvastatin	chem
【GOLD_R】
【PRE_R】

We found that atorvastatin withdrawal decreased levels of nitric oxide and mitochondrial superoxide dismutase activity , whereas increased NADPH oxidase activity and immunoreactivity for the protein nitration marker 3 - nitrotyrosine in the cerebral cortex .
【GOLD_E】
mitochondrialsuperoxidedismutase	geneY
NADPHoxidase	geneN
atorvastatin	chem
nitricoxide	chem
superoxide	chem
NADPH	chem
3-nitrotyrosine	chem
【PRE_E】
atorvastatin	chem
nitricoxide	chem
superoxidedismutase	geneN
NADPHoxidase	geneN
3-nitrotyrosine	chem
【GOLD_R】
3-nitrotyrosine	NADPHoxidase	C3
【PRE_R】

Catalase , glutathione - S - transferase and xanthine oxidase activities were not altered by atorvastatin treatment or withdrawal , as well as protein carbonyl and 4 - hydroxy - 2 - nonenal immunoreactivity .
【GOLD_E】
glutathione	chem
S	chem
xanthine	chem
atorvastatin	chem
carbonyl	chem
4-hydroxy-2-nonenal	chem
Catalase	geneY
glutathione-S-transferase	geneN
xanthineoxidase	geneY
【PRE_E】
Catalase	geneY
glutathione-S-transferase	geneN
xanthineoxidase	geneN
atorvastatin	chem
carbonyl	chem
4-hydroxy-2-nonenal	chem
【GOLD_R】
【PRE_R】

Immunoprecipitation of mitochondrial SOD followed by analysis of 3 - nitrotyrosine revealed increased levels of nitrated mitochondrial SOD , suggesting the mechanism underlying the atorvastatin withdrawal - induced decrease in enzyme activity .
【GOLD_E】
3-nitrotyrosine	chem
atorvastatin	chem
mitochondrialSOD	geneY
mitochondrialSOD	geneY
【PRE_E】
SOD	geneN
3-nitrotyrosine	chem
SOD	geneN
atorvastatin	chem
【GOLD_R】
【PRE_R】
SOD	3-nitrotyrosine	C3
3-nitrotyrosine	SOD	C3

Altogether , our results indicate the atorvastatin withdrawal elicits oxidative / nitrosative damage in the rat cerebral cortex , and that changes in NADPH oxidase activity and mitochondrial superoxide dismutase activities may underlie such harmful effects .
【GOLD_E】
atorvastatin	chem
NADPH	chem
superoxide	chem
NADPHoxidase	geneN
mitochondrialsuperoxidedismutase	geneY
【PRE_E】
atorvastatin	chem
NADPHoxidase	geneN
superoxidedismutase	geneN
【GOLD_R】
【PRE_R】

Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study elucidates the role of metabolic remodeling in cardiac dysfunction induced by hyperthyroidism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cardiac hypertrophy , structural remodeling , and expression of the genes associated with fatty acid metabolism were examined in rats treated with triiodothyronine ( T3 ) alone ( 8 μg / 100 g body weight ( BW ) , i.p . ) for 15 days or along with a peroxisome proliferator - activated receptor alpha agonist bezafibrate ( Bzf ; 30 μg / 100 g BW , oral ) and were found to improve in the Bzf co - treated condition .
【GOLD_E】
roxisomeproliferator-activatedreceptoralphaag	geneY
fattyacid	chem
triiodothyronine	chem
zafibrate(B	chem
f;3	chem
o-t	chem
【PRE_E】
fattyacid	chem
triiodothyronine	chem
peroxisomeproliferator-activatedreceptoralpha	geneY
bezafibrate	chem
Bzf	chem
Bzf	chem
【GOLD_R】
zafibrate(B	roxisomeproliferator-activatedreceptoralphaag	C5
f;3	roxisomeproliferator-activatedreceptoralphaag	C5
【PRE_R】

Ultrastructure of mitochondria was damaged in T3 - treated rat heart , which was prevented by Bzf co - administration .
【GOLD_E】
Bzf	chem
【PRE_E】
Bzf	chem
【GOLD_R】
【PRE_R】

Hyperthyroidism - induced oxidative stress , reduction in cytochrome c oxidase activity , and myocardial ATP concentration were also significantly checked by Bzf .
【GOLD_E】
cytochromecoxidase	geneN
ATP	chem
Bzf	chem
【PRE_E】
cytochromecoxidase	geneN
ATP	chem
Bzf	chem
【GOLD_R】
【PRE_R】
cytochromecoxidase	Bzf	C3

Heart function studied at different time points during the course of T3 treatment shows an initial improvement and then a gradual but progressive decline with time , which is prevented by Bzf co - treatment .
【GOLD_E】
Bzf	chem
【PRE_E】
Bzf	chem
【GOLD_R】
【PRE_R】

In summary , the results demonstrate that hyperthyroidism inflicts structural and functional damage to mitochondria , leading to energy depletion and cardiac dysfunction .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Endothelial cell response to ( co ) polymer nanoparticles depending on the inflammatory environment and comonomer ratio .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Endothelial cells lining the lumen of blood vessels serve as a physiological barrier controlling nanoparticle movement from the vasculature into the tissue .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For exploring the effect of polymer hydrophilicity on nanoparticle interactions with human umbilical vein endothelial cells ( HUVECs ) in vitro , a series of monomodal poly [ acrylonitrile - co - ( N - vinylpyrrolidone ) ] model nanoparticles with increasing hydrophilicity as related to their increasing content ( 0 - 30mol . % ) of N - vinylpyrrolidone ( NVP ) were synthesized by miniemulsion polymerization .
【GOLD_E】
poly[acrylonitrile-co-(N-vinylpyrrolidone)]	chem
N-vinylpyrrolidone	chem
NVP	chem
【PRE_E】
poly[acrylonitrile-co-(N-vinylpyrrolidone)	chem
N-vinylpyrrolidone	chem
NVP	chem
miniemulsion	chem
【GOLD_R】
【PRE_R】

Nanoparticles with a low NVP content were rapidly endocytized into all cells independent from the particle dose with toxic effects only observed at high particle concentrations , while only 10 - 30 % of the cells incorporated particles with ⩾ 20mol . % NVP .
【GOLD_E】
NVP	chem
NVP	chem
【PRE_E】
NVP	chem
20mol	chem
NVP	chem
【GOLD_R】
【PRE_R】

Since pathologies are often related to inflammation , an inflammatory HUVEC culture condition with IL - 1β stimulation has been introduced and suggested to be widely applied for studying nanocarriers , since cellular uptake in this assay was clearly increased for NVP contents ⩾ 20mol . % .
【GOLD_E】
NVP	chem
IL-1β	geneY
【PRE_E】
IL-1β	geneY
NVP	chem
20mol	chem
【GOLD_R】
【PRE_R】
IL-1β	NVP	C3
IL-1β	20mol	C3

Importantly , the secretion of functional biological mediators by HUVEC was not relevantly influenced by the nanoparticles for both homeostatic and inflammatory conditions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These findings may motivate concepts for nanocarriers specifically targeted to pathologic regions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Additionally , rapidly endocytized RhodaminB loaded particles with low NVP content may be explored for cell labeling and tracking .
【GOLD_E】
RhodaminB	chem
NVP	chem
【PRE_E】
RhodaminB	chem
NVP	chem
【GOLD_R】
【PRE_R】

Molecular mechanism regulating 24 - hour rhythm of dopamine d3 receptor expression in mouse ventral striatum .
【GOLD_E】
dopamined3receptor	geneY
dopamine	chem
【PRE_E】
dopamined3receptor	geneY
【GOLD_R】
【PRE_R】

The dopamine D3 receptor ( DRD3 ) in the ventral striatum is thought to influence motivation and motor functions .
【GOLD_E】
DRD3	geneY
dopamineD3receptor	geneY
dopamine	chem
【PRE_E】
dopamineD3receptor	geneY
DRD3	geneY
【GOLD_R】
【PRE_R】

Although the expression of DRD3 in the ventral striatum has been shown to exhibit 24 - hour variations , the mechanisms underlying the variation remain obscure .
【GOLD_E】
DRD3	geneY
【PRE_E】
DRD3	geneY
【GOLD_R】
【PRE_R】

Here , we demonstrated that molecular components of the circadian clock act as regulators that control the 24 - hour variation in the expression of DRD3 .
【GOLD_E】
DRD3	geneY
【PRE_E】
clock	geneY
DRD3	geneY
【GOLD_R】
【PRE_R】

The transcription of DRD3 was enhanced by the retinoic acid - related orphan receptor α ( RORα ) , and its activation was inhibited by the orphan receptor REV - ERBα , an endogenous antagonist of RORα .
【GOLD_E】
DRD3	geneY
retinoicacid-relatedorphanreceptorα	geneY
RORα	geneY
orphanreceptor	geneN
REV-ERBα	geneY
RORα	geneY
retinoicacid	chem
【PRE_E】
DRD3	geneY
retinoicacid-relatedorphanreceptorα	geneY
RORα	geneY
orphanreceptorREV	geneN
ERBα	geneY
RORα	geneY
【GOLD_R】
【PRE_R】

The serum or dexamethasone - induced oscillation in the expression of DRD3 in cells was abrogated by the downregulation or overexpression of REV - ERBα , suggesting that REV - ERBα functions as a regulator of DRD3 oscillations in the cellular autonomous clock .
【GOLD_E】
DRD3	geneY
REV-ERBα	geneY
REV-ERBα	geneY
DRD3	geneY
dexamethasone	chem
【PRE_E】
dexamethasone	chem
DRD3	geneY
REV-ERBα	geneY
REV-ERBα	geneY
DRD3	geneY
clock	geneY
【GOLD_R】
【PRE_R】

Chromatin immunoprecipitation assays of the DRD3 promoter indicated that the binding of the REV - ERBα protein to the DRD3 promoter increased in the early dark phase .
【GOLD_E】
DRD3promoter	geneN
REV-ERBα	geneY
DRD3promoter	geneN
【PRE_E】
DRD3promoter	geneN
REV-ERBα	geneY
DRD3promoter	geneN
【GOLD_R】
【PRE_R】

DRD3 protein expression varied with higher levels during the dark phase .
【GOLD_E】
DRD3	geneY
【PRE_E】
DRD3	geneY
【GOLD_R】
【PRE_R】

Moreover , the effects of the DRD3 agonist 7 - hydroxy - N , N - dipropyl - 2 - aminotetralin ( 7 - OH - DPAT ) - induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant .
【GOLD_E】
7-hydroxy-N,N-dipropyl-2-aminotetralin	chem
7-OH-DPAT	chem
DRD3	geneY
DRD3	geneY
【PRE_E】
DRD3	geneY
7-hydroxy-N,N-dipropyl-2-aminotetralin	chem
7-OH-DPAT	chem
DRD3	geneY
【GOLD_R】
7-hydroxy-N,N-dipropyl-2-aminotetralin	DRD3	C5
7-hydroxy-N,N-dipropyl-2-aminotetralin	DRD3	C5
7-OH-DPAT	DRD3	C5
7-OH-DPAT	DRD3	C5
【PRE_R】
DRD3	7-hydroxy-N,N-dipropyl-2-aminotetralin	C4
7-OH-DPAT	DRD3	C4

These results suggest that RORα and REV - ERBα consist of a reciprocating mechanism wherein RORα upregulates the expression of DRD3 , whereas REV - ERBα periodically suppresses the expression at the time of day when REV - ERBα is abundant .
【GOLD_E】
RORα	geneY
REV-ERBα	geneY
RORα	geneY
DRD3	geneY
REV-ERBα	geneY
REV-ERBα	geneY
【PRE_E】
RORα	geneY
REV	geneY
ERBα	geneY
RORα	geneY
DRD3	geneY
REV	geneY
ERBα	geneY
REV-ERBα	geneY
【GOLD_R】
【PRE_R】

Our present findings revealed that a molecular link between the circadian clock and the function of DRD3 in the ventral striatum acts as a modulator of the pharmacological actions of DRD3 agonists / antagonists .
【GOLD_E】
DRD3	geneY
DRD3	geneY
【PRE_E】
clock	geneY
DRD3	geneY
DRD3	geneY
【GOLD_R】
【PRE_R】

Studies on an ( S ) - 2 - amino - 3 - ( 3 - hydroxy - 5 - methyl - 4 - isoxazolyl ) propionic acid ( AMPA ) receptor antagonist IKM - 159 : asymmetric synthesis , neuroactivity , and structural characterization .
【GOLD_E】
IKM-159	chem
(S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionicacid	chem
AMPA	chem
(AMPA)receptor	geneN
【PRE_E】
(S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl	chem
propionicacid(AMPA)receptor	geneN
IKM-159	chem
【GOLD_R】
IKM-159	(AMPA)receptor	C6
【PRE_R】

IKM - 159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor - selective antagonists .
【GOLD_E】
AMPAreceptor	geneN
IKM-159	chem
AMPA	chem
glutamate	chem
【PRE_E】
IKM-159	chem
heterotricyclicglutamate	chem
AMPAreceptor	geneN
【GOLD_R】
IKM-159	AMPAreceptor	C6
glutamate	AMPAreceptor	C6
【PRE_R】

However , it was not known which enantiomer of IKM - 159 was responsible for its pharmacological activities .
【GOLD_E】
IKM-159	chem
【PRE_E】
IKM-159	chem
【GOLD_R】
【PRE_R】

Here , we report in vivo and in vitro neuronal activities of both enantiomers of IKM - 159 prepared by enantioselective asymmetric synthesis .
【GOLD_E】
IKM-159	chem
【PRE_E】
IKM-159	chem
【GOLD_R】
【PRE_R】

By employment of ( R ) - 2 - amino - 2 - ( 4 - methoxyphenyl ) ethanol as a chiral auxiliary , ( 2R ) - IKM - 159 and the ( 2S ) - counterpart were successfully synthesized in 0.70 % and 1.5 % yields , respectively , over a total of 18 steps .
【GOLD_E】
(R)-2-amino-2-(4-methoxyphenyl)ethanol	chem
(2R)-IKM-159	chem
【PRE_E】
(R)-2-amino-2-(4-methoxyphenyl)ethanol	chem
(2R)-IKM-159	chem
【GOLD_R】
【PRE_R】

Both behavioral and electrophysiological assays showed that the biological activity observed for the racemic mixture was reproduced only with ( 2R ) - IKM - 159 , whereas the ( 2S ) - counterpart was inactive in both assays .
【GOLD_E】
(2R)-IKM-159	chem
【PRE_E】
(2R)-IKM-159	chem
【GOLD_R】
【PRE_R】

Racemic IKM - 159 was crystallized with the ligand - binding domain of GluA2 , and the structure revealed a complex containing ( 2R ) - IKM - 159 at the glutamate binding site .
【GOLD_E】
(2R)-IKM-159	chem
GluA2	geneY
RacemicIKM-159	chem
【PRE_E】
RacemicIKM-159	chem
GluA2	geneY
(2R)-IKM	chem
glutamate	chem
【GOLD_R】
【PRE_R】

( 2R ) - IKM - 159 locks the GluA2 in an open form , consistent with a pharmacological action as competitive antagonist of AMPA receptors .
【GOLD_E】
(2R)-IKM-159	chem
GluA2	geneY
AMPAreceptors	geneN
【PRE_E】
(2R)-IKM-159	chem
GluA2	geneY
AMPAreceptors	geneN
【GOLD_R】
(2R)-IKM-159	GluA2	C4
(2R)-IKM-159	AMPAreceptors	C6
【PRE_R】
(2R)-IKM-159	GluA2	C6

Binding of Diverse Environmental Chemicals with Human Cytochromes P450 2A13 , 2A6 , and 1B1 and Enzyme Inhibition .
【GOLD_E】
HumanCytochromesP4502A13,2A6,and1B1	geneN
【PRE_E】
HumanCytochromesP4502A13,2A6,and1B1andEnzyme	geneN
【GOLD_R】
【PRE_R】

A total of 68 chemicals including derivatives of naphthalene , phenanthrene , fluoranthene , pyrene , biphenyl , and flavone were examined for their abilities to interact with human P450s 2A13 and 2A6 .
【GOLD_E】
phenanthrene	chem
fluoranthene	chem
pyrene	chem
biphenyl	chem
humanP450s2A13and2A6	geneN
flavone	chem
naphthalene	chem
【PRE_E】
naphthalene	chem
phenanthrene	chem
fluoranthene	chem
pyrene	chem
biphenyl	chem
flavone	chem
humanP450s2A13and2A6	geneN
【GOLD_R】
【PRE_R】

Fifty - one of these 68 chemicals induced stronger Type I binding spectra ( iron low - to high - spin state shift ) with P450 2A13 than those seen with P450 2A6 , i.e . , the spectral binding intensities ( Δ Amax / Ks ratio ) determined with these chemicals were always higher for P450 2A13 .
【GOLD_E】
P4502A13	geneY
P4502A6	geneN
P4502A13	geneY
iron	chem
【PRE_E】
iron	chem
P4502A13	geneY
P4502A6	geneY
P4502A13	geneY
【GOLD_R】
【PRE_R】

In addition , benzo [ c ] phenanthrene , fluoranthene , 2,3 - dihydroxy - 2,3 - dihydrofluoranthene , pyrene , 1 - hydroxypyrene , 1 - nitropyrene , 1 - acetylpyrene , 2 - acetylpyrene , 2,5,2',5 ' - tetrachlorobiphenyl , 7 - hydroxyflavone , chrysin , and galangin were found to induce a Type I spectral change only with P450 2A13 .
【GOLD_E】
fluoranthene	chem
2,3-dihydroxy-2,3-dihydrofluoranthene	chem
pyrene	chem
1-hydroxypyrene	chem
1-nitropyrene	chem
1-acetylpyrene	chem
2-acetylpyrene	chem
2,5,2',5'-tetrachlorobiphenyl	chem
7-hydroxyflavone	chem
chrysin	chem
galangin	chem
P4502A13	geneY
benzo[c]phenanthrene	chem
【PRE_E】
benzo[c]phenanthrene	chem
fluoranthene	chem
2,3-dihydroxy-2,3-dihydrofluoranthene	chem
pyrene	chem
1-hydroxypyrene	chem
1-nitropyrene	chem
1-acetylpyrene	chem
2-acetylpyrene	chem
2,5,2',5'-tetrachlorobiphenyl	chem
7-hydroxyflavone	chem
chrysin	chem
galangin	chem
P4502A13	geneN
【GOLD_R】
【PRE_R】

Coumarin 7 - hydroxylation , catalyzed by P450 2A13 , was strongly inhibited by 2 ' - methoxy - 5,7 - dihydroxyflavone , 2 - ethynylnaphthalene , 2 ' - methoxyflavone , 2 - naphththalene propargyl ether , acenaphthene , acenaphthylene , naphthalene , 1 - acetylpyrene , flavanone , chrysin , 3 - ethynylphenanthrene , flavone , and 7 - hydroxyflavone ; these chemicals induced Type I spectral changes with low Ks values .
【GOLD_E】
flavanone	chem
Coumarin	chem
2'-methoxy-5,7-dihydroxyflavone	chem
2-ethynylnaphthalene	chem
2'-methoxyflavone	chem
2-naphththalenepropargylether	chem
acenaphthene	chem
chrysin	chem
acenaphthylene	chem
naphthalene	chem
1-acetylpyrene	chem
3-ethynylphenanthrene	chem
P4502A13	geneY
flavone	chem
7-hydroxyflavone	chem
【PRE_E】
Coumarin	chem
P4502A13	geneN
2'-methoxy-5,7-dihydroxyflavone	chem
2-ethynylnaphthalene	chem
2'-methoxyflavone	chem
2-naphththalenepropargylether	chem
acenaphthene	chem
acenaphthylene	chem
naphthalene	chem
1-acetylpyrene	chem
flavanone	chem
chrysin	chem
3-ethynylphenanthrene	chem
flavone	chem
7-hydroxyflavone	chem
【GOLD_R】
flavanone	P4502A13	C4
2'-methoxy-5,7-dihydroxyflavone	P4502A13	C4
2-ethynylnaphthalene	P4502A13	C4
2'-methoxyflavone	P4502A13	C4
2-naphththalenepropargylether	P4502A13	C4
acenaphthene	P4502A13	C4
chrysin	P4502A13	C4
acenaphthylene	P4502A13	C4
naphthalene	P4502A13	C4
1-acetylpyrene	P4502A13	C4
3-ethynylphenanthrene	P4502A13	C4
flavone	P4502A13	C4
7-hydroxyflavone	P4502A13	C4
Coumarin	P4502A13	C9
【PRE_R】
P4502A13	2'-methoxy-5,7-dihydroxyflavone	C4
P4502A13	2-ethynylnaphthalene	C4
P4502A13	2'-methoxyflavone	C4
P4502A13	2-naphththalenepropargylether	C4
P4502A13	acenaphthene	C4
P4502A13	acenaphthylene	C4
P4502A13	naphthalene	C4
P4502A13	1-acetylpyrene	C4
P4502A13	flavanone	C4
P4502A13	chrysin	C4
P4502A13	3-ethynylphenanthrene	C4
P4502A13	flavone	C4
P4502A13	7-hydroxyflavone	C4

On the basis of the intensities of the spectral changes and inhibition of P450 2A13 , we classified the 68 chemicals into eight groups based on the order of affinities for these chemicals and inhibition of P450 2A13 .
【GOLD_E】
P4502A13	geneY
P4502A13	geneY
【PRE_E】
P4502A13	geneN
P4502A13	geneN
【GOLD_R】
【PRE_R】

The metabolism of chemicals by P450 2A13 during the assays explained why some of the chemicals that bound well were poor inhibitors of P450 2A13 .
【GOLD_E】
P4502A13	geneY
P4502A13	geneY
【PRE_E】
P4502A13	geneN
P4502A13	geneN
【GOLD_R】
【PRE_R】

Finally , we compared the 68 chemicals for their abilities to induce Type I spectral changes of P450 2A13 with the Reverse Type I binding spectra observed with P450 1B1 : 45 chemicals interacted with both P450s 2A13 and 1B1 , indicating that the two enzymes have some similarty of structural features regarding these chemicals .
【GOLD_E】
P4502A13	geneY
P4501B1	geneY
P450s2A13and1B1	geneN
【PRE_E】
P4502A13	geneY
P4501B1	geneY
P450s2A13and1B1	geneN
【GOLD_R】
【PRE_R】

Molecular docking analyses suggest similarities at the active sites of these P450 enzymes .
【GOLD_E】
P450enzymes	geneN
【PRE_E】
P450	geneN
【GOLD_R】
【PRE_R】

These results indicate that P450 2A13 , as well as Family 1 P450 enzymes , is able to catalyze many detoxication and activation reactions with chemicals of environmental interest .
【GOLD_E】
P4502A13	geneY
P450enzymes	geneN
【PRE_E】
P4502A13	geneY
Family1P450	geneN
【GOLD_R】
【PRE_R】

Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated in Silico / in Vitro Work Flow .
【GOLD_E】
PPARγ	geneY
【PRE_E】
PPARγ	geneY
【GOLD_R】
【PRE_R】

Full agonists to the peroxisome proliferator - activated receptor ( PPAR ) γ , such as Rosiglitazone , have been associated with a series of undesired side effects , such as weight gain , fluid retention , cardiac hypertrophy , and hepatotoxicity .
【GOLD_E】
Rosiglitazone	chem
peroxisomeproliferator-activatedreceptor(PPAR)γ	geneY
【PRE_E】
peroxisomeproliferator-activatedreceptor(PPAR)γ	geneY
Rosiglitazone	chem
【GOLD_R】
Rosiglitazone	peroxisomeproliferator-activatedreceptor(PPAR)γ	C5
【PRE_R】

Nevertheless , PPARγ is involved in the expression of genes that control glucose and lipid metabolism and is an important target for drugs against type 2 diabetes , dyslipidemia , atherosclerosis , and cardiovascular disease .
【GOLD_E】
glucose	chem
PPARγ	geneY
【PRE_E】
PPARγ	geneY
glucose	chem
【GOLD_R】
【PRE_R】

In an effort to identify novel PPARγ ligands with an improved pharmacological profile , emphasis has shifted to selective ligands with partial agonist binding properties .
【GOLD_E】
PPARγ	geneY
【PRE_E】
PPARγ	geneY
【GOLD_R】
【PRE_R】

Toward this end we applied an integrated in silico / in vitro workflow , based on pharmacophore - and structure - based virtual screening of the ZINC library , coupled with competitive binding and transactivation assays , and adipocyte differentiation and gene expression studies .
【GOLD_E】
【PRE_E】
ZINC	chem
【GOLD_R】
【PRE_R】

Hit compound 9 was identified as the most potent ligand ( IC50 = 0.3 μM ) and a relatively poor inducer of adipocyte differentiation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The binding mode of compound 9 was confirmed by molecular dynamics simulation , and the calculated free energy of binding was - 8.4 kcal / mol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A novel functional group , the carbonitrile group , was identified to be a key substituent in the ligand - protein interactions .
【GOLD_E】
carbonitrile	chem
【PRE_E】
carbonitrile	chem
【GOLD_R】
【PRE_R】

Further studies on the transcriptional regulation properties of compound 9 revealed a gene regulatory profile that was to a large extent unique , however functionally closer to that of a partial agonist .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Structural Characterization of an LPA1 Second Extracellular Loop Mimetic with a Self - Assembling Coiled - Coil Folding Constraint .
【GOLD_E】
LPA1	geneY
SecondExtracellularLoop	geneN
Coiled-Coil	geneN
【PRE_E】
LPA1	geneY
【GOLD_R】
【PRE_R】

G protein - coupled receptor ( GPCR ) structures are of interest as a means to understand biological signal transduction and as tools for therapeutic discovery .
【GOLD_E】
GPCR	geneN
Gprotein-coupledreceptor	geneN
【PRE_E】
Gprotein-coupledreceptor	geneN
GPCR	geneN
【GOLD_R】
【PRE_R】

The growing number of GPCR crystal structures demonstrates that the extracellular loops ( EL ) connecting the membrane - spanning helices show tremendous structural variability relative to the more structurally - conserved seven transmembrane α - helical domains .
【GOLD_E】
extracellularloops	geneN
EL	geneN
membrane-spanninghelices	geneN
α-helicaldomains	geneN
GPCR	geneN
【PRE_E】
GPCR	geneN
α-helicaldomains	geneN
【GOLD_R】
【PRE_R】

The EL of the LPA ( 1 ) receptor have not yet been conclusively resolved , and bear limited sequence identity to known structures .
【GOLD_E】
EL	geneN
LPA(1)	geneY
LPA	chem
【PRE_E】
LPA(1)	geneY
【GOLD_R】
【PRE_R】

This study involved development of a peptide to characterize the intrinsic structure of the LPA ( 1 ) GPCR second EL .
【GOLD_E】
LPA(1)	geneY
GPCR	geneN
EL	geneN
LPA	chem
【PRE_E】
LPA(1)GPCR	geneY
【GOLD_R】
【PRE_R】

The loop was embedded between two helices that assemble into a coiled - coil , which served as a receptor - mimetic folding constraint ( LPA ( 1 ) - CC - EL2 peptide ) .
【GOLD_E】
coiled-coil	geneN
LPA(1)	geneY
EL2	geneN
LPA	chem
【PRE_E】
LPA(1)	geneY
CC	geneY
EL2	geneN
【GOLD_R】
【PRE_R】

The ensemble of structures from multi - dimensional NMR experiments demonstrated that a robust coiled - coil formed without noticeable deformation due to the EL2 sequence .
【GOLD_E】
coiled-coil	geneN
EL2	geneN
【PRE_E】
EL2	geneY
【GOLD_R】
【PRE_R】

In contrast , the EL2 sequence showed well - defined structure only near its C - terminal residues .
【GOLD_E】
C	chem
EL2	geneN
【PRE_E】
EL2	geneY
C	chem
【GOLD_R】
【PRE_R】

The NMR ensemble was combined with a computational model of the LPA ( 1 ) receptor that had previously been validated .
【GOLD_E】
LPA	chem
LPA(1)	geneY
【PRE_E】
LPA(1)	geneY
【GOLD_R】
【PRE_R】

The resulting hybrid models were evaluated using docking .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Nine different hybrid models interacted with LPA 18 : 1 as expected , based on prior mutagenesis studies , and one was additionally consistent with antagonist affinity trends .
【GOLD_E】
LPA	chem
【PRE_E】
LPA18:1	geneN
【GOLD_R】
【PRE_R】

The ( R ) - omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers .
【GOLD_E】
(R)-omeprazole	chem
CYP2C19	geneY
【PRE_E】
(R)-omeprazole	chem
CYP2C19	geneY
【GOLD_R】
(R)-omeprazole	CYP2C19	C9
【PRE_R】
(R)-omeprazole	CYP2C19	C3

PURPOSE : Omeprazole has ( R ) - and ( S ) - enantiomers , which exhibit different pharmacokinetics ( PK ) among patients with cytochrome P450 ( CYP ) 2C19 genotype groups .
【GOLD_E】
Omeprazole	chem
cytochromeP450(CYP)2C19	geneY
【PRE_E】
Omeprazole	chem
cytochromeP450(CYP)2C19	geneY
【GOLD_R】
Omeprazole	cytochromeP450(CYP)2C19	C9
【PRE_R】

The aim of this study was to investigate whether the 1 - point , 4 - h postdose ( R ) - omeprazole hydroxylation index ( HI ) of racemic omeprazole reflects the three CYP2C19 genotype groups in Japanese individuals .
【GOLD_E】
CYP2C19	geneY
(R)-omeprazole	chem
racemicomeprazole	chem
【PRE_E】
4-hpostdose(R)-omeprazole	chem
omeprazole	chem
CYP2C19	geneY
【GOLD_R】
【PRE_R】

METHODS : Ninety healthy Japanese individuals were enrolled and classified into the three different CYP2C19 genotype groups : homozygous extensive metabolizers ( hmEMs ; n = 34 ) , heterozygous EMs ( htEMs ; n = 44 ) , and poor metabolizers ( PMs ; n = 12 ) .
【GOLD_E】
CYP2C19	geneY
【PRE_E】
CYP2C19	geneY
【GOLD_R】
【PRE_R】

Blood samples were drawn 4 h after the intake of an oral dose of omeprazole 40 mg , and plasma levels of omeprazole and its metabolites were analyzed by high - performance liquid chromatography ( HPLC ) using a chiral column .
【GOLD_E】
meprazole4	chem
eprazolean	chem
【PRE_E】
omeprazole	chem
omeprazole	chem
【GOLD_R】
【PRE_R】

RESULTS : Mean plasma concentrations of ( R ) - and ( S ) - omeprazole in PMs were significantly higher than those in hmEMs and htEMs , and similar results were obtained in the case of omeprazole sulfone .
【GOLD_E】
(R)-and(S)-omeprazole	chem
omeprazolesulfone	chem
【PRE_E】
(R)-and(S)-omeprazole	chem
PMs	chem
omeprazolesulfone	chem
【GOLD_R】
【PRE_R】

Additionally , there was a significant difference in plasma concentrations of ( R ) - 5 - hydroxyomeprazole among CYP2C19 genotype groups , whereas no significant differences were observed in that of ( S ) - 5 - hydroxyomeprazole .
【GOLD_E】
CYP2C19	geneY
(R)-5-hydroxyomeprazole	chem
(S)-5-hydroxyomeprazole	chem
【PRE_E】
(R)-5-hydroxyomeprazole	chem
CYP2C19	geneY
(S)-5-hydroxyomeprazole	chem
【GOLD_R】
(R)-5-hydroxyomeprazole	CYP2C19	C9
(S)-5-hydroxyomeprazole	CYP2C19	C9
【PRE_R】

Similarly , ( R ) - omeprazole HI in hmEMs , htEMs , and PMs were 5.6 , 3.1 , and 0.3 , respectively , which were significantly different , but no significant difference was present in the ( S ) - omeprazole HI .
【GOLD_E】
(R)-omeprazole	chem
(S)-omeprazole	chem
【PRE_E】
(R)-omeprazole	chem
(S)-omeprazole	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Our findings demonstrate that ( R ) - omeprazole HI correlated better with CYP2C19 genotype groups than racemic - omeprazole HI , and these results may be useful for classification among patients in CYP2C19 genotype groups prior to omeprazole treatment .
【GOLD_E】
CYP2C19	geneY
CYP2C19	geneY
(R)-omeprazole	chem
racemic-omeprazole	chem
【PRE_E】
(R)-omeprazole	chem
CYP2C19	geneY
racemic-omeprazole	chem
CYP2C19	geneY
omeprazole	chem
【GOLD_R】
(R)-omeprazole	CYP2C19	C9
racemic-omeprazole	CYP2C19	C9
【PRE_R】

Induction of xenobiotic receptors , transporters , and drug metabolizing enzymes by oxycodone .
【GOLD_E】
oxycodone	chem
xenobioticreceptors	geneN
【PRE_E】
xenobioticreceptors,transporters	geneN
oxycodone	chem
【GOLD_R】
【PRE_R】

Perturbations of the expression of transporters and drug - metabolizing enzymes ( DMEs ) by opioids can be the locus of deleterious drug - drug interactions ( DDIs ) .
【GOLD_E】
【PRE_E】
drug-metabolizingenzymes	geneN
DMEs	geneN
DDIs	chem
【GOLD_R】
【PRE_R】

Many transporters and DMEs are regulated by xenobiotic receptors [ XRs ; e.g . , pregnane X receptor ( PXR ) , constitutive androstane receptor ( CAR ) , and Aryl hydrocarbon receptor ( AhR ) ] ; however , there is a paucity of information regarding the influence of opioids on XRs .
【GOLD_E】
xenobioticreceptors	geneN
XRs	geneN
pregnaneXreceptor	geneY
PXR	geneY
constitutiveandrostanereceptor	geneY
CAR	geneY
Arylhydrocarbonreceptor	geneY
AhR	geneY
XRs	geneN
androstane	chem
Arylhydrocarbon	chem
【PRE_E】
DMEs	geneN
xenobioticreceptors	geneN
XRs	geneY
pregnaneXreceptor	geneY
PXR	geneY
constitutiveandrostanereceptor	geneY
CAR	geneY
Arylhydrocarbonreceptor	geneY
AhR	geneY
XRs	geneY
【GOLD_R】
【PRE_R】

The objective of this study was to determine the influence of oxycodone administration ( 15 mg / kg intraperitoneally twice daily for 8 days ) on liver expression of XRs , transporters , and DMEs in rats .
【GOLD_E】
oxycodone	chem
XRs	geneN
【PRE_E】
oxycodone	chem
XRs	geneY
DMEs	geneN
【GOLD_R】
【PRE_R】

Microarray , quantitative real - time polymerase chain reaction and immunoblotting analyses were used to identify significantly regulated genes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Three XRs ( e.g . , PXR , CAR , and AhR ) , 27 transporters ( e.g . , ABCB1 and SLC22A8 ) , and 19 DMEs ( e.g . , CYP2B2 and CYP3A1 ) were regulated ( P < 0.05 ) with fold changes ranging from - 46.3 to 17.1 .
【GOLD_E】
XRs	geneN
PXR	geneY
CAR	geneY
AhR	geneY
ABCB1	geneY
SLC22A8	geneY
CYP2B2	geneY
CYP3A1	geneY
【PRE_E】
XRs	geneY
PXR	geneY
CAR	geneY
AhR),27transporters	geneN
ABCB1	geneY
SLC22A8	geneY
DMEs	geneY
CYP2B2	geneY
CYP3A1	geneY
【GOLD_R】
【PRE_R】

Using MetaCore ( computational platform ) , we identified a unique gene - network of transporters and DMEs assembled around PXR , CAR , and AhR .
【GOLD_E】
PXR	geneY
CAR	geneY
AhR	geneY
【PRE_E】
MetaCore	geneY
DMEs	geneN
PXR	geneY
CAR	geneY
AhR	geneY
【GOLD_R】
【PRE_R】

Therefore , a series of transactivation / translocation assays were conducted to determine whether the observed changes of transporters / DMEs are mediated by direct activation of PXR , CAR , or AhR by oxycodone or its major metabolites ( noroxycodone and oxymorphone ) .
【GOLD_E】
PXR	geneY
CAR	geneY
AhR	geneY
oxycodone	chem
noroxycodone	chem
oxymorphone	chem
【PRE_E】
DMEs	geneN
PXR	geneY
CAR	geneY
AhR	geneY
oxycodone	chem
noroxycodone	chem
oxymorphone	chem
【GOLD_R】
【PRE_R】

Neither oxycodone nor its metabolites activated PXR , CAR , or AhR .
【GOLD_E】
PXR	geneY
CAR	geneY
AhR	geneY
oxycodone	chem
【PRE_E】
oxycodone	chem
PXR	geneY
CAR	geneY
AhR	geneY
【GOLD_R】
【PRE_R】

Taken together , these findings identify a signature hepatic gene - network associated with repeated oxycodone administration in rats and demonstrate that oxycodone alters the expression of many transporters and DMEs ( without direct activation of PXR , CAR , and AhR ) , which could lead to undesirable DDIs after coadministration of substrates of these transporters / DMEs with oxycodone .
【GOLD_E】
PXR	geneY
CAR	geneY
AhR	geneY
oxycodone	chem
oxycodone	chem
oxycodone	chem
【PRE_E】
oxycodone	chem
oxycodone	chem
DMEs	geneN
PXR	geneY
CAR	geneY
AhR	geneY
DDIs	chem
DMEs	geneN
oxycodone	chem
【GOLD_R】
【PRE_R】
oxycodone	DMEs	C3
oxycodone	DMEs	C3
oxycodone	PXR	C3
oxycodone	CAR	C3
oxycodone	AhR	C3
DDIs	DMEs	C9
DMEs	oxycodone	C4

Strain - dependent dysregulation of one - carbon metabolism in male mice is associated with choline - and folate - deficient diet - induced liver injury .
【GOLD_E】
folate	chem
carbon	chem
choline	chem
【PRE_E】
carbon	chem
choline	chem
folate	chem
【GOLD_R】
【PRE_R】

Dysregulation of one - carbon metabolism - related metabolic processes is a major contributor to the pathogenesis of nonalcoholic fatty liver disease ( NAFLD ) .
【GOLD_E】
carbon	chem
【PRE_E】
carbon	chem
【GOLD_R】
【PRE_R】

It is well established that genetic and gender - specific variations in one - carbon metabolism contribute to the vulnerability to NAFLD in humans .
【GOLD_E】
carbon	chem
【PRE_E】
carbon	chem
NAFLD	geneN
【GOLD_R】
【PRE_R】

To examine the role of one - carbon metabolism dysregulation in the pathogenesis and individual susceptibility to NAFLD , we used a `` population - based `` mouse model where male mice from 7 inbred were fed a choline - and folate - deficient ( CFD ) diet for 12 wk .
【GOLD_E】
ndfola	chem
carbon	chem
dacholi	chem
【PRE_E】
carbon	chem
NAFLD	geneY
choline	chem
folate	chem
【GOLD_R】
【PRE_R】

Strain - dependent down - regulation of several key one - carbon metabolism genes , including methionine adenosyltransferase 1α ( Mat1a ) , cystathionine - β - synthase ( Cbs ) , methylenetetrahydrofolate reductase ( Mthfr ) , adenosyl - homocysteinase ( Ahcy ) , and methylenetetrahydrofolate dehydrogenase 1 ( Mthfd1 ) , was observed .
【GOLD_E】
carbon	chem
methionine	chem
cystathionine	chem
methylenetetrahydrofolate	chem
adenosyl	chem
methylenetetrahydrofolate	chem
methionineadenosyltransferase1α	geneY
Mat1a	geneY
cystathionine-β-synthase	geneY
Cbs	geneY
methylenetetrahydrofolatereductase	geneY
Mthfr	geneY
adenosyl-homocysteinase	geneY
Ahcy	geneY
methylenetetrahydrofolatedehydrogenase1	geneY
Mthfd1	geneY
【PRE_E】
carbon	chem
methionineadenosyltransferase1α	geneY
Mat1a	geneY
cystathionine-β-synthase	geneY
Cbs	geneY
methylenetetrahydrofolatereductase	geneY
Mthfr	geneY
adenosyl-homocysteinase	geneY
Ahcy	geneY
methylenetetrahydrofolatedehydrogenase1	geneY
Mthfd1	geneY
【GOLD_R】
【PRE_R】

These changes were strongly associated with interstrain variability in liver injury ( steatosis , necrosis , inflammation , and activation of fibrogenesis ) and hyperhomocysteinemia .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Mechanistically , the decreased expression of Mat1a , Ahcy , and Mthfd1 was linked to a reduced level and promoter binding of transcription factor CCAAT / enhancer binding protein β ( CEBPβ ) , which directly regulates their transcription .
【GOLD_E】
Mat1a	geneY
Ahcy	geneY
Mthfd1	geneY
CCAAT/enhancerbindingproteinβ	geneY
CEBPβ	geneY
【PRE_E】
Mat1a	geneY
Ahcy	geneY
Mthfd1	geneY
CCAAT/enhancerbindingproteinβ	geneY
CEBPβ	geneY
【GOLD_R】
【PRE_R】

The strain specificity of diet - induced dysregulation of one - carbon metabolism suggests that interstrain variation in the regulation of one - carbon metabolism may contribute to the differential vulnerability to NFLD and that correcting the imbalance may be considered as preventive and treatment strategies for NAFLD . - Pogribny , I .
【GOLD_E】
carbon	chem
carbon	chem
【PRE_E】
carbon	chem
carbon	chem
NAFLD.-Pogribny,I	geneN
【GOLD_R】
【PRE_R】

P. , Kutanzi , K. , Melnyk , S. , de Conti , A. , Tryndyak , V. , Montgomery , B. , Pogribna , M. , Muskhelishvili , L. , Latendresse , J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

R. , James , S .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

J. , Beland , F .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A. , Rusyn , I .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Strain - dependent dysregulation of one - carbon metabolism in male mice is associated with choline - and folate - deficient diet - induced liver injury .
【GOLD_E】
carbon	chem
choline	chem
folate	chem
【PRE_E】
carbon	chem
choline	chem
folate	chem
【GOLD_R】
【PRE_R】

Vitamin A and retinoid signaling : genomic and non - genomic effects .
【GOLD_E】
VitaminA	chem
retinoid	chem
【PRE_E】
VitaminA	chem
retinoid	chem
【GOLD_R】
【PRE_R】

Vitamin A or retinol is arguably the most multifunctional vitamin in the human body as it is essential from embryogenesis to adulthood .
【GOLD_E】
VitaminA	chem
retinol	chem
vitamin	chem
【PRE_E】
VitaminA	chem
retinol	chem
vitamin	chem
【GOLD_R】
【PRE_R】

The pleiotropic effects of vitamin A are exerted mainly by one active metabolite , all - trans retinoic acid ( atRA ) , which regulates the expression of a battery of target genes through several families of nuclear receptors ( RARs , RXRs and PPARβ / δ ) , polymorphic retinoic acid ( RA ) response elements and multiple coregulators .
【GOLD_E】
nuclearreceptors	geneN
RARs	geneN
RXRs	geneN
PPARβ/δ	geneN
polymorphicretinoicacid(RA)responseelements	geneN
vitaminA	chem
all-transretinoicacid	chem
atRA	chem
retinoicacid	chem
【PRE_E】
vitaminA	chem
all-transretinoicacid	chem
atRA	chem
nuclearreceptors	geneN
RARs	geneN
RXRs	geneN
PPARβ/δ	geneN
retinoicacid	chem
【GOLD_R】
all-transretinoicacid	nuclearreceptors	C3
all-transretinoicacid	RARs	C3
all-transretinoicacid	RXRs	C3
all-transretinoicacid	polymorphicretinoicacid(RA)responseelements	C3
atRA	nuclearreceptors	C3
atRA	RARs	C3
atRA	RXRs	C3
atRA	polymorphicretinoicacid(RA)responseelements	C3
【PRE_R】

It also involves extra nuclear and non - transcriptional effects such as the activation of kinase cascades , which are integrated in the nucleus via the phosphorylation of several actors of RA signaling .
【GOLD_E】
kinase	geneN
【PRE_E】
kinase	geneN
【GOLD_R】
【PRE_R】

However , vitamin A itself proved recently to be active and RARs to be present in the cytosol to regulate translation and cell plasticity .
【GOLD_E】
RARs	geneN
vitaminA	chem
【PRE_E】
vitaminA	chem
RARs	geneY
【GOLD_R】
【PRE_R】

All these new concepts expand the scope of the biologic functions of vitamin A and RA .
【GOLD_E】
vitaminA	chem
【PRE_E】
vitaminA	chem
【GOLD_R】
【PRE_R】

Phase stability and elastic properties of chromium borides with various stoichiometries .
【GOLD_E】
chromiumborides	chem
【PRE_E】
chromiumborides	chem
【GOLD_R】
【PRE_R】

Phase stability is important to the application of materials .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

By first - principles calculations , we establish the phase stability of chromium borides with various stoichiometries .
【GOLD_E】
chromiumborides	chem
【PRE_E】
chromiumborides	chem
【GOLD_R】
【PRE_R】

Moreover , the phases of CrB3 and CrB4 have been predicted by using a newly developed particle swarm optimization ( PSO ) algorithm .
【GOLD_E】
CrB3	chem
CrB4	chem
【PRE_E】
CrB3	geneY
CrB4	geneY
【GOLD_R】
【PRE_R】

Formation enthalpy - pressure diagrams reveal that the MoB - type structure is more energetically favorable than the TiI - type structure for CrB .
【GOLD_E】
TiI	chem
CrB	chem
MoB	chem
【PRE_E】
MoB	geneN
CrB	geneN
【GOLD_R】
【PRE_R】

For CrB2 , the WB2 - type structure is preferred at zero pressure .
【GOLD_E】
CrB2	chem
WB2	chem
【PRE_E】
CrB2	geneY
WB2	geneN
【GOLD_R】
【PRE_R】

The predicted new phase of CrB3 belongs to the hexagonal P - 6m2 space group and it transforms into an orthorhombic phase as the pressure exceeds 93 GPa .
【GOLD_E】
CrB3	chem
【PRE_E】
CrB3	geneY
【GOLD_R】
【PRE_R】

The predicted CrB4 ( space group : Pnnm ) phase is more energetically favorable than the previously proposed Immm structure .
【GOLD_E】
CrB4	chem
【PRE_E】
【GOLD_R】
【PRE_R】

The mechanical and thermodynamic stabilities of predicted CrB3 and CrB4 are verified by the calculated elastic constants and formation enthalpies .
【GOLD_E】
CrB3	chem
CrB4	chem
【PRE_E】
CrB3	geneY
CrB4	geneY
【GOLD_R】
【PRE_R】

The full phonon dispersion calculations confirm the dynamic stability of WB2 - type CrB2 and predicted CrB3 .
【GOLD_E】
WB2	chem
CrB2	chem
CrB3	chem
【PRE_E】
WB2	geneY
CrB2	geneY
CrB3	geneY
【GOLD_R】
【PRE_R】

The large shear moduli , large Young 's moduli , low Poisson ratios , and low bulk and shear modulus ratios of CrB4 PSC and CrB4 PSD indicate that they are potential hard materials .
【GOLD_E】
CrB4	chem
CrB4	chem
【PRE_E】
CrB4PSC	geneY
【GOLD_R】
【PRE_R】

Analyses of Debye temperature , electronic localization function , and electronic structure provide further understanding of the chemical and physical properties of these borides .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effect of miR - 21 on Renal Fibrosis by Regulating MMP - 9 and TIMP1 in kk - ay Diabetic Nephropathy Mice .
【GOLD_E】
miR-21	geneY
MMP-9	geneY
TIMP1	geneY
【PRE_E】
miR-21	geneY
MMP-9	geneY
TIMP1	geneY
【GOLD_R】
【PRE_R】

MicroRNAs ( miRs ) play important roles in initiation and progression of many pathologic processes .
【GOLD_E】
【PRE_E】
MicroRNAs	geneN
miRs	geneY
【GOLD_R】
【PRE_R】

However , the roles of miRs in diabetic nephropathy remain unclear .
【GOLD_E】
【PRE_E】
miRs	geneN
【GOLD_R】
【PRE_R】

This study was to determine whether miR - 21 was involved in diabetic nephropathy and to explore the relationship between miR - 21 and MMP9 / TIMP1 expression in diabetic nephropathy .
【GOLD_E】
TIMP1	geneY
miR-21	geneY
miR-21	geneY
MMP9	geneY
【PRE_E】
miR-21	geneY
miR-21	geneY
MMP9	geneY
TIMP1	geneY
【GOLD_R】
【PRE_R】

In situ hybridization studies showed that miR - 21 was primarily localized and distributed in cortical glomerular and renal tubular cells in diabetic kk - ay kidney .
【GOLD_E】
miR-21	geneY
【PRE_E】
miR-21	geneY
【GOLD_R】
【PRE_R】

Real - time quantitative RT - PCR demonstrated that the expression of miR - 21 was significantly increased in kk - ay mice , compared with control C57BL mice .
【GOLD_E】
miR-21	geneY
【PRE_E】
miR-21	geneY
【GOLD_R】
【PRE_R】

Interestingly , miR - 21 expression positively correlated with urine albumin creatine ratio ( ACR ) , TIMP1 , collagen IV ( ColIV ) , and fibronectin ( FN ) ; while negatively correlated with creatine clearance ratio ( Ccr ) and MMP - 9 protein .
【GOLD_E】
miR-21	geneY
albumin	geneY
TIMP1	geneY
collagenIV	geneN
ColIV	geneN
fibronectin	geneY
FN	geneY
creatine	chem
MMP-9	geneY
creatine	chem
【PRE_E】
miR-21	geneY
albumin	geneY
creatineratio	geneN
TIMP1	geneY
collagenIV	geneY
ColIV	geneY
fibronectin	geneY
FN	geneY
creatineclearanceratio	geneY
MMP-9	geneY
【GOLD_R】
creatine	miR-21	C3
creatine	miR-21	C4
【PRE_R】

Importantly , antagomir - 21 not only ameliorated Ccr and ACR but also decreased TIMP1 , ColIV , and FN proteins .
【GOLD_E】
TIMP1	geneY
ColIV	geneN
FN	geneY
【PRE_E】
TIMP1	geneY
ColIV	geneY
FN	geneY
【GOLD_R】
【PRE_R】

In conclusion , our data demonstrate that miR - 21 contributes to renal fibrosis by mediating MMP9 / TIMP1 and that inhibition of miR - 21 may be a novel target for diabetic nephropathy .
【GOLD_E】
miR-21	geneY
MMP9	geneY
TIMP1	geneY
miR-21	geneY
【PRE_E】
miR-21	geneY
MMP9	geneY
TIMP1	geneY
miR-21	geneY
【GOLD_R】
【PRE_R】

Modification of the Catalytic Function of Human Hydroxysteroid Sulfotransferase hSULT2A1 by Formation of Disulfide Bonds .
【GOLD_E】
Disulfide	chem
Hydroxysteroid	chem
HumanHydroxysteroidSulfotransferasehSULT2A1	geneY
【PRE_E】
HumanHydroxysteroidSulfotransferasehSULT2A1	geneY
Disulfide	chem
【GOLD_R】
【PRE_R】

The human cytosolic sulfotransferase hSULT2A1 catalyzes the sulfation of a broad range of xenobiotics , as well as endogenous hydroxysteroids and bile acids .
【GOLD_E】
humancytosolicsulfotransferasehSULT2A1	geneY
hydroxysteroids	chem
bileacids	chem
【PRE_E】
humancytosolicsulfotransferasehSULT2A1	geneY
sulfation	chem
hydroxysteroids	chem
bileacids	chem
【GOLD_R】
hydroxysteroids	humancytosolicsulfotransferasehSULT2A1	C9
bileacids	humancytosolicsulfotransferasehSULT2A1	C9
【PRE_R】
humancytosolicsulfotransferasehSULT2A1	sulfation	C9
humancytosolicsulfotransferasehSULT2A1	hydroxysteroids	C9
humancytosolicsulfotransferasehSULT2A1	bileacids	C9

Reversible modulation of the catalytic activity of this enzyme could play important roles in its physiologic functions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Whereas other mammalian sulfotransferases are known to be reversibly altered by changes in their redox environment , this has not been previously shown for hSULT2A1 .
【GOLD_E】
mammaliansulfotransferases	geneN
hSULT2A1	geneY
【PRE_E】
mammaliansulfotransferases	geneN
hSULT2A1	geneY
【GOLD_R】
【PRE_R】

We have examined the hypothesis that the formation of disulfide bonds in hSULT2A1 can reversibly regulate the catalytic function of the enzyme .
【GOLD_E】
disulfide	chem
hSULT2A1	geneY
【PRE_E】
disulfide	chem
hSULT2A1	geneN
【GOLD_R】
【PRE_R】

Three thiol oxidants were used as model compounds to investigate their effects on homogeneous preparations of hSULT2A1 : glutathione disulfide , 5,5 ' - dithiobis ( 2 - nitrobenzoic acid ) , and 1,1 ' - azobis ( N , N - dimethylformamide ) ( diamide ) .
【GOLD_E】
thiol	chem
glutathionedisulfide	chem
5,5'-dithiobis(2-nitrobenzoicacid)	chem
1,1'-azobis(N,N-dimethylformamide	chem
diamide	chem
hSULT2A1	geneY
【PRE_E】
thiol	chem
hSULT2A1	chem
glutathionedisulfide	chem
5,5'-dithiobis	chem
2-nitrobenzoicacid	chem
1,1'-azobis	chem
N,N-dimethylformamide)	chem
diamide	chem
【GOLD_R】
【PRE_R】

Examination of the effects of disulfide bond formation with these agents indicated that the activity of the enzyme is reversibly altered .
【GOLD_E】
disulfide	chem
【PRE_E】
disulfide	chem
【GOLD_R】
【PRE_R】

Studies on the kinetics of the hSULT2A1 - catalyzed sulfation of dehydroepiandrosterone ( DHEA ) showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme .
【GOLD_E】
dehydroepiandrosterone	chem
hSULT2A1	geneY
DHEA	chem
disulfide	chem
【PRE_E】
hSULT2A1	geneY
dehydroepiandrosterone	chem
DHEA	chem
disulfide	chem
【GOLD_R】
dehydroepiandrosterone	hSULT2A1	C9
DHEA	hSULT2A1	C9
【PRE_R】
hSULT2A1	dehydroepiandrosterone	C9
hSULT2A1	DHEA	C9
hSULT2A1	disulfide	C9

The effects of these agents on the binding of substrates and products , liquid chromatography - mass spectrometry identification of the disulfides formed , and structural modeling of the modified enzyme were examined .
【GOLD_E】
disulfides	chem
【PRE_E】
disulfides	chem
【GOLD_R】
【PRE_R】

Our results indicate that conformational changes at cysteines near the nucleotide binding site affect the binding of both the nucleotide and DHEA to the enzyme , with the specific effects dependent on the structure of the resulting disulfide .
【GOLD_E】
DHEA	chem
disulfide	chem
cysteines	chem
nucleotide	chem
nucleotide	chem
【PRE_E】
cysteines	chem
nucleotide	chem
nucleotide	chem
DHEA	chem
disulfide	chem
【GOLD_R】
【PRE_R】

Thus , the formation of disulfide bonds in hSULT2A1 is a potentially important reversible mechanism for alterations in the rates of sulfation of both endogenous and xenobiotic substrates .
【GOLD_E】
disulfide	chem
hSULT2A1	geneY
【PRE_E】
disulfide	chem
hSULT2A1	geneY
【GOLD_R】
【PRE_R】

Synthesis of novel estrogen receptor antagonists using metal - catalyzed coupling reactions and characterization of their biological activity .
【GOLD_E】
estrogenreceptor	geneY
estrogen	chem
【PRE_E】
estrogenreceptor	geneN
【GOLD_R】
【PRE_R】

Estrogen receptor ( ER ) antagonists are valuable in the treatment of ER - positive human breast cancer .
【GOLD_E】
ER	geneY
Estrogen	chem
Estrogenreceptor	geneY
ER	geneN
【PRE_E】
Estrogenreceptor	geneY
ER	geneY
ER	geneY
【GOLD_R】
【PRE_R】

In this study , we designed and synthesized nine new derivatives of 17β - estradiol ( E2 ) with a bulky side chain attached to its C - 7α position , and determined their ER antagonistic activity using in vitro bioassays .
【GOLD_E】
17β-estradiol	chem
ER	geneY
【PRE_E】
17β-estradiol	chem
E2	chem
C-7α	chem
ER	geneY
【GOLD_R】
【PRE_R】

Four of the derivatives showed a strong inhibition of ERα transactivation activity in a luciferase reporter assay and blocked ERα interactions with coactivators .
【GOLD_E】
ERα	geneY
ERα	geneY
【PRE_E】
ERα	geneY
ERα	geneY
coactivators	geneN
【GOLD_R】
【PRE_R】

Similarly , these derivatives also strongly inhibited the growth of the ERα - positive human breast cancer cells .
【GOLD_E】
ERα	geneY
【PRE_E】
ERα	geneY
【GOLD_R】
【PRE_R】

Computational docking analysis was conducted to model the interaction of these antagonists with the human ERα and showed that they could tightly bind to the ERα in a manner similar to that of ICI - 182,780 , a pure ER antagonist .
【GOLD_E】
humanERα	geneY
ERα	geneN
ER	geneY
ICI-182,780	chem
【PRE_E】
humanERα	geneY
ERα	geneY
ICI-182,780	chem
ER	geneY
【GOLD_R】
ICI-182,780	ER	C6
【PRE_R】

These results provide an example that attachment of a bulky side chain to the C - 7α position of E2 can produce ER antagonists with ER affinity comparable to that of ICI - 182,780 .
【GOLD_E】
ER	geneY
ER	geneY
ICI-182,780	chem
【PRE_E】
C-7α	chem
E2	chem
ER	geneY
ER	geneY
ICI-182,780	chem
【GOLD_R】
ICI-182,780	ER	C6
【PRE_R】
C-7α	ER	C5
E2	ER	C5
ER	ICI-182,780	C5

Discovery of 7 - methoxy - 6 - [ 4 - ( 4 - methyl - 1,3 - thiazol - 2 - yl ) - 1H - imidazol - 5 - yl ] - 1,3 - benzothiazole ( TASP0382088 ) : a potent and selective transforming growth factor - β type I receptor inhibitor as a topical drug for alopecia .
【GOLD_E】
transforminggrowthfactor-βtypeIreceptor	geneY
7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	chem
TASP0382088	chem
【PRE_E】
7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	chem
TASP0382088	chem
transforminggrowthfactor-βtypeIreceptor	geneY
【GOLD_R】
7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	transforminggrowthfactor-βtypeIreceptor	C4
TASP0382088	transforminggrowthfactor-βtypeIreceptor	C4
【PRE_R】
TASP0382088	transforminggrowthfactor-βtypeIreceptor	C4

7 - Methoxy - 6 - [ 4 - ( 4 - methyl - 1,3 - thiazol - 2 - yl ) - 1H - imidazol - 5 - yl ] - 1,3 - benzothiazole 11 ( TASP0382088 ) was synthesized and evaluated as transforming growth factor - β ( TGF - β ) type I receptor ( also known as activin receptor - like kinase 5 or ALK5 ) inhibitor .
【GOLD_E】
activinreceptor-likekinase5	geneY
ALK5	geneY
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	chem
TASP0382088	chem
transforminggrowthfactor-β(TGF-β)typeIreceptor	geneY
【PRE_E】
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole11	chem
TASP0382088	chem
transforminggrowthfactor-β	geneY
TGF-β)typeIreceptor	geneY
activinreceptor-likekinase5	geneY
ALK5	geneY
【GOLD_R】
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	activinreceptor-likekinase5	C4
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	ALK5	C4
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole	transforminggrowthfactor-β(TGF-β)typeIreceptor	C4
TASP0382088	activinreceptor-likekinase5	C4
TASP0382088	ALK5	C4
TASP0382088	transforminggrowthfactor-β(TGF-β)typeIreceptor	C4
【PRE_R】
7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole11	transforminggrowthfactor-β	C4
TASP0382088	transforminggrowthfactor-β	C4
TASP0382088	TGF-β)typeIreceptor	C4
TASP0382088	activinreceptor-likekinase5	C4
TASP0382088	ALK5	C4

Compound 11 , a potent and selective ALK5 inhibitor , exhibited good enzyme inhibitory activity ( IC50 = 4.8 nM ) as well as inhibitory activity against TGF - β - induced Smad2 / 3 phosphorylation at a cellular level ( IC50 = 17 nM ) .
【GOLD_E】
ALK5	geneY
GF-β-	geneY
mad2/3phosphorylationa	geneN
【PRE_E】
ALK5	geneN
TGF-β	geneY
Smad2/3	geneN
【GOLD_R】
【PRE_R】

The introduction of a methoxy group to the benzothiazole ring in 1 and the break up of the planarity between the imidazole ring and the thiazole ring improved the solubility in the lotion base of 11 .
【GOLD_E】
methoxy	chem
benzothiazole	chem
imidazole	chem
thiazole	chem
【PRE_E】
methoxy	chem
benzothiazole	chem
imidazole	chem
thiazole	chem
【GOLD_R】
【PRE_R】

Furthermore , the topical application of 3 % 11 lotion significantly inhibited Smad2 phosphorylation in mouse skin at 8 h after application ( 71 % inhibition , compared with vehicle - treated animals ) .
【GOLD_E】
Smad2phosphorylation	geneY
【PRE_E】
Smad2	geneY
【GOLD_R】
【PRE_R】

ARF represses androgen receptor transactivation in prostate cancer .
【GOLD_E】
androgenreceptor	geneY
androgen	chem
【PRE_E】
ARF	geneN
androgenreceptor	geneY
【GOLD_R】
【PRE_R】

Androgen receptor ( AR ) signaling is essential for prostate cancer ( PCa ) development in humans .
【GOLD_E】
Androgenreceptor	geneY
Androgen	chem
AR	geneY
【PRE_E】
Androgenreceptor	geneY
AR	geneY
【GOLD_R】
【PRE_R】

The initiation of prostate malignancy and progression to a castration - resistant stage are largely contributed by the modulation of AR activity through its coregulatory proteins .
【GOLD_E】
AR	geneY
【PRE_E】
AR	geneY
【GOLD_R】
【PRE_R】

We and others previously reported that p14 alternative reading frame ( ARF ) expression is positively correlated with the disease progression and severity of PCa .
【GOLD_E】
p14alternativereadingframe	geneY
ARF	geneY
【PRE_E】
p14alternativereadingframe	geneN
ARF	geneN
【GOLD_R】
【PRE_R】

Here , we provide evidence that p14ARF physically interacts with AR and functions as an AR corespressor in both an androgen - dependent and androgen - independent manner .
【GOLD_E】
p14ARF	geneY
AR	geneY
AR	geneY
androgen	chem
androgen	chem
【PRE_E】
p14ARF	geneY
AR	geneY
AR	geneY
androgen	chem
androgen	chem
【GOLD_R】
【PRE_R】

Endogenous ARF ( p14ARF in human and p19ARF in mouse ) and AR colocalize in both human PCa cells in vitro and PCa tissues of mouse and human in vivo .
【GOLD_E】
ARF	geneY
p14ARF	geneY
p19ARF	geneY
AR	geneY
【PRE_E】
ARF	geneN
p14ARF	geneY
p19ARF	geneY
mouse)	geneY
AR	geneY
【GOLD_R】
【PRE_R】

Overexpression of p14ARF in PCa cells significantly attenuates the activities of androgen response region ( ARR2 ) - probasin and prostate - specific antigen ( PSA ) promoters .
【GOLD_E】
p14ARF	geneY
androgenresponseregion	geneN
ARR2	geneN
probasinandprostate-specificantigen(PSA)promoters	geneN
androgen	chem
【PRE_E】
p14ARF	geneY
androgenresponseregion(ARR2)-probasin	geneY
prostate-specificantigen	geneY
PSA	geneY
【GOLD_R】
【PRE_R】

The forced expression of p14ARF in cells resulted in a suppression of PSA and NK transcription factor locus 1 ( NKX3.1 ) expression .
【GOLD_E】
NKX3.1	geneY
p14ARF	geneY
PSA	geneY
NKtranscriptionfactorlocus1	geneY
【PRE_E】
p14ARF	geneY
PSA	geneY
NKtranscriptionfactorlocus1	geneY
NKX3.1	geneY
【GOLD_R】
【PRE_R】

Conversely , knockdown of endogenous p14ARF in human PCa cells with short hairpin RNA enhanced AR transactivation activities in a dose - dependent and p53 - independent manner .
【GOLD_E】
p14ARF	geneY
AR	geneY
p53	geneY
【PRE_E】
p14ARF	geneY
AR	geneY
p53	geneY
【GOLD_R】
【PRE_R】

Furthermore , we demonstrated that p14ARF binds to both the N - terminal domain and the ligand - binding domain of AR , and the human double minute 2 ( HDM2 ) - binding motif of p14ARF is required for the interaction of p14ARF and AR proteins . p14ARF perturbs the androgen - induced interaction between the N terminus and C terminus of AR .
【GOLD_E】
p14ARF	geneY
AR	geneY
humandoubleminute2(HDM2)-bindingmotif	geneN
p14ARF	geneY
p14ARF	geneY
AR	geneY
p14ARF	geneY
AR	geneY
N	chem
androgen	chem
N	chem
C	chem
【PRE_E】
p14ARF	geneY
N	chem
AR	geneY
humandoubleminute2(HDM2)-bindingmotif	geneN
p14ARF	geneY
p14ARF	geneY
AR	geneY
p14ARF	geneY
androgen	chem
N	chem
C	chem
AR	geneY
【GOLD_R】
【PRE_R】

Most importantly , we observed that the expression of PSA is reversely correlated with p14ARF in human prostate tissues .
【GOLD_E】
PSA	geneY
p14ARF	geneY
【PRE_E】
PSA	geneY
p14ARF	geneY
【GOLD_R】
【PRE_R】

Taken together , our results reveal a novel function of ARF in modulation of AR transactivation in PCa .
【GOLD_E】
ARF	geneY
AR	geneY
【PRE_E】
ARF	geneN
AR	geneY
【GOLD_R】
【PRE_R】

Role of oxidative stress in chemical allergens induced skin cells activation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Allergic contact dermatitis ( ACD ) is an important occupational and environmental disease caused by topical exposure to chemical allergens .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It describes the adverse effects that may results when exposure to a chemical elicits a T cell - mediated inflammatory skin disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The ability of contact sensitizers to induce the oxidative stress pathway in keratinocytes and dendritic cells has been confirmed by several authors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Reactive oxygen species ( ROS ) can serve as essential second messengers mediating cellular responses resulting in immune cells activation .
【GOLD_E】
oxygen	chem
【PRE_E】
oxygen	chem
【GOLD_R】
【PRE_R】

Oxidative stress may be the starter point , as it leads to the activation of transcription factors and signaling pathways , including NF - kB and p38 MAPK , which leads to the release of cytokines and chemokines .
【GOLD_E】
NF-kB	geneN
p38	geneN
MAPK	geneN
cytokines	geneN
chemokines	geneN
【PRE_E】
NF-kB	geneN
p38	geneN
MAPK	geneN
cytokines	geneN
chemokines	geneN
【GOLD_R】
【PRE_R】

ROS are also involved in the activation of the NLRP3 / NALP3 inflammasome , which is required to direct the proteolytic maturation of inflammatory cytokines such as IL - 1β and IL - 18 , which are all integral to the process of dendritic cells mobilization , migration and functional maturation .
【GOLD_E】
IL-1β	geneY
IL-18	geneY
NLRP3	geneY
NALP3	geneY
cytokines	geneN
【PRE_E】
NLRP3	geneY
NALP3	geneY
cytokines	geneN
IL-1β	geneY
IL-18	geneY
【GOLD_R】
【PRE_R】

Moreover , emerging evidence correlates ROS to changes in the constitution of the extracellular microenvironment found to facilitate ACD .
【GOLD_E】
【PRE_E】
ACD	geneN
【GOLD_R】
【PRE_R】

The purpose of this review is to provide both conceptual and technical frameworks on the role of oxidative stress in chemical allergy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Relative expression of cholesterol transport - related proteins and inflammation markers through the induction of 7 - ketosterol - mediated stress in Caco - 2 cells .
【GOLD_E】
7-ketosterol	chem
cholesterol	chem
holesteroltransport-relatedproteins	geneN
【PRE_E】
cholesterol	chem
7-ketosterol	chem
【GOLD_R】
【PRE_R】

Human diets contain sterol oxidation products that can induce cytotoxic effects , mainly caused by cholesterol oxides .
【GOLD_E】
sterol	chem
cholesteroloxides	chem
【PRE_E】
sterol	chem
cholesteroloxides	chem
【GOLD_R】
【PRE_R】

However , phytosterol oxides effects have been less extensively investigated .
【GOLD_E】
phytosteroloxides	chem
【PRE_E】
phytosteroloxides	chem
【GOLD_R】
【PRE_R】

This study evaluates the production of inflammatory biomarkers ( IL - 1β , IL - 8 , IL - 10 , TNFα ) and the influence of gene expression transporters and enzymes related to cholesterol absorption and metabolism ( NPC1L1 , ABCG5 / 8 , HMGCoA , ACAT ) produced by 7 - ketosterols ( stigmasterol / cholesterol ) in Caco - 2 cells .
【GOLD_E】
cholesterol	chem
HMGCoA	chem
7-ketosterols	chem
stigmasterol	chem
cholesterol	chem
IL-1β	geneY
IL-8	geneY
IL-10	geneY
TNFα	geneY
NPC1L1	geneY
ABCG5/8	geneN
HMGCoA	geneY
ACAT	geneY
【PRE_E】
IL-1β	geneY
IL-8	geneY
IL-10	geneY
TNFα	geneY
cholesterol	chem
NPC1L1	geneY
ABCG5	geneY
HMGCoA	geneN
ACAT	geneN
7-ketosterols	chem
stigmasterol	chem
cholesterol	chem
【GOLD_R】
【PRE_R】
cholesterol	NPC1L1	C9
cholesterol	ABCG5	C9
HMGCoA	7-ketosterols	C9
ACAT	7-ketosterols	C9
ACAT	stigmasterol	C9
ACAT	cholesterol	C9

These effects were linked to intracellular signaling pathways by using several inhibitors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results showed 7 - ketostigmasterol to have a greater proinflammatory potential than 7 - ketocholesterol .
【GOLD_E】
7-ketostigmasterol	chem
7-ketocholesterol	chem
【PRE_E】
7-ketocholesterol	chem
【GOLD_R】
【PRE_R】

In non - pre - treated cells , only efflux transporters were down - regulated by 7 - ketosterols , showing a greater influence upon ABCG5 expression .
【GOLD_E】
7-ketosterols	chem
effluxtransporters	geneN
ABCG5	geneY
【PRE_E】
effluxtransporters	geneN
7-ketosterols	chem
ABCG5	geneY
【GOLD_R】
7-ketosterols	effluxtransporters	C4
【PRE_R】
effluxtransporters	7-ketosterols	C4

Cell - pre - incubation with bradykinin induced changes in ABCG expression levels after 7 - ketostigmasterol - incubation ; however , the energetic metabolism inhibition reduced NPC1L1 expression only in 7 - ketocholesterol - incubated cells .
【GOLD_E】
bradykinin	chem
7-ketocholesterol	chem
7-ketostigmasterol	chem
bradykinin	geneY
ABCG	geneN
NPC1L1	geneY
【PRE_E】
bradykinin	geneY
ABCG	geneN
NPC1L1	geneY
7-ketocholesterol	chem
【GOLD_R】
7-ketocholesterol	NPC1L1	C4
【PRE_R】
NPC1L1	7-ketocholesterol	C4

In non - pre - treated cells , HMG - CoA was up - regulated by both 7 - ketosterols .
【GOLD_E】
HMG-CoA	geneY
HMG-CoA	chem
7-ketosterols	chem
【PRE_E】
HMG-CoA	chem
7-ketosterols	chem
【GOLD_R】
7-ketosterols	HMG-CoA	C3
【PRE_R】

However , exposure to inhibitors down - regulated the expression levels , mainly in 7 - ketocholesterol - incubated cells .
【GOLD_E】
7-ketocholesterol	chem
【PRE_E】
7-ketocholesterol	chem
【GOLD_R】
【PRE_R】

While ACAT expression values in non - pre - treated cells were unchanged , exposure to inhibitors caused down - regulation of mRNA levels .
【GOLD_E】
ACAT	geneY
【PRE_E】
ACAT	geneN
【GOLD_R】
【PRE_R】

These results suggest that internalization and excretion of 7 - ketostigmasterol is probably influenced by [ Ca ] i , which also could mediate HMGCoA activity in POPs metabolism .
【GOLD_E】
HMGCoA	geneY
7-ketostigmasterol	chem
Ca	chem
HMGCoA	chem
【PRE_E】
7-ketostigmasterol	chem
Ca]i	chem
HMGCoA	geneN
【GOLD_R】
【PRE_R】

However , energetic metabolism and reducing equivalents exert different influences upon the 7 - ketosterol internalization .
【GOLD_E】
7-ketosterol	chem
【PRE_E】
7-ketosterol	chem
【GOLD_R】
【PRE_R】

Caffeic acid treatment alters the extracellular adenine nucleotide hydrolysis in platelets and lymphocytes of adult rats .
【GOLD_E】
Caffeicacid	chem
adeninenucleotide	chem
【PRE_E】
Caffeicacid	chem
adeninenucleotide	chem
【GOLD_R】
【PRE_R】

This study evaluated the effects of caffeic acid on ectonucleotidase activities such as NTPDase ( nucleoside triphosphate diphosphohydrolase ) , Ecto - NPP ( nucleotide pyrophosphatase / phosphodiesterase ) , 5 ' - nucleotidase and adenosine deaminase ( ADA ) in platelets and lymphocytes of rats , as well as in the profile of platelet aggregation .
【GOLD_E】
nucleosidetriphosphate	chem
Ecto-NPP(nucleotidepyrophosphatase/phosphodiesterase)	geneN
5'-nucleotidase	geneY
adenosinedeaminase	geneY
ADA	geneY
NTPDase	geneN
nucleosidetriphosphatediphosphohydrolase	geneN
nucleotide	chem
adenosine	chem
caffeicacid	chem
【PRE_E】
caffeicacid	chem
NTPDase	geneN
nucleosidetriphosphatediphosphohydrolase	geneN
Ecto-NPP	geneN
nucleotidepyrophosphatase	geneN
phosphodiesterase	geneN
5'-nucleotidase	geneY
adenosinedeaminase	geneY
ADA	geneY
【GOLD_R】
【PRE_R】

Animals were divided into five groups : I ( control ) ; II ( oil ) ; III ( caffeic acid 10mg / kg ) ; IV ( caffeic acid 50mg / kg ) ; and V ( caffeic acid 100mg / kg ) .
【GOLD_E】
caffeicacid	chem
caffeicacid	chem
caffeicacid	chem
【PRE_E】
caffeicacid	chem
caffeicacid	chem
【GOLD_R】
【PRE_R】

Animals were treated with caffeic acid diluted in oil for 30days .
【GOLD_E】
caffeicacid	chem
【PRE_E】
caffeicacid	chem
【GOLD_R】
【PRE_R】

In platelets , caffeic acid decreased the ATP hydrolysis and increased ADP hydrolysis in groups III , IV and V when compared to control ( P < 0.05 ) .
【GOLD_E】
caffeicacid	chem
ATP	chem
ADP	chem
【PRE_E】
caffeicacid	chem
ATP	chem
ADP	chem
【GOLD_R】
【PRE_R】

The 5 ' - nucleotidase activity was decreased , while E - NPP and ADA activities were increased in platelets of rats of groups III , IV and V ( P < 0.05 ) .
【GOLD_E】
E-NPP	geneN
ADA	geneY
【PRE_E】
5'-nucleotidase	geneY
E-NPP	geneY
ADA	geneY
【GOLD_R】
【PRE_R】

Caffeic acid reduced significantly the platelet aggregation in the animals of groups III , IV and V in relation to group I ( P < 0.05 ) .
【GOLD_E】
Caffeicacid	chem
【PRE_E】
Caffeicacid	chem
【GOLD_R】
【PRE_R】

In lymphocytes , the NTPDase and ADA activities were increased in all groups treated with caffeic acid when compared to control ( P < 0.05 ) .
【GOLD_E】
ADA	geneY
caffeicacid	chem
NTPDase	geneN
【PRE_E】
NTPDase	geneN
ADA	geneY
caffeicacid	chem
【GOLD_R】
caffeicacid	ADA	C3
caffeicacid	NTPDase	C3
【PRE_R】
ADA	caffeicacid	C4

These findings demonstrated that the enzymes were altered in tissues by caffeic acid and this compound decreased the platelet aggregation suggesting that caffeic acid should be considered a potentially therapeutic agent in disorders related to the purinergic system .
【GOLD_E】
caffeicacid	chem
caffeicacid	chem
【PRE_E】
caffeicacid	chem
caffeicacid	chem
【GOLD_R】
【PRE_R】

Mutant B - RAF - Mcl - 1 survival signaling depends on the STAT3 transcription factor .
【GOLD_E】
Mcl-1	geneY
STAT3	geneY
B-RAF	geneY
【PRE_E】
B-RAF	geneY
Mcl-1	geneY
STAT3	geneY
【GOLD_R】
【PRE_R】

Approximately 50 % of melanomas depend on mutant B - RAF for proliferation , metastasis and survival .
【GOLD_E】
B-RAF	geneY
【PRE_E】
B-RAF	geneY
【GOLD_R】
【PRE_R】

The inhibition of oncogenic B - RAF with highly targeted compounds has produced remarkable albeit short - lived clinical responses in B - RAF mutant melanoma patients .
【GOLD_E】
B-RAF	geneY
B-RAF	geneY
【PRE_E】
B-RAF	geneY
B-RAF	geneY
【GOLD_R】
【PRE_R】

Reactivation of signaling downstream of B - RAF is frequently associated with acquired resistance to B - RAF inhibitors , and the identification of B - RAF targets may provide new strategies for managing melanoma .
【GOLD_E】
B-RAF	geneY
B-RAF	geneY
B-RAF	geneY
【PRE_E】
B-RAF	geneY
B-RAF	geneY
B-RAF	geneY
【GOLD_R】
【PRE_R】

Oncogenic B - RAF ( V600E ) is known to promote the stabilizing phosphorylation of the anti - apoptotic protein Mcl - 1 , implicated in melanoma survival and chemoresistance .
【GOLD_E】
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【PRE_E】
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【GOLD_R】
【PRE_R】

We now show that B - RAF ( V600E ) signaling also induces the transcription of Mcl - 1 in melanocytes and melanoma .
【GOLD_E】
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【PRE_E】
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【GOLD_R】
【PRE_R】

We demonstrate that activation of STAT3 serine - 727 and tyrosine - 705 phosphorylations is promoted by B - RAF ( V600E ) activity and that the Mcl - 1 promoter is dependent on a STAT consensus - site for B - RAF - mediated activation .
【GOLD_E】
serine	chem
STAT3	geneY
B-RAF	geneY
V600E	geneN
Mcl-1promoter	geneN
STAT	geneN
B-RAF	geneY
tyrosine	chem
【PRE_E】
STAT3	geneY
serine-727	geneN
tyrosine-705phosphorylations	geneY
B-RAF	geneY
V600E	geneN
Mcl-1promoter	geneN
STAT	geneN
B-RAF	geneY
【GOLD_R】
【PRE_R】

Consequently , suppression of STAT3 activity disrupted B - RAF ( V600E ) - mediated induction of Mcl - 1 and reduced melanoma cell survival .
【GOLD_E】
STAT3	geneY
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【PRE_E】
STAT3	geneY
B-RAF	geneY
V600E	geneN
Mcl-1	geneY
【GOLD_R】
【PRE_R】

We propose that STAT3 has a central role in the survival and contributes to chemoresistance of B - RAF ( V600E ) melanoma.Oncogene advance online publication , 4 March 2013 ; doi : 10.1038 / onc.2013.45 .
【GOLD_E】
STAT3	geneY
B-RAF	geneY
V600E	geneN
【PRE_E】
STAT3	geneY
B-RAF	geneY
V600E	geneN
doi	chem
【GOLD_R】
【PRE_R】

Aldehyde oxidase importance in vivo in xenobiotic metabolism : imidacloprid nitroreduction in mice .
【GOLD_E】
Aldehyde	chem
imidacloprid	chem
Aldehydeoxidase	geneN
【PRE_E】
Aldehydeoxidase	geneN
imidaclopridnitroreduction	chem
【GOLD_R】
【PRE_R】

Aldehyde oxidase ( AOX ) metabolizes many xenobiotics in vitro , but its importance in vivo is usually unknown relative to cytochrome P450s ( CYPs ) and other detoxification systems .
【GOLD_E】
Aldehyde	chem
Aldehydeoxidase	geneN
cytochromeP450s	geneN
CYPs	geneN
AOX	geneN
【PRE_E】
Aldehydeoxidase	geneN
AOX	geneN
cytochromeP450s	geneN
CYPs	geneN
【GOLD_R】
【PRE_R】

Currently , the most important insecticides are neonicotinoids , which are metabolized in vitro by AOX on reduction of the nitroimino group and by CYPs via oxidation reactions .
【GOLD_E】
neonicotinoids	chem
nitroimino	chem
AOX	geneN
CYPs	geneN
【PRE_E】
AOX	geneY
nitroimino	chem
CYPs	geneN
【GOLD_R】
neonicotinoids	AOX	C9
neonicotinoids	CYPs	C9
nitroimino	AOX	C9
【PRE_R】

The goal of this study was to establish the relative importance of AOX and CYPs in vivo using the mouse model .
【GOLD_E】
AOX	geneN
CYPs	geneN
【PRE_E】
AOX	geneN
CYPs	geneN
【GOLD_R】
【PRE_R】

The procedure was to reduce liver AOX activity by providing tungsten or hydralazine in the drinking water or to use the AOX - deficient DBA / 2 mouse strain .
【GOLD_E】
tungsten	chem
hydralazine	chem
AOX	geneN
AOX	geneN
【PRE_E】
AOX	geneN
tungsten	chem
hydralazine	chem
AOX	geneY
【GOLD_R】
tungsten	AOX	C4
hydralazine	AOX	C4
【PRE_R】
AOX	tungsten	C3
AOX	hydralazine	C3

None of these approaches reduced CYP activity measured in vitro with an isozyme nonspecific substrate .
【GOLD_E】
CYP	geneN
【PRE_E】
CYP	geneN
【GOLD_R】
【PRE_R】

Liver AOX activity was reduced by 45 % with tungsten and 61 % with hydralazine and 81 % in AOX - deficient mice relative to controls .
【GOLD_E】
tungsten	chem
hydralazine	chem
AOX	geneN
AOX	geneN
【PRE_E】
AOX	geneN
tungsten	chem
hydralazine	chem
AOX	geneY
【GOLD_R】
tungsten	AOX	C4
hydralazine	AOX	C4
【PRE_R】

When mice were treated ip with the major neonicotinoid imidacloprid ( IMI ) , metabolism by CYP oxidation reactions was not appreciably affected , whereas the AOX - generated nitrosoguanidine metabolite was decreased by 30 % with tungsten and 56 % with hydralazine and 86 % in the AOX - deficient mice .
【GOLD_E】
imidacloprid	chem
IMI	chem
AOX	geneN
AOX	geneN
nitrosoguanidine	chem
tungsten	chem
CYP	geneN
hydralazine	chem
【PRE_E】
imidacloprid	chem
IMI	chem
CYP	geneN
AOX	geneN
nitrosoguanidine	chem
tungsten	chem
hydralazine	chem
AOX	geneN
【GOLD_R】
tungsten	AOX	C4
hydralazine	AOX	C4
nitrosoguanidine	AOX	C9
【PRE_R】
AOX	nitrosoguanidine	C9

The other IMI nitroreduction metabolite , desnitro - IMI , was decreased by 55 % , 65 % , and 81 % with tungsten , hydralazine , and in the AOX - deficient mice , respectively .
【GOLD_E】
AOX	geneN
IMI	chem
IMI	chem
tungsten	chem
hydralazine	chem
【PRE_E】
IMInitroreduction	chem
desnitro-IMI	chem
tungsten	chem
hydralazine	chem
AOX	geneY
【GOLD_R】
【PRE_R】

Thus , decreasing liver AOX activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of IMI - treated mice .
【GOLD_E】
AOX	geneN
IMI	chem
【PRE_E】
AOX	geneN
IMI	chem
【GOLD_R】
IMI	AOX	C9
【PRE_R】

Possible AOX involvement in IMI metabolism in insects was evaluated using AOX - expressing and AOX - deficient Drosophila , but no differences were found in IMI nitroreduction or sensitivity between the two strains .
【GOLD_E】
IMI	chem
IMI	chem
AOX	geneN
AOX	geneN
AOX	geneN
【PRE_E】
AOX	geneN
IMI	chem
AOX	geneN
AOX	geneY
IMInitroreduction	chem
【GOLD_R】
IMI	AOX	C9
IMI	AOX	C9
【PRE_R】
AOX	IMI	C9
IMI	AOX	C9
AOX	IMInitroreduction	C9

This is the first study to establish the in vivo relevance of AOX in neonicotinoid metabolism in mammals and one of the first for xenobiotics in general .
【GOLD_E】
neonicotinoid	chem
AOX	geneN
【PRE_E】
AOX	geneN
【GOLD_R】
neonicotinoid	AOX	C9
【PRE_R】

Non - front - fanged colubroid snakes : A current evidence - based analysis of medical significance .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Non - front - fanged colubroid snakes ( NFFC ; formerly and artificially taxonomically assembled as `` colubrids `` ) comprise about 70 % of extant snake species and include several taxa now known to cause lethal or life threatening envenoming in humans .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Although the medical risks of bites by only a handful of species have been documented , a growing number of NFFC are implicated in medically significant bites .
【GOLD_E】
【PRE_E】
NFFC	geneN
【GOLD_R】
【PRE_R】

The majority of these snakes have oral products ( Duvernoy 's secretions , or venoms ) with unknown biomedical properties and their potential for causing harm in humans is unknown .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Increasingly , multiple NFFC species are entering the commercial snake trade posing an uncertain risk .
【GOLD_E】
【PRE_E】
NFFC	geneN
【GOLD_R】
【PRE_R】

Published case reports describing NFFC bites were assessed for evidence - based value , clinical detail and verified species identification .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These data were subjected to meta - analysis and a hazard index was generated for select taxa .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cases on which we consulted or personally treated were included and subjected to the same assessment criteria .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cases involving approximately 120 species met the selection criteria , and a small subset designated Hazard Level 1 ( most hazardous ) , contained 5 species with lethal potential .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recommended management of these cases included antivenom for 3 species , Dispholidus typus , Rhabdophis tiginis , Rhabdophis subminiatus , whereas others in this subset without commercially available antivenoms ( Thelotornis spp . ) were treated with plasma / erythrocyte replacement therapy and supportive care .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Heparin , antifibrinolytics and / or plasmapheresis / exchange transfusion have been used in the management of some Hazard Level 1 envenomings , but evidence - based analysis positively contraindicates the use of any of these interventions .
【GOLD_E】
【PRE_E】
antifibrinolytics	chem
plasmapheresis	chem
【GOLD_R】
【PRE_R】

Hazard Level 2 / 3 species were involved in cases containing mixed quality data that implicated these taxa ( e.g .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Boiga irregularis , Philodryas olfersii , Malpolon monspessulanus ) with bites that caused rare systemic effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recommended management may include use of acetylcholinesterase inhibitors ( e.g . neostigmine ) and wound care on a case - by - case basis .
【GOLD_E】
neostigmine	chem
acetylcholinesterase	geneY
【PRE_E】
acetylcholinesterase	geneY
neostigmine	chem
【GOLD_R】
neostigmine	acetylcholinesterase	C4
【PRE_R】
acetylcholinesterase	neostigmine	C4

Hazard level 3 species comprised a larger group capable of producing significant local effects only , often associated with a protracted bite ( eg Heterodon nasicus , Borikenophis ( Alsophis ) portoricensis , Platyceps ( Coluber ) rhodorachis ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Management is restricted to wound care .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Bites by Hazard level 4 species comprised the majority of surveyed taxa and these showed only minor effects of no clinical importance .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study has produced a comprehensive evidence - based listing of NFFC snakes tabulated against medical significance of bites , together with best - practice management recommendations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This analysis assumes increasing importance , as there is growing exposure to lesser - known NFFC snakes , particularly in captive collections that may uncover further species of significance in the future .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Careful and accurate documentation of bites by verified species of NFFC snakes is required to increase the evidence base and establish the best medical management approach for each species .
【GOLD_E】
【PRE_E】
NFFC	geneN
【GOLD_R】
【PRE_R】

Cell cycle arrest , extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy .
【GOLD_E】
Boron	chem
【PRE_E】
Boron	chem
【GOLD_R】
【PRE_R】

Boron Neutron Capture Therapy ( BNCT ) involves the selective accumulation of boron carriers in tumor tissue followed by irradiation with a thermal or epithermal neutron beam .
【GOLD_E】
Boron	chem
【PRE_E】
Boron	chem
boron	chem
【GOLD_R】
【PRE_R】

This therapy is therefore a cellular irradiation suited to treat tumors that have infiltrated into healthy tissues .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

BNCT has been used clinically to treat patients with cutaneous melanomas which have a high mortality .
【GOLD_E】
【PRE_E】
BNCT	chem
【GOLD_R】
【PRE_R】

Human normal melanocytes and melanoma cells were treated with BNCT at different boronophenylalanine concentrations for signaling pathways analysis .
【GOLD_E】
boronophenylalanine	chem
【PRE_E】
BNCT	chem
boronophenylalanine	chem
【GOLD_R】
【PRE_R】

BNCT induced few morphological alterations in normal melanocytes , with a negligible increase in free radical production .
【GOLD_E】
【PRE_E】
BNCT	chem
【GOLD_R】
【PRE_R】

Melanoma cells treated with BNCT showed significant extracellular matrix ( ECM ) changes and a significant cyclin D1 decrease , suggesting cell death by necrosis and apoptosis and cell cycle arrest , respectively .
【GOLD_E】
cyclinD1	geneY
【PRE_E】
BNCT	chem
cyclinD1	geneY
【GOLD_R】
【PRE_R】

BNCT also induced a significant increase in cleaved caspase - 3 and a decrease in the mitochondrial electrical potential with selectivity for melanoma cells .
【GOLD_E】
caspase-3	geneY
【PRE_E】
BNCT	chem
caspase-3	geneY
【GOLD_R】
【PRE_R】
BNCT	caspase-3	C3

Normal melanocytes had no significant differences due to BNCT treatment , confirming the data from the literature regarding the selectivity of BNCT .
【GOLD_E】
【PRE_E】
BNCT	chem
BNCT	chem
【GOLD_R】
【PRE_R】

The results from this study suggest that some signaling pathways are involved in human melanoma treatment by BNCT , such as cell cycle arrest , ECM changes and intrinsic apoptosis .
【GOLD_E】
【PRE_E】
BNCT	chem
【GOLD_R】
【PRE_R】

Anti - adipogenic diarylheptanoids from Alnus hirsuta f. sibirica on 3T3 - L1 cells .
【GOLD_E】
diarylheptanoids	chem
【PRE_E】
diarylheptanoids	chem
【GOLD_R】
【PRE_R】

A new diarylheptanoid , ( 5S ) - hydroxy - 1 - ( 3,4 - dihydroxyphenyl ) - 7 - ( 4 - hydroxyphenyl ) - hepta - 1E - en - 3 - one ( 1 ) , was isolated along with seventeen known diarylheptanoids ( 2 - 18 ) from the methanol extract of Alnus hirsuta f. sibirica leaves using bioactivity - guided fractionation .
【GOLD_E】
diarylheptanoids	chem
methanol	chem
(5S)-hydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-hepta-1E-en-3-one	chem
diarylheptanoid	chem
【PRE_E】
diarylheptanoid	chem
(5S)-hydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-hepta-1E-en-3-one	chem
diarylheptanoids	chem
methanol	chem
【GOLD_R】
【PRE_R】

Among the isolated compounds , compounds 1 and 2 and 4 - 12 reduced lipid accumulation dose - dependently in 3T3 - L1 preadipocytes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Of the compounds active in the present assay system , the most potent compound 7 , platyphyllonol - 5 - O - β - d - xylopyranoside , significantly suppressed the induction of peroxisome proliferator activated receptor γ ( PPARγ and CCAAT / enhancer binding protein α ( C / EBPα ) protein expression , and inhibited adipocyte differentiation induced by troglitazone , a PPARγ agonist .
【GOLD_E】
CCAAT/enhancerbindingproteinα	geneY
C/EBPα	geneY
PPARγ	geneY
platyphyllonol-5-O-β-d-xylopyranoside	chem
troglitazone	chem
peroxisomeproliferatoractivatedreceptorγ	geneY
PPARγ	geneY
【PRE_E】
platyphyllonol-5-O-β-d-xylopyranoside	chem
peroxisomeproliferatoractivatedreceptorγ	geneY
PPARγ	geneY
CCAAT/enhancerbindingproteinα	geneY
C/EBPα	geneY
troglitazone	chem
PPARγ	geneY
【GOLD_R】
platyphyllonol-5-O-β-d-xylopyranoside	CCAAT/enhancerbindingproteinα	C4
platyphyllonol-5-O-β-d-xylopyranoside	C/EBPα	C4
platyphyllonol-5-O-β-d-xylopyranoside	peroxisomeproliferatoractivatedreceptorγ	C4
platyphyllonol-5-O-β-d-xylopyranoside	PPARγ	C4
troglitazone	PPARγ	C5
【PRE_R】
platyphyllonol-5-O-β-d-xylopyranoside	peroxisomeproliferatoractivatedreceptorγ	C4
platyphyllonol-5-O-β-d-xylopyranoside	PPARγ	C4
CCAAT/enhancerbindingproteinα	troglitazone	C4
C/EBPα	troglitazone	C4

It was demonstrated that compound 7 has anti - adipogenic activity mediated by the regulation of PPARγ dependent pathways .
【GOLD_E】
PPARγ	geneY
【PRE_E】
PPARγ	geneY
【GOLD_R】
【PRE_R】

Benzenesulfonamides : a unique class of chemokine receptor type 4 inhibitors .
【GOLD_E】
chemokinereceptortype4	geneY
Benzenesulfonamides	chem
【PRE_E】
Benzenesulfonamides	chem
chemokinereceptortype4	geneY
【GOLD_R】
Benzenesulfonamides	chemokinereceptortype4	C4
【PRE_R】
Benzenesulfonamides	chemokinereceptortype4	C4

The interaction of CXCR4 with CXCL12 ( SDF - 1 ) plays a critical role in cancer metastasis by facilitating the homing of tumor cells to metastatic sites .
【GOLD_E】
CXCR4	geneY
CXCL12	geneY
SDF-1	geneY
【PRE_E】
CXCR4	geneY
CXCL12	geneY
SDF-1	geneY
【GOLD_R】
【PRE_R】

Based on our previously published work on CXCR4 antagonists , we have synthesized a series of aryl sulfonamides that inhibit the CXCR4 / CXCL12 interaction .
【GOLD_E】
arylsulfonamides	chem
CXCR4	geneY
CXCR4	geneY
CXCL12	geneY
【PRE_E】
CXCR4	geneY
arylsulfonamides	chem
CXCR4	geneY
CXCL12	geneY
【GOLD_R】
arylsulfonamides	CXCR4	C4
arylsulfonamides	CXCL12	C4
【PRE_R】
arylsulfonamides	CXCR4	C4
arylsulfonamides	CXCL12	C4

Analogue bioactivities were assessed with binding affinity and Matrigel invasion assays .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Computer modeling was employed to evaluate a selection of the new analogues docked into the CXCR4 X - ray structure and to rationalize discrepancies between the affinity and Matrigel in vitro assays .
【GOLD_E】
CXCR4	geneY
【PRE_E】
CXCR4	geneY
【GOLD_R】
【PRE_R】

A lead compound displays nanomolar potency in the binding affinity assay ( IC ( 50 ) = 8.0 nM ) and the Matrigel invasion assay ( 100 % blockade of invasion at 10 nM ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These data demonstrate that benzenesulfonamides are a unique class of CXCR4 inhibitors with high potency .
【GOLD_E】
CXCR4	geneY
benzenesulfonamides	chem
【PRE_E】
benzenesulfonamides	chem
CXCR4	geneY
【GOLD_R】
benzenesulfonamides	CXCR4	C4
【PRE_R】
benzenesulfonamides	CXCR4	C4

Oncolytic activity and mechanism of action of a novel L - cysteine derivative , L - cysteine , ethyl ester , S - ( N - methylcarbamate ) monohydrochloride .
【GOLD_E】
L-cysteine	chem
L-cysteine,ethylester,S-(N-methylcarbamate)monohydrochloride	chem
【PRE_E】
L-cysteine	chem
L-cysteine	chem
ethylester	chem
S-(N-methylcarbamate)monohydrochloride	chem
【GOLD_R】
【PRE_R】

A study on the oncolytic activity of the L - cysteine derivative L - cysteine , ethyl ester , S - ( N - methylcarbamate ) monohydrochloride ( NSC 303861 ) , revealed that the drug caused complete regression of the MX - 1 human mammary tumor xenograft .
【GOLD_E】
L-cysteine	chem
L-cysteine,ethylester,S-(N-methylcarbamate)monohydrochloride	chem
NSC303861	chem
【PRE_E】
L-cysteine	chem
L-cysteine	chem
ethylester	chem
S-(N-methylcarbamate)monohydrochloride	chem
NSC303861	chem
【GOLD_R】
【PRE_R】

The compound also exhibited moderate antitumor activity against murine leukemia P388 ( T / C value of 169 % at a daily dose of 400 mg / kg ) and against M5076 sarcoma ( T / C value of 135 % at a daily dose of 600 mg / kg ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The drug was inactive against B16 melanoma , Lewis lung , colon 38 and CD8F1 mammary carcinomas .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The compound exhibited significant cytotoxicity against hepatoma 3924A cells in culture ( LC50 = 6 microM ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Studies on the mechanism of action revealed that the cytotoxicity of the drug could be partially abrogated by protecting hepatoma 3924A cells in culture with L - glutamine .
【GOLD_E】
L-glutamine	chem
【PRE_E】
L-glutamine	chem
【GOLD_R】
【PRE_R】

At 6 h after injection of the compound ( 400 mg / kg ) into rats bearing hepatoma 3924A , the pools of L - glutamine and L - glutamate in the tumor decreased to 33 % and 71 % , respectively , of control levels ; the drug selectively inhibited the activities of L - glutamine - requiring enzymes of purine nucleotide biosynthesis , amidophosphoribosyltransferase , FGAM synthase , and GMP synthase , to 21 % , 1 % , and 69 % , respectively , without significantly altering the activities of pyrimidine biosynthetic enzymes , carbamoylphosphate synthase II and CTP synthase .
【GOLD_E】
L-glutamine	chem
L-glutamine	chem
L-glutamate	chem
amidophosphoribosyltransferase	geneY
FGAMsynthase	geneY
GMPsynthase	geneY
carbamoylphosphatesynthaseII	geneY
purinenucleotide	chem
CTPsynthase	geneY
FGAM	chem
GMP	chem
pyrimidine	chem
carbamoylphosphate	chem
CTP	chem
【PRE_E】
L-glutamine	chem
L-glutamate	chem
L-glutamine	chem
purinenucleotide	chem
amidophosphoribosyltransferase	geneN
FGAMsynthase	geneY
GMPsynthase	geneY
pyrimidine	chem
carbamoylphosphatesynthaseII	geneY
CTPsynthase	geneY
【GOLD_R】
【PRE_R】
amidophosphoribosyltransferase	pyrimidine	C9

Measurement of the nucleotide concentrations further corroborated the actions of the drug on the purine nucleotide biosynthetic enzyme activities .
【GOLD_E】
purinenucleotide	chem
nucleotide	chem
【PRE_E】
nucleotide	chem
purinenucleotide	chem
【GOLD_R】
【PRE_R】

Drug injection ( 400 mg / kg ) in the hepatoma 3924A - bearing rats reduced the concentrations of IMP in the tumor to 52 % , those of total adenylates to 52 % , those of total guanylates to 57 % , and those of NAD to 73 % , without significantly perturbing the pyrimidine nucleotide pools .
【GOLD_E】
IMP	chem
adenylates	chem
guanylates	chem
NAD	chem
pyrimidinenucleotide	chem
【PRE_E】
NAD	geneN
pyrimidinenucleotide	chem
【GOLD_R】
【PRE_R】

Studies on the mechanism of action of the L - cysteine derivative suggested that the compound behaved as an L - glutamine antagonist , selectively acting on the enzymes of purine nucleotide biosynthesis .
【GOLD_E】
L-cysteine	chem
L-glutamine	chem
purinenucleotide	chem
【PRE_E】
L-cysteine	chem
L-glutamine	chem
purinenucleotide	chem
【GOLD_R】
【PRE_R】

Measurement of Transport Activities of 3β - Hydroxy - Δ ( 5 ) - bile Acids in Bile Salt Export Pump and Multidrug Resistance - Associated Proteins Using LC - MS / MS .
【GOLD_E】
3β-Hydroxy-Δ(5)-bileAcids	chem
BileSalt	chem
BileSaltExportPump	geneY
MultidrugResistance-AssociatedProteins	geneN
【PRE_E】
3β-Hydroxy-Δ(5)-bileAcids	chem
ExportPump	geneN
【GOLD_R】
3β-Hydroxy-Δ(5)-bileAcids	BileSaltExportPump	C9
3β-Hydroxy-Δ(5)-bileAcids	MultidrugResistance-AssociatedProteins	C9
【PRE_R】
3β-Hydroxy-Δ(5)-bileAcids	ExportPump	C9

A method has been developed for the measurement of transport activities in membrane vesicles obtained from Sf9 cells for 3β - hydroxy - Δ ( 5 ) - bile acids by high - performance liquid chromatography - electrospray ionization - tandem mass spectrometry .
【GOLD_E】
3β-hydroxy-Δ(5)-bileacids	chem
【PRE_E】
3β-hydroxy-Δ(5)-bileacids	chem
【GOLD_R】
【PRE_R】

Calibration curves for the bile acids were linear over the range of 10 to 2000 pmol / mL , and the detection limit was less than 1 pmol / mL for 3β - hydroxy - Δ ( 5 ) - bile acids using selected reaction monitoring analysis .
【GOLD_E】
bileacids	chem
-hydroxy-Δ(5)-bileacidsus	chem
【PRE_E】
bileacids	chem
3β-hydroxy-Δ(5)-bileacids	chem
【GOLD_R】
【PRE_R】

The analytical method was applied to measurements of transport activities in membrane vesicles obtained from human multidrug resistance - associated protein 2 - , 3 - , and human bile salt export pump - expressing Sf9 cells for conjugated 3β - hydroxy - Δ ( 5 ) - bile acids .
【GOLD_E】
humanmultidrugresistance-associatedprotein2-,3	geneN
humanbilesaltexportpump	geneY
bilesalt	chem
3β-hydroxy-Δ(5)-bileacids	chem
【PRE_E】
humanmultidrugresistance-associatedprotein2-,3-,andhumanbilesaltexportpump	geneN
3β-hydroxy-Δ(5)-bileacids	chem
【GOLD_R】
3β-hydroxy-Δ(5)-bileacids	humanbilesaltexportpump	C9
【PRE_R】

The present study demonstrated that human multidrug resistance - associated protein 3 vesicles accepted conjugated 3β - hydroxy - Δ ( 5 ) - bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3 - sulfate .
【GOLD_E】
humanmultidrugresistance-associatedprotein3	geneY
3β-hydroxy-Δ(5)-bileacids	chem
bileacids	chem
glycocholicacid	chem
taurolithocholicacid3-sulfate	chem
【PRE_E】
humanmultidrugresistance-associatedprotein3	geneY
3β-hydroxy-Δ(5)-bileacids	chem
bileacids	chem
glycocholicacid	chem
taurolithocholicacid3-sulfate	chem
【GOLD_R】
3β-hydroxy-Δ(5)-bileacids	humanmultidrugresistance-associatedprotein3	C9
bileacids	humanmultidrugresistance-associatedprotein3	C9
glycocholicacid	humanmultidrugresistance-associatedprotein3	C9
taurolithocholicacid3-sulfate	humanmultidrugresistance-associatedprotein3	C9
【PRE_R】

An Intracellular Domain Fragment of the p75 Neurotrophin Receptor ( p75NTR ) Enhances Tropomyosin Receptor Kinase A ( TrkA ) Receptor Function .
【GOLD_E】
TrkA	geneY
p75NeurotrophinReceptor	geneY
p75NTR	geneY
TropomyosinReceptorKinaseA	geneY
【PRE_E】
p75NeurotrophinReceptor	geneY
p75NTR	geneY
TropomyosinReceptorKinaseA(TrkA)Receptor	geneY
【GOLD_R】
【PRE_R】

Facilitation of nerve growth factor ( NGF ) signaling by the p75 neurotrophin receptor ( p75 ( NTR ) ) is critical for neuronal survival and differentiation .
【GOLD_E】
p75neurotrophinreceptor	geneY
p75(NTR)	geneY
nervegrowthfactor	geneY
NGF	geneY
【PRE_E】
nervegrowthfactor	geneY
NGF	geneY
p75neurotrophinreceptor	geneN
p75	geneN
NTR	geneN
【GOLD_R】
【PRE_R】

However , the interaction between p75 ( NTR ) and TrkA receptors required for this activity is not understood .
【GOLD_E】
p75(NTR)	geneY
TrkA	geneY
【PRE_E】
p75(NTR)	geneY
TrkA	geneY
【GOLD_R】
【PRE_R】

Here , we report that a specific 29 - amino acid peptide derived from the intracellular domain fragment of p75 ( NTR ) interacts with and potentiates binding of NGF to TrkA - expressing cells , leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced Erk1 / 2 and Akt signaling .
【GOLD_E】
NGF	geneY
TrkA	geneY
Erk1/2	geneN
Akt	geneN
aminoacid	chem
p75(NTR)	geneY
【PRE_E】
aminoacid	chem
p75	geneN
NTR	geneN
NGF	geneY
TrkA	geneY
Erk1/2	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

An endogenous intracellular domain fragment of p75 ( NTR ) ( p75 ( ICD ) ) containing these 29 amino acids is produced by regulated proteolysis of the full - length receptor .
【GOLD_E】
p75(NTR)	geneY
p75(ICD)	geneN
aminoacids	chem
【PRE_E】
p75(NTR)	geneY
p75(ICD)	geneY
aminoacids	chem
【GOLD_R】
【PRE_R】

We demonstrate that generation of this fragment is a requirement for p75 ( NTR ) to facilitate TrkA signaling in neurons and propose that the juxtamembrane region of p75 ( ICD ) acts to cause a conformational change within the extracellular domain of TrkA .
【GOLD_E】
p75(NTR)	geneY
TrkA	geneY
p75(ICD)	geneN
TrkA	geneY
【PRE_E】
p75	geneN
NTR	geneN
TrkA	geneY
juxtamembrane	geneN
p75(ICD)	geneY
TrkA	geneY
【GOLD_R】
【PRE_R】

This finding provides new insight into the mechanism by which p75 ( NTR ) and TrkA interact to enhance neurotrophic signaling .
【GOLD_E】
p75(NTR)	geneY
TrkA	geneY
【PRE_E】
p75(NTR)	geneY
TrkA	geneY
【GOLD_R】
【PRE_R】

Synthesis and evaluation of 3 - ( benzylthio ) - 5 - ( 1H - indol - 3 - yl ) - 1,2,4 - triazol - 4 - amines as Bcl - 2 inhibitory anticancer agents .
【GOLD_E】
Bcl-2	geneY
3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines	chem
【PRE_E】
3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines	chem
Bcl-2	geneY
【GOLD_R】
3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines	Bcl-2	C4
【PRE_R】
3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines	Bcl-2	C4

A series of substituted 3 - ( benzylthio ) - 5 - ( 1H - indol - 3 - yl ) - 4H - 1,2,4 - triazol - 4 - amines has been synthesised and tested in vitro as potential pro - apoptotic Bcl - 2 - inhibitory anticancer agents .
【GOLD_E】
3-(benzylthio)-5-(1H-indol-3-yl)-4H-1,2,4-triazol-4-amines	chem
Bcl-2	geneY
【PRE_E】
3-(benzylthio)-5-(1H-indol-3-yl)-4H-1,2,4-triazol-4-amines	chem
Bcl-2	geneY
【GOLD_R】
3-(benzylthio)-5-(1H-indol-3-yl)-4H-1,2,4-triazol-4-amines	Bcl-2	C4
【PRE_R】
3-(benzylthio)-5-(1H-indol-3-yl)-4H-1,2,4-triazol-4-amines	Bcl-2	C4

Synthesis of the target compounds was readily accomplished in good yields through a cyclisation reaction between indole - 3 - carboxylic acid hydrazide and carbon disulfide under basic conditions , followed by S - benzylation .
【GOLD_E】
indole-3-carboxylicacidhydrazide	chem
carbondisulfide	chem
S	chem
【PRE_E】
cyclisation	chem
indole-3-carboxylicacidhydrazide	chem
carbondisulfide	chem
S-benzylation	chem
【GOLD_R】
【PRE_R】

Active compounds , such as the nitrobenzyl analogue 6c , were found to exhibit sub - micromolar IC50 values in Bcl - 2 expressing human cancer cell lines .
【GOLD_E】
nitrobenzyl	chem
Bcl-2	geneY
【PRE_E】
nitrobenzyl	chem
Bcl-2	geneY
【GOLD_R】
nitrobenzyl	Bcl-2	C4
【PRE_R】
nitrobenzyl	Bcl-2	C4

Molecular modelling and ELISA studies further implicated anti - apoptotic Bcl - 2 as a candidate molecular target underpinning anticancer activity .
【GOLD_E】
Bcl-2	geneY
【PRE_E】
Bcl-2	geneY
【GOLD_R】
【PRE_R】

Effect of nicotine pretreatment on arsenic - induced oxidative stress in male Wistar rats .
【GOLD_E】
nicotine	chem
arsenic	chem
【PRE_E】
nicotine	chem
arsenic	chem
【GOLD_R】
【PRE_R】

Humans are commonly exposed to nicotine , one of the most important lifestyle chemicals .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

The occurrence of high levels of arsenic in the groundwater of the southeast region of Asia has received much attention in the past decade and has become a global health concern .
【GOLD_E】
arsenic	chem
【PRE_E】
arsenic	chem
【GOLD_R】
【PRE_R】

Predominant occurrence of both these chemicals and ease of their human exposure led us to investigate the effect of nicotine , a major tobacco alkaloid , on arsenic toxicity .
【GOLD_E】
nicotine	chem
arsenic	chem
【PRE_E】
nicotine	chem
arsenic	chem
【GOLD_R】
【PRE_R】

Adult male rats were pre - exposed to two different doses of nicotine ( 0.75 and 3 mg / kg , intraperitoneally ) for 7 days followed by 30 days of arsenic exposure ( 50 ppm sodium arsenite in drinking water ) .
【GOLD_E】
nicotine	chem
enicexp	chem
umarseniteindr	chem
【PRE_E】
nicotine	chem
arsenic	chem
sodiumarsenite	chem
【GOLD_R】
【PRE_R】

Nicotine pre - exposure resulted in an increased brain arsenic accumulation and a decreased liver arsenic concentration .
【GOLD_E】
Nicotine	chem
arsenic	chem
arsenic	chem
【PRE_E】
Nicotine	chem
arsenic	chem
arsenic	chem
【GOLD_R】
【PRE_R】

Arsenic also caused a significant oxidative stress in the blood , brain and liver of the exposed rats .
【GOLD_E】
Arsenic	chem
【PRE_E】
Arsenic	chem
【GOLD_R】
【PRE_R】

Glutathione - S - transferase , a phase II enzyme , was inhibited by both arsenic and nicotine but no such inhibition was noted in arsenic - treated animals pre - exposed to nicotine .
【GOLD_E】
Glutathione	chem
nicotine	chem
S	chem
arsenic	chem
nicotine	chem
arsenic	chem
Glutathione-S-transferase	geneN
【PRE_E】
Glutathione-S-transferase	geneN
arsenic	chem
nicotine	chem
arsenic	chem
nicotine	chem
【GOLD_R】
arsenic	Glutathione-S-transferase	C4
nicotine	Glutathione-S-transferase	C4
【PRE_R】

Upon nicotine pre - exposure , brain acetylcholinesterase increased , while monoamine oxidase ( MAO ) decreased .
【GOLD_E】
acetylcholinesterase	geneY
monoamineoxidase	geneN
MAO	geneN
nicotine	chem
【PRE_E】
nicotine	chem
acetylcholinesterase	geneY
monoamineoxidase	geneN
MAO	geneN
【GOLD_R】
nicotine	acetylcholinesterase	C3
nicotine	monoamineoxidase	C4
nicotine	MAO	C4
【PRE_R】
nicotine	acetylcholinesterase	C3

The toxic effects of MAO significantly attenuated with nicotine pre - exposure .
【GOLD_E】
MAO	geneN
nicotine	chem
【PRE_E】
MAO	geneN
nicotine	chem
【GOLD_R】
nicotine	MAO	C4
【PRE_R】

The present study suggests that nicotine may not be the major contributing factor for the previously reported synergistic toxic interaction between tobacco and arsenic .
【GOLD_E】
nicotine	chem
arsenic	chem
【PRE_E】
nicotine	chem
arsenic	chem
【GOLD_R】
【PRE_R】

Nicotine pre - exposure in arsenic - exposed animals revealed interesting toxicokinetics and oxidative stress modulating interactions in the brain and liver of rats , which requires further exploration .
【GOLD_E】
Nicotine	chem
arsenic	chem
【PRE_E】
Nicotine	chem
arsenic	chem
【GOLD_R】
【PRE_R】

Developing Predictive Approaches to Characterize Adaptive Responses of the Reproductive Endocrine Axis to Aromatase Inhibition : II . Computational Modeling .
【GOLD_E】
Aromatase	geneY
【PRE_E】
Aromatase	geneY
【GOLD_R】
【PRE_R】

Endocrine - disrupting chemicals can affect reproduction and development in humans and wildlife .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We developed a computational model of the hypothalamic - pituitary - gonadal ( HPG ) axis in female fathead minnows to predict dose - response and time - course ( DRTC ) behaviors for endocrine effects of the aromatase inhibitor , fadrozole ( FAD ) .
【GOLD_E】
fadrozole	chem
FAD	chem
aromatase	geneY
【PRE_E】
aromatase	geneY
fadrozole	chem
【GOLD_R】
fadrozole	aromatase	C4
FAD	aromatase	C4
【PRE_R】
aromatase	fadrozole	C4

The model describes adaptive responses to endocrine stress involving regulated secretion of a generic gonadotropin ( LH / FSH ) from the hypothalamic - pituitary complex .
【GOLD_E】
FSH	geneN
gonadotropin	geneN
LH	geneN
【PRE_E】
gonadotropin	geneN
LH	geneN
FSH	geneN
【GOLD_R】
【PRE_R】

For model development , we used plasma 17β - estradiol ( E2 ) concentrations and ovarian cytochrome P450 ( CYP ) 19A aromatase mRNA data from two time - course experiments , each of which included both an exposure and a depuration phase , and plasma E2 data from a third 4 - day study .
【GOLD_E】
cytochromeP450(CYP)19Aaromatase	geneY
17β-estradiol	chem
【PRE_E】
17β-estradiol	chem
E2	chem
cytochromeP450(CYP)19Aaromatase	geneY
【GOLD_R】
【PRE_R】

Model parameters were estimated using E2 concentrations for 0 , 0.5 , and 3 µg / l FAD exposure concentrations , and good fits to these data were obtained .
【GOLD_E】
FAD	chem
【PRE_E】
E2	chem
【GOLD_R】
【PRE_R】

The model accurately predicted CYP19A mRNA fold changes for controls and three FAD doses ( 0 , 0.5 , and 3 µg / l ) and plasma E2 dose response from the 4 - day study .
【GOLD_E】
CYP19A	geneY
FAD	chem
【PRE_E】
CYP19A	geneY
E2	chem
【GOLD_R】
【PRE_R】

Comparing the model - predicted DRTC with experimental data provided insight into how the feedback control mechanisms in the HPG axis mediate these changes : specifically , adaptive changes in plasma E2 levels occurring during exposure and `` overshoot `` occurring postexposure .
【GOLD_E】
【PRE_E】
DRTC	geneY
E2	chem
【GOLD_R】
【PRE_R】

This study demonstrates the value of mechanistic modeling to examine and predict dynamic behaviors in perturbed systems .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

As this work progresses , we will obtain a refined understanding of how adaptive responses within the vertebrate HPG axis affect DRTC behaviors for aromatase inhibitors and other types of endocrine - active chemicals and apply that knowledge in support of risk assessments .
【GOLD_E】
aromatase	geneY
【PRE_E】
aromatase	geneY
【GOLD_R】
【PRE_R】

Benzoquinone Reveals a Cysteine - Dependent Desensitization Mechanism of TRPA1 .
【GOLD_E】
Benzoquinone	chem
Cysteine	chem
TRPA1	geneY
【PRE_E】
Benzoquinone	chem
Cysteine	chem
TRPA1	geneY
【GOLD_R】
【PRE_R】
Benzoquinone	TRPA1	C4

The transient receptor potential ankyrin 1 ( TRPA1 ) nonselective cation channel has a conserved function as a noxious chemical sensor throughout much of Metazoa .
【GOLD_E】
transientreceptorpotentialankyrin1	geneY
TRPA1)	geneY
cationchannel	geneN
【PRE_E】
transientreceptorpotentialankyrin1	geneY
TRPA1	geneY
cationchannel	geneN
Metazoa	geneN
【GOLD_R】
【PRE_R】

Electrophilic chemicals activate both insect and vertebrate TRPA1 via covalent modification of cysteine residues in the amino - terminal region .
【GOLD_E】
cysteine	chem
amino	chem
TRPA1	geneY
【PRE_E】
TRPA1	geneY
cysteine	chem
amino	chem
【GOLD_R】
【PRE_R】

Although naturally occurring electrophilic plant compounds , such as mustard oil and cinnamaldehyde , are TRPA1 agonists , it is unknown whether arthropod - produced electrophiles activate mammalian TRPA1 .
【GOLD_E】
cinnamaldehyde	chem
TRPA1	geneY
mammalianTRPA1	geneY
【PRE_E】
cinnamaldehyde	chem
TRPA1	geneY
mammalianTRPA1	geneY
【GOLD_R】
cinnamaldehyde	TRPA1	C5
【PRE_R】

We characterized the effects of the electrophilic arthropod defensive compound para - benzoquinone ( pBQN ) on the human TRPA1 channel .
【GOLD_E】
para-benzoquinone	chem
pBQN	chem
humanTRPA1	geneY
【PRE_E】
para-benzoquinone	chem
pBQN	chem
humanTRPA1	geneY
【GOLD_R】
【PRE_R】

We used whole - cell recordings of human embryonic kidney cells heterologously expressing either wild - type TRPA1 or TRPA1 with three serine - substituted cysteines crucial for electrophile activation ( C621S , C641S , C665S ) .
【GOLD_E】
serine	chem
cysteines	chem
TRPA1	geneY
TRPA1	geneY
C621S	geneN
C641S	geneN
C665S	geneN
【PRE_E】
TRPA1	geneY
TRPA1	geneY
serine	chem
cysteines	chem
C621S	geneN
C641S	geneY
C665S	geneY
【GOLD_R】
【PRE_R】

We found that pBQN activates TRPA1 starting at 10 nM and peaking at 300 nM ; higher concentrations caused rapid activation followed by a fast decline .
【GOLD_E】
pBQN	chem
TRPA1	geneY
【PRE_E】
pBQN	chem
TRPA1	geneY
【GOLD_R】
pBQN	TRPA1	C3
【PRE_R】
pBQN	TRPA1	C3

Activation by pBQN required reactivity with cysteine residues , but ones that are distinct from those previously reported to be the key targets of electrophiles .
【GOLD_E】
pBQN	chem
cysteine	chem
【PRE_E】
pBQN	chem
cysteine	chem
【GOLD_R】
【PRE_R】

The current reduction we found at higher pBQN concentrations was a cysteine - dependent desensitization of TRPA1 , and did not require prior activation .
【GOLD_E】
TRPA1	geneY
pBQN	chem
【PRE_E】
pBQN	chem
cysteine	chem
TRPA1	geneY
【GOLD_R】
【PRE_R】
pBQN	TRPA1	C4

The cysteines required for desensitization are not accessible to all electrophiles as iodoacetamide and internally applied 2 - ( trimethylammonium ) ethyl methanesulfonate failed to cause desensitization ( despite large activation ) .
【GOLD_E】
cysteines	chem
iodoacetamide	chem
2-(trimethylammonium)ethylmethanesulfonate	chem
【PRE_E】
cysteines	chem
iodoacetamide	chem
2-(trimethylammonium)ethylmethanesulfonate	chem
【GOLD_R】
【PRE_R】

Interestingly , following pBQN desensitization , wild - type TRPA1 had dramatically reduced response to the nonelectrophile agonist carvacrol , whereas the triple cysteine mutant TRPA1 retained its full response .
【GOLD_E】
TRPA1	geneY
TRPA1	geneY
pBQN	chem
carvacrol	chem
cysteine	chem
【PRE_E】
pBQN	chem
TRPA1	geneY
nonelectrophile	geneN
carvacrol	chem
cysteine	chem
TRPA1	geneY
【GOLD_R】
carvacrol	TRPA1	C5
carvacrol	TRPA1	C5
【PRE_R】
TRPA1	carvacrol	C4
nonelectrophile	carvacrol	C4
cysteine	TRPA1	C4

Our results suggest that modification of multiple cysteine residues by electrophilic compounds can generate both activation and desensitization of the TRPA1 channel .
【GOLD_E】
cysteine	chem
TRPA1	geneY
【PRE_E】
cysteine	chem
TRPA1	geneY
【GOLD_R】
【PRE_R】

A study of parabens and bisphenol A in surface water and fish brain tissue from the Greater Pittsburgh Area .
【GOLD_E】
parabens	chem
bisphenolA	chem
【PRE_E】
parabens	chem
bisphenolA	chem
【GOLD_R】
【PRE_R】

Pollution from xenoestrogens has been discovered in the aquatic environment of the Greater Pittsburgh Area and is suspected to be caused by the failing sewer system .
【GOLD_E】
xenoestrogens	chem
【PRE_E】
xenoestrogens	chem
【GOLD_R】
【PRE_R】

Personal care products and plasticizers have the potential to enter the water supply though treated and untreated sewage .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Many of these compounds are suspected xenoestrogens .
【GOLD_E】
xenoestrogens	chem
【PRE_E】
xenoestrogens	chem
【GOLD_R】
【PRE_R】

Paraben detection in surface waters was as follows : methyl paraben ranged between 2.2 to 17.3 ppt ; ethyl paraben was not detectable ; propyl paraben was detected at 9.2 and 12.0 ppt ; butyl paraben was detected at 0.2 ppt .
【GOLD_E】
Paraben	chem
methylparaben	chem
thylparabenw	chem
ropylparabenw	chem
tylparabenwa	chem
【PRE_E】
Paraben	chem
methylparaben	chem
ethylparaben	chem
propylparaben	chem
butylparaben	chem
【GOLD_R】
【PRE_R】

BPA was detected between 0.6 and 15.4 ppt .
【GOLD_E】
BPA	chem
【PRE_E】
BPA	chem
【GOLD_R】
【PRE_R】

Estrogenic potential of extracts from fish brain tissue was tested via Bromodeoxyuridine MCF - 7 analysis and paired with HPLC - MS to investigate the presence of xenoestrogens .
【GOLD_E】
Bromodeoxyuridine	chem
xenoestrogens	chem
【PRE_E】
xenoestrogens	chem
【GOLD_R】
【PRE_R】

All samples were non - detectable for parabens .
【GOLD_E】
【PRE_E】
parabens	chem
【GOLD_R】
【PRE_R】

BPA was detected in 44 of the 58 samples , with a range from non - detectable to 120 pg / g .
【GOLD_E】
BPA	chem
【PRE_E】
BPA	chem
【GOLD_R】
【PRE_R】

BCFs were calculated .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results were statistically significant for location of capture ( p < 0.05 ) and correlation existed between estrogenicity and BPA .
【GOLD_E】
A.	chem
【PRE_E】
BPA	chem
【GOLD_R】
【PRE_R】

Synthesis and in - silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors .
【GOLD_E】
cyclooxygenase	geneN
diaryltriazole	chem
【PRE_E】
diaryltriazole	chem
cyclooxygenase	geneN
【GOLD_R】
diaryltriazole	cyclooxygenase	C4
【PRE_R】
diaryltriazole	cyclooxygenase	C4

The synthesis of several 4 - phenyl - 5 - pyridin - 4 - yl - 2,3 - dihydro - 3H - 1,2,4 - triazole - 3 - thiones possessing N - 2 Mannich bases or S - alkyl substituents , is reported .
【GOLD_E】
Mannichbases	chem
S-alkyl	chem
4-phenyl-5-pyridin-4-yl-2,3-dihydro-3H-1,2,4-triazole-3-thiones	chem
【PRE_E】
4-phenyl-5-pyridin-4-yl-2,3-dihydro-3H-1,2,4-triazole-3-thiones	chem
N-2Mannich	chem
S-alkyl	chem
【GOLD_R】
【PRE_R】

Several of them exhibited a low nanomolar COX enzyme inhibition activity .
【GOLD_E】
COX	geneN
【PRE_E】
COX	geneN
【GOLD_R】
【PRE_R】

Most of the compounds showed inhibition of edema was similar to that evoked by celocoxib in animal model .
【GOLD_E】
celocoxib	chem
【PRE_E】
celocoxib	chem
【GOLD_R】
【PRE_R】

Molecular docking studies of the compounds into the binding sites of COX - 1 and COX - 2 allowed us to shed light on the binding mode of these novel COX inhibitors .
【GOLD_E】
COX-1	geneY
COX-2	geneY
COX	geneN
【PRE_E】
COX-1	geneY
COX-2	geneY
COX	geneN
【GOLD_R】
【PRE_R】

Multilevel regulation of 2 - cys peroxiredoxin reaction cycle by s - nitrosylation .
【GOLD_E】
cys	chem
2-cysperoxiredoxin	geneN
【PRE_E】
2-cysperoxiredoxin	geneN
s-nitrosylation	chem
【GOLD_R】
【PRE_R】

S - Nitrosothiols ( SNOs ) , formed by nitric oxide ( NO ) - mediated S - nitrosylation , and hydrogen peroxide ( H2O2 ) , a prominent reactive oxygen species , are implicated in diverse physiological and pathological processes .
【GOLD_E】
SNOs	chem
nitricoxide	chem
NO	chem
S-Nitrosothiols	chem
S	chem
hydrogenperoxide	chem
H2O2	chem
oxygen	chem
【PRE_E】
S-Nitrosothiols	chem
SNOs	chem
nitricoxide	chem
NO	chem
S-nitrosylation	chem
hydrogenperoxide	chem
H2O2	chem
oxygen	chem
【GOLD_R】
【PRE_R】

Recent research has shown that the cellular action and metabolism of SNOs and H2O2 involve overlapping , thiol - based mechanisms , but how these reactive species may affect each other 's fate and function is not well understood .
【GOLD_E】
SNOs	chem
H2O2	chem
thiol	chem
【PRE_E】
SNOs	chem
H2O2	chem
thiol	chem
【GOLD_R】
【PRE_R】

In this study we investigated how NO / SNO may affect the redox cycle of mammalian peroxiredoxin - 1 ( Prx1 ) , a representative of the 2 - Cys Prxs , a group of thioredoxin ( Trx ) - dependent peroxidases .
【GOLD_E】
NO	chem
SNO	chem
Cys	chem
mammalianperoxiredoxin-1	geneY
Prx1	geneY
2-CysPrxs	geneN
thioredoxin	geneY
Trx	geneY
peroxidases	geneN
【PRE_E】
NO	chem
SNO	chem
mammalianperoxiredoxin-1	geneY
Prx1	geneY
2-CysPrxs	geneN
thioredoxin	geneY
Trx	geneY
peroxidases	geneN
【GOLD_R】
【PRE_R】

We found that , both in a cell - free system and in cells , NO / SNO donors such as S - nitrosocysteine and S - nitrosoglutathione readily induced the S - nitrosylation of Prx1 , causing structural and functional alterations .
【GOLD_E】
NO	chem
SNO	chem
S-nitrosocysteine	chem
S-nitrosoglutathione	chem
S	chem
Prx1	geneY
【PRE_E】
NO	chem
SNO	chem
S-nitrosocysteine	chem
S-nitrosoglutathione	chem
Prx1	geneY
【GOLD_R】
【PRE_R】
S-nitrosoglutathione	Prx1	C3

In particular , nitrosylation promoted disulfide formation involving the pair of catalytic cysteines ( Cys - 52 and Cys - 173 ) and disrupted the oligomeric structure of Prx1 , leading to loss of peroxidase activity .
【GOLD_E】
disulfide	chem
cysteines	chem
Cys	chem
Cys	chem
Prx1	geneY
peroxidase	geneN
【PRE_E】
disulfide	chem
cysteines	chem
Cys	chem
Cys	chem
Prx1	geneY
peroxidase	geneN
【GOLD_R】
【PRE_R】

A highly potent inhibition of the peroxidase catalytic reaction by NO / SNO was seen in assays employing the coupled Prx - Trx system .
【GOLD_E】
peroxidase	geneN
Prx	geneN
Trx	geneY
NO	chem
SNO	chem
【PRE_E】
peroxidase	geneN
NO	chem
SNO	chem
Prx	geneN
Trx	geneY
【GOLD_R】
NO	peroxidase	C4
SNO	peroxidase	C4
【PRE_R】

In this setting , S - nitrosocysteine ( 10 μm ) effectively blocked the Trx - mediated regeneration of oxidized Prx1 .
【GOLD_E】
Trx	geneY
oxidizedPrx1	geneY
S-nitrosocysteine	chem
【PRE_E】
S-nitrosocysteine	chem
Trx	geneY
Prx1	geneY
【GOLD_R】
S-nitrosocysteine	Trx	C4
S-nitrosocysteine	oxidizedPrx1	C4
【PRE_R】
S-nitrosocysteine	Trx	C4

This effect appeared to be due to both competition between S - nitrosocysteine and Prx1 for the Trx system and direct modulation by S - nitrosocysteine of Trx reductase activity .
【GOLD_E】
Prx1	geneY
Trx	geneY
Trxreductase	geneN
S-nitrosocysteine	chem
S-nitrosocysteine	chem
【PRE_E】
S-nitrosocysteine	chem
Prx1	geneY
Trx	geneY
S-nitrosocysteine	chem
Trxreductase	geneY
【GOLD_R】
【PRE_R】

Our findings that NO / SNO target both Prx and Trx reductase may have implications for understanding the impact of nitrosylation on cellular redox homeostasis .
【GOLD_E】
SNO	chem
Prx	geneN
Trxreductase	geneN
NO	chem
【PRE_E】
NO	chem
SNO	chem
Prx	geneY
Trxreductase	geneY
【GOLD_R】
【PRE_R】

A Novel CUG ( exp ) · MBNL1 Inhibitor with Therapeutic Potential for Myotonic Dystrophy Type 1 .
【GOLD_E】
MBNL1	geneY
【PRE_E】
CUG	geneY
exp)	geneY
MBNL1	geneY
MyotonicDystrophyType1	geneY
【GOLD_R】
【PRE_R】

Myotonic dystrophy type 1 ( DM1 ) is caused by an expanded CUG repeat ( CUG ( exp ) ) that sequesters muscleblind - like 1 protein ( MBNL1 ) , a protein that regulates alternative splicing .
【GOLD_E】
MBNL1	geneY
muscleblind-like1protein	geneN
【PRE_E】
Myotonicdystrophytype1	geneY
DM1	geneY
expandedCUGrepeat	geneY
CUG(exp)	geneY
muscleblind-like1protein	geneY
MBNL1	geneY
【GOLD_R】
【PRE_R】

CUG ( exp ) RNA is a validated drug target for this currently untreatable disease .
【GOLD_E】
【PRE_E】
CUG(exp)	geneY
【GOLD_R】
【PRE_R】

Herein , we develop a bioactive small molecule ( 1 ) that targets CUG ( exp ) RNA and is able to inhibit the CUG ( exp ) · MBNL1 interaction in cells that model DM1 .
【GOLD_E】
MBNL1	geneY
【PRE_E】
CUG(exp)	geneY
CUG(exp)	geneY
MBNL1	geneY
【GOLD_R】
【PRE_R】

The core of this small molecule is based on ligand 2 , which was previously reported to be active in an in vitro assay .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A polyamine - derivative side chain was conjugated to this core to make it aqueous - soluble and cell - penetrable .
【GOLD_E】
polyamine	chem
【PRE_E】
polyamine	chem
【GOLD_R】
【PRE_R】

In a DM1 cell model this conjugate was found to disperse CUG ( exp ) ribonuclear foci , release MBNL1 , and partially reverse the mis - splicing of the insulin receptor pre - mRNA .
【GOLD_E】
MBNL1	geneY
insulinreceptor	geneY
【PRE_E】
CUG(exp)	geneY
MBNL1	geneY
insulinreceptor	geneY
【GOLD_R】
【PRE_R】

Direct evidence for ribonuclear foci dispersion by this ligand was obtained in a live DM1 cell model using time - lapse confocal microscopy .
【GOLD_E】
【PRE_E】
ribonuclear	geneN
【GOLD_R】
【PRE_R】

The induction of mitochondria - mediated apoptosis in cancer cells by ruthenium ( ii ) asymmetric complexes .
【GOLD_E】
ruthenium(ii)	chem
【PRE_E】
ruthenium(ii)	chem
【GOLD_R】
【PRE_R】

Four ruthenium ( ii ) asymmetric complexes , [ Ru ( bpy ) 2 ( PAIDH ) ] ( 2 + ) ( bpy = 2,2 ' - bipyridine , PAIDH = 2 - pyridyl - 1H - anthra [ 1,2 - d ] imidazole - 6,11 - dione , ) , [ Ru ( phen ) 2 ( PAIDH ) ] ( 2 + ) ( phen = 1,10 - phenanthroline , ) , [ Ru ( dmp ) 2 ( PAIDH ) ] ( 2 + ) ( dmp = 4,7 - dimethyl - 1,10 - phenanthroline , ) and [ Ru ( dip ) 2 ( PAIDH ) ] ( 2 + ) ( dip = 4,7 - diphenyl - 1,10 - phenanthroline , ) , have been synthesized and characterized .
【GOLD_E】
[Ru(bpy)2(PAIDH)](2+)	chem
ruthenium(ii)	chem
bpy	chem
2,2'-bipyridine	chem
PAIDH	chem
2-pyridyl-1H-anthra[1,2-d]imidazole-6,11-dione	chem
[Ru(phen)2(PAIDH)](2+)	chem
phen	chem
1,10-phenanthroline	chem
[Ru(dmp)2(PAIDH)](2+)	chem
dmp	chem
4,7-dimethyl-1,10-phenanthroline	chem
[Ru(dip)2(PAIDH)](2+)	chem
dip	chem
4,7-diphenyl-1,10-phenanthroline	chem
【PRE_E】
ruthenium(ii)	chem
[Ru(bpy)2(PAIDH)](2+)	chem
bpy=2,2'-bipyridine	chem
PAIDH=2-pyridyl-1H-anthra[1,2-d]imidazole-6,11-dione	chem
[Ru(phen)2(PAIDH)](2+)	chem
phen=1,10-phenanthroline	chem
[Ru(dmp)2(PAIDH)](2+)	chem
4,7-dimethyl-1,10-phenanthroline	chem
[Ru(dip)2(PAIDH)](2+)	chem
【GOLD_R】
【PRE_R】

These complexes displayed potent anti - proliferation activity against various cancer cell lines and had high selectivity between tumor cells and normal cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

HeLa cells exhibited the highest sensitivity to complex , accounting for the greatest cellular uptake .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Complex was shown to accumulate preferentially in the mitochondria of HeLa cells and induced apoptosis via the mitochondrial pathway , which involved ROS generation , mitochondrial membrane potential depolarisation , and Bcl - 2 and caspase family members activation .
【GOLD_E】
Bcl-2	geneY
caspase	geneN
【PRE_E】
Bcl-2	geneY
caspase	geneN
【GOLD_R】
【PRE_R】

These results demonstrated that complex induced cancer cell apoptosis by acting on mitochondrial pathways .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Platycodi Radix attenuates dimethylnitrosamine - induced liver fibrosis in rats by inducing Nrf2 - mediated antioxidant enzymes .
【GOLD_E】
dimethylnitrosamine	chem
Nrf2	geneY
【PRE_E】
dimethylnitrosamine	chem
Nrf2	geneY
【GOLD_R】
【PRE_R】
dimethylnitrosamine	Nrf2	C3

The purpose of this study was to investigate the anti - fibrotic effects of the aqueous extract of the Platycodi Radix root ( Changkil : CK ) on dimethylnitrosamine ( DMN ) - induced liver fibrosis in rats .
【GOLD_E】
dimethylnitrosamine	chem
DMN	chem
【PRE_E】
CK	chem
dimethylnitrosamine	chem
DMN	chem
【GOLD_R】
【PRE_R】

DMN treatment for 4weeks led to marked liver fibrosis as assessed by serum biochemistry , histopathological examination , and hepatic lipid peroxidation and collagen content .
【GOLD_E】
DMN	chem
collagen	geneN
【PRE_E】
DMN	chem
collagen	geneN
【GOLD_R】
【PRE_R】

CK significantly inhibited DMN - induced increases in serum alanine aminotransferase ( ALT ) and aspartate aminotransferase ( AST ) activities , fibrosis score , and hepatic malondialdehyde and collagen content .
【GOLD_E】
DMN	chem
alanine	chem
aspartate	chem
malondialdehyde	chem
alanineaminotransferase	geneN
ALT	geneN
aspartateaminotransferase	geneN
AST	geneN
collagen	geneN
【PRE_E】
CK	geneN
DMN	chem
alanineaminotransferase	geneN
ALT	geneN
aspartateaminotransferase	geneN
AST	geneN
malondialdehyde	chem
collagen	geneN
【GOLD_R】
DMN	alanineaminotransferase	C3
DMN	ALT	C3
DMN	aspartateaminotransferase	C3
DMN	AST	C3
DMN	collagen	C3
【PRE_R】
DMN	ALT	C3
DMN	AST	C3

CK also inhibited DMN - induced reductions in rat body and liver weights .
【GOLD_E】
DMN	chem
【PRE_E】
CK	geneN
DMN	chem
【GOLD_R】
【PRE_R】

Reverse transcription polymerase chain reaction ( RT - PCR ) and western blot analyses revealed that CK inhibited DMN - induced increases in matrix metalloproteinase - 13 ( MMP - 13 ) , tissue inhibitor of metalloproteinase - 1 ( TIMP - 1 ) , and tumor necrosis factor - α ( TNF - α ) mRNA , and collagen type I and α - smooth muscle actin protein .
【GOLD_E】
DMN	chem
matrixmetalloproteinase-13	geneY
MMP-13	geneY
tissueinhibitorofmetalloproteinase-1	geneY
TIMP-1	geneY
tumornecrosisfactor-α	geneY
TNF-α	geneY
collagentypeI	geneN
α-smoothmuscleactin	geneY
【PRE_E】
CK	chem
DMN	chem
matrixmetalloproteinase-13	geneY
MMP-13	geneY
metalloproteinase-1	geneY
TIMP-1	geneY
tumornecrosisfactor-α	geneY
TNF-α	geneY
collagentypeI	geneN
α-smoothmuscleactin	geneN
【GOLD_R】
DMN	matrixmetalloproteinase-13	C3
DMN	MMP-13	C3
DMN	tissueinhibitorofmetalloproteinase-1	C3
DMN	TIMP-1	C3
DMN	tumornecrosisfactor-α	C3
DMN	TNF-α	C3
DMN	collagentypeI	C3
DMN	α-smoothmuscleactin	C3
【PRE_R】
CK	matrixmetalloproteinase-13	C4
DMN	matrixmetalloproteinase-13	C4
DMN	MMP-13	C4
DMN	metalloproteinase-1	C4
DMN	TIMP-1	C4
DMN	tumornecrosisfactor-α	C4
DMN	TNF-α	C4
DMN	collagentypeI	C4
DMN	α-smoothmuscleactin	C4

DMN - induced cyclooxygenase - 2 ( COX - 2 ) expression and nuclear factor - kappa B ( NF - κB ) activation was reduced by CK treatment .
【GOLD_E】
DMN	chem
nuclearfactor-kappaB	geneN
NF-κB	geneN
cyclooxygenase-2	geneY
COX-2	geneY
【PRE_E】
DMN	chem
cyclooxygenase-2	geneY
COX-2	geneY
nuclearfactor-kappaB	geneN
NF-κB	geneN
CK	chem
【GOLD_R】
DMN	nuclearfactor-kappaB	C3
DMN	NF-κB	C3
DMN	cyclooxygenase-2	C3
DMN	COX-2	C3
【PRE_R】
DMN	cyclooxygenase-2	C3
COX-2	CK	C4
DMN	nuclearfactor-kappaB	C3
NF-κB	CK	C4

Furthermore , CK induced activation of nuclear erythroid 2 - related factor 2 ( Nrf2 ) - mediated antioxidant enzymes such as γ - glutamylcysteine synthetase ( γ - GCS ) , heme oxygenase - 1 ( HO - 1 ) , NAD ( P ) H quinone oxidoreductase 1 ( NQO1 ) , and glutathione - S - transferase ( GST ) in HepG2 cells .
【GOLD_E】
γ-glutamylcysteine	chem
nuclearerythroid2-relatedfactor2	geneY
Nrf2	geneY
γ-glutamylcysteinesynthetase	geneY
γ-GCS	geneY
hemeoxygenase-1	geneY
HO-1	geneY
NAD(P)Hquinoneoxidoreductase1	geneY
NQO1	geneY
glutathione-S-transferase	geneN
heme	chem
GST	geneN
NAD(P)H	chem
quinone	chem
glutathione	chem
S	chem
【PRE_E】
nuclearerythroid2-relatedfactor2	geneY
Nrf2	geneY
γ-glutamylcysteinesynthetase	geneY
γ-GCS	geneY
hemeoxygenase-1	geneY
HO-1	geneY
NAD(P)Hquinoneoxidoreductase1	geneY
NQO1	geneY
glutathione-S-transferase	geneN
GST	geneN
【GOLD_R】
【PRE_R】

These results demonstrated that CK attenuates DMN - induced liver fibrosis through the activation of Nrf2 - mediated antioxidant enzymes .
【GOLD_E】
Nrf2	geneY
DMN	chem
【PRE_E】
DMN	chem
Nrf2	geneY
【GOLD_R】
【PRE_R】
DMN	Nrf2	C3

Cadmium telluride quantum dots cause oxidative stress leading to extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2 cells .
【GOLD_E】
Cadmiumtelluride	chem
【PRE_E】
Cadmiumtelluride	chem
【GOLD_R】
【PRE_R】

The mechanisms of toxicity related to human hepatocellular carcinoma HepG2 cell exposures to cadmium telluride quantum dots ( CdTe - QDs ) were investigated .
【GOLD_E】
CdTe	chem
cadmiumtelluride	chem
【PRE_E】
cadmiumtelluride	chem
【GOLD_R】
【PRE_R】

CdTe - QDs caused cytotoxicity in HepG2 cells in a dose - and time - dependent manner .
【GOLD_E】
CdTe	chem
【PRE_E】
CdTe	chem
【GOLD_R】
【PRE_R】

Treated cells showed an increase in reactive oxygen species ( ROS ) .
【GOLD_E】
oxygen	chem
【PRE_E】
oxygen	chem
【GOLD_R】
【PRE_R】

Altered antioxidant levels were demonstrated by depletion of reduced glutathione ( GSH ) , a decreased ratio of reduced glutathione to oxidized glutathione ( GSH / GSSG ) and an increased NF - E2 - related Factor 2 ( Nrf2 ) activation .
【GOLD_E】
reducedglutathione	chem
GSH	chem
glutathione	chem
oxidizedglutathione	chem
GSH	chem
GSSG	chem
NF-E2-relatedFactor2	geneY
Nrf2	geneY
【PRE_E】
glutathione	chem
GSH	chem
glutathione	chem
glutathione	chem
GSH	chem
GSSG	chem
NF-E2-relatedFactor2	geneY
Nrf2	geneY
【GOLD_R】
【PRE_R】

Enzyme assays showed that superoxide dismutase ( SOD ) activity was elevated whereas catalase ( CAT ) and glutathione - S - transferase ( GST ) activities were depressed .
【GOLD_E】
superoxide	chem
glutathione	chem
S	chem
superoxidedismutase	geneN
SOD	geneN
catalase	geneY
CAT	geneY
glutathione-S-transferase	geneN
GST	geneN
【PRE_E】
superoxidedismutase	geneN
SOD	geneN
catalase	geneY
CAT	geneY
glutathione-S-transferase	geneN
GST	geneN
【GOLD_R】
【PRE_R】

Further analyses revealed that CdTe - QD exposure resulted in apoptosis , indicated by changes in levels of caspase - 3 activity , poly ADP - ribose polymerase ( PARP ) cleavage and phosphatidylserine externalization .
【GOLD_E】
CdTe	chem
polyADP-ribose	chem
phosphatidylserine	chem
caspase-3	geneY
polyADP-ribosepolymerase	geneN
PARP	geneN
【PRE_E】
CdTe	chem
caspase-3	geneY
polyADP-ribosepolymerase	geneN
PARP	geneN
phosphatidylserine	chem
【GOLD_R】
【PRE_R】

Extrinsic apoptotic pathway markers such as Fas levels and caspase - 8 activity increased as a result of CdTe - QD exposure .
【GOLD_E】
CdTe	chem
Fas	geneY
caspase-8	geneY
【PRE_E】
Fas	geneY
caspase-8	geneY
CdTe	chem
【GOLD_R】
CdTe	caspase-8	C3
CdTe	Fas	C3
【PRE_R】

Involvement of the intrinsic / mitochondrial apoptotic pathway was indicated by decreased levels of B - cell lymphoma 2 ( Bcl2 ) protein and mitochondrial cytochrome c , and by increased levels of mitochondrial Bcl - 2 - associated X protein ( Bax ) and cytosolic cytochrome c .
【GOLD_E】
B-celllymphoma2	geneY
Bcl2	geneY
cytochromec	geneY
Bcl-2-associatedXprotein	geneY
Bax	geneY
cytochromec	geneY
【PRE_E】
B-celllymphoma2	geneY
Bcl2	geneY
mitochondrialcytochromec	geneY
mitochondrialBcl-2-associatedXprotein	geneY
Bax	geneY
cytosoliccytochromec	geneY
【GOLD_R】
【PRE_R】

Further , mitogen - activated protein kinases ( MAPKs ) such as c - Jun N - terminal kinases ( JNK ) , extracellular signal - regulated kinases ( Erk1 / 2 ) , and p38 were all activated .
【GOLD_E】
N	chem
mitogen-activatedproteinkinases	geneN
MAPKs	geneN
c-JunN-terminalkinases	geneN
JNK	geneN
extracellularsignal-regulatedkinases	geneN
Erk1/2	geneN
p38	geneN
【PRE_E】
mitogen-activatedproteinkinases	geneN
MAPKs	geneN
c-JunN-terminalkinases	geneN
JNK	geneN
extracellularsignal-regulatedkinases	geneN
Erk1/2	geneN
p38	geneN
【GOLD_R】
【PRE_R】

Our findings reveal that CdTe - QDs cause oxidative stress , interfere with antioxidant defenses and activate protein kinases , leading to apoptosis via both extrinsic and intrinsic pathways .
【GOLD_E】
kinases	geneN
CdTe	chem
【PRE_E】
CdTe	chem
proteinkinases	geneN
【GOLD_R】
CdTe	kinases	C3
【PRE_R】

Since the effects of CdTe - QDs on selected biomarkers were similar or greater compared to those of CdCl2 at equivalent concentrations of cadmium , the study suggests that the toxicity of CdTe - QDs arises from a combination of the effects of cadmium and ROS generated from the NPs .
【GOLD_E】
CdTe	chem
CdCl2	chem
cadmium	chem
CdTe	chem
【PRE_E】
CdTe	chem
CdCl2	chem
cadmium	chem
CdTe	chem
cadmium	chem
【GOLD_R】
【PRE_R】

Reinforcement enhancing effects of nicotine via smoking .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

RATIONALE : In animals , nicotine enhances reinforcement from stimuli unrelated to nicotine intake .
【GOLD_E】
nicotine	chem
nicotine	chem
【PRE_E】
nicotine	chem
nicotine	chem
【GOLD_R】
【PRE_R】

Human research is suggestive but has not clearly shown a similar influence of nicotine .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

OBJECTIVES : We assessed acute effects of nicotine via smoking on enhancement of positive ( money , music ) or negative ( termination of noise ) reinforcers , or no `` reward `` ( control ) .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

These different rewards determined the generalizability of nicotine effects .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

MATERIALS AND METHODS : Dependent ( n = 25 ) and nondependent ( n = 27 ) smokers participated in three sessions , each after overnight abstinence .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Using a within - subjects design , sessions involved no smoking or smoking denicotinized ( 0.05 mg ) or nicotine ( 0.6 mg ) Quest ( R ) brand cigarettes .
【GOLD_E】
icotine(	chem
【PRE_E】
denicotinized	chem
nicotine	chem
【GOLD_R】
【PRE_R】

For comparison , a fourth session involved no abstinence prior to smoking one 's own brand to gauge responses under typical nicotine satiation .
【GOLD_E】
nicotine	chem
【PRE_E】
abstinence	chem
nicotine	chem
【GOLD_R】
【PRE_R】

Reinforcement was assessed by responses on a simple operant computer task for the rewards , each available singly on a progressive ratio schedule during separate trials .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

RESULTS : The reinforcing effect of music , but not other rewards , was greater due to the nicotine cigarette , compared to the denicotinized cigarette or no smoking .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

Reinforcement enhancing effects of nicotine did not differ between dependent and nondependent groups , indicating no influence of withdrawal relief .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
【GOLD_R】
【PRE_R】

Responding due to acute nicotine after abstinence was very similar to responding to one 's own brand after no abstinence .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
abstinence	chem
abstinence	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS : Acute nicotine intake per se from smoking after abstinence enhances the reinforcing value of rewards unassociated with smoking , perhaps in a manner comparable to ad lib smoking after no abstinence .
【GOLD_E】
nicotine	chem
【PRE_E】
nicotine	chem
abstinence	chem
abstinence	chem
【GOLD_R】
【PRE_R】

Nicotine 's reinforcement enhancing effects may be specific to certain rewards , perhaps those sensory in nature .
【GOLD_E】
Nicotine	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Anti - apoptotic cardioprotective effects of SHP - 1 gene silencing against ischemia - reperfusion injury : Use of deoxycholic acid - modified low molecular weight polyethyleneimine as a cardiac siRNA - carrier .
【GOLD_E】
SHP-1	geneY
deoxycholicacid	chem
polyethyleneimine	chem
【PRE_E】
SHP-1	geneY
deoxycholicacid	chem
【GOLD_R】
【PRE_R】

The cardiomyocyte apoptosis plays a critical role in the development of myocardial injury after ischemia and reperfusion .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , alteration of the major apoptosis - regulatory factors during myocardial ischemia - reperfusion is expected to have favorable cardioprotective effects .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Herein , we report ischemic - reperfused myocardial infarction ( MI ) repair with siRNA against Src homology region 2 domain - containing tyrosine phosphatase - 1 ( SHP - 1 ) , which is known as a key factor involved in regulating the progress of apoptosis in many cell types .
【GOLD_E】
Srchomologyregion2domain-containingtyrosinephosphatase-1	geneY
SHP-1	geneY
tyrosine	chem
【PRE_E】
Src	geneY
tyrosinephosphatase-1	geneY
SHP-1	geneY
【GOLD_R】
【PRE_R】

A low molecular weight polyethyleneimine modified with deoxycholic acid ( PEI1.8 - DA ) - based delivery strategy was suggested for the cardiac application of SHP - 1 siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles .
【GOLD_E】
SHP-1	geneY
polyethyleneimine	chem
deoxycholicacid	chem
【PRE_E】
deoxycholicacid	chem
PEI1.8-DA	chem
SHP-1	geneY
【GOLD_R】
【PRE_R】
PEI1.8-DA	SHP-1	C3

The PEI1.8 - DA conjugates formed stable nanocomplexes with SHP - 1 siRNA via electrostatic and hydrophobic interactions .
【GOLD_E】
SHP-1	geneY
【PRE_E】
PEI1.8	chem
DA	chem
SHP-1	geneY
【GOLD_R】
【PRE_R】

The PEI1.8 - DA / SHP - 1 siRNA polyplexes effectively silenced SHP - 1 gene expression in cardiomyocytes , leading to a significant inhibition of cardiomyocyte apoptosis under hypoxia .
【GOLD_E】
SHP-1	geneY
SHP-1	geneY
【PRE_E】
PEI1.8-DA	chem
SHP-1	geneY
polyplexes	chem
SHP-1	geneY
【GOLD_R】
【PRE_R】
PEI1.8-DA	SHP-1	C3
polyplexes	SHP-1	C3

In comparison to conventional gene carriers , relatively large amounts of siRNA molecules remained after treatment with the PEI1.8 - DA / SHP - 1 siRNA polyplexes .
【GOLD_E】
SHP-1	geneY
【PRE_E】
PEI1.8	chem
DA	chem
SHP-1	geneY
polyplexes	chem
【GOLD_R】
【PRE_R】

Cardiac administration of the PEI1.8 - DA / SHP - 1 siRNA polyplexes resulted in substantial improvement in SHP - 1 gene silencing , which can be explained by the enhancement of cardiac delivery efficiency of the PEI1.8 - DA conjugates .
【GOLD_E】
SHP-1	geneY
SHP-1	geneY
【PRE_E】
PEI1.8-DA	chem
SHP-1	geneY
polyplexes	chem
SHP-1	geneY
PEI1.8-DA	chem
【GOLD_R】
【PRE_R】
PEI1.8-DA	SHP-1	C3
SHP-1	polyplexes	C3
polyplexes	SHP-1	C3
SHP-1	PEI1.8-DA	C3

In addition , in vivo treatment with the PEI1.8 - DA / SHP - 1 siRNA polyplexes induced a highly significant reduction in myocardial apoptosis and infarct size in rat MI models .
【GOLD_E】
SHP-1	geneY
【PRE_E】
PEI1.8	chem
DA	chem
SHP-1	geneY
polyplexes	chem
【GOLD_R】
【PRE_R】

These results demonstrate that the PEI1.8 - DA / SHP - 1 siRNA polyplex formulation is a useful system for efficient gene delivery into the compact myocardium that provides a fundamental advantage in treating ischemic - reperfused MI .
【GOLD_E】
SHP-1	geneY
【PRE_E】
PEI1.8	chem
DA	chem
SHP-1	geneY
polyplex	chem
【GOLD_R】
【PRE_R】

Synthesis of C17 - OH - north unit of ritterazine G via `` Red - Ox `` modifications of hecogenin acetate .
【GOLD_E】
OH	chem
ritterazineG	chem
ofhecogeninaceta	chem
【PRE_E】
C17-OH	chem
ritterazineG	chem
Red-Ox	geneN
hecogeninacetate	chem
【GOLD_R】
【PRE_R】

The C17 - OH - north unit of ritterazine G was prepared in 13 steps from hecogenin acetate .
【GOLD_E】
ritterazineG	chem
hecogeninacetate	chem
OH	chem
【PRE_E】
C17-OH	chem
ritterazineG	chem
hecogeninacetate	chem
【GOLD_R】
【PRE_R】

This synthesis features a highly efficient and stereoselective introduction of the C17 - OH via E - ring cleavage / F - ring formation , D - ring oxidation , and F - ring cleavage / E - ring formation .
【GOLD_E】
OH	chem
【PRE_E】
C17-OH	chem
E	chem
F	chem
F	chem
【GOLD_R】
【PRE_R】

Inhibitory effects of in vivo oxidized high - density lipoproteins on platelet aggregation : evidence from patients with abetalipoproteinemia .
【GOLD_E】
oxidizedhigh-densitylipoproteins	geneN
【PRE_E】
lipoproteins	geneN
abetalipoproteinemia	geneY
【GOLD_R】
【PRE_R】

There is evidence that high - density lipoproteins ( HDLs ) may regulate platelet function , but disparate results exist regarding the effects of oxidized HDLs on platelets .
【GOLD_E】
high-densitylipoproteins	geneN
HDLs	geneN
HDLs	geneN
【PRE_E】
high-densitylipoproteins	geneN
HDLs	geneN
HDLs	chem
【GOLD_R】
【PRE_R】

The objective of our study was to determine the role of in vivo oxidized HDLs on platelet aggregation .
【GOLD_E】
oxidizedHDLs	geneN
【PRE_E】
HDLs	geneN
【GOLD_R】
【PRE_R】

Platelet aggregation and redox status were investigated in 5 patients with abetalipoproteinemia ( ABLP ) or homozygous hypobetalipoproteinemia , two rare metabolic diseases characterized by the absence of apolipoprotein B - containing lipoproteins , compared to 5 control subjects .
【GOLD_E】
apolipoproteinB	geneY
lipoproteins	geneN
【PRE_E】
abetalipoproteinemia	geneY
ABLP	geneY
hypobetalipoproteinemia	geneY
apolipoproteinB	geneY
lipoproteins	geneN
【GOLD_R】
【PRE_R】

Platelets isolated from plasma of patients with ABLP aggregated 4 to 10 times more than control platelets , depending on the agonist .
【GOLD_E】
【PRE_E】
ABLP	chem
【GOLD_R】
【PRE_R】

By contrast , no differences in the extent of platelet aggregation were observed between ABLP platelet - rich plasma ( PRP ) and control PRP , suggesting the presence of a protective factor in ABLP plasma .
【GOLD_E】
【PRE_E】
ABLPplatelet-richplasma	geneN
PRP	geneN
PRP	geneN
ABLP	geneY
【GOLD_R】
【PRE_R】

ABLP HDLs inhibited agonist - induced platelet aggregation by binding to SR - BI , while control HDLs had no effect .
【GOLD_E】
HDLs	geneN
SR-BI	geneY
HDLs	geneN
【PRE_E】
ABLPHDLs	geneY
SR-BI	geneY
HDLs	geneN
【GOLD_R】
【PRE_R】

On the other hand , lipoprotein - deficient plasma from patients with ABLP did not inhibit platelet aggregation .
【GOLD_E】
lipoprotein	geneN
【PRE_E】
lipoprotein	geneN
ABLP	geneY
【GOLD_R】
【PRE_R】

Severe oxidative stress was evidenced in patients with ABLP .
【GOLD_E】
【PRE_E】
ABLP	chem
【GOLD_R】
【PRE_R】

Compared to control HDLs , ABLP HDLs showed a 40 % decrease of α - tocopherol and an 11 - fold increased malondialdehyde concentration .
【GOLD_E】
α-tocopherol	chem
malondialdehyde	chem
HDLs	geneN
HDLs	geneN
【PRE_E】
HDLs	geneN
ABLPHDLs	geneY
α-tocopherol	chem
malondialdehyde	chem
【GOLD_R】
【PRE_R】
HDLs	α-tocopherol	C9
ABLPHDLs	α-tocopherol	C9

These results demonstrate that in vivo oxidized HDLs do not lose their antiaggregatory properties despite oxidation . - Calzada , C. , Véricel , E. , Colas , R. , Guillot , N. , El Khoury , G. , Drai , J. , Sassolas , A. , Peretti , N. , Ponsin , G. , Lagarde , M. , Moulin , P .
【GOLD_E】
oxidizedHDLs	geneN
【PRE_E】
HDLs	geneN
【GOLD_R】
【PRE_R】

Inhibitory effects of in vivo oxidized high - density lipoproteins on platelet aggregation : evidence from patients with abetalipoproteinemia .
【GOLD_E】
oxidizedhigh-densitylipoproteins	geneN
【PRE_E】
lipoproteins	geneN
abetalipoproteinemia	geneY
【GOLD_R】
【PRE_R】

Derivatives of Dictyostelium discoideum differentiation - inducing factor - 3 suppress the activities of Trypanosoma cruzi in vitro and in vivo .
【GOLD_E】
【PRE_E】
Dictyosteliumdiscoideumdifferentiation-inducingfactor-3	geneY
Trypanosomacruzi	geneN
【GOLD_R】
【PRE_R】

Chagas disease ( human American trypanosomiasis ) , which is caused by the protozoan parasite Trypanosoma cruzi , is responsible for numerous deaths each year ; however , established treatments for the disease are limited .
【GOLD_E】
【PRE_E】
protozoanparasiteTrypanosomacruzi	geneN
【GOLD_R】
【PRE_R】

Differentiation - inducing factor - 1 ( DIF - 1 ) and DIF - 3 are chlorinated alkylphenones originally found in the cellular slime mold Dictyostelium discoideum that have been shown to possess pharmacological activities .
【GOLD_E】
alkylphenones	chem
【PRE_E】
Differentiation-inducingfactor-1	geneY
DIF-1	geneY
DIF-3	geneY
chlorinatedalkylphenones	chem
【GOLD_R】
【PRE_R】

Here , we investigated the effects of DIF - 3 derivatives on the infection rate and growth of T. cruzi by using an in vitro assay system utilizing host human fibrosarcoma HT1080 cells .
【GOLD_E】
【PRE_E】
DIF-3	geneY
【GOLD_R】
【PRE_R】

Certain DIF - 3 derivatives , such as butoxy - DIF - 3 ( Bu - DIF - 3 ) , at micro - molar levels strongly suppressed both the infection rate and growth of T. cruzi in HT1080 cells and exhibited little toxicity for HT1080 cells .
【GOLD_E】
butoxy	chem
【PRE_E】
DIF-3	geneY
butoxy-DIF-3	chem
【GOLD_R】
【PRE_R】

For example , the IC50 of DIF - 3 and Bu - DIF - 3 versus the growth of T. cruzi in HT1080 cells were 3.95 and 0.72μM , respectively , and the LD50 of the two compounds versus HT1080 cells were both greater than 100μM .
【GOLD_E】
【PRE_E】
DIF-3	geneY
【GOLD_R】
【PRE_R】

We also examined the effects of DIF - 3 and Bu - DIF - 3 on T. cruzi activity in C57BL / 6 mice .
【GOLD_E】
【PRE_E】
DIF-3	geneY
Bu-DIF-3	geneY
【GOLD_R】
【PRE_R】

Intraperitoneally administered Bu - DIF - 3 ( 50mg / kg ) significantly suppressed the number of trypomastigotes in blood with no apparent adverse effects .
【GOLD_E】
【PRE_E】
Bu-DIF-3	geneY
【GOLD_R】
【PRE_R】

These results strongly suggest that DIF - 3 derivatives could be new lead compounds in the development of anti - trypanosomiasis drugs .
【GOLD_E】
【PRE_E】
DIF-3	geneY
【GOLD_R】
【PRE_R】

Neuroprotective Effects of Puerarin on 1 - methyl - 4 - phenyl - 1,2,3,6 - tetrahydropyridine induced Parkinson 's Disease Model in Mice .
【GOLD_E】
Puerarin	chem
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	chem
【PRE_E】
Puerarin	chem
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	chem
【GOLD_R】
【PRE_R】

Puerarin , an active component of Pueraria montana var . lobata ( Willd . ) Sanjappa & Pradeep is well - known for its anti - oxidative and neuroprotective activities .
【GOLD_E】
Puerarin	chem
【PRE_E】
Puerarin	chem
【GOLD_R】
【PRE_R】

Although anti - Parkinson 's disease activity of puerarin was reported in both of in vivo and in vitro model , detailed mechanisms are not clarified .
【GOLD_E】
puerarin	chem
【PRE_E】
puerarin	chem
【GOLD_R】
【PRE_R】

In this study , we addressed that puerarin attenuated 1 - methyl - 4 - phenyl - 1,2,3,6 - tetrahydropyridine ( MPTP ) - induced behavioral deficits , dopaminergic neuronal degeneration and dopamine depletion .
【GOLD_E】
puerarin	chem
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	chem
MPTP	chem
dopamine	chem
【PRE_E】
puerarin	chem
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	chem
MPTP	chem
dopamine	chem
【GOLD_R】
【PRE_R】

Puerarin administration enhanced glutathione ( GSH ) activity , glial cell line - derived neurotrophic factor ( GDNF ) expression and PI3K / Akt pathway activation , which might ameliorate MPTP injection - induced progressive elevation of reactive oxygen species ( ROS ) formation in mice .
【GOLD_E】
glutathione	chem
GSH	chem
MPTP	chem
oxygen	chem
glialcellline-derivedneurotrophicfactor	geneY
GDNF	geneY
PI3K	geneN
Akt	geneN
Puerarin	chem
【PRE_E】
Puerarin	chem
glutathione	chem
GSH	chem
glialcellline-derivedneurotrophicfactor	geneY
GDNF	geneY
PI3K	geneN
Akt	geneN
MPTP	chem
oxygen	chem
【GOLD_R】
Puerarin	PI3K	C3
Puerarin	Akt	C3
Puerarin	glialcellline-derivedneurotrophicfactor	C3
Puerarin	GDNF	C3
【PRE_R】
Puerarin	glialcellline-derivedneurotrophicfactor	C3
Puerarin	Akt	C3

In addition to the effect on ROS , puerarin ameliorated MPTP - reduced lysosome - associated membrane protein type 2A ( Lamp 2A ) expression .
【GOLD_E】
puerarin	chem
MPTP	chem
lysosome-associatedmembraneproteintype2A	geneY
Lamp2A	geneY
【PRE_E】
puerarin	chem
MPTP	chem
lysosome-associatedmembraneproteintype2A(Lamp2A	geneY
【GOLD_R】
puerarin	Lamp2A	C4
MPTP	lysosome-associatedmembraneproteintype2A	C4
MPTP	Lamp2A	C4
【PRE_R】
puerarin	lysosome-associatedmembraneproteintype2A(Lamp2A	C3
MPTP	lysosome-associatedmembraneproteintype2A(Lamp2A	C3

Taken together , our data demonstrate that puerarin attenuates MPTP - induced dopaminergic neuronal degeneration via modulating GDNF expression , PI3K / Akt pathway and GSH activation , which subsequently ameliorate MPTP - induced ROS formation and decrease of Lamp 2A expression .
【GOLD_E】
puerarin	chem
MPTP	chem
GDNF	geneY
PI3K	geneN
Akt	geneN
Lamp2A	geneY
GSH	chem
MPTP	chem
【PRE_E】
puerarin	chem
MPTP	chem
GDNF	geneY
PI3K	geneN
Akt	geneN
GSH	chem
MPTP	chem
Lamp2A	geneY
【GOLD_R】
puerarin	Lamp2A	C4
MPTP	Lamp2A	C4
【PRE_R】
puerarin	GDNF	C3
MPTP	GDNF	C3
MPTP	PI3K	C3
Akt	MPTP	C3
MPTP	Lamp2A	C3

Copyright © 2013 John Wiley & Sons , Ltd .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer .
【GOLD_E】
porphycene	chem
【PRE_E】
porphycene	chem
【GOLD_R】
【PRE_R】

In the present study we analyze the photobiological properties of 2,7,12 - tris ( α - pyridinio - p - tolyl ) - 17 - ( p - ( methoxymethyl ) phenyl ) porphycene ( Py3MeO - TBPo ) in Hela cells , in order to assess its potential as a new photosensitizer for photodynamic therapy of cultured tumor cells .
【GOLD_E】
2,7,12-tris(α-pyridinio-p-tolyl)-17-(p-(methoxymethyl)phenyl)porphycene	chem
Py3MeO-TBPo	chem
【PRE_E】
2,7,12-tris(α-pyridinio-p-tolyl)-17-(p-(methoxymethyl)phenyl)porphycene	chem
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

Using 0.5 μM Py3MeO - TBPo , flow cytometry studies demonstrated an increase of intracellular drug levels related to the incubation time , reaching a maximum at 18 h .
【GOLD_E】
y3MeO-TBPo,	chem
【PRE_E】
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

LysoTracker ( ® ) Green ( LTG ) and MitoTracker ( ® ) Green ( MTG ) probes were used to identify the subcellular localization .
【GOLD_E】
【PRE_E】
LTG	chem
【GOLD_R】
【PRE_R】

Upon exposure to ultraviolet excitation , red porphycene fluorescence was detected as red granules in the cytoplasm that colocalized with LTG .
【GOLD_E】
porphycene	chem
【PRE_E】
porphycene	chem
LTG	chem
【GOLD_R】
【PRE_R】

No significant toxic effects were detected for Py3MeO - TBPo in the dark at concentrations below 1 μM .
【GOLD_E】
Py3MeO-TBPo	chem
【PRE_E】
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

In contrast , Py3MeO - TBPo combined with red - light irradiation induced concentration - and fluence - dependent HeLa cells inactivation .
【GOLD_E】
Py3MeO-TBPo	chem
【PRE_E】
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

Besides , all photodynamic protocols assayed induced a clear effect of cell detachment inhibition after trypsin treatment .
【GOLD_E】
trypsin	geneN
【PRE_E】
trypsin	geneN
【GOLD_R】
【PRE_R】

Both apoptotic and necrotic cell death mechanisms can occur in HeLa cells depending on the experimental protocol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

After 18 h incubation with 0.5 μM Py3MeO - TBPo and subsequent red light irradiation ( 3.6 J / cm ( 2 ) ) , a high number of cells die by apoptosis , as evaluated by morphological alterations , immunofluorescent relocalization of Bax from cytosol to mitochondria , and TUNEL assay .
【GOLD_E】
fro	geneY
3MeO-TBPoan	chem
【PRE_E】
Py3MeO-TBPo	chem
Bax	geneY
【GOLD_R】
【PRE_R】

Likewise , immunofluorescence techniques showed that cytochrome c is released from mitochondria into cytosol in cells undergoing apoptosis , which occurs immediately after relocation of Bax in mitochondria .
【GOLD_E】
cytochromec	geneY
Bax	geneY
【PRE_E】
cytochromec	geneY
Bax	geneY
【GOLD_R】
【PRE_R】

The highest amount of apoptosis appeared 24 h after treatment ( 70 % ) and this cell death occurred without cell detachment to the substrate .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast , with 0.75 μM Py3MeO - TBPo and 3.6 J / cm ( 2 ) irradiation , morphological changes showed a preferential necrotic cell death .
【GOLD_E】
y3MeO-TBPoa	chem
【PRE_E】
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

Singlet oxygen was identified as the cytotoxic agent involved in cell photoinactivation .
【GOLD_E】
oxygen	chem
【PRE_E】
Singletoxygen	chem
【GOLD_R】
【PRE_R】

Moreover , cell cultures pre - exposed to the singlet oxygen scavenger sodium azide showed pronounced protection against the loss of viability induced by Py3MeO - TBPo and light .
【GOLD_E】
oxygen	chem
sodiumazide	chem
Py3MeO-TBPo	chem
【PRE_E】
singletoxygen	chem
sodiumazide	chem
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

Different changes in distribution and organization of cytoskeletal elements ( microtubules and actin microfilaments ) as well as the protein vinculin , after apoptotic and necrotic photodynamic treatments have been analyzed .
【GOLD_E】
microtubules	geneN
actin	geneN
vinculin	geneY
【PRE_E】
cytoskeletalelements	geneN
microtubules	geneN
actin	geneN
vinculin	geneN
【GOLD_R】
【PRE_R】

Neither of these two cell death mechanisms ( apoptosis or necrosis ) induced cell detachment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In summary , Py3MeO - TBPo appears to meet the requirements for further scrutiny as a very good photosensitizer for photodynamic therapy : it is water soluble , has a high absorption in the red spectral region ( where light penetration in tissue is higher ) , and is able to induce effective high apoptotic rate ( 70 % ) related to the more widely studied photosensitizers .
【GOLD_E】
Py3MeO-TBPo	chem
【PRE_E】
Py3MeO-TBPo	chem
【GOLD_R】
【PRE_R】

Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled - coil domain regulates 6 - helical bundle formation .
【GOLD_E】
Ile646Lys	geneN
gp41coiled-coildomain	geneN
【PRE_E】
Ile646Lys	chem
gp41coiled-coildomain	geneN
【GOLD_R】
【PRE_R】

HIV entry is mediated by the envelope glycoproteins gp120 and gp41 .
【GOLD_E】
envelopeglycoproteinsgp120	geneY
gp41	geneY
【PRE_E】
envelopeglycoproteinsgp120	geneN
gp41	geneN
【GOLD_R】
【PRE_R】

The gp41 subunit contains several functional domains : the N - terminal heptad repeat ( NHR ) domains fold a triple stranded coiled - coil forming a meta - stable prefusion intermediate .
【GOLD_E】
gp41	geneY
N	chem
N-terminalheptadrepeat(NHR)domains	geneN
【PRE_E】
gp41	geneN
N-terminalheptadrepeat(NHR)domains	geneN
【GOLD_R】
【PRE_R】

C - terminal heptad repeat ( CHR ) subsequently folds onto the hydrophobic grooves of the NHR coiled - coil to form a stable 6 - helix bundle , which juxtaposes the viral and cellular membranes for fusion .
【GOLD_E】
C	chem
【PRE_E】
C-terminalheptadrepeat	geneN
CHR	geneY
NHR	geneN
【GOLD_R】
【PRE_R】

The C34 which has 34 amino acid residues is known as the core structure in CHR .
【GOLD_E】
aminoacid	chem
【PRE_E】
C34	chem
aminoacid	chem
【GOLD_R】
【PRE_R】

A highly anti - HIV peptide inhibitor derived from C34 was designed .
【GOLD_E】
【PRE_E】
C34	chem
【GOLD_R】
【PRE_R】

An artificial salt bridge was added in the 6 - helical bundle by substitution of lysine for Ile646 .
【GOLD_E】
lysine	chem
Ile	chem
【PRE_E】
lysine	chem
Ile646	chem
【GOLD_R】
【PRE_R】

With a cholesterol modification at C - terminal , the inhibitor containing I646K mutation represented higher anti - viral activity than C34 - cholesterol combination without mutation .
【GOLD_E】
I646K	geneN
cholesterol	chem
C	chem
cholesterol	chem
【PRE_E】
cholesterol	chem
C	chem
I646K	geneN
C34	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

Cytotoxic mechanism of Piper gaudichaudianum Kunth essential oil and its major compound nerolidol .
【GOLD_E】
nerolidol	chem
【PRE_E】
nerolidol	chem
【GOLD_R】
【PRE_R】

Piper gaudichaudianum Kunth is used in popular medicine as anti - inflamatory and against liver disorders .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

One of the most studied components of the plant is the essential oil for which chemical analysis revealed ( E ) - nerolidol as major compound .
【GOLD_E】
(E)-nerolidol	chem
【PRE_E】
(E)-nerolidol	chem
【GOLD_R】
【PRE_R】

Recently , we have shown that P. gaudichaudianum essential oil possesses strong cytotoxic effects in mammalian V79 cells .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The aim of this study was to analyze the cytotoxicity and mutagenicity of P. gaudichaudianum essential oil and nerolidol using Saccharomyces cerevisiae as model study .
【GOLD_E】
nerolidol	chem
【PRE_E】
nerolidol	chem
【GOLD_R】
【PRE_R】

Treatment of the XV185 - 14c and N123 strains with essential oil and nerolidol led to cytotoxicity but did not induce mutagenicity .
【GOLD_E】
nerolidol	chem
【PRE_E】
XV185-14c	chem
N123	chem
nerolidol	chem
【GOLD_R】
【PRE_R】

Our results revealed an important role of base excision repair ( BER ) as the ntg1 , ntg2 , apn1 and apn2 mutants showed pronounced sensitivity to essential oil and nerolidol .
【GOLD_E】
ntg1	geneY
ntg2	geneY
apn1	geneY
apn2	geneY
nerolidol	chem
【PRE_E】
BER	geneN
ntg1	geneN
ntg2	geneN
apn1	geneN
apn2	geneN
nerolidol	chem
【GOLD_R】
【PRE_R】

In the absence of superoxide dismutase ( in sod1 Δ mutant strain ) sensitivity to the essential oil and nerolidol increased indicating that this oil and nerolidol are generating reactive oxygen species ( ROS ) .
【GOLD_E】
nerolidol	chem
superoxidedismutase	geneY
sod1	geneY
oxygen	chem
superoxide	chem
nerolidol	chem
【PRE_E】
superoxidedismutase	geneN
sod1Δ	geneY
nerolidol	chem
nerolidol	chem
oxygen	chem
【GOLD_R】
【PRE_R】

The ROS production was confirmed by DCF - DA probing assay in Sod - deficient strains .
【GOLD_E】
Sod	geneY
DCF-DA	chem
【PRE_E】
DCF-DA	chem
【GOLD_R】
【PRE_R】

From this , we conclude that the observed cytotoxicity to P. gaudichaudianum essential oil and nerolidol is mainly related to ROS and DNA single strand breaks generated by the presence of oxidative lesions .
【GOLD_E】
nerolidol	chem
【PRE_E】
nerolidol	chem
【GOLD_R】
【PRE_R】

Synthesis and biological evaluation of novel pyrrolidine - 2,5 - dione derivatives as potential antidepressant agents . Part 1 .
【GOLD_E】
pyrrolidine-2,5-dione	chem
【PRE_E】
pyrrolidine-2,5-dione	chem
【GOLD_R】
【PRE_R】

A series of 3 - ( 1H - indol - 3 - yl ) pyrrolidine - 2,5 - dione derivatives was synthesized and their biological activity was evaluated .
【GOLD_E】
3-(1H-indol-3-yl)pyrrolidine-2,5-dione	chem
【PRE_E】
3-(1H-indol-3-yl)pyrrolidine-2,5-dione	chem
【GOLD_R】
【PRE_R】

The chemical structures of the newly prepared compounds were confirmed by ( 1 ) H NMR , ( 13 ) C NMR and ESI - HRMS spectra data .
【GOLD_E】
(1)H	chem
(13)C	chem
【PRE_E】
(1)H	chem
(13)C	chem
【GOLD_R】
【PRE_R】

All tested compounds proved to be potent 5 - HT1A receptor and serotonin transporter protein ( SERT ) ligands .
【GOLD_E】
serotonin	chem
5-HT1A	geneY
serotonintransporterprotein	geneY
SERT	geneY
【PRE_E】
5-HT1A	geneY
serotonintransporterprotein	geneY
SERT	geneY
【GOLD_R】
【PRE_R】

Among them , compounds 15 , 18 , 19 and 30 showed significant affinity for 5 - HT1A and SERT .
【GOLD_E】
SERT	geneY
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
SERT	geneY
【GOLD_R】
【PRE_R】

Computer docking simulations carried out for compounds 15 , 31 and 32 to models of 5 - HT1A receptor and SERT confirm the results of biological tests .
【GOLD_E】
5-HT1A	geneY
SERT	geneY
【PRE_E】
5-HT1A	geneY
SERT	geneY
【GOLD_R】
【PRE_R】

Due to high affinity for the 5 - HT1A receptor and moderate affinity for SERT , compounds 31 , 32 , 35 , and 37 were evaluated for their affinity for D2L , 5 - HT6 , 5 - HT7 and 5 - HT2A receptors .
【GOLD_E】
5-HT1A	geneY
SERT	geneY
D2L	geneY
5-HT6	geneY
5-HT7	geneY
5-HT2A	geneY
【PRE_E】
5-HT1A	geneY
SERT	geneY
D2L	geneY
5-HT6	geneY
5-HT7	geneY
5-HT2A	geneY
【GOLD_R】
【PRE_R】

In vivo tests , in turn , resulted in determining the functional activity of compounds 15 , 18 , 19 and 30 to the 5 - HT1A receptor .
【GOLD_E】
-HT1Ar	geneY
【PRE_E】
5-HT1A	geneY
【GOLD_R】
【PRE_R】

The results of these tests indicate that all of the ligands possess properties characteristic of 5 - HT1A receptor agonists .
【GOLD_E】
5-HT1A	geneY
【PRE_E】
5-HT1A	geneY
【GOLD_R】
【PRE_R】

Metabolism Studies of Unformulated Internally [ 3H ] - labeled siRNAs in Mice .
【GOLD_E】
3H	chem
【PRE_E】
[3H]	chem
【GOLD_R】
【PRE_R】

Absorption , distribution , metabolism , and excretion properties of two unformulated model siRNAs were determined using a single internal [ ( 3 ) H ] - radiolabeling procedure , where the full - length oligonucleotides were radiolabeled by Br / ( 3 ) H - exchange .
【GOLD_E】
(3)H	chem
Br	chem
(3)H	chem
【PRE_E】
[(3)H]-radiolabeling	chem
Br/(3)H	chem
【GOLD_R】
【PRE_R】

Tissue distribution , excretion , and mass balance of radioactivity were investigated in male CD - 1 mice , following a single intravenous administration of the [ ( 3 ) H ] - siRNAs , at a target dose level of 5 mg / kg .
【GOLD_E】
(3)H	chem
【PRE_E】
[(3)H	chem
【GOLD_R】
【PRE_R】

Quantitative whole - body autoradiography ( QWBA ) and liquid scintillation counting techniques were used to determine tissue distribution .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Radiochromatogram profiles were determined in plasma , tissue extracts and urine .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Metabolites were separated by liquid chromatography and identified by radiodetection and high - resolution accurate mass spectrometry .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In general , there was little difference in the distribution of total radiolabeled components after administration of the two unformulated [ ( 3 ) H ] - siRNAs .
【GOLD_E】
(3)H	chem
【PRE_E】
[(3)H	chem
【GOLD_R】
【PRE_R】

The radioactivity was rapidly and widely distributed throughout the body , and remained detectable in all tissues investigated at later time points ( 24 and 48 hours for [ ( 3 ) H ] - MRP4 and [ ( 3 ) H ] - SSB siRNA , respectively ) .
【GOLD_E】
MRP4	geneY
(3)H	chem
(3)H	chem
【PRE_E】
[(3)H]-MRP4	chem
[(3)H]-SSB	chem
【GOLD_R】
【PRE_R】

After an initial rapid decline , concentrations of total radiolabeled components in dried blood declined at a much slower rate .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A nearly complete mass balance was obtained for the [ ( 3 ) H ] - SSB siRNA and renal excretion was the main route of elimination ( 38 % ) .
【GOLD_E】
(3)H	chem
【PRE_E】
[(3)H]-SSB	chem
【GOLD_R】
【PRE_R】

The metabolism of the two model siRNAs was rapid and extensive .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Five minutes after administration , no parent compound could be detected in plasma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Instead , radiolabeled nucleosides resulting from nuclease hydrolysis were observed .
【GOLD_E】
nuclease	geneN
nucleosides	chem
【PRE_E】
nucleosides	chem
【GOLD_R】
nucleosides	nuclease	C9
【PRE_R】

In the metabolism profiles obtained from various tissues only radiolabeled nucleosides were found , suggesting that siRNAs are rapidly metabolized and that the distribution pattern of total radiolabeled components can be ascribed to small molecular weight metabolites .
【GOLD_E】
nucleosides	chem
【PRE_E】
nucleosides	chem
【GOLD_R】
【PRE_R】

Chemical genetic analyses of quantitative changes in Cdk1 activity during the human cell cycle .
【GOLD_E】
Cdk1	geneY
【PRE_E】
Cdk1	geneY
【GOLD_R】
【PRE_R】

Cyclin - dependent kinase 1 ( Cdk1 ) controls cell proliferation and is inhibited by promising anticancer agents , but its mode of action and the consequences of its inhibition are incompletely understood .
【GOLD_E】
Cdk1	geneY
Cyclin-dependentkinase1	geneY
【PRE_E】
Cyclin-dependentkinase1	geneY
Cdk1	geneY
【GOLD_R】
【PRE_R】

Cdk1 promotes S - and M - phases during the cell - cycle but also suppresses endoreduplication , which is associated with polyploidy and genome instability .
【GOLD_E】
Cdk1	geneY
【PRE_E】
Cdk1	geneN
【GOLD_R】
【PRE_R】

The complexity of Cdk1 regulation has made it difficult to determine whether these different roles require different thresholds of kinase activity and whether the surge of activity as inhibitory phosphates are removed at mitotic onset is essential for cell proliferation .
【GOLD_E】
Cdk1	geneY
kinase	geneN
phosphates	chem
【PRE_E】
Cdk1	geneN
kinase	geneN
phosphates	chem
【GOLD_R】
【PRE_R】

Here , we have used chemical genetics in a human cell line to address these issues .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We rescued cells lethally depleted of endogenous Cdk1 with an exogenous Cdk1 conferring sensitivity to one ATP analogue inhibitor ( 1NMPP1 ) and resistance to another ( RO3306 ) .
【GOLD_E】
Cdk1	geneY
Cdk1	geneY
ATP	chem
1NMPP1	chem
RO3306	chem
【PRE_E】
Cdk1	geneY
Cdk1	geneY
ATP	chem
1NMPP1	geneY
RO3306	chem
【GOLD_R】
【PRE_R】

At no 1NMPP1 concentration was mitosis in rescued clones prevented without also inducing endoreduplication , suggesting that these two key roles for Cdk1 are not simply controlled by different Cdk1 activity thresholds .
【GOLD_E】
1NMPP1	chem
Cdk1	geneY
Cdk1	geneY
【PRE_E】
1NMPP1	geneY
Cdk1	geneN
Cdk1	geneN
【GOLD_R】
【PRE_R】

We also rescued RO3306 - resistant clones using exogenous Cdk1 without inhibitory phosphorylation sites , indicating that the mitotic surge of Cdk1 activity is dispensable for cell proliferation .
【GOLD_E】
Cdk1	geneY
Cdk1	geneY
RO3306	chem
【PRE_E】
RO3306	chem
Cdk1	geneY
Cdk1	geneN
【GOLD_R】
【PRE_R】

These results suggest that the basic mammalian cycle requires at least some qualitative changes in Cdk1 activity and that quantitative increases in activity need not be rapid .
【GOLD_E】
Cdk1	geneY
【PRE_E】
Cdk1	geneN
【GOLD_R】
【PRE_R】

Furthermore , the viability of cells that are unable to undergo rapid Cdk1 activation , and the strong association between endoreduplication and impaired proliferation , may place restrictions on the therapeutic use of a Cdk1 inhibitors .
【GOLD_E】
Cdk1	geneY
Cdk1	geneY
【PRE_E】
Cdk1	geneY
Cdk1	geneN
【GOLD_R】
【PRE_R】

Inhibition of Ebola Virus Infection : Identification of Niemann - Pick C1 as the Target by Optimization of a Chemical Probe .
【GOLD_E】
Niemann-PickC1	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

A high throughput screen identified adamantane dipeptide 1 as an inhibitor of Ebola virus ( EboV ) infection .
【GOLD_E】
adamantane	chem
【PRE_E】
adamantanedipeptide1	chem
EboV	geneN
【GOLD_R】
【PRE_R】
adamantanedipeptide1	EboV	C4

Hit - to - lead optimization to determine the structure - activity relationship ( SAR ) identified the more potent EboV inhibitor 2 and a photoaffinity labeling agent 3 .
【GOLD_E】
【PRE_E】
EboV	geneN
【GOLD_R】
【PRE_R】

These anti - viral compounds were employed to identify the target as Niemann - Pick C1 ( NPC1 ) , a host protein that binds the EboV glycoprotein and is essential for infection .
【GOLD_E】
Niemann-PickC1	geneY
NPC1	geneY
EboVglycoprotein	geneN
【PRE_E】
Niemann-PickC1	geneY
NPC1	geneY
EboVglycoprotein	geneN
【GOLD_R】
【PRE_R】

These studies establish NPC1 as a promising target for anti - viral therapy .
【GOLD_E】
NPC1	geneY
【PRE_E】
NPC1	geneY
【GOLD_R】
【PRE_R】

Exploring the effect of N - substitution in nor - lobelane on the interaction with VMAT2 : discovery of a potential clinical candidate for treatment of methamphetamine abuse .
【GOLD_E】
nor-lobelane	chem
VMAT2	geneY
methamphetamine	chem
N	chem
【PRE_E】
N	chem
nor-lobelane	chem
VMAT2	geneY
methamphetamine	chem
【GOLD_R】
【PRE_R】

A series of N - substituted lobelane analogues was synthesized and evaluated for their [ ( 3 ) H ] dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [ ( 3 ) H ] dopamine uptake .
【GOLD_E】
vesicularmonoaminetransporter	geneN
N	chem
monoamine	chem
[(3)H]dopamine	chem
lobelane	chem
[(3)H]dihydrotetrabenazine	chem
【PRE_E】
N-substitutedlobelane	chem
[(3)H]dihydrotetrabenazine	chem
monoaminetransporter	geneN
[(3)H]dopamine	chem
【GOLD_R】
[(3)H]dopamine	vesicularmonoaminetransporter	C9
【PRE_R】

Compound 19a , which contains an N - 1,2 ( R ) - dihydroxypropyl group , had been identified as a potential clinical candidate for the treatment of methamphetamine abuse .
【GOLD_E】
N-1,2(R)-dihydroxypropyl	chem
methamphetamine	chem
【PRE_E】
N-1,2(R)-dihydroxypropyl	chem
methamphetamine	chem
【GOLD_R】
【PRE_R】

The pre - clinical absorption , distribution , metabolism and excretion properties of IPI - 926 , an orally bioavailable antagonist of the hedgehog signal transduction pathway .
【GOLD_E】
IPI-926	chem
【PRE_E】
IPI-926	chem
hedgehog	geneN
【GOLD_R】
【PRE_R】
IPI-926	hedgehog	C4

Abstract 1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

IPI - 926 is a novel semisynthetic cyclopamine derivative that is a potent and selective Smoothened inhibitor that blocks the hedgehog signal transduction pathway .
【GOLD_E】
IPI-926	chem
cyclopamine	chem
【PRE_E】
IPI-926	chem
cyclopamine	chem
Smoothened	geneY
hedgehog	geneN
【GOLD_R】
【PRE_R】
IPI-926	Smoothened	C4
cyclopamine	Smoothened	C4
cyclopamine	hedgehog	C4

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The in vivo clearance of IPI - 926 is low in mouse and dog and moderate in monkey .
【GOLD_E】
IPI-926	chem
【PRE_E】
IPI-926	geneY
【GOLD_R】
【PRE_R】

The volume of distribution is high across species .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Oral bioavailability ranges from moderate in monkey to high in mouse and dog .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Predicted human clearance using simple allometry is low ( 24 L h ( - 1 ) ) , predicted volume of distribution is high ( 469 L ) and predicted half - life is long ( 20 h ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

IPI - 926 is highly bound to plasma proteins and has minimal interaction with human α - 1 - acid glycoprotein .
【GOLD_E】
humanα-1-acidglycoprotein	geneN
IPI-926	chem
【PRE_E】
IPI-926	geneY
humanα-1-acidglycoprotein	geneN
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In vitro metabolic stability ranges from stable to moderately stable .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Twelve oxidative metabolites were detected in mouse , rat , dog , monkey and human liver microsome incubations and none were unique to human .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

IPI - 926 is not a potent reversible inhibitor of CYP1A2 , 2C8 , 2C9 or 3A4 ( testosterone ) .
【GOLD_E】
CYP1A2,2C8,2C9or3A4	geneN
IPI-926	chem
testosterone	chem
【PRE_E】
IPI-926	chem
CYP1A2,2C8,2C9or3A4	geneN
testosterone	chem
【GOLD_R】
【PRE_R】

IPI - 926 is a moderate inhibitor of CYP2C19 , 2D6 and 3A4 ( midazolam ) with KI values of 19 , 16 and 4.5 µM , respectively .
【GOLD_E】
IPI-926	chem
CYP2C19,2D6and3A4	geneN
midazolam	chem
【PRE_E】
IPI-926	chem
CYP2C19,2D6and3A4	geneN
midazolam	chem
【GOLD_R】
【PRE_R】

IPI - 926 is both a substrate and inhibitor ( IC50 = 1.9 µM ) of P - glycoprotein .
【GOLD_E】
lycoprotein.	geneN
IPI-926	chem
【PRE_E】
IPI-926	chem
P-glycoprotein	geneN
【GOLD_R】
IPI-926	lycoprotein.	C4
IPI-926	lycoprotein.	C9
【PRE_R】
IPI-926	P-glycoprotein	C4

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In summary , IPI - 926 has desirable pre - clinical absorption , distribution , metabolism and excretion properties .
【GOLD_E】
IPI-926	chem
【PRE_E】
IPI-926	geneY
【GOLD_R】
【PRE_R】

Protection of glycyrrhizic acid against AGEs - induced endothelial dysfunction through inhibiting RAGE / NF - κB pathway activation in human umbilical vein endothelial cells .
【GOLD_E】
glycyrrhizicacid	chem
NF-κB	geneN
RAGE	geneY
【PRE_E】
glycyrrhizicacid	chem
RAGE	geneY
NF-κB	geneN
【GOLD_R】
【PRE_R】
glycyrrhizicacid	RAGE	C4
glycyrrhizicacid	NF-κB	C4

ETHNOPHARMACOLOGICAL RELEVANCE : Licorice ( Glycyrrhiza uralensis roots ) is used as a traditional medicine for the treatment of diabetes mellitus and its vascular complications .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Glycyrrhizic acid ( GA , also known as Glycyrrhizin ) , a triterpenoid saponin glycoside , is considered to be a bioactive component in Licorice and is beneficial to diabetic vascular complications .
【GOLD_E】
Glycyrrhizicacid	chem
Glycyrrhizin	chem
triterpenoidsaponinglycoside	chem
【PRE_E】
Glycyrrhizicacid	chem
Glycyrrhizin	chem
triterpenoidsaponinglycoside	chem
【GOLD_R】
【PRE_R】

AIM OF STUDY : The present study was conducted to evaluate the potential protective activities on AGEs - induced endothelial dysfunction , including anti - apoptosis , antioxidant stress and anti - proinflammatory responses , and explore the underlying mechanism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

MATERIALS AND METHODS : Human umbilical vein endothelial cells ( HUVECs ) were incubated and pre - treated with GA ( 10 ( - 9 ) - 10 ( - 6 ) M ) or RAGE - Ab ( 5μg / ml ) in the presence or absence of 200μg / ml AGEs .
【GOLD_E】
RAGE	geneY
【PRE_E】
RAGE	geneY
【GOLD_R】
【PRE_R】

AO / EB fluorescence staining assay was performed to evaluate anti - apoptosis activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The superoxide dismutase ( SOD ) activity and malondialdehyde ( MDA ) level in cell supernatant were detected by kits while the intracellular reactive oxygen species ( ROS ) generation was determined by 2,7 - dichlorodihydrofluorescin diacetate ( DCFH - DA ) kit .
【GOLD_E】
MDA	chem
oxygen	chem
superoxidedismutase	geneN
2,7-dichlorodihydrofluorescindiacetate	chem
SOD	geneN
DCFH-DA	chem
superoxide	chem
malondialdehyde	chem
【PRE_E】
superoxidedismutase	geneN
SOD	geneN
malondialdehyde	chem
MDA	chem
oxygen	chem
2,7-dichlorodihydrofluorescindiacetate	chem
DCFH-DA	chem
【GOLD_R】
【PRE_R】

Immunocytochemistry analysis was designed to determine transforming growth factor beta1 ( TGF - β1 ) protein expression while immunofluorescence analysis for RAGE and NF - kB .
【GOLD_E】
transforminggrowthfactorbeta1	geneY
TGF-β1	geneY
RAGE	geneY
NF-kB	geneN
【PRE_E】
transforminggrowthfactorbeta1	geneY
TGF-β1	geneY
RAGE	geneY
NF-kB	geneY
【GOLD_R】
【PRE_R】

The protein expressions of TGF - β1 , RAGE and NF - kB were analyzed by Western blot analysis .
【GOLD_E】
TGF-β1	geneY
RAGE	geneY
NF-kB	geneN
【PRE_E】
TGF-β1	geneY
RAGE	geneY
NF-kB	geneY
【GOLD_R】
【PRE_R】

RESULTS : Pretreatment with GA at a concentration of 10 ( - 8 ) - 10 ( - 6 ) M significantly reduced the AGEs - induced apoptosis in HUVECs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

GA significantly increased antioxidant enzyme SOD activity and decreased peroxide degradation product MDA level in a dose - dependent manner .
【GOLD_E】
SOD	geneN
MDA	chem
【PRE_E】
SOD	geneN
peroxide	chem
MDA	chem
【GOLD_R】
【PRE_R】

Furthermore , GA also remarkably inhibited the overgeneration of AGEs - induced ROS .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Both immunocytochemistry analysis and western blot analysis showed that GA significantly decreased the protein expression of poinflammatory cytokine TGF - β1 in a similar manner which RAGE - Ab did .
【GOLD_E】
cytokine	geneN
TGF-β1	geneY
RAGE	geneY
【PRE_E】
poinflammatorycytokineTGF-β1	geneN
RAGE	geneY
【GOLD_R】
【PRE_R】

Additionally , AGEs - induced RAGE and NF - kB protein expressions were down - regulated significantly by the pretreatment with GA or RAGE - Ab .
【GOLD_E】
RAGE	geneY
NF-kB	geneN
RAGE	geneY
【PRE_E】
RAGE	geneY
NF-kB	geneY
RAGE-Ab	geneY
【GOLD_R】
【PRE_R】

CONCLUSION : These findings provide evidences that GA possesses protective activity on AGEs - induced endothelial dysfunction , including anti - apoptosis , anti - inflammation and antioxidant stress , via inhibiting RAGE / NF - kB pathway .
【GOLD_E】
RAGE	geneY
NF-kB	geneN
【PRE_E】
RAGE	geneY
NF-kB	geneN
【GOLD_R】
【PRE_R】

GA might be an alternative for the prevention and treatment of diabetic vascular complications in an appropriate dosage .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Evaluation of body weight , insulin resistance , leptin and adiponectin levels in premenopausal women with hyperprolactinemia .
【GOLD_E】
insulin	geneY
leptin	geneN
adiponectin	geneN
【PRE_E】
insulin	geneY
leptin	geneY
adiponectin	geneY
hyperprolactinemia	chem
【GOLD_R】
【PRE_R】

The effects of hyperprolactinemia on metabolic parameters are not clear and a few data evaluating adiponectin levels in prolactinoma and idiopathic hyperprolactinemia exist .
【GOLD_E】
adiponectin	geneY
【PRE_E】
hyperprolactinemia	chem
adiponectin	geneY
hyperprolactinemia	chem
【GOLD_R】
【PRE_R】

The aim of this study was to evaluate the effects of hyperprolactinemia on body weight , insulin resistance , beta cell function , and leptin and adiponectin levels in premenopausal women with hyperprolactinemia .
【GOLD_E】
leptin	geneY
adiponectin	geneY
【PRE_E】
hyperprolactinemia	chem
insulin	geneY
leptin	geneY
adiponectin	geneY
hyperprolactinemia	chem
【GOLD_R】
【PRE_R】

Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age - matched healthy premenopausal women with regard to body weight , body mass index , waist and hip circumferences , waist to hip ratio , fasting plasma glucose , insulin levels , insulin resistance measured by homeostasis model assessment ( HOMA ) - insulin resistance index , beta cell function measured by HOMA - β index , leptin and adiponectin levels .
【GOLD_E】
insulin	geneY
insulin	geneY
insulin	geneY
leptin	geneY
adiponectin	geneY
glucose	chem
【PRE_E】
hyperprolactinemia	chem
glucose	chem
insulin	geneY
insulin	geneY
insulin	geneY
leptin	geneY
adiponectin	geneY
【GOLD_R】
【PRE_R】

Plasma insulin levels and HOMA indexes ( both insulin resistance and beta indexes ) were significantly higher in hyperprolactinemic women .
【GOLD_E】
insulin	geneY
insulin	geneY
【PRE_E】
insulin	geneY
insulin	geneY
hyperprolactinemic	chem
【GOLD_R】
【PRE_R】

The other parameters were similar between both groups .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

There was a positive correlation between prolactin levels and fasting plasma glucose in hyperprolactinemic women .
【GOLD_E】
glucose	chem
prolactin	geneY
【PRE_E】
prolactin	geneY
glucose	chem
【GOLD_R】
【PRE_R】

The results of this study showed that high prolactin levels may be associated with hyperinsulinemia and insulin resistance in premenopausal women .
【GOLD_E】
prolactin	geneY
insulin	geneY
【PRE_E】
prolactin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

This effect seems to be independent of body weight , leptin and adiponectin levels .
【GOLD_E】
leptin	geneY
adiponectin	geneY
【PRE_E】
leptin	geneY
adiponectin	geneY
【GOLD_R】
【PRE_R】

High prolactin levels may directly stimulate insulin secretion from pancreas and directly cause hepatic and whole - body insulin resistance .
【GOLD_E】
insulin	geneY
prolactin	geneY
insulin	geneY
【PRE_E】
prolactin	geneY
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Lorcaserin : a review of its use in chronic weight management .
【GOLD_E】
Lorcaserin	chem
【PRE_E】
Lorcaserin	chem
【GOLD_R】
【PRE_R】

Oral lorcaserin ( BELVIQ ( ® ) ) , a selective serotonin 5 - HT2C receptor agonist , is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults , or overweight adults with at least one weight - related comorbidity ( e.g . dyslipidaemia , hypertension , type 2 diabetes ) .
【GOLD_E】
lorcaserin	chem
5-HT2C	geneY
BELVIQ	chem
serotonin	chem
【PRE_E】
lorcaserin	chem
BELVIQ	chem
serotonin5-HT2C	geneY
【GOLD_R】
lorcaserin	5-HT2C	C5
BELVIQ	5-HT2C	C5
【PRE_R】

This article reviews the pharmacological properties , therapeutic efficacy and tolerability of oral lorcaserin in this patient population .
【GOLD_E】
lorcaserin	chem
【PRE_E】
lorcaserin	chem
【GOLD_R】
【PRE_R】

In three large randomized , double - blind , multicentre studies , oral lorcaserin was more effective than placebo in the management of obese and overweight adults with or without type 2 diabetes mellitus .
【GOLD_E】
lorcaserin	chem
【PRE_E】
lorcaserin	chem
【GOLD_R】
【PRE_R】

Following 12 months ' therapy , significantly higher proportions of lorcaserin than placebo recipients achieved a ≥ 5 and ≥ 10 % reduction from baseline in their bodyweight and a significant between - group difference favouring lorcaserin over placebo was observed for the change from baseline in bodyweight .
【GOLD_E】
orcaserint	chem
rcaserinov	chem
【PRE_E】
lorcaserin	chem
lorcaserin	chem
【GOLD_R】
【PRE_R】

Moreover , among patients who had achieved a ≥ 5 % reduction in their bodyweight after 12 months ' therapy with lorcaserin , a significantly higher proportion who received lorcaserin for a further 12 months than those who switched to placebo maintained ≥ 5 % weight loss at 24 months .
【GOLD_E】
rcaserin,a	chem
rcaserinfo	chem
【PRE_E】
lorcaserin	chem
lorcaserin	chem
【GOLD_R】
【PRE_R】

In general , oral lorcaserin was well tolerated in clinical studies , with hypoglycaemia and headache the most frequently reported adverse events in those with or without type 2 diabetes , respectively .
【GOLD_E】
lorcaserin	chem
【PRE_E】
lorcaserin	chem
【GOLD_R】
【PRE_R】

According to a pooled analysis , the risk of US - FDA - defined valvulopathy with lorcaserin is generally low and not statistically significantly different from placebo .
【GOLD_E】
lorcaserin	chem
【PRE_E】
lorcaserin	chem
【GOLD_R】
【PRE_R】

From these and other data , the FDA has concluded that lorcaserin is unlikely to elevate the risk of valvulopathy .
【GOLD_E】
lorcaserin	chem
【PRE_E】
lorcaserin	chem
valvulopathy	chem
【GOLD_R】
【PRE_R】

Design , Synthesis , Biological Evaluation , and Docking Studies of ( S ) - Phenylalanine Derivatives with a 2 - Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors .
【GOLD_E】
DipeptidylPeptidase4	geneY
2-Cyanopyrrolidine	chem
(S)-Phenylalanine	chem
【PRE_E】
(S)-Phenylalanine	chem
2-Cyanopyrrolidine	chem
DipeptidylPeptidase4	geneY
【GOLD_R】
2-Cyanopyrrolidine	DipeptidylPeptidase4	C4
(S)-Phenylalanine	DipeptidylPeptidase4	C4
【PRE_R】
(S)-Phenylalanine	DipeptidylPeptidase4	C4
2-Cyanopyrrolidine	DipeptidylPeptidase4	C4

A novel series of ( S ) - phenylalanine derivatives with a 2 - cyanopyrrolidine moiety were designed and synthesized through a rational drug design strategy .
【GOLD_E】
(S)-phenylalanine	chem
2-cyanopyrrolidine	chem
【PRE_E】
(S)-phenylalanine	chem
2-cyanopyrrolidine	chem
【GOLD_R】
【PRE_R】

Biological evaluation revealed that most tested compounds were potent dipeptidyl peptidase 4 ( DPP - 4 ) inhibitors , among them , the cyclopropyl - substituted phenylalanine derivative 11h displayed the most potent DPP - 4 inhibitory activity with an IC50 value of 0.247 μM .
【GOLD_E】
cyclopropyl-substitutedphenylalanine	chem
dipeptidylpeptidase4	geneY
DPP-4	geneY
DPP-4	geneY
【PRE_E】
dipeptidylpeptidase4	geneY
DPP-4	geneY
cyclopropyl	chem
phenylalanine	chem
11h	chem
DPP-4	geneY
【GOLD_R】
cyclopropyl-substitutedphenylalanine	DPP-4	C4
【PRE_R】
dipeptidylpeptidase4	cyclopropyl	C4
DPP-4	cyclopropyl	C4
DPP-4	phenylalanine	C4
11h	DPP-4	C4

In addition , molecular docking analysis of the representative compounds 11h , 11k , and 15a were performed , which not only revealed the impact of binding modes on DPP - 4 inhibitory activity , but also provided additional methodological values for design and optimization .
【GOLD_E】
DPP-4	geneY
【PRE_E】
DPP-4	geneY
【GOLD_R】
【PRE_R】

© 2013 John Wiley & Sons A / S .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Bioimaging real - time PXR - dependent mdr1a gene regulation in mdr1a.fLUC reporter mice .
【GOLD_E】
PXR	geneY
mdr1a	geneY
mdr1a	geneY
【PRE_E】
PXR	geneY
mdr1a	geneY
【GOLD_R】
【PRE_R】

The MDR1 gene encodes P - glycoprotein , a transmembrane drug efflux transporter that confers multidrug resistance in cancer cells and affects drug pharmacokinetics by virtue of its expression in the liver , kidney , and colon .
【GOLD_E】
P-glycoprotein,	geneY
transmembranedrugeffluxtransporter	geneN
MDR1	geneY
【PRE_E】
MDR1	geneY
P-glycoprotein	geneN
effluxtransporter	geneN
【GOLD_R】
【PRE_R】

Nuclear receptors SXR and CAR are possible master regulators of xenobiotic - inducible MDR1 expression in drug processing organs , but the mechanism of MDR1 regulation has yet to be directly demonstrated in vivo .
【GOLD_E】
Nuclearreceptors	geneN
SXR	geneY
CAR	geneY
MDR1	geneY
MDR1	geneY
【PRE_E】
NuclearreceptorsSXR	geneN
CAR	geneY
xenobiotic-inducibleMDR1	geneY
MDR1	geneY
【GOLD_R】
【PRE_R】

Moreover , it has previously been impossible to determine the sustained or cumulative effect of repeated doses of xenobiotics on in vivo MDR1 expression .
【GOLD_E】
MDR1	geneY
【PRE_E】
MDR1	geneY
【GOLD_R】
【PRE_R】

We previously reported a mouse model containing firefly luciferase ( fLUC ) knocked into the mdr1a genomic locus , allowing non - invasive bioimaging of intestinal mdr1a gene expression in live animals .
【GOLD_E】
mdr1a	geneY
mdr1a	geneY
【PRE_E】
mdr1a	geneY
mdr1a	geneY
【GOLD_R】
【PRE_R】

In the current study , we crossed mdr1a.fLUC mice into the pxr knockout ( pxr ( - / - ) ) genetic background and injected mice with pregnenolone - 16α - carbonitrile ( PCN ) , a strong PXR ligand , and two therapeutically relevant taxanes , paclitaxel and docetaxel .
【GOLD_E】
paclitaxel	chem
docetaxel	chem
mdr1a	geneY
pxr	geneY
pxr	geneY
PXR	geneY
pregnenolone-16α-carbonitrile	chem
PCN	chem
taxanes	chem
【PRE_E】
pxr	geneY
pxr	geneY
pregnenolone-16α-carbonitrile	chem
PCN	chem
PXR	geneY
taxanes	chem
paclitaxel	chem
docetaxel	chem
【GOLD_R】
【PRE_R】

All three agents induced mdr1a.fLUC expression ( bioluminescence ) , but only PCN and docetaxel appeared to act primarily via PXR .
【GOLD_E】
PXR	geneY
PCN	chem
docetaxel	chem
mdr1a	geneY
【PRE_E】
mdr1a.fLUC	geneY
PCN	chem
docetaxel	chem
PXR	geneY
【GOLD_R】
【PRE_R】

Luminescence returned to baseline by 24 - 48 hrs after drug injection and was re - inducible over two additional rounds of drug dosing in pxr ( + / + ) mice .
【GOLD_E】
pxr	geneY
【PRE_E】
Luminescence	chem
pxr	geneY
【GOLD_R】
【PRE_R】

TCPOBOP , a CAR ligand , modestly induced mdr1a.fLUC in pxr ( + / + ) and pxr ( - / - ) strains , consistent with CAR 's minor role in mdr1a regulation .
【GOLD_E】
CAR	geneY
mdr1a	geneY
pxr	geneY
pxr	geneY
CAR	geneY
mdr1a	geneY
TCPOBOP	chem
【PRE_E】
TCPOBOP	chem
CAR	geneY
mdr1a.fLUC	geneY
pxr	geneY
pxr	geneY
mdr1a	geneY
【GOLD_R】
TCPOBOP	mdr1a	C3
【PRE_R】
TCPOBOP	CAR	C3
TCPOBOP	mdr1a.fLUC	C3
TCPOBOP	pxr	C3

Collectively , these results demonstrate that the mdr1a.fLUC bioimaging model can capture changes in mdr1 gene expression under conditions of repeated xenobiotic treatment in vivo and that it can be used to probe the mechanism of gene regulation in response to different xenobiotic agents .
【GOLD_E】
mdr1a	geneY
mdr1	geneY
【PRE_E】
mdr1a.fLUC	geneY
mdr1	geneY
【GOLD_R】
【PRE_R】

Bioinformatics and Molecular Dynamics Simulation Study of L1 Stalk Non - Canonical rRNA Elements : Kink - Turns , Loops , and Tetraloops .
【GOLD_E】
L1StalkNon-CanonicalrRNAElements	geneN
Kink-Turns	geneN
【PRE_E】
rRNAElements	geneN
【GOLD_R】
【PRE_R】

The L1 stalk is a prominent mobile element of the large ribosomal subunit .
【GOLD_E】
L1stalk	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

We explore the structure and dynamics of its non - canonical rRNA elements , which include two kink - turns , an internal loop , and a tetraloop .
【GOLD_E】
kink-turns	geneN
internalloop	geneN
tetraloop	geneN
【PRE_E】
rRNAelements	geneN
【GOLD_R】
【PRE_R】

We use bioinformatics to identify the L1 stalk RNA conservation patterns and carry out over 11.5 μs of MD simulations for a set of systems ranging from isolated RNA building blocks up to complexes of L1 stalk rRNA with the L1 protein and tRNA fragment .
【GOLD_E】
L1stalk	geneN
L1stalk	geneN
L1protein	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

We show that the L1 stalk tetraloop has an unusual GNNA or UNNG conservation pattern deviating from major GNRA and YNMG RNA tetraloop families .
【GOLD_E】
L1stalktetraloop	geneN
GNNA	geneN
UNNG	geneN
GNRA	geneN
YNMG	geneN
RNAtetraloop	geneN
【PRE_E】
GNNA	geneN
UNNG	geneN
GNRA	geneN
YNMG	geneN
【GOLD_R】
【PRE_R】

We suggest that this deviation is related to a highly conserved tertiary contact within the L1 stalk .
【GOLD_E】
L1stalk	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

The available X - ray structures contain only UCCG tetraloops which in addition differ in orientation ( anti vs syn ) of the guanine .
【GOLD_E】
UCCG	geneN
tetraloops	geneN
guanine	chem
【PRE_E】
UCCGtetraloops	geneN
guanine	chem
【GOLD_R】
【PRE_R】

Our analysis suggests that the anti orientation might be a mis - refinement , although even the anti interaction would be compatible with the sequence pattern and observed tertiary interaction .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Alternatively , the anti conformation may be a real substate whose population could be pH - dependent , since the guanine syn orientation requires protonation of cytosine in the tertiary contact .
【GOLD_E】
guanine	chem
cytosine	chem
【PRE_E】
guanine	chem
cytosine	chem
【GOLD_R】
【PRE_R】

In absence of structural data , we use molecular modeling to explore the GCCA tetraloop that is dominant in bacteria and suggest that the GCCA tetraloop is structurally similar to the YNMG tetraloop .
【GOLD_E】
GCCA	geneN
tetraloop	geneN
GCCA	geneN
tetraloop	geneN
YNMG	geneN
tetraloop	geneN
【PRE_E】
GCCAtetraloop	geneN
GCCAtetraloop	geneN
YNMGtetraloop	geneN
【GOLD_R】
【PRE_R】

Kink - turn Kt - 77 is unusual due to its 11 - nucleotide bulge .
【GOLD_E】
Kink-turnKt-77	geneN
nucleotide	chem
【PRE_E】
11-nucleotide	chem
【GOLD_R】
【PRE_R】

The simulations indicate that the long bulge is a stalk - specific eight - nucleotide insertion into consensual kink - turn only subtly modifying its structural dynamics .
【GOLD_E】
kink-turn	geneN
nucleotide	chem
【PRE_E】
nucleotide	chem
【GOLD_R】
【PRE_R】

We discuss a possible evolutionary role of helix H78 and a mechanism of L1 stalk interaction with tRNA .
【GOLD_E】
helixH78	geneN
L1stalk	geneN
【PRE_E】
H78	geneN
【GOLD_R】
【PRE_R】

We also assess the simulation methodology .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The simulations provide a good description of the studied systems with the latest bsc0χOL3 force field showing improved performance .
【GOLD_E】
【PRE_E】
bsc0χOL3	geneY
【GOLD_R】
【PRE_R】

Still , even bsc0χOL3 is unable to fully stabilize an essential sugar - edge H - bond between the bulge and non - canonical stem of the kink - turn .
【GOLD_E】
kink-turn	geneN
sugar	chem
H	chem
【PRE_E】
bsc0χOL3	geneY
sugar	chem
H	chem
【GOLD_R】
【PRE_R】

Inclusion of Mg ( 2 + ) ions may deteriorate the simulations .
【GOLD_E】
Mg(2+)	chem
【PRE_E】
Mg(2+)	chem
【GOLD_R】
【PRE_R】

On the other hand , monovalent ions can in simulations readily occupy experimental Mg ( 2 + ) binding sites .
【GOLD_E】
Mg(2+)	chem
【PRE_E】
Mg(2+)	chem
【GOLD_R】
【PRE_R】

Galangin attenuates mast cell - mediated allergic inflammation .
【GOLD_E】
Galangin	chem
【PRE_E】
Galangin	chem
【GOLD_R】
【PRE_R】

A great number of people are suffering from allergic inflammatory disease such as asthma , atopic dermatitis , and sinusitis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore discovery of drugs for the treatment of these diseases is an important subject in human health .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , we investigated anti - allergic inflammatory effect of galangin and underlying mechanisms of action using in vitro and in vivo models .
【GOLD_E】
galangin	chem
【PRE_E】
galangin	chem
【GOLD_R】
【PRE_R】

Galangin inhibited histamine release by the reduction of intracellular calcium in phorbol 12 - mystate 13 - acetate plus calcium ionophore A23187 - stimulated human mast cells ( HMC - 1 ) .
【GOLD_E】
phorbol12-mystate13-acetate	chem
calcium	chem
Galangin	chem
histamine	chem
calcium	chem
【PRE_E】
Galangin	chem
histamine	chem
calcium	chem
phorbol12-mystate13-acetate	chem
calcium	chem
A23187	chem
HMC-1	geneY
【GOLD_R】
【PRE_R】

Galangin decreased expression of pro - inflammatory cytokines , such as tumor necrosis factor ( TNF ) - α , interleukin ( IL ) - 6 , IL - 1β , and IL - 8 .
【GOLD_E】
Galangin	chem
cytokines	geneN
tumornecrosisfactor(TNF)-α	geneY
interleukin	geneY
(IL)-6	geneY
IL-1β	geneY
IL-8	geneY
【PRE_E】
Galangin	chem
cytokines	geneN
tumornecrosisfactor(TNF)-α	geneY
interleukin(IL)-6	geneY
IL-1β	geneY
IL-8	geneY
【GOLD_R】
Galangin	cytokines	C4
Galangin	tumornecrosisfactor(TNF)-α	C4
Galangin	interleukin	C4
Galangin	(IL)-6	C4
Galangin	IL-1β	C4
Galangin	IL-8	C4
【PRE_R】
Galangin	cytokines	C4
Galangin	tumornecrosisfactor(TNF)-α	C4
Galangin	interleukin(IL)-6	C4
Galangin	IL-1β	C4
Galangin	IL-8	C4

The inhibitory effect of galangin on theses pro - inflammatory cytokines was related with c - Jun N - terminal kinases , and p38 mitogen - activated protein kinase , nuclear factor - κB , and caspase - 1 .
【GOLD_E】
galangin	chem
N	chem
cytokines	geneN
c-Jun	geneY
N-terminalkinases	geneN
p38	geneN
mitogen-activatedproteinkinase	geneN
nuclearfactor-κB	geneN
caspase-1	geneY
【PRE_E】
galangin	chem
cytokines	geneN
c-JunN-terminalkinases	geneN
p38	geneN
mitogen-activatedproteinkinase	geneN
nuclearfactor-κB	geneN
caspase-1	geneY
【GOLD_R】
galangin	cytokines	C4
【PRE_R】
galangin	cytokines	C4
galangin	p38	C4
galangin	mitogen-activatedproteinkinase	C4
galangin	nuclearfactor-κB	C4
galangin	caspase-1	C4

Furthermore , galangin attenuated IgE - mediated passive cutaneous anaphylaxis and the expression of histamine receptor 1 at the inflamed tissue .
【GOLD_E】
galangin	chem
histamine	chem
IgE	geneN
histaminereceptor1	geneY
【PRE_E】
galangin	chem
IgE	geneN
histaminereceptor1	geneY
【GOLD_R】
galangin	IgE	C4
galangin	histaminereceptor1	C4
【PRE_R】
galangin	IgE	C4

The inhibitory effects of galangin were more potent than cromolyn , a known anti - allergic drug .
【GOLD_E】
galangin	chem
cromolyn	chem
【PRE_E】
galangin	chem
cromolyn	chem
【GOLD_R】
【PRE_R】

Our results showed that galangin down - regulates mast cell - derived allergic inflammatory reactions by blocking histamine release and expression of pro - inflammatory cytokines .
【GOLD_E】
cytokines	geneN
galangin	chem
histamine	chem
【PRE_E】
galangin	chem
histamine	chem
cytokines	geneN
【GOLD_R】
galangin	cytokines	C4
【PRE_R】
galangin	cytokines	C4

In light of in vitro and in vivo anti - allergic inflammatory effects , galangin could be a beneficial anti - allergic inflammatory agent .
【GOLD_E】
galangin	chem
【PRE_E】
galangin	chem
【GOLD_R】
【PRE_R】

Aberrant activation of M phase proteins by cell proliferation - evoking carcinogens after 28 - day administration in rats .
【GOLD_E】
Mphaseproteins	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

We have previously reported that hepatocarcinogens increase liver cells expressing p21 ( Cip1 ) , a G1 checkpoint protein and M phase proteins after 28 - day treatment in rats .
【GOLD_E】
Mphaseproteins	geneN
p21	geneY
Cip1	geneY
【PRE_E】
hepatocarcinogens	chem
p21	geneY
Cip1	geneY
【GOLD_R】
【PRE_R】
hepatocarcinogens	p21	C3
hepatocarcinogens	Cip1	C3

This study aimed to identify early prediction markers of carcinogens available in many target organs after 28 - day treatment in rats .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Immunohistochemical analysis was performed on Ki - 67 , p21 ( Cip1 ) and M phase proteins [ nuclear Cdc2 , phospho - Histone H3 ( p - Histone H3 ) , Aurora B and heterochromatin protein 1α ( HP1α ) ] with carcinogens targeting different organs .
【GOLD_E】
Ki-67	geneY
p21	geneY
Cip1	geneY
Mphaseproteins	geneN
Cdc2	geneY
phospho-HistoneH3	geneN
p-HistoneH3	geneN
AuroraB	geneY
heterochromatinprotein1α	geneY
HP1α	geneY
【PRE_E】
Ki-67	geneY
p21	geneY
Cip1	geneY
nuclearCdc2	geneY
phospho-HistoneH3	geneY
p-HistoneH3	geneY
AuroraB	geneY
heterochromatinprotein1α	geneY
HP1α	geneY
【GOLD_R】
【PRE_R】

Carcinogens targeting thyroid ( sulfadimethoxine ; SDM ) , urinary bladder ( phenylethyl isothiocyanate ) , forestomach ( butylated hydroxyanisole ; BHA ) , glandular stomach ( catechol ; CC ) , and colon ( 2 - amino - 1 - methyl - 6 - phenylimidazo [ 4,5 - b ] pyridine and chenodeoxycholic acid ) were examined using a non - carcinogenic toxicant ( caprolactam ) and carcinogens targeting other organs as negative controls .
【GOLD_E】
caprolactam	chem
sulfadimethoxine	chem
SDM	chem
phenylethylisothiocyanate	chem
butylatedhydroxyanisole	chem
BHA	chem
catechol	chem
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine	chem
chenodeoxycholicacid	chem
【PRE_E】
sulfadimethoxine	chem
SDM	chem
phenylethylisothiocyanate	chem
butylatedhydroxyanisole	chem
BHA	chem
catechol	chem
CC	geneY
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine	chem
chenodeoxycholicacid	chem
caprolactam	chem
【GOLD_R】
【PRE_R】

All carcinogens increased Ki - 67 ( + ) , nuclear Cdc2 ( + ) , p - Histone H3 ( + ) or Aurora B ( + ) carcinogenic target cells , except for both colon carcinogens , which did not increase cell proliferation .
【GOLD_E】
Ki-67	geneY
Cdc2	geneY
p-HistoneH3	geneN
AuroraB	geneY
【PRE_E】
Ki-67(+)	chem
Cdc2(+)	geneY
p-HistoneH3(+)	geneY
AuroraB(+)	chem
【GOLD_R】
【PRE_R】

On the other hand , p21 ( Cip1 + ) cells increased with SDM and CC .
【GOLD_E】
p21	geneY
Cip1	geneY
【PRE_E】
p21	geneY
Cip1	geneY
SDM	geneY
CC	geneY
【GOLD_R】
【PRE_R】

HP1α responded only to BHA .
【GOLD_E】
HP1α	geneY
BHA	chem
【PRE_E】
HP1α	geneY
BHA	chem
【GOLD_R】
【PRE_R】

Results revealed carcinogens evoking cell proliferation concurrently induced cell cycle arrest at M phase or showing chromosomal instability reflecting aberration in cell cycle regulation , irrespective of target organs , after 28 - day treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Therefore , M phase proteins may be early prediction markers of carcinogens evoking cell proliferation in many target organs .
【GOLD_E】
Mphaseproteins	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Nobiletin attenuates metastasis via both ERK and PI3K / Akt pathways in HGF - treated liver cancer HepG2 cells .
【GOLD_E】
Nobiletin	chem
ERK	geneN
PI3K	geneN
Akt	geneN
HGF	geneY
【PRE_E】
Nobiletin	chem
ERK	geneN
PI3K	geneN
Akt	geneN
HGF	geneY
【GOLD_R】
Nobiletin	ERK	C4
Nobiletin	PI3K	C4
Nobiletin	Akt	C4
【PRE_R】
Nobiletin	ERK	C4
Nobiletin	PI3K	C4
Nobiletin	Akt	C4
Nobiletin	HGF	C4

Hepatocyte growth factor ( HGF ) , and its receptor , c - Met activation has recently been shown to play important roles in cancer invasion and metastasis in a wide variety of tumor cells .
【GOLD_E】
Hepatocytegrowthfactor	geneY
HGF	geneY
c-Met	geneY
【PRE_E】
Hepatocytegrowthfactor	geneY
HGF	geneY
c-Met	geneY
【GOLD_R】
【PRE_R】

We use HGF as an invasive inducer of human HepG2 cells to investigate the effect of four flavones including apigenin , tricetin , tangeretin , and nobiletin on HGF / c - Met - mediated tumor invasion and metastasis .
【GOLD_E】
HGF	geneY
HGF	geneY
c-Met	geneY
apigenin	chem
tricetin	chem
tangeretin	chem
nobiletin	chem
【PRE_E】
HGF	geneY
flavones	chem
apigenin	chem
tricetin	chem
tangeretin	chem
nobiletin	chem
HGF	geneY
c-Met	chem
【GOLD_R】
【PRE_R】
HGF	flavones	C4
HGF	apigenin	C4
HGF	tricetin	C4
tangeretin	HGF	C4
nobiletin	HGF	C4
HGF	c-Met	C4

Among them , nobiletin markedly inhibited HGF - induced the abilities of the adhesion , invasion , and migration by cell - matrix adhesion assay and transwell - chamber invasion / migration assay under non - cytotoxic concentrations .
【GOLD_E】
HGF	geneY
nobiletin	chem
【PRE_E】
nobiletin	chem
HGF	geneY
【GOLD_R】
nobiletin	HGF	C4
【PRE_R】
nobiletin	HGF	C4

Data also showed nobiletin inhibited HGF - induced cell scattering and cytoskeleton changed such as filopodia and lamellipodia .
【GOLD_E】
HGF	geneY
nobiletin	chem
【PRE_E】
nobiletin	chem
HGF	geneY
【GOLD_R】
nobiletin	HGF	C4
【PRE_R】
nobiletin	HGF	C4

Furthermore , nobiletin could inhibit HGF - induced the membrane localization of phosphorylated c - Met , ERK2 , and Akt , but not phosphorylated JNK1 / 2 and p38 .
【GOLD_E】
HGF	geneY
c-Met	geneY
ERK2	geneY
Akt	geneN
phosphorylatedJNK1/2	geneN
p38	geneN
nobiletin	chem
【PRE_E】
nobiletin	chem
HGF	geneY
phosphorylatedc-Met	geneY
ERK2	geneY
Akt	geneN
JNK1/2	geneN
p38	geneN
【GOLD_R】
nobiletin	HGF	C4
nobiletin	c-Met	C4
nobiletin	ERK2	C4
nobiletin	Akt	C4
【PRE_R】
nobiletin	HGF	C4
nobiletin	phosphorylatedc-Met	C4
nobiletin	ERK2	C4
nobiletin	Akt	C4
nobiletin	p38	C4

Next , nobiletin significantly decreased the levels of phospho - ERK2 and phospho - Akt in ERK2 or Akt siRNA - transfected cells concomitantly with a marked reduction on cell invasion and migration .
【GOLD_E】
phospho	chem
phospho	chem
phospho-ERK2	geneY
phospho-Akt	geneN
ERK2	geneY
Akt	geneN
nobiletin	chem
【PRE_E】
nobiletin	chem
phospho-ERK2	geneN
phospho-Akt	geneN
ERK2	geneY
Akt	geneN
【GOLD_R】
nobiletin	phospho-ERK2	C4
nobiletin	phospho-Akt	C4
nobiletin	ERK2	C4
nobiletin	Akt	C4
【PRE_R】
nobiletin	phospho-ERK2	C4
nobiletin	phospho-Akt	C4
nobiletin	ERK2	C4
nobiletin	Akt	C4

In conclusion , nobiletin attenuates HGF - induced HepG2 cells metastasis involving both ERK and PI3K / Akt pathways and are potentially useful as anti - metastatic agents for the treatment of hepatoma .
【GOLD_E】
HGF	geneY
ERK	geneN
PI3K	geneN
Akt	geneN
nobiletin	chem
【PRE_E】
nobiletin	chem
HGF	geneY
ERK	geneN
PI3K	geneN
Akt	geneN
【GOLD_R】
nobiletin	HGF	C4
nobiletin	ERK	C4
nobiletin	PI3K	C4
nobiletin	Akt	C4
【PRE_R】
nobiletin	HGF	C3
nobiletin	ERK	C3
nobiletin	Akt	C3

Cardiac natriuretic Peptide gene expression and plasma concentrations during the first 72 hours of life in piglets .
【GOLD_E】
CardiacnatriureticPeptide	geneN
【PRE_E】
CardiacnatriureticPeptide	geneY
【GOLD_R】
【PRE_R】

Plasma measurement of cardiac natriuretic peptides constitutes promising markers of congenital heart disease .
【GOLD_E】
cardiacnatriureticpeptides	geneN
【PRE_E】
cardiacnatriureticpeptides	geneN
【GOLD_R】
【PRE_R】

However , concentrations change rapidly and dramatically during the first days after delivery even in healthy neonates , which complicates clinical interpretation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It is unknown whether these changes in plasma concentrations are explained by corresponding changes in the cardiac gene expression .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We quantified the chamber - specific mRNA levels of ANP ( A - type natriuretic peptide ) and BNP ( B - type natriuretic peptide ) and plasma pro - ANP and BNP - 32 concentrations in healthy piglets during the first 72 hours of life ( from 2 litters , n = 44 ) .
【GOLD_E】
BNP	geneY
B-typenatriureticpeptide	geneN
ANP	geneY
BNP-32	geneY
ANP	geneY
A-typenatriureticpeptide	geneY
【PRE_E】
ANP	geneY
A-typenatriureticpeptide	geneY
BNP	geneY
B-typenatriureticpeptide	geneY
pro-ANP	geneY
BNP-32	geneY
【GOLD_R】
【PRE_R】

Chamber - specific ANP and BNP mRNA levels reflected hemodynamic neonate changes at birth but did not correlate with circulating natriuretic peptide concentrations .
【GOLD_E】
ANP	geneY
BNP	geneY
natriureticpeptide	geneN
【PRE_E】
ANP	geneY
BNP	geneY
circulatingnatriureticpeptide	geneY
【GOLD_R】
【PRE_R】

However , plasma pro - ANP and creatinine concentrations were closely correlated ( P < .0001 ; r = 0.73 ) .
【GOLD_E】
ANP	geneY
creatinine	chem
【PRE_E】
ANP	geneY
creatinine	chem
【GOLD_R】
【PRE_R】

Plasma pro - ANP levels were highest on the day of delivery ( 5580 pmol / L [ 4320 - 6786 ] decreasing to 2484 pmol / L [ 1602 - 2898 ] after 72 hours , P < .0001 ) .
【GOLD_E】
ANP	geneY
【PRE_E】
ANP	geneY
【GOLD_R】
【PRE_R】

During the 72 hours , gel chromatography suggested that the translational products in circulation and in atrial tissue were immature , ie , unprocessed pro - ANP .
【GOLD_E】
ANP	geneY
【PRE_E】
ANP	geneY
【GOLD_R】
【PRE_R】

In contrast to pro - ANP , BNP - 32 plasma concentrations were low at delivery and peaked after 48 hours ( 12 [ 10.5 - 20.6 ] vs .
【GOLD_E】
ANP	geneY
BNP-32	geneY
【PRE_E】
pro-ANP	geneY
BNP-32	geneY
【GOLD_R】
【PRE_R】

88.8 [ 71.7 - 101.4 ] pmol / L , P < .0001 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To conclude , ANP and BNP gene expression differs considerably between cardiac chambers in the first 72 hours of life in healthy piglets , resembling the transition from fetal to neonate circulation .
【GOLD_E】
ANP	geneY
BNP	geneY
【PRE_E】
ANP	geneY
BNP	geneY
【GOLD_R】
【PRE_R】

However , the cardiac gene expression does not explain plasma concentrations .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

T - Cells from HLA - B * 57 : 01 + Human Subjects Are Activated with Abacavir through Two Independent Pathways and Induce Cell Death by Multiple Mechanisms .
【GOLD_E】
Abacavir	chem
HLA-B*57:01	geneY
【PRE_E】
HLA-B	geneY
Abacavir	chem
【GOLD_R】
【PRE_R】

Susceptibility to abacavir hypersensitivity has been attributed to possession of the specific human leukocyte antigen allele HLA - B * 57 : 01 .
【GOLD_E】
humanleukocyteantigenalleleHLA-B*57:01	geneY
【PRE_E】
abacavir	chem
HLA-B	geneY
【GOLD_R】
【PRE_R】

HLA - B * 57 : 01 - restricted activation of CD8 + T - cells provides a link between the genetic association and the iatrogenic disease .
【GOLD_E】
HLA-B*57:01	geneY
【PRE_E】
HLA-B	geneY
CD8+T	geneN
【GOLD_R】
【PRE_R】

The objectives of this study were to characterize the functionality of drug - responsive CD8 + T - cell clones generated from HLA - B * 57 : 01 + drug - naive subjects and to explore the relationship between abacavir accumulation in antigen presenting cells and the T - cell response .
【GOLD_E】
HLA-B*57:01	geneY
abacavir	chem
【PRE_E】
CD8	geneN
HLA-B	geneY
abacavir	chem
【GOLD_R】
【PRE_R】

Seventy - four CD8 + clones expressing different Vβ receptors were shown to proliferate and kill target cells via different mechanisms when exposed to abacavir .
【GOLD_E】
Vβreceptors	geneN
abacavir	chem
【PRE_E】
CD8+	geneY
Vβreceptors	geneY
abacavir	chem
【GOLD_R】
【PRE_R】

Certain clones were activated with abacavir in the absence of antigen presenting cells .
【GOLD_E】
abacavir	chem
【PRE_E】
abacavir	chem
【GOLD_R】
【PRE_R】

Analysis of the remaining clones revealed two pathways of drug - dependent T - cell activation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overnight incubation of antigen presenting cells with abacavir , followed by repeated washing to remove soluble drug , activated approximately 50 % of the clones , and the response was blocked by glutaraldehyde fixation .
【GOLD_E】
abacavir	chem
glutaraldehyde	chem
【PRE_E】
abacavir	chem
glutaraldehyde	chem
【GOLD_R】
【PRE_R】

In contrast , a 1 h antigen presenting cell pulse did not activate any of the clones .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Accumulation of abacavir in antigen presenting cells was rapid ( less than 1 h ) , and the intracellular concentrations were maintained for 16 h .
【GOLD_E】
abacavir	chem
【PRE_E】
abacavir	chem
【GOLD_R】
【PRE_R】

However , intracellular abacavir was not detectable by mass spectrometry after pulsing .
【GOLD_E】
abacavir	chem
【PRE_E】
abacavir	chem
【GOLD_R】
【PRE_R】

These data suggest that T - cells can be activated by abacavir through a direct interaction with surface and intracellular major histocompatibility complex ( MHC ) molecules .
【GOLD_E】
majorhistocompatibilitycomplex	geneN
MHC	geneN
abacavir	chem
【PRE_E】
abacavir	chem
histocompatibilitycomplex	geneN
MHC	geneN
【GOLD_R】
【PRE_R】

With the former , abacavir seemingly participates in the MHC T - cell receptor binding interaction .
【GOLD_E】
MHC	geneN
T-cellreceptor	geneN
abacavir	chem
【PRE_E】
abacavir	chem
MHCT-cellreceptor	geneN
【GOLD_R】
【PRE_R】

In contrast , the latter pathway likely involves MHC binding peptides displayed as a consequence of abacavir exposure , but not abacavir itself .
【GOLD_E】
MHC	geneN
abacavir	chem
abacavir	chem
【PRE_E】
MHCbindingpeptides	geneN
abacavir	chem
abacavir	chem
【GOLD_R】
【PRE_R】

Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid .
【GOLD_E】
oxysterols	chem
【PRE_E】
oxysterols	chem
【GOLD_R】
【PRE_R】

The neurospecific cholesterol 24 - hydroxylase converts excess brain cholesterol into 24S - hydroxycholesterol ( 24OHC ) which , via the liver X receptor ( LXR ) , can increase the expression and synthesis of astrocyte ApoE .
【GOLD_E】
cholesterol	chem
cholesterol	chem
24S-hydroxycholesterol	chem
24OHC	chem
liverXreceptor	geneN
LXR	geneN
ApoE	geneY
【PRE_E】
neurospecificcholesterol24-hydroxylase	geneY
cholesterol	chem
24S-hydroxycholesterol	chem
24OHC	chem
liverXreceptor	geneY
LXR	geneY
astrocyteApoE	geneY
【GOLD_R】
【PRE_R】
24OHC	liverXreceptor	C3
24OHC	LXR	C3
24OHC	astrocyteApoE	C3

24OHC effluxes directly from brain into plasma where it is considered an indicator of brain cholesterol turnover .
【GOLD_E】
24OHC	chem
cholesterol	chem
【PRE_E】
24OHC	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

It is reduced in neurodegenerative disease states proportionally to the severity of disease and the degree of brain atrophy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the early phases of active disease , a higher rate of turnover may result in transitory increases in plasma 24OHC .
【GOLD_E】
24OHC	chem
【PRE_E】
24OHC	geneY
【GOLD_R】
【PRE_R】

Less than 1 % of the total brain excretion of 24OHC occurs via the cerebrospinal fluid ( CSF ) whereas almost all 27 - hydroxycholesterol ( 27OHC ) excretion is dependent on the function of the blood - cerebrospinal fluid barrier .
【GOLD_E】
24OHC	chem
27-hydroxycholesterol	chem
27OHC	chem
【PRE_E】
24OHC	chem
27-hydroxycholesterol	chem
27OHC	chem
【GOLD_R】
【PRE_R】

Iincreased CSF oxysterols were found in patients with neurodegenerative and neuroinflammatory diseases in the presence of barrier dysfunction .
【GOLD_E】
oxysterols	chem
【PRE_E】
oxysterols	chem
【GOLD_R】
【PRE_R】

In neurodegeneration , free cholesterol released from dying cells may engulf neurons .
【GOLD_E】
cholesterol	chem
【PRE_E】
cholesterol	chem
【GOLD_R】
【PRE_R】

Cholesterol also increases Amyloid β ( Aβ ) deposition and tau pathology .
【GOLD_E】
Cholesterol	chem
Amyloidβ	geneY
Aβ	geneY
tau	geneY
【PRE_E】
Cholesterol	chem
Amyloidβ	geneY
Aβ	geneY
【GOLD_R】
Cholesterol	Amyloidβ	C4
Cholesterol	Aβ	C4
Cholesterol	tau	C4
【PRE_R】

ApoE , 24OHC , tau and soluble APP were correlated in Alzheimer disease ( AD ) samples .
【GOLD_E】
ApoE	geneY
tau	geneY
solubleAPP	geneY
24OHC	chem
【PRE_E】
ApoE	geneY
24OHC	geneY
tau	geneY
APP	geneY
【GOLD_R】
【PRE_R】

Excess of cholesterol converted into 24OHC may up - regulate ApoE synthesis which is a scavenger for Aβ and Tau .
【GOLD_E】
ApoE	geneY
Aβ	geneY
Tau	geneY
cholesterol	chem
24OHC	chem
【PRE_E】
cholesterol	chem
24OHC	geneY
ApoE	geneY
Aβ	geneY
Tau	geneY
【GOLD_R】
cholesterol	ApoE	C3
24OHC	ApoE	C3
【PRE_R】
cholesterol	24OHC	C3
cholesterol	ApoE	C3

In AD this protective mechanism seems to be inefficient , probably due to the presence of high concentrations of 27OHC , microvascular dysfunction and the decreased efficiency of ApoE4 as lipid transporter and Aβ scavenger .
【GOLD_E】
ApoE4	geneY
Aβ	geneY
27OHC	chem
【PRE_E】
27OHC	chem
ApoE4	geneY
Aβ	geneY
【GOLD_R】
【PRE_R】

24OHC itself was cytotoxic .
【GOLD_E】
24OHC	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Analysis of side chain oxysterols in the CSF is likely to provided useful information about cholesterol metabolism and ApoE function in the pathogenesis of AD .
【GOLD_E】
ApoE	geneY
oxysterols	chem
cholesterol	chem
【PRE_E】
oxysterols	chem
cholesterol	chem
ApoE	geneY
【GOLD_R】
【PRE_R】

Loss of Calcium / Calmodulin - Dependent Protein Kinase II Activity in Cortical Astrocytes Decreases Glutamate Uptake and Induces Neurotoxic Release of ATP .
【GOLD_E】
ATP	chem
Calcium	chem
Glutamate	chem
Calcium/Calmodulin-DependentProteinKinaseII	geneN
【PRE_E】
Calcium/Calmodulin-DependentProteinKinaseII	geneY
Glutamate	chem
ATP	chem
【GOLD_R】
【PRE_R】

The extent of calcium / calmodulin - dependent protein kinase II ( CaMKII ) inactivation in the brain following ischemia correlates with the extent of damage .
【GOLD_E】
calcium/calmodulin-dependentproteinkinaseII	geneN
CaMKII	geneN
calcium	chem
【PRE_E】
calcium/calmodulin-dependentproteinkinaseII	geneY
CaMKII	geneY
【GOLD_R】
【PRE_R】

We have previously shown that a loss of CaMKII activity in neurons is detrimental to neuronal viability by inducing excitotoxic glutamate release .
【GOLD_E】
CaMKII	geneN
glutamate	chem
【PRE_E】
CaMKII	geneN
glutamate	chem
【GOLD_R】
【PRE_R】

In the current study , we extend these findings to show that the ability of astrocytes to buffer extracellular glutamate is reduced when CaMKII is inhibited .
【GOLD_E】
CaMKII	geneN
glutamate	chem
【PRE_E】
glutamate	chem
CaMKII	geneN
【GOLD_R】
glutamate	CaMKII	C9
【PRE_R】

Furthermore , CaMKII inhibition in astrocytes is associated with the rapid onset of intracellular calcium oscillations .
【GOLD_E】
calcium	chem
CaMKII	geneN
【PRE_E】
CaMKII	geneN
calcium	chem
【GOLD_R】
【PRE_R】

Surprisingly , this rapid calcium influx is blocked by the N - type calcium channel antagonist , omega - conotoxin .
【GOLD_E】
calcium	chem
N	chem
calcium	chem
N-typecalciumchannel	geneN
omega-conotoxin	geneN
【PRE_E】
calcium	chem
N-typecalciumchannel	geneN
【GOLD_R】
【PRE_R】

While the function of N - type calcium channels within astrocytes is controversial , these voltage - gated calcium channels have been linked to calcium - dependent vesicular gliotransmitter release .
【GOLD_E】
N	chem
calcium	chem
calcium	chem
calcium	chem
N-typecalciumchannels	geneN
voltage-gatedcalciumchannels	geneN
【PRE_E】
N-typecalciumchannels	geneN
voltage-gatedcalciumchannels	geneN
calcium-dependentvesiculargliotransmitter	geneN
【GOLD_R】
【PRE_R】

When extracellular glutamate and ATP levels are measured following CaMKII inhibition within our enriched astrocyte cultures , no alterations in glutamate levels are observed , whereas ATP levels in the extracellular environment significantly increase .
【GOLD_E】
glutamate	chem
ATP	chem
glutamate	chem
ATP	chem
CaMKII	geneN
【PRE_E】
glutamate	chem
ATP	chem
CaMKII	geneN
glutamate	chem
ATP	chem
【GOLD_R】
【PRE_R】

Extracellular ATP accumulation associated with CaMKII inhibition contributes both to calcium oscillations within astrocytes and ultimately cortical neuron toxicity .
【GOLD_E】
CaMKII	geneN
ATP	chem
calcium	chem
【PRE_E】
ATP	chem
CaMKII	geneN
calcium	chem
【GOLD_R】
【PRE_R】

Thus , a loss of CaMKII signaling within astrocytes dysregulates glutamate uptake and supports ATP release , two processes that would compromise neuronal survival following ischemic / excitotoxic insults .
【GOLD_E】
CaMKII	geneN
glutamate	chem
ATP	chem
【PRE_E】
CaMKII	geneN
glutamate	chem
ATP	chem
【GOLD_R】
【PRE_R】
CaMKII	glutamate	C9
CaMKII	ATP	C9

Stable and high - rate overcharge protection for rechargeable lithium batteries .
【GOLD_E】
lithium	chem
【PRE_E】
lithium	chem
【GOLD_R】
【PRE_R】

Rechargeable lithium or lithium - ion cells can be overcharge - protected by an electroactive polymer composite separator .
【GOLD_E】
lithium	chem
lithium	chem
【PRE_E】
lithium	chem
lithium	chem
【GOLD_R】
【PRE_R】

The use of non - woven fibrous membranes instead of conventional microporous membranes as the composite substrates allowed better distribution of the electroactive polymer , which led to improved utilization and a 40 - fold increase in sustainable current density .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For the first time , stable overcharge protection for hundreds of cycles was demonstrated in several cell chemistries , including LiNi1 / 3Co1 / 3Mn1 / 3O2 , LiFePO4 , and spinel Li1.05Mn1.95O4 half - cells .
【GOLD_E】
LiNi1	chem
3Co1	chem
3Mn1	chem
3O2	chem
LiFePO4	chem
Li1.05Mn1.95O4	chem
【PRE_E】
LiNi1	chem
3Co1	chem
3Mn1	chem
3O2	chem
LiFePO4	chem
spinelLi1.05Mn1.95O4	chem
【GOLD_R】
【PRE_R】

Protection at a charging rate as high as 5 C was achieved at a steady state cell potential below 4.85 V .
【GOLD_E】
【PRE_E】
5C	chem
【GOLD_R】
【PRE_R】

3 - Hydroxypyridin - 2 - thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition .
【GOLD_E】
HistoneDeacetylase	geneN
3-Hydroxypyridin-2-thione	chem
Zinc	chem
【PRE_E】
3-Hydroxypyridin-2-thione	chem
Zinc	chem
HistoneDeacetylase	geneN
【GOLD_R】
3-Hydroxypyridin-2-thione	HistoneDeacetylase	C4
Zinc	HistoneDeacetylase	C4
【PRE_R】
3-Hydroxypyridin-2-thione	HistoneDeacetylase	C4
Zinc	HistoneDeacetylase	C4

Small molecules bearing hydroxamic acid as the zinc binding group ( ZBG ) have been the most effective histone deacetylase inhibitors ( HDACi ) to date .
【GOLD_E】
histonedeacetylase	geneN
HDAC	geneN
zinc	chem
【PRE_E】
hydroxamicacid	chem
zinc	chem
ZBG	chem
histonedeacetylase	geneN
HDACi	geneY
【GOLD_R】
zinc	histonedeacetylase	C4
zinc	HDAC	C4
【PRE_R】
hydroxamicacid	histonedeacetylase	C4
ZBG	histonedeacetylase	C4
ZBG	HDACi	C4

However , concerns about the pharmacokinetic liabilities of the hydroxamic acid moiety have stimulated research efforts aimed at finding alternative nonhydroxamate ZBGs .
【GOLD_E】
hydroxamicacid	chem
【PRE_E】
hydroxamicacid	chem
nonhydroxamateZBGs	chem
【GOLD_R】
【PRE_R】

We have identified 3 - hydroxypyridin - 2 - thione ( 3 - HPT ) as a novel ZBG that is compatible with HDAC inhibition .
【GOLD_E】
HDAC	geneN
3-hydroxypyridin-2-thione	chem
3-HPT	chem
【PRE_E】
3-hydroxypyridin-2-thione	chem
3-HPT	chem
ZBG	chem
HDAC	geneN
【GOLD_R】
3-hydroxypyridin-2-thione	HDAC	C4
3-HPT	HDAC	C4
【PRE_R】
3-hydroxypyridin-2-thione	HDAC	C4
3-HPT	HDAC	C4
ZBG	HDAC	C4

3 - HPT inhibits HDAC 6 and HDAC 8 with an IC50 of 681 and 3675 nM , respectively .
【GOLD_E】
HDAC6	geneY
HDAC8	geneY
3-HPT	chem
【PRE_E】
3-HPT	chem
HDAC6	geneY
HDAC8	geneY
【GOLD_R】
3-HPT	HDAC6	C4
3-HPT	HDAC8	C4
【PRE_R】
3-HPT	HDAC6	C4
3-HPT	HDAC8	C4

Remarkably , 3 - HPT gives no inhibition of HDAC 1 .
【GOLD_E】
HDAC1	geneY
3-HPT	chem
【PRE_E】
3-HPT	chem
HDAC1	geneY
【GOLD_R】
【PRE_R】
3-HPT	HDAC1	C4

Subsequent optimization led to several novel 3HPT - based HDACi that are selective for HDAC 6 and HDAC 8 .
【GOLD_E】
HDAC	geneN
HDAC6	geneY
HDAC8	geneY
3HPT	chem
【PRE_E】
3HPT	chem
HDACi	chem
HDAC6	geneY
HDAC8	geneY
【GOLD_R】
3HPT	HDAC	C4
3HPT	HDAC6	C4
3HPT	HDAC8	C4
【PRE_R】

Furthermore , a subset of these inhibitors induces apoptosis in various cancer cell lines .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Histological , ultrastructural and immunohistochemical studies on the protective effect of ginger extract against cisplatin - induced nephrotoxicity in male rats .
【GOLD_E】
cisplatin	chem
【PRE_E】
cisplatin	chem
【GOLD_R】
【PRE_R】

Cisplatin ( CP ) is a widely used anticancer drug ; however , it has several side effects such as nephrotoxicity .
【GOLD_E】
Cisplatin	chem
【PRE_E】
Cisplatin	chem
CP	chem
【GOLD_R】
【PRE_R】

Ginger , the rhizome of Zingiber officinale , consumed since ancient times has numerous health benefits .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The objective of this work was to evaluate the protective effect of ginger extract ( GE ) against CP - induced nephrotoxicity .
【GOLD_E】
【PRE_E】
CP	chem
【GOLD_R】
【PRE_R】

CP group displayed a marked renal failure characterized by a significant increase in serum creatinine and blood urea nitrogen ( BUN ) levels in addition to severe histopathological and ultrastructural renal alterations .
【GOLD_E】
creatinine	chem
urea	chem
nitrogen	chem
【PRE_E】
CP	chem
creatinine	chem
ureanitrogen	chem
BUN	chem
【GOLD_R】
【PRE_R】

Also , CP group showed an increase in the immunohistochemical expression of Bax proapoptotic protein .
【GOLD_E】
Bax	geneY
【PRE_E】
CP	chem
Bax	geneY
【GOLD_R】
【PRE_R】

In contrast , GE + CP group showed significant decrease in the elevated serum creatinine and BUN levels and an improvement in the histopathological and ultrastructural renal injury induced by CP .
【GOLD_E】
creatinine	chem
【PRE_E】
GE+CP	chem
creatinine	chem
BUN	chem
CP	chem
【GOLD_R】
【PRE_R】

The overexpression of Bax proapoptotic protein was significantly decreased in the GE + CP group .
【GOLD_E】
Bax	geneY
【PRE_E】
Bax	geneY
GE+CP	chem
【GOLD_R】
【PRE_R】
Bax	GE+CP	C3

Hence , the present results indicated that GE has a protective effect against CP - induced renal damage in rats .
【GOLD_E】
【PRE_E】
GE	chem
CP	chem
【GOLD_R】
【PRE_R】

Thereby , such findings recommended the usage of GE to prevent and / or decrease the renal damage induced by CP chemotherapeutic treatment .
【GOLD_E】
【PRE_E】
GE	chem
CP	chem
【GOLD_R】
【PRE_R】

An analysis of skeletal development in osteoblast - and chondrocyte - specific Runx2 knockout mice .
【GOLD_E】
Runx2	geneY
【PRE_E】
Runx2	geneY
【GOLD_R】
【PRE_R】

Global gene deletion studies in mice and humans have established the pivotal role of runt related transcription factor - 2 ( Runx2 ) in both intramembranous and endochondral ossification processes during skeletogenesis .
【GOLD_E】
runtrelatedtranscriptionfactor-2	geneY
Runx2	geneY
【PRE_E】
runtrelatedtranscriptionfactor-2	geneY
Runx2	geneY
【GOLD_R】
【PRE_R】

In this study , we for the first time generated mice carrying a conditional Runx2 allele with exon 4 , which encodes the Runt domain , flanked by loxP sites .
【GOLD_E】
Runx2	geneY
Runtdomain	geneN
loxPsites	geneN
【PRE_E】
Runx2	geneY
Runtdomain	geneN
loxP	geneY
【GOLD_R】
【PRE_R】

These mice were crossed with α1 ( I ) - collagen - Cre or α1 ( II ) - collagen - Cre transgenic mice to obtain osteoblast - or chondrocyte - specific Runx2 deficient mice , respectively .
【GOLD_E】
α1(I)-collagen	geneY
α1(II)-collagen	geneY
Runx2	geneY
【PRE_E】
α1(I)	geneY
collagen	geneN
α1(II)	geneY
collagen	geneN
Runx2	geneY
【GOLD_R】
【PRE_R】

As seen in Runx2 ( - / - ) mice , perinatal lethality was observed in α1 ( II ) - Cre ; Runx2 ( flox / flox ) mice , but this was not the case in animals in which α1 ( I ) - collagen - Cre was used to delete Runx2 .
【GOLD_E】
Runx2	geneY
α1(II)	geneY
Runx2	geneY
α1(I)-collagen	geneY
Runx2	geneY
【PRE_E】
Runx2	geneY
α1(II)	geneY
Runx2	geneY
flox	geneY
α1(I)	geneY
collagen	geneN
Runx2	geneY
【GOLD_R】
【PRE_R】

When using double staining with Alizarin red for mineralized matrix and Alcian blue for cartilaginous matrix , we observed previously that mineralization was totally absent at embryonic day 15.5 throughout the body in Runx2 ( - / - ) mice , but was found in areas undergoing intramembranous ossification such as skull and clavicles in α1 ( II ) - Cre ; Runx2 ( flox / flox ) mice .
【GOLD_E】
Alizarinred	chem
Runx2	geneY
Alcianblue	chem
α1(II)	geneY
Runx2	geneY
【PRE_E】
Alizarin	chem
Runx2	geneY
Runx2	geneY
【GOLD_R】
【PRE_R】

In newborn α1 ( II ) - Cre ; Runx2 ( flox / flox ) mice , mineralization impairment was restricted to skeletal areas undergoing endochondral ossification including long bones and vertebrae .
【GOLD_E】
α1(II)	geneY
Runx2	geneY
【PRE_E】
α1(II)	geneY
Runx2	geneY
【GOLD_R】
【PRE_R】

In contrast , no apparent skeletal abnormalities were seen in mutant embryo , newborn , and 3 - to 6 - week old - mice in which Runx2 had been deleted with the α1 ( I ) - collagen - Cre driver .
【GOLD_E】
Runx2	geneY
α1(I)-collagen	geneY
【PRE_E】
Runx2	geneY
α1(I)	geneY
collagen	geneN
【GOLD_R】
【PRE_R】

These results suggest that Runx2 is absolutely required for endochondral ossification during embryonic and postnatal skeletogenesis , but that disrupting its expression in already committed osteoblasts as achieved here with the α1 ( I ) - collagen - Cre driver does not affect overtly intramembranous and endochondral ossification .
【GOLD_E】
Runx2	geneY
α1(I)-collagen	geneY
【PRE_E】
Runx2	geneY
α1(I)	geneY
collagen	geneN
【GOLD_R】
【PRE_R】

The Runx2 floxed allele established here is undoubtedly useful for investigating the role of Runx2 in particular cells .
【GOLD_E】
Runx2	geneY
Runx2	geneY
【PRE_E】
Runx2	geneY
Runx2	geneY
【GOLD_R】
【PRE_R】

© 2013 American Society for Bone and Mineral Research .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A Mineral Extract from red Algae Ameliorates Chronic Spontaneous Colitis in IL - 10 Deficient Mice in a Mouse Strain Dependent Manner .
【GOLD_E】
IL-10	geneY
【PRE_E】
IL-10	geneY
【GOLD_R】
【PRE_R】

Inflammatory bowel disease is an urgent public health problem with a high incidence in developed countries .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Alterations of lifestyle or dietary interventions may attenuate the disease progression and increase the efficacy of current therapies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here we tested the effect of chronic supplementation with a mineral extract from red marine algae - rich in calcium ( 34 % ) , magnesium , phosphorus , selenium and other trace minerals - in a clinically relevant model of spontaneous enterocolitis , interleukin ( IL ) - 10 ( - / - ) mice .
【GOLD_E】
calcium	chem
magnesium	chem
phosphorus	chem
selenium	chem
interleukin(IL)-10	geneY
【PRE_E】
calcium	chem
magnesium	chem
phosphorus	chem
selenium	chem
minerals	chem
interleukin(IL)-10	geneY
【GOLD_R】
【PRE_R】

The mineral extract was administered in the drinking water of Il10 ( - / - ) mice on C57BL / 6 J and BALB / c strain backgrounds for 25 weeks commencing from 3 to 4 weeks of age .
【GOLD_E】
Il10	geneY
【PRE_E】
Il10	geneY
【GOLD_R】
【PRE_R】

The mineral extract ameliorated the spontaneous development of colitis and severity of disease in Il10 ( - / - ) mice on a C57BL / 6 J background .
【GOLD_E】
Il10	geneY
【PRE_E】
Il10	geneY
【GOLD_R】
【PRE_R】

Mineral extract - treated Il10 ( - / - ) C57BL / 6 J strain mice had significantly reduced mortality , circulating levels of serum Amyloid A and reduced colonic tissue damage .
【GOLD_E】
Il10	geneY
erumAmyloidAa	geneN
【PRE_E】
Il10	geneY
AmyloidA	geneY
【GOLD_R】
【PRE_R】

In contrast , comparable treatment of Il10 ( - / - ) mice on a BALB / c background with the mineral extract did not alter the course of colitis .
【GOLD_E】
Il10	geneY
【PRE_E】
Il10	geneY
【GOLD_R】
【PRE_R】

These data demonstrate that chronic supplementation with a natural mineral extract selectively ameliorates spontaneous mild - moderate colitis in Il10 ( - / - ) mice on a C57BL / 6 J , but does not attenuate more moderate - severe colitis in BALB / c strain animals .
【GOLD_E】
Il10	geneY
【PRE_E】
Il10	geneY
【GOLD_R】
【PRE_R】

Copyright © 2013 John Wiley & Sons , Ltd .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis .
【GOLD_E】
glucosylceramidesynthase	geneY
glucosylceramide	chem
【PRE_E】
glucosylceramidesynthase	geneY
【GOLD_R】
【PRE_R】

Hypothalamic neurons are main regulators of energy homeostasis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Neuronal function essentially depends on plasma membrane - located gangliosides .
【GOLD_E】
【PRE_E】
gangliosides	geneN
【GOLD_R】
【PRE_R】

The present work demonstrates that hypothalamic integration of metabolic signals requires neuronal expression of glucosylceramide synthase ( GCS ; UDP - glucose : ceramide glucosyltransferase ) .
【GOLD_E】
GCS	geneY
UDP-glucose:ceramideglucosyltransferase	geneY
glucosylceramide	chem
UDP	chem
glucose	chem
ceramide	chem
glucosylceramidesynthase	geneY
【PRE_E】
glucosylceramidesynthase	geneY
GCS	geneN
UDP-glucose	chem
ceramideglucosyltransferase	geneY
【GOLD_R】
【PRE_R】

As a major mechanism of central nervous system ( CNS ) metabolic control , we demonstrate that GCS - derived gangliosides interacting with leptin receptors ( ObR ) in the neuronal membrane modulate leptin - stimulated formation of signaling metabolites in hypothalamic neurons .
【GOLD_E】
GCS	geneY
leptinreceptors	geneY
ObR	geneY
leptin	geneY
【PRE_E】
gangliosides	geneN
leptinreceptors	geneY
ObR	geneY
leptin	geneY
【GOLD_R】
【PRE_R】

Furthermore , ganglioside - depleted hypothalamic neurons fail to adapt their activity ( c - Fos ) in response to alterations in peripheral energy signals .
【GOLD_E】
c-Fos	geneY
【PRE_E】
ganglioside	geneN
c-Fos	geneY
【GOLD_R】
【PRE_R】

Consequently , mice with inducible forebrain neuron - specific deletion of the UDP - glucose : ceramide glucosyltransferase gene ( Ugcg ) display obesity , hypothermia , and lower sympathetic activity .
【GOLD_E】
UDP-glucose:ceramideglucosyltransferase	geneY
Ugcg	geneY
UDP	chem
glucose	chem
ceramide	chem
【PRE_E】
UDP-glucose	chem
ceramideglucosyltransferase	geneN
【GOLD_R】
【PRE_R】

Recombinant adeno - associated virus ( rAAV ) - mediated Ugcg delivery to the arcuate nucleus ( Arc ) significantly ameliorated obesity , specifying gangliosides as seminal components for hypothalamic regulation of body energy homeostasis .
【GOLD_E】
Ugcg	geneY
【PRE_E】
gangliosides	geneN
【GOLD_R】
【PRE_R】

Environmental pesticide exposure modulates cytokines , arginase and ornithine decarboxylase expression in human placenta .
【GOLD_E】
cytokines	geneN
arginase	geneN
ornithinedecarboxylase	geneY
ornithine	chem
【PRE_E】
cytokines	geneN
arginase	geneN
ornithinedecarboxylase	geneY
【GOLD_R】
【PRE_R】

To evaluate the cytokine balance and enzymatic alterations induced by environmental pesticide exposure during pregnancy , this transversal study explored placentas derived from non - exposed women ( control group - CG ) , and from women living in a rural area ( rural group - RG ) , collected during intensive organophosphate ( OP ) pesticide spraying season ( RG - SS ) and during non - spraying season ( RG - NSS ) .
【GOLD_E】
organophosphate	chem
cytokine	geneN
【PRE_E】
cytokine	geneN
organophosphate	chem
【GOLD_R】
【PRE_R】

The exposure biomarkers blood cholinesterase and placental carboxylesterase ( CaE ) were significantly decreased in RG - SS .
【GOLD_E】
cholinesterase	geneY
carboxylesterase	geneN
CaE	geneN
【PRE_E】
cholinesterase	geneY
placentalcarboxylesterase	geneY
【GOLD_R】
【PRE_R】

Among the cytokines studied IL - 8 , IL - 6 , TNFα , IL - 10 , TGFβ and IL - 13 , the expression frequency of IL - 13 increased in RG - SS .
【GOLD_E】
IL-8	geneY
IL-6	geneY
TNFα	geneY
IL-10	geneY
TGFβ	geneY
IL-13	geneY
IL-13	geneY
cytokines	geneN
【PRE_E】
cytokines	geneN
IL-8	geneY
IL-6	geneY
TNFα	geneY
IL-10	geneY
TGFβ	geneY
IL-13	geneY
IL-13	geneY
【GOLD_R】
【PRE_R】

Arginase and ornithine decarboxylase ( ODC ) enzymes were induced in syncytiotrophoblast and endothelial cells .
【GOLD_E】
Arginase	geneN
ornithinedecarboxylase	geneY
ODC	geneY
ornithine	chem
【PRE_E】
Arginase	geneN
ornithinedecarboxylase	geneY
ODC	geneY
【GOLD_R】
【PRE_R】

Interestingly , the decrease in CaE activity was associated with arginase and ODC activity induction .
【GOLD_E】
CaE	geneN
ODC	geneY
【PRE_E】
arginase	geneN
ODC	geneY
【GOLD_R】
【PRE_R】

These findings suggest that environmental pesticide exposure impacts the placenta by increasing the expression frequency of the anti - inflammatory cytokine IL - 13 , which may be related to the up - regulation of enzymes implicated in tissue repair .
【GOLD_E】
cytokine	geneN
IL-13	geneY
【PRE_E】
cytokine	geneN
IL-13	geneY
【GOLD_R】
【PRE_R】

Lixisenatide : first global approval .
【GOLD_E】
【PRE_E】
Lixisenatide	chem
【GOLD_R】
【PRE_R】

The selective once - daily prandial glucagon - like peptide - 1 ( GLP - 1 ) receptor agonist lixisenatide ( Lyxumia ( ® ) ) is under development with Sanofi for the treatment of type 2 diabetes mellitus .
【GOLD_E】
glucagon-likepeptide-1(GLP-1)receptor	geneY
【PRE_E】
glucagon-likepeptide-1(GLP-1)receptor	geneY
lixisenatide	chem
Lyxumia	chem
【GOLD_R】
【PRE_R】
glucagon-likepeptide-1(GLP-1)receptor	lixisenatide	C6
glucagon-likepeptide-1(GLP-1)receptor	Lyxumia	C6

Lixisenatide belongs to a class of GLP - 1 compounds designed to mimic the endogenous hormone GLP - 1 .
【GOLD_E】
GLP-1	geneY
GLP-1	geneY
【PRE_E】
Lixisenatide	chem
GLP-1	geneY
GLP-1	geneY
【GOLD_R】
【PRE_R】

Native GLP - 1 stimulates insulin secretion in a glucose - dependent manner , as well as suppressing glucagon production and slowing gastric emptying .
【GOLD_E】
glucose	chem
GLP-1	geneY
insulin	geneY
glucagon	geneY
【PRE_E】
GLP-1	geneY
insulin	geneY
glucose	chem
glucagon	geneY
【GOLD_R】
【PRE_R】

A once - daily subcutaneous formulation of lixisenatide has been approved in the EU , Iceland , Liechtenstein , Norway and Mexico for the treatment of type 2 diabetes , and is under regulatory review in the USA , Switzerland , Brazil , Canada , Ukraine , South Africa , Japan and Australia .
【GOLD_E】
【PRE_E】
lixisenatide	chem
【GOLD_R】
【PRE_R】

This article summarizes the milestones in the development of lixisenatide , leading to this first approval for use in adults with type 2 diabetes .
【GOLD_E】
【PRE_E】
lixisenatide	chem
【GOLD_R】
【PRE_R】

Maqui berry ( Aristotelia chilensis ) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light .
【GOLD_E】
delphinidinglycoside	chem
photoreceptor	geneN
【PRE_E】
delphinidinglycoside	chem
【GOLD_R】
delphinidinglycoside	photoreceptor	C3
【PRE_R】

The protective effects of maqui berry ( Aristotelia chilensis ) extract ( MBE ) and its major anthocyanins [ delphinidin 3,5 - O - diglucoside ( D3G5G ) and delphinidin 3 - O - sambubioside - 5 - O - glucoside ( D3S5G ) ] against light - induced murine photoreceptor cells ( 661W ) death were evaluated .
【GOLD_E】
anthocyanins	chem
delphinidin3,5-O-diglucoside	chem
D3G5G	chem
delphinidin3-O-sambubioside-5-O-glucoside	chem
D3S5G	chem
【PRE_E】
anthocyanins	chem
delphinidin3,5-O-diglucoside	chem
D3G5G	chem
delphinidin3-O-sambubioside-5-O-glucoside	chem
D3S5G	chem
【GOLD_R】
【PRE_R】

Viability of 661W after light treatment for 24h , assessed by the tetrazolium salt ( WST - 8 ) assay and Hoechst 33342 nuclear staining , was improved by addition of MBE , D3G5G , and D3S5G .
【GOLD_E】
tetrazolium	chem
Hoechst33342	chem
D3G5G	chem
D3S5G	chem
【PRE_E】
tetrazolium	chem
WST-8	chem
Hoechst33342	chem
D3G5G	chem
D3S5G	chem
【GOLD_R】
【PRE_R】

Intracellular radical activation in 661W , evaluated using the reactive oxygen species ( ROS ) - sensitive probe 5 - ( and - 6 ) - chloromethyl - 2,7 - dichlorodihydro fluorescein diacetate acetyl ester ( CM - H2DCFDA ) , was reduced by MBE and its anthocyanins .
【GOLD_E】
5-(and-6)-chloromethyl-2,7-dichlorodihydrofluoresceindiacetateacetylester	chem
CM-H2DCFDA	chem
anthocyanins	chem
oxygen	chem
【PRE_E】
oxygen	chem
5-(and-6)-chloromethyl-2,7-dichlorodihydrofluoresceindiacetateacetylester	chem
CM-H2DCFDA	chem
MBE	chem
anthocyanins	chem
【GOLD_R】
【PRE_R】

The anti - apoptosis mechanism of MBE was evaluated by light - induced phosphorylation of p38 .
【GOLD_E】
p38	geneN
【PRE_E】
p38	geneN
【GOLD_R】
【PRE_R】

MBE significantly suppressed the light - induced phosphorylation of p38 .
【GOLD_E】
p38	geneN
【PRE_E】
MBE	chem
p38	geneN
【GOLD_R】
【PRE_R】
MBE	p38	C4

These findings indicate that MBE and its anthocyanidins suppress the light - induced photoreceptor cell death by inhibiting ROS production , suggesting that the inhibition of phosphorylated - p38 may be involved in the underlying mechanism .
【GOLD_E】
anthocyanidins	chem
phosphorylated-p38	geneN
【PRE_E】
MBE	chem
anthocyanidins	chem
phosphorylated-p38	geneN
【GOLD_R】
anthocyanidins	phosphorylated-p38	C4
【PRE_R】
MBE	phosphorylated-p38	C4
anthocyanidins	phosphorylated-p38	C4

Influence of triterpenoids present in apple peel on inflammatory gene expression associated with inflammatory bowel disease ( IBD ) .
【GOLD_E】
triterpenoids	chem
【PRE_E】
triterpenoids	chem
【GOLD_R】
【PRE_R】

Various ursanic , oleanic and lupanic pentacyclic triterpenoids found in apple peel were studied for anti - inflammatory effects in vitro using T84 colon carcinoma cells .
【GOLD_E】
ursanic,oleanicandlupanicpentacyclictriterpenoids	chem
【PRE_E】
oleanicandlupanicpentacyclictriterpenoids	chem
【GOLD_R】
【PRE_R】

After pretreatment with single triterpenoids , cells were stimulated with pro - inflammatory cytokines ( TNF - α , INF - γ , IL - 1β ) .
【GOLD_E】
TNF-α	geneY
INF-γ	geneY
IL-1β	geneY
triterpenoids	chem
cytokines	geneN
【PRE_E】
triterpenoids	chem
cytokines	geneN
TNF-α	geneY
INF-γ	geneY
IL-1β	geneY
【GOLD_R】
【PRE_R】

Regulation of mRNA expression was analysed for three specific inflammation - associated marker genes ( TNF - α , IL - 8 , IP - 10 ) using qRT - PCR .
【GOLD_E】
TNF-α	geneY
IL-8	geneY
IP-10	geneY
【PRE_E】
TNF-α	geneY
IL-8	geneY
【GOLD_R】
【PRE_R】

Furthermore , the effects of ursolic acid ( UA ) and oleanolic acid ( OA ) on the synthesis of certain pro - inflammatory proteins were examined .
【GOLD_E】
ursolicacid	chem
oleanolicacid	chem
【PRE_E】
ursolicacid	chem
UA	chem
oleanolicacid	chem
【GOLD_R】
【PRE_R】

IP - 10 expression was inhibited in a dose - dependent manner by all the tested compounds at concentrations ⩾ 25μM .
【GOLD_E】
IP-10	geneY
【PRE_E】
IP-10	geneY
【GOLD_R】
【PRE_R】

The mRNA expression of TNF - α was slightly affected and the IL - 8 level was increased .
【GOLD_E】
TNF-α	geneY
IL-8	geneY
【PRE_E】
TNF-α	geneY
IL-8	geneY
【GOLD_R】
【PRE_R】

At the protein level , UA and OA ( 25μM ) reduced the synthesis of IP - 10 ; sICAM - 1 , IL - 23 and GROα were slightly repressed .
【GOLD_E】
IP-10	geneY
sICAM-1	geneY
IL-23	geneY
GROα	geneY
【PRE_E】
UA	chem
IP-10	geneY
sICAM-1	geneY
IL-23	geneY
GROα	geneY
【GOLD_R】
【PRE_R】
UA	IP-10	C4
UA	sICAM-1	C4
UA	IL-23	C4
UA	GROα	C4

The TNF - α level was not modulated , whereas induction of IL - 8 was increased .
【GOLD_E】
TNF-α	geneY
IL-8	geneY
【PRE_E】
TNF-α	geneY
IL-8	geneY
【GOLD_R】
【PRE_R】

UA also enhanced the synthesis of IL - 1ra , while OA suppressed the level of I - TAC .
【GOLD_E】
IL-1ra	geneY
I-TAC	geneY
【PRE_E】
UA	chem
IL-1ra	geneY
I-TAC	geneY
【GOLD_R】
【PRE_R】
UA	IL-1ra	C4
UA	I-TAC	C4

The present study confirms that triterpenoids present in apple peel and β - damascone may be implicated in the anti - inflammatory properties of apple constituents , suggesting that these substances might be helpful in the treatment of IBD as nutrient supplements .
【GOLD_E】
triterpenoids	chem
β-damascone	chem
【PRE_E】
triterpenoids	chem
β-damascone	chem
【GOLD_R】
【PRE_R】

Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells .
【GOLD_E】
Curcumin	chem
【PRE_E】
Curcumin	chem
【GOLD_R】
【PRE_R】

Curcumin , the active constituent of dietary spice turmeric , possesses a strong potential for cancer prevention and treatment .
【GOLD_E】
Curcumin	chem
【PRE_E】
Curcumin	chem
【GOLD_R】
【PRE_R】

However , there is no study to address the effects of curcumin on invasion and metastasis of thyroid cancers .
【GOLD_E】
curcumin	chem
【PRE_E】
curcumin	chem
【GOLD_R】
【PRE_R】

Thyroid cancer is the most common malignancy of endocrine organs , and its incidence rates have steadily increased over recent decades .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Although most indolent tumours can be effectively managed , metastatic tumours at distant secondary sites behave aggressively and currently there is no effective form of treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , for the first time it has been reported that curcumin inhibit multiple metastasis steps of K1 papillary thyroid cancer cells .
【GOLD_E】
curcumin	chem
【PRE_E】
curcumin	chem
【GOLD_R】
【PRE_R】

Curcumin dose - dependently suppressed viability of K1 cells as well as its cell attachment , spreading , migration and invasion abilities .
【GOLD_E】
Curcumin	chem
【PRE_E】
Curcumin	chem
【GOLD_R】
【PRE_R】

Moreover , curcumin could also down - regulate the expression and activity of matrix metalloproteinase - 9 ( MMP - 9 ) .
【GOLD_E】
curcumin	chem
matrixmetalloproteinase-9	geneY
MMP-9	geneY
【PRE_E】
curcumin	chem
matrixmetalloproteinase-9	geneY
MMP-9	geneY
【GOLD_R】
curcumin	matrixmetalloproteinase-9	C4
curcumin	MMP-9	C4
curcumin	matrixmetalloproteinase-9	C4
curcumin	MMP-9	C4
【PRE_R】
curcumin	matrixmetalloproteinase-9	C4
curcumin	MMP-9	C4

The findings showed that curcumin might be an effective tumouristatic agent for the treatment of aggressive papillary thyroid carcinomas .
【GOLD_E】
curcumin	chem
【PRE_E】
curcumin	chem
【GOLD_R】
【PRE_R】

Lignans extracted from Vitex negundo possess cytotoxic activity by G2 / M phase cell cycle arrest and apoptosis induction .
【GOLD_E】
Lignans	chem
【PRE_E】
Lignans	chem
【GOLD_R】
【PRE_R】

Evn - 50 is a lignan compounds mixture extracted from Vitex negundo , a widely used herb in traditional Chinese medicine .
【GOLD_E】
Evn-50	chem
lignan	chem
【PRE_E】
Evn	chem
lignan	chem
【GOLD_R】
【PRE_R】

This study is aimed to define the spectrum of cytotoxic activity of EVn - 50 , and also to investigate mechanisms underlying the anticancer actions via assessing the influence on cell cycle using EVn - 50 , and the lignan compound VB1 purified from EVn - 50 .
【GOLD_E】
EVn-50	chem
EVn-50	chem
lignan	chem
VB1	chem
EVn-50	chem
【PRE_E】
EVn	chem
EVn	chem
lignan	chem
VB1	chem
EVn	chem
【GOLD_R】
【PRE_R】

The cytotoxic effect of EVn - 50 and VB1 was determined with SRB assay using a panel of cancer cell lines .
【GOLD_E】
EVn-50	chem
VB1	chem
【PRE_E】
EVn	chem
VB1	chem
SRB	chem
【GOLD_R】
【PRE_R】

Breast cancer cell line MDA - MB - 435 and liver cancer cell line SMMC - 7721 were selected for further evaluating the effect of EVn - 50 or VB1 on cell cycle by flow cytometric analysis .
【GOLD_E】
EVn-50	chem
VB1	chem
【PRE_E】
EVn	chem
VB1	chem
【GOLD_R】
【PRE_R】

Apoptosis exerted by EVn - 50 or VB1 was measured by TUNEL assay and DAPI staining , and Western blot analysis was utilized to assess the influence on expression and phosphorylation of proteins which are closely related to cell cycle and apoptosis .
【GOLD_E】
EVn-50	chem
VB1	chem
【PRE_E】
EVn	chem
VB1	chem
DAPI	chem
【GOLD_R】
【PRE_R】

EVn - 50 possessed a broad spectrum of in vitro anticancer activity for those tested cancer cells , especially sensitive to MDA - MB - 435 , SKOV - 3 , BXPC - 3 , SMMC - 7721 , MCF - 7 , HO - 8910 , SGC - 7901 , BEL - 7402 , HCT - 116 , and 786 - O , with the respective IC50 below 10μg / ml .
【GOLD_E】
EVn-50	chem
【PRE_E】
EVn	chem
786-O	chem
【GOLD_R】
【PRE_R】

Treatment with EVn - 50 or VB1 resulted in arresting the MDA - MB - 435 and SMMC - 7721 cells at G2 / M phase , which was further supported by observations of increased phosphorylation of Histone 3 at Ser10 , phosphorylation of Cdk1 at Tyr15 , expression of cyclin B1 , and decreased expression of Cdc25c .
【GOLD_E】
Histone3	geneN
Cdk1	geneY
cyclinB1	geneY
Cdc25c	geneY
EVn-50	chem
VB1	chem
Ser	chem
Tyr	chem
【PRE_E】
EVn	chem
VB1	chem
Histone3	geneY
Ser10	geneY
Cdk1	geneY
Tyr15	geneY
cyclinB1	geneY
Cdc25c	geneY
【GOLD_R】
EVn-50	Histone3	C3
EVn-50	Cdk1	C3
VB1	Histone3	C3
VB1	Cdk1	C3
EVn-50	cyclinB1	C3
VB1	cyclinB1	C3
EVn-50	Cdc25c	C4
VB1	Cdc25c	C4
【PRE_R】
EVn	Histone3	C3
EVn	Ser10	C3
EVn	Cdk1	C3
EVn	Tyr15	C3
EVn	cyclinB1	C3
EVn	Cdc25c	C3

Moreover , we found that exposure of MDA - MB - 435 cells to EVn - 50 or VB1 caused obvious apoptosis of MDA - MB - 435 cells .
【GOLD_E】
EVn-50	chem
VB1	chem
【PRE_E】
EVn	chem
VB1	chem
【GOLD_R】
【PRE_R】

Our data show that EVn - 50 , lignan compounds extracted from Vitex negundo , possesses a broad spectrum cytotoxic effect via arresting cancer cells at G2 / M phase cell cycle and subsequently inducing apoptosis .
【GOLD_E】
lignan	chem
EVn-50	chem
【PRE_E】
EVn	chem
lignan	chem
【GOLD_R】
【PRE_R】

TRP and ASIC channels mediate the antinociceptive effect of citronellyl acetate .
【GOLD_E】
citronellylacetate	chem
TRPandASICchannels	geneN
【PRE_E】
TRPandASICchannels	geneN
citronellylacetate	chem
【GOLD_R】
【PRE_R】

Background Citronellyl acetate ( CAT ) , a monoterpene product of the secondary metabolism of plants , has been shown in the literature to possess several different biological activities .
【GOLD_E】
CAT	chem
monoterpene	chem
Citronellylacetate	chem
【PRE_E】
Citronellylacetate	chem
CAT	geneY
monoterpene	chem
【GOLD_R】
【PRE_R】

However , no antinociceptive abilities have yet been discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we used acute pain animal models to describe the antinociceptive action of CAT .
【GOLD_E】
CAT	chem
【PRE_E】
CAT	geneY
【GOLD_R】
【PRE_R】

Methods The acetic acid - induced writhing test and the paw - licking test , in which paw licking was induced by glutamate and formalin , were performed to evaluate the antinociceptive action of CAT and to determine the involvement of PKC , PKA , TRPV1 , TRPA1 , TRPM8 and ASIC in its antinociceptive mechanism .
【GOLD_E】
aceticacid	chem
glutamate	chem
formalin	chem
CAT	chem
PKC	geneN
PKA	geneN
TRPV1	geneY
TRPA1	geneY
TRPM8	geneY
ASIC	geneN
【PRE_E】
aceticacid	chem
glutamate	chem
formalin	chem
CAT	geneY
PKC	geneN
PKA	geneN
TRPV1	geneY
TRPA1	geneY
TRPM8	geneY
ASIC	geneY
【GOLD_R】
【PRE_R】
formalin	CAT	C4

To do so , we induced paw - linking using agonists .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results CAT was administered intragastrically ( 25 , 50 , 75 , 100 and 200mg / kg ) , and the two higher doses caused antinociceptive effects in the acetic acid model ; the highest dose reduced pain for 4h after it was administered ( 200mg / kg ) .
【GOLD_E】
CAT	chem
aceticacid	chem
【PRE_E】
CAT	geneY
aceticacid	chem
【GOLD_R】
【PRE_R】

In the formalin test , two doses of CAT promoted antinociception in both the early and later phases of the test .
【GOLD_E】
formalin	chem
CAT	chem
【PRE_E】
formalin	chem
CAT	geneY
【GOLD_R】
【PRE_R】
formalin	CAT	C4

The glutamate test showed that its receptors are involved in the antinociceptive mechanism of CAT .
【GOLD_E】
glutamate	chem
CAT	chem
【PRE_E】
glutamate	chem
CAT	geneY
【GOLD_R】
【PRE_R】

Pretreatment with CAT did not alter locomotor activity or motor coordination .
【GOLD_E】
CAT	chem
【PRE_E】
CAT	geneY
【GOLD_R】
【PRE_R】

In an investigation into the participation of TRP channels and ASICs in CAT 's antinociceptive mechanism , we used capsaicin ( 2.2μg / paw ) , cinnamaldehyde ( 10mmol / paw ) , menthol ( 1.2mmol / paw ) and acidified saline ( 2 % acetic acid , pH 1.98 ) .
【GOLD_E】
TRPchannels	geneN
ASICs	geneN
CAT	chem
capsaicin	chem
cinnamaldehyde	chem
menthol	chem
aceticacid	chem
【PRE_E】
TRPchannels	geneN
ASICs	geneN
capsaicin	chem
cinnamaldehyde	chem
menthol	chem
aceticacid	chem
【GOLD_R】
【PRE_R】

The results showed that TRPV1 , TRPM8 and ASIC , but not TRPA1 , are involved in the antinociceptive mechanism .
【GOLD_E】
TRPV1	geneY
TRPM8	geneY
ASIC	geneN
TRPA1	geneY
【PRE_E】
TRPV1	geneY
TRPM8	geneY
ASIC	geneY
TRPA1	geneY
【GOLD_R】
【PRE_R】

Finally , the involvement of PKC and PKA was also studied , and we showed that both play a role in the antinociceptive mechanism of CAT .
【GOLD_E】
CAT	chem
PKC	geneN
PKA	geneN
【PRE_E】
PKC	geneN
PKA	geneN
CAT	geneY
【GOLD_R】
【PRE_R】

Conclusion The results of this work contribute information regarding the antinociceptive properties of CAT on acute pain and show that , at least in part , TRPV1 , TRPM8 , ASIC , glutamate receptors , PKC and PKA participate in CAT 's antinociceptive mechanism .
【GOLD_E】
CAT	chem
glutamate	chem
CAT	chem
TRPV1	geneY
TRPM8	geneY
ASIC	geneN
glutamatereceptors	geneN
PKC	geneN
PKA	geneN
【PRE_E】
CAT	geneY
TRPV1	geneY
TRPM8	geneY
ASIC	geneY
glutamatereceptors	geneN
PKC	geneN
PKA	geneN
【GOLD_R】
【PRE_R】

2 - Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells .
【GOLD_E】
2-Hydroxychalcone	chem
xanthohumol	chem
【PRE_E】
2-Hydroxychalcone	chem
xanthohumol	chem
【GOLD_R】
【PRE_R】

Breast cancer is estimated as one of the most common causes of cancer death among women .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In particular , triple negative breast cancers ( TNBCs ) , which do not express the genes for estrogen / progesterone receptors ( ER / PR ) and human epidermal growth factor receptor 2 ( HER2 ) , have been associated with poor prognosis and metastasis .
【GOLD_E】
estrogen	chem
progesterone	chem
estrogen	geneY
progesteronereceptors	geneY
ER	geneY
PR	geneY
humanepidermalgrowthfactorreceptor2	geneY
HER2	geneY
【PRE_E】
TNBCs	geneY
estrogen/progesteronereceptors	geneY
ER	geneY
PR	geneY
humanepidermalgrowthfactorreceptor2	geneY
HER2	geneY
【GOLD_R】
【PRE_R】

Chalcones , the biosynthetic precursors of flavonoids present in edible plants , exert cytotoxic and chemopreventive activities .
【GOLD_E】
Chalcones	chem
flavonoids	chem
【PRE_E】
Chalcones	chem
flavonoids	chem
【GOLD_R】
【PRE_R】

Although mounting evidence suggests the anticancer properties of chalcones , limited information is available regarding the inhibitory effects of chalcones on the aggressiveness of breast cancer cells .
【GOLD_E】
chalcones	chem
chalcones	chem
【PRE_E】
chalcones	chem
chalcones	chem
【GOLD_R】
【PRE_R】

The present study aimed to investigate the effects of chalcone and its derivatives on the growth and the invasiveness of TNBC cells .
【GOLD_E】
chalcone	chem
【PRE_E】
chalcone	chem
【GOLD_R】
【PRE_R】

Here , we showed that treatment with chalcone , 2 - hydroxychalcone , and xanthohumol for 24h inhibited the growth of MDA - MB - 231cells with IC50 values of 18.1 , 4.6 , and 6.7μM , respectively .
【GOLD_E】
chalcone	chem
2-hydroxychalcone	chem
xanthohumol	chem
【PRE_E】
chalcone	chem
2-hydroxychalcone	chem
xanthohumol	chem
【GOLD_R】
【PRE_R】

Similarly , Chalcone , 2 - hydroxychalcone , and xanthohumol also exerted cytotoxicity in another TNBC cell line , Hs578T .
【GOLD_E】
xanthohumol	chem
Chalcone	chem
2-hydroxychalcone	chem
【PRE_E】
Chalcone	chem
2-hydroxychalcone	chem
xanthohumol	chem
【GOLD_R】
【PRE_R】

Neohesperidin dihydrochalcone , 4 - methoxychalcone , and hesperidin methylchalcone did not show the cytotoxicity on the MDA - MB - 231cells .
【GOLD_E】
Neohesperidindihydrochalcone	chem
4-methoxychalcone	chem
hesperidinmethylchalcone	chem
【PRE_E】
Neohesperidindihydrochalcone	chem
4-methoxychalcone	chem
hesperidinmethylchalcone	chem
MDA	chem
【GOLD_R】
【PRE_R】

Xanthohumol and 2 - hydroxychalcone induced apoptosis by Bcl - 2 downregulation .
【GOLD_E】
Bcl-2	geneY
Xanthohumol	chem
2-hydroxychalcone	chem
【PRE_E】
Xanthohumol	chem
2-hydroxychalcone	chem
Bcl-2	geneY
【GOLD_R】
Xanthohumol	Bcl-2	C4
2-hydroxychalcone	Bcl-2	C4
【PRE_R】
Xanthohumol	Bcl-2	C4
2-hydroxychalcone	Bcl-2	C4

Importantly , 2 - hydroxychalcone and xanthohumol exerted more potent inhibitory effects on the proliferation , MMP - 9 expression and invasive phenotype of MDA - MB - 231 than chalcone .
【GOLD_E】
MMP-9	geneY
2-hydroxychalcone	chem
xanthohumol	chem
chalcone	chem
【PRE_E】
2-hydroxychalcone	chem
xanthohumol	chem
MMP-9	geneY
chalcone	chem
【GOLD_R】
2-hydroxychalcone	MMP-9	C4
xanthohumol	MMP-9	C4
【PRE_R】
2-hydroxychalcone	MMP-9	C4
xanthohumol	MMP-9	C4
MMP-9	chalcone	C4

These results suggest a potential application of these chalcones as anticancer agents that can alleviate malignant progression of TNBC .
【GOLD_E】
chalcones	chem
【PRE_E】
chalcones	chem
TNBC	geneY
【GOLD_R】
【PRE_R】

4 - Hydroxypyridazin - 3 ( 2H ) - one Derivatives as Novel d - Amino Acid Oxidase Inhibitors .
【GOLD_E】
4-Hydroxypyridazin-3(2H)-one	chem
d-AminoAcid	chem
d-AminoAcidOxidase	geneY
【PRE_E】
4-Hydroxypyridazin-3(2H)-one	chem
d-AminoAcidOxidase	geneN
【GOLD_R】
4-Hydroxypyridazin-3(2H)-one	d-AminoAcidOxidase	C4
【PRE_R】

d - Amino acid oxidase ( DAAO ) catalyzes the oxidation of d - amino acids including d - serine , a coagonist of the N - methyl - d - aspartate receptor .
【GOLD_E】
d-serine	chem
d-Aminoacidoxidase	geneY
N-methyl-d-aspartatereceptor	geneN
DAAO	geneY
d-Aminoacid	chem
N-methyl-d-aspartate	chem
d-aminoacids	chem
【PRE_E】
d-Aminoacidoxidase	geneY
DAAO	geneY
d-aminoacids	chem
d-serine	chem
N-methyl-d-aspartatereceptor	geneN
【GOLD_R】
d-serine	N-methyl-d-aspartatereceptor	C5
d-serine	d-Aminoacidoxidase	C9
d-serine	DAAO	C9
d-aminoacids	d-Aminoacidoxidase	C9
d-aminoacids	DAAO	C9
【PRE_R】
DAAO	d-aminoacids	C9
DAAO	d-serine	C9

We identified a series of 4 - hydroxypyridazin - 3 ( 2H ) - one derivatives as novel DAAO inhibitors with high potency and substantial cell permeability using fragment - based drug design .
【GOLD_E】
DAAO	geneY
4-hydroxypyridazin-3(2H)-one	chem
【PRE_E】
4-hydroxypyridazin-3(2H)-one	chem
DAAO	geneY
【GOLD_R】
4-hydroxypyridazin-3(2H)-one	DAAO	C4
【PRE_R】
4-hydroxypyridazin-3(2H)-one	DAAO	C4

Comparisons of complex structures deposited in the Protein Data Bank as well as those determined with in - house fragment hits revealed that a hydrophobic subpocket was formed perpendicular to the flavin ring by flipping Tyr224 in a ligand - dependent manner .
【GOLD_E】
Tyr	chem
【PRE_E】
Tyr224	chem
【GOLD_R】
【PRE_R】

We investigated the ability of the initial fragment hit , 3 - hydroxy - pyridine - 2 ( 1H ) - one , to fill this subpocket with the aid of complex structure information .
【GOLD_E】
3-hydroxy-pyridine-2(1H)-one	chem
【PRE_E】
3-hydroxy-pyridine-2(1H)-one	chem
【GOLD_R】
【PRE_R】

3 - Hydroxy - 5 - ( 2 - phenylethyl ) pyridine - 2 ( 1H ) - one exhibited the predicted binding mode and demonstrated high inhibitory activity for human DAAO in enzyme - and cell - based assays .
【GOLD_E】
3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one	chem
humanDAAO	geneY
【PRE_E】
3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one	chem
humanDAAO	geneN
【GOLD_R】
3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one	humanDAAO	C4
【PRE_R】
3-Hydroxy-5-(2-phenylethyl)pyridine-2(1H)-one	humanDAAO	C4

We further designed and synthesized 4 - hydroxypyridazin - 3 ( 2H ) - one derivatives , which are equivalent to the 3 - hydroxy - pyridine - 2 ( 1H ) - one series but lack cell toxicity .
【GOLD_E】
4-hydroxypyridazin-3(2H)-one	chem
3-hydroxy-pyridine-2(1H)-one	chem
【PRE_E】
4-hydroxypyridazin-3(2H)-one	chem
3-hydroxy-pyridine-2(1H)-one	chem
【GOLD_R】
【PRE_R】

6 - [ 2 - ( 3,5 - Difluorophenyl ) ethyl ] - 4 - hydroxypyridazin - 3 ( 2H ) - one was found to be effective against MK - 801 - induced cognitive deficit in the Y - maze .
【GOLD_E】
6-[2-(3,5-Difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one	chem
MK-801	chem
【PRE_E】
6-[2-(3,5-Difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one	chem
MK-801	chem
【GOLD_R】
【PRE_R】

Comparative study on transcriptional activity of 17 parabens mediated by estrogen receptor α and β and androgen receptor .
【GOLD_E】
androgen	chem
parabens	chem
estrogen	chem
androgenreceptor	geneY
estrogenreceptorαandβ	geneN
【PRE_E】
17parabens	chem
estrogenreceptorαandβ	geneN
androgenreceptor	geneY
【GOLD_R】
【PRE_R】

The structure - activity relationships of parabens which are widely used as preservatives for transcriptional activities mediated by human estrogen receptor α ( hERα ) , hERβ and androgen receptor ( hAR ) were investigated .
【GOLD_E】
humanestrogenreceptorα	geneY
hERα	geneY
hERβ	geneY
androgenreceptor	geneY
hAR	geneY
estrogen	chem
androgen	chem
parabens	chem
【PRE_E】
parabens	chem
humanestrogenreceptorα	geneY
hERα	geneY
hERβ	geneY
androgenreceptor	geneY
hAR	geneY
【GOLD_R】
【PRE_R】

Fourteen of 17 parabens exhibited hERα and / or hERβ agonistic activity at concentrations of ⩽1×10 ( - 5 ) M , whereas none of the 17 parabens showed AR agonistic or antagonistic activity .
【GOLD_E】
hERα	geneY
hERβ	geneY
AR	geneY
parabens	chem
parabens	chem
【PRE_E】
hERα	geneY
hERβ	geneY
⩽1×10(-5)M	chem
parabens	chem
AR	geneY
【GOLD_R】
parabens	hERα	C5
parabens	hERβ	C5
【PRE_R】
hERβ	⩽1×10(-5)M	C6
parabens	AR	C6

Among 12 parabens with linear alkyl chains ranging in length from C1 to C12 , heptylparaben ( C7 ) and pentylparaben ( C5 ) showed the most potent ERα and ERβ agonistic activity in the order of 10 ( - 7 ) M and 10 ( - 8 ) M , respectively , and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12 .
【GOLD_E】
heptylparaben	chem
pentylparaben	chem
ERα	geneY
ERβ	geneY
parabens	chem
alkyl	chem
【PRE_E】
parabens	chem
alkyl	chem
C12	chem
heptylparaben	chem
C7	chem
pentylparaben	chem
C5	chem
ERα	geneY
ERβ	geneY
alkyl	chem
【GOLD_R】
heptylparaben	ERα	C5
heptylparaben	ERβ	C5
pentylparaben	ERα	C5
pentylparaben	ERβ	C5
parabens	ERα	C5
parabens	ERβ	C5
alkyl	ERα	C5
alkyl	ERβ	C5
【PRE_R】
C12	ERα	C4
heptylparaben	ERα	C4
C7	ERα	C4
pentylparaben	ERα	C4
C5	ERα	C4
C5	ERβ	C4

Most parabens showing estrogenic activity exhibited ERβ - agonistic activity at lower concentrations than those inducing ERα - agonistic activity .
【GOLD_E】
parabens	chem
ERβ	geneY
ERα	geneY
【PRE_E】
parabens	chem
ERβ	geneY
ERα	geneY
【GOLD_R】
parabens	ERβ	C5
parabens	ERα	C5
【PRE_R】
parabens	ERβ	C6

The estrogenic activity of butylparaben was markedly decreased by incubation with rat liver microsomes , and the decrease of activity was blocked by a carboxylesterase inhibitor .
【GOLD_E】
butylparaben	chem
carboxylesterase	geneN
【PRE_E】
butylparaben	chem
carboxylesterase	geneN
【GOLD_R】
【PRE_R】
butylparaben	carboxylesterase	C4

These results indicate that parabens are selective agonists for ERβ over ERα ; their interactions with ERα / β are dependent on the size and bulkiness of the alkyl groups ; and they are metabolized by carboxylesterases , leading to attenuation of their estrogenic activity .
【GOLD_E】
ERβ	geneY
ERα	geneY
parabens	chem
ERα/β	geneN
carboxylesterases	geneN
alkyl	chem
【PRE_E】
parabens	chem
ERβ	geneY
ERα	geneY
ERα/β	geneN
alkyl	chem
carboxylesterases	geneN
【GOLD_R】
parabens	ERβ	C5
parabens	ERα	C5
parabens	carboxylesterases	C9
【PRE_R】

The cyclin D1 ( CCND1 ) rs9344 G > A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5 - FU - based chemotherapy .
【GOLD_E】
CCND1	geneY
rs9344G>A	geneN
cyclinD1	geneY
5-FU	chem
【PRE_E】
cyclinD1	geneY
CCND1	geneY
rs9344	geneY
G>A	geneN
5-FU	chem
【GOLD_R】
【PRE_R】

Recent evidence indicates a potential prognostic and predictive value for germline polymorphisms in genes involved in cell cycle control .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We investigated the effect of cyclin D1 ( CCND1 ) rs9344 G > A in stage II / III colon cancer patients and validated the findings in an independent study cohort .
【GOLD_E】
cyclinD1	geneY
CCND1	geneY
rs9344G>A	geneN
【PRE_E】
cyclinD1	geneY
CCND1	geneY
rs9344G>A	geneN
【GOLD_R】
【PRE_R】

For evaluation and validation set , a total of 264 and 234 patients were included .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Patients treated with 5 - fluorouracil - based chemotherapy , carrying the CCND1 rs9344 A / A genotype had significantly decreased time - to - tumor recurrence ( TTR ) in univariate analysis and multivariate analysis ( hazard ratio ( HR ) 2.47 ; 95 % confidence interval ( CI ) 1.16 - 5.29 ; P = 0.019 ) .
【GOLD_E】
5-fluorouracil	chem
CCND1	geneY
rs9344A/A	geneN
【PRE_E】
5-fluorouracil	chem
CCND1	geneY
TTR	geneY
【GOLD_R】
【PRE_R】

There was no significant association between CCND1 rs9344 G > A and TTR in patients with curative surgery alone .
【GOLD_E】
CCND1	geneY
rs9344G>A	geneN
【PRE_E】
CCND1	geneY
rs9344G>A	geneN
TTR	geneY
【GOLD_R】
【PRE_R】

In the validation set , the A allele of CCND1 rs9344 G > A remained significantly associated with decreased TTR in univariate and multivariate analyses ( HR 1.94 ; 95 % CI 1.05 - 3.58 ; P = 0.035 ) .
【GOLD_E】
CCND1	geneY
rs9344G>A	geneN
【PRE_E】
CCND1	geneY
G>A	geneN
TTR	geneY
【GOLD_R】
【PRE_R】

CCND1 rs9344 G > A may be a predictive and / or prognostic biomarker in stage II / III colon cancer patients , however , prospective trials are warranted to confirm our findings.The Pharmacogenomics Journal advance online publication , 9 April 2013 ; doi : 10.1038 / tpj.2013.15 .
【GOLD_E】
CCND1	geneY
rs9344G>A	geneN
【PRE_E】
CCND1	geneY
rs9344G>A	geneN
doi	chem
【GOLD_R】
【PRE_R】

Evaluation of 7 - O - galloyl - d - sedoheptulose , isolated from Corni Fructus , in the adipose tissue of type 2 diabetic db / db mice .
【GOLD_E】
7-O-galloyl-d-sedoheptulose	chem
【PRE_E】
7-O-galloyl-d-sedoheptulose	chem
【GOLD_R】
【PRE_R】

The aim of the present study was to evaluate the beneficial effects of 7 - O - galloyl - d - sedoheptulose ( GS ) , isolated from Corni Fructus , using type 2 diabetic mice .
【GOLD_E】
7-O-galloyl-d-sedoheptulose	chem
【PRE_E】
7-O-galloyl-d-sedoheptulose	geneY
GS	geneY
【GOLD_R】
【PRE_R】

GS was orally administered to db / db mice at doses of 20 and 100mg / kg body weight per day for 6weeks , and the effects of GS on biochemical factors in serum and adipose tissue were investigated .
【GOLD_E】
【PRE_E】
GS	geneY
GS	geneY
【GOLD_R】
【PRE_R】

To define the underlying mechanism of these effects , protein expressions related to lipid metabolism , inflammation , fibrosis , and apoptosis , were measured .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The results showed that levels of glucose , leptin , insulin , C - peptide , resistin , tumor necrosis factor - α , interleukin - 6 , triglycerides , total cholesterol , non - esterified fatty acids , high - density lipoprotein cholesterol , very low - density lipoprotein cholesterol / low - density lipoprotein cholesterol , reactive oxygen species ( ROS ) , and thiobarbituric acid - reactive substance ( TBARS ) in serum were down - regulated , while adiponectin was augmented by GS treatment .
【GOLD_E】
cholesterol	chem
cholesterol	chem
oxygen	chem
thiobarbituricacid	chem
leptin	geneY
insulin	geneN
C-peptide	geneN
resistin	geneY
tumornecrosisfactor-α	geneY
interleukin-6	geneY
high-densitylipoprotein	geneN
low-densitylipoprotein	geneN
low-densitylipoprotein	geneN
adiponectin	geneY
glucose	chem
triglycerides	chem
cholesterol	chem
fattyacids	chem
cholesterol	chem
【PRE_E】
glucose	chem
leptin	geneY
insulin	geneY
C-peptide	geneY
resistin	geneY
tumornecrosisfactor-α	geneY
interleukin-6	geneY
triglycerides	chem
cholesterol	chem
fattyacids	chem
high-densitylipoproteincholesterol	geneN
low-densitylipoproteincholesterol/low-densitylipoproteincholesterol	geneN
oxygen	chem
thiobarbituricacid	chem
adiponectin	geneY
GS	geneY
【GOLD_R】
【PRE_R】

In addition , the elevated lipid , ROS , and TBARS contents in adipose tissue as well as serum levels in db / db mice were significantly decreased by the oral administration of GS .
【GOLD_E】
【PRE_E】
GS	geneY
【GOLD_R】
【PRE_R】

From protein analysis , the decreased expressions of peroxisome proliferator activated receptor ( PPAR ) α , PPARγ , and B - cell lymphoma 2 were up - regulated in the adipose tissue of db / db mice .
【GOLD_E】
peroxisomeproliferatoractivatedreceptor(PPAR)α	geneY
PPARγ	geneY
B-celllymphoma2	geneY
【PRE_E】
peroxisomeproliferatoractivatedreceptor(PPAR)α	geneY
PPARγ	geneY
B-celllymphoma2	geneY
【GOLD_R】
【PRE_R】

The administration of GS significantly decreased sterol regulatory element binding protein - 1 , nuclear factor - kappa ? > Bp65 , cyclooxygenase - 2 , inducible nitric oxide synthase , monocyte chemotactic protein - 1 , intracellular adhesion molecule - 1 , phosphor c - Jun N - terminal kinase , activator protein - 1 , transforming growth factor - β1 , Bax , cytochrome c , and caspase - 3 expressions .
【GOLD_E】
sterolregulatoryelementbindingprotein-1	geneY
nuclearfactor-kappa	geneN
sterol	chem
cyclooxygenase-2	geneY
induciblenitricoxidesynthase	geneY
monocytechemotacticprotein-1	geneY
intracellularadhesionmolecule-1	geneY
phosphorc-Jun	geneY
kinase	geneN
activatorprotein-1	geneY
transforminggrowthfactor-β1	geneY
Bax	geneY
cytochromec	geneY
nitricoxide	chem
caspase-3	geneY
N	chem
【PRE_E】
GS	geneY
sterolregulatoryelementbindingprotein-1	geneY
nuclearfactor-kappa?>Bp65	geneN
cyclooxygenase-2	geneY
induciblenitricoxidesynthase	geneY
monocytechemotacticprotein-1	geneY
adhesionmolecule-1	geneY
phosphorc-JunN-terminalkinase	geneY
activatorprotein-1	geneY
transforminggrowthfactor-β1	geneY
Bax	geneY
cytochromec	geneY
caspase-3	geneY
【GOLD_R】
【PRE_R】

These results suggest that GS acts as a regulator of oxidative stress , inflammation , fibrosis , and apoptosis in the adipose tissue of db / db mice .
【GOLD_E】
【PRE_E】
GS	geneY
【GOLD_R】
【PRE_R】

Extracellular Signal - Regulated Kinases ( ERK ) Inhibitors from Aristolochia yunnanensis .
【GOLD_E】
ExtracellularSignal-RegulatedKinases	geneN
ERK	geneN
【PRE_E】
ExtracellularSignal-RegulatedKinases	geneN
ERK	geneN
【GOLD_R】
【PRE_R】

Six new sesquiterpenoids , aristoyunnolins A - F ( 1 - 6 ) , an artifact of isolation [ 7 - O - ethyl madolin W ( 7 ) ] , and 12 known analogues were isolated from stems of Aristolochia yunnanensis .
【GOLD_E】
aristoyunnolinsA-F	chem
7-O-ethylmadolinW	chem
sesquiterpenoids	chem
【PRE_E】
sesquiterpenoids	chem
aristoyunnolinsA-F	chem
[7-O-ethylmadolin	chem
【GOLD_R】
【PRE_R】

The structures were determined by combined chemical and spectral methods , and the absolute configurations of compounds 2 , 3 , 5 - 7 , 9 , 14 , and 17 were determined by the modified Mosher 's method and CD analysis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Compounds 1 - 19 were screened using a bioassay system designed to evaluate the effect on mitogen - activated protein kinases ( MAPKs ) signaling pathways .
【GOLD_E】
mitogen-activatedproteinkinases	geneN
MAPKs	geneN
【PRE_E】
mitogen-activatedproteinkinases	geneN
MAPKs	geneN
【GOLD_R】
【PRE_R】

Among three MAPKs ( ERK1 / 2 , JNK , and p38 ) , compounds 1 , 4 , 10 - 13 , 16 , 18 , and 19 exhibited selective inhibition of the phosphorylation of ERK1 / 2 .
【GOLD_E】
p38	geneN
ERK1/2	geneN
MAPKs	geneN
ERK1/2	geneN
JNK	geneN
【PRE_E】
MAPKs	geneN
ERK1/2	geneN
JNK	geneN
p38	geneN
ERK1/2	geneN
【GOLD_R】
【PRE_R】

Compounds 16 and 19 were more active than the positive control PD98059 , a known inhibitor of the ERK1 / 2 signaling pathway .
【GOLD_E】
ERK1/2	geneN
PD98059	chem
【PRE_E】
PD98059	chem
ERK1/2	geneN
【GOLD_R】
【PRE_R】

In vivo and in vitro anti - inflammatory potential of pentahydroxy - pregn - 14 - ol , 20 - one - β - d - thevetopyranoside in rats .
【GOLD_E】
pentahydroxy-pregn-14-ol,20-one-β-d-thevetopyranoside	chem
【PRE_E】
pentahydroxy-pregn-14-ol	chem
20-one-β-d-thevetopyranoside	chem
【GOLD_R】
【PRE_R】

Polyhydroxy pregnane glycoside ( PPG ) , a steroidal glycoside was isolated from Wattakaka volubilis Linn .
【GOLD_E】
steroidalglycoside	chem
Polyhydroxypregnaneglycoside	chem
PPG	chem
【PRE_E】
Polyhydroxypregnaneglycoside	geneY
PPG	chem
steroidalglycoside	chem
【GOLD_R】
【PRE_R】

( Stap.f . ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

PPG was evaluated for in vivo and in vitro anti - inflammatory activity using acute inflammation and chronic model of inflammation in rats and LPS - induced RAW 264.7 macrophage cells .
【GOLD_E】
PPG	chem
【PRE_E】
【GOLD_R】
【PRE_R】

PPG seemed to be responsible for the anti - inflammatory activity in the studied models .
【GOLD_E】
PPG	chem
【PRE_E】
【GOLD_R】
【PRE_R】

PPG at dose level of both 5 and 10mg / kg significantly reduced the edema induced by the carrageenan in acute model of inflammation .
【GOLD_E】
PPG	chem
【PRE_E】
【GOLD_R】
【PRE_R】

It also showed significant anti - proliferative effect ( dry pellet weight basis ) in chronic model of inflammation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cellular content of granuloma was measured by assaying activity of N - acetyl glucosaminidase ( NAG ) and total nucleic acid content .
【GOLD_E】
N-acetyl	chem
【PRE_E】
N-acetylglucosaminidase	geneY
NAG	geneY
【GOLD_R】
【PRE_R】

PPG at 5 and 10mg / kg significantly suppressed the cellular infiltration measured by total nucleic acid content .
【GOLD_E】
PPG	chem
【PRE_E】
【GOLD_R】
【PRE_R】

In contrast , NAG activity decreased over a period of 10 days resulting in inhibition of granuloma weight gain .
【GOLD_E】
【PRE_E】
NAG	geneY
【GOLD_R】
【PRE_R】

PPG had a more effective response than the reference drug diclofenac sodium in both the models of inflammation .
【GOLD_E】
PPG	chem
diclofenacsodium	chem
【PRE_E】
diclofenacsodium	chem
【GOLD_R】
【PRE_R】

Wattakaka volubilis steroidal glycoside mixture ( WVSM ) and PPG ( 1 - 50μM ) significantly inhibited the COX - 2 and iNOS enzymes resulting in low levels of PGE2 and NO in LPS - induced RAW 264.7 macrophage cells .
【GOLD_E】
COX-2	geneY
iNOS	geneY
steroidalglycoside	chem
PPG	chem
【PRE_E】
steroidalglycoside	chem
PPG	chem
1-50μM	chem
COX-2	geneY
iNOS	geneY
PGE2	chem
NO	chem
【GOLD_R】
steroidalglycoside	COX-2	C4
steroidalglycoside	iNOS	C4
PPG	COX-2	C4
PPG	iNOS	C4
【PRE_R】
steroidalglycoside	COX-2	C4
PPG	COX-2	C4
1-50μM	COX-2	C4
1-50μM	iNOS	C4

Hence the study supports the traditional use of Wattakaka volubilis and its constituent PPG in treatment of inflammatory disorders .
【GOLD_E】
PPG	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Hypermethylation of P15 , P16 , and E - cadherin genes in ovarian cancer .
【GOLD_E】
P15	geneY
P16	geneY
E-cadherin	geneY
【PRE_E】
Hypermethylation	geneY
P15	geneY
P16	geneY
E-cadherin	geneY
【GOLD_R】
【PRE_R】

Both p16 and p15 proteins are inhibitors of cyclin - dependent kinases that prevent the cell going through the G1 / S phase transaction .
【GOLD_E】
p15	geneY
cyclin-dependentkinases	geneN
p16	geneY
【PRE_E】
p16	geneY
p15	geneY
cyclin-dependentkinases	geneN
【GOLD_R】
【PRE_R】

E - cadherin is a transmembrane glycoprotein that mediates calcium - dependent interactions between adjacent epithelial cells .
【GOLD_E】
calcium	chem
E-cadherin	geneY
【PRE_E】
E-cadherin	geneY
calcium	chem
【GOLD_R】
【PRE_R】

Two groups of patients were selected : the first group suffered from epithelial serous ovarian tumors and the second group suffered from benign ovarian lesions ; ovarian tissue samples from all the subjects ( benign and malignant ) were subjected to methylation - specific polymerase chain reaction for methylated and unmethylated alleles of the genes ( E - cadherin , p15 , and p16 ) .
【GOLD_E】
p15	geneY
p16	geneY
E-cadherin	geneY
【PRE_E】
E-cadherin	geneY
p15	geneY
p16	geneY
【GOLD_R】
【PRE_R】

Results obtained showed that aberrant methylation of p15 and p16 genes were detected in 64.29 and 50 % of ovarian cancer patients , while E - cadherin hypermethylation was detected in 78.57 % of ovarian cancer patients .
【GOLD_E】
p15	geneY
p16	geneY
E-cadherin	geneY
【PRE_E】
p15	geneY
p16	geneY
E-cadherin	geneY
【GOLD_R】
【PRE_R】

Methylation of E - cadherin was significantly correlated with different stage of disease ( p < 0.05 ) .
【GOLD_E】
E-cadherin	geneY
【PRE_E】
E-cadherin	geneY
【GOLD_R】
【PRE_R】

It was found that the risk of E - cadherin hypermethylation was 1.347 - fold , while risk of p15 hypermethylation was 1.543 - fold and p16 was 1.2 - fold among patients with ovarian cancer than that among patients with benign ovarian lesions .
【GOLD_E】
E-cadherin	geneY
p15	geneY
【PRE_E】
E-cadherin	geneY
p15	geneY
p16	geneY
【GOLD_R】
【PRE_R】

In conclusion , Dysfunction of the cell cycle and / or the cell - cell adhesion molecule plays a role in the pathogenesis of ovarian cancer and that the analysis of the methylation of p15 and E - cadherin genes can provide clinically important evidence on which to base the treatment .
【GOLD_E】
p15	geneY
E-cadherin	geneY
【PRE_E】
p15	geneY
E-cadherin	geneY
【GOLD_R】
【PRE_R】

Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism .
【GOLD_E】
glucagon	geneY
ghrelin	geneY
insulin	geneY
【PRE_E】
glucagon	geneY
ghrelin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Due to stimulated overall metabolism , a state of nutritional inadequacy often ensues , during thyrotoxicosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We aimed to investigate circulating levels of some major components of the system that regulates energy stores , glucose , and fat metabolism , during thyrotoxicosis compared to euthyroidism .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

Fasting serum ghrelin , leptin , adiponectin , insulin , glucagon , glucose , as well as body fat composition were analyzed during thyrotoxicosis in 40 hyperthyroid patients ( 50.5 ± 15.2 years old , 22 females , 31 with Graves disease , and 9 with toxic nodular goiter ) .
【GOLD_E】
ghrelin	geneY
leptin	geneY
adiponectin	geneY
insulin	geneY
glucagon	geneY
glucose	chem
【PRE_E】
ghrelin	geneY
leptin	geneY
adiponectin	geneY
insulin	geneY
glucagon	geneY
glucose	chem
【GOLD_R】
【PRE_R】

The same measurements were repeated an average 3 months later , when all patients achieved euthyroidism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Compared to euthyroidism , in thyrotoxicosis , patients had lower ghrelin and fat mass ; had comparable insulin , HOMA - IR , glucagon , and leptin levels ; higher levels of circulating adiponectin .
【GOLD_E】
ghrelin	geneY
insulin	geneY
glucagon	geneY
leptin	geneY
adiponectin	geneY
【PRE_E】
ghrelin	geneY
insulin	geneY
glucagon	geneY
leptin	geneY
adiponectin	geneY
【GOLD_R】
【PRE_R】

Fasting serum glucose tended to be higher during thyrotoxicosis .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

The unique correlation of HOMA - IR was with the - glucagon to ghrelin ratio - ( r = 0.801 , p < 0.001 ) in hyperthyrodism , and with glucagon itself in euthyroidism ( r = - 0.844 , p < 0.001 ) .
【GOLD_E】
glucagon	geneY
ghrelin	geneY
agonitse	geneY
【PRE_E】
glucagon	geneY
ghrelin	geneY
glucagon	geneY
【GOLD_R】
【PRE_R】

Circulating levels of ghrelin are decreased ; leptin , insulin , glucagon are unchanged ; adiponectin are increased during hyperthyroidism .
【GOLD_E】
ghrelin	geneY
leptin	geneY
insulin	geneY
glucagon	geneY
adiponectin	geneY
【PRE_E】
ghrelin	geneY
leptin	geneY
insulin	geneY
glucagon	geneY
adiponectin	geneY
【GOLD_R】
【PRE_R】

The fasting HOMA - IR tends to be higher , despite the decreased adiposity in hyperthyroidism .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The - glucagon to ghrelin ratio - strongly correlates with fasting HOMA - IR in hyperthyroidism .
【GOLD_E】
glucagon	geneY
ghrelin	geneY
【PRE_E】
glucagon	geneY
ghrelin	geneY
【GOLD_R】
【PRE_R】

Proposed diagnostic criteria for subclinical Cushing 's syndrome associated with adrenal incidentaloma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Subclinical Cushing 's syndrome ( SCS ) associated with adrenal incidentaloma is usually characterized by autonomous cortisol secretion without overt symptoms of Cushing 's syndrome ( CS ) .
【GOLD_E】
cortisol	chem
【PRE_E】
cortisol	chem
【GOLD_R】
【PRE_R】

Although the diagnostic criteria for SCS differ among countries , the 1 mg dexamethasone suppression test ( DST ) is essential to confirm the presence and the extent of cortisol overproduction .
【GOLD_E】
dexamethasone	chem
cortisol	chem
【PRE_E】
dexamethasone	chem
cortisol	chem
【GOLD_R】
【PRE_R】

Since 1995 , SCS has been diagnosed in Japan based on serum cortisol levels ≥ 3 μg / dl ( measured by radioimmunoassay [ RIA ] ) after a 1 mg DST .
【GOLD_E】
cortisol	chem
【PRE_E】
cortisol	chem
【GOLD_R】
【PRE_R】

However , the increasing use of enzyme immunoassays ( EIA ) instead of RIA has hindered the diagnosis of SCS because of the differing sensitivities of commercially available assays , particularly for serum cortisol levels of around 3 μg / dl .
【GOLD_E】
cortisol	chem
【PRE_E】
cortisol	chem
【GOLD_R】
【PRE_R】

One way to overcome this problem is to lower the cortisol threshold level after a 1 mg DST .
【GOLD_E】
cortisol	chem
【PRE_E】
cortisol	chem
DST	chem
【GOLD_R】
【PRE_R】

In the present study , we examined the clinical applicability of lowering the cortisol threshold to 1.8 μg / dl , similar to the American Endocrine Society 's guidelines for CS , by reanalyzing 119 patients with adrenal incidentaloma .
【GOLD_E】
cortisol	chem
【PRE_E】
cortisol	chem
【GOLD_R】
【PRE_R】

Our findings indicate that serum cortisol levels ≥ 1.8 μg / dl after 1 mg DST are useful to confirm the diagnosis of SCS if both of the following criteria are met : ( 1 ) basal ACTH level < 10 pg / ml ( or poor plasma ACTH response to corticotrophin - releasing hormone ) and ( 2 ) serum cortisol ≥ 5 μg / dl at 21 : 00 to 23 : 00 h .
【GOLD_E】
ACTH	geneY
ACTH	geneY
corticotrophin-releasinghormone	geneY
cortisol	chem
cortisol	chem
【PRE_E】
cortisol	chem
ACTH	geneY
ACTH	geneY
corticotrophin-releasinghormone	geneY
cortisol	chem
【GOLD_R】
【PRE_R】
cortisol	ACTH	C3

If only one of ( 1 ) and ( 2 ) are met , we recommend that other clinical features are considered in the diagnosis of SCS , including serum dehydroepiandrosterone sulfate levels , urine free cortisol levels , adrenal scintigraphy , and clinical manifestation .
【GOLD_E】
dehydroepiandrosteronesulfate	chem
cortisol	chem
【PRE_E】
dehydroepiandrosteronesulfate	chem
cortisol	chem
【GOLD_R】
【PRE_R】

Flexibly timed once - daily dosing with degludec : a new ultra - long - acting basal insulin .
【GOLD_E】
insulin	geneY
【PRE_E】
degludec	chem
insulin	geneY
【GOLD_R】
【PRE_R】

Insulin treatment in type 1 and type 2 diabetes ( T1D and T2D ) is highly efficacious , but in practice , non - adherence and ineffective dose titration limit its effectiveness .
【GOLD_E】
Insulin	geneY
【PRE_E】
Insulin	geneY
【GOLD_R】
【PRE_R】

Barriers to more effective insulin treatment are numerous , including hypoglycaemia , fear of hypoglycaemia and concern about weight gain .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

The regular treatment timing needed with conventional basal insulins [ neutral protamine Hagedorn ( NPH ) insulin and the first - generation analogues glargine and detemir ] may also make adherence to these treatments problematic for many patients .
【GOLD_E】
insulins	geneY
insulin	geneY
【PRE_E】
insulins	geneY
Hagedorn(NPH)insulin	geneY
【GOLD_R】
【PRE_R】

Indeed , surveys indicate that the rigidity of this schedule induces some patients with T1D and T2D to omit insulin doses .
【GOLD_E】
insulin	geneY
【PRE_E】
insulin	geneY
【GOLD_R】
【PRE_R】

Degludec is a novel , ultra - long - acting basal insulin analogue that is as effective as insulin glargine , but significantly reduces patients ' risk of nocturnal hypoglycaemia .
【GOLD_E】
insulin	geneY
insulin	geneY
【PRE_E】
Degludec	chem
insulin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】
Degludec	insulin	C3

Because of its peakless , extended and highly predictable glucose - lowering effect , once - daily dosing on a flexible schedule may be feasible with degludec .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
degludec	chem
【GOLD_R】
【PRE_R】

Studies testing this possibility suggest that degludec tolerates day - to - day variation in dose timing while maintaining full efficacy and low risk of nocturnal hypoglycaemia .
【GOLD_E】
【PRE_E】
degludec	chem
【GOLD_R】
【PRE_R】

Degludec would appear to be an appropriate choice for patients being considered for a basal analogue , and it may be particularly well suited to patients with unpredictable social or work schedules , those who travel frequently and those who find rigid scheduling of their insulin injections a burden or barrier to regular treatment .
【GOLD_E】
insulin	geneY
【PRE_E】
Degludec	chem
insulin	geneY
【GOLD_R】
【PRE_R】

Evaluation of a predictive in vitro Leydig cell assay for anti - androgenicity of phthalate esters in the rat .
【GOLD_E】
phthalateesters	chem
【PRE_E】
phthalateesters	chem
【GOLD_R】
【PRE_R】

An in vitro assay using the rat Leydig cell line R2C was evaluated for its ability to quantitatively predict inhibition of testosterone synthesis .
【GOLD_E】
testosterone	chem
【PRE_E】
testosterone	chem
【GOLD_R】
【PRE_R】

Results obtained for endocrine active phthalates ( MEHP , MBP ) , and inactive phthalates ( MMP and MEP ) were highly consistent with in vivo results based on tissue and media concentrations .
【GOLD_E】
MEP	chem
phthalates	chem
MEHP	chem
MBP	chem
phthalates	chem
MMP	chem
【PRE_E】
phthalates	chem
MEHP	chem
MBP	geneY
phthalates	chem
MMP	geneN
【GOLD_R】
【PRE_R】

Statistically significant inhibition of testosterone synthesis ( p < 0.05 , 1 - way ANOVA ) was observed at 1μM MBP and 3μM MEHP , while MEP and MMP did not affect inhibition of testosterone synthesis until much higher concentrations ( ≫ 100μM ) .
【GOLD_E】
testosterone	chem
MBP	chem
MEHP	chem
MEP	chem
MMP	chem
testosterone	chem
【PRE_E】
testosterone	chem
3μMMEHP	chem
MMP	geneN
testosterone	chem
【GOLD_R】
【PRE_R】
3μMMEHP	MMP	C4

Concentrations causing 50 % inhibition of testosterone synthesis for MBP and MEHP ( 3 and 6μM respectively ) , were similar to in vivo values ( 3 and 7μM ) .
【GOLD_E】
testosterone	chem
MBP	chem
MEHP	chem
【PRE_E】
testosterone	chem
MBP	geneN
MEHP(3and6μM	chem
【GOLD_R】
【PRE_R】

The R2C assay was used to determine the relative potency of 14 structurally diverse monoesters and oxidative metabolites of MEHP .
【GOLD_E】
monoesters	chem
MEHP	chem
【PRE_E】
R2C	geneY
MEHP	chem
【GOLD_R】
【PRE_R】

Monoesters with alkyl chains 4 - 5 carbons in length had the highest potency for testosterone inhibition , while 0 - 2 carbon alkyl chains were least potent .
【GOLD_E】
Monoesters	chem
carbons	chem
testosterone	chem
carbon	chem
【PRE_E】
Monoesters	chem
alkyl	chem
4-5carbons	chem
testosterone	chem
carbonalkyl	chem
【GOLD_R】
【PRE_R】

Phase I metabolism did not completely inactivate MEHP , underscoring the need for metabolism data when interpreting in vitro pharmacodynamic data .
【GOLD_E】
MEHP	chem
【PRE_E】
MEHP	chem
【GOLD_R】
【PRE_R】

This steroid inhibition assay provides a predictive in vitro alternative to expensive and timeconsuming developmental rat studies for phthalate - induced antiandrogenicity .
【GOLD_E】
steroid	chem
phthalate	chem
【PRE_E】
steroid	chem
phthalate	chem
【GOLD_R】
【PRE_R】

Quercetin suppressed CYP2E1 - dependent ethanol hepatotoxicity via depleting heme pool and releasing CO .
【GOLD_E】
Quercetin	chem
ethanol	chem
CO	chem
CYP2E1	geneY
【PRE_E】
Quercetin	chem
CYP2E1	geneY
ethanol	chem
【GOLD_R】
Quercetin	CYP2E1	C4
【PRE_R】
Quercetin	CYP2E1	C3

Naturally occuring quercetin protects hepatocytes from ethanol - induced oxidative stress , and heme oxygenase - 1 ( HO - 1 ) induction and carbon monoxide ( CO ) metabolite may be implicated in the beneficial effect .
【GOLD_E】
ethanol	chem
heme	chem
HO-1	geneY
hemeoxygenase-1	geneY
carbonmonoxide	chem
CO	chem
quercetin	chem
【PRE_E】
quercetin	chem
ethanol	chem
hemeoxygenase-1	geneY
HO-1	geneY
carbonmonoxide	chem
【GOLD_R】
【PRE_R】

However , the precise mechanism by which quercetin counteracts CYP2E1 - mediated ethanol hepatotoxicity through HO - 1 system is still remained unclear .
【GOLD_E】
ethanol	chem
CYP2E1	geneY
HO-1	geneY
quercetin	chem
【PRE_E】
quercetin	chem
CYP2E1	geneY
ethanol	chem
HO-1	geneY
【GOLD_R】
quercetin	CYP2E1	C4
【PRE_R】
quercetin	CYP2E1	C3
CYP2E1	ethanol	C3
ethanol	HO-1	C3

To explore the potential mechanism , herein , ethanol ( 4.0g / kg.bw . ) was administrated to rats for 90 days .
【GOLD_E】
ethanol	chem
【PRE_E】
ethanol	chem
【GOLD_R】
【PRE_R】

Our data showed that chronic ethanol over - activated CYP2E1 but suppressed HO - 1 with concurrent hepatic oxidative damage , which was partially normalized by quercetin ( 100mg / kg.bw . ) .
【GOLD_E】
ethanol	chem
quercetin	chem
CYP2E1	geneY
HO-1	geneY
【PRE_E】
ethanol	chem
CYP2E1	geneY
HO-1	geneY
quercetin	chem
【GOLD_R】
ethanol	CYP2E1	C3
ethanol	HO-1	C4
【PRE_R】
ethanol	CYP2E1	C3
HO-1	quercetin	C3

Quercetin ( 100μM ) induced HO - 1 and depleted heme pool when incubated to human hepatocytes .
【GOLD_E】
Quercetin	chem
HO-1	geneY
【PRE_E】
Quercetin	chem
HO-1	geneY
【GOLD_R】
Quercetin	HO-1	C3
【PRE_R】
Quercetin	HO-1	C3

Ethanol - stimulated ( 100mM ) CYP2E1 upregulation was suppressed by quercetin but further enhanced by HO - 1 inhibition with resultant heme accumulation .
【GOLD_E】
Ethanol	chem
quercetin	chem
heme	chem
CYP2E1	geneY
HO-1	geneY
【PRE_E】
Ethanol	chem
CYP2E1	geneY
quercetin	chem
HO-1	geneY
【GOLD_R】
Ethanol	CYP2E1	C3
quercetin	CYP2E1	C4
Ethanol	HO-1	C4
heme	HO-1	C9
【PRE_R】
CYP2E1	quercetin	C4
quercetin	HO-1	C4

CO scavenging blocked the suppression of quercetin only on CYP2E1 activity .
【GOLD_E】
CO	chem
quercetin	chem
CYP2E1	geneY
【PRE_E】
quercetin	chem
CYP2E1	geneY
【GOLD_R】
CO	CYP2E1	C4
【PRE_R】

CO donor dose - dependently inactivated CYP2E1 of ethanol - incubated microsome , which was mimicked by HO - 1 substrate but abolished by CO scavenger .
【GOLD_E】
ethanol	chem
CO	chem
HO-1	geneY
CO	chem
CYP2E1	geneY
【PRE_E】
CYP2E1	geneY
ethanol	chem
HO-1	geneY
CO	chem
【GOLD_R】
ethanol	CYP2E1	C3
CO	CYP2E1	C4
CO	CYP2E1	C4
【PRE_R】

Thus , CYP2E1 - mediated ethanol hepatotoxicity was alleviated by quercetin through HO - 1 induction .
【GOLD_E】
CYP2E1	geneY
HO-1	geneY
ethanol	chem
quercetin	chem
【PRE_E】
CYP2E1	geneY
ethanol	chem
quercetin	chem
HO-1	geneY
【GOLD_R】
quercetin	HO-1	C3
【PRE_R】
ethanol	HO-1	C3
quercetin	HO-1	C3

Depleted heme pool and CO releasing limited protein synthesis and inhibited enzymatic activity of CYP2E1 , respectively .
【GOLD_E】
CYP2E1	geneY
CO	chem
【PRE_E】
CYP2E1	geneY
【GOLD_R】
CO	CYP2E1	C4
【PRE_R】

Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors .
【GOLD_E】
tetrahydrocurcuminoiddihydropyrimidinone	chem
acetylcholinesterase	geneY
【PRE_E】
racemictetrahydrocurcuminoiddihydropyrimidinone	chem
acetylcholinesterase	geneY
【GOLD_R】
tetrahydrocurcuminoiddihydropyrimidinone	acetylcholinesterase	C4
【PRE_R】
racemictetrahydrocurcuminoiddihydropyrimidinone	acetylcholinesterase	C4

The synthesis of racemic tetrahydrocurcumin - ( THC - ) , tetrahydrodemethoxycurcumin - ( THDC - ) and tetrahydrobisdemethoxycurcumin - ( THBDC - ) dihydropyrimidinone ( DHPM ) analogues was achieved by utilizing the multi - component Biginelli reaction in the presence of copper sulphate as a catalyst .
【GOLD_E】
THDC	chem
tetrahydrobisdemethoxycurcumin	chem
THBDC	chem
dihydropyrimidinone	chem
DHPM	chem
tetrahydrocurcumin	chem
coppersulphate	chem
THC	chem
tetrahydrodemethoxycurcumin	chem
【PRE_E】
racemictetrahydrocurcumin	chem
THC	chem
tetrahydrodemethoxycurcumin	chem
THDC	chem
tetrahydrobisdemethoxycurcumin-(THBDC-)dihydropyrimidinone	chem
DHPM	chem
Biginelli	chem
coppersulphate	chem
【GOLD_R】
【PRE_R】

The evaluation of acetylcholinesterase inhibitors for Alzheimer 's disease of these compounds showed that they exhibited higher inhibitory activity than their parent analogues .
【GOLD_E】
acetylcholinesterase	geneY
【PRE_E】
acetylcholinesterase	geneY
【GOLD_R】
【PRE_R】

THBDC - DHPM demonstrated the most potent inhibitory activity with an IC50 value of 1.34±0.03μM which was more active than the approved drug galanthamine ( IC50 = 1.45±0.04μM ) .
【GOLD_E】
THBDC-DHPM	chem
galanthamine	chem
【PRE_E】
THBDC-DHPM	chem
galanthamine	chem
【GOLD_R】
【PRE_R】

Agonistic activity of ICI 182 780 on activation of GSK 3β / AKT pathway in the rat uterus during the estrous cycle .
【GOLD_E】
ICI182780	chem
GSK3β	geneY
AKT	geneN
【PRE_E】
ICI182	chem
GSK3β	geneY
AKT	geneN
【GOLD_R】
ICI182780	AKT	C3
ICI182780	GSK3β	C5
【PRE_R】
ICI182	GSK3β	C4
ICI182	AKT	C4

We examined the ability of ICI 182,780 ( ICI ) to block uterine cell proliferation via protein kinase b / AKT pathway in the uterus of the rat during the estrous cycle .
【GOLD_E】
AKT	geneN
proteinkinaseb	geneN
ICI182,780	chem
ICI	chem
【PRE_E】
ICI182,780	chem
ICI	chem
proteinkinaseb	geneN
AKT	geneN
【GOLD_R】
【PRE_R】
ICI182,780	proteinkinaseb	C4
ICI	proteinkinaseb	C4
ICI	AKT	C4

Intact rats , with regular estrous cycles , received a subcutaneous ( s.c. ) injection of either vehicle or ICI at 08 : 00h on the day of proestrus or at 00 : 00h on the day of estrus and sacrificed at 13 : 00h of metaestrus .
【GOLD_E】
ICI	chem
【PRE_E】
【GOLD_R】
【PRE_R】

Estradiol ( E2 ) and progesterone ( P4 ) plasma levels were measured by radioimmunoassay .
【GOLD_E】
Estradiol	chem
progesterone	chem
【PRE_E】
Estradiol	chem
E2	chem
progesterone	chem
【GOLD_R】
【PRE_R】

Both ICI treatments , induced a significant decrease ( p < 0.01 ) in uterine estrogen receptor alpha ( ERα ) content , had no effect on uterine progesterone receptor ( PR ) protein expression and caused marked nuclear localization of cyclin D1 , in both luminal and glandular uterine epithelium , as compared to vehicle - treated animals .
【GOLD_E】
ICI	chem
estrogen	chem
progesterone	chem
estrogenreceptoralpha	geneY
ERα	geneY
progesteronereceptor	geneY
PR	geneY
cyclinD1	geneY
【PRE_E】
uterineestrogenreceptoralpha	geneY
ERα	geneY
uterineprogesteronereceptor	geneY
PR	geneY
cyclinD1	geneY
【GOLD_R】
ICI	estrogenreceptoralpha	C4
ICI	ERα	C4
【PRE_R】

Furthermore , we detected that ICI treatment induced glycogen synthase kinase ( Gsk3 - β ) Ser 9 phosphorylation , which correlates with cyclin D1 nuclear localization .
【GOLD_E】
ICI	chem
glycogensynthasekinase	geneN
Gsk3-β	geneY
cyclinD1	geneY
【PRE_E】
ICI	chem
glycogensynthasekinase	geneN
Gsk3-β	geneY
Ser9	geneY
cyclinD1	geneY
【GOLD_R】
ICI	glycogensynthasekinase	C3
ICI	Gsk3-β	C3
【PRE_R】

However , some differences were observed between the two different time schedules of administration .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We observed that the administration of ICI at 08 : 00h on proestrus day produced a 15 % inhibition of luminal epithelial cell proliferation , reduced uterine wet weight by 21 % and caused reduction of Akt phosphorylation at Ser 473 as compared to vehicle - treated animals , whereas ICI treatment at 00 : 00h on estrus day had no effect on these parameters .
【GOLD_E】
Akt	geneN
ICI	chem
Ser	chem
ICI	chem
【PRE_E】
ICI	chem
Akt	geneN
Ser	chem
【GOLD_R】
ICI	Akt	C4
【PRE_R】
ICI	Akt	C4

The overall results indicate that ICI may exert agonistic and antagonistic effects on uterine cell proliferation through differential activation of the Akt pathway depending on the administration period during the estrous cycle , and indicates that the mechanism of cell proliferation during the physiological conditions of the estrous cycle , is under a different and more complex regulation than in the ovariectomized + E2 animal model .
【GOLD_E】
Akt	geneN
ICI	chem
【PRE_E】
ICI	chem
Akt	geneN
【GOLD_R】
ICI	Akt	C3
【PRE_R】

Aminopropylindenes derived from Grundmann 's ketone as a novel chemotype of oxidosqualene cyclase inhibitors .
【GOLD_E】
oxidosqualenecyclase	geneY
Aminopropylindenes	chem
Grundmann'sketone	chem
【PRE_E】
ketone	chem
oxidosqualenecyclase	geneN
【GOLD_R】
Aminopropylindenes	oxidosqualenecyclase	C4
Grundmann'sketone	oxidosqualenecyclase	C4
【PRE_R】
ketone	oxidosqualenecyclase	C4

A series of aminopropylindenes , designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase ( 1 ) ( OSC ) - mediated cyclization of 2,3 - oxidosqualen to lanosterol was prepared from Grundmann 's ketone .
【GOLD_E】
OSC	geneY
oxidosqualenecyclase(1)	geneY
aminopropylindenes	chem
2,3-oxidosqualen	chem
lanosterol	chem
Grundmann'sketone	chem
oxidosqualene	chem
【PRE_E】
aminopropylindenes	chem
oxidosqualenecyclase(1)	geneY
OSC	geneY
2,3-oxidosqualen	chem
lanosterol	chem
ketone	chem
【GOLD_R】
lanosterol	OSC	C9
lanosterol	oxidosqualenecyclase(1)	C9
2,3-oxidosqualen	OSC	C9
2,3-oxidosqualen	oxidosqualenecyclase(1)	C9
【PRE_R】
oxidosqualenecyclase(1)	2,3-oxidosqualen	C9
OSC	2,3-oxidosqualen	C9
OSC	lanosterol	C9
OSC	ketone	C9

Screening on OSCs from five different organisms revealed interesting activities and selectivities of some of the compounds .
【GOLD_E】
OSCs	geneN
【PRE_E】
OSCs	chem
【GOLD_R】
【PRE_R】

A N , N - dimethylaminopropyl derivative showed promising inhibition of Trypanosoma cruzi OSC in combination with low cytotoxicity , and showed significant reduction of cholesterol biosynthesis in a human cell line .
【GOLD_E】
TrypanosomacruziOSC	geneY
N,N-dimethylaminopropyl	chem
cholesterol	chem
【PRE_E】
N	chem
N-dimethylaminopropyl	chem
TrypanosomacruziOSC	geneN
cholesterol	chem
【GOLD_R】
N,N-dimethylaminopropyl	TrypanosomacruziOSC	C4
cholesterol	TrypanosomacruziOSC	C9
【PRE_R】
N	TrypanosomacruziOSC	C4
N-dimethylaminopropyl	TrypanosomacruziOSC	C4

The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels .
【GOLD_E】
ATP	chem
pannexin	geneN
【PRE_E】
ATP	chem
pannexinhemichannels	geneN
【GOLD_R】
ATP	pannexin	C9
【PRE_R】

During repetitive stimulation of skeletal muscle , extracellular ATP levels raise , activating purinergic receptors , increasing Ca ( 2 + ) influx , and enhancing contractile force , a response called potentiation .
【GOLD_E】
ATP	chem
Ca(2+)	chem
purinergicreceptors	geneN
【PRE_E】
ATP	chem
purinergicreceptors	geneN
Ca(2+)	chem
【GOLD_R】
ATP	purinergicreceptors	C3
【PRE_R】

We found that ATP appears to be released through pannexin1 hemichannels ( Panx1 HCs ) .
【GOLD_E】
pannexin1	geneY
Panx1	geneY
ATP	chem
【PRE_E】
ATP	chem
pannexin1hemichannels	geneY
Panx1	geneY
【GOLD_R】
【PRE_R】

Immunocytochemical analyses and function were consistent with pannexin1 localization to T - tubules intercalated with dihydropyridine and ryanodine receptors in slow ( soleus ) and fast ( extensor digitorum longus , EDL ) muscles .
【GOLD_E】
dihydropyridine	chem
ryanodine	chem
pannexin1	geneY
ryanodinereceptors	geneN
【PRE_E】
pannexin1	geneY
dihydropyridine	chem
ryanodinereceptors	geneN
【GOLD_R】
【PRE_R】

Isolated myofibers took up ethidium ( Etd ( + ) ) and released small molecules ( as ATP ) during electrical stimulation .
【GOLD_E】
ethidium	chem
Etd(+)	chem
ATP	chem
【PRE_E】
ethidium	chem
Etd(+)	chem
ATP	chem
【GOLD_R】
【PRE_R】

Consistent with two glucose uptake pathways , induced uptake of 2 - NBDG , a fluorescent glucose derivative , was decreased by inhibition of HCs or glucose transporter ( GLUT4 ) , and blocked by dual blockade .
【GOLD_E】
glucose	chem
2-NBDG	chem
glucose	chem
glucose	chem
glucosetransporter	geneN
GLUT4	geneY
【PRE_E】
glucose	chem
2-NBDG	chem
glucose	chem
HCs	geneY
glucosetransporter	geneY
GLUT4	geneY
【GOLD_R】
glucose	glucosetransporter	C9
glucose	GLUT4	C9
2-NBDG	glucosetransporter	C9
2-NBDG	GLUT4	C9
【PRE_R】
2-NBDG	HCs	C4
glucose	HCs	C4
glucose	GLUT4	C4

Adult skeletal muscles apparently do not express connexins , making it unlikely that connexin hemichannels contribute to the uptake and release of small molecules .
【GOLD_E】
connexins	geneN
connexin	geneN
【PRE_E】
connexins	geneN
connexinhemichannels	geneN
【GOLD_R】
【PRE_R】

ATP release , Etd ( + ) uptake , and potentiation induced by repetitive electrical stimulation were blocked by HC blockers and did not occur in muscles of pannexin1 knockout mice .
【GOLD_E】
Etd(+)	chem
ATP	chem
pannexin1	geneY
【PRE_E】
ATP	chem
Etd(+)	chem
pannexin1	geneY
【GOLD_R】
【PRE_R】

MRS2179 , a P2Y1R blocker , prevented potentiation in EDL , but not soleus muscles , suggesting that in fast muscles ATP activates P2Y1 but not P2X receptors .
【GOLD_E】
P2Y1R	geneY
P2Y1	geneY
P2Xreceptors	geneN
ATP	chem
【PRE_E】
MRS2179	chem
P2Y1R	geneY
ATP	chem
P2Y1	geneY
P2Xreceptors	geneY
【GOLD_R】
ATP	P2Y1	C3
【PRE_R】

Phosphorylation on Ser and Thr residues of pannexin1 was increased during potentiation , possibly mediating HC opening .
【GOLD_E】
pannexin1	geneY
Ser	chem
Thr	chem
【PRE_E】
Ser	chem
Thr	chem
pannexin1	geneN
HC	geneN
【GOLD_R】
【PRE_R】

Opening of Panx1 HCs during repetitive activation allows efflux of ATP , influx of glucose and possibly Ca ( 2 + ) too , which are required for potentiation of contraction .
【GOLD_E】
Panx1	geneY
ATP	chem
glucose	chem
Ca(2+)	chem
【PRE_E】
Panx1	geneY
ATP	chem
glucose	chem
Ca(2+)	chem
【GOLD_R】
ATP	Panx1	C9
glucose	Panx1	C9
Ca(2+)	Panx1	C9
【PRE_R】
Panx1	ATP	C9
Panx1	glucose	C9
Panx1	Ca(2+)	C9

This article is part of a Special Issue entitled ' Connexin based channels ' .
【GOLD_E】
Connexin	geneN
【PRE_E】
Connexin	geneY
【GOLD_R】
【PRE_R】

tert - Butylhydroquinone reduces lipid accumulation in C57BL / 6 mice with lower body weight gain .
【GOLD_E】
tert-Butylhydroquinone	chem
【PRE_E】
tert-Butylhydroquinone	chem
【GOLD_R】
【PRE_R】

tert - Butylhydroquinone ( tBHQ ) is a commonly used antioxidant additive that is approved for human use by both the Food and Agriculture Organization and the World Health Organization ( FAO / WHO ) .
【GOLD_E】
tert-Butylhydroquinone	chem
tBHQ	chem
【PRE_E】
tert-Butylhydroquinone	chem
tBHQ	chem
【GOLD_R】
【PRE_R】

In this study , we examined the effect of tBHQ on body weight gain and found that food supplementation with 0.001 % ( w / w ) tBHQ inhibited 61.4 % ( P < 0.01 ) of body weight gain in high - fat diet ( HFD ) - induced C57BL / 6 mice , and the oral administration of tBHQ ( 1.5 mg / kg ) reduced 47.5 % ( P < 0.05 ) of body weight gain in normal diet fed db / db mice .
【GOLD_E】
tBHQ	chem
BHQi	chem
(1.5	chem
【PRE_E】
tBHQ	chem
tBHQ	chem
tBHQ	chem
【GOLD_R】
【PRE_R】

The HFD increased lipid deposit in adipocytes , but these were reduced significantly by tBHQ treatment in C57BL / 6 mice . tBHQ supplementation significantly lowered the plasma triglyceride and total cholesterol , with reduced size of accumulated fat mass .
【GOLD_E】
tBHQ	chem
tBHQ	chem
triglyceride	chem
cholesterol	chem
【PRE_E】
tBHQ	chem
tBHQ	chem
triglyceride	chem
cholesterol	chem
【GOLD_R】
【PRE_R】

The rate limiting enzyme of beta - oxidation ( ACOX1 ) was significantly over - expressed in the liver with tBHQ treatment .
【GOLD_E】
tBHQ	chem
ACOX1	geneY
【PRE_E】
beta-oxidation	geneY
ACOX1	geneY
tBHQ	chem
【GOLD_R】
tBHQ	ACOX1	C3
【PRE_R】
beta-oxidation	tBHQ	C3

These results indicate that tBHQ suppresses body weight gain in mice , possibly at least related to the up - regulation of ACOX1 gene expression .
【GOLD_E】
tBHQ	chem
ACOX1	geneY
【PRE_E】
tBHQ	chem
ACOX1	geneY
【GOLD_R】
tBHQ	ACOX1	C3
【PRE_R】
tBHQ	ACOX1	C3

Dual Growth Factor Delivery Using Biocompatible Core - Shell Microcapsules for Angiogenesis .
【GOLD_E】
【PRE_E】
GrowthFactor	geneY
【GOLD_R】
【PRE_R】

An optimized electrodropping system produces homogeneous core - shell microcapsules ( C - S MCs ) by using poly ( L - lactic - co - glycolic acid ) ( PLGA ) and alginate .
【GOLD_E】
poly(L-lactic-co-glycolicacid)	chem
PLGA	chem
【PRE_E】
C-SMCs	chem
poly(L-lactic-co-glycolicacid)	chem
PLGA	chem
alginate	chem
【GOLD_R】
【PRE_R】

Fluorescence imaging clearly shows the C - S domain in the MC .
【GOLD_E】
【PRE_E】
C-Sdomain	geneN
【GOLD_R】
【PRE_R】

For release control , the use of high - molecular - weight PLGA ( HMW 270 000 ) restrains the initial burst release of protein compared to that of low - MW PLGA ( LMW 40 000 ) .
【GOLD_E】
PLGA	chem
PLGA	chem
【PRE_E】
PLGA	chem
PLGA	chem
LMW	chem
【GOLD_R】
【PRE_R】

Layer - by - layer ( LBL ) assembly of chitosan and alginate on MCs is also useful in controlling the release profile of biomolecules .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

LBL ( 7 - layer ) treatment is effective in suppressing the initial burst release of protein compared to no LBL ( 0 - layer ) .
【GOLD_E】
【PRE_E】
LBL(7-layer)	chem
【GOLD_R】
【PRE_R】

The difference of cumulative albumin release between HMW ( 7 - layer LBL ) and LMW ( 0 - layer LBL ) PLGA is determined to be more than 40 % on day 5 .
【GOLD_E】
PLGA	chem
【PRE_E】
albumin	geneY
HMW	geneY
PLGA	chem
【GOLD_R】
【PRE_R】

When dual angiogenic growth factors ( GFs ) , such as platelet - derived GF ( PDGF ) and vascular endothelial GF ( VEGF ) , are encapsulated separately in the core and shell domains , respectively , the VEGF release rate is much greater than that of PDGF , and the difference of the cumulative release percentage between the two GFs is about 30 % on day 7 with LMW core PLGA and more than 45 % with HMW core PLGA .
【GOLD_E】
platelet-derivedGF	geneN
PDGF	geneN
vascularendothelialGF	geneN
VEGF	geneN
VEGF	geneN
PLGA	chem
PLGA	chem
PDGF	geneN
【PRE_E】
platelet-derivedGF	geneY
PDGF	geneN
vascularendothelialGF	geneY
VEGF	geneY
VEGF	geneY
PDGF	geneN
LMW	geneN
PLGA	chem
HMW	geneN
PLGA	chem
【GOLD_R】
PLGA	VEGF	C3
PLGA	PDGF	C3
PLGA	VEGF	C3
PLGA	PDGF	C3
【PRE_R】

As for the angiogenic potential of MC GFs with human umbilical vein endothelial cells ( HUVECs ) , the fluorescence signal of CD31 + suggests that the angiogenic sprout of ECs is more active in MC - mediated GF delivery than conventional GF delivery , and this difference is significant , based on the number of capillary branches in the unit area .
【GOLD_E】
CD31	geneY
【PRE_E】
CD31+	geneY
ECs	geneY
【GOLD_R】
【PRE_R】

This study demonstrates that the fabrication of biocompatible C - S MCs is possible , and that the release control of biomolecules is adjustable .
【GOLD_E】
【PRE_E】
C-S	chem
【GOLD_R】
【PRE_R】

Furthermore , MC - mediated GFs remain in an active form and can upregulate the angiogenic activity of ECs .
【GOLD_E】
【PRE_E】
ECs	geneY
【GOLD_R】
【PRE_R】

Potency switch between CHK1 and MK2 : Discovery of imidazo [ 1,2 - a ] pyrazine - and imidazo [ 1,2 - c ] pyrimidine - based kinase inhibitors .
【GOLD_E】
MK2	geneY
imidazo[1,2-a]pyrazine	chem
imidazo[1,2-c]pyrimidine	chem
kinase	geneN
CHK1	geneY
【PRE_E】
CHK1	geneN
MK2	geneN
imidazo[1,2-a]pyrazine-andimidazo[1,2-c]pyrimidine	chem
kinase	geneN
【GOLD_R】
imidazo[1,2-a]pyrazine	MK2	C4
imidazo[1,2-a]pyrazine	kinase	C4
imidazo[1,2-a]pyrazine	CHK1	C4
imidazo[1,2-c]pyrimidine	MK2	C4
imidazo[1,2-c]pyrimidine	kinase	C4
imidazo[1,2-c]pyrimidine	CHK1	C4
【PRE_R】
CHK1	imidazo[1,2-a]pyrazine-andimidazo[1,2-c]pyrimidine	C4
MK2	imidazo[1,2-a]pyrazine-andimidazo[1,2-c]pyrimidine	C4
imidazo[1,2-a]pyrazine-andimidazo[1,2-c]pyrimidine	kinase	C4

Chemistry has been developed to access both imidazo [ 1,2 - a ] pyrazines and imidazo [ 1,2 - c ] pyrimidines .
【GOLD_E】
imidazo[1,2-a]pyrazines	chem
imidazo[1,2-c]pyrimidines	chem
【PRE_E】
imidazo[1,2-a]pyrazines	chem
imidazo[1,2-c]pyrimidines	chem
【GOLD_R】
【PRE_R】

Small structural modifications in both series led to a switch of potency between two kinases involved in mediating cell cycle checkpoint control , CHK1 and MK2 .
【GOLD_E】
kinases	geneN
CHK1	geneY
MK2	geneY
【PRE_E】
kinases	geneN
CHK1	geneY
MK2	geneN
【GOLD_R】
【PRE_R】

The Fer tyrosine kinase is important for platelet - derived growth factor - BB - induced Stat3 phosphorylation , colony formation in soft agar and tumor growth in vivo .
【GOLD_E】
platelet-derivedgrowthfactor-BB	geneY
Fer	geneY
tyrosinekinase	geneN
Stat3	geneY
tyrosine	chem
【PRE_E】
Fer	geneY
tyrosinekinase	geneN
platelet-derivedgrowthfactor-BB	geneY
Stat3	geneY
【GOLD_R】
【PRE_R】

Fer is a cytoplasmic tyrosine kinase that is activated in response to platelet - derived growth factor ( PDGF ) stimulation .
【GOLD_E】
tyrosinekinase	geneN
tyrosine	chem
platelet-derivedgrowthfactor	geneN
Fer	geneY
PDGF	geneN
【PRE_E】
Fer	geneY
tyrosinekinase	geneN
platelet-derivedgrowthfactor	geneN
PDGF	geneN
【GOLD_R】
【PRE_R】

In the present report , we show that Fer associates with the activated PDGFbeta receptor ( PDGFRbeta ) through multiple autophosphorylation sites , i.e .
【GOLD_E】
Fer	geneY
PDGFbetareceptor	geneY
PDGFRbeta	geneY
【PRE_E】
Fer	geneY
PDGFbetareceptor	geneY
PDGFRbeta	geneY
【GOLD_R】
【PRE_R】

Tyr579 , Tyr581 , Tyr740 and Tyr1021 .
【GOLD_E】
Tyr	chem
Tyr	chem
Tyr	chem
Tyr	chem
【PRE_E】
Tyr579	geneN
Tyr581	geneY
Tyr740	geneN
Tyr1021	geneN
【GOLD_R】
【PRE_R】

Using low molecular weight inhibitors , we found that PDGF - BB - induced Fer activation is dependent on PDGFRbeta kinase activity , but not on the enzymatic activity of Src or Jak kinases .
【GOLD_E】
PDGF-BB	geneY
Fer	geneY
PDGFRbeta	geneY
kinase	geneN
Src	geneY
Jak	geneN
kinases	geneN
【PRE_E】
PDGF-BB	geneY
Fer	geneN
PDGFRbetakinase	geneN
Src	geneY
Jakkinases	geneN
【GOLD_R】
【PRE_R】

In cells in which Fer was downregulated using siRNA , PDGF - BB was unable to induce phosphorylation of Stat3 , whereas phosphorylations of Stat5 , Erk1 / 2 and Akt were unaffected .
【GOLD_E】
Fer	geneY
PDGF-BB	geneY
Stat3	geneY
Stat5	geneN
Erk1/2	geneN
Akt	geneN
【PRE_E】
Fer	geneY
PDGF-BB	geneY
Stat3	geneY
phosphorylations	geneN
Stat5	geneY
Erk1/2	geneN
Akt	geneN
【GOLD_R】
【PRE_R】

PDGF - BB - induced activation of Stat3 occurred also in cells expressing kinase - dead Fer , suggesting a kinase - independent adaptor role of Fer .
【GOLD_E】
PDGF-BB	geneY
Stat3	geneY
kinase	geneN
Fer	geneY
kinase	geneN
Fer	geneY
【PRE_E】
PDGF-BB	geneY
Stat3	geneY
kinase	geneN
Fer	geneY
kinase	geneN
adaptor	geneN
Fer	geneY
【GOLD_R】
【PRE_R】

Expression of Fer was dispensable for PDGF - BB - induced proliferation and migration , but essential for colony formation in soft agar .
【GOLD_E】
Fer	geneY
PDGF-BB	geneY
【PRE_E】
Fer	geneY
PDGF-BB	geneY
【GOLD_R】
【PRE_R】

Tumor growth in vivo was delayed in cells depleted of Fer expression .
【GOLD_E】
Fer	geneY
【PRE_E】
Fer	geneY
【GOLD_R】
【PRE_R】

Our data suggests a critical role of Fer in PDGF - BB - induced Stat3 activation and cell transformation .
【GOLD_E】
PDGF-BB	geneY
Stat3	geneY
Fer	geneY
【PRE_E】
Fer	geneY
PDGF-BB	geneY
Stat3	geneY
【GOLD_R】
【PRE_R】

Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity ( Part I ) .
【GOLD_E】
histamineH3receptor	geneY
arylureas	chem
arylamides	chem
histamine	chem
【PRE_E】
arylureas	chem
arylamides	chem
histamineH3receptor	geneY
【GOLD_R】
arylureas	histamineH3receptor	C6
arylamides	histamineH3receptor	C6
【PRE_R】

A series of structurally novel aryl ureas was derived from optimization of the HTS lead as selective histamine H3 receptor ( H3R ) antagonists .
【GOLD_E】
histamine	chem
arylureas	chem
histamineH3receptor	geneY
H3R	geneY
【PRE_E】
arylureas	chem
histamineH3receptor	geneY
H3R	geneY
【GOLD_R】
arylureas	histamineH3receptor	C6
arylureas	H3R	C6
【PRE_R】

The SAR was explored and the data obtained set up the starting point and foundation for further optimization .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The most potent tool compounds , as exemplified by compounds 2l , 5b , 5d , and 5e , displayed antagonism potencies in the subnanomolar range in in vitro human - H3R FLIPR assays and rhesus monkey H3R binding assays .
【GOLD_E】
human-H3R	geneY
rhesusmonkeyH3R	geneY
【PRE_E】
human-H3R	geneY
H3R	geneY
【GOLD_R】
【PRE_R】

Structure and energetics of gas phase halogen - bonding in mono - , bi - , and tri - dentate anion receptors as studied by BIRD .
【GOLD_E】
halogen	chem
mono-,bi-,andtri-dentateanionreceptors	geneN
【PRE_E】
halogen	chem
mono-,bi-,andtri-dentateanionreceptors	geneN
【GOLD_R】
【PRE_R】

Complexes of mono - , bi - ( RB ) , and tridentate ( RT ) receptors with a range of anions ( Cl ( - ) , Br ( - ) , I ( - ) , NO3 ( - ) , H2PO4 ( - ) , HSO4 ( - ) , and tosylate ( TsO ( - ) ) ) have been studied in the gas phase by both experimental and theoretical methods .
【GOLD_E】
NO3(-)	chem
Cl(-)	chem
Br(-)	chem
I(-)	chem
mono-,bi-(RB),andtridentate(RT)receptors	geneN
H2PO4(-)	chem
HSO4(-)	chem
tosylate	chem
TsO(-)	chem
【PRE_E】
mono-,bi-(RB),andtridentate(RT)receptors	geneN
Cl(-)	chem
Br(-)	chem
NO3(-)	chem
H2PO4(-)	chem
HSO4(-)	chem
tosylate	chem
TsO(-)	chem
【GOLD_R】
【PRE_R】

Temperature dependent blackbody infrared radiative dissociation ( BIRD ) experiments were performed on complexes of C8F17I with Br ( - ) and I ( - ) , RB with I ( - ) , NO3 ( - ) , HSO4 ( - ) , H2PO4 ( - ) , and TsO ( - ) , and RT with I ( - ) , HSO4 ( - ) and TsO ( - ) and the observed Arrhenius parameters are reported here .
【GOLD_E】
C8F17I	chem
Br(-)	chem
I(-)	chem
I(-)	chem
NO3(-)	chem
HSO4(-)	chem
H2PO4(-)	chem
TsO(-)	chem
I(-)	chem
HSO4(-)	chem
TsO(-)	chem
【PRE_E】
C8F17I	chem
Br(-)	chem
RB	chem
NO3(-)	chem
HSO4(-)	chem
H2PO4(-)	chem
TsO(-)	chem
HSO4(-)	chem
TsO(-)	chem
【GOLD_R】
【PRE_R】

Master equation modeling of the BIRD kinetics data was carried out to determine threshold dissociation energies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Geometry optimizations and thermochemistry calculations were performed using the B3LYP / 6 - 31 + G ( d , p ) level of theory .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Additional single point energies were calculated using MP2 / 6 - 311 + + G ( 2d , p ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results were examined in terms of the binding order of various anions as well as the added binding strength from additional halogen bonding ( XB ) interactions .
【GOLD_E】
halogen	chem
【PRE_E】
halogen	chem
【GOLD_R】
【PRE_R】

The relative binding energies of ions were generally consistent with the ordering previously reported from solution phase experiments ; however , the relatively strong binding of H2PO4 ( - ) to the bidentate receptor contrasted the solution phase observation of oxoanions having weaker interactions when compared to halides .
【GOLD_E】
H2PO4(-)	chem
oxo	chem
halides	chem
【PRE_E】
H2PO4(-)	chem
bidentatereceptor	geneN
oxoanions	chem
halides	chem
【GOLD_R】
【PRE_R】

An increase in the energy required to remove the same anion from the tridentate receptor when compared to the bidentate and monodentate receptors is explained as being due to the increase in halogen bonding interactions .
【GOLD_E】
tridentatereceptor	geneN
bidentateandmonodentatereceptors	geneN
halogen	chem
【PRE_E】
tridentatereceptor	geneN
bidentateandmonodentatereceptors	geneN
halogen	chem
【GOLD_R】
【PRE_R】

The possibility of mixed halogen and hydrogen bonded complexes were considered .
【GOLD_E】
halogen	chem
hydrogen	chem
【PRE_E】
halogen	chem
hydrogen	chem
【GOLD_R】
【PRE_R】

Anandamide deficiency and heightened neuropathic pain in aged mice .
【GOLD_E】
Anandamide	chem
【PRE_E】
Anandamide	chem
【GOLD_R】
【PRE_R】

Damaging of peripheral nerves may result in chronic neuropathic pain for which the likelihood is increased in the elderly .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We assessed in mice if age - dependent alterations of endocannabinoids contributed to the heightened vulnerability to neuropathic pain at old age .
【GOLD_E】
【PRE_E】
endocannabinoids	geneN
【GOLD_R】
【PRE_R】

We assessed nociception , endocannabinoids and the therapeutic efficacy of R - flurbiprofen in young and aged mice in the spared nerve injury model of neuropathic pain .
【GOLD_E】
R-flurbiprofen	chem
【PRE_E】
R-flurbiprofen	chem
【GOLD_R】
【PRE_R】

R - flurbiprofen was used because it is able to reduce neuropathic pain in young mice in part by increasing anandamide .
【GOLD_E】
R-flurbiprofen	chem
anandamide	chem
【PRE_E】
R-flurbiprofen	chem
anandamide	chem
【GOLD_R】
【PRE_R】

Aged mice developed stronger nociceptive hypersensitivity after sciatic nerve injury than young mice .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This was associated with low anandamide levels in the dorsal root ganglia , spinal cord , thalamus and cortex , which further decreased after nerve injury .
【GOLD_E】
anandamide	chem
【PRE_E】
anandamide	chem
【GOLD_R】
【PRE_R】

In aged mice , R - flurbiprofen had only weak antinociceptive efficacy and it failed to restore normal anandamide levels after nerve injury .
【GOLD_E】
R-flurbiprofen	chem
anandamide	chem
【PRE_E】
R-flurbiprofen	chem
anandamide	chem
【GOLD_R】
【PRE_R】

In terms of the mechanisms , we found that fatty acid amide hydrolase ( FAAH ) which degrades anandamide , was upregulated after nerve injury at both ages , so that this upregulation likely did not account for the age - dependent differences .
【GOLD_E】
fattyacid	chem
amide	chem
FAAH	geneN
fattyacidamidehydrolase	geneN
anandamide	chem
【PRE_E】
fattyacidamidehydrolase	geneY
FAAH	geneY
anandamide	chem
【GOLD_R】
anandamide	FAAH	C9
anandamide	fattyacidamidehydrolase	C9
【PRE_R】
FAAH	anandamide	C9

However , enzymes contributing to oxidative metabolism of anandamide , namely cyclooxygenase - 1 and Cyp2D6 , were increased in the brain of aged mice , possibly enhancing the oxidative breakdown of anandamide .
【GOLD_E】
cyclooxygenase-1	geneY
Cyp2D6	geneN
anandamide	chem
anandamide	chem
【PRE_E】
anandamide	chem
cyclooxygenase-1	geneY
Cyp2D6	geneY
anandamide	chem
【GOLD_R】
anandamide	cyclooxygenase-1	C9
anandamide	Cyp2D6	C9
anandamide	cyclooxygenase-1	C9
anandamide	Cyp2D6	C9
【PRE_R】
anandamide	cyclooxygenase-1	C9
Cyp2D6	anandamide	C9

This may overwhelm the capacity of R - flurbiprofen to restore anandamide homeostasis and may contribute to the heightened risk for neuropathic pain at old age .
【GOLD_E】
R-flurbiprofen	chem
anandamide	chem
【PRE_E】
R-flurbiprofen	chem
anandamide	chem
【GOLD_R】
【PRE_R】

Polymer - based protein engineering can rationally tune enzyme activity , pH - dependence , and stability .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The attachment of inert polymers , such as polyethyleneglycol , to proteins has driven the emergence of a multibillion dollar biotechnology industry .
【GOLD_E】
polyethyleneglycol	chem
【PRE_E】
polyethyleneglycol	chem
【GOLD_R】
【PRE_R】

In all cases , proteins have been stabilized or altered by covalently coupling the pre - existing polymer to the surface of the protein .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This approach is inherently limited by a lack of exquisite control of polymer architecture , chain length , site and density of attachment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Using a novel water - soluble atom transfer radical polymerization initiator , we have grown temperature - and pH - responsive polymers from the surface of a model protein , the enzyme chymotrypsin .
【GOLD_E】
chymotrypsin	geneN
【PRE_E】
chymotrypsin	geneN
【GOLD_R】
【PRE_R】

Poly ( 2 - ( dimethylamino ) ethyl methacrylate ) changes in conformation with altered temperature and pH .
【GOLD_E】
Poly(2-(dimethylamino)ethylmethacrylate)	chem
【PRE_E】
Poly(2-(dimethylamino)ethylmethacrylate	chem
【GOLD_R】
【PRE_R】

Growing the polymer from the surface of chymotrypsin we were able to demonstrate that changes in temperature or pH can change predictably the conformation of the polymer surrounding the enzyme , which in turn enabled the rational tailoring of enzyme activity and stability .
【GOLD_E】
chymotrypsin	geneN
【PRE_E】
chymotrypsin	geneN
【GOLD_R】
【PRE_R】

Using what we now term `` Polymer - Based Protein Engineering `` we have increased the activity and stability of chymotrypsin by an order of magnitude at pH 's where the enzyme is usually inactive or unstable .
【GOLD_E】
ofchymotryps	geneN
【PRE_E】
chymotrypsin	geneN
【GOLD_R】
【PRE_R】

24 ( S ) - hydroxycholesterol is actively eliminated from neuronal cells by ABCA1 .
【GOLD_E】
24(S)-hydroxycholesterol	chem
ABCA1	geneY
【PRE_E】
24(S)-hydroxycholesterol	chem
ABCA1	geneY
【GOLD_R】
24(S)-hydroxycholesterol	ABCA1	C9
【PRE_R】

High cholesterol turnover catalyzed by cholesterol 24 - hydroxylase is essential for neural functions , especially learning .
【GOLD_E】
cholesterol24-hydroxylase	geneY
cholesterol	chem
cholesterol	chem
【PRE_E】
cholesterol	chem
cholesterol24-hydroxylase	geneY
【GOLD_R】
cholesterol	cholesterol24-hydroxylase	C9
【PRE_R】

Because 24 ( S ) - hydroxycholesterol ( 24 - OHC ) , produced by 24 - hydroxylase , induces apoptosis of neuronal cells , it is vital to eliminate it rapidly from cells .
【GOLD_E】
24-hydroxylase	geneY
24(S)-hydroxycholesterol	chem
24-OHC	chem
【PRE_E】
(S)-hydroxycholesterol	chem
24-OHC	chem
24-hydroxylase	geneY
【GOLD_R】
24(S)-hydroxycholesterol	24-hydroxylase	C9
24-OHC	24-hydroxylase	C9
【PRE_R】

Here , using differentiated SH - SY5Y neuron - like cells as a model , we examined whether 24 - OHC is actively eliminated via transporters induced by its accumulation .
【GOLD_E】
transporters	geneN
24-OHC	chem
【PRE_E】
24-OHC	geneY
【GOLD_R】
【PRE_R】

The expression of ABCA1 and ABCG1 was induced by 24 - OHC , as well as TO901317 and retinoic acid , which are ligands of the nuclear receptors LXR / RXR .
【GOLD_E】
retinoicacid	chem
ABCA1	geneY
ABCG1	geneY
nuclearreceptors	geneN
LXR	geneN
RXR	geneN
24-OHC	chem
TO901317	chem
【PRE_E】
ABCA1	geneY
ABCG1	geneY
24-OHC	chem
TO901317	geneY
retinoicacid	chem
nuclearreceptorsLXR	geneN
RXR	geneN
【GOLD_R】
retinoicacid	ABCA1	C3
retinoicacid	ABCG1	C3
24-OHC	ABCA1	C3
24-OHC	ABCG1	C3
TO901317	ABCA1	C3
TO901317	ABCG1	C3
【PRE_R】
ABCA1	24-OHC	C3
retinoicacid	RXR	C3

When the expression of ABCA1 and ABCG1 was induced , 24 - OHC efflux was stimulated in the presence of high density lipoprotein ( HDL ) , whereas apolipoprotein A - I was not an efficient acceptor .
【GOLD_E】
24-OHC	chem
ABCA1	geneY
ABCG1	geneY
highdensitylipoprotein	geneN
HDL	geneN
apolipoproteinA-I	geneY
【PRE_E】
ABCA1	geneY
ABCG1	geneY
OHC	geneY
highdensitylipoprotein	geneN
HDL	geneN
apolipoproteinA-I	geneY
【GOLD_R】
【PRE_R】

The efflux was suppressed by the addition of siRNA against ABCA1 , but not by ABCG1 siRNA .
【GOLD_E】
ABCA1	geneY
ABCG1	geneY
【PRE_E】
ABCA1	geneY
ABCG1	geneY
【GOLD_R】
【PRE_R】

To confirm the role of each transporter , we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1 ; we clearly observed 24 - OHC efflux in the presence of HDL , whereas efflux in the presence of apolipoprotein A - I was marginal .
【GOLD_E】
24-OHC	chem
HDL	geneN
apolipoproteinA-I	geneY
humanABCA1	geneY
ABCG1	geneY
【PRE_E】
humanABCA1	geneY
ABCG1	geneY
24-OHC	geneY
HDL	geneN
apolipoproteinA-I	geneY
【GOLD_R】
24-OHC	humanABCA1	C9
24-OHC	ABCG1	C9
【PRE_R】

Furthermore , the treatment of primary cerebral neurons with LXR / RXR ligands suppressed the toxicity of 24 - OHC .
【GOLD_E】
LXR	geneN
RXR	geneN
24-OHC	chem
【PRE_E】
LXR	geneY
RXR	geneN
24-OHC	chem
【GOLD_R】
【PRE_R】

These results suggest that ABCA1 actively eliminates 24 - OHC in the presence of HDL as a lipid acceptor and protects neuronal cells .
【GOLD_E】
ABCA1	geneY
HDL	geneN
24-OHC	chem
【PRE_E】
ABCA1	geneY
24-OHC	chem
HDL	geneN
【GOLD_R】
24-OHC	ABCA1	C9
【PRE_R】

This article is protected by copyright .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All rights reserved .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Design , Synthesis and biological evaluation of catecholamine vehicle for studying dopaminergic system .
【GOLD_E】
catecholamine	chem
【PRE_E】
catecholamine	chem
【GOLD_R】
【PRE_R】

Catecholamine mimetic EDTA - bis ( tyramide ) was synthesized and characterized by various spectroscopic techniques ( NMR , Mass spectroscopy ) and λem 310 nm for the excitation at 270 nm .
【GOLD_E】
Catecholamine	chem
EDTA-bis(tyramide)	chem
【PRE_E】
Catecholamine	chem
EDTA-bis	chem
tyramide	chem
【GOLD_R】
【PRE_R】

Molecular docking studies were performed with Human Serum Albumin ( HSA : PDB 1E78 ) , showing binding pattern with amino acid residues Arg218 , Arg222 and Lys444 , identifies the ligand - HSA interaction for the transportation affinity of the ligand at the specific site of the target .
【GOLD_E】
HumanSerumAlbumin	geneY
HSA	geneY
HSA	geneY
aminoacid	chem
Arg	chem
Arg	chem
Lys	chem
【PRE_E】
HumanSerumAlbumin	geneY
HSA	geneY
PDB1E78	geneY
aminoacid	chem
Arg218	chem
Arg222	chem
Lys444	chem
HSA	geneY
【GOLD_R】
【PRE_R】

Subsequently binding study with HSA at λex = 350 nm found to be 5.847x10 ( 4 ) M ( - 1 ) shows effective quenching effect .
【GOLD_E】
【PRE_E】
HSA	geneY
【GOLD_R】
【PRE_R】

Additionally to go more insight AChE binding affinity was investigated , which shows 90 % binding affinity for the 10 mM concentration .
【GOLD_E】
【PRE_E】
AChE	geneY
【GOLD_R】
【PRE_R】

IC50 value was was found 18.60 μM for MAO - B inhibition .
【GOLD_E】
MAO-B	geneY
【PRE_E】
MAO-B	geneY
【GOLD_R】
【PRE_R】

Finally , EDTA - bis ( tyramide ) labeled with ( 99m ) Tc to investigate its in - vivo radiopharmaceutical efficiency , having 97 % binding affinity with 98 % radiochemical purity .
【GOLD_E】
EDTA-bis(tyramide)	chem
(99m)Tc	chem
【PRE_E】
EDTA-bis	chem
tyramide	chem
(99m)Tc	chem
【GOLD_R】
【PRE_R】

In - vivo studies were carried out for ( 99m ) Tc - EDTA - bis ( tyramide ) included blood kinetics showed a quick wash out from the circulation via renal route and biodistribution revealed that maximum % ID / g was found in kidney at 1h and its scintigraphy image shows 3.96 % brain uptake with respect to whole body .
【GOLD_E】
(99m)Tc-EDTA-bis(tyramide)	chem
【PRE_E】
(99m)Tc-EDTA-bis	chem
tyramide	chem
biodistribution	chem
【GOLD_R】
【PRE_R】

This article is protected by copyright .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All rights reserved .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer - drug conjugates and gold nanorod induced hyperthermia .
【GOLD_E】
HPMA	chem
heatshockprotein	geneN
【PRE_E】
HPMA	chem
【GOLD_R】
【PRE_R】

In the field of nanomedicine , selective delivery to cancer cells is a common goal , where active targeting strategies are often employed to increase tumor accumulation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this study , tumor hyperthermia was utilized as a means to increase the active delivery of heat shock protein ( HSP ) targeted N - ( 2 - hydroxypropyl ) methacrylamide ( HPMA ) copolymer - drug conjugates .
【GOLD_E】
heatshockprotein	geneN
HSP	geneN
N-(2-hydroxypropyl)methacrylamide	chem
HPMA	chem
【PRE_E】
heatshockprotein	geneN
HSP	geneN
N-(2-hydroxypropyl)methacrylamide	chem
HPMA	chem
【GOLD_R】
【PRE_R】

Following hyperthermia , induced expression of cell surface heat shock protein ( HSP ) glucose regulated protein 78kDa ( GRP78 ) was utilized for targeted drug therapy .
【GOLD_E】
heatshockprotein	geneN
HSP	geneN
glucoseregulatedprotein78kDa	geneY
GRP78	geneY
glucose	chem
【PRE_E】
cellsurfaceheatshockprotein(HSP)glucoseregulatedprotein78kDa	geneY
GRP78	geneY
【GOLD_R】
【PRE_R】

Conjugates bearing the anticancer agents aminohexylgeldanamycin ( AHGDM ) , docetaxel ( DOC ) , or cisplatin and the GRP78 targeting peptide WDLAWMFRLPVG were synthesized and characterized .
【GOLD_E】
aminohexylgeldanamycin	chem
AHGDM	chem
docetaxel	chem
DOC	chem
cisplatin	chem
GRP78	geneY
【PRE_E】
aminohexylgeldanamycin	chem
AHGDM	chem
docetaxel	chem
DOC	chem
cisplatin	chem
GRP78	geneY
WDLAWMFRLPVG	geneY
【GOLD_R】
【PRE_R】

Binding to cell surface expressed heat shock protein GRP78 on the surface of human prostate cancer DU145 cells was evaluated .
【GOLD_E】
heatshockprotein	geneN
GRP78	geneY
【PRE_E】
heatshockproteinGRP78	geneN
【GOLD_R】
【PRE_R】

HSP targeted AHGDM and DOC conjugates demonstrated active binding comparable to native targeting peptide .
【GOLD_E】
AHGDM	chem
DOC	chem
HSP	geneN
【PRE_E】
HSP	geneN
AHGDM	chem
DOC	chem
【GOLD_R】
【PRE_R】

They were then assessed in vitro for the ability to synergistically induce cytotoxicity in combination with moderate hyperthermia ( 43°C , 30min ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

HSP targeted DOC conjugates exhibited high potency against DU145 cells with an IC50 of 2.4nM .
【GOLD_E】
HSP	geneN
DOC	chem
【PRE_E】
HSP	geneN
DOC	chem
【GOLD_R】
【PRE_R】

HSP targeted AHGDM and DOC conjugates demonstrated synergistic effects in combination with hyperthermia with combination index values of 0.65 and 0.45 respectively .
【GOLD_E】
HSP	geneN
AHGDM	chem
DOC	chem
【PRE_E】
HSP	geneN
AHGDM	chem
DOC	chem
【GOLD_R】
【PRE_R】

Based on these results , HSP targeted DOC conjugates were selected for in vivo evaluation .
【GOLD_E】
HSP	geneN
DOC	chem
【PRE_E】
HSP	geneN
DOC	chem
【GOLD_R】
【PRE_R】

In DU145 tumor bearing mice , a single treatment of tumor hyperthermia , induced via gold nanorod mediated plasmonic photothermal therapy , and intravenous administration of HSP targeted HPMA copolymer - docetaxel at 10mg / kg resulted in maintained tumor regression for a period of 30days .
【GOLD_E】
HSP	geneN
HPMA	chem
docetaxel	chem
【PRE_E】
HSP	geneY
HPMA	chem
docetaxel	chem
【GOLD_R】
【PRE_R】

These results demonstrate the potential for tumor hyperthermia to increase the delivery of HSP targeted macromolecular chemotherapeutics .
【GOLD_E】
HSP	geneN
【PRE_E】
HSP	geneN
【GOLD_R】
【PRE_R】

Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca ( 2 + ) dependent manner .
【GOLD_E】
Ca(2+)	chem
dopamine	chem
CaMKIIα	geneY
dopamineD3receptor	geneY
【PRE_E】
CaMKIIα	geneY
dopamineD3receptor	geneY
Ca(2+)	chem
【GOLD_R】
【PRE_R】

CaMKIIα is expressed at high density in the nucleus accumbens where it binds to postsynaptic D3 receptors inhibiting their effects .
【GOLD_E】
CaMKIIα	geneY
D3receptors	geneY
【PRE_E】
CaMKIIα	geneY
D3receptors	geneY
【GOLD_R】
【PRE_R】

In striatonigral projections , activation of presynaptic D3 receptors potentiates D1 receptor - induced stimulation of cAMP production and GABA release .
【GOLD_E】
D3receptors	geneY
D1receptor	geneY
【PRE_E】
D3receptors	geneY
D1receptor	geneY
cAMP	chem
GABA	chem
【GOLD_R】
【PRE_R】

In this study we examined whether the presynaptic effects of D3 receptor stimulation in the substantia nigra reticulata ( SNr ) are modulated by Ca ( 2 + ) activation of CaMKIIα .
【GOLD_E】
Ca(2+)	chem
D3receptor	geneY
CaMKIIα	geneY
【PRE_E】
D3receptor	geneY
Ca(2+)	chem
CaMKIIα	geneY
【GOLD_R】
【PRE_R】

In SNr synaptosomes two procedures that increase cytoplasmic Ca ( 2 + ) , ionomycin and K ( + ) - depolarization , blocked the additional stimulation of cAMP accumulation produced by coactivating D3 and D1 dopamine receptors .
【GOLD_E】
Ca(2+)	chem
ionomycin	chem
K(+)	chem
cAMP	chem
dopamine	chem
D3andD1dopaminereceptors	geneN
【PRE_E】
Ca(2+)	chem
ionomycin	chem
K(+)	chem
cAMP	chem
D3andD1dopaminereceptors	geneY
【GOLD_R】
【PRE_R】

The selective CaMKIIα inhibitor KN - 62 reversed the blockade produced by ionomycin and K ( + ) - depolarization .
【GOLD_E】
KN-62	chem
ionomycin	chem
K(+)	chem
CaMKIIα	geneY
【PRE_E】
CaMKIIα	geneY
KN-62	chem
ionomycin	chem
K(+)	chem
【GOLD_R】
KN-62	CaMKIIα	C4
ionomycin	CaMKIIα	C4
【PRE_R】
CaMKIIα	KN-62	C4
CaMKIIα	ionomycin	C4

Incubation in either Ca ( 2 ) - free solutions or with the selective Ca ( 2 + ) blocker nifedipine , also reversed the blocking effects of K ( + ) - depolarization .
【GOLD_E】
Ca(2)	chem
Ca(2+)	chem
nifedipine	chem
K(+)	chem
【PRE_E】
Ca(2)	chem
Ca(2+)	chem
nifedipine	chem
K(+)	chem
【GOLD_R】
【PRE_R】

Immunoblot studies showed that K ( + ) - depolarization increased CaMKIIα phosphorylation in a KN - 62 sensitive manner and promoted CaMKIIα binding to D3 receptors .
【GOLD_E】
KN-62	chem
K(+)	chem
CaMKIIα	geneY
D3receptors	geneY
CaMKIIα	geneY
【PRE_E】
K(+)	chem
CaMKIIα	geneY
KN-62	chem
CaMKIIα	geneY
D3receptors	geneY
【GOLD_R】
【PRE_R】
K(+)	CaMKIIα	C3
CaMKIIα	KN-62	C3
KN-62	CaMKIIα	C3
KN-62	D3receptors	C3

In K ( + ) - depolarized tissues , D3 receptors potentiated D1 receptor - induced stimulation of [ ( 3 ) H ] GABA release only when CaMKIIα was blocked with KN - 62 .
【GOLD_E】
K(+)	chem
D3receptors	geneY
D1receptor	geneN
CaMKIIα	geneY
[(3)H]GABA	chem
KN-62	chem
【PRE_E】
K(+)	chem
D3receptors	geneY
D1receptor	geneY
[(3)H]GABA	chem
CaMKIIα	geneY
KN-62	chem
【GOLD_R】
KN-62	CaMKIIα	C4
【PRE_R】
D1receptor	KN-62	C3

In the presence of this inhibitor , the selective D3 agonist PD 128,907 reduced the ED50 for the D1 agonist SKF 38393 from 56 to 4 nM .
【GOLD_E】
D3	geneY
D1	geneY
PD128,907	chem
SKF38393	chem
【PRE_E】
D3	geneY
PD128,907	chem
D1	geneY
SKF38393	chem
【GOLD_R】
PD128,907	D3	C5
SKF38393	D1	C5
【PRE_R】

KN - 62 also enhanced the effects of dopamine on depolarization induced [ ( 3 ) H ] GABA release .
【GOLD_E】
KN-62	chem
dopamine	chem
[(3)H]GABA	chem
【PRE_E】
KN-62	chem
dopamine	chem
[(3)H]GABA	chem
【GOLD_R】
【PRE_R】

KN - 62 changed ED50 for dopamine from 584 to 56 nM .
【GOLD_E】
KN-62	chem
dopamine	chem
【PRE_E】
dopamine	chem
【GOLD_R】
【PRE_R】

KN - 62 did not affect D1 and D4 receptor responses .
【GOLD_E】
KN-62	chem
D1andD4receptor	geneN
【PRE_E】
KN-62	chem
D1	geneY
D4receptor	geneY
【GOLD_R】
【PRE_R】

These experiments show that in striatonigral projections , CaMKIIα inhibits the action of D3 receptors in a Ca ( 2 + ) dependent manner blocking their modulatory effects on GABA release .
【GOLD_E】
Ca(2+)	chem
GABA	chem
CaMKIIα	geneY
D3receptors	geneY
【PRE_E】
CaMKIIα	geneY
D3receptors	geneY
Ca(2+)	chem
GABA	chem
【GOLD_R】
【PRE_R】

These findings suggest a mechanism through which the frequency of action potential discharge in presynaptic terminals regulates dopamine effects .
【GOLD_E】
dopamine	chem
【PRE_E】
dopamine	chem
【GOLD_R】
【PRE_R】

Ellagic acid attenuates bleomycin and cyclophosphamide - induced pulmonary toxicity in Wistar rats .
【GOLD_E】
Ellagicacid	chem
bleomycin	chem
cyclophosphamide	chem
【PRE_E】
Ellagicacid	chem
bleomycin	chem
cyclophosphamide	chem
【GOLD_R】
【PRE_R】

Use of bleomycin ( BLM ) and cyclophosphamide ( CP ) as chemotherapeutic drugs is associated with side effects including toxicity to respiratory system .
【GOLD_E】
BLM	chem
cyclophosphamide	chem
bleomycin	chem
【PRE_E】
bleomycin	chem
BLM	chem
cyclophosphamide	chem
CP	chem
【GOLD_R】
【PRE_R】

Their co - administration may enhance lung toxicity which may subsequently progress to the lung fibrosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Natural compounds have shown mitigating effects against toxicity of anticancer drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Ellagic acid ( EA ) , a polyphenolic compound present in many fruits and nuts in addition to walnut has shown promising protective effect against toxicity of drugs and chemicals .
【GOLD_E】
Ellagicacid	chem
【PRE_E】
Ellagicacid	chem
polyphenolic	chem
【GOLD_R】
【PRE_R】

We studied the ameliorative effect of EA on lung toxicity in rats exposed to CP ( 150mg / kgb.w . , i.p . ) and BLM ( 10U / kgb.w . , i.t . ) .
【GOLD_E】
BLM	chem
【PRE_E】
CP	chem
kgb.w	chem
【GOLD_R】
【PRE_R】

EA ( 15mg / kgb.w . , p.o.×14days ) treatment modulated enhanced hydroxyproline level , lipid peroxidation , myeloperoxidase activity , nitric oxide production and protein carbonyl formation in lungs of rats exposed to toxic anticancer drugs .
【GOLD_E】
myeloperoxidase	geneY
hydroxyproline	chem
nitricoxide	chem
carbonyl	chem
【PRE_E】
hydroxyproline	chem
myeloperoxidase	geneY
nitricoxide	chem
carbonyl	chem
【GOLD_R】
【PRE_R】

There was a marked decrease in GSH content and activities of antioxidant enzymes as a result of BLM and CP treatment .
【GOLD_E】
BLM	chem
GSH	chem
【PRE_E】
GSH	chem
BLM	chem
CP	chem
【GOLD_R】
【PRE_R】

Bronchoalveolar lavage fluid showed increased level of cytotoxicity markers in drug treated animals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Treatment with EA attenuated these changes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Histopathological findings also showed protective effects of EA .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , EA emerged as a natural protectant with an ability to protect lungs from onslaught of pulmonary toxicity of anticancer drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Effects of High Iron and Glucose Concentrations over the Relative Expression of Bcl2 , Bax , and Mfn2 in MIN6 Cells .
【GOLD_E】
Iron	chem
Glucose	chem
Bcl2	geneY
Bax	geneY
Mfn2	geneY
【PRE_E】
Iron	chem
Glucose	chem
Bcl2	geneY
Bax	geneY
Mfn2	geneY
【GOLD_R】
【PRE_R】

Type 2 diabetes is characterized by hyperglycemia and oxidative stress .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hyperglycemia is linked to mitochondrial dysfunction and reduced β - cell mass due to the reduced expression of genes such as Mfn2 as well as the participation of the Bcl2 gene family , responsible for increased apoptosis .
【GOLD_E】
Mfn2	geneY
Bcl2	geneY
【PRE_E】
Mfn2	geneY
Bcl2	geneY
【GOLD_R】
【PRE_R】

The purpose of this study was to describe the effect of different iron and / or glucose concentrations over Mfn2 , Bax , and Bcl2 expressions in a β - pancreatic cell line ( MIN6 cells ) .
【GOLD_E】
Mfn2	geneY
Bax	geneY
Bcl2	geneY
iron	chem
glucose	chem
【PRE_E】
iron	chem
glucose	chem
Mfn2	geneY
Bax	geneY
Bcl2	geneY
【GOLD_R】
【PRE_R】

MIN6 cells were pre - incubated with different iron and / or glucose concentrations , and the relative mRNA abundance of the Bcl2 / Bax ratio and of Mfn2 genes was measured by qRT - PCR .
【GOLD_E】
Bcl2	geneY
Bax	geneY
Mfn2	geneY
iron	chem
glucose	chem
【PRE_E】
iron	chem
glucose	chem
Bcl2	geneY
Bax	geneY
Mfn2	geneY
【GOLD_R】
【PRE_R】

Heme oxygenase ( HO ) activity , iron uptake , superoxide dismutase activity , and glutathione content were also determined .
【GOLD_E】
Hemeoxygenase	geneN
HO	geneN
superoxidedismutase	geneN
iron	chem
superoxide	chem
glutathione	chem
【PRE_E】
Hemeoxygenase	geneN
HO	geneY
iron	chem
superoxidedismutase	geneN
glutathione	chem
【GOLD_R】
【PRE_R】

The Bcl2 / Bax ratio increased and Mfn2 expression decreased in MIN6 cells after glucose stimulation .
【GOLD_E】
glucose	chem
Bcl2	geneY
Bax	geneY
Mfn2	geneY
【PRE_E】
Bcl2	geneY
Bax	geneY
Mfn2	geneY
glucose	chem
【GOLD_R】
glucose	Bcl2	C3
glucose	Bax	C3
glucose	Mfn2	C4
【PRE_R】
Bcl2	glucose	C3
Bax	glucose	C3
Mfn2	glucose	C3

These effects were higher when glucose and iron were incubated together .
【GOLD_E】
glucose	chem
iron	chem
【PRE_E】
glucose	chem
iron	chem
【GOLD_R】
【PRE_R】

Additionally , treatment with glucose / iron showed a higher HO activity .
【GOLD_E】
glucose	chem
iron	chem
HO	geneN
【PRE_E】
glucose	chem
iron	chem
HO	geneY
【GOLD_R】
glucose	HO	C3
iron	HO	C3
【PRE_R】

Our study revealed that high glucose / Fe concentrations in MIN6 cells induced an increase of the Bcl2 / Bax ratio , an indicator of increased cell apoptosis .
【GOLD_E】
Bcl2	geneY
Bax	geneY
glucose	chem
Fe	chem
【PRE_E】
glucose	chem
Fe	chem
Bcl2	geneY
Bax	geneY
【GOLD_R】
glucose	Bcl2	C3
glucose	Bax	C3
Fe	Bcl2	C3
Fe	Bax	C3
【PRE_R】
glucose	Bcl2	C3
Fe	Bcl2	C3
Fe	Bax	C3

Genetic Insights into Pyralomicin Biosynthesis in Nonomuraea spiralis IMC A - 0156 .
【GOLD_E】
Pyralomicin	chem
【PRE_E】
A-0156	chem
【GOLD_R】
【PRE_R】

The biosynthetic gene cluster for the pyralomicin antibiotics has been cloned and sequenced from Nonomuraea spiralis IMC A - 0156 .
【GOLD_E】
pyralomicin	chem
【PRE_E】
pyralomicin	geneN
IMCA-0156	chem
【GOLD_R】
【PRE_R】

The 41 kb gene cluster contains 27 ORFs predicted to encode all of the functions for pyralomicin biosynthesis .
【GOLD_E】
pyralomicin	chem
【PRE_E】
ORFs	geneN
pyralomicin	geneN
【GOLD_R】
【PRE_R】

This includes nonribosomal peptide synthetases ( NRPS ) and polyketide synthases ( PKS ) required for the formation of the benzopyranopyrrole core unit , as well as a suite of tailoring enzymes ( e.g . , four halogenases , an O - methyltransferase , and an N - glycosyltransferase ) necessary for further modifications of the core structure .
【GOLD_E】
nonribosomalpeptidesynthetases	geneN
NRPS	geneN
polyketidesynthases	geneN
PKS	geneN
halogenases	geneN
O-methyltransferase	geneN
N-glycosyltransferase	geneN
benzopyranopyrrole	chem
O	chem
N	chem
【PRE_E】
nonribosomalpeptidesynthetases	geneN
NRPS	geneN
polyketidesynthases	geneN
PKS	geneN
benzopyranopyrrole	geneN
O-methyltransferase	geneN
N-glycosyltransferase	geneN
【GOLD_R】
benzopyranopyrrole	nonribosomalpeptidesynthetases	C9
benzopyranopyrrole	NRPS	C9
benzopyranopyrrole	polyketidesynthases	C9
benzopyranopyrrole	PKS	C9
benzopyranopyrrole	halogenases	C9
benzopyranopyrrole	O-methyltransferase	C9
benzopyranopyrrole	N-glycosyltransferase	C9
【PRE_R】

The N - glycosyltransferase is predicted to transfer either glucose or a pseudosugar ( cyclitol ) to the aglycone .
【GOLD_E】
cyclitol	chem
N-glycosyltransferase	geneN
N	chem
glucose	chem
【PRE_E】
N-glycosyltransferase	geneN
glucose	chem
pseudosugar	chem
cyclitol	chem
aglycone	chem
【GOLD_R】
【PRE_R】

A gene cassette encoding C7 - cyclitol biosynthetic enzymes was identified upstream of the benzopyranopyrrole - specific ORFs .
【GOLD_E】
C7	chem
cyclitol	chem
benzopyranopyrrole	chem
【PRE_E】
C7-cyclitol	chem
benzopyranopyrrole	geneN
ORFs	geneN
【GOLD_R】
【PRE_R】

Targeted disruption of the gene encoding the N - glycosyltransferase , prlH , abolished pyralomicin production , and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7 - cyclitol moiety .
【GOLD_E】
N	chem
pyralomicin	chem
sugar	chem
phosphate	chem
C7	chem
N-glycosyltransferase	geneN
prlH	geneY
PrlA	geneY
cyclitol	chem
sugarphosphatecyclase	geneN
【PRE_E】
N-glycosyltransferase	geneN
prlH	geneN
pyralomicin	geneN
PrlA	geneY
sugarphosphatecyclase	geneN
C7-cyclitol	chem
【GOLD_R】
pyralomicin	N-glycosyltransferase	C9
pyralomicin	prlH	C9
C7	PrlA	C9
C7	sugarphosphatecyclase	C9
cyclitol	PrlA	C9
cyclitol	sugarphosphatecyclase	C9
【PRE_R】

Synaptotagmin 1 is required for vesicular Ca ( 2 + ) / H ( + ) - antiport activity .
【GOLD_E】
Ca(2+)	chem
H(+)	chem
Synaptotagmin1	geneY
【PRE_E】
Synaptotagmin1	geneY
Ca(2+)/H(+)-antiport	geneN
【GOLD_R】
【PRE_R】

A low - affinity Ca ( 2 + ) / H ( + ) - antiport was described in the membrane of mammalian brain synaptic vesicles .
【GOLD_E】
Ca(2+)	chem
H(+)	chem
【PRE_E】
Ca(2+)	chem
H(+)-antiport	chem
【GOLD_R】
【PRE_R】

Electrophysiological studies showed that this antiport contributes to the extreme brevity of excitation - release coupling in rapid synapses .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synaptotagmin - 1 , a vesicular protein interacting with membranes upon low - affinity Ca ( 2 + ) - binding , plays a major role in excitation - release coupling , by synchronizing calcium entry with fast neurotransmitter release .
【GOLD_E】
Synaptotagmin-1	geneY
Ca(2+)	chem
calcium	chem
【PRE_E】
Synaptotagmin-1	geneY
Ca(2+)	chem
calcium	chem
【GOLD_R】
【PRE_R】

Here , we report that synaptotagmin - 1 is necessary for expression of the vesicular Ca ( 2 + ) / H ( + ) - antiport .
【GOLD_E】
Ca(2+)	chem
H(+)	chem
synaptotagmin-1	geneY
【PRE_E】
synaptotagmin-1	geneY
Ca(2+)	chem
H(+)-antiport	chem
【GOLD_R】
【PRE_R】

We measured Ca ( 2 + ) / H ( + ) - antiport activity in vesicles and granules of pheochromocytoma PC12 cells by three methods : ( 1 ) Ca ( 2 + ) - induced dissipation of the vesicular H ( + ) - gradient ; ( 2 ) bafilomycin - sensitive calcium accumulation and ( 3 ) pH - jump - induced calcium accumulation .
【GOLD_E】
Ca(2+)	chem
H(+)	chem
Ca(2+)	chem
H(+)	chem
bafilomycin	chem
calcium	chem
calcium	chem
【PRE_E】
Ca(2+)	chem
H(+)-antiport	geneN
Ca(2+)	chem
H(+)	chem
(2)bafilomycin	chem
calcium	chem
calcium	chem
【GOLD_R】
【PRE_R】

The results were congruent and highly significant : Ca ( 2 + ) / H ( + ) - antiport activity is detectable only in acidic organelles expressing functional synaptotagmin - 1 .
【GOLD_E】
Ca(2+)	chem
H(+)	chem
synaptotagmin-1	geneY
【PRE_E】
Ca(2+)/H(+)-antiport	geneN
synaptotagmin-1	geneY
【GOLD_R】
【PRE_R】

In contrast , synaptotagmin - 1 - deficient cells - and cells where transgenically encoded synaptotagmin - 1 was acutely photo - inactivated - were devoid of any Ca ( 2 + ) / H ( + ) - antiport activity .
【GOLD_E】
Ca(2+)	chem
synaptotagmin-1	geneY
synaptotagmin-1	geneY
H(+)	chem
【PRE_E】
synaptotagmin-1	geneY
synaptotagmin-1	geneY
Ca(2+)/H(+)-antiport	geneN
【GOLD_R】
【PRE_R】

Therefore , in addition to its previously described functions , synaptotagmin - 1 is involved in a rapid vesicular Ca ( 2 + ) sequestration through a Ca ( 2 + ) / H ( + ) antiport .
【GOLD_E】
synaptotagmin-1	geneY
Ca(2+)	chem
Ca(2+)	chem
H(+)	chem
【PRE_E】
synaptotagmin-1	geneY
Ca(2+)	chem
Ca(2+)	chem
H(+)antiport	chem
【GOLD_R】
【PRE_R】

This article is protected by copyright .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

All rights reserved .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Estradiol replacement enhances cocaine - stimulated locomotion in female C57BL / 6 mice through estrogen receptor alpha .
【GOLD_E】
Estradiol	chem
cocaine	chem
estrogen	chem
estrogenreceptoralpha	geneY
【PRE_E】
Estradiol	chem
cocaine	chem
estrogenreceptoralpha	geneY
【GOLD_R】
【PRE_R】

Psychostimulant effects are enhanced by ovarian hormones in women and female rodents .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Estradiol increases behavioral responses to psychostimulants in women and female rats , although the underlying mechanism is unknown .
【GOLD_E】
Estradiol	chem
【PRE_E】
Estradiol	chem
【GOLD_R】
【PRE_R】

This study utilized mice to investigate the time frame and receptor mediation of estradiol 's enhancement of cocaine - induced behavior as mice enable parallel use of genetic , surgical and pharmacological methods .
【GOLD_E】
estradiol	chem
cocaine	chem
【PRE_E】
estradiol	chem
cocaine	chem
【GOLD_R】
【PRE_R】

The spontaneous behavior of Sham and Ovariectomized ( Ovx ) female wildtype ( WT ) mice was determined during habituation to a novel environment and after cocaine administration .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

Ovx mice were replaced with vehicle ( sesame oil ) or 17β - estradiol ( E2 ) for 2 days or 30 min prior to a cocaine challenge to investigate the time course of E2 's effects .
【GOLD_E】
17β-estradiol	chem
ocainec	chem
【PRE_E】
17β-estradiol	chem
cocaine	chem
【GOLD_R】
【PRE_R】

To examine receptor mediation of estradiol effects , Ovx mice replaced for 2 days with either the ERα - selective agonist PPT or the ERβ - selective agonist DPN were compared to Sham mice , and mice lacking either ERα ( αERKO ) or ERβ ( βERKO ) were compared to WT littermates .
【GOLD_E】
estradiol	chem
PPT	chem
DPN	chem
βER	geneY
ERα	geneY
ERβ	geneY
ERα	geneY
αER	geneY
ERβ	geneY
【PRE_E】
estradiol	chem
ERα	geneY
PPT	geneY
ERβ	geneY
DPN	chem
ERα	geneY
αERKO	geneY
ERβ	geneY
βERKO	geneY
【GOLD_R】
PPT	ERα	C5
DPN	ERβ	C5
【PRE_R】
ERα	DPN	C6

Ovx mice exhibited fewer ambulations during habituation than Sham females .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cocaine - induced increases in behavioral ratings were greater in Sham than in Ovx mice .
【GOLD_E】
Cocaine	chem
【PRE_E】
Cocaine	chem
【GOLD_R】
【PRE_R】

Two days but not 30 min of E2 replacement in Ovx mice increased cocaine responses to Sham levels .
【GOLD_E】
ocainer	chem
【PRE_E】
E2	chem
cocaine	chem
【GOLD_R】
【PRE_R】

PPT replacement also increased the cocaine response relative to vehicle - or DPN - treated Ovx mice .
【GOLD_E】
PPT	chem
cocaine	chem
DPN	chem
【PRE_E】
PPT	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

αERKO mice displayed modestly attenuated behavioral responses to novelty and cocaine compared to αWT littermates , but no behavioral differences were found between βERKO and βWT mice .
【GOLD_E】
αER	geneY
βER	geneY
cocaine	chem
【PRE_E】
cocaine	chem
βERKO	geneY
【GOLD_R】
【PRE_R】

These results suggest that E2 enhances cocaine - stimulated locomotion in mice predominantly through ERα .
【GOLD_E】
ERα	geneY
cocaine	chem
【PRE_E】
E2	chem
cocaine	chem
ERα	geneY
【GOLD_R】
【PRE_R】

Dynamics and structural changes of small water clusters on ionization .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Despite utmost importance in understanding water ionization process , reliable theoretical results of structural changes and molecular dynamics ( MD ) of water clusters on ionization have hardly been reported yet .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we investigate the water cations [ ( H2 O ) n = 2 - 6 ( + ) ] with density functional theory ( DFT ) , Möller - Plesset second - order perturbation theory ( MP2 ) , and coupled cluster theory with single , double , and perturbative triple excitations [ CCSD ( T ) ] .
【GOLD_E】
(H2O)n	chem
【PRE_E】
[(H2O	chem
2-6(+)	chem
【GOLD_R】
【PRE_R】

The complete basis set limits of interaction energies at the CCSD ( T ) level are reported , and the geometrical structures , electronic properties , and infrared spectra are investigated .
【GOLD_E】
【PRE_E】
CCSD(T)	geneY
【GOLD_R】
【PRE_R】

The characteristics of structures and spectra of the water cluster cations reflect the formation of the hydronium cation moiety ( H3 O ( + ) ) and the hydroxyl radical .
【GOLD_E】
hydronium	chem
H3O(+)	chem
hydroxyl	chem
【PRE_E】
hydroniumcation	chem
O(+)	chem
hydroxyl	chem
【GOLD_R】
【PRE_R】

Although most density functionals fail to predict reasonable energetics of the water cations , some functionals are found to be reliable , in reasonable agreement with high - level ab initio results .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To understand the ionization process of water clusters , DFT - and MP2 - based Born - Oppenheimer MD ( BOMD ) simulations are performed on ionization .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

On ionization , the water clusters tend to have an Eigen - like form with the hydronium cation instead of a Zundel - like form , based on reliable BOMD simulations .
【GOLD_E】
hydronium	chem
【PRE_E】
hydroniumcation	chem
Zundel	chem
【GOLD_R】
【PRE_R】

For the vertically ionized water hexamer , the relatively stable ( H2 O ) 5 ( + ) ( 5sL4A ) cluster tends to form with a detached water molecule ( H2 O ) .
【GOLD_E】
(H2O)5(+)	chem
H2O	chem
【PRE_E】
O)5(+)	chem
5sL4A	chem
O	chem
【GOLD_R】
【PRE_R】

© 2013 Wiley Periodicals , Inc .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The Intermediate - conductance Calcium - activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium - dependent Signaling .
【GOLD_E】
Calcium	chem
Calcium	chem
Potassium	chem
Intermediate-conductanceCalcium-activatedPotassiumChannelKCa3.1	geneY
【PRE_E】
Calcium-activatedPotassiumChannelKCa3.1	geneN
Calcium	chem
【GOLD_R】
Calcium	Intermediate-conductanceCalcium-activatedPotassiumChannelKCa3.1	C9
【PRE_R】

The intermediate - conductance calcium - activated potassium channel KCa3.1 contributes to a variety of cell activation processes in pathologies such as inflammation , carcinogenesis and vascular remodeling .
【GOLD_E】
intermediate-conductancecalcium-activatedpotassiumchannelKCa3.1	geneY
calcium	chem
potassium	chem
【PRE_E】
intermediate-conductancecalcium-activatedpotassiumchannelKCa3.1	geneN
【GOLD_R】
【PRE_R】

We examined the electrophysiological and transcriptional mechanisms by which KCa3.1 regulates vascular smooth muscle cell ( VSMC ) proliferation .
【GOLD_E】
KCa3.1	geneY
【PRE_E】
KCa3.1	geneY
【GOLD_R】
【PRE_R】

Platelet - derived growth factor - BB ( PDGF ) - induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular Ca ( 2 + ) concentration ( [ Ca ( 2 + ) ] i ) and was enhanced by elevating [ Ca ( 2 + ) ] i .
【GOLD_E】
Platelet-derivedgrowthfactor-BB	geneY
PDGF	geneN
Ca(2+)	chem
Ca(2+)	chem
Ca(2+)	chem
【PRE_E】
Platelet-derivedgrowthfactor-BB	geneY
PDGF	geneY
Ca(2+)	chem
Ca(2+)	chem
Ca(2+)	chem
【GOLD_R】
【PRE_R】

KCa3.1 blockade or knockdown inhibited proliferation by suppressing the rise in [ Ca ( 2 + ) ] i and attenuating the expression of phosphorylated cAMP response element binding protein ( CREB ) , c - fos and neuron - derived orphan receptor - 1 ( NOR - 1 ) .
【GOLD_E】
KCa3.1	geneY
phosphorylatedcAMPresponseelementbindingprotein	geneN
CREB	geneN
c-fos	geneY
neuron-derivedorphanreceptor-1	geneY
NOR-1	geneY
Ca(2+)	chem
cAMP	chem
【PRE_E】
KCa3.1	geneY
Ca(2+)	chem
phosphorylatedcAMPresponseelementbindingprotein	geneN
CREB	geneN
c-fos	geneY
neuron-derivedorphanreceptor-1	geneY
NOR-1	geneY
【GOLD_R】
【PRE_R】

This anti - proliferative effect was abolished by elevating [ Ca ( 2 + ) ] i .
【GOLD_E】
Ca(2+)	chem
【PRE_E】
Ca(2+)	chem
【GOLD_R】
【PRE_R】

KCa3.1 overexpression induced VSMC proliferation , and potentiated PDGF - induced proliferation , by inducing CREB phosphorylation , c - fos and NOR - 1 .
【GOLD_E】
NOR-1	geneY
KCa3.1	geneY
PDGF	geneN
CREB	geneN
c-fos	geneY
【PRE_E】
KCa3.1	geneY
PDGF	geneN
CREB	geneN
c-fos	geneY
NOR-1	geneY
【GOLD_R】
【PRE_R】

Pharmacological stimulation of KCa3.1 unexpectedly suppressed proliferation by inhibiting the rise in [ Ca ( 2 + ) ] i and abolishing the expression and activity of KCa3.1 and PDGF β - receptors .
【GOLD_E】
KCa3.1	geneY
KCa3.1	geneY
PDGFβ-receptors	geneY
Ca(2+)	chem
【PRE_E】
KCa3.1	geneY
Ca(2+)	chem
KCa3.1	geneY
PDGFβ-receptors	geneN
【GOLD_R】
【PRE_R】

The stimulation also attenuated the levels of phosphorylated CREB , c - fos and cyclins expression .
【GOLD_E】
phosphorylatedCREB	geneN
c-fos	geneY
cyclins	geneN
【PRE_E】
phosphorylatedCREB	geneN
c-fos	geneY
cyclins	geneN
【GOLD_R】
【PRE_R】

After KCa3.1 blockade , the characteristic round shape of VSMCs expressing high l - caldesmon and low calponin - 1 ( dedifferentiation state ) was maintained , whereas KCa3.1 stimulation induced a spindle - shape cellular appearance , with low l - caldesmon and high calponin - 1 .
【GOLD_E】
KCa3.1	geneY
l-caldesmon	geneY
calponin-1	geneY
KCa3.1	geneY
l-caldesmon	geneY
calponin-1	geneY
【PRE_E】
KCa3.1	geneY
l-caldesmon	geneY
calponin-1	geneY
KCa3.1	geneN
l-caldesmon	geneY
calponin-1	geneY
【GOLD_R】
【PRE_R】

In conclusion , KCa3.1 plays an important role in VSMC proliferation via controlling Ca ( 2 + ) - dependent signaling pathways and its modulation may therefore constitute a new therapeutic target for cell proliferative diseases such as atherosclerosis .
【GOLD_E】
KCa3.1	geneY
Ca(2+)	chem
【PRE_E】
KCa3.1	geneY
Ca(2+)	chem
【GOLD_R】
【PRE_R】

Reactive Metabolite Trapping Studies on Imidazo - and 2 - Methylimidazo [ 2,1 - b ] thiazole - based Inverse Agonists of the Ghrelin Receptor .
【GOLD_E】
Imidazo-and2-Methylimidazo[2,1-b]thiazole	chem
GhrelinReceptor	geneY
【PRE_E】
Imidazo-and2-Methylimidazo[2,1-b]thiazole	chem
GhrelinReceptor	geneY
【GOLD_R】
Imidazo-and2-Methylimidazo[2,1-b]thiazole	GhrelinReceptor	C5
【PRE_R】

The current study examined the bioactivation potential of ghrelin receptor inverse agonists , 1 - ( 2 - ( 2 - chloro - 4 - ( 2H - 1,2,3 - triazol - 2 - yl ) benzyl ) - 2,7 - diazaspiro [ 3.5 ] nonan - 7 - yl ) - 2 - ( imidazo [ 2,1 - b ] thiazol - 6 - yl ) ethanone ( 1 ) and 1 - ( 2 - ( 2 - chloro - 4 - ( 2H - 1,2,3 - triazol - 2 - yl ) benzyl ) - 2,7 - diazaspiro [ 3.5 ] nonan - 7 - yl ) - 2 - ( 2 - methylimidazo [ 2,1 - b ] thiazol - 6 - yl ) ethanone ( 2 ) , containing a fused imidazo [ 2,1 - b ] thiazole motif in the core structure .
【GOLD_E】
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone	chem
imidazo[2,1-b]thiazole	chem
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone	chem
ghrelinreceptor	geneY
【PRE_E】
ghrelinreceptor	geneY
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone	chem
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-	chem
【GOLD_R】
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone	ghrelinreceptor	C5
imidazo[2,1-b]thiazole	ghrelinreceptor	C5
1-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(imidazo[2,1-b]thiazol-6-yl)ethanone	ghrelinreceptor	C5
【PRE_R】

Both compounds underwent oxidative metabolism in NADPH - and glutathione - supplemented human liver microsomes to yield glutathione conjugates , which was consistent with their bioactivation to reactive species .
【GOLD_E】
NADPH	chem
glutathione	chem
glutathione	chem
【PRE_E】
NADPH	chem
glutathione	chem
glutathione	chem
【GOLD_R】
【PRE_R】

Mass spectral fragmentation and NMR analysis indicated that the site of attachment of the glutathionyl moiety in the thiol conjugates was on the thiazole ring within the bicycle .
【GOLD_E】
glutathionyl	chem
thiol	chem
thiazole	chem
【PRE_E】
glutathionyl	chem
thiol	chem
thiazole	chem
【GOLD_R】
【PRE_R】

Two glutathione conjugates were discerned with the imidazo [ 2,1 - b ] thiazole derivative 1 .
【GOLD_E】
glutathione	chem
imidazo[2,1-b]thiazole	chem
【PRE_E】
glutathione	chem
imidazo[2,1-b]thiazole	chem
【GOLD_R】
【PRE_R】

One adduct was derived from the Michael addition of glutathione to a putative S - oxide metabolite of 1 , whereas , the second adduct was formed via the reaction of a second glutathione molecule with the initial glutathione - S - oxide adduct .
【GOLD_E】
glutathione	chem
glutathione	chem
S-oxide	chem
glutathione-S-oxide	chem
【PRE_E】
glutathione	chem
S-oxide	chem
glutathione	chem
glutathione-S-oxide	chem
【GOLD_R】
【PRE_R】

In the case of the 2 - methylimidazo [ 2,1 - b ] thiazole analog 2 , glutathione conjugation occurred via an oxidative desulfation mechanism , possibly involving thiazole ring epoxidation as the rate - limiting step .
【GOLD_E】
2-methylimidazo[2,1-b]thiazole	chem
glutathione	chem
thiazole	chem
【PRE_E】
2-methylimidazo[2,1-b]thiazoleanalog2,glutathione	chem
thiazole	chem
epoxidation	chem
【GOLD_R】
【PRE_R】

Additional insights into the mechanism were obtained via 18O exchange and trapping studies with potassium cyanide .
【GOLD_E】
18O	chem
potassiumcyanide	chem
【PRE_E】
18O	chem
potassiumcyanide	chem
【GOLD_R】
【PRE_R】

The mechanistic insights into the bioactivation pathways of 1 and 2 allowed the deployment of a rational chemical intervention strategy that involved replacement of the thiazole ring with a 1,2,4 - thiadiazole group to yield - ( 2 - ( 2 - chloro - 4 - ( 2H - 1,2,3 - triazol - 2 - yl ) benzyl ) - 2,7 - diazaspiro [ 3.5 ] nonan - 7 - yl ) - 2 - ( 2 - methylimidazo [ 2,1 - b ] [ 1,3,4 ] thiadiazol - 6 - yl ) ethanone ( 3 ) .
【GOLD_E】
-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)ethanone	chem
thiazole	chem
1,2,4-thiadiazole	chem
【PRE_E】
thiazole	chem
1,2,4-thiadiazole	chem
-(2-(2-chloro-4-(2H-1,2,3-triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)ethanone	chem
【GOLD_R】
【PRE_R】

These structural changes not only abrogated the bioactivation liability but also retained the attractive pharmacological attributes of the prototype agents .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Adenovirus - delivered angiopoietin - 1 treatment for phosgene - induced acute lung injury .
【GOLD_E】
phosgene	chem
angiopoietin-1	geneY
【PRE_E】
angiopoietin-1	geneY
phosgene	chem
【GOLD_R】
【PRE_R】

Abstract Context : Exposure to phosgene can result in an acute lung injury , leading to pulmonary edema and even death .
【GOLD_E】
phosgene	chem
【PRE_E】
phosgene	chem
【GOLD_R】
【PRE_R】

Angiopoietin - 1 ( Ang1 ) is a critical factor for vascular stabilization due to its ability to reduce endothelial permeability and inflammation .
【GOLD_E】
Angiopoietin-1	geneY
Ang1	geneY
【PRE_E】
Angiopoietin-1	geneY
Ang1	geneY
【GOLD_R】
【PRE_R】

Objective : In this study , the histopathological changes of the lungs after exposure to phosgene and the effect of Ang1 treatment were examined .
【GOLD_E】
Ang1	geneY
phosgene	chem
【PRE_E】
phosgene	chem
Ang1	geneY
【GOLD_R】
【PRE_R】

Materials and methods : Rats were exposed to phosgene gas at 8.33 g / m ( 3 ) for 5 min .
【GOLD_E】
phosgene	chem
【PRE_E】
phosgene	chem
【GOLD_R】
【PRE_R】

Ang1 overexpressing rats were established by an intravenous injection of adenovirus - Ang1 ( Ad / Ang1 ) .
【GOLD_E】
Ang1	geneY
Ang1	geneY
【PRE_E】
Ang1	geneY
adenovirus-Ang1	geneY
Ang1	geneY
【GOLD_R】
【PRE_R】

The histological changes of the lung were examined by Haematoxylin - Eosin ( H & E ) staining and fluorescence microscopy .
【GOLD_E】
Haematoxylin	chem
Eosin	chem
【PRE_E】
Eosin	chem
【GOLD_R】
【PRE_R】

The inferior lobe was used for the determination of the ratio of wet weight to dry weight of the lung .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The concentration of cytokines in the serum and bronchoalveolar lavage fluid was determined by enzyme - linked immunosorbent assay .
【GOLD_E】
cytokines	geneN
【PRE_E】
cytokines	geneN
【GOLD_R】
【PRE_R】

Results : The pathological analysis showed signs of inflammation and edema , evident from a significant increase in the number of leukocytes in bronchoalveolar lavage fluid and the ratio of wet to dry weight of the lungs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The lung injury induced by phosgene was markedly reduced after the injection of Ad / Ang1 .
【GOLD_E】
Ang1	geneY
phosgene	chem
【PRE_E】
phosgene	chem
Ang1	geneY
【GOLD_R】
【PRE_R】

The increase of IL - 1β and IL - 17 and decrease of vascular endothelial growth factor in the serum and bronchoalveolar lavage fluid of phosgene - exposed animals were abolished by the administration of Ad / Ang1 .
【GOLD_E】
IL-1β	geneY
IL-17	geneY
vascularendothelialgrowthfactor	geneY
Ang1	geneY
phosgene	chem
【PRE_E】
IL-1β	geneY
IL-17	geneY
vascularendothelialgrowthfactor	geneY
phosgene	chem
Ang1	geneY
【GOLD_R】
【PRE_R】
vascularendothelialgrowthfactor	phosgene	C3

Discussion and conclusions : Ang1 has the beneficial effects on phosgene - induced lung injury .
【GOLD_E】
Ang1	geneY
phosgene	chem
【PRE_E】
Ang1	geneY
phosgene	chem
【GOLD_R】
【PRE_R】

The adenovirus - delivered Ang1 may have the potential as a novel approach for the treatment of the acute lung injury caused by phosgene gas inhalation in humans .
【GOLD_E】
Ang1	geneY
phosgene	chem
【PRE_E】
Ang1	geneY
phosgene	chem
【GOLD_R】
【PRE_R】

Probing the Role of the Vancomycin E - Ring Aryl Chloride : Selective Divergent Synthesis and Evaluation of Alternatively Substituted E - Ring Analogues .
【GOLD_E】
Vancomycin	chem
ArylChloride	chem
【PRE_E】
VancomycinE	chem
ArylChloride	chem
E-Ring	chem
【GOLD_R】
【PRE_R】

The selective functionalization of a vancomycin aglycon derivative through direct conversion of the E - ring aryl chloride to a reactive boronic acid , and its use in the synthesis of a systematic series of vancomycin E - ring analogues are described .
【GOLD_E】
arylchloride	chem
boronicacid	chem
vancomycin	chem
vancomycin	chem
【PRE_E】
vancomycinaglycon	chem
E-ringarylchloride	chem
boronicacid	chem
vancomycinE	chem
【GOLD_R】
【PRE_R】

The series of analogues was used to examine the impact of the E - ring chloride in binding D - Ala - D - Ala and on antimicrobial activity .
【GOLD_E】
D-Ala-D-Ala	chem
【PRE_E】
E-ringchloride	chem
D-Ala-D-Ala	chem
【GOLD_R】
【PRE_R】

In contrast to the reduced activity of the unsubstituted E - ring derivatives , hydrophobic and relatively non - polar substituents approach or match the chloro substituted vancomycin and was insensitive to the electronic character of the substituent ( e.g .
【GOLD_E】
chlorosubstitutedvancomycin	chem
【PRE_E】
unsubstitutedE	chem
chloro	chem
vancomycin	chem
【GOLD_R】
【PRE_R】

Cl vs CN or OMe ) , whereas highly polar substituents fail to provide the enhancements .
【GOLD_E】
Cl	chem
CN	chem
OMe	chem
【PRE_E】
OMe	chem
【GOLD_R】
【PRE_R】

Moreover , the active permethylated vancomycin aglycon derivatives examined exhibit VanB VRE antimicrobial activity at levels that approach ( typically within 2 - fold ) their activity against sensitive bacteria .
【GOLD_E】
vancomycin	chem
VanB	chem
VanB	geneN
【PRE_E】
permethylatedvancomycinaglycon	chem
VanBVRE	geneY
【GOLD_R】
【PRE_R】
permethylatedvancomycinaglycon	VanBVRE	C4

The robust borylation reaction also enabled the selective functionalization of a minimally protected vancomycin aglycon ( N - Boc vancomycin aglycon ) , and provides a direct method for the preparation of previously inaccessible analogues .
【GOLD_E】
vancomycin	chem
N-Boc	chem
vancomycin	chem
【PRE_E】
borylation	chem
vancomycinaglycon	chem
N-Bocvancomycinaglycon	chem
【GOLD_R】
【PRE_R】

Exposure to DEHP decreased four fatty acid levels in plasma of prepartum mice .
【GOLD_E】
DEHP	chem
fattyacid	chem
【PRE_E】
DEHP	chem
fattyacid	chem
【GOLD_R】
【PRE_R】

Maternal exposure to di ( 2 - ethylhexyl ) phthalate ( DEHP ) decreased the plasma triglyceride in prepartum mice .
【GOLD_E】
di(2-ethylhexyl)phthalate	chem
DEHP	chem
triglyceride	chem
【PRE_E】
di(2-ethylhexyl)phthalate	chem
DEHP	chem
triglyceride	chem
【GOLD_R】
【PRE_R】

To identify the fatty acid ( FA ) species involved and to understand the underlying mechanisms , pregnant Sv / 129 wild - type ( mPPARα ) , peroxisome proliferator - activated receptor α - null ( Pparα - null ) and humanized PPARα ( hPPARα ) mice were treated with diets containing 0 % , 0.01 % , 0.05 % or 0.1 % DEHP .
【GOLD_E】
DEHP	chem
mPPARα	geneY
peroxisomeproliferator-activatedreceptorα	geneY
Pparα	geneY
humanizedPPARα	geneY
hPPARα	geneY
fattyacid	chem
【PRE_E】
fattyacid	chem
FA	chem
mPPARα	geneY
peroxisomeproliferator-activatedreceptorα-null	geneY
Pparα	geneY
PPARα	geneY
hPPARα	geneY
DEHP	chem
【GOLD_R】
【PRE_R】

Dams were dissected on gestational day 18 together with fetuses , and on postnatal day 2 together with newborns . n - 3 / n - 6 polyunsaturated , saturated , and monounsaturated FAs in maternal plasma and in liver of wild - type offspring , and representative enzymes for FA desaturation and elongation in maternal liver , were measured .
【GOLD_E】
n-3/n-6polyunsaturated,saturated,andmonounsaturatedFAs	chem
【PRE_E】
polyunsaturated	chem
monounsaturatedFAs	chem
FA	chem
【GOLD_R】
【PRE_R】

The plasma levels of linoleic acid , α - linolenic acid , palmitic acid and oleic acid were higher in the pregnant control mPPARa mice than in Ppara - null and hPPARa mice .
【GOLD_E】
linoleicacid	chem
α-linolenicacid	chem
palmiticacid	chem
oleicacid	chem
mPPARa	geneY
Ppara	geneY
hPPARa	geneY
【PRE_E】
linoleicacid	chem
α-linolenicacid	chem
palmiticacid	chem
oleicacid	chem
Ppara	geneY
hPPARa	geneY
【GOLD_R】
【PRE_R】

DEHP exposure significantly decreased the levels of these four FAs only in pregnant mPPARα mice .
【GOLD_E】
DEHP	chem
mPPARα	geneY
【PRE_E】
DEHP	chem
【GOLD_R】
【PRE_R】

Plasma levels of many FAs were higher in pregnant mice than in postpartum ones in a genotype - independent manner , while it was lower in the livers of fetuses than pups .
【GOLD_E】
【PRE_E】
FAs	chem
【GOLD_R】
【PRE_R】

DEHP exposure slightly increased hepatic arachidonic acid , α - linolenic acid , palmitoleic acid and oleic acid in fetuses , but not in pups .
【GOLD_E】
DEHP	chem
arachidonicacid	chem
α-linolenicacid	chem
palmitoleicacid	chem
oleicacid	chem
【PRE_E】
DEHP	chem
arachidonicacid	chem
α-linolenicacid	chem
palmitoleicacid	chem
oleicacid	chem
【GOLD_R】
【PRE_R】

However , DEHP exposure did not clearly influence FA desaturase 1 and 2 nor elongase 2 and 5 expressions in the liver of all maternal mice .
【GOLD_E】
FAdesaturase1and2	geneN
elongase2and5	geneN
DEHP	chem
【PRE_E】
DEHP	chem
FAdesaturase1and2norelongase2and5	geneN
【GOLD_R】
【PRE_R】

Taken together , the levels of plasma four FAs with shorter carbon chains were higher in pregnant mPPARα mice than in other genotypes , and DEHP exposure decreased these specific FA concentrations only in mPPARα mice , similarly to triglyceride levels .
【GOLD_E】
triglyceride	chem
mPPARα	geneY
mPPARα	geneY
carbon	chem
DEHP	chem
【PRE_E】
FAs	chem
carbon	chem
mPPARα	geneY
DEHP	chem
triglyceride	chem
【GOLD_R】
【PRE_R】

Soluble polysialylated NCAM : a novel player of the innate immune system in the lung .
【GOLD_E】
polysialylatedNCAM	geneY
【PRE_E】
polysialylatedNCAM	geneY
【GOLD_R】
【PRE_R】

Posttranslational modification of the neural cell adhesion molecule ( NCAM ) by polysialic acid ( polySia ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration , axon fasciculation , and synaptic plasticity .
【GOLD_E】
polySia	chem
neuralcelladhesionmolecule	geneY
NCAM	geneY
polysialicacid	chem
【PRE_E】
neuralcelladhesionmolecule	geneY
NCAM	geneY
polysialicacid	chem
polySia	geneN
【GOLD_R】
【PRE_R】

Here , we describe a novel function of polysialylated NCAM ( polySia - NCAM ) in innate immunity of the lung .
【GOLD_E】
polysialylatedNCAM	geneY
polySia-NCAM	geneY
polySia	chem
【PRE_E】
polysialylatedNCAM	geneY
polySia	geneY
NCAM	geneY
【GOLD_R】
【PRE_R】

In mature lung tissue of healthy donors , polySia was exclusively attached to the transmembrane isoform NCAM - 140 and located to intracellular compartments of epithelial cells .
【GOLD_E】
NCAM-140	geneY
polySia	chem
【PRE_E】
polySia	geneN
NCAM-140	geneN
【GOLD_R】
【PRE_R】

In patients with chronic obstructive pulmonary disease , however , increased polySia levels and processing of the NCAM carrier were observed .
【GOLD_E】
NCAM	geneY
polySia	chem
【PRE_E】
polySia	geneY
NCAM	geneY
【GOLD_R】
【PRE_R】

Processing of polysialylated NCAM was reproduced in a mouse model by bleomycin administration leading to an activation of the inflammasome and secretion of interleukin ( IL ) - 1β .
【GOLD_E】
polysialylatedNCAM	geneY
interleukin(IL)-1β	geneY
bleomycin	chem
【PRE_E】
NCAM	geneY
bleomycin	chem
interleukin(IL)-1β	geneY
【GOLD_R】
bleomycin	interleukin(IL)-1β	C3
【PRE_R】
NCAM	bleomycin	C3
bleomycin	interleukin(IL)-1β	C3

As shown in a cell culture model , polySia - NCAM - 140 was kept in the late trans - Golgi apparatus of lung epithelial cells and stimulation by IL - 1β or lipopolysaccharide induced metalloprotease - mediated ectodomain shedding , resulting in the secretion of soluble polySia - NCAM .
【GOLD_E】
IL-1β	geneY
metalloprotease	geneN
ectodomain	geneN
polySia-NCAM	geneY
polySia	chem
NCAM-140	geneY
polySia	chem
【PRE_E】
polySia-NCAM-140	geneY
IL-1β	geneY
metalloprotease	geneN
ectodomain	geneN
polySia-NCAM	geneY
【GOLD_R】
【PRE_R】

Interestingly , polySia chains of secreted NCAM neutralized the cytotoxic activity of extracellular histones as well as DNA / histone - network - containing `` neutrophil extracellular traps `` , which are formed during invasion of microorganisms .
【GOLD_E】
NCAM	geneY
histones	geneN
histone	geneN
polySia	chem
【PRE_E】
NCAM	geneY
extracellularhistones	geneN
histone	geneN
【GOLD_R】
【PRE_R】

Thus , shedding of polySia - NCAM by lung epithelial cells may provide a host - protective mechanism to reduce tissue damage during inflammatory processes .
【GOLD_E】
polySia-NCAM	geneY
polySia	chem
【PRE_E】
polySia	geneN
NCAM	geneY
【GOLD_R】
【PRE_R】

Study of endothelial cell apoptosis using fluorescence resonance energy transfer ( FRET ) biosensor cell line with hemodynamic microfluidic chip system .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To better understand how hyperglycemia induces endothelial cell dysfunction under the diabetic conditions , a hemodynamic microfluidic chip system was developed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The system combines a caspase - 3 - based fluorescence resonance energy transfer ( FRET ) biosensor cell line which can detect endothelial cell apoptosis in real - time , post - treatment effect and with a limited cell sample , by using a microfluidic chip which can mimic the physiological pulsatile flow profile in the blood vessel .
【GOLD_E】
caspase-3	geneY
【PRE_E】
caspase-3	geneY
【GOLD_R】
【PRE_R】

The caspase - 3 - based FRET biosensor endothelial cell line ( HUVEC - C3 ) can produce a FRET - based sensor protein capable of probing caspase - 3 activation .
【GOLD_E】
caspase-3	geneY
caspase-3	geneY
【PRE_E】
caspase-3	geneY
FRET	geneY
FRET	geneY
caspase-3	geneY
【GOLD_R】
【PRE_R】

When the endothelial cells undergo apoptosis , the color of the sensor cells changes from green to blue , thus sensing apoptosis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A double - labeling fluorescent technique ( yo pro - 1 and propidium iodide ) was used to validate the findings revealed by the FRET - based caspase sensor .
【GOLD_E】
caspase	geneN
yopro-1	chem
propidiumiodide	chem
【PRE_E】
propidiumiodide	chem
FRET	geneN
caspase	geneN
【GOLD_R】
【PRE_R】

The results show high rates of apoptosis and necrosis of endothelial cells when high glucose concentration was applied in our hemodynamic microfluidic chip combined with an exhaustive pulsatile flow profile .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

The two apoptosis detection techniques ( fluorescent method and FRET biosensor ) are comparable ; but FRET biosensor offers more advantages such as real - time observation and a convenient operating process to generate more accurate and reliable data .
【GOLD_E】
【PRE_E】
FRET	geneY
FRET	geneY
【GOLD_R】
【PRE_R】

Furthermore , the activation of the FRET biosensor also confirms the endothelial cell apoptosis induced by the abnormal pulsatile shear stress and high glucose concentration is through caspase - 3 pathway .
【GOLD_E】
glucose	chem
caspase-3	geneY
【PRE_E】
FRET	geneY
glucose	chem
caspase-3	geneY
【GOLD_R】
【PRE_R】

A 12 % apoptotic rate ( nearly a 4 - fold increase compared to the static condition ) was observed when the endothelial cells were exposed to a high glucose concentration of 20 mM under 2 h exhaustive pulsatile shear stress of 30 dyne cm ( - 2 ) and followed with another 10 h normal pulsatile shear stress of 15 dyne cm ( - 2 ) .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

Therefore , the most important finding of this study is to develop a novel endothelial cell apoptosis detection method , which combines the microfluidic chip system and FRET biosensor .
【GOLD_E】
【PRE_E】
FRET	geneY
【GOLD_R】
【PRE_R】

This finding may provide new insight into how glucose causes endothelial cell dysfunction , which is the major cause of diabetes - derived complications .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

High salt diets during pregnancy affected fetal and offspring renal renin - angiotensin system .
【GOLD_E】
renin	geneY
angiotensin	geneY
【PRE_E】
renin	geneY
angiotensin	geneY
【GOLD_R】
【PRE_R】

Intrauterine environments are linked to fetal renal development and postnatal health .
【GOLD_E】
【PRE_E】
Intrauterine	chem
【GOLD_R】
【PRE_R】

Influence of salt diets during pregnancy on renal functions and renin - angiotensin system ( RAS ) were determined in the ovine fetus and offspring .
【GOLD_E】
renin	geneY
angiotensin	geneY
【PRE_E】
renin	geneY
angiotensin	geneY
RAS	geneN
【GOLD_R】
【PRE_R】

Pregnant ewes were fed high - salt diet ( HSD ) or normal - salt diet ( NSD ) for two months during middle - later gestation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Fetal renal functions , plasma hormones , mRNA and protein expressions of the key elements of renal RAS were measured in the fetus and offspring .
【GOLD_E】
【PRE_E】
RAS	geneN
【GOLD_R】
【PRE_R】

Fetal renal excretion of sodium was increased while urine volume decreased in HSD group .
【GOLD_E】
sodium	chem
【PRE_E】
sodium	chem
【GOLD_R】
【PRE_R】

Fetal blood urea nitrogen was increased , while kidney / body weight ratio decreased in HSD group .
【GOLD_E】
urea	chem
nitrogen	chem
【PRE_E】
ureanitrogen	chem
【GOLD_R】
【PRE_R】

The altered ratio also was observed in the offspring at 15 - day - old and 90 - day - old .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Maternal and fetal plasma antidiuretic hormone was elevated without change in plasma renin activity and Ang I levels , while plasma Ang II was decreased .
【GOLD_E】
AngII	geneY
antidiuretichormone	geneY
renin	geneY
AngI	geneY
【PRE_E】
antidiuretichormone	geneY
renin	geneY
AngI	geneY
AngII	geneY
【GOLD_R】
【PRE_R】

The key elements of local renal RAS , including angiotensinogen , ACE , ACE2 , AT1 and AT2 receptor expression in both mRNA and protein , except renin , were altered following maternal high salt intake .
【GOLD_E】
angiotensinogen	geneY
ACE	geneY
ACE2	geneY
AT1	geneY
AT2receptor	geneY
renin	geneY
【PRE_E】
RAS	geneN
angiotensinogen	geneY
ACE	geneY
ACE2	geneY
AT1	geneY
AT2receptor	geneY
renin	geneY
【GOLD_R】
【PRE_R】

The results suggest that High intake of salt during pregnancy affected fetal renal development associated with an altered expression of the renal key elements of RAS , some alterations of fetal origins remained after birth as possible risks in developing renal or cardiovascular diseases .
【GOLD_E】
【PRE_E】
RAS	geneN
【GOLD_R】
【PRE_R】

Synthesis of pyrazolo [ 1,5 - a ] pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents .
【GOLD_E】
pyrazolo[1,5-a]pyrimidine	chem
aminobenzothiazole	chem
【PRE_E】
pyrazolo[1,5-a]pyrimidine	chem
aminobenzothiazole	chem
【GOLD_R】
【PRE_R】

A series of pyrazolo [ 1,5 - a ] pyrimidine linked 2 - aminobenzothizole conjugates ( 6a - t ) were synthesized and evaluated for their anticancer activity against five human cancer cell lines .
【GOLD_E】
pyrazolo[1,5-a]pyrimidine	chem
2-aminobenzothizole	chem
【PRE_E】
pyrazolo[1,5-a]pyrimidine	chem
2-aminobenzothizole	chem
【GOLD_R】
【PRE_R】

Among them two compounds 6p and 6m showed significant anticancer activity with IC50 values ranging from 2.01 to 7.07 and 1.94 - 3.46μM , respectively .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Moreover , cell cycle arrest in G2 / M and reduction in Cdk1 expression level were observed upon treatment of these compounds and they also induced caspase - 3 dependent apoptosis .
【GOLD_E】
Cdk1	geneY
caspase-3	geneY
【PRE_E】
Cdk1	geneY
caspase-3	geneY
【GOLD_R】
【PRE_R】

This was further confirmed by staining as well as DNA fragmentation analysis .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Evaluation of the positive effects on insulin - resistance and β - cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients .
【GOLD_E】
metformin	chem
vildagliptin	chem
insulin	geneY
【PRE_E】
insulin	geneY
vildagliptin	chem
metformin	chem
【GOLD_R】
【PRE_R】

We evaluated the positive effects of vildagliptin in addition to metformin on glycemic control and β - cell function in type 2 diabetic patients .
【GOLD_E】
vildagliptin	chem
metformin	chem
【PRE_E】
vildagliptin	chem
metformin	chem
【GOLD_R】
【PRE_R】

One hundred and seventy - one type 2 diabetic patients were instructed to add vildaglipin 50mg twice a day or placebo to metformin for 12 months .
【GOLD_E】
vildaglipin	chem
metformin	chem
【PRE_E】
vildaglipin	chem
metformin	chem
【GOLD_R】
【PRE_R】

Body mass index ( BMI ) , glycemic control , fasting plasma insulin ( FPI ) , HOMA - IR , HOMA - β , fasting plasma proinsulin ( FPPr ) , proinsulin / fasting plasma insulin ratio ( Pr / FPI ratio ) , C - peptide , glucagon , vaspin , visfatin , and omentin - 1 were evaluated .
【GOLD_E】
insulin	geneY
proinsulin	geneY
proinsulin	geneY
insulin	geneY
C-peptide	geneY
glucagon	geneY
vaspin	geneY
visfatin	geneY
omentin-1	geneY
【PRE_E】
insulin	geneY
FPI	geneY
proinsulin	geneY
FPPr	geneY
proinsulin	geneY
insulin	geneY
Pr/FPI	geneY
C-peptide	geneY
glucagon	geneY
vaspin	geneY
visfatin	geneY
omentin-1	geneY
【GOLD_R】
【PRE_R】

Before , and after 12 months since the addition of vildagliptin , patients underwent a combined euglycemic hyperinsulinemic and hyperglycemic clamp , with subsequent arginine stimulation .
【GOLD_E】
arginine	chem
vildagliptin	chem
【PRE_E】
vildagliptin	chem
arginine	chem
【GOLD_R】
【PRE_R】

Vildagliptin + metformin were more effective than placebo + metformin in reducing body weight and BMI , glycemic control , HOMA - IR , glucagon and insulin resistance measurements .
【GOLD_E】
Vildagliptin	chem
metformin	chem
metformin	chem
glucagon	geneY
insulin	geneY
【PRE_E】
Vildagliptin	chem
metformin	chem
metformin	chem
glucagon	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

Vildagliptin + metformin gave also a better increase of HOMA - β , and of all β - cell parameters after the clamp .
【GOLD_E】
Vildagliptin	chem
metformin	chem
【PRE_E】
Vildagliptin	chem
metformin	chem
【GOLD_R】
【PRE_R】

We also recorded a significant correlation between M value increase and the decrease of vaspin , visfatin , and omentin - 1 obtained with vildagliptin + metformin .
【GOLD_E】
vaspin	geneY
visfatin	geneY
vildagliptin	chem
omentin-1	geneY
metformin	chem
【PRE_E】
vaspin	geneY
visfatin	geneY
omentin-1	geneY
vildagliptin	chem
metformin	chem
【GOLD_R】
【PRE_R】
vaspin	metformin	C3
visfatin	metformin	C3
omentin-1	metformin	C3

Vildagliptin , in addition to metformin , proved to be effective in improving β - cell function and in reducing insulin resistance measurements .
【GOLD_E】
insulin	geneY
Vildagliptin	chem
metformin	chem
【PRE_E】
Vildagliptin	chem
metformin	chem
insulin	geneY
【GOLD_R】
【PRE_R】

4 - Hydroxytamoxifen - stimulated processing of cyclin E is mediated via G protein - coupled receptor 30 ( GPR30 ) and accompanied by enhanced migration in MCF - 7 breast cancer cells .
【GOLD_E】
4-Hydroxytamoxifen	chem
GPR30)	geneY
cyclinE	geneY
Gprotein-coupledreceptor30	geneY
【PRE_E】
4-Hydroxytamoxifen	chem
cyclinE	geneY
Gprotein-coupledreceptor30	geneY
GPR30	geneY
【GOLD_R】
4-Hydroxytamoxifen	cyclinE	C3
【PRE_R】
4-Hydroxytamoxifen	cyclinE	C3

Over - expression of cleaved cyclin E in breast tumors is closely associated with tumor progression and resistance to antiestrogens .
【GOLD_E】
cyclinE	geneY
【PRE_E】
cyclinE	geneY
【GOLD_R】
【PRE_R】

17β - Estradiol ( E2 ) has been recently shown to induce cyclin E processing in breast cancer cells .
【GOLD_E】
cyclinE	geneY
17β-Estradiol	chem
【PRE_E】
17β-Estradiol	chem
E2	chem
cyclinE	geneY
【GOLD_R】
17β-Estradiol	cyclinE	C3
【PRE_R】

Tamoxifen has been used in patients with estrogen - sensitive breast cancer , yet resistance to antiestrogens and recurrence will appear in some of the patients after its continued use .
【GOLD_E】
Tamoxifen	chem
estrogen	chem
【PRE_E】
Tamoxifen	chem
estrogen	chem
【GOLD_R】
【PRE_R】

We therefore addressed possible effects of tamoxifen on the generation of cleaved cyclin E and its signal mechanism ( s ) in estrogen - responsive MCF - 7 breast cancer cells that express both G protein - coupled protein ( GPR ) 30 and estrogen receptor α ( ERα ) .
【GOLD_E】
cyclinE	geneY
Gprotein-coupledprotein(GPR)30	geneY
estrogenreceptorα	geneY
ERα	geneN
tamoxifen	chem
estrogen	chem
estrogen	chem
【PRE_E】
tamoxifen	chem
cyclinE	geneY
estrogen	chem
Gprotein-coupledprotein	geneN
GPR	geneN
estrogenreceptorα	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

4 - Hydroxytamoxifen ( OHT , tamoxifen 's active form ) failed to prevent E2 - induced proteolysis of cyclin E and migration , but rather triggered cyclin E cleavage coincident with augmented migration .
【GOLD_E】
4-Hydroxytamoxifen	chem
OHT	chem
tamoxifen	chem
cyclinE	geneY
cyclinE	geneY
【PRE_E】
4-Hydroxytamoxifen	chem
OHT	chem
tamoxifen	chem
E2	chem
cyclinE	geneY
cyclinE	geneY
【GOLD_R】
【PRE_R】
E2	cyclinE	C3

OHT - induced cyclin E truncation also occurred in SK - BR - 3 cells that express GPR30 and lack ERα , but not in MDA - MB - 231 cells that express neither GPR30 nor ERα .
【GOLD_E】
OHT	chem
GPR30	geneY
ERα	geneY
cyclinE	geneY
GPR30	geneY
ERα	geneY
【PRE_E】
OHT	chem
cyclinE	geneY
GPR30	geneY
ERα	geneY
GPR30	geneY
ERα	geneY
【GOLD_R】
【PRE_R】

G1 , a specific GPR 30 agonist , caused dramatic proteolysis of cyclin E and enhanced migration .
【GOLD_E】
GPR30	geneY
cyclinE	geneY
【PRE_E】
GPR	geneY
cyclinE	geneY
【GOLD_R】
【PRE_R】

Furthermore , OHT - stimulated cleavage of cyclin E and migration were tremendously attenuated by G15 , a GPR30 antagonist , or siRNA against GPR30 .
【GOLD_E】
cyclinE	geneY
OHT	chem
GPR30	geneY
GPR30	geneY
【PRE_E】
OHT	chem
cyclinE	geneY
G15	chem
GPR30	geneY
GPR30	geneY
【GOLD_R】
【PRE_R】
OHT	cyclinE	C4
G15	GPR30	C6

In addition , inhibitors for EGFR or ERK1 / 2 remarkably suppressed OHT - induced truncation of cyclin E , suggesting involvement of EGFR signaling .
【GOLD_E】
EGFR	geneY
ERK1/2	geneN
cyclinE	geneY
EGFR	geneY
OHT	chem
【PRE_E】
EGFR	geneY
ERK1/2	geneN
OHT	chem
cyclinE	geneY
EGFR	geneY
【GOLD_R】
【PRE_R】

Collectively , our data indicate that OHT contributes to the production of proteolyzed cyclin E via GPR30 with augmented migration in MCF - 7 cells .
【GOLD_E】
cyclinE	geneY
GPR30	geneY
OHT	chem
【PRE_E】
OHT	chem
proteolyzedcyclinE	geneY
GPR30	geneY
【GOLD_R】
OHT	cyclinE	C3
【PRE_R】
OHT	proteolyzedcyclinE	C3
OHT	GPR30	C3

Mechanistic Aspects of hSOD1 Maturation from the Solution Structure of Cu ( I ) - Loaded hCCS Domain 1 and Analysis of Disulfide - Free hSOD1 Mutants .
【GOLD_E】
hSOD1	geneY
hSOD1	geneY
hCCSDomain1	geneN
Disulfide	chem
Cu(I)	chem
【PRE_E】
hSOD1	geneY
Cu(I)	chem
hCCSDomain1	geneN
Disulfide	chem
hSOD1	geneY
【GOLD_R】
【PRE_R】

Superoxide dismutase 1 ( SOD1 ) maturation within the cell is mainly accomplished with the SOD1 - specific chaperone , CCS , a dimeric protein with three distinct domains in each monomer .
【GOLD_E】
CCS	geneY
SOD1	geneY
Superoxide	chem
SOD1-specificchaperone	geneY
Superoxidedismutase1	geneY
【PRE_E】
Superoxidedismutase1	geneY
SOD1	geneY
SOD1	geneY
chaperone	geneN
CCS	geneN
【GOLD_R】
【PRE_R】

We recently showed that the first domain of human CCS ( hCCSD1 ) is responsible for copper transfer to its protein partner , human SOD1 ( hSOD1 ) .
【GOLD_E】
humanCCS	geneY
hCCSD1	geneN
humanSOD1	geneY
hSOD1	geneY
copper	chem
【PRE_E】
humanCCS	geneY
hCCSD1	geneN
copper	chem
humanSOD1	geneY
hSOD1	geneY
【GOLD_R】
【PRE_R】

The NMR solution structure of the copper ( I ) - loaded form of hCCSD1 reported here contributes further to characterization of the copper - transfer mechanism to hSOD1 .
【GOLD_E】
hCCSD1	geneN
hSOD1	geneY
copper(I)	chem
【PRE_E】
copper(I)	chem
hCCSD1	geneY
copper	chem
hSOD1	geneY
【GOLD_R】
【PRE_R】

NMR spectroscopy was also used to examine the hSOD1 mutants C57A , C146A , and C57A / C146A , which are unable to form the structurally conserved disulfide bond in SOD1 , in order to investigate the role of these cysteines during hSOD1 copper acquisition .
【GOLD_E】
hSOD1	geneY
C57A	geneN
C146A	geneN
C57A	geneN
C146A	geneN
SOD1	geneY
hSOD1	geneY
disulfide	chem
cysteines	chem
【PRE_E】
hSOD1	geneY
C57A	geneY
C146A	geneY
C57A	geneY
C146A	geneN
disulfide	chem
SOD1	geneY
cysteines	chem
hSOD1	geneY
copper	chem
【GOLD_R】
【PRE_R】

Together , the information on both hCCS and hSOD1 , along with a sequence analysis of eukaryotic CCSD1 , allows us to propose important mechanistic aspects regarding the copper - transfer process from hCCS to hSOD1 .
【GOLD_E】
hCCS	geneY
hSOD1	geneY
CCSD1	geneN
hCCS	geneY
hSOD1	geneY
copper	chem
【PRE_E】
hCCS	geneY
hSOD1	geneY
CCSD1	geneN
copper	chem
hSOD1	geneY
【GOLD_R】
【PRE_R】

Novel pentablock copolymer ( PLA - PCL - PEG - PCL - PLA ) based nanoparticles for controlled drug delivery : Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles .
【GOLD_E】
PLA	chem
PCL	chem
PEG	chem
PCL	chem
PLA	chem
【PRE_E】
PEG	chem
PLA	geneN
【GOLD_R】
【PRE_R】

The purpose of this investigation was to design novel pentablock copolymers ( polylatide - polycaprolactone - polyethylene glycol - polycaprolactone - polylatide ) ( PLA - PCL - PEG - PCL - PLA ) to prepare nanoparticle formulations which provide continuous delivery of steroids over a longer duration with minimal burst effect .
【GOLD_E】
steroids	chem
polylatide	chem
polycaprolactone	chem
polyethyleneglycol	chem
polycaprolactone	chem
polylatide	chem
PLA	chem
PCL	chem
PEG	chem
PCL	chem
PLA	chem
【PRE_E】
polylatide	chem
polyethyleneglycol-polycaprolactone-polylatide	chem
PLA-PCL	chem
PEG	chem
PCL-PLA	chem
steroids	chem
【GOLD_R】
【PRE_R】

Another purpose was to evaluate the effect of poly ( L - lactide ) ( PLLA ) or poly ( D , L - lactide ) ( PDLLA ) incorporation on crystallinity of pentablock copolymers and in vitro release profile of triamcinolone acetonide ( selected as model drug ) from nanoparticles .
【GOLD_E】
poly(L-lactide)	chem
PLLA	chem
poly(D,L-lactide)	chem
PDLLA	chem
triamcinoloneacetonide	chem
【PRE_E】
poly(L-lactide)	chem
PLLA	chem
poly(D,L-lactide)	chem
PDLLA	chem
triamcinoloneacetonide	chem
【GOLD_R】
【PRE_R】

PLA - PCL - PEG - PCL - PLA copolymers with different block ratio of PCL / PLA segment were synthesized .
【GOLD_E】
PLA	chem
PCL	chem
PEG	chem
PCL	chem
PLA	chem
PCL	chem
PLA	chem
【PRE_E】
PEG	chem
PLA	geneN
PCL	chem
PLA	geneN
【GOLD_R】
【PRE_R】

Release of triamcinolone acetonide from nanoparticles was significantly affected by crystallinity of the copolymers .
【GOLD_E】
triamcinoloneacetonide	chem
【PRE_E】
triamcinoloneacetonide	chem
【GOLD_R】
【PRE_R】

Burst release of triamcinolone acetonide from nanoparticles was significantly minimized with incorporation of proper ratio of PDLLA in the existing triblock ( PCL - PEG - PCL ) copolymer .
【GOLD_E】
triamcinoloneacetonide	chem
PDLLA	chem
PCL	chem
PEG	chem
PCL	chem
【PRE_E】
triamcinoloneacetonide	chem
PDLLA	chem
PEG	chem
PCL	chem
【GOLD_R】
【PRE_R】

Moreover , pentablock copolymer based nanoparticles exhibited continuous release of triamcinolone acetonide .
【GOLD_E】
triamcinoloneacetonide	chem
【PRE_E】
triamcinoloneacetonide	chem
【GOLD_R】
【PRE_R】

Pentablock copolymer based nanoparticles can be utilized to achieve continuous near zero - order delivery of corticosteroids from nanoparticles without any burst effect .
【GOLD_E】
【PRE_E】
Pentablock	chem
【GOLD_R】
【PRE_R】

PICK1 Deficiency Impairs Secretory Vesicle Biogenesis and Leads to Growth Retardation and Decreased Glucose Tolerance .
【GOLD_E】
Glucose	chem
PICK1	geneY
【PRE_E】
PICK1	geneY
Glucose	chem
【GOLD_R】
【PRE_R】

Secretory vesicles in endocrine cells store hormones such as growth hormone ( GH ) and insulin before their release into the bloodstream .
【GOLD_E】
growthhormone	geneY
GH	geneY
insulin	geneY
【PRE_E】
asgrowthhormone	geneY
GH	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

The molecular mechanisms governing budding of immature secretory vesicles from the trans - Golgi network ( TGN ) and their subsequent maturation remain unclear .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we identify the lipid binding BAR ( Bin / amphiphysin / Rvs ) domain protein PICK1 ( protein interacting with C kinase 1 ) as a key component early in the biogenesis of secretory vesicles in GH - producing cells .
【GOLD_E】
lipidbindingBAR(Bin/amphiphysin/Rvs)domainprotein	geneN
PICK1	geneY
proteininteractingwithCkinase1	geneY
GH	geneY
【PRE_E】
BAR	geneY
Bin/amphiphysin/Rvs)domain	geneN
PICK1	geneY
Ckinase1	geneY
GH	geneY
【GOLD_R】
【PRE_R】

Both PICK1 - deficient Drosophila and mice displayed somatic growth retardation .
【GOLD_E】
PICK1	geneN
【PRE_E】
PICK1	geneY
【GOLD_R】
【PRE_R】

Growth retardation was rescued in flies by reintroducing PICK1 in neurosecretory cells producing somatotropic peptides .
【GOLD_E】
PICK1	geneY
【PRE_E】
PICK1	geneY
【GOLD_R】
【PRE_R】

PICK1 - deficient mice were characterized by decreased body weight and length , increased fat accumulation , impaired GH secretion , and decreased storage of GH in the pituitary .
【GOLD_E】
PICK1	geneY
GH	geneY
GH	geneY
【PRE_E】
PICK1	geneY
GH	geneY
GH	geneY
【GOLD_R】
【PRE_R】

Decreased GH storage was supported by electron microscopy showing prominent reduction in secretory vesicle number .
【GOLD_E】
GH	geneY
【PRE_E】
GH	geneY
【GOLD_R】
【PRE_R】

Evidence was also obtained for impaired insulin secretion associated with decreased glucose tolerance .
【GOLD_E】
glucose	chem
【PRE_E】
insulin	geneY
glucose	chem
【GOLD_R】
【PRE_R】

PICK1 localized in cells to immature secretory vesicles , and the PICK1 BAR domain was shown by live imaging to associate with vesicles budding from the TGN and to possess membrane - sculpting properties in vitro .
【GOLD_E】
PICK1	geneY
PICK1BARdomain	geneN
【PRE_E】
PICK1	geneY
PICK1	geneY
BARdomain	geneN
【GOLD_R】
【PRE_R】

In mouse pituitary , PICK1 co - localized with the BAR domain protein ICA69 , and PICK1 deficiency abolished ICA69 protein expression .
【GOLD_E】
PICK1	geneY
BARdomainprotein	geneN
ICA69	geneY
PICK1	geneY
ICA69	geneY
【PRE_E】
PICK1	geneY
BARdomain	geneN
ICA69	geneY
PICK1	geneY
ICA69	geneY
【GOLD_R】
【PRE_R】

In the Drosophila brain , PICK1 and ICA69 co - immunoprecipitated and showed mutually dependent expression .
【GOLD_E】
PICK1	geneY
ICA69	geneY
【PRE_E】
PICK1	geneY
ICA69	geneY
【GOLD_R】
【PRE_R】

Finally , both in a Drosophila model of type 2 diabetes and in high - fat - diet - induced obese mice , we observed up - regulation of PICK1 mRNA expression .
【GOLD_E】
PICK1	geneN
【PRE_E】
PICK1	geneY
【GOLD_R】
【PRE_R】

Our findings suggest that PICK1 , together with ICA69 , is critical during budding of immature secretory vesicles from the TGN and thus for vesicular storage of GH and possibly other hormones .
【GOLD_E】
PICK1	geneN
ICA69	geneN
GH	geneN
【PRE_E】
PICK1	geneY
ICA69	geneY
GH	geneY
【GOLD_R】
【PRE_R】

The data link two BAR domain proteins to membrane remodeling processes in the secretory pathway of peptidergic endocrine cells and support an important role of PICK1 / ICA69 in maintenance of metabolic homeostasis .
【GOLD_E】
BARdomainproteins	geneN
PICK1	geneY
ICA69	geneY
【PRE_E】
BARdomain	geneN
PICK1	geneY
ICA69	geneY
【GOLD_R】
【PRE_R】

Design , Synthesis and Biological Evaluation of Aminoalkylindole Derivatives as Cannabinoid Receptor Ligands with Potential for Treatment of Alcohol Abuse .
【GOLD_E】
Alcohol	chem
Aminoalkylindole	chem
CannabinoidReceptor	geneY
【PRE_E】
Aminoalkylindole	chem
CannabinoidReceptor	geneY
Alcohol	chem
【GOLD_R】
【PRE_R】

Attenuation of increased endocannabinoid signaling with a CB1R neutral antagonist might offer a new therapeutic direction for treatment of alcohol abuse .
【GOLD_E】
CB1R	geneY
alcohol	chem
【PRE_E】
CB1R	geneY
alcohol	chem
【GOLD_R】
【PRE_R】

We have recently reported that a mono - hydroxylated metabolite of the synthetic aminoalkylindole cannabinoid JHW - 073 ( 3 ) exhibits neutral antagonist activity at CB1Rs and thus may serve as a promising lead for the development of novel alcohol abuse therapies .
【GOLD_E】
CB1Rs	geneY
aminoalkylindole	chem
JHW-073	chem
alcohol	chem
【PRE_E】
mono-hydroxylated	chem
aminoalkylindole	chem
JHW-073	chem
CB1Rs	geneY
alcohol	chem
【GOLD_R】
aminoalkylindole	CB1Rs	C6
JHW-073	CB1Rs	C6
【PRE_R】
JHW-073	CB1Rs	C5

In the current study , we show that systematic modification of an aminoalkylindole scaffold identifies two new compounds with dual CB1R antagonist / CB2R agonist activity .
【GOLD_E】
CB1R	geneY
CB2R	geneY
aminoalkylindole	chem
【PRE_E】
aminoalkylindole	chem
CB1R	geneY
CB2R	geneY
【GOLD_R】
aminoalkylindole	CB2R	C5
aminoalkylindole	CB1R	C6
【PRE_R】
aminoalkylindole	CB1R	C6
aminoalkylindole	CB2R	C6

Similar to the CB1R antagonist / inverse agonist rimonabant , analogues 27 and 30 decrease oral alcohol self - administration , without affecting total fluid intake and block the development of alcohol - conditioned place preference .
【GOLD_E】
CB1R	geneN
alcohol	chem
alcohol	chem
【PRE_E】
CB1R	geneY
rimonabant	chem
alcohol	chem
alcohol	chem
【GOLD_R】
【PRE_R】
CB1R	rimonabant	C6

Collectively , these initial findings suggest that design and systematic modification of aminoalkylindoles such as 3 may lead to development of novel cannabinoid ligands with dual CB1R antagonist / CB2R agonist activity with potential for use as treatments of alcohol abuse .
【GOLD_E】
CB2R	geneY
CB1R	geneY
alcohol	chem
aminoalkylindoles	chem
【PRE_E】
aminoalkylindoles	chem
CB1R	geneY
CB2R	geneY
alcohol	chem
【GOLD_R】
aminoalkylindoles	CB2R	C5
aminoalkylindoles	CB1R	C6
【PRE_R】

Immunoregulatory effects of Glycyrrhizic acid exerts anti - asthmatic effects via modulation of Th1 / Th2 cytokines and enhancement of CD4 ( + ) CD25 ( + ) Foxp3 ( + ) regulatory T cells in ovalbumin - sensitized mice .
【GOLD_E】
cytokines	geneN
ovalbumin	geneY
Glycyrrhizicacid	chem
【PRE_E】
Glycyrrhizicacid	chem
Th1/Th2cytokines	geneN
CD25	geneY
Foxp3	geneY
ovalbumin	geneY
【GOLD_R】
【PRE_R】

ETHNOPHARMACOLOGICAL RELEVANCE : Glycyrrhizic acid ( GA ) is the main bioactive ingredient of licorice ( Glycyrrhiza glabra ) , and has been found to be associated with multiple therapeutic properties .
【GOLD_E】
Glycyrrhizicacid	chem
【PRE_E】
Glycyrrhizicacid	chem
【GOLD_R】
【PRE_R】

AIM OF THE STUDY : In this study , we investigated immunoregulatory effects of glycyrrhizic acid on anti - asthmatic effects and underlying mechanisms .
【GOLD_E】
glycyrrhizicacid	chem
【PRE_E】
glycyrrhizicacid	chem
【GOLD_R】
【PRE_R】

MATERIALS AND METHODS : Asthma model was established by ovalbumin - induced .
【GOLD_E】
ovalbumin	geneY
【PRE_E】
ovalbumin	geneY
【GOLD_R】
【PRE_R】

A total of 60 mice were randomly assigned to six experimental groups : control , model , dexamethasone ( 2mg / kg ) and GA ( 10mg / kg , 20mg / kg , 40mg / kg ) .
【GOLD_E】
dexamethasone	chem
【PRE_E】
dexamethasone	chem
【GOLD_R】
【PRE_R】

Airway resistance ( Raw ) were measured by the forced oscillation technique , histological studies were evaluated by The hematoxylin and eosin ( HE ) staining , Th1 / Th2 and Th17 cytokines were evaluated by enzyme - linked immunosorbent assay ( ELISA ) , and CD4 ( + ) CD25 ( + ) Foxp3 ( + ) regulatory T cells ( Tregs ) was evaluated by Flow Cytometry ( FCM ) , the forkhead / winged helix transcription factor ( Foxp3 ) was evaluated by western blotting .
【GOLD_E】
cytokines	geneN
forkhead/wingedhelixtranscriptionfactor	geneN
Foxp3	geneY
hematoxylin	chem
eosin	chem
【PRE_E】
hematoxylin	chem
eosin	chem
Th1/Th2andTh17cytokines	geneN
CD25	geneY
Foxp3	geneY
forkhead/wingedhelixtranscriptionfactor	geneY
Foxp3	geneY
【GOLD_R】
【PRE_R】

RESULTS : Our study demonstrated that , compared with model group , GA inhibited OVA - induced increases in Raw and eosinophil count ; interleukin ( IL ) - 4 , IL - 5 , IL - 13 levels were recovered in bronchoalveolar lavage fluid compared ; increased IFN - γlevel in bronchoalveolar lavage fluid ; histological studies demonstrated that GA substantially inhibited OVA - induced eosinophilia in lung tissue and airway tissue compared with model group .
【GOLD_E】
IL-13	geneY
IFN-γ	geneY
OVA	geneY
OVA	geneY
interleukin(IL)-4	geneY
IL-5	geneY
【PRE_E】
OVA	geneY
interleukin(IL)-4	geneY
IL-5	geneY
IL-13	geneY
IFN-γlevel	geneY
OVA	geneY
【GOLD_R】
【PRE_R】

Flow cytometry studies demonstrated that GA substantially enhanced Tregs compared with model group .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

CONCLUSION : These findings suggest that GA may effectively ameliorate the progression of asthma and could be used as a therapy for patients with allergic asthma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Enhanced beta cell function and anti - inflammatory effect after chronic treatment with the dipeptidyl peptidase - 4 inhibitor vildagliptin in an advanced - aged diet - induced obesity mouse model .
【GOLD_E】
dipeptidylpeptidase-4	geneY
vildagliptin	chem
【PRE_E】
dipeptidylpeptidase-4	geneY
vildagliptin	chem
【GOLD_R】
vildagliptin	dipeptidylpeptidase-4	C4
【PRE_R】
dipeptidylpeptidase-4	vildagliptin	C4

AIMS / HYPOTHESIS : Studies have shown that dipeptidyl peptidase - 4 ( DPP4 ) inhibitors stimulate insulin secretion and increase beta cell mass in rodents .
【GOLD_E】
dipeptidylpeptidase-4	geneY
DPP4	geneY
insulin	geneN
【PRE_E】
dipeptidylpeptidase-4	geneY
DPP4	geneY
insulin	geneN
【GOLD_R】
【PRE_R】

However , in these models hyperglycaemia has been induced early on in life and the treatment periods have been short .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To explore the long - term effects of DPP4 inhibition on insulin secretion and beta cell mass , we have generated a high - fat diet ( HFD ) - induced - obesity model in mice of advanced age ( 10 months old ) .
【GOLD_E】
DPP4	geneY
insulin	geneN
【PRE_E】
DPP4	geneN
insulin	geneY
【GOLD_R】
【PRE_R】

METHODS : After 1 month of HFD alone , the mice were given the DPP4 inhibitor vildagliptin for a further 11 months .
【GOLD_E】
PP4i	geneY
ildagliptinf	chem
【PRE_E】
DPP4	geneN
vildagliptin	chem
【GOLD_R】
ildagliptinf	PP4i	C4
【PRE_R】
DPP4	vildagliptin	C4

At multiple time points throughout the study , OGTTs were performed and beta cell area and long - term survival were evaluated .
【GOLD_E】
【PRE_E】
OGTTs	geneY
【GOLD_R】
【PRE_R】

RESULTS : Beta cell function and glucose tolerance were significantly improved by vildagliptin with both diets .
【GOLD_E】
glucose	chem
vildagliptin	chem
【PRE_E】
glucose	chem
vildagliptin	chem
【GOLD_R】
【PRE_R】

In contrast , in spite of the long treatment period , beta cell area was not significantly different between vildagliptin - treated mice and controls .
【GOLD_E】
vildagliptin	chem
【PRE_E】
vildagliptin	chem
【GOLD_R】
【PRE_R】

Mice of advanced age chronically fed an HFD displayed clear and extensive pancreatic inflammation and peri - insulitis , mainly formed by CD3 - positive T cells , which were completely prevented by vildagliptin treatment .
【GOLD_E】
vildagliptin	chem
【PRE_E】
CD3	geneN
vildagliptin	chem
【GOLD_R】
【PRE_R】

Chronic vildagliptin treatment also improved survival rates for HFD - fed mice .
【GOLD_E】
vildagliptin	chem
【PRE_E】
vildagliptin	chem
【GOLD_R】
【PRE_R】

CONCLUSIONS / INTERPRETATION : In a unique advanced - aged HFD - induced - obesity mouse model , insulin secretion was improved and the extensive peri - insulitis prevented by chronic DPP4 inhibition .
【GOLD_E】
DPP4	geneY
insulin	geneN
【PRE_E】
insulin	geneY
DPP4	geneN
【GOLD_R】
【PRE_R】

The improved survival rates for obese mice chronically treated with vildagliptin suggest that chronic DPP4 inhibition potentially results in additional quality - adjusted life - years for individuals with type 2 diabetes , which is the primary goal of any diabetes therapy .
【GOLD_E】
DPP4	geneY
vildagliptin	chem
【PRE_E】
vildagliptin	chem
DPP4	geneN
【GOLD_R】
vildagliptin	DPP4	C4
【PRE_R】
vildagliptin	DPP4	C4

Amelioration of palmitate - induced insulin resistance in C2C12 muscle cells by rooibos ( Aspalathus linearis ) .
【GOLD_E】
palmitate	chem
insulin	geneN
【PRE_E】
palmitate	chem
insulin	geneY
rooibos	chem
【GOLD_R】
【PRE_R】
palmitate	insulin	C3
insulin	rooibos	C3

Increased levels of free fatty acids ( FFAs ) , specifically saturated free fatty acids such as palmitate are associated with insulin resistance of muscle , fat and liver .
【GOLD_E】
freefattyacids	chem
FFAs	chem
saturatedfreefattyacids	chem
palmitate	chem
insulin	geneY
【PRE_E】
fattyacids	chem
FFAs	chem
fattyacids	chem
palmitate	chem
insulin	geneN
【GOLD_R】
【PRE_R】

Skeletal muscle , responsible for up to 80 % of the glucose disposal from the peripheral circulation , is particularly vulnerable to increased levels of saturated FFAs .
【GOLD_E】
glucose	chem
FFAs	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

Rooibos ( Aspalathus linearis ) and its unique dihydrochalcone C - glucoside , aspalathin , shown to reduce hyperglycemia in diabetic rats , could play a role in preventing or ameliorating the development of insulin resistance .
【GOLD_E】
dihydrochalconeC-glucoside	chem
aspalathin	chem
insulin	geneN
【PRE_E】
Rooibos	chem
dihydrochalconeC-glucoside	chem
aspalathin	chem
insulin	geneY
【GOLD_R】
【PRE_R】

This study aims to establish whether rooibos can ameliorate experimentally - induced insulin - resistance in C2C12 skeletal muscle cells .
【GOLD_E】
insulin	geneN
【PRE_E】
rooibos	chem
insulin	geneY
【GOLD_R】
【PRE_R】
rooibos	insulin	C3

Palmitate - induced insulin resistant C2C12 cells were treated with an aspalathin - enriched green ( unfermented ) rooibos extract ( GRE ) , previously shown for its blood glucose lowering effect in vitro and in vivo or an aqueous extract of fermented rooibos ( FRE ) .
【GOLD_E】
Palmitate	chem
aspalathin	chem
glucose	chem
【PRE_E】
Palmitate	chem
insulin	geneY
aspalathin	chem
glucose	chem
rooibos	chem
【GOLD_R】
【PRE_R】
insulin	rooibos	C3

Glucose uptake and mitochondrial activity were measured using 2 - deoxy - [ ( 3 ) H ] - d - glucose , MTT and ATP assays , respectively .
【GOLD_E】
2-deoxy-[(3)H]-d-glucose	chem
Glucose	chem
MTT	chem
ATP	chem
【PRE_E】
Glucose	chem
2-deoxy-[(3)H]-d-glucose	chem
MTT	chem
ATP	chem
【GOLD_R】
【PRE_R】

Expression of proteins relevant to glucose metabolism was analysed by Western blot .
【GOLD_E】
glucose	chem
【PRE_E】
glucose	chem
【GOLD_R】
【PRE_R】

GRE contained higher levels of all compounds , except the enolic phenylpyruvic acid - 2 - O - glucoside and luteolin - 7 - O - glucoside .
【GOLD_E】
phenylpyruvicacid-2-O-glucoside	chem
luteolin-7-O-glucoside	chem
【PRE_E】
enolicphenylpyruvicacid-2-O-glucoside	chem
luteolin-7-O-glucoside	chem
【GOLD_R】
【PRE_R】

Both rooibos extracts increased glucose uptake , mitochondrial activity and ATP production .
【GOLD_E】
glucose	chem
ATP	chem
【PRE_E】
glucose	chem
ATP	chem
【GOLD_R】
【PRE_R】

Compared to FRE , GRE was more effective at increasing glucose uptake and ATP production .
【GOLD_E】
ATP	chem
glucose	chem
【PRE_E】
FRE	geneN
GRE	geneY
glucose	chem
ATP	chem
【GOLD_R】
【PRE_R】
FRE	ATP	C9
GRE	ATP	C9

At a mechanistic level both extracts down - regulated PKC θ activation , which is associated with palmitate - induced insulin resistance .
【GOLD_E】
palmitate	chem
PKCθ	geneY
insulin	geneN
【PRE_E】
PKCθ	geneY
palmitate	chem
insulin	geneY
【GOLD_R】
【PRE_R】
palmitate	insulin	C3

Furthermore , the extracts increased activation of key regulatory proteins ( AKT and AMPK ) involved in insulin - dependent and non - insulin regulated signalling pathways .
【GOLD_E】
AKT	geneY
AMPK	geneY
insulin	geneN
insulin	geneN
【PRE_E】
keyregulatoryproteins	geneN
AKT	geneN
AMPK	geneN
insulin	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

Protein levels of the glucose transporter ( GLUT4 ) involved in glucose transport via these two pathways were also increased .
【GOLD_E】
glucose	chem
glucose	chem
glucosetransporter	geneN
GLUT4	geneY
【PRE_E】
glucosetransporter	geneY
GLUT4	geneY
glucose	chem
【GOLD_R】
glucose	glucosetransporter	C9
glucose	GLUT4	C9
【PRE_R】

This in vitro study therefore confirms that rooibos can ameliorate palmitate - induced insulin resistance in C2C12 skeletal muscle cells .
【GOLD_E】
palmitate	chem
insulin	geneN
【PRE_E】
rooibos	chem
palmitate	chem
insulin	geneN
【GOLD_R】
【PRE_R】
rooibos	insulin	C3
palmitate	insulin	C3

Inhibition of PKC θ activation and increased activation of AMPK and AKT offer a plausible mechanistic explanation for this ameliorative effect .
【GOLD_E】
PKCθ	geneY
AMPK	geneY
AKT	geneY
【PRE_E】
PKCθ	geneY
AMPK	geneN
AKT	geneN
【GOLD_R】
【PRE_R】

Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG - 63 cells via ER - dependent MEK / ERK and PI3K / Akt activation .
【GOLD_E】
Puerarin	chem
ER	geneY
MEK	geneN
ERK	geneN
PI3K	geneN
Akt	geneN
【PRE_E】
Puerarin	chem
ER	geneY
MEK	geneN
ERK	geneN
PI3K	geneN
Akt	geneN
【GOLD_R】
Puerarin	MEK	C3
Puerarin	ERK	C3
Puerarin	PI3K	C3
Puerarin	Akt	C3
【PRE_R】
Puerarin	ER	C3
Puerarin	MEK	C3
Puerarin	ERK	C3
Puerarin	Akt	C3

Puerarin , the main isoflavone glycoside found in the Chinese herb radix of Pueraria lobata ( Willd . ) Ohwi , has received increasing attention because of its possible role in the prevention of osteoporosis .
【GOLD_E】
Puerarin	chem
isoflavoneglycoside	chem
【PRE_E】
Puerarin	chem
isoflavoneglycoside	chem
【GOLD_R】
【PRE_R】

Previously , we showed that puerarin could inhibit the bone absorption of osteoclasts and promote long bone growth in fetal mouse in vitro .
【GOLD_E】
puerarin	chem
【PRE_E】
puerarin	chem
【GOLD_R】
【PRE_R】

Further study confirmed that puerarin stimulated proliferation and differentiation of osteoblasts in rat .
【GOLD_E】
puerarin	chem
【PRE_E】
puerarin	chem
【GOLD_R】
【PRE_R】

However , the mechanisms underlying its actions on human bone cells have not been well defined .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here we show that puerarin increases proliferation and differentiation and opposes cisplatin - induced apoptosis in human osteoblastic MG - 63 cells containing two estrogen receptor ( ER ) isoforms .
【GOLD_E】
cisplatin	chem
estrogen	chem
estrogenreceptor	geneY
ER	geneY
puerarin	chem
【PRE_E】
puerarin	chem
cisplatin	chem
estrogenreceptor	geneY
ER	geneY
【GOLD_R】
【PRE_R】

Puerarin promotes proliferation by altering cell cycle distribution whereas puerarin - mediated survival may be associated with up - regulation of Bcl - xL expression .
【GOLD_E】
Puerarin	chem
puerarin	chem
Bcl-xL	geneY
【PRE_E】
Puerarin	chem
puerarin	chem
Bcl-xL	geneY
【GOLD_R】
puerarin	Bcl-xL	C3
【PRE_R】
Puerarin	Bcl-xL	C3
puerarin	Bcl-xL	C3

Treatment with the ER antagonist ICI 182,780 abolishes the above actions of puerarin on osteoblast - derived cells .
【GOLD_E】
ICI182,780	chem
puerarin	chem
ER	geneY
【PRE_E】
ER	geneY
ICI182,780	chem
puerarin	chem
【GOLD_R】
ICI182,780	ER	C6
【PRE_R】

Using small interfering double - stranded RNA technology , we further demonstrate that the effects of puerarin on proliferation , differentiation and survival are mediated by both ERα and ERβ .
【GOLD_E】
ERα	geneY
ERβ	geneY
puerarin	chem
【PRE_E】
puerarin	chem
ERα	geneY
ERβ	geneY
【GOLD_R】
【PRE_R】

Moreover , we also demonstrate that puerarin functions at least partially through activation of MEK / ERK and PI3K / Akt signaling .
【GOLD_E】
MEK	geneN
ERK	geneN
PI3K	geneN
Akt	geneN
puerarin	chem
【PRE_E】
puerarin	chem
MEK	geneN
ERK	geneN
PI3K	geneN
Akt	geneN
【GOLD_R】
puerarin	MEK	C3
puerarin	ERK	C3
puerarin	PI3K	C3
puerarin	Akt	C3
【PRE_R】
puerarin	PI3K	C4

This agent also shows much weaker effect on breast epithelial cell growth than that of estrogen .
【GOLD_E】
estrogen	chem
【PRE_E】
estrogen	chem
【GOLD_R】
【PRE_R】

Therefore , puerarin will be a promising agent that prevents or retards osteoporosis .
【GOLD_E】
puerarin	chem
【PRE_E】
puerarin	chem
【GOLD_R】
【PRE_R】

Bone Morphogenetic Protein - 7 inhibits silica - induced pulmonary fibrosis in rats .
【GOLD_E】
silica	chem
BoneMorphogeneticProtein-7	geneY
【PRE_E】
BoneMorphogeneticProtein-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

Bone morphogenetic protein - 7 ( BMP - 7 ) has been shown to inhibit liver and renal fibrosis in in vivo and in vitro studies .
【GOLD_E】
Bonemorphogeneticprotein-7	geneY
BMP-7	geneY
【PRE_E】
Bonemorphogeneticprotein-7	geneY
BMP-7	geneY
【GOLD_R】
【PRE_R】

There is no study to investigate BMP - 7 's role in the development of pulmonary fibrosis induced by silica .
【GOLD_E】
BMP-7	geneY
silica	chem
【PRE_E】
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

In the current study , we used the rat model to explore the potential antifibrotic role of BMP - 7 and its underlying mechanism in silica - induced pulmonary fibrosis .
【GOLD_E】
BMP-7	geneY
silica	chem
【PRE_E】
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】
BMP-7	silica	C4

Sixty Wistar rats were randomly assigned into three groups .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Control group received saline , silica group received silica and BMP - 7 treated group received silica and BMP - 7 .
【GOLD_E】
BMP-7	geneY
BMP-7	geneY
silica	chem
silica	chem
silica	chem
【PRE_E】
silica	chem
silica	chem
BMP-7	geneY
silica	chem
BMP-7	geneY
【GOLD_R】
【PRE_R】

BMP - 7 was administered to silica - treated rats intraperitoneally at a dose of 300μg / kg / injection from day 8 to day 30 every other day .
【GOLD_E】
silica	chem
BMP-7	geneY
【PRE_E】
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

After the animals were sacrificed on day 15 and 30 , hydroxyproline levels , the protein expressions of BMP / Smad and TGF - β / Smad signaling , and histopathology in lung tissues were analyzed .
【GOLD_E】
hydroxyproline	chem
BMP	geneN
Smad	geneN
TGF-β	geneY
Smad	geneN
【PRE_E】
hydroxyproline	chem
BMP/Smad	geneN
TGF-β	geneY
Smad	geneY
【GOLD_R】
【PRE_R】
hydroxyproline	BMP/Smad	C3
hydroxyproline	TGF-β	C3

The hydroxyproline contents in BMP - 7 treated groups were significantly lower than the silica groups ( P < 0.05 ) .
【GOLD_E】
hydroxyproline	chem
silica	chem
BMP-7	geneY
【PRE_E】
hydroxyproline	chem
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

Histopathological results showed BMP - 7 could reduce the progression of silica induced fibrosis .
【GOLD_E】
BMP-7	geneY
silica	chem
【PRE_E】
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

Furthermore , the expression of p - Smad1 / 5 / 8 , a marker of BMP / Smad signaling , was significantly up - regulated in BMP - 7 treated groups ( P < 0.05 ) compared with the silica groups .
【GOLD_E】
p-Smad1/5/8	geneN
BMP	geneN
Smad	geneN
BMP-7	geneY
silica	chem
【PRE_E】
p-Smad1/5/8	geneN
BMP	geneN
Smad	geneY
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】
Smad	silica	C3

On the contrary , the expression of p - Smad2 / 3 , a marker for TGF - β / Smad signaling , reduced significantly in BMP - 7 - treated groups compared with silica groups ( P < 0.05 ) .
【GOLD_E】
p-Smad2/3	geneN
TGF-β	geneY
Smad	geneN
BMP-7	geneY
silica	chem
【PRE_E】
p-Smad2/3	geneN
TGF-β	geneY
Smad	geneN
BMP-7	geneY
silica	chem
【GOLD_R】
【PRE_R】

In conclusion , the pulmonary fibrosis induced by silica in rats was significantly reduced with the therapeutic treatment of BMP - 7 .
【GOLD_E】
BMP-7	geneY
silica	chem
【PRE_E】
silica	chem
BMP-7	geneY
【GOLD_R】
【PRE_R】
silica	BMP-7	C4

The antifibrotic effect of BMP - 7 could be related to the activation of BMP / Smad signaling and inhibition of TGF - β / Smad pathways .
【GOLD_E】
BMP-7	geneY
BMP	geneN
Smad	geneN
TGF-β	geneY
Smad	geneN
【PRE_E】
BMP-7	geneY
BMP	geneN
Smad	geneN
TGF-β	geneY
Smad	geneN
【GOLD_R】
【PRE_R】

The preventive effect of uncarboxylated osteocalcin against free fatty acid - induced endothelial apoptosis through the activation of phosphatidylinositol 3 - kinase / Akt signaling pathway : Uncarboxylated osteocalcin and endothelial apoptosis .
【GOLD_E】
phosphatidylinositol	chem
freefattyacid	chem
phosphatidylinositol3-kinase	geneN
Akt	geneN
Uncarboxylatedosteocalcin	geneY
osteocalcin	geneY
【PRE_E】
uncarboxylated	geneN
osteocalcin	geneY
fattyacid	chem
phosphatidylinositol3-kinase	geneN
Akt	geneN
Uncarboxylated	geneN
osteocalcin	geneY
【GOLD_R】
【PRE_R】

OBJECTIVE : Increasing evidence suggests that osteocalcin ( OC ) , one of the osteoblast - specific proteins , has been associated with atherosclerosis , but results are conflicting .
【GOLD_E】
osteocalcin	geneY
OC	geneY
osteoblast-specificproteins	geneN
【PRE_E】
osteocalcin	geneY
OC	geneY
【GOLD_R】
【PRE_R】

The aim of this study was to elucidate the independent effect of uncarboxylated osteocalcin ( ucOC ) , an active form of osteocalcin which has been suggested to have an insulin sensitizing effect , on vascular endothelial cells .
【GOLD_E】
uncarboxylatedosteocalcin	geneY
ucOC	geneY
osteocalcin	geneY
insulin	geneY
【PRE_E】
uncarboxylatedosteocalcin	geneY
ucOC	geneY
osteocalcin	geneY
insulin	geneY
【GOLD_R】
【PRE_R】

MATERIALS AND METHODS : We used human aortic endothelial cells and treated them with ucOC .
【GOLD_E】
ucOC	geneY
【PRE_E】
ucOC	geneY
【GOLD_R】
【PRE_R】

Linoleic acid ( LA ) was used as a representative free fatty acid .
【GOLD_E】
Linoleicacid	chem
freefattyacid	chem
【PRE_E】
Linoleicacid	chem
LA	chem
fattyacid	chem
【GOLD_R】
【PRE_R】

Apoptosis was evaluated using various methods including a terminal deoxyribonucleotide transferase - mediated deoxyuridine triphosphate nick - end labeling analysis kit and Western blotting for cleaved caspase 3 , cleaved poly ( ADP - ribose ) polymerase and Bcl - xL .
【GOLD_E】
deoxyribonucleotidetransferase	geneY
caspase3	geneY
poly(ADP-ribose)polymerase	geneN
Bcl-xL	geneY
deoxyribonucleotide	chem
deoxyuridinetriphosphate	chem
poly(ADP-ribose)	chem
【PRE_E】
deoxyuridinetriphosphate	chem
caspase3	geneY
poly(ADP-ribose)polymerase	geneN
Bcl-xL	geneY
【GOLD_R】
【PRE_R】

The phosphorylations of Akt and endothelial nitric oxide synthase ( eNOS ) as well as the level of NO were measured to confirm the effect of ucOC on insulin signaling pathway .
【GOLD_E】
NO	chem
Akt	geneN
endothelialnitricoxidesynthase	geneY
eNOS	geneY
ucOC	geneY
insulin	geneY
nitricoxide	chem
【PRE_E】
phosphorylations	geneN
Akt	geneN
endothelialnitricoxidesynthase	geneY
eNOS	geneY
NO	chem
ucOC	geneN
insulin	geneN
【GOLD_R】
【PRE_R】

RESULTS : Pretreatment of ucOC ( 30ng / ml ) prevented LA - induced apoptosis in insulin - stimulated endothelial cells ; effects were abolished by pretreatment with the phosphatidylinositol 3 - kinase ( PI3 - kinase ) inhibitor , wortmannin .
【GOLD_E】
ucOC	geneY
insulin	geneY
phosphatidylinositol3-kinase	geneN
PI3-kinase	geneN
phosphatidylinositol	chem
wortmannin	chem
【PRE_E】
ucOC	geneY
insulin	geneY
phosphatidylinositol3-kinase	geneN
PI3-kinase	geneN
wortmannin	chem
【GOLD_R】
wortmannin	phosphatidylinositol3-kinase	C4
wortmannin	PI3-kinase	C4
【PRE_R】
PI3-kinase	wortmannin	C4

Treatment of ucOC ( ranged from 0.3 to 30ng / ml ) significantly increased the phosphorylation of Akt and eNOS and nitric oxide secretion from endothelial cells in a PI3 - kinase dependent manner .
【GOLD_E】
ucOC	geneY
Akt	geneN
eNOS	geneY
PI3-kinase	geneN
nitricoxide	chem
【PRE_E】
ucOC	geneY
Akt	geneN
eNOS	geneY
nitricoxide	chem
PI3-kinase	geneN
【GOLD_R】
【PRE_R】

CONCLUSIONS : Our study is the first to demonstrate the independent effect of ucOC on vascular endothelial cells .
【GOLD_E】
ucOC	geneY
【PRE_E】
ucOC	geneY
【GOLD_R】
【PRE_R】

Our results further suggest that ucOC could have beneficial effects on atherosclerosis .
【GOLD_E】
ucOC	geneY
【PRE_E】
ucOC	geneY
【GOLD_R】
【PRE_R】

Free volume in ionic liquids : a connection of experimentally accessible observables from PALS and PVT experiments with the molecular structure from XRD data .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In the current work , free volume concepts , primarily applied to glass formers in the literature , were transferred to ionic liquids ( ILs ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A series of 1 - butyl - 3 - methylimidazolium ( [ C4MIM ] ( + ) ) based ILs was investigated by Positron Annihilation Lifetime Spectroscopy ( PALS ) .
【GOLD_E】
1-butyl-3-methylimidazolium	chem
[C4MIM](+)	chem
【PRE_E】
1-butyl-3-methylimidazolium([C4MIM](+)	chem
【GOLD_R】
【PRE_R】

The phase transition and dynamic properties of the ILs [ C4MIM ] [ X ] with [ X ] ( - ) = [ Cl ] ( - ) , [ BF4 ] ( - ) , [ PF6 ] ( - ) , [ OTf ] ( - ) , [ NTf2 ] ( - ) and [ B ( hfip ) 4 ] ( - ) were reported recently ( Yu et al . , Phys .
【GOLD_E】
C4MIM	chem
[Cl](-)	chem
[BF4](-)	chem
[PF6](-)	chem
[OTf](-)	chem
[NTf2](-)	chem
[B(hfip)4](-)	chem
【PRE_E】
C4MIM	chem
Cl](-)	chem
[BF4](-)	chem
[PF6](-)	chem
[OTf](-)	chem
NTf2	chem
[B(hfip)	chem
【GOLD_R】
【PRE_R】

Chem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Phys . , 2012 , 14 , 6856 - 6868 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In this subsequent work , attention was paid to the connection of the free volume from PALS ( here the mean hole volume , 〈vh〉 ) with the molecular structure , represented by volumes derived from X - ray diffraction ( XRD ) data .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These were the scaled molecular volume Vm , scaled and the van der Waals volume Vvdw .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Linear correlations of 〈vh〉 at the `` knee `` temperature ( 〈vh〉 ( Tk ) ) with Vm , scaled and Vvdw gave good results for the [ C4MIM ] ( + ) series .
【GOLD_E】
he[C4MIM](	chem
【PRE_E】
C4MIM](+)	chem
【GOLD_R】
【PRE_R】

Further relationships between volumes from XRD data with the occupied volume Vocc determined from PALS / PVT ( Pressure Volume Temperature ) measurements and from Sanchez - Lacombe Equation of State ( SL - EOS ) fits were elaborated ( Vocc ( SL - EOS ) ≈ 1.63 Vvdw , R ( 2 ) = 0.981 and Vocc ( SL - EOS ) ≈ 1.12 Vm , scaled , R ( 2 ) = 0.980 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Finally , the usability of Vm , scaled was justified in terms of the Cohen - Turnbull ( CT ) free volume theory .
【GOLD_E】
【PRE_E】
Cohen-Turnbull	chem
CT	chem
【GOLD_R】
【PRE_R】

Empirical CT type plots of viscosity and electrical conductivity showed a systematic increase in the critical free volume with molecular size .
【GOLD_E】
【PRE_E】
CT	chem
【GOLD_R】
【PRE_R】

Such correlations allow descriptions of IL properties with the easily accessible quantity Vm , scaled within the context of the free volume .
【GOLD_E】
【PRE_E】
IL	geneN
【GOLD_R】
【PRE_R】

Distinct role of PYK2 in mediating thromboxane generation downstream of both G12 / 13 and integrin αiibβ in platelets .
【GOLD_E】
thromboxane	chem
PYK2	geneY
G12/13	geneN
integrinαiibβ	geneY
【PRE_E】
PYK2	geneN
thromboxane	chem
G12/13	geneN
integrinαiibβ	geneN
【GOLD_R】
【PRE_R】

Proline - rich tyrosine kinase 2 ( Pyk2 ) is activated by various agonists in platelets .
【GOLD_E】
Proline-richtyrosinekinase2	geneY
Proline	chem
Pyk2	geneY
tyrosine	chem
【PRE_E】
Proline-richtyrosinekinase2	geneY
Pyk2	geneY
【GOLD_R】
【PRE_R】

We evaluated the signaling mechanism and the functional role of Pyk2 in platelets by using pharmacological inhibitors and Pyk2 - deficient platelets .
【GOLD_E】
Pyk2	geneY
Pyk2	geneY
【PRE_E】
Pyk2	geneN
Pyk2	geneN
【GOLD_R】
【PRE_R】

We found that platelet aggregation and secretion in response to 2 - MeSADP and AYPGKF were diminished in the presence of Pyk2 inhibitors or in Pyk2 - deficient platelets , suggesting that Pyk2 plays a positive regulatory role in platelet functional responses .
【GOLD_E】
Pyk2	geneY
Pyk2	geneY
Pyk2	geneY
2-MeSADP	chem
【PRE_E】
2-MeSADP	chem
AYPGKF	geneN
Pyk2	geneN
Pyk2	geneN
Pyk2	geneN
【GOLD_R】
【PRE_R】

It has been shown that ADP - , but not thrombin - , induced thromboxane ( TxA2 ) generation depends on integrin signaling .
【GOLD_E】
thrombin	geneY
integrin	geneN
ADP	chem
thromboxane	chem
TxA2	chem
【PRE_E】
ADP	chem
thrombin	geneY
thromboxane	chem
TxA2	chem
integrin	geneN
【GOLD_R】
【PRE_R】

Unlike ADP , thrombin activates G12 / 13 pathways , and G12 / 13 pathways can substitute for integrin signaling for TxA2 generation .
【GOLD_E】
ADP	chem
TxA2	chem
thrombin	geneY
G12/13	geneN
G12/13	geneN
integrin	geneN
【PRE_E】
ADP	chem
thrombin	geneY
G12/13	geneN
G12/13	geneN
integrin	geneN
TxA2	chem
【GOLD_R】
【PRE_R】

We found that Pyk2 was activated downstream of both G12 / 13 and integrin - mediated pathways , and both 2 - MeSADP - and AYPGKF - induced TxA2 generation was significantly diminished in Pyk2 - deficient platelets .
【GOLD_E】
2-MeSADP	chem
TxA2	chem
Pyk2	geneY
G12/13	geneN
integrin	geneN
Pyk2	geneY
【PRE_E】
Pyk2	geneN
G12/13	geneN
integrin	geneN
2-MeSADP	chem
AYPGKF	geneN
TxA2	chem
Pyk2	geneN
【GOLD_R】
【PRE_R】

In addition , TxA2 generation induced by co - stimulation of Gi and Gz pathways , which is dependent on integrin signaling , was inhibited by blocking Pyk2 .
【GOLD_E】
TxA2	chem
Gz	geneY
integrin	geneN
Pyk2	geneY
Gi	geneN
【PRE_E】
TxA2	chem
Gi	geneN
Gz	chem
integrin	geneN
Pyk2	geneN
【GOLD_R】
【PRE_R】

Furthermore , inhibition of 2 - MeSADP - induced TxA2 generation by fibrinogen receptor antagonist was not rescued by co - stimulation of G12 / 13 pathways in the presence of Pyk2 inhibitor .
【GOLD_E】
fibrinogenreceptor	geneY
G12/13	geneN
Pyk2	geneY
2-MeSADP	chem
TxA2	chem
【PRE_E】
2-MeSADP	chem
TxA2	chem
fibrinogenreceptor	geneN
G12/13	geneN
Pyk2	geneN
【GOLD_R】
【PRE_R】

We conclude that Pyk2 is a common signaling effector downstream of both G12 / 13 and integrin αIIbβ3 signaling which contributes to thromboxane generation .
【GOLD_E】
Pyk2	geneY
G12/13	geneN
integrinαIIbβ3	geneY
thromboxane	chem
【PRE_E】
Pyk2	geneN
G12/13	geneN
integrinαIIbβ3	geneN
thromboxane	chem
【GOLD_R】
【PRE_R】

The use of antioxidant enzymes in freshwater biofilms : Temporal variability vs. toxicological responses .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This study aims to investigate the potential of antioxidant enzyme activities ( AEA ) as biomarkers of oxidative stress in freshwater biofilms .
【GOLD_E】
【PRE_E】
AEA	geneN
【GOLD_R】
【PRE_R】

Therefore , biofilms were grown in channels for 38 days and then exposed to different concentrations ( 0 - 150μgL ( - 1 ) ) of the herbicide oxyfluorfen for 5 more weeks .
【GOLD_E】
oxyfluorfen	chem
【PRE_E】
oxyfluorfen	chem
【GOLD_R】
【PRE_R】

Under control conditions , the AEA of biofilms were found to change throughout time with a significant increase in ascorbate peroxidase ( APX ) activity during the exponential growth and a more important role of catalase ( CAT ) and glutathione reductase ( GR ) activities during the slow growth phase .
【GOLD_E】
ascorbateperoxidase	geneN
APX	geneN
catalase	geneN
CAT	geneN
glutathionereductase	geneN
GR	geneN
ascorbate	chem
glutathione	chem
【PRE_E】
AEA	geneY
ascorbateperoxidase	geneY
APX	geneY
catalase	geneY
CAT	geneY
glutathionereductase	geneY
GR	geneY
【GOLD_R】
【PRE_R】

Chronic exposure to oxyfluorfen led to slight variations in AEA , however , the ranges of variability of AEA in controls and exposed communities were similar , highlighting the difficulty of a direct interpretation of AEA values .
【GOLD_E】
oxyfluorfen	chem
【PRE_E】
oxyfluorfen	chem
AEA	geneN
AEA	geneN
【GOLD_R】
【PRE_R】
oxyfluorfen	AEA	C3

After 5 weeks of exposure to oxyfluorfen , no clear effects were observed on chl - a concentration or on the composition of other pigments suggesting that algal group composition was not affected .
【GOLD_E】
oxyfluorfen	chem
chl-a	chem
【PRE_E】
oxyfluorfen	chem
chl	chem
【GOLD_R】
【PRE_R】

Eukaryotic communities were structured clearly by toxicant concentration and both eukaryotic and bacterial richness were reduced in communities exposed to the highest concentration .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In addition , during acute exposure tests performed at the end of the chronic exposure , biofilms chronically exposed to 75 and 150μgL ( - 1 ) oxyfluorfen showed a higher CAT activity than controls .
【GOLD_E】
oxyfluorfen	chem
CAT	geneN
【PRE_E】
150μgL(-1)oxyfluorfen	chem
CAT	geneY
【GOLD_R】
oxyfluorfen	CAT	C3
【PRE_R】

Chronic exposure to oxyfluorfen provoked then structural changes but also functional changes in the capacity of biofilm CAT activity to respond to a sudden increase in concentration , suggesting a selection of species with higher antioxidant capacity .
【GOLD_E】
CAT	geneN
oxyfluorfen	chem
【PRE_E】
oxyfluorfen	chem
CAT	geneY
【GOLD_R】
【PRE_R】
oxyfluorfen	CAT	C3

This study highlighted the difficulty of interpretation of AEA values due to their temporal variation and to the absence of absolute threshold value indicative of oxidative stress induced by contaminants .
【GOLD_E】
【PRE_E】
AEA	chem
【GOLD_R】
【PRE_R】

Nevertheless , the determination of AEA pattern throughout acute exposure test is of high interest to compare oxidative stress levels undergone by different biofilm communities and thus determine their antioxidant capacity .
【GOLD_E】
【PRE_E】
AEA	chem
【GOLD_R】
【PRE_R】

Pharmacological and genetic evidence for pre - and postsynaptic D2 receptor involvement in motor responses to nociceptin / orphanin FQ receptor ligands .
【GOLD_E】
nociceptin/orphaninFQreceptor	geneY
D2receptor	geneY
【PRE_E】
D2receptor	geneY
nociceptin/orphaninFQreceptor	geneN
【GOLD_R】
【PRE_R】

A combined pharmacological and genetic approach was undertaken to investigate the contribution of endogenous dopamine to the motor actions of nociceptin / orphanin FQ ( N / OFQ ) receptor ( NOP receptor ) ligands .
【GOLD_E】
dopamine	chem
nociceptin/orphaninFQ(N/OFQ)receptor	geneY
NOPreceptor	geneY
【PRE_E】
dopamine	chem
nociceptin/orphaninFQ(N/OFQ)receptor	geneN
NOPreceptor	geneY
【GOLD_R】
【PRE_R】

Motor activity was evaluated by a battery of behavioural tests in mice .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The involvement of the various DA receptor subtypes in the motor effects of N / OFQ and NOP receptor antagonists was evaluated pharmacologically , using D1 / D5 ( SCH23390 ) , D2 / D3 ( raclopride , amisulpride ) and D3 ( S33084 ) receptor antagonists , and by using D2 receptor knockout mice .
【GOLD_E】
DAreceptor	geneN
N/OFQ	geneY
NOPreceptor	geneY
D1	geneY
D5	geneY
D2	geneY
D3	geneY
D3	geneY
D2receptor	geneY
SCH23390	chem
raclopride	chem
amisulpride	chem
S33084	chem
【PRE_E】
DAreceptor	geneN
N/OFQandNOPreceptor	geneN
D1/D5(SCH23390),D2/D3(raclopride,amisulpride)andD3(S33084)receptor	geneN
D2receptor	geneY
【GOLD_R】
SCH23390	D1	C6
SCH23390	D5	C6
raclopride	D2	C6
raclopride	D3	C6
amisulpride	D2	C6
amisulpride	D3	C6
S33084	D3	C6
【PRE_R】

Low doses of N / OFQ and NOP receptor antagonists promoted movement whereas higher doses inhibited it .
【GOLD_E】
N/OFQ	geneY
NOPreceptor	geneY
【PRE_E】
N/OFQandNOPreceptor	geneN
【GOLD_R】
【PRE_R】

Motor facilitation was selectively prevented by raclopride while motor inhibition was prevented by amisulpride .
【GOLD_E】
raclopride	chem
amisulpride	chem
【PRE_E】
raclopride	chem
amisulpride	chem
【GOLD_R】
【PRE_R】

Amisulpride also attenuated the hypolocomotion induced by the D2 / D3 receptor agonist pramipexole and dopamine precursor L - 3,4 - dihydroxyphenylalanine , whereas raclopride ( and S33084 ) worsened it .
【GOLD_E】
Amisulpride	chem
pramipexole	chem
dopamine	chem
L-3,4-dihydroxyphenylalanine	chem
raclopride	chem
S33084	chem
D2/D3receptor	geneN
【PRE_E】
Amisulpride	chem
D2/D3	geneY
pramipexole	chem
dopamine	chem
L-3,4-dihydroxyphenylalanine	chem
raclopride	chem
S33084	chem
【GOLD_R】
【PRE_R】
Amisulpride	D2/D3	C5
D2/D3	L-3,4-dihydroxyphenylalanine	C5
D2/D3	S33084	C5

To dissect out the contribution of pre - and postsynaptic D2 receptors , mice lacking the D2 receptor ( D2R ( - / - ) ) or its long isoform ( D2L ( - / - ) ) were used .
【GOLD_E】
D2receptors	geneY
D2receptor	geneY
D2R	geneY
D2L	geneY
【PRE_E】
D2receptors	geneY
D2receptor	geneY
D2R	geneY
D2L	geneY
【GOLD_R】
【PRE_R】

Motor facilitation induced by N / OFQ and NOP receptor antagonists was lost in D2R ( - / - ) and D2L ( - / - ) mice whereas motor inhibition induced by NOP receptor antagonists ( and pramipexole ) was lost in D2R ( - / - ) but preserved in D2L ( - / - ) mice .
【GOLD_E】
N/OFQ	geneY
NOPreceptor	geneY
D2R	geneY
D2L	geneY
NOPreceptor	geneY
D2R	geneY
D2L	geneY
pramipexole	chem
【PRE_E】
N/OFQandNOPreceptor	geneN
D2R	geneY
D2L	geneY
NOPreceptor	geneY
pramipexole	chem
D2R	geneY
D2L	geneY
【GOLD_R】
【PRE_R】
NOPreceptor	pramipexole	C5

N / OFQ - induced hypolocomotion was observed in both genotypes .
【GOLD_E】
N/OFQ	geneY
【PRE_E】
N	chem
OFQ	chem
【GOLD_R】
【PRE_R】

We demonstrate that motor actions of NOP receptor ligands rely on the modulation of endogenous dopamine .
【GOLD_E】
NOPreceptor	geneY
dopamine	chem
【PRE_E】
NOPreceptor	geneY
dopamine	chem
【GOLD_R】
【PRE_R】

Motor facilitation induced by NOP receptor antagonists as well as low dose N / OFQ is mediated through D2L postsynaptic receptors whereas motor inhibition observed with higher doses of N / OFQ occurs by direct inhibition of mesencephalic DA neurons .
【GOLD_E】
NOPreceptor	geneY
N/OFQ	geneY
D2L	geneY
N/OFQ	geneY
【PRE_E】
NOPreceptor	geneY
N	chem
OFQ	chem
D2Lpostsynapticreceptors	geneN
N/OFQ	chem
【GOLD_R】
【PRE_R】
NOPreceptor	N	C5
OFQ	D2Lpostsynapticreceptors	C5

Motor inhibition seen with high doses of NOP receptor antagonists appears to be mediated through the D2 presynaptic autoreceptors .
【GOLD_E】
NOPreceptor	geneY
D2presynapticautoreceptors	geneY
【PRE_E】
NOP	geneY
D2presynapticautoreceptors	geneN
【GOLD_R】
【PRE_R】

These data confirm that endogenous N / OFQ is a powerful modulator of dopamine transmission in vivo and that the effects of NOP receptor antagonists on motor function reflect the blockade of this endogenous N / OFQ tone .
【GOLD_E】
N/OFQ	geneY
NOPreceptor	geneY
N/OFQ	geneY
【PRE_E】
N	chem
OFQ	chem
dopamine	chem
NOPreceptor	geneY
N	chem
OFQ	chem
【GOLD_R】
【PRE_R】

Haloperidol promotes mTORC1 - dependent phosphorylation of ribosomal protein S6 via dopamine - and cAMP - regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase - 1 .
【GOLD_E】
Haloperidol	chem
dopamine	chem
cAMP	chem
proteinphosphatase-1	geneN
mTORC1	geneN
ribosomalproteinS6	geneY
dopamine-andcAMP-regulatedphosphoproteinof32kDa	geneY
【PRE_E】
Haloperidol	chem
mTORC1	geneN
ribosomalproteinS6	geneN
dopamine-andcAMP-regulatedphosphoproteinof32	geneN
proteinphosphatase-1	geneY
【GOLD_R】
Haloperidol	ribosomalproteinS6	C3
Haloperidol	proteinphosphatase-1	C4
【PRE_R】
Haloperidol	mTORC1	C3
Haloperidol	ribosomalproteinS6	C3

The ribosomal protein S6 ( rpS6 ) is a component of the small 40S ribosomal subunit , involved in multiple physiological functions .
【GOLD_E】
rpS6	geneY
ribosomalproteinS6	geneY
40Sribosomalsubunit	geneN
【PRE_E】
ribosomalproteinS6	geneN
rpS6	geneN
【GOLD_R】
【PRE_R】

Here , we examined the effects produced by haloperidol , a typical antipsychotic drug , on the phosphorylation of rpS6 at Ser240 / 244 in the striatum , a brain region involved in neurodegenerative and neuropsychiatric disorders .
【GOLD_E】
rpS6	geneY
haloperidol	chem
Ser	chem
【PRE_E】
haloperidol	chem
rpS6	geneN
Ser240/244	geneN
【GOLD_R】
【PRE_R】

Administration of haloperidol increased Ser240 / 244 phosphorylation in a subpopulation of GABA - ergic medium spiny neurons ( MSNs ) , which express dopamine D2 receptors ( D2Rs ) .
【GOLD_E】
Ser	chem
GABA	chem
dopamine	chem
dopamineD2receptors	geneY
D2Rs	geneY
haloperidol	chem
【PRE_E】
haloperidol	chem
Ser240/244	geneN
GABA	chem
dopamineD2receptors	geneY
D2Rs	geneY
【GOLD_R】
【PRE_R】
haloperidol	Ser240/244	C3

This effect was prevented by rapamycin , an inhibitor of the mammalian target of rapamycin complex 1 ( mTORC1 ) , or by PF470867 , a selective inhibitor of the p70 ribosomal S6 kinase 1 ( S6K1 ) .
【GOLD_E】
rapamycin	chem
rapamycin	chem
PF470867	chem
mammaliantargetofrapamycincomplex1	geneN
mTORC1	geneN
p70ribosomalS6kinase1	geneY
S6K1	geneN
【PRE_E】
rapamycin	chem
mammaliantargetofrapamycincomplex1	geneN
mTORC1	geneN
PF470867	chem
p70ribosomalS6kinase1	geneY
S6K1	geneY
【GOLD_R】
rapamycin	mammaliantargetofrapamycincomplex1	C4
rapamycin	mTORC1	C4
PF470867	p70ribosomalS6kinase1	C4
PF470867	S6K1	C4
【PRE_R】
rapamycin	mammaliantargetofrapamycincomplex1	C4
mTORC1	PF470867	C4
PF470867	p70ribosomalS6kinase1	C4
PF470867	S6K1	C4

We also found that the effect of haloperidol on Ser240 / 244 phosphorylation was prevented by functional inactivation of dopamine - and cAMP - regulated phosphoprotein of 32 kDa ( DARPP - 32 ) , an endogenous inhibitor of protein phosphatase - 1 ( PP - 1 ) .
【GOLD_E】
haloperidol	chem
Ser	chem
dopamine	chem
cAMP	chem
dopamine-andcAMP-regulatedphosphoproteinof32kDa	geneY
DARPP-32	geneY
proteinphosphatase-1	geneN
PP-1	geneN
【PRE_E】
haloperidol	chem
Ser240/244	geneN
dopamine-andcAMP-regulatedphosphoproteinof32kDa	geneN
DARPP-32	geneY
proteinphosphatase-1	geneY
PP-1	geneY
【GOLD_R】
【PRE_R】

In line with this observation , incubation of striatal slices with okadaic acid and calyculin A , two inhibitors of PP - 1 , increased Ser240 / 244 phosphorylation .
【GOLD_E】
okadaicacid	chem
PP-1	geneN
calyculinA	chem
Ser	chem
【PRE_E】
okadaicacid	chem
calyculinA	chem
PP-1	geneY
Ser240/244	geneN
【GOLD_R】
okadaicacid	PP-1	C4
calyculinA	PP-1	C4
【PRE_R】
okadaicacid	PP-1	C4
calyculinA	PP-1	C4
calyculinA	Ser240/244	C4

These results show that haloperidol promotes mTORC1 - and S6K1 - dependent phosphorylation of rpS6 at Ser240 / 244 , in a subpopulation of striatal MSNs expressing D2Rs .
【GOLD_E】
mTORC1	geneN
S6K1	geneN
rpS6	geneY
D2Rs	geneY
haloperidol	chem
Ser	chem
【PRE_E】
haloperidol	chem
mTORC1	geneN
S6K1	geneY
rpS6	geneY
Ser240/244	geneN
D2Rs	geneY
【GOLD_R】
haloperidol	rpS6	C3
【PRE_R】
haloperidol	mTORC1	C3
haloperidol	S6K1	C3
haloperidol	rpS6	C3
haloperidol	Ser240/244	C3
haloperidol	D2Rs	C3

They also indicate that this effect is exerted by suppressing dephosphorylation at Ser240 / 244 , through PKA - dependent activation of DARPP - 32 and inhibition of PP - 1 .
【GOLD_E】
PKA	geneN
DARPP-32	geneY
PP-1	geneN
Ser	chem
【PRE_E】
Ser240/244	geneN
PKA	geneN
DARPP-32	geneY
PP-1	geneY
【GOLD_R】
【PRE_R】

Designing , structural elucidation , comparison of DNA binding , cleavage , radical scavenging activity and anticancer activity of copper ( I ) complex with 5 - dimethyl - 2 - phenyl - 4 - [ ( pyridin - 2 - ylmethylene ) - amino ] - 1,2 - dihydro - pyrazol - 3 - one Schiff base ligand .
【GOLD_E】
opper(I)c	chem
-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-oneS	chem
chiffbasel	chem
【PRE_E】
copper(I)	chem
5-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-one	chem
【GOLD_R】
【PRE_R】

A novel copper ( I ) Schiff base complex has been synthesized and fully characterized by spectral , analytical and structural modes .
【GOLD_E】
copper(I)Schiffbase	chem
【PRE_E】
copper(I)	chem
【GOLD_R】
【PRE_R】

Single crystal X - ray diffraction studies revealed that the copper ( I ) complex [ CuCl ( PPh3 ) L ] has a distorted tetrahedral geometry around the central copper ( I ) ion .
【GOLD_E】
copper(I)	chem
[CuCl(PPh3)L]	chem
copper(I)	chem
【PRE_E】
copper(I)	chem
CuCl(PPh3)L	chem
copper(I)	chem
【GOLD_R】
【PRE_R】

The interaction of the ligand and the complex with CT - DNA has been explored by absorption titration method which revealed that the compounds could interact with CT - DNA through intercalation .
【GOLD_E】
【PRE_E】
CT	chem
CT	chem
【GOLD_R】
【PRE_R】

A gel electrophoresis assay demonstrated the ability of the complex to cleave the pBR322 DNA .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The antioxidative properties showed that the copper ( I ) complex has a strong radical - scavenging potency than ligands .
【GOLD_E】
copper(I)	chem
【PRE_E】
copper(I)	chem
【GOLD_R】
【PRE_R】

Further the cytotoxic effect of the compounds examined on cancerous cell lines showed that the complex exhibited substantial anticancer activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb / IIIa with highly overlapped pharmacophores .
【GOLD_E】
factorXa	geneY
fibrinogen	geneN
GPIIb/IIIa	geneY
【PRE_E】
factorXa	geneY
fibrinogen	geneN
GPIIb/IIIa	geneN
【GOLD_R】
【PRE_R】

Dual antithrombotic agents acting as anticoagulants and aggregation inhibitors could have substantial advantages over currently prescribed combinations of antithrombotic drugs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Herein , we report compounds with moderate inhibitory activity for factor Xa and fibrinogen GPIIb / IIIa binding ( both in the micromolar range ) .
【GOLD_E】
factorXa	geneY
fibrinogen	geneN
GPIIb/IIIa	geneY
【PRE_E】
factorXa	geneY
fibrinogenGPIIb/IIIa	geneN
【GOLD_R】
【PRE_R】

These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the Arg - Gly - Asp ( RGD ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .
【GOLD_E】
fibrinogen	geneN
rivaroxaban	chem
Arg-Gly-Asp	chem
factorXa	geneY
Arg-Gly-Asp	geneN
RGD	geneN
【PRE_E】
factorXa	geneY
rivaroxaban	chem
Arg-Gly-Asp	geneN
RGD	geneN
fibrinogen	geneN
【GOLD_R】
rivaroxaban	factorXa	C4
【PRE_R】
factorXa	rivaroxaban	C4

Resulting from this study , a structurally novel class of submicromolar fibrinogen GPIIb / IIIa binding inhibitor bearing 1,2,4 - oxadiazol - 5 ( 4H ) - one moiety is also described .
【GOLD_E】
GPIIb/IIIa	geneY
1,2,4-oxadiazol-5(4H)-one	chem
【PRE_E】
fibrinogenGPIIb/IIIa	geneN
1,2,4-oxadiazol-5(4H)-one	chem
【GOLD_R】
1,2,4-oxadiazol-5(4H)-one	GPIIb/IIIa	C4
【PRE_R】
fibrinogenGPIIb/IIIa	1,2,4-oxadiazol-5(4H)-one	C4

Role of quercetin in cadmium - induced oxidative stress , neuronal damage , and apoptosis in rats .
【GOLD_E】
cadmium	chem
quercetin	chem
【PRE_E】
quercetin	chem
cadmium	chem
【GOLD_R】
【PRE_R】

The present study was carried out to evaluate the neuroprotective effect of quercetin ( QE ) in protecting the cadmium ( Cd ) - induced neuronal injury in frontal cortex of rats .
【GOLD_E】
quercetin	chem
cadmium	chem
Cd	chem
【PRE_E】
quercetin	chem
QE	chem
cadmium	chem
Cd	chem
【GOLD_R】
【PRE_R】

A total of 30 adult male Sprague - Dawley rats were randomly divided into three groups of 10 animals each : control , Cd treated and Cd treated with QE .
【GOLD_E】
Cd	chem
Cd	chem
【PRE_E】
QE	chem
【GOLD_R】
【PRE_R】

The Cd - treated group was injected subcutaneously with cadmium chloride ( CdCl2 ) dissolved in saline at a dose of 2 ml / kg / day for 30 days , resulting in a dosage of 1 mg / kg Cd .
【GOLD_E】
Cd	chem
cadmiumchloride	chem
CdCl2	chem
Cd	chem
【PRE_E】
Cd	chem
cadmiumchloride	chem
CdCl2	chem
【GOLD_R】
【PRE_R】

The rats in QE - treated groups were given QE ( 15 mg / kg body weight ) once a day intraperitoneally starting 2 days prior to Cd injection , during the study period .
【GOLD_E】
Cd	chem
【PRE_E】
QE	chem
QE	chem
【GOLD_R】
【PRE_R】

Rats were sacrificed at the end of the study and the frontal cortex tissues were removed for biochemical and histopathological investigation .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

To date , there is no available information on the effect of QE on neuronal injury after Cd exposure .
【GOLD_E】
Cd	chem
【PRE_E】
QE	chem
Cd	chem
【GOLD_R】
【PRE_R】

Rats intoxicated with Cd for 30 days , significantly increased tissue malondialdehyde ( MDA ) levels and significantly decreased enzymatic antioxidants superoxide dismutase , glutathione peroxidase and catalase in the frontal cortex tissue .
【GOLD_E】
superoxide	chem
Cd	chem
malondialdehyde	chem
MDA	chem
superoxidedismutase	geneN
glutathioneperoxidase	geneN
catalase	geneY
glutathione	chem
【PRE_E】
Cd	chem
malondialdehyde	chem
MDA	chem
superoxidedismutase	geneN
glutathioneperoxidase	geneN
catalase	geneY
【GOLD_R】
Cd	superoxidedismutase	C4
Cd	glutathioneperoxidase	C4
Cd	catalase	C4
【PRE_R】

Administration of QE with Cd significantly diminished the levels of MDA and significantly elevated the levels of enzymatic antioxidants in the frontal cortex tissue .
【GOLD_E】
Cd	chem
MDA	chem
【PRE_E】
QE	chem
Cd	chem
MDA	chem
【GOLD_R】
【PRE_R】

The histopathological studies in the brain of rats also supported that QE markedly reduced the Cd - induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue .
【GOLD_E】
Cd	chem
【PRE_E】
Cd	chem
【GOLD_R】
【PRE_R】

The caspase - 3 immunopositivity was increased in degenerating neurons of the Cd group .
【GOLD_E】
caspase-3	geneY
Cd	chem
【PRE_E】
caspase-3	geneY
Cd	chem
【GOLD_R】
Cd	caspase-3	C3
【PRE_R】
caspase-3	Cd	C3

Treatment with QE markedly reduced the immunoreactivity of degenerating neurons .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , the results of the current study suggest that QE may be beneficial in combating the Cd - induced neurotoxicity in the brain of rats .
【GOLD_E】
Cd	chem
【PRE_E】
QE	chem
Cd	chem
【GOLD_R】
【PRE_R】

We believe that further preclinical research into the utility of QE may indicate its usefulness as a potential treatment for neurodegeneration after Cd exposure in rats .
【GOLD_E】
Cd	chem
【PRE_E】
QE	chem
Cd	chem
【GOLD_R】
【PRE_R】

Oestrogen action on thyroid progenitor cells : relevant for the pathogenesis of thyroid nodules ?
【GOLD_E】
Oestrogen	chem
【PRE_E】
Oestrogen	chem
【GOLD_R】
【PRE_R】

Benign and malignant thyroid nodules are more prevalent in females than in men .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Experimental data suggest that the proliferative effect of oestrogen rather than polymorphisms is responsible for this gender difference .
【GOLD_E】
oestrogen	chem
【PRE_E】
oestrogen	chem
【GOLD_R】
【PRE_R】

This study analysed whether both differentiated thyroid cells and thyroid stem and progenitor cells are a target of oestrogen action .
【GOLD_E】
oestrogen	chem
【PRE_E】
oestrogen	chem
【GOLD_R】
【PRE_R】

In thyroid stem / progenitor cells derived from nodular goitres the ability of 17beta - oestradiol to induce thyrosphere formation , the expression of oestrogen receptors and the effect of 17beta - oestradiol on growth , expression of marker of stem cells and thyroid differentiation ( TSH receptor , thyroperoxidase , thyroglobulin , sodium iodide symporter expression ) were analysed .
【GOLD_E】
17beta-oestradiol	chem
sodiumiodide	chem
oestrogenreceptors	geneY
TSHreceptor	geneY
thyroperoxidase	geneY
thyroglobulin	geneY
sodiumiodidesymporter	geneY
17beta-oestradiol	chem
oestrogen	chem
【PRE_E】
17beta-oestradiol	chem
oestrogenreceptors	geneY
17beta-oestradiol	chem
TSHreceptor	geneY
thyroperoxidase	geneN
thyroglobulin	geneY
sodiumiodidesymporter	geneY
【GOLD_R】
【PRE_R】

17beta - oestradiol induced thyrosphere formation , albeit to lower extent than other growth factors .
【GOLD_E】
17beta-oestradiol	chem
【PRE_E】
17beta-oestradiol	chem
【GOLD_R】
【PRE_R】

Thyroid stem and progenitor cells expressed oestrogen receptor alpha and beta with an 8 time higher expression level of oestrogen receptor alpha mRNA compared to differentiated thyrocytes .
【GOLD_E】
oestrogen	chem
oestrogen	chem
oestrogenreceptoralphaandbeta	geneN
oestrogenreceptoralpha	geneN
【PRE_E】
oestrogenreceptoralphaandbeta	geneY
oestrogenreceptoralpha	geneY
【GOLD_R】
【PRE_R】

17beta - oestradiol was a potent stimulator of thyroid stem / progenitor cell growth .
【GOLD_E】
17beta-oestradiol	chem
【PRE_E】
17beta-oestradiol	chem
【GOLD_R】
【PRE_R】

In contrast , TSH - induced differentiation of progenitor cells , in particular the expression of the sodium iodide symporter , was significantly inhibited by 17beta - oestradiol.In conclusion , oestrogen stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem / progenitor cells .
【GOLD_E】
sodiumiodidesymporter	geneY
sodiumiodide	chem
17beta-oestradiol	chem
oestrogen	chem
【PRE_E】
TSH	geneN
sodiumiodidesymporter	geneY
17beta-oestradiol.In	chem
oestrogen	chem
【GOLD_R】
17beta-oestradiol	sodiumiodidesymporter	C4
【PRE_R】

From these data and based on the concept of cellular heterogeneity , we hypothesize a supportive role of oestrogen in the propagation of thyroid stem / progenitor cells leading to a selection of a progeny of growth - prone cells with a decreased differentiation .
【GOLD_E】
oestrogen	chem
【PRE_E】
oestrogen	chem
【GOLD_R】
【PRE_R】

These cells may be the origin of hypo - or non - functioning thyroid nodules in females .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Differential regulation of Arabidopsis plastid gene expression and RNA editing in non - photosynthetic tissues .
【GOLD_E】
Arabidopsisplastid	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

RNA editing is one of the post - transcriptional processes that commonly occur in plant plastids and mitochondria .
【GOLD_E】
plantplastids	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

In Arabidopsis , 34 C - to - U RNA editing events , affecting transcripts of 18 plastid genes , have been identified .
【GOLD_E】
plastid	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Here , we examined the editing and expression of these transcripts in different organs , and in green and non - green seedlings ( etiolated , cia5 - 2 , ispF and ispG albino mutants , lincomycin - , and norflurazon - treated ) .
【GOLD_E】
lincomycin	chem
norflurazon	chem
【PRE_E】
cia5-2	geneY
ispF	geneN
ispG	geneN
lincomycin	chem
norflurazon	chem
【GOLD_R】
【PRE_R】

The editing efficiency of Arabidopsis plastid transcripts varies from site to site , and may be specifically regulated in different tissues .
【GOLD_E】
Arabidopsisplastid	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

Steady state levels of plastid transcripts are low or undetectable in etiolated seedlings , but most editing sites are edited with efficiencies similar to those observed in green seedlings .
【GOLD_E】
plastid	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

By contrast , the editing of some sites is completely lost or significantly reduced in other non - green tissues ; for instance , the editing of ndhB - 149 , ndhB - 1255 , and ndhD - 2 is completely lost in roots and in lincomycin - treated seedlings .
【GOLD_E】
ndhB-149	geneN
ndhB-1255	geneN
ndhD-2	geneN
lincomycin	chem
【PRE_E】
ndhB-149	geneY
ndhB-1255	geneY
ndhD-2	geneY
lincomycin	chem
【GOLD_R】
【PRE_R】

The editing of ndhD - 2 is also completely lost in albino mutants and norflurazon - treated seedlings .
【GOLD_E】
norflurazon	chem
ndhD-2	geneN
【PRE_E】
ndhD-2	geneY
norflurazon	chem
【GOLD_R】
【PRE_R】

However , matK - 640 is completely edited , and accD - 794 , atpF - 92 , psbE - 214 , psbF - 77 , psbZ - 50 , and rps14 - 50 are completely or highly edited in both green and non - green tissues .
【GOLD_E】
psbF-77	geneN
psbZ-50	geneN
rps14-50	geneN
accD-794	geneN
atpF-92	geneN
psbE-214	geneN
【PRE_E】
psbE-214	geneY
psbF	geneN
psbZ	geneN
rps14	geneY
【GOLD_R】
【PRE_R】

In addition , the expression of nucleus - encoded RNA polymerase dependent transcripts is specifically induced by lincomycin , and the splicing of ndhB transcripts is significantly reduced in the albino mutants and inhibitor - treated seedlings .
【GOLD_E】
RNApolymerase	geneN
ndhB	geneN
lincomycin	chem
【PRE_E】
RNApolymerase	geneN
lincomycin	chem
ndhB	geneY
【GOLD_R】
【PRE_R】
lincomycin	ndhB	C3

Our results indicate that plastid gene expression , and the splicing and editing of plastid transcripts are specifically and differentially regulated in various types of non - green tissues .
【GOLD_E】
plastid	geneN
plastid	geneN
【PRE_E】
plastid	geneN
plastid	geneN
【GOLD_R】
【PRE_R】

Drug - drug interactions between HMG - CoA reductase inhibitors ( statins ) and antiviral protease inhibitors .
【GOLD_E】
HMG-CoA	chem
HMG-CoAreductase	geneY
protease	geneN
【PRE_E】
HMG-CoAreductase	geneY
protease	geneN
【GOLD_R】
【PRE_R】

The HMG - CoA reductase inhibitors are a class of drugs also known as statins .
【GOLD_E】
HMG-CoA	chem
HMG-CoAreductase	geneY
【PRE_E】
HMG-CoAreductase	geneY
【GOLD_R】
【PRE_R】

These drugs are effective and widely prescribed for the treatment of hypercholesterolemia and prevention of cardiovascular morbidity and mortality .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Seven statins are currently available : atorvastatin , fluvastatin , lovastatin , pitavastatin , pravastatin , rosuvastatin and simvastatin .
【GOLD_E】
atorvastatin	chem
fluvastatin	chem
lovastatin	chem
pitavastatin	chem
pravastatin	chem
rosuvastatin	chem
simvastatin	chem
【PRE_E】
atorvastatin	chem
fluvastatin	chem
lovastatin	chem
pitavastatin	chem
pravastatin	chem
rosuvastatin	chem
simvastatin	chem
【GOLD_R】
【PRE_R】

Although these drugs are generally well tolerated , skeletal muscle abnormalities from myalgia to severe lethal rhabdomyolysis can occur .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Factors that increase statin concentrations such as drug - drug interactions can increase the risk of these adverse events .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Drug - drug interactions are dependent on statins ' pharmacokinetic profile : simvastatin , lovastatin and atorvastatin are metabolized through cytochrome P450 ( CYP ) 3A , while the metabolism of the other statins is independent of this CYP .
【GOLD_E】
simvastatin	chem
lovastatin	chem
atorvastatin	chem
cytochromeP450(CYP)3A	geneN
CYP	geneN
【PRE_E】
simvastatin	chem
lovastatin	chem
atorvastatin	chem
cytochromeP450(CYP)3A	geneN
CYP	geneN
【GOLD_R】
simvastatin	cytochromeP450(CYP)3A	C9
lovastatin	cytochromeP450(CYP)3A	C9
atorvastatin	cytochromeP450(CYP)3A	C9
【PRE_R】
lovastatin	cytochromeP450(CYP)3A	C4
atorvastatin	cytochromeP450(CYP)3A	C4

All statins are substrate of organic anion transporter polypeptide 1B1 , an uptake transporter expressed in hepatocyte membrane that may also explain some drug - drug interactions .
【GOLD_E】
organicaniontransporterpolypeptide1B1	geneY
【PRE_E】
organicaniontransporterpolypeptide1B1	geneY
uptaketransporter	geneN
【GOLD_R】
【PRE_R】

Many HIV - infected patients have dyslipidemia and comorbidities that may require statin treatment .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

HIV - protease inhibitors ( HIV PIs ) are part of recommended antiretroviral treatment in combination with two reverse transcriptase inhibitors .
【GOLD_E】
HIV-protease	geneN
reversetranscriptase	geneN
【PRE_E】
HIV-protease	geneN
【GOLD_R】
【PRE_R】

All HIV PIs except nelfinavir are coadministered with a low dose of ritonavir , a potent CYP3A inhibitor to improve their pharmacokinetic properties .
【GOLD_E】
nelfinavir	chem
CYP3A	geneN
ritonavir	chem
【PRE_E】
nelfinavir	chem
coadministered	chem
ritonavir	chem
CYP3A	geneN
【GOLD_R】
ritonavir	CYP3A	C4
【PRE_R】
nelfinavir	CYP3A	C4
coadministered	CYP3A	C4
ritonavir	CYP3A	C4

Cobicistat is a new potent CYP3A inhibitor that is combined with elvitegravir and will be combined with HIV - PIs in the future .
【GOLD_E】
CYP3A	geneN
【PRE_E】
Cobicistat	chem
CYP3A	geneN
elvitegravir	chem
【GOLD_R】
【PRE_R】
Cobicistat	CYP3A	C4
CYP3A	elvitegravir	C4

The HCV - PIs boceprevir and telaprevir are both , to different extents , inhibitors of CYP3A .
【GOLD_E】
CYP3A	geneN
boceprevir	chem
telaprevir	chem
【PRE_E】
HCV	geneN
boceprevir	chem
telaprevir	chem
CYP3A	geneN
【GOLD_R】
boceprevir	CYP3A	C4
telaprevir	CYP3A	C4
【PRE_R】
boceprevir	CYP3A	C4
telaprevir	CYP3A	C4

This review summarizes the pharmacokinetic properties of statins and PIs with emphasis on their metabolic pathways explaining clinically important drug - drug interactions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug - drug interaction with potent CYP3A inhibitors such as ritonavir - or cobicistat - boosted HIV - PI or the hepatitis C virus ( HCV ) PI , telaprevir or boceprevir , and therefore their coadministration is contraindicated .
【GOLD_E】
boceprevir	chem
CYP3A	geneN
CYP3A	geneN
Simvastatin	chem
lovastatin	chem
ritonavir	chem
cobicistat	chem
telaprevir	chem
【PRE_E】
Simvastatin	chem
lovastatin	chem
CYP3A	geneN
CYP3A	geneN
ritonavir	chem
cobicistat	chem
HIV-PI	chem
hepatitisCvirus(HCV)PI	geneY
telaprevir	chem
boceprevir	chem
【GOLD_R】
boceprevir	CYP3A	C4
ritonavir	CYP3A	C4
cobicistat	CYP3A	C4
telaprevir	CYP3A	C4
Simvastatin	CYP3A	C9
lovastatin	CYP3A	C9
【PRE_R】
Simvastatin	CYP3A	C4
lovastatin	CYP3A	C4
CYP3A	ritonavir	C4
CYP3A	cobicistat	C4
HIV-PI	hepatitisCvirus(HCV)PI	C4
hepatitisCvirus(HCV)PI	telaprevir	C4
hepatitisCvirus(HCV)PI	boceprevir	C4

Atorvastatin is also a CYP3A substrate , but less potent drug - drug interactions have been reported with CYP3A inhibitors .
【GOLD_E】
Atorvastatin	chem
CYP3A	geneN
CYP3A	geneN
【PRE_E】
Atorvastatin	chem
CYP3A	geneN
CYP3A	geneN
【GOLD_R】
Atorvastatin	CYP3A	C9
【PRE_R】
Atorvastatin	CYP3A	C4
Atorvastatin	CYP3A	C4

Non - CYP3A - dependent statin concentrations are also affected although to a lesser extent when coadministered with HIV or HCV PIs , mainly through interaction with OATP1B1 , and treatment should start with the lowest available statin dose .
【GOLD_E】
CYP3A	geneN
OATP1B1	geneY
【PRE_E】
CYP3A	geneN
HCV	geneN
OATP1B1	geneY
【GOLD_R】
【PRE_R】

Effectiveness and occurrence of adverse effects should be monitored at regular time intervals .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Synthesis , structure - activity relationships , and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase ( ALK ) inhibitor 5 - chloro - N2 - ( 2 - isopropoxy - 5 - methyl - 4 - ( piperidin - 4 - yl ) phenyl ) - N4 - ( 2 - ( isopropylsulf onyl ) phenyl ) pyrimidine - 2,4 - diamine ( LDK378 ) currently in phase 1 and phase 2 clinical trials .
【GOLD_E】
5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine	chem
LDK378	chem
anaplasticlymphomakinase	geneY
ALK	geneY
【PRE_E】
anaplasticlymphomakinase	geneY
ALK	geneY
5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine	chem
LDK378	chem
【GOLD_R】
【PRE_R】
anaplasticlymphomakinase	5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine	C4
ALK	5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine	C4
ALK	LDK378	C4

The synthesis , preclinical profile , and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b ( LDK378 ) are described .
【GOLD_E】
LDK378	chem
anaplasticlymphomakinase	geneY
【PRE_E】
anaplasticlymphomakinase	geneY
15b	chem
LDK378	chem
【GOLD_R】
LDK378	anaplasticlymphomakinase	C4
【PRE_R】
anaplasticlymphomakinase	15b	C4
anaplasticlymphomakinase	LDK378	C4

In this initial report , preliminary structure - activity relationships ( SARs ) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation ALK inhibitor 4 ( TAE684 ) .
【GOLD_E】
TAE684	chem
ALK	geneY
【PRE_E】
ALK	geneY
TAE684	geneY
【GOLD_R】
TAE684	ALK	C4
【PRE_R】

Compound 15b is currently in phase 1 and phase 2 clinical trials with substantial antitumor activity being observed in ALK - positive cancer patients .
【GOLD_E】
ALK	geneY
【PRE_E】
ALK	geneY
【GOLD_R】
【PRE_R】

Benzodiazepines , but not beta carbolines , limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture .
【GOLD_E】
Benzodiazepines	chem
betacarbolines	chem
【PRE_E】
Benzodiazepines	chem
betacarbolines	chem
【GOLD_R】
【PRE_R】

Effects of benzodiazepines ( BDZs ) and beta carbolines ( beta CCs ) on sustained repetitive firing at high frequency ( SRF ) of action potentials of mouse spinal cord neurons in cell culture were examined using intracellular recording techniques .
【GOLD_E】
BDZs	chem
betacarbolines	chem
betaCCs	chem
benzodiazepines	chem
【PRE_E】
benzodiazepines	chem
BDZs	chem
betacarbolines	chem
betaCCs	geneY
【GOLD_R】
【PRE_R】

In control medium neurons responded to depolarizing current pulses with SRF .
【GOLD_E】
【PRE_E】
SRF	geneY
【GOLD_R】
【PRE_R】

Limitation of SRF was produced by the anticonvulsant BDZs ( diazepam , clonazepam , nitrazepam and lorazepam ) at low to mid nanomolar concentrations , by a convulsant BDZ which does not bind to high affinity BDZ receptors ( Ro 5 - 4864 ) at high nanomolar concentrations and by a BDZ receptor weak partial agonist ( Ro 15 - 1788 ) at micromolar concentrations .
【GOLD_E】
BDZs	chem
diazepam	chem
clonazepam	chem
nitrazepam	chem
lorazepam	chem
BDZ	chem
BDZ	chem
Ro5-4864	chem
BDZ	chem
Ro15-1788	chem
BDZreceptors	geneN
BDZreceptor	geneN
【PRE_E】
SRF	geneY
BDZs	chem
diazepam	chem
clonazepam	chem
nitrazepam	chem
lorazepam	chem
BDZ	chem
BDZreceptors	geneN
5-4864	chem
BDZreceptor	geneN
15-1788	chem
【GOLD_R】
Ro15-1788	BDZreceptor	C5
【PRE_R】
SRF	BDZs	C4
SRF	diazepam	C4
SRF	clonazepam	C4
SRF	nitrazepam	C4
SRF	lorazepam	C4
SRF	15-1788	C4

The limitation of SRF was accompanied by use - and voltage - dependent reduction of maximal rate of rise ( Vmax ) of sodium - dependent action potentials .
【GOLD_E】
sodium	chem
【PRE_E】
SRF	geneY
sodium	chem
【GOLD_R】
【PRE_R】

Partial agonist and inverse agonist beta CCs did not limit SRF at concentrations up to 200 nM .
【GOLD_E】
【PRE_E】
betaCCs	geneY
SRF	geneY
【GOLD_R】
【PRE_R】

The limitation of SRF by diazepam was not prevented by inverse or partial agonists at the BDZ receptor , including Ro 15 - 1788 and the beta CCs .
【GOLD_E】
BDZ	chem
diazepam	chem
BDZreceptor	geneN
Ro15-1788	chem
betaCCs	chem
【PRE_E】
SRF	geneY
diazepam	chem
BDZreceptor	geneN
15-1788	chem
betaCCs	geneY
【GOLD_R】
Ro15-1788	BDZreceptor	C5
betaCCs	BDZreceptor	C5
Ro15-1788	BDZreceptor	C5
betaCCs	BDZreceptor	C5
【PRE_R】

These findings suggest that limitation of SRF was produced by binding of BDZs , but not beta CCs , to voltage - dependent sodium channels and not to high affinity central BDZ receptors , and that BDZs limit SRF by slowing recovery of sodium channels from inactivation .
【GOLD_E】
sodium	chem
voltage-dependentsodiumchannels	geneN
BDZreceptors	geneN
sodiumchannels	geneN
BDZs	chem
betaCCs	chem
sodium	chem
BDZ	chem
BDZs	chem
【PRE_E】
SRF	geneY
BDZs	chem
betaCCs	geneY
voltage-dependentsodiumchannels	geneN
BDZreceptors	geneN
BDZs	chem
SRF	geneY
sodiumchannels	geneN
【GOLD_R】
BDZs	sodiumchannels	C3
【PRE_R】
BDZs	SRF	C4
BDZs	SRF	C4

We propose that the limitation of SRF may contribute to the efficacy of BDZs against generalized tonic - clonic seizures and status epilepticus .
【GOLD_E】
BDZs	chem
【PRE_E】
SRF	geneY
BDZs	chem
【GOLD_R】
【PRE_R】

Androgens directly stimulate proliferation of bone cells in vitro .
【GOLD_E】
Androgens	chem
【PRE_E】
Androgens	chem
【GOLD_R】
【PRE_R】

This report describes the first observation of a direct mitogenic effect of androgens on isolated osteoblastic cells in serum - free culture .
【GOLD_E】
androgens	chem
【PRE_E】
androgens	chem
【GOLD_R】
【PRE_R】

[ 3H ] thymidine incorporation into DNA and cell counts were used as measures of cell proliferation .
【GOLD_E】
[3H]thymidine	chem
【PRE_E】
[3H]thymidine	chem
【GOLD_R】
【PRE_R】

The percentage of cells that stained for alkaline phosphatase was used as a measure of differentiation .
【GOLD_E】
alkalinephosphatase	geneN
【PRE_E】
alkalinephosphatase	geneN
【GOLD_R】
【PRE_R】

Dihydrotestosterone ( DHT ) enhanced mouse osteoblastic cell proliferation in a dose dependent manner over a wide range of doses ( 10 ( - 8 ) to 10 ( - 11 ) molar ) , and was maximally active at 10 ( - 9 ) M .
【GOLD_E】
Dihydrotestosterone	chem
DHT	chem
【PRE_E】
Dihydrotestosterone	chem
DHT	chem
【GOLD_R】
【PRE_R】

DHT also stimulated proliferation in human osteoblast cell cultures and in cultures of the human osteosarcoma cell line , TE89 .
【GOLD_E】
DHT	chem
【PRE_E】
DHT	chem
【GOLD_R】
【PRE_R】

Testosterone , fluoxymesterone ( a synthetic androgenic steroid ) and methenolone ( an anabolic steroid ) were also mitogenic in the mouse bone cell system .
【GOLD_E】
steroid	chem
methenolone	chem
steroid	chem
Testosterone	chem
fluoxymesterone	chem
【PRE_E】
Testosterone	chem
fluoxymesterone	chem
steroid	chem
methenolone	chem
steroid	chem
【GOLD_R】
【PRE_R】

The mitogenic effect of DHT on bone cells was inhibited by antiandrogens ( hydroxyflutamide and cyproterone acetate ) which compete for binding to the androgen receptor .
【GOLD_E】
DHT	chem
hydroxyflutamide	chem
cyproteroneacetate	chem
androgen	chem
androgenreceptor	geneN
【PRE_E】
DHT	chem
antiandrogens	chem
hydroxyflutamide	chem
cyproteroneacetate	chem
androgenreceptor	geneY
【GOLD_R】
【PRE_R】

In addition to effects on cell proliferation , DHT increased the percentage of alkaline phosphatase ( ALP ) positive cells in all three bone cell systems tested , and this effect was inhibited by antiandrogens .
【GOLD_E】
alkalinephosphatase	geneN
DHT	chem
ALP	geneN
【PRE_E】
DHT	chem
alkalinephosphatase	geneN
ALP	geneN
antiandrogens	chem
【GOLD_R】
DHT	alkalinephosphatase	C3
DHT	ALP	C3
【PRE_R】
ALP	antiandrogens	C4

We conclude that androgens can stimulate human and murine osteoblastic cell proliferation in vitro , and induce expression of the osteoblast - line differentiation marker ALP , presumably by an androgen receptor mediated mechanism .
【GOLD_E】
osteoblast-linedifferentiationmarker	geneN
ALP	geneN
androgenreceptor	geneN
androgens	chem
androgen	chem
【PRE_E】
androgens	chem
ALP	geneN
androgenreceptor	geneY
【GOLD_R】
androgens	osteoblast-linedifferentiationmarker	C3
androgens	ALP	C3
【PRE_R】

The effect of histamine - H1 receptor antagonism with terfenadine on concentration - related AMP - induced bronchoconstriction in asthma .
【GOLD_E】
histamine	chem
terfenadine	chem
AMP	chem
histamine-H1receptor	geneY
【PRE_E】
histamine-H1receptor	geneY
terfenadine	chem
AMP	chem
【GOLD_R】
terfenadine	histamine-H1receptor	C6
【PRE_R】

Selective histamine - H1 receptor antagonists inhibit adenosine 5 ' - monophosphate ( AMP ) - induced bronchoconstriction by greater than 80 % when expressed as a percentage inhibition of the FEV1 time - response curve following inhalation of the provocation concentration of AMP required to produce a 20 % decrease in FEV1 from baseline ( PC20 ) .
【GOLD_E】
histamine-H1receptor	geneY
histamine	chem
AMP	chem
adenosine5'-monophosphate	chem
AMP	chem
【PRE_E】
histamine-H1receptor	geneY
adenosine5'-monophosphate	chem
AMP	chem
AMP	chem
【GOLD_R】
【PRE_R】

To investigate this further we have determined that , in eight mild atopic asthmatic subjects , terfenadine ( 180 mg ) , administered 3 hr pre - challenge , increases the geometric mean PC20 for histamine from 0.4 ( range 0.03 - 3 ) mg / ml after placebo , to 20.2 ( range 0.6 - 64 ) mg / ml following active treatment ( P less than 0.0001 ) .
【GOLD_E】
terfenadine	chem
histamine	chem
【PRE_E】
terfenadine	chem
PC20	chem
histamine	chem
【GOLD_R】
【PRE_R】

For AMP , the PC20 increased from 9.3 ( range 1.0 - 113.3 ) mg / ml after placebo , to 150.2 ( range 32.1 - 1177.7 ) mg / ml with terfenadine ( P less than 0.0001 ) .
【GOLD_E】
AMP	chem
terfenadine	chem
【PRE_E】
AMP	chem
PC20	chem
terfenadine	chem
【GOLD_R】
【PRE_R】

This 16.2 - fold ( range , 5.5 - 47.9 ) displacement to the right of the AMP concentration - response curve by a selective histamine - H1 receptor antagonist emphasizes the central role of histamine in the airways response to this nucleotide .
【GOLD_E】
histamine	chem
histamine	chem
histamine-H1receptor	geneY
AMP	chem
【PRE_E】
AMP	chem
histamine-H1receptor	geneY
histamine	chem
nucleotide	chem
【GOLD_R】
【PRE_R】

Ibrutinib : a review of its use in patients with mantle cell lymphoma or chronic lymphocytic leukaemia .
【GOLD_E】
Ibrutinib	chem
【PRE_E】
Ibrutinib	chem
【GOLD_R】
【PRE_R】

Ibrutinib ( Imbruvica ( R ) ) is a first - in - class , potent , orally administered , covalent inhibitor of Bruton 's tyrosine kinase ( BTK ) that inhibits B - cell antigen receptor signalling downstream of BTK .
【GOLD_E】
BTK	geneY
B-cellantigenreceptor	geneN
BTK	geneY
Bruton'styrosinekinase	geneY
Ibrutinib	chem
tyrosine	chem
Imbruvica(R)	chem
【PRE_E】
Ibrutinib	chem
Imbruvica	chem
Bruton'styrosinekinase	geneY
BTK	geneN
B-cellantigenreceptor	geneN
BTK	geneY
【GOLD_R】
Ibrutinib	B-cellantigenreceptor	C4
Imbruvica(R)	B-cellantigenreceptor	C4
Ibrutinib	BTK	C4
Ibrutinib	BTK	C4
Ibrutinib	Bruton'styrosinekinase	C4
Imbruvica(R)	BTK	C4
Imbruvica(R)	Bruton'styrosinekinase	C4
【PRE_R】
Ibrutinib	Bruton'styrosinekinase	C4
Imbruvica	Bruton'styrosinekinase	C4
Imbruvica	BTK	C4
Imbruvica	B-cellantigenreceptor	C4
Imbruvica	BTK	C4

Oral ibrutinib is indicated for the treatment of patients with relapsed / refractory mantle cell lymphoma ( MCL ) or chronic lymphocytic leukaemia ( CLL ) and for the treatment of patients with CLL and a chromosome 17 deletion ( del 17p ) or TP53 mutation .
【GOLD_E】
TP53	geneY
ibrutinib	chem
【PRE_E】
ibrutinib	chem
TP53	geneY
【GOLD_R】
【PRE_R】

This article summarizes pharmacological , efficacy and tolerability data relevant to the use of ibrutinib in these indications .
【GOLD_E】
ibrutinib	chem
【PRE_E】
ibrutinib	chem
【GOLD_R】
【PRE_R】

In clinical studies , ibrutinib induced a high overall response rate in patients with relapsed / refractory MCL ( phase II study ) .
【GOLD_E】
ibrutinib	chem
【PRE_E】
ibrutinib	chem
MCL	geneY
【GOLD_R】
【PRE_R】

In addition , ibrutinib significantly prolonged progression - free survival and significantly improved the partial response rate and overall survival in patients with relapsed / refractory CLL ( RESONATE study ) , including in those with del 17p , a subgroup with a poor prognosis .
【GOLD_E】
ibrutinib	chem
【PRE_E】
ibrutinib	chem
【GOLD_R】
【PRE_R】

Ibrutinib had an acceptable tolerability profile in these studies with < 10 % of patients discontinuing treatment because of adverse events .
【GOLD_E】
Ibrutinib	chem
【PRE_E】
Ibrutinib	chem
【GOLD_R】
【PRE_R】

Given its efficacy and tolerability , once - daily , oral ibrutinib is an emerging treatment option for patients with relapsed / refractory MCL or CLL and CLL patients with del 17p or TP53 mutation .
【GOLD_E】
TP53	geneY
ibrutinib	chem
【PRE_E】
ibrutinib	chem
MCL	geneY
CLL	geneY
CLL	geneY
del17p	geneY
TP53	geneY
【GOLD_R】
【PRE_R】
ibrutinib	MCL	C4
ibrutinib	CLL	C4
ibrutinib	CLL	C4
ibrutinib	del17p	C4
ibrutinib	TP53	C4

Effects of beta - adrenoceptor antagonist administration on beta 2 - adrenoceptor density in human lymphocytes . The role of the `` intrinsic sympathomimetic activity `` .
【GOLD_E】
beta-adrenoceptor	geneN
beta2-adrenoceptor	geneY
【PRE_E】
beta-adrenoceptor	geneY
beta2-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

Abrupt withdrawal of beta - adrenoceptor antagonists may lead to `` rebound - effects `` .
【GOLD_E】
beta-adrenoceptor	geneN
【PRE_E】
beta-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

To study the mechanism underlying this phenomenon , the effects of the nonselective beta - adrenoceptor antagonists propranolol [ no intrinsic sympathomimetic activity ( ISA ) ] , alprenolol ( weak ISA ) and mepindolol ( strong ISA ) on lymphocyte beta 2 - adrenoceptor density - - assessed by ( + / - ) - [ 125I ] - iodocyanopindolol ( ICYP ) binding - - and plasma renin activity ( PRA ) were investigated in male healthy volunteers aged 23 - 35 years .
【GOLD_E】
beta-adrenoceptor	geneN
beta2-adrenoceptor	geneY
renin	geneY
propranolol	chem
alprenolol	chem
mepindolol	chem
(+/-)-[125I]-iodocyanopindolol	chem
ICYP	chem
【PRE_E】
beta-adrenoceptor	geneN
propranolol	chem
alprenolol	chem
ISA	chem
mepindolol	chem
ISA	chem
lymphocytebeta2-adrenoceptor	geneY
(+/-)-[125I]-iodocyanopindolol	chem
ICYP	chem
renin	geneY
【GOLD_R】
propranolol	beta-adrenoceptor	C6
alprenolol	beta-adrenoceptor	C6
mepindolol	beta-adrenoceptor	C6
【PRE_R】
beta-adrenoceptor	alprenolol	C6
beta-adrenoceptor	ISA	C6
mepindolol	lymphocytebeta2-adrenoceptor	C6
ISA	lymphocytebeta2-adrenoceptor	C6

Propranolol treatment ( 4 X 40 mg / day ) increased the density of beta 2 - adrenoceptors by 25 % after 2 days ; concomitantly PRA and heart rate were reduced .
【GOLD_E】
Propranolol	chem
beta2-adrenoceptors	geneY
【PRE_E】
Propranolol	chem
beta2-adrenoceptors	geneY
【GOLD_R】
Propranolol	beta2-adrenoceptors	C3
【PRE_R】

During treatment beta 2 - adrenoceptor density remained elevated .
【GOLD_E】
beta2-adrenoceptor	geneY
【PRE_E】
beta2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

After withdrawal of propranolol PRA reached pre - drug levels rapidly , while heart rate was significantly enhanced .
【GOLD_E】
propranolol	chem
【PRE_E】
propranolol	chem
【GOLD_R】
【PRE_R】

Beta 2 - Adrenoceptor density , however , declined slowly being still significantly increased after 3 days , although propranolol was not detectable in plasma after 24 h .
【GOLD_E】
propranolol	chem
Beta2-Adrenoceptor	geneY
【PRE_E】
Beta2-Adrenoceptor	geneY
propranolol	chem
【GOLD_R】
【PRE_R】

The affinity of ICYP to beta 2 - adrenoceptors was not changed during or after treatment .
【GOLD_E】
beta2-adrenoceptors	geneY
ICYP	chem
【PRE_E】
ICYP	geneY
beta2-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

Mepindolol treatment ( 2 X 5 mg / day ) caused a 30 % decrease of beta 2 - adrenoceptor density and PRA after 2 days ; both parameters remained reduced during treatment .
【GOLD_E】
beta2-adrenoceptor	geneY
Mepindolol	chem
【PRE_E】
Mepindolol	chem
beta2-adrenoceptor	geneY
【GOLD_R】
Mepindolol	beta2-adrenoceptor	C4
【PRE_R】
Mepindolol	beta2-adrenoceptor	C4

After withdrawal , PRA reached rapidly pre - drug levels , whereas beta 2 - adrenoceptor density was still after 4 days significantly diminished .
【GOLD_E】
beta2-adrenoceptor	geneY
【PRE_E】
beta2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

The KD - values for ICYP , however , were not changed .
【GOLD_E】
ICYP	chem
【PRE_E】
ICYP	geneY
【GOLD_R】
【PRE_R】

During and after treatment heart rate was not affected .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Alprenolol treatment ( 4 X 100 mg / day ) led to a rapid fall in PRA , but did not significantly affect beta 2 - adrenoceptor density .
【GOLD_E】
beta2-adrenoceptor	geneY
Alprenolol	chem
【PRE_E】
Alprenolol	chem
beta2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

It is concluded , that the ISA may play an important role in modulating beta 2 - adrenoceptor density and hence tissue responsiveness to beta - adrenoceptor stimulation . ( ABSTRACT TRUNCATED AT 250 WORDS )
【GOLD_E】
beta2-adrenoceptor	geneY
beta-adrenoceptor	geneN
【PRE_E】
ISA	chem
beta2-adrenoceptor	geneN
beta-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Inhibition of 5 - lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5 - aminosalicylic acid .
【GOLD_E】
5-aminosalicylicacid	chem
arachidonicacid	chem
sulfasalazine	chem
5-lipoxygenase	geneY
【PRE_E】
5-lipoxygenase	geneY
arachidonicacid	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【GOLD_R】
5-aminosalicylicacid	5-lipoxygenase	C4
sulfasalazine	5-lipoxygenase	C4
arachidonicacid	5-lipoxygenase	C9
【PRE_R】
5-lipoxygenase	5-aminosalicylicacid	C4

The possible effect of sulfasalazine , 5 - aminosalicylic acid , and acetyl - 5 - aminosalicylic acid on endogenous arachidonic acid release and metabolism was studied in human polymorphonuclear leukocytes ( PMNs ) .
【GOLD_E】
acetyl-5-aminosalicylicacid	chem
arachidonicacid	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【PRE_E】
sulfasalazine	chem
5-aminosalicylicacid	chem
acetyl-5-aminosalicylicacid	chem
arachidonicacid	chem
【GOLD_R】
【PRE_R】

A new in vitro assay was used by which [ 1 - 14C ] arachidonic acid is incorporated by purified peripheral PMNs until steady state was obtained ( 5 hr ) .
【GOLD_E】
[1-14C]arachidonicacid	chem
【PRE_E】
[1-14C]arachidonicacid	chem
【GOLD_R】
【PRE_R】

After preincubation with the test drugs prior to activation with calcium ionophore A23187 , the released eicosanoids were isolated by extraction and thin - layer chromatography ( TLC ) and quantitated by autoradiography and laser densitometry .
【GOLD_E】
calciumionophoreA23187	chem
eicosanoids	chem
【PRE_E】
calcium	chem
A23187	chem
eicosanoids	chem
【GOLD_R】
【PRE_R】

Median drug concentrations needed for 50 % inhibition of leukotriene B4 and 5 - hydroxyeicosatetraenoic acid ( 5 - HETE ) release was 4 - 5 mM ( range 1 - 9 mM ) for both sulfasalazine and 5 - aminosalicylic acid .
【GOLD_E】
leukotrieneB4	chem
5-hydroxyeicosatetraenoicacid	chem
5-HETE	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【PRE_E】
leukotrieneB4	chem
5-hydroxyeicosatetraenoicacid	chem
5-HETE	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【GOLD_R】
【PRE_R】

The acetylated derivative of 5 - aminosalicylic acid was ineffective .
【GOLD_E】
acetylatedderivativeof5-aminosalicylicacid	chem
【PRE_E】
5-aminosalicylicacid	chem
【GOLD_R】
【PRE_R】

The present data suggest that inhibition of arachidonic acid lipoxygenation may be an essential action of sulfasalazine and its active metabolite , 5 - aminosalicylic acid .
【GOLD_E】
arachidonicacid	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【PRE_E】
arachidonicacidlipoxygenation	chem
sulfasalazine	chem
5-aminosalicylicacid	chem
【GOLD_R】
【PRE_R】

Interference with lipoxygenase enzymes , rather than a steroid - like inhibition of arachidonic acid release from intracellular phospholipids , seems to be the mode of action .
【GOLD_E】
lipoxygenase	geneN
steroid	chem
arachidonicacid	chem
【PRE_E】
lipoxygenase	geneN
steroid	chem
arachidonicacid	chem
【GOLD_R】
steroid	lipoxygenase	C4
arachidonicacid	lipoxygenase	C9
【PRE_R】

Bevantolol : a beta - 1 adrenoceptor antagonist with unique additional actions .
【GOLD_E】
beta-1adrenoceptor	geneY
Bevantolol	chem
【PRE_E】
Bevantolol	chem
beta-1adrenoceptor	geneY
【GOLD_R】
Bevantolol	beta-1adrenoceptor	C6
【PRE_R】
Bevantolol	beta-1adrenoceptor	C6

UNLABELLED : Bevantolol is a beta - 1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension .
【GOLD_E】
beta-1adrenoceptor	geneY
Bevantolol	chem
【PRE_E】
Bevantolol	chem
beta-1adrenoceptor	geneY
【GOLD_R】
Bevantolol	beta-1adrenoceptor	C6
【PRE_R】
Bevantolol	beta-1adrenoceptor	C6

Some interesting additional properties , such as the absence of the side effect of cold extremities , required investigation , and a great deal of new evidence has been accumulated during the last three years .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This new data is consistent with the proposal put forward a couple of years ago that bevantolol interacts with alpha - adrenoceptors .
【GOLD_E】
alpha-adrenoceptors	geneN
【PRE_E】
bevantolol	chem
alpha-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

All the available evidence , published and unpublished , has been reviewed and fits into a coherent pattern , here arranged into five sections .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Chemistry : affinity for alpha - adrenoceptors .
【GOLD_E】
alpha-adrenoceptors	geneN
【PRE_E】
alpha-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

Animal experiments confirm both agonist and antagonist effects on alpha - receptors , in addition to antagonist activity at beta - 1 receptors .
【GOLD_E】
beta-1receptors	geneN
【PRE_E】
alpha-receptors	geneN
beta-1receptors	geneN
【GOLD_R】
【PRE_R】

In addition , bevantolol has electrophysiologic effects , including bradycardia by a direct action on the sinus node and a class 1 antiarrhythmic action .
【GOLD_E】
bevantolol	chem
【PRE_E】
bevantolol	chem
【GOLD_R】
【PRE_R】

Investigations in humans have shown that although bevantolol has a short half - life , good control of hypertension can be achieved on once - a - day dosing .
【GOLD_E】
bevantolol	chem
【PRE_E】
bevantolol	chem
【GOLD_R】
【PRE_R】

SAFETY : bevantolol has remarkably few side effects , does not cause cold extremities , and does not significantly affect glomerular filtration rate in patients with renal impairment .
【GOLD_E】
bevantolol	chem
【PRE_E】
bevantolol	chem
【GOLD_R】
【PRE_R】

Evidence has been obtained in man for interaction with alpha - adrenoceptors in the brain ; and in the peripheral circulation bevantolol does not , as do other beta blockers , increase peripheral vascular resistance , but reduces it .
【GOLD_E】
bevantolol	chem
alpha-adrenoceptors	geneN
【PRE_E】
alpha-adrenoceptors	geneN
bevantolol	chem
【GOLD_R】
【PRE_R】

It is suggested that all the additional actions of bevantolol can be attributed to a partial agonist action on alpha - adrenoceptors .
【GOLD_E】
bevantolol	chem
alpha-adrenoceptors	geneN
【PRE_E】
bevantolol	chem
alpha-adrenoceptors	geneN
【GOLD_R】
bevantolol	alpha-adrenoceptors	C5
【PRE_R】

Benzodiazepine receptor binding of triazolobenzodiazepines in vivo : increased receptor number with low - dose alprazolam .
【GOLD_E】
Benzodiazepine	chem
alprazolam	chem
triazolobenzodiazepines	chem
Benzodiazepinereceptor	geneN
【PRE_E】
Benzodiazepinereceptor	geneN
triazolobenzodiazepines	chem
alprazolam	chem
【GOLD_R】
【PRE_R】

Triazolobenzodiazepines are in clinical use as hypnotics and anxiolytics .
【GOLD_E】
Triazolobenzodiazepines	chem
【PRE_E】
Triazolobenzodiazepines	chem
anxiolytics	chem
【GOLD_R】
【PRE_R】

We analyzed in vivo receptor binding and brain concentrations of alprazolam , triazolam , and estazolam .
【GOLD_E】
alprazolam	chem
triazolam	chem
estazolam	chem
【PRE_E】
alprazolam	chem
triazolam	chem
estazolam	chem
【GOLD_R】
【PRE_R】

Drug concentrations measured in the cerebral cortex 1 h after administration were directly proportional to dose for all three compounds .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In vivo receptor binding , as defined by the specific uptake of [ 3H ] Ro15 - 1788 , decreased with increasing doses of estazolam and triazolam , a finding indicating dose - related increases in receptor occupancy due to these compounds .
【GOLD_E】
estazolam	chem
triazolam	chem
[3H]Ro15-1788	chem
【PRE_E】
[3H]Ro15-1788	chem
estazolam	chem
triazolam	chem
【GOLD_R】
【PRE_R】

Triazolam was substantially more potent , with an IC50 value of 16 ng / g , compared with 117 ng / g for estazolam .
【GOLD_E】
Triazolam	chem
estazolam	chem
【PRE_E】
Triazolam	chem
estazolam	chem
【GOLD_R】
【PRE_R】

At higher doses of alprazolam ( greater than 0.2 mg / kg ) , receptor binding by [ 3H ] Ro15 - 1788 , likewise decreased with increasing dose of the former drug .
【GOLD_E】
alprazolam	chem
[3H]Ro15-1788	chem
【PRE_E】
alprazolam	chem
[3H]Ro15-1788	chem
【GOLD_R】
【PRE_R】

However , at lower doses of alprazolam ( 0.02 - 0.05 mg / kg ) , which resulted in cortex concentrations of 2 - 7 ng / g , receptor binding was increased above control values in cortex , hypothalamus , and hippocampus but not in several other brain regions .
【GOLD_E】
alprazolam	chem
【PRE_E】
alprazolam	chem
【GOLD_R】
【PRE_R】

Binding returned to control values at doses of greater than or equal to 0.01 mg / kg .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Similar results were obtained in time course studies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

At 8 and 10 h after a dose of 1 mg / kg i.p . , corresponding to cortex concentrations of 2.7 - 7 ng / g , receptor binding was increased compared with controls .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Similarly , at 1 , 2 , and 3 h after a single dose of 0.05 mg / kg , corresponding to cortex concentrations of 3.7 - 5.8 ng / g , receptor binding was also increased .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The apparent affinity of benzodiazepine receptors for clonazepam in mice receiving alprazolam ( 0.05 mg / kg ) was unchanged from that in untreated control mice , an observation suggesting that low doses of alprazolam increased receptor number . ( ABSTRACT TRUNCATED AT 250 WORDS )
【GOLD_E】
benzodiazepinereceptors	geneN
benzodiazepine	chem
clonazepam	chem
alprazolam	chem
alprazolam	chem
【PRE_E】
benzodiazepinereceptors	geneN
clonazepam	chem
alprazolam	chem
alprazolam	chem
【GOLD_R】
alprazolam	benzodiazepinereceptors	C3
【PRE_R】

Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites .
【GOLD_E】
histamine	chem
phenothiazine	chem
histamineH1receptor	geneY
【PRE_E】
histamineH1receptor	geneY
phenothiazine	chem
【GOLD_R】
【PRE_R】

In vitro binding affinities of chlorpromazine , fluphenazine , levomepromazine , perphenazine and some of their metabolites for dopamine D2 receptors , alpha 1 - and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories .
【GOLD_E】
fluphenazine	chem
levomepromazine	chem
perphenazine	chem
dopamineD2receptors	geneY
alpha1-andalpha2adrenoceptors	geneN
dopamine	chem
chlorpromazine	chem
【PRE_E】
chlorpromazine	chem
fluphenazine	chem
levomepromazine	chem
perphenazine	chem
dopamineD2receptors	geneY
alpha1-andalpha2adrenoceptors	geneN
【GOLD_R】
【PRE_R】

The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain , using 3H - quinuclidinyl benzilate and 3H - mepyramine as radioligands .
【GOLD_E】
muscariniccholinergicreceptors	geneN
histamineH1receptors	geneY
histamine	chem
3H-quinuclidinylbenzilate	chem
3H-mepyramine	chem
【PRE_E】
muscariniccholinergicreceptors	geneN
histamineH1receptors	geneY
3H-quinuclidinylbenzilate	chem
3H-mepyramine	chem
【GOLD_R】
【PRE_R】

Chlorpromazine , levomepromazine , and their metabolites had 5 - 30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine , perphenazine and their metabolites .
【GOLD_E】
levomepromazine	chem
fluphenazine	chem
perphenazine	chem
muscariniccholinergicreceptors	geneN
Chlorpromazine	chem
【PRE_E】
Chlorpromazine	chem
levomepromazine	chem
muscariniccholinergicreceptors	geneN
fluphenazine	chem
perphenazine	chem
【GOLD_R】
【PRE_R】

Levomepromazine was the most potent and fluphenazine the least potent of the four drugs in histamine H1 receptor binding .
【GOLD_E】
Levomepromazine	chem
fluphenazine	chem
histamine	chem
histamineH1receptor	geneY
【PRE_E】
Levomepromazine	chem
fluphenazine	chem
histamineH1receptor	geneY
【GOLD_R】
【PRE_R】

7 - Hydroxy levomepromazine , 3 - hydroxy levomepromazine and 7 - hydroxy fluphenazine had only 10 % of the potency of the parent drug in histamine H1 receptor binding , while the 7 - hydroxy - metabolites of chlorpromazine and perphenazine had about 75 % of the potency of the parent drug in this binding system .
【GOLD_E】
7-Hydroxylevomepromazine	chem
3-hydroxylevomepromazine	chem
7-hydroxyfluphenazine	chem
histamine	chem
7-hydroxy	chem
chlorpromazine	chem
perphenazine	chem
histamineH1receptor	geneY
【PRE_E】
7-Hydroxylevomepromazine	chem
3-hydroxylevomepromazine	chem
7-hydroxyfluphenazine	chem
histamineH1receptor	geneY
7-hydroxy	chem
chlorpromazine	chem
perphenazine	chem
【GOLD_R】
【PRE_R】

Their histamine H1 receptor binding affinities indicate that metabolites may contribute to the sedative effects of chlorpromazine and levomepromazine .
【GOLD_E】
histamine	chem
histamineH1receptor	geneY
chlorpromazine	chem
levomepromazine	chem
【PRE_E】
histamineH1receptor	geneY
chlorpromazine	chem
levomepromazine	chem
【GOLD_R】
【PRE_R】

Retinoid - induced hemorrhaging and bone toxicity in rats fed diets deficient in vitamin K .
【GOLD_E】
Retinoid	chem
vitaminK	chem
【PRE_E】
Retinoid	chem
vitaminK	chem
【GOLD_R】
【PRE_R】

The recent increase in the clinical use of synthetic vitamin A compounds has led to concern of possible side effects .
【GOLD_E】
vitaminA	chem
【PRE_E】
vitaminA	chem
【GOLD_R】
【PRE_R】

Some of these effects are known to be influenced by dietary levels of vitamin K .
【GOLD_E】
vitaminK	chem
【PRE_E】
vitaminK	chem
【GOLD_R】
【PRE_R】

We therefore compared the toxic effects of 13 - cis - retinoic acid ( 13cisRA ) , retinyl acetate ( ROAc ) , and N - ( 4 - hydroxyphenyl ) retinamide ( 4HPR ) in male Sprague - Dawley rats maintained on diets containing different levels of vitamin K .
【GOLD_E】
13-cis-retinoicacid	chem
13cisRA	chem
retinylacetate	chem
ROAc	chem
N-(4-hydroxyphenyl)retinamide	chem
4HPR	chem
vitaminK	chem
【PRE_E】
13-cis-retinoicacid	chem
13cisRA	chem
retinylacetate	chem
ROAc	chem
N-(4-hydroxyphenyl)retinamide	chem
4HPR	chem
vitaminK	chem
【GOLD_R】
【PRE_R】

Animals were fed either an NIH - 07 diet supplemented with menadione ( 3.1 ppm vitamin K3 ) , an NIH - 07 diet not supplemented with menadione , or an AIN - 076 purified diet devoid of vitamin K .
【GOLD_E】
menadione	chem
vitaminK3	chem
menadione	chem
vitaminK	chem
【PRE_E】
menadione	chem
vitaminK3	chem
menadione	chem
AIN-076	chem
vitaminK	chem
【GOLD_R】
【PRE_R】

The retinoids had no effect on prothrombin times of animals fed the supplemented diet .
【GOLD_E】
retinoids	chem
prothrombin	geneY
【PRE_E】
retinoids	chem
prothrombin	geneY
【GOLD_R】
【PRE_R】

When menadione was omitted from the diet , however , 4HPR - dosed animals had elevated prothrombin times .
【GOLD_E】
menadione	chem
4HPR	chem
prothrombin	geneY
【PRE_E】
menadione	chem
4HPR	chem
prothrombin	geneY
【GOLD_R】
4HPR	prothrombin	C3
【PRE_R】

This effect was observed as early as Day 7 and was accompanied by one confirmed hemorrhagic death .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

13cisRA - dosed animals showed no change in prothrombin times .
【GOLD_E】
13cisRA	chem
prothrombin	geneY
【PRE_E】
13cisRA	chem
prothrombin	geneY
【GOLD_R】
【PRE_R】

In the high - dose ROAc group , there was a twofold increase in prothrombin times but only after prolonged dosing .
【GOLD_E】
ROAc	chem
prothrombin	geneY
【PRE_E】
prothrombin	geneY
【GOLD_R】
ROAc	prothrombin	C3
【PRE_R】

In animals fed the NIH - 07 diets , 13cisRA and ROAc induced multiple bone fractures at all dose levels .
【GOLD_E】
13cisRA	chem
ROAc	chem
【PRE_E】
13cisRA	chem
ROAc	chem
【GOLD_R】
【PRE_R】

In contrast , 4HPR administered at the highest dose induced only one fracture in one animal .
【GOLD_E】
4HPR	chem
【PRE_E】
4HPR	chem
【GOLD_R】
【PRE_R】

Animals fed the purified diet lost weight faster and diet sooner than those maintained on the other diets .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Bone fractures were not observed in these animals because of early deaths resulting from hemorrhaging .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

For all retinoid - dosed groups maintained on the purified diet , changes in prothrombin times occured as early as 1 week .
【GOLD_E】
prothrombin	geneY
retinoid	chem
【PRE_E】
retinoid	chem
prothrombin	geneY
【GOLD_R】
【PRE_R】

The order of effect was 4HPR greater than ROAc greater than 13cisRA , with increases in prothrombin times correlating with increases in hemorrhagic deaths .
【GOLD_E】
prothrombin	geneY
4HPR	chem
ROAc	chem
13cisRA	chem
【PRE_E】
4HPR	chem
ROAc	geneY
13cisRA	chem
prothrombin	geneY
【GOLD_R】
4HPR	prothrombin	C3
ROAc	prothrombin	C3
13cisRA	prothrombin	C3
【PRE_R】

Hence , the degree of retinoid - induced hemorrhage , but not the incidence of bone fractures , was inversely related to vitamin K levels in the diet .
【GOLD_E】
retinoid	chem
vitaminK	chem
【PRE_E】
retinoid	chem
vitaminK	chem
【GOLD_R】
【PRE_R】

13cisRA and ROAc , but not 4HPR , caused a dose - dependent reduction in plasma osteocalcin , an effect that correlated with retinoid - induced bone effects .
【GOLD_E】
13cisRA	chem
ROAc	chem
4HPR	chem
retinoid	chem
osteocalcin	geneY
【PRE_E】
13cisRA	chem
ROAc	chem
4HPR	chem
osteocalcin	geneY
retinoid	chem
【GOLD_R】
13cisRA	osteocalcin	C4
ROAc	osteocalcin	C4
4HPR	osteocalcin	C4
【PRE_R】
13cisRA	osteocalcin	C3
ROAc	osteocalcin	C3
4HPR	osteocalcin	C3

In contrast , serum alkaline phosphatase was elevated in animals dosed with 13cisRA or 4HPR but not in those dose with ROAc .
【GOLD_E】
13cisRA	chem
4HPR	chem
ROAc	chem
alkalinephosphatase	geneN
【PRE_E】
alkalinephosphatase	geneN
13cisRA	chem
4HPR	chem
【GOLD_R】
13cisRA	alkalinephosphatase	C3
4HPR	alkalinephosphatase	C3
【PRE_R】

For this enzyme , the electrophoretic pattern on agarose gel showed a decrease , compared to controls , in the major isozyme in serum of ROAc - dosed animals .
【GOLD_E】
ROAc	chem
【PRE_E】
ROAc	geneY
【GOLD_R】
【PRE_R】

Hence , plasma osteocalcin is a better predictor of retinoid - induced bone effects than serum alkaline phosphatase .
【GOLD_E】
retinoid	chem
osteocalcin	geneY
alkalinephosphatase	geneN
【PRE_E】
osteocalcin	geneY
retinoid	chem
alkalinephosphatase	geneN
【GOLD_R】
【PRE_R】

Multiple affinity states of opiate receptor in neuroblastoma x glioma NG108 - 15 hybrid cells . Opiate agonist association rate is a function of receptor occupancy .
【GOLD_E】
opiatereceptor	geneN
【PRE_E】
【GOLD_R】
【PRE_R】

The existence of multiple affinity states for the opiate receptor in neuroblastoma x glioma NG108 - 15 hybrid cells has been demonstrated by competition binding studies with tritiated diprenorphine and [ D - Ala2 , D - Leu5 ] enkephalin ( DADLE ) .
【GOLD_E】
[D-Ala2,D-Leu5]enkephalin	chem
DADLE	chem
enkephalin	geneN
tritiateddiprenorphine	chem
【PRE_E】
tritiateddiprenorphine	chem
[D-Ala2	chem
D-Leu5]enkephalin	chem
DADLE	chem
【GOLD_R】
【PRE_R】

In the presence of 10 mM Mg2 + , all receptors exist in a high affinity state with Kd = 1.88 + / - 0.16 nM .
【GOLD_E】
Mg2+	chem
【PRE_E】
Mg2+,allreceptors	geneN
【GOLD_R】
【PRE_R】

Addition of 10 microM guanyl - 5 ' - yl imidodiphosphate ( Gpp ( NH ) p ) decreased the affinity of DADLE to Kd = 8.08 + / - 0.93 nM .
【GOLD_E】
guanyl-5'-ylimidodiphosphate	chem
Gpp(NH)p	chem
DADLE	chem
【PRE_E】
guanyl-5'-ylimidodiphosphate	chem
Gpp(NH)p	chem
DADLE	chem
【GOLD_R】
【PRE_R】

However , in the presence of 100 mM Na + , which is required for opiate inhibition of adenylate cyclase activity , analysis of competition binding data revealed three sites : the first , consisting of 17.5 % of total receptor population has a Kd = 0.38 + / - 0.18 nM ; the second , 50.6 % of the population , has a Kd = 6.8 + / - 2.2 nM ; and the third , 31.9 % of the population , has a Kd of 410 + / - 110 nM .
【GOLD_E】
Na+	chem
adenylate	chem
adenylatecyclase	geneN
【PRE_E】
Na+	chem
adenylatecyclase	geneN
【GOLD_R】
Na+	adenylatecyclase	C4
【PRE_R】

Thus , in the presence of sodium , a high affinity complex between receptor ( R ) , GTP binding component ( Ni ) , and ligand ( L ) was formed which was different from that formed in the absence of sodium .
【GOLD_E】
sodium	chem
sodium	chem
GTP	chem
【PRE_E】
sodium	chem
receptor(R)	geneN
GTP	chem
Ni	chem
sodium	chem
【GOLD_R】
【PRE_R】

These multiple affinity states of receptor in the hybrid cells are agonist - specific , and the percentage of total opiate receptor in high affinity state is relatively constant in various concentrations of Na + .
【GOLD_E】
opiatereceptor	geneN
Na+	chem
【PRE_E】
Na+	chem
【GOLD_R】
【PRE_R】

Multiple affinity states of opiate receptor can be demonstrated further by Scatchard analysis of saturation binding studies with [ 3H ] DADLE .
【GOLD_E】
opiatereceptor	geneN
[3H]DADLE	chem
【PRE_E】
[3H]DADLE	chem
【GOLD_R】
【PRE_R】

In the presence of Mg2 + , or Gpp ( NH ) p , analysis of [ 3H ] DADLE binding demonstrates that opiate receptor can exist in a single affinity state , with apparent Kd values of [ 3H ] DADLE in 10 mM Mg2 + = 1.75 + / - 0.28 nM and in 10 microM Gpp ( NH ) p = 0.85 + / - 0.12 nM .
【GOLD_E】
Mg2+	chem
Gpp(NH)p	chem
[3H]DADLE	chem
[3H]DADLE	chem
Gpp(NH)p	chem
【PRE_E】
Mg2+	chem
Gpp(NH)p	chem
[3H]DADLE	chem
[3H]DADLE	chem
Mg2	chem
Gpp	chem
NH	chem
【GOLD_R】
【PRE_R】

There is a reduction of Bmax value from 0.19 + / - 0.02 nM in the presence of Mg2 + to 0.14 + / - 0.03 nM in the presence of Gpp ( NH ) p .
【GOLD_E】
Mg2+	chem
Gpp(NH)p	chem
【PRE_E】
Mg2+	chem
Gpp(NH)p	chem
【GOLD_R】
【PRE_R】

In the presence of 100 mM Na + , Scatchard analysis of saturation binding of [ 3H ] DADLE reveals nonlinear plots ; two - site analysis of the curves yields Kd = 0.43 + / - 0.09 and 7.9 + / - 3.2 nM .
【GOLD_E】
Na+	chem
[3H]DADLE	chem
【PRE_E】
Na+	chem
[3H]DADLE	chem
【GOLD_R】
【PRE_R】

These Kd values are analogous to that obtained with competition binding studies .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Again , this conversion of single site binding Scatchard plots to multiple sites binding plots in the presence of Na + is restricted to 3H - agonist binding only . ( ABSTRACT TRUNCATED AT 400 WORDS )
【GOLD_E】
Na+	chem
3H	chem
【PRE_E】
Na+	chem
【GOLD_R】
【PRE_R】

Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine , and synergism between diethylcarbamazine and piriprost , a 5 - lipoxygenase inhibitor .
【GOLD_E】
diethylcarbamazine	chem
piriprost	chem
leukotriene	chem
diethylcarbamazine	chem
5-lipoxygenase	geneY
leukotrienesynthetase	geneN
【PRE_E】
leukotrienesynthetase	geneN
diethylcarbamazine	chem
synergism	chem
diethylcarbamazine	chem
piriprost	chem
5-lipoxygenase	geneY
【GOLD_R】
diethylcarbamazine	5-lipoxygenase	C4
piriprost	5-lipoxygenase	C4
diethylcarbamazine	leukotrienesynthetase	C4
【PRE_R】
diethylcarbamazine	5-lipoxygenase	C4
synergism	5-lipoxygenase	C4
diethylcarbamazine	5-lipoxygenase	C4
piriprost	5-lipoxygenase	C4

Diethylcarbamazine inhibited the formation of sulfidopeptide leukotrienes in rat basophil leukemia ( RBL ) cells ( 50 % inhibitory concentration , EC50 , 3 mM ) .
【GOLD_E】
sulfidopeptideleukotrienes	chem
Diethylcarbamazine	chem
【PRE_E】
Diethylcarbamazine	chem
sulfidopeptideleukotrienes	chem
【GOLD_R】
【PRE_R】

Similar concentrations also inhibited the formation of leukotriene C4 ( LTC4 ) by LTC synthetase , a detergent - solubilized cell free particulate enzyme from RBL cells which is capable of coupling LTA4 to glutathione .
【GOLD_E】
leukotrieneC4	chem
LTC4	chem
LTA4	chem
glutathione	chem
LTCsynthetase	geneY
【PRE_E】
leukotrieneC4	chem
LTC4	chem
LTCsynthetase	geneY
LTA4	chem
glutathione	chem
【GOLD_R】
leukotrieneC4	LTCsynthetase	C9
LTC4	LTCsynthetase	C9
LTA4	LTCsynthetase	C9
【PRE_R】

By contrast , the conversion of LTA4 to LTC4 using enzymes from rat liver was at least ten times less sensitive to this inhibitor .
【GOLD_E】
LTA4	chem
LTC4	chem
【PRE_E】
LTA4	geneY
LTC4	chem
【GOLD_R】
【PRE_R】
LTA4	LTC4	C9

The EC50 for inhibition of the leukotriene C synthetase of RBL cells was directly proportional to the LTA4 concentration in the incubations , ranging from 1.5 mM at 10 microM LTA4 to over 40 mM at 500 microM LTA4 .
【GOLD_E】
leukotrieneC	chem
LTA4	chem
LTA4	chem
LTA4	chem
leukotrieneCsynthetase	geneY
【PRE_E】
leukotrieneCsynthetase	geneY
LTA4	chem
LTA4	chem
LTA4	geneN
【GOLD_R】
LTA4	leukotrieneCsynthetase	C9
【PRE_R】

Kinetic analysis revealed that the inhibition of the leukotriene C synthetase reaction by diethylcarbamazine was competitive with respect to LTA4 .
【GOLD_E】
leukotrieneC	chem
diethylcarbamazine	chem
LTA4	chem
leukotrieneCsynthetase	geneY
【PRE_E】
leukotrieneCsynthetase	geneY
diethylcarbamazine	chem
LTA4	geneN
【GOLD_R】
diethylcarbamazine	leukotrieneCsynthetase	C4
【PRE_R】

In contrast to diethylcarbamazine , piriprost ( U - 60,257 ; 6,9 - deepoxy - 6,9 - ( phenylimino ) - delta 6,8 - prostaglandin I1 ) , which inhibits the formation of sulfidopeptide leuktrienes in RBL cells at the 5 - lipoxygenase step ( EC50 5 microM ) , did not inhibit the leukotriene synthetase of these cells .
【GOLD_E】
diethylcarbamazine	chem
piriprost	chem
U-60,257	chem
6,9-deepoxy-6,9-(phenylimino)-delta6,8-prostaglandinI1	chem
sulfidopeptideleuktrienes	chem
5-lipoxygenase	geneY
leukotrienesynthetase	geneN
leukotriene	chem
【PRE_E】
diethylcarbamazine	chem
piriprost	chem
U-60,257	chem
6,9-deepoxy-6,9-(phenylimino)-delta6,8-prostaglandinI1	chem
sulfidopeptideleuktrienes	chem
5-lipoxygenase	geneY
leukotrienesynthetase	geneY
【GOLD_R】
diethylcarbamazine	5-lipoxygenase	C4
diethylcarbamazine	leukotrienesynthetase	C4
piriprost	5-lipoxygenase	C4
U-60,257	5-lipoxygenase	C4
6,9-deepoxy-6,9-(phenylimino)-delta6,8-prostaglandinI1	5-lipoxygenase	C4
sulfidopeptideleuktrienes	5-lipoxygenase	C9
【PRE_R】
diethylcarbamazine	5-lipoxygenase	C4
piriprost	5-lipoxygenase	C4
U-60,257	5-lipoxygenase	C4
6,9-deepoxy-6,9-(phenylimino)-delta6,8-prostaglandinI1	5-lipoxygenase	C4

On the other hand , low concentrations of piriprost , which had no demonstrable inhibitory activity on leukotriene formation by themselves , markedly synergized the inhibitory activity of diethylcarbamazine .
【GOLD_E】
piriprost	chem
leukotriene	chem
diethylcarbamazine	chem
【PRE_E】
piriprost	chem
leukotriene	chem
diethylcarbamazine	chem
【GOLD_R】
【PRE_R】

These results are consistent with the interpretation that both piriprost and diethylcarbamazine inhibit leukotriene formation but that they act on sequential steps in the biosynthetic pathway in such a manner as to synergistically interfere with the availability or utilization of LTA4 in the leukotriene C synthetase reaction .
【GOLD_E】
LTA4	chem
leukotrieneC	chem
leukotrieneCsynthetase	geneY
piriprost	chem
diethylcarbamazine	chem
leukotriene	chem
【PRE_E】
piriprost	chem
diethylcarbamazine	chem
leukotriene	chem
LTA4	geneN
leukotrieneCsynthetase	geneY
【GOLD_R】
LTA4	leukotrieneCsynthetase	C9
【PRE_R】

Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non - invasive differential sugar permeation .
【GOLD_E】
lactose	chem
【PRE_E】
lactose	chem
sugar	chem
【GOLD_R】
【PRE_R】

Changes in intestinal permeability and lactose hydrolysis have been investigated in three adults and fifteen infants with acute rotaviral gastroenteritis by differential sugar absorption .
【GOLD_E】
lactose	chem
【PRE_E】
lactose	chem
sugar	chem
【GOLD_R】
【PRE_R】

The method involves chromatographic measurement of urinary lactose , lactulose and L - rhamnose excretion following combined ingestion in an iso - osmolar test solution .
【GOLD_E】
lactose	chem
lactulose	chem
L-rhamnose	chem
【PRE_E】
lactose	chem
lactulose	chem
L-rhamnose	chem
iso	chem
【GOLD_R】
【PRE_R】

All patients had abnormal intestinal permeability indicated by raised urine lactulose / L - rhamnose excretion , ratio of percentages recovered in 5 h , of 0.462 ( 0.100 - 1.227 ) mean and range , compared with 0.027 ( 0.008 - 0.052 ) for healthy controls ( P less than 0.001 ) .
【GOLD_E】
lactulose	chem
L-rhamnose	chem
【PRE_E】
lactulose	chem
L-rhamnose	chem
【GOLD_R】
【PRE_R】

Ten patients also had urinary lactose / lactulose excretion ratios raised above the normal range ( 0.014 - 0.41 , mean 0.258 ) during their acute illness , indicating impaired intestinal lactose hydrolysis .
【GOLD_E】
lactose	chem
lactulose	chem
lactose	chem
【PRE_E】
lactose	chem
lactulose	chem
lactose	chem
【GOLD_R】
【PRE_R】

Both indices had become normal 4 weeks after the acute illness , serial investigation of five patients showing that improvement was complete much earlier .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Except for the short duration these changes are similar to those associated with villous atrophy in coeliac disease .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The test procedure was verified with respect to intestinal lactose hydrolysis by demonstrating a linear relationship between lactose / lactulose excretion and log jejunal mucosal lactase activity by in vitro assay ( R2 = 0.95 ) in a further group of subjects .
【GOLD_E】
lactase	geneY
lactose	chem
lactose	chem
lactulose	chem
【PRE_E】
lactose	chem
lactose	chem
lactulose	chem
lactase	geneN
【GOLD_R】
lactose	lactase	C9
lactose	lactase	C9
lactulose	lactase	C9
【PRE_R】

Differential lactose / lactulose / L - rhamnose absorption provides a non - invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal lactase deficiency .
【GOLD_E】
lactase	geneY
lactose	chem
lactulose	chem
L-rhamnose	chem
【PRE_E】
lactose	chem
lactulose	chem
L-rhamnose	chem
lactase	geneY
【GOLD_R】
lactose	lactase	C9
lactulose	lactase	C9
L-rhamnose	lactase	C9
【PRE_R】

Characteristics of the binding of phenoxybenzamine to calmodulin .
【GOLD_E】
phenoxybenzamine	chem
calmodulin	geneN
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

To determine the factors that influence the interaction between phenoxybenzamine and calmodulin , the binding of phenoxybenzamine to calmodulin was determined by equilibrium dialysis under a variety of experimental conditions .
【GOLD_E】
phenoxybenzamine	chem
calmodulin	geneN
phenoxybenzamine	chem
calmodulin	geneN
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

This interaction was found to be similar in some respects to the interaction between phenothiazines and calmodulin .
【GOLD_E】
calmodulin	geneN
phenothiazines	chem
【PRE_E】
phenothiazines	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

It was saturable , with between 1 and 2 mol of phenoxybenzamine bound to 1 mol of calmodulin .
【GOLD_E】
phenoxybenzamine	chem
calmodulin	geneN
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

It was also dependent upon temperature , the presence of a divalent cation such as calcium , and on pH , showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0 .
【GOLD_E】
calcium	chem
【PRE_E】
calcium	chem
【GOLD_R】
【PRE_R】

The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind , since several of them , including penfluridol , pimozide and spiroperidol , prevented the binding of phenoxybenzamine to calmodulin .
【GOLD_E】
phenoxybenzamine	chem
penfluridol	chem
pimozide	chem
spiroperidol	chem
phenoxybenzamine	chem
calmodulin	geneN
calmodulin	geneN
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
penfluridol	chem
pimozide	chem
spiroperidol	chem
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

However , in contrast to the reversible binding of most phenothiazines to calmodulin , phenoxybenzamine bound to calmodulin irreversibly .
【GOLD_E】
phenothiazines	chem
phenoxybenzamine	chem
calmodulin	geneN
calmodulin	geneN
【PRE_E】
phenothiazines	chem
calmodulin	geneY
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

The binding of phenoxybenzamine to calmodulin was fairly selective in that other alpha - adrenergic agents such as prazosin , yohimbine and clonidine failed to bind to calmodulin when examined under the same experimental conditions .
【GOLD_E】
phenoxybenzamine	chem
calmodulin	geneN
alpha-adrenergic	geneN
calmodulin	geneN
prazosin	chem
yohimbine	chem
clonidine	chem
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
prazosin	chem
yohimbine	chem
clonidine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

In addition , phenoxybenzamine showed little or no calcium - dependent binding to the S - 100 protein , bovine serum albumin or cytochrome c .
【GOLD_E】
S-100protein	geneN
bovineserumalbumin	geneY
cytochromec	geneY
phenoxybenzamine	chem
calcium	chem
【PRE_E】
phenoxybenzamine	chem
calcium	chem
bovineserumalbumin	geneY
cytochromec	geneY
【GOLD_R】
【PRE_R】

The irreversible complex between phenoxybenzamine and calmodulin may be useful for inhibiting certain calmodulin - dependent reactions and for studying the various biological functions of calmodulin .
【GOLD_E】
calmodulin	geneN
calmodulin	geneN
calmodulin	geneN
phenoxybenzamine	chem
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
calmodulin	geneY
calmodulin	geneY
【GOLD_R】
phenoxybenzamine	calmodulin	C4
【PRE_R】

Pharmacological and clinical studies of the antiandrogen Anandron .
【GOLD_E】
Anandron	chem
【PRE_E】
Anandron	chem
【GOLD_R】
【PRE_R】

This paper summarizes the animal and human studies with Anandron available at the time of the meeting .
【GOLD_E】
Anandron	chem
【PRE_E】
Anandron	chem
【GOLD_R】
【PRE_R】

The following was demonstrated in the rat and confirmed in man : interaction of Anandron with the prostatic androgen receptor , antiandrogen activity against testosterone ( in particular against the early transient rise induced by LHRH analogs ) and adrenal androgens .
【GOLD_E】
Anandron	chem
androgen	chem
testosterone	chem
androgens	chem
prostaticandrogenreceptor	geneN
LHRH	geneN
【PRE_E】
Anandron	chem
androgenreceptor	geneY
testosterone	chem
LHRH	geneY
androgens	chem
【GOLD_R】
【PRE_R】

Thus , as shown in 4 different double blind studies performed in stage D2 prostrate cancer patients , the combination of Anandron with surgical or chemical castration enhanced the beneficial effects of castration alone and thus seems a step forward in the hormonal treatment of prostatic carcinoma .
【GOLD_E】
Anandron	chem
【PRE_E】
D2	geneY
Anandron	chem
【GOLD_R】
【PRE_R】

Adenosine receptors : development of selective agonists and antagonists .
【GOLD_E】
Adenosine	chem
Adenosinereceptors	geneN
【PRE_E】
Adenosinereceptors	geneY
【GOLD_R】
【PRE_R】

Adenosine modulates a variety of physiological functions through interaction with A1 and A2 adenosine receptors , where agonists mediate inhibition and stimulation , respectively , of adenylate cyclase .
【GOLD_E】
adenylate	chem
Adenosine	chem
adenosine	chem
adenylatecyclase	geneN
A1andA2adenosinereceptors	geneN
【PRE_E】
Adenosine	chem
A1andA2adenosinereceptors	geneN
adenylatecyclase	geneN
【GOLD_R】
【PRE_R】

In the cardiovascular system , A2 receptors mediate vasodilation and reduction in blood pressure , while A1 receptors mediate cardiac depression .
【GOLD_E】
A2receptors	geneN
A1receptors	geneY
【PRE_E】
A2receptors	geneY
A1receptors	geneY
【GOLD_R】
【PRE_R】

The involvement of adenylate cyclase in these responses remains unresolved .
【GOLD_E】
adenylate	chem
adenylatecyclase	geneN
【PRE_E】
adenylatecyclase	geneN
【GOLD_R】
【PRE_R】

Adenosine analogs in particular the N6 - substituted compounds are more potent at A1 receptors than at A2 receptors .
【GOLD_E】
Adenosine	chem
N6	chem
A1receptors	geneY
A2receptors	geneN
【PRE_E】
Adenosine	chem
N6	chem
A1receptors	geneY
A2receptors	geneY
【GOLD_R】
【PRE_R】

The subregion of the adenosine receptor that interacts with the N6 - substituent is different for A1 and A2 receptors , particularly with respect to phenyl interactions , bulk tolerance and stereoselectivity .
【GOLD_E】
adenosine	chem
N6	chem
phenyl	chem
adenosinereceptor	geneN
A1andA2receptors	geneN
【PRE_E】
adenosinereceptor	geneY
N6	chem
A1andA2receptors	geneN
phenyl	chem
【GOLD_R】
【PRE_R】

A series of para - substituted N6 - phenyladenosines have been synthesized based on a `` functionalized congener `` approach in which a chemically reactive group , such as an amine or carboxylic acid , is introduced at the terminus of a chain .
【GOLD_E】
N6-phenyladenosines	chem
anami	chem
orcarboxylicac	chem
【PRE_E】
para-substitutedN6-phenyladenosines	chem
congener	chem
amine	chem
carboxylicacid	chem
【GOLD_R】
【PRE_R】

From the `` functionalized congener `` are synthesized a variety of conjugates each containing a common pharmacophore .
【GOLD_E】
【PRE_E】
congener	chem
【GOLD_R】
【PRE_R】

Certain of the adenosine conjugates are highly selective for A1 receptors .
【GOLD_E】
adenosine	chem
A1receptors	geneY
【PRE_E】
adenosine	chem
A1receptors	geneY
【GOLD_R】
【PRE_R】

Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors .
【GOLD_E】
adenosinereceptors	geneN
Xanthines	chem
adenosinereceptors	geneN
adenosine	chem
adenosine	chem
【PRE_E】
Xanthines	chem
adenosinereceptors	geneN
adenosinereceptors	geneY
【GOLD_R】
Xanthines	adenosinereceptors	C4
Xanthines	adenosinereceptors	C6
【PRE_R】

Caffeine and theophylline are virtually non - selective for A2 and A2 receptors .
【GOLD_E】
A2andA2receptors	geneN
Caffeine	chem
theophylline	chem
【PRE_E】
Caffeine	chem
theophylline	chem
A2andA2receptors	geneN
【GOLD_R】
【PRE_R】

Replacement of the methyl groups of theophylline with n - propyl or larger alkyl groups yields xanthines with selectivity for A1 receptors , particularly when combined with an 8 - phenyl moiety .
【GOLD_E】
n-propyl	chem
alkyl	chem
xanthines	chem
8-phenyl	chem
A1receptors	geneY
methyl	chem
theophylline	chem
【PRE_E】
methyl	chem
theophylline	chem
n-propyl	chem
alkyl	chem
xanthines	chem
A1receptors	geneY
8-phenyl	chem
【GOLD_R】
【PRE_R】

Most 1,3 - dialkyl - 8 - phenyl xanthines are very insoluble , but incorporation of polar aryl substituents , such as sulfo or carboxy to increase solubility , results in marked reduction in potency and selectivity .
【GOLD_E】
1,3-dialkyl-8-phenylxanthines	chem
aryl	chem
sulfo	chem
carboxy	chem
【PRE_E】
1,3-dialkyl-8-phenylxanthines	chem
aryl	chem
sulfo	chem
carboxy	chem
【GOLD_R】
【PRE_R】

A new series of more hydrophilic 1,3 - dipropyl - 8 - phenylxanthines has been synthesized using the `` functionalized congener `` approach .
【GOLD_E】
1,3-dipropyl-8-phenylxanthines	chem
【PRE_E】
1,3-dipropyl-8-phenylxanthines	chem
congener	chem
【GOLD_R】
【PRE_R】

Certain conjugates of 8 - [ 4 - ( carboxymethyloxy ) phenyl 1 ] 1,3 - dipropylxanthine display A1 selectivity in biochemical and cardiovascular models .
【GOLD_E】
8-[4-(carboxymethyloxy)phenyl1]1,3-dipropylxanthine	chem
【PRE_E】
8-[4-(carboxymethyloxy)phenyl1]1,3-dipropylxanthine	chem
【GOLD_R】
【PRE_R】

Certain analogs of caffeine in which the methyl group at the 1 - or 7 - position is replaced with a propargyl or propyl group display selectivity for A2 receptors .
【GOLD_E】
caffeine	chem
methyl	chem
propyl	chem
A2receptors	geneN
【PRE_E】
caffeine	chem
methyl	chem
propargyl	chem
propyl	chem
A2receptors	geneY
【GOLD_R】
【PRE_R】

The profile of a series of adenosine analogs or of xanthine antagonists can be used to define the nature of adenosine receptors .
【GOLD_E】
adenosine	chem
xanthine	chem
adenosine	chem
adenosinereceptors	geneN
【PRE_E】
adenosine	chem
xanthine	chem
adenosinereceptors	geneN
【GOLD_R】
【PRE_R】

Inhibition of testicular LDH - X from laboratory animals and man by gossypol and its isomers .
【GOLD_E】
gossypol	chem
LDH-X	geneN
【PRE_E】
LDH-X	geneY
gossypol	chem
【GOLD_R】
gossypol	LDH-X	C4
【PRE_R】
LDH-X	gossypol	C4

The inhibitory effect of ( + ) - , ( - ) - , ( + / - ) - gossypol and ( + / - ) - gossypol acetic acid upon testicular cytosolic LDH - X was measured in vitro .
【GOLD_E】
LDH-X	geneY
(+)-,(-)-,(+/-)-gossypol	chem
(+/-)-gossypolaceticacid	chem
【PRE_E】
(+)-,(-)-,(+/-)-gossypol	chem
(+/-)-gossypolaceticacid	chem
LDH-X	geneY
【GOLD_R】
(+)-,(-)-,(+/-)-gossypol	LDH-X	C4
(+/-)-gossypolaceticacid	LDH-X	C4
【PRE_R】

Gossypol acetic acid ( 0 - 100 mumol / l ) inhibited LDH - X prepared from the testes of the mouse greater than rabbit greater than human greater than rat greater than hamster .
【GOLD_E】
LDH-X	geneN
Gossypolaceticacid	chem
【PRE_E】
Gossypolaceticacid	chem
LDH-X	geneY
【GOLD_R】
Gossypolaceticacid	LDH-X	C4
【PRE_R】
Gossypolaceticacid	LDH-X	C4

There was no relationship between inhibition and in - vivo antifertility activity .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

LDH activity measured in vitro in serum of men and hamsters was unaffected by gossypol .
【GOLD_E】
LDH	geneN
gossypol	chem
【PRE_E】
LDH	geneN
gossypol	chem
【GOLD_R】
【PRE_R】

Gossypol and its isomers were non - competitive inhibitors of human and hamster LDH - X with respect to the coenzyme NADH , competitive inhibitors of human LDH - X and noncompetitive - competitive inhibitors of hamster LDH - X with respect to the substrate alpha - ketobutyrate .
【GOLD_E】
humanandhamsterLDH-X	geneN
humanLDH-X	geneY
hamsterLDH-X	geneY
Gossypol	chem
NADH	chem
alpha-ketobutyrate	chem
【PRE_E】
Gossypol	chem
humanandhamsterLDH-X	geneY
coenzymeNADH	chem
humanLDH-X	geneY
hamsterLDH-X	geneY
alpha-ketobutyrate	chem
【GOLD_R】
Gossypol	humanandhamsterLDH-X	C4
NADH	humanLDH-X	C4
alpha-ketobutyrate	hamsterLDH-X	C9
【PRE_R】
Gossypol	humanandhamsterLDH-X	C4
humanandhamsterLDH-X	coenzymeNADH	C4
coenzymeNADH	humanLDH-X	C4
coenzymeNADH	hamsterLDH-X	C4

Co - incubation with human serum albumin or poly - L - lysine but not lysine protected human and hamster LDH - X from gossypol .
【GOLD_E】
gossypol	chem
humanserumalbumin	geneY
humanandhamsterLDH-X	geneN
poly-L-lysine	chem
lysine	chem
【PRE_E】
humanserumalbumin	geneY
poly-L-lysine	chem
lysine	chem
LDH-X	geneY
gossypol	chem
【GOLD_R】
【PRE_R】

Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone . Requirement for peroxidative metabolism .
【GOLD_E】
prostaglandinH	chem
prostacyclin	chem
phenylbutazone	chem
prostaglandinHsynthase	geneN
prostacyclinsynthase	geneY
【PRE_E】
prostaglandinHsynthase	geneY
prostacyclinsynthase	geneY
phenylbutazone	chem
peroxidative	chem
【GOLD_R】
phenylbutazone	prostaglandinHsynthase	C4
phenylbutazone	prostacyclinsynthase	C4
【PRE_R】

Phenylbutazone ( PB ) , a nonsteroidal anti - inflammatory drug , is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase ( PHS ) .
【GOLD_E】
PB	chem
Phenylbutazone	chem
prostaglandinHsynthase	geneN
PHS	geneN
prostaglandinH	chem
【PRE_E】
Phenylbutazone	chem
PB	chem
peroxidase	geneN
prostaglandinHsynthase	geneY
PHS	geneY
【GOLD_R】
【PRE_R】

Most reducing cofactors for the peroxidase protect PHS and prostacyclin synthase from inactivation by hydroperoxides .
【GOLD_E】
prostacyclin	chem
hydroperoxides	chem
PHS	geneN
prostacyclinsynthase	geneY
【PRE_E】
peroxidase	geneN
PHS	geneN
prostacyclinsynthase	geneY
【GOLD_R】
hydroperoxides	PHS	C4
hydroperoxides	prostacyclinsynthase	C4
【PRE_R】

PB , however , does not protect these enzymes , but rather augments their hydroperoxide - dependent inactivation .
【GOLD_E】
PB	chem
hydroperoxide	chem
【PRE_E】
PB	chem
hydroperoxide	chem
【GOLD_R】
【PRE_R】

Using ram seminal vesicle microsomes as a source of PHS and prostacyclin synthase , we have examined the interaction of PB and exogenous hydroperoxides .
【GOLD_E】
prostacyclin	chem
PB	chem
hydroperoxides	chem
PHS	geneN
prostacyclinsynthase	geneY
【PRE_E】
PHS	geneN
prostacyclinsynthase	geneY
PB	chem
【GOLD_R】
【PRE_R】

Chromatographic analysis of the metabolism of 14C - labeled arachidonic acid in this system revealed that PB - dependent inactivation of PHS is markedly increased in the presence of 100 microM H2O2 .
【GOLD_E】
14C-labeledarachidonicacid	chem
PB	chem
H2O2	chem
PHS	geneN
【PRE_E】
14C	chem
arachidonicacid	chem
PB	chem
PHS	chem
H2O2	chem
【GOLD_R】
H2O2	PHS	C4
14C-labeledarachidonicacid	PHS	C9
【PRE_R】

This inactivation is a linear function of PB concentration between 10 and 250 microM , with a half - maximal effect in this range at about 100 microM PB .
【GOLD_E】
PB	chem
【PRE_E】
PB	chem
PB	chem
【GOLD_R】
【PRE_R】

Prostacyclin synthase is even more sensitive to inactivation by the combined PB and H2O2 treatment , with a corresponding half - maximal effect at PB concentrations near 25 microM .
【GOLD_E】
Prostacyclin	chem
PB	chem
PB	chem
H2O2	chem
Prostacyclinsynthase	geneY
【PRE_E】
Prostacyclinsynthase	geneY
PB	chem
H2O2	chem
PB	chem
【GOLD_R】
【PRE_R】

This PB - and H2O2 - dependent inactivation is demonstrable whether PGH2 is generated in situ from arachidonic acid or is added exogenously , supporting a direct effect of the treatment on prostacyclin synthase .
【GOLD_E】
prostacyclinsynthase	geneY
PB	chem
H2O2	chem
PGH2	chem
arachidonicacid	chem
prostacyclin	chem
【PRE_E】
PB	chem
H2O2	chem
PGH2	chem
arachidonicacid	chem
prostacyclinsynthase	geneY
【GOLD_R】
【PRE_R】

As PB undergoes peroxide - dependent co - oxygenation catalyzed by PHS , we propose that it is an oxygenated derivative of PB , rather than the parent compound , which is responsible for the inactivation of PHS and prostacyclin synthase .
【GOLD_E】
peroxide	chem
PB	chem
prostacyclin	chem
PHS	geneN
PHS	geneN
prostacyclinsynthase	geneY
PB	chem
【PRE_E】
PB	chem
peroxide	chem
PHS	chem
PB	chem
PHS	geneN
prostacyclinsynthase	geneY
【GOLD_R】
【PRE_R】
PB	PHS	C4

Nafazatrom , a competitive inhibitor of PB co - oxygenation , blocks the effects of the PB and H2O2 treatment , supporting our proposal .
【GOLD_E】
Nafazatrom	chem
PB	chem
PB	chem
H2O2	chem
【PRE_E】
Nafazatrom	chem
PB	chem
PB	chem
H2O2	chem
【GOLD_R】
【PRE_R】

Drug - protein interactions : isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin .
【GOLD_E】
phenoxybenzamine	chem
calmodulin	geneY
【PRE_E】
phenoxybenzamine	chem
calmodulin	geneY
【GOLD_R】
【PRE_R】

Phenoxybenzamine , an alpha - adrenergic antagonist containing a ( chloroethyl ) amine group , labels calmodulin in the presence of calcium .
【GOLD_E】
Phenoxybenzamine	chem
calmodulin	geneY
calcium	chem
(chloroethyl)amine	chem
【PRE_E】
Phenoxybenzamine	chem
a(chloroethyl)amine	chem
calmodulin	geneY
calcium	chem
【GOLD_R】
【PRE_R】
a(chloroethyl)amine	calmodulin	C6

The covalent interaction is inhibited by chlorpromazine in a concentration - dependent manner .
【GOLD_E】
chlorpromazine	chem
【PRE_E】
chlorpromazine	chem
【GOLD_R】
【PRE_R】

Adducts of calmodulin and phenoxybenzamine were separated by high - performance liquid chromatography into four major fractions : two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol / mol .
【GOLD_E】
calmodulin	geneY
phenoxybenzamine	chem
【PRE_E】
calmodulin	geneY
phenoxybenzamine	chem
【GOLD_R】
【PRE_R】

Each adduct had a reduced ability to activate cyclic nucleotide phosphodiesterase and myosin light chain kinase , and the chlorpromazine binding capacities of the phenoxybenzamine - calmodulin adducts were diminished to the extent of phenoxybenzamine incorporation into each adduct .
【GOLD_E】
cyclicnucleotidephosphodiesterase	geneN
myosinlightchainkinase	geneY
calmodulin	geneY
cyclicnucleotide	chem
chlorpromazine	chem
phenoxybenzamine	chem
phenoxybenzamine	chem
【PRE_E】
cyclicnucleotidephosphodiesterase	geneN
myosinlightchainkinase	geneY
chlorpromazine	chem
phenoxybenzamine-calmodulin	geneY
phenoxybenzamine	chem
【GOLD_R】
【PRE_R】

Isolation and characterization of labeled peptides from phenoxybenzamine - modified calmodulins indicated that peptides encompassing residues 38 - 75 , 107 - 126 , and 127 - 148 contained phenoxybenzamine label .
【GOLD_E】
phenoxybenzamine	chem
phenoxybenzamine	chem
calmodulins	geneY
【PRE_E】
phenoxybenzamine	chem
calmodulins	geneN
phenoxybenzamine	chem
【GOLD_R】
【PRE_R】

These studies directly demonstrate the relatedness between the binding activities of two structurally dissimilar calmodulin antagonists , demonstrate that covalent adducts of calmodulin and drugs with equal stoichiometries of labeling can have quantitative differences in activity and sites of modification , and provide direct evidence of distinct drug binding regions in calmodulin located in the amphipathic alpha - helical regions of the second and fourth domains .
【GOLD_E】
calmodulin	geneY
calmodulin	geneY
calmodulin	geneY
【PRE_E】
calmodulin	geneY
calmodulin	geneY
calmodulin	geneY
【GOLD_R】
【PRE_R】

Amine oxidase activities in brown adipose tissue of the rat : identification of semicarbazide - sensitive ( clorgyline - resistant ) activity at the fat cell membrane .
【GOLD_E】
Amine	chem
clorgyline	chem
semicarbazide	chem
Amineoxidase	geneN
【PRE_E】
Amineoxidase	geneN
semicarbazide	chem
clorgyline	chem
【GOLD_R】
【PRE_R】

Amine oxidase activity , previously described in homogenates of brown adipose tissue of the rat , has now been investigated in preparations of isolated fat cells .
【GOLD_E】
Amineoxidase	geneN
Amine	chem
【PRE_E】
Amineoxidase	geneN
【GOLD_R】
【PRE_R】

It was found that the specific activities of both monoamine oxidase A ( MAO ) and of the semicarbazide - sensitive clorgyline - resistant amine oxidase ( SSAO ) were higher in isolated fat cells than in the original whole tissue .
【GOLD_E】
monoamineoxidaseA	geneY
MAO	geneN
semicarbazide-sensitiveclorgyline-resistantamineoxidase	geneY
SSAO	geneY
monoamine	chem
semicarbazide	chem
clorgyline	chem
【PRE_E】
monoamineoxidaseA	geneN
MAO	geneN
semicarbazide-sensitiveclorgyline-resistantamineoxidase	geneN
SSAO	geneN
【GOLD_R】
【PRE_R】

Brown adipocytes therefore represent a major source of both these enzymes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In plasma membranes prepared from these isolated brown fat cells by borate extraction there was a similar enrichment of activity of SSAO and of the plasma membrane marker enzyme , phosphodiesterase I .
【GOLD_E】
borate	chem
SSAO	geneY
phosphodiesteraseI	geneN
【PRE_E】
borate	chem
SSAO	geneN
phosphodiesteraseI	geneY
【GOLD_R】
borate	SSAO	C3
【PRE_R】

However in preparations of cell membranes made by binding the cells to polycation - coated beads , enrichment of phosphodiesterase I activity was much greater than that of SSAO .
【GOLD_E】
phosphodiesteraseI	geneN
SSAO	geneY
【PRE_E】
polycation	chem
phosphodiesteraseI	geneN
SSAO	geneN
【GOLD_R】
【PRE_R】

It is suggested that the disposition of the enzyme within the cell membrane may account for the discrepancy in these results , i.e . the sidedness of the membrane may be important .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Histochemical visualization of enzyme activity in whole tissue at the ultrastructural level was undertaken .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Positive staining of mitochondria was achieved in the presence of the MAO substrate , tryptamine .
【GOLD_E】
MAO	geneN
tryptamine	chem
【PRE_E】
MAO	geneN
tryptamine	chem
【GOLD_R】
tryptamine	MAO	C9
【PRE_R】

Staining around the edges of the brown fat cells was observed with the SSAO substrates , tyramine and benzylamine .
【GOLD_E】
SSAO	geneY
tyramine	chem
benzylamine	chem
【PRE_E】
SSAO	geneN
tyramine	chem
benzylamine	chem
【GOLD_R】
tyramine	SSAO	C9
benzylamine	SSAO	C9
【PRE_R】
SSAO	benzylamine	C9

Staining was largely absent when substrate was omitted or after pretreatment with the irreversible SSAO inhibitor , hydralazine and the slowly reversible inhibitor , semicarbazide .
【GOLD_E】
SSAO	geneY
hydralazine	chem
semicarbazide	chem
【PRE_E】
SSAO	geneN
hydralazine	chem
semicarbazide	chem
【GOLD_R】
hydralazine	SSAO	C4
semicarbazide	SSAO	C4
【PRE_R】
SSAO	hydralazine	C4
SSAO	semicarbazide	C4

It is not definitely proven that this staining represents sites of enzyme activity but the results are consistent with evidence from other studies indicating that SSAO in brown adipose tissue of the rat may be found predominantly at the fat cell surface . ( ABSTRACT TRUNCATED AT 250 WORDS )
【GOLD_E】
SSAO	geneY
【PRE_E】
SSAO	geneN
【GOLD_R】
【PRE_R】

Penicillin - binding proteins and role of amdinocillin in causing bacterial cell death .
【GOLD_E】
Penicillin	chem
amdinocillin	chem
Penicillin-bindingproteins	geneN
【PRE_E】
Penicillin-bindingproteins	geneN
amdinocillin	chem
【GOLD_R】
【PRE_R】

The activity of penicillins against bacteria is in large part related to binding to specific receptor proteins involved in cell wall biosynthesis .
【GOLD_E】
penicillins	chem
【PRE_E】
penicillins	chem
【GOLD_R】
【PRE_R】

These proteins have been designated penicillin - binding proteins .
【GOLD_E】
penicillin	chem
penicillin-bindingproteins	geneN
【PRE_E】
penicillin-bindingproteins	geneN
【GOLD_R】
【PRE_R】

They can be separated into distinct entities through the use of acrylamide gel electrophoresis and binding of radioactive 14C - labeled penicillin G .
【GOLD_E】
acrylamide	chem
14C-labeledpenicillinG	chem
【PRE_E】
acrylamide	chem
14C	chem
penicillinG	geneN
【GOLD_R】
【PRE_R】

Six major proteins have been defined in the Enterobacteriaceae , penicillin - binding proteins 1 to 6 .
【GOLD_E】
penicillin	chem
penicillin-bindingproteins1to6	geneN
【PRE_E】
Enterobacteriaceae	geneN
penicillin-bindingproteins1to6	geneN
【GOLD_R】
【PRE_R】

Selection of mutants has shown that there are three essential proteins : penicillin - binding protein 1 , which is divided into penicillin - binding protein 1Bs , a peptidoglycan transpeptidase , and penicillin - binding protein 1A , which acts as a replacement for penicillin - binding protein 1Bs .
【GOLD_E】
penicillin	chem
penicillin	chem
penicillin	chem
penicillin	chem
penicillin-bindingprotein1	geneN
penicillin-bindingprotein1Bs	geneN
peptidoglycantranspeptidase	geneN
penicillin-bindingprotein1A	geneN
penicillin-bindingprotein1Bs	geneN
【PRE_E】
penicillin-bindingprotein1	geneY
penicillin-bindingprotein1Bs	geneY
peptidoglycantranspeptidase	geneY
penicillin-bindingprotein1A	geneY
penicillin-bindingprotein1Bs	geneY
【GOLD_R】
【PRE_R】

Penicillin - binding protein 2 is a murein - elongation initiating enzyme and penicillin - binding protein 3 is a septal murein - synthesizing enzyme .
【GOLD_E】
Penicillin	chem
penicillin	chem
Penicillin-bindingprotein2	geneN
murein	geneN
penicillin-bindingprotein3	geneN
murein	geneN
【PRE_E】
Penicillin-bindingprotein2	geneY
penicillin-bindingprotein3	geneY
septalmurein-synthesizingenzyme	geneN
【GOLD_R】
【PRE_R】

Penicillin - binding proteins 4 , 5 , and 6 are not essential for bacterial survival .
【GOLD_E】
Penicillin	chem
Penicillin-bindingproteins4,5,and6	geneN
【PRE_E】
Penicillin-bindingproteins4,5,and6	geneN
【GOLD_R】
【PRE_R】

Binding of penicillins to penicillin - binding protein 1Bs produces lysis , binding to penicillin - binding protein 2 produces round cells , and binding to penicillin - binding protein 3 produces long filaments .
【GOLD_E】
penicillin	chem
penicillin	chem
penicillins	chem
penicillin	chem
penicillin-bindingprotein2	geneN
penicillin-bindingprotein3	geneN
penicillin-bindingprotein1Bs	geneN
【PRE_E】
penicillins	chem
penicillin-bindingprotein1Bs	geneN
penicillin-bindingprotein2	geneY
penicillin-bindingprotein3	geneY
【GOLD_R】
【PRE_R】

Amdinocillin is a beta - amidino penicillanic acid derivative that binds specifically to penicillin - binding protein 2 .
【GOLD_E】
penicillin-bindingprotein2	geneN
Amdinocillin	chem
beta-amidinopenicillanicacid	chem
penicillin	chem
【PRE_E】
Amdinocillin	chem
beta-amidinopenicillanicacid	chem
penicillin-bindingprotein2	geneY
【GOLD_R】
【PRE_R】

The compound is more beta - lactamase stable than ampicillin and has no major delay in entry into the periplasmic space as do some penicillins .
【GOLD_E】
beta-lactamase	geneN
ampicillin	chem
penicillins	chem
【PRE_E】
beta-lactamase	geneY
ampicillin	chem
penicillins	chem
【GOLD_R】
【PRE_R】

Amdinocillin inhibits most of the Enterobacteriaceae , with the exception of some indole - positive Proteus species , but it does not inhibit gram - positive cocci or Pseudomonas aeruginosa .
【GOLD_E】
Amdinocillin	chem
indole	chem
【PRE_E】
Amdinocillin	chem
Enterobacteriaceae	geneN
indole	chem
Proteus	chem
【GOLD_R】
【PRE_R】

Amdinocillin produces spherical bacterial cells that eventually lyse .
【GOLD_E】
Amdinocillin	chem
【PRE_E】
Amdinocillin	chem
【GOLD_R】
【PRE_R】

Its activity in vitro is markedly affected by ionic content of media .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This agent acts synergistically with many penicillins , such as ampicillin , carbenicillin , and the like , and with cephalosporins , cefazolin , cefamandole , or cefoxitin to inhibit gram - negative bacilli , probably on the basis of binding to different proteins needed for the production of the peptidoglycan of the bacterial cell wall .
【GOLD_E】
penicillins	chem
ampicillin	chem
carbenicillin	chem
cephalosporins	chem
cefazolin	chem
cefamandole	chem
cefoxitin	chem
peptidoglycan	geneN
【PRE_E】
penicillins	chem
ampicillin	chem
carbenicillin	chem
cephalosporins	chem
cefazolin	chem
cefamandole	chem
cefoxitin	chem
peptidoglycan	geneN
【GOLD_R】
penicillins	peptidoglycan	C3
ampicillin	peptidoglycan	C3
carbenicillin	peptidoglycan	C3
cephalosporins	peptidoglycan	C3
cefazolin	peptidoglycan	C3
cefamandole	peptidoglycan	C3
cefoxitin	peptidoglycan	C3
【PRE_R】

Amdinocillin possesses a number of the essentials for effective antimicrobial activity and , by virtue of its enhancement of the activity of other beta - lactams , may prove to be a useful agent in the chemotherapy of certain infections .
【GOLD_E】
Amdinocillin	chem
beta-lactams	chem
【PRE_E】
Amdinocillin	chem
beta-lactams	chem
【GOLD_R】
【PRE_R】

Loss of alpha 2 - macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides .
【GOLD_E】
naphthalenesulfonamides	chem
phenothiazines	chem
epidermalgrowthfactor	geneY
alpha2-macroglobulin	geneY
【PRE_E】
alpha2-macroglobulin	geneY
epidermalgrowthfactor	geneY
phenothiazines	chem
naphthalenesulfonamides	chem
【GOLD_R】
【PRE_R】

We have found that certain naphthalenesulfonamides [ e.g . , N - 6 ( - aminohexyl ) - 5 - chloro - 1 - naphthalenesulfonamide ( W - 7 ) ] and phenothiazines [ e.g . , trifluoperazine ( TFP ) ] induce a loss of cell - surface receptors for alpha 2 - macroglobulin , and epidermal growth factor ( EGF ) in fibroblasts .
【GOLD_E】
naphthalenesulfonamides	chem
N-6(-aminohexyl)-5-chloro-1-naphthalenesulfonamide	chem
W-7	chem
phenothiazines	chem
alpha2-macroglobulin	geneY
epidermalgrowthfactor	geneY
EGF	geneY
trifluoperazine	chem
TFP	chem
【PRE_E】
naphthalenesulfonamides	chem
N-6(-aminohexyl)-5-chloro-1-naphthalenesulfonamide	chem
W-7	chem
phenothiazines	chem
trifluoperazine	chem
TFP	chem
cell-surfacereceptors	geneN
alpha2-macroglobulin	geneN
epidermalgrowthfactor	geneY
EGF	geneY
【GOLD_R】
【PRE_R】
naphthalenesulfonamides	cell-surfacereceptors	C4
N-6(-aminohexyl)-5-chloro-1-naphthalenesulfonamide	cell-surfacereceptors	C4
W-7	cell-surfacereceptors	C4
phenothiazines	cell-surfacereceptors	C4
trifluoperazine	cell-surfacereceptors	C4
TFP	cell-surfacereceptors	C4
TFP	epidermalgrowthfactor	C4
TFP	EGF	C4

The loss of alpha 2 - macroglobulin receptors is independent of receptor occupancy and is rapidly reversed upon removal of these agents from the culture medium .
【GOLD_E】
alpha2-macroglobulinreceptors	geneY
【PRE_E】
alpha2-macroglobulinreceptors	geneN
【GOLD_R】
【PRE_R】

The extent of EGF receptor loss is less than for alpha 2 - macroglobulin , and the EGF receptors do not reappear at the surface when W - 7 is removed .
【GOLD_E】
W-7	chem
EGFreceptor	geneY
alpha2-macroglobulin	geneY
EGFreceptors	geneY
【PRE_E】
EGFreceptor	geneY
alpha2-macroglobulin	geneY
EGFreceptors	geneY
【GOLD_R】
【PRE_R】

Receptor loss was measured as a change in the capacity for binding iodinated ligands ; no change in affinity of binding was observed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

This receptor loss could reflect inactivation of receptors or internalization .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

W - 7 did not induce a loss of cell surface beta 2 - microglobulin , a membrane protein which is excluded from coated pits and which is not internalized , indicating that the effect of W - 7 was specific for membrane receptors and not a result of bulk depletion of plasma membrane .
【GOLD_E】
W-7	chem
W-7	chem
beta2-microglobulin	geneY
【PRE_E】
beta2-microglobulin	geneN
W	chem
【GOLD_R】
【PRE_R】

The loss of alpha 2 - macroglobulin and EGF receptors occurs at concentrations which do not cause an increase in the pH of endocytic vesicles or the cytoplasm , indicating that these agents act by a mechanism distinct from the effect of other weak bases .
【GOLD_E】
alpha2-macroglobulin	geneY
EGFreceptors	geneY
【PRE_E】
alpha2-macroglobulin	geneY
EGFreceptors	geneY
【GOLD_R】
【PRE_R】

Since both TFP and W - 7 are potent inhibitors of calmodulin , we investigated the possibility that inhibition of calmodulin was responsible for the loss of receptors .
【GOLD_E】
calmodulin	geneN
calmodulin	geneN
TFP	chem
W-7	chem
【PRE_E】
TFP	chem
W-7	chem
calmodulin	geneY
calmodulin	geneY
【GOLD_R】
TFP	calmodulin	C4
W-7	calmodulin	C4
【PRE_R】
TFP	calmodulin	C4
W-7	calmodulin	C4
W-7	calmodulin	C4

Three lines of evidence suggest that calmodulin inhibition is not responsible for the inhibition of binding and endocytosis : 1 ) Promethazine , a phenothiazine that is a poor inhibitor of calmodulin , is nearly as effective as TFP at inhibiting endocytosis ; calmidazolium , a potent inhibitor of several calmodulin functions , did not cause a loss of binding ; 2 ) the microinjection of calmodulin into cells did not reverse the effects of W - 7 ; using pressure microinjection , we introduced up to a 100 - fold excess of calmodulin over native levels into individual gerbil fibroma cells ; using rhodamine - labeled alpha 2 - macroglobulin , we saw that the W - 7 induced inhibition of receptor - mediated endocytosis was the same in injected and uninjected cells ; 3 ) we injected calcineurin , a calmodulin - binding protein , into cells ( 1 - 3 pg / cell ) and observed no effect on the receptor - mediated endocytosis of rhodamine - labeled alpha 2 - macroglobulin .
【GOLD_E】
W-7	chem
rhodamine	chem
W-7	chem
rhodamine	chem
calmodulin	geneN
calmodulin	geneN
calmodulin	geneN
calmodulin	geneN
alpha2-macroglobulin	geneY
calcineurin	geneN
calmodulin-bindingprotein	geneN
alpha2-macroglobulin	geneY
Promethazine	chem
phenothiazine	chem
TFP	chem
【PRE_E】
calmodulin	geneY
Promethazine	chem
phenothiazine	chem
calmodulin	geneY
TFP	chem
calmidazolium	chem
calmodulin	geneY
calmodulin	geneY
calmodulin	geneY
rhodamine	chem
alpha2-macroglobulin	geneY
【GOLD_R】
Promethazine	calmodulin	C4
phenothiazine	calmodulin	C4
TFP	calmodulin	C4
【PRE_R】
calmodulin	Promethazine	C4
phenothiazine	calmodulin	C4
calmodulin	TFP	C4
calmidazolium	calmodulin	C4

These data indicated that cell surface receptor numbers can be regulated by a cellular component that is not cytoplasmic calmodulin but that shares some drug sensitivities with calmodulin .
【GOLD_E】
cytoplasmiccalmodulin	geneN
calmodulin	geneN
【PRE_E】
calmodulin	geneY
calmodulin	geneY
【GOLD_R】
【PRE_R】

The effect of various amino acids and drugs on the para - and meta - hydroxyphenylacetic acid concentrations in the mouse caudate nucleus .
【GOLD_E】
aminoacids	chem
para-andmeta-hydroxyphenylaceticacid	chem
【PRE_E】
aminoacids	chem
para-andmeta-hydroxyphenylaceticacid	chem
【GOLD_R】
【PRE_R】

Injection of L - p - tyrosine ( 800 mg / kg , 2 h ) increased the mouse striatal para - hydroxyphenylacetic acid ( p - HPAA ) concentrations .
【GOLD_E】
para-hydroxyphenylaceticacid	chem
p-HPAA	chem
L-p-tyrosine	chem
【PRE_E】
L-p-tyrosine	chem
para-hydroxyphenylaceticacid	chem
p-HPAA	chem
【GOLD_R】
【PRE_R】

A smaller dose of D , L - m - tyrosine ( 20 mg / kg , 2 h ) produced a larger increase in mouse striatal meta - hydroxyphenylacetic acid ( m - HPAA ) concentrations .
【GOLD_E】
D,L-m-tyrosine	chem
meta-hydroxyphenylaceticacid	chem
m-HPAA	chem
【PRE_E】
D,L-m-tyrosine	chem
meta-hydroxyphenylaceticacid	chem
m-HPAA	chem
【GOLD_R】
【PRE_R】

The administration of L - phenylalanine to mice caused a slight increase in the p - HPAA concentration in the corpus striatum after 2 h while a larger dose of L - phenylalanine ( 800 mg / kg ) produced a greater increase .
【GOLD_E】
p-HPAA	chem
L-phenylalanine	chem
L-phenylalanine	chem
【PRE_E】
L-phenylalanine	chem
p-HPAA	geneY
L-phenylalanine	chem
【GOLD_R】
【PRE_R】

Eight hours following L - phenylalanine injection , p - HPAA concentrations were still elevated .
【GOLD_E】
L-phenylalanine	chem
p-HPAA	chem
【PRE_E】
L-phenylalanine	chem
p-HPAA	geneY
【GOLD_R】
【PRE_R】

With D - phenylalanine a significant increase was observed at eight hours after drug administration .
【GOLD_E】
D-phenylalanine	chem
【PRE_E】
D-phenylalanine	chem
【GOLD_R】
【PRE_R】

Two drugs which reduce dopamine synthesis , alpha - methyl - para - tyrosine and apomorphine , decreased m - HPAA striatal concentrations without affecting p - HPAA concentrations .
【GOLD_E】
dopamine	chem
alpha-methyl-para-tyrosine	chem
apomorphine	chem
m-HPAA	chem
p-HPAA	chem
【PRE_E】
dopamine	chem
alpha-methyl-para-tyrosine	chem
apomorphine	chem
m-HPAA	geneY
p-HPAA	geneY
【GOLD_R】
【PRE_R】

From these results , it is proposed that tyrosine hydroxylase activity determines p - HPAA concentrations by regulating p - tyrosine availability .
【GOLD_E】
tyrosine	chem
p-HPAA	chem
p-tyrosine	chem
tyrosinehydroxylase	geneY
【PRE_E】
tyrosinehydroxylase	geneY
p-HPAA	geneY
p-tyrosine	chem
【GOLD_R】
p-tyrosine	tyrosinehydroxylase	C9
【PRE_R】
p-HPAA	p-tyrosine	C9

This enzyme may also synthesize m - tyrosine which is subsequently decarboxylated to form m - tyramine and then oxidatively deaminated to form m - HPAA .
【GOLD_E】
m-tyrosine	chem
m-tyramine	chem
m-HPAA	chem
【PRE_E】
m-tyrosine	chem
decarboxylated	chem
m-tyramine	chem
m-HPAA	geneY
【GOLD_R】
【PRE_R】
m-tyrosine	m-HPAA	C9
decarboxylated	m-HPAA	C9
m-tyramine	m-HPAA	C9

Demonstration of histamine receptors on human platelets by flow cytometry .
【GOLD_E】
histaminereceptors	geneN
histamine	chem
【PRE_E】
histaminereceptors	geneN
【GOLD_R】
【PRE_R】

Fluoresceinated human albumin conjugated with histamine ( FHA - HIS ) has been used for the demonstration of histamine receptors on human platelets .
【GOLD_E】
Fluoresceinatedhumanalbumin	geneY
histaminereceptors	geneN
FHA	geneY
histamine	chem
histamine	chem
【PRE_E】
Fluoresceinatedhumanalbumin	geneY
histamine	chem
FHA-HIS	chem
histaminereceptors	geneN
【GOLD_R】
【PRE_R】

Such receptors were demonstrated on 40 - 63 % of peripheral blood platelets in 4 healthy donors .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The binding of FHA - HIS was inhibited on 35 - 79 % of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine .
【GOLD_E】
FHA	geneY
histamineH1receptor	geneY
histamine	chem
diphenhydramine	chem
clemastine	chem
【PRE_E】
FHA-HIS	chem
histamineH1receptor	geneY
diphenhydramine	chem
clemastine	chem
【GOLD_R】
diphenhydramine	FHA	C4
clemastine	FHA	C4
diphenhydramine	histamineH1receptor	C6
clemastine	histamineH1receptor	C6
【PRE_R】

The histamine H2 receptor antagonist cimetidine blocked the FHA - HIS binding on 14 - 37 % of the platelets .
【GOLD_E】
histamineH2receptor	geneY
FHA	geneY
histamine	chem
cimetidine	chem
【PRE_E】
histamineH2receptor	geneN
cimetidine	chem
FHA-HIS	chem
【GOLD_R】
cimetidine	FHA	C4
cimetidine	histamineH2receptor	C6
【PRE_R】

It is concluded that histamine H1 as well as H2 receptors occur on human platelets but the receptors are not equally distributed in the platelet population .
【GOLD_E】
histamineH1	geneY
H2receptors	geneY
histamine	chem
【PRE_E】
histamineH1	geneY
H2receptors	geneN
【GOLD_R】
【PRE_R】

The effect of vitamin B6 deficiency on alanine : glyoxylate aminotransferase isoenzymes in rat liver .
【GOLD_E】
vitaminB6	chem
alanine	chem
glyoxylate	chem
alanine:glyoxylateaminotransferase	geneN
【PRE_E】
vitaminB6	chem
alanine	chem
glyoxylateaminotransferase	geneN
【GOLD_R】
【PRE_R】

Endogenous synthesis of oxalate has been reported to increase in vitamin B6 deficiency probably due to defective transamination of glyoxylate , the direct source of oxalate , to glycine .
【GOLD_E】
oxalate	chem
vitaminB6	chem
glyoxylate	chem
oxalate	chem
glycine	chem
【PRE_E】
oxalate	chem
vitaminB6	chem
glyoxylate	geneN
oxalate	chem
glycine	chem
【GOLD_R】
【PRE_R】
oxalate	glyoxylate	C9

Alanine : glyoxylate aminotransferase ( AGT ) in the liver catalyzes most of the glyoxylate transamination in mammalian tissues ( E .
【GOLD_E】
glyoxylate	chem
Alanine:glyoxylateaminotransferase	geneN
AGT	geneN
Alanine	chem
glyoxylate	chem
【PRE_E】
Alanine	chem
glyoxylateaminotransferase	geneY
glyoxylate	chem
【GOLD_R】
glyoxylate	Alanine:glyoxylateaminotransferase	C9
glyoxylate	AGT	C9
【PRE_R】
glyoxylateaminotransferase	glyoxylate	C9

V .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rowsell , K .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Snell , J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Carnie , and K .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

V .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Rowsell ( 1972 ) Biochem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

127 , 155 - 165 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effects of vitamin B6 deficiency on hepatic AGT isoenzymes , designated AGT 1 and AGT 2 , respectively , were examined with male rats ; AGT 1 is located both in the peroxisomes and in the mitochondria , and AGT 2 only in the mitochondria .
【GOLD_E】
vitaminB6	chem
AGT	geneN
AGT1	geneY
AGT2	geneY
AGT1	geneY
AGT2	geneY
【PRE_E】
vitaminB6	chem
peroxisomes	geneN
【GOLD_R】
【PRE_R】

The holo activity of combined peroxisomal and mitochondrial AGT 1 with a low Km for L - alanine rapidly decreased after a lag time of about 2 days during feeding of the vitamin B6 - deficient diet ( by 50 % in 5 days , by 86 % in 14 days ) .
【GOLD_E】
L-alanine	chem
vitaminB6	chem
AGT1	geneY
【PRE_E】
peroxisomal	geneN
mitochondrialAGT1	geneY
L-alanine	chem
vitaminB6	chem
【GOLD_R】
L-alanine	AGT1	C9
【PRE_R】
peroxisomal	L-alanine	C9
mitochondrialAGT1	L-alanine	C9

Peroxisomal AGT 1 activity was more affected than the mitochondrial .
【GOLD_E】
AGT1	geneY
【PRE_E】
PeroxisomalAGT1	geneY
【GOLD_R】
【PRE_R】

The holo activity of AGT 2 with a high Km for L - alanine decreased more slowly than AGT 1 ( by 33 % in 14 days , by 60 % in 28 days ) .
【GOLD_E】
L-alanine	chem
AGT1	geneY
AGT2	geneY
【PRE_E】
L-alanine	chem
【GOLD_R】
L-alanine	AGT1	C9
L-alanine	AGT2	C9
【PRE_R】

Urinary excretion of oxalate began to increase in 8 - 9 days , when AGT 2 remained intact but most of AGT 1 is depleted .
【GOLD_E】
oxalate	chem
AGT2	geneY
AGT1	geneY
【PRE_E】
oxalate	chem
【GOLD_R】
【PRE_R】

When the defect in the glyoxylate transamination in vivo in vitamin B6 deficiency is considered , these findings suggest that it is due to the deficiency of AGT 1 .
【GOLD_E】
AGT1	geneY
glyoxylate	chem
vitaminB6	chem
【PRE_E】
glyoxylate	chem
vitaminB6	chem
【GOLD_R】
【PRE_R】

The importance of peroxisomal AGT 1 is discussed , since peroxisomes have been described to be probably the major site of glyoxylate formation .
【GOLD_E】
AGT1	geneY
glyoxylate	chem
【PRE_E】
peroxisomalAGT1	geneY
peroxisomes	geneN
glyoxylate	chem
【GOLD_R】
【PRE_R】

How do volatile anesthetics inhibit Ca ( 2 + ) - ATPases ?
【GOLD_E】
Ca(2+)	chem
Ca(2+)-ATPases	geneN
【PRE_E】
Ca(2+)	chem
ATPases	geneN
【GOLD_R】
【PRE_R】

Volatile anesthetics at concentrations that are used in clinical practice to induce anesthesia selectively inhibit activity of the plasma membrane Ca ( 2 + ) - transport ATPase ( Kosk - Kosicka , D. , and Roszczynska , G .
【GOLD_E】
Ca(2+)-transportATPase	geneN
Ca(2+)	chem
【PRE_E】
Ca(2+)	chem
ATPase	geneN
Kosk-Kosicka	geneN
Roszczynska,G	geneN
【GOLD_R】
【PRE_R】

( 1993 ) Anesthesiology 79 , 774 - 780 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We have investigated the mechanism of the inhibitory action of several anesthetics on the purified erythrocyte Ca ( 2 + ) - ATPase by employing fluorescence spectroscopy measurements that report changes in the environment of intrinsic tryptophans and of an extrinsic probe attached in the active site of the enzyme .
【GOLD_E】
Ca(2+)-ATPase	geneN
Ca(2+)	chem
tryptophans	chem
【PRE_E】
Ca(2+)	chem
ATPase	geneN
【GOLD_R】
【PRE_R】

We have shown that the observed inhibition of the Ca ( 2 + ) - dependent activation of the enzyme correlates well with the elimination of the Ca ( 2 + ) - induced conformation change that is important for the proper function of the enzyme .
【GOLD_E】
Ca(2+)	chem
Ca(2+)	chem
【PRE_E】
Ca(2+)	chem
Ca(2+)	chem
【GOLD_R】
【PRE_R】

Analysis of the anesthetics effects on the total tryptophan fluorescence indicates a significant effect on enzyme conformation .
【GOLD_E】
tryptophan	chem
【PRE_E】
tryptophan	chem
【GOLD_R】
【PRE_R】

Similar changes have been observed in the sarcoplasmic reticulum Ca ( 2 + ) - ATPase .
【GOLD_E】
sarcoplasmicreticulumCa(2+)-ATPase	geneN
Ca(2+)	chem
【PRE_E】
Ca(2+)	chem
ATPase	geneN
【GOLD_R】
【PRE_R】

We propose that volatile anesthetics inhibit Ca ( 2 + ) - ATPase by interacting with nonpolar sites in protein interior , in analogy to the binding demonstrated for myoglobin , hemoglobin , and adenylate kinase ( Schoenborn , B .
【GOLD_E】
Ca(2+)-ATPase	geneN
myoglobin	geneY
hemoglobin	geneN
adenylatekinase	geneN
Ca(2+)	chem
adenylate	chem
【PRE_E】
Ca(2+)-ATPase	geneN
myoglobin	geneN
hemoglobin	geneN
adenylatekinase	geneN
Schoenborn,B	geneN
【GOLD_R】
【PRE_R】

P. , and Featherstone , R .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

M .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 1967 ) Adv .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Pharmacol .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

5 , 1 - 17 ; Tilton , R .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

F. , Kuntz , I .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

D. , and Petsko , G .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 1984 ) Biochemistry 23 , 2849 - 2857 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Such binding is expected to modify conformational substate ( s ) of the enzyme and perturb its function .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We view this process as an example of a general phenomena of interaction of small molecules with internal sites in proteins .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effect of triclosan on mediators of gingival inflammation .
【GOLD_E】
triclosan	chem
【PRE_E】
triclosan	chem
【GOLD_R】
【PRE_R】

Triclosan ( 2,4,4 ' , - trichloro - 2 ' - hydroxydiphenylether ) is a well - known and widely used nonionic antibacterial agent which has recently been introduced in toothpastes and mouthrinses .
【GOLD_E】
Triclosan	chem
2,4,4',-trichloro-2'-hydroxydiphenylether	chem
【PRE_E】
Triclosan	chem
2,4,4',-trichloro-2'-hydroxydiphenylether	chem
toothpastes	chem
mouthrinses	chem
【GOLD_R】
【PRE_R】

The efficacy of triclosan - containing toothpaste and mouthrinse to reduce both plaque and gingivitis in long - term clinical trials has been well documented .
【GOLD_E】
triclosan	chem
【PRE_E】
triclosan	chem
toothpaste	chem
mouthrinse	chem
【GOLD_R】
【PRE_R】

Until recently , it was generally assumed that triclosan 's effect on gingival inflammation was due to its antimicrobial and anti - plaque effect .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It has now become apparent that triclosan may have a direct anti - inflammatory effect on the gingival tissues .
【GOLD_E】
triclosan	chem
【PRE_E】
triclosan	chem
【GOLD_R】
【PRE_R】

Several in vitro studies were conducted to evaluate the effect of triclosan on 4 primary enzymes of the pathways of arachidonic acid metabolism , cyclo - oxygenase 1 , cyclo - oxygenase 2 , 5 - lipoxygenase and 15 - lipoxygenase .
【GOLD_E】
triclosan	chem
arachidonicacid	chem
cyclo-oxygenase1	geneY
cyclo-oxygenase2	geneY
5-lipoxygenase	geneY
15-lipoxygenase	geneY
【PRE_E】
triclosan	chem
arachidonicacid	chem
cyclo-oxygenase1	geneY
cyclo-oxygenase2	geneY
5-lipoxygenase	geneY
15-lipoxygenase	geneY
【GOLD_R】
【PRE_R】

These pathways lead to the production of known mediators of inflammation such as the prostaglandins , leukotrienes and lipoxins .
【GOLD_E】
prostaglandins	chem
leukotrienes	chem
lipoxins	chem
【PRE_E】
prostaglandins	chem
leukotrienes	chem
lipoxins	chem
【GOLD_R】
【PRE_R】

Triclosan inhibited both cyclooxygenase 1 and cyclo - oxygenase 2 with IC - 50 values of 43 microM and 227 microM , respectively .
【GOLD_E】
Triclosan	chem
cyclooxygenase1	geneY
cyclo-oxygenase2	geneY
【PRE_E】
Triclosan	chem
cyclooxygenase1	geneY
cyclo-oxygenase2	geneY
【GOLD_R】
Triclosan	cyclooxygenase1	C4
Triclosan	cyclo-oxygenase2	C4
【PRE_R】
Triclosan	cyclooxygenase1	C4
Triclosan	cyclo-oxygenase2	C4

Triclosan also inhibited 5 - lipoxygenase with an IC - 50 of 43 microM .
【GOLD_E】
5-lipoxygenase	geneY
Triclosan	chem
【PRE_E】
Triclosan	chem
5-lipoxygenase	geneY
【GOLD_R】
Triclosan	5-lipoxygenase	C4
【PRE_R】
Triclosan	5-lipoxygenase	C4

The 15 - lipoxygenase was similarly inhibited by triclosan with an IC - 50 of 61 microM .
【GOLD_E】
15-lipoxygenase	geneY
triclosan	chem
【PRE_E】
15-lipoxygenase	geneY
triclosan	chem
【GOLD_R】
triclosan	15-lipoxygenase	C4
【PRE_R】
15-lipoxygenase	triclosan	C4

Hence , triclosan has the ability to inhibit both the cyclo - oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy .
【GOLD_E】
cyclo-oxygenase	geneN
lipoxygenase	geneN
triclosan	chem
arachidonicacid	chem
【PRE_E】
triclosan	chem
cyclo-oxygenase	geneN
lipoxygenase	geneN
arachidonicacid	chem
【GOLD_R】
triclosan	cyclo-oxygenase	C4
triclosan	lipoxygenase	C4
arachidonicacid	cyclo-oxygenase	C9
arachidonicacid	lipoxygenase	C9
【PRE_R】
triclosan	cyclo-oxygenase	C4
triclosan	lipoxygenase	C4

In cell culture experiments , it was found that triclosan inhibited IL - 1 beta induced prostaglandin E2 production by human gingival fibroblasts in a concentration dependent manner , and at relatively low concentrations .
【GOLD_E】
IL-1beta	geneY
triclosan	chem
prostaglandinE2	chem
【PRE_E】
triclosan	chem
IL-1	geneY
prostaglandinE2	chem
【GOLD_R】
triclosan	IL-1beta	C4
prostaglandinE2	IL-1beta	C9
【PRE_R】
triclosan	IL-1	C4

These data , taken together , indicate that triclosan can inhibit formation of several important mediators of gingival inflammation . ( ABSTRACT TRUNCATED AT 250 WORDS )
【GOLD_E】
triclosan	chem
【PRE_E】
triclosan	chem
【GOLD_R】
【PRE_R】

The dynamics of cobalamin utilization in L - 1210 mouse leukemia cells : a model of cellular cobalamin metabolism .
【GOLD_E】
cobalamin	chem
cobalamin	chem
【PRE_E】
cobalamin	chem
cobalamin	chem
【GOLD_R】
【PRE_R】

The uptake and metabolism of cobalamin ( Cbl ) has been studied in L - 1210 murine leukemia cells propagating in vitro .
【GOLD_E】
cobalamin	chem
Cbl	chem
【PRE_E】
cobalamin	chem
Cbl	chem
【GOLD_R】
【PRE_R】

Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L - 1210 cells in the presence of [ 57Co ] cyanocobalamin ( CN - Cbl ) bound to transcobalamin II ( transcobalamin , TC ) .
【GOLD_E】
CN-Cbl	chem
transcobalaminII	geneY
transcobalamin	geneN
TC	geneN
Cbl	chem
Cbl	chem
[57Co]cyanocobalamin	chem
【PRE_E】
Cbl	chem
Cbl	chem
[57Co]cyanocobalamin	chem
CN-Cbl	chem
transcobalaminII	geneY
transcobalamin	geneY
TC	geneN
【GOLD_R】
【PRE_R】

The intracellular pool of free [ 57Co ] Cbl increased during the first 24 h of culture and a substantial fraction of this free pool was effluxed from the cell to the medium .
【GOLD_E】
[57Co]Cbl	chem
【PRE_E】
[57Co]Cbl	chem
【GOLD_R】
【PRE_R】

Upon depletion of extracellular TC - [ 57Co ] CN - Cbl , the intracellular concentration of free Cbl decreased as did the efflux of Cbl to the medium .
【GOLD_E】
TC-[57Co]CN-Cbl	chem
Cbl	chem
Cbl	chem
【PRE_E】
TC-[57Co]CN-Cbl	chem
Cbl	chem
Cbl	chem
【GOLD_R】
【PRE_R】

Internalized [ 57Co ] CN - Cbl was converted to hydroxocobalamin ( OH - Cbl ) , methylcobalamin ( Me - Cbl ) and 5 ' - deoxyadenosylcobalamin .
【GOLD_E】
[57Co]CN-Cbl	chem
hydroxocobalamin	chem
OH-Cbl	chem
methylcobalamin	chem
Me-Cbl	chem
5'-deoxyadenosylcobalamin	chem
【PRE_E】
[57Co]CN-Cbl	chem
hydroxocobalamin	chem
OH-Cbl	chem
methylcobalamin	chem
Me-Cbl	chem
5'-deoxyadenosylcobalamin	chem
【GOLD_R】
【PRE_R】

These Cbl forms were found in both soluble ( cytoplasmic ) and insoluble ( membrane ) fractions .
【GOLD_E】
Cbl	chem
【PRE_E】
Cbl	chem
【GOLD_R】
【PRE_R】

Intracellular protein - bound [ 57Co ] Cbl fractionated with methionine synthase ( MS ) and methylmalonyl - CoA mutase ( MU ) activity .
【GOLD_E】
[57Co]Cbl	chem
methionine	chem
methylmalonyl-CoA	chem
methioninesynthase	geneY
MS	geneY
methylmalonyl-CoAmutase	geneY
MU	geneY
【PRE_E】
57Co]Cbl	chem
methioninesynthase	geneY
methylmalonyl-CoAmutase	geneY
MU	geneY
【GOLD_R】
【PRE_R】

The major form of Cbl associated with the two enzymes was OH - Cbl .
【GOLD_E】
Cbl	chem
OH-Cbl	chem
【PRE_E】
Cbl	chem
OH-Cbl	chem
【GOLD_R】
【PRE_R】

Cells propagated in medium containing N5 - methyltetrahydrofolate and homocysteine showed a substantial increase in MS activity which paralleled the increase in the intracellular concentration of Me - Cbl and the Cbl bound to the enzyme .
【GOLD_E】
MS	geneY
N5-methyltetrahydrofolate	chem
homocysteine	chem
Me-Cbl	chem
Cbl	chem
【PRE_E】
N5-methyltetrahydrofolate	chem
homocysteine	chem
Me-Cbl	chem
Cbl	chem
【GOLD_R】
N5-methyltetrahydrofolate	MS	C3
homocysteine	MS	C3
【PRE_R】

Ergovaline binding and activation of D2 dopamine receptors in GH4ZR7 cells .
【GOLD_E】
Ergovaline	chem
dopamine	chem
D2dopaminereceptors	geneY
【PRE_E】
Ergovaline	chem
D2dopaminereceptors	geneY
【GOLD_R】
Ergovaline	D2dopaminereceptors	C3
【PRE_R】

Ergovaline inhibition of radioligand binding to the D2 dopamine receptor and ergot alkaloid inhibition of vasoactive intestinal peptide ( VIP ) - stimulated cyclic AMP production in GH4ZR7 cells , stably transfected with a rat D2 dopamine receptor , were evaluated .
【GOLD_E】
dopamine	chem
Ergovaline	chem
ergotalkaloid	chem
vasoactiveintestinalpeptide	geneY
VIP	geneY
ratD2dopaminereceptor	geneY
D2dopaminereceptor	geneY
cyclicAMP	chem
dopamine	chem
【PRE_E】
Ergovaline	chem
D2	geneY
dopaminereceptor	geneN
vasoactiveintestinalpeptide	geneY
VIP	geneY
cyclicAMP	chem
ratD2dopaminereceptor	geneY
【GOLD_R】
ergotalkaloid	vasoactiveintestinalpeptide	C4
ergotalkaloid	VIP	C4
cyclicAMP	vasoactiveintestinalpeptide	C9
cyclicAMP	VIP	C9
【PRE_R】
Ergovaline	D2	C4
Ergovaline	vasoactiveintestinalpeptide	C4
Ergovaline	VIP	C4

Ergovaline inhibition of the binding of the D2 - specific radioligand , [ 3H ] YM - 09151 - 2 , exhibited a KI ( inhibition constant ) of 6.9 + / - 2.6 nM , whereas dopamine was much less potent ( 370 + / - 160 nM ) .
【GOLD_E】
D2	geneY
Ergovaline	chem
[3H]YM-09151-2	chem
dopamine	chem
【PRE_E】
Ergovaline	chem
D2	geneY
[3H]YM-09151-2	chem
dopamine	chem
【GOLD_R】
【PRE_R】
Ergovaline	D2	C4
D2	[3H]YM-09151-2	C4

Ergot alkaloids were also effective in inhibiting VIP - stimulated cyclic AMP production , with EC50 values for ergovaline , ergonovine , alpha - ergocryptine , ergotamine , and dopamine of 8 + / - 2 , 47 + / - 2 , 28 + / - 2 , 2 + / - 1 , and 8 + / - 1 nM , respectively .
【GOLD_E】
Ergotalkaloids	chem
cyclicAMP	chem
ergovaline	chem
ergonovine	chem
alpha-ergocryptine	chem
ergotamine	chem
dopamine	chem
VIP	geneY
【PRE_E】
VIP	geneY
cyclicAMP	chem
ergovaline	chem
ergonovine	chem
alpha-ergocryptine	chem
ergotamine	chem
dopamine	chem
【GOLD_R】
Ergotalkaloids	VIP	C4
ergovaline	VIP	C4
ergonovine	VIP	C4
alpha-ergocryptine	VIP	C4
ergotamine	VIP	C4
dopamine	VIP	C4
cyclicAMP	VIP	C9
【PRE_R】

Inhibition of cyclic AMP production by ergovaline was blocked by the dopamine receptor antagonist , ( - ) - sulpiride ( IC50 , 300 + / - 150 nM ) .
【GOLD_E】
cyclicAMP	chem
ergovaline	chem
dopamine	chem
(-)-sulpiride	chem
dopaminereceptor	geneN
【PRE_E】
cyclicAMP	chem
ergovaline	chem
dopaminereceptor	geneN
(-)-sulpiride	chem
【GOLD_R】
(-)-sulpiride	dopaminereceptor	C6
【PRE_R】

Our results indicate that ergot compounds , especially ergovaline , bind to D2 dopamine receptors and elicit second messenger responses similar to that of dopamine .
【GOLD_E】
ergovaline	chem
dopamine	chem
dopamine	chem
D2dopaminereceptors	geneY
【PRE_E】
ergovaline	chem
D2dopaminereceptors	geneY
dopamine	chem
【GOLD_R】
【PRE_R】

These findings suggest that some of the deleterious effects of consumption of endophyte - infected tall fescue , which contains several ergot alkaloids including ergovaline , may be due to D2 dopamine receptor activation .
【GOLD_E】
D2dopaminereceptor	geneY
ergotalkaloids	chem
ergovaline	chem
dopamine	chem
【PRE_E】
endophyte	chem
ergovaline	chem
D2dopaminereceptor	geneY
【GOLD_R】
ergotalkaloids	D2dopaminereceptor	C3
ergovaline	D2dopaminereceptor	C3
【PRE_R】

Binding of antipsychotic drugs at alpha 1A - and alpha 1B - adrenoceptors : risperidone is selective for the alpha 1B - adrenoceptors .
【GOLD_E】
risperidone	chem
alpha1B-adrenoceptors	geneY
alpha1A-andalpha1B-adrenoceptors	geneN
【PRE_E】
alpha1A-andalpha1B-adrenoceptors	geneN
risperidone	chem
alpha1B-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

The binding of the antipsychotic drugs risperidone , ( + ) - butaclamol , clozapine , haloperidol , spiperone , thioridazine and YM - 09151 - 2 was studied at the subtypes of the alpha 1 - adrenoceptor .
【GOLD_E】
clozapine	chem
haloperidol	chem
spiperone	chem
alpha1-adrenoceptor	geneN
thioridazine	chem
YM-09151-2	chem
risperidone	chem
(+)-butaclamol	chem
【PRE_E】
risperidone	chem
(+)-butaclamol	chem
clozapine	chem
haloperidol	chem
spiperone	chem
thioridazine	chem
YM-09151-2	chem
alpha1-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Saturation experiments showed that [ 3H ] prazosin labelled a single population of binding sites in the spleen ( alpha 1B ) and hippocampus ( alpha 1A and alpha 1B ) ( dissociation constants ( KD ) : 0.26 nM and 0.14 nM respectively ) .
【GOLD_E】
alpha1B	geneY
alpha1A	geneY
alpha1B	geneY
[3H]prazosin	chem
【PRE_E】
[3H]prazosin	chem
【GOLD_R】
【PRE_R】

Prazosin displaced the radioligand in a monophasic manner in both the spleen and hippocampus whereas 5 - methyl - urapidil , phentolamine and WB 4101 displaced the radioligand in a monophasic manner in the spleen but in a biphasic manner in the hippocampus .
【GOLD_E】
phentolamine	chem
WB4101	chem
Prazosin	chem
5-methyl-urapidil	chem
【PRE_E】
Prazosin	chem
5-methyl-urapidil	chem
phentolamine	chem
WB4101	chem
【GOLD_R】
【PRE_R】

The affinity of these three compounds for the low affinity site in the hippocampus was similar to that observed in the spleen , suggesting that all three were selective for the alpha 1A - adrenoceptor .
【GOLD_E】
alpha1A-adrenoceptor	geneY
【PRE_E】
alpha1A-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Furthermore , the affinities for the alpha 1A - and alpha 1B - adrenoceptors calculated in this manner were in agreement with literature values .
【GOLD_E】
alpha1A-andalpha1B-adrenoceptors	geneN
【PRE_E】
alpha1A-andalpha1B-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

With the exception of risperidone , all the antipsychotic drugs tested failed to show selectivity for either of the alpha 1 - adrenoceptor subtypes .
【GOLD_E】
alpha1-adrenoceptor	geneN
risperidone	chem
【PRE_E】
risperidone	chem
alpha1-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

Risperidone was 120 - fold more selective for the alpha 1B - adrenoceptor with respect to the alpha 1A - adrenoceptor ( Ki values : 2.3 + / - 1.2 nM and 283.6 + / - 174.1 nM respectively ) .
【GOLD_E】
alpha1B-adrenoceptor	geneY
alpha1A-adrenoceptor	geneY
Risperidone	chem
【PRE_E】
Risperidone	chem
alpha1B-adrenoceptor	geneY
alpha1A-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Mediation of noradrenaline - induced contractions of rat aorta by the alpha 1B - adrenoceptor subtype .
【GOLD_E】
noradrenaline	chem
alpha1B-adrenoceptor	geneY
【PRE_E】
noradrenaline	chem
alpha1B-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The subtypes of alpha 1 - adrenoceptor mediating contractions to exogenous noradrenaline ( NA ) in rat aorta have been examined in both biochemical and functional studies .
【GOLD_E】
noradrenaline	chem
NA	chem
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1-adrenoceptor	geneN
noradrenaline	chem
NA	chem
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Incubation of rat aortic membranes with the irreversible alpha 1B - adrenoceptor antagonist , chloroethylclonidine ( CEC : 10 microM ) did not change the KD of [ 3H ] - prazosin binding in comparison to untreated membranes , but reduced by 88 % the total number of binding sites ( Bmax ) .
【GOLD_E】
alpha1B-adrenoceptor	geneY
chloroethylclonidine	chem
CEC	chem
[3H]-prazosin	chem
【PRE_E】
alpha1B-adrenoceptor	geneY
chloroethylclonidine	chem
CEC	chem
[3H]-prazosin	chem
【GOLD_R】
chloroethylclonidine	alpha1B-adrenoceptor	C6
CEC	alpha1B-adrenoceptor	C6
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Contractions of rat aortic strips to NA after CEC ( 50 microM for 30 min ) incubation followed by repetitive washing , showed a marked shift in the potency of NA and a partial reduction in the maximum response .
【GOLD_E】
NA	chem
NA	chem
CEC	chem
【PRE_E】
NA	chem
NA	chem
【GOLD_R】
【PRE_R】

The residual contractions to NA after CEC incubation were not affected by prazosin ( 10 nM ) .
【GOLD_E】
NA	chem
CEC	chem
prazosin	chem
【PRE_E】
NA	chem
CEC	chem
prazosin	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The competitive antagonists prazosin , terazosin , ( R ) - YM - 12617 , phentolamine , 5 - methylurapidil and spiperone inhibited contractions to NA with estimated pA2 values of 9.85 , 8.54 , 9.34 , 7.71 , 7.64 and 8.41 , respectively .
【GOLD_E】
prazosin	chem
terazosin	chem
(R)-YM-12617	chem
phentolamine	chem
5-methylurapidil	chem
spiperone	chem
NA	chem
【PRE_E】
prazosin	chem
terazosin	chem
(R)-YM-12617	chem
phentolamine	chem
5-methylurapidil	chem
spiperone	chem
NA	chem
【GOLD_R】
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The affinity of the same antagonists for the alpha 1A - and alpha 1B - adrenoceptors was evaluated by utilizing membranes from rat hippocampus pretreated with CEC , and rat liver , respectively .
【GOLD_E】
CEC	chem
alpha1A-andalpha1B-adrenoceptors	geneN
【PRE_E】
alpha1A-andalpha1B-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

5 - Methylurapidil and phentolamine were confirmed as selective for the alpha 1A - adrenoceptors , whereas spiperone was alpha 1B - selective .
【GOLD_E】
alpha1A-adrenoceptors	geneY
5-Methylurapidil	chem
phentolamine	chem
spiperone	chem
【PRE_E】
5-Methylurapidil	chem
phentolamine	chem
alpha1A-adrenoceptors	geneY
spiperone	chem
【GOLD_R】
【PRE_R】

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A significant correlation was found between the pA2 values of the alpha 1 - adrenoceptor antagonists tested and their affinity for the alpha 1B - adrenoceptor subtype , but not for the alpha 1A - subtype .
【GOLD_E】
alpha1-adrenoceptor	geneN
alpha1B-adrenoceptor	geneY
【PRE_E】
alpha1-adrenoceptor	geneN
alpha1B-adrenoceptor	geneN
alpha1A-subtype	geneY
【GOLD_R】
【PRE_R】

7 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , these findings indicate that in rat aorta most of the contraction is mediated by alpha 1B - adrenoceptors , and that the potency ( pA2 ) of an antagonist in this tissue should be related to its antagonistic effect on this subtype of the alpha 1 - adrenoceptor population .
【GOLD_E】
alpha1B-adrenoceptors	geneY
alpha1-adrenoceptor	geneN
【PRE_E】
alpha1B-adrenoceptors	geneN
alpha1-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

Beta 2 - but not beta 1 - adrenoceptors are involved in desipramine enhancement of aggressive behavior in long - term isolated mice .
【GOLD_E】
desipramine	chem
beta1-adrenoceptors	geneY
【PRE_E】
Beta2	geneY
beta1-adrenoceptors	geneN
desipramine	chem
【GOLD_R】
【PRE_R】

The effects of several beta - adrenoceptor antagonists on the desipramine - induced increase in aggressive behavior in long - term isolated mice were examined .
【GOLD_E】
beta-adrenoceptor	geneN
desipramine	chem
【PRE_E】
beta-adrenoceptor	geneN
desipramine	chem
【GOLD_R】
【PRE_R】

Desipramine HCl ( 10 mg / kg , IP ) significantly increased the duration of aggressive behavior in isolated mice but did not significantly change the latency to the first attack consistent with our previous reports .
【GOLD_E】
DesipramineHCl	chem
【PRE_E】
DesipramineHCl	chem
【GOLD_R】
【PRE_R】

Intraperitoneal administration of ( + / - ) propranolol HCl ( 2.5 - 10 mg / kg ) , a nonselective beta - adrenoceptor antagonist , dose dependently attenuated the desipramine - induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses .
【GOLD_E】
beta-adrenoceptor	geneN
(+/-)propranololHCl	chem
desipramine	chem
【PRE_E】
(+/-)propranololHCl	chem
beta-adrenoceptor	geneY
desipramine	chem
【GOLD_R】
(+/-)propranololHCl	beta-adrenoceptor	C6
【PRE_R】
(+/-)propranololHCl	beta-adrenoceptor	C6

ICI118,551 HCl ( 1.25 - 5 mg / kg , IP ) , a selective beta 2 - adrenoceptor antagonist , also blocked the desipramine - induced enhancement of aggressive behavior in a dose - dependent manner , whereas metoprolol tartrate ( 5 - 20 mg / kg , IP ) , a selective beta 1 - adrenoceptor antagonist , did not affect it .
【GOLD_E】
beta2-adrenoceptor	geneY
beta1-adrenoceptor	geneY
ICI118,551HCl	chem
metoprololtartrate	chem
【PRE_E】
ICI118,551HCl	chem
beta2-adrenoceptor	geneY
desipramine	chem
metoprololtartrate	chem
beta1-adrenoceptor	geneY
【GOLD_R】
ICI118,551HCl	beta2-adrenoceptor	C6
metoprololtartrate	beta1-adrenoceptor	C6
【PRE_R】
ICI118,551HCl	beta2-adrenoceptor	C6
ICI118,551HCl	beta1-adrenoceptor	C6

Moreover , clenbuterol HCl ( 0.1 - 0.5 mg / kg , IP ) , a lipophilic beta 2 - adrenoceptor agonist , significantly increased the duration of basal aggressive behavior .
【GOLD_E】
beta2-adrenoceptor	geneY
clenbuterolHCl	chem
【PRE_E】
clenbuterolHCl	chem
beta2-adrenoceptor	geneY
【GOLD_R】
clenbuterolHCl	beta2-adrenoceptor	C5
【PRE_R】

Taken together with our previous finding that the desipramine - induced enhancement of aggressive behavior can be blocked by yohimbine , an alpha 2 - adrenoceptor antagonist , the present results indicate that not only alpha 2 - but also beta 2 - adrenoceptor stimulation plays important roles in modulation of aggressive behavior in long - term isolated mice .
【GOLD_E】
alpha2-adrenoceptor	geneN
beta2-adrenoceptor	geneY
desipramine	chem
yohimbine	chem
【PRE_E】
desipramine	chem
yohimbine	chem
alpha2-adrenoceptor	geneN
beta2-adrenoceptor	geneN
【GOLD_R】
yohimbine	alpha2-adrenoceptor	C6
【PRE_R】
yohimbine	alpha2-adrenoceptor	C6

Alpha 1 - adrenoceptor subtypes mediating the regulation and modulation of Ca2 + sensitization in rabbit thoracic aorta .
【GOLD_E】
Ca2+	chem
Alpha1-adrenoceptor	geneN
【PRE_E】
Alpha1-adrenoceptor	geneN
Ca2+	chem
【GOLD_R】
【PRE_R】

Norepinephrine ( 10 microM ) , methoxamine ( 100 microM ) and clonidine ( 100 microM ) with guanosine 5 ' - triphosphate ( GTP , 50 microM ) or guanosine 5 ' - O - ( 3 - thiotriphosphate ) ( GTP gamma - S , 10 microM ) all significantly enhanced the contraction induced by 0.3 microM Ca2 + ( pCa6.5 ) in beta - escin - skinned smooth muscle of rabbit thoracic aorta .
【GOLD_E】
GTPgamma-S	chem
Ca2+	chem
methoxamine	chem
Norepinephrine	chem
clonidine	chem
guanosine5'-triphosphate	chem
guanosine5'-O-(3-thiotriphosphate)	chem
【PRE_E】
Norepinephrine	chem
methoxamine	chem
clonidine	chem
guanosine5'-triphosphate	chem
GTP	chem
guanosine5'-O-(3-thiotriphosphate)	chem
GTPgamma-S	chem
Ca2+	chem
pCa6.5	chem
beta-escin	chem
【GOLD_R】
【PRE_R】

The enhancement of Ca2 + contraction produced by norepinephrine was greater than that produced by methoxamine or clonidine .
【GOLD_E】
Ca2+	chem
norepinephrine	chem
methoxamine	chem
clonidine	chem
【PRE_E】
Ca2+	chem
norepinephrine	chem
methoxamine	chem
clonidine	chem
【GOLD_R】
【PRE_R】

In beta - escin - skinned strips of chloroethylclonidine - pretreated smooth muscle , the enhancement of Ca2 + contraction produced by norepinephrine was significantly decreased , whereas the amplitude was the same as that produced by methoxamine or clonidine ; this enhancement was inhibited by the selective alpha 1A - adrenoceptor antagonist WB 4101 ( 100 nM ) .
【GOLD_E】
chloroethylclonidine	chem
Ca2+	chem
norepinephrine	chem
methoxamine	chem
clonidine	chem
WB4101	chem
alpha1A-adrenoceptor	geneY
【PRE_E】
chloroethylclonidine	chem
Ca2+	chem
norepinephrine	chem
methoxamine	chem
clonidine	chem
alpha1A-adrenoceptor	geneY
WB4101	chem
【GOLD_R】
WB4101	alpha1A-adrenoceptor	C6
【PRE_R】

The enhancement of Ca2 + contraction produced by methoxamine and clonidine was not affected by chloroethylclonidine pretreatment .
【GOLD_E】
Ca2+	chem
methoxamine	chem
clonidine	chem
chloroethylclonidine	chem
【PRE_E】
Ca2+	chem
methoxamine	chem
clonidine	chem
chloroethylclonidine	chem
【GOLD_R】
【PRE_R】

The effects of methoxamine , clonidine and norepinephrine in the chloroethylclonidine - pretreated tissue were all inhibited by guanosine 5 ' - O - ( 2 - thiodiphosphate ) ( GDP beta - S , 1 mM ) and 1 - ( 5 - isoquinolinylsulfonyl ) - methylpiperazine ( H - 7 , 20 microM ) .
【GOLD_E】
chloroethylclonidine	chem
methoxamine	chem
clonidine	chem
norepinephrine	chem
guanosine5'-O-(2-thiodiphosphate)	chem
GDPbeta-S	chem
1-(5-isoquinolinylsulfonyl)-methylpiperazine	chem
【PRE_E】
methoxamine	chem
clonidine	chem
norepinephrine	chem
chloroethylclonidine	chem
guanosine5'-O-(2-thiodiphosphate)	chem
GDPbeta-S	chem
1-(5-isoquinolinylsulfonyl)-methylpiperazine	chem
H-7	chem
【GOLD_R】
【PRE_R】

Furthermore , the phosphorylation of myosin light chain produced by norepinephrine was greater than that produced by clonidine .
【GOLD_E】
myosinlightchain	geneN
norepinephrine	chem
clonidine	chem
【PRE_E】
myosinlightchain	geneY
norepinephrine	chem
clonidine	chem
【GOLD_R】
norepinephrine	myosinlightchain	C3
clonidine	myosinlightchain	C3
【PRE_R】
myosinlightchain	clonidine	C4

These results suggest that both alpha 1 - adrenoceptor subtypes ( alpha 1A and alpha 1B ) increase the Ca2 + sensitivity of contractile elements , and that the Ca2 + sensitization produced by alpha 1A - subtype receptors is mediated through G - protein and protein kinase C , and plays an important role in contraction of smooth muscle of rabbit thoracic aorta .
【GOLD_E】
Ca2+	chem
alpha1-adrenoceptorsubtypes(alpha1Aandalpha1B	geneN
alpha1A-subtypereceptors	geneY
G-protein	geneN
proteinkinaseC	geneN
Ca2+	chem
【PRE_E】
alpha1-adrenoceptor	geneY
Ca2+	chem
Ca2+	chem
alpha1A-subtypereceptors	geneN
G-protein	geneN
proteinkinaseC	geneY
【GOLD_R】
【PRE_R】

STZ transport and cytotoxicity . Specific enhancement in GLUT2 - expressing cells .
【GOLD_E】
GLUT2	geneY
【PRE_E】
STZ	chem
GLUT2	geneY
【GOLD_R】
【PRE_R】
STZ	GLUT2	C3

The glucose analog streptozotocin ( STZ ) has long been used as a tool for creating experimental diabetes because of its relatively specific beta - cell cytotoxic effect , but the mechanism by which systemic injection of STZ causes beta - cell destruction is not well understood .
【GOLD_E】
streptozotocin	chem
STZ	chem
STZ	chem
glucose	chem
【PRE_E】
glucose	chem
streptozotocin	chem
STZ	chem
STZ	chem
【GOLD_R】
【PRE_R】

In the current study , we have used insulinoma ( RIN ) and AtT - 20ins cell lines engineered for overexpression of GLUT2 or GLUT1 to investigate the role of glucose transporter isoforms in mediating STZ cytotoxicity .
【GOLD_E】
GLUT2	geneY
GLUT1	geneY
glucosetransporter	geneN
glucose	chem
STZ	chem
【PRE_E】
GLUT2	geneY
GLUT1	geneY
glucosetransporter	geneY
STZ	chem
【GOLD_R】
【PRE_R】

The in vivo effects of STZ were evaluated by implantation of RIN cells expressing or lacking GLUT2 into athymic nude rats .
【GOLD_E】
GLUT2	geneY
STZ	chem
【PRE_E】
STZ	chem
GLUT2	geneY
【GOLD_R】
【PRE_R】

The drug had a potent cytotoxic effect on RIN cells expressing GLUT2 , but had no effect on cells lacking GLUT2 expression , as indicated by histological analysis and measurement of the blood glucose levels of treated animals .
【GOLD_E】
glucose	chem
GLUT2	geneY
GLUT2	geneY
【PRE_E】
GLUT2	geneY
GLUT2	geneY
glucose	chem
【GOLD_R】
glucose	GLUT2	C9
【PRE_R】

The preferential cytotoxic effect of STZ on GLUT2 - expressing cell lines was confirmed by in vitro analysis of GLUT2 - expressing and untransfected RIN cells , as well as GLUT2 - and GLUT1 - overexpressing AtT - 20ins cells .
【GOLD_E】
STZ	chem
GLUT2	geneY
GLUT1	geneY
GLUT2	geneY
GLUT2	geneY
【PRE_E】
STZ	chem
GLUT2	geneY
GLUT2	geneY
GLUT2	geneY
GLUT1	geneY
【GOLD_R】
【PRE_R】

Consistent with these data , only GLUT2 - expressing RIN or AtT - 20ins cells transported STZ efficiently .
【GOLD_E】
GLUT2	geneY
STZ	chem
【PRE_E】
GLUT2	geneY
STZ	chem
【GOLD_R】
STZ	GLUT2	C9
【PRE_R】

We conclude that expression of GLUT2 is required for efficient killing of neuroendocrine cells by STZ , and this effect is related to specific recognition of the drug as a transported substrate by GLUT2 but not GLUT1 .
【GOLD_E】
GLUT2	geneY
GLUT2	geneY
GLUT1	geneY
STZ	chem
【PRE_E】
GLUT2	geneY
STZ	chem
GLUT2	geneY
GLUT1	geneY
【GOLD_R】
STZ	GLUT2	C9
STZ	GLUT2	C9
【PRE_R】

Annexin 1 regulation in human epidermal cells .
【GOLD_E】
Annexin1	geneY
【PRE_E】
Annexin1	geneY
【GOLD_R】
【PRE_R】

Annexin 1 ( named p35 , lipocortin I or calpactin II ) , initially described as a glucocorticoid induced protein , belongs to a new characterized family of intracellular proteins .
【GOLD_E】
calpactinII	geneY
Annexin1	geneY
p35	geneY
lipocortinI	geneY
【PRE_E】
Annexin1	geneY
p35	geneY
lipocortinI	geneY
calpactinII	geneY
【GOLD_R】
【PRE_R】

In the skin , the role of annexins has still not been elucidated .
【GOLD_E】
annexins	geneN
【PRE_E】
annexins	geneN
【GOLD_R】
【PRE_R】

In a previous study , we reported the localization of annexin 1 in both freshly isolated human epidermal cells and in cultured keratinocytes using immunofluorescence , FACS analysis and immunoblotting techniques .
【GOLD_E】
annexin1	geneY
【PRE_E】
annexin1	geneY
【GOLD_R】
【PRE_R】

The protein was characterized by Western blot and immunoprecipitation as a 35 kDa protein .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Results from in vivo studies confirmed the presence of annexin 1 in basal and suprabasal layers of normal human skin with modified reactivity patterns in hyperproliferative lesions .
【GOLD_E】
annexin1	geneY
【PRE_E】
annexin1	geneY
【GOLD_R】
【PRE_R】

In the present study , the role of glucocorticoids in annexin 1 regulation was investigated in epidermal cells by Western blot and immunoprecipation assays .
【GOLD_E】
annexin1	geneY
【PRE_E】
annexin1	geneY
【GOLD_R】
【PRE_R】

In contrast to other studies , we found that glucocorticoid treatment of epidermal cells led to a decrease in annexin 1 content in the cytoplasm and the membranes of cells .
【GOLD_E】
annexin1	geneY
【PRE_E】
glucocorticoid	geneY
annexin1	geneY
【GOLD_R】
【PRE_R】

As annexin 1 was not detected in the nucleus of cells , we conclude that there was a down regulation of annexin 1 after glucocorticoid treatments rather than a translocation of the protein to the nucleus .
【GOLD_E】
annexin1	geneY
annexin1	geneY
【PRE_E】
annexin1	geneY
annexin1	geneY
【GOLD_R】
【PRE_R】

Despite the absence of the signal peptide sequence necessary for protein secretion , annexin 1 was released in the keratinocyte culture medium .
【GOLD_E】
annexin1	geneY
【PRE_E】
annexin1	geneY
【GOLD_R】
【PRE_R】

We found that the protein was secreted only in low Ca2 + medium ( 0.15 mM ) , this process required an active metabolism .
【GOLD_E】
Ca2+	chem
【PRE_E】
Ca2+	chem
【GOLD_R】
【PRE_R】

Inhibitory effects of lysine analogues on t - PA induced whole blood clot lysis .
【GOLD_E】
lysine	chem
t-PA	geneY
【PRE_E】
lysine	chem
t-PA	geneY
【GOLD_R】
lysine	t-PA	C4
【PRE_R】

The lysine analogues epsilon - aminocaproic acid ( EACA ) and trans - 4 - amino - methyl cyclohexane carboxylic acid ( AMCA ) are used to prevent excessive bleeding in patients with coagulopathies , such as hemophilia and thrombocytopenia , or in those who have received tissue plasminogen activator ( t - PA ) .
【GOLD_E】
AMCA	chem
tissueplasminogenactivator	geneY
t-PA	geneY
epsilon-aminocaproicacid	chem
lysine	chem
EACA	chem
trans-4-amino-methylcyclohexanecarboxylicacid	chem
【PRE_E】
lysine	chem
epsilon-aminocaproicacid	chem
EACA	chem
trans-4-amino-methylcyclohexanecarboxylicacid	chem
AMCA	chem
tissueplasminogenactivator	geneY
t-PA	geneY
【GOLD_R】
【PRE_R】
trans-4-amino-methylcyclohexanecarboxylicacid	t-PA	C4

However , their relative efficacy in inhibiting lysis of clots that have been formed in the presence of exogenous t - PA or that have been formed and then exposed to exogenous t - PA has not been well characterized .
【GOLD_E】
t-PA	geneY
t-PA	geneY
【PRE_E】
t-PA	geneY
t-PA	geneY
【GOLD_R】
【PRE_R】

The present study utilized blood from normal volunteers and 125I - fibrinogen in a dilute whole blood clot assay to determine the relative concentrations of lysine analogues required for inhibition of clot lysis induced by exogenous t - PA .
【GOLD_E】
fibrinogen	geneN
t-PA	geneY
125I	chem
lysine	chem
【PRE_E】
125I-fibrinogen	geneN
lysine	chem
t-PA	geneY
【GOLD_R】
lysine	t-PA	C4
【PRE_R】
lysine	t-PA	C4

AMCA ( 0.06 mM ) and EACA ( 0.6 mM ) were effective in prolonging clot lysis if ( 1 ) whole blood clots were formed and then exposed to a lysine analogue and exogenous t - PA or if ( 2 ) whole blood clots were formed in the presence of exogenous t - PA and a lysine analogue .
【GOLD_E】
AMCA	chem
EACA	chem
lysine	chem
lysine	chem
t-PA	geneY
t-PA	geneY
【PRE_E】
AMCA	chem
EACA	chem
lysine	chem
t-PA	geneY
t-PA	geneY
lysine	chem
【GOLD_R】
AMCA	t-PA	C4
AMCA	t-PA	C4
EACA	t-PA	C4
EACA	t-PA	C4
【PRE_R】

However , their inhibitory effect was markedly reduced if clots were formed in the presence of t - PA and then exposed to either of the lysine analogues .
【GOLD_E】
t-PA	geneY
lysine	chem
【PRE_E】
t-PA	geneY
lysine	chem
【GOLD_R】
lysine	t-PA	C4
【PRE_R】
t-PA	lysine	C4

The analogues did not inhibit the initial binding of t - PA to fibrin .
【GOLD_E】
t-PA	geneY
fibrin	geneN
【PRE_E】
t-PA	geneN
fibrin	geneN
【GOLD_R】
【PRE_R】

They did inhibit binding of plasminogen to fibrin as well as the activation of plasminogen by t - PA in the absence of fibrin .
【GOLD_E】
plasminogen	geneY
fibrin	geneN
plasminogen	geneY
t-PA	geneY
fibrin	geneN
【PRE_E】
plasminogen	geneN
fibrin	geneN
plasminogen	geneN
t-PA	geneY
fibrin	geneN
【GOLD_R】
【PRE_R】

The data suggest that lysine analogues , even at low concentrations , reduce the rate of t - PA induced whole blood clot lysis by several mechanisms .
【GOLD_E】
t-PA	geneY
lysine	chem
【PRE_E】
lysine	chem
t-PA	geneY
【GOLD_R】
lysine	t-PA	C4
【PRE_R】
lysine	t-PA	C4

Histamine enhances the depolarizing afterpotential of immunohistochemically identified vasopressin neurons in the rat supraoptic nucleus via H1 - receptor activation .
【GOLD_E】
Histamine	chem
vasopressin	chem
H1-receptor	geneY
【PRE_E】
Histamine	chem
vasopressin	geneY
H1-receptor	geneY
【GOLD_R】
Histamine	H1-receptor	C3
【PRE_R】

Previous studies have demonstrated that histamine primarily excites unidentified neurons in the rat supraoptic nucleus .
【GOLD_E】
histamine	chem
【PRE_E】
histamine	chem
【GOLD_R】
【PRE_R】

We investigated the neuromodulatory effects of histamine on immunohistochemically identified vasopressin neurons in the rat supraoptic nucleus using intracellular recording techniques from the hypothalamo - neurohypophysial explant .
【GOLD_E】
histamine	chem
vasopressin	chem
【PRE_E】
histamine	chem
vasopressin	geneY
hypothalamo-neurohypophysialexplant	geneY
【GOLD_R】
【PRE_R】

Exogenous application of histamine ( 0.1 - 100 microM ) to vasopressinergic neurons produced a small membrane depolarization accompanied by an increase of up to 100 % in the amplitude of the depolarizing afterpotential that follows current - evoked trains of action potentials .
【GOLD_E】
histamine	chem
【PRE_E】
histamine	chem
【GOLD_R】
【PRE_R】

The enhancement of the depolarizing afterpotential by histamine did not depend upon the depolarization .
【GOLD_E】
histamine	chem
【PRE_E】
histamine	chem
【GOLD_R】
【PRE_R】

Further , histamine enhanced the amplitude of the depolarizing afterpotential when blocking the afterhyperpolarizing potential with d - tubocurarine or apamin , and in the presence of tetrodotoxin and d - tubocurarine or apamin , indicating a postsynaptic action of histamine on the depolarizing afterpotential that is not simply a reflection of a decrease in the afterhyperpolarizing potential .
【GOLD_E】
histamine	chem
d-tubocurarine	chem
tetrodotoxin	chem
d-tubocurarine	chem
histamine	chem
【PRE_E】
histamine	chem
d-tubocurarine	chem
apamin	chem
tetrodotoxin	chem
d-tubocurarine	chem
apamin	chem
histamine	chem
【GOLD_R】
【PRE_R】

These toxins also had no effect on the histamine - induced depolarization .
【GOLD_E】
histamine	chem
【PRE_E】
histamine	chem
【GOLD_R】
【PRE_R】

The enhancement of the depolarizing afterpotential by histamine was mimicked by the histamine H1 - receptor agonist 2 - thiazolylethylamine and was reduced or blocked by the H1 - receptor antagonist promethazine , but was not blocked or reduced in the presence of the histamine H2 - receptor antagonist , cimetidine .
【GOLD_E】
histamineH1-receptor	geneY
H1-receptor	geneY
histamineH2-receptor	geneY
histamine	chem
histamine	chem
2-thiazolylethylamine	chem
promethazine	chem
histamine	chem
cimetidine	chem
【PRE_E】
histamine	chem
histamineH1-receptor	geneY
2-thiazolylethylamine	chem
H1-receptor	geneY
promethazine	chem
histamineH2-receptor	geneN
cimetidine	chem
【GOLD_R】
2-thiazolylethylamine	histamineH1-receptor	C5
promethazine	H1-receptor	C6
cimetidine	histamineH2-receptor	C6
【PRE_R】
2-thiazolylethylamine	H1-receptor	C5

In summary , these results show that the excitatory effect of histamine on immunohistochemically identified vasopressin neurons in the supraoptic nucleus is due in part to the H1 - receptor - mediated enhancement of the depolarizing afterpotential independent of any change in the afterhyperpolarizing potential or membrane potential .
【GOLD_E】
H1-receptor	geneY
histamine	chem
vasopressin	chem
【PRE_E】
histamine	chem
vasopressin	geneY
H1-receptor	geneY
【GOLD_R】
histamine	H1-receptor	C3
【PRE_R】

Adapalene , a new chemical entity with retinoid activity .
【GOLD_E】
Adapalene	chem
retinoid	chem
【PRE_E】
Adapalene	chem
retinoid	chem
【GOLD_R】
【PRE_R】

Adapalene is a novel chemical entity which , in terms of pharmacology , behaves similar to tretinoin , but is chemically and photochemically stable .
【GOLD_E】
tretinoin	chem
Adapalene	chem
【PRE_E】
Adapalene	chem
tretinoin	chem
【GOLD_R】
【PRE_R】

It has a particular selectivity profile for the known nuclear retinoic acid receptors with low affinity for RAR alpha and no transactivating potential for RXR alpha .
【GOLD_E】
retinoicacidreceptors	geneN
RARalpha	geneY
RXRalpha	geneY
retinoicacid	chem
【PRE_E】
nuclearretinoicacidreceptors	geneN
RARalpha	geneY
RXRalpha	geneY
【GOLD_R】
【PRE_R】

This receptor profile could imply that adapalene , in contrast to tretinoin , affects the terminal differentiation pathway of epidermal cells rather than their proliferation .
【GOLD_E】
adapalene	chem
tretinoin	chem
【PRE_E】
adapalene	chem
tretinoin	chem
【GOLD_R】
【PRE_R】

Furthermore , adapalene does not bind to members of the cellular retinoic acid binding protein family .
【GOLD_E】
retinoicacidbindingprotein	geneN
adapalene	chem
retinoicacid	chem
【PRE_E】
adapalene	chem
retinoicacid	chem
【GOLD_R】
【PRE_R】

Adapalene has comedolytic activity in the topical rhino mouse model .
【GOLD_E】
Adapalene	chem
【PRE_E】
Adapalene	chem
【GOLD_R】
【PRE_R】

It exerts a moderate - to - potent anti - inflammatory effect in a series of in vitro and in vivo models .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In comparative clinical studies involving 72 acne patients , the efficacy of adapalene was comparable , if not superior , to tretinoin , but adapalene was better tolerated .
【GOLD_E】
adapalene	chem
adapalene	chem
tretinoin	chem
【PRE_E】
adapalene	chem
tretinoin	chem
adapalene	chem
【GOLD_R】
【PRE_R】

The data reviewed in this paper indicate that adapalene should be particularly beneficial in the treatment of acne .
【GOLD_E】
adapalene	chem
【PRE_E】
adapalene	chem
【GOLD_R】
【PRE_R】

Comparative effects of three different potent renin inhibitors in primates .
【GOLD_E】
renin	geneN
【PRE_E】
renin	geneY
【GOLD_R】
【PRE_R】

The goal of the present study was to compare the effects of three potent reference renin inhibitors ( remikiren , CGP 38560A , and enalkiren ) in sodium - depleted normotensive squirrel monkeys .
【GOLD_E】
remikiren	chem
renin	geneY
CGP38560A	chem
enalkiren	chem
sodium	chem
【PRE_E】
renin	geneY
remikiren	chem
CGP38560A	chem
enalkiren	chem
sodium	chem
【GOLD_R】
remikiren	renin	C4
CGP38560A	renin	C4
enalkiren	renin	C4
【PRE_R】
renin	remikiren	C4
renin	CGP38560A	C4
renin	enalkiren	C4

In these monkeys , arterial pressure was measured in the conscious state with a telemetry system .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Oral and intravenous maximal effective doses of the three renin inhibitors were compared in parallel groups of monkeys .
【GOLD_E】
renin	geneY
【PRE_E】
renin	geneY
【GOLD_R】
【PRE_R】

In additional experiments , remikiren was given on top of either CGP 38560A or enalkiren in the same animals .
【GOLD_E】
CGP38560A	chem
enalkiren	chem
【PRE_E】
remikiren	chem
CGP38560A	chem
enalkiren	chem
【GOLD_R】
【PRE_R】

Finally , the three drugs were compared with the angiotensin converting enzyme inhibitor cilazapril .
【GOLD_E】
cilazapril	chem
angiotensinconvertingenzyme	geneY
【PRE_E】
angiotensinconvertingenzyme	geneY
cilazapril	chem
【GOLD_R】
cilazapril	angiotensinconvertingenzyme	C4
【PRE_R】

The effects of the three drugs on the plasma components of the renin - angiotensin system ( plasma renin activity , immunoreactive renin , and immunoreactive angiotensin II concentrations ) were also measured .
【GOLD_E】
renin	geneY
angiotensin	geneY
renin	geneY
renin	geneY
angiotensinII	geneY
【PRE_E】
renin	geneY
angiotensin	geneY
renin	geneY
renin	geneY
angiotensinII	geneY
【GOLD_R】
【PRE_R】

Our results show that remikiren was as effective as cilazapril and markedly more effective than CGP 38560A or enalkiren in reducing arterial pressure in our monkey model .
【GOLD_E】
remikiren	chem
cilazapril	chem
CGP38560A	chem
enalkiren	chem
【PRE_E】
remikiren	chem
cilazapril	chem
CGP38560A	chem
enalkiren	chem
【GOLD_R】
【PRE_R】

Interestingly , these differences in arterial pressure could not be explained by differences of in vitro potency or different biochemical changes of the plasma components of the renin - angiotensin system , because the inhibitors all reduced immunoreactive angiotensin II to similarly low levels .
【GOLD_E】
renin	geneY
angiotensin	geneY
angiotensinII	geneY
【PRE_E】
renin	geneY
angiotensin	geneY
angiotensinII	geneY
【GOLD_R】
【PRE_R】

One possible explanation is that , in our model , remikiren in contrast to CGP 38560A and enalkiren is able to inhibit renin in a functionally important extraplasmatic compartment .
【GOLD_E】
renin	geneY
remikiren	chem
CGP38560A	chem
enalkiren	chem
【PRE_E】
remikiren	chem
CGP38560A	chem
enalkiren	chem
renin	geneY
【GOLD_R】
remikiren	renin	C4
CGP38560A	renin	C4
enalkiren	renin	C4
【PRE_R】
remikiren	renin	C4
CGP38560A	renin	C4
enalkiren	renin	C4

Inhibition of cytokine - primed eosinophil chemotaxis by nedocromil sodium .
【GOLD_E】
nedocromilsodium	chem
cytokine	geneN
【PRE_E】
cytokine	geneN
nedocromilsodium	chem
【GOLD_R】
nedocromilsodium	cytokine	C4
【PRE_R】
cytokine	nedocromilsodium	C4

BACKGROUND : Eosinophil influx into the lung tissue is considered to be relevant for the pathogenesis of asthma .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Various chemotactic factors may be responsible for this influx .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Recently it has been demonstrated that the cytokines granulocyte - macrophage colony - stimulating factor ( GM - CSF ) , interleukin - 3 ( IL - 3 ) , and interleukin - 5 ( IL - 5 ) are present in the circulation of individuals with allergic asthma .
【GOLD_E】
cytokines	geneN
granulocyte-macrophagecolony-stimulatingfactor	geneY
GM-CSF	geneY
interleukin-3	geneY
IL-3	geneY
interleukin-5	geneY
IL-5	geneY
【PRE_E】
cytokines	geneN
granulocyte-macrophagecolony-stimulatingfactor	geneY
GM-CSF	geneY
interleukin-3	geneY
IL-3	geneY
interleukin-5	geneY
IL-5	geneY
【GOLD_R】
【PRE_R】

These cytokines have the capacity to modulate chemotactic responses of eosinophils toward platelet - activating factor , formyl - methionyl - leucyl - phenylalanine , ( FMLP ) and neutrophil - activating factor ( NAF ) / IL - 8 , but not toward complement fragment C5a ( C5a ) .
【GOLD_E】
cytokines	geneN
neutrophil-activatingfactor	geneY
NAF	geneY
IL-8	geneY
complementfragmentC5a	geneY
C5a	geneY
formyl-methionyl-leucyl-phenylalanine	chem
FMLP	chem
【PRE_E】
cytokines	geneN
platelet-activatingfactor	geneN
formyl-methionyl-leucyl-phenylalanine	geneY
FMLP	geneY
neutrophil-activatingfactor	geneY
NAF	geneY
IL-8	geneY
C5a	geneY
C5a	geneY
【GOLD_R】
【PRE_R】

Here the effect of nedocromil sodium on the chemotactic response of eosinophils from allergic asthmatic individuals and from normal donors preincubated with GM - CSF or IL - 3 toward FMLP , NAF / IL - 8 was evaluated .
【GOLD_E】
GM-CSF	geneY
IL-3	geneN
NAF	geneY
IL-8	geneY
nedocromilsodium	chem
【PRE_E】
nedocromilsodium	chem
GM-CSF	geneY
IL-3	geneY
FMLP	geneY
NAF	chem
IL-8	geneY
【GOLD_R】
【PRE_R】

RESULTS : Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF / IL - 8 of GM - CSF primed eosinophils approximately 60 % ( inhibitory concentration of 50 % [ IC50 ] approximately 1 to 10 nmol / L ) , whereas these responses of IL - 3 primed eosinophils was completely inhibited ( IC50 approximately 1 nmol / L ) .
【GOLD_E】
IL-3	geneY
NAF	geneY
IL-8	geneY
GM-CSF	geneY
Nedocromilsodium	chem
FMLP	chem
【PRE_E】
Nedocromilsodium	chem
FMLP	geneN
NAF	chem
IL-8	geneY
GM-CSF	geneY
IL-3	geneY
【GOLD_R】
Nedocromilsodium	GM-CSF	C4
Nedocromilsodium	IL-3	C4
Nedocromilsodium	NAF	C4
Nedocromilsodium	IL-8	C4
【PRE_R】
Nedocromilsodium	FMLP	C4
Nedocromilsodium	IL-8	C4
Nedocromilsodium	GM-CSF	C4
Nedocromilsodium	IL-3	C4

CONCLUSIONS : The chemotactic responses toward C5a were inhibited by nedocromil sodium at higher concentrations than were required in the priming studies ( IC50 approximately 10 to 100 nmol / L ) .
【GOLD_E】
C5a	geneY
nedocromilsodium	chem
【PRE_E】
C5a	geneY
nedocromilsodium	chem
【GOLD_R】
nedocromilsodium	C5a	C4
【PRE_R】
C5a	nedocromilsodium	C4

Nedocromil sodium ( 0.1 mumol / L ) was also effective in inhibiting the chemotactic response toward FMLP ( 10 nmol / L ) of eosinophils isolated from the circulation of patients with allergic asthma 3 hours after allergen challenge .
【GOLD_E】
Nedocromilsodium	chem
FMLP	chem
【PRE_E】
Nedocromilsodium	chem
chemotacticresponsetowardFMLP	geneN
【GOLD_R】
【PRE_R】
Nedocromilsodium	chemotacticresponsetowardFMLP	C4

These findings might explain in part the antiinflammatory action of nedocromil sodium .
【GOLD_E】
nedocromilsodium	chem
【PRE_E】
nedocromilsodium	chem
【GOLD_R】
【PRE_R】

Dominant expression of mRNA for prostaglandin D synthase in leptomeninges , choroid plexus , and oligodendrocytes of the adult rat brain .
【GOLD_E】
prostaglandinDsynthase	geneY
prostaglandinD	chem
【PRE_E】
prostaglandinDsynthase	geneY
【GOLD_R】
【PRE_R】

Glutathione - independent prostaglandin D synthase [ prostaglandin - H2 D - isomerase ; ( 5Z,13E ) - ( 15S ) - 9 alpha,11 alpha - epidioxy - 15 - hydroxyprosta - 5,13 - dienoate D - isomerase , EC 5.3.99.2 ] is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system .
【GOLD_E】
prostaglandin-H2D-isomerase	geneY
(5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoateD-isomerase	geneY
Glutathione	chem
prostaglandinD2	chem
prostaglandinD	chem
prostaglandin-H2	chem
(5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate	chem
EC5.3.99.2	geneY
prostaglandinDsynthase	geneY
【PRE_E】
Glutathione	chem
prostaglandinDsynthase	geneY
prostaglandin-H2D-isomerase	geneY
(5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoateD-isomerase	chem
EC5.3.99.2	geneY
prostaglandinD2	chem
【GOLD_R】
prostaglandinD2	prostaglandin-H2D-isomerase	C9
prostaglandinD2	(5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoateD-isomerase	C9
prostaglandinD2	EC5.3.99.2	C9
prostaglandinD2	prostaglandinDsynthase	C9
【PRE_R】

In situ hybridization with antisense RNA for the enzyme indicated that mRNA for the enzyme was predominantly expressed in the leptomeninges , choroid plexus , and oligodendrocytes of the adult rat brain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The findings agree with those obtained by immunohistochemical staining with antibodies against the enzyme .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It was further revealed that prostaglandin D synthase activity was considerably greater in the isolated leptomeninges ( 14.2 nmol per min per mg of protein ) and choroid plexus ( 7.0 nmol per min per mg of protein ) than the activity in the whole brain ( 2.0 nmol per min per mg of protein ) .
【GOLD_E】
prostaglandinDsynthase	geneY
prostaglandinD	chem
【PRE_E】
prostaglandinDsynthase	geneY
【GOLD_R】
【PRE_R】

These results , taken together , indicate that the enzyme is mainly synthesized and located in the leptomeninges , choroid plexus , and oligodendrocytes in the brain .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

cDNA cloning and functional properties of human glutamate receptor EAA3 ( GluR5 ) in homomeric and heteromeric configuration .
【GOLD_E】
glutamate	chem
humanglutamatereceptor	geneN
EAA3	geneY
GluR5	geneY
【PRE_E】
humanglutamatereceptorEAA3	geneY
GluR5	geneY
【GOLD_R】
【PRE_R】

We have isolated a new member of the human glutamate receptor family from a fetal brain cDNA library .
【GOLD_E】
glutamate	chem
humanglutamatereceptor	geneN
【PRE_E】
humanglutamatereceptor	geneN
【GOLD_R】
【PRE_R】

This cDNA clone , designated EAA3a , shares a 90 % nucleotide identity with the previously reported rat GluR5 - 2b cDNA splice variant and differed from human GluR5 - 1d in the amino and carboxy terminal regions .
【GOLD_E】
nucleotide	chem
amino	chem
carboxy	chem
EAA3a	geneY
ratGluR5-2b	geneY
humanGluR5-1d	geneY
【PRE_E】
EAA3a	geneY
nucleotide	chem
ratGluR5-2b	geneY
humanGluR5-1d	geneY
amino	chem
carboxy	chem
【GOLD_R】
【PRE_R】

Cell lines stably expressing EAA3a protein formed homomeric ligand - gated ion channels responsive , in order of decreasing affinity to domoate , kainate , L - glutamate and ( RS ) - alpha - amino - 3 - hydroxy - 5 - methylisoxazole - propionate ( AMPA ) .
【GOLD_E】
kainate	chem
L-glutamate	chem
(RS)-alpha-amino-3-hydroxy-5-methylisoxazole-propionate	chem
AMPA	chem
EAA3a	geneY
ligand-gatedionchannels	geneN
【PRE_E】
EAA3a	geneY
homomericligand-gatedionchannels	geneN
domoate	chem
kainate	chem
L-glutamate	chem
(RS)-alpha-amino-3-hydroxy-5-methylisoxazole-propionate	chem
AMPA	chem
【GOLD_R】
【PRE_R】

Kainate - evoked currents showed partial desensitization that was reduced on incubation with concanavalin A ( conA ) but not cyclothiazide and were attenuated by the non - N - methyl - D - aspartate ( NMDA ) receptor antagonist CNQX ( 6 - cyano - 7 - nitro - quinoxalinedione ) .
【GOLD_E】
Kainate	chem
cyclothiazide	chem
non-N-methyl-D-aspartate	chem
NMDA	chem
CNQX	chem
6-cyano-7-nitro-quinoxalinedione	chem
concanavalinA	geneN
conA	geneN
N-methyl-D-aspartate(NMDA)receptor	geneN
【PRE_E】
Kainate	chem
concanavalinA	chem
conA	chem
cyclothiazide	chem
N-methyl-D-aspartate(NMDA)receptor	geneN
CNQX	chem
6-cyano-7-nitro-quinoxalinedione	chem
【GOLD_R】
CNQX	N-methyl-D-aspartate(NMDA)receptor	C6
6-cyano-7-nitro-quinoxalinedione	N-methyl-D-aspartate(NMDA)receptor	C6
【PRE_R】

Coexpression of EAA3a and human EAA1 cDNAs in HEK 293 cells formed a heteromeric channel with unique properties .
【GOLD_E】
EAA3a	geneY
humanEAA1	geneY
【PRE_E】
EAA3a	geneY
humanEAA1	geneY
【GOLD_R】
【PRE_R】

Kainate and AMPA activated the heteromeric channel with significantly higher affinities than observed for EAA3a alone .
【GOLD_E】
Kainate	chem
AMPA	chem
EAA3a	geneY
【PRE_E】
Kainate	chem
AMPA	chem
EAA3a	geneN
【GOLD_R】
【PRE_R】

Ligand binding studies with the recombinant EAA3a receptor expressed in mammalian cells indicated a high affinity kainate binding site ( Kd = 120 + / - 15.0 nM ) .
【GOLD_E】
kainate	chem
EAA3a	geneY
【PRE_E】
EAA3areceptor	geneN
kainatebindingsite	geneN
【GOLD_R】
【PRE_R】

The relative potency of compounds in displacing [ 3H ] - kainate binding to EAA3a receptor was : domoate > kainate > L - glutamate = quisqualate > 6,7 - dinitroquinoxaline - 2,3 - dione ( DNQX ) = CNQX > AMPA > dihydrokainate > NMDA .
【GOLD_E】
dihydrokainate	chem
NMDA	chem
[3H]-kainate	chem
EAA3a	geneY
kainate	chem
L-glutamate	chem
quisqualate	chem
6,7-dinitroquinoxaline-2,3-dione	chem
DNQX	chem
CNQX	chem
AMPA	chem
【PRE_E】
[3H]-kainate	chem
EAA3areceptor	geneY
domoate	chem
kainate	chem
L-glutamate	chem
quisqualate	chem
6,7-dinitroquinoxaline-2,3-dione	chem
DNQX	chem
CNQX	chem
AMPA	chem
dihydrokainate	chem
NMDA	chem
【GOLD_R】
【PRE_R】

Leukotrienes in the pathogenesis of pulmonary blast injury .
【GOLD_E】
Leukotrienes	chem
【PRE_E】
Leukotrienes	chem
【GOLD_R】
【PRE_R】

Our previous studies demonstrate a significant increase of sulfidopeptide leukotriene concentrations in animals exposed to a free air blast .
【GOLD_E】
leukotriene	chem
【PRE_E】
sulfidopeptideleukotriene	chem
【GOLD_R】
【PRE_R】

The aim of this study was to analyze the role of leukotrienes in the local response of lung tissue as well as in the general response of organisms to blast overpressure .
【GOLD_E】
leukotrienes	chem
【PRE_E】
leukotrienes	chem
【GOLD_R】
【PRE_R】

The study was conducted on adult rabbits exposed to moderate blast overpressure ( four pulmonary contusions characterized as confluent ecchymoses involving 30 to 60 % of the lungs ) , generated in laboratory conditions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

One group of experimental animals was treated with 5 - lipoxygenase ( 5 - LO ) inhibitor , diethylcarbamazine ( DEC , Sigma , St .
【GOLD_E】
5-lipoxygenase	geneY
5-LO	geneY
diethylcarbamazine	chem
DEC	chem
【PRE_E】
5-lipoxygenase	geneY
5-LO	geneY
diethylcarbamazine	chem
DEC	chem
Sigma	chem
【GOLD_R】
diethylcarbamazine	5-lipoxygenase	C4
diethylcarbamazine	5-LO	C4
DEC	5-lipoxygenase	C4
DEC	5-LO	C4
【PRE_R】
5-lipoxygenase	diethylcarbamazine	C4
5-LO	diethylcarbamazine	C4
5-LO	DEC	C4
5-LO	Sigma	C4

Louis , Missouri ) ( 50 mg / kg , i.v . ) , immediately before blast .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The early posttraumatic period was observed ( 30 minutes after blast ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Hemodynamic parameters ( mean arterial pressure , heart rate , blood gases ) as well as arterial plasma levels of conjugated dienes were observed .
【GOLD_E】
【PRE_E】
dienes	chem
【GOLD_R】
【PRE_R】

The myeloperoxidase activity , lipid peroxidation products levels , and water contents were measured in the lung tissue of injured rabbits .
【GOLD_E】
myeloperoxidase	geneY
【PRE_E】
myeloperoxidase	geneY
【GOLD_R】
【PRE_R】

We observed that 5 - LO inhibition reduced edema formation , accumulation of neutrophils , and generation of lipid peroxidation products in injured lungs .
【GOLD_E】
5-LO	geneY
【PRE_E】
5-LO	geneY
【GOLD_R】
【PRE_R】

In this study , we demonstrated that treatment with DEC inhibits the increased systemic generation of conjugated dienes after blast injury .
【GOLD_E】
DEC	chem
【PRE_E】
DEC	chem
dienes	chem
【GOLD_R】
【PRE_R】

Although DEC exerts local antioxidant activity with beneficial effects on lung tissue , this 5 - LO inhibitor intensifies the blast overpressure caused hemodynamic insufficiency .
【GOLD_E】
DEC	chem
5-LO	geneY
【PRE_E】
DEC	chem
5-LO	geneY
【GOLD_R】
DEC	5-LO	C4
【PRE_R】
DEC	5-LO	C4

Tamsulosin , the first prostate - selective alpha 1A - adrenoceptor antagonist . A meta - analysis of two randomized , placebo - controlled , multicentre studies in patients with benign prostatic obstruction ( symptomatic BPH ) . European Tamsulosin Study Group .
【GOLD_E】
Tamsulosin	chem
Tamsulosin	chem
alpha1A-adrenoceptor	geneY
【PRE_E】
Tamsulosin	chem
alpha1A-adrenoceptor	geneY
Tamsulosin	chem
【GOLD_R】
Tamsulosin	alpha1A-adrenoceptor	C6
【PRE_R】
Tamsulosin	alpha1A-adrenoceptor	C6

OBJECTIVE : This meta - analysis of two European studies evaluated the efficacy and safety of modified - release tamsulosin 0.4 mg once daily compared with placebo in patients with benign prostatic enlargement , lower urinary tract symptoms and prostatic obstruction ( symptomatic BPH ) .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

METHODS : Patients entered a 2 - week placebo run - in period , followed by randomization to treatment with tamsulosin ( 382 patients ) or placebo ( 193 patients ) once daily for 12 weeks .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

RESULTS : Maximum urinary flow rate improved to a greater extent in the tamsulosin group ( 1.6 ml / s , 16 % ) than the placebo group ( 0.6 ml / s , 6 % ) ( p = 0.002 ) .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

Total Boyarsky symptom score also improved to a greater extent in the tamsulosin group ( 3.3 points , 35.1 % reduction ) than the placebo group ( 2.4 points , 25.5 % reduction ) ( p = 0.002 ) .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

Significantly more tamsulosin patients ( 66 % ) than placebo patients ( 49 % ) had a > or = 25 % decrease in total symptom score at endpoint ( p < 0.001 ) .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

Twelve weeks of treatment with tamsulosin also produced significant improvements in average urinary flow rate ( p = 0.005 ) and voiding or `` obstructive `` ( p = 0.008 ) and storage or `` irritative ' ( p = 0.017 ) symptom scores .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

The incidence of drug - related adverse events was comparable for the tamsulosin and placebo groups ( 13 and 12 % respectively , p = 0.802 ) .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

The same applies to the incidence of adverse events commonly attributed to alpha 1 - adrenoceptor antagonists , such as dizziness , headache , postural hypotension , syncope , asthenia , somnolence and rhinitis .
【GOLD_E】
alpha1-adrenoceptor	geneY
【PRE_E】
alpha1-adrenoceptor	geneN
【GOLD_R】
【PRE_R】

There were no clinically significant changes in blood pressure or pulse rate in tamsulosin patients compared with placebo patients both in hypertensive and normotensive BPH patients .
【GOLD_E】
tamsulosin	chem
【PRE_E】
tamsulosin	chem
【GOLD_R】
【PRE_R】

CONCLUSION : Tamsulosin 0.4 mg once daily is safe , well - tolerated and improves both the symptoms and urinary flow rate in patients with benign prostatic obstruction ( symptomatic BPH ) .
【GOLD_E】
Tamsulosin	chem
【PRE_E】
Tamsulosin	chem
【GOLD_R】
【PRE_R】

Human prohormone convertase 3 gene : exon - intron organization and molecular scanning for mutations in Japanese subjects with NIDDM .
【GOLD_E】
Humanprohormoneconvertase3	geneY
【PRE_E】
Humanprohormoneconvertase3	geneY
NIDDM	geneN
【GOLD_R】
【PRE_R】

Proinsulin is converted to insulin by the concerted action of two sequence - specific subtilisin - like proteases termed prohormone convertase 2 ( PC2 ) and prohormone convertase 3 ( PC3 ) .
【GOLD_E】
PC2	geneY
prohormoneconvertase3	geneY
PC3	geneY
insulin	geneY
subtilisin-likeproteases	geneN
Proinsulin	geneY
prohormoneconvertase2	geneY
【PRE_E】
Proinsulin	geneY
insulin	geneY
subtilisin-likeproteases	geneN
prohormoneconvertase2	geneY
PC2	geneN
prohormoneconvertase3	geneY
PC3	geneY
【GOLD_R】
【PRE_R】

PC3 is a type I proinsulin - processing enzyme that initiates the sequential processing of proinsulin to insulin by cleaving the proinsulin molecule on the COOH - terminal side of the dibasic peptide , Arg31 - Arg32 , joining the B - chain and C - peptide .
【GOLD_E】
PC3	geneY
typeIproinsulin-processingenzyme	geneN
proinsulin	geneY
insulin	geneY
proinsulin	geneY
COOH	chem
C	chem
【PRE_E】
PC3	geneY
proinsulin	geneY
proinsulin	geneY
insulin	geneY
proinsulin	geneY
COOH	chem
Arg31	chem
Arg32	chem
C-peptide	geneY
【GOLD_R】
【PRE_R】

Thus , PC3 plays a key role in regulating insulin biosynthesis .
【GOLD_E】
PC3	geneY
insulin	geneY
【PRE_E】
PC3	geneY
insulin	geneN
【GOLD_R】
【PRE_R】

Expressions of insulin and PC3 , but not PC2 , are coordinately regulated by glucose , consistent with the important role of PC3 in regulating proinsulin processing .
【GOLD_E】
insulin	geneY
PC3	geneY
PC2	geneY
PC3	geneY
proinsulin	geneY
glucose	chem
【PRE_E】
insulin	geneY
PC3	geneY
PC2	geneN
glucose	chem
PC3	geneY
proinsulin	geneY
【GOLD_R】
glucose	insulin	C3
glucose	PC3	C3
【PRE_R】

NIDDM is associated with increased secretion of proinsulin and proinsulin - like molecules , suggesting that mutations in the PC3 gene may be involved in the development of this disorder .
【GOLD_E】
proinsulin	geneY
proinsulin	geneY
PC3	geneY
【PRE_E】
NIDDM	geneY
proinsulin	geneY
proinsulin	geneY
PC3	geneY
【GOLD_R】
【PRE_R】

To examine this hypothesis , we have isolated and characterized the human PC3 gene and screened it for mutations in a group of Japanese subjects with NIDDM .
【GOLD_E】
humanPC3	geneY
【PRE_E】
humanPC3	geneY
NIDDM	geneY
【GOLD_R】
【PRE_R】

The PC3 gene consists of 14 exons spanning more than 35 kb .
【GOLD_E】
PC3	geneY
【PRE_E】
PC3	geneY
【GOLD_R】
【PRE_R】

The exon - intron organization of PC2 and PC3 genes are conserved , consistent with a common evolutionary origin for the prohormone convertase gene family .
【GOLD_E】
PC2	geneY
PC3	geneY
prohormoneconvertase	geneN
【PRE_E】
PC2	geneN
PC3	geneY
prohormoneconvertase	geneN
【GOLD_R】
【PRE_R】

Single - strand conformational analysis and nucleotide sequencing of the entire coding region of the PC3 gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 ( Arg / Gln53 ) and 14 ( Gln / Glu638 ) , neither of which was associated with NIDDM in this population .
【GOLD_E】
PC3	geneY
Arg/Gln53	geneN
Gln/Glu638	geneN
nucleotide	chem
【PRE_E】
nucleotide	chem
PC3	geneY
102	chem
NIDDM	geneY
Arg	chem
Gln53	chem
Gln	chem
Glu638	chem
NIDDM	geneN
【GOLD_R】
【PRE_R】

These data suggest that genetic variation in the PC3 gene is unlikely to be a major contributor to NIDDM susceptibility in Japanese .
【GOLD_E】
PC3	geneY
【PRE_E】
PC3	geneY
NIDDM	geneY
【GOLD_R】
【PRE_R】

Desipramine administration in the olfactory bulbectomized rat : changes in brain beta - adrenoceptor and 5 - HT2A binding sites and their relationship to behaviour .
【GOLD_E】
Desipramine	chem
5-HT2A	geneY
beta-adrenoceptor	geneN
【PRE_E】
Desipramine	chem
beta-adrenoceptor	geneY
5-HT2A	geneY
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effects of repeated administration of the tricyclic antidepressant drug , desipramine ( DMI ) , on behaviour ( locomotor activity and rearing ) and the number and affinity of brain beta - adrenoceptor and 5 - HT2A receptor binding sites were examined in olfactory bulbectomized ( OB ) and sham - operated control rats .
【GOLD_E】
DMI	chem
beta-adrenoceptor	geneN
5-HT2A	geneY
tricyclic	chem
desipramine	chem
【PRE_E】
tricyclic	chem
desipramine	chem
DMI	chem
beta-adrenoceptor	geneY
5-HT2A	geneY
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Locomotor activity and rearing were increased in OB rats compared to sham - operated controls .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The effect of various doses of DMI ( administered orally twice daily for 21 days ) on these behavioural measures was examined .
【GOLD_E】
DMI	chem
【PRE_E】
DMI	chem
【GOLD_R】
【PRE_R】

A dose of 7.5 mg kg - 1 provided optimal reversal of hyperlocomotion and increased rearing in OB rats , without changing these measures in sham - operated controls .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The time course of DMI ( 7.5 mg kg - 1 ) on behavioural and neurochemical measures was examined . locomotion and rearing in OB rats were not significantly altered after 7 days , were significantly attenuated after 14 days and were normalized after 21 days .
【GOLD_E】
DMI	chem
【PRE_E】
DMI	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

After 7 days of DMI administration the number of beta - adrenoceptors was lower in frontal and occipital cortex and hippocampus .
【GOLD_E】
DMI	chem
beta-adrenoceptors	geneN
【PRE_E】
DMI	chem
beta-adrenoceptors	geneN
【GOLD_R】
DMI	beta-adrenoceptors	C4
【PRE_R】

This reduction was largely restricted to the beta 1 - adrenoceptor subtype .
【GOLD_E】
beta1-adrenoceptor	geneY
【PRE_E】
beta1-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Administration of DMI for 14 or 21 days did not further reduce the number of beta - adrenoceptors .
【GOLD_E】
beta-adrenoceptors	geneN
DMI	chem
【PRE_E】
DMI	chem
beta-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

The DMI induced reduction in beta - adrenoceptors did not differ in OB and sham - operated control rats .
【GOLD_E】
beta-adrenoceptors	geneN
DMI	chem
【PRE_E】
DMI	chem
beta-adrenoceptors	geneN
【GOLD_R】
DMI	beta-adrenoceptors	C4
【PRE_R】
DMI	beta-adrenoceptors	C3

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

DMI administration for up to 21 days produced a progressive reduction in the number of 5 - HT2A receptors in frontal cortex , without significant alterations in occipital cortex .
【GOLD_E】
5-HT2A	geneY
DMI	chem
【PRE_E】
DMI	chem
5-HT2A	geneY
【GOLD_R】
DMI	5-HT2A	C4
【PRE_R】

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The time course of the reduction in the number of 5 - HT2A receptors was similar to that of the DMI - induced behavioural changes whereas that for the reduction in beta - adrenoceptors was clearly different .
【GOLD_E】
5-HT2A	geneY
beta-adrenoceptors	geneN
DMI	chem
【PRE_E】
5-HT2A	geneY
DMI	chem
beta-adrenoceptors	geneN
【GOLD_R】
DMI	5-HT2A	C4
DMI	beta-adrenoceptors	C4
【PRE_R】
DMI	beta-adrenoceptors	C3

7 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in beta - adrenoceptors but may be related to a reduction in frontal cortical 5 - HT2A receptors .
【GOLD_E】
beta-adrenoceptors	geneN
5-HT2A	geneY
DMI	chem
【PRE_E】
DMI	chem
beta-adrenoceptors	geneY
5-HT2A	geneY
【GOLD_R】
DMI	beta-adrenoceptors	C4
DMI	5-HT2A	C4
【PRE_R】
DMI	beta-adrenoceptors	C3

Binding of thalidomide to alpha1 - acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production .
【GOLD_E】
alpha1-acidglycoprotein	geneN
tumornecrosisfactoralpha	geneY
thalidomide	chem
【PRE_E】
thalidomide	chem
alpha1-acidglycoprotein	geneN
tumornecrosisfactoralpha	geneY
【GOLD_R】
thalidomide	tumornecrosisfactoralpha	C4
【PRE_R】
thalidomide	tumornecrosisfactoralpha	C4

In addition to its well known sedative and teratogenic effects , thalidomide also possesses potent immunomodulatory and antiinflammatory activities , being most effective against leprosy and chronic graft - versus - host disease .
【GOLD_E】
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

The immunomodulatory activity of thalidomide has been ascribed to the selective inhibition of tumor necrosis factor alpha from monocytes .
【GOLD_E】
tumornecrosisfactoralpha	geneY
thalidomide	chem
【PRE_E】
thalidomide	chem
tumornecrosisfactoralpha	geneY
【GOLD_R】
thalidomide	tumornecrosisfactoralpha	C4
【PRE_R】
thalidomide	tumornecrosisfactoralpha	C4

The molecular mechanism for the immunomodulatory effect of thalidomide remains unknown .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

To elucidate this mechanism , we synthesized an active photoaffinity label of thalidomide as a probe to identify the molecular target of the drug .
【GOLD_E】
thalidomide	chem
【PRE_E】
thalidomide	chem
【GOLD_R】
【PRE_R】

Using the probe , we specifically labeled a pair of proteins of 43 - 45 kDa with high acidity from bovine thymus extract .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Purification of these proteins and partial peptide sequence determination revealed them to be alpha1 - acid glycoprotein ( AGP ) .
【GOLD_E】
alpha1-acidglycoprotein	geneY
AGP	geneY
【PRE_E】
alpha1-acidglycoprotein	geneN
AGP	geneN
【GOLD_R】
【PRE_R】

We show that the binding of thalidomide photoaffinity label to authentic human AGP is competed with both thalidomide and the nonradioactive photoaffinity label at concentrations comparable to those required for inhibition of production of tumor necrosis factor alpha from human monocytes , suggesting that AGP may be involved in the immunomodulatory activity of thalidomide .
【GOLD_E】
humanAGP	geneN
thalidomide	chem
thalidomide	chem
thalidomide	chem
tumornecrosisfactoralpha	geneY
AGP	geneN
【PRE_E】
thalidomide	chem
humanAGP	geneY
thalidomide	chem
tumornecrosisfactoralpha	geneY
AGP	geneY
thalidomide	chem
【GOLD_R】
thalidomide	tumornecrosisfactoralpha	C4
【PRE_R】
thalidomide	tumornecrosisfactoralpha	C4
thalidomide	AGP	C4

AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide .
【GOLD_E】
AMPA	chem
cyclothiazide	chem
AMPAreceptor	geneN
【PRE_E】
AMPAreceptor	geneN
cyclothiazide	chem
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The kinetics of onset of alpha - amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid ( AMPA ) receptor desensitization by glutamate , and the extent of attenuation of AMPA receptor desensitization by cyclothiazide , showed pronounced cell - to - cell variation in cultures of rat hippocampal neurons .
【GOLD_E】
cyclothiazide	chem
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionicacid	chem
AMPA	chem
AMPAreceptor	geneN
glutamate	chem
(AMPA)receptor	geneN
AMPA	chem
【PRE_E】
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionicacid(AMPA)receptor	geneN
glutamate	chem
AMPAreceptor	geneN
cyclothiazide	chem
【GOLD_R】
【PRE_R】

Cultures prepared from area CA1 stratum radiatum tended to show weaker modulation by cyclothiazide than cultures prepared from the whole hippocampus .
【GOLD_E】
cyclothiazide	chem
【PRE_E】
cyclothiazide	chem
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Kinetic analysis of concentration jump responses to glutamate revealed multiple populations of receptors with fast ( approximately 400 ms ) , intermediate ( approximately 2 - 4 s ) , and slow ( > 20 s ) time constants for recovery from modulation by cyclothiazide .
【GOLD_E】
glutamate	chem
cyclothiazide	chem
【PRE_E】
glutamate	chem
cyclothiazide	chem
【GOLD_R】
【PRE_R】

The amplitudes of these components varied widely between cells , suggesting the existence of at least three populations of AMPA receptor subtypes , the relative density of which varied from cell to cell .
【GOLD_E】
AMPA	chem
AMPAreceptor	geneN
【PRE_E】
AMPAreceptor	geneN
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The complex patterns of sensitivity to cyclothiazide seen in hippocampal neurons could be reconstituted by assembly of recombinant AMPA receptor subunits generated from cDNAs encoding the flip ( i ) and flop ( o ) splice variants of the GluR - A and GluR - B subunits .
【GOLD_E】
cyclothiazide	chem
AMPA	chem
AMPAreceptor	geneN
GluR-A	geneY
GluR-B	geneY
【PRE_E】
cyclothiazide	chem
AMPAreceptor	geneN
flip(i)	geneY
flop(o)	geneY
GluR-A	geneY
GluR-B	geneY
【GOLD_R】
【PRE_R】

Recovery from modulation by cyclothiazide was slower for GluR - AiBi and GluR - AoBi than for GluR - AiBo and GluR - AoBo .
【GOLD_E】
GluR-AiBi	geneN
GluR-AoBi	geneN
GluR-AiBo	geneN
GluR-AoBo	geneN
cyclothiazide	chem
【PRE_E】
cyclothiazide	chem
GluR-AiBi	geneY
GluR-AoBi	geneY
GluR-AiBo	geneY
GluR-AoBo	geneY
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Coexpression of the flip and flop splice variants of GluR - A , in the absence of GluR - B , revealed that heteromeric AMPA receptors with intermediate sensitivity to cyclothiazide , similar to responses observed for the combinations GluR - AoBi or GluR - AiBo , could be generated independently of the presence of the GluR - B subunit .
【GOLD_E】
GluR-A	geneY
GluR-B	geneY
AMPAreceptors	geneN
GluR-AoBi	geneN
GluR-AiBo	geneN
GluR-B	geneY
AMPA	chem
cyclothiazide	chem
【PRE_E】
flip	geneN
flop	geneN
GluR-A	geneY
GluR-B	geneY
AMPAreceptors	geneN
cyclothiazide	chem
GluR-AoBi	geneY
GluR-AiBo	geneY
GluR-B	geneY
【GOLD_R】
【PRE_R】

However , recovery from modulation by cyclothiazide was twofold slower for GluR - AiBi than for homomeric GluR - Ai , indicating that the GluR - A and GluR - B subunits are not functionally equivalent in controlling sensitivity to cyclothiazide .
【GOLD_E】
GluR-AiBi	geneN
GluR-Ai	geneN
GluR-A	geneY
GluR-B	geneY
cyclothiazide	chem
cyclothiazide	chem
【PRE_E】
cyclothiazide	chem
GluR-AiBi	geneY
GluR-Ai	geneY
GluR-A	geneY
GluR-B	geneY
cyclothiazide	chem
【GOLD_R】
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

These results demonstrate that AMPA receptors expressed in hippocampal neurons are assembled in a variety of subunit and splice variant combinations that might serve as a mechanism to fine - tune the kinetics of synaptic transmission .
【GOLD_E】
AMPAreceptors	geneN
AMPA	chem
【PRE_E】
AMPAreceptors	geneN
【GOLD_R】
【PRE_R】

Striatal dopamine , dopamine transporter , and vesicular monoamine transporter in chronic cocaine users .
【GOLD_E】
dopamine	chem
monoamine	chem
cocaine	chem
dopamine	chem
dopaminetransporter	geneY
vesicularmonoaminetransporter	geneY
【PRE_E】
dopamine,dopaminetransporter	geneN
vesicularmonoaminetransporter	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

Depletion of striatal dopamine ( DA ) has been hypothesized to explain some of the neurological and psychiatric complications of chronic use of cocaine , including increased risk for neuroleptic - precipitated movement disorders .
【GOLD_E】
cocaine	chem
dopamine	chem
DA	chem
【PRE_E】
dopamine	chem
DA	chem
cocaine	chem
【GOLD_R】
【PRE_R】

We measured levels of DA , as well as two DA nerve terminal indices , namely , the DA transporter ( DAT ) and the vesicular monoamine transporter ( VMAT2 ) in autopsied brain of 12 chronic cocaine users .
【GOLD_E】
DAtransporter	geneY
DAT	geneY
vesicularmonoaminetransporter	geneY
VMAT2	geneY
DA	chem
DA	chem
DA	chem
monoamine	chem
cocaine	chem
【PRE_E】
DA	chem
DA	chem
DAtransporter	geneY
DAT	geneY
vesicularmonoaminetransporter	geneY
VMAT2	geneY
cocaine	chem
【GOLD_R】
【PRE_R】

Mean DA levels were normal in the putamen , the motor component of the striatum ; however 4 of the 12 subjects had DA values below the lower limit of the control range .
【GOLD_E】
DA	chem
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

DA concentrations were significantly reduced in the caudate head ( head , - 33 % ; tail , - 39 % ) with a trend for reduction in nucleus accumbens ( - 27 % ) .
【GOLD_E】
DA	chem
【PRE_E】
DA	chem
【GOLD_R】
【PRE_R】

Striatal DAT protein ( - 25 to - 46 % ) and VMAT2 ( - 17 to - 22 % ) were reduced , whereas DAT determined by [ 3H ] WIN 35,428 binding was normal .
【GOLD_E】
[3H]WIN35,428	chem
DAT	geneY
VMAT2	geneY
DAT	geneY
【PRE_E】
DAT	geneY
VMAT2	geneY
DAT	geneY
[3H]WIN35,428	chem
【GOLD_R】
【PRE_R】

In conclusion , our data suggest that chronic cocaine use is associated with modestly reduced levels of striatal DA and the DA transporter in some subjects and that these changes might contribute to the neurological and psychiatric effects of the drug .
【GOLD_E】
cocaine	chem
DA	chem
DA	chem
DAtransporter	geneY
【PRE_E】
cocaine	chem
DAandtheDAtransporter	geneN
【GOLD_R】
cocaine	DAtransporter	C4
【PRE_R】

Purification and characterization of a novel hyaluronan - binding protein ( PHBP ) from human plasma : it has three EGF , a kringle and a serine protease domain , similar to hepatocyte growth factor activator .
【GOLD_E】
serineproteasedomain	geneN
hyaluronan-bindingprotein	geneN
PHBP	geneY
serine	chem
【PRE_E】
hyaluronan-bindingprotein	geneN
PHBP	geneN
EGF	geneN
kringle	geneN
serineproteasedomain	geneN
hepatocytegrowthfactoractivator	geneY
【GOLD_R】
【PRE_R】

A novel hyaluronan - binding protein ( PHBP ) was purified from human plasma by affinity chromatography on hyaluronan - conjugated Sepharose .
【GOLD_E】
PHBP	geneY
hyaluronan-bindingprotein	geneN
【PRE_E】
hyaluronan-bindingprotein	geneN
PHBP	geneN
hyaluronan-conjugatedSepharose	geneN
【GOLD_R】
【PRE_R】

The contaminating IgM and albumin in the partially purified preparation were removed with anti - IgG antibody - conjugated Sepharose and anti - albumin antibody - conjugated Sepharose , respectively , and no other contaminant was observed .
【GOLD_E】
IgM	geneN
albumin	geneN
IgG	geneN
albumin	geneN
【PRE_E】
IgM	geneN
albumin	geneY
IgG	geneN
albumin	geneY
【GOLD_R】
【PRE_R】

Finally , 800 micrograms of PHBP was isolated from 500 ml of human plasma .
【GOLD_E】
PHBP	geneY
【PRE_E】
PHBP	geneY
【GOLD_R】
【PRE_R】

PHBP gave a single 70 - kDa band on SDS - PAGE under non - reducing conditions , and 50 - kDa and 17 - kDa bands under reducing conditions .
【GOLD_E】
PHBP	geneY
【PRE_E】
PHBP	geneY
SDS	chem
【GOLD_R】
【PRE_R】

Thus , PHBP was a heterodimer composed of 50 - kDa and 17 - kDa subunits , bridged by a disulfide linkage .
【GOLD_E】
PHBP	geneY
disulfide	chem
【PRE_E】
PHBP	geneY
disulfide	chem
【GOLD_R】
【PRE_R】

Both subunits had novel N - terminal amino acid sequences , indicating that PHBP was a novel hyaluronan - binding protein in human plasma .
【GOLD_E】
PHBP	geneY
N-terminalaminoacid	chem
【PRE_E】
N	chem
aminoacid	chem
PHBP	geneN
hyaluronan-bindingprotein	geneN
【GOLD_R】
【PRE_R】

The amino acid sequence deduced from the nucleotide sequence of the cloned PHBP cDNA exhibited significant homology to that of hepatocyte growth factor activator ( HGFA ) .
【GOLD_E】
PHBP	geneY
hepatocytegrowthfactoractivator	geneY
HGFA	geneY
aminoacid	chem
nucleotide	chem
【PRE_E】
aminoacid	chem
nucleotide	chem
PHBP	geneN
hepatocytegrowthfactoractivator	geneY
HGFA	geneY
【GOLD_R】
【PRE_R】

The results of Northern blot analysis indicated that liver , kidney , and pancreas expressed PHBP mRNA .
【GOLD_E】
PHBP	geneY
【PRE_E】
PHBP	geneY
【GOLD_R】
【PRE_R】

The predicted structure of PHBP showed three epidermal growth factor ( EGF ) domains , a kringle domain and a serine protease domain , from its N - terminus , although HGFA has a fibronectin type II domain , an EGF domain , a fibronectin type I domain , an EGF domain , a kringle domain , and a serine protease domain , from its N - terminus .
【GOLD_E】
PHBP	geneY
epidermalgrowthfactor(EGF)domains	geneN
kringledomain	geneN
serineproteasedomain	geneN
HGFA	geneY
fibronectintypeIIdomain	geneN
EGFdomain	geneN
fibronectintypeIdomain	geneN
EGFdomain	geneN
serine	chem
kringledomain	geneN
serineproteasedomain	geneN
N	chem
serine	chem
N	chem
【PRE_E】
PHBP	geneN
epidermalgrowthfactor(EGF)domains	geneN
kringledomain	geneN
serineproteasedomain	geneN
N	chem
HGFA	geneN
fibronectintypeIIdomain	geneN
EGFdomain	geneN
fibronectintypeIdomain	geneN
EGFdomain	geneN
kringledomain	geneN
serineproteasedomain	geneN
N	chem
【GOLD_R】
【PRE_R】

Hypoxemia associated with cimetidine therapy in a newborn infant .
【GOLD_E】
cimetidine	chem
【PRE_E】
cimetidine	chem
【GOLD_R】
【PRE_R】

Cimetidine therapy used for the treatment of gastric bleeding due to tolazoline therapy in a newborn infant was temporally associated with episodes of severe hypoxemia .
【GOLD_E】
Cimetidine	chem
tolazoline	chem
【PRE_E】
Cimetidine	chem
tolazoline	chem
【GOLD_R】
【PRE_R】

It appears likely that the histamine H2 receptor blocked by cimetidine obviated the pulmonary vasodilator effect of tolazoline therapy .
【GOLD_E】
histamine	chem
cimetidine	chem
tolazoline	chem
histamineH2receptor	geneY
【PRE_E】
histamineH2receptor	geneN
cimetidine	chem
tolazoline	chem
【GOLD_R】
cimetidine	histamineH2receptor	C4
【PRE_R】

Interactions of 2,3 - benzodiazepines and cyclothiazide at AMPA receptors : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices .
【GOLD_E】
2,3-benzodiazepines	chem
cyclothiazide	chem
AMPA	chem
AMPAreceptors	geneN
【PRE_E】
2,3-benzodiazepines	chem
cyclothiazide	chem
AMPAreceptors	geneN
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The 2,3 - benzodiazepines GYKI 52466 , GYKI 53405 and GYKI 53655 antagonized AMPA - induced currents in cultured superior colliculus neurones in a non use - dependent manner ( steady state IC50s : GYKI 52466 9.8 + / - 0.6 microM ; GYKI 53405 3.1 + / - 0.6 microM ; GYKI 53655 0.8 + / - 0.1 microM ) .
【GOLD_E】
GYKI52466	chem
GYKI53405	chem
GYKI53655	chem
GYKI52466	chem
GYKI53405	chem
GYKI53655	chem
2,3-benzodiazepines	chem
AMPA	chem
【PRE_E】
2,3-benzodiazepinesGYKI52466	chem
GYKI53405	chem
GYKI53655	chem
AMPA	chem
GYKI52466	chem
GYKI53405	chem
GYKI53655	chem
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Higher concentrations of all three antagonists slowed the onset kinetics and quickened the offset kinetics of AMPA - induced currents indicative of an allosteric interaction with the AMPA recognition site .
【GOLD_E】
AMPA	chem
AMPA	chem
【PRE_E】
AMPA	chem
AMPA	chem
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cyclothiazide ( 3 - 300 microM ) dramatically slowed desensitization of AMPA - induced currents and potentiated steady state currents ( EC50 10.0 + / - 2.5 microM ) to a much greater degree than peak currents .
【GOLD_E】
Cyclothiazide	chem
AMPA	chem
【PRE_E】
Cyclothiazide	chem
AMPA	chem
【GOLD_R】
【PRE_R】

Both tau on and tau off were also increased by cyclothiazide in a concentration - dependent manner ( EC50 : tau on 42.1 + / - 4.5 microM ; tau off 31.6 + / - 6.6 microM ) .
【GOLD_E】
cyclothiazide	chem
【PRE_E】
cyclothiazide	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cyclothiazide ( 10 - 100 microM ) shifted the concentration - response curves of the 2,3 - benzodiazepines to the right .
【GOLD_E】
Cyclothiazide	chem
2,3-benzodiazepines	chem
【PRE_E】
Cyclothiazide	chem
2,3-benzodiazepines	chem
【GOLD_R】
【PRE_R】

For example , with 10 microM cyclothiazide the IC50s of GYKI 52466 and GYKI 53405 on steady - state AMPA - induced currents were 57.9 + / - 9.5 and 41.6 + / - 1.5 microM , respectively .
【GOLD_E】
cyclothiazide	chem
GYKI52466	chem
GYKI53405	chem
AMPA	chem
【PRE_E】
cyclothiazide	chem
GYKI52466	chem
GYKI53405	chem
AMPA	chem
【GOLD_R】
【PRE_R】

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

GYKI 53405 and GYKI 52466 concentration - dependently reversed the effects of cyclothiazide ( 100 microM ) on offset kinetics ( GYKI 53405 IC50 16.6 + / - 4.2 microM ) .
【GOLD_E】
GYKI53405	chem
GYKI52466	chem
cyclothiazide	chem
GYKI53405	chem
【PRE_E】
GYKI53405	chem
GYKI52466	chem
cyclothiazide	chem
GYKI	chem
【GOLD_R】
【PRE_R】

However , the 2,3 - benzodiazepines were unable to reintroduce desensitization in the presence of cyclothiazide and even concentration - dependently slowed the onset kinetics of AMPA responses further ( GYKI 53405 EC50 8.0 + / - 2.8 microM ) .
【GOLD_E】
cyclothiazide	chem
AMPA	chem
GYKI53405	chem
2,3-benzodiazepines	chem
【PRE_E】
2,3-benzodiazepines	chem
cyclothiazide	chem
AMPA	chem
GYKI53405	chem
【GOLD_R】
【PRE_R】

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

GYKI 52466 decreased the peak amplitude of hippocampal area CA1 AMPA receptor - mediated excitatory postsynaptic currents ( e.p.s.cs ) ( IC50 10.8 + / - 0.8 microM ) with no apparent effect on response kinetics .
【GOLD_E】
GYKI52466	chem
AMPA	chem
AMPAreceptor	geneN
【PRE_E】
GYKI52466	chem
AMPAreceptor	geneN
【GOLD_R】
GYKI52466	AMPAreceptor	C4
【PRE_R】

Cyclothiazide prolonged the decay time constant of AMPA receptor - mediated e.p.s.cs ( EC50 35.7 + / - 6.5 microM ) with less pronounced effects in slowing e.p.s.c . onset kinetics and increasing e.p.s.c . amplitude .
【GOLD_E】
Cyclothiazide	chem
AMPA	chem
AMPAreceptor	geneN
【PRE_E】
Cyclothiazide	chem
AMPAreceptor	geneN
【GOLD_R】
Cyclothiazide	AMPAreceptor	C4
【PRE_R】

7 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cyclothiazide ( 330 microM ) shifted the concentration - response curve for the effects of GYKI 52466 on AMPA receptor - mediated e.p.s.c . peak amplitude to the right ( GYKI 52466 IC50 26.9 + / - 9.4 microM ) .
【GOLD_E】
Cyclothiazide	chem
GYKI52466	chem
AMPA	chem
GYKI52466	chem
AMPAreceptor	geneN
【PRE_E】
Cyclothiazide	chem
GYKI52466	chem
AMPAreceptor	geneN
【GOLD_R】
【PRE_R】

Likewise , GYKI 52466 ( 30 - 100 microM ) ) shifted the concentration - response curve for the effects of cyclothiazide on AMPA receptor - mediated e.p.s.c . decay time constants to the right .
【GOLD_E】
GYKI52466	chem
cyclothiazide	chem
AMPA	chem
AMPAreceptor	geneN
【PRE_E】
GYKI52466	chem
cyclothiazide	chem
AMPAreceptor	geneN
【GOLD_R】
【PRE_R】

8 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In conclusion , cyclothiazide and the 2,3 - benzodiazepines seem to bind to different sites on AMPA receptors but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site .
【GOLD_E】
cyclothiazide	chem
2,3-benzodiazepines	chem
AMPA	chem
AMPAreceptors	geneN
【PRE_E】
cyclothiazide	chem
2,3-benzodiazepines	chem
AMPAreceptors	geneN
【GOLD_R】
【PRE_R】

The interactions of GYKI 52466 and cyclothiazide on AMPA receptor - mediated e.p.s.cs in area CA1 of hippocampal slices provide evidence that the decay time constant of these synaptic events are not governed by desensitization .
【GOLD_E】
GYKI52466	chem
cyclothiazide	chem
AMPA	chem
AMPAreceptor	geneN
【PRE_E】
GYKI52466	chem
cyclothiazide	chem
AMPAreceptor	geneN
【GOLD_R】
【PRE_R】

Comparison of ligand binding affinities at human I1 - imidazoline binding sites and the high affinity state of alpha - 2 adrenoceptor subtypes .
【GOLD_E】
imidazoline	chem
alpha-2adrenoceptor	geneN
humanI1-imidazolinebindingsites	geneN
【PRE_E】
humanI1-imidazoline	geneN
alpha-2adrenoceptor	geneN
【GOLD_R】
【PRE_R】

To identify selective compounds for nonadrenergic I1 - imidazoline receptors ( I1 ) , the affinities of 22 ligands for [ 125I ] p - iodoclonidine binding have been compared at human platelet I1 - imidazoline binding sites ( analyzed under norepinephrine mask of alpha - 2 AR ) and at human alpha - 2A , alpha - 2B and alpha - 2C adrenoceptors stably expressed on transfected Chinese hamster ovary cells .
【GOLD_E】
imidazoline	chem
[125I]p-iodoclonidine	chem
humanplateletI1-imidazolinebindingsites	geneN
alpha-2AR	geneN
humanalpha-2A	geneY
alpha-2B	geneY
alpha-2Cadrenoceptors	geneY
I1-imidazolinereceptors	geneY
I1	geneY
imidazoline	chem
norepinephrine	chem
【PRE_E】
I1-imidazolinereceptors	geneN
I1	geneN
[125I]p-iodoclonidine	chem
humanplateletI1-imidazolinebindingsites	geneN
norepinephrine	chem
alpha-2AR	geneY
humanalpha-2A,alpha-2Bandalpha-2Cadrenoceptors	geneN
【GOLD_R】
【PRE_R】

Competition curves at the platelet I1 - imidazoline binding site were biphasic for most compounds .
【GOLD_E】
I1-imidazolinebindingsite	geneN
imidazoline	chem
【PRE_E】
I1-imidazolinebindingsite	geneN
【GOLD_R】
【PRE_R】

Only tizanidine and BDF,6143 displayed monophasic I1 competition curves .
【GOLD_E】
tizanidine	chem
BDF,6143	chem
【PRE_E】
tizanidine	chem
BDF,6143	chem
monophasicI1	geneN
【GOLD_R】
【PRE_R】

Agmatine , an endogenous neurotransmitter candidate for the I1 - imidazoline receptor , was identified as the most selective agent for a subcomponent of platelet I1 sites .
【GOLD_E】
Agmatine	chem
imidazoline	chem
I1-imidazolinereceptor	geneY
I1sites	geneN
【PRE_E】
Agmatine	chem
I1-imidazolinereceptor	geneY
plateletI1	geneN
【GOLD_R】
【PRE_R】

The affinity of agmatine at the high affinity component of platelet I1 sites was 1400 - fold selective over alpha - 2A adrenoceptors , 5000 - fold selective over alpha - 2B adrenoceptors and 800 - fold selective over alpha - 2C adrenoceptors .
【GOLD_E】
agmatine	chem
I1sites	geneN
alpha-2Aadrenoceptors	geneY
alpha-2Badrenoceptors	geneY
alpha-2Cadrenoceptors	geneY
【PRE_E】
agmatine	chem
plateletI1	geneN
alpha-2Aadrenoceptors	geneN
alpha-2Badrenoceptors	geneN
alpha-2Cadrenoceptors	geneN
【GOLD_R】
【PRE_R】

Moxonidine and tizanidine also displayed selectivities for a high affinity component of the platelet I1 binding sites over alpha - 2 adrenoceptors .
【GOLD_E】
Moxonidine	chem
tizanidine	chem
I1bindingsites	geneN
alpha-2adrenoceptors	geneN
【PRE_E】
Moxonidine	chem
tizanidine	chem
plateletI1	geneN
alpha-2adrenoceptors	geneN
【GOLD_R】
【PRE_R】

Naphazoline was the most selective compound for the high affinity state of the alpha - 2A adrenoceptor , displaying 7 - , 23 - and 9 - fold higher affinity than alpha - 2B , alpha - 2C and platelet I1 - midazoline binding sites , respectively .
【GOLD_E】
Naphazoline	chem
alpha-2Aadrenoceptor	geneY
alpha-2B	geneY
alpha-2C	geneY
I1-midazolinebindingsites	geneN
midazoline	chem
【PRE_E】
Naphazoline	chem
alpha-2Aadrenoceptor	geneY
alpha-2B,alpha-2CandplateletI1-midazoline	geneN
【GOLD_R】
【PRE_R】

No single selective compound was identified for the alpha - 2B adrenoceptor .
【GOLD_E】
alpha-2Badrenoceptor	geneY
【PRE_E】
alpha-2Badrenoceptor	geneY
【GOLD_R】
【PRE_R】

Norepinephrine displayed , respectively , 18 - and 31 - fold selectivity for the high affinity state of the alpha - 2C adrenoceptor as compared to alpha - 2A - or alpha - 2B adrenoceptors , and was > 100,000 - fold selective over platelet I1 - imidazoline sites .
【GOLD_E】
alpha-2Cadrenoceptor	geneY
alpha-2A	geneY
alpha-2Badrenoceptors	geneY
I1-imidazolinesites	geneN
Norepinephrine	chem
imidazoline	chem
【PRE_E】
Norepinephrine	chem
alpha-2Cadrenoceptor	geneN
alpha-2A-oralpha-2Badrenoceptors	geneN
I1-imidazoline	chem
【GOLD_R】
【PRE_R】

Thus , human alpha - 2 adrenoceptors and the platelet I1 - imidazoline binding site can be clearly discriminated based on their affinities for certain compounds .
【GOLD_E】
humanalpha-2adrenoceptors	geneN
I1-imidazolinebindingsite	geneN
imidazoline	chem
【PRE_E】
humanalpha-2adrenoceptors	geneN
I1-imidazoline	chem
【GOLD_R】
【PRE_R】

Activation of cytoprotective prostaglandin synthase - 1 by minoxidil as a possible explanation for its hair growth - stimulating effect .
【GOLD_E】
prostaglandin	chem
minoxidil	chem
prostaglandinsynthase-1	geneY
【PRE_E】
cytoprotectiveprostaglandinsynthase-1	geneY
minoxidil	chem
【GOLD_R】
minoxidil	prostaglandinsynthase-1	C3
【PRE_R】

Data from the literature indicate that nonsteroidal anti - inflammatory drugs ( NSAIDs ) , such as indomethacin , naproxen , piroxicam , or ibuprofen , induce hair loss in vivo .
【GOLD_E】
indomethacin	chem
naproxen	chem
piroxicam	chem
ibuprofen	chem
【PRE_E】
indomethacin	chem
naproxen	chem
piroxicam	chem
ibuprofen	chem
【GOLD_R】
【PRE_R】

These NSAIDs are well - known inhibitors of both the cytoprotective isoform of prostaglandin endoperoxide synthase - 1 ( PGHS - 1 ) and of the inducible form ( PGHS - 2 ) .
【GOLD_E】
prostaglandinendoperoxidesynthase-1	geneY
PGHS-1	geneY
PGHS-2	geneY
prostaglandin	chem
【PRE_E】
prostaglandinendoperoxidesynthase-1	geneY
PGHS-1	geneY
PGHS-2	geneY
【GOLD_R】
【PRE_R】

By immunohistochemical staining , we found that PGHS - 1 is the main isoform present in the dermal papilla from normal human hair follicle ( either anagen or catagen ) , whereas PGHS - 2 was only faintly and exclusively expressed in anagen dermal papilla .
【GOLD_E】
PGHS-1	geneY
PGHS-2	geneY
【PRE_E】
PGHS-1	geneY
PGHS-2	geneY
【GOLD_R】
【PRE_R】

Thus , PGHS - 1 might be the primary target of the hair growth - inhibitory effects of NSAIDs .
【GOLD_E】
PGHS-1	geneY
【PRE_E】
PGHS-1	geneY
【GOLD_R】
【PRE_R】

We thus speculated that activation of PGHS - 1 might be a mechanism by which minoxidil ( 2,4 - diamino - 6 - piperidinopyrimidine - 3 - oxyde ) stimulates hair growth in vivo .
【GOLD_E】
PGHS-1	geneY
minoxidil	chem
2,4-diamino-6-piperidinopyrimidine-3-oxyde	chem
【PRE_E】
PGHS-1	geneY
minoxidil	chem
2,4-diamino-6-piperidinopyrimidine-3-oxyde	chem
【GOLD_R】
minoxidil	PGHS-1	C3
2,4-diamino-6-piperidinopyrimidine-3-oxyde	PGHS-1	C3
【PRE_R】
PGHS-1	minoxidil	C4
PGHS-1	2,4-diamino-6-piperidinopyrimidine-3-oxyde	C4

We demonstrate here that minoxidil is a potent activator of purified PGHS - 1 ( AC50 = 80 microM ) , as assayed by oxygen consumption and PGE2 production .
【GOLD_E】
PGHS-1	geneY
minoxidil	chem
oxygen	chem
【PRE_E】
minoxidil	chem
PGHS-1	geneY
oxygen	chem
PGE2	chem
【GOLD_R】
minoxidil	PGHS-1	C3
【PRE_R】
minoxidil	PGHS-1	C4

This activation was also evidenced by increased PGE2 production by BALB / c 3T3 fibroblasts and by human dermal papilla fibroblasts in culture .
【GOLD_E】
【PRE_E】
PGE2	chem
【GOLD_R】
【PRE_R】

Our findings suggest that minoxidil and its derivatives may have a cytoprotective activity in vivo and that more potent second - generation hair growth - promoting drugs might be designed , based on this mechanism .
【GOLD_E】
minoxidil	chem
【PRE_E】
minoxidil	chem
【GOLD_R】
【PRE_R】

Clonal CD8 + and CD52 - T cells are induced in responding B cell lymphoma patients treated with Campath - 1H ( anti - CD52 ) .
【GOLD_E】
CD52	geneY
【PRE_E】
Campath-1H	chem
【GOLD_R】
【PRE_R】

Five patients with non - Hodgkin 's lymphoma ( NHL ) and 4 patients with chronic lymphocytic leukaemia ( CLL ) were treated with the CDR - grafted ( rat x human ) monoclonal antibody ( mAb ) Campath - 1H ( anti - CD52 ) .
【GOLD_E】
CD52	geneY
【PRE_E】
(mAb)Campath-1H	chem
CD52	geneN
【GOLD_R】
【PRE_R】

Tumour regression was noted preferentially in peripheral blood and in the bone marrow but lymph nodes were less affected .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Normal blood B and T cells were profoundly reduced in all patients whereas CD16 + NK cells and CD14 + monocytes decreased marginally .
【GOLD_E】
【PRE_E】
CD16	geneY
【GOLD_R】
【PRE_R】

In all responding CLL patients CD52 - negative T but not B cells appeared during treatment and persisted for several months ( 4 - 19 + ) during unmaintained follow - up .
【GOLD_E】
CD52	geneY
【PRE_E】
【GOLD_R】
【PRE_R】

Clonal T cells defined as a predominance of a single T cell receptor ( TCR ) V gene usage , in one case verified by TCR CDR3 fragment analysis and nucleotide sequencing , emerged within the CD52 - / CD8 + cell population during Campath - 1H therapy in 2 CLL patients , both achieving a long - lasting remission .
【GOLD_E】
nucleotide	chem
Tcellreceptor(TCR)V	geneN
TCR	geneN
【PRE_E】
singleTcellreceptor(TCR)V	geneY
TCR	geneY
CDR3	geneN
nucleotide	chem
CD52	geneN
CD8	geneY
Campath-1H	chem
【GOLD_R】
【PRE_R】

The increase in CD8 + T cell expansions ( up to 23 - fold ) during unmaintained remission and follow - up suggest that the clonal CD8 + cells may represent regulatory T cells controlling the growth of the tumour B cell clone .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Clonal T cells might thus be a target for an immune therapeutic intervention in B cell tumours .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Clinical manifestations of genetic defects affecting gonadotrophins and their receptors .
【GOLD_E】
gonadotrophins	geneN
【PRE_E】
gonadotrophins	chem
【GOLD_R】
【PRE_R】

Raised activity of the LH axis caused by activating mutations of LH receptor gene presents with precocious puberty in boys , analogous to the presentation of LH secreting pituitary adenomas ( Faggiano et al . , 1983 ; Ambrosi et al . , 1990 ) .
【GOLD_E】
LH	geneN
LHreceptor	geneY
LH	geneN
【PRE_E】
LH	geneN
LHreceptor	geneN
LH	geneN
【GOLD_R】
【PRE_R】

LH `` hyperactivity ' in females appears to have no effect .
【GOLD_E】
LH	geneN
【PRE_E】
LH	geneN
【GOLD_R】
【PRE_R】

Hyperactivity of the FSH axis caused by activating mutations of the FSH receptor gene might parallel the presentation of FSH secreting pituitary adenomas with Sertoli cell hypertrophy in men ( Heseltine et al . , 1989 ) or reversible premature ovarian failure in women ( Moses et al . , 1986 ; Okuda et al . , 1989 ) .
【GOLD_E】
FSH	geneN
FSHreceptor	geneY
FSH	geneN
【PRE_E】
FSH	geneN
FSHreceptor	geneY
FSH	geneN
【GOLD_R】
【PRE_R】

Indeed the first such case to be described is a male who maintained testicular volume and fertility in the absence of gonadotrophins ( Gromoll et al . , 1996 ) .
【GOLD_E】
gonadotrophins	geneN
【PRE_E】
gonadotrophins	chem
【GOLD_R】
【PRE_R】

Female precocious puberty may require hyperactivity of both gonadotrophin axes because of the `` two - cell ' arrangement required for ovarian oestrogen production .
【GOLD_E】
noestroge	chem
gonadotrophin	geneN
【PRE_E】
gonadotrophin	geneY
oestrogen	chem
【GOLD_R】
【PRE_R】

Mutations of the Gs alpha - subunit gene can mimic this situation in some women with the McCune - Albright syndrome ( Malchoff et al . , 1994 ) .
【GOLD_E】
Gsalpha	geneN
【PRE_E】
Gs	geneY
【GOLD_R】
【PRE_R】

Lack of LH activity caused by defects in the LH beta molecule causes infertility in men and that resulting from inactivating mutations of the LH receptor gene causes Leydig cell agenesis in men while ovarian development in females is relatively normal .
【GOLD_E】
LH	geneN
LHbeta	geneY
LHreceptor	geneY
【PRE_E】
LH	geneN
LHbeta	geneN
LHreceptor	geneN
【GOLD_R】
【PRE_R】

Lack of FSH activity caused by defects in the FSH beta caused infertility in a female , and that caused by inactivating mutations of the FSH receptor gene causes ovarian dysgenesis in women but only variable depression of spermatogenesis in men .
【GOLD_E】
FSH	geneN
FSHbeta	geneY
FSHreceptor	geneY
【PRE_E】
FSH	geneN
FSHbeta	geneY
FSHreceptor	geneN
【GOLD_R】
【PRE_R】

Incidentally , this categorization of reproductive disorders may also be applied to the TSH axis .
【GOLD_E】
TSH	geneN
【PRE_E】
TSH	geneN
【GOLD_R】
【PRE_R】

Pituitary adenomas and activating mutations of the TSH receptor gene ( Parma et al . , 1993 ) cause hyperthyroidism and TSH beta gene defects ( Hayashizaki et al . , 1989 ) and inactivating mutations of the TSH receptor gene ( Sunthornthepvarakul et al . , 1995 ) cause hypothyroidism .
【GOLD_E】
TSHreceptor	geneY
TSHbeta	geneY
TSHreceptor	geneY
【PRE_E】
TSHreceptor	geneY
TSHbeta	geneY
TSHreceptor	geneY
【GOLD_R】
【PRE_R】

To complete the analogy with thyroid disorders , it is curious that despite structural similarities with the TSH receptor , neither LH nor FSH receptor autoantibodies have a prominent role in ovarian pathophysiology ( Moncayo et al . , 1989 ; Van Weissenbruch et al . , 1991 ; Simoni et al . , 1993 ) .
【GOLD_E】
TSHreceptor	geneY
LHnorFSHreceptor	geneN
【PRE_E】
TSHreceptor	geneN
LH	geneN
FSHreceptor	geneN
【GOLD_R】
【PRE_R】

Complete gonadotrophin resistance is likely to be very rare , however , so what are we likely to find in partial gonadotrophin resistance ? Might the `` resistant ovary syndrome ' come right in the end , with corresponding minor FSH receptor mutations ? Experience with insulin and androgen resistance syndromes suggests that such a scenario is unlikely .
【GOLD_E】
gonadotrophin	geneN
gonadotrophin	geneN
rFSHrecepto	geneY
hinsuli	geneY
【PRE_E】
gonadotrophin	geneY
gonadotrophin	geneY
FSHreceptor	geneY
insulin	geneY
androgen	chem
【GOLD_R】
【PRE_R】

Insulin receptor gene mutations are found in extreme Type A insulin resistance but not in moderate forms of insulin resistance ( O'Rahilly et al . , 1991 ) .
【GOLD_E】
Insulinreceptor	geneY
insulin	geneY
insulin	geneY
【PRE_E】
Insulinreceptor	geneY
TypeAinsulin	geneN
insulin	geneY
【GOLD_R】
【PRE_R】

Androgen receptor gene mutations are found in nearly all cases of complete androgen insensitivity but rarely in partial forms ( Patterson et al . , 1994 ) .
【GOLD_E】
Androgenreceptor	geneY
【PRE_E】
Androgenreceptor	geneY
androgen	chem
【GOLD_R】
【PRE_R】

Mild resistance to hormone action is rarely detectable in relatives who are heterozygous for receptor mutations which are inherited in a recessive pattern .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

It seems unlikely therefore , that individuals heterozygous for inactivating receptor mutations will manifest symptoms of reproductive disorders and account for common conditions .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Thus , while mutation analysis provides new insights into the gender specific role of the gonadotrophins the cause of early gonadal failure in the majority of individuals remains a mystery .
【GOLD_E】
gonadotrophins	geneN
【PRE_E】
gonadotrophins	chem
【GOLD_R】
【PRE_R】

Evolution of the aminoacyl - tRNA synthetase family and the organization of the Drosophila glutamyl - prolyl - tRNA synthetase gene . Intron / exon structure of the gene , control of expression of the two mRNAs , selective advantage of the multienzyme complex .
【GOLD_E】
aminoacyl-tRNAsynthetase	geneN
glutamyl-prolyl-tRNAsynthetase	geneY
aminoacyl	chem
glutamyl	chem
【PRE_E】
aminoacyl-tRNAsynthetase	geneN
Drosophilaglutamyl-prolyl-tRNAsynthetase	geneY
multienzyme	geneN
【GOLD_R】
【PRE_R】

In Drosophila , glutamyl - prolyl - tRNA synthetase is a multifunctional synthetase encoded by a unique gene and composed of three domains : the amino - and carboxy - terminal domains catalyze the aminoacylation of glutamic acid and proline tRNA species , respectively , and the central domain is made of 75 amino acids repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [ Cerini , C. , Kerjan , P. , Astier , M. , Gratecos , D. , Mirande , M .
【GOLD_E】
glutamyl-prolyl-tRNAsynthetase	geneY
amino	chem
carboxy	chem
glutamyl	chem
glutamicacid	chem
aminoacids	chem
【PRE_E】
glutamyl-prolyl-tRNAsynthetase	geneY
multifunctionalsynthetase	geneN
amino	chem
carboxy	chem
glutamicacid	chem
proline	chem
aminoacids	chem
【GOLD_R】
【PRE_R】

& Semeriva , M .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 1991 ) EMBO J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

10 , 4267 - 4277 ] .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The intron / exon organization of the Drosophila gene reveals the presence of six exons among which four are in the 5 ' - end encoding glutamic acid activity .
【GOLD_E】
glutamicacid	chem
【PRE_E】
Drosophila	geneN
glutamicacid	chem
【GOLD_R】
【PRE_R】

Only one exon encodes the repeated motifs .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

A comparison of introns positions , intron classes and intron / exon boundaries in the Drosophila gene and in its human counterpart is compatible with the intron - early hypothesis presiding , at least in part , to the evolution of the synthetases .
【GOLD_E】
synthetases	geneN
【PRE_E】
Drosophila	geneN
synthetases	geneN
【GOLD_R】
【PRE_R】

The full - length fly protein is encoded by a 6.1 - kb mRNA which is expressed throughout development .
【GOLD_E】
【PRE_E】
6.1-kb	geneY
【GOLD_R】
【PRE_R】

In addition , a shorter transcript encompasses the 3 ' - end of the cDNA and it is especially abundant in 5 - 10 - h embryos until the first larval stage .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Expression of these two mRNAs seems to be controlled by two independent promoters .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The 6.1 - kb mRNA promoter is probably localized in the 5 ' - end of the gene .
【GOLD_E】
【PRE_E】
6.1-kbmRNApromoter	geneN
【GOLD_R】
【PRE_R】

The small mRNA promoter resides in the 4th intron and evidence is provided that the mRNA encodes only the domain corresponding to prolyl - tRNA synthetase and is functional in vivo .
【GOLD_E】
prolyl-tRNAsynthetase	geneY
prolyl	chem
【PRE_E】
prolyl-tRNAsynthetase	geneY
【GOLD_R】
【PRE_R】

Finally , transgenic flies have been established by using constructs corresponding to the three domains of the protein .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Overexpression of the repeated motifs leads to a sterility of the flies that suggests a role of these motifs in linking the multienzyme complex to an , as yet , unknown structure of the protein synthesis apparatus .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Pharmacology and chemistry of adapalene .
【GOLD_E】
adapalene	chem
【PRE_E】
adapalene	chem
【GOLD_R】
【PRE_R】

BACKGROUND : Retinoid research in the field of dermatology has been influenced by the clinical success of topical tretinoin and oral isotretinoin in the treatment of acne , and by the discovery of high - affinity binding proteins for retinoic acid mediating its action and interaction with other vitamins and hormones .
【GOLD_E】
tretinoin	chem
Retinoid	chem
isotretinoin	chem
retinoicacid	chem
vitamins	chem
【PRE_E】
Retinoid	chem
tretinoin	chem
isotretinoin	chem
retinoicacid	chem
vitamins	chem
【GOLD_R】
【PRE_R】

OBJECTIVE : We sought molecules with an optimal balance between stability , efficacy , and local tolerance for topical acne therapy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

METHODS : In vitro and in vivo bioassay systems were used to test the ability of retinoids to modulate cell proliferation and differentiation .
【GOLD_E】
retinoids	chem
【PRE_E】
retinoids	chem
【GOLD_R】
【PRE_R】

In addition , antiinflammatory properties were assessed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors , retinoic acid receptors ( RARs ) .
【GOLD_E】
tretinoin	chem
retinoicacid	chem
nucleartranscriptionfactors	geneN
retinoicacidreceptors	geneN
RARs	geneN
adapalene	chem
【PRE_E】
adapalene	chem
tretinoin	chem
retinoicacidreceptors	geneN
RARs	geneY
【GOLD_R】
【PRE_R】
adapalene	RARs	C4
tretinoin	RARs	C4

RESULTS AND CONCLUSION : Adapalene is a stable naphthoic acid derivative with potent retinoid pharmacology , controlling cell proliferation and differentiation .
【GOLD_E】
Adapalene	chem
naphthoicacid	chem
retinoid	chem
【PRE_E】
Adapalene	chem
naphthoicacid	chem
retinoid	chem
【GOLD_R】
【PRE_R】

In addition it has significant antiinflammatory action .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The nuclear gene transcription factors RAR beta and RAR gamma mediate the retinoid activity of adapalene .
【GOLD_E】
nucleargenetranscriptionfactors	geneN
RARbeta	geneY
RARgamma	geneY
retinoid	chem
adapalene	chem
【PRE_E】
RARbeta	geneY
RARgamma	geneY
retinoid	chem
adapalene	chem
【GOLD_R】
【PRE_R】
RARbeta	retinoid	C4
RARgamma	retinoid	C4
RARgamma	adapalene	C4

Cinitapride protects against ethanol - induced gastric mucosal injury in rats : role of 5 - hydroxytryptamine , prostaglandins and sulfhydryl compounds .
【GOLD_E】
Cinitapride	chem
prostaglandins	chem
sulfhydryl	chem
ethanol	chem
5-hydroxytryptamine	chem
【PRE_E】
Cinitapride	chem
ethanol	chem
5-hydroxytryptamine	chem
prostaglandins	chem
sulfhydryl	chem
【GOLD_R】
【PRE_R】

This study was designed to determine the gastroprotective properties of cinitapride ( CNT ) , a novel prokinetic benzamide derivative agonist of 5 - HT4 and 5 - HT1 receptors and 5 - HT2 antagonist , on mucosal injury produced by 50 % ( v / v ) ethanol .
【GOLD_E】
cinitapride	chem
benzamide	chem
CNT	chem
5-HT4	geneY
5-HT1	geneN
5-HT2	geneN
ethanol	chem
【PRE_E】
cinitapride	chem
CNT	chem
benzamide	chem
5-HT4	geneY
5-HT1	geneY
5-HT2	geneN
(v/v)ethanol	chem
【GOLD_R】
cinitapride	5-HT4	C5
cinitapride	5-HT1	C5
benzamide	5-HT4	C5
benzamide	5-HT1	C5
CNT	5-HT4	C5
CNT	5-HT1	C5
cinitapride	5-HT2	C6
benzamide	5-HT2	C6
CNT	5-HT2	C6
【PRE_R】
cinitapride	5-HT4	C6
benzamide	5-HT4	C6
benzamide	5-HT1	C6
benzamide	5-HT2	C6

Results were compared with those for 5 - hydroxytryptamine ( 5 - HT : 10 mg kg - 1 ) .
【GOLD_E】
5-hydroxytryptamine	chem
5-HT	chem
【PRE_E】
5-hydroxytryptamine	chem
5-HT	chem
【GOLD_R】
【PRE_R】

The possible involvements of gastric mucus secretion , endogenous prostaglandins ( PGs ) and sulfhydryl compounds ( SH ) in the protection mediated by CNT were also examined .
【GOLD_E】
sulfhydryl	chem
SH	chem
CNT	chem
prostaglandins	chem
PGs	chem
【PRE_E】
prostaglandins	chem
PGs	chem
sulfhydryl	chem
CNT	chem
【GOLD_R】
【PRE_R】

Intraperitoneal administration of CNT ( 0.50 and 1 mg kg - 1 ) , 30 min before ethanol , significantly prevented gastric ulceration and increased the hexosamine content of gastric mucus .
【GOLD_E】
CNT	chem
ethanol	chem
hexosamine	chem
【PRE_E】
CNT	chem
ethanol	chem
hexosamine	chem
【GOLD_R】
【PRE_R】

CNT ( 1 mg kg - 1 ) also produced a significant increase in gastric mucosal levels of PGE2 , but did not induce any significant changes in SH values .
【GOLD_E】
CNT	chem
PGE2	chem
SH	chem
【PRE_E】
CNT	chem
PGE2	chem
【GOLD_R】
【PRE_R】

On the contrary , pretreatment with 5 - HT worsened ethanol - induced erosions , however , did not affect gastric mucus secretion , glycoprotein content or PGE2 levels , although the non - protein SH fraction was significantly decreased .
【GOLD_E】
5-HT	chem
ethanol	chem
PGE2	chem
SH	chem
glycoprotein	geneN
【PRE_E】
5-HT	chem
ethanol	chem
PGE2	chem
【GOLD_R】
【PRE_R】

The present results demonstrate that the gastroprotective effects of CNT could be partly explained by a complex PG dependent mechanism .
【GOLD_E】
CNT	chem
PG	chem
【PRE_E】
CNT	chem
【GOLD_R】
【PRE_R】

We suggest that 5 - HT dependent mechanisms through 5 - HT2 receptor blockade and 5 - HT1 receptor activation could be also involved .
【GOLD_E】
5-HT2	geneN
5-HT1	geneN
5-HT	chem
【PRE_E】
5-HT	chem
5-HT2receptor	geneN
5-HT1	geneY
【GOLD_R】
【PRE_R】

Cloning , characterization , and expression of a calcitonin receptor from guinea pig brain .
【GOLD_E】
calcitoninreceptor	geneY
【PRE_E】
calcitoninreceptor	geneY
【GOLD_R】
【PRE_R】

A calcitonin receptor was cloned from guinea pig brain by using a degenerate reverse transcription - polymerase chain reaction ( RT - PCR ) strategy .
【GOLD_E】
calcitoninreceptor	geneY
【PRE_E】
calcitoninreceptor	geneY
【GOLD_R】
【PRE_R】

When the cloned guinea pig calcitonin receptor was transfected into COS 1 cells , salmon calcitonin stimulated intracellular cyclic AMP accumulation with an EC50 of 0.1 nM , whereas human calcitonin was > 250 - fold less potent ( EC50 27.6 nM ) .
【GOLD_E】
cyclicAMP	chem
guineapigcalcitoninreceptor	geneY
salmoncalcitonin	geneN
humancalcitonin	geneY
【PRE_E】
guineapigcalcitoninreceptor	geneY
calcitonin	geneN
cyclicAMP	chem
humancalcitonin	geneY
【GOLD_R】
【PRE_R】

Related neuropeptides rat alphaCGRP and rat amylin did not activate the guinea pig calcitonin receptor at physiologic concentrations .
【GOLD_E】
ratalphaCGRP	geneY
ratamylin	geneY
guineapigcalcitoninreceptor	geneY
【PRE_E】
ratalphaCGRP	geneY
ratamylin	geneY
guineapigcalcitoninreceptor	geneY
【GOLD_R】
【PRE_R】

Stimulation of the transfected guinea pig calcitonin receptor by salmon calcitonin also resulted in phosphatidylinositol hydrolysis with an EC50 of 2.5 nM .
【GOLD_E】
guineapigcalcitoninreceptor	geneY
phosphatidylinositol	chem
【PRE_E】
guineapigcalcitoninreceptor	geneY
calcitonin	geneN
phosphatidylinositol	chem
【GOLD_R】
【PRE_R】

Expression of the calcitonin receptor was mapped by a combination of RT - PCR , northern analysis , and expression in Xenopus oocytes .
【GOLD_E】
calcitoninreceptor	geneY
【PRE_E】
calcitoninreceptor	geneY
【GOLD_R】
【PRE_R】

The guinea pig calcitonin receptor was most highly expressed in diencephalon and a single subtype was detected .
【GOLD_E】
guineapigcalcitoninreceptor	geneY
【PRE_E】
guineapigcalcitoninreceptor	geneY
【GOLD_R】
【PRE_R】

Adenosine deaminase is a specific partner for the Grb2 isoform Grb3 - 3 .
【GOLD_E】
Adenosinedeaminase	geneY
Grb2	geneY
Grb3-3	geneY
Adenosine	chem
【PRE_E】
Adenosinedeaminase	geneY
Grb2	geneN
Grb3-3	geneY
【GOLD_R】
【PRE_R】

Grb3 - 3 is an isoform of Grb2 , thought to arise by alternative splicing , that lacks a functional SH2 domain but retains functional SH3 domains , which allow interaction with other proteins through binding to prolinerich sequences .
【GOLD_E】
SH2domain	geneN
Grb3-3	geneY
SH3domains	geneN
Grb2	geneY
【PRE_E】
Grb3-3	geneY
Grb2	geneN
SH2domain	geneN
SH3domains	geneN
prolinerich	geneN
【GOLD_R】
【PRE_R】

Several evidences suggest that besides common partners for Grb2 and Grb3 - 3 , specific targets could exist .
【GOLD_E】
Grb2	geneY
Grb3-3	geneY
【PRE_E】
Grb2	geneN
Grb3-3	geneY
【GOLD_R】
【PRE_R】

In order to find specific partners for Grb3 - 3 , we have screened a human cDNA library by the yeast two - hybrid system with Grb3 - 3 as a bait .
【GOLD_E】
Grb3-3	geneY
Grb3-3	geneY
【PRE_E】
Grb3-3	geneY
Grb3-3	geneY
【GOLD_R】
【PRE_R】

We have identified adenosine deaminase , an enzyme involved in purine metabolism whose deficiency is associated with severe combined immunodeficiency , as a Grb3 - 3 binding protein that is not able to bind to Grb2 .
【GOLD_E】
adenosinedeaminase	geneY
Grb3-3	geneY
Grb2	geneY
adenosine	chem
purine	chem
【PRE_E】
adenosinedeaminase	geneY
purine	chem
Grb3-3	geneY
Grb2	geneN
【GOLD_R】
purine	adenosinedeaminase	C9
【PRE_R】

This interaction has been confirmed in vitro with GST fusion proteins and in vivo by coimmunoprecipitation experiments in NIH3T3 cells stably transfected with Grb3 - 3 .
【GOLD_E】
GST	geneN
Grb3-3	geneY
【PRE_E】
GST	geneN
Grb3-3	geneY
【GOLD_R】
【PRE_R】

The functional significance of this finding is discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Alendronate inhibition of protein - tyrosine - phosphatase - meg1 .
【GOLD_E】
Alendronate	chem
tyrosine	chem
protein-tyrosine-phosphatase-meg1	geneY
【PRE_E】
Alendronate	chem
protein-tyrosine-phosphatase-meg1	geneY
【GOLD_R】
Alendronate	protein-tyrosine-phosphatase-meg1	C4
【PRE_R】
Alendronate	protein-tyrosine-phosphatase-meg1	C4

Alendronate ( 4 - amino - 1 - hydroxybutylidene - 1,1 - bisphosphonate ) is a potent bisphosphonate that inhibits osteoclastic bone resorption and has proven effective for the treatment of osteoporosis .
【GOLD_E】
bisphosphonate	chem
Alendronate	chem
4-amino-1-hydroxybutylidene-1,1-bisphosphonate	chem
【PRE_E】
Alendronate	chem
4-amino-1-hydroxybutylidene-1,1-bisphosphonate	chem
bisphosphonate	chem
【GOLD_R】
【PRE_R】

Its molecular mechanism of action , however , has not been defined precisely .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Here we report that alendronate is a potent inhibitor of the protein - tyrosine - phosphatase - meg1 ( PTPmeg1 ) .
【GOLD_E】
alendronate	chem
tyrosine	chem
protein-tyrosine-phosphatase-meg1	geneY
PTPmeg1	geneY
【PRE_E】
alendronate	chem
protein-tyrosine-phosphatase-meg1	geneY
PTPmeg1	geneY
【GOLD_R】
alendronate	protein-tyrosine-phosphatase-meg1	C4
alendronate	PTPmeg1	C4
【PRE_R】
alendronate	protein-tyrosine-phosphatase-meg1	C4
alendronate	PTPmeg1	C4

Two substrates were employed in this study : fluorescein diphosphate and the phosphotyrosyl peptide src - pY527 .
【GOLD_E】
diphosphate	chem
src	geneY
【PRE_E】
fluoresceindiphosphate	chem
phosphotyrosyl	geneN
src-pY527	geneY
【GOLD_R】
【PRE_R】

With either substrate , alendronate was a slow binding inhibitor of PTPmeg1 .
【GOLD_E】
alendronate	chem
PTPmeg1	geneY
【PRE_E】
alendronate	chem
PTPmeg1	geneY
【GOLD_R】
alendronate	PTPmeg1	C4
【PRE_R】
alendronate	PTPmeg1	C4

Among the other bisphosphonates studied , alendronate was more potent and selective for PTPmeg1 .
【GOLD_E】
bisphosphonates	chem
alendronate	chem
PTPmeg1	geneY
【PRE_E】
bisphosphonates	chem
alendronate	chem
PTPmeg1	geneY
【GOLD_R】
bisphosphonates	PTPmeg1	C4
alendronate	PTPmeg1	C4
【PRE_R】

The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate , with IC50 values of less than 1 microM ; PTPsigma , however , under the same conditions , was inhibited by only 50 % with 141 microM alendronate .
【GOLD_E】
diphosphate	chem
alendronate	chem
alendronate	chem
PTPepsilon	geneY
PTPmeg1	geneY
PTPsigma	geneY
【PRE_E】
fluoresceindiphosphate	chem
PTP	geneN
PTPmeg1	geneN
alendronate	chem
PTPsigma	geneN
alendronate	chem
【GOLD_R】
alendronate	PTPsigma	C4
diphosphate	PTPepsilon	C9
diphosphate	PTPmeg1	C9
【PRE_R】
PTP	alendronate	C4
PTPmeg1	alendronate	C4
alendronate	PTPsigma	C4
PTPsigma	alendronate	C4

Similarly , with the src - pY527 substrate , alendronate inhibition was also PTP dependent .
【GOLD_E】
alendronate	chem
src	geneY
PTP	geneN
【PRE_E】
src	geneY
pY527	geneN
alendronate	chem
PTP	geneN
【GOLD_R】
【PRE_R】
pY527	alendronate	C4
alendronate	PTP	C4

Alendronate inhibited PTPmeg1 with an IC50 value of 23 microM , PTPsigma with an IC50 value of 2 microM , and did not inhibit PTP epsilon at concentrations up to 1 mM .
【GOLD_E】
Alendronate	chem
PTPmeg1	geneY
PTPsigma	geneY
PTPepsilon	geneY
【PRE_E】
Alendronate	chem
PTPmeg1	chem
PTPsigma	geneY
PTP	geneN
【GOLD_R】
Alendronate	PTPmeg1	C4
Alendronate	PTPsigma	C4
【PRE_R】
Alendronate	PTPsigma	C4
PTPmeg1	PTPsigma	C4
PTPmeg1	PTP	C4

The alendronate inhibition of these three PTPs and two substrates is consistent with the formation of a ternary complex comprised of enzyme , substrate , and inhibitor .
【GOLD_E】
PTPs	geneN
alendronate	chem
【PRE_E】
alendronate	chem
PTPs	geneN
【GOLD_R】
alendronate	PTPs	C4
【PRE_R】
alendronate	PTPs	C4

PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA , or by the reducing agent dithiothreitol , suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition .
【GOLD_E】
PTP	geneN
hisphosphonates	chem
vanadate	chem
EDTA	chem
dithiothreitol	chem
cysteine	chem
【PRE_E】
PTP	geneN
hisphosphonates	chem
vanadate	chem
EDTA	chem
dithiothreitol	chem
cysteine	chem
【GOLD_R】
hisphosphonates	PTP	C4
vanadate	PTP	C4
【PRE_R】
PTP	hisphosphonates	C4
PTP	vanadate	C4

These observations show substrate - and enzyme - specific PTP inhibition by alendronate and support the possibility that a certain PTP ( s ) may be the molecular target for alendronate action .
【GOLD_E】
alendronate	chem
PTP	geneN
PTP	geneN
alendronate	chem
【PRE_E】
PTP	geneN
alendronate	chem
PTP(s)	geneY
alendronate	chem
【GOLD_R】
alendronate	PTP	C4
【PRE_R】
PTP	alendronate	C4

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells .
【GOLD_E】
mouseprostanoidreceptors	geneN
prostanoid	chem
【PRE_E】
mouseprostanoidreceptors	geneN
【GOLD_R】
【PRE_R】

1 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Eight types and subtypes of the mouse prostanoid receptor , the prostaglandin D ( DP ) receptor , the prostaglandin F ( FP ) receptor , the prostaglandin I ( IP ) receptor , the thromboxane A ( TP ) receptor and the EP1 , EP2 , EP3 and EP4 subtypes of the prostaglandin E receptor , were stably expressed in Chinese hamster ovary cells .
【GOLD_E】
EP4	geneY
prostaglandinEreceptor	geneN
mouseprostanoidreceptor	geneN
prostaglandinD(DP)receptor	geneY
FP	chem
prostaglandinI	chem
IP	chem
prostaglandinF	chem
thromboxaneA	chem
TP	chem
prostaglandinE	chem
prostanoid	chem
prostaglandinD	chem
DP	chem
prostaglandinF(FP)receptor	geneY
prostaglandinI(IP)receptor	geneY
thromboxaneA(TP)receptor	geneY
EP1	geneY
EP2	geneY
EP3	geneY
【PRE_E】
mouseprostanoidreceptor	geneY
prostaglandinD(DP)receptor	geneY
prostaglandinF(FP)receptor	geneY
prostaglandinI(IP)receptor	geneY
thromboxaneA(TP)receptor	geneY
EP1	geneY
EP2	geneY
EP3	geneY
EP4	geneY
prostaglandinEreceptor	geneY
【GOLD_R】
【PRE_R】

Their ligand binding characteristics were examined with thirty two prostanoids and their analogues by determining the Ki values from the displacement curves of radioligand binding to the respective receptors .
【GOLD_E】
prostanoids	chem
【PRE_E】
prostanoids	chem
【GOLD_R】
【PRE_R】

2 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The DP , IP and TP receptors showed high ligand binding specificity and only bound their own putative ligands with high affinity such as PGD2 , BW245C and BW868C for DP , cicaprost , iloprost and isocabacyclin for IP , and S - 145 , I - BOP and GR 32191 for TP .
【GOLD_E】
DP	geneY
IP	geneY
TPreceptors	geneY
DP	geneY
IP	geneY
TP	geneY
DP	chem
IP	chem
TP	chem
PGD2	chem
BW245C	chem
BW868C	chem
DP	chem
cicaprost	chem
iloprost	chem
isocabacyclin	chem
IP	chem
S-145	chem
I-BOP	chem
GR32191	chem
TP	chem
【PRE_E】
DP,IPandTPreceptors	geneN
PGD2	chem
BW245C	chem
BW868C	chem
DP	chem
cicaprost	chem
iloprost	chem
isocabacyclin	chem
S-145	geneY
I-BOP	geneY
GR32191	geneY
TP	geneY
【GOLD_R】
【PRE_R】

3 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The FP receptor bound PGF2 alpha and fluprostenol with Ki values of 3 - 4 nM .
【GOLD_E】
FPreceptor	geneY
FP	chem
PGF2	chem
fluprostenol	chem
【PRE_E】
FPreceptor	geneY
PGF2alpha	geneY
fluprostenol	chem
【GOLD_R】
【PRE_R】

In addition , PGD2 , 17 - phenyl - PGE2 , STA2 , I - BOP , PGE2 and M & B - 28767 bound to this receptor with Ki values less than 100 nM .
【GOLD_E】
PGD2	chem
17-phenyl-PGE2	chem
STA2	chem
I-BOP	chem
PGE2	chem
M&B-28767	chem
【PRE_E】
PGD2	chem
17-phenyl-PGE2	chem
STA2	chem
I-BOP	chem
PGE2	chem
M&B-28767	chem
【GOLD_R】
【PRE_R】

4 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The EP1 receptor bound 17 - phenyl - PGE2 , sulprostone and iloprost in addition to PGE2 and PGE1 , with Ki values of 14 - 36 nM .
【GOLD_E】
EP1	geneY
17-phenyl-PGE2	chem
sulprostone	chem
iloprost	chem
PGE2	chem
PGE1	chem
【PRE_E】
EP1receptor	geneY
17-phenyl-PGE2	chem
sulprostone	chem
iloprost	chem
PGE2	chem
PGE1	chem
【GOLD_R】
【PRE_R】

16,16 - dimethyl - PGE2 and two putative EP1 antagonists , AH6809 and SC - 19220 , did not show any significant binding to this receptor .
【GOLD_E】
EP1	geneY
16,16-dimethyl-PGE2	chem
AH6809	chem
SC-19220	chem
【PRE_E】
16,16-dimethyl-PGE2	chem
EP1	geneY
AH6809	chem
SC-19220	chem
【GOLD_R】
AH6809	EP1	C6
SC-19220	EP1	C6
【PRE_R】
EP1	AH6809	C5

M & B - 28767 , a putative EP3 agonist , and misoprostol , a putative EP2 / EP3 agonist , also bound to this receptor with Ki values of 120 nM .
【GOLD_E】
M&B-28767	chem
misoprostol	chem
EP3	geneY
EP2	geneY
EP3	geneY
【PRE_E】
M&B-28767	chem
EP3	geneY
misoprostol	chem
EP2/EP3	geneN
【GOLD_R】
M&B-28767	EP3	C5
misoprostol	EP2	C5
misoprostol	EP3	C5
【PRE_R】
M&B-28767	EP3	C6
EP3	misoprostol	C6

5 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The EP2 and EP4 receptors showed similar binding profiles .
【GOLD_E】
EP2	geneY
EP4	geneY
【PRE_E】
EP2	geneY
EP4receptors	geneY
【GOLD_R】
【PRE_R】

They bound 16,16 - dimethyl PGE2 and 11 - deoxy - PGE1 in addition to PGE2 and PGE1 .
【GOLD_E】
16,16-dimethylPGE2	chem
11-deoxy-PGE1	chem
PGE2	chem
PGE1	chem
【PRE_E】
16,16-dimethylPGE2	chem
11-deoxy-PGE1	chem
PGE2	chem
PGE1	chem
【GOLD_R】
【PRE_R】

The two receptors were discriminated by butaprost , AH - 13205 and AH - 6809 that bound to the EP2 receptor but not to the EP4 receptor , and by 1 - OH - PGE1 that bound to the EP4 but not to the EP2 receptor .
【GOLD_E】
butaprost	chem
AH-13205	chem
AH-6809	chem
1-OH-PGE1	chem
EP2	geneY
EP4	geneY
EP4	geneY
EP2	geneY
【PRE_E】
butaprost	chem
AH-13205	chem
AH-6809	chem
EP2receptor	geneY
EP4receptor	geneY
1-OH-PGE1	chem
EP4	geneY
EP2receptor	geneY
【GOLD_R】
【PRE_R】

6 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The EP3 receptor showed the broadest binding profile , and bound sulprostone , M & B - 28767 , GR63799X , 11 - deoxy - PGE1 , 16,16 - dimethyl - PGE2 and 17 - phenyl - PGE2 , in addition to PGE2 and PGE1 , with Ki values of 0.6 - 3.7 nM .
【GOLD_E】
sulprostone	chem
M&B-28767	chem
GR63799X	chem
11-deoxy-PGE1	chem
16,16-dimethyl-PGE2	chem
17-phenyl-PGE2	chem
PGE2	chem
PGE1	chem
EP3	geneY
【PRE_E】
EP3receptor	geneY
sulprostone	chem
M&B-28767	chem
GR63799X	chem
11-deoxy-PGE1	chem
16,16-dimethyl-PGE2	chem
17-phenyl-PGE2	chem
PGE2	chem
PGE1	chem
【GOLD_R】
【PRE_R】

In addition , three IP ligands , iloprost , carbacyclin and isocarbacyclin , and one TP ligand , STA2 , bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors , respectively .
【GOLD_E】
IP	chem
iloprost	chem
carbacyclin	chem
isocarbacyclin	chem
TP	chem
STA2	chem
IP	chem
TP	chem
IP	geneY
TP	geneY
IP	geneY
TPreceptors	geneY
【PRE_E】
iloprost	chem
carbacyclin	chem
isocarbacyclin	chem
TP	geneY
STA2	chem
IPandTPreceptors	geneN
【GOLD_R】
【PRE_R】

7 .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

8 - Epi - PGF2 alpha showed only weak binding to the IP , TP , FP , EP2 and EP3 receptor at 10 microM concentration .
【GOLD_E】
EP3	geneY
IP	chem
TP	chem
FP	chem
IP	geneY
TP	geneY
FP	geneY
EP2	geneY
【PRE_E】
8-Epi	chem
PGF2alpha	geneY
TP	geneY
FP	geneY
EP2	geneY
EP3receptor	geneY
【GOLD_R】
【PRE_R】

The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue .
【GOLD_E】
thymidine	chem
thymidinekinase	geneY
【PRE_E】
thymidinekinase	geneN
herpessimplexvirustype1	geneY
【GOLD_R】
【PRE_R】

Thymidine kinase from Herpes simplex virus type 1 ( TK ) was crystallized in an N - terminally truncated but fully active form .
【GOLD_E】
Thymidine	chem
N	chem
Thymidinekinase	geneY
TK	geneY
【PRE_E】
Thymidinekinase	geneY
Herpessimplexvirustype1	geneY
TK	geneN
N	chem
【GOLD_R】
【PRE_R】

The structures of TK complexed with ADP at the ATP - site and deoxythymidine - 5 ' - monophosphate ( dTMP ) , deoxythymidine ( dT ) , or idoxuridine - 5 ' - phosphate ( 5 - iodo - dUMP ) at the substrate - site were refined to 2.75 A , 2.8 A , and 3.0 A resolution , respectively .
【GOLD_E】
dT	chem
idoxuridine-5'-phosphate	chem
5-iodo-dUMP	chem
TK	geneY
ADP	chem
ATP	chem
deoxythymidine-5'-monophosphate	chem
dTMP	chem
deoxythymidine	chem
【PRE_E】
TK	geneN
ADP	chem
ATP	chem
deoxythymidine-5'-monophosphate	chem
dTMP	chem
deoxythymidine	chem
dT	chem
idoxuridine-5'-phosphate	chem
5-iodo-dUMP	chem
【GOLD_R】
【PRE_R】

TK catalyzes the phosphorylation of dT resulting in an ester , and the phosphorylation of dTMP giving rise to an anhydride .
【GOLD_E】
TK	chem
dT	chem
ester	chem
dTMP	chem
anhydride	chem
TK	geneY
【PRE_E】
TK	geneN
dT	chem
dTMP	chem
anhydride	chem
【GOLD_R】
【PRE_R】
TK	dT	C9
TK	dTMP	C9
TK	anhydride	C9

The presented TK structures indicate that there are only small differences between these two modes of action .
【GOLD_E】
TK	chem
TK	geneY
【PRE_E】
TK	geneN
【GOLD_R】
【PRE_R】

Glu83 serves as a general base in the ester reaction .
【GOLD_E】
ester	chem
【PRE_E】
Glu83	geneN
【GOLD_R】
【PRE_R】

Arg163 parks at an internal aspartate during ester formation and binds the alpha - phosphate of dTMP during anhydride formation .
【GOLD_E】
aspartate	chem
ester	chem
alpha-phosphate	chem
dTMP	chem
anhydride	chem
【PRE_E】
Arg163	chem
aspartate	chem
alpha-phosphate	chem
dTMP	chem
anhydride	chem
【GOLD_R】
【PRE_R】

The bound deoxythymidine leaves a 35 A3 cavity at position 5 of the base and two sequestered water molecules at position 2 .
【GOLD_E】
deoxythymidine	chem
【PRE_E】
deoxythymidine	chem
【GOLD_R】
【PRE_R】

Cavity and water molecules reduce the substrate specificity to such an extent that TK can phosphorylate various substrate analogues useful in pharmaceutical applications .
【GOLD_E】
TK	chem
phosphorylate	chem
TK	geneY
【PRE_E】
TK	geneN
phosphorylate	geneN
【GOLD_R】
【PRE_R】

TK is structurally homologous to the well - known nucleoside monophosphate kinases but contains large additional peptide segments .
【GOLD_E】
TK	geneY
nucleosidemonophosphatekinases	geneN
TK	chem
nucleosidemonophosphate	chem
【PRE_E】
TK	geneN
nucleosidemonophosphatekinases	geneN
【GOLD_R】
【PRE_R】

Blockage of the HERG human cardiac K + channel by the gastrointestinal prokinetic agent cisapride .
【GOLD_E】
K+	chem
cisapride	chem
HERGhumancardiacK+channel	geneY
【PRE_E】
HERG	geneY
humancardiacK+channel	geneN
cisapride	chem
【GOLD_R】
cisapride	HERGhumancardiacK+channel	C4
【PRE_R】
HERG	cisapride	C4

Cisapride , a gastrointestinal prokinetic agent , is known to cause long Q - T syndrome and ventricular arrhythmias .
【GOLD_E】
Cisapride	chem
【PRE_E】
Cisapride	chem
【GOLD_R】
【PRE_R】

The cellular mechanism is not known .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The human ether - a - go - go - related gene ( HERG ) , which encodes the rapidly activating delayed rectifier K + current and is important in cardiac repolarization , may serve as a target for the action of cisapride .
【GOLD_E】
humanether-a-go-go-relatedgene	geneY
HERG	geneY
K+	chem
cisapride	chem
【PRE_E】
humanether-a-go-go-relatedgene	geneY
HERG	geneY
K+	chem
cisapride	chem
【GOLD_R】
【PRE_R】

We tested the hypothesis that cisapride blocks HERG .
【GOLD_E】
HERG	geneY
cisapride	chem
【PRE_E】
cisapride	chem
HERG	geneY
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
cisapride	HERG	C4

The whole cell patch - clamp recording technique was used to study HERG channels stably expressed heterologously in HEK293 cells .
【GOLD_E】
HERG	geneY
【PRE_E】
HERG	geneY
【GOLD_R】
【PRE_R】

Under voltage - clamp conditions , cisapride block of HERG is dose dependent with a half - maximal inhibitory concentration of 6.5 nM at 22 degrees C ( n = 25 cells ) .
【GOLD_E】
HERG	geneY
cisapride	chem
【PRE_E】
cisapride	chem
HERG	geneY
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
cisapride	HERG	C4

Currents rapidly recovered with drug washout .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The onset of block by cisapride required channel activation indicative of open or inactivated state blockage .
【GOLD_E】
cisapride	chem
【PRE_E】
cisapride	chem
【GOLD_R】
【PRE_R】

Block of HERG with cisapride after channel activation was voltage dependent .
【GOLD_E】
cisapride	chem
HERG	geneY
【PRE_E】
HERG	geneY
cisapride	chem
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
HERG	cisapride	C4

At - 20 mV , 10 nM cisapride reduced HERG tail - current amplitude by 5 % , whereas , at + 20 mV , the tail - current amplitude was reduced by 45 % ( n = 4 cells ) .
【GOLD_E】
cisapride	chem
HERG	geneY
【PRE_E】
cisapride	chem
HERG	geneY
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
cisapride	HERG	C4

At - 20 and + 20 mV , 100 nM cisapride reduced tail - current amplitude by 66 and 90 % , respectively .
【GOLD_E】
cisapride	chem
【PRE_E】
cisapride	chem
【GOLD_R】
【PRE_R】

We conclude that cisapride is a potent blocker of HERG channels expressed in HEK293 cells .
【GOLD_E】
HERG	geneY
cisapride	chem
【PRE_E】
cisapride	chem
HERG	geneY
【GOLD_R】
cisapride	HERG	C4
【PRE_R】
cisapride	HERG	C4

This effect may account for the clinical occurrence of Q - T prolongation and ventricular arrhythmias observed with cisapride .
【GOLD_E】
cisapride	chem
【PRE_E】
Q-T	geneY
cisapride	chem
【GOLD_R】
【PRE_R】

Analysis of NMDA receptors in the human spinal cord .
【GOLD_E】
NMDA	chem
NMDAreceptors	geneN
【PRE_E】
NMDAreceptors	geneN
【GOLD_R】
【PRE_R】

NMDA receptors in postmortem human spinal cord were analyzed using [ 3H ] MK - 801 ligand binding and immunoblotting with NMDA receptor subunit - specific antibodies .
【GOLD_E】
NMDAreceptors	geneN
NMDAreceptor	geneN
NMDA	chem
NMDA	chem
[3H]MK-801	chem
【PRE_E】
NMDAreceptors	geneN
[3H]MK-801	chem
NMDAreceptor	geneN
【GOLD_R】
【PRE_R】

The average KD for [ 3H ] MK - 801 binding was 1.77 nM with a Bmax of 0.103 pmol / mg .
【GOLD_E】
[3H]MK-801	chem
【PRE_E】
[3H]MK-801	chem
【GOLD_R】
【PRE_R】

The EC50 for stimulation of - 3H - MK - 801 binding with L - glutamate was 0.34 microM .
【GOLD_E】
3H-MK-801	chem
L-glutamate	chem
【PRE_E】
-3H-MK-801	chem
L-glutamate	chem
【GOLD_R】
【PRE_R】

None of these parameters were affected by postmortem intervals up to 72 h .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Immunoblotting of native NMDA receptors showed that NR1 , NR2A , NR2C , and NR2D subunits could all be found in the human spinal cord of which NR1 was preferentially located to the dorsal half .
【GOLD_E】
NMDAreceptors	geneN
NR1	geneY
NR2A	geneY
NR2C	geneN
NR2D	geneY
NR1	geneY
NMDA	chem
【PRE_E】
NMDAreceptors	geneN
NR1	geneY
NR2A	geneY
NR2C	geneY
NR2D	geneY
NR1	geneY
【GOLD_R】
【PRE_R】

Immunoprecipitation of solubilized receptors revealed that NR1 , NR2C , and NR2D subunits coprecipitated with the NR2A subunit , indicating that native human spinal cord NMDA receptors are heteroligimeric receptors assembled by at least three different receptor subunits .
【GOLD_E】
NR1	geneY
NR2C	geneN
NR2D	geneY
NR2A	geneY
NMDAreceptors	geneN
heteroligimericreceptors	geneN
NMDA	chem
heteroligimeric	chem
【PRE_E】
solubilizedreceptors	geneN
NR1	geneY
NR2C	geneY
NR2D	geneY
NR2A	geneY
NMDAreceptors	geneN
heteroligimericreceptors	geneN
【GOLD_R】
【PRE_R】

These results provide a basis for the development of drugs selectively aimed at spinal cord NMDA receptors for the future treatment of spinal cord disorders .
【GOLD_E】
NMDA	chem
NMDAreceptors	geneN
【PRE_E】
NMDAreceptors	geneN
【GOLD_R】
【PRE_R】

Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine .
【GOLD_E】
Monoamine	chem
sodium	chem
cocaine	chem
Monoaminetransporter	geneN
sodiumchannel	geneN
【PRE_E】
Monoaminetransporter	geneN
sodiumchannel	geneN
cocaine	chem
【GOLD_R】
【PRE_R】

Intravenous ( I.V . ) cocaine ( 0.03 - 3 mg / kg ) produced dose - dependent , rapid , and brief increases in blood pressure ( BP ) in conscious rats pretreated with the dopamine receptor antagonist , SCH 23390 .
【GOLD_E】
dopamine	chem
SCH23390	chem
cocaine	chem
dopaminereceptor	geneN
【PRE_E】
cocaine	chem
dopaminereceptor	geneY
SCH23390	chem
【GOLD_R】
SCH23390	dopaminereceptor	C6
【PRE_R】

Monoamine uptake inhibitors structurally analogous to cocaine ( cocaethylene , CFT , betaCIT , CPT , ( + ) - cocaine , norcocaine , and benztropine ) also produced this rapid pressor response , whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities ( BTCP , indatraline , GBR 12935 , mazindol , nomifensine , and zimeldine ) either did not produce a rapid pressor response or produced only a small pressor response .
【GOLD_E】
Monoamine	chem
cocaine	chem
cocaethylene	chem
CFT	chem
betaCIT	chem
CPT	chem
(+)-cocaine	chem
norcocaine	chem
benztropine	chem
monoamine	chem
BTCP	chem
indatraline	chem
GBR12935	chem
mazindol	chem
nomifensine	chem
zimeldine	chem
monoaminetransporter	geneN
【PRE_E】
Monoamine	chem
cocaine	chem
cocaethylene	chem
CFT	chem
betaCIT	chem
CPT	chem
(+)-cocaine	chem
norcocaine	chem
benztropine	chem
monoaminetransporter	geneN
BTCP	chem
indatraline	chem
GBR12935	chem
mazindol	chem
nomifensine	chem
zimeldine	chem
【GOLD_R】
BTCP	monoaminetransporter	C4
indatraline	monoaminetransporter	C4
GBR12935	monoaminetransporter	C4
mazindol	monoaminetransporter	C4
nomifensine	monoaminetransporter	C4
zimeldine	monoaminetransporter	C4
【PRE_R】

At nonconvulsant doses , the sodium channel blockers acetylprocainamide , dibucaine , dyclonine , prilocaine , proparacaine , quinidine , and tetracaine produced a small pressor response or no increase in BP .
【GOLD_E】
sodium	chem
acetylprocainamide	chem
dibucaine	chem
dyclonine	chem
prilocaine	chem
proparacaine	chem
quinidine	chem
tetracaine	chem
sodiumchannel	geneN
【PRE_E】
sodiumchannel	geneN
acetylprocainamide	chem
dibucaine	chem
dyclonine	chem
prilocaine	chem
proparacaine	chem
quinidine	chem
tetracaine	chem
【GOLD_R】
acetylprocainamide	sodiumchannel	C4
dibucaine	sodiumchannel	C4
dyclonine	sodiumchannel	C4
prilocaine	sodiumchannel	C4
proparacaine	sodiumchannel	C4
quinidine	sodiumchannel	C4
tetracaine	sodiumchannel	C4
【PRE_R】

In rats implanted with telemetric devices , cocaine and its analog , CFT , produced a biphasic pharmacological response that consisted of an initial brief and abrupt behavioral arousal associated with a rapid , large increase in BP followed by prolonged , parallel increases in BP and locomotor activity .
【GOLD_E】
cocaine	chem
CFT	chem
【PRE_E】
cocaine	chem
CFT	chem
【GOLD_R】
【PRE_R】

Pretreatment with SCH 23390 prevented the prolonged but not the initial rapid and brief pressor and activity responses to both cocaine and CFT administration .
【GOLD_E】
SCH23390	chem
cocaine	chem
CFT	chem
【PRE_E】
SCH23390	chem
cocaine	chem
CFT	chem
【GOLD_R】
【PRE_R】

The present data suggest that the inhibition of dopamine , norepinephrine , or serotonin transporter functions , either alone or in combination , does not mediate the rapid pressor response to cocaine .
【GOLD_E】
dopamine,norepinephrine,orserotonintransporter	geneN
dopamine	chem
norepinephrine	chem
serotonin	chem
cocaine	chem
【PRE_E】
dopamine,norepinephrine,orserotonintransporter	geneN
cocaine	chem
【GOLD_R】
【PRE_R】

The sodium channel - blocking action of cocaine per se does not appear to be involved in the rapid pressor response to cocaine .
【GOLD_E】
cocaine	chem
sodiumchannel	geneN
sodium	chem
cocaine	chem
【PRE_E】
sodiumchannel	geneN
cocaine	chem
cocaine	chem
【GOLD_R】
cocaine	sodiumchannel	C4
【PRE_R】

Finally , the present results confirm previous findings that dopaminergic mechanisms mediate the prolonged increases in BP and locomotor activity produced by cocaine .
【GOLD_E】
cocaine	chem
【PRE_E】
cocaine	chem
【GOLD_R】
【PRE_R】

Identification of cDNAs encoding two human alpha class glutathione transferases ( GSTA3 and GSTA4 ) and the heterologous expression of GSTA4 - 4 .
【GOLD_E】
GSTA4-4	geneY
humanalphaclassglutathionetransferases	geneN
GSTA3	geneY
GSTA4	geneY
glutathione	chem
【PRE_E】
humanalphaclassglutathionetransferases	geneN
GSTA3	geneY
GSTA4	geneY
GSTA4-4	geneY
【GOLD_R】
【PRE_R】

The Expressed Sequence Tag database has been searched for examples of previously undescribed human Alpha class glutathione transferases .
【GOLD_E】
humanAlphaclassglutathionetransferases	geneN
glutathione	chem
【PRE_E】
humanAlphaclassglutathionetransferases	geneN
【GOLD_R】
【PRE_R】

An incomplete transcript of the previously described GSTA3 gene was identified in a cDNA library derived from 8 - 9 week placenta .
【GOLD_E】
GSTA3	geneY
【PRE_E】
GSTA3	geneY
【GOLD_R】
【PRE_R】

This indicates that the GSTA3 gene is functional and is possibly under specific developmental regulation .
【GOLD_E】
GSTA3	geneY
【PRE_E】
GSTA3	geneY
【GOLD_R】
【PRE_R】

A second cDNA , termed GSTA4 , was identified in a brain cDNA library .
【GOLD_E】
GSTA4	geneY
【PRE_E】
GSTA4	geneY
【GOLD_R】
【PRE_R】

The encoded GSTA4 - 4 enzyme was expressed in Escherichia coli and was found to be immunologically distinct from GSTA1 - 1 and to have high activity with alk - 2 - enals .
【GOLD_E】
GSTA4-4	geneY
GSTA1-1	geneY
【PRE_E】
GSTA4-4	geneY
GSTA1-1	geneY
alk-2-enals	chem
【GOLD_R】
【PRE_R】
GSTA4-4	alk-2-enals	C9
GSTA1-1	alk-2-enals	C9

Although GSTA4 - 4 appears to be functionally similar to the mouse GST5.7 and rat GST8 - 8 Alpha class enzymes , sequence comparisons and phylogenetic analysis suggest that GSTA4 - 4 may be a member of a distinct Alpha class subgroup .
【GOLD_E】
ratGST8-8	geneY
GSTA4-4	geneY
GSTA4-4	geneY
mouseGST5.7	geneY
【PRE_E】
GSTA4-4	geneY
mouseGST5.7	geneY
ratGST8-8Alphaclassenzymes	geneN
GSTA4-4	geneY
【GOLD_R】
【PRE_R】

Characterization of binding sites of a new neurotensin receptor antagonist , [ 3H ] SR 142948A , in the rat brain .
【GOLD_E】
neurotensin	chem
[3H]SR142948A	chem
neurotensinreceptor	geneN
【PRE_E】
neurotensinreceptor	geneN
[3H]SR142948A	chem
【GOLD_R】
[3H]SR142948A	neurotensinreceptor	C6
【PRE_R】

The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of neurotensin receptors , [ 3H ] SR 142948A ( 2 - [ [ 5 - ( 2,6 - dimethoxyphenyl ) - 1 - ( 4 - ( N - ( 3 - dimethylaminopropyl ) - N - methyl carbamoyl ) - 2 - isopropylphenyl ) - 1H - pyrazole - 3 - carbonyl ] - amino ] - ad amantane - 2 - carboxylic acid , hydrochloride ) , in the rat brain .
【GOLD_E】
[3H]SR142948A	chem
2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylcarbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-adamantane-2-carboxylicacid,hydrochloride	chem
neurotensinreceptors	geneN
neurotensin	chem
【PRE_E】
neurotensinreceptors	geneN
[3H]SR142948A	chem
2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylcarbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino	chem
amantane-2-carboxylicacid	chem
hydrochloride	chem
【GOLD_R】
[3H]SR142948A	neurotensinreceptors	C6
2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylcarbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-adamantane-2-carboxylicacid,hydrochloride	neurotensinreceptors	C6
【PRE_R】

The binding of [ 3H ] SR 142948A in brain membrane homogenates was specific , time - dependent , reversible and saturable .
【GOLD_E】
[3H]SR142948A	chem
【PRE_E】
[3H]SR142948A	chem
【GOLD_R】
【PRE_R】

[ 3H ] SR 142948A bound to an apparently homogeneous population of sites , with a Kd of 3.5 nM and a Bmax value of 508 fmol / mg of protein , which was 80 % higher than that observed in saturation experiments with [ 3H ] neurotensin .
【GOLD_E】
[3H]SR142948A	chem
[3H]neurotensin	chem
【PRE_E】
[3H]SR142948A	chem
[3H]neurotensin	chem
【GOLD_R】
【PRE_R】

[ 3H ] SR 142948A binding was inhibited by SR 142948A , the related nonpeptide receptor antagonist , SR 48692 ( 2 - [ [ 1 - ( 7 - chloroquinolin - 4 - yl ) - 5 - ( 2,6 - dimethoxyphenyl ) - 1H - pyrazole - 3 - carbonyl ] amino ] - adamantane - 2 - carboxylic acid ) and neurotensin .
【GOLD_E】
[3H]SR142948A	chem
SR142948A	chem
SR48692	chem
2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carbonyl]amino]-adamantane-2-carboxylicacid	chem
neurotensin	chem
neurotensin	geneY
【PRE_E】
[3H]SR142948A	chem
SR142948A	chem
nonpeptidereceptor	geneN
SR48692	chem
2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carbonyl]amino]-adamantane-2-carboxylicacid	chem
neurotensin	chem
【GOLD_R】
【PRE_R】
nonpeptidereceptor	SR48692	C5
nonpeptidereceptor	2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carbonyl]amino]-adamantane-2-carboxylicacid	C5
nonpeptidereceptor	neurotensin	C5

Saturation and competition studies in the presence or absence of the histamine H1 receptor antagonist , levocabastine , revealed that [ 3H ] SR 142948A bound with similar affinities to both the levocabastine - insensitive neurotensin NT1 receptors ( 20 % of the total binding population ) and the recently cloned levocabastine - sensitive neurotensin NT2 receptors ( 80 % of the receptors ) ( Kd = 6.8 and 4.8 nM , respectively ) .
【GOLD_E】
histamine	chem
histamineH1receptor	geneY
neurotensinNT1receptors	geneY
neurotensinNT2receptors	geneY
levocabastine	chem
[3H]SR142948A	chem
levocabastine	chem
neurotensin	chem
levocabastine	chem
【PRE_E】
histamineH1receptor	geneY
levocabastine	chem
[3H]SR142948A	chem
levocabastine	chem
neurotensinNT1receptors	geneY
levocabastine-sensitiveneurotensinNT2receptors	geneY
【GOLD_R】
levocabastine	histamineH1receptor	C6
【PRE_R】

The regional distribution of [ 3H ] SR 142948A binding in the rat brain closely matched the distribution of [ 125I ] neurotensin binding .
【GOLD_E】
[3H]SR142948A	chem
[125I]neurotensin	chem
【PRE_E】
[3H]SR142948A	chem
[125I]neurotensin	chem
【GOLD_R】
【PRE_R】

In conclusion , these findings indicate that [ 3H ] SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain .
【GOLD_E】
[3H]SR142948A	chem
neurotensin	chem
neurotensin	chem
neurotensinNT1	geneY
NT2receptors	geneY
neurotensinreceptors	geneN
【PRE_E】
[3H]SR142948A	chem
neurotensinNT1	geneY
NT2receptors	geneY
neurotensinreceptors	geneN
【GOLD_R】
[3H]SR142948A	neurotensinNT1	C6
[3H]SR142948A	NT2receptors	C6
【PRE_R】

A new concept of drug delivery for acne .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Adapalene is a stable naphthoic acid derivative that displays a strong retinoid agonist pharmacology .
【GOLD_E】
Adapalene	chem
naphthoicacid	chem
retinoid	chem
【PRE_E】
Adapalene	chem
naphthoicacid	chem
retinoid	geneY
【GOLD_R】
【PRE_R】

This drug controls cell proliferation and differentiation , and possesses significant anti - inflammatory action .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

The retinoid action of adapalene are mediated by the ligand - activated gene transcription factors retinoic acid receptors RAR beta and RAR gamma .
【GOLD_E】
RARbeta	geneY
RARgamma	geneY
retinoid	chem
adapalene	chem
retinoicacid	chem
ligand-activatedgenetranscriptionfactors	geneN
retinoicacidreceptors	geneN
【PRE_E】
retinoid	chem
adapalene	chem
retinoicacidreceptorsRARbeta	geneY
RARgamma	geneY
【GOLD_R】
【PRE_R】
adapalene	RARgamma	C4

We describe here how an aqueous gel containing adapalene was selected for the topical treatment of acne .
【GOLD_E】
adapalene	chem
【PRE_E】
adapalene	chem
【GOLD_R】
【PRE_R】

Isoform - specific inhibition of L - type calcium channels by dihydropyridines is independent of isoform - specific gating properties .
【GOLD_E】
calcium	chem
dihydropyridines	chem
L-typecalciumchannels	geneN
【PRE_E】
L-typecalciumchannels	geneN
dihydropyridines	chem
【GOLD_R】
dihydropyridines	L-typecalciumchannels	C4
【PRE_R】

Dihydropyridines ( DHPs ) block L - type Ca2 + channels more potently at depolarized membrane potentials , consistent with high affinity binding to the inactivated state .
【GOLD_E】
L-typeCa2+channels	geneN
Dihydropyridines	chem
DHPs	chem
Ca2+	chem
【PRE_E】
Dihydropyridines	chem
DHPs	chem
L-typeCa2+channels	geneN
【GOLD_R】
Dihydropyridines	L-typeCa2+channels	C4
DHPs	L-typeCa2+channels	C4
【PRE_R】

Nisoldipine ( a DHP antagonist ) blocks the smooth muscle channel more potently than the cardiac one , a phenomenon observed not only in native channels but also in expressed channels .
【GOLD_E】
smoothmusclechannel	geneN
Nisoldipine	chem
DHP	chem
【PRE_E】
Nisoldipine	chem
DHP	chem
smoothmusclechannel	geneN
【GOLD_R】
Nisoldipine	smoothmusclechannel	C4
DHP	smoothmusclechannel	C4
【PRE_R】
Nisoldipine	smoothmusclechannel	C4
DHP	smoothmusclechannel	C4

We examined whether this tissue specificity was attributable to differences of inactivation in the two channel types .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We expressed cardiac or smooth muscle alpha1C subunits in combination with beta2a and alpha2 / delta subunits in human embryonic kidney cells , and used 2 mM Ca2 + as the permeant ion .
【GOLD_E】
Ca2+	chem
smoothmusclealpha1C	geneY
【PRE_E】
smoothmusclealpha1C	geneY
beta2aandalpha2/delta	geneN
Ca2+	chem
【GOLD_R】
【PRE_R】

This system thus reproduces the in vivo topology and charge carrier of the channels while facilitating comparison of the two alpha1C splice variants .
【GOLD_E】
【PRE_E】
alpha1C	geneN
【GOLD_R】
【PRE_R】

Both voltage - dependent and isoform - specific sensitivity of 10 nM nisoldipine inhibition of the channel were demonstrated , with the use of - 100 mV as the holding potential for fully reprimed channels and - 65 mV to populate the inactivated state .
【GOLD_E】
nisoldipine	chem
【PRE_E】
nisoldipine	chem
reprimedchannelsand-65	geneN
【GOLD_R】
【PRE_R】

Under drug - free conditions , we characterized fast inactivation ( 1 - sec prepulses ) and slow inactivation ( 3 min prepulses ) in the two isoforms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Inactivation parameters were not statistically different in the two channel isoforms ; if anything , cardiac channels tended to inactivate more than the smooth muscle channels at relevant voltages .
【GOLD_E】
cardiacchannels	geneN
smoothmusclechannels	geneN
【PRE_E】
cardiacchannels	geneN
smoothmusclechannels	geneN
【GOLD_R】
【PRE_R】

Likewise , the voltage - dependent activation was identical in the two isoforms .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

We thus conclude that the more potent nisoldipine inhibition of smooth muscle versus cardiac L - type Ca2 + channels is not attributable to differences in channel inactivation or activation .
【GOLD_E】
cardiacL-typeCa2+channels	geneN
nisoldipine	chem
Ca2+	chem
【PRE_E】
nisoldipine	chem
L-typeCa2+channels	geneN
【GOLD_R】
nisoldipine	cardiacL-typeCa2+channels	C4
【PRE_R】

Intrinsic , gating - independent DHP receptor binding affinity differences must be invoked to explain the isoform - specific sensitivity of the DHP block .
【GOLD_E】
DHPreceptor	geneN
DHP	chem
DHP	chem
【PRE_E】
DHPreceptor	geneN
DHP	chem
【GOLD_R】
【PRE_R】

Remethylation defects : guidelines for clinical diagnosis and treatment .
【GOLD_E】
【PRE_E】
Remethylation	chem
【GOLD_R】
【PRE_R】

The main remethylation defects include disorders which all have defective methionine synthesis in common .
【GOLD_E】
methionine	chem
【PRE_E】
methionine	chem
【GOLD_R】
【PRE_R】

Methylenetetrahydrofolate reductase deficiency impairs methyltetrahydrofolate synthesis , defects in cytosolic reduction of hydroxocobalamin ( CblC / D ) impair the synthesis of both methyl - and adenosyl cobalamin and deficiencies of methionine synthase ( CblE / G ) are associated with defective methyl cobalamin synthesis .
【GOLD_E】
Methylenetetrahydrofolatereductase	geneY
methioninesynthase	geneY
Methylenetetrahydrofolate	chem
methyltetrahydrofolate	chem
hydroxocobalamin	chem
methyl	chem
adenosylcobalamin	chem
methionine	chem
methylcobalamin	chem
【PRE_E】
Methylenetetrahydrofolatereductase	geneY
methyltetrahydrofolate	chem
hydroxocobalamin	chem
CblC/D	geneY
methyl-andadenosylcobalamin	chem
methioninesynthase	geneN
CblE/G	geneN
methylcobalamin	chem
【GOLD_R】
methyltetrahydrofolate	Methylenetetrahydrofolatereductase	C9
methylcobalamin	methioninesynthase	C9
【PRE_R】
methyltetrahydrofolate	CblC/D	C9
hydroxocobalamin	CblC/D	C9
CblC/D	methyl-andadenosylcobalamin	C9
CblE/G	methylcobalamin	C9

The clinical presentation is characterized by acute neurological distress in early infancy .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In childhood , patients present with progressive encephalopathy with an end - stage which has many signs in common with the adult onset form .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

In fact , both have more or less severe signs of subacute degeneration of the cord .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cobalamin defective patients must be treated with parenteral supplementation of hydroxocobalamin ( 1 - 2 mg per dose ) .
【GOLD_E】
hydroxocobalamin	chem
Cobalamin	chem
【PRE_E】
Cobalamin	chem
hydroxocobalamin	chem
【GOLD_R】
【PRE_R】

Some methylenetetrahydrofolate patients could be folate responsive and must have a high - dosage folate trial .
【GOLD_E】
methylenetetrahydrofolate	chem
folate	chem
【PRE_E】
folate	chem
folate	chem
【GOLD_R】
【PRE_R】

In addition , oral betaine supplementation ( 2 - 9 g per day depending on age ) appears an effective means to prevent further neurological deterioration .
【GOLD_E】
betaine	chem
【PRE_E】
betaine	chem
【GOLD_R】
【PRE_R】

Increased Cat3 - mediated cationic amino acid transport functionally compensates in Cat1 knockout cell lines .
【GOLD_E】
Cat3	geneY
Cat1	geneY
aminoacid	chem
【PRE_E】
Cat3	geneY
aminoacid	chem
Cat1	geneY
【GOLD_R】
aminoacid	Cat3	C9
【PRE_R】
Cat3	aminoacid	C9
aminoacid	Cat1	C9

Arginine transport is important for a number of biological processes in vertebrates , and its transport may be rate - limiting for the production of nitric oxide .
【GOLD_E】
Arginine	chem
nitricoxide	chem
【PRE_E】
Arginine	chem
nitricoxide	chem
【GOLD_R】
【PRE_R】

The majority of L - Arg transport is mediated by System y + , although several other carriers have been kinetically defined .
【GOLD_E】
Systemy+	geneN
L-Arg	chem
【PRE_E】
L-Arg	geneY
【GOLD_R】
L-Arg	Systemy+	C9
【PRE_R】

System y + cationic amino acid transport is mediated by proteins encoded by a family of genes , Cat1 , Cat2 , and Cat3 .
【GOLD_E】
Systemy+	geneN
Cat1	geneY
Cat2	geneY
Cat3	geneY
aminoacid	chem
【PRE_E】
aminoacid	chem
Cat1	geneY
Cat2	geneY
Cat3	geneY
【GOLD_R】
aminoacid	Systemy+	C9
aminoacid	Cat1	C9
aminoacid	Cat2	C9
aminoacid	Cat3	C9
【PRE_R】

High affinity L - arginine transport was investigated in embryonic fibroblast cells derived from Cat1 knockout mice that lack functional Cat1 .
【GOLD_E】
Cat1	geneY
Cat1	geneY
L-arginine	chem
【PRE_E】
L-arginine	chem
Cat1	geneY
Cat1	geneY
【GOLD_R】
【PRE_R】

Both wild type and knockout cells transport arginine with comparable Km and Vmax .
【GOLD_E】
arginine	chem
【PRE_E】
arginine	chem
【GOLD_R】
【PRE_R】

However , the apparent affinity for lysine transport was 2.4 times lower in Cat1 ( - / - ) cells when compared with wild type cells , a property characteristic of Cat3 - mediated transport .
【GOLD_E】
Cat1	geneY
Cat3	geneY
lysine	chem
【PRE_E】
lysine	chem
Cat1	geneY
Cat3	geneY
【GOLD_R】
lysine	Cat3	C9
【PRE_R】

Northern analysis - documented Cat2 mRNA increased 2 - fold , whereas Cat3 mRNA levels increased 11 - fold in Cat1 ( - / - ) relative to Cat1 ( + / + ) cells .
【GOLD_E】
Cat2	geneY
Cat3	geneY
Cat1	geneY
Cat1	geneY
【PRE_E】
Cat2	geneY
Cat3	geneY
Cat1	geneY
Cat1	geneY
【GOLD_R】
【PRE_R】

The low affinity Cat2a mRNA was not detectably expressed in these cells .
【GOLD_E】
Cat2a	geneN
【PRE_E】
Cat2a	geneY
【GOLD_R】
【PRE_R】

Even though Cat3 expression is normally limited to adult brain , there was a large increase in the amount of Cat3 protein present at the plasma membrane of Cat1 ( - / - ) embryonic fibroblast cells .
【GOLD_E】
Cat3	geneY
Cat3	geneY
Cat1	geneY
【PRE_E】
Cat3	geneY
Cat3	geneY
Cat1	geneY
【GOLD_R】
【PRE_R】

These results suggest that Cat3 compensates for the loss of functional Cat1 in cells derived from Cat1 knockout mice and mediates the majority of high affinity arginine transport .
【GOLD_E】
Cat3	geneY
Cat1	geneY
Cat1	geneY
arginine	chem
【PRE_E】
Cat3	geneY
Cat1	geneY
Cat1	geneY
arginine	chem
【GOLD_R】
arginine	Cat3	C9
【PRE_R】
Cat3	arginine	C9
Cat1	arginine	C9
Cat1	arginine	C9

Effect of lintitript , a new CCK - A receptor antagonist , on gastric emptying of a solid - liquid meal in humans .
【GOLD_E】
CCK-Areceptor	geneY
lintitript	chem
【PRE_E】
CCK-A	geneY
【GOLD_R】
lintitript	CCK-Areceptor	C6
【PRE_R】

The role of cholecystokinin ( CCK ) in the regulation of gastric emptying of physiological meals containing solids and liquids in humans remains controversial .
【GOLD_E】
cholecystokinin	geneY
CCK	geneY
【PRE_E】
cholecystokinin	geneY
CCK	geneY
【GOLD_R】
【PRE_R】

We studied the role of endogenous CCK in the emptying of a solid / liquid meal administering the new , highly specific and potent CCK - A receptor antagonist lintitript .
【GOLD_E】
CCK	geneY
CCK-Areceptor	geneY
lintitript	chem
【PRE_E】
CCK	geneY
CCK-A	geneY
【GOLD_R】
lintitript	CCK-Areceptor	C6
【PRE_R】

Gastric emptying was assessed in nine healthy male volunteers using a randomized , double blind , two - period crossover design with oral lintitript ( 15 mg 1 h prior to meal intake ) or placebo on two different days .
【GOLD_E】
lintitript	chem
【PRE_E】
lintitript	chem
【GOLD_R】
【PRE_R】

After ingestion of a pancake ( 570 kcal ) labelled with 500 microCi of 99mTc - sulfur colloid and 500 ml 10 % dextrose containing 80 microCi .
【GOLD_E】
99mTc-sulfur	chem
【PRE_E】
microCi	chem
99mTc	chem
sulfur	chem
dextrose	chem
microCi	chem
【GOLD_R】
【PRE_R】

111In - DTPA , subjects were studied in a sitting position , using a dual - headed gamma camera .
【GOLD_E】
111In-DTPA	chem
【PRE_E】
111In-DTPA	chem
【GOLD_R】
【PRE_R】

Plasma CCK and pancreatic polypeptide ( PP ) were measured by a specific RIA .
【GOLD_E】
CCK	geneY
pancreaticpolypeptide	geneY
PP	geneY
【PRE_E】
CCK	geneY
pancreaticpolypeptide	geneY
PP	geneN
【GOLD_R】
【PRE_R】

Lintitript distinctly accelerated gastric emptying of solids , while gastric emptying of liquids was not significantly altered .
【GOLD_E】
Lintitript	chem
【PRE_E】
【GOLD_R】
【PRE_R】

The lag period was shortened by 20 % ( P < 0.05 ) , AUC and half emptying time of solid emptying were lowered by 12 % and 13 % , respectively ( P < 0.03 ) .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Lintitript markedly increased postprandial plasma CCK release ( P < 0.001 ) while distinctly reducing postprandial PP levels ( P < 0.01 ) as compared to placebo .
【GOLD_E】
PP	geneY
Lintitript	chem
CCK	geneY
【PRE_E】
Lintitript	chem
CCK	geneY
【GOLD_R】
Lintitript	CCK	C3
Lintitript	PP	C4
【PRE_R】
Lintitript	CCK	C3

These data provide further evidence for a significant role of CCK in the regulation of gastric emptying of solids .
【GOLD_E】
CCK	geneY
【PRE_E】
CCK	geneY
【GOLD_R】
【PRE_R】

The study demonstrates for the first time the marked gastrokinetic properties of the new CCK - A receptor antagonist lintitript in humans .
【GOLD_E】
CCK-Areceptor	geneY
lintitript	chem
【PRE_E】
gastrokinetic	chem
CCK-A	geneY
【GOLD_R】
lintitript	CCK-Areceptor	C6
【PRE_R】

Beta - adrenoceptor - mediated inhibition of IFN - gamma , IL - 3 , and GM - CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2 - adrenoceptor subtype .
【GOLD_E】
Beta-adrenoceptor	geneN
beta2-adrenoceptor	geneY
IFN-gamma	geneY
IL-3	geneY
GM-CSF	geneY
【PRE_E】
Beta-adrenoceptor	geneY
IFN-gamma	geneY
IL-3	geneY
GM-CSF	geneY
beta2-adrenoceptor	geneY
【GOLD_R】
【PRE_R】

Cytokine gene expression in T lymphocytes is a strictly regulated process , involving both stimulatory and inhibitory signals . beta - Adrenoceptor ( betaAR ) agonists are widely used in the treatment of asthma and are able to induce an inhibitory signal on immunological responses after binding to their specific receptors .
【GOLD_E】
Cytokine	geneN
beta-Adrenoceptor	geneN
betaAR	geneN
【PRE_E】
Cytokine	geneN
beta-Adrenoceptor	geneN
betaAR	geneN
【GOLD_R】
【PRE_R】

In this study , the characterization of betaAR subtype ( s ) ( beta1 , beta2 , and beta3 ) involved in the regulation of interleukin ( IL ) - 3 , IL - 4 , granulocyte - macrophage colony - stimulating factor ( GM - CSF ) , and interferon - gamma ( IFN - gamma ) mRNA accumulation was studied by using various betaAR agonists and antagonists .
【GOLD_E】
betaAR	geneN
interleukin(IL)-3	geneY
IL-4	geneY
granulocyte-macrophagecolony-stimulatingfactor	geneY
GM-CSF	geneY
interferon-gamma	geneY
IFN-gamma	geneY
betaAR	geneN
【PRE_E】
betaARsubtype(s)	geneY
interleukin(IL)-3	geneY
IL-4	geneY
granulocyte-macrophagecolony-stimulatingfactor	geneY
GM-CSF	geneY
interferon-gamma	geneY
IFN-gamma	geneY
betaAR	geneN
【GOLD_R】
【PRE_R】

Concanavalin A ( Con A ) - induced IFN - gamma , GM - CSF , and IL - 3 mRNAs are dose - dependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol .
【GOLD_E】
ConcanavalinA	geneN
ConA	geneN
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
betaAR	geneN
beta2AR	geneY
isoproterenol	chem
fenoterol	chem
【PRE_E】
ConcanavalinA	geneY
ConA	geneY
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
betaAR	geneY
isoproterenol	chem
beta2AR	geneY
fenoterol	chem
【GOLD_R】
isoproterenol	IFN-gamma	C4
isoproterenol	GM-CSF	C4
isoproterenol	IL-3	C4
fenoterol	IFN-gamma	C4
fenoterol	GM-CSF	C4
fenoterol	IL-3	C4
isoproterenol	betaAR	C5
fenoterol	beta2AR	C5
【PRE_R】
betaAR	isoproterenol	C6
isoproterenol	beta2AR	C6

IL - 4 mRNA accumulation was not susceptible to betaAR stimulation .
【GOLD_E】
IL-4	geneY
betaAR	geneN
【PRE_E】
IL-4	geneY
betaAR	geneN
【GOLD_R】
【PRE_R】

The observed inhibition on IFN - gamma , GM - CSF , and IL - 3 mRNA was blocked by the selective beta2AR antagonist ICI 118,551 ( 10 ( - 6 ) M ) and by timolol ( 10 ( - 6 ) M ) , a nonselective antagonist .
【GOLD_E】
ICI118,551	chem
timolol	chem
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
beta2AR	geneY
【PRE_E】
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
beta2AR	geneY
ICI118,551	chem
timolol	chem
【GOLD_R】
ICI118,551	IFN-gamma	C3
ICI118,551	GM-CSF	C3
ICI118,551	IL-3	C3
timolol	IFN-gamma	C3
timolol	GM-CSF	C3
timolol	IL-3	C3
ICI118,551	beta2AR	C6
timolol	beta2AR	C6
【PRE_R】
beta2AR	ICI118,551	C6
beta2AR	timolol	C6

The selective beta1AR antagonist atenolol ( 0.3 x 10 ( - 6 ) M ) did not have any effect .
【GOLD_E】
beta1AR	geneY
atenolol	chem
【PRE_E】
beta1AR	geneY
atenolol	chem
【GOLD_R】
atenolol	beta1AR	C6
【PRE_R】
beta1AR	atenolol	C6

Secretion of GM - CSF protein in the presence of increasing concentrations of isoproterenol followed a similar pattern as observed for GM - CSF mRNA .
【GOLD_E】
GM-CSF	geneY
GM-CSF	geneY
isoproterenol	chem
【PRE_E】
GM-CSF	geneY
isoproterenol	chem
GM-CSF	geneY
【GOLD_R】
isoproterenol	GM-CSF	C3
isoproterenol	GM-CSF	C3
【PRE_R】
GM-CSF	isoproterenol	C3

In addition , the betaAR - mediated inhibition of IFN - gamma , GM - CSF , and IL - 3 mRNA accumulation and GM - CSF protein secretion were related to the accumulation of intracellular cyclic adenosine monophosphate ( cAMP ) levels .
【GOLD_E】
betaAR	geneN
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
GM-CSF	geneY
cyclicadenosinemonophosphate	chem
cAMP	chem
【PRE_E】
betaAR	geneN
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
GM-CSF	geneY
cyclicadenosinemonophosphate	chem
cAMP	chem
【GOLD_R】
【PRE_R】

Although beta3AR mRNA was detectable in Con A - activated T lymphocytes , we could not demonstrate a functional activity in the regulation of cytokine expression : the beta3AR agonist BRL 37344 had no effect on the accumulation of the studied cytokine mRNAs , and did not significantly affect cellular cAMP levels .
【GOLD_E】
beta3AR	geneY
ConA	geneN
cytokine	geneN
beta3AR	geneY
cytokine	geneN
BRL37344	chem
cAMP	chem
【PRE_E】
beta3AR	geneY
ConA-activatedT	geneN
cytokine	geneN
beta3AR	geneY
BRL37344	chem
cytokine	geneN
cAMP	chem
【GOLD_R】
BRL37344	beta3AR	C5
【PRE_R】

These data demonstrate that beta - agonist - induced inhibition of IFN - gamma , GM - CSF , and IL - 3 mRNA accumulation is solely mediated by beta2 - adrenoceptors .
【GOLD_E】
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
beta2-adrenoceptors	geneY
【PRE_E】
IFN-gamma	geneY
GM-CSF	geneY
IL-3	geneY
beta2-adrenoceptors	geneN
【GOLD_R】
【PRE_R】

Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation .
【GOLD_E】
Oxytocin	chem
carbetocin	chem
Oxytocinreceptor	geneY
【PRE_E】
Oxytocinreceptor	geneY
carbetocin	chem
【GOLD_R】
【PRE_R】

Metabolites of the analogue 1 - deamino - 1 - carba - 2 - tyrosine ( O - methyl ) - oxytocin ( carbetocin ) following incubation with a rat kidney homogenate were isolated and their pharmacodynamic properties investigated .
【GOLD_E】
1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin	chem
carbetocin	chem
oxytocin	geneY
【PRE_E】
1-deamino-1-carba-2-tyrosine	chem
O-methyl)-oxytocin	chem
carbetocin	chem
【GOLD_R】
【PRE_R】

Apart from the parent compound two metabolites were identified namely desGlyNH2 - carbetocin ( carbetocin metabolite I ) and desLeuGlyNH2 - carbetocin ( carbetocin metabolite II ) .
【GOLD_E】
desGlyNH2	chem
carbetocin	chem
carbetocin	chem
desLeuGlyNH2	chem
carbetocin	chem
carbetocin	chem
【PRE_E】
desGlyNH2-carbetocin	chem
carbetocin	chem
desLeuGlyNH2-carbetocin	chem
carbetocin	chem
【GOLD_R】
【PRE_R】

Both carbetocin , carbetocin metabolite I and carbetocin metabolite II displayed binding affinities to the myometrial oxytocin receptor of a similar magnitude as oxytocin .
【GOLD_E】
carbetocin	chem
carbetocin	chem
carbetocin	chem
oxytocin	chem
oxytocin	chem
oxytocinreceptor	geneY
oxytocin	geneY
【PRE_E】
carbetocin	chem
carbetocin	chem
carbetocin	chem
oxytocinreceptor	geneY
oxytocin	geneY
【GOLD_R】
【PRE_R】

Carbetocin was found to have agonistic properties on isolated myometrial strips and it was found to exert this effect through generation of inositol phosphates , as is the case for oxytocin .
【GOLD_E】
Carbetocin	chem
inositolphosphates	chem
oxytocin	chem
oxytocin	geneY
【PRE_E】
Carbetocin	chem
inositolphosphates	chem
oxytocin	geneY
【GOLD_R】
【PRE_R】

However , maximal contractile effect of carbetocin was approximately 50 % lower than that of oxytocin ( 2.70 + / - 0.12 g compared to 5.22 + / - 0.26 g ) and EC50 was approximately ten times higher ( 48.0 + / - 8.20 nM compared to 5.62 + / - 1.22 nM ) .
【GOLD_E】
carbetocin	chem
oxytocin	chem
oxytocin	geneY
【PRE_E】
carbetocin	chem
oxytocin	geneY
【GOLD_R】
【PRE_R】

Neither carbetocin metabolite I nor carbetocin metabolite II were able to contract isolated myometrial tissue .
【GOLD_E】
carbetocin	chem
carbetocin	chem
【PRE_E】
carbetocin	chem
carbetocin	chem
【GOLD_R】
【PRE_R】

All three compounds displayed antagonistic properties against oxytocin in vitro , with carbetocin being the strongest inhibitor ( pA2 = 8.21 ) and carbetocin metabolite II ( pA2 = 8.01 ) being stronger than carbetocin metabolite I ( pA2 = 7.81 ) .
【GOLD_E】
oxytocin	chem
oxytocin	geneY
carbetocin	chem
carbetocin	chem
carbetocin	chem
【PRE_E】
oxytocin	geneY
carbetocin	chem
carbetocin	chem
carbetocin	chem
【GOLD_R】
carbetocin	oxytocin	C4
carbetocin	oxytocin	C4
carbetocin	oxytocin	C4
【PRE_R】
oxytocin	carbetocin	C4

These results indicate that carbetocin is a partial agonist / antagonist to the oxytocin receptor while the two metabolites carbetocin metabolite I and carbetocin metabolite II are pure antagonists .
【GOLD_E】
oxytocinreceptor	geneY
carbetocin	chem
oxytocin	chem
carbetocin	chem
carbetocin	chem
【PRE_E】
carbetocin	chem
oxytocinreceptor	geneY
carbetocin	chem
carbetocin	chem
【GOLD_R】
carbetocin	oxytocinreceptor	C5
carbetocin	oxytocinreceptor	C6
carbetocin	oxytocinreceptor	C6
carbetocin	oxytocinreceptor	C6
【PRE_R】

All three analogues bound to the myometrial vasopressin V1 receptor , albeit with much lower affinities than to the oxytocin receptor .
【GOLD_E】
vasopressin	chem
oxytocin	chem
vasopressinV1receptor	geneN
oxytocinreceptor	geneY
【PRE_E】
vasopressinV1receptor	geneY
oxytocinreceptor	geneY
【GOLD_R】
【PRE_R】

Carbetocin metabolite II showed the weakest binding affinity of 33.7 + / - 7.34 nM compared to 7.24 + / - 0.29 nM for carbetocin and 9.89 + 2.80 nM for carbetocin metabolite I .
【GOLD_E】
Carbetocin	chem
carbetocin	chem
carbetocin	chem
【PRE_E】
Carbetocin	chem
carbetocin	chem
carbetocin	chem
【GOLD_R】
【PRE_R】

Only carbetocin bound to the renal vasopressin V2 receptor though the binding affinity was very low ( 61.3 + / - 14.6 nM ) .
【GOLD_E】
carbetocin	chem
vasopressin	chem
vasopressinV2receptor	geneY
【PRE_E】
carbetocin	chem
vasopressinV2receptor	geneY
【GOLD_R】
【PRE_R】

Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution .
【GOLD_E】
phenylalanine	chem
catechol	chem
humanphenylalaninehydroxylasecatalyticdomain	geneN
【PRE_E】
humanphenylalaninehydroxylasecatalyticdomain	geneN
catechol	chem
【GOLD_R】
catechol	humanphenylalaninehydroxylasecatalyticdomain	C4
【PRE_R】

The aromatic amino acid hydroxylases represent a superfamily of structurally and functionally closely related enzymes , one of those functions being reversible inhibition by catechol derivatives .
【GOLD_E】
aromaticaminoacid	chem
aromaticaminoacidhydroxylases	geneN
catechol	chem
【PRE_E】
aromaticaminoacidhydroxylases	geneN
catechol	chem
【GOLD_R】
catechol	aromaticaminoacidhydroxylases	C4
【PRE_R】

Here we present the crystal structure of the dimeric catalytic domain ( residues 117 - 424 ) of human phenylalanine hydroxylase ( hPheOH ) , cocrystallized with various potent and well - known catechol inhibitors and refined at a resolution of 2.0 A .
【GOLD_E】
humanphenylalaninehydroxylase	geneY
hPheOH	geneY
phenylalanine	chem
catechol	chem
【PRE_E】
humanphenylalaninehydroxylase	geneY
hPheOH	geneN
catechol	chem
【GOLD_R】
catechol	humanphenylalaninehydroxylase	C4
catechol	hPheOH	C4
【PRE_R】

The catechols bind by bidentate coordination to each iron in both subunits of the dimer through the catechol hydroxyl groups , forming a blue - green colored ligand - to - metal charge - transfer complex .
【GOLD_E】
catechols	chem
iron	chem
catecholhydroxyl	chem
【PRE_E】
catechols	chem
bidentate	chem
iron	chem
catecholhydroxyl	chem
blue	chem
【GOLD_R】
【PRE_R】

In addition , Glu330 and Tyr325 are identified as determinant residues in the recognition of the inhibitors .
【GOLD_E】
【PRE_E】
Glu330	geneN
Tyr325	geneN
【GOLD_R】
【PRE_R】

In particular , the interaction with Glu330 conforms to the structural explanation for the pH dependence of catecholamine binding to PheOH , with a pKa value of 5.1 ( 20 degreesC ) .
【GOLD_E】
catecholamine	chem
PheOH	chem
【PRE_E】
Glu330	geneN
catecholamine	chem
PheOH	geneN
【GOLD_R】
【PRE_R】

The overall structure of the catechol - bound enzyme is very similar to that of the uncomplexed enzyme ( rms difference of 0.2 A for the Calpha atoms ) .
【GOLD_E】
catechol	chem
【PRE_E】
catechol	chem
Calpha	geneN
【GOLD_R】
【PRE_R】

Most striking is the replacement of two iron - bound water molecules with catechol hydroxyl groups .
【GOLD_E】
catecholhydroxyl	chem
【PRE_E】
iron	chem
catecholhydroxyl	chem
【GOLD_R】
【PRE_R】

This change is consistent with a change in the ligand field symmetry of the high - spin ( S = 5 / 2 ) Fe ( III ) from a rhombic to a nearly axial ligand field symmetry as seen upon noradrenaline binding using EPR spectroscopy [ Martinez , A. , Andersson , K .
【GOLD_E】
noradrenaline	chem
【PRE_E】
Fe(III)	chem
noradrenaline	chem
【GOLD_R】
【PRE_R】

K. , Haavik , J. , and Flatmark , T .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

( 1991 ) Eur .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

J .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Biochem .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

198 , 675 - 682 ] .
【GOLD_E】
【PRE_E】
675-682	chem
【GOLD_R】
【PRE_R】

Crystallographic comparison with the structurally related rat tyrosine hydroxylase binary complex with the oxidized cofactor 7,8 - dihydrobiopterin revealed overlapping binding sites for the catechols and the cofactor , compatible with a competitive type of inhibition of the catechols versus BH4 .
【GOLD_E】
rattyrosinehydroxylase	geneY
tyrosine	chem
7,8-dihydrobiopterin	chem
catechols	chem
catechols	chem
【PRE_E】
rattyrosinehydroxylase	geneY
7,8-dihydrobiopterin	chem
catechols	chem
catechols	chem
BH4	chem
【GOLD_R】
catechols	rattyrosinehydroxylase	C4
【PRE_R】

The comparison demonstrates some structural differences at the active site as the potential basis for the different substrate specificity of the two enzymes .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Various glucocorticoids differ in their ability to induce gene expression , apoptosis and to repress NF - kappaB - dependent transcription .
【GOLD_E】
NF-kappaB	geneN
【PRE_E】
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

Glucocorticoids ( GCs ) influence a great variety of cellular functions by at least three important modes of action : the activation ( or repression ) of genes controlled by binding sites for the glucocorticoid receptor ( GR ) , the induction of apoptosis in lymphocytes and the recently discovered cross - talk to other transcription factors such as NF - kappaB .
【GOLD_E】
GR	geneY
NF-kappaB	geneN
glucocorticoidreceptor	geneY
【PRE_E】
glucocorticoidreceptor	geneY
GR	geneY
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

In this study we systematically compared various natural and synthetic steroid hormones frequently used as therapeutic agents on their ability to mediate these three modes of action .
【GOLD_E】
steroid	chem
【PRE_E】
steroid	chem
【GOLD_R】
【PRE_R】

Betamethasone , triamcinolone , dexamethasone and clobetasol turned out to be the best inducers of gene expression and apoptosis .
【GOLD_E】
Betamethasone	chem
triamcinolone	chem
dexamethasone	chem
clobetasol	chem
【PRE_E】
Betamethasone	chem
triamcinolone	chem
dexamethasone	chem
clobetasol	chem
【GOLD_R】
【PRE_R】

All GCs including the antagonistic compound RU486 efficiently reduced NF - kappaB - mediated transactivation to comparable extents , suggesting that ligand - induced nuclear localization of the GR is sufficient for transrepression .
【GOLD_E】
NF-kappaB	geneN
GR	geneY
RU486	chem
【PRE_E】
RU486	chem
NF-kappaB	geneN
GR	geneY
【GOLD_R】
RU486	NF-kappaB	C4
【PRE_R】
RU486	NF-kappaB	C4

Glucocorticoid treatment of cells did not result in elevated IkappaB - alpha expression , but impaired the tumor necrosis factor ( TNF ) - alpha - induced degradation of IkappaB - alpha without affecting DNA binding of NF - kappaB .
【GOLD_E】
IkappaB-alpha	geneY
tumornecrosisfactor(TNF)-alpha	geneY
IkappaB-alpha	geneY
NF-kappaB	geneN
【PRE_E】
Glucocorticoid	geneY
IkappaB-alpha	geneY
tumornecrosisfactor(TNF)-alpha	geneY
IkappaB-alpha	geneY
NF-kappaB	geneN
【GOLD_R】
【PRE_R】

The structural requirements for the various functions of glucocorticoids are discussed .
【GOLD_E】
【PRE_E】
【GOLD_R】
【PRE_R】

Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide .
【GOLD_E】
ATP	chem
MgADP	chem
sulfonylurea	chem
glibenclamide	chem
sulfonylureareceptor	geneN
【PRE_E】
ATP	chem
MgADP	geneN
sulfonylureareceptor	geneN
glibenclamide	chem
【GOLD_R】
【PRE_R】

The ATP - sensitive potassium ( KATP ) channels in pancreatic beta cells are critical in the regulation of glucose - induced insulin secretion .
【GOLD_E】
potassium	chem
ATP	chem
glucose	chem
insulin	geneY
ATP-sensitivepotassium(KATP)channels	geneN
【PRE_E】
ATP-sensitivepotassium(KATP)channels	geneN
glucose	chem
insulin	geneN
【GOLD_R】
glucose	insulin	C3
【PRE_R】
glucose	insulin	C3

Although electrophysiological studies provide clues to the complex control of KATP channels by ATP , MgADP , and pharmacological agents , the molecular mechanism of KATP - channel regulation remains unclear .
【GOLD_E】
ATP	chem
MgADP	chem
KATPchannels	geneN
KATP-channel	geneN
【PRE_E】
KATPchannels	geneN
ATP	chem
MgADP	chem
KATP-channel	geneN
【GOLD_R】
【PRE_R】

The KATP channel is a heterooligomeric complex of SUR1 subunits of the ATP - binding - cassette superfamily with two nucleotide - binding folds ( NBF1 and NBF2 ) and the pore - forming Kir6.2 subunits .
【GOLD_E】
ATP	chem
nucleotide	chem
KATPchannel	geneN
SUR1	geneY
nucleotide-bindingfolds	geneN
NBF1	geneN
NBF2	geneN
Kir6.2	geneY
【PRE_E】
KATPchannel	geneN
SUR1	geneY
ATP-binding-cassettesuperfamily	geneN
nucleotide-bindingfolds	geneN
NBF1	geneN
NBF2	geneN
Kir6.2	geneY
【GOLD_R】
【PRE_R】

Here , we report that MgATP and MgADP , but not the Mg salt of gamma - thio - ATP , stabilize the binding of prebound 8 - azido - [ alpha - 32P ] ATP to SUR1 .
【GOLD_E】
MgATP	chem
MgADP	chem
Mg	chem
gamma-thio-ATP	chem
8-azido-[alpha-32P]ATP	chem
SUR1	geneY
【PRE_E】
MgATP	geneN
MgADP	geneN
gamma-thio-ATP	chem
8-azido-[alpha-32P]ATP	chem
SUR1	geneY
【GOLD_R】
【PRE_R】
MgADP	gamma-thio-ATP	C9
MgADP	8-azido-[alpha-32P]ATP	C9

Mutation in the Walker A and B motifs of NBF2 of SUR1 abolished this stabilizing effect of MgADP .
【GOLD_E】
MgADP	chem
WalkerAandBmotifs	geneN
NBF2	geneN
SUR1	geneY
【PRE_E】
WalkerAandB	geneN
NBF2	geneN
SUR1	geneY
MgADP	geneN
【GOLD_R】
【PRE_R】

These results suggest that SUR1 binds 8 - azido - ATP strongly at NBF1 and that MgADP , either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2 , stabilizes prebound 8 - azido - ATP binding at NBF1 .
【GOLD_E】
8-azido-ATP	chem
MgADP	chem
MgATP	chem
8-azido-ATP	chem
SUR1	geneY
NBF1	geneN
NBF2	geneN
NBF2	geneN
NBF1	geneN
【PRE_E】
SUR1	geneY
8-azido-ATP	chem
NBF1	geneY
MgADP	geneN
NBF2	geneN
MgATP	geneN
NBF2	geneN
8-azido-ATP	chem
NBF1	geneN
【GOLD_R】
MgATP	NBF2	C9
【PRE_R】

The sulfonylurea glibenclamide caused release of prebound 8 - azido - [ alpha - 32P ]tive binding of ATP and MgADP and , in cooperation with the MgADP bound at NBF2 , causes ATP to be released from NBF1 .
【GOLD_E】
ATP	chem
NBFs	geneN
SUR1	geneY
NBF2	geneN
NBF1	geneN
nucleotide	chem
glibenclamide	chem
ATP	chem
MgADP	chem
MgADP	chem
【PRE_E】
nucleotide	chem
NBFs	geneN
SUR1	geneY
glibenclamide	chem
ATP	chem
MgADP	chem
MgADP	geneN
NBF2	geneN
ATP	chem
NBF1	geneN
【GOLD_R】
【PRE_R】

action in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this coopera                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 to be released from NBF1 .
【GOLD_E】 
ATP	chem
NBFs	geneN
SUR1	geneY
NBF2	geneN
NBF1	geneN
nucleotide	chem
glibenclamide	chem
ATP	chem
MgADP	chem
MgADP	chem
【PRE_E】 
nucleotide	chem
NBFs	geneN
SUR1	geneY
glibenclamide	chem
ATP	chem
MgADP	chem
MgADP	geneN
NBF2	geneN
ATP	chem
NBF1	geneN
【GOLD_R】 
【PRE_R】 

